Citrus Sinensis ID: 041632

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450--
Protein Sequence
MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD
Secondary Structure (PSIPRED)
cccccccccccHHHHcHHHcccHHccccccccccccHHccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHcccccccccccccccccccccccccccccHHHccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHHccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHcccccccccEEEEcccccccccEEEEEEEccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccEEEcccHHHHccccccccccEEcccccccEEEccccccccccccccccccHHHHHHHHHHHcccccc
Secondary Structure Prediction (SSPRO)
cccccccccccHHHccHHHHHHHEEcccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEcccccccccccHHHccccEEEEEEcccccccccccccccccccHHHHcccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEcHHHHHHHHccccHHcEEEcccccEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHEEcccccccccccEEEEEEccccccHHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEEcccccccccEEEEEEEEEEccccHHHcccccccccccHHHHHHHHHHHHccccccc
Coil and Loop (DISEMBL)
mfendlsgtipeAIFSISYLSnslnlaenhfvgsipprignlkalrsfdvsnnglsgeipielglcsslediylggnffhgsipsffrtsrgirkldlsrnnlsgqIPLFLEALSLEYLNLsfndfegkvptkgifantSAISVAGCHrlcggipelqlpkctenkssnqRISRSLKILISIVSIFLGIVMVSFFIFSwhkrsrpsrqpsepMIRKALLKMSYKSLLkatdgfsstnligvgsfgsvykgvfdedgTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCssvdfqgnDFKAIVYkympngslekwlhpdaipqrDREIEIQKLTLLQRISIAIDVASALDYLHqhcqepilhcdlkpsnilldndlsahigdfglsrfyqavsnptvsssigvrgtigyvapeyglgsevstngdvYSYGILLLEMVTTKKPTD
Flexible Loop (DISEMBL)
mfendlsgtiPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWhkrsrpsrqpsePMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITScssvdfqgNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNptvsssigvrGTIGYVAPEYGLGSEVSTNGDVYSYGILLlemvttkkptd
Low Complexity Region (SEG)
MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQrisrslkilisivsiFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD
Disordered region (IsUnstruct)
*********IPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKC*********ISRSLKILISIVSIFLGIVMVSFFIFSWH****************ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT******
Disordered Region (DISOPRED)
MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIP**********************ILISIVSIFLGIVMVSFFIFS********************LKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAI**********KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY*************VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP**
Disordered Region (DISEMBL)
MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWH***********PMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD
Disordered Region (DISPRO)
**ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWHKRSR*****SEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA********EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	452	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.986	0.441	0.494	1e-125
C0LGT6	1031	LRR receptor-like serine/	no	no	0.984	0.431	0.472	1e-113
Q9SD62	1025	Putative receptor-like pr	no	no	0.984	0.434	0.494	1e-107
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.949	0.437	0.387	4e-77
Q9FL28	1173	LRR receptor-like serine/	no	no	0.957	0.369	0.353	4e-67
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.964	0.349	0.350	9e-66
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.929	0.352	0.355	9e-66
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.960	0.346	0.343	2e-64
P47735	999	Receptor-like protein kin	no	no	0.933	0.422	0.367	3e-58
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.935	0.383	0.327	9e-58

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  448 bits (1153), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 228/461 (49%), Positives = 319/461 (69%), Gaps = 15/461 (3%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N L+GTIP  I  I  L   L+++ N  +GS+P  IG L+ L +  + +N LSG++P  
Sbjct: 466 DNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQT 524

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNL 121
           LG C ++E ++L GN F+G IP   +   G++++DLS N+LSG IP +  + S LEYLNL
Sbjct: 525 LGNCLTMESLFLEGNLFYGDIPDL-KGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNL 583

Query: 122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSS--NQRISRSLKIL 179
           SFN+ EGKVP KGIF N + +S+ G + LCGGI   QL  C     S   +  SR  K++
Sbjct: 584 SFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVV 643

Query: 180 ISI---VSIFLGIVMVSFFIFSWHKR--SRPSRQPSEPMIRKALLKMSYKSLLKATDGFS 234
           I +   +++ L + M S  +    KR  ++ +  P+   +     K+SY  L  AT+GFS
Sbjct: 644 IGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFS 703

Query: 235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           S+N++G GSFG+VYK +   +  VVA+KV+N+QR+GA KSFMAEC++LK+IRH+NLV+++
Sbjct: 704 SSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLL 763

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
           T+CSS+DFQGN+F+A++Y++MPNGSL+ WLHP+ + +  R    + LTLL+R++IAIDVA
Sbjct: 764 TACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHR--PSRTLTLLERLNIAIDVA 821

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV---SSSIGV 411
           S LDYLH HC EPI HCDLKPSN+LLD+DL+AH+ DFGL+R        +     SS GV
Sbjct: 822 SVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGV 881

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           RGTIGY APEYG+G + S NGDVYS+GILLLEM T K+PT+
Sbjct: 882 RGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTN 922

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  407 bits (1047), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 221/468 (47%), Positives = 304/468 (64%), Gaps = 23/468 (4%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           M  N L+GTIP+ I  I  L+  ++L+ N   G  P  +G L+ L     S N LSG++P
Sbjct: 472 MDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMP 530

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
             +G C S+E +++ GN F G+IP   R    ++ +D S NNLSG+IP +L +L SL  L
Sbjct: 531 QAIGGCLSMEFLFMQGNSFDGAIPDISRLV-SLKNVDFSNNNLSGRIPRYLASLPSLRNL 589

Query: 120 NLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLK-- 177
           NLS N FEG+VPT G+F N +A+SV G   +CGG+ E+QL  C    S  +R   S++  
Sbjct: 590 NLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKK 649

Query: 178 ----ILISIVSIFLGIVMVSFFIFSWHKRSR------PSRQPSEPMIRKALLKMSYKSLL 227
               I I I S+ L I++ S   F   K+        PS   +  M  +   K+SY+ L 
Sbjct: 650 VVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHE---KVSYEELH 706

Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRH 287
            AT  FSSTNLIG G+FG+V+KG+   +  +VA+KV+NL + GA+KSFMAEC+  K IRH
Sbjct: 707 SATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           +NLV++IT CSS+D +GNDF+A+VY++MP GSL+ WL  + + + +     + LT  +++
Sbjct: 767 RNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVND--HSRSLTPAEKL 824

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF---YQAVSNPT 404
           +IAIDVASAL+YLH HC +P+ HCD+KPSNILLD+DL+AH+ DFGL++    Y   S   
Sbjct: 825 NIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLN 884

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             SS GVRGTIGY APEYG+G + S  GDVYS+GILLLEM + KKPTD
Sbjct: 885 QFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTD 932

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  387 bits (995), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 228/461 (49%), Positives = 299/461 (64%), Gaps = 16/461 (3%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L+G+IP  +  +  L   LN++ N  VG +   IG LK L + DVS N LSG+IP  L
Sbjct: 483 NKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTL 541

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLS 122
             C SLE + L GN F G IP   R   G+R LDLS+NNLSG IP ++   S L+ LNLS
Sbjct: 542 ANCLSLEFLLLQGNSFVGPIPDI-RGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLS 600

Query: 123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCT-ENKSSNQRISRSLKILIS 181
            N+F+G VPT+G+F NTSA+SV G   LCGGIP LQL  C+ E    +  + + + I +S
Sbjct: 601 LNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVS 660

Query: 182 IVSIFLGIVMVSFFIFSWHK-RSRPSR------QPSEPMIRKALLKMSYKSLLKATDGFS 234
            V   L ++ +      W+K R +  R        S   ++    K+SY  L K T GFS
Sbjct: 661 AVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFS 720

Query: 235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           S+NLIG G+FG+V+KG        VAIKV+NL ++GA+KSF+AEC+AL  IRH+NLV+++
Sbjct: 721 SSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLV 780

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
           T CSS DF+GNDF+A+VY++MPNG+L+ WLHPD I +       + L L  R++IAIDVA
Sbjct: 781 TICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGN--PSRTLGLFARLNIAIDVA 838

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS---SSIGV 411
           SAL YLH +C  PI HCD+KPSNILLD DL+AH+ DFGL++        T     SS GV
Sbjct: 839 SALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGV 898

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           RGTIGY APEYG+G   S  GDVYS+GI+LLE+ T K+PT+
Sbjct: 899 RGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTN 939

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  288 bits (738), Expect = 4e-77,   Method: Compositional matrix adjust.
 Identities = 183/472 (38%), Positives = 269/472 (56%), Gaps = 43/472 (9%)

Query: 3   ENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
            N+L+GTIP E + ++  L   LNL+ NH  G IP  +  +  + S D+S+N LSG+IP 
Sbjct: 426 HNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPP 485

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQI-PLFLEALSLEYLN 120
           +LG C +LE + L  N F  ++PS       +++LD+S N L+G I P F ++ +L++LN
Sbjct: 486 QLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLN 545

Query: 121 LSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILI 180
            SFN   G V  KG F+  +  S  G   LCG I  +Q  K      S         I  
Sbjct: 546 FSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIAT 605

Query: 181 SIVSIF-LGIVMVSFF-----IFSWHKRSRPSRQ----PSEPMIRKALLKMSYKSLLKAT 230
            ++ +F   +V  S F     +++  +     +Q    P  P       ++SY+ L+ AT
Sbjct: 606 PVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP-------RISYQQLIAAT 658

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKN 289
            GF++++LIG G FG VYKGV   + T VA+KV++ +     S SF  EC+ LK  RH+N
Sbjct: 659 GGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRN 717

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L+R+IT+CS   F      A+V   MPNGSLE+ L+P        E   + L L+Q ++I
Sbjct: 718 LIRIITTCSKPGFN-----ALVLPLMPNGSLERHLYPG-------EYSSKNLDLIQLVNI 765

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             DVA  + YLH +    ++HCDLKPSNILLD++++A + DFG+SR  Q V   TVS+  
Sbjct: 766 CSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEE-TVSTDD 824

Query: 410 GVR---------GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            V          G++GY+APEYG+G   ST+GDVYS+G+LLLE+V+ ++PTD
Sbjct: 825 SVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTD 876

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  255 bits (652), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 172/486 (35%), Positives = 262/486 (53%), Gaps = 53/486 (10%)

Query: 3    ENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
            +N L+GTIP E + S+  +   LN + N   G+IP  +G L+ ++  D+SNN  SG IP 
Sbjct: 608  DNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPR 667

Query: 62   ELGLCSSL---------------EDIYLG----------GNFFHGSIPSFFRTSRGIRKL 96
             L  C ++               ++++ G           N F G IP  F     +  L
Sbjct: 668  SLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSL 727

Query: 97   DLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIP 155
            DLS NNL+G+IP  L  LS L++L L+ N+ +G VP  G+F N +A  + G   LCG   
Sbjct: 728  DLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK 787

Query: 156  ELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFF-----IFSWHKRSRPSRQPS 210
             L+   CT  + S+    R+  ILI + S    ++++             K+   S + S
Sbjct: 788  PLK--PCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESS 845

Query: 211  EPMIRKALL--KMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR 268
             P +  AL   +   K L +ATD F+S N+IG  S  +VYKG   EDGTV+A+KV+NL+ 
Sbjct: 846  LPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKE 904

Query: 269  QGAS--KSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP 326
              A   K F  E K L  ++H+NLV+++       ++    KA+V  +M NG+LE  +H 
Sbjct: 905  FSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHG 960

Query: 327  DAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA 386
             A P           +LL++I + + +AS +DYLH     PI+HCDLKP+NILLD+D  A
Sbjct: 961  SAAPIG---------SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVA 1011

Query: 387  HIGDFGLSRFYQAVSN-PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
            H+ DFG +R      +  T +S+    GTIGY+APE+    +V+T  DV+S+GI+++E++
Sbjct: 1012 HVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELM 1071

Query: 446  TTKKPT 451
            T ++PT
Sbjct: 1072 TKQRPT 1077

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  251 bits (641), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 166/473 (35%), Positives = 256/473 (54%), Gaps = 37/473 (7%)

Query: 4    NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            N L+G+IP+ I ++  L N LNL +N F GS+P  +G L  L    +S N L+GEIP+E+
Sbjct: 705  NSLNGSIPQEIGNLGAL-NVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEI 763

Query: 64   GLCSSLED-IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFL-EALSLEYLNL 121
            G    L+  + L  N F G IPS   T   +  LDLS N L+G++P  + +  SL YLN+
Sbjct: 764  GQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNV 823

Query: 122  SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLK--IL 179
            SFN+  GK+  K  F+   A S  G   LCG      L +C   +S+N++   S +  ++
Sbjct: 824  SFNNLGGKL--KKQFSRWPADSFLGNTGLCGS----PLSRCNRVRSNNKQQGLSARSVVI 877

Query: 180  ISIVS----IFLGIVMVSFFIFSWHK--------------RSRPSRQPSEPMIRKALLK- 220
            IS +S    I L I++++ F    H                S  S+   +P+ R    K 
Sbjct: 878  ISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKS 937

Query: 221  -MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAEC 279
             + ++ +++AT   S   +IG G  G VYK   +   TV   K++      ++KSF  E 
Sbjct: 938  DIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREV 997

Query: 280  KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
            K L  IRH++LV+++  CSS   +      ++Y+YM NGS+  WLH D  P  +++ ++ 
Sbjct: 998  KTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDK-PVLEKKKKL- 1052

Query: 340  KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             L    R+ IA+ +A  ++YLH  C  PI+H D+K SN+LLD+++ AH+GDFGL++    
Sbjct: 1053 -LDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTE 1111

Query: 400  VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              +    S+     + GY+APEY    + +   DVYS GI+L+E+VT K PTD
Sbjct: 1112 NCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTD 1164

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  251 bits (641), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 173/486 (35%), Positives = 252/486 (51%), Gaps = 66/486 (13%)

Query: 4    NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            N L+G IPE+   +  L   LNL +N   G +P  +GNLK L   D+S N LSGE+  EL
Sbjct: 662  NQLNGHIPESFGLLGSLV-KLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSEL 720

Query: 64   GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
                 L  +Y+  N F G IPS       +  LD+S N LSG+IP  +  L +LE+LNL+
Sbjct: 721  STMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLA 780

Query: 123  FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRS-LKILIS 181
             N+  G+VP+ G+  + S   ++G   LCG +             S+ +I  + L+    
Sbjct: 781  KNNLRGEVPSDGVCQDPSKALLSGNKELCGRV-----------VGSDCKIEGTKLRSAWG 829

Query: 182  IVSIFLGIVMVSF-FIFS---W------HKRSRPSR--------------------QPSE 211
            I  + LG  ++ F F+FS   W       +R  P R                    +  E
Sbjct: 830  IAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSRE 889

Query: 212  P------MIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN 265
            P      M  + LLK+    +++ATD FS  N+IG G FG+VYK     + TV   K+  
Sbjct: 890  PLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSE 949

Query: 266  LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH 325
             + QG ++ FMAE + L  ++H NLV ++  CS      ++ K +VY+YM NGSL+ WL 
Sbjct: 950  AKTQG-NREFMAEMETLGKVKHPNLVSLLGYCSF-----SEEKLLVYEYMVNGSLDHWL- 1002

Query: 326  PDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS 385
                  R++   ++ L   +R+ IA+  A  L +LH      I+H D+K SNILLD D  
Sbjct: 1003 ------RNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFE 1056

Query: 386  AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
              + DFGL+R   A  +  VS+ I   GT GY+ PEYG  +  +T GDVYS+G++LLE+V
Sbjct: 1057 PKVADFGLARLISACES-HVSTVIA--GTFGYIPPEYGQSARATTKGDVYSFGVILLELV 1113

Query: 446  TTKKPT 451
            T K+PT
Sbjct: 1114 TGKEPT 1119

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  246 bits (629), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 161/469 (34%), Positives = 246/469 (52%), Gaps = 35/469 (7%)

Query: 4    NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            N L+G+IP+ I ++  L N+LNL EN   G +P  IG L  L    +S N L+GEIP+E+
Sbjct: 706  NSLNGSIPQEIGNLQAL-NALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEI 764

Query: 64   GLCSSLED-IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNL 121
            G    L+  + L  N F G IPS   T   +  LDLS N L G++P  +  + SL YLNL
Sbjct: 765  GQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNL 824

Query: 122  SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQR-ISRSLKILI 180
            S+N+ EGK+  K  F+   A +  G   LCG      L  C    S NQR +S    ++I
Sbjct: 825  SYNNLEGKL--KKQFSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVVII 878

Query: 181  SIVSIFLGIVMVSFFIFSWHKRSRP---------------SRQPSEPMIRKALLK--MSY 223
            S +S    I ++   I  + K++                 S     P+      K  + +
Sbjct: 879  SAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKW 938

Query: 224  KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALK 283
              +++AT   +   +IG G  G VYK       T+   K++      ++KSF  E K L 
Sbjct: 939  DDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLG 998

Query: 284  NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
             IRH++LV+++  CSS   + +    ++Y+YM NGS+  WLH +   ++ +E+    L  
Sbjct: 999  TIRHRHLVKLMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKK-KEV----LGW 1050

Query: 344  LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
              R+ IA+ +A  ++YLH  C  PI+H D+K SN+LLD+++ AH+GDFGL++      + 
Sbjct: 1051 ETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDT 1110

Query: 404  TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
               S+    G+ GY+APEY    + +   DVYS GI+L+E+VT K PT+
Sbjct: 1111 NTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE 1159

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score =  226 bits (576), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 172/468 (36%), Positives = 240/468 (51%), Gaps = 46/468 (9%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N  SG+IP  I S++ +   ++ AEN F G IP  +  LK L   D+S N LSGEIP E
Sbjct: 460 KNRFSGSIPNEIGSLNGII-EISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRE 518

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           L    +L ++ L  N   G IP        +  LDLS N  SG+IPL L+ L L  LNLS
Sbjct: 519 LRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLS 578

Query: 123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISI 182
           +N   GK+P   ++AN         H   G  P L    C +     ++I+RS  I    
Sbjct: 579 YNHLSGKIPP--LYANKIY-----AHDFIGN-PGL----CVDLDGLCRKITRSKNI--GY 624

Query: 183 VSIFLGIVMVSFFIF-----SWHKRSRPSRQPSEPMIRKALLKMSYK---SLLKATDGFS 234
           V I L I +++  +F      +  + R  R      +  +  +  +K   S  +  D   
Sbjct: 625 VWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWRSFHKLHFSEHEIADCLD 684

Query: 235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS----------FMAECKALKN 284
             N+IG GS G VYK V    G VVA+K +N   +G              F AE + L  
Sbjct: 685 EKNVIGFGSSGKVYK-VELRGGEVVAVKKLNKSVKGGDDEYSSDSLNRDVFAAEVETLGT 743

Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           IRHK++VR+   CSS      D K +VY+YMPNGSL   LH       DR+  +  L   
Sbjct: 744 IRHKSIVRLWCCCSS-----GDCKLLVYEYMPNGSLADVLH------GDRKGGVV-LGWP 791

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
           +R+ IA+D A  L YLH  C  PI+H D+K SNILLD+D  A + DFG+++  Q   + T
Sbjct: 792 ERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKT 851

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             +  G+ G+ GY+APEY     V+   D+YS+G++LLE+VT K+PTD
Sbjct: 852 PEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTD 899

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  224 bits (572), Expect = 9e-58,   Method: Compositional matrix adjust.
 Identities = 163/497 (32%), Positives = 246/497 (49%), Gaps = 74/497 (14%)

Query: 4    NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            N L+G +P  IF+   L   L++  N+F G++P  +G+L  L    +SNN LSG IP+ L
Sbjct: 539  NKLTGEVPSEIFNCKMLQR-LDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVAL 597

Query: 64   GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIR-KLDLSRNNLSGQIPLFLEAL-------- 114
            G  S L ++ +GGN F+GSIP    +  G++  L+LS N L+G+IP  L  L        
Sbjct: 598  GNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLL 657

Query: 115  -----------------SLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPEL 157
                             SL   N S+N   G +P   +  N S  S  G   LCG  P L
Sbjct: 658  NNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCG--PPL 712

Query: 158  QLPKCTENKSSNQRIS-----RSLKILISIVSIFLGIVMVSFFIFSWHKRSRPSR----- 207
                 T+  + +Q        RS KI+    ++  G+ ++   +  +  R RP R     
Sbjct: 713  NQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMR-RPVRTVASS 771

Query: 208  ----QPSEPMIRKALLK---MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVA 260
                QPSE  +          +++ L+ ATD F  + ++G G+ G+VYK V    G  +A
Sbjct: 772  AQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPA-GYTLA 830

Query: 261  IKVINLQRQGASK-----SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
            +K +    +G +      SF AE   L NIRH+N+V++   C   + QG++   ++Y+YM
Sbjct: 831  VKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFC---NHQGSNL--LLYEYM 885

Query: 316  PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
            P GSL + LH  +            L   +R  IA+  A  L YLH  C+  I H D+K 
Sbjct: 886  PKGSLGEILHDPSC----------NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKS 935

Query: 376  SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
            +NILLD+   AH+GDFGL++    +  P   S   + G+ GY+APEY    +V+   D+Y
Sbjct: 936  NNILLDDKFEAHVGDFGLAK---VIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIY 992

Query: 436  SYGILLLEMVTTKKPTD 452
            SYG++LLE++T K P  
Sbjct: 993  SYGVVLLELLTGKAPVQ 1009

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	452
224141953	1026	predicted protein [Populus trichocarpa]	0.988	0.435	0.587	1e-150
359482058	1040	PREDICTED: probable LRR receptor-like se	0.986	0.428	0.580	1e-148
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.986	0.234	0.580	1e-148
359486510	965	PREDICTED: probable LRR receptor-like se	0.986	0.462	0.593	1e-146
224090977	1034	predicted protein [Populus trichocarpa]	0.988	0.432	0.556	1e-143
255577438	1028	receptor-kinase, putative [Ricinus commu	0.988	0.434	0.572	1e-142
224081190	1011	predicted protein [Populus trichocarpa]	0.986	0.441	0.568	1e-141
449441592	1023	PREDICTED: probable LRR receptor-like se	0.988	0.436	0.547	1e-139
224121660	774	predicted protein [Populus trichocarpa]	0.984	0.574	0.563	1e-138
449499190	1023	PREDICTED: LOW QUALITY PROTEIN: probable	0.991	0.437	0.541	1e-138

>gi|224141953|ref|XP_002324325.1| predicted protein [Populus trichocarpa] gi|222865759|gb|EEF02890.1| predicted protein [Populus trichocarpa]

 Score =  538 bits (1386), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 265/451 (58%), Positives = 340/451 (75%), Gaps = 4/451 (0%)

Query: 5   DLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG 64
           +L+G+IPE +F  S +  SLNL+ N F GS+P  IG+LK L   DVS N LSGEIP   G
Sbjct: 477 NLNGSIPEQLFGTSSVLFSLNLSHNQFTGSLPSTIGSLKGLSELDVSWNMLSGEIPTSFG 536

Query: 65  LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
            C+SLE +++  NFF GSIPS F + RGI+ LDLS NNLSGQ+P FL  +    LNLS+N
Sbjct: 537 GCTSLEVLHMEDNFFQGSIPSSFSSLRGIQFLDLSCNNLSGQLPNFLVTIPFISLNLSYN 596

Query: 125 DFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKIL-ISIV 183
           +FEG+VP KG+F N SA+SV G  +LCGGI EL LP+C   +    ++S    +L I+I 
Sbjct: 597 NFEGEVPRKGVFTNESAVSVVGNDKLCGGILELHLPECPNKEPKKTKMSHLQYLLAITIP 656

Query: 184 SIFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGS 243
              +G + VS F+F W K+ R     S+ +++++  ++SY+ L KATDGFS+TNLIGVGS
Sbjct: 657 CALVGAITVSSFLFCWFKKKR-KEHSSDTLLKESFPQISYERLFKATDGFSTTNLIGVGS 715

Query: 244 FGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ 303
           F SVYKG  DEDGT+VAIKV+NLQR+GASKSF  EC+AL+NIRH+NLV++ITSCSS+DFQ
Sbjct: 716 FSSVYKGRIDEDGTLVAIKVLNLQRRGASKSFKDECEALRNIRHRNLVKIITSCSSIDFQ 775

Query: 304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI-EIQKLTLLQRISIAIDVASALDYLHQ 362
           GN+FKA+VY+YMP GSLEKWLHP      D++I ++Q+  LL+RI+IAIDVA+ALDYLH 
Sbjct: 776 GNNFKALVYEYMPKGSLEKWLHPTQETHDDQQINQVQRPNLLERINIAIDVAAALDYLHH 835

Query: 363 HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV-SSSIGVRGTIGYVAPE 421
           HC  PI+HCD+KPSNILLD D+  H+GDFGL+R +Q  S P++ SSS G++GT GY APE
Sbjct: 836 HCHSPIIHCDVKPSNILLDKDMIGHLGDFGLARIFQEFSEPSLESSSAGIKGTTGYAAPE 895

Query: 422 YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           YG G EVS +GDVYSYGILLLEM+T K+P D
Sbjct: 896 YGQGREVSIDGDVYSYGILLLEMMTGKRPID 926

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  533 bits (1372), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 264/455 (58%), Positives = 339/455 (74%), Gaps = 9/455 (1%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L+GTIPE +  +  L+ SLNLA N   G +P  +  LK L   DVS N LSGEIP  L
Sbjct: 483 NSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGL 542

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
           G C +LE +++ GNFF GSIP  F + RG+  LDLSRNNLSGQIP FL+ LSL  LNLSF
Sbjct: 543 GSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSLSNLNLSF 602

Query: 124 NDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIV 183
           N+FEG++PTKG+F N ++ SVAG ++LCGGIPEL LP C   K       R LK++I ++
Sbjct: 603 NNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLL 662

Query: 184 SIFLGIVMV-SFFIFSWHKRSRPSRQPSEPMI--RKALLKMSYKSLLKATDGFSSTNLIG 240
           + FLG+V++ S  + +  +R +  R+PS+     +  +L +SY  L KAT GFSS NLIG
Sbjct: 663 TGFLGLVLIMSLLVINRLRRVK--REPSQTSASSKDLILNVSYDGLFKATGGFSSANLIG 720

Query: 241 VGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSV 300
            G FGSVYKG+  +D TVVA+KVI L ++GA KSF AEC+AL+NIRH+NLV+V+T+CSSV
Sbjct: 721 TGGFGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSV 780

Query: 301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL 360
           D+QGNDFKA+VY++MPNGSLE WLHP   P    ++ ++ L+L QR++IAIDVASALDYL
Sbjct: 781 DYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDV-LRILSLPQRLNIAIDVASALDYL 839

Query: 361 HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV---SNPTVSSSIGVRGTIGY 417
           H HC +PI+HCDLKPSNILLDND++AH+GDFGL+RF       S+P+ SSSIG++GTIGY
Sbjct: 840 HHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGY 899

Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            APEYG+G++VS  GD YSYGILLLEM T K+PT+
Sbjct: 900 AAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTE 934

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  530 bits (1365), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 264/455 (58%), Positives = 338/455 (74%), Gaps = 9/455 (1%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L+GTIPE +  +  L+ SLNLA N   G +P  +  LK L   DVS N LSGEIP  L
Sbjct: 514 NSLNGTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGL 573

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
           G C +LE +++ GNFF GSIP  F + RG+  LDLSRNNLSGQIP FL+ LSL  LNLSF
Sbjct: 574 GSCLTLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLSLSNLNLSF 633

Query: 124 NDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIV 183
           N+FEG++PTKG+F N ++ SVAG ++LCGGIPEL LP C   K       R LK++I ++
Sbjct: 634 NNFEGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLL 693

Query: 184 SIFLGIVMV-SFFIFSWHKRSRPSRQPSEPMI--RKALLKMSYKSLLKATDGFSSTNLIG 240
           + FLG+V++ S  + +  +R +  R+PS+     +  +L +SY  L KAT GFSS NLIG
Sbjct: 694 TGFLGLVLIMSLLVINRLRRVK--REPSQTSASSKDLILNVSYDGLFKATGGFSSANLIG 751

Query: 241 VGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSV 300
            G FGSVYKG   +D TVVA+KVI L ++GA KSF AEC+AL+NIRH+NLV+V+T+CSSV
Sbjct: 752 TGGFGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSV 811

Query: 301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL 360
           D+QGNDFKA+VY++MPNGSLE WLHP   P    ++ ++ L+L QR++IAIDVASALDYL
Sbjct: 812 DYQGNDFKALVYEFMPNGSLENWLHPVPTPDEINDV-LRILSLPQRLNIAIDVASALDYL 870

Query: 361 HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV---SNPTVSSSIGVRGTIGY 417
           H HC +PI+HCDLKPSNILLDND++AH+GDFGL+RF       S+P+ SSSIG++GTIGY
Sbjct: 871 HHHCHKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGY 930

Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            APEYG+G++VS  GD YSYGILLLEM T K+PT+
Sbjct: 931 AAPEYGMGTKVSALGDTYSYGILLLEMFTGKRPTE 965

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  526 bits (1354), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 269/453 (59%), Positives = 348/453 (76%), Gaps = 7/453 (1%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N+LSGTIP  + S+S LS SL++++N   G++P  +GNLK L   DVSNN LSG IP  +
Sbjct: 410 NNLSGTIPPQVVSLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSV 469

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
           G C+SLE + + GNFF GSIPS F + RGIR LDLS NNLSG+IP FL+ +  + +NLS+
Sbjct: 470 GSCTSLEYLSMKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHFQLVNLSY 529

Query: 124 NDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIV 183
           NDFEG +PT+G+F N SA S+ G  +LCGGIPE QLPKC   +   + +S +LKI+I+ V
Sbjct: 530 NDFEGILPTEGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATV 589

Query: 184 SIFLGIVMV-SFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVG 242
           S  L I  V SF IF W ++ +   +P+     K+LLK+SY+SLL+ATDGFSS+NLIGVG
Sbjct: 590 SGLLAITCVLSFLIFLWLRKKK--GEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGVG 647

Query: 243 SFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF 302
           SFGSVYKG+ D DGT +A+KV+NL R+GASKSF+AEC+AL+NIRH+NLV+V+T+CS VD+
Sbjct: 648 SFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDY 707

Query: 303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ 362
           QGNDFKA+VY++M NGSLE+WLHP      +     +KL  LQR++IAIDVA ALDYLH 
Sbjct: 708 QGNDFKAVVYEFMVNGSLEQWLHPTPT-TAEASAPPRKLNFLQRLNIAIDVACALDYLHH 766

Query: 363 HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY--QAVSNPTV-SSSIGVRGTIGYVA 419
            CQ PI+HCDLKPSN+LLD +++ H+GDFG+++F    A   P + SSSIG+RGTIGY A
Sbjct: 767 QCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAA 826

Query: 420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           PEYG+GSEVST+GDVYS+GILLLEM T K+PT+
Sbjct: 827 PEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTE 859

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224090977|ref|XP_002309132.1| predicted protein [Populus trichocarpa] gi|222855108|gb|EEE92655.1| predicted protein [Populus trichocarpa]

 Score =  515 bits (1326), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 255/458 (55%), Positives = 345/458 (75%), Gaps = 11/458 (2%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N LSGTIP+ +  +S L+ SLNLA+N   G +PP   NL  L   DVS N L G+IP  
Sbjct: 479 QNLLSGTIPKEVMGLSSLTISLNLAQNQLTGPLPPEAQNLMNLGYLDVSENKLYGQIPSS 538

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           LG C +LE +++ GNFF G+IP  F + RG+R +DLSRNNLSGQIP FL+ L+L  LNLS
Sbjct: 539 LGSCVTLEKLHMQGNFFEGAIPPSFSSLRGLRDMDLSRNNLSGQIPQFLKRLALISLNLS 598

Query: 123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISI 182
           FN FEG+VP +G F N +AIS++G  RLCGGIP+L+LP+C  N+S N + SR +K++I+I
Sbjct: 599 FNHFEGEVPREGAFLNATAISLSGNKRLCGGIPQLKLPRCVVNRSKNGKTSRRVKLMIAI 658

Query: 183 VSIFLGIVMVSFFIFSWHKRSRPSRQPSEPMI----RKALLKMSYKSLLKATDGFSSTNL 238
           ++  L +V V   I   ++  + +RQ S        ++ LLK+SY++L KAT GFSS NL
Sbjct: 659 LTPLLVLVFV-MSILVINRLRKKNRQSSLASSLSSKQELLLKVSYRNLHKATAGFSSANL 717

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GSFGSVY+G+ D + TVVA+KV+ ++++   KSFMAEC+ LKNIRH+NLV+++T+CS
Sbjct: 718 IGAGSFGSVYRGILDPNETVVAVKVLFMRQRKTLKSFMAECEILKNIRHRNLVKILTACS 777

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTLLQRISIAIDVASAL 357
           SVDFQGNDFKA+VY++MPNG+LE WLH  + P+ +   E ++ L+  QR++IAIDVA+AL
Sbjct: 778 SVDFQGNDFKALVYEFMPNGTLESWLH--SFPRTNGINEDLKILSFHQRLNIAIDVAAAL 835

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT---VSSSIGVRGT 414
           +YLH  C +P++HCDLKPSN+LLDND++AH+GDFGL+RF +   NP+    SSS+G++GT
Sbjct: 836 NYLHYQCHKPVVHCDLKPSNVLLDNDMTAHVGDFGLARFIEEAINPSHRNESSSVGLKGT 895

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           +GY APEYG+GS+ S NGDVYSYGILLLEM T K+PTD
Sbjct: 896 VGYAAPEYGMGSKPSMNGDVYSYGILLLEMFTGKRPTD 933

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis]

 Score =  511 bits (1317), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 260/454 (57%), Positives = 338/454 (74%), Gaps = 7/454 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N+LSGTIP+ + SI  LS SL+L+EN F GS+P  +G L  L   DVS N LSGEIP  
Sbjct: 476 RNNLSGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEIPKS 535

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP-LFLEALSLEYLNL 121
           LG C+ LE +YL GN F G+IP    + RGI  L+LS NNL+GQIP  F E  SLE L+L
Sbjct: 536 LGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEKLDL 595

Query: 122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILIS 181
           S+NDFEG+VP +G+F N SA S++G   LCGGIPE+ LP+CT NKS   + S  L+++I 
Sbjct: 596 SYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRLIIV 655

Query: 182 IVSIFLG--IVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLI 239
           +    +   +++ S  +F   K  R +++ S   +     K+SY++LLKATDGFSS NLI
Sbjct: 656 VACCGVVGVLLLTSALLFCCLKM-RKNKEASGSSLDIFFQKVSYQNLLKATDGFSSANLI 714

Query: 240 GVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSS 299
           G GSFGSVYKG+   D T++A+KV+NLQ +GAS+SFM EC+AL N+RH+NLV+V+T+CSS
Sbjct: 715 GAGSFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLTACSS 774

Query: 300 VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDY 359
            DF+ NDFKA+VY+YM NGSLE+WLHP   P +D+   I  L+L++R+SI+IDVASALDY
Sbjct: 775 SDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPRI--LSLIERLSISIDVASALDY 832

Query: 360 LHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY-QAVSNPTVSSSIGVRGTIGYV 418
           LH  CQ P++HCDLKPSNILLD+D++AH+GDFGL+RF   A  + + SSSIG+RGT+GY 
Sbjct: 833 LHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIAAPHHSSPSSSIGIRGTVGYA 892

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           APEYG+GS+VST GDVY+YGILLLE+ T KKPTD
Sbjct: 893 APEYGMGSDVSTYGDVYTYGILLLELFTGKKPTD 926

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa]

 Score =  507 bits (1305), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 258/454 (56%), Positives = 331/454 (72%), Gaps = 8/454 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N+LSG IP+ +  IS LS  L L +N   GS+P  +G L  L    VS N LSGEIP  
Sbjct: 474 QNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEIPKS 533

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSL-EYLNL 121
           L  C SLE + LGGNFF G +P    + R ++ L LS NNLSGQIP FL+   L E L+L
Sbjct: 534 LDSCKSLEGLDLGGNFFEGPVPDL-SSLRALQMLLLSYNNLSGQIPQFLKDFKLLETLDL 592

Query: 122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILIS 181
           S+NDFEG+VP +G+F NTS ISV G  +LCGGIP+L LPKCT N+ +  +    L ++I+
Sbjct: 593 SYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLILIIA 652

Query: 182 IVSIFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGV 241
           I   FLGIV+++ F+  + ++++     S P    +  +++Y+ LL+ATDGFSS+NL+G 
Sbjct: 653 IPCGFLGIVLMTSFLLFYSRKTK-DEPASGPSWESSFQRLTYQDLLQATDGFSSSNLVGA 711

Query: 242 GSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD 301
           G+FGSVY+G    DG VVA+KV+NL R+GASKSFMAEC AL NIRH+NLV+VIT+CSS D
Sbjct: 712 GAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITACSSND 771

Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           FQGNDFKA+VY++M NGSLE+WLHP  I   D   E + L L+QR++IAIDVASALDYLH
Sbjct: 772 FQGNDFKALVYEFMVNGSLEEWLHPVHI--SDVTPETRNLDLVQRLNIAIDVASALDYLH 829

Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN---PTVSSSIGVRGTIGYV 418
            HCQ P++HCDLKPSN+LL +D++A +GDFGL+RF    SN      SSS+G++GTIGY 
Sbjct: 830 NHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEASNQLPADESSSVGLKGTIGYA 889

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           APEYG+GSEVST GDVYSYGILLLEM T ++PTD
Sbjct: 890 APEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTD 923

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449441592|ref|XP_004138566.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  501 bits (1291), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 249/455 (54%), Positives = 328/455 (72%), Gaps = 8/455 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N LSG IP+ + SIS LS +L+L+EN+  GSIP  +G L  L    +S+N L+G IP  
Sbjct: 480 QNQLSGAIPKELLSISSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLTGVIPST 539

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNL 121
           L  C+SLED+YL GNF  G IP    + RGI +LDLSRNNLSG+IP +L+    L YLNL
Sbjct: 540 LSACTSLEDLYLDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSYLNL 599

Query: 122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILIS 181
           SFN+ EG+VPT+G+F NT+A S+ G  +LC GI EL LP+C  +    Q+++  LKI+IS
Sbjct: 600 SFNNLEGEVPTQGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKIIIS 659

Query: 182 IVSIFLG-IVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIG 240
           +VS  +G ++++   +F W  R + ++    P ++ +   +SY  LLKAT+ FS  NLIG
Sbjct: 660 VVSGLVGALLIICCLLFFW-SRKKKNKSDLSPSLKASYFAVSYNDLLKATNEFSPDNLIG 718

Query: 241 VGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSV 300
           VG +GSVYKG+  +D +VVA+KV NLQ +GASKSF+AEC+ALKNIRH+NLVR++++CS V
Sbjct: 719 VGGYGSVYKGILSQDKSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILSACSGV 778

Query: 301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL 360
           DFQGNDF A+V+ +M NGSLEKWLHP  +   ++E E   L ++QR+ IAIDVASALDYL
Sbjct: 779 DFQGNDFMALVFDFMVNGSLEKWLHP--VDNLNQEGEKMYLNIMQRLDIAIDVASALDYL 836

Query: 361 HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS---NPTVSSSIGVRGTIGY 417
           H     PI HCDLKPSN+LLD D++AH+GDFGL++F    S     T S SIG+RGT+GY
Sbjct: 837 HNGSPMPIAHCDLKPSNVLLDADMTAHVGDFGLAKFMAETSFQNRSTESESIGIRGTVGY 896

Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             PEY +GS++ST GDVYSYGILLLEM T K PTD
Sbjct: 897 APPEYAMGSKISTYGDVYSYGILLLEMFTGKSPTD 931

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121660|ref|XP_002330621.1| predicted protein [Populus trichocarpa] gi|222872225|gb|EEF09356.1| predicted protein [Populus trichocarpa]

 Score =  498 bits (1282), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 257/456 (56%), Positives = 337/456 (73%), Gaps = 11/456 (2%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N+LSG IP+ + SI   + SLNL+ENH  GS+P  +GNL  L   DVS N LSGEIP  L
Sbjct: 214 NNLSGPIPKELLSIPLGTVSLNLSENHLTGSLPLEVGNLVHLGEIDVSKNRLSGEIPRSL 273

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSL-EYLNLS 122
           G C+SLE + L GNFF GSIP    + R ++ LDLS NNLSGQIP FL  L L E L+LS
Sbjct: 274 GSCASLELLSLKGNFFKGSIPESLSSLRALKVLDLSYNNLSGQIPKFLGDLKLLESLDLS 333

Query: 123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISI 182
           FND EG+VP +G+F NTS IS+AG  +LCGGIP+L L +CT N+S+  ++  S KILI  
Sbjct: 334 FNDLEGQVPVQGVFGNTSVISIAGNKKLCGGIPQLNLSRCTTNESA--KLKSSTKILIVA 391

Query: 183 VS--IFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIG 240
           +S  + + I++VS  +F + ++++  +  S         +++Y+ LL AT+ FSS N IG
Sbjct: 392 MSGGLLVVILLVSSMLFYFFRKTKDMQASSTSTWGIPFRRVAYQDLLLATNEFSSANSIG 451

Query: 241 VGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSV 300
           VGSFGSVY+G+   DG  VA+KV+NL R+GAS+SFMAEC AL NIRH+NLVRV+++CSS+
Sbjct: 452 VGSFGSVYRGILPPDGMAVAVKVLNLLRKGASRSFMAECAALVNIRHRNLVRVVSACSSI 511

Query: 301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL 360
           DFQGNDFKAIVY+ M NGSLE+WLHP  I Q +   E++ L L+QR++I+IDVA+AL+YL
Sbjct: 512 DFQGNDFKAIVYELMVNGSLEEWLHP--IHQPNNAQELRSLNLIQRLNISIDVANALNYL 569

Query: 361 HQHC-QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS---SSIGVRGTIG 416
           HQHC   PI+HCDLKPSN+LL+ +++A +GDFGL+R    VS+   S   SS+G++GTIG
Sbjct: 570 HQHCGSTPIVHCDLKPSNVLLNAEMTACVGDFGLARLRPEVSHQLSSGQTSSVGLKGTIG 629

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           Y APEYG+GS+VST GDVYS+GILLLEM T K+PT+
Sbjct: 630 YAAPEYGVGSDVSTYGDVYSFGILLLEMFTGKRPTE 665

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449499190|ref|XP_004160745.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  497 bits (1279), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 246/454 (54%), Positives = 324/454 (71%), Gaps = 6/454 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N LSG IP+ + SIS LS +L+L+EN+  GSIP  +G L  L    +S+N L+G IP  
Sbjct: 480 QNQLSGAIPKELLSISSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLTGVIPST 539

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNL 121
           L  C+SLED+YL GNF  G IP    + RGI +LDLSRNNLSG+IP +L+    L YLNL
Sbjct: 540 LSACTSLEDLYLDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSYLNL 599

Query: 122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILIS 181
           SFN+ EG+VPT+G+F NT+A S+ G  +LC GI EL LP+C  +    Q+++  LKI+IS
Sbjct: 600 SFNNLEGEVPTQGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKIIIS 659

Query: 182 IVSIFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGV 241
           +VS  +G +++   +     +   ++    P ++ +   +SY  LLKAT+ FS  NLIGV
Sbjct: 660 VVSGLVGALLIICCLLFXLVKEEKNKSDLSPSLKASYFAVSYNDLLKATNEFSPDNLIGV 719

Query: 242 GSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD 301
           G +GSVYKG+  +D +VVA+KV NLQ +GASKSF+AEC+ALKNIRH+NLVR++++CS VD
Sbjct: 720 GGYGSVYKGILSQDKSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILSACSGVD 779

Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           FQGNDF A+V+ +M NGSLEKWLHP  +   ++E E   L ++QR+ IAIDVASALDYLH
Sbjct: 780 FQGNDFMALVFDFMVNGSLEKWLHP--VDNLNQEGEKMYLNIMQRLDIAIDVASALDYLH 837

Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS---NPTVSSSIGVRGTIGYV 418
                PI HCDLKPSN+LLD D++AH+GDFGL++F    S     T S SIG+RGT+GY 
Sbjct: 838 NGSPMPIAHCDLKPSNVLLDADMTAHVGDFGLAKFMAETSFQNRSTESESIGIRGTVGYA 897

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            PEY +GS++ST GDVYSYGILLLEM T K PTD
Sbjct: 898 PPEYAMGSKISTYGDVYSYGILLLEMFTGKSPTD 931

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	452
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.986	0.441	0.483	5.2e-113
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.984	0.441	0.493	5.2e-113
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.971	0.428	0.501	6.8e-111
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.984	0.440	0.469	1.4e-110
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.984	0.434	0.490	8.6e-104
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.991	0.434	0.458	2e-102
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.769	0.693	0.458	1.2e-81
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.75	0.416	0.462	2.1e-75
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.484	0.223	0.465	4.1e-74
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.953	0.367	0.376	1.4e-66

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1115 (397.6 bits), Expect = 5.2e-113, P = 5.2e-113
 Identities = 223/461 (48%), Positives = 311/461 (67%)

Query:     3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
             +N L+GTIP  I  I  L   L+++ N  +GS+P  IG L+ L +  + +N LSG++P  
Sbjct:   466 DNKLNGTIPLEIMKIQQLLR-LDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQT 524

Query:    63 LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNL 121
             LG C ++E ++L GN F+G IP   +   G++++DLS N+LSG IP +  + S LEYLNL
Sbjct:   525 LGNCLTMESLFLEGNLFYGDIPDL-KGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNL 583

Query:   122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSS----NQXXXXXXX 177
             SFN+ EGKVP KGIF N + +S+ G + LCGGI   QL  C     S    +        
Sbjct:   584 SFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVV 643

Query:   178 XXXXXXXXFLGIVMVSFFIFSW---HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFS 234
                      L ++ ++     W    K+++ +  P+   +     K+SY  L  AT+GFS
Sbjct:   644 IGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFS 703

Query:   235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
             S+N++G GSFG+VYK +   +  VVA+KV+N+QR+GA KSFMAEC++LK+IRH+NLV+++
Sbjct:   704 SSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLL 763

Query:   295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             T+CSS+DFQGN+F+A++Y++MPNGSL+ WLHP+ + +  R    + LTLL+R++IAIDVA
Sbjct:   764 TACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPS--RTLTLLERLNIAIDVA 821

Query:   355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF---YQAVSNPTVSSSIGV 411
             S LDYLH HC EPI HCDLKPSN+LLD+DL+AH+ DFGL+R    +   S     SS GV
Sbjct:   822 SVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGV 881

Query:   412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             RGTIGY APEYG+G + S NGDVYS+GILLLEM T K+PT+
Sbjct:   882 RGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTN 922

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1115 (397.6 bits), Expect = 5.2e-113, P = 5.2e-113
 Identities = 226/458 (49%), Positives = 310/458 (67%)

Query:     4 NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             N L+GTIP+ I  I  L + LN+  N   GS+P  IG L+ L    + NN LSG +P  L
Sbjct:   468 NKLNGTIPKEIMQIPTLVH-LNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTL 526

Query:    64 GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLS 122
             G C S+E IYL  N F G+IP   +   G++ +DLS NNLSG I  + E  S LEYLNLS
Sbjct:   527 GKCLSMEVIYLQENHFDGTIPDI-KGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLS 585

Query:   123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQXXXXXXXXXXXX 182
              N+FEG+VPT+GIF N + +SV G   LCG I EL+L  C       +            
Sbjct:   586 DNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAI 645

Query:   183 XXXF-LGIVMVSFFI-FSWHKRSRPSRQ--PSEPMIRKALL-KMSYKSLLKATDGFSSTN 237
                  + ++++ F +  SW K+ + +++   S P   +    K+SY  L  ATDGFSS+N
Sbjct:   646 GVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSN 705

Query:   238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
             ++G GSFG+V+K +   +  +VA+KV+N+QR+GA KSFMAEC++LK+IRH+NLV+++T+C
Sbjct:   706 IVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTAC 765

Query:   298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
             +S+DFQGN+F+A++Y++MPNGSL+KWLHP+ + +  R    + LTLL+R++IAIDVAS L
Sbjct:   766 ASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPS--RTLTLLERLNIAIDVASVL 823

Query:   358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF---YQAVSNPTVSSSIGVRGT 414
             DYLH HC EPI HCDLKPSNILLD+DL+AH+ DFGL+R    +   S     SS GVRGT
Sbjct:   824 DYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGT 883

Query:   415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             IGY APEYG+G + S +GDVYS+G+L+LEM T K+PT+
Sbjct:   884 IGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTN 921

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1095 (390.5 bits), Expect = 6.8e-111, P = 6.8e-111
 Identities = 227/453 (50%), Positives = 304/453 (67%)

Query:     4 NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             N+LSG IP  +F+I  LS  +N+++N+  GSIP  IG+LK L  F   +N LSG+IP  L
Sbjct:   482 NNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTL 541

Query:    64 GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLS 122
             G C  L  +YL  N   GSIPS     +G+  LDLS NNLSGQIP  L  ++ L  LNLS
Sbjct:   542 GDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLS 601

Query:   123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQXXXXXXXXXXXX 182
             FN F G+VPT G FA  S IS+ G  +LCGGIP+L LP+C     + +            
Sbjct:   602 FNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLA 661

Query:   183 XXXFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVG 242
                 L I+   + + +WHKR++    PS   ++   L +SY  L+KATDGF+ TNL+G G
Sbjct:   662 AA--LAILSSLYLLITWHKRTKKGA-PSRTSMKGHPL-VSYSQLVKATDGFAPTNLLGSG 717

Query:   243 SFGSVYKGVFD-EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD 301
             SFGSVYKG  + +D   VA+KV+ L+   A KSF AEC+AL+N+RH+NLV+++T CSS+D
Sbjct:   718 SFGSVYKGKLNIQDH--VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSID 775

Query:   302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
              +GNDFKAIVY +MPNGSLE W+HP+   Q D+    + L L +R++I +DVA ALDYLH
Sbjct:   776 NRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQ----RHLNLHRRVTILLDVACALDYLH 831

Query:   362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN--PTVSSSIGVRGTIGYVA 419
             +H  EP++HCD+K SN+LLD+D+ AH+GDFGL+R     ++     +SS+G  GTIGY A
Sbjct:   832 RHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSSMGFIGTIGYAA 891

Query:   420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             PEYG+G   ST+GD+YSYGIL+LE+VT K+PTD
Sbjct:   892 PEYGVGLIASTHGDIYSYGILVLEIVTGKRPTD 924

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1092 (389.5 bits), Expect = 1.4e-110, P = 1.4e-110
 Identities = 216/460 (46%), Positives = 310/460 (67%)

Query:     4 NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             N L+GTIP+ I  I  L N L++  N   GS+P  IG+L+ L    + NN  SG +P  L
Sbjct:   468 NKLNGTIPKEIMQIPTLVN-LSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQTL 526

Query:    64 GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLS 122
             G C ++E ++L GN F G+IP+  R   G+R++DLS N+LSG IP +    S LEYLNLS
Sbjct:   527 GNCLAMEQLFLQGNSFDGAIPNI-RGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLS 585

Query:   123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENK----SSNQXXXXXXXX 178
              N+F GKVP+KG F N++ + V G   LCGGI +L+L  C   +    + +         
Sbjct:   586 INNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAI 645

Query:   179 XXXXXXXFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALL---KMSYKSLLKATDGFSS 235
                     L +++++  +  W ++ R ++Q +  +  K  +   K+SY  L  AT+GFSS
Sbjct:   646 LVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSS 705

Query:   236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVIT 295
             +N++G GSFG+V+K +   +  +VA+KV+N+QR+GA KSFMAEC++LK+ RH+NLV+++T
Sbjct:   706 SNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLT 765

Query:   296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
             +C+S DFQGN+F+A++Y+Y+PNGS++ WLHP+ + +  R    + LTLL+R++I IDVAS
Sbjct:   766 ACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPP--RTLTLLERLNIVIDVAS 823

Query:   356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF---YQAVSNPTVSSSIGVR 412
              LDYLH HC EPI HCDLKPSN+LL++DL+AH+ DFGL+R    +   S     SS GVR
Sbjct:   824 VLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVR 883

Query:   413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             GTIGY APEYG+G + S +GDVYS+G+LLLEM T K+PTD
Sbjct:   884 GTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTD 923

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1028 (366.9 bits), Expect = 8.6e-104, P = 8.6e-104
 Identities = 226/461 (49%), Positives = 293/461 (63%)

Query:     4 NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             N L+G+IP  +  +  L   LN++ N  VG +   IG LK L + DVS N LSG+IP  L
Sbjct:   483 NKLNGSIPHELMELPSLV-VLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTL 541

Query:    64 GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLS 122
               C SLE + L GN F G IP   R   G+R LDLS+NNLSG IP ++   S L+ LNLS
Sbjct:   542 ANCLSLEFLLLQGNSFVGPIPDI-RGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLS 600

Query:   123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCT-ENKSSNQXXXXXXXXXXX 181
              N+F+G VPT+G+F NTSA+SV G   LCGGIP LQL  C+ E    +            
Sbjct:   601 LNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVS 660

Query:   182 XXXXFLGIVMVSFFIFSWHK-RSRPSRQPSEPMIR-----KALL-KMSYKSLLKATDGFS 234
                  L ++ +      W+K R +  R  +    R     K+   K+SY  L K T GFS
Sbjct:   661 AVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFS 720

Query:   235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
             S+NLIG G+FG+V+KG        VAIKV+NL ++GA+KSF+AEC+AL  IRH+NLV+++
Sbjct:   721 SSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLV 780

Query:   295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             T CSS DF+GNDF+A+VY++MPNG+L+ WLHPD I +       + L L  R++IAIDVA
Sbjct:   781 TICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPS--RTLGLFARLNIAIDVA 838

Query:   355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS---SSIGV 411
             SAL YLH +C  PI HCD+KPSNILLD DL+AH+ DFGL++        T     SS GV
Sbjct:   839 SALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGV 898

Query:   412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             RGTIGY APEYG+G   S  GDVYS+GI+LLE+ T K+PT+
Sbjct:   899 RGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTN 939

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 1015 (362.4 bits), Expect = 2.0e-102, P = 2.0e-102
 Identities = 213/465 (45%), Positives = 296/465 (63%)

Query:     1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
             M  N L+GTIP+ I  I  L+  ++L+ N   G  P  +G L+ L     S N LSG++P
Sbjct:   472 MDTNRLNGTIPQEILQIPSLAY-IDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKMP 530

Query:    61 IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
               +G C S+E +++ GN F G+IP   R    ++ +D S NNLSG+IP +L +L SL  L
Sbjct:   531 QAIGGCLSMEFLFMQGNSFDGAIPDISRLV-SLKNVDFSNNNLSGRIPRYLASLPSLRNL 589

Query:   120 NLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQXXXXXXXXX 179
             NLS N FEG+VPT G+F N +A+SV G   +CGG+ E+QL  C    S  +         
Sbjct:   590 NLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKK 649

Query:   180 XXXX-----XXFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKAL----LKMSYKSLLKAT 230
                         L I++V+   +   ++ + +     P     L     K+SY+ L  AT
Sbjct:   650 VVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSAT 709

Query:   231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
               FSSTNLIG G+FG+V+KG+   +  +VA+KV+NL + GA+KSFMAEC+  K IRH+NL
Sbjct:   710 SRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNL 769

Query:   291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
             V++IT CSS+D +GNDF+A+VY++MP GSL+ WL  + + +R  +   + LT  ++++IA
Sbjct:   770 VKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDL-ERVND-HSRSLTPAEKLNIA 827

Query:   351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF---YQAVSNPTVSS 407
             IDVASAL+YLH HC +P+ HCD+KPSNILLD+DL+AH+ DFGL++    Y   S     S
Sbjct:   828 IDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFS 887

Query:   408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             S GVRGTIGY APEYG+G + S  GDVYS+GILLLEM + KKPTD
Sbjct:   888 SAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTD 932

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 173/377 (45%), Positives = 234/377 (62%)

Query:    88 RTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFN--------DFEGKVPTKGIFAN 138
             R    +  LDL    LSG I   +  LS L  LNL  N        +FEG VPTKG+F N
Sbjct:    70 RKQERVTSLDLGGFKLSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQN 129

Query:   139 TSAISVAGCHRLCGGIPELQLPKCTENKSSNQXXXXXXXXXXXXXXXFLGIVMVSFFIFS 198
              + +SV G   LCGG+ E+QL  C E+    +                L + ++   + S
Sbjct:   130 GTTVSVFGNENLCGGVIEMQLKPCIESPRQKKPFSLGEKVAVGVGVALLFLFIIVASL-S 188

Query:   199 WHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTV 258
             W K+                 K+SY+ L  AT GFSS+NLIG G+F  V+KG+   +  +
Sbjct:   189 WFKKKND--------------KISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKL 234

Query:   259 VAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNG 318
             VA+KV+NL + GA+KSF+AEC++ K IRH+NL ++IT CSS+D QGNDF+A+VY++MP G
Sbjct:   235 VAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKG 294

Query:   319 SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI 378
             SL+ WL P+ +   +     + LT  ++++IAIDVASAL+YLH +C +P+ HCD+KPSN+
Sbjct:   295 SLDMWLQPEDLESANNHS--RSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNV 352

Query:   379 LLDNDLSAHIGDFGLSRFYQAVSNPTVS---SSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
             LLD+DL+AH+ DFGL+R        T     SS GVRGTIGY APEYG+GS+ S  GDVY
Sbjct:   353 LLDDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVY 412

Query:   436 SYGILLLEMVTTKKPTD 452
             S+G+LLLEM T KKPTD
Sbjct:   413 SFGVLLLEMFTGKKPTD 429

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 760 (272.6 bits), Expect = 2.1e-75, P = 2.1e-75
 Identities = 162/350 (46%), Positives = 220/350 (62%)

Query:     4 NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             N+  G IP  IFSI  LS  L+++ N+  GSIP  IG LK +  F   +N LSGE P  +
Sbjct:   456 NNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGENPSTI 515

Query:    64 GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEY-LNLS 122
             G C  L+ ++L  NF +GSIP      +G+  LDLS NNLSGQIP+ L  + L + LNLS
Sbjct:   516 GECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLS 575

Query:   123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQXXXXXXXXXXXX 182
             FN F G+VPT G+FAN S I + G   +CGGIPEL LP C+      +            
Sbjct:   576 FNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILLLVVVIC 635

Query:   183 XXXFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVG 242
                 L +  + + + + HKR R    P+   ++   + ++YK L+KATDGFSS++L+G G
Sbjct:   636 LVSTLAVFSLLYMLLTCHKR-RKKEVPATTSMQGHPM-ITYKQLVKATDGFSSSHLLGSG 693

Query:   243 SFGSVYKGVFD-EDGTV---VAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
             SFGSVYKG FD +DG +   VA++V+ L+   A KSF AEC+ L+N RH+NLV+++T CS
Sbjct:   694 SFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICS 753

Query:   299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
             S+D +GNDFKAIVY +MPNGSLE WLHP+   Q ++    + LTL QR+S
Sbjct:   754 SIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQ----RHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 515 (186.3 bits), Expect = 4.1e-74, Sum P(2) = 4.1e-74
 Identities = 113/243 (46%), Positives = 161/243 (66%)

Query:   220 KMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAE 278
             ++SY+ L+ AT GF++++LIG G FG VYKGV   + T VA+KV++ +     S SF  E
Sbjct:   648 RISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTKVAVKVLDPKTALEFSGSFKRE 706

Query:   279 CKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
             C+ LK  RH+NL+R+IT+CS     G  F A+V   MPNGSLE+ L+P        E   
Sbjct:   707 CQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPG-------EYSS 754

Query:   339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
             + L L+Q ++I  DVA  + YLH +    ++HCDLKPSNILLD++++A + DFG+SR  Q
Sbjct:   755 KNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQ 814

Query:   399 AVSNPTVSS----SIG-----VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
              V   TVS+    S G     + G++GY+APEYG+G   ST+GDVYS+G+LLLE+V+ ++
Sbjct:   815 GVEE-TVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRR 873

Query:   450 PTD 452
             PTD
Sbjct:   874 PTD 876

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 685 (246.2 bits), Expect = 1.4e-66, P = 1.4e-66
 Identities = 175/465 (37%), Positives = 261/465 (56%)

Query:     2 FENDL-SGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
             F N+L +GTIP+ +  +  +   ++L+ N F GSIP  +   K + + D S N LSG IP
Sbjct:   632 FSNNLLTGTIPKELGKLEMVQE-IDLSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIP 690

Query:    61 IEL--GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LE 117
              E+  G+   +  + L  N F G IP  F     +  LDLS NNL+G+IP  L  LS L+
Sbjct:   691 DEVFQGM-DMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLK 749

Query:   118 YLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCT-ENKSSNQXXXXXX 176
             +L L+ N+ +G VP  G+F N +A  + G   LCG    L+ P CT + KSS+       
Sbjct:   750 HLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLK-P-CTIKQKSSHFSKRTRV 807

Query:   177 XXXXXXXXXFLGIVMVSFFIFSWHKRSRP----SRQPSEPMIRKAL-LK-MSYKSLLKAT 230
                       L +V++   I +  K+       S + S P +  AL LK    K L +AT
Sbjct:   808 ILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQAT 867

Query:   231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHK 288
             D F+S N+IG  S  +VYKG   EDGTV+A+KV+NL+   A   K F  E K L  ++H+
Sbjct:   868 DSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHR 926

Query:   289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
             NLV+++       ++    KA+V  +M NG+LE  +H  A P           +LL++I 
Sbjct:   927 NLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG---------SLLEKID 973

Query:   349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVSNPTVS 406
             + + +AS +DYLH     PI+HCDLKP+NILLD+D  AH+ DFG +R   ++   + T S
Sbjct:   974 LCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAS 1033

Query:   407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT 451
             +S    GTIGY+APE+    +V+T  DV+S+GI+++E++T ++PT
Sbjct:  1034 TS-AFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPT 1077

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XVIII.1848.1 hypothetical protein (976 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	452
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-44
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-41
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-34
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-25
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-22
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-20
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-19
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-19
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-17
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	6e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-16
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-11
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-11
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	9e-08
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	9e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (411), Expect = 2e-47
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 25/209 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSC 297
           +G G FG+VY     + G  VAIK+I  +      +  + E + LK + H N+V++    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                   +   +V +Y   GSL+  L               KL+  + + I + +   L
Sbjct: 61  ED-----ENHLYLVMEYCEGGSLKDLLKE----------NEGKLSEDEILRILLQILEGL 105

Query: 358 DYLHQHCQEPILHCDLKPSNILLDND-LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +YLH +    I+H DLKP NILLD+D     + DFGLS+   +  +   +    + GT  
Sbjct: 106 EYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT----IVGTPA 158

Query: 417 YVAPEYGLG-SEVSTNGDVYSYGILLLEM 444
           Y+APE  LG    S   D++S G++L E+
Sbjct: 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (395), Expect = 2e-44
 Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVIT 295
             +G GSFG VY     + G +VAIKVI  ++     +  + E K LK ++H N+VR+  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
                 F+  D   +V +Y   G L   L            +  +L+  +       + S
Sbjct: 65  V-----FEDEDKLYLVMEYCEGGDLFDLLK-----------KRGRLSEDEARFYLRQILS 108

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           AL+YLH      I+H DLKP NILLD D    + DFGL+R         +++ +   GT 
Sbjct: 109 ALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLD--PGEKLTTFV---GTP 160

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            Y+APE  LG       D++S G++L E++T
Sbjct: 161 EYMAPEVLLGKGYGKAVDIWSLGVILYELLT 191

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  156 bits (397), Expect = 3e-41
 Identities = 131/459 (28%), Positives = 213/459 (46%), Gaps = 51/459 (11%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N   G +P++ F    L N L+L+ N F G++P ++G+L  L    +S N LSGEIP EL
Sbjct: 462 NKFFGGLPDS-FGSKRLEN-LDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
             C  L  + L  N   G IP+ F     + +LDLS+N LSG+IP  L  + SL  +N+S
Sbjct: 520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579

Query: 123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLK---IL 179
            N   G +P+ G F   +A +VAG   LCGG     LP C       +R+ ++      +
Sbjct: 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC-------KRVRKTPSWWFYI 632

Query: 180 ISIVSIFLGIVMVSF-FIF-SWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSST- 236
              +  FL + +V+F F+F          R  +E    +     S  S     +   S+ 
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL 692

Query: 237 ---NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
              N+I  G  G+ YKG   ++G    +K IN        S +A+   +  ++H N+V++
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKL 748

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I  C S          ++++Y+   +L + L              + L+  +R  IAI +
Sbjct: 749 IGLCRS-----EKGAYLIHEYIEGKNLSEVL--------------RNLSWERRRKIAIGI 789

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A AL +LH  C   ++  +L P  I++D     H+    L       +   +SS+     
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSA----- 843

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              YVAPE     +++   D+Y +G++L+E++T K P D
Sbjct: 844 ---YVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (372), Expect = 3e-41
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 26/215 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           +G GSFG+VYK      G +VA+K++  + + + K  +   E + L+ + H N+VR+I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                F+  D   +V +Y   G L  +L                L+  +   IA+ +   
Sbjct: 67  -----FEDKDHLYLVMEYCEGGDLFDYLSRG-----------GPLSEDEAKKIALQILRG 110

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           L+YLH +    I+H DLKP NILLD +    I DFGL++     S+ ++++     GT  
Sbjct: 111 LEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKK-LLKSSSSLTT---FVGTPW 163

Query: 417 YVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y+APE    G+      DV+S G++L E++T K P
Sbjct: 164 YMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (358), Expect = 4e-39
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 21/216 (9%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVI 294
            L+G GSFGSVY  +  + G ++A+K + L        ++   E + L +++H N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S    +    +   I  +Y+  GSL   L       +  E  I+K T          + 
Sbjct: 66  GSERDEE---KNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYT--------RQIL 111

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L YLH +    I+H D+K +NIL+D+D    + DFG ++  +     T   +  VRGT
Sbjct: 112 EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAK--RLGDIETGEGTGSVRGT 166

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             ++APE   G E     D++S G  ++EM T K P
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  134 bits (340), Expect = 2e-36
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 239 IGVGSFGSVYKGV----FDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG VYKG      +   T VA+K +     +   + F+ E   +K + H N+VR+
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C+    QG     IV +YMP G L  +L       R      +KLTL   + +A+ +
Sbjct: 67  LGVCT----QGEPLY-IVTEYMPGGDLLDFL-------RKHG---EKLTLKDLLQMALQI 111

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  ++YL        +H DL   N L+  +L   I DFGLSR              G + 
Sbjct: 112 AKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKL 166

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            I ++APE     + ++  DV+S+G+LL E+ T
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  128 bits (324), Expect = 3e-34
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 31/216 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTV----VAIKVINLQRQGAS----KSFMAECKALKNIRHKNL 290
           +G G+FG VYKG     G      VA+K +   ++ AS    + F+ E + ++ + H N+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V+++  C+    +      IV +YMP G L  +L         R+   ++L+L   +S A
Sbjct: 64  VKLLGVCTE---EEPLM--IVMEYMPGGDLLDYL---------RKNRPKELSLSDLLSFA 109

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + +A  ++YL        +H DL   N L+  +L   I DFGLSR    + +       G
Sbjct: 110 LQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYKVKG 163

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +  I ++APE     + ++  DV+S+G+LL E+ T
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  127 bits (321), Expect = 7e-34
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 32/216 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGT----VVAIKVINLQRQGAS----KSFMAECKALKNIRHKNL 290
           +G G+FG VYKG     G      VA+K +   ++ AS    + F+ E + ++ + H N+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V+++  C+    +   +  IV +YM  G L  +L       R       KL+L   +S A
Sbjct: 64  VKLLGVCTE---EEPLY--IVMEYMEGGDLLSYL-------RKNR---PKLSLSDLLSFA 108

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + +A  ++YL        +H DL   N L+  +L   I DFGLSR    + +       G
Sbjct: 109 LQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSR---DLYDDDYYRKRG 162

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +  I ++APE     + ++  DV+S+G+LL E+ T
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  125 bits (316), Expect = 4e-33
 Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 26/219 (11%)

Query: 237 NLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
             +G G+FG VYKG     D   T VA+K +   ++ AS+     F+ E + +K + H N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPN 57

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +VR++  C+    +   +  +V +YM  G L  +L            E   L+L   +S 
Sbjct: 58  VVRLLGVCTE---EEPLY--LVLEYMEGGDLLDYLR--KSRPVFPSPEKSTLSLKDLLSF 110

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS- 408
           AI +A  ++YL        +H DL   N L+  DL   I DFGLSR           +  
Sbjct: 111 AIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167

Query: 409 -IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + +R    ++APE       ++  DV+S+G+LL E+ T
Sbjct: 168 KLPIR----WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 1e-31
 Identities = 74/219 (33%), Positives = 110/219 (50%), Gaps = 31/219 (14%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVI 294
           +LIG G+FG VYKG+  E G  VAIK I+L++  + A KS M E   LKN++H N+V+ I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S      + +D   I+ +Y  NGSL +               I+K        +A+ V 
Sbjct: 66  GS-----IETSDSLYIILEYAENGSLRQ--------------IIKKFGPFPESLVAVYVY 106

Query: 355 ---SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
                L YLH   ++ ++H D+K +NIL   D    + DFG++     VS    S    V
Sbjct: 107 QVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS----V 159

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  ++APE    S  ST  D++S G  ++E++T   P
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (293), Expect = 7e-30
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 21/216 (9%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
             IG GSFG VY      DG +  +K I+L        +  + E K LK + H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S     F+      IV +Y   G L + +         ++ E +     Q +   + + 
Sbjct: 66  ES-----FEEKGKLCIVMEYADGGDLSQKIK-------KQKKEGKPFPEEQILDWFVQLC 113

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            AL YLH      ILH D+KP NI L ++    +GDFG+S+      + TV  +  V GT
Sbjct: 114 LALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKTVVGT 166

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Y++PE       +   D++S G +L E+ T K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  115 bits (291), Expect = 1e-29
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG VYK      G  VAIKVI L+ +   +  + E + LK  +H N+V+   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS-- 65

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   IV ++   GSL+  L   +  Q   E +I          +  ++   L+
Sbjct: 66  ---YLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAY--------VCKELLKGLE 112

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YLH +    I+H D+K +NILL +D    + DFGLS   Q       ++ +   GT  ++
Sbjct: 113 YLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMV---GTPYWM 164

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE   G       D++S GI  +E+   K P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 2e-29
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 36/221 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVR---V 293
           IG G++G VYK    + G +VA+K I ++  ++G   + + E K L+ +RH N+VR   +
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 294 ITSCSSVDFQGNDFKAIVYKYMP---NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +TS      +G+ +  +V++YM     G L+    P+            K T  Q     
Sbjct: 67  VTSKG----KGSIY--MVFEYMDHDLTGLLD---SPE-----------VKFTESQIKCYM 106

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             +   L YLH +    ILH D+K SNIL++ND    + DFGL+R Y   ++   ++ + 
Sbjct: 107 KQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV- 162

Query: 411 VRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKP 450
           +  T+ Y  PE  LG+       D++S G +L E+    KP
Sbjct: 163 I--TLWYRPPELLLGATRYGPEVDMWSVGCILAELF-LGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (277), Expect = 1e-27
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVI 294
           N IG G+FG VY  V  + G ++A+K I +Q       K    E K L+ ++H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                V+        I  +Y   G+LE+ L             I    +++  ++ +   
Sbjct: 64  --YYGVEVHREKV-YIFMEYCSGGTLEELLE---------HGRILDEHVIRVYTLQL--L 109

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L YLH H    I+H D+KP+NI LD++    +GDFG +   +  +         + GT
Sbjct: 110 EGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Query: 415 IGYVAPEYGLGSEVSTNG---DVYSYGILLLEMVTTKKP 450
             Y+APE   G +   +G   D++S G ++LEM T K+P
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 1e-27
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 33/210 (15%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            IG G FG V  G +   G  VA+K +      A+++F+AE   +  +RH NLV+++   
Sbjct: 13  TIGKGEFGDVMLGDYR--GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLL--- 66

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
             V  QGN    IV +YM  GSL  +L       R R   +  +TL Q++  A+DV   +
Sbjct: 67  -GVVLQGNPL-YIVTEYMAKGSLVDYL-------RSRGRAV--ITLAQQLGFALDVCEGM 115

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT--- 414
           +YL +   +  +H DL   N+L+  DL A + DFGL++           +S G       
Sbjct: 116 EYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK----------EASQGQDSGKLP 162

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
           + + APE     + ST  DV+S+GILL E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 28/211 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTV-VAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVIT 295
           +G G FG V+ G ++  GT  VA+K +   + G    ++F+ E + +K +RH  LV++  
Sbjct: 14  LGAGQFGEVWMGTWN--GTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            CS    +      IV +YM  GSL  +L            E +KL L Q + +A  +A 
Sbjct: 69  VCS----EEEPI-YIVTEYMSKGSLLDFLKSG---------EGKKLRLPQLVDMAAQIAE 114

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YL        +H DL   NIL+  +L   I DFGL+R    + +   ++  G +  I
Sbjct: 115 GMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARL---IEDDEYTAREGAKFPI 168

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + APE       +   DV+S+GILL E+VT
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 28/211 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKALKNIRHKNLVRVITS 296
           +G G FG V++G+++ + T VA+K +   + G    K F+AE + +K +RH  L+++   
Sbjct: 14  LGAGQFGEVWEGLWN-NTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+       +   IV + M  GSL ++L   A          + L L Q I +A  VAS 
Sbjct: 70  CTL-----EEPIYIVTELMKYGSLLEYLQGGAG---------RALKLPQLIDMAAQVASG 115

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGVRGTI 415
           + YL        +H DL   N+L+  +    + DFGL+R   + +         G +  I
Sbjct: 116 MAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPI 168

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + APE  L +  S   DV+S+GILL E+VT
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  106 bits (264), Expect = 3e-25
 Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 29/229 (12%)

Query: 232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS---FMAECKALKNIRH- 287
            +     +G GSFG VY      D  +VA+KV+  + +  SK    F+ E + L ++ H 
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+V++        FQ      +V +Y+  GSLE  L                L+  + +
Sbjct: 58  PNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLKKI--------GRKGPLSESEAL 104

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQA--VSNPT 404
            I   + SAL+YLH      I+H D+KP NILLD +     + DFGL++       ++  
Sbjct: 105 FILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI 161

Query: 405 VSSSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
            +      GT GY+APE  LG      S++ D++S GI L E++T   P
Sbjct: 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (258), Expect = 5e-25
 Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 22/214 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    +G G FG V++G++ ++   VAIK++        + F  E +ALK +RHK+L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +   CS       +   I+ + M  GSL  +L         R  E Q L +   I +A  
Sbjct: 67  LFAVCS-----VGEPVYIITELMEKGSLLAFL---------RSPEGQVLPVASLIDMACQ 112

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  + YL    ++  +H DL   NIL+  DL   + DFGL+R  +     +    I  +
Sbjct: 113 VAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK 169

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            T    APE       ST  DV+S+GILL EM T
Sbjct: 170 WT----APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 6e-25
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 33/224 (14%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNL 290
           +     +G G++G VYK    + G +VA+K I L  +  G   + + E   LK ++H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 291 VR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           V+   VI +   +         +V++Y     L+K+L      +R   +    +      
Sbjct: 61  VKLLDVIHTERKL--------YLVFEYCDM-DLKKYLD-----KRPGPLSPNLIK----- 101

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           SI   +   L Y H H    ILH DLKP NIL++ D    + DFGL+R +     P  + 
Sbjct: 102 SIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF---GIPLRTY 155

Query: 408 SIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           +  V  T+ Y APE  LGS+  ST  D++S G +  EM+ T KP
Sbjct: 156 THEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI-TGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 2e-24
 Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 46/225 (20%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G GSFG V      + G + A+KV+    + ++   +  + E   L  I H  +V+   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK--L 58

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS------- 348
             +   FQ  +   +V +Y P G L                     + L +         
Sbjct: 59  HYA---FQTEEKLYLVLEYAPGGEL--------------------FSHLSKEGRFSEERA 95

Query: 349 --IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTV 405
              A ++  AL+YLH      I++ DLKP NILLD D    + DFGL++           
Sbjct: 96  RFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRT 150

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++     GT  Y+APE  LG       D +S G+LL EM+T K P
Sbjct: 151 NTFC---GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 36/227 (15%)

Query: 237 NLIGVGSFGSVYKGVFD--EDGT--VVAIKVINLQRQGASKS-FMAECKALKNIRHKNLV 291
             +G G FG V    +D   D T   VA+K +N   +   +S F  E + L+ + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +    C      G     ++ +Y+P+GSL  +L      QR R+    ++ L + +  + 
Sbjct: 70  KYKGVCEK---PGGRSLRLIMEYLPSGSLRDYL------QRHRD----QINLKRLLLFSS 116

Query: 352 DVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF------YQAVSNPT 404
            +   +DYL  Q      +H DL   NIL++++    I DFGL++       Y  V  P 
Sbjct: 117 QICKGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT 451
            S        I + APE    S+ S+  DV+S+G+ L E+ T   P+
Sbjct: 173 ESP-------IFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVITSC 297
           +G GS G VYK      G + A+K I++       K  + E K L++     +V+    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               ++  +  +IV +YM  GSL      D + ++  +I    L       IA  +   L
Sbjct: 65  YGAFYKEGEI-SIVLEYMDGGSLA-----DLL-KKVGKIPEPVLAY-----IARQILKGL 112

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR----G 413
           DYLH   +  I+H D+KPSN+L+++     I DFG+S+         + +++       G
Sbjct: 113 DYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISK--------VLENTLDQCNTFVG 162

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T+ Y++PE   G   S   D++S G+ LLE    K P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 236 TNLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLV 291
             +IG G FG V +G     G     VAIK +        +  F+ E   +    H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 292 R---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           R   V+T    V         I+ +YM NGSL+K+L       R+ +    K T+ Q + 
Sbjct: 69  RLEGVVTKSRPV--------MIITEYMENGSLDKFL-------REND---GKFTVGQLVG 110

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           +   +AS + YL +      +H DL   NIL++++L   + DFGLSR  +  S  T ++ 
Sbjct: 111 MLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED-SEATYTTK 166

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE     + ++  DV+S+GI++ E+++
Sbjct: 167 -GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.4 bits (245), Expect = 3e-23
 Identities = 59/211 (27%), Positives = 110/211 (52%), Gaps = 23/211 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
           + +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 297 CS-SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           C+    F       I+ ++M  G+L  +L      + +R+ E+  + LL    +A  ++S
Sbjct: 71  CTREPPFY------IITEFMTYGNLLDYLR-----ECNRQ-EVNAVVLLY---MATQISS 115

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           A++YL    ++  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPI 169

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + APE    ++ S   DV+++G+LL E+ T
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 97.5 bits (243), Expect = 8e-23
 Identities = 73/231 (31%), Positives = 115/231 (49%), Gaps = 41/231 (17%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG V+ G       + D  +VA+K +       A K F  E + L N +H+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQKLTLLQRISI 349
               C+    +G D   +V++YM +G L K+L    PDA   +  +  + +LTL Q + I
Sbjct: 73  FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 350 AIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVSN 402
           A+ +AS + YL  QH     +H DL   N L+  DL   IGDFG+SR      +Y+    
Sbjct: 128 AVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---- 179

Query: 403 PTVSSSIGVRGT----IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
                   V G     I ++ PE  +  + +T  DV+S+G++L E+ T  K
Sbjct: 180 --------VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.0 bits (242), Expect = 8e-23
 Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 37/227 (16%)

Query: 232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHK 288
            F    +IG G+FG V      +   + A+K +N Q    +G+ ++ + E + L+ + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ-KLTLLQRI 347
            LV +     S  FQ  +   +V   +  G L    H   + Q+ +  E Q K       
Sbjct: 61  FLVNL---WYS--FQDEENMYLVVDLLLGGDLR--YH---LSQKVKFSEEQVKF------ 104

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
               ++  AL+YLH      I+H D+KP NILLD     HI DF ++      +  T   
Sbjct: 105 -WICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT--- 157

Query: 408 SIGVRGTIGYVAPE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT GY+APE     G    V    D +S G+   E +  K+P
Sbjct: 158 --STSGTPGYMAPEVLCRQGYSVAV----DWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 35/217 (16%)

Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVR 292
           +G G FG V    ++G  D     VAIK+I   R+GA     F+ E K +  + H NLV+
Sbjct: 12  LGSGQFGVVHLGKWRGKID-----VAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +   C+    Q   F  IV +YM NG L  +L       R+R+ ++    LL    +  D
Sbjct: 64  LYGVCTK---QRPIF--IVTEYMANGCLLNYL-------RERKGKLGTEWLL---DMCSD 108

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           V  A++YL  +     +H DL   N L+  D    + DFGL+R+   V +   +SS G +
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY---VLDDQYTSSQGTK 162

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
             + +  PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 68/223 (30%), Positives = 100/223 (44%), Gaps = 47/223 (21%)

Query: 239 IGVGSFGSVYKGVFDEDGTV---VAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV KGV+         VA+K +         K F+ E   +  + H  +VR+I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C     +G     +V +  P G L K+L      ++ REI +  L  L     A  VA
Sbjct: 63  GVC-----KGEPL-MLVMELAPLGPLLKYL------KKRREIPVSDLKEL-----AHQVA 105

Query: 355 SALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-------FYQAVSNPTVS 406
             + YL  +H     +H DL   N+LL N   A I DFG+SR       +Y+A +     
Sbjct: 106 MGMAYLESKH----FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT----- 156

Query: 407 SSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + + APE   YG   + S+  DV+SYG+ L E  +
Sbjct: 157 ---AGRWPLKWYAPECINYG---KFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 69/228 (30%), Positives = 105/228 (46%), Gaps = 48/228 (21%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINL-----QRQGASKSFMAECKALKNIRHKNLVR 292
           L+G GSFGSVY+G+  +DG   A+K ++L       Q A K    E   L  ++H N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLT--LLQRISI 349
            + +         D   I  + +P GSL K L    + P    E  I+  T  +L     
Sbjct: 67  YLGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFP----EPVIRLYTRQIL----- 112

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                  L+YLH       +H D+K +NIL+D +    + DFG+++  Q V      S  
Sbjct: 113 -----LGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKS-- 160

Query: 410 GVRGTIGYVAPE-------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +G+  ++APE       YGL +      D++S G  +LEM T K P
Sbjct: 161 -FKGSPYWMAPEVIAQQGGYGLAA------DIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 23/207 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G VYK      G  VAIK + L++Q        E   +K+ +H N+V    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDYYDS-- 83

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +YM  GSL      D I Q        ++   Q   +  +V   L+
Sbjct: 84  ---YLVGDELWVVMEYMDGGSLT-----DIITQNF-----VRMNEPQIAYVCREVLQGLE 130

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YLH      ++H D+K  NILL  D S  + DFG    + A      S    V GT  ++
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG----FAAQLTKEKSKRNSVVGTPYWM 183

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMV 445
           APE     +     D++S GI+ +EM 
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 98.8 bits (246), Expect = 6e-22
 Identities = 56/131 (42%), Positives = 80/131 (61%), Gaps = 3/131 (2%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N LSG IP+ IF+ S     LNL+ N+F GSIP   G++  L + D+SNN LSGEIP ++
Sbjct: 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI 160

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
           G  SSL+ + LGGN   G IP+       +  L L+ N L GQIP  L  + SL+++ L 
Sbjct: 161 GSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220

Query: 123 FNDFEGKVPTK 133
           +N+  G++P +
Sbjct: 221 YNNLSGEIPYE 231

Length = 968

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 39/233 (16%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKAL-KNIRHKNLVRV 293
           +IG GSF +V      E     AIK+++   L ++   K    E + L +   H  ++++
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             +     FQ  +    V +Y PNG L +++        D E   +          A ++
Sbjct: 68  YYT-----FQDEENLYFVLEYAPNGELLQYIRK--YGSLD-EKCTR--------FYAAEI 111

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY---------QAVSNPT 404
             AL+YLH      I+H DLKP NILLD D+   I DFG ++           +  +   
Sbjct: 112 LLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 405 VSSSIGVR-------GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            S     R       GT  YV+PE         + D+++ G ++ +M+T K P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 33/219 (15%)

Query: 238 LIGVGSFGSVYKGVFDEDG---TVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLV 291
           +IG G FG V +G     G     VAIK +     ++Q   + F++E   +    H N++
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPNII 68

Query: 292 R---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
               V+T    V         I+ ++M NG+L+ +L      Q D      + T++Q + 
Sbjct: 69  HLEGVVTKSRPV--------MIITEFMENGALDSFLR-----QND-----GQFTVIQLVG 110

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ-AVSNPTVSS 407
           +   +A+ + YL +      +H DL   NIL++++L   + DFGLSRF +   S+PT +S
Sbjct: 111 MLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           S+G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 168 SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 92.4 bits (230), Expect = 5e-21
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+ G V+K    E G  VA+K + L+R   G     + E KAL+  +H  +V+++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL-- 65

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
              V   G+ F  +V +YMP   L + L       RD E   + L   Q  S    +   
Sbjct: 66  --DVFPHGSGF-VLVMEYMP-SDLSEVL-------RDEE---RPLPEAQVKSYMRMLLKG 111

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + Y+H      I+H DLKP+N+L+  D    I DFGL+R +        S  +  R    
Sbjct: 112 VAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR---W 165

Query: 417 YVAPEYGLGSEVSTNG-DVYSYGILLLEM 444
           Y APE   G+     G D+++ G +  E+
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAEL 194

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 91.9 bits (229), Expect = 8e-21
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 35/216 (16%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK---SFMA--ECKALKNIRHKN-- 289
             +G G++  VYK    E G +VAIK I L  +  +K   +F A  E K L+ ++H N  
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
            L+ V    S+++        +V+++M    LEK +       +D+ I    LT     S
Sbjct: 66  GLLDVFGHKSNIN--------LVFEFME-TDLEKVI-------KDKSI---VLTPADIKS 106

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
             +     L+YLH +    ILH DLKP+N+L+ +D    + DFGL+R +   S     + 
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF--GSPNRKMTH 161

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLE 443
             V  T  Y APE   G+     G D++S G +  E
Sbjct: 162 QVV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 35/217 (16%)

Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVR 292
           +G G FG V    ++G +D     VAIK+I   ++G+     F+ E K +  + H+ LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----VAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +   C+    Q   +  IV +YM NG L  +L         RE   ++    Q + +  D
Sbjct: 64  LYGVCTK---QRPIY--IVTEYMSNGCLLNYL---------REHG-KRFQPSQLLEMCKD 108

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           V   + YL        +H DL   N L+D+     + DFGLSR+   V +   +SS+G +
Sbjct: 109 VCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY---VLDDEYTSSVGSK 162

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
             + +  PE  L S+ S+  DV+++G+L+ E+ +  K
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 39/216 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVR---V 293
           +G G FG V+ G ++   T VAIK +   +QG+   ++F+AE   +K ++H  LVR   V
Sbjct: 14  LGAGQFGEVWMGYYNGH-TKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +T          +   I+ +YM NGSL  +L            E  KLT+ + I +A  +
Sbjct: 70  VT---------QEPIYIITEYMENGSLVDFLKTP---------EGIKLTINKLIDMAAQI 111

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + ++ +   +  +H DL+ +NIL+   L   I DFGL+R    + +   ++  G + 
Sbjct: 112 AEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKF 165

Query: 414 TIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
            I + APE   YG     +   DV+S+GILL E+VT
Sbjct: 166 PIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 27/224 (12%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V+       + ++D  +VA+K +    + A + F  E + L  ++H+++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDA-IPQRDREIEIQKLTLLQRISI 349
              C+           +V++YM +G L ++L    PDA I     ++   +LTL Q ++I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 350 AIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSS 407
           A  +AS + YL   H     +H DL   N L+   L   IGDFG+SR  Y      T   
Sbjct: 128 ASQIASGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-----TDYY 178

Query: 408 SIGVRGT--IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            +G R    I ++ PE  L  + +T  D++S+G++L E+ T  K
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 29/206 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG+V +G +   G  VA+K  N++    +++F+ E   +  + HKNLVR++    
Sbjct: 14  IGEGEFGAVLQGEYT--GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL---G 66

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            +   G     IV + M  G+L  +L       R R +    ++++Q +  ++DVA  ++
Sbjct: 67  VILHNG---LYIVMELMSKGNLVNFLR-----TRGRAL----VSVIQLLQFSLDVAEGME 114

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL     + ++H DL   NIL+  D  A + DFGL+R    V +  V +S   +  + + 
Sbjct: 115 YLES---KKLVHRDLAARNILVSEDGVAKVSDFGLAR----VGSMGVDNS---KLPVKWT 164

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEM 444
           APE     + S+  DV+SYG+LL E+
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 40/225 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVITSC 297
           IGVG+   VY  +   +   VAIK I+L++   S      E +A+    H N+V+  TS 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS- 67

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI---DVA 354
               F   D   +V  Y+  GSL      D +              L    IA    +V 
Sbjct: 68  ----FVVGDELWLVMPYLSGGSLL-----DIMKS------SYPRGGLDEAIIATVLKEVL 112

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-- 412
             L+YLH + Q   +H D+K  NILL  D S  I DFG+S     +++    +   VR  
Sbjct: 113 KGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTR-KVRKT 165

Query: 413 --GTIGYVAPE-----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT  ++APE     +G   +     D++S+GI  +E+ T   P
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 70/228 (30%), Positives = 105/228 (46%), Gaps = 52/228 (22%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVR---V 293
           IG G++G VYK      G +VA+K I L+   +G   + + E   LK + H N+VR   V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 294 ITSCSSV----DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           + S + +    +F   D K    KYM           D+ P    +  + K  L Q +  
Sbjct: 67  VHSENKLYLVFEFLDLDLK----KYM-----------DSSPLTGLDPPLIKSYLYQLLQ- 110

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                  + Y H H    +LH DLKP N+L+D + +  + DFGL+R +           +
Sbjct: 111 ------GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAF----------GV 151

Query: 410 GVRG------TIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKP 450
            VR       T+ Y APE  LGS + ST  D++S G +  EMV  ++P
Sbjct: 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV-NRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 9e-20
 Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 23/208 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++ + T VA+K +      + +SF+ E + +K +RH  LV++    S
Sbjct: 14  LGNGQFGEVWMGTWNGN-TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L         ++ E + L L   + +A  VA+ + 
Sbjct: 72  EEPIY------IVTEYMSKGSLLDFL---------KDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+ + L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 117 YIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL---IEDNEYTARQGAKFPIKWT 170

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+VT
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 87.9 bits (218), Expect = 9e-20
 Identities = 69/213 (32%), Positives = 102/213 (47%), Gaps = 28/213 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITS 296
            IG G+FG VYKGV  +  T VA+K           + F+ E + LK   H N+V++I  
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C  V  Q      IV + +P GSL  +L       R ++  +    LLQ   +++D A+ 
Sbjct: 61  C--VQKQP---IYIVMELVPGGSLLTFL-------RKKKNRLTVKKLLQ---MSLDAAAG 105

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YL        +H DL   N L+  +    I DFG+SR  +     TVS  +  +  I 
Sbjct: 106 MEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLK-QIPIK 160

Query: 417 YVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           + APE   YG     ++  DV+SYGILL E  +
Sbjct: 161 WTAPEALNYG---RYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 28/216 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           I  G++G V+       G + AIKVI    + R+      + E   L   +   +V++  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLTLLQRISIAIDVA 354
           S     FQG     +V +Y+P G L   L    ++ +            + RI IA ++ 
Sbjct: 61  S-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----------VARIYIA-EIV 103

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF----YQAVSNPTVSSSIG 410
            AL+YLH +    I+H DLKP NIL+D++    + DFGLS+      Q   N        
Sbjct: 104 LALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + GT  Y+APE  LG   S   D +S G +L E + 
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G VYK      G +VAIK I L  + +G  K+ + E K LK + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
              V     D   +V+++M +  L K +        +  I+     LLQ           
Sbjct: 65  --DVFRHKGDL-YLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQ----------G 110

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           L + H H    ILH DLKP N+L++ +    + DFGL+R +        +  +  R    
Sbjct: 111 LAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTR---W 163

Query: 417 YVAPEYGLGSEV-STNGDVYSYGILLLEMVT 446
           Y APE  LG +  ST  D++S G +  E+++
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 86.3 bits (214), Expect = 4e-19
 Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 34/230 (14%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL-------QRQGASKSFMAECKAL 282
              F     IG G F  VYK +   DG VVA+K + +        RQ   K    E   L
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK----EIDLL 56

Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K + H N+++ + S     F  N+   IV +    G L + +         +  + QK  
Sbjct: 57  KQLDHPNVIKYLAS-----FIENNELNIVLELADAGDLSRMI---------KHFKKQKRL 102

Query: 343 LLQRI--SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           + +R      + + SAL+++H      I+H D+KP+N+ +       +GD GL RF+   
Sbjct: 103 IPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--- 156

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S+ T ++   V GT  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 157 SSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 24/219 (10%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM--AECKALKNIRHKNLVRVITS 296
           IG GSFG+V K     DG ++  K I+       +     +E   L+ ++H N+VR    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY-- 65

Query: 297 CSSVDFQGNDFKAIVYKYMP---NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
               D   +     +Y  M     G L + +      Q+ ++ E + +       I   +
Sbjct: 66  ----DRIIDRSNQTLYIVMEYCEGGDLAQLI------QKCKK-ERKYIEEEFIWRILTQL 114

Query: 354 ASALDYLH--QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
             AL   H        +LH DLKP+NI LD + +  +GDFGL++    + + +  +   V
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---LGHDSSFAKTYV 171

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  Y++PE           D++S G L+ E+     P
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G GSFG VY+G     V  E  T VAIK +N   + AS      F+ E   +K     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQKLTLLQR 346
           +VR++   S     G     +V + M  G L+ +L    P+A             TL + 
Sbjct: 71  VVRLLGVVS----TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGP----PTLQKF 121

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--FYQAVSNPT 404
           I +A ++A  + YL     +  +H DL   N ++  DL+  IGDFG++R  +        
Sbjct: 122 IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG 178

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               + VR    ++APE       +T  DV+S+G++L EM T
Sbjct: 179 GKGLLPVR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.2 bits (213), Expect = 5e-19
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITS 296
           IG G FG V+ G + E    VAIK I   R+GA   + F+ E + +  + H  LV++   
Sbjct: 12  IGSGQFGLVWLGYWLEK-RKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+           +V+++M +G L  +L       R +  +  + TLL    + +DV   
Sbjct: 68  CTE-----RSPICLVFEFMEHGCLSDYL-------RAQRGKFSQETLLG---MCLDVCEG 112

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + YL       ++H DL   N L+  +    + DFG++RF   V +   +SS G +  + 
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF---VLDDQYTSSTGTKFPVK 166

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +PE    S+ S+  DV+S+G+L+ E+ +  K
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.6 bits (212), Expect = 6e-19
 Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 23/222 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA--ECKALKNIRHKNL 290
           F   N IG GSFG V+K V   D  V A+K I+L +    +   A  E + L  +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +R   S     F       IV +Y  NG L K L      QR R      L   Q     
Sbjct: 62  IRYYES-----FLDKGKLNIVMEYAENGDLHKLLK----MQRGR-----PLPEDQVWRFF 107

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           I +   L +LH    + ILH D+K  N+ LD   +  IGD G+++    + +   + +  
Sbjct: 108 IQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK----LLSDNTNFANT 160

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           + GT  Y++PE       +   DV++ G++L E  T K P D
Sbjct: 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 85.8 bits (212), Expect = 6e-19
 Identities = 66/225 (29%), Positives = 112/225 (49%), Gaps = 47/225 (20%)

Query: 238 LIGVGSFGSVYKGVFDEDG---TVVAIKVINL-----QRQGASKSFMAECKALKNIRHKN 289
           +IG G FG V++G+    G     VAIK +       QRQ     F++E   +    H N
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ----DFLSEASIMGQFSHHN 67

Query: 290 LVR---VITSCSSVDFQGNDFK--AIVYKYMPNGSLEKWLHPDAIPQRDREIE---IQKL 341
           ++R   V+T           FK   I+ +YM NG+L+K+L       RD + E    Q +
Sbjct: 68  IIRLEGVVTK----------FKPAMIITEYMENGALDKYL-------RDHDGEFSSYQLV 110

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            +L+ I+  +   S ++Y+H+         DL   NIL++++L   + DFGLSR  +   
Sbjct: 111 GMLRGIAAGMKYLSDMNYVHR---------DLAARNILVNSNLECKVSDFGLSRVLEDDP 161

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T ++S G +  I + APE     + ++  DV+S+GI++ E+++
Sbjct: 162 EGTYTTS-GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 30/216 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            +G GS+GSVYK +  E G VVAIKV+ +  +   +  + E   LK      +V+   S 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGS- 66

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR---EIEIQKLTLLQRISIAIDVA 354
               +  N    IV +Y   GS+      D +   ++   E EI         +I     
Sbjct: 67  ----YFKNTDLWIVMEYCGAGSVS-----DIMKITNKTLTEEEIA--------AILYQTL 109

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L+YLH +     +H D+K  NILL+ +  A + DFG+S   Q     T++    V GT
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTD--TMAKRNTVIGT 162

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             ++APE       +   D++S GI  +EM   K P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 85.4 bits (211), Expect = 9e-19
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 27/206 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG V  G  D  G  VA+K I  +    +++F+AE   +  +RH NLV+++    
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+ +G  +  IV +YM  GSL  +L       R R + +    LL+    ++DV  A++
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSLVDYLR-----SRGRSV-LGGDCLLK---FSLDVCEAME 116

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL  +     +H DL   N+L+  D  A + DFGL++     S+   +  + V+ T    
Sbjct: 117 YLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT---- 166

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEM 444
           APE     + ST  DV+S+GILL E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 85.1 bits (210), Expect = 1e-18
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 14  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 72  EEPIY------IVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 116

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 117 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 170

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 22/222 (9%)

Query: 239 IGVGSFGSV-----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V     Y     +D  +VA+K +      A K F  E + L N++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQK--LTLLQRIS 348
              C        D   +V++YM +G L K+L    PDA+   D +    K  L L Q + 
Sbjct: 73  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 349 IAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           IA  +AS + YL  QH     +H DL   N L+  +L   IGDFG+SR   +     V  
Sbjct: 128 IASQIASGMVYLASQH----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
              +   I ++ PE  +  + +T  DV+S+G++L E+ T  K
Sbjct: 184 HTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 61/213 (28%), Positives = 108/213 (50%), Gaps = 29/213 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVR---VI 294
           +G G++ +VYKG     G +VA+K I+L   +G   + + E   +K ++H+N+VR   VI
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            + + +         +V++YM +  L+K++        D       L      S    + 
Sbjct: 68  HTENKL--------MLVFEYM-DKDLKKYM--------DTHGVRGALDPNTVKSFTYQLL 110

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + + H++    +LH DLKP N+L++      + DFGL+R +    N T S+ +    T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEV---VT 163

Query: 415 IGYVAPEYGLGSEV-STNGDVYSYGILLLEMVT 446
           + Y AP+  LGS   ST+ D++S G ++ EM+T
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 66/233 (28%), Positives = 97/233 (41%), Gaps = 63/233 (27%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIK--VINLQRQGASKSFMAECKALKNIR---HKNLV 291
             IG G++G+VYK      G  VA+K   + L  +G   S + E   LK +    H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI--------QKL-T 342
           R++  C                                P+ DRE+++        Q L T
Sbjct: 65  RLLDVC------------------------------HGPRTDRELKLTLVFEHVDQDLAT 94

Query: 343 LLQRIS-----------IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF 391
            L +             +   +   +D+LH H    I+H DLKP NIL+ +D    I DF
Sbjct: 95  YLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF 151

Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
           GL+R Y      T   S+ V  T+ Y APE  L S  +T  D++S G +  E+
Sbjct: 152 GLARIYSFEMALT---SVVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 64/224 (28%), Positives = 100/224 (44%), Gaps = 31/224 (13%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRH---K 288
           +    LIG G++G+VY+G     G VVA+K+INL       S    E   L  +R     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N+ +   S      +G     I+ +Y   GS+   +    I ++              IS
Sbjct: 63  NITKYYGSY----LKGPRL-WIIMEYAEGGSVRTLMKAGPIAEK-------------YIS 104

Query: 349 IAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           + I +V  AL Y+H   +  ++H D+K +NIL+ N  +  + DFG++    A+ N   S 
Sbjct: 105 VIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVA----ALLNQNSSK 157

Query: 408 SIGVRGTIGYVAPEYGL-GSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT  ++APE    G    T  D++S GI + EM T   P
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 68/220 (30%), Positives = 110/220 (50%), Gaps = 27/220 (12%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNL 290
           F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 291 VRVITSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           V+++      D    + K  +V++++ +  L+K++  DA P     + + K  L Q +  
Sbjct: 62  VKLL------DVIHTENKLYLVFEFL-HQDLKKFM--DASPLSGIPLPLIKSYLFQLLQ- 111

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                  L + H H    +LH DLKP N+L++ + +  + DFGL+R   A   P  + + 
Sbjct: 112 ------GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYTH 159

Query: 410 GVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTK 448
            V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 160 EVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVRVITSC 297
           +G G+ G V K +    G ++A+K I L+   A  K  + E   L       +V    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLH--PDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
               +   D  +I  +YM  GSL+K L      IP+R          +L +I++A  V  
Sbjct: 69  ----YNNGDI-SICMEYMDGGSLDKILKEVQGRIPER----------ILGKIAVA--VLK 111

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            L YLH+  +  I+H D+KPSNIL+++     + DFG+S   Q V N    + +G   T 
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLV-NSLAKTFVG---TS 163

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y+APE   G++ S   D++S G+ L+E+ T + P
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 73/234 (31%), Positives = 113/234 (48%), Gaps = 38/234 (16%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           D F     IG G++G VYK    + G +VA+K + L  +++G   + + E K L+ + H+
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR 66

Query: 289 NLVR----VITSCSSVDF---QGNDFKAIVYKYMPN---GSLEKWLHPDAIPQRDREIEI 338
           N+V     V     ++DF   +G  +  +V++YM +   G LE  L    +   +  I+ 
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGL----VHFSEDHIK- 119

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
                    S    +   L+Y H+   +  LH D+K SNILL+N     + DFGL+R Y 
Sbjct: 120 ---------SFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167

Query: 399 A-VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKP 450
           +  S P  +  I    T+ Y  PE  LG E      DV+S G +L E+  TKKP
Sbjct: 168 SEESRPYTNKVI----TLWYRPPELLLGEERYGPAIDVWSCGCILGELF-TKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 37/231 (16%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVF-DEDGTV---VAIKVINLQRQGASKS----FMAECKAL 282
           D  + ++L+  G+FG ++ G+  DE       V +K +   +  AS+      + E   L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV---KDHASEIQVTLLLQESCLL 62

Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI---Q 339
             + H+N++ ++  C     +  +   ++Y YM  G+L+ +L      Q+ R  E    Q
Sbjct: 63  YGLSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFL------QQCRLGEANNPQ 112

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--FY 397
            L+  Q + +AI +A  + YLH+     ++H D+   N ++D +L   I D  LSR  F 
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLF- 168

Query: 398 QAVSNPTVSSSIGVRGT--IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                P     +G      + ++A E  +  E S+  DV+S+G+LL E++T
Sbjct: 169 -----PMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 33/213 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G++G VYK      G +VAIKVI L+     +    E   LK  RH N+V    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-- 68

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTLLQRISIAIDVASAL 357
              +   D   IV +Y   GSL+        P  + +I  + + TL             L
Sbjct: 69  ---YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK-----------GL 114

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            YLH   +   +H D+K +NILL  D    + DFG+S    A    T++      GT  +
Sbjct: 115 AYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSFIGTPYW 167

Query: 418 VAPEYGLGSEVSTNG------DVYSYGILLLEM 444
           +APE    + V   G      D+++ GI  +E+
Sbjct: 168 MAPEV---AAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 83.2 bits (205), Expect = 6e-18
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +        ++F+ E + +K +RH  LV +    S
Sbjct: 14  LGQGCFGEVWMGTWN-GTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV ++M  GSL  +L         +E + + L L Q + +A  +A  + 
Sbjct: 72  EEPIY------IVTEFMGKGSLLDFL---------KEGDGKYLKLPQLVDMAAQIADGMA 116

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+ ++L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 117 YIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL---IEDNEYTARQGAKFPIKWT 170

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+VT
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 27/217 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIR---HKNLVRV 293
           IGVG++G+VYK      G  VA+K + +Q    G   S + E   LK +    H N+VR+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C++          +V++++ +  L  +L  D +P      E  K  + Q +      
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL--DKVPPPGLPAETIKDLMRQFLR----- 119

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY--QAVSNPTVSSSIGV 411
              LD+LH +C   I+H DLKP NIL+ +     + DFGL+R Y  Q    P V      
Sbjct: 120 --GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV----- 169

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
             T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 170 --TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 21/220 (9%)

Query: 239 IGVGSFGSV-----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V     Y    ++D  +VA+K +      A K F  E + L N++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQKLTLLQRISIA 350
              C        D   +V++YM +G L K+L    PDA+   +     + LT  Q + IA
Sbjct: 73  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE-LTQSQMLHIA 126

Query: 351 IDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             +A+ + YL  QH     +H DL   N L+  +L   IGDFG+SR   +     V    
Sbjct: 127 QQIAAGMVYLASQH----FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            +   I ++ PE  +  + +T  DV+S G++L E+ T  K
Sbjct: 183 ML--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 73/222 (32%), Positives = 103/222 (46%), Gaps = 25/222 (11%)

Query: 232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKN 289
            F     +G GS+GSVYK     D    A+K ++L    Q   +  + E + L ++ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI-S 348
           ++      + +D  GN    IV +Y P G L K     AI +R ++   +KL   Q I  
Sbjct: 61  IISY--KEAFLD--GNKL-CIVMEYAPFGDLSK-----AISKRKKK---RKLIPEQEIWR 107

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           I I +   L  LH+   + ILH DLK +NILL  +    IGD G+S+  +     T    
Sbjct: 108 IFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-- 162

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               GT  Y+APE   G   S   D++S G LL EM T   P
Sbjct: 163 ----GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 22/219 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVV--AIKVI-NLQRQGASKSFMAECKALKNI-RHKNLVR 292
           ++IG G+FG V K    +DG  +  AIK +     +   + F  E + L  +  H N++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLLQRI 347
           ++ +C   + +G  + AI  +Y P+G+L  +L    + + D    I       L+  Q +
Sbjct: 73  LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A DVA  +DYL    Q+  +H DL   NIL+  +  A I DFGLSR  +     T+  
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 183

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               R  + ++A E    S  +TN DV+SYG+LL E+V+
Sbjct: 184 ----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 40/229 (17%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHK 288
           D +     IG G++G VYK         +A+K I L+++  G   + + E   LK ++H 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 289 NLVRVITSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           N+VR+       D   ++ +  +V++Y+ +  L+K  H D+ P   +   + K  L Q  
Sbjct: 62  NIVRL------QDVVHSEKRLYLVFEYL-DLDLKK--HMDSSPDFAKNPRLIKTYLYQ-- 110

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVS 406
                +   + Y H H    +LH DLKP N+L+D   +A  + DFGL+R +         
Sbjct: 111 -----ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--------- 153

Query: 407 SSIGVRG------TIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
             I VR       T+ Y APE  LGS   ST  D++S G +  EMV  K
Sbjct: 154 -GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 25/223 (11%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNL 290
           +    ++G G+FG V+      D  +V IK I +++  +    +   EC+ LK + H N+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +    +     F  +    IV +Y P G+L ++     I +R   +  +   L   + I 
Sbjct: 62  IEYYEN-----FLEDKALMIVMEYAPGGTLAEY-----IQKRCNSLLDEDTILHFFVQIL 111

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           +    AL ++H      ILH DLK  NILLD + +   IGDFG+S+        + S + 
Sbjct: 112 L----ALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS-----SKSKAY 159

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            V GT  Y++PE   G   +   D+++ G +L E+ + K+  +
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 27/219 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-----KSFMAECKALKNIRHKNLVR 292
           L+G G+FG VY     + G  +A+K +              +   E + LKN++H+ +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C     + ++  +I  +YMP GS++     D +       E    T+ ++ +  I 
Sbjct: 69  YY-GC----LRDDETLSIFMEYMPGGSVK-----DQLKAYGALTE----TVTRKYTRQI- 113

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV-SNPTVSSSIGV 411
               ++YLH +    I+H D+K +NIL D+  +  +GDFG S+  Q + S+ T   S  V
Sbjct: 114 -LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--V 167

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  +++PE   G       DV+S G  ++EM+T K P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 45/231 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINL----------QRQGASKSFMAECKALKNIRH 287
           LIG G++G VY  +    G ++A+K + L          +++   K+  +E + LK++ H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+V+ +           ++ +I  +Y+P GS+   L       R  E  ++  T     
Sbjct: 68  LNIVQYL-GFE----TTEEYLSIFLEYVPGGSIGSCLR---TYGRFEEQLVRFFTE---- 115

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR----FYQAVSNP 403
                V   L YLH    + ILH DLK  N+L+D D    I DFG+S+     Y    N 
Sbjct: 116 ----QVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168

Query: 404 TVSSSIGVRGTIGYVAPE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +      ++G++ ++APE    Y  G   S   D++S G ++LEM   ++P
Sbjct: 169 S------MQGSVFWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 28/214 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR---VIT 295
           +G G FG V+ G ++ + T VA+K +        ++F+ E   +K ++H  LVR   V+T
Sbjct: 14  LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
               +         I+ +YM  GSL  +L  D         E  K+ L + I  +  +A 
Sbjct: 72  KEEPI--------YIITEYMAKGSLLDFLKSD---------EGGKVLLPKLIDFSAQIAE 114

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + Y+ +   +  +H DL+ +N+L+   L   I DFGL+R    + +   ++  G +  I
Sbjct: 115 GMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPI 168

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            + APE       +   DV+S+GILL E+VT  K
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 70/222 (31%), Positives = 111/222 (50%), Gaps = 39/222 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G VYKG   + G +VA+K I L+   +G   + + E   LK ++H N+V +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ-- 65

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR-EIEIQKLTLLQRISIAIDVAS 355
              V  Q +    ++++++ +  L+K+L  D++P+    + E+ K  L Q       +  
Sbjct: 66  --DVLMQESRL-YLIFEFL-SMDLKKYL--DSLPKGQYMDAELVKSYLYQ-------ILQ 112

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG-- 413
            + + H      +LH DLKP N+L+DN     + DFGL+R +           I VR   
Sbjct: 113 GILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF----------GIPVRVYT 159

Query: 414 ----TIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKP 450
               T+ Y APE  LGS   ST  D++S G +  EM  TKKP
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA-TKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.8 bits (203), Expect = 4e-17
 Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 37/225 (16%)

Query: 236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVR- 292
              IG G++G V   V    G  VAIK I+        +K  + E K L+++RH+N++  
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 293 --VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
             ++   S  DF  ND   IV + M    L K +              Q LT        
Sbjct: 65  LDILRPPSPEDF--NDV-YIVTELMET-DLHKVIKSP-----------QPLTDDHIQYFL 109

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             +   L YLH      ++H DLKPSNIL++++    I DFGL+R               
Sbjct: 110 YQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD-------PDEDE 159

Query: 411 VRGTIGYV------APEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
                 YV      APE  L S   T   D++S G +  E++T K
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 27/220 (12%)

Query: 239 IGVGSFGSVYKGVFDEDG----TVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG+VYKGV+  +G      VAIKV+       A+K  + E   + ++ H ++VR+
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C S   Q      ++ + MP G L  ++       R+ +  I    LL   +  + +
Sbjct: 75  LGICLSSQVQ------LITQLMPLGCLLDYV-------RNHKDNIGSQYLL---NWCVQI 118

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL +     ++H DL   N+L+       I DFGL++          +   G + 
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE--GGKV 173

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
            I ++A E  L    +   DV+SYG+ + E++T   KP +
Sbjct: 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 39/222 (17%)

Query: 238 LIGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLV 291
            +G G+FGSV    Y  + D  G VVA+K   LQ   A   + F  E + LK+++H N+V
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +    C S    G     +V +Y+P GSL  +L      Q+ RE  +    LL   S   
Sbjct: 69  KYKGVCYSA---GRRNLRLVMEYLPYGSLRDYL------QKHRE-RLDHRKLLLYAS--- 115

Query: 352 DVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF------YQAVSNPT 404
            +   ++YL  +      +H DL   NIL++++    IGDFGL++       Y  V  P 
Sbjct: 116 QICKGMEYLGSKRY----VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            S        I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 172 ESP-------IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 37/223 (16%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKN 289
           D +     +G GS+ +VYKG    +G +VA+KVI LQ  +G   + + E   LK ++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 290 LV---RVITSCSSVDFQGNDFKAIVYKYM---PNGSLEKWLHPDAIPQRDREIEIQKLTL 343
           +V    +I +  ++          + +YM   P G     LHP+ +          KL L
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG-----LHPENV----------KLFL 109

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
            Q +         L Y+HQ     ILH DLKP N+L+ +     + DFGL+R  ++V + 
Sbjct: 110 FQLL-------RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH 158

Query: 404 TVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
           T S+ +    T+ Y  P+  LGS E ST  D++  G + +EM+
Sbjct: 159 TYSNEV---VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 42/229 (18%)

Query: 239 IGVGSFGSVYKGVFDE--DGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKN---L 290
           IG G++G VYK       DG   AIK       Q  G S+S   E   L+ ++H+N   L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 291 VRVITSCSS------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           V V    +        D+  +D   I+          K+ H     ++ + + I    + 
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQII----------KF-H-----RQAKRVSIPPSMVK 111

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH----IGDFGLSRFYQAV 400
              S+   + + + YLH +    +LH DLKP+NIL+  +        IGD GL+R + A 
Sbjct: 112 ---SLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
             P ++    V  TI Y APE  LG+   T   D+++ G +  E++T +
Sbjct: 166 LKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 68/225 (30%), Positives = 112/225 (49%), Gaps = 32/225 (14%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---------KSFMAECKALKNIRHK 288
           LIG GSFGSVY G+    G ++A+K + L    AS          +   E   LK ++H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLTLLQRI 347
           N+V+ + S    D        I  +Y+P GS+   L+   A  +          TL++  
Sbjct: 67  NIVQYLGSSLDADHLN-----IFLEYVPGGSVAALLNNYGAFEE----------TLVR-- 109

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA--VSNPTV 405
           +    +   L+YLH      I+H D+K +NIL+DN     I DFG+S+  +A  +S  T 
Sbjct: 110 NFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +   ++G++ ++APE    +  +   D++S G L++EM+T K P
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 79.5 bits (196), Expect = 9e-17
 Identities = 73/232 (31%), Positives = 110/232 (47%), Gaps = 46/232 (19%)

Query: 237 NLIGVGSFGSVYKG-VFDEDG-----TVVAIKVINLQRQGAS----KSFMAECKALKNIR 286
           N +G G+FG VY+G   D  G       VA+K +   R+GA+    K F+ E   + N  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFN 57

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N+V+++  C       N+ + I+ + M  G L  +L  DA   R        LTL + 
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLR-DA---RVERFGPPLLTLKEL 108

Query: 347 ISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILL-----DNDLSAHIGDFGLSR----- 395
           + I +DVA    YL Q H     +H DL   N L+     D D    IGDFGL+R     
Sbjct: 109 LDICLDVAKGCVYLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS 164

Query: 396 -FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +Y+          + VR    ++APE  L  + +T  DV+S+G+L+ E++T
Sbjct: 165 DYYRKEG----EGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 68/232 (29%), Positives = 100/232 (43%), Gaps = 42/232 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITS 296
           +G G+FG VYK    + G VVA+K I +  ++ G   + + E K LK ++H N+V +I  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 297 CSSVDFQGNDFKAIVYKYMP------NGSLE----KWLHPDAIPQRDREIEIQKLTLLQR 346
                 +    +  VY   P      +G LE    K                 K  +LQ 
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI-----------KCYMLQ- 123

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTV 405
                 +   ++YLH+     ILH D+K +NIL+DN     I DFGL+R +     NP  
Sbjct: 124 ------LLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 406 SSSIGVRG------TIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKP 450
               G R       T  Y  PE  LG    +T  D++  G +  EM  T++P
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-TRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 68/226 (30%), Positives = 102/226 (45%), Gaps = 38/226 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNL 290
           F   N IG G++G VY+      G +VA+K + +  +R G   S + E   L N+RH N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 291 VR---VITSCSSVDFQGNDFKAI--VYKYMPN--GSLEKWLHPDAIPQRDREIEIQKLTL 343
           V    V+         G    +I  V +Y      SL      D +P    E +++ L L
Sbjct: 69  VELKEVV--------VGKHLDSIFLVMEYCEQDLASL-----LDNMPTPFSESQVKCLML 115

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L YLH++    I+H DLK SN+LL +     I DFGL+R Y   + P
Sbjct: 116 --------QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164

Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
                +    T+ Y APE  LG    T   D+++ G +L E++  K
Sbjct: 165 MTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 22/219 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVV--AIKVIN-LQRQGASKSFMAECKALKNI-RHKNLVR 292
           ++IG G+FG V + +  +DG  +  AIK++     +   + F  E + L  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ-----KLTLLQRI 347
           ++ +C     +   +  I  +Y P G+L  +L    + + D     +      LT  Q +
Sbjct: 68  LLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A DVA+ + YL    ++  +H DL   N+L+  +L++ I DFGLSR  +     T+  
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG- 178

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               R  + ++A E    S  +T  DV+S+G+LL E+V+
Sbjct: 179 ----RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 49/231 (21%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL----------QRQGASKSFMAECKAL 282
           F+    IG GSFG VYK +      VVAIKVI+L          Q++     F+++C++ 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQE---IQFLSQCRS- 58

Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
                  + +   S     F       I+ +Y   GS    L P     +  E  I    
Sbjct: 59  -----PYITKYYGS-----FLKGSKLWIIMEYCGGGSCLDLLKP----GKLDETYIA--- 101

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS---RFYQA 399
                 I  +V   L+YLH+   E  +H D+K +NILL  +    + DFG+S       +
Sbjct: 102 -----FILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             N  V       GT  ++APE    S      D++S GI  +E+   + P
Sbjct: 154 KRNTFV-------GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 67/227 (29%), Positives = 116/227 (51%), Gaps = 33/227 (14%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           D +   N I  G++G VY+    + G +VA+K + +  +++G   + + E   L  ++H 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP 64

Query: 289 NLVRV--ITSCSSVD--FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           N+V V  +   S++D  +       +V +Y+ +  L+  +  + + Q   + E++   L+
Sbjct: 65  NIVTVKEVVVGSNLDKIY-------MVMEYVEH-DLKSLM--ETMKQPFLQSEVK--CLM 112

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
            ++       S + +LH +    ILH DLK SN+LL+N     I DFGL+R Y   S   
Sbjct: 113 LQL------LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLK 161

Query: 405 VSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKP 450
             + + V  T+ Y APE  LG  E ST  D++S G +  E++ TKKP
Sbjct: 162 PYTQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL-TKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVR 292
           +G G+FG VYKG           T VAIK +    +   +  F  E + + +++H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLLQRI 347
           ++  C+           ++++Y+ +G L ++L     H D   +   E     L     +
Sbjct: 73  LLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVS 401
            IAI +A+ ++YL  H     +H DL   N L+   L+  I DFGLSR      +Y+  S
Sbjct: 128 HIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
                S + VR    ++ PE  L  + +T  D++S+G++L E+
Sbjct: 185 K----SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.3 bits (198), Expect = 5e-16
 Identities = 53/156 (33%), Positives = 71/156 (45%), Gaps = 26/156 (16%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG--- 57
           +F N+ +G IP A+ S+  L   L L  N F G IP  +G    L   D+S N L+G   
Sbjct: 315 LFSNNFTGKIPVALTSLPRL-QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373

Query: 58  ---------------------EIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKL 96
                                EIP  LG C SL  + L  N F G +PS F     +  L
Sbjct: 374 EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433

Query: 97  DLSRNNLSGQI-PLFLEALSLEYLNLSFNDFEGKVP 131
           D+S NNL G+I     +  SL+ L+L+ N F G +P
Sbjct: 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.6 bits (191), Expect = 5e-16
 Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 33/221 (14%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           ++G G++G VY          +AIK I  +     +    E      ++H+N+V+ + S 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
           S      N F  I  + +P GSL   L     P +D E  I   T          +   L
Sbjct: 75  SE-----NGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK--------QILEGL 121

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSA--HIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            YLH      I+H D+K  N+L+ N  S    I DFG S+    + NP   +     GT+
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGI-NPCTET---FTGTL 173

Query: 416 GYVAPEY------GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y+APE       G G+      D++S G  ++EM T K P
Sbjct: 174 QYMAPEVIDKGPRGYGAP----ADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 34/218 (15%)

Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G +VA+K +  +  Q  +  +  E   LK + H+N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              CS    QG     ++ +Y+P GSL  +L     P+        KL L Q +  A  +
Sbjct: 72  KGCCSE---QGGKGLQLIMEYVPLGSLRDYL-----PK-------HKLNLAQLLLFAQQI 116

Query: 354 ASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
              + YLH QH     +H DL   N+LLDND    IGDFGL++   AV  P       VR
Sbjct: 117 CEGMAYLHSQH----YIHRDLAARNVLLDNDRLVKIGDFGLAK---AV--PEGHEYYRVR 167

Query: 413 ----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 + + A E    ++ S   DV+S+G+ L E++T
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.2 bits (190), Expect = 6e-16
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 27/213 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITS 296
           +G G FG V+ G +      VAIK IN   +GA   + F+ E K +  + H  LV++   
Sbjct: 12  LGSGQFGVVHLGKWRAQ-IKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+    Q   +  IV ++M NG L  +L       R R+ ++ K  LL   S+  DV   
Sbjct: 68  CTQ---QKPLY--IVTEFMENGCLLNYL-------RQRQGKLSKDMLL---SMCQDVCEG 112

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YL ++     +H DL   N L+ +     + DFG++R+   V +   +SS G +  + 
Sbjct: 113 MEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRY---VLDDEYTSSSGAKFPVK 166

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           +  PE    S+ S+  DV+S+G+L+ E+ T  K
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTV----VAIKVINLQRQGASKSFMA---ECKALKNIRHKNL 290
           L+G G FG+V+KG++  +G      VAIK I  Q +   ++F        A+ ++ H  +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           VR++  C     Q      +V +  P GSL      D + Q    ++ Q+L     ++  
Sbjct: 72  VRLLGICPGASLQ------LVTQLSPLGSLL-----DHVRQHRDSLDPQRL-----LNWC 115

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + +A  + YL +H    ++H +L   NILL +D    I DFG++            S   
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH- 171

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +  I ++A E  L    +   DV+SYG+ + EM++
Sbjct: 172 -KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 27/209 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVRVITS 296
           L+G G+FG V+KG   +D T VA+K          K  F++E + LK   H N+V++I  
Sbjct: 2   LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+           IV + +P G    +L      ++ ++    +L   Q +  A+D A+ 
Sbjct: 61  CTQ-----RQPIYIVMELVPGGDFLSFL------RKKKD----ELKTKQLVKFALDAAAG 105

Query: 357 LDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT- 414
           + YL  ++C    +H DL   N L+  +    I DFG+SR      +  + SS G++   
Sbjct: 106 MAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIP 157

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           I + APE       S+  DV+SYGILL E
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 31/231 (13%)

Query: 232 GFSSTNLIGVGSFGSVYKGVFDEDG-TVVAIKVINL----------QRQGASKSFMAECK 280
            ++    +G G+FG VYK     +G  ++A+K IN+          +R  +    ++E  
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 281 ALK-NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
            +K  +RH N+VR   +     F  ND   IV   +    L +  H +++ ++ +    +
Sbjct: 61  IIKEQLRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEE 113

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
           ++      +I + +  AL YLH+  ++ I+H DL P+NI+L  D    I DFGL++  Q 
Sbjct: 114 RIW-----NIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QK 164

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                ++S   V GTI Y  PE           DV+++G +L +M T + P
Sbjct: 165 QPESKLTS---VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 39/219 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNIRHKNLVRVI 294
           ++G G++G V K      G +VAIK    + +      K+ + E K L+ +RH+N+V + 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLE------KWLHPDAIPQRDREIEIQKLTLLQRIS 348
            +      +G  +  +V++Y+    LE        L PDA+          +  + Q   
Sbjct: 67  EAFRR---KGRLY--LVFEYVERTLLELLEASPGGLPPDAV----------RSYIWQ--- 108

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
               +  A+ Y H H    I+H D+KP NIL+       + DFG +R  +A     ++  
Sbjct: 109 ----LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161

Query: 409 IGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
           +  R    Y APE  +G        DV++ G ++ E++ 
Sbjct: 162 VATR---WYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 49/129 (37%), Positives = 74/129 (57%), Gaps = 2/129 (1%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N+L+G IP ++ ++  L   L L +N   G IPP I +L+ L S D+S+N LSGEIP  +
Sbjct: 246 NNLTGPIPSSLGNLKNL-QYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFL-EALSLEYLNLS 122
               +LE ++L  N F G IP    +   ++ L L  N  SG+IP  L +  +L  L+LS
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLS 364

Query: 123 FNDFEGKVP 131
            N+  G++P
Sbjct: 365 TNNLTGEIP 373

Length = 968

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 28/216 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G+V+K    E   +VA+K + L    +G   S + E   LK ++HKN+VR+   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65

Query: 297 CSSVDFQGNDFK-AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
               D   +D K  +V++Y  +  L+K+   D+    D + EI K  + Q +        
Sbjct: 66  ----DVLHSDKKLTLVFEYC-DQDLKKYF--DSC-NGDIDPEIVKSFMFQLLK------- 110

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            L + H H    +LH DLKP N+L++ +    + DFGL+R +     P    S  V  T+
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI---PVRCYSAEVV-TL 163

Query: 416 GYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
            Y  P+   G+++ ST+ D++S G +  E+    +P
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 29/210 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G GSFG V        G   A+K+++     +    +  + E + L++IRH  LV +  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           S     FQ +    +V +Y+P G L   L      ++                 A  V  
Sbjct: 69  S-----FQDDSNLYLVMEYVPGGELFSHL------RKSGRFPEPVARFY-----AAQVVL 112

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           AL+YLH      I++ DLKP N+LLD+D    I DFG ++    V   T +      GT 
Sbjct: 113 ALEYLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR---VKGRTYTLC----GTP 162

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
            Y+APE  L        D ++ GIL+ EM+
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 66/234 (28%), Positives = 117/234 (50%), Gaps = 30/234 (12%)

Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQRQG--ASKSFMAEC 279
           +LK T+      ++G G+FG+VYKG++  +G      VAIK++N +  G  A+  FM E 
Sbjct: 3   ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 60

Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
             + ++ H +LVR++  C S   Q      +V + MP+G L  ++H     +    I  Q
Sbjct: 61  LIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVH-----EHKDNIGSQ 109

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L     ++  + +A  + YL    +  ++H DL   N+L+ +     I DFGL+R  + 
Sbjct: 110 LL-----LNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
             +    ++ G +  I ++A E     + +   DV+SYG+ + E++T   KP D
Sbjct: 162 --DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 35/219 (15%)

Query: 238 LIGVGSFGSVYKGVFDEDG---TVVAIKVINL---QRQGASKSFMAECKALKNIRHKNLV 291
           +IG G FG V  G     G     VAIK +     ++Q   + F++E   +    H N++
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ--RRDFLSEASIMGQFDHPNII 68

Query: 292 R---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
               V+T    V         IV +YM NGSL+ +L         R+ + Q  T++Q + 
Sbjct: 69  HLEGVVTKSKPV--------MIVTEYMENGSLDAFL---------RKHDGQ-FTVIQLVG 110

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-S 407
           +   +AS + YL        +H DL   NIL++++L   + DFGLSR  +   +P  + +
Sbjct: 111 MLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYT 165

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 67/233 (28%), Positives = 98/233 (42%), Gaps = 44/233 (18%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN------LQRQGASKSFMAECKALKN 284
           +     + +G G+ GSV K      G + A+K I       LQ+Q      + E +  K+
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ-----ILRELEINKS 55

Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
            +   +V+   +   +D   +    I  +Y   GSL      D+I ++ ++         
Sbjct: 56  CKSPYIVKYYGAF--LDESSSSIG-IAMEYCEGGSL------DSIYKKVKK-------RG 99

Query: 345 QRIS------IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
            RI       IA  V   L YLH      I+H D+KPSNILL       + DFG      
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFG------ 150

Query: 399 AVSNPTVSSSIGV-RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            VS   V+S  G   GT  Y+APE   G   S   DV+S G+ LLE+   + P
Sbjct: 151 -VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 45/232 (19%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGAS----KSFMAECKALKNIRHKN 289
           IG G+FG V++      +  E  T+VA+K++   ++ AS      F  E   +    H N
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQK------ 340
           +V+++  C+     G     ++++YM  G L ++L    P A           +      
Sbjct: 70  IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124

Query: 341 --LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--- 395
             L+  +++ IA  VA+ + YL    +   +H DL   N L+  ++   I DFGLSR   
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 396 ---FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
              +Y+A  N  +         I ++ PE    +  +T  DV++YG++L E+
Sbjct: 182 SADYYKASENDAIP--------IRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 30/222 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTV---VAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVR 292
           ++G G FGSV +G   +D      VA+K + L     S  + F++E   +K+  H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 293 VITSC-SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +I  C  +   Q      ++  +M +G L  +L    +     ++ +Q L         +
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF-----MV 120

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           D+A  ++YL        +H DL   N +L  D++  + DFGLS+         + S    
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYY 169

Query: 412 RGT------IGYVAPEYGLGSEVST-NGDVYSYGILLLEMVT 446
           R        + ++A E  L   V T   DV+++G+ + E+ T
Sbjct: 170 RQGRIAKMPVKWIAIE-SLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 4e-15
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 35/215 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVR---VI 294
           +G GS+ +VYKG     G +VA+K I L+  +GA  + + E   LK+++H N+V    +I
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQKLTLLQRISIAID 352
            +  ++          V++Y+ +  L++++      +   +      +L L Q +     
Sbjct: 73  HTKKTLTL--------VFEYL-DTDLKQYMDDCGGGLSMHN-----VRLFLFQLLR---- 114

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
               L Y HQ     +LH DLKP N+L+       + DFGL+R   A S P+ + S  V 
Sbjct: 115 ---GLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV 165

Query: 413 GTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
            T+ Y  P+  LGS E ST+ D++  G +  EM T
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 38/229 (16%)

Query: 238 LIGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNI-RHKNL 290
            +G G+FG V K          + + VA+K++            ++E + +K I +HKN+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH------PDAIPQRDREIEIQKLTLL 344
           + ++  C+    +G  +  +V +Y  +G+L  +L         A P   R  E + LT  
Sbjct: 79  INLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE-ETLTQK 132

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  +++L     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 133 DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTN-GDVYSYGILLLEMVT 446
             +N         R  + ++APE  L   V T+  DV+S+G+LL E+ T
Sbjct: 190 KTTNG--------RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 56/156 (35%), Positives = 74/156 (47%), Gaps = 28/156 (17%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L G IP ++ +++ L   L LA N  VG IP  +G +K+L+   +  N LSGEIP E+
Sbjct: 174 NVLVGKIPNSLTNLTSLE-FLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLS 122
           G  +SL                          LDL  NNL+G IP  L  L  L+YL L 
Sbjct: 233 GGLTSLN------------------------HLDLVYNNLTGPIPSSLGNLKNLQYLFLY 268

Query: 123 FNDFEGKVPTKGIFANTSAISV-AGCHRLCGGIPEL 157
            N   G +P   IF+    IS+    + L G IPEL
Sbjct: 269 QNKLSGPIP-PSIFSLQKLISLDLSDNSLSGEIPEL 303

Length = 968

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 43/218 (19%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA-ECKALKNIRHKNLVRVIT 295
           N IG G+ G+VYK +    G + A+KVI    +   +  +  E + L+++ H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C  +     + + ++ ++M  GSLE              I  +         +A  + S
Sbjct: 137 -CHDMFDHNGEIQ-VLLEFMDGGSLE-----------GTHIADE----QFLADVARQILS 179

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YLH+     I+H D+KPSN+L+++  +  I DFG+SR      +P  SS     GTI
Sbjct: 180 GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV----GTI 232

Query: 416 GYVAPEYGLGSEVSTN----------GDVYSYGILLLE 443
            Y++PE      ++T+          GD++S G+ +LE
Sbjct: 233 AYMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAIK +NLQ+Q   +  + E   ++  +H N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-- 84

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI---DVAS 355
              +   D   +V +Y+  GSL      D + +          T +    IA    +   
Sbjct: 85  ---YLVGDELWVVMEYLAGGSLT-----DVVTE----------TCMDEGQIAAVCRECLQ 126

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           AL++LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT 
Sbjct: 127 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTP 179

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++APE           D++S GI+ +EMV  + P
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 66/249 (26%), Positives = 98/249 (39%), Gaps = 61/249 (24%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFD-EDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           D F    +IG G+FG V+  V D + G V A+KV+    + ++       AE   L +  
Sbjct: 1   DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL--- 343
              +V++  S     FQ  +   +V +YMP G L   L             I+K      
Sbjct: 60  SPWIVKLYYS-----FQDEEHLYLVMEYMPGGDLMNLL-------------IRKDVFPEE 101

Query: 344 LQRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAV 400
             R  IA ++  ALD +H+       +H D+KP NIL+D D   HI   DFGL +     
Sbjct: 102 TARFYIA-ELVLALDSVHKLGF----IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKA 154

Query: 401 SNPTVSSSIGVR-------------------------GTIGYVAPEYGLGSEVSTNGDVY 435
            +     +                             GT  Y+APE   G+      D +
Sbjct: 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWW 214

Query: 436 SYGILLLEM 444
           S G++L EM
Sbjct: 215 SLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 18/213 (8%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA--ECKALKNIRHKNLVRVITS 296
           IG G+FG V+K    +   +VA+K + ++ +       A  E K L+ ++H+N+V +I  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 297 CSSVDFQGNDFKAIVYKYMP--NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
           C +     N +K   Y         L   L    +     EI+     LL          
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL---------- 129

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           + L Y+H++    ILH D+K +NIL+  D    + DFGL+R +    N   +       T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 415 IGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
           + Y  PE  LG  +     D++  G ++ EM T
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 74.8 bits (184), Expect = 8e-15
 Identities = 69/211 (32%), Positives = 92/211 (43%), Gaps = 27/211 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKAL-KNIRHKNLVRVI 294
           IG GSFG V       DG   A+KV+    + ++   K  MAE   L KN++H  LV + 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S     FQ  D    V  Y+  G L   L      QR+R     +         A ++A
Sbjct: 63  YS-----FQTADKLYFVLDYVNGGELFFHL------QRERSFPEPRARFY-----AAEIA 106

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           SAL YLH      I++ DLKP NILLD+     + DFGL +     S  T +      GT
Sbjct: 107 SALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC----GT 159

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             Y+APE           D +  G +L EM+
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.0 bits (181), Expect = 9e-15
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVV--AIKVIN-LQRQGASKSFMAECKALKNI-RHKNLVR 292
           ++IG G+FG V K    +DG  +  AIK +     +   + F  E + L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ-----KLTLLQRI 347
           ++ +C     +   +  +  +Y P+G+L  +L    + + D    I       L+  Q +
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A DVA  +DYL Q   +  +H DL   NIL+  +  A I DFGLSR  +     T+  
Sbjct: 116 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 171

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               R  + ++A E    S  +TN DV+SYG+LL E+V+
Sbjct: 172 ----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+   +++  T VA+K +         +F+AE   +K ++H  LV++    +
Sbjct: 14  LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      I+ ++M  GSL  +L  D         E  K  L + I  +  +A  + 
Sbjct: 72  KEPIY------IITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQIAEGMA 116

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           ++ Q      +H DL+ +NIL+   L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFPIKWT 170

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE       +   DV+S+GILL+E+VT
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 239 IGVGSFGSVYKGV-FDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIR---HKNLVR 292
           IG G++G V+K       G  VA+K + +Q   +G   S + E   L+++    H N+VR
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +   C+           +V++++ +  L  +L  D +P+     E  K  + Q       
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGVPTETIKDMMFQ------- 118

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   LD+LH H    ++H DLKP NIL+ +     + DFGL+R Y   S     +S+ V 
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV- 171

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
            T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 172 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 39/216 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLV---RVI 294
           +G GS+ +VYKG+   +G +VA+KVI+++  +G   + + E   LK ++H N+V    +I
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72

Query: 295 TSCSSVDFQGNDFKAIVYKYM---PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            +  ++ F        + +YM   P G     LHP  +          +L + Q +    
Sbjct: 73  HTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNV----------RLFMFQLL---- 113

Query: 352 DVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
                L Y+H QH    ILH DLKP N+L+       + DFGL+R  +++ + T SS + 
Sbjct: 114 ---RGLAYIHGQH----ILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEV- 164

Query: 411 VRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
              T+ Y  P+  LG+ + S+  D++  G + +EM+
Sbjct: 165 --VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 31/217 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA--ECKALKNIRHKNLVRVITS 296
           +G G+FG        ED ++V  K +NL R    +   A  E   L  ++H N++     
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQR---ISIAID 352
                F  ++   I  +Y   G+L +K +              QK  L +    +     
Sbjct: 68  -----FMDDNTLLIEMEYANGGTLYDKIVR-------------QKGQLFEEEMVLWYLFQ 109

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           + SA+ Y+H+     ILH D+K  NI L       +GDFG+S+    +     S +  V 
Sbjct: 110 IVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISK----ILGSEYSMAETVV 162

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           GT  Y++PE   G + +   D+++ G +L E++T K+
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G  VA+K +  +  G        E + L+N+ H+N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C+  +  GN  K I+ +++P+GSL+++L     P+        K+ L Q++  A+ +
Sbjct: 72  KGICT--EDGGNGIKLIM-EFLPSGSLKEYL-----PR-----NKNKINLKQQLKYAVQI 118

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN-PTVSSSIGVR 412
              +DYL        +H DL   N+L++++    IGDFGL++  +      TV   +   
Sbjct: 119 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLD-- 173

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             + + APE  + S+     DV+S+G+ L E++T
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 26/223 (11%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIK---VINLQRQGASKSFMAECKALKNIRHKN 289
           F     IG G F  VY+     DG  VA+K   + +L    A    + E   LK + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI-- 347
           +++   S     F  ++   IV +    G L + +         +  + QK  + ++   
Sbjct: 64  VIKYYAS-----FIEDNELNIVLELADAGDLSRMI---------KHFKKQKRLIPEKTVW 109

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
              + + SAL+++H      ++H D+KP+N+ +       +GD GL RF+   S  T + 
Sbjct: 110 KYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAH 164

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S+   GT  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 165 SL--VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 43/223 (19%)

Query: 238 LIGVGSFGSVYKGVFDE-DGTV--VAIKVINLQR-QGASKSFMAECKALKNIRHKNLVR- 292
            +G GSFG V +G +    G V  VA+K +   +       F+ E   + ++ H+NL+R 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 293 --VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
             V+ +   +         +V +  P GSL   L  DA+           ++ L   ++ 
Sbjct: 62  YGVVLTHPLM---------MVTELAPLGSLLDRLRKDALG-------HFLISTLCDYAVQ 105

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-------FYQAVSNP 403
           I  A+ + YL     +  +H DL   NILL +D    IGDFGL R        Y    + 
Sbjct: 106 I--ANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160

Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            V           + APE       S   DV+ +G+ L EM T
Sbjct: 161 KVP--------FAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 71.8 bits (177), Expect = 6e-14
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 36/218 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAEC------KALKNI-RHKNLV 291
           +G G+FGSVY     E G +VAIK   ++++  S     EC      K+L+ +  H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK--MKKKFYSWE---ECMNLREVKSLRKLNEHPNIV 61

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++        F+ ND    V++YM  G+L +      +  R      +  +     SI  
Sbjct: 62  KLKEV-----FRENDELYFVFEYM-EGNLYQ-----LMKDRKG----KPFSESVIRSIIY 106

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +   L ++H+H      H DLKP N+L+       I DFGL+R  +  S P  +  +  
Sbjct: 107 QILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVST 161

Query: 412 RGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTK 448
           R    Y APE  L S   S+  D+++ G ++ E+ T +
Sbjct: 162 R---WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 31/211 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRVITSC 297
           IG G+FG V+ G    D T VA+K          K+ F+ E + LK   H N+VR+I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
           +    Q      IV + +  G    +L  +    + +E+          I +  + A+ +
Sbjct: 63  T----QKQPI-YIVMELVQGGDFLTFLRTEGPRLKVKEL----------IQMVENAAAGM 107

Query: 358 DYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT-I 415
           +YL  +HC    +H DL   N L+       I DFG+SR      +   +S+ G++   +
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPV 160

Query: 416 GYVAPE---YGLGSEVSTNGDVYSYGILLLE 443
            + APE   YG     S+  DV+S+GILL E
Sbjct: 161 KWTAPEALNYG---RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 31/215 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVR---VI 294
           +G G++ +V+KG       +VA+K I L+  +GA  + + E   LKN++H N+V    +I
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            +   +         +V++Y+ +  L+++L           ++I    LL+         
Sbjct: 73  HTERCL--------TLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR--------- 114

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L Y H+     ILH DLKP N+L++      + DFGL+R   A S PT + S  V  T
Sbjct: 115 -GLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVV-T 166

Query: 415 IGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
           + Y  P+  LGS E ST  D++  G +L EM T +
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+         AE   +++I+ +  + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 293 VITSCSS---VDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L P  +       E Q  T+L+
Sbjct: 55  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILR 108

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                 ++   LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 109 ------EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI 156

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 157 KRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 31/219 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+FG VYK    E G + A KVI+ + +   + +M E   L +  H N+V+++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-LTLLQRISIAIDVASAL 357
              F   +   I+ ++   G++      DA+      +E+++ LT  Q   +      AL
Sbjct: 71  ---FYYENNLWILIEFCAGGAV------DAV-----MLELERPLTEPQIRVVCKQTLEAL 116

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           +YLH++    I+H DLK  NIL   D    + DFG+S    A +  T+       GT  +
Sbjct: 117 NYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYW 169

Query: 418 VAPEYGLGSEVSTN------GDVYSYGILLLEMVTTKKP 450
           +APE  +  E S +       DV+S GI L+EM   + P
Sbjct: 170 MAPEVVM-CETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 30/179 (16%)

Query: 24  LNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSI 83
           L L      G IP  I  L+ L+S ++S N + G IP  LG  +SLE + L  N F+GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 84  PSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAIS 143
           P        +R L+L+ N+LSG++P  L    L   + +F D  G               
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG--------------- 527

Query: 144 VAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWHKR 202
                 LC GIP   L  C  + S   +I  +  + ++       + +V   +  W +R
Sbjct: 528 ------LC-GIP--GLRACGPHLSVGAKIGIAFGVSVAF------LFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 28/233 (12%)

Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQGAS----KSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+  S    K  + E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 110

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL    +  ++H DL   N+L+       I DFGL++   A 
Sbjct: 111 L-----LNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA- 161

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
            +     + G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 162 -DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 72.9 bits (179), Expect = 1e-13
 Identities = 66/239 (27%), Positives = 105/239 (43%), Gaps = 43/239 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS------KSFMAECKALKNIRHKNLV 291
           LIG G  G VY          VA+K I   R+  S      K F+ E K   ++ H  +V
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKI---REDLSENPLLKKRFLREAKIAADLIHPGIV 65

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMP---NGSLEKWLHPDAIPQRD---REIEIQKLTLLQ 345
            V + CS  D         VY  MP     +L+  L   ++ Q++   +E+  +  ++  
Sbjct: 66  PVYSICSDGD--------PVYYTMPYIEGYTLKSLLK--SVWQKESLSKELAEKT-SVGA 114

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            +SI   + + ++Y+H    + +LH DLKP NILL       I D+G + F +      +
Sbjct: 115 FLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171

Query: 406 SSSIGVR--------------GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +  R              GT  Y+APE  LG   S + D+Y+ G++L +M+T   P
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+FG VYK    E G + A KVI  + +   + +M E + L    H  +V+++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIP-QRDREIEIQKLTLLQRISIAIDVASAL 357
              F  +    I+ ++ P G++      DAI  + DR +   ++ ++ R      +  AL
Sbjct: 78  ---FYWDGKLWIMIEFCPGGAV------DAIMLELDRGLTEPQIQVICR-----QMLEAL 123

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            YLH      I+H DLK  N+LL  D    + DFG+S    A +  T+       GT  +
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYW 176

Query: 418 VAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKP 450
           +APE  +      +      D++S GI L+EM   + P
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+FG VYK    E G   A K+I ++ +   + FM E   L   +H N+V +     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---- 68

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-LTLLQRISIAIDVASAL 357
              F  N    I+ ++   G+L      D+I      +E+++ LT  Q   +   +  AL
Sbjct: 69  EAYFYENKL-WILIEFCDGGAL------DSI-----MLELERGLTEPQIRYVCRQMLEAL 116

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           ++LH H    ++H DLK  NILL  D    + DFG+S    A +  T+       GT  +
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS----AKNKSTLQKRDTFIGTPYW 169

Query: 418 VAPEYGLGSEVSTN-----GDVYSYGILLLEMVTTKKP 450
           +APE         N      D++S GI L+E+   + P
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 62/222 (27%), Positives = 90/222 (40%), Gaps = 43/222 (19%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           I  G+FGSVY       G   AIKV+        KS M     + N++ +  + +I   S
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVL-------KKSDMIAKNQVTNVKAERAIMMIQGES 56

Query: 299 S------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ----RIS 348
                    FQ  D+  +V +Y+  G              D    I+ L  L     +  
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGG--------------DCASLIKTLGGLPEDWAKQY 102

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           IA +V   ++ LHQ     I+H D+KP N+L+D      + DFGLSR    + N      
Sbjct: 103 IA-EVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSR--NGLENKKFV-- 154

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               GT  Y+APE  LG       D +S G ++ E +    P
Sbjct: 155 ----GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-----FMAECKALKNIRHKNLVR 292
           L+G G+FG VY     + G  +A K +    +    S        E + LKN++H+   R
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE---R 65

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++     +  +      I  +YMP GS+           +D+      LT          
Sbjct: 66  IVQYYGCLRDRAEKTLTIFMEYMPGGSV-----------KDQLKAYGALTESVTRKYTRQ 114

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   + YLH +    I+H D+K +NIL D+  +  +GDFG S+  Q +      S  G+R
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI----CMSGTGIR 167

Query: 413 ---GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  +++PE   G       DV+S G  ++EM+T K P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 29/220 (13%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK----SFMAECKALKNIRHKN 289
           +G GSFG VY+G     V DE  T VAIK +N   + AS      F+ E   +K     +
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 70

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +VR++   S    QG     ++ + M  G L+ +L     P+ +        +L + I +
Sbjct: 71  VVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPSLKKMIQM 124

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+     T    
Sbjct: 125 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----TDYYR 176

Query: 409 IGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAIK +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   ALD
Sbjct: 85  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALD 129

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWM 182

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EMV  + P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 36/225 (16%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS------KSFMAECKALKNIRHKNLV 291
            +G G+F S Y+    + GT++A+K +   R  +S      ++   E + +  + H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 292 RVI-TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           R++  +C    F       +  ++M  GS+   L      +             + + I 
Sbjct: 67  RMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFK-------------EAVIIN 107

Query: 351 --IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH---IGDFGLSRFYQAVSNPTV 405
               +   L YLH++    I+H D+K +N+L+D+  +     I DFG +    A      
Sbjct: 108 YTEQLLRGLSYLHEN---QIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAG 162

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                + GTI ++APE   G +   + DV+S G +++EM T K P
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 237 NLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNL 290
             +G G+FG VY+G++   D D   + + V  L     +     F+ E   +    H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           VR+I     V F+    + I+ + M  G L+ +L  +    R R      LT+   +  A
Sbjct: 72  VRLI----GVSFERLP-RFILLELMAGGDLKSFLREN----RPRPERPSSLTMKDLLFCA 122

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSR------FYQAVS 401
            DVA    YL ++     +H D+   N LL        A I DFG++R      +Y+   
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR--- 176

Query: 402 NPTVSSSIGVRGT--IGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
                   G R    I ++ PE  L    ++  DV+S+G+LL E+
Sbjct: 177 -------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 54/225 (24%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVI------NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+ G+VYK        ++A+KVI       LQ+Q      M+E            + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ-----IMSE------------LE 51

Query: 293 VITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           ++  C S   + F G  F     +I  ++M  GSL+ +     IP+           +L 
Sbjct: 52  ILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---RKIPEH----------VLG 98

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
           RI++A  V   L YL       ILH D+KPSN+L++      + DFG+S   Q V N   
Sbjct: 99  RIAVA--VVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVST--QLV-NSIA 150

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + +G   T  Y+APE   G +   + DV+S GI  +E+   + P
Sbjct: 151 KTYVG---TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 27/218 (12%)

Query: 238 LIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRV 293
            IG G FG VY+GV+   + +   VA+K        + +  F+ E   ++   H ++V++
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I   +       +   IV +  P G L  +L      Q ++      L L   I  +  +
Sbjct: 73  IGVIT------ENPVWIVMELAPLGELRSYL------QVNKY----SLDLASLILYSYQL 116

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           ++AL YL     +  +H D+   N+L+ +     +GDFGLSR+   + + +   +   + 
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKL 170

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLE-MVTTKKP 450
            I ++APE       ++  DV+ +G+ + E ++   KP
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 25/215 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G G FG V        G + A K ++   L+++   +  + E K L+ +  + +V    
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV---- 56

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
              +  F+  D   +V   M  G L+  ++          +        + I  A  +  
Sbjct: 57  -SLAYAFETKDDLCLVMTLMNGGDLKYHIY---------NVGEPGFPEARAIFYAAQIIC 106

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            L++LHQ     I++ DLKP N+LLD+  +  I D GL     AV         G  GT 
Sbjct: 107 GLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGL-----AVELKGGKKIKGRAGTP 158

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GY+APE   G     + D ++ G  L EM+  + P
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 26/229 (11%)

Query: 233 FSSTNL-----IGVGSFGSVY----KGVFDEDG-TVVAIKVIN-LQRQGASKSFMAECKA 281
           F  +NL     +G G FG V+    KG+ +E G T+V +K +   + +     F  E   
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
            + + HKN+VR++  C   +        ++ +Y   G L+++L   A   +D +++   L
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH-----YMILEYTDLGDLKQFLR--ATKSKDEKLKPPPL 114

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAV 400
           +  Q++++   +A  +D+L        +H DL   N L+ +     +    LS+  Y + 
Sbjct: 115 STKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
                ++ I +R    ++APE     + ST  DV+S+G+L+ E+ T  +
Sbjct: 172 YYKLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 45/231 (19%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECK-ALKN--IRH 287
           D F     +G G+ G V K +    G ++A K+I+L           E K A++N  IR 
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-----------EIKPAIRNQIIRE 49

Query: 288 KNLVRVITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
              ++V+  C+S   V F G  +     +I  ++M  GSL      D + ++   I    
Sbjct: 50  ---LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL------DQVLKKAGRIPEN- 99

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQA 399
             +L +ISIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +
Sbjct: 100 --ILGKISIA--VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++N  V       GT  Y++PE   G+  +   D++S G+ L+EM   + P
Sbjct: 154 MANSFV-------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 67/219 (30%), Positives = 95/219 (43%), Gaps = 37/219 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL------QRQGASKSFMAECKALKNIRHKNLVR 292
           IG GSFG        EDG    IK IN+      +R+ + K    E   L N++H N+V+
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK----EVAVLSNMKHPNIVQ 63

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA-- 350
              S     F+ N    IV  Y   G L K            +I  Q+  L     I   
Sbjct: 64  YQES-----FEENGNLYIVMDYCEGGDLYK------------KINAQRGVLFPEDQILDW 106

Query: 351 -IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
            + +  AL ++H      ILH D+K  NI L  D +  +GDFG++R    V N TV  + 
Sbjct: 107 FVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR----VLNSTVELAR 159

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
              GT  Y++PE       +   D+++ G +L EM T K
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 37/225 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+         AE   +++I+ +  + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 293 VITSCSS---VDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L            E Q  T+L+
Sbjct: 55  VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD------EFQIATMLK 108

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            I         LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 109 EI------LKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQI 156

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 157 KRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 37/225 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG VYKG+ +    VVAIK+I+L+         AE   +++I+ +  + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AE-DEIEDIQQE--IT 54

Query: 293 VITSCSS---VDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L P  +       E    T+L+
Sbjct: 55  VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLE------ETYIATILR 108

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            I         LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 109 EI------LKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQI 156

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S      D++S GI  +E+   + P
Sbjct: 157 KRNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 239 IGVGSFGSVYKGVF--DEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVRVIT 295
           +G G+FG V KGV+   +    VAIKV+  + + + +   M E + +  + +  +VR+I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRISIAIDVA 354
            C +          +V +    G L K+L      ++D EI +  +  L+ ++S+ +   
Sbjct: 63  VCEAEALM------LVMEMASGGPLNKFL----SGKKD-EITVSNVVELMHQVSMGMKYL 111

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
              +++H+         DL   N+LL N   A I DFGLS+   A  +   + S G +  
Sbjct: 112 EGKNFVHR---------DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG-KWP 161

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+SYGI + E
Sbjct: 162 LKWYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.4 bits (167), Expect = 6e-13
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 30/218 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL-----QRQGASKSFMAECKALKNIRHKNLVRV 293
           IG GSFG +Y      D     IK I+L     + + ASK    E   L  ++H N+V  
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIVTF 64

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             S     FQ N    IV +Y   G L K +       R R +   +  +L   S  + +
Sbjct: 65  FAS-----FQENGRLFIVMEYCDGGDLMKRI------NRQRGVLFSEDQIL---SWFVQI 110

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +  L ++H      ILH D+K  NI L  N + A +GDFG++R      N ++  +    
Sbjct: 111 SLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR----QLNDSMELAYTCV 163

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT  Y++PE       +   D++S G +L E+ T K P
Sbjct: 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.4 bits (167), Expect = 6e-13
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 30/218 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA---SKSFMAECKALKNIRHKNLVRVIT 295
           IG G FG V  G  +   T   + V  L+   +      F+ E +  ++++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C+ V         +V ++ P G L+ +L       R  E+     T LQR+  A ++A 
Sbjct: 63  QCTEVTPY-----LLVMEFCPLGDLKGYLRS----CRKAELMTPDPTTLQRM--ACEIAL 111

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            L +LH++     +H DL   N LL  DL+  IGD+GLS              + V   +
Sbjct: 112 GLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PL 166

Query: 416 GYVAPEYGLGSEVSTN---------GDVYSYGILLLEM 444
            ++APE  L  EV  N          +V+S G+ + E+
Sbjct: 167 RWIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 66/229 (28%), Positives = 115/229 (50%), Gaps = 41/229 (17%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G ++A K+I+L+ + A ++        + IR    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN--------QIIRE--- 53

Query: 291 VRVITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLT 342
           ++V+  C+S   V F G  +     +I  ++M  GSL++ L     IP++          
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ---------- 103

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVS 401
           +L ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++
Sbjct: 104 ILGKVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           N  V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 160 NSFV-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.3 bits (172), Expect = 9e-13
 Identities = 49/130 (37%), Positives = 69/130 (53%), Gaps = 2/130 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +N LSG IPE +  +  L   L+L  N+F G IP  + +L  L+   + +N  SGEIP  
Sbjct: 293 DNSLSGEIPELVIQLQNLE-ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNL 121
           LG  ++L  + L  N   G IP    +S  + KL L  N+L G+IP  L A  SL  + L
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRL 411

Query: 122 SFNDFEGKVP 131
             N F G++P
Sbjct: 412 QDNSFSGELP 421

Length = 968

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 42/231 (18%)

Query: 239 IGVGSFGSVYKGV---FDED----GTVVAIKVINLQRQGASKSF---MAECKALKNI-RH 287
           +G G FG V        D+D       VA+K+  L+     K     ++E + +K I +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLT 342
           KN++ ++ +C+    Q      +V +Y   G+L ++L     P  D   +      ++LT
Sbjct: 78  KNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 343 LLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------ 395
               +S A  VA  ++YL  Q C    +H DL   N+L+  D    I DFGL+R      
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +Y+  +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 189 YYKKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.2 bits (166), Expect = 1e-12
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+V+  +    G  VAIK INLQ+Q   +  + E   +K +++ N+V  + S  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS-- 84

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              F   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 85  ---FLVGDELFVVMEYLAGGSLTDVVTETCMDEA------------QIAAVCRECLQALE 129

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  N+LL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWM 182

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EMV  + P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKAL-KNIRHKNLVRV 293
           +IG GSFG V       DG+  A+KV+    + ++      MAE   L KN++H  LV +
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             S     FQ  +    V  Y+  G L  + H     QR+R     +         A +V
Sbjct: 62  HYS-----FQTAEKLYFVLDYVNGGEL--FFHL----QRERCFLEPRARFY-----AAEV 105

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           ASA+ YLH      I++ DLKP NILLD+     + DFGL +  + V     +S+    G
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFC--G 158

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE           D +  G +L EM+    P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 31/223 (13%)

Query: 237 NLIGVGSFGSVYKGVF-DEDG--TVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLVR 292
            +IG G FG VY G   D DG     A+K +N +      + F+ E   +K+  H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++  C  +  +G+    +V  YM +G L  ++       R    E    T+   I   + 
Sbjct: 61  LLGIC--LPSEGSPL--VVLPYMKHGDLRNFI-------RS---ETHNPTVKDLIGFGLQ 106

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-----FYQAVSNPTVSS 407
           VA  ++YL     +  +H DL   N +LD   +  + DFGL+R      Y +V N T   
Sbjct: 107 VAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT--- 160

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             G +  + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 161 --GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 50/213 (23%), Positives = 104/213 (48%), Gaps = 15/213 (7%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVRVI 294
           +G G FGSV +G  ++D +++ + V  ++    ++S    F++E   +K   H N++R+I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 295 TSC-SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             C  +V+ +G     ++  +M +G L  +L    +    + +  Q L     +    D+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML-----VKFMTDI 121

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           AS ++YL     +  +H DL   N +L+ +++  + DFGLS+  +  +          + 
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK--KIYNGDYYRQGRIAKM 176

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + ++A E       +T  DV+S+G+ + E+ T
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 32/235 (13%)

Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+      ++G G+FG+VYKG++  DG  V I V I + R+     A+K  + E  
Sbjct: 3   ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEI 338
            +  +    + R++  C +   Q      +V + MP G L  ++  + D I  +D     
Sbjct: 62  VMAGVGSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQD----- 110

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
                   ++  + +A  + YL    +  ++H DL   N+L+ +     I DFGL+R   
Sbjct: 111 -------LLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
              + T   + G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 161 I--DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 59/225 (26%), Positives = 107/225 (47%), Gaps = 34/225 (15%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSF---MAECKALKNIRHKNL 290
            ++G G++G+VY G+ ++ G ++A+K + L       A K +     E   LK+++H N+
Sbjct: 6   EVLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLT--LLQRI 347
           V+ + +C       N   +I  +++P GS+   L+    +P    E    K T  +L  +
Sbjct: 65  VQYLGTC----LDDNTI-SIFMEFVPGGSISSILNRFGPLP----EPVFCKYTKQILDGV 115

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           +          YLH +C   ++H D+K +N++L  +    + DFG +R    V      S
Sbjct: 116 A----------YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162

Query: 408 SI--GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++   + GT  ++APE    S      D++S G  + EM T K P
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKNLVRVIT 295
           +G G FG V        G + A K +N +R    K +   M E + L  +  + +V +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           +     FQ      +V   M  G L   ++       + + E       +       + S
Sbjct: 61  A-----FQTKTDLCLVMTIMNGGDLRYHIY-------NVDEENPGFPEPRACFYTAQIIS 108

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            L++LHQ     I++ DLKP N+LLDND +  I D GL+   +   + T     G  GT 
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK----GYAGTP 161

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           G++APE   G E   + D ++ G+ L EM+  + P
Sbjct: 162 GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 41/222 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +GVG FG V            A+K +    +   G  +   +E + L+   H  +V++  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           +     F+   +  ++ +Y   G L  W     +  RDR +  +      R  IA  V  
Sbjct: 61  T-----FKDKKYIYMLMEYCLGGEL--W---TIL--RDRGLFDEYTA---RFYIAC-VVL 104

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR--- 412
           A +YLH      I++ DLKP N+LLD++    + DFG ++             +      
Sbjct: 105 AFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK------------KLKSGQKT 149

Query: 413 ----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               GT  YVAPE  L      + D +S GILL E++T + P
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 49/238 (20%)

Query: 233 FSSTNL-----IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIR 286
           F++ +L     IG G+FG+V K +    GT++A+K I         K  + +   +   R
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM--R 58

Query: 287 HKNLVRVITSCSSVDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             +   +      V F G  F+     I  + M + SL+K+             E+ K  
Sbjct: 59  SSDCPYI------VKFYGALFREGDCWICMELM-DISLDKFYK--------YVYEVLKSV 103

Query: 343 LLQRI--SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           + + I   IA+    AL+YL +  +  I+H D+KPSNILLD + +  + DFG+S   Q V
Sbjct: 104 IPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISG--QLV 159

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG--------DVYSYGILLLEMVTTKKP 450
            +   +   G R    Y+APE      +  +         DV+S GI L E+ T K P
Sbjct: 160 DSIAKTRDAGCR---PYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 35/217 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVR---VI 294
           +G G++ +VYKG       +VA+K I L+  +GA  + + E   LK+++H N+V    +I
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP--DAIPQRDREIEIQKLTLLQRISIAID 352
            +  S+         +V++Y+ +  L+++L    ++I   +      KL L Q +     
Sbjct: 74  HTEKSL--------TLVFEYL-DKDLKQYLDDCGNSINMHN-----VKLFLFQLLR---- 115

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
               L+Y H+     +LH DLKP N+L++      + DFGL+R   A S PT + S  V 
Sbjct: 116 ---GLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVV 166

Query: 413 GTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
            T+ Y  P+  LGS + ST  D++  G +  EM T +
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.7 bits (162), Expect = 3e-12
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 86  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALE 130

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWM 183

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EM+  + P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 64/248 (25%), Positives = 99/248 (39%), Gaps = 54/248 (21%)

Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI 285
           L   T  F    +IG G++G VYK    + G +VAIK++++  +   +    E   L+  
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-IEDEEEEIKEEYNILRKY 59

Query: 286 -RHKNLVRVITSCSSVDFQGNDFKA----------IVYKYMPNGS---LEKWLHPDAIPQ 331
             H N+           F G   K           +V +    GS   L K L      +
Sbjct: 60  SNHPNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLR--KKGK 108

Query: 332 RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF 391
           R +E  I          I  +    L YLH++    ++H D+K  NILL  +    + DF
Sbjct: 109 RLKEEWIA--------YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157

Query: 392 GLSRFYQAVSNPTVSSSIGVRGT-IG---YVAPE-----YGLGSEVSTNGDVYSYGILLL 442
           G+S          + S++G R T IG   ++APE         +      DV+S GI  +
Sbjct: 158 GVSA--------QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAI 209

Query: 443 EMVTTKKP 450
           E+   K P
Sbjct: 210 ELADGKPP 217

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 37/234 (15%)

Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKA 281
           K++ +  D + + + +G G++G V      + G  VAIK ++   Q    +K    E + 
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRL 67

Query: 282 LKNIRHKN---LVRVITSCSSV-DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD--RE 335
           LK++ H+N   L+ V T  SS+ DFQ       VY                +   D    
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQD------VYLVTH------------LMGADLNNI 109

Query: 336 IEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           ++ QKL+      +   +   L Y+H      I+H DLKPSNI ++ D    I DFGL+R
Sbjct: 110 VKCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
                   T     G   T  Y APE  L         D++S G ++ E++T K
Sbjct: 167 --HTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 72/218 (33%), Positives = 98/218 (44%), Gaps = 29/218 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKAL-KNIRHKNLVR 292
           +IG GSFG V       DG   A+KV+     L R+   K  MAE   L KN++H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHIMAERNVLLKNVKHPFLVG 60

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +  S     FQ  +    V  ++  G L  + H     QR+R     +     R   A +
Sbjct: 61  LHYS-----FQTTEKLYFVLDFVNGGEL--FFHL----QRERSFPEPR----ARFYAA-E 104

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +ASAL YLH      I++ DLKP NILLD+     + DFGL +   A S+ T +      
Sbjct: 105 IASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---- 157

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT  Y+APE           D +  G +L EM+    P
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 66/229 (28%), Positives = 113/229 (49%), Gaps = 41/229 (17%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V K      G ++A K+I+L+ + A ++        + IR    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN--------QIIRE--- 53

Query: 291 VRVITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLT 342
           ++V+  C+S   V F G  +     +I  ++M  GSL++ L     IP+           
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE---------- 103

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVS 401
           +L ++SIA  V   L YL +  Q  I+H D+KPSNIL+++     + DFG+S +   +++
Sbjct: 104 ILGKVSIA--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           N  V       GT  Y++PE   G+  S   D++S G+ L+E+   + P
Sbjct: 160 NSFV-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 23/223 (10%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHK 288
           D +     IG G++G VYK      G +VA+K   L+   +G   + + E   L+ +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 289 N-LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQKLTLLQ 345
             +VR++      +  G     +V++Y+ +  L+K++  +     +      I+      
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPT 404
              +A        + H+H    ++H DLKP N+L+D       I D GL R   A S P 
Sbjct: 120 LKGVA--------HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR---AFSIPV 165

Query: 405 VSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
            S +  +  T+ Y APE  LGS   ST  D++S G +  EM  
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 41/228 (17%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIRHKN 289
           F+    IG GSFG+VY         VVAIK ++    Q     +  + E + L+ +RH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 290 LVRVITSCSSVDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
                    +++++G   +     +V +Y   GS    L     P ++ EI         
Sbjct: 77  ---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-------- 118

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
             +I       L YLH H +   +H D+K  NILL    +  + DFG        S   V
Sbjct: 119 --AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG--------SASLV 165

Query: 406 SSSIGVRGTIGYVAPEYGLG-SEVSTNG--DVYSYGILLLEMVTTKKP 450
           S +    GT  ++APE  L   E   +G  DV+S GI  +E+   K P
Sbjct: 166 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 37/231 (16%)

Query: 239 IGVGSFGSVYKG-VFDEDG----TVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G G FG V K   F   G    T VA+K++   ++ AS S     ++E   LK + H +
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHPH 64

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH-------------PDAIPQRDREI 336
           ++++  +CS      +    ++ +Y   GSL  +L               +         
Sbjct: 65  VIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR- 395
           + + LT+   IS A  ++  + YL    +  ++H DL   N+L+       I DFGLSR 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            Y+   +  V  S G R  + ++A E       +T  DV+S+G+LL E+VT
Sbjct: 177 VYE--EDSYVKRSKG-RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 67.2 bits (164), Expect = 9e-12
 Identities = 47/137 (34%), Positives = 71/137 (51%), Gaps = 8/137 (5%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL-GLCSSLEDIYLGGNFFHG 81
           S++L+  +  G I   I  L  +++ ++SNN LSG IP ++    SSL  + L  N F G
Sbjct: 73  SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132

Query: 82  SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTS 140
           SIP        +  LDLS N LSG+IP  + + S L+ L+L  N   GK+P      N +
Sbjct: 133 SIPRGSIP--NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP--NSLTNLT 188

Query: 141 AISV--AGCHRLCGGIP 155
           ++       ++L G IP
Sbjct: 189 SLEFLTLASNQLVGQIP 205

Length = 968

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 60/233 (25%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVI--------NLQRQGASKSFMAECKALKNIRHKNL 290
           +G G++G V+K +      VVA+K I        + QR      F+ E   L +  H N+
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE---LGD--HPNI 69

Query: 291 VRVITSCSSVDFQGNDFKA-------IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
           V+++          N  KA       +V++YM     E  LH  A+        I+   +
Sbjct: 70  VKLL----------NVIKAENDKDIYLVFEYM-----ETDLH--AV--------IRA-NI 103

Query: 344 LQRI---SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR----F 396
           L+ +    I   +  AL Y+H      ++H DLKPSNILL++D    + DFGL+R     
Sbjct: 104 LEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
            +   NP ++  +  R    Y APE  LGS   T G D++S G +L EM+  K
Sbjct: 161 EENPENPVLTDYVATR---WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 37/227 (16%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRH 287
           D       +G G+FG V+           A+KV+ +    R    +    E + LK + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             ++R+    +  D     F  ++ +Y+P G L  +L       R+      + +    +
Sbjct: 61  PFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYL-------RNS----GRFSNSTGL 104

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A ++  AL+YLH      I++ DLKP NILLD +    + DFG   F + + + T + 
Sbjct: 105 FYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG---FAKKLRDRTWT- 157

Query: 408 SIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT  Y+APE     G    V    D ++ GIL+ EM+    P
Sbjct: 158 ---LCGTPEYLAPEVIQSKGHNKAV----DWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 71/223 (31%), Positives = 107/223 (47%), Gaps = 33/223 (14%)

Query: 238 LIGVGSFGSVYKGVFDED-GTVVAIKVINLQ--RQGASKSFMA-EC--KALKNIRHKNLV 291
           L+G G+FG VY   +D D G  +A+K +      Q  SK   A EC  + LKN+RH  +V
Sbjct: 9   LLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQR-DREIEIQKLTLLQRISI 349
           +        D +     +I  +YMP GS++  L    A+ +   R    Q   +LQ +S 
Sbjct: 68  QYYGCLR--DPEEKKL-SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ---ILQGVS- 120

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV--SNPTVSS 407
                    YLH +    I+H D+K +NIL D+  +  +GDFG S+  Q +  S   + S
Sbjct: 121 ---------YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              V GT  +++PE   G       DV+S    ++EM+T K P
Sbjct: 169 ---VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 26/217 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIK---VINLQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           IG G F  VY+     D   VA+K   +  +    A +  + E   LK + H N+++ + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI--SIAIDV 353
           S     F  ++   IV +    G L + +         +  + QK  + +R      + +
Sbjct: 70  S-----FIEDNELNIVLELADAGDLSQMI---------KYFKKQKRLIPERTVWKYFVQL 115

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            SA++++H      ++H D+KP+N+ +       +GD GL RF+   S  T + S+   G
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSL--VG 168

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y++PE    +  +   D++S G LL EM   + P
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 59/223 (26%), Positives = 102/223 (45%), Gaps = 34/223 (15%)

Query: 240 GVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           G+  F       FD    +VA+K++     + A   F+ E K +  +++ N++R++  C 
Sbjct: 28  GLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE--------IQKLTLLQRISIA 350
           S     +D   ++ +YM NG L ++L         REIE        I  +++   + +A
Sbjct: 88  S-----DDPLCMITEYMENGDLNQFL-------SQREIESTFTHANNIPSVSIANLLYMA 135

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + +AS + YL        +H DL   N L+ N  +  I DFG+SR      N        
Sbjct: 136 VQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR------NLYSGDYYR 186

Query: 411 VRG----TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           ++G     I ++A E  L  + +T  DV+++G+ L EM T  K
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 58/229 (25%), Positives = 106/229 (46%), Gaps = 38/229 (16%)

Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASKS----FMAECKALKNI-RHKN 289
           +G G FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 83  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    VA  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 138 DLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 194 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 28/214 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G  VA+K ++L++Q   +    E   +++ +H N+V + +S  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS-- 84

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L      D +          ++   Q  ++ + V  AL 
Sbjct: 85  ---YLVGDELWVVMEFLEGGALT-----DIVTH-------TRMNEEQIATVCLAVLKALS 129

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN--PTVSSSIGVRGTIG 416
           +LH      ++H D+K  +ILL +D    + DFG   F   VS   P   S +G   T  
Sbjct: 130 FLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKSLVG---TPY 180

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE        T  D++S GI+++EMV  + P
Sbjct: 181 WMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 23/220 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL--KNIRHKNL 290
           F    ++G G FG V        G + A K +  +R    K    E  AL  K I  K  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK---GESMALNEKQILEKVN 58

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
            + + + +   ++  D   +V   M  G L+  ++    P  + E         + +  A
Sbjct: 59  SQFVVNLAYA-YETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE---------RALFYA 108

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++   L+ LH+   E  ++ DLKP NILLD+     I D GL     AV  P   S  G
Sbjct: 109 AEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGL-----AVKIPEGESIRG 160

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT+GY+APE       + + D +  G L+ EM+  + P
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 53/241 (21%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINL---------QRQ-----GASKSFMAECKAL 282
             +G G++G V K      G +VAIK + +          RQ     G   + + E K +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 283 KNIRHKNLVRVITSCSSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
             I+H+N++ +      VD +   DF  +V   M    L+K +        DR+I   +L
Sbjct: 75  NEIKHENIMGL------VDVYVEGDFINLVMDIM-ASDLKKVV--------DRKI---RL 116

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
           T  Q   I + + + L+ LH+      +H DL P+NI +++     I DFGL+R Y    
Sbjct: 117 TESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY---G 170

Query: 402 NPTVSSSIGVRG-------------TIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTT 447
            P  S ++                 T+ Y APE  +G+E      D++S G +  E++T 
Sbjct: 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Query: 448 K 448
           K
Sbjct: 231 K 231

Length = 335

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
           G++    +  GS G V+          V +K+      G   + + E   L+N+ H +++
Sbjct: 67  GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPSVI 120

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R+  +  S         AI    +P+ S + + +   + +R R + I +  ++++     
Sbjct: 121 RMKDTLVS--------GAITCMVLPHYSSDLYTY---LTKRSRPLPIDQALIIEK----- 164

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +   L YLH      I+H D+K  NI +++     IGD G ++F   V  P   + +G+
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAP---AFLGL 216

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
            GT+   APE     + ++  D++S GI+L EM+
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNIRHKNLVRVI 294
           L+G GS+G V K    E G +VAIK   L+ +      K  M E + LK +RH+NLV +I
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDV 353
                  F+      +V++++ +  L+     P+ +     +    +  L Q       +
Sbjct: 67  EV-----FRRKKRLYLVFEFVDHTVLDDLEKYPNGL-----DESRVRKYLFQ-------I 109

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              +++ H H    I+H D+KP NIL+       + DFG +R   A      +  +  R 
Sbjct: 110 LRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATR- 164

Query: 414 TIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVT 446
              Y APE  +G ++     D+++ G L+ EM+T
Sbjct: 165 --WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNI-RHKNLVR 292
           ++G GSFG V          + A+KV+     LQ     +  M E + L    +H  L +
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV-ECTMTEKRVLALAGKHPFLTQ 60

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
            + SC    FQ  D    V +Y+  G L    H     QR       +    +    A +
Sbjct: 61  -LHSC----FQTKDRLFFVMEYVNGGDL--MFHI----QRSG-----RFDEPRARFYAAE 104

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   L +LH+     I++ DLK  N+LLD++    I DFG+ +  + +     +S+    
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFC-- 157

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           GT  Y+APE           D ++ G+LL EM+  + P +
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 9/104 (8%)

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           I V  A+ ++H    + ++H D+K +NILL ++    +GDFG S+ Y A    TVS  +G
Sbjct: 150 IQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----TVSDDVG 202

Query: 411 VR--GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
               GT  YVAPE       S   D++S G+LL E++T K+P D
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 58/238 (24%), Positives = 100/238 (42%), Gaps = 53/238 (22%)

Query: 239 IGVGSFGSVY---------------KGVFDEDGTV-VAIKVINLQRQGASKS----FMAE 278
           +G G FG V+                   + D  V VA+KV+   R  AS +    F+ E
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL---RPDASDNAREDFLKE 69

Query: 279 CKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
            K L  +   N+ R++  C+      +    ++ +YM NG L ++L              
Sbjct: 70  VKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--- 395
           + L+    + +A  +AS + YL        +H DL   N L+  + +  I DFG+SR   
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 396 ---FYQAVSNPTVSSSIGVRGT----IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
              +Y+            V+G     I ++A E  L  + +T  DV+++G+ L E++T
Sbjct: 182 SSDYYR------------VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 32/220 (14%)

Query: 238 LIGVGSFGSVY--KGVFDED-GTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLV 291
           ++G GSFG V+  + +   D G + A+KV+    L+ +   ++ M E   L  + H  +V
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAI-PQRDREIEIQKLTLLQRISIA 350
           ++        FQ      ++  ++  G L   L  + +  + D +  + +L L       
Sbjct: 62  KL-----HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------- 109

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
                ALD+LH      I++ DLKP NILLD +    + DFGLS+  +++ +   + S  
Sbjct: 110 -----ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFC 159

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT+ Y+APE       + + D +S+G+L+ EM+T   P
Sbjct: 160 --GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKA--LKNIRHKNLVRVITS 296
           +G GS+G V       DG    IK +NL+     +   AE +A  L  ++H N+V    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 297 CSSVDFQGND-FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL---QRISIAID 352
                ++G D    IV  +   G L              +++ QK  LL   Q +   + 
Sbjct: 68  -----WEGEDGLLYIVMGFCEGGDLY------------HKLKEQKGKLLPENQVVEWFVQ 110

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A AL YLH+   + ILH DLK  N+ L       +GD G++R  +       S+ I   
Sbjct: 111 IAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN-QCDMASTLI--- 163

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           GT  Y++PE       +   DV++ G  + EM T K
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 54/220 (24%), Positives = 106/220 (48%), Gaps = 16/220 (7%)

Query: 233 FSSTNLIGVGSFGSVYKGVFD-EDGTV--VAIKVINLQRQGAS--KSFMAECKALKNIRH 287
           F+   ++G G FGSV +     EDG+   VA+K++      +S  + F+ E   +K   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 288 KNLVRVI-TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
            N++++I  S  S          ++  +M +G L  +L    I +    + +Q L     
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----- 115

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           +   ID+AS ++YL     +  +H DL   N +L+ +++  + DFGLS+  +  S     
Sbjct: 116 VRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYR 170

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                +  + ++A E    +  +T+ DV+++G+ + E++T
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 34/223 (15%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNL 290
           ++S   +G G++GSV   +    G  VAIK ++   Q +  +K    E   LK+++H+N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 291 VR---VITSCSSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           +    V TS  S D FQ  DF    Y  MP      ++  D        +   K+  L  
Sbjct: 77  IGLLDVFTSAVSGDEFQ--DF----YLVMP------YMQTDLQKIMGHPLSEDKVQYL-- 122

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 +   L Y+H      I+H DLKP N+ ++ D    I DFGL+R   A       
Sbjct: 123 ---VYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA------- 169

Query: 407 SSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
              G   T  Y APE  L     +   D++S G ++ EM+T K
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 63/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA---------ECKALKNIRHKN 289
           IG G++G V   +    G  VAIK I         +F           E K L++ +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKI-------PHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 290 LVRVITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           ++ +          G DFK +  V   M +  L   +H D           Q LT     
Sbjct: 66  IIAIRDILRP---PGADFKDVYVVMDLMES-DLHHIIHSD-----------QPLTEEHIR 110

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                +   L Y+H      ++H DLKPSN+L++ D    IGDFG++R     S+PT   
Sbjct: 111 YFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHK 165

Query: 408 SIGVR--GTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
                   T  Y APE  L   E +T  D++S G +  EM+
Sbjct: 166 YFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 60/230 (26%), Positives = 106/230 (46%), Gaps = 40/230 (17%)

Query: 239 IGVGSFGSVYKGV---FDEDG----TVVAIKVINLQRQGASKSF---MAECKALKNI-RH 287
           +G G FG V        D++     T VA+K+  L+     K     ++E + +K I +H
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKM--LKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLT 342
           KN++ ++ +C+    Q      IV +Y   G+L ++L     P  +      ++  ++L+
Sbjct: 84  KNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------F 396
               +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +
Sbjct: 139 FKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195

Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           Y+  +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 196 YKKTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 27/210 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGT--VVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG++    +   VA+K++       +     + E   ++ + +  +VR+I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRISIAIDV 353
             C +  +       +V +    G L K+L      Q+++ +  + +T L+ ++S+    
Sbjct: 63  GICEAESWM------LVMELAELGPLNKFL------QKNKHVTEKNITELVHQVSMG--- 107

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              + YL +      +H DL   N+LL     A I DFGLS+   A  N   + + G + 
Sbjct: 108 ---MKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG-KW 160

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
            + + APE     + S+  DV+S+G+L+ E
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 28/216 (12%)

Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVIN-LQRQGASKSFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+   D  + VA+K++         ++ M+E K + ++  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            ++ +C+     G     ++ +Y   G L  +L       R RE     LTL   +S + 
Sbjct: 103 NLLGACTI---GGPIL--VITEYCCYGDLLNFLR------RKRE---SFLTLEDLLSFSY 148

Query: 352 DVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            VA  + +L  ++C    +H DL   N+LL +     I DFGL+R     SN  V  +  
Sbjct: 149 QVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGN-- 202

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 37/219 (16%)

Query: 238 LIGVGSFGSVYKGVFDEDGT---VVAIKVINLQRQGAS----KSFMAECKALKNIRHKNL 290
           ++G G FG + +G           VAI  +   R G S    + F+AE   L    H N+
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 291 VR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           VR   VIT  +++         IV +YM NG+L+ +L         R+ E Q L   Q +
Sbjct: 69  VRLEGVITRGNTM--------MIVTEYMSNGALDSFL---------RKHEGQ-LVAGQLM 110

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
            +   +AS + YL    +   +H  L    +L+++DL   I  F   R  Q   +  + +
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYT 164

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           ++  +  + + APE       S+  DV+S+GI++ E+++
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL--KNIRHKNL 290
           F    ++G G FG V        G + A K +  +R    K    E  AL  K I  K  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMALNEKQILEKVN 58

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH--PDAIPQRDREIEIQKLTLLQRIS 348
            R + S +   ++  D   +V   M  G L+  ++   +A  +  R +            
Sbjct: 59  SRFVVSLAYA-YETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAV-----------F 106

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            A ++   L+ LHQ   E I++ DLKP NILLD+     I D GL     AV  P   + 
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGL-----AVHVPEGQTI 158

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            G  GT+GY+APE       + + D ++ G LL EM+  + P
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 50/223 (22%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+FG VY+    +   + A+KV+       SK  +    A K + H    R I   +
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL-------SKKEIV---AKKEVAHTIGERNILVRT 50

Query: 299 SVD-----------FQGNDFKAIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQR 346
            +D           FQ +    +V  YM  G L   L  +    +   +  I +L L   
Sbjct: 51  LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL--- 107

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                    AL++LH++    I++ DLKP NILLD      + DFGLS+      N T +
Sbjct: 108 ---------ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTN 154

Query: 407 SSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEM 444
           +     GT  Y+APE      G    V    D +S G+L+ EM
Sbjct: 155 TFC---GTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 42/231 (18%)

Query: 239 IGVGSFGSVYK----GV---FDEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RH 287
           +G G FG V +    G+     +    VA+K+  L+     K     ++E + +K I +H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKM--LKDNATDKDLADLISEMELMKLIGKH 77

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-----LT 342
           KN++ ++  C+    Q      IV +Y   G+L ++L     P  D   +I K     L+
Sbjct: 78  KNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132

Query: 343 LLQRISIAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------ 395
               +S A  VA  ++YL  + C    +H DL   N+L+  D    I DFGL+R      
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +Y+  SN         R  + ++APE       +   DV+S+GIL+ E+ T
Sbjct: 189 YYKKTSNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 45/231 (19%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVI----NLQRQGASKSFMAECKALKNIRHKNL 290
           +G  +FG +YKG       +   +VAIK +    N Q+ G    F  E   +  + H N+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69

Query: 291 V---RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQK-L 341
           V    V+T    V         ++++Y+  G L ++L     H D     D +  ++  L
Sbjct: 70  VCLLGVVTQEQPV--------CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------ 395
                + IAI +A+ ++YL  H     +H DL   NIL+   L   I D GLSR      
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +Y+      +         I ++ PE  +  + S++ D++S+G++L E+ +
Sbjct: 179 YYRVQPKSLLP--------IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G  VA+K+++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY- 87

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                G +   ++ +++  G+L      D + Q        +L   Q  ++   V  AL 
Sbjct: 88  ---LVGEELWVLM-EFLQGGALT-----DIVSQ-------TRLNEEQIATVCESVLQALC 131

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YLH    + ++H D+K  +ILL  D    + DFG    + A  +  V     + GT  ++
Sbjct: 132 YLH---SQGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWM 184

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE    +   T  D++S GI+++EMV  + P
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 23/218 (10%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-----FMAECKALKNIRHKNLVR 292
           L+G G+FG VY     + G  +A+K +    +    S        E + LKN+ H+ +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
                   D       +I  ++MP GS+           +D+      LT          
Sbjct: 69  YYGCLR--DPMERTL-SIFMEHMPGGSI-----------KDQLKSYGALTENVTRKYTRQ 114

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   + YLH +    I+H D+K +NIL D+  +  +GDFG S+  Q +   + +    V 
Sbjct: 115 ILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC-LSGTGMKSVT 170

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT  +++PE   G       D++S G  ++EM+T K P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 68/236 (28%), Positives = 104/236 (44%), Gaps = 41/236 (17%)

Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKA 281
           K++ +  D +     +G G++G+V   +    G  VAIK +    Q +  +K    E + 
Sbjct: 8   KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67

Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPN-----GSLEKWLHPDAIPQRD 333
           LK+++H+N   L+ V T   S+D + +DF    Y  MP      G L K        ++ 
Sbjct: 68  LKHMKHENVIGLLDVFTPDLSLD-RFHDF----YLVMPFMGTDLGKLMKH-------EKL 115

Query: 334 REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL 393
            E  IQ L           +   L Y+H      I+H DLKP N+ ++ D    I DFGL
Sbjct: 116 SEDRIQFLVY--------QMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 164

Query: 394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           +R        T S   G   T  Y APE  L     +   D++S G ++ EM+T K
Sbjct: 165 AR-------QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 41/218 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+ G V        G  VA+K ++   Q Q  +K    E   LK + HKN++ ++  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                            + P  SLE++     +      +E+    L Q I + +D    
Sbjct: 89  -----------------FTPQKSLEEFQDVYLV------MELMDANLCQVIHMELD-HER 124

Query: 357 LDYL---------HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           + YL         H H    I+H DLKPSNI++ +D +  I DFGL+R   A +N  ++ 
Sbjct: 125 MSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTP 181

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
            +  R    Y APE  LG     N D++S G ++ E+V
Sbjct: 182 YVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 8e-11
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 48/222 (21%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIK---------VINLQRQGASKSFMAECKALKNIRHKN 289
           IG GS+G V+K    E G +VAIK         VI        K  + E + LK ++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-------KIALREIRMLKQLKHPN 61

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPN---GSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           LV +I       F+      +V++Y  +     LEK  +P  +P    E  I+K+     
Sbjct: 62  LVNLIEV-----FRRKRKLHLVFEYCDHTVLNELEK--NPRGVP----EHLIKKIIW--- 107

Query: 347 ISIAIDVASALDYLHQH-CQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                    A+++ H+H C    +H D+KP NIL+       + DFG +R          
Sbjct: 108 -----QTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL----TGPG 154

Query: 406 SSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVT 446
                   T  Y APE  +G ++     DV++ G +  E++T
Sbjct: 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 29/205 (14%)

Query: 254 EDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI 310
             G  VAIK++     + +     F  E      + H N+V ++ S  +           
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFA 56

Query: 311 VYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL 369
           V++Y+P  +L + L  D A+P      E  +L +LQ       V  AL   H    + I+
Sbjct: 57  VFEYVPGRTLREVLAADGALPA----GETGRL-MLQ-------VLDALACAHN---QGIV 101

Query: 370 HCDLKPSNILL---DNDLSAHIGDFGLSRF---YQAVSNPTVSSSIGVRGTIGYVAPEYG 423
           H DLKP NI++        A + DFG+       +     T++ +  V GT  Y APE  
Sbjct: 102 HRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

Query: 424 LGSEVSTNGDVYSYGILLLEMVTTK 448
            G  V+ N D+Y++G++ LE +T +
Sbjct: 162 RGEPVTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.0 bits (150), Expect = 9e-11
 Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 33/225 (14%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVR 292
           +G   FG VYKG        E    VAIK +  + +G   + F  E      ++H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLLQRI 347
           ++   +          ++++ Y  +  L ++L     H D     D +     L     +
Sbjct: 73  LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVS 401
            I   +A+ +++L  H    ++H DL   N+L+ + L+  I D GL R      +Y+ + 
Sbjct: 128 HIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           N  +         I +++PE  +  + S + D++SYG++L E+ +
Sbjct: 185 NSLLP--------IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 35/223 (15%)

Query: 239 IGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQGASK----SFMAECKALKNIRHKN 289
           +G GSFG VY+G        E  T VA+K +N   + AS      F+ E   +K     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN---ESASLRERIEFLNEASVMKGFTCHH 70

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQKLTLLQR 346
           +VR++   S           +V + M +G L+ +L    P+A     R       TL + 
Sbjct: 71  VVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP----TLQEM 121

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTV 405
           I +A ++A  + YL+    +  +H DL   N ++ +D +  IGDFG++R  Y+     T 
Sbjct: 122 IQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TD 173

Query: 406 SSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               G +G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L        I    R  E Q         + + V  AL 
Sbjct: 86  ---YLVGDELWVVMEFLEGGALTD------IVTHTRMNEEQIAA------VCLAVLKALS 130

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH    + ++H D+K  +ILL +D    + DFG    + A  +  V     + GT  ++
Sbjct: 131 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWM 183

Query: 419 APE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE       G EV    D++S GI+++EMV  + P
Sbjct: 184 APELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 24/220 (10%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           +   S   IG GS G V        G  VA+K ++L++Q   +    E   +++  H+N+
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V +  S     +   D   +V +++  G+L        I    R  E Q  T      + 
Sbjct: 82  VDMYNS-----YLVGDELWVVMEFLEGGALTD------IVTHTRMNEEQIAT------VC 124

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + V  AL YLH    + ++H D+K  +ILL +D    + DFG   F   VS   V     
Sbjct: 125 LSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSK-EVPKRKS 177

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + GT  ++APE        T  D++S GI+++EM+  + P
Sbjct: 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 36/230 (15%)

Query: 233 FSSTNLIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNI 285
           F    ++G G++G V+   K    + G + A+KV+     +Q+   ++    E + L+ +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 286 RHKN-LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD--REIEIQKLT 342
           R    LV +  +     FQ +    ++  Y+  G L   L+     QR+   E E+    
Sbjct: 62  RRCPFLVTLHYA-----FQTDTKLHLILDYVNGGELFTHLY-----QREHFTESEV---- 107

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
              R+ IA ++  ALD+LHQ     I++ D+K  NILLD++    + DFGLS+ + A   
Sbjct: 108 ---RVYIA-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA--- 157

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNG--DVYSYGILLLEMVTTKKP 450
                +    GTI Y+APE   G     +   D +S G+L  E++T   P
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKNLVRVI 294
           L+G G+FG V        G   A+K++  +   A       + E + LKN RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S     FQ  D    V +Y+  G L   L  + +   DR           R   A ++ 
Sbjct: 62  YS-----FQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR----------TRFYGA-EIV 105

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           SALDYLH      I++ DLK  N++LD D    I DFGL +  + +++     +    GT
Sbjct: 106 SALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFC--GT 158

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 31/215 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVR---VI 294
           +G G++ +V+KG       +VA+K I L+  +GA  + + E   LK+++H N+V    ++
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            +  S+         +V++Y+ +  L++++           +   K+ L Q       + 
Sbjct: 74  HTDKSL--------TLVFEYL-DKDLKQYMDDCGNIMSMHNV---KIFLYQ-------IL 114

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L Y H+     +LH DLKP N+L++      + DFGL+R   A S PT + S  V  T
Sbjct: 115 RGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVV-T 167

Query: 415 IGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           + Y  P+  LG SE ST  D++  G +  EM + +
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 62/220 (28%), Positives = 94/220 (42%), Gaps = 23/220 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL--KNIRHKNL 290
           F    ++G G FG V        G + A K +  +R    K    E  AL  K I  K  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GEAMALNEKRILEKVN 58

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
            R + S +   ++  D   +V   M  G L+  ++    P  D +         + I  A
Sbjct: 59  SRFVVSLAYA-YETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---------RAIFYA 108

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++   L+ L +   E I++ DLKP NILLD+     I D GL     AV  P   +  G
Sbjct: 109 AELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGL-----AVQIPEGETVRG 160

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT+GY+APE     + + + D +  G L+ EM+  + P
Sbjct: 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 32/228 (14%)

Query: 233 FSSTNLIGVGSFGSVY--KGVFDED-GTVVAIKVIN----LQRQGASKSFMAECKALKNI 285
           F    ++G G++G V+  + V   D G + A+KV+     +Q+   ++    E + L++I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           R    +  +       FQ +    ++  Y+  G L  + H   + QR+R  E       Q
Sbjct: 62  RQSPFLVTLHYA----FQTDTKLHLILDYINGGEL--FTH---LSQRERFKE-------Q 105

Query: 346 RISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
            + I   ++  AL++LH+     I++ D+K  NILLD++    + DFGLS+ +       
Sbjct: 106 EVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER 162

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNG--DVYSYGILLLEMVTTKKP 450
             S     GTI Y+AP+   G +   +   D +S G+L+ E++T   P
Sbjct: 163 AYS---FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 70/218 (32%), Positives = 95/218 (43%), Gaps = 29/218 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKAL-KNIRHKNLVRV 293
           +IG GSFG V       +    A+KV+    + ++   K  M+E   L KN++H  LV +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI-AID 352
             S     FQ  D    V  Y+  G L   L      QR+R        L  R    A +
Sbjct: 62  HFS-----FQTADKLYFVLDYINGGELFYHL------QRER------CFLEPRARFYAAE 104

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +ASAL YLH      I++ DLKP NILLD+     + DFGL +      N T S+     
Sbjct: 105 IASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC--- 157

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT  Y+APE           D +  G +L EM+    P
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 37/227 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           + + + IG G++G V        G  VAIK I+  + Q   +  + E K L+  +H+N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 292 RVITSCSSVDFQGNDFKA--IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT------- 342
            ++       F+   F    IV + M        L+        + I+ Q L+       
Sbjct: 67  GILDIIRPPSFE--SFNDVYIVQELMETD-----LY--------KLIKTQHLSNDHIQYF 111

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
           L Q       +   L Y+H      +LH DLKPSN+LL+ +    I DFGL+R      +
Sbjct: 112 LYQ-------ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
            T   +  V  T  Y APE  L S   +   D++S G +L EM++ +
Sbjct: 162 HTGFLTEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 27/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHKNLVRV 293
           ++G GSFG V          V AIKV+     LQ      + M E + L        +  
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCT-MTEKRILALAAKHPFLTA 60

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C    FQ  D    V +Y+  G L   +      QR R+ +  +         A +V
Sbjct: 61  LHCC----FQTKDRLFFVMEYVNGGDLMFQI------QRSRKFDEPRSRFY-----AAEV 105

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
             AL +LH+H    +++ DLK  NILLD +    + DFG+ +  + + N   +++    G
Sbjct: 106 TLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFC--G 158

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE     E   + D ++ G+L+ EM+  + P
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 23/220 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL--KNIRHKNL 290
           F    ++G G FG V        G + A K +  +R    K    E  AL  K I  K  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GEAMALNEKQILEKVN 58

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
            R + S +   ++  D   +V   M  G L+  ++    P  D E         + +  A
Sbjct: 59  SRFVVSLAYA-YETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE---------RAVFYA 108

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++   L+ LH+   E I++ DLKP NILLD+     I D GL     AV  P   +  G
Sbjct: 109 AEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGL-----AVEIPEGETIRG 160

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT+GY+APE       + + D +  G L+ EM+  K P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 32/225 (14%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECK---ALKNI 285
           F    ++G G FG V    + + G + AIK +     + R    +S M E +      + 
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-ESLMCEKRIFETANSE 59

Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           RH  LV +  +C    FQ  D    V +Y   G L   +H D   +             +
Sbjct: 60  RHPFLVNLF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------------R 102

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            +  A  V   L YLH++    I++ DLK  N+LLD +    I DFGL +      + T 
Sbjct: 103 AVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +      GT  ++APE    +  +   D +  G+L+ EM+  + P
Sbjct: 160 TFC----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 63/228 (27%), Positives = 94/228 (41%), Gaps = 41/228 (17%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIRHKN 289
           F   + IG GSFG+VY         VVA+K ++    Q     +  + E K L+ ++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 290 LVRVITSCSSVDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
                    +++++G   K     +V +Y   GS    L     P ++ EI         
Sbjct: 83  ---------TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------- 124

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
             +I       L YLH H    ++H D+K  NILL       + DFG        S    
Sbjct: 125 --AITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFG--------SASKS 171

Query: 406 SSSIGVRGTIGYVAPEYGLG-SEVSTNG--DVYSYGILLLEMVTTKKP 450
           S +    GT  ++APE  L   E   +G  DV+S GI  +E+   K P
Sbjct: 172 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 47/221 (21%)

Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  V  ++   VAIK ++   Q    +K    E   +K + HKN++ +
Sbjct: 24  IGSGAQGIVCAAYDTVTGQN---VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +          N F        P  SLE++     +      +E+    L Q I + +D 
Sbjct: 81  L----------NVFT-------PQKSLEEFQDVYLV------MELMDANLCQVIQMDLD- 116

Query: 354 ASALDYL---------HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
              + YL         H H    I+H DLKPSNI++ +D +  I DFGL+R   A ++  
Sbjct: 117 HERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 173

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           ++  +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 174 MTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 36/225 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV--ITS 296
           +G GS G V+  V  +    VA+K I L    + K  + E K ++ + H N+V+V  +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 297 CSSVDFQ---GNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            S  D     G+  +     IV +YM    L   L    + +     E  +L + Q +  
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSE-----EHARLFMYQLLR- 125

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSS- 407
                  L Y+H      +LH DLKP+N+ ++  DL   IGDFGL+R    + +P  S  
Sbjct: 126 ------GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLAR----IVDPHYSHK 172

Query: 408 ---SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
              S G+  T  Y +P   L     T   D+++ G +  EM+T K
Sbjct: 173 GYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 58/226 (25%), Positives = 94/226 (41%), Gaps = 32/226 (14%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           + F     IG G++G VYK      G + AIKVI L+          E   +K+ +H N+
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V    S     +   D   I  ++   GSL+   H               L+  Q   ++
Sbjct: 69  VAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVTG-----------PLSESQIAYVS 112

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            +    L YLH   +   +H D+K +NILL ++    + DFG+S    A    T++    
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS----AQITATIAKRKS 165

Query: 411 VRGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVTTKKP 450
             GT  ++APE    + V   G      D+++ GI  +E+   + P
Sbjct: 166 FIGTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 28/219 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS--FMAECKALKNIRHKNLVRV-- 293
           +IG GS+G V   +    G  VAIK IN   +  S +   + E K L+ +RH ++V +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 294 ITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           I    S      +FK I  V++ M     E  LH       D   E  +  L Q +    
Sbjct: 67  IMLPPS----RREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR--- 114

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
               AL Y+H      + H DLKP NIL + D    I DFGL+R     +   +  +  V
Sbjct: 115 ----ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 412 RGTIGYVAPEY--GLGSEVSTNGDVYSYGILLLEMVTTK 448
             T  Y APE      S+ +   D++S G +  E++T K
Sbjct: 168 -ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 47/224 (20%)

Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 82  LNV-----------------FTPQKSLEEFQDVYLV------MELMDANLCQVIQMELD- 117

Query: 354 ASALDYL---------HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
              + YL         H H    I+H DLKPSNI++ +D +  I DFGL+R   A ++  
Sbjct: 118 HERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 174

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 175 MTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 25/216 (11%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKNLVRVI 294
           L+G G+FG V        G   A+K++  +   A       + E + L+N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S     FQ +D    V +Y   G L   L  + +   DR           R   A ++ 
Sbjct: 62  YS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYGA-EIV 105

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           SALDYLH   ++ +++ DLK  N++LD D    I DFGL +  + + +     +    GT
Sbjct: 106 SALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFC--GT 159

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK----SFMAECKALKNIRHKNLVRVI 294
           IG G FG V  G     G   A  V+   R  A+      F+ E +  + + H N+++ +
Sbjct: 3   IGNGWFGKVLLGEAHR-GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 295 TSC-SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             C  S+ +       +V ++ P G L+ +L  +    R    ++ +  +LQR+  A +V
Sbjct: 62  GQCIESIPY------LLVLEFCPLGDLKNYLRSN----RGMVAQMAQKDVLQRM--ACEV 109

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL--SRFYQAVSNPTVSSSIGV 411
           AS L +LHQ      +H DL   N  L  DLS  IGD+GL   ++ +         ++ +
Sbjct: 110 ASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166

Query: 412 RGTIGYVAPEYG---LGSEVSTNGDVYSYGILLLEMVT 446
           R     +    G   L  + +   +++S G+ + E+ T
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 27/214 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSC 297
           +G G+ GSV K      GTV+A KV+++  +    K  + E + +   R   +V    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA- 71

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F   +   +  ++M  GSL      D I ++   I ++ L       IA+ V   L
Sbjct: 72  ----FLNENNICMCMEFMDCGSL------DRIYKKGGPIPVEILG-----KIAVAVVEGL 116

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPTVSSSIGVRGTIG 416
            YL+      I+H D+KPSNIL+++     + DFG+S     ++++  V       GT  
Sbjct: 117 TYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-------GTST 167

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y++PE   G + +   DV+S GI ++E+   K P
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 27/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK-NIRHKNLVRV 293
           ++G GSFG V+           AIK +    +      +  M E + L     H  L  +
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             +     FQ  +    V +Y+  G L   +               K  L +    A ++
Sbjct: 62  YCT-----FQTKENLFFVMEYLNGGDLMFHIQ-----------SCHKFDLPRATFYAAEI 105

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              L +LH    + I++ DLK  NILLD D    I DFG+ +  + +     + +    G
Sbjct: 106 ICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFC--G 158

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE  LG + +T+ D +S+G+LL EM+  + P
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 34/222 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G++GSVYK +    G  +A+K I L+   +   F      L +I HK +   I    
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK--FNQIIMEL-DILHKAVSPYI---- 61

Query: 299 SVDFQGNDF-KAIVY---KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            VDF G  F +  VY   +YM  GSL+K      +       E     +L+RI+ A  V 
Sbjct: 62  -VDFYGAFFIEGAVYMCMEYMDAGSLDK------LYAGGVATEGIPEDVLRRITYA--VV 112

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L +L +  +  I+H D+KP+N+L++ +    + DFG+S       N   S +    G 
Sbjct: 113 KGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGC 164

Query: 415 IGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVTTKKP 450
             Y+APE       + N       DV+S G+ +LEM   + P
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 41/228 (17%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIRHKN 289
           FS    IG GSFG+VY      +  VVAIK ++    Q     +  + E + L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 290 LVRVITSCSSVDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
                    ++ ++G   +     +V +Y   GS    L     P ++ EI         
Sbjct: 77  ---------TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-------- 118

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
             ++       L YLH H    ++H D+K  NILL       +GDFG        S   +
Sbjct: 119 --AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG--------SASIM 165

Query: 406 SSSIGVRGTIGYVAPEYGLG-SEVSTNG--DVYSYGILLLEMVTTKKP 450
           + +    GT  ++APE  L   E   +G  DV+S GI  +E+   K P
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 56/228 (24%), Positives = 94/228 (41%), Gaps = 31/228 (13%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
              F    ++G GSFG V          + AIK++    + +    +  M E + L    
Sbjct: 1   DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
               +  + SC    FQ  D    V +Y+  G L   +            ++ K    Q 
Sbjct: 59  KPPFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQ-----------QVGKFKEPQA 103

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--FYQAVSNPT 404
           +  A +++  L +LH+     I++ DLK  N++LD++    I DFG+ +      V+  T
Sbjct: 104 VFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
                   GT  Y+APE         + D ++YG+LL EM+  + P D
Sbjct: 161 FC------GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)

Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 114

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 169

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 170 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 66/265 (24%), Positives = 103/265 (38%), Gaps = 71/265 (26%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHK 288
           F     IG+G+FG V      +   + A+K +     L R  A     A  KA ++I  +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQA-----AHVKAERDILAE 57

Query: 289 N----LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
                +V++  S     FQ  D    V  Y+P G +   L    I + D          L
Sbjct: 58  ADNEWVVKLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED----------L 102

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL---------SR 395
            R  IA ++  A++ +H+      +H D+KP NIL+D D    + DFGL         S+
Sbjct: 103 ARFYIA-ELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158

Query: 396 FYQAVSNPTVSS----------------SIGVR--------------GTIGYVAPEYGLG 425
           +YQ   +    S                 +  R              GT  Y+APE  L 
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218

Query: 426 SEVSTNGDVYSYGILLLEMVTTKKP 450
           +  +   D +S G++L EM+  + P
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G++G VYK      G + A+K+I L+          E   +K  +H N+V    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS-- 74

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   +   I  +Y   GSL+   H               L+ LQ   +  +    L 
Sbjct: 75  ---YLSREKLWICMEYCGGGSLQDIYHVTG-----------PLSELQIAYVCRETLQGLA 120

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YLH   +   +H D+K +NILL ++    + DFG++    A    T++      GT  ++
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA----AKITATIAKRKSFIGTPYWM 173

Query: 419 APEYGLGSEVSTNG------DVYSYGILLLEMVTTKKP 450
           APE    + V  NG      D+++ GI  +E+   + P
Sbjct: 174 APEV---AAVEKNGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 67/230 (29%), Positives = 100/230 (43%), Gaps = 45/230 (19%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F+    IG GSFG+VY         VVAIK ++   + +++ +   + E K L+ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 290 LVRVITSCSSVDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--L 343
                    S++++G   +     +V +Y   GS    L     P +  E+EI  +T   
Sbjct: 87  ---------SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ--EVEIAAITHGA 134

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           LQ           L YLH H    ++H D+K  NILL       + DFG        S  
Sbjct: 135 LQ----------GLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG--------SAS 173

Query: 404 TVSSSIGVRGTIGYVAPEYGLG-SEVSTNG--DVYSYGILLLEMVTTKKP 450
             S +    GT  ++APE  L   E   +G  DV+S GI  +E+   K P
Sbjct: 174 IASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 20/154 (12%)

Query: 301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDRE----IEIQKLTLLQRISIAIDVASA 356
           DF+ +D   ++ +Y   G L K      I QR +E     E +   L  +I +A      
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNK-----QIKQRLKEHLPFQEYEVGLLFYQIVLA------ 181

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           LD +H      ++H DLK +NI L       +GDFG S+ Y    +  V+SS    GT  
Sbjct: 182 LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC--GTPY 236

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y+APE       S   D++S G++L E++T  +P
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 37/225 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKN 289
           F     +G GSFG V        G   AIK +  +   +    +    E   L  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V ++ S     FQ  +    + +++  G L   L        D    + K         
Sbjct: 80  IVNMMCS-----FQDENRVYFLLEFVVGGELFTHLRKAGRFPND----VAKF-------Y 123

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++  A +YLH    + I++ DLKP N+LLDN     + DFG   F + V + T +   
Sbjct: 124 HAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG---FAKKVPDRTFT--- 174

Query: 410 GVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + GT  Y+APE     G G  V    D ++ G+LL E +    P
Sbjct: 175 -LCGTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 66/251 (26%), Positives = 116/251 (46%), Gaps = 32/251 (12%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVV 259
           H  +    +  E MI   + +   KS       +   N+IG GSFG VY+ +  +    V
Sbjct: 42  HNNNAGEDEDEEKMIDNDINRSPNKS-------YKLGNIIGNGSFGVVYEAICIDTSEKV 94

Query: 260 AIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND---FKAIVYKYMP 316
           AIK +    Q  ++  +     +KN+ H N++ +     +  F+ N+   F  +V +++P
Sbjct: 95  AIKKVLQDPQYKNRELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP 150

Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS 376
             ++ K++   A       + + KL   Q       +  AL Y+H    + I H DLKP 
Sbjct: 151 Q-TVHKYMKHYARNNHALPLFLVKLYSYQ-------LCRALAYIH---SKFICHRDLKPQ 199

Query: 377 NILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDV 434
           N+L+D N  +  + DFG ++    ++     S I  R    Y APE  LG+   +T+ D+
Sbjct: 200 NLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSR---FYRAPELMLGATNYTTHIDL 254

Query: 435 YSYGILLLEMV 445
           +S G ++ EM+
Sbjct: 255 WSLGCIIAEMI 265

Length = 440

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 26/216 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKNLVRVI 294
           L+G G+FG V        G   A+K++  +   A       + E + L+N RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            +     FQ +D    V +Y   G L   L  + +   +R           R   A ++ 
Sbjct: 62  YA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEER----------ARFYGA-EIV 105

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+     +    GT
Sbjct: 106 SALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC--GT 158

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.7 bits (137), Expect = 8e-09
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHKNLVRV 293
           L+G G+FG V        G   A+K++     + +   + + + E + L+N RH  L  +
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHPFLTAL 60

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             S     FQ +D    V +Y   G L   L  + +   DR           R   A ++
Sbjct: 61  KYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYGA-EI 104

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            SAL YLH      +++ DLK  N++LD D    I DFGL +  + +S+     +    G
Sbjct: 105 VSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC--G 157

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 56.4 bits (136), Expect = 9e-09
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHKNLVRV 293
           ++G GSFG V      E G + A+KV+     LQ      + M E + L   R+   +  
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFLTQ 60

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C    FQ  D    V +++  G L    H     Q+ R  +  +         A ++
Sbjct: 61  LYCC----FQTPDRLFFVMEFVNGGDL--MFHI----QKSRRFDEARARFY-----AAEI 105

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            SAL +LH    + I++ DLK  N+LLD++    + DFG+ +  + + N   +S+    G
Sbjct: 106 TSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFC--G 158

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE         + D ++ G+LL EM+    P
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 22/223 (9%)

Query: 232 GFSSTNLIGVGSFGSVYKGVFDE--DGTVVAIKVIN--LQRQGASKSFMAECKALKNIR- 286
            +     +G G++G V      E  +   VAIK I     ++  +K  + E K L++ R 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           HKN+  +      + F GN  +  +Y+ +    L + +      Q   +   Q       
Sbjct: 61  HKNITCLYDM--DIVFPGNFNELYLYEELMEADLHQIIRSG---QPLTDAHFQ------- 108

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S    +   L Y+H      +LH DLKP N+L++ D    I DFGL+R +         
Sbjct: 109 -SFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164

Query: 407 SSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                  T  Y APE  L     +   DV+S G +L E++  K
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G G +G V+     + G +VA+K +    L +    +  + E   L   + + LV+++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           +     FQ +++  +  +Y+P G     L+   +   D            R  +A ++  
Sbjct: 69  A-----FQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------ARFYMA-EMFE 112

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           A+D LH+      +H DLKP N L+D      + DFGLS+     +N  V       G+ 
Sbjct: 113 AVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-------GSP 162

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            Y+APE   G       D +S G +L E + 
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 29/228 (12%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           + F    +IG G+FG V          V A+K++N   + ++  +  F  E   L N  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           + +  +  +     FQ  +   +V  Y   G L   L        DR  E      L  +
Sbjct: 61  QWITTLHYA-----FQDENNLYLVMDYYVGGDLLTLLSK----FEDRLPEDMARFYLAEM 111

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
            IAID    L Y+H+         D+KP NIL+D +    + DFG     + + + TV S
Sbjct: 112 VIAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQS 160

Query: 408 SIGVRGTIGYVAPEYGLGSE-----VSTNGDVYSYGILLLEMVTTKKP 450
           S+ V GT  Y++PE     E          D +S G+ + EM+  + P
Sbjct: 161 SVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 39/207 (18%)

Query: 258 VVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK 313
           +VA+K++   R  A+K+    F+ E K L  ++  N++R++  C        D   ++ +
Sbjct: 48  LVAVKIL---RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITE 99

Query: 314 YMPNGSLEKWLH-----------PDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ 362
           YM NG L ++L             DA+P       I   +LL    +A+ +AS + YL  
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL---HVALQIASGMKYL-- 154

Query: 363 HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG----TIGYV 418
                 +H DL   N L+  +L+  I DFG+SR      N        ++G     I ++
Sbjct: 155 -SSLNFVHRDLATRNCLVGENLTIKIADFGMSR------NLYAGDYYRIQGRAVLPIRWM 207

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMV 445
           A E  L  + +T  DV+++G+ L E++
Sbjct: 208 AWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITS 296
           ++G GSFG              A+K I L +   A +    E   L  ++H N+V    S
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA---IDV 353
                F+ +    IV +Y   G L +            +I++Q+  L    +I    + +
Sbjct: 67  -----FEADGHLYIVMEYCDGGDLMQ------------KIKLQRGKLFPEDTILQWFVQM 109

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              + ++H+   + +LH D+K  NI L  +    +GDFG +R    +++P   +   V G
Sbjct: 110 CLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL---LTSPGAYACTYV-G 162

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  YV PE       +   D++S G +L E+ T K P
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 64/234 (27%), Positives = 97/234 (41%), Gaps = 59/234 (25%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            IG G+ G VYK  F + G V+A+K   ++R G  +         +N R    + V+   
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVK--QMRRTGNKE---------ENKRILMDLDVVLKS 70

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-----LLQRIS---- 348
                  +D   IV  Y   G          I   D  I ++ ++     LL+RI     
Sbjct: 71  -------HDCPYIVKCY---GYF--------ITDSDVFICMELMSTCLDKLLKRIQGPIP 112

Query: 349 ------IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                 + + +  AL YL +  +  ++H D+KPSNILLD   +  + DFG+S        
Sbjct: 113 EDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL----- 165

Query: 403 PTVSSSIGVR--GTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             V S    R  G   Y+APE         +     DV+S GI L+E+ T + P
Sbjct: 166 --VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 7/101 (6%)

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++   L +LH+   + I++ DLK  N+LLD D    I DFG+ +  + ++    +S+ 
Sbjct: 102 AAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTF 156

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE   G + + + D +S+G+LL EM+  + P
Sbjct: 157 C--GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 35/109 (32%), Positives = 60/109 (55%), Gaps = 13/109 (11%)

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           IA+ +  AL+YLH   +  ++H D+KPSN+L++ +    + DFG+S     V +   +  
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLVDSVAKTID 163

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNG-----DVYSYGILLLEMVTTKKPTD 452
            G +    Y+APE  +  E++  G     DV+S GI ++E+ T + P D
Sbjct: 164 AGCK---PYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 47/224 (20%)

Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVIQMELD- 124

Query: 354 ASALDYL---------HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
              + YL         H H    I+H DLKPSNI++ +D +  I DFGL+R   A ++  
Sbjct: 125 HERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFM 181

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  +  R    Y APE  LG     N D++S G ++ EM+   
Sbjct: 182 MTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 65/240 (27%), Positives = 94/240 (39%), Gaps = 53/240 (22%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVI 294
           L+G G  G V+       G + A+KV++   + ++   K  + E + L  + H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S     FQ   +  +V  Y P G L + L      Q  + +  +      R   A +V 
Sbjct: 68  AS-----FQTETYLCLVMDYCPGGELFRLLQR----QPGKCLSEEVA----RFYAA-EVL 113

Query: 355 SALDYLHQHCQEPILHCDLKPSNILL---------DNDLSAHIGDFGLSRFYQA------ 399
            AL+YLH      I++ DLKP NILL         D DLS                    
Sbjct: 114 LALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 400 -----VSNPTVSSSIGVR-----GTIGYVAPE----YGLGSEVSTNGDVYSYGILLLEMV 445
                + + T S     R     GT  Y+APE     G GS V    D ++ GILL EM+
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 47/199 (23%), Positives = 97/199 (48%), Gaps = 29/199 (14%)

Query: 258 VVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK 313
           +VA+K++   R+ A+K+    F+ E K +  ++  N++R++  C +     +D   ++ +
Sbjct: 48  LVAVKML---REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITE 99

Query: 314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL 373
           YM NG L ++L      +   + ++  ++    I +A  +AS + YL        +H DL
Sbjct: 100 YMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156

Query: 374 KPSNILLDNDLSAHIGDFGLSR------FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE 427
              N L+  + +  I DFG+SR      +Y+      +         I +++ E  L  +
Sbjct: 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLP--------IRWMSWESILLGK 208

Query: 428 VSTNGDVYSYGILLLEMVT 446
            +T  DV+++G+ L E++T
Sbjct: 209 FTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 54/239 (22%)

Query: 225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASKSFMAECKAL 282
           ++ + T+ +     +G+G+FG V        G  VAIK I         +K    E K L
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63

Query: 283 KNIRHKNLVRV----ITSCSSVDF----QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           K++RH+N++ +    I+    + F     G D    +++ + +  LEK            
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTD----LHRLLTSRPLEKQF---------- 109

Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
              IQ             +   L Y+H      ++H DLKPSNIL++ +    I DFGL+
Sbjct: 110 ---IQYF--------LYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155

Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTK 448
           R    + +P ++  +  R    Y APE  L       EV    D++S G +  EM+  K
Sbjct: 156 R----IQDPQMTGYVSTR---YYRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           D F    +IG G+FG V          + A+K++N   + ++  +  F  E    +N+  
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNVLV 56

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP--DAIPQRDREIEIQKLTLLQ 345
               + IT+     FQ  ++  +V  Y   G L   L    D +P+      I ++ L  
Sbjct: 57  NGDCQWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL-- 113

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
               AI     L Y+H+         D+KP N+LLD +    + DFG     +   + TV
Sbjct: 114 ----AIHSIHQLHYVHR---------DIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTV 158

Query: 406 SSSIGVRGTIGYVAPEY------GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            SS+ V GT  Y++PE       G+G +     D +S G+ + EM+  + P
Sbjct: 159 QSSVAV-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIK-VINL-QRQGASKSFMAECKALKNIRHKNLVRV--I 294
           IG G+FG V+      DG  VA+K + N+ Q   + K    E K L   +H N++    I
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                +D     F+ I   Y+    ++  LH   +  +    +  K+ L Q       + 
Sbjct: 68  LQPPHIDP----FEEI---YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQ-------IL 113

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-G 413
             L YLH      ILH D+KP N+L++++    I DFGL+R    V  P  S  +     
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR----VEEPDESKHMTQEVV 166

Query: 414 TIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  Y APE  +GS   T+  D++S G +  E++  +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 52/219 (23%), Positives = 104/219 (47%), Gaps = 33/219 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK---SFMAECKALKNIRHKNLVRVIT 295
           IG G FG V       D  V  + V  L+   +SK    F+ +    + ++H N+++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 296 SC-SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            C  ++ +       +V++Y   G L+ +L  +   +R+ ++      LLQR+  A ++A
Sbjct: 63  QCVEAIPY------LLVFEYCELGDLKSYLSQEQWHRRNSQL-----LLLQRM--ACEIA 109

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL--SRFYQAVSNPTVSSSIGVR 412
           + + ++H+H     LH DL   N  L +DL+  +GD+G+  SR+ +          + +R
Sbjct: 110 AGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 413 GTIGYVAPEYG-------LGSEVSTNGDVYSYGILLLEM 444
               ++APE         + +E +   +V++ G+ L E+
Sbjct: 167 ----WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 22/166 (13%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKN 289
           F     I  G+FG VY G    +  + A+KV+   ++  +       AE  AL   +   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V +  S      Q  +   +V +Y+  G ++  LH       D E        ++ IS 
Sbjct: 66  IVHLYYS-----LQSANNVYLVMEYLIGGDVKSLLH--IYGYFDEE------MAVKYIS- 111

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
             +VA ALDYLH+H    I+H DLKP N+L+ N+    + DFGLS+
Sbjct: 112 --EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 35/231 (15%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           D F    +IG G+FG V        G V A+K++N   + ++  +  F  E   L N   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP--DAIPQRDREIEIQKLTLLQ 345
               R IT+     FQ  +   +V  Y   G L   L    D +P+     ++ +  L +
Sbjct: 61  ----RWITNLHYA-FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-----DMARFYLAE 110

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            + +AID    L Y+H+         D+KP N+LLD +    + DFG     + +++ TV
Sbjct: 111 MV-LAIDSVHQLGYVHR---------DIKPDNVLLDKNGHIRLADFG--SCLRLLADGTV 158

Query: 406 SSSIGVRGTIGYVAPEY------GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            S++ V GT  Y++PE       G G       D +S G+ + EM+  + P
Sbjct: 159 QSNVAV-GTPDYISPEILQAMEDGKGR-YGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 64/222 (28%), Positives = 92/222 (41%), Gaps = 40/222 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G V      E    VAIK I      +  +K  + E K L+++ H+N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 297 CSSVDFQGNDFKA--IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-------LLQRI 347
                     F    IVY+ M        LH     Q  R    Q L+       L Q  
Sbjct: 73  MPPP--HREAFNDVYIVYELMDTD-----LH-----QIIRSS--QTLSDDHCQYFLYQ-- 116

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                +   L Y+H      +LH DLKPSN+LL+ +    I DFGL+R     ++     
Sbjct: 117 -----LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR----TTSEKGDF 164

Query: 408 SIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                 T  Y APE  L  SE +T  DV+S G +  E++  K
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 29/213 (13%)

Query: 239 IGVGSFGSVY-----KGVFDEDGTVVAIKVINLQRQGASKSFMA--ECKALKNIRHKNLV 291
           +G GSFG+VY     K V +E   V  +K I +     +++  A  E + L  + H  +V
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKV--LKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +   S     F   D   I+ +Y     L+  L        + +   + L+  Q     I
Sbjct: 66  KFHAS-----FLERDAFCIITEYCEGRDLDCKL-------EELKHTGKTLSENQVCEWFI 113

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +   + Y+HQ     ILH DLK  NI L N+L   IGDFG+SR      +   + +   
Sbjct: 114 QLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT--- 166

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
            GT  Y++PE        +  D++S G +L EM
Sbjct: 167 -GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 60/257 (23%), Positives = 103/257 (40%), Gaps = 59/257 (22%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F S  +IG G+FG V      + G + A+K++        K+ M E + + +IR +  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 291 VRVITSCSSV-----DFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLL 344
           + V    + V      FQ      ++ +++P G +   L   D + +   +  I +  L 
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL- 112

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL---------SR 395
                AID    L ++H+         D+KP N+LLD      + DFGL         + 
Sbjct: 113 -----AIDAIHQLGFIHR---------DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158

Query: 396 FYQAVS-NPTVSSSI---------------------GVRGTIGYVAPEYGLGSEVSTNGD 433
           FY+ ++ NP    S                         GT  Y+APE  + +  +   D
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218

Query: 434 VYSYGILLLEMVTTKKP 450
            +S G+++ EM+    P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 29/211 (13%)

Query: 242 GSFGSVYKGVF--DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSS 299
           GS G V+      DE    V +K +        K+   E   LK I H+ ++ +I +   
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYR- 156

Query: 300 VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDY 359
                  +K+ V   MP     K+   D     DR      L L Q I+I   +  AL Y
Sbjct: 157 -------WKSTVCMVMP-----KYKC-DLFTYVDR---SGPLPLEQAITIQRRLLEALAY 200

Query: 360 LHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVA 419
           LH      I+H D+K  NI LD   +A +GDFG +   +  ++P      G  GT+   +
Sbjct: 201 LHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTPQCYGWSGTLETNS 255

Query: 420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           PE           D++S G++L EM      
Sbjct: 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 51/215 (23%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASKSFMAECKALKNIRHKNL 290
           F    ++G G++G V K    E   +VAIK    + + +   ++ + E K L+ ++ +N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLLQRISI 349
           V +  +     F+      +V++Y+    LE     P+ +P       I +L        
Sbjct: 63  VELKEA-----FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI------- 110

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                 A+ + H++    I+H D+KP N+L+ ++    + DFG +R     SN   +  +
Sbjct: 111 -----KAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV 162

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
             R    Y +PE  LG+      D++S G +L E+
Sbjct: 163 ATR---WYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 30/220 (13%)

Query: 238 LIGVGSFGSVY---KGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI----RHKNL 290
           ++G G +G V+   K    + G + A+KV+       ++   A  KA +NI    +H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V +I +     FQ      ++ +Y+  G L   L  + I   D          L  IS+A
Sbjct: 63  VDLIYA-----FQTGGKLYLILEYLSGGELFMHLEREGIFMED-----TACFYLSEISLA 112

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
                 L++LHQ   + I++ DLKP NILLD      + DFGL +  +++   TV+ +  
Sbjct: 113 ------LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFC 161

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GTI Y+APE  + S      D +S G L+ +M+T   P
Sbjct: 162 --GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.7 bits (129), Expect = 9e-08
 Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 73/284 (25%)

Query: 233 FSSTNL-----IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKA 281
           F   NL     +G G+FG V +    G+  ED  + VA+K++        + + M+E K 
Sbjct: 35  FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94

Query: 282 LKNI-RHKNLVR------------VITS-CSSVDF-----------------------QG 304
           L ++ +HKN+V             VIT  C   D                          
Sbjct: 95  LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETS 154

Query: 305 NDFKAIV--YKYMPNGS------LEKWLHPDAIPQR-----DREIEIQK-----LTLLQR 346
           +D+K I    KY+ + S       + ++    +        D + E        L L   
Sbjct: 155 SDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDL 214

Query: 347 ISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
           +  +  VA  +D+L  ++C    +H D+   N+LL +   A I DFGL+R     SN  V
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
             +   R  + ++APE       +   DV+SYGILL E+ +  K
Sbjct: 271 KGN--ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 9e-08
 Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 7/104 (6%)

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L L Q  ++A  + SA+DY+H    E I+H D+K  N+L++      +GDFG + F +  
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313

Query: 401 -SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
            S P      G+ GT+   APE   G   + + D++S G+++ E
Sbjct: 314 WSTPF---HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 58/234 (24%), Positives = 103/234 (44%), Gaps = 41/234 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTV---VAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           LIG G FG VY+     D  +      K+ NL+    +++ + E     NI   + + + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLE----NETIVMETLVYNNIYDIDKIALW 74

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-----LLQRI-- 347
            +  ++D  G      + KY   GS ++           R I ++KL      + +RI  
Sbjct: 75  KNIHNIDHLG------IPKYYGCGSFKR------CRMYYRFILLEKLVENTKEIFKRIKC 122

Query: 348 -------SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
                  +I  D+ + L+Y+H+H    I H D+KP NI++D +   +I D+G++  +  +
Sbjct: 123 KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHF-II 178

Query: 401 SNPTVSSSIGV----RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               +  S       RGT+ Y   +   G+ V+  GD+ S G  +L+    K P
Sbjct: 179 HGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.9 bits (129), Expect = 9e-08
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 28/174 (16%)

Query: 278 ECKALKNIRHKNLVRVITSCSSVDF-----QGNDFKAIVYKYMPNGSLEKWLHPDAIPQR 332
           E  AL  + H+N++++     S        Q  DF   +Y +M + + + W        +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-W--------K 261

Query: 333 DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG 392
           DR +      L Q  +I   +  A++Y+H    + ++H D+K  NI L+ D    +GDFG
Sbjct: 262 DRPL------LKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFG 312

Query: 393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +  ++       +   G  GT+   +PE   G       D++S G++LL+M++
Sbjct: 313 TAMPFE---KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 67/265 (25%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI----RHK 288
           F     +G+G+FG V      +   + A+K +  ++    ++ +A  KA ++I     ++
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLR-KKDVLLRNQVAHVKAERDILAEADNE 61

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
            +VR+  S     FQ  D    V  Y+P G +   L    I   D          L R  
Sbjct: 62  WVVRLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED----------LARFY 106

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL---------SRFYQA 399
           IA ++  A++ +H+      +H D+KP NIL+D D    + DFGL         S++YQ+
Sbjct: 107 IA-ELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162

Query: 400 VSNPTVSS-------------SIGVR---------------------GTIGYVAPEYGLG 425
             +    S               G R                     GT  Y+APE  L 
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 426 SEVSTNGDVYSYGILLLEMVTTKKP 450
           +  +   D +S G++L EM+  + P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 7/103 (6%)

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++  AL++LH+     I++ DLK  N+LLD D    + D+G+ +  + +     +S+ 
Sbjct: 102 AAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTF 156

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE   G E   + D ++ G+L+ EM+  + P D
Sbjct: 157 C--GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 9/118 (7%)

Query: 331 QRDREIEIQKLTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIG 389
           +   E+  + LTL   IS +  VA  +++L  + C    +H DL   NILL  +    I 
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKIC 215

Query: 390 DFGLSR-FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           DFGL+R  Y+   +P        R  + ++APE       +T  DV+S+G+LL E+ +
Sbjct: 216 DFGLARDIYK---DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 11/97 (11%)

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVSSSIGVRG 413
           AL+ LH+     +++ DLKP NILL  D   HI   DFGL +      + T +      G
Sbjct: 105 ALENLHKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFC----G 155

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE  LG   +   D ++ G+LL EM+T   P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 69/266 (25%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI----RHK 288
           F     +G+G+FG V      +   + A+K +  ++   +++ +A  KA ++I     ++
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR-KKDVLNRNQVAHVKAERDILAEADNE 61

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLLQRI 347
            +V++  S     FQ  D    V  Y+P G +   L   +  P+      I +LTL    
Sbjct: 62  WVVKLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL---- 112

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL---------SRFYQ 398
             AI+    + ++H+         D+KP NIL+D D    + DFGL         S++YQ
Sbjct: 113 --AIESVHKMGFIHR---------DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161

Query: 399 A-----------------VSNPTVSSSI-----------------GVRGTIGYVAPEYGL 424
                             VSN      +                  + GT  Y+APE  L
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221

Query: 425 GSEVSTNGDVYSYGILLLEMVTTKKP 450
               +   D +S G++L EM+  + P
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 66/257 (25%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F S  +IG G+FG V      + G + A+K +        KS M E + + ++R +  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERD 53

Query: 291 VRVITSCSSV-----DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +        V      FQ  ++  ++ +Y+P G +   L             ++K T  +
Sbjct: 54  ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL-------------MKKDTFTE 100

Query: 346 ---RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL--------- 393
              R  IA +   A+D +H+      +H D+KP N+LLD      + DFGL         
Sbjct: 101 EETRFYIA-ETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Query: 394 SRFYQAVSN--PTVSSSIGVR-----------------------GTIGYVAPEYGLGSEV 428
           + FY+ +S+  P+       +                       GT  Y+APE  L +  
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216

Query: 429 STNGDVYSYGILLLEMV 445
           +   D +S G+++ EM+
Sbjct: 217 NKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 28/228 (12%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
             F   +L+G G FG V        G + A+KV+  +    ++  ++  +  ++I   + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQKLTLLQRIS 348
              I       FQ  D   +V +Y P G L   L  + D   +   +  + +L L     
Sbjct: 60  SPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVL----- 113

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            AI     + Y+H+         D+KP N+L+D      + DFG +   +  +N  V+S 
Sbjct: 114 -AIHSVHQMGYVHR---------DIKPENVLIDRTGHIKLADFGSAA--RLTANKMVNSK 161

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVTTKKP 450
           + V GT  Y+APE          G      D +S G++  EM+  + P
Sbjct: 162 LPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 30/228 (13%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLV 291
           F    L+G G++G VYKG   + G + AIKV+++      +    E   LK    H+N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIA 66

Query: 292 RVITSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
               +    +  G D +  +V ++   GS+               I+  K   L+   IA
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------------IKNTKGNTLKEEWIA 114

Query: 351 I---DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
               ++   L +LHQH    ++H D+K  N+LL  +    + DFG+S    A  + TV  
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGR 167

Query: 408 SIGVRGTIGYVAPEYGLGSE-----VSTNGDVYSYGILLLEMVTTKKP 450
                GT  ++APE     E          D++S GI  +EM     P
Sbjct: 168 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 43/233 (18%)

Query: 233 FSSTNLIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNI 285
           F    ++G G++G V+   K    + G + A+KV+     +Q+    +    E   L+++
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD--REIEIQKLTL 343
           R    +  +       FQ      ++  Y+  G +   L+     QRD   E E+     
Sbjct: 62  RQSPFLVTLHYA----FQTEAKLHLILDYVSGGEMFTHLY-----QRDNFSEDEV----- 107

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSN 402
             R     ++  AL++LH+     I++ D+K  NILLD++    + DFGLS+ F      
Sbjct: 108 --RFYSG-EIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161

Query: 403 PTVSSSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            T S      GTI Y+APE      G G  V    D +S GIL+ E++T   P
Sbjct: 162 RTYSFC----GTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 7/101 (6%)

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++   L +LH    + I++ DLK  N++LD D    I DFG+ +  + V     +S+ 
Sbjct: 102 AAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTF 156

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE   G + + + D +S+G+LL EM+  + P
Sbjct: 157 C--GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 27/180 (15%)

Query: 267 QRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP 326
           QR G +     E   L+ I H +++++  +     F  N F  ++   +P    + + + 
Sbjct: 126 QRGGTA----TEAHILRAINHPSIIQLKGT-----FTYNKFTCLI---LPRYKTDLYCYL 173

Query: 327 DAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA 386
            A     R I I  +  ++R      V  A+ YLH++    I+H D+K  NI +++    
Sbjct: 174 AA----KRNIAICDILAIER-----SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDV 221

Query: 387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +GDFG + F   +     +   G  GTI   APE           D++S GI+L EM T
Sbjct: 222 CLGDFGAACFPVDI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 30/245 (12%)

Query: 216 KALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF 275
           ++L  +   +L      F    ++G G++G VYKG   + G + AIKV+++  +   +  
Sbjct: 1   RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEI 59

Query: 276 MAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRD 333
             E   LK    H+N+     +       G+D +  +V ++   GS+             
Sbjct: 60  KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL---------- 109

Query: 334 REIEIQKLTLLQRISIAI---DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD 390
             ++  K   L+   IA    ++   L +LH H    ++H D+K  N+LL  +    + D
Sbjct: 110 --VKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVD 164

Query: 391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEMV 445
           FG+S    A  + TV       GT  ++APE         +      D++S GI  +EM 
Sbjct: 165 FGVS----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA 220

Query: 446 TTKKP 450
               P
Sbjct: 221 EGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 26/62 (41%), Positives = 38/62 (61%), Gaps = 1/62 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N + G IP ++ SI+ L   L+L+ N F GSIP  +G L +LR  +++ N LSG +P  
Sbjct: 451 GNSIRGNIPPSLGSITSLE-VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509

Query: 63  LG 64
           LG
Sbjct: 510 LG 511

Length = 623

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 25/215 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G G FG V        G + A K ++   L+++   K  + E + L+ +    +V +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           +     F+      +V   M  G L+   H   + +R  E+E       + I  +  +  
Sbjct: 61  A-----FESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEME-------RVIHYSAQITC 106

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + +LH      I++ D+KP N+LLD+  +  + D GL     AV      +     GT 
Sbjct: 107 GILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL-----AVELKDGKTITQRAGTN 158

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GY+APE       S   D ++ G  + EMV  + P
Sbjct: 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 35/228 (15%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGT--VVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           F+   ++G GSFG V     +  GT  + AIK++    + +    +  M E + L     
Sbjct: 2   FNFLMVLGKGSFGKVMLA--ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL--- 344
              +  + SC    FQ  D    V +Y+  G L                 IQ++      
Sbjct: 60  PPFLTQLHSC----FQTMDRLYFVMEYVNGGDLM--------------YHIQQVGKFKEP 101

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
             +  A ++A  L +LH    + I++ DLK  N++LD +    I DFG+ +  + +    
Sbjct: 102 HAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGK 156

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            + +    GT  Y+APE         + D +++G+LL EM+  + P D
Sbjct: 157 TTRTFC--GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 30/219 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV---- 293
           +IG G FG VY     + G + A+K ++ +R    K    E  AL      +LV      
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCP 57

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C +  F   D    +   M  G L   L    +   ++E+             A ++
Sbjct: 58  FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRF----------YATEI 106

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPTVSSSIGVR 412
              L+++H      +++ DLKP+NILLD      I D GL+  F +   + +V       
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------- 156

Query: 413 GTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT GY+APE    G+   ++ D +S G +L +++    P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 58/257 (22%), Positives = 104/257 (40%), Gaps = 59/257 (22%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           + F S  +IG G+FG V      + G V A+K++        K+ M E + + +IR +  
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53

Query: 291 VRVITSCSSV-----DFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLL 344
           + V      V      FQ      ++ +++P G +   L   D + + + +  I +  L 
Sbjct: 54  ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL- 112

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL---------SR 395
                AID    L ++H+         D+KP N+LLD+     + DFGL         + 
Sbjct: 113 -----AIDSIHQLGFIHR---------DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158

Query: 396 FYQAVSNPTVSS----------------------SIGVRGTIGYVAPEYGLGSEVSTNGD 433
           FY+ +++   S                       +    GT  Y+APE  + +  +   D
Sbjct: 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218

Query: 434 VYSYGILLLEMVTTKKP 450
            +S G+++ EM+    P
Sbjct: 219 WWSLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 41/222 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTV----------VAIKVINLQRQGASKSFMAECKALKNIRHK 288
           +G G+F ++YKGV      +          V +KV+       S +F      +  + HK
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           +LV++   C   +        +V +Y+  G L+ +LH +             ++L  ++ 
Sbjct: 62  HLVKLYGVCVRDENI------MVEEYVKFGPLDVFLHREKNN----------VSLHWKLD 105

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           +A  +ASAL YL     + ++H ++   NIL+     A  G       +  +S+P +  +
Sbjct: 106 VAKQLASALHYLE---DKKLVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPIT 157

Query: 409 IGVRGT----IGYVAPEY--GLGSEVSTNGDVYSYGILLLEM 444
           +  R      I ++APE      + ++   D +S+G  LLE+
Sbjct: 158 VLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 39/142 (27%), Positives = 62/142 (43%), Gaps = 12/142 (8%)

Query: 309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-----LTLLQRISIAIDVASALDYL-HQ 362
            + Y         + +   +   +D   EI +     L     +S +  VA  + +L  +
Sbjct: 174 GVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK 233

Query: 363 HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEY 422
           +C    +H DL   NILL +     I DFGL+R  +  SN  V  +   R  + ++APE 
Sbjct: 234 NC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN--ARLPVKWMAPES 287

Query: 423 GLGSEVSTNGDVYSYGILLLEM 444
                 +   DV+SYGILL E+
Sbjct: 288 IFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 30/101 (29%), Positives = 57/101 (56%), Gaps = 7/101 (6%)

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           +++ AL+YLH+     I++ DLK  N+LLD++    + D+G+ +  + +     +S+   
Sbjct: 104 EISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFC- 157

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            GT  Y+APE   G +   + D ++ G+L+ EM+  + P D
Sbjct: 158 -GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 28/218 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV---- 293
           +IG G FG VY     + G + A+K ++ +R    K    E  AL      +LV      
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCP 57

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C S  F   D  + +   M  G L   L    +            +  +    A ++
Sbjct: 58  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----------FSEAEMRFYAAEI 106

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              L+++H      +++ DLKP+NILLD      I D GL+  +   S     +S+   G
Sbjct: 107 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASV---G 157

Query: 414 TIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T GY+APE    G    ++ D +S G +L +++    P
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV---RVIT 295
           +G G++G VYK    +        +  ++  G S S   E   L+ ++H N++   +V  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 296 SCSS------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           S S        D+  +D   I+  +  + + +K   P  +P+          ++++  S+
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK---PMQLPR----------SMVK--SL 113

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDND----LSAHIGDFGLSRFYQAVSNPTV 405
              +   + YLH +    +LH DLKP+NIL+  +        I D G +R + +   P +
Sbjct: 114 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-L 169

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           +    V  T  Y APE  LG+   T   D+++ G +  E++T++
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 64/235 (27%), Positives = 99/235 (42%), Gaps = 33/235 (14%)

Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECK 280
           K  +KA D F    +IG G+FG V          V A+K+++   + ++  S  F  E  
Sbjct: 37  KLRMKAED-FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE-- 93

Query: 281 ALKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
             ++I  H N   ++    +  FQ + +  +V +YMP G L   +    IP++       
Sbjct: 94  --RDIMAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK------- 142

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
                 R   A +V  ALD +H       +H D+KP N+LLD      + DFG     + 
Sbjct: 143 ----WARFYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC--MKM 192

Query: 400 VSNPTVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +N  V     V GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 193 DANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 31/231 (13%)

Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 40  MKAED-YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L   +    +P++  +    ++ L
Sbjct: 99  FANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                       ALD +H      ++H D+KP N+LLD      + DFG           
Sbjct: 154 ------------ALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198

Query: 404 TVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +++   GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 199 RCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.7 bits (116), Expect = 4e-06
 Identities = 30/73 (41%), Positives = 39/73 (53%), Gaps = 4/73 (5%)

Query: 67  SSLEDIYLGGNFFHGSI-PSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSF 123
           S +  I L G    G I  + FR    I+ ++LS N LSG IP  +F  + SL YLNLS 
Sbjct: 69  SRVVSIDLSGKNISGKISSAIFRLPY-IQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127

Query: 124 NDFEGKVPTKGIF 136
           N+F G +P   I 
Sbjct: 128 NNFTGSIPRGSIP 140

Length = 968

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 29/103 (28%), Positives = 57/103 (55%), Gaps = 7/103 (6%)

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           + +++ AL++LH+     I++ DLK  N+LLD +    + D+G+ +  + +     +S+ 
Sbjct: 102 SAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTF 156

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE   G +   + D ++ G+L+ EM+  + P D
Sbjct: 157 C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 17/148 (11%)

Query: 301 DFQGNDF-KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDY 359
           D Q +++ +   YK   +  ++  L  D           + LT L  +S    VA  +++
Sbjct: 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGS---------EGLTTLDLLSFTYQVARGMEF 252

Query: 360 L-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           L  ++C    +H DL   N+LL       I DFGL+R     SN     S  +   + ++
Sbjct: 253 LASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWM 306

Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    +  +T  DV+SYGILL E+ +
Sbjct: 307 APESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 31/216 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKN---LVRV 293
           +G G++GSV           VA+K ++   Q    ++    E + LK+++H+N   L+ V
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
            T  +S++    +F  +   Y+    +   L        +  ++ QKL+      +   +
Sbjct: 83  FTPATSIE----NFNEV---YLVTNLMGADL--------NNIVKCQKLSDEHVQFLIYQL 127

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              L Y+H      I+H DLKPSN+ ++ D    I DFGL+R  QA    T     G   
Sbjct: 128 LRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT-----GYVA 177

Query: 414 TIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           T  Y APE  L     +   D++S G ++ E++  K
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 239 IGVGSFGSVYK-----GVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV-- 291
           +G G++G VYK     G  D D    A+K I  +  G S S   E   L+ ++H N++  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRD---YALKQI--EGTGISMSACREIALLRELKHPNVISL 63

Query: 292 -RVITSCSS------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
            +V  S +        D+  +D   I+  +  + + +K   P  +P+      + K  L 
Sbjct: 64  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKK---PVQLPR-----GMVKSLLY 115

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND----LSAHIGDFGLSRFYQAV 400
           Q       +   + YLH +    +LH DLKP+NIL+  +        I D G +R + + 
Sbjct: 116 Q-------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
             P ++    V  T  Y APE  LG+   T   D+++ G +  E++T++
Sbjct: 166 LKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)

Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 40  MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L   +    +P++           
Sbjct: 99  FANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----------- 142

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             R   A +V  ALD +H       +H D+KP N+LLD      + DFG     +     
Sbjct: 143 WARFYTA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEG 196

Query: 404 TVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            V     V GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 41/261 (15%)

Query: 195 FIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVF-D 253
           F+ +     +     ++   RK   KM Y+        F+    +G GSFG V    + +
Sbjct: 3   FLKNLQLHKKKDSDSTKEPKRKN--KMKYED-------FNFIRTLGTGSFGRVILATYKN 53

Query: 254 EDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI 310
           ED   VAIK      + +Q       +E K L  I H   V +  S     F+   +  +
Sbjct: 54  EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS-----FKDESYLYL 108

Query: 311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQE-PIL 369
           V +++  G    +L  +     D               +    A+ +  + ++ Q   I+
Sbjct: 109 VLEFVIGGEFFTFLRRNKRFPND---------------VGCFYAAQIVLIFEYLQSLNIV 153

Query: 370 HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVS 429
           + DLKP N+LLD D    + DFG ++          + +  + GT  Y+APE  L     
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFAKVVD-------TRTYTLCGTPEYIAPEILLNVGHG 206

Query: 430 TNGDVYSYGILLLEMVTTKKP 450
              D ++ GI + E++    P
Sbjct: 207 KAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 34/117 (29%), Positives = 54/117 (46%), Gaps = 5/117 (4%)

Query: 330 PQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG 389
           PQ   ++    LT+   I  +  VA  +++L        +H DL   NILL  +    I 
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKIC 216

Query: 390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           DFGL+R      +P        R  + ++APE       +T  DV+S+G+LL E+ +
Sbjct: 217 DFGLAR--DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 5/106 (4%)

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           LTL   I  +  VA  +++L        +H DL   NILL  +    I DFGL+R     
Sbjct: 176 LTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIY 230

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +P        R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 29/225 (12%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           F+   ++G GSFG V          + AIK++    + +    +  M E + L       
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            +  + SC    FQ  D    V +Y+  G L   +            ++ +      +  
Sbjct: 62  FLTQLHSC----FQTMDRLYFVMEYVNGGDLMYQIQ-----------QVGRFKEPHAVFY 106

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--FYQAVSNPTVSS 407
           A ++A  L +LH    + I++ DLK  N++LD++    I DFG+ +   +  V+  T   
Sbjct: 107 AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC- 162

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
                GT  Y+APE         + D +++G+LL EM+  + P +
Sbjct: 163 -----GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 24/239 (10%)

Query: 212 PMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA 271
           P+  K ++   + S    +D +     IG G++G V+K +  ++G+  A+K+++      
Sbjct: 2   PLSGKTII---FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDI 57

Query: 272 SKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIP 330
            +   AE   LK +  H N+V+        D +  D   +V +    GS+   L    + 
Sbjct: 58  DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD-LVKGFLK 116

Query: 331 QRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD 390
           + +R         ++   IA  +  AL  L        +H D+K +NILL  +    + D
Sbjct: 117 RGER---------MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167

Query: 391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEM 444
           FG+S     +++  +  +  V GT  ++APE       L S      DV+S GI  +E+
Sbjct: 168 FGVS---AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 31/241 (12%)

Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECK 280
           +  +SL   TD +     IG G++G VYK    +DG++ A+K+++       +   AE  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYN 70

Query: 281 ALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
            L+++  H N+V+         F G  +KA     +  G L  WL  + +       E+ 
Sbjct: 71  ILQSLPNHPNVVK---------FYGMFYKA---DKLVGGQL--WLVLE-LCNGGSVTELV 115

Query: 340 KLTL-----LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           K  L     L    I+  +  AL  L       I+H D+K +NILL  +    + DFG+S
Sbjct: 116 KGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175

Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEMVTTKK 449
                +++  +  +  V GT  ++APE                DV+S GI  +E+     
Sbjct: 176 ---AQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 450 P 450
           P
Sbjct: 232 P 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 50/225 (22%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIR-HKNLVRVI-- 294
           IG G+F  V K    + G   AIK +    +   + + + E +AL+ +  H N++R+I  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 295 -----TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
                T   ++ F+  D    +Y+ +      K   P+   +R +    Q L        
Sbjct: 67  LFDRKTGRLALVFELMDMN--LYELIKG---RKRPLPE---KRVKSYMYQLL-------- 110

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                 +LD++H++    I H D+KP NIL+ +D+   + DFG  R     S P  +  I
Sbjct: 111 -----KSLDHMHRN---GIFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYI 159

Query: 410 GVRGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVTTK 448
             R    Y APE  L     T+G      D+++ G +  E+++  
Sbjct: 160 STR---WYRAPECLL-----TDGYYGPKMDIWAVGCVFFEILSLF 196

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 44.6 bits (105), Expect = 7e-05
 Identities = 32/105 (30%), Positives = 46/105 (43%), Gaps = 4/105 (3%)

Query: 22  NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG 81
           N+L+L+ N     +PP I  L AL   D+SNN +  E+   L    +L  + L  N    
Sbjct: 189 NNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-E 245

Query: 82  SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDF 126
            +P        +  LDLS N +S  I       +L  L+LS N  
Sbjct: 246 DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSL 289

Length = 394

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 34/99 (34%), Positives = 46/99 (46%), Gaps = 10/99 (10%)

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++  ALD LH+   E I+  DL P+NILLD       G   L+ F +           
Sbjct: 91  AAEMVVALDALHR---EGIVCRDLNPNNILLD-----DRGHIQLTYFSRWSEVEDSCDGE 142

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
            V     Y APE G  SE +   D +S G +L E++T K
Sbjct: 143 AVENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 17/62 (27%), Positives = 30/62 (48%)

Query: 336 IEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
             + +++  ++  IA  +A  L  LHQ     + H DL P NIL+D+     I D+  + 
Sbjct: 78  ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137

Query: 396 FY 397
           + 
Sbjct: 138 YG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 49/218 (22%), Positives = 98/218 (44%), Gaps = 34/218 (15%)

Query: 239 IGVGSFGSVYKGVFDEDG-------TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
           +G G+F  ++KG+  E G       T V +KV++   +  S+SF      +  + HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
                C        D   +V +Y+  GSL+ +L      ++++      + +  ++ +A 
Sbjct: 63  LNYGVC-----VCGDESIMVQEYVKFGSLDTYL------KKNK----NLINISWKLEVAK 107

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +A AL +L     + + H ++   N+LL  +     G    +  +  +S+P +S ++  
Sbjct: 108 QLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTG----NPPFIKLSDPGISITVLP 160

Query: 412 RGT----IGYVAPEYGLGSE-VSTNGDVYSYGILLLEM 444
           +      I +V PE     + +S   D +S+G  L E+
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI 198

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 43/161 (26%), Positives = 64/161 (39%), Gaps = 27/161 (16%)

Query: 238 LIGVGSFG--SVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRV 293
           LIG        V+        T+VA+K INL        K    E    + ++H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL---HPDAIPQRDREIEIQKLTLLQRISIA 350
           +TS     F  +    +V   M  GS E  L    P+ +P    E+ I          I 
Sbjct: 65  VTS-----FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP----ELAIA--------FIL 107

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF 391
            DV +ALDY+H    +  +H  +K S+ILL  D    +   
Sbjct: 108 KDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 24/168 (14%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN- 289
           + F +  +IG G+FG V      + G + A+K + L+ +   K  +A  KA +++  ++ 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 290 ---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
              +V +  S     FQ   +  ++ +++P G L   L        D    + +  + + 
Sbjct: 60  SPWVVSLYYS-----FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED----VTRFYMAEC 110

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           + +AI+    L ++H+         D+KP NIL+D      + DFGLS
Sbjct: 111 V-LAIEAVHKLGFIHR---------DIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 7/107 (6%)

Query: 341 LTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
           L+ +  +  +  VA+ +++L  ++C    +H DL   N+L+       I DFGL+R    
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMR 291

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            SN     S  +   + ++APE    +  +T  DV+S+GILL E+ T
Sbjct: 292 DSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 12/112 (10%)

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQ 398
           KL+  +   I   +  AL+ LH+H    I+H D+K  N+L D      ++ D+GL +   
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK--- 158

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +  P+        GT+ Y +PE   G     + D ++ G+L  E++T K P
Sbjct: 159 IIGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 5e-04
 Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 54/244 (22%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G FG V+             K I+ +  ++      + E   ++ ++HKN+VR I  
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +   + N    I+ ++   G L + +      Q+  ++   K+     + I   +  A
Sbjct: 81  FLN---KANQKLYILMEFCDAGDLSRNI------QKCYKM-FGKIEEHAIVDITRQLLHA 130

Query: 357 LDYLHQHCQEP----ILHCDLKPSNILLD-------------NDLS----AHIGDFGLSR 395
           L Y H     P    +LH DLKP NI L              N+L+    A IGDFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 396 FYQAVSNPTVSSSIGVR-------GTIGYVAPEYGLGSEVSTN--GDVYSYGILLLEMVT 446
                       +IG+        GT  Y +PE  L    S +   D+++ G ++ E+ +
Sbjct: 191 ------------NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 447 TKKP 450
            K P
Sbjct: 239 GKTP 242

Length = 1021

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 35/105 (33%), Positives = 50/105 (47%), Gaps = 26/105 (24%)

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG----- 410
           AL+YLH +    I+H DLKP N+L+ +     + DFGLS+    + + T +   G     
Sbjct: 113 ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI--GLMSLTTNLYEGHIEKD 167

Query: 411 --------VRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLE 443
                   V GT  Y+APE     G G  V    D ++ GI+L E
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.002
 Identities = 19/60 (31%), Positives = 28/60 (46%), Gaps = 1/60 (1%)

Query: 68  SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP-LFLEALSLEYLNLSFNDF 126
           +L+ + L  N         F+    ++ LDLS NNL+   P  F    SL  L+LS N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	452
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.78
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.77
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.76
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.68
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.67
PLN03150	623	hypothetical protein; Provisional	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.66
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.62
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.62
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.59
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.58
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.51
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.39
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.37
PLN03150	623	hypothetical protein; Provisional	99.37
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.34
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.34
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.34
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.31
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.3
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.3
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.3
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.27
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.22
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.21
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.2
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.11
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.09
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.08
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.05
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.03
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.03
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.03
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.0
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.95
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.94
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.93
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.85
COG4248	637	Uncharacterized protein with protein kinase and he	98.83
PRK09902	216	hypothetical protein; Provisional	98.81
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.71
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.64
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.58
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.56
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.55
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.42
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.42
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.41
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.34
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.32

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.4e-59  Score=507.12  Aligned_cols=411  Identities=29%  Similarity=0.505  Sum_probs=306.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++.+.+|..+ ...+| +.|+|++|++++.+|..+.++++|+.|+|++|++.+.+|+.+..+++|++|+|++|.++
T Consensus       459 L~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        459 LARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             CcCceeeeecCccc-ccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            34555555555543 34566 77888888888888888888999999999999999899999999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccccCCCCCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQL  159 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~~~~~~~  159 (452)
                      +.+|..|..+++|+.|+|++|++++..|..+..++ |+.|++++|++.+..|..+.+..+....+.+|+.+|++.+....
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~  616 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL  616 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC
Confidence            89999999999999999999999987776666554 99999999999988888888888888888999999987655555


Q ss_pred             CccccCCCcccccccceeeehhHHHHHHHHHHhhhheecccccCCCC--C--CCChhH-H---H-hhhcccChHHHHHhh
Q 041632          160 PKCTENKSSNQRISRSLKILISIVSIFLGIVMVSFFIFSWHKRSRPS--R--QPSEPM-I---R-KALLKMSYKSLLKAT  230 (452)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~i~i~~~~~~~~~~~~~~~~~~~~~r~~~~--~--~~~~~~-~---~-~~~~~~~~~~~~~~~  230 (452)
                      +.|....   ....+ ..++++++++++++++++++++.+++|++..  +  ...... .   . .....+++++.   .
T Consensus       617 ~~c~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  689 (968)
T PLN00113        617 PPCKRVR---KTPSW-WFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---L  689 (968)
T ss_pred             CCCcccc---cccee-eeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---H
Confidence            6674211   11111 2222222222222233333333333222111  1  000000 0   0 00111223332   3


Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ..|...+.||+|+||.||+|+...+|+.||||.++....    ....|++.+++++||||++++++|..     .+..++
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~-----~~~~~l  760 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS-----EKGAYL  760 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc-----CCCCEE
Confidence            457778899999999999999988999999999864322    12356889999999999999999743     346799


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.++++              .++|.++.+++.|+++||+|||+.+.++|+||||||+||+++.++..++. 
T Consensus       761 v~Ey~~~g~L~~~l~--------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-  825 (968)
T PLN00113        761 IHEYIEGKNLSEVLR--------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-  825 (968)
T ss_pred             EEeCCCCCcHHHHHh--------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-
Confidence            999999999999984              37889999999999999999997767799999999999999999988875 


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.+......        ....+|+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       826 ~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        826 LSLPGLLCTD--------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD  879 (968)
T ss_pred             eccccccccC--------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            5554322111        11357899999999999999999999999999999999999984

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=364.26  Aligned_cols=200  Identities=34%  Similarity=0.557  Sum_probs=178.8

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ..++|...+.||+|+||+||+|+++.++..||||.+...  ..+..+.+..|+++|+.++|||||++++++     ..++
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            346788999999999999999999999999999999765  344556788999999999999999999984     4456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC---
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---  383 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---  383 (452)
                      ..|+|||||.+|+|.+|++..+           .+++..+..++.|+|.||++||+.   +||||||||+|||++..   
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~-----------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~  148 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG-----------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARN  148 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCC
Confidence            8999999999999999998654           789999999999999999999998   99999999999999865   


Q ss_pred             ---CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 ---LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ---~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                         -.+||+|||+|+........     ...+|++.|||||++...+|+.|+|+||+|+++|++++|+.||+
T Consensus       149 ~~~~~LKIADFGfAR~L~~~~~a-----~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  149 DTSPVLKIADFGFARFLQPGSMA-----ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             CCCceEEecccchhhhCCchhHH-----HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence               46899999999987743222     24789999999999999999999999999999999999999996

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=367.77  Aligned_cols=218  Identities=44%  Similarity=0.772  Sum_probs=189.1

Q ss_pred             hhcccChHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeee
Q 041632          217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS  296 (452)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~  296 (452)
                      ....++++++..||++|...+.||+|+||.||+|... +|+.||||++........++|.+|++++.+++|||+|+++|+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4567899999999999999999999999999999996 568999998875443214669999999999999999999999


Q ss_pred             eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       297 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                      |.+..    +..++|||||++|+|.++|+...        .. .++|.+|++||.++|+||+|||+.+.++|+||||||+
T Consensus       140 C~e~~----~~~~LVYEym~nGsL~d~L~~~~--------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss  206 (361)
T KOG1187|consen  140 CLEGG----EHRLLVYEYMPNGSLEDHLHGKK--------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS  206 (361)
T ss_pred             EecCC----ceEEEEEEccCCCCHHHHhCCCC--------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence            96533    25899999999999999998654        11 7899999999999999999999999899999999999


Q ss_pred             CeeecCCCceEECccccccccccCCCCceeccccc-cccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV-RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       377 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+|+++++||+|||+|+..+.. ..   ..... .||.+|+|||+...+..+.|+|||||||+|.||+||+.|.|
T Consensus       207 NILLD~~~~aKlsDFGLa~~~~~~-~~---~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d  279 (361)
T KOG1187|consen  207 NILLDEDFNAKLSDFGLAKLGPEG-DT---SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD  279 (361)
T ss_pred             HeeECCCCCEEccCccCcccCCcc-cc---ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence            999999999999999999654421 11   11111 69999999999999999999999999999999999998865

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=354.39  Aligned_cols=199  Identities=26%  Similarity=0.429  Sum_probs=182.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..|...+.||+|||+.+|.++...+|..||+|+++..   +....+...+||++.+.++|||||+++++     |++.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecCCc
Confidence            4588999999999999999999889999999999753   45556788999999999999999999998     888999


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+|+|+|+.++|..+++..           +.+++.++..+..||+.||.|||+.   +|+|||||..|+|++++.++|
T Consensus        93 VYivLELC~~~sL~el~Krr-----------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VK  158 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKRR-----------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVK  158 (592)
T ss_pred             eEEEEEecCCccHHHHHHhc-----------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEE
Confidence            99999999999999999744           4799999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|.........    ....+|||.|.|||++....++..+||||+||+||.|++|++||+
T Consensus       159 IgDFGLAt~le~~~Er----k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe  219 (592)
T KOG0575|consen  159 IGDFGLATQLEYDGER----KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE  219 (592)
T ss_pred             ecccceeeeecCcccc----cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc
Confidence            9999999987744332    345789999999999999999999999999999999999999996

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-46  Score=336.15  Aligned_cols=200  Identities=33%  Similarity=0.475  Sum_probs=179.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||+||.++.+.+++.+|+|++++..   .+..+...+|..+|.+++||.||++.-.     |++.+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQt~~   98 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQTEE   98 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cccCC
Confidence            568999999999999999999999999999999997543   2345678899999999999999999876     88889


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+|+||+.||.|..+|+++.           .+++..+..++..|+.||.|||+.   +||||||||+|||+|++|++
T Consensus        99 kLylVld~~~GGeLf~hL~~eg-----------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi  164 (357)
T KOG0598|consen   99 KLYLVLDYLNGGELFYHLQREG-----------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHI  164 (357)
T ss_pred             eEEEEEeccCCccHHHHHHhcC-----------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcE
Confidence            9999999999999999997654           689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|+|||+++.--....    .....+||+.|||||++.+..|+.++|.||+||++|||++|.+||.
T Consensus       165 ~LtDFgL~k~~~~~~~----~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  165 KLTDFGLCKEDLKDGD----ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             EEeccccchhcccCCC----ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence            9999999985432222    2234789999999999999999999999999999999999999995

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-45  Score=332.35  Aligned_cols=196  Identities=30%  Similarity=0.430  Sum_probs=173.3

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc-eeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND-FKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~-~~~  309 (452)
                      +++..+.||+|..|+||+++++.+++.+|+|.+.... ....+++.+|++++++.+||+||+++|++     ..+. ...
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF-----~~~~~~is  154 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAF-----YSNGEEIS  154 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEE-----EeCCceEE
Confidence            4556788999999999999999999999999996443 34457899999999999999999999994     4444 589


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      |+||||++|||++++...           .++++...-+++.++++||.|||+.  .+||||||||+||||+..|++||+
T Consensus       155 I~mEYMDgGSLd~~~k~~-----------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV-----------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             eehhhcCCCCHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence            999999999999998643           3689999999999999999999963  399999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||.++.+...      -..+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||
T Consensus       222 DFGVS~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~  277 (364)
T KOG0581|consen  222 DFGVSGILVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPY  277 (364)
T ss_pred             cccccHHhhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCC
Confidence            99999876533      123467999999999999999999999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-47  Score=330.87  Aligned_cols=208  Identities=28%  Similarity=0.400  Sum_probs=178.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .+|++.+.||+|.||+||+++...+|..||.|.+.....  +..++...|+.+|++++|||||++++.-.   .++....
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchhh
Confidence            357788899999999999999999999999999975432  33467899999999999999999987421   2333448


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEecccCCCCeeecCCCceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQE-PILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      +||||+|.+|+|.+.++..+       ...+.+++..+|+++.|++.||.++|+.... -|.||||||.||+++.+|.||
T Consensus        96 nivmE~c~~GDLsqmIk~~K-------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFK-------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHH-------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            99999999999999997544       3346789999999999999999999994322 389999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.++...    +...+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.
T Consensus       169 LGDfGL~r~l~s~~----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKT----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             eccchhHhHhcchh----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence            99999999887432    33456889999999999999999999999999999999999999994

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=344.46  Aligned_cols=199  Identities=40%  Similarity=0.621  Sum_probs=169.5

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcE-EEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTV-VAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++...+.+|+|+||+||+|.++  |+. ||||++.......  .++|.+|+.+|.+++|||||+++|+|....    ...
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cce
Confidence            3445566999999999999995  555 9999997543322  468999999999999999999999986432    257


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEecccCCCCeeecCCC-ce
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP-ILHCDLKPSNILLDNDL-SA  386 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dlk~~Nill~~~~-~~  386 (452)
                      ++|||||++|+|.++++..         ....+++..++.+|.|||.||.|||+.   + ||||||||+|||++.++ ++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~---------~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~  183 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK---------RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTL  183 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc---------ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEE
Confidence            9999999999999999763         125799999999999999999999998   6 99999999999999997 99


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccC--CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL--GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++......    .......||+.|||||++.  ...|+.|+|||||||++|||+||+.||+
T Consensus       184 KI~DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~  247 (362)
T KOG0192|consen  184 KIADFGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE  247 (362)
T ss_pred             EECCCccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence            999999998654321    1223357999999999999  5689999999999999999999999995

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-44  Score=330.32  Aligned_cols=199  Identities=31%  Similarity=0.432  Sum_probs=170.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-------GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      .+.|.+.+.||+|+||.|-+|..+.+|+.||||+++.+..       ......++|+++|++++|||||++.++     |
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~-----f  245 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF-----F  245 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee-----e
Confidence            3567888999999999999999999999999999974321       122456899999999999999999998     6


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      +..+..|+||||++||+|.+++-..+           .+.+.....+++|++.|+.|||++   ||+||||||+|||++.
T Consensus       246 ~~~ds~YmVlE~v~GGeLfd~vv~nk-----------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~  311 (475)
T KOG0615|consen  246 EVPDSSYMVLEYVEGGELFDKVVANK-----------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSN  311 (475)
T ss_pred             ecCCceEEEEEEecCccHHHHHHhcc-----------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEecc
Confidence            66778899999999999999986554           466667788999999999999998   9999999999999986


Q ss_pred             C---CceEECccccccccccCCCCceeccccccccccccCccccCCCCC---CcccceeehhHHHHHHHhCCCCCC
Q 041632          383 D---LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV---STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~---~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +   ..+||+|||+|+....     ...+...+|||.|.|||++.+..+   ..++|+||+||+||-+++|.+||.
T Consensus       312 ~~e~~llKItDFGlAK~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS  382 (475)
T KOG0615|consen  312 DAEDCLLKITDFGLAKVSGE-----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFS  382 (475)
T ss_pred             CCcceEEEecccchhhcccc-----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcc
Confidence            6   7799999999987542     234556899999999999877543   347899999999999999999994

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=309.85  Aligned_cols=197  Identities=29%  Similarity=0.435  Sum_probs=178.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|+..++||.|+||+|..++.+.+|..+|+|+++...   .+..+...+|..+|+.+.||.++++.+.     +.+.+
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t-----~~d~~  117 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT-----FKDNS  117 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe-----eccCC
Confidence            357889999999999999999999999999999997543   3444667899999999999999999987     55677


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||.+||.|..++++.+           ++++..++.+|.||+.|++|||+.   +|++|||||+|||+|.+|.+
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~-----------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~i  183 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG-----------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHI  183 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC-----------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcE
Confidence            8999999999999999998654           789999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.|||.|+....       .....+|||.|+|||++....++.++|.|||||++|||+.|.+||-
T Consensus       184 KitDFGFAK~v~~-------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  184 KITDFGFAKRVSG-------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             EEEeccceEEecC-------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence            9999999987652       2345789999999999999999999999999999999999999993

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=331.90  Aligned_cols=206  Identities=29%  Similarity=0.456  Sum_probs=181.4

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~  303 (452)
                      +...+|.+++.||+|+|++|++|+.+.+++++|||++++.   +....+.+.+|-.+|.+| .||.|++++..     |+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T-----FQ  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT-----FQ  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE-----ee
Confidence            3456899999999999999999999999999999999743   334446678899999999 89999999876     78


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +....|+|+||+++|+|.++|++..           .+++.....+|.+|+.||+|||+.   |||||||||+|||+|+|
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~G-----------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~d  210 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKYG-----------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKD  210 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHhC-----------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCC
Confidence            8889999999999999999998764           789999999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCC---------ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNP---------TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++||.|||.|+.+......         ...+..+.+||..|.+||++.....+..+|+|+|||++|+|+.|++||.
T Consensus       211 mhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr  288 (604)
T KOG0592|consen  211 GHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR  288 (604)
T ss_pred             CcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence            99999999999987543222         1111145789999999999999999999999999999999999999993

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=328.17  Aligned_cols=207  Identities=27%  Similarity=0.413  Sum_probs=180.7

Q ss_pred             HHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       227 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      ....++|+.+..||+|+||+||.|+-+.+|..+|+|++++..   .+..+.+..|-.+|....+|.||+++..     |+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----FQ  211 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----FQ  211 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----ec
Confidence            335588999999999999999999999999999999998543   3455678899999999999999999977     88


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.++.||||||.+||++..+|....           .+++..+..++.+++.|++.+|+.   |+|||||||+|+|||..
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~-----------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~  277 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKD-----------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAK  277 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcC-----------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCC
Confidence            8899999999999999999997654           799999999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCC------------------CC-cee------c------------------cccccccccccCc
Q 041632          384 LSAHIGDFGLSRFYQAVS------------------NP-TVS------S------------------SIGVRGTIGYVAP  420 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~------------------~~-~~~------~------------------~~~~~gt~~y~aP  420 (452)
                      |++||+|||++..+....                  .+ ...      .                  ..+.+|||.||||
T Consensus       278 GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAP  357 (550)
T KOG0605|consen  278 GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAP  357 (550)
T ss_pred             CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccch
Confidence            999999999987432200                  00 000      0                  1246799999999


Q ss_pred             cccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          421 EYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       421 E~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++.+..|+..+|.||+|||+|||+.|.+||.
T Consensus       358 EVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~  389 (550)
T KOG0605|consen  358 EVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC  389 (550)
T ss_pred             HHHhcCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999999999994

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=330.89  Aligned_cols=198  Identities=34%  Similarity=0.543  Sum_probs=169.2

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +...+.||+|.||+||.|.++ ....||+|.++.. ....++|.+|+++|++++|+|||+++++|...     +..+|||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVt  280 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVT  280 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEE
Confidence            344578999999999999996 3447999999744 34458899999999999999999999998642     2689999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      |||+.|+|.+||+..         ....+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||
T Consensus       281 E~m~~GsLl~yLr~~---------~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTR---------EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             EecccCcHHHHhhhc---------CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccc
Confidence            999999999999862         235688889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|+.....   ......+..-+..|+|||.+..+.++.|||||||||+||||+| |+.||+
T Consensus       349 LAr~~~d~---~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~  406 (468)
T KOG0197|consen  349 LARLIGDD---EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP  406 (468)
T ss_pred             cccccCCC---ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence            99944322   2222333446788999999999999999999999999999999 999974

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-42  Score=321.99  Aligned_cols=202  Identities=31%  Similarity=0.462  Sum_probs=175.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .+.|+..+.||+|.||.||+|+...+|+.||+|++..+.  ++......+||.+|++++||||+++.+...+.   ....
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s  192 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS  192 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence            345777889999999999999999999999999998654  56667788999999999999999999986443   2467


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+|+||| .-+|..++....          -.+++.++..++.|++.||+|+|+.   +|.|||||.+|||||++|.+|
T Consensus       193 iYlVFeYM-dhDL~GLl~~p~----------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LK  258 (560)
T KOG0600|consen  193 IYLVFEYM-DHDLSGLLSSPG----------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLK  258 (560)
T ss_pred             EEEEEecc-cchhhhhhcCCC----------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEE
Confidence            99999999 558887776433          4789999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||+|+++.......   .+..+-|..|.|||++.+. .|+.+.|+||.||||.||++|++.|
T Consensus       259 iaDFGLAr~y~~~~~~~---~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~  320 (560)
T KOG0600|consen  259 IADFGLARFYTPSGSAP---YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL  320 (560)
T ss_pred             eccccceeeccCCCCcc---cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence            99999999887655433   2346789999999998874 6999999999999999999999876

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.6e-42  Score=327.93  Aligned_cols=197  Identities=35%  Similarity=0.508  Sum_probs=177.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|-+.+.||+|+||.||||+.+.+.+.||+|.+++...  +..+.+.+|+++++.++||||+.++++     |+...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccceE
Confidence            467778899999999999999999999999999986543  334678999999999999999999988     7778899


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||+.| +|..+|....           .++++++..++++++.||.|||+.   +|.|||+||+|||++.++++|+
T Consensus        77 ~vVte~a~g-~L~~il~~d~-----------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Kl  141 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG-----------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKL  141 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceee
Confidence            999999966 9999997654           799999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||+|+.....    ..-.....|||.|||||+..+.+|+..+|.||+||++||+++|++||
T Consensus       142 cdFg~Ar~m~~~----t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF  200 (808)
T KOG0597|consen  142 CDFGLARAMSTN----TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF  200 (808)
T ss_pred             chhhhhhhcccC----ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence            999999865532    11233467999999999999999999999999999999999999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=324.89  Aligned_cols=201  Identities=29%  Similarity=0.435  Sum_probs=174.9

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc----CC-ccHHHHHHHHHHHhcCC-CCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ----RQ-GASKSFMAECKALKNIR-HKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~  302 (452)
                      ..+.|...+.||+|+||+|+.|++..+|+.||+|+++..    .. ...+.+.+|+.+++.++ ||||++++++     +
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev-----~   89 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV-----F   89 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE-----E
Confidence            456799999999999999999999999999999987653    12 23456778999999998 9999999998     4


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ......++||||+.+|+|.+++...           .++.+.++..++.|++.|++|+|+.   +|+||||||+|||+|.
T Consensus        90 ~t~~~~~ivmEy~~gGdL~~~i~~~-----------g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~  155 (370)
T KOG0583|consen   90 ATPTKIYIVMEYCSGGDLFDYIVNK-----------GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDG  155 (370)
T ss_pred             ecCCeEEEEEEecCCccHHHHHHHc-----------CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecC
Confidence            4455699999999999999999763           3688899999999999999999998   9999999999999999


Q ss_pred             C-CceEECccccccccccCCCCceeccccccccccccCccccCCCC-CC-cccceeehhHHHHHHHhCCCCCC
Q 041632          383 D-LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VS-TNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      + +++||+|||++.....    ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+
T Consensus       156 ~~~~~Kl~DFG~s~~~~~----~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~  224 (370)
T KOG0583|consen  156 NEGNLKLSDFGLSAISPG----EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD  224 (370)
T ss_pred             CCCCEEEeccccccccCC----CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence            9 9999999999987631    112234468999999999999977 75 67999999999999999999997

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=7.5e-42  Score=340.20  Aligned_cols=212  Identities=28%  Similarity=0.465  Sum_probs=176.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      .+.+..+.||+|+||+||+|+...     +...||||.++..... ...+|++|+++++.++|||||+++|+|..     
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-----  560 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-----  560 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-----
Confidence            445667889999999999999742     3457999999876665 67899999999999999999999999864     


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCccc--cc-ccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDR--EI-EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~--~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ++..++|+|||..|||.+||..........  .. ....++..+.+.||.|||.||+||-++   .+|||||..+|+||.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence            348899999999999999998765332111  11 144599999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++..|||+|||+++.....+......  ...-+.+|||||.+..++|+.+||||||||+|||++| |+.||.
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~--~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~  707 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRG--NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY  707 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccC--CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence            99999999999999654333222211  1224789999999999999999999999999999999 999984

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.1e-42  Score=301.38  Aligned_cols=198  Identities=24%  Similarity=0.373  Sum_probs=168.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +.|+....+|+|+||+||+++++.+|+.||||++-.+.+  ...+-.++||++|++++|||+|.++++     |......
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhccee
Confidence            357788899999999999999999999999999964322  334567899999999999999999998     5556689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+|||+..-|.+. ...          ...++.....++++|++.|+.|+|++   +++||||||+||||+.++.+||
T Consensus        77 hLVFE~~dhTvL~eL-e~~----------p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKL  142 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHEL-ERY----------PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKL  142 (396)
T ss_pred             EEEeeecchHHHHHH-Hhc----------cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEe
Confidence            999999976555543 322          24678889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||||+|+.+.....    .-+.++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|
T Consensus       143 CDFGFAR~L~~pgd----~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~  202 (396)
T KOG0593|consen  143 CDFGFARTLSAPGD----NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW  202 (396)
T ss_pred             ccchhhHhhcCCcc----hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence            99999997763221    1234789999999999887 68999999999999999999999866

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=310.66  Aligned_cols=205  Identities=34%  Similarity=0.532  Sum_probs=171.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .++...+.||+|+||.||++....+|...|||.+........+.+.+|+.+|++++|||||+++|.....   +...+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeEe
Confidence            3467778999999999999999988999999999865433356789999999999999999999863221   1136889


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CCceEEC
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DLSAHIG  389 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~  389 (452)
                      +|||+++|+|.+++....          ..+++..+..++.|+++||+|||++   +|+||||||+|||++. ++.+||+
T Consensus        94 ~mEy~~~GsL~~~~~~~g----------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG----------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             eeeccCCCcHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEec
Confidence            999999999999997643          2589999999999999999999998   9999999999999999 7999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.... ............||+.|||||++..+ ....++||||+||++.||+||+.||.
T Consensus       161 DFG~a~~~~~-~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~  223 (313)
T KOG0198|consen  161 DFGLAKKLES-KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS  223 (313)
T ss_pred             cCcccccccc-ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence            9999986663 11122223356799999999998853 33459999999999999999999984

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=319.45  Aligned_cols=197  Identities=28%  Similarity=0.411  Sum_probs=178.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ..|.....||+|+.|.||.|+...+++.||||+++.......+-..+|+.+|+..+|+|||.++..+     -..+..|+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sy-----lv~deLWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSY-----LVGDELWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHh-----cccceeEE
Confidence            3577778899999999999999999999999999988888888899999999999999999999874     33468999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |||||++|+|.+.+...            .+++.+...|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|
T Consensus       348 VMEym~ggsLTDvVt~~------------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltD  412 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKT------------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTD  412 (550)
T ss_pred             EEeecCCCchhhhhhcc------------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEee
Confidence            99999999999987643            488999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||++..+.....    .....+|||.|||||+.....|+++.||||||++++||+-|++||
T Consensus       413 FGFcaqi~~~~~----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY  469 (550)
T KOG0578|consen  413 FGFCAQISEEQS----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY  469 (550)
T ss_pred             eeeeeccccccC----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc
Confidence            999987764432    123478999999999999999999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-40  Score=287.93  Aligned_cols=198  Identities=30%  Similarity=0.465  Sum_probs=172.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|...+.+|+|.||.||+|+...+|+.||||+++..  .++......+||+.|+.++|+||+.++++     |...+..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCCce
Confidence            4577789999999999999999999999999999754  33445678899999999999999999998     6666788


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      .+|+||| ..+|...++...          ..++..+...++.++++|++|||+.   .|+||||||.|+|++++|.+||
T Consensus        77 ~lVfEfm-~tdLe~vIkd~~----------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKi  142 (318)
T KOG0659|consen   77 SLVFEFM-PTDLEVVIKDKN----------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKI  142 (318)
T ss_pred             EEEEEec-cccHHHHhcccc----------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEe
Confidence            9999999 679999998654          5788999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||+|+.+.+......    ..+-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|
T Consensus       143 ADFGLAr~f~~p~~~~~----~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  143 ADFGLARFFGSPNRIQT----HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             ecccchhccCCCCcccc----cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence            99999998875443322    23679999999998774 6999999999999999999887644

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=331.49  Aligned_cols=200  Identities=29%  Similarity=0.522  Sum_probs=174.3

Q ss_pred             CCCCCceeccCceeEEEEEEcCCC---cEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..+.++||.|.||+||+|+.+..|   ..||||.++... ++...+|..|+.+|.++.||||+++.|+     .......
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~Pv  705 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKPV  705 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCcee
Confidence            456689999999999999998666   479999998543 4455789999999999999999999999     5556688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +||+|||++|+|+.||++..          .++++.+...|.++||.||.||.++   ++|||||.++||||+.+..+||
T Consensus       706 MIiTEyMENGsLDsFLR~~D----------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKV  772 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQND----------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKV  772 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcC----------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEe
Confidence            99999999999999998654          4689999999999999999999999   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      +|||+++.++.+.... ....+-.-+.+|.|||.+...+++.+||||||||+|||.++ |..||
T Consensus       773 sDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  773 SDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             ccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence            9999999886554322 22233334688999999999999999999999999999988 99997

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=304.53  Aligned_cols=206  Identities=29%  Similarity=0.394  Sum_probs=177.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc-HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .+.|+..+.||.|..++||+|++...+..||||+++.++-.. .+.+.+|+..|+.++||||++++..     |..+...
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~s-----Fvv~~~L   99 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCS-----FVVDSEL   99 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEE-----EEeccee
Confidence            467899999999999999999999999999999998654433 4789999999999999999999876     5667789


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      |+||.||.+||+.+.++..-         ...+.+..+..|.+++++||.|||.+   |.||||||+.||||+++|.|||
T Consensus       100 WvVmpfMa~GS~ldIik~~~---------~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkL  167 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYY---------PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKL  167 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHc---------cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEE
Confidence            99999999999999987543         23478888899999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+..+.........+.....||+.|||||++..  ..|+.|+||||||++..||.+|+.||.
T Consensus       168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~  233 (516)
T KOG0582|consen  168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS  233 (516)
T ss_pred             cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence            9999887665443332222245689999999999544  469999999999999999999999994

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.3e-41  Score=304.95  Aligned_cols=198  Identities=27%  Similarity=0.435  Sum_probs=179.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHH---HHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK---SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .+|++.+.||+|.||.|-+|+....|+.||||.++.+..+..+   .+.+||++|+.++||||++++++     |++.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence            4577888999999999999999889999999999876655544   46899999999999999999998     788889


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      ..|||||..+|.|++|+.+.           ..+++.++.+++.||+.|+.|+|.+   +++|||||.+|||+|.++++|
T Consensus       128 IvivMEYaS~GeLYDYiSer-----------~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiK  193 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER-----------GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIK  193 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCee
Confidence            99999999999999999765           4799999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++.++.....     ....+|+|.|.+||+..+.+| ++.+|.||+||+||.|+.|..|||
T Consensus       194 IADFGLSNly~~~kf-----LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD  254 (668)
T KOG0611|consen  194 IADFGLSNLYADKKF-----LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD  254 (668)
T ss_pred             eeccchhhhhccccH-----HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence            999999988764332     234789999999999999988 678999999999999999999997

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=317.76  Aligned_cols=206  Identities=32%  Similarity=0.508  Sum_probs=171.7

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccc
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSV  300 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~  300 (452)
                      .+++....+++.....||+|.||+||+|+|-+   .||||++.....  ...+.|.+|+..+++-+|.||+-|.|+|...
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34455555667778999999999999999963   499999986544  3457899999999999999999999997532


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                            ...||+.||+|.+|+.+|+..+          .++++.+.+.||.|+|+||.|||.+   +|||||||..|||+
T Consensus       461 ------~~AIiTqwCeGsSLY~hlHv~e----------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl  521 (678)
T KOG0193|consen  461 ------PLAIITQWCEGSSLYTHLHVQE----------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFL  521 (678)
T ss_pred             ------ceeeeehhccCchhhhhccchh----------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEE
Confidence                  3489999999999999998654          5788999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+++.|||+|||++..-..-...  .......|...|||||++..   .+|++++||||||+|+|||+||..||.
T Consensus       522 ~~~~kVkIgDFGLatvk~~w~g~--~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  522 HEDLKVKIGDFGLATVKTRWSGE--QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             ccCCcEEEecccceeeeeeeccc--cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            99999999999998743221111  11122347889999998754   479999999999999999999999984

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8e-40  Score=319.39  Aligned_cols=203  Identities=26%  Similarity=0.373  Sum_probs=172.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||+||+++...+++.||+|+++...   ......+.+|++++.+++||||+++++.     +.+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~-----~~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS-----FQDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEE-----EecCCe
Confidence            46888999999999999999999899999999997432   2233567889999999999999999988     445568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vk  141 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKK-----------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVK  141 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEE
Confidence            89999999999999998643           3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCc-------------------------------eeccccccccccccCccccCCCCCCcccceee
Q 041632          388 IGDFGLSRFYQAVSNPT-------------------------------VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYS  436 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  436 (452)
                      |+|||+++.........                               .......+||+.|+|||++.+..++.++||||
T Consensus       142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS  221 (363)
T cd05628         142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (363)
T ss_pred             EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence            99999987543211000                               00012356999999999999889999999999


Q ss_pred             hhHHHHHHHhCCCCCC
Q 041632          437 YGILLLEMVTTKKPTD  452 (452)
Q Consensus       437 lGv~l~elltg~~Pf~  452 (452)
                      |||++|||++|+.||.
T Consensus       222 lGvil~ell~G~~Pf~  237 (363)
T cd05628         222 LGVIMYEMLIGYPPFC  237 (363)
T ss_pred             hHHHHHHHHhCCCCCC
Confidence            9999999999999994

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-40  Score=318.30  Aligned_cols=200  Identities=28%  Similarity=0.416  Sum_probs=174.6

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      ..++|...++||+|.||+|+++..+.+++.+|||++++..   ....+..+.|.+++.-. +||.++.++.+     |+.
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----fQT  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----FQT  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----ccc
Confidence            4468999999999999999999999999999999998553   34446677888887766 69999999987     788


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..|+||||..||++..+.+.            ..+++..+..+|..++.||.|||++   +||+||||.+|||+|.+|
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~~------------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eG  505 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIHT------------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEG  505 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEec------------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccC
Confidence            8899999999999996655443            4689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++||+|||+++.--....    .....+|||.|||||++.+..|+..+|.|||||+||||++|+.||.
T Consensus       506 h~kiADFGlcKe~m~~g~----~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~  569 (694)
T KOG0694|consen  506 HVKIADFGLCKEGMGQGD----RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP  569 (694)
T ss_pred             cEEecccccccccCCCCC----ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999984321222    3345789999999999999999999999999999999999999995

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5e-40  Score=293.37  Aligned_cols=201  Identities=29%  Similarity=0.400  Sum_probs=173.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|+..+.|++|.||.||+|+++.+++.||+|+++...  .+..-...+||.+|.+.+|||||.+-++....   +-+.
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDK  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccce
Confidence            456888999999999999999999999999999997543  34455678999999999999999998885533   2446


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||| .-+|...+...+          +++...++..++.|++.|++|||..   .|+|||||++|+|+++.|.+|
T Consensus       152 iy~VMe~~-EhDLksl~d~m~----------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lK  217 (419)
T KOG0663|consen  152 IYIVMEYV-EHDLKSLMETMK----------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILK  217 (419)
T ss_pred             eeeeHHHH-HhhHHHHHHhcc----------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEE
Confidence            89999999 458888887554          6789999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||+|+.+.....    ..+..+-|..|.|||++.+. .|+...|+||+|||+.||+++++-|
T Consensus       218 iaDFGLAR~ygsp~k----~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf  278 (419)
T KOG0663|consen  218 IADFGLAREYGSPLK----PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF  278 (419)
T ss_pred             ecccchhhhhcCCcc----cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence            999999998875422    23346689999999998875 5999999999999999999998866

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-40  Score=316.40  Aligned_cols=198  Identities=28%  Similarity=0.416  Sum_probs=176.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .-|..++.||.|+.|.|..|++..+|+.+|||++....   ......+.+||-+|+-+.|||+++++++     |++..+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----eccCce
Confidence            45778899999999999999999999999999997542   2334568899999999999999999998     777889


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      +|+|.||+++|-|.+|+-..+           .+++.++.+++.||+.|++|+|..   +|+||||||+|+|+|..+++|
T Consensus        87 lylvlEyv~gGELFdylv~kG-----------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIK  152 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKG-----------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIK  152 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEe
Confidence            999999999999999997554           789999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|..-.....     ....||+|.|.|||++.+.+| +.++||||.|||||.|+||+.|||
T Consensus       153 IADFGMAsLe~~gkl-----LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd  213 (786)
T KOG0588|consen  153 IADFGMASLEVPGKL-----LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD  213 (786)
T ss_pred             eeccceeecccCCcc-----ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence            999999975433222     224689999999999999998 667999999999999999999997

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=314.14  Aligned_cols=184  Identities=28%  Similarity=0.487  Sum_probs=163.3

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ++-||.|+.|-||+|+.  .++.||||+++.       .-..+|+.|++++||||+.|.|+|...     ..+|||||||
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfC  194 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFC  194 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeecc
Confidence            46699999999999999  478999998852       224678999999999999999998654     4789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      +.|-|++.|+..+           .++......|..+||.||.|||.+   .|||||||.-||||+.+..|||+|||.++
T Consensus       195 a~GqL~~VLka~~-----------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  195 AQGQLYEVLKAGR-----------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             ccccHHHHHhccC-----------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence            9999999998664           677888899999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .....     ....+..||..|||||++...+.++|+||||||||||||+||..||.
T Consensus       261 e~~~~-----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk  312 (904)
T KOG4721|consen  261 ELSDK-----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK  312 (904)
T ss_pred             hhhhh-----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence            55422     33456789999999999999999999999999999999999999984

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=301.55  Aligned_cols=206  Identities=27%  Similarity=0.390  Sum_probs=169.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--------------CccHHHHHHHHHHHhcCCCCCceeEe
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--------------QGASKSFMAECKALKNIRHKNLVRVI  294 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~ei~~l~~l~h~niv~l~  294 (452)
                      ..++|+..+.||+|.||.|-+|+...+++.||+|+++...              ....+...+||.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3478999999999999999999999999999999996321              11225789999999999999999999


Q ss_pred             eeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 041632          295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK  374 (452)
Q Consensus       295 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  374 (452)
                      ++..   -...+..|+|+|||..|.+..- ..          ....+++.++++++.+++.||+|||.+   +|+|||||
T Consensus       175 EvLD---DP~s~~~YlVley~s~G~v~w~-p~----------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIK  237 (576)
T KOG0585|consen  175 EVLD---DPESDKLYLVLEYCSKGEVKWC-PP----------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIK  237 (576)
T ss_pred             Eeec---CcccCceEEEEEeccCCccccC-CC----------CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccc
Confidence            9853   3446689999999998887532 11          112389999999999999999999998   99999999


Q ss_pred             CCCeeecCCCceEECccccccccccCCCCc-eeccccccccccccCccccCCCC----CCcccceeehhHHHHHHHhCCC
Q 041632          375 PSNILLDNDLSAHIGDFGLSRFYQAVSNPT-VSSSIGVRGTIGYVAPEYGLGSE----VSTNGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       375 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~  449 (452)
                      |+|+|++++|++||+|||.+..+....... ........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.
T Consensus       238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            999999999999999999998664332111 11122367999999999977632    3667899999999999999999


Q ss_pred             CC
Q 041632          450 PT  451 (452)
Q Consensus       450 Pf  451 (452)
                      ||
T Consensus       318 PF  319 (576)
T KOG0585|consen  318 PF  319 (576)
T ss_pred             Cc
Confidence            99

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=305.76  Aligned_cols=198  Identities=31%  Similarity=0.458  Sum_probs=161.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHh--cCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALK--NIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~--~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +..+..+++|+|+||.||+|+.  +++.||||++...   ..+.|++|-++.+  .++|+||++|+++-...+. ....+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~ey  283 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEY  283 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccce
Confidence            3455668899999999999999  4689999999743   3356666666554  5589999999987433221 24478


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC------CCCCeEecccCCCCeeecC
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH------CQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~Dlk~~Nill~~  382 (452)
                      +||+||++.|+|.+||+..            ..+|....+|+..+++||+|||+.      ++++|+|||||++||||.+
T Consensus       284 wLVt~fh~kGsL~dyL~~n------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~  351 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN  351 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc
Confidence            9999999999999999754            689999999999999999999974      4789999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCC-C-----CcccceeehhHHHHHHHhCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-V-----STNGDVYSYGILLLEMVTTK  448 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGv~l~elltg~  448 (452)
                      |+++.|+|||+|..+........  ....+||.+|||||++.+.- +     -.+.||||+|.|||||+++-
T Consensus       352 DlTccIaDFGLAl~~~p~~~~~d--~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC  421 (534)
T KOG3653|consen  352 DLTCCIADFGLALRLEPGKPQGD--THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC  421 (534)
T ss_pred             CCcEEeeccceeEEecCCCCCcc--hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence            99999999999998875544333  33478999999999987742 1     23589999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-40  Score=282.07  Aligned_cols=201  Identities=26%  Similarity=0.416  Sum_probs=178.8

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +.++|++++.||+|-||.||.|+.+.++-.||+|++...   ..+..+++.+|+++-+.++||||++++++     |.+.
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~   94 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS   94 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence            457899999999999999999999999999999999643   34556789999999999999999999999     6667


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...|+++||.++|.+...|+..+         ..++++.....+..|+|.|+.|+|..   .|+||||||+|+|++.++.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~---------~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~  162 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGR---------MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGE  162 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcc---------cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCC
Confidence            78999999999999999998543         24678888899999999999999997   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||.+..-+..      .-...+||..|.+||+..+..++...|+|++|++.||++.|.+||+
T Consensus       163 lkiAdfGwsV~~p~~------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe  223 (281)
T KOG0580|consen  163 LKIADFGWSVHAPSN------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE  223 (281)
T ss_pred             eeccCCCceeecCCC------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence            999999998644311      1123689999999999999999999999999999999999999996

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=316.50  Aligned_cols=203  Identities=26%  Similarity=0.399  Sum_probs=172.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||+||+|+...+|+.||||++....   ......+.+|+++++.++||||++++++     +.+.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYS-----FQDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCe
Confidence            36888999999999999999999899999999997532   2334567899999999999999999988     445668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~k  141 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKK-----------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIK  141 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEE
Confidence            99999999999999998643           2588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCce----------------------------------eccccccccccccCccccCCCCCCcccc
Q 041632          388 IGDFGLSRFYQAVSNPTV----------------------------------SSSIGVRGTIGYVAPEYGLGSEVSTNGD  433 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  433 (452)
                      |+|||+++.+........                                  .......||+.|+|||++.+..++.++|
T Consensus       142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  221 (364)
T cd05599         142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD  221 (364)
T ss_pred             EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence            999999875432111000                                  0011245999999999999889999999


Q ss_pred             eeehhHHHHHHHhCCCCCC
Q 041632          434 VYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       434 vwSlGv~l~elltg~~Pf~  452 (452)
                      ||||||++|||++|+.||+
T Consensus       222 iwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         222 WWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             eecchhHHHHhhcCCCCCC
Confidence            9999999999999999984

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4e-39  Score=316.47  Aligned_cols=202  Identities=25%  Similarity=0.358  Sum_probs=170.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .|+..+.||+|+||+||+|+...+++.||+|++....   ......+.+|+++++.++||||+++++.+     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence            5788899999999999999999999999999997532   23345788999999999999999999884     445689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~-----------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL  142 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM-----------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKL  142 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEE
Confidence            9999999999999998643           2578888899999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCC-------------------------------------------ceeccccccccccccCccccCC
Q 041632          389 GDFGLSRFYQAVSNP-------------------------------------------TVSSSIGVRGTIGYVAPEYGLG  425 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~  425 (452)
                      +|||+++.+......                                           .........||+.|+|||++.+
T Consensus       143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  222 (381)
T cd05626         143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR  222 (381)
T ss_pred             eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence            999997643211000                                           0000123469999999999988


Q ss_pred             CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          426 SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       426 ~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ..++.++|||||||++|||+||+.||.
T Consensus       223 ~~~~~~~DiwSlG~il~elltG~~Pf~  249 (381)
T cd05626         223 KGYTQLCDWWSVGVILFEMLVGQPPFL  249 (381)
T ss_pred             CCCCCccceeehhhHHHHHHhCCCCCc
Confidence            889999999999999999999999994

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=308.63  Aligned_cols=197  Identities=26%  Similarity=0.401  Sum_probs=170.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHH--HHHHHHHHhcCC-CCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS--FMAECKALKNIR-HKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|...+.||.|.||.||+|+...+|..||||.++..-.. .++  =.+|++.|++++ ||||+++.+++     .+.+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi-----~d~~   82 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVI-----RDND   82 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHh-----hccC
Confidence            35688889999999999999999999999999999744333 333  368999999998 99999999884     3444


Q ss_pred             -eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          307 -FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       307 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                       ..++||||| ..+|++.++.+.          ..+++.++..|+.||++||+|+|.+   |++|||+||+|||+.....
T Consensus        83 ~~L~fVfE~M-d~NLYqLmK~R~----------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~  148 (538)
T KOG0661|consen   83 RILYFVFEFM-DCNLYQLMKDRN----------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDV  148 (538)
T ss_pred             ceEeeeHHhh-hhhHHHHHhhcC----------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccce
Confidence             899999999 789999997654          6899999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +||+|||+||........     +.++.|.+|+|||++.. ..|+.+.|+||+||+++|+.+-++-|
T Consensus       149 iKiaDFGLARev~SkpPY-----TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF  210 (538)
T KOG0661|consen  149 IKIADFGLAREVRSKPPY-----TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF  210 (538)
T ss_pred             eEecccccccccccCCCc-----chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence            999999999977643322     34789999999998655 56899999999999999999988766

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=316.09  Aligned_cols=203  Identities=24%  Similarity=0.354  Sum_probs=170.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|.+.+.||+|+||+||+++...+++.||+|++....   ....+.+.+|+++++.++||||++++++     +.+.+.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~-----~~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYS-----FQDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCe
Confidence            36888999999999999999999999999999986432   2234568899999999999999999988     445668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~k  141 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY-----------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIK  141 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEE
Confidence            99999999999999998643           2578888999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCc-----------e--------------------------------eccccccccccccCccccC
Q 041632          388 IGDFGLSRFYQAVSNPT-----------V--------------------------------SSSIGVRGTIGYVAPEYGL  424 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~-----------~--------------------------------~~~~~~~gt~~y~aPE~~~  424 (452)
                      |+|||+++.+.......           .                                .......||+.|+|||++.
T Consensus       142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  221 (377)
T cd05629         142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL  221 (377)
T ss_pred             EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence            99999986432110000           0                                0001246999999999999


Q ss_pred             CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          425 GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       425 ~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +..++.++|||||||++|||+||+.||+
T Consensus       222 ~~~~~~~~DiwSlGvil~elltG~~Pf~  249 (377)
T cd05629         222 QQGYGQECDWWSLGAIMFECLIGWPPFC  249 (377)
T ss_pred             cCCCCCceeeEecchhhhhhhcCCCCCC
Confidence            8899999999999999999999999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=306.40  Aligned_cols=196  Identities=27%  Similarity=0.413  Sum_probs=171.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||+|+...+|+.||+|+++...   ....+.+.+|++++++++||||+++++.     +.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT-----EHDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh-----hccCCe
Confidence            36888999999999999999999899999999997432   2234568899999999999999999877     445668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~k  141 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS-----------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIK  141 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEE
Confidence            89999999999999998643           2578889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.....       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  199 (291)
T cd05612         142 LTDFGFAKKLRDR-------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF  199 (291)
T ss_pred             EEecCcchhccCC-------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999998765321       112458999999999998889999999999999999999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.5e-39  Score=309.83  Aligned_cols=196  Identities=25%  Similarity=0.361  Sum_probs=171.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||+|+++.+++.||+|+++...   ....+.+.+|++++++++||||+++++.+     .+.+.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCCE
Confidence            57888999999999999999999899999999997432   23346788999999999999999999884     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  158 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA-----------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVK  158 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEE
Confidence            89999999999999998643           2578888899999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++......       ....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       159 l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  216 (329)
T PTZ00263        159 VTDFGFAKKVPDRT-------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF  216 (329)
T ss_pred             EeeccCceEcCCCc-------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCC
Confidence            99999997553211       12468999999999999889999999999999999999999984

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.2e-39  Score=315.97  Aligned_cols=202  Identities=25%  Similarity=0.350  Sum_probs=170.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .|+..+.||+|+||+||+|+...+++.||+|++....   ......+.+|++++++++||||+++++.+     .+.+..
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCEE
Confidence            5788899999999999999999899999999997432   23345788999999999999999999884     455689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++....           .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        77 ~lv~E~~~gg~L~~~l~~~~-----------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL  142 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRMG-----------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKL  142 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999986432           577888899999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCC-------------------------------------------ceeccccccccccccCccccCC
Q 041632          389 GDFGLSRFYQAVSNP-------------------------------------------TVSSSIGVRGTIGYVAPEYGLG  425 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~  425 (452)
                      +|||+++.+......                                           .........||+.|+|||++.+
T Consensus       143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  222 (382)
T cd05625         143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR  222 (382)
T ss_pred             eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence            999997533210000                                           0000113469999999999998


Q ss_pred             CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          426 SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       426 ~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ..++.++||||+||++|||++|+.||.
T Consensus       223 ~~~~~~~DiwSlGvil~elltG~~Pf~  249 (382)
T cd05625         223 TGYTQLCDWWSVGVILYEMLVGQPPFL  249 (382)
T ss_pred             CCCCCeeeEEechHHHHHHHhCCCCCC
Confidence            899999999999999999999999994

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.9e-39  Score=301.38  Aligned_cols=198  Identities=25%  Similarity=0.367  Sum_probs=169.3

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      |...+.||+|+||+||++.+..+|+.||+|.+....   ......+.+|++++++++|+|++++.+.+     .+.+..+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            667789999999999999998899999999987432   22234678999999999999999998874     4456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++|+|.+++....         ...+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        77 lv~e~~~~g~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNMG---------NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             EEEEecCCCcHHHHHHhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence            9999999999998875322         13578899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........     .....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       145 Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~  202 (285)
T cd05631         145 DLGLAVQIPEGET-----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR  202 (285)
T ss_pred             eCCCcEEcCCCCe-----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence            9999976432211     123468999999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.2e-39  Score=307.30  Aligned_cols=193  Identities=27%  Similarity=0.371  Sum_probs=166.1

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.||+|+||.||+++...+|+.||+|+++...   ......+.+|++++++++||||+++.+.     +...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-----~~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS-----FQTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEE-----EEcCCEEEEEEe
Confidence            46999999999999999899999999997432   2233567889999999999999999887     445568899999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      |+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        76 ~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~  141 (323)
T cd05571          76 YANGGELFFHLSRE-----------RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             CCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999988643           3578899999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.......    ......||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus       142 a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  196 (323)
T cd05571         142 CKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             CcccccCCC----cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCC
Confidence            874322111    1123569999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-39  Score=309.93  Aligned_cols=197  Identities=25%  Similarity=0.399  Sum_probs=170.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC-cEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG-TVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||.||+|+++.++ ..||+|.+....   ....+.+.+|+++++.++||||+++++++     .+.
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~  103 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KDE  103 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----EeC
Confidence            356888999999999999999976554 689999986432   23346788999999999999999999984     445


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++....           .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~  169 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRNK-----------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGF  169 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCC
Confidence            68899999999999999986542           578889999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.....       .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       170 ikL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  229 (340)
T PTZ00426        170 IKMTDFGFAKVVDTR-------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY  229 (340)
T ss_pred             EEEecCCCCeecCCC-------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCC
Confidence            999999999765421       123468999999999988889999999999999999999999984

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6e-39  Score=314.89  Aligned_cols=202  Identities=25%  Similarity=0.358  Sum_probs=170.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +|++.+.||+|+||+||+++...+++.||+|++....   ......+.+|++++++++||||+++++.     +.+++..
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~-----~~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYS-----FQDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EEcCCEE
Confidence            6888999999999999999999899999999996432   2334668899999999999999999987     4456689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++....           .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        77 ~lv~E~~~~g~L~~~i~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL  142 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRLG-----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  142 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEE
Confidence            99999999999999986532           577888889999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCC---------------------------------------ceeccccccccccccCccccCCCCCC
Q 041632          389 GDFGLSRFYQAVSNP---------------------------------------TVSSSIGVRGTIGYVAPEYGLGSEVS  429 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~  429 (452)
                      +|||++..+......                                       .........||+.|+|||++.+..++
T Consensus       143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  222 (376)
T cd05598         143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT  222 (376)
T ss_pred             EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence            999997533110000                                       00001134699999999999998999


Q ss_pred             cccceeehhHHHHHHHhCCCCCC
Q 041632          430 TNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       430 ~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++|||||||++|||++|+.||+
T Consensus       223 ~~~DiwSlGvilyell~G~~Pf~  245 (376)
T cd05598         223 QLCDWWSVGVILYEMLVGQPPFL  245 (376)
T ss_pred             cceeeeeccceeeehhhCCCCCC
Confidence            99999999999999999999984

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-39  Score=309.03  Aligned_cols=195  Identities=25%  Similarity=0.394  Sum_probs=171.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +|++.+.||+|+||.||+|++..+++.||+|+++...   ......+.+|++++..++||||+++++++     .+.+..
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            6888999999999999999999889999999997442   23345788999999999999999999884     455688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        77 ~lv~e~~~g~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL  142 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNNL-----------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKL  142 (333)
T ss_pred             EEEEeCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence            9999999999999998643           2578889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       143 ~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  199 (333)
T cd05600         143 TDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS  199 (333)
T ss_pred             EeCcCCccccc-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCC
Confidence            99999975542       1123468999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=9.5e-39  Score=311.84  Aligned_cols=202  Identities=24%  Similarity=0.363  Sum_probs=171.5

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ...++|+..+.||+|+||.||++++..+++.||+|+++..   .....+.+.+|+++++.++||||+++++.     +.+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-----~~~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA-----FQD  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEc
Confidence            3457899999999999999999999989999999999642   22234568899999999999999999987     445


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ++..++||||+++|+|.+++...            .+++.++..++.|++.||+|||+.   +|+||||||+|||+++++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~~------------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~  179 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSNY------------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHG  179 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCC
Confidence            66899999999999999998532            467888999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCC----CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS----EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||++........   .......||+.|+|||++.+.    .++.++||||+||++|||+||+.||.
T Consensus       180 ~~kL~DFG~a~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~  248 (370)
T cd05621         180 HLKLADFGTCMKMDETGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY  248 (370)
T ss_pred             CEEEEecccceecccCCc---eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence            999999999986542211   112235699999999998654    37889999999999999999999984

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=291.74  Aligned_cols=206  Identities=29%  Similarity=0.378  Sum_probs=178.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEee--ccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ....|...+.||+|+||.|+.+..+.+|+.||+|.+.  .+..-..++-.+|+++++.++|+||+.+...........-.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3455666789999999999999999999999999997  55555667889999999999999999999887653334456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+|+|+| +.+|.+.++...           .++...+..+.+|+++||.|+|+.   +|+||||||.|++++.+..+
T Consensus       100 DvYiV~elM-etDL~~iik~~~-----------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQ-----------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCc-----------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCE
Confidence            789999999 789999987543           588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+|+..+..  ......+.++.|..|.|||++.. ..|+.+.||||.||++.||++|++-|
T Consensus       165 KI~DFGLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF  228 (359)
T KOG0660|consen  165 KICDFGLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF  228 (359)
T ss_pred             Eeccccceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence            99999999987654  33334566889999999998654 57999999999999999999999877

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-38  Score=304.02  Aligned_cols=193  Identities=26%  Similarity=0.362  Sum_probs=165.5

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.||+|+||.||+++...+|+.||+|+++...   ......+.+|+++++.++||||+++++.+     ...+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            46999999999999998899999999997432   23345678899999999999999998874     44568899999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      |+++|+|..++...           ..+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+
T Consensus        76 ~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  141 (323)
T cd05595          76 YANGGELFFHLSRE-----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGL  141 (323)
T ss_pred             CCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHH
Confidence            99999999888643           2578999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  196 (323)
T cd05595         142 CKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             hccccCCCC----ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCC
Confidence            874321111    1123568999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-39  Score=294.35  Aligned_cols=200  Identities=29%  Similarity=0.414  Sum_probs=165.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      .|...+++|+|+||.||+|+...+++.||||++..++..    -.+|+++|+++.|||||+++-++....-.+.-+..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            456678999999999999999999999999998654432    2478999999999999999988765432222355689


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-CceEECc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-LSAHIGD  390 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~D  390 (452)
                      |||| ..+|.++++...       ...+.++...+.-+..|+.+||+|||+.   +|+||||||+|+|+|.+ |.+||||
T Consensus       101 leym-P~tL~~~~r~~~-------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicD  169 (364)
T KOG0658|consen  101 LEYM-PETLYRVIRHYT-------RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICD  169 (364)
T ss_pred             HHhc-hHHHHHHHHHHh-------hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEecc
Confidence            9999 568988887421       1124677778888999999999999997   99999999999999976 8999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||.|+.......     ..++..|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|
T Consensus       170 FGSAK~L~~~ep-----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF  226 (364)
T KOG0658|consen  170 FGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF  226 (364)
T ss_pred             CCcceeeccCCC-----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc
Confidence            999998764322     2457789999999998875 6999999999999999999999876

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-38  Score=311.03  Aligned_cols=203  Identities=25%  Similarity=0.374  Sum_probs=172.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||+||+++...+++.||+|+++...   ......+.+|++++..++||||+++++.     +.+.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-----~~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-----FQDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-----EEcCCE
Confidence            46888899999999999999999899999999997432   2334678889999999999999999987     455668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vk  141 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK-----------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVK  141 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEE
Confidence            99999999999999998643           2578889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCc-------------------------------eeccccccccccccCccccCCCCCCcccceee
Q 041632          388 IGDFGLSRFYQAVSNPT-------------------------------VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYS  436 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  436 (452)
                      |+|||+++.........                               ........||+.|+|||++.+..++.++||||
T Consensus       142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS  221 (360)
T cd05627         142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS  221 (360)
T ss_pred             EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence            99999987543211000                               00012346999999999999999999999999


Q ss_pred             hhHHHHHHHhCCCCCC
Q 041632          437 YGILLLEMVTTKKPTD  452 (452)
Q Consensus       437 lGv~l~elltg~~Pf~  452 (452)
                      |||++|||+||+.||+
T Consensus       222 lGvilyel~tG~~Pf~  237 (360)
T cd05627         222 LGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccceeeecccCCCCCC
Confidence            9999999999999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-38  Score=303.14  Aligned_cols=193  Identities=29%  Similarity=0.389  Sum_probs=166.0

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.||+|+||.||+++...+|+.||+|++....   ......+.+|+++++.++||||+++.+.     +.+.+..++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~-----~~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS-----FQTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE-----EEcCCEEEEEEe
Confidence            46999999999999999899999999997432   2334578899999999999999999887     445668899999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      |+++|+|..++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+
T Consensus        76 y~~~g~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~  141 (328)
T cd05593          76 YVNGGELFFHLSRE-----------RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGL  141 (328)
T ss_pred             CCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcC
Confidence            99999999888643           2588999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~  196 (328)
T cd05593         142 CKEGITDAA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  196 (328)
T ss_pred             CccCCCccc----ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCC
Confidence            874321111    1123468999999999988899999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=301.67  Aligned_cols=191  Identities=28%  Similarity=0.390  Sum_probs=164.7

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||+||++++..+++.||+|+++...   ......+.+|++++++++||||+++++.+     .+.+..++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999899999999997432   23345678999999999999999998874     4456889999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        76 ~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~  141 (312)
T cd05585          76 NGGELFHHLQRE-----------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK  141 (312)
T ss_pred             CCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccc
Confidence            999999998643           2578889999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .......    ......||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus       142 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         142 LNMKDDD----KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             cCccCCC----ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcC
Confidence            5322111    1123568999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.3e-38  Score=309.39  Aligned_cols=205  Identities=24%  Similarity=0.329  Sum_probs=172.6

Q ss_pred             HHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       225 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      +.....++|++.+.||+|+||.||++++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++.+    
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~----  112 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF----  112 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence            33445578999999999999999999999999999999986422   22335678999999999999999999884    


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                       .+++..++||||+++|+|.+++...            .+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       113 -~~~~~~~lv~Ey~~gg~L~~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~  176 (371)
T cd05622         113 -QDDRYLYMVMEYMPGGDLVNLMSNY------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD  176 (371)
T ss_pred             -EcCCEEEEEEcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEC
Confidence             4556899999999999999998532            367778889999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCC----CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS----EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++.+||+|||+++.......   .......||+.|+|||++...    .++.++|||||||++|||++|+.||.
T Consensus       177 ~~~~ikL~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  248 (371)
T cd05622         177 KSGHLKLADFGTCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (371)
T ss_pred             CCCCEEEEeCCceeEcCcCCc---ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence            999999999999976542211   112235699999999998653    37889999999999999999999994

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.4e-38  Score=287.68  Aligned_cols=206  Identities=30%  Similarity=0.449  Sum_probs=172.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCC-ceeEeeeecccc-CCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKN-LVRVITSCSSVD-FQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~n-iv~l~~~~~~~~-~~~~~~  307 (452)
                      .|+..+.||+|.||+||+|+.+.+|+.||+|++.....  +......+|+.++++++|+| |+++.+++.... +.....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            45566789999999999999999999999999986543  46677899999999999999 999999875433 122347


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||+ .-+|..|+.......       +.++...+..++.|++.||+|||++   +|+||||||+||||+++|.+|
T Consensus        92 l~lvfe~~-d~DL~~ymd~~~~~~-------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lK  160 (323)
T KOG0594|consen   92 LYLVFEFL-DRDLKKYMDSLPKKP-------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLK  160 (323)
T ss_pred             EEEEEEee-cccHHHHHHhccccc-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEe
Confidence            88999999 779999997643110       3466678999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+.+.-....    ....++|..|.|||++.+. .|+...||||+||+++||++++.-|.
T Consensus       161 laDFGlAra~~ip~~~----yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp  222 (323)
T KOG0594|consen  161 LADFGLARAFSIPMRT----YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP  222 (323)
T ss_pred             eeccchHHHhcCCccc----ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence            9999999965422221    2345689999999998886 68999999999999999999988773

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=309.92  Aligned_cols=202  Identities=28%  Similarity=0.433  Sum_probs=169.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCc---E-EEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGT---V-VAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      ..++....+.||+|+||+||+|+++..+.   . ||||..+..   ......+|.+|+++|++++|||||+++|++.   
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~---  231 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV---  231 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc---
Confidence            34455666899999999999999975432   3 899998742   2455678999999999999999999999964   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                        .....++|||+|+||+|.+||++..          ..++..++..++.++|.||+|||+.   +++||||.++|+|++
T Consensus       232 --~~~Pl~ivmEl~~gGsL~~~L~k~~----------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~  296 (474)
T KOG0194|consen  232 --LEEPLMLVMELCNGGSLDDYLKKNK----------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYS  296 (474)
T ss_pred             --CCCccEEEEEecCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheec
Confidence              3457899999999999999998754          3689999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .++.+||+|||+++.-.....    ......-+..|+|||.+....|+.++|||||||++||+++ |..||.
T Consensus       297 ~~~~vKISDFGLs~~~~~~~~----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~  364 (474)
T KOG0194|consen  297 KKGVVKISDFGLSRAGSQYVM----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP  364 (474)
T ss_pred             CCCeEEeCccccccCCcceee----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence            999999999999875431111    1101135788999999999999999999999999999999 888984

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.2e-38  Score=308.47  Aligned_cols=201  Identities=25%  Similarity=0.363  Sum_probs=170.1

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ..++|++.+.||+|+||.||+++...+++.||+|+++...   ....+.+.+|+++++.++||||++++++     +.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~-----~~~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYA-----FQDD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEE-----EecC
Confidence            4567999999999999999999999899999999996432   2333567899999999999999999987     4456


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++...            .+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~  180 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY------------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH  180 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCC
Confidence            6899999999999999998532            367788889999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCC----CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS----EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++.........   ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.
T Consensus       181 ~kL~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  248 (370)
T cd05596         181 LKLADFGTCMKMDANGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  248 (370)
T ss_pred             EEEEeccceeeccCCCcc---cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence            999999999765422111   11234699999999987653    47889999999999999999999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.4e-38  Score=304.39  Aligned_cols=214  Identities=26%  Similarity=0.400  Sum_probs=169.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||.||+|.+.     .+++.||+|++..... ...+.+.+|+++++.+ +||||++++++|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK---   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence            467899999999999999999852     3456899999874332 2345789999999999 89999999998642   


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCc--------------------------------------------------
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQR--------------------------------------------------  332 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------  332 (452)
                       .....+++|||+++|+|.+++........                                                  
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             33467899999999999999975321000                                                  


Q ss_pred             -ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccc
Q 041632          333 -DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV  411 (452)
Q Consensus       333 -~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~  411 (452)
                       ........+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++.......  .......
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~  236 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSA  236 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCC
Confidence             0000124588899999999999999999998   999999999999999999999999999975432211  1111223


Q ss_pred             cccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       412 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+++.|+|||++.+..++.++|||||||++|||++ |..||+
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~  278 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP  278 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCC
Confidence            46788999999988899999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.1e-38  Score=300.61  Aligned_cols=198  Identities=26%  Similarity=0.352  Sum_probs=167.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCC-CceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHK-NLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~-niv~l~~~~~~~~~~~~~~  307 (452)
                      +|++.+.||+|+||.||+|+...+++.||+|++....   ....+.+..|+++++.++|+ +|+++.++     +.+.+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE-----EEcCCE
Confidence            4778899999999999999999889999999997432   23346678899999999765 47777766     344567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k  141 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV-----------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIK  141 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEE
Confidence            89999999999999988643           2578889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......    ......||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus       142 L~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~  202 (324)
T cd05587         142 IADFGMCKENIFGGK----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  202 (324)
T ss_pred             EeecCcceecCCCCC----ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            999999864321111    1123568999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.3e-38  Score=302.00  Aligned_cols=193  Identities=28%  Similarity=0.374  Sum_probs=165.0

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.||+|+||.||+++...+|+.||+|+++...   ......+..|+++++.++||||+++.++     +...+..++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~-----~~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEE-----EEcCCEEEEEEe
Confidence            46999999999999998899999999997532   2234567889999999999999999887     445568899999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      |+++|+|..++...           ..+++.++..++.|++.||+|||+ .   +|+||||||+|||+++++.+||+|||
T Consensus        76 ~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg  141 (325)
T cd05594          76 YANGGELFFHLSRE-----------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFG  141 (325)
T ss_pred             CCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCC
Confidence            99999999888643           258899999999999999999997 5   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~  197 (325)
T cd05594         142 LCKEGIKDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  197 (325)
T ss_pred             CCeecCCCCc----ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence            9874322111    1123469999999999988899999999999999999999999983

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.5e-38  Score=300.32  Aligned_cols=198  Identities=25%  Similarity=0.334  Sum_probs=166.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +|.+.+.||+|+||+||+|+...+++.||+|+++...   ....+.+..|.+++..+ +|++|+++.+++     .+.+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4778899999999999999999899999999997532   22234567788888777 588888888774     44567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k  141 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV-----------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEE
Confidence            89999999999999988643           2578889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       142 L~DfG~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~  202 (323)
T cd05616         142 IADFGMCKENMWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE  202 (323)
T ss_pred             EccCCCceecCCCCC----ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence            999999874331111    1123568999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=326.92  Aligned_cols=205  Identities=27%  Similarity=0.470  Sum_probs=170.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCC-Cc----EEEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDED-GT----VVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ..+..+.||+|+||+||.|..... |.    .||+|.++.. +.+...+|.+|..+|++++|||||+++|+|..     .
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-----~  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-----S  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-----C
Confidence            345567899999999999998532 32    3889988644 44556899999999999999999999999854     3


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...+|++|||++|+|..||++.+.....    ...++..+.+.++.|||+|+.||+++   ++|||||.++|+|++....
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~----~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQ----PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCC----CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCc
Confidence            4678999999999999999987543222    46789999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccc-cccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGV-RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |||+|||+|+.+......   +.... .-+..|||||.+....++.|+|||||||++||++| |..||
T Consensus       841 VKIaDFGlArDiy~~~yy---r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY  905 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDYY---RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPY  905 (1025)
T ss_pred             EEEcccchhHhhhhchhe---eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCC
Confidence            999999999943322111   11111 24578999999999999999999999999999999 99998

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=289.58  Aligned_cols=199  Identities=27%  Similarity=0.366  Sum_probs=159.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +....+.||+|.||+||+|+|+  |..||||++....+ ....-+.||..-..++|+||+.|++.-... -..-...++|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~-~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKD-NGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccC-CCceEEEEEe
Confidence            4556688999999999999995  78899999974432 222223455555566999999999873211 1112368999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEecccCCCCeeecCCCce
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-----HCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ++|++.|||++||..            .+++....++++..+|.||+|||.     +.+|.|.|||||+.||||..++.+
T Consensus       288 TdYHe~GSL~DyL~r------------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR------------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             eecccCCcHHHHHhh------------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            999999999999975            368999999999999999999995     357899999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCC------CCcccceeehhHHHHHHHh
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE------VSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGv~l~ellt  446 (452)
                      .|+|+|+|-..+...+.-.......+||.+|||||++...-      .-..+||||||.|+||+.-
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            99999999877766555555556688999999999976531      1335899999999999875

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.2e-37  Score=299.95  Aligned_cols=193  Identities=24%  Similarity=0.364  Sum_probs=165.3

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||++++..+++.||+|+++...   ....+.+..|+.++..+ +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            46999999999999999899999999997532   22335678899999888 799999999884     4556889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 e~~~~g~L~~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg  141 (329)
T cd05588          76 EFVSGGDLMFHMQRQ-----------RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG  141 (329)
T ss_pred             eCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCc
Confidence            999999999888543           3689999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         142 MCKEGIRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             cccccccCCC----ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence            9864221111    1123568999999999999899999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-38  Score=305.65  Aligned_cols=203  Identities=29%  Similarity=0.414  Sum_probs=173.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|.+.+.||+|+||+||+|+...+|+.||+|+++...   ......+.+|+++++.++||||++++++     +.+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS-----FQDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh-----eecCCe
Confidence            36888999999999999999998899999999997432   2345678899999999999999999877     455668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~k  141 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK-----------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIK  141 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence            99999999999999998643           3578899999999999999999997   999999999999999999999


Q ss_pred             ECccccccccccCCC-------------------------CceeccccccccccccCccccCCCCCCcccceeehhHHHH
Q 041632          388 IGDFGLSRFYQAVSN-------------------------PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLL  442 (452)
Q Consensus       388 l~Dfgla~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~  442 (452)
                      |+|||++........                         ..........||+.|+|||++.+..++.++|||||||++|
T Consensus       142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  221 (350)
T cd05573         142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY  221 (350)
T ss_pred             eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence            999999976543220                         0001122346899999999999999999999999999999


Q ss_pred             HHHhCCCCCC
Q 041632          443 EMVTTKKPTD  452 (452)
Q Consensus       443 elltg~~Pf~  452 (452)
                      ||++|+.||.
T Consensus       222 ell~g~~Pf~  231 (350)
T cd05573         222 EMLYGFPPFY  231 (350)
T ss_pred             hhccCCCCCC
Confidence            9999999984

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.4e-38  Score=301.63  Aligned_cols=201  Identities=24%  Similarity=0.322  Sum_probs=169.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|.+.+.||+|+||+||+++...+++.||+|++....   ......+.+|+.++..++|+||+++.+++     .+.+.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            46888999999999999999999899999999986421   22335578899999999999999999874     45668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~k  142 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE----------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIR  142 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEE
Confidence            999999999999999996432          3578888999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........   ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.
T Consensus       143 l~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         143 LADFGSCLKMNQDGTV---QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             EEeccceeeccCCCce---eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            9999998765422211   1112458999999998765     467889999999999999999999984

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-38  Score=300.96  Aligned_cols=201  Identities=26%  Similarity=0.337  Sum_probs=169.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+++...+++.||+|+++..   .....+.+.+|+.++..++|+||+++++++     .+.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            4688899999999999999999989999999999742   223345688999999999999999999874     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~k  142 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKFE----------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIR  142 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEE
Confidence            999999999999999986422          3578889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++.........   ......||+.|+|||++..     ..++.++||||+||++|||++|+.||.
T Consensus       143 l~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         143 LADFGSCLRLLADGTV---QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             EEECCceeecCCCCCc---cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            9999998755422211   1112358999999999763     457889999999999999999999984

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=301.28  Aligned_cols=201  Identities=28%  Similarity=0.425  Sum_probs=177.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce-
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF-  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~-  307 (452)
                      ++|...+.+|+|+||.++..+++.+++.+++|.+......  ..+....|+.++++++|||||.+.+.     |.+++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds-----~~~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS-----FEEDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc-----hhcCCce
Confidence            5788899999999999999999999999999999765432  23467899999999999999999987     555555 


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+|||+|++||++.+.|.+.+         ...+++.+.+.|+.|++.|+.|||+.   .|+|||||+.|||++.+..||
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k---------~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~Vk  146 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQK---------GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVK  146 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHh---------hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCcee
Confidence            999999999999999997654         35688999999999999999999987   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+.......    ......||+.||+||++.+.+|+.|+||||+||++|||++-+.+|+
T Consensus       147 LgDfGlaK~l~~~~~----~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~  207 (426)
T KOG0589|consen  147 LGDFGLAKILNPEDS----LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK  207 (426)
T ss_pred             ecchhhhhhcCCchh----hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC
Confidence            999999997764431    2234679999999999999999999999999999999999999985

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-37  Score=299.67  Aligned_cols=193  Identities=25%  Similarity=0.373  Sum_probs=164.4

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+++...+++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence            46999999999999999899999999997542   22335677888888777 899999999884     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 E~~~~~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG  141 (329)
T cd05618          76 EYVNGGDLMFHMQRQ-----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYG  141 (329)
T ss_pred             eCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999887543           3588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         142 MCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             ccccccCCCC----ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            9874322111    1123468999999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-37  Score=297.68  Aligned_cols=193  Identities=27%  Similarity=0.420  Sum_probs=162.3

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|++..+++.||+|+++...   ....+.+..|.+++... +||||+++++.     +...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~-----~~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT-----FQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeE-----EEcCCEEEEEE
Confidence            46999999999999999899999999997432   22334556677777654 89999999987     34456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 e~~~gg~L~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg  141 (316)
T cd05592          76 EYLNGGDLMFHIQSS-----------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFG  141 (316)
T ss_pred             cCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCc
Confidence            999999999988643           2578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~  197 (316)
T cd05592         142 MCKENMNGEG----KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             CCeECCCCCC----ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCC
Confidence            9875432211    1123468999999999998889999999999999999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.7e-38  Score=302.35  Aligned_cols=205  Identities=27%  Similarity=0.346  Sum_probs=169.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|++.+.||+|+||.||+|+...+|+.||+|++...  .......+.+|++++++++||||+++++++...........+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999999989999999998643  223345688999999999999999999887544333344689


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+ +++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        81 lv~e~~-~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~  145 (338)
T cd07859          81 VVFELM-ESDLHQVIKAN-----------DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKIC  145 (338)
T ss_pred             EEEecC-CCCHHHHHHhc-----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEc
Confidence            999999 57899888643           2588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++......... .......||+.|+|||++.+  ..++.++|||||||++|||+||+.||.
T Consensus       146 Dfg~~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~  209 (338)
T cd07859         146 DFGLARVAFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP  209 (338)
T ss_pred             cCccccccccccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence            999997543221111 11123568999999998765  578999999999999999999999983

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-37  Score=298.86  Aligned_cols=193  Identities=28%  Similarity=0.372  Sum_probs=164.2

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|+...+++.||+|+++...   ....+.+..|.+++..+ +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999999889999999997532   23335677888888866 899999999884     4556789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++....           .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 E~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg  141 (321)
T cd05591          76 EYVNGGDLMFQIQRSR-----------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFG  141 (321)
T ss_pred             eCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecc
Confidence            9999999998886432           578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~  197 (321)
T cd05591         142 MCKEGILNGV----TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE  197 (321)
T ss_pred             cceecccCCc----cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCC
Confidence            9875332111    1123468999999999998899999999999999999999999985

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-37  Score=298.85  Aligned_cols=196  Identities=28%  Similarity=0.428  Sum_probs=165.0

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHH---hcCCCCCceeEeeeeccccCCCCc
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKAL---KNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l---~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      |.+.+.||+|+||.||+|++..+|+.||||+++...   ....+.+.+|++++   +.++||||+++++++     ...+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            566789999999999999999899999999997432   22335566666554   567899999999984     4556


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|..++..            ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~------------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~  140 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT------------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFV  140 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcE
Confidence            88999999999999988753            2588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......    ......|++.|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus       141 kL~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~  202 (324)
T cd05589         141 KIADFGLCKEGMGFGD----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP  202 (324)
T ss_pred             EeCcccCCccCCCCCC----cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence            9999999864322111    1123568999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.4e-37  Score=298.33  Aligned_cols=193  Identities=27%  Similarity=0.395  Sum_probs=164.5

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|+.+.+++.||+|+++..   .....+.+..|.+++... +||||++++++     +.+.+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~-----~~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC-----FQTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeE-----EEcCCEEEEEE
Confidence            4699999999999999989999999999743   223345677888888876 79999999987     44556889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++....           .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 Ey~~~g~L~~~i~~~~-----------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG  141 (320)
T cd05590          76 EFVNGGDLMFHIQKSR-----------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFG  141 (320)
T ss_pred             cCCCCchHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCC
Confidence            9999999999886432           588899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (320)
T cd05590         142 MCKEGIFNGK----TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE  197 (320)
T ss_pred             CCeecCcCCC----cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence            9875321111    1123468999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-37  Score=294.11  Aligned_cols=199  Identities=27%  Similarity=0.455  Sum_probs=168.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||+|+||.||+|+...+++.||+|.++... ......+.+|++++++++||||+++++++     ...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeEE
Confidence            56889999999999999999999899999999997543 23345778999999999999999999884     4455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||++ |+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        80 lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~  145 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNCG----------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLA  145 (288)
T ss_pred             EEEeCCC-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEC
Confidence            9999996 59998885432          3468889999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.......    ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||.
T Consensus       146 DfG~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~  205 (288)
T cd07871         146 DFGLARAKSVPTK----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFP  205 (288)
T ss_pred             cCcceeeccCCCc----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999875432211    1122457999999998765 568999999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.2e-38  Score=302.30  Aligned_cols=201  Identities=24%  Similarity=0.305  Sum_probs=171.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|.+.+.||+|+||+||+++...+|+.||+|+++....   ...+.+.+|+.+++.++||||+++.+++     .+.+.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            368889999999999999999999999999999975422   2345688999999999999999998873     44567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~k  142 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE----------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIK  142 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEE
Confidence            899999999999999986542          3588889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccC------CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL------GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++..+......   ......||+.|+|||++.      ...++.++|||||||++|||++|+.||+
T Consensus       143 L~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  210 (330)
T cd05601         143 LADFGSAARLTANKMV---NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH  210 (330)
T ss_pred             eccCCCCeECCCCCce---eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence            9999999765432221   112346899999999976      4567899999999999999999999984

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-37  Score=296.04  Aligned_cols=200  Identities=29%  Similarity=0.467  Sum_probs=167.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||+||+|+...+++.||+|++..... .....+.+|+++++.++||||+++++++     .+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecCCeE
Confidence            4679999999999999999999998999999999974432 2335678999999999999999999884     445678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+ .++|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        79 ~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl  144 (303)
T cd07869          79 TLVFEYV-HTDLCQYMDKHP----------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKL  144 (303)
T ss_pred             EEEEECC-CcCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence            9999999 578888875432          3578888999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.......    ......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||+
T Consensus       145 ~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  205 (303)
T cd07869         145 ADFGLARAKSVPSH----TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP  205 (303)
T ss_pred             CCCCcceeccCCCc----cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999875432211    1123458999999998765 457889999999999999999999984

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-37  Score=299.25  Aligned_cols=199  Identities=26%  Similarity=0.391  Sum_probs=172.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|+..+.||+|+||.||++++..+|..||+|.++.... ...+.+.+|++++++++||||+++++++.     .++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            3679999999999999999999999999999999975432 33467899999999999999999999853     44578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.  .+|+||||||+||++++++.+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl  145 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA-----------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKL  145 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEE
Confidence            9999999999999998643           2578889999999999999999985  26999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++.......      .....||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       146 ~Dfg~~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  203 (331)
T cd06649         146 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP  203 (331)
T ss_pred             ccCcccccccccc------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9999987543211      122458999999999998899999999999999999999999984

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.7e-37  Score=298.11  Aligned_cols=198  Identities=27%  Similarity=0.362  Sum_probs=166.7

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +|+..+.||+|+||+||+|+.+.+|+.||+|+++...   ....+.+..|.++++.+. |++|+++.++     +.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC-----FQTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE-----EecCCE
Confidence            3677889999999999999999899999999997432   233356778889988885 5667777776     444567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~-----------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ik  141 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV-----------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIK  141 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEE
Confidence            89999999999999998643           3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......    ......||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus       142 L~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~  202 (323)
T cd05615         142 IADFGMCKEHMVDGV----TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD  202 (323)
T ss_pred             EeccccccccCCCCc----cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCC
Confidence            999999875322111    1123458999999999998889999999999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-37  Score=298.72  Aligned_cols=201  Identities=24%  Similarity=0.317  Sum_probs=169.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+++++.+++.+|+|++...   .......+.+|+.++..++|+||+++.+.+     .+.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            3688899999999999999999989999999998632   222334588899999999999999999874     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~----------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~k  142 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE----------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR  142 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence            899999999999999996532          3578888999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++.........   ......||+.|+|||++.     ...++.++|||||||++|||++|+.||.
T Consensus       143 L~DfG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         143 LADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             EeecchheecccCCcc---eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence            9999998754322111   112246899999999875     3468899999999999999999999984

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=296.40  Aligned_cols=199  Identities=29%  Similarity=0.409  Sum_probs=173.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ..|...+.||+|.||.||+|....+++.||+|+++.... ...++.+.|+.++..++++||.++++.     +-.+...+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygs-----yl~g~~Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGS-----YLKGTKLW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhh-----eeecccHH
Confidence            457777899999999999999999999999999986544 345789999999999999999999988     44456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ++||||.+|++.+.++...           .+.+....-+++++..|+.|||++   +.+|||||+.|||+..+|.+|++
T Consensus        88 iiMey~~gGsv~~lL~~~~-----------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~  153 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGN-----------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLA  153 (467)
T ss_pred             HHHHHhcCcchhhhhccCC-----------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEE
Confidence            9999999999999997654           335566667889999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++..........    ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+.
T Consensus       154 DfgVa~ql~~~~~rr----~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s  212 (467)
T KOG0201|consen  154 DFGVAGQLTNTVKRR----KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHS  212 (467)
T ss_pred             ecceeeeeechhhcc----ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCc
Confidence            999997665333222    34689999999999998899999999999999999999999973

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.8e-37  Score=296.70  Aligned_cols=193  Identities=28%  Similarity=0.393  Sum_probs=162.9

Q ss_pred             CceeccCceeEEEEEEc---CCCcEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          237 NLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR----QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +.||+|+||.||+++..   .+++.||+|+++...    ......+.+|+++++.++||||+++++.+     ..++..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            67999999999999863   468899999997432    22335678899999999999999999874     4456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....           .+.+..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  142 (323)
T cd05584          77 LILEYLSGGELFMHLEREG-----------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLT  142 (323)
T ss_pred             EEEeCCCCchHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEe
Confidence            9999999999999986432           567788889999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       143 Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~  201 (323)
T cd05584         143 DFGLCKESIHEGT----VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT  201 (323)
T ss_pred             eCcCCeecccCCC----cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCC
Confidence            9999874322111    1123468999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-37  Score=292.99  Aligned_cols=200  Identities=24%  Similarity=0.351  Sum_probs=169.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|++.+.||+|+||+||+++++.+++.||+|++....  ....+.+.+|+++++.++||||+++++++     ..++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            36888999999999999999999899999999997442  23346788999999999999999998874     445688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||++++.+..+....           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        76 ~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl  141 (287)
T cd07848          76 YLVFEYVEKNMLELLEEMP-----------NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKL  141 (287)
T ss_pred             EEEEecCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEE
Confidence            9999999987776554321           3578889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++........   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~  202 (287)
T cd07848         142 CDFGFARNLSEGSNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP  202 (287)
T ss_pred             eeccCcccccccccc---cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence            999999865422211   1123458999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.7e-37  Score=296.83  Aligned_cols=193  Identities=34%  Similarity=0.416  Sum_probs=161.4

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECK-ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++.+     .+.+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999899999999997432   122234555544 56789999999998874     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||
T Consensus        76 e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg  141 (323)
T cd05575          76 DYVNGGELFFHLQRE-----------RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (323)
T ss_pred             cCCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccC
Confidence            999999999988643           2578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~  197 (323)
T cd05575         142 LCKEGIEHSK----TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (323)
T ss_pred             CCcccccCCC----ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCC
Confidence            9874321111    1123468999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-37  Score=297.82  Aligned_cols=193  Identities=33%  Similarity=0.404  Sum_probs=161.8

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECK-ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|+...+|+.||+|++....   ......+..|.. +++.++||||+++++.+     ...+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46999999999999999899999999997432   222344555554 46778999999999874     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||
T Consensus        76 e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG  141 (325)
T cd05604          76 DFVNGGELFFHLQRE-----------RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFG  141 (325)
T ss_pred             cCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecC
Confidence            999999999888643           3578999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~  197 (325)
T cd05604         142 LCKEGIAQSD----TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             CcccCCCCCC----CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence            9874321111    1123568999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.2e-37  Score=296.70  Aligned_cols=193  Identities=26%  Similarity=0.387  Sum_probs=165.1

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+++...+++.||+|+++...   ....+.+..|+.++.++ +||||++++++     +.+.+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC-----FQTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEE-----EEeCCEEEEEE
Confidence            46999999999999999899999999997542   22335678899999888 69999999987     44456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (327)
T cd05617          76 EYVNGGDLMFHMQRQ-----------RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYG  141 (327)
T ss_pred             eCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccc
Confidence            999999999888543           2588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         142 MCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             cceeccCCCC----ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence            9874321111    1123568999999999999999999999999999999999999994

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-37  Score=295.08  Aligned_cols=193  Identities=29%  Similarity=0.432  Sum_probs=163.1

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|++..+++.||+|+++...   ......+..|..++... +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence            46999999999999999889999999997542   23335567788888764 999999999884     4456789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 ey~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05619          76 EYLNGGDLMFHIQSC-----------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFG  141 (316)
T ss_pred             eCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCC
Confidence            999999999998643           2578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~  197 (316)
T cd05619         142 MCKENMLGDA----KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             cceECCCCCC----ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence            9874322111    1123468999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.4e-37  Score=295.04  Aligned_cols=193  Identities=26%  Similarity=0.418  Sum_probs=163.3

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|+++.+|+.||+|.++...   .........|.+++... +||||++++++     +.+.+..++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~-----~~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT-----FQTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEE-----EEeCCEEEEEE
Confidence            46999999999999999999999999997532   22335567788887754 89999999988     44566899999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 E~~~~g~L~~~i~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg  141 (316)
T cd05620          76 EFLNGGDLMFHIQDK-----------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFG  141 (316)
T ss_pred             CCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccC
Confidence            999999999988643           2578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~  197 (316)
T cd05620         142 MCKENVFGDN----RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             CCeecccCCC----ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            9864321111    1123568999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.1e-37  Score=289.93  Aligned_cols=203  Identities=28%  Similarity=0.434  Sum_probs=167.3

Q ss_pred             CCCCCCceeccCceeEEEEEEcC-CCcEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDE-DGTVVAIKVINLQR--QGASKSFMAECKALKNI---RHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l---~h~niv~l~~~~~~~~~~~~  305 (452)
                      +|++.+.||+|+||+||+|+... +++.||+|.++...  .+....+.+|+++++.+   +||||++++++|........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            68889999999999999999853 46889999987443  22334566777777665   69999999998764444455


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++|+||++ ++|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVP---------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence            67899999995 79999886432         23578899999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       149 ~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~  210 (290)
T cd07862         149 IKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  210 (290)
T ss_pred             EEEccccceEeccCCc-----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence            9999999997654221     1123458999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.6e-37  Score=295.78  Aligned_cols=193  Identities=32%  Similarity=0.395  Sum_probs=160.7

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECK-ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|++..+|+.||+|++....   ......+..|.. +++.++||||+++++.+     .+.+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999899999999997432   222334555554 57889999999998874     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        76 e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  141 (321)
T cd05603          76 DYVNGGELFFHLQRE-----------RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFG  141 (321)
T ss_pred             cCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCC
Confidence            999999999888543           3577888899999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       142 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  197 (321)
T cd05603         142 LCKEGVEPEE----TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (321)
T ss_pred             CCccCCCCCC----ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCC
Confidence            9874321111    1123468999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4e-37  Score=289.69  Aligned_cols=195  Identities=29%  Similarity=0.403  Sum_probs=164.8

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||+||++.+..+|+.||+|.+.....   ...+.+..|+++++.++||||+++.++     +......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-----~~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYA-----FQTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEE-----EcCCCeEEEEEeCC
Confidence            6999999999999998999999999864322   223567889999999999999999887     34456789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++|+|..++....       .....+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus        76 ~~g~L~~~~~~~~-------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  145 (280)
T cd05608          76 NGGDLRYHIYNVD-------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV  145 (280)
T ss_pred             CCCCHHHHHHhcc-------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccce
Confidence            9999998875322       1124688999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ........    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       146 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  198 (280)
T cd05608         146 ELKDGQSK----TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR  198 (280)
T ss_pred             ecCCCCcc----ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            55432211    123468999999999999999999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.9e-37  Score=295.33  Aligned_cols=193  Identities=32%  Similarity=0.388  Sum_probs=160.3

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHH-HHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECK-ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~-~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|++..+++.||+|++....   ......+..|.. +++.++||||+++++.+     .+.+..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            46999999999999999899999999997432   122234444443 56788999999998874     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|.+++....           .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG  141 (325)
T cd05602          76 DYINGGELFYHLQRER-----------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFG  141 (325)
T ss_pred             eCCCCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCC
Confidence            9999999999986432           467788888999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       142 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  197 (325)
T cd05602         142 LCKENIEHNG----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY  197 (325)
T ss_pred             CCcccccCCC----CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence            9874322111    1123569999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-37  Score=284.48  Aligned_cols=205  Identities=28%  Similarity=0.403  Sum_probs=176.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +.|+..+.||+|.-|+||+++.+.++..+|+|+++...   .+...+.+.|-++|+.++||.++.+++.     |+.+.+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~~~  151 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETDKY  151 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eeccce
Confidence            34666788999999999999999889999999998543   3334677889999999999999999988     777889


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|++||||+||+|...+++..         ...+++..+..++.+++.||+|||-.   |||.|||||+||||.++|++-
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp---------~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIM  219 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQP---------GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIM  219 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCC---------CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEE
Confidence            999999999999999887543         46799999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccC----------------------------------C------------------CCceeccccccccc
Q 041632          388 IGDFGLSRFYQAV----------------------------------S------------------NPTVSSSIGVRGTI  415 (452)
Q Consensus       388 l~Dfgla~~~~~~----------------------------------~------------------~~~~~~~~~~~gt~  415 (452)
                      |+||.++......                                  .                  .+...++.+.+||-
T Consensus       220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh  299 (459)
T KOG0610|consen  220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH  299 (459)
T ss_pred             eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence            9999987532100                                  0                  11112234577999


Q ss_pred             cccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       416 ~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|.|||++.+..++.++|.|+|||++|||+.|..||.
T Consensus       300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFK  336 (459)
T KOG0610|consen  300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFK  336 (459)
T ss_pred             ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcC
Confidence            9999999999999999999999999999999999994

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.2e-37  Score=296.74  Aligned_cols=199  Identities=26%  Similarity=0.374  Sum_probs=166.6

Q ss_pred             CCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR----QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~  303 (452)
                      +|++.+.||+|+||.||+++..   .+++.||+|++....    ....+.+..|+++++.+ +||||+++.++     +.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYA-----FQ   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEE-----Ee
Confidence            4778899999999999998863   468899999997432    22345678899999999 59999999877     45


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      ..+..++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~  141 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR-----------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSE  141 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCC
Confidence            566889999999999999998643           2578889999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||+++.+.......   .....||+.|+|||++.+. .++.++|||||||++|||+||+.||+
T Consensus       142 ~~~kl~DfG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~  208 (332)
T cd05614         142 GHVVLTDFGLSKEFLSEEKER---TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT  208 (332)
T ss_pred             CCEEEeeCcCCccccccCCCc---cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence            999999999987543222211   1235699999999998765 47889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=303.71  Aligned_cols=204  Identities=29%  Similarity=0.409  Sum_probs=170.9

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~~~~~l  310 (452)
                      +...+.||+||||.||+|+++.+|+.||||.++... ....+.+.+|+++|++++|||||+++++-.+.. .--.....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345578999999999999999999999999997543 334577889999999999999999987632211 111345689


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC--CC--ce
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN--DL--SA  386 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~--~~  386 (452)
                      +||||.+|||...+....        ....+++.+.+.+..+++.||.|||++   +|+||||||.||++..  +|  .-
T Consensus        95 vmEyC~gGsL~~~L~~PE--------N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~Iy  163 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE--------NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIY  163 (732)
T ss_pred             EEeecCCCcHHHHhcCcc--------cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEE
Confidence            999999999999997543        346799999999999999999999998   9999999999999953  33  36


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||.|+..+...     ...+.+||..|.+||+... +.|+..+|.|||||++||..||..||.
T Consensus       164 KLtDfG~Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  164 KLTDFGAARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             eeecccccccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence            999999999776433     3345789999999999985 788999999999999999999999994

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-37  Score=288.22  Aligned_cols=199  Identities=26%  Similarity=0.361  Sum_probs=169.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .|+..+.||+|+||+||++....+++.||+|.+.....   .....+.+|++++++++||||+++++.+     .+++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            36778899999999999999988899999999964322   2234578899999999999999998874     445688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++....         ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l  143 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMG---------NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRI  143 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcC---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEE
Confidence            99999999999998875422         13588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++........     .....|++.|+|||++.+..++.++||||+||++|||++|+.||+
T Consensus       144 ~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~  202 (285)
T cd05605         144 SDLGLAVEIPEGET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFR  202 (285)
T ss_pred             eeCCCceecCCCCc-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCC
Confidence            99999876542211     112468999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-36  Score=287.10  Aligned_cols=194  Identities=22%  Similarity=0.321  Sum_probs=163.8

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc---HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA---SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      ...||+|+++.||+|.+  +|+.||||.++......   .+.+.+|++++++++||||+++++++... .......++||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~~~~~~lv~  101 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI-VDDLPRLSLIL  101 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec-ccCCCceEEEE
Confidence            36799999999999998  68899999997543333   46788999999999999999999986542 12234678999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|.+++...           ..+++...+.++.|++.||+|||+.  .+++||||||+||++++++.+||+|||
T Consensus       102 Ey~~~g~L~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg  168 (283)
T PHA02988        102 EYCTRGYLREVLDKE-----------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHG  168 (283)
T ss_pred             EeCCCCcHHHHHhhC-----------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccc
Confidence            999999999999753           2578889999999999999999974  278899999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++......       ....|+..|+|||++.+  ..++.++|||||||++|||+||+.||+
T Consensus       169 ~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        169 LEKILSSPP-------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             hHhhhcccc-------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            987543211       12357899999999876  678999999999999999999999995

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=310.79  Aligned_cols=204  Identities=24%  Similarity=0.332  Sum_probs=172.5

Q ss_pred             CCCCCCceeccCceeEEEEEEcCC-CcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDED-GTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .|...+.||+|++|.||+|....+ ++.||+|.+..........+.+|+++++.++||||+++++++     ...+..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCEEEE
Confidence            378889999999999999998766 778999987655555556788999999999999999999985     34568999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.+++....       .....+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       143 v~E~~~gg~L~~~l~~~~-------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~D  212 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRL-------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGD  212 (478)
T ss_pred             EEECCCCCCHHHHHHHHH-------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEe
Confidence            999999999999886421       1123578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+++.+......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       213 Fgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~  272 (478)
T PTZ00267        213 FGFSKQYSDSVSL--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK  272 (478)
T ss_pred             CcCceecCCcccc--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            9999865432211  11223569999999999998899999999999999999999999984

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.4e-37  Score=295.29  Aligned_cols=199  Identities=27%  Similarity=0.403  Sum_probs=171.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||.||++++..++..+|+|.+..... .....+.+|+++++.++||||+++++++.     +++..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            4679999999999999999999998999999999875432 33467899999999999999999999854     34588


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.  .+|+||||||+|||+++++.+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL  145 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA-----------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL  145 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEE
Confidence            9999999999999998643           2577888899999999999999974  27999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++..+.....      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus       146 ~Dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~  203 (333)
T cd06650         146 CDFGVSGQLIDSMA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP  203 (333)
T ss_pred             eeCCcchhhhhhcc------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999875432111      12458999999999988889999999999999999999999984

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.9e-37  Score=292.52  Aligned_cols=193  Identities=25%  Similarity=0.362  Sum_probs=164.6

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||++++..+++.||+|+++...   ......+..|+++++.+ +||||+++++++     .+.+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            46999999999999999889999999997542   23345677888888887 799999999884     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        76 e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg  141 (318)
T cd05570          76 EYVNGGDLMFHIQRS-----------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFG  141 (318)
T ss_pred             cCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccC
Confidence            999999999888643           2588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       142 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~  197 (318)
T cd05570         142 MCKEGILGGV----TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE  197 (318)
T ss_pred             CCeecCcCCC----cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCC
Confidence            9864321111    1123458999999999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.1e-37  Score=318.50  Aligned_cols=214  Identities=28%  Similarity=0.364  Sum_probs=173.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||+|++..+|+.||+|+++....   ...+++.+|++++++++||||+++++++.     +++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            468889999999999999999988999999999974322   23467899999999999999999998853     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+++|+|.+++........-........++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence            89999999999999998642211100111123567788899999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCC--------------ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNP--------------TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........              .........||+.|+|||.+.+..++.++|||||||++|||+||+.||.
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~  232 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR  232 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            9999999865211100              0011112469999999999999999999999999999999999999984

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=296.30  Aligned_cols=195  Identities=30%  Similarity=0.470  Sum_probs=162.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||+|+||.||+|++..+|+.||+|++..... .....+.+|+++++.++|+||++++++     +...+..+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-----~~~~~~~~  148 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM-----FDHNGEIQ  148 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeE-----eccCCeEE
Confidence            356677899999999999999988999999999964432 234678999999999999999999988     44556789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+..               ...+..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus       149 lv~e~~~~~~L~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~  210 (353)
T PLN00034        149 VLLEFMDGGSLEGTH---------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA  210 (353)
T ss_pred             EEEecCCCCcccccc---------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEc
Confidence            999999999986532               245567788999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++........    .....||..|+|||++..     ...+.++|||||||++|||++|+.||.
T Consensus       211 DfG~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        211 DFGVSRILAQTMDP----CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             ccccceeccccccc----ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            99999865432211    123468999999998743     234568999999999999999999984

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-37  Score=293.74  Aligned_cols=193  Identities=28%  Similarity=0.386  Sum_probs=164.2

Q ss_pred             CceeccCceeEEEEEE---cCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          237 NLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +.||+|+||.||+++.   ..+|+.||+|+++....  .....+..|++++++++||||+++++.+     .+.+..++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            5799999999999876   35789999999975432  2234577899999999999999999884     445688999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      |||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        77 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Df  142 (318)
T cd05582          77 LDFLRGGDLFTRLSKE-----------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDF  142 (318)
T ss_pred             EcCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeec
Confidence            9999999999998543           3578999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+++.......    ......||+.|+|||.+.+..++.++|||||||++|||+||+.||+
T Consensus       143 g~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  199 (318)
T cd05582         143 GLSKESIDHEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ  199 (318)
T ss_pred             cCCcccCCCCC----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCC
Confidence            99875432211    1123568999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=287.28  Aligned_cols=199  Identities=27%  Similarity=0.379  Sum_probs=175.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +.|..-++||+||||+||.++.+.+|+.+|.|.++...   ........+|-.++.+++.+.||.+-.+     |+..+.
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd~  259 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKDA  259 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCCc
Confidence            56778899999999999999999999999999986432   2334567889999999999999988665     677789


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+|+..|.||+|.-+|....         ...+++..++.+|.+|+.||++||+.   +||.||+||+|||+|+.|+++
T Consensus       260 LClVLtlMNGGDLkfHiyn~g---------~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHG---------NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             eEEEEEeecCCceeEEeeccC---------CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence            999999999999999887654         25789999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|.|+|..+.....     ..+.+||.+|||||++.+..|+...|.||+||++|||+.|+.||
T Consensus       328 ISDLGLAvei~~g~~-----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPF  386 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKP-----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPF  386 (591)
T ss_pred             eeccceEEecCCCCc-----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCch
Confidence            999999987653322     22357999999999999999999999999999999999999998

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=308.66  Aligned_cols=211  Identities=24%  Similarity=0.322  Sum_probs=172.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCC--Ccee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQG--NDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~--~~~~  308 (452)
                      ++++.+.|.+|||+.||.|+....|..+|+|++-..++...+...+||++|+.++ |+|||.+++.........  .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            4566789999999999999998777999999998777777788999999999995 999999998422222122  2467


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +|+||||.+|+|-+++..+.         ...+++.++++|+.++++|+++||.. +++|||||||-+||||+.+++.||
T Consensus       118 llLmEyC~gg~Lvd~mn~Rl---------q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRL---------QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             EeehhhccCCcHHHHHHHHH---------hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence            89999999999999997543         23599999999999999999999994 788999999999999999999999


Q ss_pred             CccccccccccCCCCce-----eccccccccccccCcccc---CCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTV-----SSSIGVRGTIGYVAPEYG---LGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||||.++-.-.......     ........|+.|+|||++   .+...++|+|||||||+||-|+....|||
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe  259 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE  259 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence            99999873221110000     001124479999999975   46679999999999999999999999997

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.6e-37  Score=300.10  Aligned_cols=192  Identities=25%  Similarity=0.389  Sum_probs=165.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+|++.+.||+|+||.||+++...+++.||+|...      ...+.+|++++++++||||+++++++     ......++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCeeEE
Confidence            57999999999999999999999999999999753      24567999999999999999999884     34557899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+|++ .++|..++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       161 v~e~~-~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAK-----------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             EEecC-CCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEe
Confidence            99999 57898887543           2578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+++........   ......||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       226 FG~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~  283 (391)
T PHA03212        226 FGAACFPVDINAN---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL  283 (391)
T ss_pred             CCccccccccccc---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            9999753321111   122356999999999999889999999999999999999999875

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=272.89  Aligned_cols=199  Identities=26%  Similarity=0.413  Sum_probs=171.1

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++.|++.+.||+|.|+.||++.+..+|+.+|+|++....  ....+++.+|+++.+.++||||+++...     +.+..
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcccc
Confidence            4567888899999999999999999999999999986432  2345788999999999999999999887     45566


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---C
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---D  383 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~  383 (452)
                      ..|+|+|+|+|++|..-|-+.           ...++..+-..+.||+++|+|+|..   +|||||+||+|+++-.   .
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~R-----------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~  149 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVAR-----------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKG  149 (355)
T ss_pred             eeEEEEecccchHHHHHHHHH-----------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCC
Confidence            899999999999998665322           3467778889999999999999998   9999999999999953   3


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      --+|++|||+|.....     .....+..|||+|||||+....+|+..+|||+.||+||-|+.|..||
T Consensus       150 A~vKL~~FGvAi~l~~-----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF  212 (355)
T KOG0033|consen  150 AAVKLADFGLAIEVND-----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF  212 (355)
T ss_pred             CceeecccceEEEeCC-----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCC
Confidence            4589999999986652     12234578999999999999999999999999999999999999999

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=266.01  Aligned_cols=215  Identities=22%  Similarity=0.274  Sum_probs=180.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ..+|.+.+.||+|||+-||.++.-.+++.+|+|++.....+..+..++|++..++++|||+++++.++...........|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            45789999999999999999999889999999999877777778899999999999999999999887554434556789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++.|...|+|.+.+...+       .+...+++.+.+.|+.++++||.+||+. .++++||||||.|||+++++.+++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k-------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLK-------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             EEeehhccccHHHHHHHHh-------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence            9999999999999997654       3445789999999999999999999997 3469999999999999999999999


Q ss_pred             ccccccccccCCCCc-----eeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPT-----VSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.++...-.-...     .........|..|+|||.+.   +...++++|||||||++|+|+.|..|||
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe  242 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE  242 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch
Confidence            999987543111100     00011244789999999864   3467999999999999999999999997

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.6e-36  Score=289.23  Aligned_cols=201  Identities=26%  Similarity=0.481  Sum_probs=168.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcE----EEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|+..+.||+|+||.||+|++..++..    ||+|.++... ....+++.+|+.+++.++||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            4688999999999999999998655553    8999986433 3345688999999999999999999998743      


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++++||+++|+|.+++....          ..+++...+.++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~  147 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQH  147 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCc
Confidence            24578999999999999987542          3578888999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       148 ~kl~DfG~a~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~  213 (316)
T cd05108         148 VKITDFGLAKLLGADEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  213 (316)
T ss_pred             EEEccccccccccCCCcce--eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            9999999998665322211  1112335678999999998899999999999999999998 999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=306.71  Aligned_cols=212  Identities=27%  Similarity=0.371  Sum_probs=174.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC---
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ---  303 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~---  303 (452)
                      ..++|.+.+.||+|+||+||+|+...+|+.||||+++....  .....+.+|+..+..++|+|++++...+...+..   
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            34689999999999999999999988999999999975432  3345688999999999999999987664322111   


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .....++||||+++|+|.++++...       .....+++..+..++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~-------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRA-------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN  179 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhh-------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC
Confidence            1124679999999999999986432       1224688899999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||+++.+.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~--~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~  246 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDD--VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD  246 (496)
T ss_pred             CCEEEEecccCeecccccccc--ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            999999999998654322111  1123569999999999999899999999999999999999999984

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.6e-36  Score=282.74  Aligned_cols=192  Identities=24%  Similarity=0.362  Sum_probs=162.9

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||+||+++.+.+|+.||+|.+....   ......+..|++++++++||||+++.+.     +.++...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~-----~~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYA-----FESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEE-----EecCCeEEEEEecC
Confidence            699999999999999899999999996432   1223456679999999999999999887     44556889999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....         ...+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++.
T Consensus        76 ~g~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~  143 (277)
T cd05607          76 NGGDLKYHIYNVG---------ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAV  143 (277)
T ss_pred             CCCCHHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeee
Confidence            9999998875432         23478888999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .......     .....|+..|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       144 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~  195 (277)
T cd05607         144 ELKDGKT-----ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK  195 (277)
T ss_pred             ecCCCce-----eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            6542211     122458999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-36  Score=296.76  Aligned_cols=213  Identities=27%  Similarity=0.408  Sum_probs=169.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC-----CcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||.||+|++...     +..||+|.++.... .....+.+|+++++.+ +||||++++++|.    
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~----  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT----  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence            35788999999999999999986433     35799999975432 2345688999999999 8999999999854    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCC----------------------------------------------------
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIP----------------------------------------------------  330 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  330 (452)
                       ..+..++||||+++|+|.+++......                                                    
T Consensus       113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence             345789999999999999998643210                                                    


Q ss_pred             -------CcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCC
Q 041632          331 -------QRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP  403 (452)
Q Consensus       331 -------~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~  403 (452)
                             ..........+++.++++++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence                   000011224578899999999999999999998   9999999999999999999999999999765422211


Q ss_pred             ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       404 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                        .......++..|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus       269 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~  316 (374)
T cd05106         269 --VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYP  316 (374)
T ss_pred             --eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence              11112235678999999988899999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.9e-36  Score=283.43  Aligned_cols=203  Identities=30%  Similarity=0.437  Sum_probs=167.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNI---RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l---~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +|++.+.||+|+||+||+|+.+.+|+.||+|.++...  ......+.+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999999999999999987432  22234566777777665   799999999987554444455


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++++||++ ++|.+++....         ...+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~  147 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVP---------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQV  147 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            6899999996 58988886432         13578999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......     .....||..|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       148 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~  208 (288)
T cd07863         148 KLADFGLARIYSCQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC  208 (288)
T ss_pred             EECccCccccccCccc-----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence            9999999976543221     112457999999999988899999999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-36  Score=287.63  Aligned_cols=211  Identities=25%  Similarity=0.417  Sum_probs=167.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC----------------CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE----------------DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRV  293 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l  293 (452)
                      ++|.+.+.||+|+||.||++++..                ++..||+|.+...... ...+|.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            468888999999999999998632                3447999998754322 34578999999999999999999


Q ss_pred             eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcc--------cccccccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 041632          294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD--------REIEIQKLTLLQRISIAIDVASALDYLHQHCQ  365 (452)
Q Consensus       294 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~--------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  365 (452)
                      ++++.     +.+..+++|||+++|+|.+++.........        .......+++.+.+.++.|++.||+|||+.  
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--  157 (304)
T cd05096          85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--  157 (304)
T ss_pred             EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence            99854     345689999999999999998654321110        012234678899999999999999999998  


Q ss_pred             CCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHH
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV  445 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell  445 (452)
                       +|+||||||+|||+++++.+||+|||+++.........  ......++..|+|||++....++.++||||||+++|||+
T Consensus       158 -~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         158 -NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             -CccccCcchhheEEcCCccEEECCCccceecccCceeE--ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence             99999999999999999999999999997553222111  111234578899999988888999999999999999998


Q ss_pred             h--CCCCC
Q 041632          446 T--TKKPT  451 (452)
Q Consensus       446 t--g~~Pf  451 (452)
                      +  +..||
T Consensus       235 ~~~~~~p~  242 (304)
T cd05096         235 MLCKEQPY  242 (304)
T ss_pred             HccCCCCC
Confidence            7  56676

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.2e-37  Score=269.29  Aligned_cols=197  Identities=25%  Similarity=0.456  Sum_probs=171.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc----H----HHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA----S----KSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~----~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      ..|...+.+|+|..++|.++.++.+|+..|+|+++......    .    +.-..|+.+|+++ .||+|+.+.++     
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~-----   91 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV-----   91 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee-----
Confidence            45778889999999999999999999999999997543211    1    3456789999998 79999999988     


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ++.+...++|+|.|+.|.|.+||...           -.+++.+..+|+.|+.+|++|||..   .||||||||+|||+|
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~-----------VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILld  157 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSK-----------VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLD  157 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhh-----------eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeec
Confidence            66677899999999999999999754           3789999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccC------CCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL------GSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ++.++||+|||.|+.++....     ....+|||+|.|||.+.      ...|+...|+||.||+||.|+.|-+||
T Consensus       158 dn~~i~isDFGFa~~l~~Gek-----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  158 DNMNIKISDFGFACQLEPGEK-----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             cccceEEeccceeeccCCchh-----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            999999999999987764432     34578999999999853      235888999999999999999999998

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=290.99  Aligned_cols=198  Identities=27%  Similarity=0.395  Sum_probs=175.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc---HHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA---SKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~  305 (452)
                      .+.|+..+.||+|.||.||+++.+.+|+.+|+|.++......   .+.+.+|+.+|+++. ||||+.+.++     +++.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----FEDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----EEcC
Confidence            456888899999999999999999999999999998655433   368999999999998 9999999998     6666


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC--
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND--  383 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--  383 (452)
                      ...++|||++.||.|.+.+...            .+++.++..++.|++.+++|||+.   ||+||||||+|+|+...  
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC
Confidence            7899999999999999998542            288999999999999999999998   99999999999999643  


Q ss_pred             --CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 --LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 --~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                        +.+|++|||++......     ......+||+.|+|||++....|+..+||||+||++|.|++|..||.
T Consensus       174 ~~~~ik~~DFGla~~~~~~-----~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~  239 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKPG-----ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW  239 (382)
T ss_pred             CCCcEEEeeCCCceEccCC-----ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence              47999999999877641     12334789999999999998999999999999999999999999994

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-37  Score=297.79  Aligned_cols=197  Identities=28%  Similarity=0.483  Sum_probs=168.9

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeecc----CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ----RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .....||+|+|-+||+|.+..+|.+||.-.++..    .+...++|..|+++|+.|+||||++++.++.+..   ....-
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in  119 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN  119 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence            3446899999999999999999999998766532    3344578999999999999999999999865432   34567


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-CceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-LSAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl  388 (452)
                      +|+|.|..|+|..|+++.+           ..+......|++||++||.|||++ .|+|+|||||-+||||+.+ |.|||
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~-----------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKI  187 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR-----------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKI  187 (632)
T ss_pred             eeeecccCCcHHHHHHHhc-----------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceee
Confidence            8999999999999998765           677788999999999999999996 6899999999999999865 89999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|+|+|+.......      ....|||.|||||++. ..|++..||||||+.++||+|+.+||.
T Consensus       188 GDLGLAtl~r~s~a------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  188 GDLGLATLLRKSHA------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             cchhHHHHhhcccc------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            99999987653221      2357999999999987 689999999999999999999999983

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-36  Score=282.84  Aligned_cols=201  Identities=24%  Similarity=0.404  Sum_probs=166.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.++.... ...+.+.+|+..+++++||||+++++++.     ..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            46888899999999999999875   3456899999875432 33457899999999999999999999853     455


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~  146 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHE----------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVC  146 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcE
Confidence            7899999999999999986432          3578999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |++|||.+........   .......++..|+|||.+.+..++.++|||||||++||+++ |+.||.
T Consensus       147 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~  210 (266)
T cd05064         147 KISGFRRLQEDKSEAI---YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             EECCCcccccccccch---hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            9999998764321111   11112335678999999988899999999999999999875 999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=271.44  Aligned_cols=205  Identities=26%  Similarity=0.401  Sum_probs=173.3

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      +.++.+.++     +.||+|+|+.|-.++...+|.++|||++++...-...+..+|++++... .|+||++++++     
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief-----  144 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF-----  144 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH-----
Confidence            555555554     6899999999999999999999999999988655567889999999998 69999999998     


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      |+++...|+|||-|.||+|..+|++.+           -+++.++.++..+|+.||.|||..   ||.|||+||+|||-.
T Consensus       145 FEdd~~FYLVfEKm~GGplLshI~~~~-----------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~  210 (463)
T KOG0607|consen  145 FEDDTRFYLVFEKMRGGPLLSHIQKRK-----------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCE  210 (463)
T ss_pred             hcccceEEEEEecccCchHHHHHHHhh-----------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeec
Confidence            888889999999999999999998664           689999999999999999999998   999999999999997


Q ss_pred             CCC---ceEECccccccccccCCCC---ceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCC
Q 041632          382 NDL---SAHIGDFGLSRFYQAVSNP---TVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       382 ~~~---~~kl~Dfgla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      +..   -+||+||.++.-......-   ........+|+..|||||+..     ...|+.++|.||+||++|-|++|.+|
T Consensus       211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP  290 (463)
T KOG0607|consen  211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP  290 (463)
T ss_pred             CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence            654   4899999988644322111   111223567999999999743     24589999999999999999999999


Q ss_pred             C
Q 041632          451 T  451 (452)
Q Consensus       451 f  451 (452)
                      |
T Consensus       291 F  291 (463)
T KOG0607|consen  291 F  291 (463)
T ss_pred             c
Confidence            9

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.7e-36  Score=293.66  Aligned_cols=213  Identities=26%  Similarity=0.379  Sum_probs=169.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||.||+|++     ..++..||||+++... ....+.+.+|+++++.+ +||||++++++|     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            34688899999999999999974     3356789999986433 23346788999999999 899999999985     


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcc-------------------------------------------------
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-------------------------------------------------  333 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------  333 (452)
                      .+.+..++||||+++|+|.++++........                                                 
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            3445789999999999999999653210000                                                 


Q ss_pred             ---------------cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccc
Q 041632          334 ---------------REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       334 ---------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                                     .......+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                           001123578999999999999999999998   99999999999999999999999999997654


Q ss_pred             cCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       399 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       266 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~  318 (375)
T cd05104         266 NDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP  318 (375)
T ss_pred             Cccccc--ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence            322111  1112335678999999999899999999999999999998 888884

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.2e-36  Score=281.85  Aligned_cols=198  Identities=26%  Similarity=0.380  Sum_probs=168.6

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      |+..+.||+|+||+||++....+++.||+|.+.....   ...+.+.+|+.++++++|+|++++.+.+     ...+..+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence            6677899999999999999999999999999864322   2234577899999999999999998884     3445789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....         ...+++.++..++.|++.||+|||+.   +|+||||||+||++++++.++|+
T Consensus        77 lv~e~~~g~~L~~~l~~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~  144 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMG---------EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRIS  144 (285)
T ss_pred             EEEEecCCCcHHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEe
Confidence            9999999999999885322         23578889999999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........     .....|+..|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       145 Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~  202 (285)
T cd05630         145 DLGLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ  202 (285)
T ss_pred             eccceeecCCCcc-----ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            9999875432211     112458999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.2e-36  Score=281.87  Aligned_cols=198  Identities=25%  Similarity=0.357  Sum_probs=168.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      |+..+.||+|+||+||+|.+..+++.||+|.+....   ......+.+|++++++++|+|++++.+.+     ..++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            566788999999999999999899999999986432   22234578899999999999999998873     4456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+
T Consensus        77 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~  144 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMG---------NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             EEEEeccCccHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEe
Confidence            9999999999998885322         13589999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........     .....|+..|+|||.+.+..++.++|+|||||++|||++|+.||+
T Consensus       145 Dfg~~~~~~~~~~-----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~  202 (285)
T cd05632         145 DLGLAVKIPEGES-----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR  202 (285)
T ss_pred             cCCcceecCCCCc-----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            9999875432211     123468999999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-36  Score=300.63  Aligned_cols=203  Identities=28%  Similarity=0.404  Sum_probs=163.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC---CCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ---GND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~---~~~  306 (452)
                      ..+|...+.||+|+||.||+|+...+++.||||++....    ....+|+.+++.++||||+++.+++....+.   ...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            357999999999999999999998899999999885322    2345799999999999999998875332221   223


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-c
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-S  385 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~  385 (452)
                      ..++||||++ +++.+++....       .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++ .
T Consensus       141 ~l~lvmE~~~-~~l~~~~~~~~-------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~  209 (440)
T PTZ00036        141 FLNVVMEFIP-QTVHKYMKHYA-------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHT  209 (440)
T ss_pred             EEEEEEecCC-ccHHHHHHHHh-------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCc
Confidence            5678999996 57777664321       1124688999999999999999999998   999999999999999664 7


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.+.....     .....||+.|+|||++.+. .++.++|||||||++|||+||+.||.
T Consensus       210 vkL~DFGla~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~  272 (440)
T PTZ00036        210 LKLCDFGSAKNLLAGQR-----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS  272 (440)
T ss_pred             eeeeccccchhccCCCC-----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999986543221     1235689999999987654 68999999999999999999999984

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=291.47  Aligned_cols=191  Identities=29%  Similarity=0.369  Sum_probs=157.8

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcC---CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNI---RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l---~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      ||+|+||+||+|+...+++.||+|++.....   .....+..|..++...   +||||+++...     +.+.+..++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~-----~~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFS-----FQTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEE-----EecCCeEEEEE
Confidence            6999999999999998999999999964321   1223445566666655   69999999887     44556889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        76 e~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg  141 (330)
T cd05586          76 DYMSGGELFWHLQKE-----------GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFG  141 (330)
T ss_pred             cCCCCChHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCC
Confidence            999999999988643           3578899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.......    ......||+.|+|||++.+. .++.++||||+||++|||+||+.||.
T Consensus       142 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~  198 (330)
T cd05586         142 LSKANLTDNK----TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY  198 (330)
T ss_pred             cCcCCCCCCC----CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence            9875322111    11235699999999998654 47999999999999999999999984

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=313.46  Aligned_cols=206  Identities=27%  Similarity=0.364  Sum_probs=178.9

Q ss_pred             HHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeec---cCCccHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       225 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~---~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      .+....++|.+.++||+|+||+|..++++.+++.+|.|++..   -+......|..|-.+|..-+.+=|+++.-+     
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA-----  143 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA-----  143 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH-----
Confidence            334455789999999999999999999999999999999975   334555789999999998888889988765     


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      |++..+.|+|||||+||+|-..+.+..           .+++..+..++..|+.||+-+|+.   |+|||||||+|||+|
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLlSk~~-----------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld  209 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLLSKFD-----------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLD  209 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHHhhcC-----------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEec
Confidence            889999999999999999999986542           689999999999999999999999   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ..|++||+|||.+-.+...+  . ..+...+|||.|.+||++..     +.|+..+|.||+||++|||+.|..||.
T Consensus       210 ~~GHikLADFGsClkm~~dG--~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  210 KSGHIKLADFGSCLKMDADG--T-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             ccCcEeeccchhHHhcCCCC--c-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            99999999999887655332  2 23344679999999998642     579999999999999999999999994

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.6e-36  Score=293.35  Aligned_cols=203  Identities=26%  Similarity=0.333  Sum_probs=167.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|+||+||++....+|+.||+|.+...  .....+.+.+|+++++.++||||+++++++...+.......+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999889999999998643  223346788999999999999999999886543222223679


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+. ++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        81 lv~e~~~-~~l~~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-----------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEec
Confidence            9999995 6888877543           3688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++........   ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||+
T Consensus       146 Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  206 (372)
T cd07853         146 DFGLARVEEPDESK---HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ  206 (372)
T ss_pred             cccceeecccCccc---cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence            99999765422111   11224578999999998764 47899999999999999999999984

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.4e-36  Score=291.15  Aligned_cols=201  Identities=26%  Similarity=0.295  Sum_probs=167.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~~  306 (452)
                      .++|+..+.||+|+||.||+++...+|+.||+|.+...  .......+.+|+.+++.++||||+++++++.... .....
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999999889999999998643  2233467889999999999999999998864322 12223


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||++ +++.+++.             ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       100 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIH-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHh-------------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence            5799999995 46666553             2367788889999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++......     ......||+.|+|||.+.+..++.++||||+||++|||+||+.||.
T Consensus       163 kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~  223 (359)
T cd07876         163 KILDFGLARTACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ  223 (359)
T ss_pred             EEecCCCccccccCc-----cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            999999987543211     1123468999999999999899999999999999999999999983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.5e-36  Score=285.12  Aligned_cols=199  Identities=25%  Similarity=0.439  Sum_probs=166.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|...+.||+|+||.||+|+...+++.||+|.++... ......+.+|++++++++||||+++++++.     .++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            56888999999999999999998889999999997543 233456789999999999999999999853     445789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||++ ++|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus        81 lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~  146 (309)
T cd07872          81 LVFEYLD-KDLKQYMDDCG----------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLA  146 (309)
T ss_pred             EEEeCCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEC
Confidence            9999996 58888875432          3578888999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++........    .....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||.
T Consensus       147 Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~  206 (309)
T cd07872         147 DFGLARAKSVPTKT----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP  206 (309)
T ss_pred             ccccceecCCCccc----cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99998754322111    112357899999998765 468899999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-35  Score=276.85  Aligned_cols=198  Identities=26%  Similarity=0.380  Sum_probs=169.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++||||+++++.+.     ..+..++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence            56899999999999999999998899999999997655555567889999999999999999998853     3457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++++|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        84 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~d  149 (267)
T cd06646          84 CMEYCGGGSLQDIYHVT-----------GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLAD  149 (267)
T ss_pred             EEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECc
Confidence            99999999999988643           2578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+++.......    ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||
T Consensus       150 fg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~  209 (267)
T cd06646         150 FGVAAKITATIA----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM  209 (267)
T ss_pred             Cccceeeccccc----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence            999976542211    112245889999999874   345788999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=288.54  Aligned_cols=202  Identities=27%  Similarity=0.425  Sum_probs=169.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccH-HHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +...+.+.||+|-||+|..+... .+..||||.++....... .+|..|+++|.+++||||++++|+|...     +..+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchH
Confidence            44567789999999999999985 468999999987665554 7899999999999999999999998643     4789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++|||++|+|.+|+.++..         .........+|+.||+.||+||.+.   .+||||+.++|+|++.++++||+
T Consensus       612 mI~EYmEnGDLnqFl~ahea---------pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKia  679 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL---------PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIA  679 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC---------cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEec
Confidence            99999999999999987642         2234456678999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh--CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT--TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~Pf~  452 (452)
                      |||+++.+.+......  ....+-+.+|||||.+..++++.++|||+|||++||+++  .+.||+
T Consensus       680 dfgmsR~lysg~yy~v--qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~  742 (807)
T KOG1094|consen  680 DFGMSRNLYSGDYYRV--QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS  742 (807)
T ss_pred             CcccccccccCCceee--ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence            9999985543322211  112346789999999999999999999999999999865  778874

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.9e-35  Score=278.17  Aligned_cols=192  Identities=28%  Similarity=0.383  Sum_probs=166.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +|+..+.||+|+||.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++.+.     ..+..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEEE
Confidence            5778899999999999999998899999999986542 233467889999999999999999999854     3457889


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++++|..+.               .+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|
T Consensus        77 v~e~~~~~~l~~~~---------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d  138 (279)
T cd06619          77 CTEFMDGGSLDVYR---------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD  138 (279)
T ss_pred             EEecCCCCChHHhh---------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence            99999999997652               356778889999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.......      .....|+..|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       139 fg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  194 (279)
T cd06619         139 FGVSTQLVNSI------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP  194 (279)
T ss_pred             CCcceeccccc------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence            99987554221      112468999999999998889999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-35  Score=282.78  Aligned_cols=198  Identities=27%  Similarity=0.397  Sum_probs=170.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|++.+.||+|+||.||++++..++..+|+|.+..... ....++.+|++++++++||||+++++.+     .+++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEEE
Confidence            368889999999999999999998999999999874422 2335688999999999999999999985     3456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++...           ..+++..+..++.|++.||+|||+.  .+++||||||+||++++++.+||+
T Consensus        76 lv~ey~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~  142 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA-----------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC  142 (308)
T ss_pred             EEeeccCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEc
Confidence            999999999999998643           2578889999999999999999973  289999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.......      .....++..|+|||.+.+..++.++|||||||++|||+||+.||+
T Consensus       143 dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         143 DFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             cCCCcccccccc------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            999986543211      122458899999999888889999999999999999999999984

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-35  Score=290.23  Aligned_cols=202  Identities=26%  Similarity=0.273  Sum_probs=168.6

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~  305 (452)
                      ..++|...+.||+|+||.||+++...+++.||||++...  .......+.+|+.+++.++||||+++++++.... +...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346799999999999999999999889999999998643  2333467889999999999999999998754322 2233


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++||||++ ++|.+++.             ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  164 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  164 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHH-------------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCc
Confidence            46799999995 57777663             2367788899999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.......     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       165 ~kL~DfG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  226 (364)
T cd07875         165 LKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP  226 (364)
T ss_pred             EEEEeCCCccccCCCCc-----ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence            99999999975432211     122458999999999999899999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=296.65  Aligned_cols=199  Identities=27%  Similarity=0.483  Sum_probs=170.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCc----EEEEEEee-ccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGT----VVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~-~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ....++||+|+||+||+|.|-..|+    +||+|++. ....+...++.+|+..|.+++|||+++++++|...      .
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence            3445789999999999999976664    68999885 34455678999999999999999999999998643      3


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      ..||++||+.|+|.+|++.++          ..+.....+.|..|||+||.|||++   ++|||||.++||||..-..+|
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr----------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvk  838 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHR----------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVK  838 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhh----------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEE
Confidence            678999999999999998765          4677788999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |.|||+++........-...  ...-.+.|||-|.+....|+.++|||||||++||++| |..|++
T Consensus       839 itdfgla~ll~~d~~ey~~~--~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~  902 (1177)
T KOG1025|consen  839 ITDFGLAKLLAPDEKEYSAP--GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD  902 (1177)
T ss_pred             EEecchhhccCccccccccc--ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence            99999999776544332221  2234678999999999999999999999999999999 999985

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-35  Score=273.64  Aligned_cols=200  Identities=31%  Similarity=0.435  Sum_probs=172.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|++|.||+|+...+++.|++|.++...  ....+.+.+|+++++.++|||++++++.+     .+.+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence            4677889999999999999999899999999987442  33456789999999999999999999884     3456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++....         ...+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||+
T Consensus        76 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~  143 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQR---------GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIG  143 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEc
Confidence            9999999999999986531         24688889999999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++........    .....|++.|+|||+..+..++.++|+|||||++|||++|+.||+
T Consensus       144 df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  202 (256)
T cd08529         144 DLGVAKLLSDNTNF----ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD  202 (256)
T ss_pred             ccccceeccCccch----hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            99998865432211    122457899999999998889999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-35  Score=280.78  Aligned_cols=198  Identities=27%  Similarity=0.392  Sum_probs=172.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+|+..+.||+|++|.||+|+...+++.||+|.+........+.+.+|+++++.++|||++++++.+.     .....++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence            46888899999999999999998889999999998766666678899999999999999999998853     3457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++++|.+++...            .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        95 v~e~~~~~~L~~~~~~~------------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~d  159 (296)
T cd06654          95 VMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  159 (296)
T ss_pred             eecccCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECc
Confidence            99999999999998532            467889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....+++.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       160 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~  217 (296)
T cd06654         160 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (296)
T ss_pred             cccchhccccccc----cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            9998754322111    112358899999999988889999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-35  Score=289.70  Aligned_cols=202  Identities=26%  Similarity=0.278  Sum_probs=168.2

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~  305 (452)
                      ..++|...+.||+|+||.||+++...+++.||+|.+....  ......+.+|+.+++.++||||+++++++.... ....
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999998889999999986432  233467789999999999999999998864322 1233


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++||||++ +++.+++.             ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        95 ~~~~lv~e~~~-~~l~~~~~-------------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~  157 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHHh-------------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCC
Confidence            45799999995 56766653             2467888899999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  219 (355)
T cd07874         158 LKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_pred             EEEeeCcccccCCCcc-----ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999997543221     1123468999999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=281.61  Aligned_cols=199  Identities=24%  Similarity=0.364  Sum_probs=174.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .-|...+.||+|.|+.|-.|++--+|..||||+++..+...  ...+..|++.|+-++|||||+++++     .......
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQTKl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQTKL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccceE
Confidence            34777889999999999999999999999999998665433  3567899999999999999999998     4556689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec-CCCceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~k  387 (452)
                      |+|+|.=.+|+|++||.++.          ..+.+..+.+++.||+.|+.|+|+.   .+|||||||+||.+- .-|-||
T Consensus        93 yLiLELGD~GDl~DyImKHe----------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVK  159 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHE----------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVK  159 (864)
T ss_pred             EEEEEecCCchHHHHHHhhh----------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceE
Confidence            99999999999999997664          5788999999999999999999998   999999999998775 568899


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCc-ccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVST-NGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |.|||++..+.+....     ...+|+..|-|||++.+..|+. ++||||+||+||-|++|+.||.
T Consensus       160 LTDFGFSNkf~PG~kL-----~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq  220 (864)
T KOG4717|consen  160 LTDFGFSNKFQPGKKL-----TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ  220 (864)
T ss_pred             eeeccccccCCCcchh-----hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence            9999999877654433     3468999999999999998865 6899999999999999999995

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.7e-35  Score=273.44  Aligned_cols=199  Identities=29%  Similarity=0.465  Sum_probs=167.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||.||+++++ ++..+|+|.+... ....+++.+|++++++++||||+++++++.     +.+..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~i   76 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYI   76 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEE
Confidence            45788899999999999999986 5668999988633 333568899999999999999999999853     3457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      +|||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|
T Consensus        77 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d  143 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQ----------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSD  143 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECC
Confidence            999999999999986432          2578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||.++.......   .......++..|+|||...+..++.++||||||+++|||++ |+.||+
T Consensus       144 ~g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~  203 (256)
T cd05114         144 FGMTRYVLDDEY---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE  203 (256)
T ss_pred             CCCccccCCCce---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCC
Confidence            999875432211   11122345678999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-38  Score=276.04  Aligned_cols=196  Identities=28%  Similarity=0.394  Sum_probs=172.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      |.+.+.||+|+||.||+|.++++|+.+|+|.+...  ...+++..|+.+|++...|++|+++|.+     -.....++||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSY-----FK~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSY-----FKHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhh-----ccCCceEeeh
Confidence            55668899999999999999999999999998754  3457889999999999999999999984     3344689999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      |||..|++.+.++..+          +++++.+...++...++||+|||..   .-+|||||+.|||++.+|.+|++|||
T Consensus       108 EYCGAGSiSDI~R~R~----------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR----------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             hhcCCCcHHHHHHHhc----------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence            9999999999987654          6899999999999999999999998   88999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .|..+......    .....|||.|||||++..-.|+.++||||+|++..||..|++||.
T Consensus       175 VAGQLTDTMAK----RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs  230 (502)
T KOG0574|consen  175 VAGQLTDTMAK----RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS  230 (502)
T ss_pred             ccchhhhhHHh----hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence            98755432211    123679999999999999999999999999999999999999984

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.9e-35  Score=277.03  Aligned_cols=207  Identities=26%  Similarity=0.378  Sum_probs=172.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC-Cc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG-ND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~-~~  306 (452)
                      +++.|+..+.||+|+||.||+|....+++.||+|.+.... .....+..|+.++.++ +|||++++++.+....... ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999999899999999997543 3446788999999998 7999999999875432221 34


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..+++|||+++++|.+++....         ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTK---------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCE
Confidence            6889999999999999986532         23578889999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++........    ......|++.|+|||++.     ...++.++|||||||++|||++|+.||+
T Consensus       151 ~l~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~  217 (272)
T cd06637         151 KLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             EEccCCCceecccccc----cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999999875532211    122345899999999875     3457889999999999999999999984

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-35  Score=273.41  Aligned_cols=202  Identities=28%  Similarity=0.451  Sum_probs=170.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-----cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-----ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|...+.||+|++|.||++....+++.||+|.+......     ..+.+.+|++++++++||||+++++++     .+.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            4688899999999999999999888999999998643221     235688999999999999999999984     445


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++++||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +++||||+|+||++++++.
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~  142 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAY-----------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGN  142 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence            5899999999999999988643           2577888999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++|+|||+++.......... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus       143 ~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~  208 (263)
T cd06625         143 VKLGDFGASKRLQTICSSGT-GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA  208 (263)
T ss_pred             EEEeecccceeccccccccc-cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence            99999999875542211110 0122457889999999998889999999999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-35  Score=274.24  Aligned_cols=204  Identities=27%  Similarity=0.397  Sum_probs=169.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-----ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-----GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|+..+.||+|+||.||+|+...+|+.||+|.+.....     ...+.+.+|++++++++||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            468889999999999999999988999999998864321     223578889999999999999999987432   113


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++++|.+++....           .+++.....++.|++.||+|||+.   +++|+||||+||+++.++.
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  144 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSYG-----------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGN  144 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCC
Confidence            46789999999999999986432           467888899999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++........ ........++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       145 ~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  210 (265)
T cd06652         145 VKLGDFGASKRLQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA  210 (265)
T ss_pred             EEECcCcccccccccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence            999999998754321111 111122458899999999988889999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-35  Score=281.58  Aligned_cols=205  Identities=25%  Similarity=0.362  Sum_probs=161.3

Q ss_pred             CCceeccCceeEEEEEEc--CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          236 TNLIGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      .+.||+|+||+||+|+..  .+++.||+|.+...  .....+.+|++++++++||||+++++.+..   ..+...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            468999999999999975  35688999998643  233567899999999999999999987532   23456889999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee----cCCCceEEC
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIG  389 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~  389 (452)
                      |+ +++|.+++........  ......+++..+..++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+
T Consensus        81 ~~-~~~l~~~~~~~~~~~~--~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          81 YA-EHDLWHIIKFHRASKA--NKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             cc-CCCHHHHHHhcccccc--cCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            99 5688888754321111  11123588899999999999999999998   99999999999999    456789999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.+...... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus       155 DfG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         155 DMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ecCceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99999866432211 111223568999999999876 458999999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-35  Score=285.04  Aligned_cols=202  Identities=25%  Similarity=0.341  Sum_probs=168.3

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QG  304 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~  304 (452)
                      ...++|...+.||+|+||+||+|....+++.||||.+.....  ...+.+.+|+++++.++||||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            345789999999999999999999988999999999864321  233567789999999999999999987543211 12


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ....++++|++ +++|.+++..            ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~  155 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC------------QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDC  155 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCC
Confidence            24568999988 8899888753            2588899999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.....       .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus       156 ~~kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  217 (343)
T cd07878         156 ELRILDFGLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP  217 (343)
T ss_pred             CEEEcCCccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999754421       123468999999999876 568899999999999999999999983

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-35  Score=276.61  Aligned_cols=198  Identities=28%  Similarity=0.385  Sum_probs=169.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|.+.+.||+|+||.||+|+...+++.||+|.++.........+.+|+.+++.++||||+++++.+     ...+..++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCCEEEE
Confidence            4677778999999999999999889999999999766555556788999999999999999999884     34567899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+++++|.+++...           ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+||+|
T Consensus        84 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~d  149 (267)
T cd06645          84 CMEFCGGGSLQDIYHVT-----------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLAD  149 (267)
T ss_pred             EEeccCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence            99999999999998643           2588999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||++........    ......|+..|+|||++.   ...++.++|||||||++|||++|+.||
T Consensus       150 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~  209 (267)
T cd06645         150 FGVSAQITATIA----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM  209 (267)
T ss_pred             ceeeeEccCccc----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCc
Confidence            999875432211    112346899999999874   456888999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.7e-35  Score=275.46  Aligned_cols=201  Identities=26%  Similarity=0.417  Sum_probs=165.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT----VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|...+.||+|+||+||+|++..+++    .+++|.+..... ....++..|+..+++++||||+++++++.      .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence            468888999999999999999976665    477777753322 22357788888999999999999999853      2


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~  147 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR----------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSI  147 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCc
Confidence            34678999999999999996532          3578999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       148 ~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~  213 (279)
T cd05111         148 VQIADFGVADLLYPDDKKY--FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA  213 (279)
T ss_pred             EEEcCCccceeccCCCccc--ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999997654222111  1122346788999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1e-35  Score=288.92  Aligned_cols=194  Identities=31%  Similarity=0.433  Sum_probs=168.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-C-----CCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-H-----KNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h-----~niv~l~~~~~~~~~~~~  305 (452)
                      +|++.+.||+|.||.|.+|....+++.||||+++... ....+-..|+.+|..++ |     -|+|+++++     |.-.
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~-----F~fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY-----FYFR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec-----cccc
Confidence            6888999999999999999999999999999998543 34466788999999886 3     579999998     5667


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC--
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND--  383 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--  383 (452)
                      ++.|||+|.+ .-+|+++|+..+.         ..++...+..++.||+.||.+||+.   +|||+||||+|||+.+-  
T Consensus       261 ~HlciVfELL-~~NLYellK~n~f---------~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  261 NHLCIVFELL-STNLYELLKNNKF---------RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             cceeeeehhh-hhhHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCc
Confidence            7999999999 7899999987763         4688999999999999999999998   99999999999999754  


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ..+||+|||.|+.......       .+.-+..|+|||++.+.+|+.+.||||||||++||+||.+-|
T Consensus       328 ~~vKVIDFGSSc~~~q~vy-------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  328 SRIKVIDFGSSCFESQRVY-------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             CceeEEecccccccCCcce-------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            4799999999986543221       356788999999999999999999999999999999997765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-35  Score=277.52  Aligned_cols=212  Identities=31%  Similarity=0.482  Sum_probs=171.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|.+.+.||+|+||.||+|++..     +++.||+|.++..... ..+.+.+|++++++++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-----E   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----c
Confidence            457788999999999999998742     3578999998754443 4578999999999999999999999853     3


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcc---cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRD---REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ....+++|||+++++|.+++.........   .......+++.++..++.|++.|++|||+.   +++||||||+||+++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~  156 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEc
Confidence            45789999999999999999754321110   122335688999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .++.+||+|||+++.........  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~  226 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             CCCeEEECCcccceecccCccee--cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence            99999999999987543221111  1112335788999999999999999999999999999999 999983

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=291.34  Aligned_cols=194  Identities=28%  Similarity=0.410  Sum_probs=165.2

Q ss_pred             ceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCC
Q 041632          238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPN  317 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  317 (452)
                      +||+|.||+||.|+...+...+|||.+........+-+.+||.+.+.++|.|||+++|.|     .++++.-|.||..+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            699999999999999999999999999877666677889999999999999999999984     445688899999999


Q ss_pred             CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec-CCCceEECccccccc
Q 041632          318 GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRF  396 (452)
Q Consensus       318 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~  396 (452)
                      |+|.+.|+..=        ..-+=.+...-.+.+||++||.|||+.   .|||||||-+||||+ -.|.+||+|||.++.
T Consensus       657 GSLSsLLrskW--------GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKR  725 (1226)
T KOG4279|consen  657 GSLSSLLRSKW--------GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKR  725 (1226)
T ss_pred             CcHHHHHHhcc--------CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchh
Confidence            99999996431        111125566777899999999999998   999999999999996 578999999999986


Q ss_pred             cccCCCCceeccccccccccccCccccCCC--CCCcccceeehhHHHHHHHhCCCCC
Q 041632          397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGS--EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       397 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +..-..-+    ....||..|||||++..+  .|+.++|||||||++.||.||++||
T Consensus       726 LAginP~T----ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF  778 (1226)
T KOG4279|consen  726 LAGINPCT----ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF  778 (1226)
T ss_pred             hccCCccc----cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence            65332222    234599999999998875  4889999999999999999999998

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4e-35  Score=273.49  Aligned_cols=201  Identities=27%  Similarity=0.493  Sum_probs=169.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+|...+.||+|+||.||+|.+..+++.||+|.+... ....+++.+|++.++.++|||++++++++.     ..+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI   79 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEE
Confidence            3577788999999999999999888999999998643 333467899999999999999999999853     3456799


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      +|||+++++|.+++....         ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        80 v~e~~~~~~L~~~~~~~~---------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  147 (263)
T cd05052          80 ITEFMTYGNLLDYLRECN---------RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD  147 (263)
T ss_pred             EEEeCCCCcHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCC
Confidence            999999999999986432         24578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||++........   .......++..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       148 f~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~  207 (263)
T cd05052         148 FGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  207 (263)
T ss_pred             Ccccccccccee---eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            999876542211   11112234678999999988899999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-35  Score=289.13  Aligned_cols=214  Identities=28%  Similarity=0.401  Sum_probs=170.1

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCC-----CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCC-CCCceeEeeeecccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQ-GASKSFMAECKALKNIR-HKNLVRVITSCSSVD  301 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~  301 (452)
                      ..++|.+.+.||+|+||.||+|++...     +..||||+++.... ...+.+.+|+++++++. ||||++++++|.   
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---  111 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---  111 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence            356788999999999999999987422     34799999964433 23467899999999995 999999999864   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcc------------------------------------------------
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD------------------------------------------------  333 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------  333 (452)
                        +.+..++||||+++|+|.+++.........                                                
T Consensus       112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence              345789999999999999998653210000                                                


Q ss_pred             -------------------------------------cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          334 -------------------------------------REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       334 -------------------------------------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                                                           .......+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChH
Confidence                                                 000123578899999999999999999998   9999999999


Q ss_pred             CeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       377 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||++++++.+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNY--VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccc--cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            999999999999999999765322111  11122346788999999988889999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6e-35  Score=272.74  Aligned_cols=203  Identities=28%  Similarity=0.453  Sum_probs=169.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||+||+|++..+   ...||+|.++.... ....+|.+|+..+++++||||+++++.+     ...
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   77 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKS   77 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecC
Confidence            35688899999999999999998643   45799999875433 3346789999999999999999999984     345


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..+++|||+++++|.+++....          ..+++.+++.++.|++.|++|||+.   +|+||||||+||++++++.
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~  144 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLREND----------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLV  144 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCC
Confidence            57899999999999999986532          3678999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++.........  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus       145 ~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         145 CKVSDFGLSRRLEDSEATY--TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             EEECccchhhcccccccce--eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence            9999999998764211111  1112345678999999988899999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.3e-35  Score=275.52  Aligned_cols=198  Identities=28%  Similarity=0.420  Sum_probs=167.8

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      |++.+.||+|+||.||+|+...++..+++|.+........+.+.+|+++++.++|||++++++.+.     ..+..++|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence            566788999999999999999889999999997555455577899999999999999999999853     345789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++++|..++....          ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        82 e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          82 EFCAGGAVDAVMLELE----------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             EecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            9999999998875422          3588999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++........    ......+++.|+|||++.     +..++.++|||||||++|||++|+.||+
T Consensus       149 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  209 (282)
T cd06643         149 VSAKNTRTIQ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH  209 (282)
T ss_pred             cccccccccc----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc
Confidence            9875432211    112345899999999873     3457889999999999999999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.1e-35  Score=297.46  Aligned_cols=199  Identities=24%  Similarity=0.338  Sum_probs=161.3

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCC------CCceeEeeeecccc
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRH------KNLVRVITSCSSVD  301 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h------~niv~l~~~~~~~~  301 (452)
                      ...++|.+.+.||+|+||+||+|++..+++.||||+++... ...+.+..|+++++.++|      ++++++++++.   
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~---  201 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ---  201 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE---
Confidence            34578999999999999999999998889999999996432 223455667777766654      45777777643   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                       .+....++|||++ +++|.+++...           ..+++.++..++.|++.||+|||+.  .+|+||||||+|||++
T Consensus       202 -~~~~~~~iv~~~~-g~~l~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~  266 (467)
T PTZ00284        202 -NETGHMCIVMPKY-GPCLLDWIMKH-----------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILME  266 (467)
T ss_pred             -cCCceEEEEEecc-CCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEe
Confidence             2235688999988 88899888643           2588889999999999999999973  2999999999999998


Q ss_pred             CCC----------------ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHH
Q 041632          382 NDL----------------SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV  445 (452)
Q Consensus       382 ~~~----------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell  445 (452)
                      .++                .+||+|||.+.....       ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell  339 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY  339 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCcc-------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence            765                499999998753221       112356999999999999999999999999999999999


Q ss_pred             hCCCCCC
Q 041632          446 TTKKPTD  452 (452)
Q Consensus       446 tg~~Pf~  452 (452)
                      ||+.||+
T Consensus       340 tG~~pf~  346 (467)
T PTZ00284        340 TGKLLYD  346 (467)
T ss_pred             hCCCCCC
Confidence            9999995

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.6e-35  Score=275.48  Aligned_cols=202  Identities=27%  Similarity=0.489  Sum_probs=168.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCc----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGT----VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      .++|+..+.||+|+||+||+|++..+|+    .||+|.+..... ...+.+.+|+.+++.++||||+++++.|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            4578889999999999999999876766    489999864332 334678899999999999999999998642     


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                       ...++++||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||++++++
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~  146 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK----------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPN  146 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence             24678999999999999986532          3588899999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++........  .......+++.|+|||...+..++.++|||||||++|||+| |..||+
T Consensus       147 ~~kL~dfG~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  213 (279)
T cd05109         147 HVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD  213 (279)
T ss_pred             cEEECCCCceeecccccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999866432111  11112235678999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5e-35  Score=277.56  Aligned_cols=198  Identities=28%  Similarity=0.414  Sum_probs=172.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+|+..+.||.|++|.||+|+...+|+.||+|.+........+.+.+|++.++.++|||++++++.+     ...+..++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCceEEE
Confidence            3588889999999999999999889999999999866555667889999999999999999999984     34567899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++++|..++..            ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        94 v~e~~~~~~L~~~~~~------------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~d  158 (296)
T cd06655          94 VMEYLAGGSLTDVVTE------------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTD  158 (296)
T ss_pred             EEEecCCCcHHHHHHh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence            9999999999998853            2478899999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....++..|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus       159 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~  216 (296)
T cd06655         159 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (296)
T ss_pred             Cccchhccccccc----CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9998755422211    122458899999999988889999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=277.06  Aligned_cols=201  Identities=28%  Similarity=0.418  Sum_probs=171.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||++.+..++..||+|.++.......+.+.+|++++++++|||++++++.+     ..+...+
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCeEE
Confidence            35688889999999999999999888999999999866555567899999999999999999999984     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....          ..+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+
T Consensus        79 lv~e~~~~~~L~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~  145 (280)
T cd06611          79 ILIEFCDGGALDSIMLELE----------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLA  145 (280)
T ss_pred             EEeeccCCCcHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEc
Confidence            9999999999999986432          3588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........    ......+++.|+|||.+.     ...++.++|+||||+++|||++|+.||+
T Consensus       146 d~g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~  209 (280)
T cd06611         146 DFGVSAKNKSTLQ----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH  209 (280)
T ss_pred             cCccchhhccccc----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc
Confidence            9998865432211    112245899999999864     3457889999999999999999999984

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7e-35  Score=276.13  Aligned_cols=200  Identities=28%  Similarity=0.411  Sum_probs=169.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +.|++.+.||+|+||.||+|+...+++.|++|.+........+.+.+|++.++.++|||++++++.+.     .++..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence            56888999999999999999998889999999997665555678899999999999999999999843     3457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++++|..++.+..          ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        87 v~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  153 (292)
T cd06644          87 MIEFCPGGAVDAIMLELD----------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLAD  153 (292)
T ss_pred             EEecCCCCcHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEcc
Confidence            999999999988875432          3578899999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++........    ......+++.|+|||++.     ...++.++|||||||++|||++|+.||.
T Consensus       154 fg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  216 (292)
T cd06644         154 FGVSAKNVKTLQ----RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH  216 (292)
T ss_pred             Cccceecccccc----ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc
Confidence            998865332111    112245788999999874     3457889999999999999999999984

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=285.33  Aligned_cols=199  Identities=28%  Similarity=0.427  Sum_probs=174.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ...|.+..+||+|.|++|..|++..++..||+|.++.+.-..  ...+.+|+++|+.++|||||+++.+     .+....
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v-----~~t~~~  129 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV-----IETEAT  129 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee-----eeecce
Confidence            456888999999999999999999999999999998654332  2458899999999999999999998     444568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||+.+|.+.+|+....           ...+..+..++.|+.+|++|||++   .|||||||++|||++.+.++|
T Consensus       130 lylV~eya~~ge~~~yl~~~g-----------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnik  195 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHG-----------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIK  195 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcc-----------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccccccee
Confidence            999999999999999998664           345577889999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++..+.....     ....+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..|||
T Consensus       196 IaDfgfS~~~~~~~~-----lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD  256 (596)
T KOG0586|consen  196 IADFGFSTFFDYGLM-----LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD  256 (596)
T ss_pred             eeccccceeeccccc-----ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence            999999998873322     224689999999999998776 678999999999999999999997

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.5e-35  Score=276.33  Aligned_cols=212  Identities=28%  Similarity=0.437  Sum_probs=171.6

Q ss_pred             cCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|.+.+.||+|+||+||++..     ..++..+|+|.++.......+.+.+|++++++++|||++++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            4688889999999999999985     2345679999987555555678999999999999999999999854     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCC--cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQ--RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +..++++||+++++|.+++.......  .........+++.+++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence            57899999999999999997543111  11112234589999999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +.+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||+| |..||.
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~  224 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  224 (288)
T ss_pred             CcEEeccCCccccccCCcee--ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999998755322111  11112335778999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.7e-35  Score=277.96  Aligned_cols=198  Identities=28%  Similarity=0.399  Sum_probs=172.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+|...+.||+|+||.||+++...+++.||+|.+........+.+.+|+.+++.++|||++++++.+     ..++..++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCEEEE
Confidence            5788999999999999999999889999999999866555567789999999999999999999985     34567899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++++|.+++...            .+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        94 v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~D  158 (297)
T cd06656          94 VMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  158 (297)
T ss_pred             eecccCCCCHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECc
Confidence            99999999999998532            467888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....+++.|+|||...+..++.++|+|||||++|+|++|+.||.
T Consensus       159 fg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~  216 (297)
T cd06656         159 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (297)
T ss_pred             CccceEccCCccC----cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9998754322111    112458889999999988889999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.2e-35  Score=276.28  Aligned_cols=212  Identities=26%  Similarity=0.461  Sum_probs=170.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCC-----cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDG-----TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|++.+.||+|+||.||+|.....+     ..||+|.+..... .....+.+|++.+++++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            46888899999999999999976444     6799999864432 23457899999999999999999999853     3


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                      ....++++||+++|+|.+++........     ........+++.+.+.++.|++.||+|||+.   +++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence            4568999999999999999975431110     0011125688999999999999999999998   9999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++++.+||+|||+++.........  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYR--VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             EcCCCcEEECCCcceeecccccccc--ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999987543222111  1122346788999999888889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-35  Score=277.08  Aligned_cols=215  Identities=24%  Similarity=0.313  Sum_probs=177.2

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      +..+..+.++|++.+.||+|+||.||++....+++.+|+|.++... .....+.+|+.+++++ +|||++++++++....
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            4455567789999999999999999999998899999999886432 2346788999999999 7999999999876544


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ...++..+++|||+++++|.+++....       .....+++..+..++.|++.||.|||+.   +++||||||+||+++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~  158 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFL-------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLT  158 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhh-------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEEC
Confidence            455677899999999999999875321       1124578888999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.+||+|||+++.......    ......|++.|+|||++..     ..++.++||||+||++|||++|+.||.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~  230 (286)
T cd06638         159 TEGGVKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA  230 (286)
T ss_pred             CCCCEEEccCCceeecccCCC----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence            999999999999876542211    1122458999999998743     457889999999999999999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.8e-35  Score=274.12  Aligned_cols=202  Identities=24%  Similarity=0.403  Sum_probs=170.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||+|+...+++.||+|.++...   ......+.+|+++++.++|||++++++.+.     +.+.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            47889999999999999999998899999999886422   233457889999999999999999998743     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++++||+++|+|.+++....       .....+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~  146 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFK-------KQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhh-------hccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEE
Confidence            899999999999998885321       1123578888999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||++........    ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||
T Consensus       147 l~d~g~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~  206 (267)
T cd08228         147 LGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             ECccccceeccchhH----HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence            999999876543211    111245888999999998888999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-35  Score=307.88  Aligned_cols=210  Identities=26%  Similarity=0.396  Sum_probs=170.9

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ...++|.+.+.||+|+||+||++++..++..||+|.+....  ......+..|+.+++.++||||+++++++..   ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---KAN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---cCC
Confidence            34568999999999999999999999899999999987542  2334678899999999999999999987532   234


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEecccCCCCeeec
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC----QEPILHCDLKPSNILLD  381 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dlk~~Nill~  381 (452)
                      ...++||||+++|+|.++|....       .....+++..++.|+.||+.||+|||+..    ..+|+||||||+|||++
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~-------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCY-------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence            56899999999999999986432       11236899999999999999999999852    13699999999999996


Q ss_pred             C-----------------CCceEECccccccccccCCCCceeccccccccccccCccccCC--CCCCcccceeehhHHHH
Q 041632          382 N-----------------DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLL  442 (452)
Q Consensus       382 ~-----------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~  442 (452)
                      .                 .+.+||+|||++........     .....||+.|+|||++.+  ..++.++|||||||++|
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM-----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCcccccccccc-----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence            4                 23589999999976542211     122468999999998754  45889999999999999


Q ss_pred             HHHhCCCCCC
Q 041632          443 EMVTTKKPTD  452 (452)
Q Consensus       443 elltg~~Pf~  452 (452)
                      ||+||+.||+
T Consensus       235 ELLTGk~PF~  244 (1021)
T PTZ00266        235 ELCSGKTPFH  244 (1021)
T ss_pred             HHHHCCCCCC
Confidence            9999999994

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.2e-35  Score=283.69  Aligned_cols=214  Identities=27%  Similarity=0.402  Sum_probs=169.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||.||+|+...     +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|.    
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence            3578899999999999999997532     357899999874322 2235678899999999 8999999999864    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCC--------------------------------------------------c
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQ--------------------------------------------------R  332 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------~  332 (452)
                      ..+...++++||+++++|.+++.......                                                  .
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            23456789999999999999986432100                                                  0


Q ss_pred             ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceecccccc
Q 041632          333 DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR  412 (452)
Q Consensus       333 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~  412 (452)
                      ........+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.+.....  ........
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~  236 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGDAR  236 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcc--hhhccCCC
Confidence            0001123689999999999999999999998   999999999999999999999999999986532211  11112234


Q ss_pred             ccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       413 gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~  277 (337)
T cd05054         237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP  277 (337)
T ss_pred             CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCC
Confidence            6778999999999999999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.8e-35  Score=272.02  Aligned_cols=201  Identities=29%  Similarity=0.509  Sum_probs=168.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+     .+.+..+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIY   77 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcE
Confidence            357888999999999999999975 56789999886432 2357889999999999999999999874     3455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        78 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~  145 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDE---------GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIA  145 (261)
T ss_pred             EEEecCCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEEC
Confidence            9999999999999986432         23578888999999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++........   ......++..|+|||......++.++|||||||++|||+| |+.||.
T Consensus       146 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~  206 (261)
T cd05072         146 DFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP  206 (261)
T ss_pred             CCccceecCCCcee---ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCC
Confidence            99999865432111   1112346778999999988889999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=271.53  Aligned_cols=200  Identities=30%  Similarity=0.402  Sum_probs=173.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|+..+.||+|+||.||+|....+++.+++|.+........+.+.+|++++++++|||++++++.+     .+....++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEEEE
Confidence            5788899999999999999999888899999999866555667899999999999999999999874     44567899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      +|||+++++|.+++....          ..+++.++..++.|++.||+|||+.   +++|+||||+||++++++.+||+|
T Consensus        78 ~~e~~~~~~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d  144 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTR----------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLAD  144 (262)
T ss_pred             EEeCCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECc
Confidence            999999999999886532          3578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC---CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS---EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.+........    ......++..|+|||.+...   .++.++||||||+++|||+||+.||.
T Consensus       145 ~g~~~~~~~~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~  205 (262)
T cd06613         145 FGVSAQLTATIA----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF  205 (262)
T ss_pred             cccchhhhhhhh----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            999876543211    11224578899999998776   78999999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.9e-35  Score=278.46  Aligned_cols=199  Identities=26%  Similarity=0.447  Sum_probs=167.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||+|+||.||+|+.+.+++.||+|.++... ......+.+|++.+++++||||+++++++     ...+..+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeEE
Confidence            56888999999999999999998889999999997543 23345778999999999999999999984     4456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||++ ++|.+++....          ..+++..+..++.|++.||+|||+.   +|+|+||||+||++++++.+||+
T Consensus        81 lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  146 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCG----------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA  146 (301)
T ss_pred             EEEeccc-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence            9999996 68988886432          3578889999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.........    .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.
T Consensus       147 dfg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~  206 (301)
T cd07873         147 DFGLARAKSIPTKT----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP  206 (301)
T ss_pred             cCcchhccCCCCCc----ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC
Confidence            99998754322111    112347899999998765 357889999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6e-35  Score=276.33  Aligned_cols=196  Identities=31%  Similarity=0.433  Sum_probs=171.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|++|.||++.+..+++.||+|.+....   ....+.+.+|++++++++||||+++++.+     .+.+.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence            36888899999999999999998889999999986432   23346788999999999999999999884     44567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+|
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~k  141 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS-----------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIK  141 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence            89999999999999998643           3678889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++......       .....+++.|+|||.+.+...+.++||||||+++|||++|+.||.
T Consensus       142 l~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  199 (290)
T cd05580         142 ITDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF  199 (290)
T ss_pred             EeeCCCccccCCC-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999998765432       122458899999999888888999999999999999999999984

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.2e-35  Score=271.36  Aligned_cols=200  Identities=24%  Similarity=0.355  Sum_probs=171.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +|++.+.||+|+||.||++++..+++.+|+|.++... ....+.+.+|+.+++.++|||++++.+.+     .+.+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            4778899999999999999999899999999986432 33456788999999999999999999884     45568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+++|+|.+++....         ...+++...+.++.|++.||.|||+.   +|+|+||||+||++++++.++++|
T Consensus        76 v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~d  143 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQR---------GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGD  143 (255)
T ss_pred             EEeeCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcc
Confidence            999999999999886432         23578888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.++........    .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||+
T Consensus       144 fg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  201 (255)
T cd08219         144 FGSARLLTSPGAY----ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ  201 (255)
T ss_pred             cCcceeecccccc----cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence            9998765432211    122458899999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.9e-35  Score=274.62  Aligned_cols=204  Identities=28%  Similarity=0.455  Sum_probs=168.2

Q ss_pred             cCCCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .+|++.+.||+|+||.||+++.    ..+++.||+|.+........+.+.+|++++++++||||+++.+++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            4678889999999999999985    34688999999876555556788999999999999999999987642   2345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|+||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~  147 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR----------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRV  147 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeE
Confidence            6889999999999999986432          3578999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+++.......... ......++..|+|||...+..++.++|||||||++|||++|..|+
T Consensus       148 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~  211 (284)
T cd05081         148 KIGDFGLTKVLPQDKEYYK-VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKS  211 (284)
T ss_pred             EECCCcccccccCCCccee-ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcC
Confidence            9999999986543221111 111122455699999998888999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.8e-35  Score=279.10  Aligned_cols=204  Identities=25%  Similarity=0.371  Sum_probs=160.4

Q ss_pred             CceeccCceeEEEEEEcC--CCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEec
Q 041632          237 NLIGVGSFGSVYKGVFDE--DGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKY  314 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  314 (452)
                      ..||+|+||+||+|+...  +++.||+|.++..  .....+.+|++++++++||||+++++++..   ..+...++++||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEee
Confidence            579999999999999753  5578999988643  233567899999999999999999988642   234577899999


Q ss_pred             cCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee----cCCCceEECc
Q 041632          315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGD  390 (452)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~~kl~D  390 (452)
                      ++ ++|.+++.......  .......+++..+..++.|++.||+|||+.   +|+||||||+||++    ++++.+||+|
T Consensus        82 ~~-~~l~~~~~~~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          82 AE-HDLWHIIKFHRASK--ANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             eC-CcHHHHHHhhhccc--cCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            85 58888775332110  011223588899999999999999999998   99999999999999    5667899999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||+
T Consensus       156 fG~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         156 MGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ccceeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence            9999865432211 111223468999999999876 457899999999999999999999984

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.8e-35  Score=269.35  Aligned_cols=196  Identities=28%  Similarity=0.432  Sum_probs=162.6

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      +.||+|+||.||+|+...+++.||+|.+.... ......+.+|++++++++||||++++++|.     ..+..++|+||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            36999999999999998899999999886432 233467899999999999999999999853     345789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....          ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        76 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  142 (252)
T cd05084          76 QGGDFLTFLRTEG----------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSR  142 (252)
T ss_pred             cCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCc
Confidence            9999999986432          3578889999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .........  .......+..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       143 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~  198 (252)
T cd05084         143 EEEDGVYAS--TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA  198 (252)
T ss_pred             ccccccccc--cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            543211110  0011123567999999988889999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.2e-35  Score=270.64  Aligned_cols=199  Identities=29%  Similarity=0.498  Sum_probs=166.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|.+.+.||+|+||+||+|++. ++..+|+|.+... ....+.+.+|+.++++++||||+++++++.     ..+..++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   76 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYI   76 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEE
Confidence            45778899999999999999885 4556999988643 233567999999999999999999999854     3346799


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      +|||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|
T Consensus        77 v~e~~~~~~l~~~i~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d  143 (256)
T cd05113          77 VTEYMSNGCLLNYLREHG----------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSD  143 (256)
T ss_pred             EEEcCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECC
Confidence            999999999999986432          2578999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||.++......   ........++..|+|||...+..++.++|||||||++|||+| |+.||+
T Consensus       144 ~g~~~~~~~~~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~  203 (256)
T cd05113         144 FGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE  203 (256)
T ss_pred             CccceecCCCc---eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcC
Confidence            99987543221   111122345678999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-35  Score=270.03  Aligned_cols=198  Identities=30%  Similarity=0.466  Sum_probs=165.5

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +|++.+.||+|+||.||++++. ++..+|+|.+... ......+.+|++++++++||||+++++++     .+.+..++|
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            5778899999999999999986 5668999998633 23346788999999999999999999884     344578999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++++|.+++....          ..+++..++.++.|++.|++|||+.   +++||||||+||++++++.+||+||
T Consensus        78 ~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          78 TEYMANGCLLNYLRERK----------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             EecCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence            99999999999986432          2578999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |+++........   ......++..|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       145 g~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  203 (256)
T cd05059         145 GLARYVLDDQYT---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE  203 (256)
T ss_pred             ccceeccccccc---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCC
Confidence            998754321111   1111224567999999988899999999999999999999 899984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.4e-35  Score=273.81  Aligned_cols=213  Identities=25%  Similarity=0.411  Sum_probs=169.0

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..++|+..+.||+|+||.||+|++.     .++..||+|.+..... ....++.+|+.+++.++||||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            4567999999999999999999864     2356799998864322 2345688999999999999999999885     


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ......++|+||+++|+|.+++....... ........+++..+..++.|++.||+|||+.   +++||||||+||++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~  154 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEM-ENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  154 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccc-cccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcC
Confidence            34457899999999999999986533110 0111123567888999999999999999997   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++.+||+|||+++.........  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~  223 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  223 (277)
T ss_pred             CCCEEECCCCCccccCCcceee--cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999987543221111  1111235788999999988889999999999999999999 788873

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-34  Score=269.87  Aligned_cols=204  Identities=28%  Similarity=0.424  Sum_probs=169.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-----ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-----GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|+..+.||+|+||.||+|....+++.||+|.+.....     ...+.+.+|+.+++.++||||+++++.+..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            368889999999999999999988899999999864321     223568899999999999999999987532   223


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++++|.+++...           ..+++...+.++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~  144 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAY-----------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGN  144 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence            5678999999999999998643           2478888999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......... .......++..|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus       145 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~  210 (266)
T cd06651         145 VKLGDFGASKRLQTICMSG-TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA  210 (266)
T ss_pred             EEEccCCCccccccccccC-CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence            9999999987543211111 11122457899999999988889999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-34  Score=270.30  Aligned_cols=203  Identities=27%  Similarity=0.435  Sum_probs=172.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||+|....+|+.||+|.++...   ....+.+.+|++++++++|+|++++++.+     .+.+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~-----~~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASF-----IENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence            57888999999999999999998899999999886322   23356789999999999999999999884     34567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+++|+|.+++....       .....+++.+++.++.|++.||+|||+.   +++||||+|+||+++.++.++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~  146 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFK-------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhc-------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEE
Confidence            899999999999999986432       1124578899999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++.........    .....++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       147 l~d~~~~~~~~~~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  207 (267)
T cd08224         147 LGDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             EeccceeeeccCCCcc----cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence            9999998765432211    122458889999999988889999999999999999999999983

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.7e-35  Score=273.32  Aligned_cols=202  Identities=33%  Similarity=0.513  Sum_probs=172.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ...+|+..+.||.|+||.||+|+... ++.+|+|.+..........+.+|+.+++.++||||+++++++.     +.+..
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   77 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPV   77 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCe
Confidence            34568888999999999999999975 8899999998665555678999999999999999999998853     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++|||+++++|.+++....         ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.+||
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl  145 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPE---------GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKV  145 (261)
T ss_pred             EEEEeecccCCHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEE
Confidence            99999999999999997532         24578899999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||.+........    ......++..|+|||......++.++||||||+++|||++ |+.||+
T Consensus       146 ~d~g~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~  206 (261)
T cd05148         146 ADFGLARLIKEDVY----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP  206 (261)
T ss_pred             ccccchhhcCCccc----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            99999876532211    1112346778999999988889999999999999999998 899984

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8.6e-35  Score=274.25  Aligned_cols=211  Identities=24%  Similarity=0.393  Sum_probs=168.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEc----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|++.+.||+|+||+||+|++.    .+++.||+|.+..... .....+.+|++++++++||||+++++++     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ecC
Confidence            46788899999999999999852    3567899999864322 2336788999999999999999999884     344


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCc------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQR------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                      +..+++|||+++++|.+++........      ........+++.+.+.++.|++.||+|||+.   +++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence            578999999999999999864321100      0111234588999999999999999999998   9999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      +++++.+||+|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~  227 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYR--VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY  227 (283)
T ss_pred             EcCCCcEEeccccccccccCCccee--cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            9999999999999997653221111  1122345778999999988889999999999999999999 99887

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=270.19  Aligned_cols=210  Identities=24%  Similarity=0.425  Sum_probs=168.0

Q ss_pred             CCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCc
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGND  306 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~  306 (452)
                      |.+.+.||+|+||.||+|....+   +..||+|.++....  .....+.+|++.++.++||||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45678999999999999998643   37899999875432  223578999999999999999999998654322 2233


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++++||+++|+|..++......     .....+++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~  152 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG-----GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTV  152 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc-----CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeE
Confidence            578999999999999998654311     1124688999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       153 kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~  217 (273)
T cd05035         153 CVADFGLSKKIYSGDYYR--QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP  217 (273)
T ss_pred             EECCccceeecccccccc--ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            999999998654322111  1111235678999999988889999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-34  Score=271.31  Aligned_cols=203  Identities=27%  Similarity=0.373  Sum_probs=168.8

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+++++.++|+||+++++++.     ..+.
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~   79 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGF   79 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCE
Confidence            45566666778999999999999998889999999987655555678999999999999999999999853     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CC
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL--TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DL  384 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~  384 (452)
                      .++++||+++++|.+++....          ..+  ++..+..++.|++.||+|||+.   +|+||||||+||+++. ++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~  146 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKW----------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSG  146 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhc----------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCC
Confidence            899999999999999986432          123  6778888999999999999998   9999999999999986 67


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCC--CCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE--VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||.+........    ......+++.|+|||.+....  ++.++||||||+++|||++|+.||.
T Consensus       147 ~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~  212 (268)
T cd06624         147 VVKISDFGTSKRLAGINP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI  212 (268)
T ss_pred             eEEEecchhheecccCCC----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCc
Confidence            999999999875532211    111235789999999976543  7889999999999999999999984

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=265.80  Aligned_cols=200  Identities=29%  Similarity=0.366  Sum_probs=172.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccH---HHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~---~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|+..++||+|.||+|-.++.+.+|+.+|+|+++....-..   ..-..|-++|+..+||.+..+-..     |+..+
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccCc
Confidence            3678899999999999999999999999999999975433222   234568889999999999877544     78888


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+||||..||.|.-+|...+           .+++.....+-..|+.||.|||+.   +||.||||.+|.|+|.+|++
T Consensus       242 rlCFVMeyanGGeLf~HLsrer-----------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHI  307 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRER-----------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHI  307 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhh-----------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCce
Confidence            9999999999999998886544           678888888999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.--..    .......+|||.|.|||++....|+.++|.|.+||++|||++|+.||.
T Consensus       308 KitDFGLCKE~I~~----g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  308 KITDFGLCKEEIKY----GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             Eeeecccchhcccc----cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccc
Confidence            99999999742211    122345789999999999999999999999999999999999999993

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=286.65  Aligned_cols=192  Identities=29%  Similarity=0.405  Sum_probs=164.6

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      |...+.||.|+||-||-|++..+...||||.+.....   +.+.++..|++.|++++|||++.+-|++.     .....|
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~TaW  102 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTAW  102 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchHH
Confidence            4456789999999999999999999999999986544   33467899999999999999999999853     234578


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||| -|+-.+.+.-.+          +++.+-++..|..+.+.||+|||+.   +.||||||+.|||+++.|.||++
T Consensus       103 LVMEYC-lGSAsDlleVhk----------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             HHHHHH-hccHHHHHHHHh----------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence            999999 667777665433          5788888999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||.|....+        ..+.+|||.|||||++.   .+.|+-++||||+|++..||..+++|+
T Consensus       169 DFGSAsi~~P--------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  169 DFGSASIMAP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             cccchhhcCc--------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence            9999875442        22367999999999864   578999999999999999999999995

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-35  Score=291.30  Aligned_cols=195  Identities=24%  Similarity=0.363  Sum_probs=164.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ..+|.+.+.||+|+||.||++++..+++.||||...      ...+.+|++++++++|+||+++++++.     ..+..+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~  236 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTC  236 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEE
Confidence            457899999999999999999999889999999643      234678999999999999999999853     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++|++ .++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       237 lv~e~~-~~~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~  302 (461)
T PHA03211        237 LVLPKY-RSDLYTYLGARL----------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLG  302 (461)
T ss_pred             EEEEcc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEc
Confidence            999999 578988885432          3689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||+++.........  ......||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       303 DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        303 DFGAACFARGSWSTP--FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ccCCceecccccccc--cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            999997654221111  112356999999999999989999999999999999999987653

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-34  Score=269.22  Aligned_cols=198  Identities=31%  Similarity=0.426  Sum_probs=172.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|+..+.||+|+||.||+|++..+++.+++|.++....  .+++.+|++.+++++|||++++++.+     .+....++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSY-----FKNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCcEEE
Confidence            578899999999999999999988889999999975433  67899999999999999999999984     34467899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+++++|.+++....          ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+||+|
T Consensus        76 ~~e~~~~~~L~~~l~~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d  142 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN----------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD  142 (256)
T ss_pred             EEecCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence            999999999999986432          4688999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....++..|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus       143 fg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~  200 (256)
T cd06612         143 FGVSGQLTDTMAK----RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS  200 (256)
T ss_pred             cccchhcccCccc----cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9998765432211    112347889999999988889999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=272.37  Aligned_cols=198  Identities=30%  Similarity=0.405  Sum_probs=171.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||.|++|.||+|+...+++.||+|.+.... ......+.+|+++++.++|+|++++.+.+.     ++...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEE
Confidence            35788899999999999999998899999999997543 334467889999999999999999998743     446889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++...            .+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+
T Consensus        76 ~v~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~  140 (274)
T cd06609          76 IIMEYCGGGSCLDLLKPG------------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLA  140 (274)
T ss_pred             EEEEeeCCCcHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEc
Confidence            999999999999998632            578899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.......    ......+++.|+|||.+.+..++.++|||||||++|||+||+.||+
T Consensus       141 d~g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~  199 (274)
T cd06609         141 DFGVSGQLTSTMS----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS  199 (274)
T ss_pred             ccccceeeccccc----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999987653321    1122457889999999988889999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2e-34  Score=267.90  Aligned_cols=194  Identities=29%  Similarity=0.466  Sum_probs=159.8

Q ss_pred             eeccCceeEEEEEEc--CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||.||+|++.  .++..||+|++..... ...+.+.+|+.++++++||||+++++++.      .+..++|+||+
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~~   76 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEMA   76 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEeC
Confidence            899999999999874  4456799999875433 23467899999999999999999999753      23578999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....          ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        77 ~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          77 SGGPLNKFLSGKK----------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CCCCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence            9999999986432          3688999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+........ ......++..|+|||.+....++.++|||||||++||+++ |+.||+
T Consensus       144 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  200 (257)
T cd05115         144 ALGADDSYYK-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK  200 (257)
T ss_pred             cccCCcccee-ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence            5543222111 1111224678999999888889999999999999999996 999984

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=269.00  Aligned_cols=201  Identities=32%  Similarity=0.517  Sum_probs=168.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+++.+|++.+++++|||++++++++     ...+..+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPIY   77 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCee
Confidence            456888899999999999999975 56789999986443 3357789999999999999999999874     3345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ...+++.++..++.|++.|+.|||+.   +++||||||+||++++++.+||+
T Consensus        78 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~  145 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGA---------GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVA  145 (261)
T ss_pred             eeeecccCCcHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEEC
Confidence            9999999999999986432         24678999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++........   .......+..|+|||...+..++.++||||||+++|||+| |+.||.
T Consensus       146 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  206 (261)
T cd05068         146 DFGLARVIKEDIYE---AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYP  206 (261)
T ss_pred             CcceEEEccCCccc---ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            99999866422111   1111223467999999988899999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1e-34  Score=276.46  Aligned_cols=209  Identities=31%  Similarity=0.481  Sum_probs=166.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcE--EEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTV--VAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||.||+|+++.++..  +|+|.++... ....+.+.+|++++.++ +||||+++++++     ...+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            5688889999999999999998777754  5777665322 23346788999999999 899999999984     3445


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ..++++||+++|+|.++++........     .......+++.+++.++.|++.|++|||+.   +++||||||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEec
Confidence            789999999999999999754321110     011224688999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++.+||+|||+++......     ......++..|+|||.+.+..++.++|||||||++|||+| |..||.
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  225 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  225 (303)
T ss_pred             CCCcEEeCccccCcccchhh-----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence            99999999999986322111     1111224677999999888889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-34  Score=274.48  Aligned_cols=214  Identities=26%  Similarity=0.308  Sum_probs=175.6

Q ss_pred             HHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       224 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++..+.++|.+.+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...+.
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~   93 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK   93 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence            445556788999999999999999999998899999999986432 2346778899999999 89999999998765443


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ...+..++|+||+++++|.++++...       .....+++..++.++.|++.||+|||+.   +++||||||+||++++
T Consensus        94 ~~~~~~~lv~ey~~~~sL~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~  163 (291)
T cd06639          94 LVGGQLWLVLELCNGGSVTELVKGLL-------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTT  163 (291)
T ss_pred             cCCCeeEEEEEECCCCcHHHHHHHhh-------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcC
Confidence            33456899999999999999886422       1124578899999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCC-----CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-----EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||++.........    .....|+..|+|||.+...     .++.++|||||||++|||++|+.||.
T Consensus       164 ~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~  234 (291)
T cd06639         164 EGGVKLVDFGVSAQLTSTRLR----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF  234 (291)
T ss_pred             CCCEEEeecccchhccccccc----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence            999999999998765422211    1123578999999987543     36889999999999999999999983

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-34  Score=272.69  Aligned_cols=209  Identities=26%  Similarity=0.381  Sum_probs=168.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|.+.+.||+|++|.||+|.+..     .+..||+|.+..... .....+.+|+.++++++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            4568888999999999999999976     677899998864433 23457899999999999999999999853     


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..+++|||+++++|.+++.......    .....+++.+++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~----~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~  152 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRP----ERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCK  152 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEecc
Confidence            3346789999999999999997553111    1223689999999999999999999998   99999999999999875


Q ss_pred             C---ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          384 L---SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       384 ~---~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +   .+||+|||+++.........  .......+..|+|||++.+..++.++|||||||++|||++ |+.||+
T Consensus       153 ~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~  223 (277)
T cd05036         153 GPGRVAKIADFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP  223 (277)
T ss_pred             CCCcceEeccCccccccCCcccee--cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            4   59999999998653211110  1111223568999999988889999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-34  Score=267.42  Aligned_cols=201  Identities=27%  Similarity=0.392  Sum_probs=170.7

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|++.+.||+|++|.||+++...+++.||+|.+.....  ...+.+.+|++++++++|+|++++.+.+.    ..+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            47888999999999999999988899999999974432  33457889999999999999999987632    2334678


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ...+++.+++.++.|++.|++|||+.   +++||||||+||++++++.++|+
T Consensus        77 lv~e~~~~~~l~~~l~~~~---------~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~  144 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQK---------GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVG  144 (257)
T ss_pred             EEecccCCCcHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEe
Confidence            9999999999999986432         23578999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.........    .....+++.|+|||+..+..++.++||||+|+++|||++|+.||+
T Consensus       145 df~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  203 (257)
T cd08223         145 DLGIARVLENQCDM----ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN  203 (257)
T ss_pred             cccceEEecccCCc----cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99999866432211    123458899999999998889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-34  Score=269.55  Aligned_cols=202  Identities=32%  Similarity=0.501  Sum_probs=168.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc---------HHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA---------SKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      +|.+.+.||+|++|.||+|....+++.+|+|.+.......         .+.+.+|++++++++||||+++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            3667789999999999999998889999999886433221         256889999999999999999998843    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                       +.+..++++||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +++||||+|+||++++
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~  141 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNNY-----------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDN  141 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHhc-----------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcC
Confidence             345789999999999999999643           2578888999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCce--eccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTV--SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||.++..........  .......|+..|+|||.+.+..++.++|+||+||++|||++|+.||+
T Consensus       142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  213 (267)
T cd06628         142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP  213 (267)
T ss_pred             CCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence            99999999999886642211110  01112357889999999988889999999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-35  Score=287.97  Aligned_cols=194  Identities=26%  Similarity=0.346  Sum_probs=164.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEc--CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .+|.+.+.||+|+||.||++...  ..++.||+|.+...     +...+|++++++++||||+++++++     ......
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~  161 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKSTV  161 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEE
Confidence            46899999999999999999764  34578999987532     3456899999999999999999874     445678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++||++ .++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       162 ~lv~e~~-~~~l~~~l~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l  226 (392)
T PHA03207        162 CMVMPKY-KCDLFTYVDRS-----------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL  226 (392)
T ss_pred             EEEehhc-CCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence            9999999 47888888432           3688999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||+++........  .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       227 ~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf  287 (392)
T PHA03207        227 GDFGAACKLDAHPDT--PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL  287 (392)
T ss_pred             ccCccccccCccccc--ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999765432211  1122456999999999999889999999999999999999999998

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=284.37  Aligned_cols=201  Identities=27%  Similarity=0.483  Sum_probs=172.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ..+....+.||.|.||.||.|.|+.-...||||.++.+.. ..++|..|+.+|+.++|||+|+++|+|...     ...|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFY  339 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFY  339 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeE
Confidence            3455667889999999999999998888999999975543 458999999999999999999999998643     3689


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ||+|||..|+|.+||++..         ...++.-..+.||.||+.||+||...   .+|||||.++|+||.++..|||+
T Consensus       340 IiTEfM~yGNLLdYLRecn---------r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECN---------RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             EEEecccCccHHHHHHHhc---------hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEee
Confidence            9999999999999998654         24566667889999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |||+++.+..+.   .+..-+..-+..|.|||.+....++.|+|||+|||+|||+.| |..||
T Consensus       408 DFGLsRlMtgDT---YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY  467 (1157)
T KOG4278|consen  408 DFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY  467 (1157)
T ss_pred             ccchhhhhcCCc---eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence            999999875332   222222334678999999999999999999999999999998 99987

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-34  Score=274.00  Aligned_cols=212  Identities=29%  Similarity=0.440  Sum_probs=171.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|...+.||+|+||.||++++.     .++..+++|.++.......+.+.+|++.+++++||||+++++++.     +.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            35777889999999999999863     245679999987555555578999999999999999999999853     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCC-----cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQ-----RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                      +..++||||+++++|.+++.......     .........+++..++.++.|++.|++|||+.   +|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence            57899999999999999997543211     01111224589999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++++.+||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             ccCCcEEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999998754322211  11122346788999999988889999999999999999999 999973

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-34  Score=270.45  Aligned_cols=209  Identities=24%  Similarity=0.420  Sum_probs=166.7

Q ss_pred             CCCCceeccCceeEEEEEEcCCCc--EEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCcee
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGT--VVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGNDFK  308 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~~~  308 (452)
                      .+.+.||+|+||.||+|++..++.  .||+|.++...  ....+.+.+|++.++.++||||+++++.|..... ......
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999876665  58999886432  2334678899999999999999999998743211 122356


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++++||+++|+|.+++......     .....+++.....++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLG-----DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhccc-----CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence            8999999999999988543211     1124578999999999999999999997   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++........  .......+++.|+|||...+..++.++||||||+++|||++ |+.||.
T Consensus       154 ~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  216 (272)
T cd05075         154 ADFGLSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP  216 (272)
T ss_pred             CCCCcccccCcccce--ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999865432211  11112346778999999988889999999999999999999 888884

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-34  Score=270.65  Aligned_cols=202  Identities=25%  Similarity=0.408  Sum_probs=169.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ------GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +|+..+.||+|++|.||++....+++.||+|.++....      ...+.+.+|++.+++++|+|++++++.+     .+.
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            47788999999999999999988999999999974332      1236788999999999999999999984     455


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-  384 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-  384 (452)
                      +..++|+||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++ 
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~  141 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY-----------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQ  141 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence            6789999999999999998643           2578889999999999999999998   999999999999998776 


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||.+..................++..|+|||.+.+..++.++||||+|+++|||++|+.||+
T Consensus       142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  209 (268)
T cd06630         142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN  209 (268)
T ss_pred             EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            59999999987664331111111122457899999999988889999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=277.36  Aligned_cols=204  Identities=30%  Similarity=0.400  Sum_probs=171.5

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +|+..+.||+|++|.||+++...+++.||+|.+......   ..+.+.+|++.++.++||||+++++.+     .+....
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            678889999999999999999888999999999754332   345788999999999999999999874     445678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++|||+++++|.+++....         ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~---------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l  144 (316)
T cd05574          77 CLVMDYCPGGELFRLLQRQP---------GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIML  144 (316)
T ss_pred             EEEEEecCCCCHHHHHHhCC---------CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEE
Confidence            99999999999999986432         24688899999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCce-------------------------eccccccccccccCccccCCCCCCcccceeehhHHHHH
Q 041632          389 GDFGLSRFYQAVSNPTV-------------------------SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE  443 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e  443 (452)
                      +|||++...........                         .......|+..|+|||++.+..++.++||||||+++||
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~  224 (316)
T cd05574         145 SDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYE  224 (316)
T ss_pred             eecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence            99999875432211100                         01112357899999999988889999999999999999


Q ss_pred             HHhCCCCCC
Q 041632          444 MVTTKKPTD  452 (452)
Q Consensus       444 lltg~~Pf~  452 (452)
                      |++|+.||.
T Consensus       225 l~~g~~pf~  233 (316)
T cd05574         225 MLYGTTPFK  233 (316)
T ss_pred             HhhCCCCCC
Confidence            999999984

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-34  Score=270.53  Aligned_cols=203  Identities=28%  Similarity=0.512  Sum_probs=166.7

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCc---EEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGT---VVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +|.+.+.||+|+||.||+|++..+++   .||+|.++... .....+|..|+..++.++||||+++.+++     .++..
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence            46778999999999999999876654   69999986432 23346899999999999999999999884     44557


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||+++|+|.+++....          ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+|
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          80 VMIITEFMENGALDSFLRQND----------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence            899999999999999986432          3578899999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCC-ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          388 IGDFGLSRFYQAVSNP-TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |+|||++......... ..........+..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~  213 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  213 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence            9999998765432211 1111111112457999999988899999999999999999987 999984

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.7e-34  Score=269.00  Aligned_cols=198  Identities=27%  Similarity=0.493  Sum_probs=158.3

Q ss_pred             CceeccCceeEEEEEEcC---CCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDE---DGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|.+..   .+..||+|.+.... ....+.+.+|+.+++.++|||++++++.|..    .++..++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            468999999999998743   34579999885332 2335678899999999999999999997632    334578999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+.+|+|.+++....          ...++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        77 e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg  143 (262)
T cd05058          77 PYMKHGDLRNFIRSET----------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG  143 (262)
T ss_pred             ecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence            9999999999986432          2356777889999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhC-CCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT-KKPT  451 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf  451 (452)
                      +++.................++..|+|||.+.+..++.++|||||||++|||++| ..||
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~  203 (262)
T cd05058         144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  203 (262)
T ss_pred             ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence            9875432211111111223467789999999888899999999999999999995 5555

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=268.08  Aligned_cols=204  Identities=28%  Similarity=0.411  Sum_probs=169.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-----QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|...+.||+|+||.||+|+...+++.||+|.+....     ......+.+|++++++++||||+++++.+..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            46888999999999999999998899999999885321     2233578899999999999999999987532   123


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++++|.+++...           ..+++.....++.|++.||+|||+.   +++|+||||+||+++.++.
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~  144 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAY-----------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGN  144 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence            4678999999999999998643           2477888999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++|+|||+++......... .......++..|+|||.+.+..++.++|+|||||++|||++|+.||.
T Consensus       145 ~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  210 (264)
T cd06653         145 VKLGDFGASKRIQTICMSG-TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA  210 (264)
T ss_pred             EEECccccccccccccccC-ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999998653221111 11123458899999999988889999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.7e-34  Score=272.36  Aligned_cols=200  Identities=30%  Similarity=0.441  Sum_probs=166.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|++|.||+|+...+++.||+|.++...  ....+.+.+|+.+++.++|||++++++++     .+++..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence            4778899999999999999998899999999986432  23346788999999999999999999984     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||++ ++|.+++....        ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~  143 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLP--------KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLA  143 (285)
T ss_pred             EEEecCC-CCHHHHHhcCC--------CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEEC
Confidence            9999996 68988875432        124688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........    ......+++.|+|||.+.+. .++.++|||||||++|||+||+.||.
T Consensus       144 dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~  203 (285)
T cd07861         144 DFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH  203 (285)
T ss_pred             cccceeecCCCcc----cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999875432211    11123468899999987654 57889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-35  Score=273.21  Aligned_cols=198  Identities=37%  Similarity=0.621  Sum_probs=161.7

Q ss_pred             CCceeccCceeEEEEEEc----CCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          236 TNLIGVGSFGSVYKGVFD----EDGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+.||.|+||.||+|.+.    ..+..|+||.+...... ..+.+.+|++.+++++||||++++|+|..     .+..++
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-----~~~~~l   78 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-----NEPLFL   78 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-----SSSEEE
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-----cccccc
Confidence            467999999999999997    34578999999653332 35789999999999999999999999762     335899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++|+|.++|....         ...+++.+++.|+.|++.||+|||+.   +++|+||+++||++++++.+||+|
T Consensus        79 v~e~~~~g~L~~~L~~~~---------~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~  146 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKN---------KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD  146 (259)
T ss_dssp             EEE--TTEBHHHHHHHTC---------TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred             cccccccccccccccccc---------cccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            999999999999997641         24689999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||++........  ............|+|||.+....++.++||||||+++|||+| |+.||+
T Consensus       147 f~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~  207 (259)
T PF07714_consen  147 FGLSRPISEKSK--YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS  207 (259)
T ss_dssp             TTTGEETTTSSS--EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred             cccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999976521111  112223447889999999988889999999999999999999 788874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-34  Score=271.73  Aligned_cols=200  Identities=30%  Similarity=0.462  Sum_probs=165.2

Q ss_pred             CCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          234 SSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ...+.||+|+||+||++.+    ..+++.||+|.++.... ...+.+.+|++++++++||||+++.+++..   ......
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCceE
Confidence            7789999999999988654    34678999999875432 345678899999999999999999988643   234467


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++|||+++++|.+++...            .+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+||
T Consensus        84 ~lv~e~~~~~~l~~~~~~~------------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l  148 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH------------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKI  148 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEE
Confidence            8999999999999998532            488999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.......... ......++..|+|||......++.++||||||+++|||+||..||.
T Consensus       149 ~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~  211 (283)
T cd05080         149 GDFGLAKAVPEGHEYYR-VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ  211 (283)
T ss_pred             eecccccccCCcchhhc-cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence            99999986543221110 0111235677999999988889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-34  Score=273.19  Aligned_cols=201  Identities=25%  Similarity=0.365  Sum_probs=168.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|++.+.||+|+||.||++++..+|+.||+|.+.... ......+.+|++++++++||||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeEE
Confidence            36888899999999999999998899999999987542 23346788999999999999999999874     3456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|..++....        ....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+
T Consensus        76 lv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~  145 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGV--------ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLC  145 (286)
T ss_pred             EEEeecCCCCHHHHHHhcc--------ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEe
Confidence            9999999999999886431        123688999999999999999999963  289999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC------CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+..+.....      ....+++.|+|||.+.+.      .++.++|+|||||++|||++|+.||+
T Consensus       146 dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  208 (286)
T cd06622         146 DFGVSGNLVASLA------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP  208 (286)
T ss_pred             ecCCcccccCCcc------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence            9999875532211      123478899999987543      35889999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3e-34  Score=266.34  Aligned_cols=200  Identities=26%  Similarity=0.382  Sum_probs=172.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||.|+||.||.++...+++.+++|.+....  ....+++.+|++++++++|+||+++++++     .+.+..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence            4778899999999999999999899999999987543  34456788999999999999999999984     4456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ++|||+++++|.+++....         ...+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+
T Consensus        76 ~~~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~  143 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK---------GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLG  143 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEEC
Confidence            9999999999999986432         23578899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........    ......+++.|+|||...+..++.++||||||+++|||++|+.||+
T Consensus       144 d~~~~~~~~~~~~----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08221         144 DFGISKILGSEYS----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD  202 (256)
T ss_pred             cCcceEEcccccc----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCC
Confidence            9999876543221    1123458999999999988888999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=8.2e-35  Score=271.91  Aligned_cols=202  Identities=25%  Similarity=0.412  Sum_probs=170.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|++|.||+++...+++.+|||.+.....   ....++.+|+++++.++||||+++++.+     ..++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence            467888999999999999999988999999998864322   2335788999999999999999999874     34457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++++||+++++|.+++....       .....+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++.++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~  146 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFK-------KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK  146 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhh-------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence            899999999999999886321       1124688999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||++..+......    .....++..|+|||...+..++.++|+||||+++|||++|..||
T Consensus       147 l~dfg~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  206 (267)
T cd08229         147 LGDLGLGRFFSSKTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF  206 (267)
T ss_pred             ECcchhhhccccCCcc----cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCc
Confidence            9999998765432211    12245889999999998888999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-34  Score=271.33  Aligned_cols=199  Identities=26%  Similarity=0.378  Sum_probs=168.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|++|.||+|+...+|+.||+|++....  ....+.+.+|+++++.++|||++++++.+     ......
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence            46888899999999999999998889999999986432  22346688999999999999999999884     445678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||++++++..++...           ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        76 ~~v~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l  141 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP-----------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKL  141 (286)
T ss_pred             EEEEeccCccHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEE
Confidence            9999999998888876432           2588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++.........    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus       142 ~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~  202 (286)
T cd07847         142 CDFGFARILTGPGDD----YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP  202 (286)
T ss_pred             CccccceecCCCccc----ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence            999999865432211    112347889999999765 457889999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.9e-34  Score=269.64  Aligned_cols=203  Identities=27%  Similarity=0.508  Sum_probs=167.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc---EEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT---VVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|+..+.||+|+||.||+|+...++.   .+|+|.++... ....+.+..|++++++++|||++++.+++.     ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            467788999999999999999875554   79999886442 233467899999999999999999999853     445


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++....          ..+++.++..++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~  146 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHD----------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLEC  146 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcE
Confidence            7899999999999999986432          3578889999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||++............ ......+..|+|||++....++.++|||||||++|||++ |+.||.
T Consensus       147 kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~  212 (268)
T cd05063         147 KVSDFGLSRVLEDDPEGTYT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             EECCCccceeccccccccee-ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999998765432221111 111223567999999988889999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.6e-34  Score=266.99  Aligned_cols=202  Identities=31%  Similarity=0.474  Sum_probs=171.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|...+.||+|+||.||+|....+++.|++|.++.....  ..+.+.+|+++++.++|+||+++++.+     .+.+..+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            477789999999999999999888999999999765443  557899999999999999999999874     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+
T Consensus        76 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~  141 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG-----------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLG  141 (264)
T ss_pred             EEEecCCCCcHHHHHhhc-----------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            999999999999998643           2467888999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCC---CCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++..................++..|+|||++.+..   ++.++||||||+++|||++|+.||+
T Consensus       142 d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~  207 (264)
T cd06626         142 DFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS  207 (264)
T ss_pred             ccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence            99998866533222111011245788999999987766   8899999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.9e-34  Score=273.21  Aligned_cols=214  Identities=26%  Similarity=0.411  Sum_probs=170.9

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCC-----CcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      ..++|+..+.||+|+||.||++.+...     ...+|+|.+..... ....++.+|++++.++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc---
Confidence            345688889999999999999998533     36899999874322 2335688999999999 8999999999853   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                        ..+..+++|||+++|+|.+++.........     .......+++..++.++.|++.||+|||+.   +|+||||||+
T Consensus        87 --~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~  161 (293)
T cd05053          87 --QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAAR  161 (293)
T ss_pred             --CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccccccee
Confidence              345789999999999999999754311111     112345789999999999999999999997   9999999999


Q ss_pred             CeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       377 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||++++++.+||+|||+++.+.......  ......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYR--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             eEEEcCCCeEEeCcccccccccccccee--ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            9999999999999999998654322111  1112235678999999888889999999999999999998 998873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-34  Score=273.47  Aligned_cols=209  Identities=28%  Similarity=0.471  Sum_probs=166.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc--EEEEEEeecc-CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT--VVAIKVINLQ-RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||.||+|+...++.  .+++|.++.. .....+.+.+|+++++++ +||||+++++++.     +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            578889999999999999999876664  4688887632 223346789999999999 7999999998853     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ..++++||+++|+|.+++........     ........+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence            78999999999999999975432110     0111224688999999999999999999997   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++.+||+|||++......     ........+..|+|||...+..++.++|||||||++|||+| |+.||.
T Consensus       154 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~  220 (297)
T cd05089         154 ENLASKIADFGLSRGEEVY-----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC  220 (297)
T ss_pred             CCCeEEECCcCCCccccce-----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999998633211     01111223567999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-35  Score=273.23  Aligned_cols=197  Identities=33%  Similarity=0.551  Sum_probs=167.6

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHH--HHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |+..+.||+|+||+||+++...+++.||+|++.........  ...+|+..+++++||||+++++++.     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            45678899999999999999999999999999865433322  3356999999999999999999854     3567889


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      +|||+++++|.+++..           ...+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.++|+|
T Consensus        76 v~~~~~~~~L~~~l~~-----------~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~D  141 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK-----------NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLID  141 (260)
T ss_dssp             EEEEETTEBHHHHHHH-----------HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESS
T ss_pred             cccccccccccccccc-----------cccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            9999999999999962           24678999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccC-CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.+.......    .......++..|+|||+.. +..++.++||||+|+++|+|++|..||+
T Consensus       142 fg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~  200 (260)
T PF00069_consen  142 FGSSVKLSENN----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFE  200 (260)
T ss_dssp             GTTTEESTSTT----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSST
T ss_pred             ccccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99987541111    1222356899999999988 7889999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-35  Score=283.18  Aligned_cols=191  Identities=24%  Similarity=0.399  Sum_probs=161.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ..+|++.+.||+|+||.||+|+...+++.||+|....      .....|+.++++++||||+++++++.     .....+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~  133 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLV-----SGAITC  133 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEE-----eCCeeE
Confidence            4579999999999999999999988889999997532      22356899999999999999998853     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+|++ .++|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       134 lv~e~~-~~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~  199 (357)
T PHA03209        134 MVLPHY-SSDLYTYLTKRS----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIG  199 (357)
T ss_pred             EEEEcc-CCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence            999999 578888885432          4688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      |||+++......     ......||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus       200 DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        200 DLGAAQFPVVAP-----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             cCccccccccCc-----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence            999987432111     11234589999999999998999999999999999999985544

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.3e-34  Score=266.15  Aligned_cols=195  Identities=30%  Similarity=0.490  Sum_probs=165.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|.+.+.||+|+||.||++..  .|..||+|.++..  ...+.+.+|+..+++++|+|++++++++    +..++..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~----~~~~~~~~l   77 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYI   77 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEE----EcCCCceEE
Confidence            4688889999999999999987  4778999998643  3346789999999999999999999874    233456799


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+++++|.+++....         ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        78 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  145 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSD  145 (256)
T ss_pred             EEECCCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecC
Confidence            999999999999986532         13578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+++.......       ...++..|+|||+..+..++.++|||||||++|||++ |+.||.
T Consensus       146 fg~~~~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~  201 (256)
T cd05082         146 FGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             CccceeccccCC-------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            999875432211       1235678999999988889999999999999999998 999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8e-35  Score=275.64  Aligned_cols=196  Identities=27%  Similarity=0.391  Sum_probs=167.9

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      |.....||+|+||.||++....++..||+|.++.......+.+.+|+..++.++|||++++++.+     ...+..++||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~~lv~   98 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDELWVVM   98 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeEEEEE
Confidence            33346799999999999999888999999998765555567789999999999999999998874     3456789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++++|.+++..            ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||
T Consensus        99 e~~~~~~L~~~~~~------------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg  163 (292)
T cd06658          99 EFLEGGALTDIVTH------------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFG  163 (292)
T ss_pred             eCCCCCcHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCc
Confidence            99999999998753            2478889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++........    ......|+..|+|||...+..++.++|||||||++|||++|+.||.
T Consensus       164 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  219 (292)
T cd06658         164 FCAQVSKEVP----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF  219 (292)
T ss_pred             chhhcccccc----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9875432211    1122458899999999988889999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.8e-34  Score=277.86  Aligned_cols=201  Identities=20%  Similarity=0.247  Sum_probs=162.9

Q ss_pred             CCCceecc--CceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          235 STNLIGVG--SFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       235 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ..++||+|  +|++||+++.+.+|+.||+|+++...  ....+.+.+|+++++.++||||+++++++.     .++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEE
Confidence            35789999  78999999999999999999997543  233456788999999999999999999853     4457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++|+|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++|
T Consensus        77 v~e~~~~~~l~~~~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~  144 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF---------MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG  144 (327)
T ss_pred             EEeccCCCcHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcc
Confidence            999999999999986432         13478899999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCc---eeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+.+..........   ........++..|+|||++.+  ..++.++|||||||++|||++|+.||+
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  211 (327)
T cd08227         145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  211 (327)
T ss_pred             cchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            98654322111000   000112346788999999875  458999999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.7e-34  Score=271.97  Aligned_cols=201  Identities=27%  Similarity=0.447  Sum_probs=166.2

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++++|...+.||+|+||.||+|....+|+.||+|.+.... ......+.+|++.++.++|+||+++.+++     .+.+.
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII-----HTKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecCCe
Confidence            3567999999999999999999998889999999997543 23335678999999999999999999884     34557


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||+. +++.+++....          ..+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+|
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~  143 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP----------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELK  143 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEE
Confidence            899999995 78877764321          2467778889999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........    .....+++.|+|||.+.+. .++.++|||||||++|||+||+.||+
T Consensus       144 l~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~  205 (291)
T cd07870         144 LADFGLARAKSIPSQT----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP  205 (291)
T ss_pred             EeccccccccCCCCCC----CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999998754322111    1123478899999998653 57889999999999999999999984

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-34  Score=270.30  Aligned_cols=202  Identities=26%  Similarity=0.477  Sum_probs=166.8

Q ss_pred             CCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          233 FSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      |++.+.||+|+||.||++++    +.+++.||+|.++... ....+.+.+|+++++.++|||++++.+++...   +...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGNG   82 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCCc
Confidence            67788999999999999985    3467899999987443 33346799999999999999999999886432   2356


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK----------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence            789999999999999985432          3578999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||+++......... .......++..|+|||.+.+..++.++|||||||++|||+|++.|+
T Consensus       150 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         150 IGDFGLTKAIETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ECCCccccccccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            99999998654322211 1112244677899999988888999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.2e-34  Score=273.29  Aligned_cols=212  Identities=24%  Similarity=0.403  Sum_probs=169.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC----------------CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE----------------DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRV  293 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l  293 (452)
                      ++|++.+.||+|+||.||++.+..                ++..||+|.+..... ....++.+|++.++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468899999999999999986432                345799999875432 334678999999999999999999


Q ss_pred             eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 041632          294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL  373 (452)
Q Consensus       294 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  373 (452)
                      ++++.     ..+..+++|||+++|+|.+++................+++.++..++.|++.||+|||+.   +++||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl  156 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL  156 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence            99853     345689999999999999999765422222223345688899999999999999999998   9999999


Q ss_pred             CCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh--CCCCC
Q 041632          374 KPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT--TKKPT  451 (452)
Q Consensus       374 k~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~Pf  451 (452)
                      ||+||++++++.+||+|||+++.+.......  ......++..|+|||......++.++|||||||++|||+|  |..||
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~  234 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY  234 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCccee--ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999987553221111  1111234678999998888889999999999999999998  77887


Q ss_pred             C
Q 041632          452 D  452 (452)
Q Consensus       452 ~  452 (452)
                      .
T Consensus       235 ~  235 (296)
T cd05095         235 S  235 (296)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.9e-34  Score=267.10  Aligned_cols=206  Identities=29%  Similarity=0.394  Sum_probs=173.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|++.+.||.|+||+||+|....++..+|+|++.... ....+.+.+|++.++.++|+|++++++.+     ..++..+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEEE
Confidence            46889999999999999999998889999999986443 23457889999999999999999999874     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++|++++++|.+++....        ....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+
T Consensus        76 iv~e~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~  144 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSY--------PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIA  144 (267)
T ss_pred             EEEeccCCCcHHHHHHHhc--------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence            9999999999999986432        113578899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++..+...............|+..|+|||.+... .++.++|+|||||++|||++|+.||+
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  208 (267)
T cd06610         145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS  208 (267)
T ss_pred             ccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence            9999886654332211112234588999999998776 78999999999999999999999984

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-34  Score=268.41  Aligned_cols=203  Identities=28%  Similarity=0.483  Sum_probs=166.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCC---cEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .+|++.+.||+|+||.||+|++..++   ..+|+|.++... ....+.+.+|+.++++++||||+++.+++     ..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            46788899999999999999985443   379999886433 23346789999999999999999999884     3445


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..+++|||+++++|.+++....          ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  145 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD----------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVC  145 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeE
Confidence            7899999999999999986432          3578899999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |++|||++........... ......++..|+|||.+.+..++.++|+||||+++||+++ |+.||.
T Consensus       146 ~l~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~  211 (267)
T cd05066         146 KVSDFGLSRVLEDDPEAAY-TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  211 (267)
T ss_pred             EeCCCCcccccccccceee-ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcc
Confidence            9999999986543221111 1111224568999999988889999999999999999887 999983

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=278.56  Aligned_cols=206  Identities=28%  Similarity=0.378  Sum_probs=171.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||.||+|++..+|+.||+|.++.. .......+.+|+.++++++||||+++++++....+......
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999999989999999998632 23344678899999999999999999988766555555678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++++||++ +++.+++..            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        84 ~lv~e~~~-~~l~~~~~~------------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          84 YIVQELME-TDLYKLIKT------------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             EEEehhcc-cCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEE
Confidence            99999995 588877643            3588889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++........... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus       148 ~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~  211 (336)
T cd07849         148 CDFGLARIADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP  211 (336)
T ss_pred             CcccceeeccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999876543221111 1223468999999998654 568899999999999999999999983

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=279.42  Aligned_cols=196  Identities=28%  Similarity=0.494  Sum_probs=170.0

Q ss_pred             CCCCceeccCceeEEEEEEcCC----CcEEEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          234 SSTNLIGVGSFGSVYKGVFDED----GTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +..+.||+|.||.||+|.+...    .-.||||.-+.+ .....+.|..|..+|++++||||++++|+|.+.      ..
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~  465 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM  465 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence            4457899999999999998532    236889988753 345568899999999999999999999998654      58


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      |||||.++-|.|..||+..+          ..++......++.|++.||+|||+.   .+|||||.++||||....-||+
T Consensus       466 WivmEL~~~GELr~yLq~nk----------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL  532 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK----------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL  532 (974)
T ss_pred             eEEEecccchhHHHHHHhcc----------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence            99999999999999998765          5788888999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      +|||+++.++.......+   ...-+..|||||.+.-.+++.++|||-|||.+||++. |..||
T Consensus       533 aDFGLSR~~ed~~yYkaS---~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPf  593 (974)
T KOG4257|consen  533 ADFGLSRYLEDDAYYKAS---RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPF  593 (974)
T ss_pred             cccchhhhccccchhhcc---ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcc
Confidence            999999988755443322   2335778999999999999999999999999999987 99998

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.8e-34  Score=265.25  Aligned_cols=194  Identities=26%  Similarity=0.451  Sum_probs=160.6

Q ss_pred             ceeccCceeEEEEEE--cCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          238 LIGVGSFGSVYKGVF--DEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      .||+|+||.||+|.+  ..+++.+|+|+++....  ...+.+.+|+.+++.++||||+++++++.      .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            589999999999975  35678999999864432  23467899999999999999999998753      235689999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      |+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+
T Consensus        76 ~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~  141 (257)
T cd05116          76 LAELGPLNKFLQKN-----------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGL  141 (257)
T ss_pred             cCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcc
Confidence            99999999998643           2578889999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++......... .......++..|+|||.+....++.++|||||||++|||+| |+.||+
T Consensus       142 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  200 (257)
T cd05116         142 SKALGADENYY-KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYK  200 (257)
T ss_pred             ccccCCCCCee-eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            97654322211 11112234678999999888889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-34  Score=269.15  Aligned_cols=201  Identities=27%  Similarity=0.494  Sum_probs=168.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT----VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|...+.||+|+||.||+|.+..+|.    .+|+|.+..... .....+.+|+..+++++|||+++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            467888999999999999999876554    589998864433 334678899999999999999999998643      


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +++||||||+||++++++.
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~  147 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK----------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQH  147 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCe
Confidence            46789999999999999986543          3488999999999999999999997   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||.++.........  ......++..|+|||.+....++.++|+||||+++||++| |+.||+
T Consensus       148 ~kL~dfg~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  213 (279)
T cd05057         148 VKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE  213 (279)
T ss_pred             EEECCCcccccccCcccce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence            9999999998654322111  1111224678999999888889999999999999999999 999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.3e-34  Score=274.81  Aligned_cols=196  Identities=26%  Similarity=0.377  Sum_probs=168.2

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      |+....||+|+||.||++....+++.||+|.++.......+.+.+|+..++.++|||++++++.+     ...+..++++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~iv~   97 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEELWVLM   97 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeEEEEE
Confidence            33445799999999999999888999999999765555567788999999999999999999874     3456789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++++|..++..            ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        98 e~~~~~~L~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg  162 (297)
T cd06659          98 EFLQGGALTDIVSQ------------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFG  162 (297)
T ss_pred             ecCCCCCHHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeech
Confidence            99999999988743            2478889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++........    ......|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       163 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         163 FCAQISKDVP----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             hHhhcccccc----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9875442211    1123458999999999988889999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.3e-34  Score=271.61  Aligned_cols=198  Identities=28%  Similarity=0.404  Sum_probs=171.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|...+.||+|+||.||++....+++.||+|.++.......+.+.+|+.+++.++|||++++++.+.     ..+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence            57888999999999999999988889999999997655555678899999999999999999998743     3457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||+++++|.+++...            .+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        94 v~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~d  158 (293)
T cd06647          94 VMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  158 (293)
T ss_pred             EEecCCCCcHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEcc
Confidence            99999999999998642            467888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....+++.|+|||.+....++.++|||||||++||+++|+.||+
T Consensus       159 fg~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~  216 (293)
T cd06647         159 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (293)
T ss_pred             Ccceecccccccc----cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9988755432211    122458889999999888889999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-34  Score=279.33  Aligned_cols=214  Identities=25%  Similarity=0.390  Sum_probs=168.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|.+.+.||+|+||+||+|++     ..+++.||||+++.... .....+.+|++++.++ +||||++++++|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence            45799999999999999999984     24578999999975432 2335688999999999 78999999988642   


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCc--------------------------------------------------
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQR--------------------------------------------------  332 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------  332 (452)
                       .+...++++||+++|+|.+++........                                                  
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence             23467899999999999999865321000                                                  


Q ss_pred             ------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCcee
Q 041632          333 ------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS  406 (452)
Q Consensus       333 ------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~  406 (452)
                            ........+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++........  ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~  236 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YV  236 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcc--hh
Confidence                  0000113478889999999999999999998   999999999999999999999999999875432211  11


Q ss_pred             ccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       407 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||+
T Consensus       237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  283 (343)
T cd05103         237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  283 (343)
T ss_pred             hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            1112335678999999988889999999999999999997 999973

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-34  Score=271.23  Aligned_cols=199  Identities=28%  Similarity=0.458  Sum_probs=166.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||+|++|.||+|+.+.+++.||+|.+..... .....+.+|++++++++||||+++++++     .+.+..+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence            578889999999999999999988899999999874432 2335677899999999999999999884     4456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||++ ++|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus        80 lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~  145 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCG----------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLA  145 (291)
T ss_pred             EEEecCC-CCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEEC
Confidence            9999997 59999886432          2578889999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++........    .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||+
T Consensus       146 dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  205 (291)
T cd07844         146 DFGLARAKSVPSKT----YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP  205 (291)
T ss_pred             ccccccccCCCCcc----ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99998754321111    112246888999998765 457899999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.3e-34  Score=265.44  Aligned_cols=197  Identities=29%  Similarity=0.444  Sum_probs=168.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-----ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-----GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +|...+.||+|++|+||+|....+++.|++|.+.....     ...+.+.+|+++++.++|+|++++.+++     .+..
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            36777899999999999999988899999999875432     2346789999999999999999999874     3456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++++||+++++|.+++...           ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~  141 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY-----------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVV  141 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            789999999999999998643           2578889999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++.......     ......++..|+|||.+.... ++.++|+|||||++|||++|+.||+
T Consensus       142 kl~d~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~  203 (258)
T cd06632         142 KLADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS  203 (258)
T ss_pred             EEccCccceeccccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence            999999987654222     112345889999999987766 8999999999999999999999984

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-34  Score=265.01  Aligned_cols=204  Identities=31%  Similarity=0.505  Sum_probs=169.4

Q ss_pred             CceeccCceeEEEEEEcCC---CcEEEEEEeeccCCcc-HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|.....   +..|++|.++...... .+.+.+|++.++.++|+|++++++++.     .....++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            4699999999999999765   8899999997554433 578899999999999999999999854     356789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++++|.+++.......  .......+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        76 e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg  150 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVF--PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFG  150 (262)
T ss_pred             EeccCCcHHHHHhhccccc--cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccc
Confidence            9999999999997642100  001125689999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+........  ........++..|+|||.+....++.++||||+|+++|||++ |..||+
T Consensus       151 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  209 (262)
T cd00192         151 LSRDVYDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP  209 (262)
T ss_pred             cccccccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCC
Confidence            9986653321  111223457889999999888889999999999999999999 699985

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-34  Score=267.47  Aligned_cols=199  Identities=31%  Similarity=0.532  Sum_probs=166.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|.+.+.||+|+||.||+|++..+ ..||+|.++... ...+.+.+|+++++.++||||+++++.+.      .+..++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~l   77 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYI   77 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEE
Confidence            4688899999999999999998644 569999987433 23467899999999999999999988632      234689


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.+++....         ...+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        78 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEM---------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             EEEcCCCCcHHHHHhhcc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEecc
Confidence            999999999999996432         13578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||.++........   ......++..|+|||+..+..++.++||||||+++|||+| |+.||+
T Consensus       146 fg~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~  205 (262)
T cd05071         146 FGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  205 (262)
T ss_pred             CCceeeccccccc---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999765432211   1112346778999999988889999999999999999999 888884

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.5e-34  Score=270.51  Aligned_cols=213  Identities=25%  Similarity=0.400  Sum_probs=170.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC----------------cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG----------------TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVR  292 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~  292 (452)
                      ..+|++.+.||+|+||.||+|+....+                ..||+|.+..... ...+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357889999999999999998875433                5689999875433 33567899999999999999999


Q ss_pred             EeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 041632          293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCD  372 (452)
Q Consensus       293 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  372 (452)
                      +++++.     .++..++++||+++++|.+++................+++..++.++.|++.||+|||+.   +++|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            999853     345789999999999999999754321111112234689999999999999999999998   999999


Q ss_pred             cCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh--CCCC
Q 041632          373 LKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT--TKKP  450 (452)
Q Consensus       373 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~P  450 (452)
                      |||+||++++++.++|+|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||++  |..|
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  233 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR--VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP  233 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCccee--ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence            99999999999999999999987543221111  1112346788999999888889999999999999999998  7777


Q ss_pred             CC
Q 041632          451 TD  452 (452)
Q Consensus       451 f~  452 (452)
                      |+
T Consensus       234 ~~  235 (296)
T cd05051         234 YE  235 (296)
T ss_pred             CC
Confidence            64

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=269.28  Aligned_cols=212  Identities=26%  Similarity=0.423  Sum_probs=170.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC-----CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|.+.+.||+|+||.||+|.....     +..||+|.+..... .....+.+|+.+++.++||||+++++++     .
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----c
Confidence            35688889999999999999998643     37899999864432 3345788999999999999999999984     3


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .....++||||+++|+|.+++....... ........+++..++.++.|++.||+|||+.   +++||||||+||+++++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~  155 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEA-ENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAED  155 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccch-hhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCC
Confidence            4467899999999999999997543111 0011234578899999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +.+||+|||+++.........  ......++..|+|||...+..++.++|||||||++||++| |+.||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  223 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ  223 (277)
T ss_pred             CCEEECCcccchhhccCcccc--cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence            999999999987554222111  1112346788999999888889999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-34  Score=269.98  Aligned_cols=212  Identities=28%  Similarity=0.450  Sum_probs=170.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .+|...+.||+|+||.||++...     .++..+|+|.+........+.+.+|++.++.++|+||+++++++.     +.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            35777899999999999999742     346689999887655555678999999999999999999998853     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCc----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQR----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      +..++++||+++++|.+++........    ........+++.+++.++.|++.|++|||+.   +++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence            568999999999999999975431100    0111224588999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++.+||+|||+++........  .......+++.|+|||...+..++.++|||||||++|||++ |+.||.
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  226 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYY--RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             CCCCEEECCCCceeEcCCCcee--ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999998754322111  11112235788999999988899999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=246.74  Aligned_cols=207  Identities=26%  Similarity=0.325  Sum_probs=166.4

Q ss_pred             HHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcC-CCCCceeEeeeeccccCC
Q 041632          226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       226 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~  303 (452)
                      +....++......||+|++|.|-+.++..+|...|+|.+..+-.. ..++..+|+.+..+- ..|.+|.|+|..     .
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~  115 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----F  115 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-----h
Confidence            444455666778899999999999999999999999999865433 235677888875554 799999999973     3


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .....++.||.| ..||+.|-++-       .......++...-+||..+.+||.|||++  ..++|||+||+|||++.+
T Consensus       116 regdvwIcME~M-~tSldkfy~~v-------~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~  185 (282)
T KOG0984|consen  116 REGDVWICMELM-DTSLDKFYRKV-------LKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYD  185 (282)
T ss_pred             ccccEEEeHHHh-hhhHHHHHHHH-------HhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccC
Confidence            345689999999 67887665321       12235678888899999999999999997  689999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCC----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++|+||||.+-++...-     +.....|...|||||.+..    ..|+.++||||+|+++.||.+++.||+
T Consensus       186 GqVKiCDFGIsG~L~dSi-----Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  186 GQVKICDFGISGYLVDSI-----AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             CcEEEcccccceeehhhh-----HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            999999999998765321     1112348889999998654    368999999999999999999999996

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=286.96  Aligned_cols=198  Identities=27%  Similarity=0.401  Sum_probs=170.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      -|+++..||.|+||.||+|+.+.++-..|.|++........++|.-||++|+...||+||++++.     |...+..+++
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~a-----yy~enkLwil  107 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSA-----YYFENKLWIL  107 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHH-----HhccCceEEE
Confidence            35566789999999999999998888889999987777778999999999999999999999988     3445678999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      .|||.||-++..+-.-.          ..+++.++.-+++|++.||.|||++   .|||||||+.|||++-+|.++|+||
T Consensus       108 iEFC~GGAVDaimlEL~----------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADF  174 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG----------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADF  174 (1187)
T ss_pred             EeecCCchHhHHHHHhc----------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecc
Confidence            99999999988775433          5789999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCcccc-----CCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG-----LGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |.+......    .....+..|||+|||||+.     ...+|++++||||||++|.||.-+.+|-
T Consensus       175 GVSAKn~~t----~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH  235 (1187)
T KOG0579|consen  175 GVSAKNKST----RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH  235 (1187)
T ss_pred             cccccchhH----HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence            987532211    1112246799999999974     4578999999999999999999999984

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-34  Score=271.49  Aligned_cols=198  Identities=27%  Similarity=0.376  Sum_probs=169.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|++.+.||+|+||+||++++..+|+.||+|++.... ....+.+.+|+++++.++||||+++++.+.     ..+..+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            46778899999999999999998889999999886543 334578899999999999999999999854     346889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++...           ..+++..+..++.+++.||.|||+.  .+++||||||+||++++++.++|+
T Consensus        80 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~  146 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKG-----------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLC  146 (284)
T ss_pred             EEEecCCCCCHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEc
Confidence            999999999999988643           2578899999999999999999974  289999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........      ....|+..|+|||++.+..++.++|+|||||++|||+||+.||+
T Consensus       147 d~gl~~~~~~~~~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~  203 (284)
T cd06620         147 DFGVSGELINSIA------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA  203 (284)
T ss_pred             cCCcccchhhhcc------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence            9999864432111      12458999999999888889999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-34  Score=272.24  Aligned_cols=197  Identities=27%  Similarity=0.459  Sum_probs=164.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|+||.||+|++..+|+.||+|.++...  ......+.+|++++++++|||+++++++     +.+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~-----~~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV-----LHSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHH-----hccCCceE
Confidence            3777889999999999999999899999999997432  2233567889999999999999999987     45566889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||++ ++|.+++....          ..+++..++.++.|+++||+|||+.   +++||||||+||+++.++.+||+
T Consensus        76 lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~  141 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCN----------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLA  141 (284)
T ss_pred             EEEecCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEEC
Confidence            9999996 68888775322          3588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||+++.+......    .....+++.|+|||.+.+. .++.++|||||||++|||+||+.||
T Consensus       142 dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~  200 (284)
T cd07839         142 DFGLARAFGIPVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  200 (284)
T ss_pred             ccchhhccCCCCCC----cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence            99998755422111    1123578899999987664 4789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-34  Score=264.14  Aligned_cols=195  Identities=31%  Similarity=0.476  Sum_probs=162.2

Q ss_pred             CceeccCceeEEEEEEcCCC---cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|++...+   ..+|+|.++.... ...+++.+|+++++.+.|||++++++++.      .+..++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            46999999999999875444   7899999875443 24567899999999999999999998743      23578999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|.+++....           .+++..+..++.|++.||+|||+.   +++||||||+||++++++.+||+|||
T Consensus        75 e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~  140 (257)
T cd05060          75 ELAPLGPLLKYLKKRR-----------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFG  140 (257)
T ss_pred             EeCCCCcHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccc
Confidence            9999999999996432           578899999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++......... .......++..|+|||...+..++.++||||||+++|||++ |..||+
T Consensus       141 ~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~  200 (257)
T cd05060         141 MSRALGAGSDYY-RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYG  200 (257)
T ss_pred             ccceeecCCccc-ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcc
Confidence            998664322211 11112224568999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.2e-34  Score=265.27  Aligned_cols=201  Identities=25%  Similarity=0.421  Sum_probs=167.5

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ------GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +|...+.||+|+||+||+|... +|+.+|+|.++....      .....+.+|++.++.++|+||+++.+++.     +.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            4778899999999999999874 788999999874322      12256889999999999999999999854     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++++||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +|+|+||+|+||++++++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  140 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNRF-----------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGI  140 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCe
Confidence            6889999999999999998643           2478888899999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCC--ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNP--TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++.........  .........|+..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  209 (265)
T cd06631         141 IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA  209 (265)
T ss_pred             EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence            999999998754321111  0111123458999999999988889999999999999999999999984

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-34  Score=267.53  Aligned_cols=200  Identities=25%  Similarity=0.365  Sum_probs=156.1

Q ss_pred             CceeccCceeEEEEEEcC--CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDE--DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.||+|+||+||+|....  ....+|+|.+..... .....+.+|++.++.++||||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            358999999999997532  345788888764332 23457889999999999999999999854     3457899999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      |+++|+|.+++.....      ......++.....++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+
T Consensus        76 ~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  146 (269)
T cd05042          76 FCPLGDLKNYLRSNRG------MVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGL  146 (269)
T ss_pred             eCCCCcHHHHHHhccc------cccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEecccc
Confidence            9999999999975431      1112356778889999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccC-------CCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-------GSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +..........  ......++..|+|||+..       ...++.++|||||||++|||++ |..||.
T Consensus       147 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (269)
T cd05042         147 ALEQYPEDYYI--TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP  211 (269)
T ss_pred             ccccccchhee--ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence            86433221111  112234677899999864       2456889999999999999999 788873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.1e-34  Score=265.02  Aligned_cols=200  Identities=32%  Similarity=0.544  Sum_probs=166.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||+|... ++..||+|.++.... ..+.+.+|+.++++++|+|++++++.+.      .+..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~   76 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIY   76 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcE
Confidence            356888999999999999999876 567799999874333 3567999999999999999999998742      23468


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ++|||+++++|.+++....         ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        77 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~  144 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGE---------GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIA  144 (260)
T ss_pred             EEEEecCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeC
Confidence            9999999999999986432         23578999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||++..+......   ......++..|+|||...+..++.++||||||+++|||++ |+.||+
T Consensus       145 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~  205 (260)
T cd05070         145 DFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP  205 (260)
T ss_pred             CceeeeeccCcccc---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence            99999765422111   1112235678999999888889999999999999999999 899984

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.7e-34  Score=272.45  Aligned_cols=204  Identities=27%  Similarity=0.420  Sum_probs=168.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|.+.+.||+|+||.||++..     ..++..||+|.++.... ...+.+.+|+++++++ +||||+++++.+.    
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  109 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----  109 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe----
Confidence            35688899999999999999975     23456899999875432 3346789999999999 8999999999853    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                       ..+..++++||+++|+|.++++...         ...+++.+...++.|++.||+|||+.   +++|+||||+||++++
T Consensus       110 -~~~~~~lv~e~~~~~~L~~~i~~~~---------~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~  176 (302)
T cd05055         110 -IGGPILVITEYCCYGDLLNFLRRKR---------ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTH  176 (302)
T ss_pred             -cCCceEEEEEcCCCCcHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcC
Confidence             3456899999999999999986432         12378999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++.+|++|||+++.........  ......++..|+|||.+.+..++.++||||+||++|||+| |+.||.
T Consensus       177 ~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~  245 (302)
T cd05055         177 GKIVKICDFGLARDIMNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP  245 (302)
T ss_pred             CCeEEECCCcccccccCCCcee--ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcC
Confidence            9999999999987554322111  1112346788999999988889999999999999999998 999973

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.4e-34  Score=268.64  Aligned_cols=214  Identities=24%  Similarity=0.345  Sum_probs=174.3

Q ss_pred             ChHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          222 SYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       222 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      +..++..+.+.|++.+.||+|+||.||+|++..+++.+|+|++.... ....++..|+.+++++ +|||++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34444456678999999999999999999998899999999986543 2335688899999998 799999999986432


Q ss_pred             cC-CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          301 DF-QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       301 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                      .. ...+..+++|||+++|+|.+++....         ...+++..+..++.|++.|++|||+.   +|+|+||||+||+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nil  153 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK---------GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVL  153 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence            21 23457899999999999999986432         13467888899999999999999998   9999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++++.++|+|||++........    ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||.
T Consensus       154 i~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~  227 (282)
T cd06636         154 LTENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC  227 (282)
T ss_pred             ECCCCCEEEeeCcchhhhhcccc----CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence            99999999999999875432211    112345899999999875     3467889999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-34  Score=271.48  Aligned_cols=196  Identities=29%  Similarity=0.420  Sum_probs=167.4

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      |+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++.+++++||||+++++.+     .+.+..++|
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv   80 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKLWII   80 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCceEEE
Confidence            455678999999999999998889999999987443 33346789999999999999999999874     445678999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++++|.+++..            ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+|++||
T Consensus        81 ~e~~~~~~L~~~~~~------------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06642          81 MEYLGGGSALDLLKP------------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADF  145 (277)
T ss_pred             EEccCCCcHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccc
Confidence            999999999998853            2478889999999999999999997   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++........    ......++..|+|||.+.+..++.++|||||||++|||+||+.||+
T Consensus       146 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         146 GVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             cccccccCcch----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCc
Confidence            99876543211    1112357889999999988889999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.8e-34  Score=271.56  Aligned_cols=203  Identities=27%  Similarity=0.337  Sum_probs=169.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||.||++++..+++.||+|.+....   ......+.+|+++++.++||||+++++.+     ..++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            36888899999999999999999899999999987543   22345788999999999999999999874     44567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+++++|.+++...           ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~  141 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNI-----------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIK  141 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEE
Confidence            89999999999999998643           2578888999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCc-----------eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPT-----------VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.........           ........++..|+|||.+....++.++|+|||||++|||++|+.||.
T Consensus       142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~  217 (305)
T cd05609         142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  217 (305)
T ss_pred             EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999986421110000           000112347889999999888889999999999999999999999983

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.5e-34  Score=265.63  Aligned_cols=190  Identities=23%  Similarity=0.398  Sum_probs=156.3

Q ss_pred             CceeccCceeEEEEEEcCC------------CcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          237 NLIGVGSFGSVYKGVFDED------------GTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~------------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      +.||+|+||.||+|++..+            ...|++|.++.........+.+|+.+++.++||||+++++++.     .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            3689999999999986422            2358999887655555568899999999999999999999854     3


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ....+++|||+++|+|..++....          ..+++..++.++.|+++||+|||+.   +|+||||||+|||++.++
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~  142 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS----------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREG  142 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCC
Confidence            346789999999999999886432          3578889999999999999999998   999999999999998766


Q ss_pred             c-------eEECccccccccccCCCCceeccccccccccccCccccC-CCCCCcccceeehhHHHHHHH-hCCCCCC
Q 041632          385 S-------AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-GSEVSTNGDVYSYGILLLEMV-TTKKPTD  452 (452)
Q Consensus       385 ~-------~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~ell-tg~~Pf~  452 (452)
                      .       +|++|||++......        ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||.
T Consensus       143 ~~~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  211 (262)
T cd05077         143 IDGECGPFIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK  211 (262)
T ss_pred             ccCCCCceeEeCCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            4       899999988644311        1234788899999876 466899999999999999997 5888873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.7e-34  Score=265.72  Aligned_cols=200  Identities=24%  Similarity=0.392  Sum_probs=158.2

Q ss_pred             CceeccCceeEEEEEEcC--CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDE--DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.||+|+||.||+|++..  ++..+|+|.++.... .....+.+|+.++++++||||+++++.+.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            358999999999998642  346799998875433 23357889999999999999999999854     3446799999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      |+++|+|.+++.....      ......++..+..++.|++.|++|||+.   +++||||||+||+++.++++||+|||+
T Consensus        76 ~~~~g~L~~~l~~~~~------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~  146 (269)
T cd05087          76 FCPLGDLKGYLRSCRK------AELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGL  146 (269)
T ss_pred             CCCCCcHHHHHHHhhh------cccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccc
Confidence            9999999999965321      1123456777888999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccCCC-------CCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-------EVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++.......  ........++..|+|||++...       .++.++|+||||+++|||++ |+.||.
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  211 (269)
T cd05087         147 SHNKYKEDY--YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR  211 (269)
T ss_pred             cccccCcce--eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            864332111  1111224478889999987542       35789999999999999996 999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-34  Score=268.22  Aligned_cols=197  Identities=26%  Similarity=0.405  Sum_probs=169.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .|+..+.||.|+||.||+|.+..++..||+|.++... ......+.+|+++++.++||||+++++.+.     ++...++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4667788999999999999998889999999987543 334567889999999999999999999853     4568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.+++...            .+++.+...++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        80 v~e~~~~~~L~~~i~~~------------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d  144 (277)
T cd06640          80 IMEYLGGGSALDLLRAG------------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             EEecCCCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence            99999999999998532            467888899999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....++..|+|||++.+..++.++|+|||||++|||+||+.||+
T Consensus       145 fg~~~~~~~~~~~----~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06640         145 FGVAGQLTDTQIK----RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             cccceeccCCccc----cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence            9998765432211    122357889999999988889999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-34  Score=267.00  Aligned_cols=197  Identities=30%  Similarity=0.429  Sum_probs=171.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +|++.+.||.|+||.||+++...+++.||+|.+....   ....+.+.+|++.+++++||||+++++.     +.+.+..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-----FQDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-----hcCCCeE
Confidence            4778899999999999999998889999999997443   2345788999999999999999999877     4556789


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||+++++|.+++...           ..+++.++..++.|+++||+|||+.   +++|+||+|+||++++++.++|
T Consensus        76 ~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l  141 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK-----------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHI  141 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc-----------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEE
Confidence            9999999999999998643           3578889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+.......     ......|+..|+|||...+..++.++|+||||+++|+|++|+.||+
T Consensus       142 ~d~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  200 (258)
T cd05578         142 TDFNIATKVTPDT-----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR  200 (258)
T ss_pred             eecccccccCCCc-----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCC
Confidence            9999987654321     1123458889999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.9e-34  Score=269.52  Aligned_cols=211  Identities=26%  Similarity=0.379  Sum_probs=167.3

Q ss_pred             CCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +|+..+.||+|+||.||+|+...     ....+++|.+..... ...+++.+|+..++.++||||+++++.|.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            36778999999999999998742     235789998864432 23467889999999999999999999853     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCc-------------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQR-------------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCD  372 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  372 (452)
                      +..++++||+++|+|.+++........             ........+++..++.++.|++.||+|||+.   +++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence            568999999999999999875421110             0011224688999999999999999999997   999999


Q ss_pred             cCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          373 LKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       373 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |||+||++++++.+||+|||+++........  .......++..|+|||...+..++.++||||||+++|||+| |..||
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~  230 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  230 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999998754322111  11112335678999999888889999999999999999999 99988


Q ss_pred             C
Q 041632          452 D  452 (452)
Q Consensus       452 ~  452 (452)
                      +
T Consensus       231 ~  231 (290)
T cd05045         231 P  231 (290)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.5e-34  Score=264.83  Aligned_cols=200  Identities=31%  Similarity=0.515  Sum_probs=167.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.... ...+++.+|+.++++++|+|++++++..      ..+..+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~~~~~   76 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV------TQEPIY   76 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE------ccCCcE
Confidence            356888999999999999999875 67889999987433 3457899999999999999999998763      224579


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ...+++.++..++.|++.||+|||+.   +++||||||+||++++++.++|+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05067          77 IITEYMENGSLVDFLKTPE---------GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIA  144 (260)
T ss_pred             EEEEcCCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEc
Confidence            9999999999999986432         23678889999999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||++.........   ......++..|+|||++....++.++||||||+++|||++ |+.||+
T Consensus       145 dfg~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  205 (260)
T cd05067         145 DFGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP  205 (260)
T ss_pred             cCcceeecCCCCcc---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence            99998765422111   1112345778999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.4e-34  Score=270.13  Aligned_cols=211  Identities=23%  Similarity=0.365  Sum_probs=167.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +|.+.+.||+|+||.||+|++..     .++.||+|.++..... ..+.+.+|+.+++.++||||+++++.+.     ..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence            46667889999999999998753     3578999999744332 2366889999999999999999999853     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCC-----cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQ-----RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                      ...++++||+++++|.+++.......     .........+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence            56889999999999999985432110     01111234588889999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++++.+||+|||+++.........  ......+++.|+|||.+....++.++|||||||++|||+| |..||.
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  228 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYK--LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  228 (283)
T ss_pred             cCCCceEecccccccccccchhee--eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999987553222111  1112346788999999988889999999999999999998 888873

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-34  Score=270.45  Aligned_cols=212  Identities=25%  Similarity=0.417  Sum_probs=166.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCC--------------CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDED--------------GTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVIT  295 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~  295 (452)
                      ++|++.+.||+|+||.||+++....              ...||+|.++.... .....+.+|++++++++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788999999999999999887432              23589999874422 23457899999999999999999999


Q ss_pred             eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCc-ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 041632          296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK  374 (452)
Q Consensus       296 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  374 (452)
                      ++.     ..+..++||||+++++|.+++........ ........+++.+++.++.|++.||+|||+.   +++|||||
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk  156 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA  156 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence            853     34578999999999999999865321100 0111123578889999999999999999998   99999999


Q ss_pred             CCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh--CCCCCC
Q 041632          375 PSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT--TKKPTD  452 (452)
Q Consensus       375 ~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~Pf~  452 (452)
                      |+||++++++.+||+|||++........  ........++..|+|||...+..++.++|||||||++|||++  |..||+
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999999999999875432211  111112335778999999888889999999999999999998  667763

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4e-34  Score=270.45  Aligned_cols=213  Identities=24%  Similarity=0.406  Sum_probs=168.1

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..++|++.+.||+|+||.||+|..+.     .+..||+|.++.... .....+.+|+..++.++||||+++++.+.    
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            45679999999999999999997642     355899998864332 22356889999999999999999999843    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                       +.+..+++|||+++|+|.+++...... ..........++..+..++.|++.||+|||+.   +|+||||||+||++++
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~  154 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPE-AENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH  154 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccc-cccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC
Confidence             345789999999999999999653210 00111234567778899999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++.+||+|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~  223 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ  223 (288)
T ss_pred             CCcEEECcCCcccccccccccc--ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999987543222111  1111235678999999988889999999999999999999 788873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.4e-34  Score=280.02  Aligned_cols=213  Identities=26%  Similarity=0.391  Sum_probs=169.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCC-CCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIR-HKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~  302 (452)
                      .++|.+.+.||+|+||.||+|++.     ..++.||+|+++.... ...+.+.+|++++.++. ||||++++++|..   
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~---  112 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK---  112 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence            346778899999999999999964     2456899999975432 22357889999999997 9999999998643   


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCC---------------------------------------------------
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQ---------------------------------------------------  331 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~---------------------------------------------------  331 (452)
                        .+..++|+||+++|+|.++++......                                                   
T Consensus       113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence              346899999999999999997542100                                                   


Q ss_pred             ------------------------------------cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          332 ------------------------------------RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       332 ------------------------------------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                                                          .........+++.+.+.++.|++.||+|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                00001123578888999999999999999997   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++++.+||+|||+++.+......  .......++..|+|||.+.+..++.++|||||||++|||++ |+.||+
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999764322111  11122346788999999988889999999999999999998 888984

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1e-33  Score=263.82  Aligned_cols=198  Identities=30%  Similarity=0.448  Sum_probs=173.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +|++.+.||+|++|.||+|+...+++.|++|++..... .....+.+|++.+.+++|+|++++++.+     ...+..++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeEEE
Confidence            67888999999999999999998899999999975543 3457899999999999999999999984     34468899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCCeeecCCCceEEC
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ++||+++++|.+++...           ..+++..++.++.|++.|++|||+ .   +++||||+|+||+++.++.++|+
T Consensus        77 v~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~  142 (264)
T cd06623          77 VLEYMDGGSLADLLKKV-----------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIA  142 (264)
T ss_pred             EEEecCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEc
Confidence            99999999999998643           368899999999999999999999 8   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+..........    ....++..|+|||.+.+..++.++|+||||+++|||+||+.||+
T Consensus       143 df~~~~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~  201 (264)
T cd06623         143 DFGISKVLENTLDQC----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFL  201 (264)
T ss_pred             cCccceecccCCCcc----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            999988654322221    12357899999999988889999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.5e-34  Score=263.51  Aligned_cols=197  Identities=28%  Similarity=0.445  Sum_probs=164.8

Q ss_pred             CceeccCceeEEEEEEcC-CCc--EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDE-DGT--VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|++|.||+|.+.. +++  .||+|.++.... ...+.+.+|++.+++++||||+++++.+.     + ...++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            468999999999999854 333  699999976554 45578999999999999999999998853     2 5789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++++|.+++....         ...+++...+.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        75 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg  142 (257)
T cd05040          75 ELAPLGSLLDRLRKDA---------LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG  142 (257)
T ss_pred             EecCCCcHHHHHHhcc---------cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccc
Confidence            9999999999986532         13578999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++......... .......++..|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       143 ~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         143 LMRALPQNEDHY-VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             ccccccccccce-ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            998764322111 11112447788999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.1e-34  Score=270.84  Aligned_cols=213  Identities=23%  Similarity=0.435  Sum_probs=169.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-------CCCcEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-------EDGTVVAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|.+.+.||+|+||.||+|++.       .++..||+|.++... ....+++.+|+.+++.+ +||||+++++.+.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            456888899999999999999852       234579999986432 23346789999999999 8999999999853  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         .....+++|||+++|+|.+++.........     .......+++.++..++.|++.||+|||+.   +++||||||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  165 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA  165 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence               345789999999999999999764321110     011234688999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||++++++.+||+|||+++.........  ......+++.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccc--cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999998654322111  1112345678999999988889999999999999999998 788873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=7.1e-34  Score=268.26  Aligned_cols=199  Identities=27%  Similarity=0.395  Sum_probs=169.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|++.+.||+|++|.||+|++..+|+.||+|++....  ....+.+.+|+.++++++|||++++++++     ......+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence            4778899999999999999998889999999997543  33457899999999999999999999884     4456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.++|+
T Consensus        76 ~v~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~  141 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEE----------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIA  141 (286)
T ss_pred             EEeccc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEe
Confidence            999999 999999986432          4588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+.........   ......++..|+|||.+.+. .++.++||||+|+++|||+||+.||+
T Consensus       142 dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         142 DFGLARLFSEEEPR---LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             eeeecccccCCCCC---ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence            99998865433211   11224589999999987654 46899999999999999999988773

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.5e-34  Score=270.96  Aligned_cols=201  Identities=29%  Similarity=0.516  Sum_probs=165.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc----EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT----VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|+..+.||+|+||.||+|++..+|.    .||+|.+..... .....+.+|+.+++.++||||+++++.|..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence            567888999999999999999876665    468888864432 223478899999999999999999998642      


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~  147 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHK----------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNH  147 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCc
Confidence            23578999999999999986432          3578889999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++........  .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus       148 ~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~  213 (303)
T cd05110         148 VKITDFGLARLLEGDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD  213 (303)
T ss_pred             eEEccccccccccCcccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999865432211  11122345778999999988889999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-33  Score=262.74  Aligned_cols=200  Identities=29%  Similarity=0.413  Sum_probs=170.7

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|+||.+|+++...+|+.||+|.+....  ....+++.+|++++++++||||+++.++     +.+.+..+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES-----FEENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEee-----ecCCCeEE
Confidence            4778899999999999999998899999999987432  2334678999999999999999999987     45566889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++....         ...+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++|+
T Consensus        76 lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~  143 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQR---------GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLG  143 (256)
T ss_pred             EEEecCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEe
Confidence            9999999999999886432         13578889999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+.........    .....|++.|+|||...+..++.++|+|||||++|||+||+.||+
T Consensus       144 d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08218         144 DFGIARVLNSTVEL----ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE  202 (256)
T ss_pred             eccceeecCcchhh----hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence            99998765422111    112347889999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.7e-34  Score=267.30  Aligned_cols=211  Identities=24%  Similarity=0.421  Sum_probs=171.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC----CCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE----DGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      .++|.+.+.||+|+||.||+|.+..    .+..|++|.+.... ....+.+.+|+.++++++|||++++++++.    .+
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----ED   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----cC
Confidence            4678889999999999999999864    25789999886432 233467889999999999999999999863    33


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      +...++++||+++|+|.+++.......   ......+++.+++.++.|++.||+|||+.   +++||||||+||++++++
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~  154 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGE---ANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL  154 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccc---cccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCC
Confidence            456789999999999999986543110   11235689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++.+.......  ......++..|+|||++.+..++.++|||||||++||+++ |+.||+
T Consensus       155 ~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  221 (280)
T cd05043         155 QVKITDNALSRDLFPMDYHC--LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV  221 (280)
T ss_pred             cEEECCCCCcccccCCceEE--eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence            99999999997553221111  1112335778999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=264.77  Aligned_cols=203  Identities=31%  Similarity=0.476  Sum_probs=161.8

Q ss_pred             CceeccCceeEEEEEEcCCCc--EEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGT--VVAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|+...++.  .+|+|.++... ....+.+.+|++++.++ +||||+++++++.     ..+..+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            368999999999999977765  46888876332 23346788999999999 8999999999854     345679999


Q ss_pred             eccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          313 KYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      ||+++|+|.+++........     ........+++.+++.++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence            99999999999975432110     0112234688999999999999999999997   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |+|||++.......     .......+..|+|||++....++.++|||||||++|||++ |+.||+
T Consensus       153 l~dfgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~  213 (270)
T cd05047         153 IADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  213 (270)
T ss_pred             ECCCCCccccchhh-----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            99999986322110     1111224667999999988889999999999999999997 999984

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.8e-34  Score=266.94  Aligned_cols=202  Identities=25%  Similarity=0.335  Sum_probs=162.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHH-HhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKA-LKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~-l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|++.+.||+|+||.||++++..+|+.||+|+++.... .....+..|+.. ++..+|||++++++++.     .++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            368888999999999999999998999999999975432 223455566665 56679999999999853     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++++||++ |+|.+++....       .....+++..++.++.|++.||+|||+.  .+++||||||+||+++.++.+||
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVY-------DKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhc-------cCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEE
Confidence            99999995 78888875422       1124689999999999999999999984  38999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++........     .....++..|+|||.+.+    ..++.++|+|||||++|||++|+.||+
T Consensus       146 ~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         146 CDFGISGYLVDSVA-----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             eecccccccccccc-----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence            99999875532111     112347889999998764    456889999999999999999999984

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.8e-34  Score=270.15  Aligned_cols=199  Identities=27%  Similarity=0.405  Sum_probs=167.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++.....  ...+.+.+|+++++.++||||+++++++     .+++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            367888999999999999999988899999998864322  2346788999999999999999999884     456688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||+++++|..+....           ..+++.+++.++.|++.||+|||+.   +++|+||+|+||++++++.+||
T Consensus        76 ~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l  141 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYP-----------NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKL  141 (286)
T ss_pred             EEEEecCCccHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEE
Confidence            9999999999998876432           2478999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++........    ......++..|+|||+..+ ..++.++||||||+++|||++|+.||+
T Consensus       142 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~  202 (286)
T cd07846         142 CDFGFARTLAAPGE----VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             EeeeeeeeccCCcc----ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence            99999876543221    1122457899999998765 347889999999999999999999883

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=265.05  Aligned_cols=209  Identities=25%  Similarity=0.358  Sum_probs=173.2

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC-CCCc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF-QGND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~-~~~~  306 (452)
                      ++++|+..+.||+|++|.||+|..+.+++.+++|+++.... ..+.+.+|+++++++ +|+||+++++++..... ....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            46789999999999999999999988899999999875433 346789999999999 79999999998755332 3355


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++....       .....+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~  152 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLR-------KKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEV  152 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHh-------hcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeE
Confidence            6899999999999999885421       1124678899999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||.+........    ......|+..|+|||++..     ..++.++|||||||++|||+||+.||.
T Consensus       153 ~l~d~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  219 (275)
T cd06608         153 KLVDFGVSAQLDSTLG----RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC  219 (275)
T ss_pred             EECCCccceecccchh----hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence            9999999875442211    1123458899999998653     346788999999999999999999984

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.8e-34  Score=264.25  Aligned_cols=207  Identities=27%  Similarity=0.394  Sum_probs=171.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|++.+.||.|+||.||++....+++.||+|.+....  ....+.+..|++.++.++|||++++++.+..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            4778899999999999999998899999999987433  2334578899999999999999999887532   2345678


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCCeeecCCCceE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC--QEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      +++||+++++|.+++....       .....+++..++.++.|++.||+|||..+  ..+++|+||||+||++++++.+|
T Consensus        78 ~~~e~~~~~~L~~~l~~~~-------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCK-------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             EEehhccCCCHHHHHHHHh-------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence            9999999999999986432       12346889999999999999999999221  23999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++.........    .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||+
T Consensus       151 l~d~g~~~~~~~~~~~----~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  211 (265)
T cd08217         151 LGDFGLAKILGHDSSF----AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT  211 (265)
T ss_pred             EecccccccccCCccc----ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCccc
Confidence            9999999866532211    122458999999999988889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1e-33  Score=266.25  Aligned_cols=190  Identities=25%  Similarity=0.351  Sum_probs=155.2

Q ss_pred             ceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHH---hcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKAL---KNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l---~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      .||+|+||.||++....+++.+|+|.+.....   .....+.+|..++   ...+|||++.+.+.+     ...+..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence            48999999999999988899999999864322   1123344554433   344799999998874     344578999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      |||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+||
T Consensus        76 ~e~~~~~~L~~~i~~~-----------~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~df  141 (279)
T cd05633          76 LDLMNGGDLHYHLSQH-----------GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (279)
T ss_pred             EecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccC
Confidence            9999999999988643           2589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++........      ....|+..|+|||...+ ..++.++||||+||++|||++|+.||.
T Consensus       142 g~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  197 (279)
T cd05633         142 GLACDFSKKKP------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR  197 (279)
T ss_pred             CcceeccccCc------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence            99875432211      12358999999998764 568999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=263.48  Aligned_cols=201  Identities=31%  Similarity=0.544  Sum_probs=168.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.... ...+++.+|+..+++++|+|++++++.+     ......+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   77 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEPIY   77 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCceE
Confidence            467889999999999999999975 56789999987433 3457899999999999999999999874     3445789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ...+++.++..++.|++.|++|||+.   +++|+||||+||++++++.+|++
T Consensus        78 ~v~e~~~~~~L~~~i~~~~---------~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGE---------GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             EEEeccCCCCHHHHHhccc---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999996532         24688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||.++.......   .......++..|+|||.+.+..++.++||||+|+++|||+| |+.||.
T Consensus       146 d~g~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  206 (261)
T cd05034         146 DFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP  206 (261)
T ss_pred             ccccceeccchhh---hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999876542111   11112235678999999988889999999999999999999 999983

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=305.27  Aligned_cols=202  Identities=32%  Similarity=0.436  Sum_probs=169.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++.....||.|.||.||.|....+|...|+|.+..+..  ...+.+.+|+.++..++|||+|+++|+-     ...+..+
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-----vHRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-----VHREKVY 1310 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-----ecHHHHH
Confidence            45667889999999999999999999999999875443  3346788999999999999999999982     3345788


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      |.||||++|+|.+.+...+           ..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|.+
T Consensus      1311 IFMEyC~~GsLa~ll~~gr-----------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR-----------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc-----------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence            9999999999999986543           345556667889999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC---CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS---EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.|..+.............+.||+.|||||++.+.   ...-+.||||+|||+.||+||+.||.
T Consensus      1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred             cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence            9999987765432222233467799999999998764   35678999999999999999999983

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-33  Score=261.93  Aligned_cols=196  Identities=32%  Similarity=0.530  Sum_probs=167.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||+|..  .|+.||+|.++.... ..+++.+|+.++++++|+|++++++++.     +.+..+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   76 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLY   76 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeE
Confidence            35688899999999999999987  478999999975543 4578999999999999999999999853     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++....         ...+++..++.++.|++.|++|||+.   +++||||||+||++++++.+||+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~  144 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRG---------RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVS  144 (256)
T ss_pred             EEEEecCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEc
Confidence            9999999999999986432         13588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||.++.......       ....+..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       145 d~g~~~~~~~~~~-------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  201 (256)
T cd05039         145 DFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             ccccccccccccc-------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence            9999976532111       1234677999999988889999999999999999997 999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.3e-34  Score=274.38  Aligned_cols=207  Identities=27%  Similarity=0.367  Sum_probs=171.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|++|.||+|+...+|+.||+|++....  ....+.+.+|+.+++.++||||+++.+++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            367899999999999999999999899999999987432  233467788999999999999999988754322 33456


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||+. ++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+|
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD-----------QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEE
Confidence            899999995 6899888643           2588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++..................++..|+|||.+.+ ..++.++|||||||++|||++|+.||+
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~  213 (334)
T cd07855         148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP  213 (334)
T ss_pred             ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence            99999997654332222112223468899999998765 458899999999999999999999984

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-33  Score=268.95  Aligned_cols=198  Identities=28%  Similarity=0.414  Sum_probs=166.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-----cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-----ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +|+..+.||+|++|.||+|....+|+.||+|.++.....     ....+..|++.+++++|+||+++++++.     +.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            377788999999999999999888999999999754332     2356778999999999999999999853     356


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+ +|+|.+++....          ..+++..++.++.|+++||+|||+.   +++|+||||+||+++.++.+
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~----------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~  141 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS----------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVL  141 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCE
Confidence            789999999 999999986432          2588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.........    ....+++.|+|||.+.+ ..++.++|||||||++|||++|..||+
T Consensus       142 ~l~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~  204 (298)
T cd07841         142 KLADFGLARSFGSPNRKM----THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             EEccceeeeeccCCCccc----cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence            999999997654322111    12346788999998754 457889999999999999999987763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6.7e-34  Score=271.37  Aligned_cols=213  Identities=25%  Similarity=0.429  Sum_probs=168.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC-------CCcEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE-------DGTVVAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|.+.+.||+|+||.||++++..       ++..+|+|.++... .....++.+|+++++++ +||||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence            3568899999999999999998642       23579999997542 23345788899999999 8999999999854  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         ..+..++|+||+++|+|.+++........     ........+++.+++.++.|++.||+|||+.   +++||||||
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  168 (307)
T cd05098          95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA  168 (307)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence               34578999999999999999975431110     0111234689999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+++.++.+||+|||.++.........  ......++..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhh--ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999987553211111  0111224578999999988889999999999999999998 888874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-33  Score=261.58  Aligned_cols=199  Identities=29%  Similarity=0.489  Sum_probs=169.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|+||.||++....+++.+|+|.+....  ......+.+|++++++++|||++++++.     +...+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-----~~~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN-----FLEDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeee-----EecCCEEE
Confidence            4778899999999999999998899999999997543  2334678899999999999999999887     34556789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-CceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-LSAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl  388 (452)
                      +|+||+++++|.+++....         ...+++..+..++.|++.|++|||+.   +++|+||||+||+++++ +.+||
T Consensus        76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l  143 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC---------NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKI  143 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999996532         23578889999999999999999998   99999999999999865 46899


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+........     .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+
T Consensus       144 ~d~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~  202 (256)
T cd08220         144 GDFGISKILSSKSK-----AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE  202 (256)
T ss_pred             ccCCCceecCCCcc-----ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcc
Confidence            99999876543221     112458899999999988888999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.7e-34  Score=267.98  Aligned_cols=203  Identities=28%  Similarity=0.349  Sum_probs=170.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||.|++|.||++....+++.+|+|.+..... .....+.+|++.+++++||||+++++++..   ...+..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLD---ESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc---cCCCeEE
Confidence            367788999999999999999988899999999975433 345678999999999999999999988643   2344679


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....       .....+++.....++.|++.||+|||+.   +++|+||+|+||++++++.++|+
T Consensus        78 lv~e~~~~~~L~~~l~~~~-------~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVK-------KRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             EEEEecCCCCHHHHHHHHH-------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEe
Confidence            9999999999998875321       1124578888999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.........      ...++..|+|||.+.+..++.++||||+||++|||++|+.||+
T Consensus       148 dfg~~~~~~~~~~~------~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  204 (287)
T cd06621         148 DFGVSGELVNSLAG------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP  204 (287)
T ss_pred             eccccccccccccc------cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99998654322111      2347888999999988889999999999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.7e-34  Score=266.84  Aligned_cols=189  Identities=24%  Similarity=0.388  Sum_probs=154.1

Q ss_pred             ceeccCceeEEEEEEcCC------------------------CcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeE
Q 041632          238 LIGVGSFGSVYKGVFDED------------------------GTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV  293 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l  293 (452)
                      .||+|+||.||+|++..+                        ...||+|.++.........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999986321                        23588998875544445678899999999999999999


Q ss_pred             eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 041632          294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL  373 (452)
Q Consensus       294 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  373 (452)
                      +++|..     .+..++||||+++|+|..++....          ..+++..+..++.|++.||+|||+.   +|+||||
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dl  143 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK----------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNV  143 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCC
Confidence            998643     346799999999999999986432          3578889999999999999999998   9999999


Q ss_pred             CCCCeeecCCC-------ceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHH
Q 041632          374 KPSNILLDNDL-------SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV  445 (452)
Q Consensus       374 k~~Nill~~~~-------~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~ell  445 (452)
                      ||+||+++..+       .+|++|||.+......        ....++..|+|||.+.+ ..++.++|||||||++|||+
T Consensus       144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             CcccEEEeccCcccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            99999998644       3899999987533211        11246788999998765 56899999999999999995


Q ss_pred             -hCCCCCC
Q 041632          446 -TTKKPTD  452 (452)
Q Consensus       446 -tg~~Pf~  452 (452)
                       +|+.||+
T Consensus       216 ~~g~~p~~  223 (274)
T cd05076         216 FDGEVPLK  223 (274)
T ss_pred             hCCCCCcc
Confidence             6999984

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-33  Score=260.50  Aligned_cols=194  Identities=32%  Similarity=0.468  Sum_probs=160.9

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ++||+|+||.||+|... +++.+|+|.++.... .....+.+|++.++.++||||+++++.+..     .+..++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            36899999999999875 688999999865432 223578899999999999999999998643     34689999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....          ..+++..+..++.|++.||.|+|+.   +++||||||+||++++++.+||+|||++.
T Consensus        75 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~  141 (250)
T cd05085          75 PGGDFLSFLRKKK----------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR  141 (250)
T ss_pred             CCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccce
Confidence            9999999986432          3478899999999999999999997   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ........   ......++..|+|||++.+..++.++||||||+++||+++ |..||.
T Consensus       142 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~  196 (250)
T cd05085         142 QEDDGIYS---SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYP  196 (250)
T ss_pred             eccccccc---cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCC
Confidence            54321111   1111234678999999988889999999999999999998 999983

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-33  Score=270.05  Aligned_cols=213  Identities=25%  Similarity=0.424  Sum_probs=168.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-------CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-------EDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|.+.+.||+|+||.||+++..       .....+|+|.++.... .....+..|+++++++ +||||++++++|.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            356888999999999999999863       2345799999874322 3345788999999999 6999999999853  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         +.+..++++||+++|+|.+++........     ........+++.++..++.|++.||+|||+.   +++||||||
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp  162 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA  162 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence               34568999999999999999976431110     0111234689999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||++++++.+||+|||+++..........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||+
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKK--TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccc--cccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999976542211111  111224567999999988889999999999999999999 888874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-33  Score=265.52  Aligned_cols=197  Identities=26%  Similarity=0.377  Sum_probs=168.8

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      .|...+.||+|++|.||++....+++.+++|.++.......+.+.+|+.+++.++|||++++++.+     ...+..+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-----~~~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-----LVGDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-----EcCCeEEEE
Confidence            345567899999999999999888999999998765555556788999999999999999999974     345678999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++++|.+++..            ..+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.++|+||
T Consensus        95 ~e~~~~~~L~~~~~~------------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~  159 (285)
T cd06648          95 MEFLEGGALTDIVTH------------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF  159 (285)
T ss_pred             EeccCCCCHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEccc
Confidence            999999999998864            2478889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |.+........    ......|++.|+|||...+..++.++|||||||++|||++|+.||.
T Consensus       160 g~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~  216 (285)
T cd06648         160 GFCAQVSKEVP----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYF  216 (285)
T ss_pred             ccchhhccCCc----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCc
Confidence            98865432211    1122458899999999988889999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.6e-34  Score=266.48  Aligned_cols=198  Identities=30%  Similarity=0.437  Sum_probs=170.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|+..+.||+|++|.||++.+..+++.||+|.+..... ...+++.+|++.+++++||||+++++.+     ...+..+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEEE
Confidence            357778899999999999999998899999999975533 3446789999999999999999999884     3346889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCCeeecCCCceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++||+++++|.+++....          ..+++.....++.|++.|++|||+ .   +++|+||||+||++++++.+||
T Consensus        76 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l  142 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ----------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKL  142 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc----------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999986532          467888899999999999999999 7   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+.........      ...++..|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus       143 ~d~g~~~~~~~~~~~------~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  200 (265)
T cd06605         143 CDFGVSGQLVNSLAK------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP  200 (265)
T ss_pred             eecccchhhHHHHhh------cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999998755322111      1457889999999988899999999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.6e-33  Score=263.46  Aligned_cols=190  Identities=25%  Similarity=0.359  Sum_probs=155.8

Q ss_pred             ceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHH---HHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECK---ALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~---~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      .||+|+||.||+++...+++.||+|.+.....   .....+..|..   .++...||||+++.+.     +.+.+..++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeee-----eecCCEEEEE
Confidence            48999999999999988899999999874322   11223344433   4445689999999887     4455688999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++|+|..++...           ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+||
T Consensus        76 ~e~~~g~~L~~~l~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~df  141 (278)
T cd05606          76 LDLMNGGDLHYHLSQH-----------GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDL  141 (278)
T ss_pred             EecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccC
Confidence            9999999999988543           3589999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++..+.....      ....|+..|+|||.+.+. .++.++||||+||++|||++|+.||+
T Consensus       142 g~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~  197 (278)
T cd05606         142 GLACDFSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  197 (278)
T ss_pred             cCccccCccCC------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence            99875432211      124589999999998754 68999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.1e-33  Score=268.21  Aligned_cols=209  Identities=26%  Similarity=0.403  Sum_probs=168.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccC---CC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDF---QG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~---~~  304 (452)
                      .++|+..+.||+|+||.||+|+...+++.||+|.+....  ......+.+|++++++++||||++++++|.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457889999999999999999999899999999986432  2233456789999999999999999998755332   12


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ....++|+||+. ++|.+++....          ..+++.+++.++.|++.||+|||+.   +++|+||||+||+++.++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~  156 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN----------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDG  156 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCC
Confidence            345699999995 58888775432          3588999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||++..+...............++..|+|||.+.+. .++.++||||||+++|||+||+.||.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~  225 (310)
T cd07865         157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ  225 (310)
T ss_pred             cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence            999999999986643322111111234578899999987664 47889999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.5e-33  Score=263.84  Aligned_cols=200  Identities=26%  Similarity=0.438  Sum_probs=165.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|...+.||+|+||.||+|.+...   ...||+|...... ....+.+.+|+.++++++||||+++++++..      +
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4577889999999999999997533   3468999887544 3345689999999999999999999987532      3


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..+++|||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~  146 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK----------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCV  146 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCe
Confidence            4689999999999999996432          3578999999999999999999997   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++........   ......++..|+|||.+....++.++||||||+++|||++ |+.||.
T Consensus       147 ~l~d~g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~  210 (270)
T cd05056         147 KLGDFGLSRYLEDESYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQ  210 (270)
T ss_pred             EEccCceeeecccccce---ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence            99999998765432111   1112234578999999888889999999999999999996 999984

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-33  Score=262.14  Aligned_cols=199  Identities=31%  Similarity=0.522  Sum_probs=165.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|.+.+.||+|++|.||++.+.. +..+|+|.+.... ...+.+.+|++++++++|||++++++++.      .+..++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG-TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYI   77 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC-CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEE
Confidence            457888999999999999999864 4569999886433 33467899999999999999999988742      235789


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      +|||+++++|.+++....         ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++.+||+|
T Consensus        78 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~d  145 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGD---------GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIAD  145 (260)
T ss_pred             EEEcCCCCCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECC
Confidence            999999999999996432         23578889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+++........   ......++..|+|||...+..++.++|||||||++|||+| |+.||.
T Consensus       146 fg~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  205 (260)
T cd05069         146 FGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP  205 (260)
T ss_pred             CccceEccCCccc---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999765422211   1112346778999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.8e-34  Score=266.15  Aligned_cols=189  Identities=26%  Similarity=0.415  Sum_probs=156.4

Q ss_pred             CceeccCceeEEEEEEcCCCc-------EEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGT-------VVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +.||+|+||+||+|.....+.       .||+|.++.......+.+.+|+.+++.++|||++++++++.     .++..+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence            369999999999999865443       48888886555455578899999999999999999999854     334678


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc----
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS----  385 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~----  385 (452)
                      +||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.    
T Consensus        76 lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~  142 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK----------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTG  142 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccC
Confidence            9999999999999997543          2578889999999999999999998   9999999999999987765    


Q ss_pred             ----eEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCC-CCC
Q 041632          386 ----AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK-KPT  451 (452)
Q Consensus       386 ----~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~-~Pf  451 (452)
                          ++++|||.+......        ....++..|+|||.+.+ ..++.++|||||||++|||++|. .||
T Consensus       143 ~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~  206 (258)
T cd05078         143 NPPFIKLSDPGISITVLPK--------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL  206 (258)
T ss_pred             CCceEEecccccccccCCc--------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence                699999988643311        12347889999999876 45789999999999999999984 565

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=264.14  Aligned_cols=197  Identities=28%  Similarity=0.431  Sum_probs=167.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCC---CCCceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIR---HKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~---h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++... .....++.+|++++++++   |||++++++.+     .+.+.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCCE
Confidence            3677789999999999999998899999999987543 334467889999999986   99999999874     34557


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+++++|.+++...            .+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.++
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~  141 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG------------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVK  141 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEE
Confidence            89999999999999988532            578899999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++..+.....    ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||+
T Consensus       142 l~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  203 (277)
T cd06917         142 LCDFGVAALLNQNSS----KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS  203 (277)
T ss_pred             EccCCceeecCCCcc----ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC
Confidence            999999886653221    1122458899999998765 456889999999999999999999984

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.8e-33  Score=264.41  Aligned_cols=192  Identities=27%  Similarity=0.384  Sum_probs=163.5

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||+||++....+|+.||+|.+....   ......+.+|+++++.++|||++++++.+     ...+..++|+||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999998899999999986432   22345677899999999999999998873     4456789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....         ...+++.++..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||.+.
T Consensus        76 ~~~~L~~~l~~~~---------~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~  143 (277)
T cd05577          76 NGGDLKYHIYNVG---------EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAV  143 (277)
T ss_pred             CCCcHHHHHHHcC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchh
Confidence            9999999986432         13578999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .......     .....++..|+|||.+.+..++.++||||+||++|+|++|+.||.
T Consensus       144 ~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  195 (277)
T cd05577         144 ELKGGKK-----IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFR  195 (277)
T ss_pred             hhccCCc-----cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence            6542111     122457889999999888889999999999999999999999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-33  Score=263.60  Aligned_cols=196  Identities=28%  Similarity=0.426  Sum_probs=167.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      |+..+.||+|+||.||+|....+++.||+|.++... ....+.+.+|++.+++++||||+++++.+     .+++..++|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEEEE
Confidence            667789999999999999998889999999986433 23346788999999999999999999984     345678999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++++|.+++..            ..+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++|+||
T Consensus        81 ~e~~~~~~l~~~i~~------------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~df  145 (277)
T cd06641          81 MEYLGGGSALDLLEP------------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADF  145 (277)
T ss_pred             EEeCCCCcHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeec
Confidence            999999999999853            2478889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++........    ......++..|+|||.+....++.++|+|||||++|||++|..||+
T Consensus       146 g~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  202 (277)
T cd06641         146 GVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS  202 (277)
T ss_pred             ccceecccchh----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99875542211    1112357889999999988888999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2e-33  Score=264.80  Aligned_cols=205  Identities=26%  Similarity=0.456  Sum_probs=169.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC----CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE----DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +.|...+.||+|+||.||++++..    +++.+|||.++..... ..+.+.+|++.++.++||||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            356777899999999999999753    3789999999755443 45789999999999999999999987542   224


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++++||+++++|.+++....          ..+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~----------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~  147 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR----------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDL  147 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc----------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCC
Confidence            56899999999999999996543          2588999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||.+......... ........++..|+|||...+..++.++||||||+++|||+||+.||.
T Consensus       148 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~  213 (284)
T cd05038         148 VKISDFGLAKVLPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ  213 (284)
T ss_pred             EEEcccccccccccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence            999999999865422111 111112335667999999988889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-33  Score=266.00  Aligned_cols=198  Identities=30%  Similarity=0.497  Sum_probs=165.7

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|++|.||+|+...+|+.||||.++...  ......+.+|++.+++++||||+++++++     .+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            4778899999999999999998899999999987433  23346788999999999999999999884     4556789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ++|||+. ++|.+++....         ...+++.++..++.|++.||+|||+.   +++||||+|+||++++++.+||+
T Consensus        76 ~v~e~~~-~~l~~~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~  142 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASP---------LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLA  142 (284)
T ss_pred             EEeeccc-cCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEe
Confidence            9999995 68988886432         24578999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||++.........    .....+++.|+|||.+.+.. ++.++|||||||++|||+||+.||
T Consensus       143 dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~  201 (284)
T cd07860         143 DFGLARAFGVPVRT----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF  201 (284)
T ss_pred             eccchhhcccCccc----cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99998755422111    11234688999999876644 588999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-33  Score=262.56  Aligned_cols=200  Identities=28%  Similarity=0.475  Sum_probs=166.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---c-------cHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---G-------ASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~-------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      +|...+.||+|+||.||+|....+|+.||+|.++....   .       ..+.+.+|+..++.++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            36677899999999999999988899999998863211   1       124678899999999999999999985    


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                       ...+..++|+||+++++|.+++...           ..+++..+..++.|++.||.|||+.   +++||||+|+||+++
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~  142 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRTY-----------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVD  142 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEc
Confidence             3445789999999999999998643           2578888999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCC--CCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE--VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++.+|++|||+++.........  ......++..|+|||......  ++.++|+||||+++||+++|..||.
T Consensus       143 ~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  213 (272)
T cd06629         143 ADGICKISDFGISKKSDDIYDND--QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS  213 (272)
T ss_pred             CCCeEEEeecccccccccccccc--ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence            99999999999987543221111  112345889999999977654  7899999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.6e-33  Score=266.24  Aligned_cols=212  Identities=25%  Similarity=0.429  Sum_probs=169.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|+..+.||+|+||.||+++...     ++..||+|.++.... ....++.+|+..+++++|||++++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            4578899999999999999998742     567899999874432 23467889999999999999999999854     


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCc-----------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQR-----------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCD  372 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  372 (452)
                      .++..++++||+++|+|.+++........           ........+++.+++.++.|++.||+|||+.   +++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            34568999999999999999975321100           0112224578999999999999999999998   999999


Q ss_pred             cCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          373 LKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       373 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |||+||++++++.+||+|||++..........  .......+..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK--ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcccc--ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999987543221111  1111234677999999888899999999999999999998 88887

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=269.72  Aligned_cols=194  Identities=28%  Similarity=0.457  Sum_probs=166.9

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      .++||+|.||+||-|+++.+|+.||||++++.+  .+.+..+++|+.+|+++.||.||.+..-     ++..+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEEeh
Confidence            378999999999999999999999999997543  3445788999999999999999998755     677789999999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC---CceEECc
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LSAHIGD  390 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~~kl~D  390 (452)
                      -+ .|+..++|-.         .+..++++.....+..||+.||.|||..   +|+|.||||+|||+.+.   ..+||+|
T Consensus       644 Kl-~GDMLEMILS---------sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCD  710 (888)
T KOG4236|consen  644 KL-HGDMLEMILS---------SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCD  710 (888)
T ss_pred             hh-cchHHHHHHH---------hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecc
Confidence            99 5666665532         2346788888888999999999999998   99999999999999654   4799999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.|+++.....     ..+.+|||.|.|||++..+.|+..-|+||.||++|--++|..||+
T Consensus       711 FGfARiIgEksF-----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  711 FGFARIIGEKSF-----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             ccceeecchhhh-----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence            999998764322     234789999999999999999999999999999999999999995

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.4e-33  Score=260.33  Aligned_cols=199  Identities=27%  Similarity=0.497  Sum_probs=166.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+|++.+.||+|+||.||++.+. +++.+|+|.+... .....++.+|++++++++|||++++++.+     ......++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   76 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICL   76 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEE
Confidence            46778899999999999999885 5778999988643 23346789999999999999999999884     34457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+++++|.+++....          ..+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        77 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d  143 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQR----------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSD  143 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECC
Confidence            999999999999986432          3478889999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||.++.......   .......++..|+|||...+..++.++||||||+++|||++ |+.||+
T Consensus       144 ~g~~~~~~~~~~---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  203 (256)
T cd05112         144 FGMTRFVLDDQY---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE  203 (256)
T ss_pred             CcceeecccCcc---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999875432111   11112335678999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.1e-33  Score=260.31  Aligned_cols=200  Identities=29%  Similarity=0.498  Sum_probs=166.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|...+.||+|+||.||++... ++..+|+|.+... ....+.+.+|++++++++|+|++++.+.+..      ...+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~   76 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY   76 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence            357888999999999999999865 5667999988643 2234678999999999999999999887532      4578


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....         ....++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        77 ~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDE---------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIA  144 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCC---------ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEEC
Confidence            9999999999999986532         23578888999999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||.+.........   ......++..|+|||++....++.++|+|||||++||++| |+.||.
T Consensus       145 d~~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~  205 (260)
T cd05073         145 DFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP  205 (260)
T ss_pred             CCcceeeccCCCcc---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence            99998765422111   1112335678999999988889999999999999999999 999984

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-33  Score=261.46  Aligned_cols=187  Identities=26%  Similarity=0.461  Sum_probs=157.4

Q ss_pred             CceeccCceeEEEEEEcCCC----------cEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          237 NLIGVGSFGSVYKGVFDEDG----------TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +.||+|+||.||+|.+..++          ..|++|.+...... ...+.+|+.+++.++||||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            46899999999999997665          35788877644333 6789999999999999999999998643      3


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC--
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL--  384 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--  384 (452)
                      ..++|+||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++  
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~  140 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREK----------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLN  140 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccc
Confidence            4689999999999999987543          2578889999999999999999998   999999999999999887  


Q ss_pred             -----ceEECccccccccccCCCCceeccccccccccccCccccCCC--CCCcccceeehhHHHHHHHh-CCCCC
Q 041632          385 -----SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS--EVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       385 -----~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                           .+||+|||++......        ....++..|+|||++...  .++.++|||||||++|||++ |..||
T Consensus       141 ~~~~~~~kl~Dfg~a~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~  207 (259)
T cd05037         141 EGYVPFIKLSDPGIPITVLSR--------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL  207 (259)
T ss_pred             cCCceeEEeCCCCcccccccc--------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCc
Confidence                 7999999998754321        113467789999998776  78999999999999999999 57776

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-34  Score=274.42  Aligned_cols=203  Identities=26%  Similarity=0.350  Sum_probs=171.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .-|..++.||-|+||+|.+++-..+...+|.|.+++.+   .........|-++|+.-..+=||+++-.     |++.+.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDkdn  703 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDKDN  703 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccCCc
Confidence            45788899999999999999988788899999886432   2333557889999999999999999866     788889


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      +|+||||++||++-..|-+..           .+.+..+..++.++++|+++.|..   |+|||||||+|||||.+|++|
T Consensus       704 LYFVMdYIPGGDmMSLLIrmg-----------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMG-----------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhc-----------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCcee
Confidence            999999999999999886543           577888889999999999999999   999999999999999999999


Q ss_pred             ECccccccccccCCCCceec--------------------------------------cccccccccccCccccCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSS--------------------------------------SIGVRGTIGYVAPEYGLGSEVS  429 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~--------------------------------------~~~~~gt~~y~aPE~~~~~~~~  429 (452)
                      |.|||+++-+.-..+.....                                      ....+||+.|+|||++....|+
T Consensus       770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            99999987332111100000                                      1246799999999999999999


Q ss_pred             cccceeehhHHHHHHHhCCCCCC
Q 041632          430 TNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       430 ~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ..||.||.||+||||+.|+.||.
T Consensus       850 q~cdwws~gvil~em~~g~~pf~  872 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFL  872 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCcc
Confidence            99999999999999999999993

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-33  Score=264.17  Aligned_cols=201  Identities=29%  Similarity=0.418  Sum_probs=173.1

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++.|+..+.||+|++|.||+|.+..++..|++|.++.... ..+.+.+|++.++.++|+|++++++.+.     ..+..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCEE
Confidence            45678888999999999999999988899999999976544 4577899999999999999999999854     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++++||+++++|.+++....          ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l  157 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF----------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKL  157 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEE
Confidence            99999999999999987532          3688999999999999999999997   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++.........    .....++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~d~~~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~  217 (286)
T cd06614         158 ADFGFAAQLTKEKSK----RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL  217 (286)
T ss_pred             Cccchhhhhccchhh----hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            999988654422111    112347889999999988889999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=266.60  Aligned_cols=199  Identities=26%  Similarity=0.377  Sum_probs=168.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|++|.||+|.+..+++.||+|.++...  ....+.+.+|++++++++|+||+++++.+.     ..+..+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEEE
Confidence            5788899999999999999998889999999986432  333467899999999999999999999853     355789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||++++.+..+....           ..+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+
T Consensus        77 iv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~  142 (288)
T cd07833          77 LVFEYVERTLLELLEASP-----------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC  142 (288)
T ss_pred             EEEecCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEE
Confidence            999999887776655332           3478899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.........   ......++..|+|||++.+. .++.++||||||+++|||++|+.||.
T Consensus       143 d~g~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~  203 (288)
T cd07833         143 DFGFARALRARPAS---PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP  203 (288)
T ss_pred             eeecccccCCCccc---cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99998866533221   11224578899999998887 78999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.6e-33  Score=260.13  Aligned_cols=193  Identities=24%  Similarity=0.332  Sum_probs=159.6

Q ss_pred             HhhcCCCCCCce--eccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          228 KATDGFSSTNLI--GVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       228 ~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      ...++|++.+.+  |+|+||.||+++.+.+++.+|+|.+........     |+.....+ +|||++++++.+     ..
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~-----~~   80 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV-----TT   80 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE-----ec
Confidence            344567777776  999999999999998999999999864322211     22222222 799999999884     34


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++++|.+++...           ..+++.++..++.|+++||+|||+.   +++||||||+||+++.++
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  146 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE-----------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK  146 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence            45889999999999999998643           2688999999999999999999998   999999999999999998


Q ss_pred             -ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 -SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 -~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                       .++|+|||+++......        ...++..|+|||++.+..++.++||||+||++|||++|+.||+
T Consensus       147 ~~~~l~dfg~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~  207 (267)
T PHA03390        147 DRIYLCDYGLCKIIGTPS--------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK  207 (267)
T ss_pred             CeEEEecCccceecCCCc--------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence             99999999987543211        2357899999999998889999999999999999999999984

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.3e-33  Score=258.64  Aligned_cols=200  Identities=29%  Similarity=0.521  Sum_probs=168.0

Q ss_pred             CCCCCceeccCceeEEEEEEcCCC----cEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDG----TVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +++.+.||+|+||.||++++...+    ..||+|.+...... ..+.+..|++.++.++|+|++++++.+.     +.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence            356788999999999999997665    88999999755433 4578999999999999999999999853     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+++++|.+++....         ...+++.++..++.|++.|++|||+.   +++|+||||+||++++++.++
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~  143 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNR---------PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK  143 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhh---------hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEE
Confidence            899999999999999986533         11289999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |+|||+++..........   ....+++.|+|||...+..++.++||||+|+++|||++ |+.||+
T Consensus       144 l~dfg~~~~~~~~~~~~~---~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~  206 (258)
T smart00219      144 ISDFGLSRDLYDDDYYKK---KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP  206 (258)
T ss_pred             EcccCCceeccccccccc---ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            999999976553311111   11236789999999888889999999999999999998 888874

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=251.49  Aligned_cols=198  Identities=25%  Similarity=0.338  Sum_probs=158.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +.+....||.|..|.|++++++.+|...|||.+.....+ ..+++...++++.+- ..|.||+.+|++     -.+...+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF-----i~n~dV~  167 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF-----ITNTDVF  167 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE-----eeCchHH
Confidence            345566799999999999999999999999999755432 335677777776655 489999999994     3344677


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +.||.| ...+...++..+          ..+++.-.-++...++.||.||-+.|  +|+|||+||+|||+|+.|++|++
T Consensus       168 IcMelM-s~C~ekLlkrik----------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  168 ICMELM-STCAEKLLKRIK----------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             HHHHHH-HHHHHHHHHHhc----------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence            889988 445555554332          45778778889999999999999874  99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++-.+-....     .....|.+.|||||.+.-   ..|+.++||||||++++||.||+.||.
T Consensus       235 DFGIsGrlvdSkA-----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~  295 (391)
T KOG0983|consen  235 DFGISGRLVDSKA-----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYK  295 (391)
T ss_pred             cccccceeecccc-----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCC
Confidence            9999875542221     122458999999998764   468999999999999999999999985

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-33  Score=266.33  Aligned_cols=201  Identities=30%  Similarity=0.424  Sum_probs=167.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||.||+|.+..+++.+|+|.++....  .....+.+|++++++++||||+++++++...   +.+..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            568888999999999999999988899999999974432  2334677899999999999999999885432   13678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||++ ++|.+++....          ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l  147 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMK----------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKI  147 (293)
T ss_pred             EEEehhcC-cCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEE
Confidence            99999996 59988886432          2589999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++.........    .....+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.
T Consensus       148 ~d~g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~  208 (293)
T cd07843         148 CDFGLAREYGSPLKP----YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP  208 (293)
T ss_pred             eecCceeeccCCccc----cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence            999998765432111    1123478899999987654 46889999999999999999999984

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=252.87  Aligned_cols=201  Identities=25%  Similarity=0.317  Sum_probs=170.5

Q ss_pred             hhcCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          229 ATDGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       229 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .+++|.+. ++||-|-.|.|-.+.++.+|+.+|+|++...     ...++|+++.-.. .|||||++++++... +....
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENS-YQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence            45667664 5799999999999999999999999998632     3456888876655 799999999987553 56677


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---C
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---D  383 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~  383 (452)
                      ...+|||.|+||.|.+.+++..         .+.+++.++-.|+.||+.|+.|||+.   .|.||||||+|+|.+.   |
T Consensus       133 cLLiVmE~meGGeLfsriq~~g---------~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~n  200 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRG---------DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPN  200 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcc---------cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCC
Confidence            8889999999999999997654         35799999999999999999999998   9999999999999975   4


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      -.+||+|||+|+......     .....+-||.|.|||++...+|+..+|+||+||++|-|++|.+||.
T Consensus       201 a~lKLtDfGFAK~t~~~~-----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY  264 (400)
T KOG0604|consen  201 APLKLTDFGFAKETQEPG-----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_pred             cceEecccccccccCCCc-----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence            569999999998654221     1223567999999999999999999999999999999999999993

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.1e-33  Score=265.95  Aligned_cols=195  Identities=28%  Similarity=0.381  Sum_probs=163.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..|+..+.||+|+||+||+|+...+|+.||+|.+.....   ...+++.+|+++++.++|||++++.++|.     +.+.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence            458888999999999999999988899999999864332   22356889999999999999999999864     3456


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||++ |++.+++....          ..+++.++..++.|++.||.|||+.   +|+||||+|+||++++++.+|
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~k  155 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHK----------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVK  155 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEE
Confidence            899999996 67777764322          3578999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++......        ....++..|+|||++.   ...++.++||||||+++|||+||+.||.
T Consensus       156 L~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~  215 (307)
T cd06607         156 LADFGSASLVSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (307)
T ss_pred             EeecCcceecCCC--------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence            9999998754321        1234788999999874   3568899999999999999999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.6e-33  Score=265.56  Aligned_cols=206  Identities=24%  Similarity=0.322  Sum_probs=154.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCCccH-----------HHHHHHHHHHhcCCCCCceeEeee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQGAS-----------KSFMAECKALKNIRHKNLVRVITS  296 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~ei~~l~~l~h~niv~l~~~  296 (452)
                      .+|.+.+.||+|+||.||+|++..+   +..+|+|..........           .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5789999999999999999998766   56777776543322111           112233445667799999999986


Q ss_pred             eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       297 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                      +.... ......++++|+. ..++.+.+...           ...++..+..++.|++.||+|||+.   +|+||||||+
T Consensus        92 ~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~  155 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKL-VENTKEIFKRI-----------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPE  155 (294)
T ss_pred             eeEec-CCceEEEEEEehh-ccCHHHHHHhh-----------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            54321 1122456778876 34565555322           1346777889999999999999998   9999999999


Q ss_pred             CeeecCCCceEECccccccccccCCCCc---eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          377 NILLDNDLSAHIGDFGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       377 Nill~~~~~~kl~Dfgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.++.+||+|||+|+.+.......   ........||+.|+|||+..+..++.++|||||||++|||++|+.||+
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~  234 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK  234 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999998664221110   011122469999999999999999999999999999999999999994

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=265.69  Aligned_cols=199  Identities=27%  Similarity=0.349  Sum_probs=168.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .+|.+..+||+|+||.|-+|..+.+.+.+|||+++.+-.   ...+--+.|-++|+-- +-|.++++..+     |+.-+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQTmD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQTMD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hhhhh
Confidence            469999999999999999999999999999999975422   1122335666777666 57788888776     56667


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+||||+.||+|-..+++-.           .+.+..+..+|..||-||=+||+.   ||+.||||.+|||+|.+|++
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~G-----------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHi  489 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVG-----------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI  489 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhc-----------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCce
Confidence            8999999999999998887543           577778899999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.--    .........+|||.|+|||++...+|+..+|.|||||+||||+.|++|||
T Consensus       490 Ki~DFGmcKEni----~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd  551 (683)
T KOG0696|consen  490 KIADFGMCKENI----FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  551 (683)
T ss_pred             Eeeecccccccc----cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence            999999997321    12223345789999999999999999999999999999999999999997

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4e-33  Score=259.75  Aligned_cols=190  Identities=27%  Similarity=0.403  Sum_probs=164.4

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||.|++|.||+++...+++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+     .+++..++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence            6899999999999988899999999974332   3346789999999999999999999874     4456789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....           .+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.
T Consensus        76 ~~~~L~~~l~~~~-----------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~  141 (262)
T cd05572          76 LGGELWTILRDRG-----------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK  141 (262)
T ss_pred             CCCcHHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence            9999999996542           478889999999999999999997   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ......     ......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.
T Consensus       142 ~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  193 (262)
T cd05572         142 KLKSGQ-----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG  193 (262)
T ss_pred             ccCccc-----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcC
Confidence            654321     1122457899999999888889999999999999999999999984

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-33  Score=257.48  Aligned_cols=195  Identities=32%  Similarity=0.480  Sum_probs=162.4

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      +.||+|+||.||++.... ++.||+|.++..... ..+.+.+|++++++++||||+++++++     .+....++|+||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEcC
Confidence            469999999999999876 899999998754443 456889999999999999999999884     3445789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....          ..+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||.+.
T Consensus        75 ~~~~l~~~l~~~~----------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~  141 (251)
T cd05041          75 PGGSLLTFLRKKK----------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR  141 (251)
T ss_pred             CCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccc
Confidence            9999999986432          3578888999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ........  .......++..|+|||.+.+..++.++|+|||||++|||+| |..||.
T Consensus       142 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~  197 (251)
T cd05041         142 EEEGGIYT--VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP  197 (251)
T ss_pred             cccCCcce--eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence            54321111  11111234667999999988889999999999999999999 888873

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.4e-33  Score=271.73  Aligned_cols=202  Identities=25%  Similarity=0.281  Sum_probs=168.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~  305 (452)
                      ..++|+..+.||+|+||.||+|+...+|+.||+|.+...  .......+.+|++++++++||||+++++++.... +.+.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346799999999999999999999989999999998632  2233456788999999999999999998764322 2233


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++|+||+. ++|.+++..             .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~  156 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCT  156 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence            45799999994 688877642             267788899999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.......     .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.
T Consensus       157 ~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  218 (353)
T cd07850         157 LKILDFGLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP  218 (353)
T ss_pred             EEEccCccceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence            99999999976542211     122357899999999998899999999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-33  Score=269.84  Aligned_cols=212  Identities=25%  Similarity=0.431  Sum_probs=168.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-------CCcEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-------DGTVVAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      .+|++.+.||+|+||.||++++..       .+..||+|.++... ....+++.+|+++++++ +||||++++++|.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            468889999999999999998642       22368999887432 23346789999999999 8999999999854   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                        ..+..++++||+++|+|.+++.........     .......+++.++..++.|++.||+|||+.   +++||||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~  163 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR  163 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence              345789999999999999999754311100     012234688999999999999999999998   9999999999


Q ss_pred             CeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       377 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||++++++.+||+|||+++.........  ......++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccc--cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999987654221111  1112234578999999988889999999999999999998 888873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=268.10  Aligned_cols=207  Identities=27%  Similarity=0.401  Sum_probs=167.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcC--CCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDE--DGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +|.+.+.||+|++|.||+|+...  +++.||+|.+....   .+..+.+.+|+.++++++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            47778899999999999999987  78999999997633   44456788999999999999999999986432   235


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC----
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN----  382 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----  382 (452)
                      ..++||||++ +++.+++.....      .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.    
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~  147 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQ------AKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPE  147 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhcc------CCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCc
Confidence            7899999996 577776643321      1113678889999999999999999998   9999999999999999    


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus       148 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~  217 (316)
T cd07842         148 RGVVKIGDLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK  217 (316)
T ss_pred             cceEEECCCccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            999999999999865432221 111223457899999998766 457899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3e-33  Score=259.38  Aligned_cols=193  Identities=30%  Similarity=0.526  Sum_probs=162.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||.||++..  +++.||+|.++..  ...+.+.+|+.++++++|||++++++++..      +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~   75 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYI   75 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEE
Confidence            4588889999999999999975  6788999998643  234678999999999999999999988532      23689


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+++++|.+++....         ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+||+|
T Consensus        76 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~D  143 (254)
T cd05083          76 VMELMSKGNLVNFLRTRG---------RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSD  143 (254)
T ss_pred             EEECCCCCCHHHHHHhcC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECC
Confidence            999999999999986432         23578889999999999999999997   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||++........       ....+..|+|||.+.+..++.++|+|||||++|||++ |+.||.
T Consensus       144 fg~~~~~~~~~~-------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  199 (254)
T cd05083         144 FGLARVGSMGVD-------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYP  199 (254)
T ss_pred             CccceeccccCC-------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            999875432111       1224577999999988889999999999999999998 999984

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.7e-33  Score=265.81  Aligned_cols=202  Identities=30%  Similarity=0.438  Sum_probs=167.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+|....+|+.||+|.++....  .....+.+|++++++++|+|++++++++..   ...+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVG---KHLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEec---CCCCe
Confidence            4679999999999999999999998999999999974432  223456789999999999999999988542   22346


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||++ ++|.+++....          ..+++.++..++.|++.||+|||+.   +++||||||+||++++++.+|
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~k  148 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP----------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLK  148 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            799999995 58888876432          4688999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||.+.........    .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus       149 L~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~  210 (309)
T cd07845         149 IADFGLARTYGLPAKP----MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP  210 (309)
T ss_pred             ECccceeeecCCccCC----CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999865432111    112235788999998765 457899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4e-33  Score=261.66  Aligned_cols=208  Identities=22%  Similarity=0.387  Sum_probs=168.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|+..+.||+|+||+||+|+.+.     +.+.|++|.+...... ..+.+.+|++++++++|||++++++++.     +
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence            468888999999999999999753     3467999988754443 3467999999999999999999999853     3


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++|+|.+++......  ........+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~--~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~  154 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSK--DEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQR  154 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccc--cccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCC
Confidence            45789999999999999999754311  1111223689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      .++++|||++........   .......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       155 ~~~l~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~  219 (275)
T cd05046         155 EVKVSLLSLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF  219 (275)
T ss_pred             cEEEcccccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            999999999864332111   11122346788999999888888999999999999999999 88887

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-33  Score=264.16  Aligned_cols=207  Identities=26%  Similarity=0.386  Sum_probs=166.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||.||+|++..+++.||+|.++....  .....+.+|+.+++.+ +||||+++++++...+......
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            368888999999999999999998999999999864432  2346788999999999 4699999998865443323334


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CCce
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DLSA  386 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~  386 (452)
                      .+++|||+++ +|.+++.....      .....+++..++.++.|++.||+|||+.   +|+||||||+||+++. ++.+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~------~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~  150 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGR------GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLL  150 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcc------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeE
Confidence            7999999974 89888864320      1124579999999999999999999998   9999999999999998 8899


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+++.+......    .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||
T Consensus       151 kl~dfg~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~  212 (295)
T cd07837         151 KIADLGLGRAFSIPVKS----YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF  212 (295)
T ss_pred             EEeecccceecCCCccc----cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC
Confidence            99999998755322111    112346888999998765 45789999999999999999999998

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.8e-33  Score=259.18  Aligned_cols=198  Identities=22%  Similarity=0.390  Sum_probs=153.9

Q ss_pred             ceeccCceeEEEEEEcCC--CcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEec
Q 041632          238 LIGVGSFGSVYKGVFDED--GTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKY  314 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  314 (452)
                      .||+|+||+||+|+...+  ...+++|.+.... ....+.+.+|+..++.++||||+++++.|.     +....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            599999999999986432  2346677665432 234568999999999999999999999854     34578999999


Q ss_pred             cCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccc
Q 041632          315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS  394 (452)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  394 (452)
                      +++|+|.+++.....       .....++.....++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~  146 (268)
T cd05086          77 CELGDLKSYLSQEQW-------HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG  146 (268)
T ss_pred             CCCCcHHHHHHhhhc-------ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccc
Confidence            999999999975431       123456677889999999999999998   9999999999999999999999999987


Q ss_pred             cccccCCCCceeccccccccccccCccccCC-------CCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-------SEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ........  ........++..|+|||++..       ..++.++|||||||++|||++ |..||+
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~  210 (268)
T cd05086         147 PSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS  210 (268)
T ss_pred             cccCcchh--hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence            64221111  111123457889999998743       245788999999999999997 567873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-33  Score=264.78  Aligned_cols=193  Identities=26%  Similarity=0.387  Sum_probs=165.9

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ...||+|+||.||++....+|+.||+|.++.........+.+|+..++.++|+|++++++.+     ...+..+++|||+
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   99 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWVVMEFL   99 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEEEEEEecC
Confidence            35799999999999999889999999998755545556789999999999999999999884     4456889999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++...            .+++.....++.|++.|++|||+.   +++||||+|+||++++++.++|+|||++.
T Consensus       100 ~~~~L~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~  164 (292)
T cd06657         100 EGGALTDIVTHT------------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  164 (292)
T ss_pred             CCCcHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccce
Confidence            999999987432            468888999999999999999998   99999999999999999999999999887


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .......    ......|++.|+|||...+..++.++|+||+||++|||++|+.||.
T Consensus       165 ~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~  217 (292)
T cd06657         165 QVSKEVP----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  217 (292)
T ss_pred             ecccccc----cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            5442211    1123458899999999888888999999999999999999999983

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.9e-33  Score=255.29  Aligned_cols=198  Identities=33%  Similarity=0.468  Sum_probs=172.5

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +|+..+.||+|++|.||++....+++.+++|++..........+.+|++.++.++|+|++++++.+     ..+...+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY-----LKKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEE-----ecCCeEEEE
Confidence            467788999999999999999888999999999765554567899999999999999999999984     334678999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++++|.+++....          ..+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++|+||
T Consensus        76 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  142 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN----------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDF  142 (253)
T ss_pred             EecCCCCcHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeec
Confidence            99999999999986542          3689999999999999999999997   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |.+........     .....++..|+|||.+.+..++.++||||||+++|+|++|+.||+
T Consensus       143 ~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  198 (253)
T cd05122         143 GLSAQLSDTKA-----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS  198 (253)
T ss_pred             ccccccccccc-----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            99876543221     122458899999999988889999999999999999999999984

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-33  Score=261.66  Aligned_cols=202  Identities=30%  Similarity=0.468  Sum_probs=162.3

Q ss_pred             CceeccCceeEEEEEEcCCC------cEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          237 NLIGVGSFGSVYKGVFDEDG------TVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +.||+|+||.||+|++....      +.+|+|.+.... ......+.+|+..++.++||||+++++++.     ..+..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            36899999999999985433      679999886432 234567899999999999999999999853     345689


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-----
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-----  384 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-----  384 (452)
                      +++||+++++|.+++......    ......+++.++..++.|++.||+|||+.   +++|+||||+||+++.++     
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~  148 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVE----RFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADR  148 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhc----ccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCc
Confidence            999999999999999753211    01224578899999999999999999997   999999999999999887     


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+|++|||+++.........  ......++..|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       149 ~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~  215 (269)
T cd05044         149 VVKIGDFGLARDIYKSDYYR--KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP  215 (269)
T ss_pred             ceEECCcccccccccccccc--cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence            89999999987543221111  1112235788999999998899999999999999999998 999984

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.7e-34  Score=253.43  Aligned_cols=207  Identities=28%  Similarity=0.385  Sum_probs=170.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC----cEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG----TVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      ...|+....||+|.||.||+|+.+.+.    +.+|+|.++.++  .+.....-+|+.+++.++|||++.+..++..    
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~----   98 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS----   98 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----
Confidence            356899999999999999999765332    378999997543  3445677899999999999999999887543    


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .+...++++||.+ -+|.+.|+-++.      .....++...+.+|+.||+.|+.|||+.   =|+||||||.||||..+
T Consensus        99 ~d~~v~l~fdYAE-hDL~~II~fHr~------~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgd  168 (438)
T KOG0666|consen   99 HDKKVWLLFDYAE-HDLWHIIKFHRA------SKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGD  168 (438)
T ss_pred             cCceEEEEehhhh-hhHHHHHHHhcc------chhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEecc
Confidence            2567899999995 588888875542      2225788899999999999999999998   79999999999999887


Q ss_pred             ----CceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          384 ----LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       384 ----~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                          |.|||+|||+++.+...-.+- ......+-|..|.|||++.+. .|+.+.||||.||++.||+|-++-|
T Consensus       169 gperG~VKIaDlGlaR~~~~plkpl-~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  169 GPERGRVKIADLGLARLFNNPLKPL-ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             CCccCeeEeecccHHHHhhcccccc-ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence                899999999999887543332 223346689999999998885 5888999999999999999988766

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.1e-33  Score=262.19  Aligned_cols=200  Identities=29%  Similarity=0.473  Sum_probs=166.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +|+..+.||.|++|.||+|+...+|+.||+|.++.... ...+.+.+|++++++++|||++++++.+.     +.+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            47788999999999999999988999999999975432 33467788999999999999999999853     4457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||++ ++|.+++....        ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+|
T Consensus        76 v~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d  143 (284)
T cd07836          76 VFEYMD-KDLKKYMDTHG--------VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLAD  143 (284)
T ss_pred             EEecCC-ccHHHHHHhcC--------CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEee
Confidence            999997 58888875432        123589999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....++..|+|||.+.+. .++.++|||||||++|||++|+.||+
T Consensus       144 ~g~~~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~  202 (284)
T cd07836         144 FGLARAFGIPVNT----FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP  202 (284)
T ss_pred             cchhhhhcCCccc----cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9998755422111    1123478899999987654 56889999999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.4e-33  Score=258.60  Aligned_cols=200  Identities=29%  Similarity=0.415  Sum_probs=168.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|...+.||+|+||.||++....+|..+|+|.+....  ....+.+.+|+++++.++|+|++++++.+     ...+..+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            4677889999999999999999899999999997542  23346788999999999999999999874     4456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-ceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-SAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl  388 (452)
                      +++||+++++|.+++....         ...+++..+..++.|++.||+|||+.   +++|+||||+||++++++ .+||
T Consensus        76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l  143 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQR---------GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKL  143 (257)
T ss_pred             EEEecCCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEe
Confidence            9999999999999986432         13578899999999999999999998   999999999999999886 4699


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+.........    .....|++.|+|||...+..++.++|+||||+++|||++|+.||+
T Consensus       144 ~d~~~~~~~~~~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  203 (257)
T cd08225         144 GDFGIARQLNDSMEL----AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE  203 (257)
T ss_pred             cccccchhccCCccc----ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999998765422111    112348899999999888889999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-33  Score=269.07  Aligned_cols=204  Identities=28%  Similarity=0.351  Sum_probs=169.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..+|.+.+.||+|+||+||+|+...+++.||+|.++..  .......+.+|+.+++.++||||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35688899999999999999999989999999998643  2233456788999999999999999998765443333346


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++++||+. ++|.+++...           ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+|
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-----------QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence            899999995 7898888643           3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......    ......++..|+|||.+.. ..++.++|||||||++|||++|+.||+
T Consensus       149 L~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  210 (337)
T cd07858         149 ICDFGLARTTSEKGD----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP  210 (337)
T ss_pred             ECcCccccccCCCcc----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence            999999976543211    1123457889999998764 468899999999999999999999984

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1e-32  Score=262.57  Aligned_cols=207  Identities=29%  Similarity=0.431  Sum_probs=168.7

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeecccc-----
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVD-----  301 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-----  301 (452)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.++...  ......+.+|+++++.++|||++++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4567999999999999999999999889999999997543  233457788999999999999999998864422     


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ..+....++++||+++ ++..++....          ..+++.++..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~  150 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGL----------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLN  150 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            1123478999999965 7777765322          3588999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.+||+|||++..........   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||+
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~  219 (302)
T cd07864         151 NKGQIKLADFGLARLYNSEESRP---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ  219 (302)
T ss_pred             CCCcEEeCcccccccccCCcccc---cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999998654332211   112346788999998765 357889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.6e-33  Score=261.56  Aligned_cols=199  Identities=26%  Similarity=0.392  Sum_probs=164.8

Q ss_pred             CCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR----QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~  303 (452)
                      +|++.+.||+|+||.||+++..   .+|+.||+|+++...    ....+.+.+|+++++++ +|+||+++.+.     ++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~-----~~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----FQ   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeE-----ee
Confidence            3677889999999999999874   478899999997432    23346788999999999 69999999877     44


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .+...++|+||+++++|.+++...           ..+++.++..++.|++.||+|||+.   +++||||+|+||+++++
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~  141 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR-----------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSN  141 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCC
Confidence            556789999999999999998643           2577888899999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCC--CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS--EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||++.........   ......|+..|+|||.....  .++.++||||||+++|||+||+.||+
T Consensus       142 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~  209 (290)
T cd05613         142 GHVVLTDFGLSKEFHEDEVE---RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT  209 (290)
T ss_pred             CCEEEeeCccceeccccccc---ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence            99999999998765422111   11234588999999997653  46789999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-33  Score=261.01  Aligned_cols=198  Identities=30%  Similarity=0.491  Sum_probs=165.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |+..+.||.|++|.||+|.+..+|+.||+|++....  .+....+.+|++.++.++|||++++++++     .+.+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence            567789999999999999998899999999987543  23346788999999999999999999884     34568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||+ +++|.+++....         ...+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++|+|
T Consensus        76 v~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~d  142 (283)
T cd07835          76 VFEFL-DLDLKKYMDSSP---------LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLAD  142 (283)
T ss_pred             EEecc-CcCHHHHHhhCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEee
Confidence            99999 578999886432         13588999999999999999999997   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++.........    .....++..|+|||++.+. .++.++||||||+++|||+||+.||+
T Consensus       143 f~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  201 (283)
T cd07835         143 FGLARAFGVPVRT----YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP  201 (283)
T ss_pred             cccccccCCCccc----cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9998755322111    1123468899999987654 57889999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.4e-33  Score=259.50  Aligned_cols=195  Identities=30%  Similarity=0.440  Sum_probs=164.3

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||.||+++...+|+.+++|.+.....   ...+.+.+|++.+++++|||++++++.     +......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-----~~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS-----FQGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHh-----eecCcEEEEEEecC
Confidence            6899999999999988899999999864433   345678899999999999999999876     44566889999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++...           ..+++..+..++.|++.||+|||+.   +++|+||+|+||++++++.+||+|||++.
T Consensus        76 ~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~  141 (265)
T cd05579          76 PGGDLASLLENV-----------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSK  141 (265)
T ss_pred             CCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccch
Confidence            999999998643           2578899999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCCCc----eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPT----VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .........    ........++..|+|||.......+.++||||||+++|||++|+.||+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  202 (265)
T cd05579         142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH  202 (265)
T ss_pred             hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            543221100    011123457889999999888888999999999999999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.7e-33  Score=259.31  Aligned_cols=202  Identities=30%  Similarity=0.453  Sum_probs=166.3

Q ss_pred             CCCCCCceeccCceeEEEEEEcC-CCcEEEEEEeeccC----------CccHHHHHHHHHHHhc-CCCCCceeEeeeecc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDE-DGTVVAIKVINLQR----------QGASKSFMAECKALKN-IRHKNLVRVITSCSS  299 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~ei~~l~~-l~h~niv~l~~~~~~  299 (452)
                      +|++.+.||+|+||.||+|.+.. +++.+|+|.+....          .....++..|+.++.+ ++|||++++++.+  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            47788899999999999999976 67899999886321          1223457788888865 7999999999984  


Q ss_pred             ccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          300 VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       300 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                         ..++..++++||+++++|.+++....       .....+++..++.++.|++.||.|||+.  .+++|+||+|+||+
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~-------~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil  146 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLK-------EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIM  146 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHH-------hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEE
Confidence               34568899999999999998875321       1124688899999999999999999963  28999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++++.+||+|||.+.......     ......|+..|+|||...+..++.++||||||+++|||++|+.||.
T Consensus       147 ~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~  214 (269)
T cd08528         147 LGEDDKVTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY  214 (269)
T ss_pred             ECCCCcEEEecccceeeccccc-----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccc
Confidence            9999999999999997654322     1123458899999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-32  Score=263.71  Aligned_cols=193  Identities=29%  Similarity=0.393  Sum_probs=162.3

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      |...+.||+|+||.||+++...++..||+|.+.....   .....+..|++.+++++|||++++++++.     +++..+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeEE
Confidence            6667889999999999999988899999999874322   23357889999999999999999999854     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||++ |++.+++....          ..+++.++..++.|++.||.|||+.   +|+||||+|+||++++++.+||+
T Consensus       102 lv~e~~~-g~l~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~  167 (317)
T cd06635         102 LVMEYCL-GSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA  167 (317)
T ss_pred             EEEeCCC-CCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEe
Confidence            9999996 57877765322          3578999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++......        ....+++.|+|||.+.   ...++.++|||||||++|||++|+.||.
T Consensus       168 dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         168 DFGSASIASPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             cCCCccccCCc--------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            99988654321        1235788999999863   4568899999999999999999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-32  Score=257.67  Aligned_cols=210  Identities=24%  Similarity=0.423  Sum_probs=164.9

Q ss_pred             CCCCCceeccCceeEEEEEEcC---CCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC-Cc
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDE---DGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG-ND  306 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~-~~  306 (452)
                      |.+.+.||+|+||.||+|.+..   +++.||+|++....  ....+++.+|++.+++++|||++++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5567899999999999998643   46899999986432  233567889999999999999999999764321111 12


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++++||+++|+|.+++......     .....+++...+.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~  152 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG-----EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTV  152 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCE
Confidence            347889999999999887543211     1123578889999999999999999997   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++.......  ........+++.|++||......++.++|||||||++|||++ |+.||.
T Consensus       153 kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~  217 (273)
T cd05074         153 CVADFGLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA  217 (273)
T ss_pred             EECcccccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCC
Confidence            9999999885532211  111112335678999999988889999999999999999999 888873

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-32  Score=261.44  Aligned_cols=200  Identities=29%  Similarity=0.430  Sum_probs=163.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|++|+||+|+...+|+.||+|.+.....  ...+.+.+|++.+++++|||++++++++     .+....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence            468888999999999999999988899999999864332  3346788999999999999999999984     345688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CCceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DLSAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~k  387 (452)
                      ++|+||++ ++|.+++....         ....++..+..++.|++.||+|||+.   +++||||+|+||+++. ++.+|
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~k  143 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSP---------DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALK  143 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCC---------CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEE
Confidence            99999995 68887775322         12357788889999999999999998   9999999999999985 56799


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++........    ......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||+
T Consensus       144 l~dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~  205 (294)
T PLN00009        144 LADFGLARAFGIPVR----TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP  205 (294)
T ss_pred             EcccccccccCCCcc----ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999975432211    1112347889999998765 457889999999999999999999983

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-34  Score=274.42  Aligned_cols=199  Identities=27%  Similarity=0.408  Sum_probs=166.8

Q ss_pred             CCCCceeccCceeEEEEEEcCCC---cEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ...+.||+|.||.|++|.|+..+   ..||||.++..... ...+|.+|+.+|.+++|||+++++|+..+      ....
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPAM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chhh
Confidence            34578999999999999997432   36999999866554 55899999999999999999999998432      3578


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+|.++.|+|.+.|++..         ...+.......++.|||.||.||.++   +.|||||.++|+|+-....|||+
T Consensus       187 MV~ELaplGSLldrLrka~---------~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~  254 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAK---------KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKIC  254 (1039)
T ss_pred             HHhhhcccchHHHHHhhcc---------ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeee
Confidence            9999999999999998632         24677788889999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |||+.+.+......-. -.....-...|+|||.+....++-++|||+|||++|||+| |+.||
T Consensus       255 DFGLmRaLg~ned~Yv-m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW  316 (1039)
T KOG0199|consen  255 DFGLMRALGENEDMYV-MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW  316 (1039)
T ss_pred             cccceeccCCCCcceE-ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence            9999987653322211 1112335678999999999999999999999999999999 88887

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=256.38  Aligned_cols=189  Identities=28%  Similarity=0.359  Sum_probs=157.4

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHH-hcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKAL-KNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l-~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||.||+|....+|+.||+|.++....   .....+..|..++ ...+|+|++++++.+     ...+..++++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            468999999999999988899999999864322   1123344554444 455899999999884     4456889999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++++|.+++...           ..+++..+..++.|++.||.|||+.   +++||||+|+||++++++.+||+|||
T Consensus        77 e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  142 (260)
T cd05611          77 EYLNGGDCASLIKTL-----------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFG  142 (260)
T ss_pred             eccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecc
Confidence            999999999998643           2578889999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++....        .....++..|+|||.+.+..++.++||||||+++|||+||..||+
T Consensus       143 ~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  194 (260)
T cd05611         143 LSRNGLE--------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH  194 (260)
T ss_pred             cceeccc--------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence            8874332        112347889999999988888999999999999999999999984

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.6e-32  Score=254.65  Aligned_cols=202  Identities=30%  Similarity=0.469  Sum_probs=173.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|...+.||+|+||.||++.+..+++.||+|++.....  ...+.+.+|++.++.++|||++++.+.+     ...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~-----~~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF-----EEKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEE-----ecCCEEE
Confidence            47778899999999999999988899999999975533  4456789999999999999999999874     3446889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++....       .....+++.++..++.+++.||+|||+.   +++|+||+|+||++++++.++|+
T Consensus        76 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~  145 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQK-------KEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLG  145 (258)
T ss_pred             EEEEecCCCcHHHHHHHhh-------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEEC
Confidence            9999999999999987542       1225689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+........    ......|++.|+|||...+..++.++|+||+|+++|+|++|+.||+
T Consensus       146 d~~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  204 (258)
T cd08215         146 DFGISKVLSSTVD----LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE  204 (258)
T ss_pred             CccceeecccCcc----eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCC
Confidence            9999876543321    1122458899999999888889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-33  Score=289.44  Aligned_cols=204  Identities=30%  Similarity=0.406  Sum_probs=158.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC---
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN---  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~---  305 (452)
                      ..+|+..+.||+||||.||+++++-+|+.+|||++.... ........+|++.+++++|||||+++..+.+......   
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            356888999999999999999999999999999997553 3334667899999999999999999765533110000   


Q ss_pred             --------------------------------------------------------------------------------
Q 041632          306 --------------------------------------------------------------------------------  305 (452)
Q Consensus       306 --------------------------------------------------------------------------------  305 (452)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHH
Q 041632          306 -------------------------------DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA  354 (452)
Q Consensus       306 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  354 (452)
                                                     -..||-||||+...+.++++....          .-.....|+++.+|+
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~----------~~~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF----------NSQRDEAWRLFREIL  707 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc----------chhhHHHHHHHHHHH
Confidence                                           123556666666666666554331          114567899999999


Q ss_pred             HHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccc--------------cCCCCceeccccccccccccCc
Q 041632          355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ--------------AVSNPTVSSSIGVRGTIGYVAP  420 (452)
Q Consensus       355 ~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~--------------~~~~~~~~~~~~~~gt~~y~aP  420 (452)
                      +||+|+|++   |||||||||.|||+|++..|||+|||+|+...              ..........++.+||.-|+||
T Consensus       708 EGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  708 EGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            999999998   99999999999999999999999999998621              0011111233567899999999


Q ss_pred             cccCCC---CCCcccceeehhHHHHHHHh
Q 041632          421 EYGLGS---EVSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       421 E~~~~~---~~~~~~DvwSlGv~l~ellt  446 (452)
                      |++.+.   .|+.|+|+||+|||++||+.
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc
Confidence            998764   49999999999999999985

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=260.28  Aligned_cols=200  Identities=32%  Similarity=0.457  Sum_probs=167.0

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |++.+.||+|++|.||+|+...+++.+|+|.+....  .+....+.+|+++++.++|||++++++++....   .+..++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            566788999999999999998889999999998653  344567889999999999999999999864321   357899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||++ ++|.+++....          ..+++.+++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|
T Consensus        78 v~e~~~-~~l~~~~~~~~----------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d  143 (287)
T cd07840          78 VFEYMD-HDLTGLLDSPE----------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLAD  143 (287)
T ss_pred             Eecccc-ccHHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcc
Confidence            999996 58888875432          3688999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||++..........   .....++..|+|||.+.+ ..++.++||||||+++|||+||+.||+
T Consensus       144 ~g~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~  203 (287)
T cd07840         144 FGLARPYTKRNSAD---YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ  203 (287)
T ss_pred             ccceeeccCCCccc---ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            99998665332111   122346888999997664 457899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-32  Score=266.85  Aligned_cols=205  Identities=25%  Similarity=0.370  Sum_probs=169.2

Q ss_pred             HHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeecccc-
Q 041632          225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVD-  301 (452)
Q Consensus       225 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-  301 (452)
                      .+...+++|+..+.||+|+||.||+|....+|+.||+|+++...  ....+.+.+|++++++++||||+++.+++.... 
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            44557789999999999999999999998889999999986432  223456788999999999999999998764322 


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      +......+++++++ +++|.+++..            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~  154 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVKC------------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN  154 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEc
Confidence            22234567888887 8899887753            2478889999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.+||+|||+++.....       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus       155 ~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  219 (345)
T cd07877         155 EDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  219 (345)
T ss_pred             CCCCEEEeccccccccccc-------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999998754321       122457899999998766 467889999999999999999999983

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1e-32  Score=266.11  Aligned_cols=205  Identities=26%  Similarity=0.317  Sum_probs=165.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCC--CcEEEEEEeecc--CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDED--GTVVAIKVINLQ--RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +|.+.+.||+|+||.||+++...+  ++.||+|.++..  .....+.+.+|+++++++ +||||+++++.+... .....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec-cccCC
Confidence            467788999999999999999877  889999998643  222346788999999999 599999999865322 12234


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++++||+. ++|.+++...           ..+++..+..++.|++.||+|||+.   +++||||||+||++++++.+
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~  144 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG-----------QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCEL  144 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCE
Confidence            5788889885 7899888543           3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.+...............|+..|+|||...+ ..++.++|+||+||++|+|++|+.||+
T Consensus       145 kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~  211 (332)
T cd07857         145 KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK  211 (332)
T ss_pred             EeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence            999999998654322221111223468999999998765 468999999999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=253.14  Aligned_cols=198  Identities=35%  Similarity=0.493  Sum_probs=171.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|++|.||+++...+++.|++|.+.....  ...+.+.+|++++++++|||++++++++.     +.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            47778999999999999999988899999999975543  34567899999999999999999998843     346789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++...           ..+++..++.++.|++.|+.|||+.   +|+||||||+||+++.++.+||+
T Consensus        76 ~v~e~~~~~~L~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~  141 (254)
T cd06627          76 IILEYAENGSLRQIIKKF-----------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLA  141 (254)
T ss_pred             EEEecCCCCcHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEe
Confidence            999999999999998643           3688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+.........    .....++..|+|||...+..++.++||||+|+++|||++|+.||+
T Consensus       142 d~~~~~~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~  200 (254)
T cd06627         142 DFGVATKLNDVSKD----DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY  200 (254)
T ss_pred             ccccceecCCCccc----ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            99999866532221    122457899999999888778999999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-32  Score=266.17  Aligned_cols=204  Identities=27%  Similarity=0.402  Sum_probs=166.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||.||+|....+|+.+|+|.+...  .......+.+|+.+++++ +||||+++++++..   .+..
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~   82 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK   82 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence            45788889999999999999999888999999988532  223335677899999999 99999999998642   2234


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|+||++ ++|.+++...            .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~------------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~  146 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN------------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRV  146 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence            6799999996 6998887532            467888899999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCc-eeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPT-VSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++.......... ........|+..|+|||.+.+ ..++.++||||||+++|||+||+.||.
T Consensus       147 kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~  214 (337)
T cd07852         147 KLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP  214 (337)
T ss_pred             EEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence            999999998664332210 011223458999999998755 457889999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-33  Score=283.79  Aligned_cols=203  Identities=21%  Similarity=0.317  Sum_probs=155.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC-cEEEEEEe--------------e---ccCCccHHHHHHHHHHHhcCCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG-TVVAIKVI--------------N---LQRQGASKSFMAECKALKNIRHKNLV  291 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~ei~~l~~l~h~niv  291 (452)
                      .++|++.+.||+|+||+||++..+... ..++.|.+              .   .........+.+|++++++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998764322 22222211              0   01112235688999999999999999


Q ss_pred             eEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041632          292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHC  371 (452)
Q Consensus       292 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  371 (452)
                      ++++++.     ..+..++++|++ .+++..++.......      .......+...++.|++.||+|||+.   +|+||
T Consensus       227 ~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~~~------~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHr  291 (501)
T PHA03210        227 KIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAFDW------KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHR  291 (501)
T ss_pred             cEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhccccc------cccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            9999853     445788999998 567877775433111      12234566788999999999999998   99999


Q ss_pred             ccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          372 DLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       372 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      ||||+|||++.++.+||+|||+++.+......   ......||..|+|||++.+..++.++|||||||++|||++|..|
T Consensus       292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        292 DIKLENIFLNCDGKIVLGDFGTAMPFEKEREA---FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCHHHEEECCCCCEEEEeCCCceecCccccc---ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999866432211   12235699999999999999999999999999999999998754

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-32  Score=258.26  Aligned_cols=197  Identities=24%  Similarity=0.300  Sum_probs=160.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |.+.+.||+|+||.||+|....+++.||+|.++... ........+|+..+.++. |+|++++++++...   ..+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            556788999999999999998899999999987432 222234567888898885 99999999986432   2257899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||++ |++.+++....          ..+++.++..++.|++.||+|||+.   +++||||||+||++++ +.+||+|
T Consensus        78 v~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~d  142 (282)
T cd07831          78 VFELMD-MNLYELIKGRK----------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLAD  142 (282)
T ss_pred             EEecCC-ccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEe
Confidence            999996 68888875432          3688999999999999999999998   9999999999999999 9999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+++........     ....++..|+|||.+.. ..++.++||||+||++|||++|+.||.
T Consensus       143 fg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~  200 (282)
T cd07831         143 FGSCRGIYSKPPY-----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP  200 (282)
T ss_pred             cccccccccCCCc-----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence            9999765422211     12347889999997644 557889999999999999999999984

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.9e-32  Score=252.90  Aligned_cols=202  Identities=30%  Similarity=0.461  Sum_probs=172.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|...+.||+|++|.||+|....+++.|++|++.....  ...+.+.+|++.+++++|||++++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            36677899999999999999988899999999975543  34578899999999999999999998854321   25789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+
T Consensus        78 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~  143 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKF-----------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLA  143 (260)
T ss_pred             EEEEecCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence            999999999999998643           2688999999999999999999997   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+.........  .......++..|+|||...+...+.++||||||+++|+|++|+.||+
T Consensus       144 d~~~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  204 (260)
T cd06606         144 DFGCAKRLGDIETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS  204 (260)
T ss_pred             ccccEEeccccccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99998866543221  01123458899999999988889999999999999999999999984

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-32  Score=259.19  Aligned_cols=203  Identities=30%  Similarity=0.477  Sum_probs=172.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|...+.||+|+||.||+++...+|+.||+|++....   ....+.+.+|++++++++ ||||+++++.     +.+.+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~-----~~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYT-----FQDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHH-----hcCCc
Confidence            36888899999999999999999899999999987532   233467889999999998 9999999887     44566


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..+++|||+++++|.+++....           .+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~  141 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG-----------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHI  141 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence            8899999999999999986432           689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCc----------------eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPT----------------VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      +++|||++..........                ........++..|+|||......++.++|+||||+++||+++|+.|
T Consensus       142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p  221 (280)
T cd05581         142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP  221 (280)
T ss_pred             EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            999999987654322110                0111234578999999998888899999999999999999999999


Q ss_pred             CC
Q 041632          451 TD  452 (452)
Q Consensus       451 f~  452 (452)
                      |.
T Consensus       222 ~~  223 (280)
T cd05581         222 FR  223 (280)
T ss_pred             CC
Confidence            84

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=228.78  Aligned_cols=197  Identities=26%  Similarity=0.452  Sum_probs=164.8

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .|...+.||+|.||+||+|+.+.+++.||+|+++.+  +++......+||-+++.++|.|||+++..     ...+....
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCceeE
Confidence            355567899999999999999999999999998754  44556778999999999999999999987     44566889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||| ..+|..|.....          ..++.+.+.+++.|+++|+.|+|++   .+.|||+||+|.+|+.+|++|++
T Consensus        78 lvfe~c-dqdlkkyfdsln----------g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkla  143 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFDSLN----------GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_pred             EeHHHh-hHHHHHHHHhcC----------CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEec
Confidence            999999 668888775433          4688889999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHh-CCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |||+++-+...-    ..-...+-|..|.+|.++.+.+ |+...|+||.||++.|+.. |++-|
T Consensus       144 dfglarafgipv----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf  203 (292)
T KOG0662|consen  144 DFGLARAFGIPV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_pred             ccchhhhcCCce----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence            999998654221    1112345799999999988754 7889999999999999987 44433

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.8e-32  Score=261.85  Aligned_cols=209  Identities=30%  Similarity=0.411  Sum_probs=167.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC---CC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF---QG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~---~~  304 (452)
                      .++|++.+.||+|+||.||+|++..+++.+|+|.+.....  .....+.+|+++++.++||||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4689999999999999999999988999999999864332  223567899999999999999999887543221   22


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ....++|+||+. +++..++....          ..+++.++..++.|+++||+|||+.   +|+|+||||+||++++++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~~----------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~  152 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENPS----------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQG  152 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            346789999995 56777665322          3689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCce-------eccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTV-------SSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++..........       .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||+
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~  228 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ  228 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence            999999999976543221111       01122457888999998765 357899999999999999999999984

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-32  Score=266.65  Aligned_cols=205  Identities=26%  Similarity=0.359  Sum_probs=166.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeecccc---------
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD---------  301 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~---------  301 (452)
                      .+|...+.||.|+||.||+|+...+|+.||+|.+........+.+.+|++++++++||||+++++.+....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999999899999999997666566678899999999999999999987643321         


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      +.+....++++||++ ++|.+++..            ..+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~  148 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ------------GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN  148 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence            112235789999996 689887743            2478889999999999999999998   999999999999998


Q ss_pred             -CCCceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 -NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                       +++.+|++|||.++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||+
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  220 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA  220 (342)
T ss_pred             CCCceEEECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence             45678999999987553221111 11112347889999997654 567889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.7e-33  Score=260.91  Aligned_cols=202  Identities=28%  Similarity=0.325  Sum_probs=161.2

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|+..+.||+|+||.||++++..+++.||+|.+..... .....+.+|+..+.++. ||||+++++++.     ..+..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence            45666789999999999999998999999999874432 33467889999999995 999999999843     345678


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||+. +++.++.....      ......+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+
T Consensus        80 ~~~e~~~-~~l~~l~~~~~------~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~  150 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVY------EVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLC  150 (288)
T ss_pred             EEEeccc-CCHHHHHHHHH------HhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEe
Confidence            9999985 45544332100      00124688899999999999999999974  389999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC---CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS---EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++........     ....|+..|+|||.+.+.   .++.++|||||||++|||++|+.||.
T Consensus       151 dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  211 (288)
T cd06616         151 DFGISGQLVDSIAK-----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP  211 (288)
T ss_pred             ecchhHHhccCCcc-----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence            99998755422111     123478899999998765   68999999999999999999999984

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-32  Score=255.14  Aligned_cols=200  Identities=31%  Similarity=0.419  Sum_probs=170.8

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|++.+.||+|++|.||+++...+++.+|+|.+....  ......+.+|++.+++++|+||+++.+.+     .+....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-----LDGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhh-----ccCCEEE
Confidence            4778889999999999999998899999999987543  23345778999999999999999998773     4456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++++|.+++....       .....+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+
T Consensus        76 ~v~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~  145 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRK-------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIG  145 (256)
T ss_pred             EEehhcCCCCHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEe
Confidence            9999999999999986422       1124678899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........      ....+++.|+|||.+.+..++.++|+||+|+++|||++|+.||+
T Consensus       146 d~g~~~~~~~~~~------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~  202 (256)
T cd08530         146 DLGISKVLKKNMA------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE  202 (256)
T ss_pred             eccchhhhccCCc------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999986653311      12347889999999988889999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=256.05  Aligned_cols=202  Identities=29%  Similarity=0.423  Sum_probs=165.2

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcC---CCCCceeEeeeeccccCCCCce
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNI---RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l---~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      |++.+.||+|+||.||+|+++.+++.||+|.++....  .....+.+|+.+++++   +|||++++++.+...+......
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5667889999999999999988899999999974322  2234566777776655   6999999999976544333345


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++++||+. ++|.+++....         ...+++.+++.++.|++.||+|||+.   +++|+||+|+||++++++.+|
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~---------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP---------KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEE
Confidence            899999996 58988886432         12588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||.+..+......     ....++..|+|||.+.+..++.++|+|||||++|||++|+.||+
T Consensus       148 l~dfg~~~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~  207 (287)
T cd07838         148 IADFGLARIYSFEMAL-----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR  207 (287)
T ss_pred             EeccCcceeccCCccc-----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence            9999998765432211     12347889999999988889999999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-32  Score=264.03  Aligned_cols=205  Identities=29%  Similarity=0.341  Sum_probs=170.3

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +|.+.+.||+|++|.||+|+...+++.||+|.+....  ....+.+.+|++.++.++||||+++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998889999999987433  34456889999999999999999999886443222234679


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +++||++ ++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        81 lv~e~~~-~~l~~~l~~~-----------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~  145 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-----------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKIC  145 (330)
T ss_pred             EEecchh-hhHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence            9999996 5898888643           2688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||.+......... ........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.
T Consensus       146 dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~  208 (330)
T cd07834         146 DFGLARGVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP  208 (330)
T ss_pred             ccCceEeecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence            99999865533210 0112234578899999998887 78999999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.8e-32  Score=262.40  Aligned_cols=199  Identities=28%  Similarity=0.362  Sum_probs=166.8

Q ss_pred             HHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       227 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ...+++|+..+.||+|+||.||+++...+++.||+|++...  .....+.+.+|+++++.++|||++++.+++..    .
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~   81 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----P   81 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----C
Confidence            44678899999999999999999999989999999988532  22334678899999999999999999987532    2


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ....++++||+ +++|.+++...            .+++.....++.|+++||+|||+.   +|+||||+|+||++++++
T Consensus        82 ~~~~~lv~e~~-~~~L~~~~~~~------------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~  145 (328)
T cd07856          82 LEDIYFVTELL-GTDLHRLLTSR------------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENC  145 (328)
T ss_pred             CCcEEEEeehh-ccCHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCC
Confidence            34678999998 67898887532            467778888999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||.+......       .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||.
T Consensus       146 ~~~l~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~  207 (328)
T cd07856         146 DLKICDFGLARIQDPQ-------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP  207 (328)
T ss_pred             CEEeCccccccccCCC-------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999998754321       112357889999998765 568999999999999999999999983

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=252.12  Aligned_cols=200  Identities=28%  Similarity=0.349  Sum_probs=158.5

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +....||.|+||+|++..+++.|+..|||+++.... ...+++..|.+...+- +.||||+++|++    |.++ .-|+.
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~----F~EG-dcWiC  141 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL----FSEG-DCWIC  141 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh----hcCC-ceeee
Confidence            334579999999999999999999999999986554 4457788888865444 899999999996    4443 45899


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      ||.| .-|++.+-+.-      -......+++.-.-+|+...+.||.||-+.  ..|+|||+||+|||++..|.+|||||
T Consensus       142 MELM-d~SlDklYk~v------y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRV------YSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             HHHH-hhhHHHHHHHH------HHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecc
Confidence            9999 66766543210      011224577777778888899999999986  58999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCC--CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS--EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++-.+...     .+...-.|...|||||.+...  .|+.+|||||+|++|||+.||+.||.
T Consensus       213 GIcGqLv~S-----iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr  270 (361)
T KOG1006|consen  213 GICGQLVDS-----IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR  270 (361)
T ss_pred             cchHhHHHH-----HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence            998755422     122224588899999998653  48999999999999999999999984

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-32  Score=263.51  Aligned_cols=199  Identities=28%  Similarity=0.382  Sum_probs=163.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~  306 (452)
                      .++|...+.||+|+||.||+|+...+|+.||+|.+...  .......+.+|+++++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            46899999999999999999999888999999998643  22234568899999999999999999988643221 2223


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|+||+. .++..+..             ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus        94 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG-------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             eEEEEecccc-cCHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            5689999995 46766542             2478888999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.....       .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus       157 kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~  216 (342)
T cd07879         157 KILDFGLARHADAE-------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK  216 (342)
T ss_pred             EEeeCCCCcCCCCC-------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence            99999998754321       112457889999998766 468899999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-32  Score=263.86  Aligned_cols=201  Identities=26%  Similarity=0.354  Sum_probs=166.6

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~  305 (452)
                      ..++|+..+.||+|+||.||++....+|+.||||++....  ....+.+.+|++++++++||||+++++++..... ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999998899999999985332  2233568899999999999999999987543211 112


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++|+||+ +++|.+++..            ..+++..+..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~------------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~  156 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH------------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCE  156 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCC
Confidence            3468999999 7899888753            2478889999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++.......       ....+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.
T Consensus       157 ~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  217 (343)
T cd07880         157 LKILDFGLARQTDSEM-------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK  217 (343)
T ss_pred             EEEeecccccccccCc-------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999987543211       12357889999998765 457889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-33  Score=247.91  Aligned_cols=200  Identities=25%  Similarity=0.370  Sum_probs=172.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~  305 (452)
                      ..+|...++||+|+|++|..++++.+.+.+|+|++++.   ..+..+-.+.|-.+...- +||.+|.+..+     |+..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqte  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQTE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hccc
Confidence            35788999999999999999999999999999999743   334445566777666665 89999999876     6777


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++|.||.+||+|--+++..           .+++++.+..+...|+.||.|||+.   ||+.||||.+|||+|.+|+
T Consensus       324 srlffvieyv~ggdlmfhmqrq-----------rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaegh  389 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQ-----------RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGH  389 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhh-----------hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCc
Confidence            7899999999999998776544           3789999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|+.|||+++.--.....    ....+|||.|.|||++.+..|+...|.|++||+++||+.|+.|||
T Consensus       390 ikltdygmcke~l~~gd~----tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  390 IKLTDYGMCKEGLGPGDT----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             eeecccchhhcCCCCCcc----cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence            999999999743222222    234789999999999999999999999999999999999999997

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.98  E-value=3.2e-33  Score=265.68  Aligned_cols=197  Identities=22%  Similarity=0.373  Sum_probs=170.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--------ccHHHHHHHHHHHhcCC---CCCceeEeeeecc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--------GASKSFMAECKALKNIR---HKNLVRVITSCSS  299 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~---h~niv~l~~~~~~  299 (452)
                      .+|...+.+|+|+||.|+.|.++.+..+|+||.+.+.+.        ...-....||.+|+.++   |+||++++.+   
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf---  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF---  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe---
Confidence            468889999999999999999999999999999864431        11224678999999997   9999999998   


Q ss_pred             ccCCCCceeEEEEeccC-CCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          300 VDFQGNDFKAIVYKYMP-NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       300 ~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                        |++++++|++||-.. +-+|.+||...           ..+++.++.-|++|++.|+++||++   +|||||||-+||
T Consensus       638 --FEddd~yyl~te~hg~gIDLFd~IE~k-----------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenv  701 (772)
T KOG1152|consen  638 --FEDDDYYYLETEVHGEGIDLFDFIEFK-----------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENV  701 (772)
T ss_pred             --eecCCeeEEEecCCCCCcchhhhhhcc-----------CccchHHHHHHHHHHHhcccccccc---CceecccccccE
Confidence              888999999999884 45899998654           4789999999999999999999998   999999999999


Q ss_pred             eecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       379 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++.+|-+||+|||.|.+.......      ..+||..|.|||++.+.+| +...|||++|++||.++....||.
T Consensus       702 ivd~~g~~klidfgsaa~~ksgpfd------~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  702 IVDSNGFVKLIDFGSAAYTKSGPFD------VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEecCCeEEEeeccchhhhcCCCcc------eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999999999765533222      2569999999999999887 556999999999999999999983

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.7e-31  Score=255.39  Aligned_cols=193  Identities=28%  Similarity=0.395  Sum_probs=161.5

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      |...+.||+|+||+||+|+...+|+.|++|.+.....   ...+.+.+|+++++.++|||++++.+++.     +.+..+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence            5556789999999999999988999999999974432   22356789999999999999999999854     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+. |++.+++....          ..+++.++..++.|++.|++|||+.   +++|+||+|+||++++++.+||+
T Consensus        98 lv~e~~~-~~l~~~l~~~~----------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~  163 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHK----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA  163 (313)
T ss_pred             EEEecCC-CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEe
Confidence            9999995 67877775332          3578899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.....        .....|+..|+|||.+.   ...++.++|||||||++|||++|+.||.
T Consensus       164 dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         164 DFGSASKSSP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             ecCCCcccCC--------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9998853221        11245889999999874   4568889999999999999999999973

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=4.5e-32  Score=261.24  Aligned_cols=199  Identities=21%  Similarity=0.275  Sum_probs=159.2

Q ss_pred             Cceecc--CceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVG--SFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      ..||+|  +||+||++++..+|+.||+|++.....  +..+.+.+|+.+++.++||||+++++++     ...+..++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence            346666  899999999988999999999875432  2346788999999999999999999984     4456789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+.++++.+++....         ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++||+
T Consensus        79 e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          79 PFMAYGSANSLLKTYF---------PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             ecccCCCHHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence            9999999999987542         13478888899999999999999997   99999999999999999999999998


Q ss_pred             cccccccCCCCc---eeccccccccccccCccccCCC--CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          393 LSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLGS--EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+..........   ........++..|+|||++.+.  .++.++|||||||++|||++|+.||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~  211 (328)
T cd08226         147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ  211 (328)
T ss_pred             HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            654322111110   0001112356679999998763  47899999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=6.1e-32  Score=261.12  Aligned_cols=202  Identities=26%  Similarity=0.391  Sum_probs=162.9

Q ss_pred             cCCC-CCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--------------HHHHHHHHHHHhcCCCCCceeEee
Q 041632          231 DGFS-STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--------------SKSFMAECKALKNIRHKNLVRVIT  295 (452)
Q Consensus       231 ~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~ei~~l~~l~h~niv~l~~  295 (452)
                      ++|. ..+.||+|+||+||+|+...+++.||+|.+.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4454 3477999999999999998889999999986432211              125789999999999999999999


Q ss_pred             eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       296 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                      ++     ...+..+++|||++ |+|.+++...           ..+++.....++.|++.||+|||+.   +++|+||+|
T Consensus        88 ~~-----~~~~~~~lv~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~  147 (335)
T PTZ00024         88 VY-----VEGDFINLVMDIMA-SDLKKVVDRK-----------IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSP  147 (335)
T ss_pred             EE-----ecCCcEEEEEeccc-cCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            84     34557899999996 7999888543           2578889999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCC----------CceeccccccccccccCccccCCC-CCCcccceeehhHHHHHH
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSN----------PTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEM  444 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~el  444 (452)
                      +||+++.++.+||+|||.++.......          ..........+++.|+|||.+.+. .++.++||||+||++|||
T Consensus       148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el  227 (335)
T PTZ00024        148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL  227 (335)
T ss_pred             HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence            999999999999999999875541110          000111123468889999988764 468899999999999999


Q ss_pred             HhCCCCCC
Q 041632          445 VTTKKPTD  452 (452)
Q Consensus       445 ltg~~Pf~  452 (452)
                      +||+.||.
T Consensus       228 ~tg~~p~~  235 (335)
T PTZ00024        228 LTGKPLFP  235 (335)
T ss_pred             HhCCCCCC
Confidence            99999983

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=5.5e-32  Score=259.02  Aligned_cols=193  Identities=25%  Similarity=0.279  Sum_probs=154.7

Q ss_pred             CceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCCCCh
Q 041632          243 SFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSL  320 (452)
Q Consensus       243 ~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL  320 (452)
                      ++|.||.++...+++.||+|++...  .....+.+..|++.++.++||||++++++     +.+.+..+++|||+++|+|
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~-----~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS-----FIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhe-----eecCCeEEEEEeccCCCCH
Confidence            3455555555558999999999754  23445689999999999999999999987     4455678999999999999


Q ss_pred             hhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccC
Q 041632          321 EKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV  400 (452)
Q Consensus       321 ~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  400 (452)
                      .+++....         ...+++.....++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+......
T Consensus        87 ~~~l~~~~---------~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~  154 (314)
T cd08216          87 EDLLKTHF---------PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKH  154 (314)
T ss_pred             HHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccc
Confidence            99987532         13477888899999999999999998   9999999999999999999999999988754322


Q ss_pred             CCC---ceeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          401 SNP---TVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       401 ~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ...   .........++..|+|||++..  ..++.++|||||||++|||++|+.||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~  211 (314)
T cd08216         155 GKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK  211 (314)
T ss_pred             cccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence            111   0011123457888999999865  357889999999999999999999984

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=3.4e-34  Score=246.72  Aligned_cols=207  Identities=26%  Similarity=0.409  Sum_probs=174.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEee--ccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC---
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN---  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~---  305 (452)
                      +.|+....||+|.||+||+|+.+.+|+.||+|++-  ..+.+......+|++++..++|+|++.+++.|........   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666788999999999999999999999998764  3455667788999999999999999999999977543332   


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...|+|+++|+ -+|...|....          .+++..+..+++.++..||.|+|..   .|+|||+||.|+||+.++.
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~----------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgi  162 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRK----------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGI  162 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCcc----------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCce
Confidence            34789999994 57777775443          5788899999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +||+|||+++.+....+....+-...+-|..|.+||.+.+. .|+++.|||+.||++.||+||.+-+
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim  229 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM  229 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence            99999999987775554444444456679999999998774 6899999999999999999998644

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=6.3e-32  Score=256.43  Aligned_cols=200  Identities=26%  Similarity=0.357  Sum_probs=162.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++..+++.||||.++.... .....+..|++.+.+. .||||+++++++.     +...
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~   88 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSD   88 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCe
Confidence            4678889999999999999999987899999999975432 2335567788777666 5999999999853     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++|||+ ++++.+++....          ..+++..+..++.|++.||+|||+.  .+|+||||+|+||++++++.+|
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~k  155 (296)
T cd06618          89 VFICMELM-STCLDKLLKRIQ----------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVK  155 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEE
Confidence            89999998 457776654321          3688889999999999999999973  2899999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCC----CCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE----VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++..+......     ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||+
T Consensus       156 L~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  219 (296)
T cd06618         156 LCDFGISGRLVDSKAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK  219 (296)
T ss_pred             ECccccchhccCCCcc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence            9999998755422111     1234788999999987553    7889999999999999999999984

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=6.7e-32  Score=257.69  Aligned_cols=193  Identities=29%  Similarity=0.406  Sum_probs=161.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .|+..+.||+|+||.||+|+...+++.+|+|.+....   .....++.+|+++++.++|+|++++.+++.     .....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCee
Confidence            3666788999999999999998889999999986432   223456889999999999999999999854     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||+. |++.+++....          ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~----------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl  156 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL  156 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEE
Confidence            99999995 68877764322          3478889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||++......        ....+++.|+|||.+.   ...++.++|||||||++|||++|+.||
T Consensus       157 ~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~  214 (308)
T cd06634         157 GDFGSASIMAPA--------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  214 (308)
T ss_pred             CCcccceeecCc--------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCC
Confidence            999998754321        1234788999999864   356788999999999999999999997

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-33  Score=256.69  Aligned_cols=206  Identities=30%  Similarity=0.437  Sum_probs=170.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-------GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      ++|-...+||+|||++||+|......+.||||+-...+.       ...+...+|.++.+.+.||.||++++++.    -
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs----l  538 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS----L  538 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee----e
Confidence            456667889999999999999988899999998753321       11244678999999999999999999853    2


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-  382 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-  382 (452)
                      +.+..|-|+|||+|.+|+-||+..+           .+++.++..|+.||+.||.||.+. +++|+|-||||.|||+-+ 
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhk-----------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~G  606 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHK-----------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNG  606 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhh-----------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecC
Confidence            3456789999999999999998775           688899999999999999999985 689999999999999954 


Q ss_pred             --CCceEECccccccccccCCCCceecc---ccccccccccCccccCCC----CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 --DLSAHIGDFGLSRFYQAVSNPTVSSS---IGVRGTIGYVAPEYGLGS----EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 --~~~~kl~Dfgla~~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                        .|.+||.|||+++.++..........   ....||.+|++||.+.-.    ..+.|+||||.||++|..+.|+.||.
T Consensus       607 tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG  685 (775)
T KOG1151|consen  607 TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG  685 (775)
T ss_pred             cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence              57899999999998875544322111   234599999999976433    47889999999999999999999994

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=7e-32  Score=254.18  Aligned_cols=197  Identities=29%  Similarity=0.441  Sum_probs=166.0

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |+..+.||+|++|.||++....+|+.+++|.++....  .....+.+|++++++++|+|++++++.+     ...+..++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence            5667889999999999999988899999999874432  3456788999999999999999999884     34567899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++||++ +++.+++....          ..+++.++..++.|++.||+|||+.   +|+|+||||+||++++++.+||+|
T Consensus        76 v~e~~~-~~l~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d  141 (283)
T cd05118          76 VFEFMD-TDLYKLIKDRQ----------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLAD  141 (283)
T ss_pred             EEeccC-CCHHHHHHhhc----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEee
Confidence            999996 58888876432          3688999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.+........    ......++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||.
T Consensus       142 f~~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~  200 (283)
T cd05118         142 FGLARSFGSPVR----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP  200 (283)
T ss_pred             eeeeEecCCCcc----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            999876543321    11123478899999998776 78999999999999999999999983

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-32  Score=259.22  Aligned_cols=199  Identities=24%  Similarity=0.322  Sum_probs=160.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeec--cCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..|++.+.||+||.++||++... +.+.+|+|++..  .+.....-|.+|++.|.++ .|.+|++++++-     -.+++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            45888999999999999999875 456777776642  2334457899999999999 699999999883     23568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||= ..+|..+|++...         ....| .+..+..||+.++.++|.+   ||||-||||.|+|+-. |.+|
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~---------~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LK  499 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKS---------IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLK  499 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccC---------CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEE
Confidence            99999976 7799999986541         12223 6788999999999999998   9999999999999965 5899


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-----------CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-----------EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|..+..+...  ......+||+.||+||.+...           +.+.++||||+||+||+|+.|+.||.
T Consensus       500 LIDFGIA~aI~~DTTs--I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~  573 (677)
T KOG0596|consen  500 LIDFGIANAIQPDTTS--IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG  573 (677)
T ss_pred             eeeechhcccCccccc--eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence            9999999876643322  223357899999999986432           25678999999999999999999983

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-31  Score=252.63  Aligned_cols=196  Identities=28%  Similarity=0.404  Sum_probs=163.3

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |.+.+.||+|++|+||+|+...+++.|++|.+...... ......+|+..+++++ |||++++++.+     .+++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEEE
Confidence            56678999999999999999888999999998644322 2234567999999998 99999999884     34568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+ +|+|.+++....         ...+++.++..++.|++.+|.|||+.   +++|+||+|+||++++++.++|+|
T Consensus        76 v~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d  142 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRK---------GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIAD  142 (283)
T ss_pred             EEecC-CCCHHHHHHhcc---------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEee
Confidence            99999 889998886432         23678999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||.+.........     ....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||
T Consensus       143 ~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~  199 (283)
T cd07830         143 FGLAREIRSRPPY-----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF  199 (283)
T ss_pred             cccceeccCCCCc-----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc
Confidence            9998765432111     12457889999998754 45789999999999999999999988

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=278.26  Aligned_cols=217  Identities=26%  Similarity=0.427  Sum_probs=172.1

Q ss_pred             HHhhcCCCCCCceeccCceeEEEEEEc---C----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeee
Q 041632          227 LKATDGFSSTNLIGVGSFGSVYKGVFD---E----DGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSC  297 (452)
Q Consensus       227 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~  297 (452)
                      +...++..+.+.+|+|+||.|++|...   .    ....||||.++.... ...+.+..|+++|+.+ .|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            334445566679999999999999853   1    145799999974433 3457899999999999 699999999998


Q ss_pred             ccccCCCCceeEEEEeccCCCChhhhhcCCC---CCCccccccc--ccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecc
Q 041632          298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA---IPQRDREIEI--QKLTLLQRISIAIDVASALDYLHQHCQEPILHCD  372 (452)
Q Consensus       298 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D  372 (452)
                      ..     .+..++|+||+..|+|.+|++..+   ........+.  ..++..+.+.++.|||.||+||++.   ++||||
T Consensus       372 t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD  443 (609)
T KOG0200|consen  372 TQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD  443 (609)
T ss_pred             cc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence            65     457899999999999999998776   1111101112  2499999999999999999999998   999999


Q ss_pred             cCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          373 LKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       373 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      |.++|||++++..+||+|||+|+................ -+..|||||.+....|+.++|||||||+|||++| |..||
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence            999999999999999999999985543332221111111 3556999999999999999999999999999999 88887


Q ss_pred             C
Q 041632          452 D  452 (452)
Q Consensus       452 ~  452 (452)
                      .
T Consensus       523 p  523 (609)
T KOG0200|consen  523 P  523 (609)
T ss_pred             C
Confidence            3

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=7.3e-32  Score=254.95  Aligned_cols=198  Identities=28%  Similarity=0.399  Sum_probs=164.0

Q ss_pred             CCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR----QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~  303 (452)
                      +|++.+.||+|++|.||+++..   .+++.||||.++...    ....+.+.+|++++.++ +||||+++.+.     +.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA-----FQ   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhee-----ee
Confidence            3677889999999999998863   357889999986432    22345688999999999 69999999877     45


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .+...++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~  141 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR-----------EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSE  141 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc-----------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC
Confidence            566789999999999999988643           2578888999999999999999997   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCC--CCcccceeehhHHHHHHHhCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE--VSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +.++|+|||+++........   ......|+..|+|||...+..  .+.++||||||+++|||+||..||
T Consensus       142 ~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~  208 (288)
T cd05583         142 GHVVLTDFGLSKEFLAEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF  208 (288)
T ss_pred             CCEEEEECcccccccccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence            99999999998765432211   112245889999999977654  788999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1e-31  Score=252.92  Aligned_cols=197  Identities=32%  Similarity=0.483  Sum_probs=166.6

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      |+..+.||+|++|.||+|+...+++.||+|.+....  ....+.+..|++.++.++|+|++++.+++     .+.+..++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence            456678999999999999999889999999997543  34456788999999999999999999884     34467899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |+||++ ++|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||+|+||++++++.+||+|
T Consensus        76 v~e~~~-~~l~~~i~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d  141 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP----------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLAD  141 (282)
T ss_pred             EecCcC-cCHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEec
Confidence            999997 69999987532          3588999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||.++........    .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus       142 ~g~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~  200 (282)
T cd07829         142 FGLARAFGIPLRT----YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP  200 (282)
T ss_pred             CCcccccCCCccc----cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9998765432211    1123457789999998766 78999999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-31  Score=247.38  Aligned_cols=191  Identities=32%  Similarity=0.467  Sum_probs=164.7

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      ||+|+||.||++....+++.+|+|.++....   ...+.+..|+++++.++|||++++++.     ++.++..+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-----~~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-----FQTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-----eecCCeeEEEEecC
Confidence            6899999999999988899999999875432   234678999999999999999999877     45567889999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ++++|.+++....           .+++.....++.|++.|+.|||+.   +++|+||+|+||++++++.++|+|||.+.
T Consensus        76 ~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~  141 (250)
T cd05123          76 PGGELFSHLSKEG-----------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAK  141 (250)
T ss_pred             CCCcHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcce
Confidence            9999999986432           578899999999999999999997   99999999999999999999999999987


Q ss_pred             ccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       396 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .......    ......++..|+|||...+...+.++|+||||+++|||++|+.||+
T Consensus       142 ~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~  194 (250)
T cd05123         142 ELSSEGS----RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY  194 (250)
T ss_pred             ecccCCC----cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            6543211    1123457889999999988888999999999999999999999985

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.5e-31  Score=245.40  Aligned_cols=180  Identities=23%  Similarity=0.200  Sum_probs=151.4

Q ss_pred             cCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCCCChh
Q 041632          242 GSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLE  321 (452)
Q Consensus       242 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~  321 (452)
                      |.+|.||+++...+++.+|+|.+....     .+..|...+....|||++++++.     +.+.+..+++|||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKY-----IVSEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhh-----eecCCeEEEEEecCCCCCHH
Confidence            899999999999999999999996542     23345555556679999999987     34456889999999999999


Q ss_pred             hhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCC
Q 041632          322 KWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS  401 (452)
Q Consensus       322 ~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  401 (452)
                      +++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.......
T Consensus        74 ~~l~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~  139 (237)
T cd05576          74 SHISKF-----------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC  139 (237)
T ss_pred             HHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc
Confidence            998643           2488999999999999999999997   99999999999999999999999999876543211


Q ss_pred             CCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       402 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                             ....++..|+|||...+..++.++||||+|+++|||++|+.||+
T Consensus       140 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         140 -------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             -------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence                   12335778999999888889999999999999999999998763

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-32  Score=267.30  Aligned_cols=213  Identities=25%  Similarity=0.352  Sum_probs=182.9

Q ss_pred             ChHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          222 SYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       222 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++.+-..++-|++.+.||.|.+|.||+++.+.+++.+|+|+++..... .++...|.++++.. .|||++.++|++.-.
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3344444567899999999999999999999999999999999755443 36778888999888 799999999998877


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                      +-..++..|+|||||.+||..+.++...         ...+.|....-|++.++.|+.+||..   .++|||||-.|||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~---------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLL  156 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK---------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLL  156 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc---------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEE
Confidence            7777889999999999999999987654         35788888999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +.++.||+.|||++..++.......    ...|||.|||||++.-     ..|+.++|+||+|++..||.-|.+|+
T Consensus       157 T~e~~VKLvDFGvSaQldsT~grRn----T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl  228 (953)
T KOG0587|consen  157 TENAEVKLVDFGVSAQLDSTVGRRN----TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL  228 (953)
T ss_pred             eccCcEEEeeeeeeeeeeccccccc----CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence            9999999999999987765443332    3569999999999753     35788999999999999999999997

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.4e-31  Score=249.01  Aligned_cols=201  Identities=26%  Similarity=0.337  Sum_probs=163.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc-----CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-----RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      +|.+.+.||+|+||+||+++....+..+++|.++..     .......+..|+.+++.++|||++++++.+     .+.+
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hcCC
Confidence            477889999999999999998766666666666421     122334677899999999999999999874     3445


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++++||+++++|.+++....       .....+++.+++.++.|++.|++|||+.   +++|+||||+||++++ +.+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~  144 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELK-------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLL  144 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHh-------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCE
Confidence            7899999999999999886422       1224689999999999999999999998   9999999999999976 569


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++.........    .....|++.|+|||...+..++.++|+||||+++|+|++|+.||+
T Consensus       145 ~l~d~g~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         145 KIGDFGVSRLLMGSCDL----ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             eecccCceeecCCCccc----ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999998765322111    112457889999999888888999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9.9e-32  Score=260.38  Aligned_cols=201  Identities=27%  Similarity=0.370  Sum_probs=166.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~  305 (452)
                      ..++|+..+.||+|++|.||+|++..+++.||+|++...  .....+.+.+|+.+++.++|||++++.+++..... ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999888999999998643  22334567889999999999999998876432221 122


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++|+||+ +++|.+++..            ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~  156 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC------------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCE  156 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCC
Confidence            3478999999 7799988853            3588999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++......       .....++..|+|||...+ ..++.++|||||||++|||+||+.||.
T Consensus       157 ~kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         157 LKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             EEEcccccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            999999998755321       122357889999998755 367889999999999999999999983

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.2e-31  Score=277.61  Aligned_cols=146  Identities=32%  Similarity=0.463  Sum_probs=128.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|.+.+.||+|+||+||+|++..+++.||+|+++....   .....+..|+.+++.++||||+++++.+     ...+.
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECCE
Confidence            578889999999999999999998899999999974322   2236788999999999999999999774     34557


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++....           .+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        79 ~~lVmEy~~g~~L~~li~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vk  144 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIYG-----------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIK  144 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEE
Confidence            899999999999999986432           477888999999999999999998   999999999999999999999


Q ss_pred             ECcccccc
Q 041632          388 IGDFGLSR  395 (452)
Q Consensus       388 l~Dfgla~  395 (452)
                      |+|||+++
T Consensus       145 L~DFGls~  152 (669)
T cd05610         145 LTDFGLSK  152 (669)
T ss_pred             EEeCCCCc
Confidence            99999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-33  Score=261.38  Aligned_cols=198  Identities=25%  Similarity=0.367  Sum_probs=172.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .+++....||-||||.|-..+.......+|+|++++.   +....+....|-.+|...+.|.||+++-.     |.+..+
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccchh
Confidence            3456677899999999999998755556899988643   34445677889999999999999999876     778889


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|++||-|-||.++..|+...           .++......++..+++|++|||+.   +||.|||||+|.+++.+|-+|
T Consensus       495 vYmLmEaClGGElWTiLrdRg-----------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~K  560 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRG-----------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLK  560 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcC-----------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceE
Confidence            999999999999999997654           577778888999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |.|||+|+.+.....     ....+|||.|.|||++....++.++|.||+|+++|||+||.+||.
T Consensus       561 LVDFGFAKki~~g~K-----TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs  620 (732)
T KOG0614|consen  561 LVDFGFAKKIGSGRK-----TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFS  620 (732)
T ss_pred             EeehhhHHHhccCCc-----eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCC
Confidence            999999998764332     344789999999999999999999999999999999999999994

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=259.85  Aligned_cols=192  Identities=26%  Similarity=0.332  Sum_probs=162.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +++|+....+|.|+|+.|.++.+..+++..+||++....    .+-.+|+.++... +||||+++.+.     +.+....
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCCcee
Confidence            567888888999999999999999999999999997552    2335677666666 79999999988     4556789


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee-cCCCceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL-DNDLSAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill-~~~~~~k  387 (452)
                      |+|||.+.++-+.+.+....           ... .++..|+.+|+.|+.|||++   |||||||||+|||+ ++.++++
T Consensus       392 ~~v~e~l~g~ell~ri~~~~-----------~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lr  456 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP-----------EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLR  456 (612)
T ss_pred             eeeehhccccHHHHHHHhcc-----------hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEE
Confidence            99999999998887775432           222 56778999999999999998   99999999999999 5899999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||.++.....       ....+-|..|.|||++....|+++||+||||++||||++|+.||.
T Consensus       457 ltyFG~a~~~~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~  514 (612)
T KOG0603|consen  457 LTYFGFWSELERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFA  514 (612)
T ss_pred             EEEechhhhCchh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccc
Confidence            9999999866533       122346889999999999999999999999999999999999984

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.4e-33  Score=240.78  Aligned_cols=201  Identities=26%  Similarity=0.349  Sum_probs=162.8

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeec--cCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+..+.||-|+||.||...+..+|+.||.|++..  ..-...+.+.+|++++..++|.|++..++.........-.+.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            4456889999999999999999999999999863  23344578899999999999999998877643222111124678


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ++|.| ..+|...|-.           .+.++...+.-+.+||++||.|||+.   +|.||||||.|.|++.+..+||+|
T Consensus       135 ~TELm-QSDLHKIIVS-----------PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICD  199 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVS-----------PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICD  199 (449)
T ss_pred             HHHHH-Hhhhhheecc-----------CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecc
Confidence            88988 6678776643           35788888889999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+++.-+......   +...+-|..|.|||++.+. .|+.+.||||.||++.|++.++.-|
T Consensus       200 FGLARvee~d~~~h---MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF  258 (449)
T KOG0664|consen  200 FGLARTWDQRDRLN---MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF  258 (449)
T ss_pred             cccccccchhhhhh---hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence            99998655433222   2334578999999998885 5899999999999999999877654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.8e-30  Score=258.13  Aligned_cols=217  Identities=23%  Similarity=0.288  Sum_probs=156.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEc----------------CCCcEEEEEEeeccCCccHHH--------------HHHH
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFD----------------EDGTVVAIKVINLQRQGASKS--------------FMAE  278 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  278 (452)
                      ..++|++.+.||+|+||+||+|...                ..++.||||++........++              +..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                245689999987544332233              3457


Q ss_pred             HHHHhcCCCCCc-----eeEeeeecccc---CCCCceeEEEEeccCCCChhhhhcCCCCCC-------------cccccc
Q 041632          279 CKALKNIRHKNL-----VRVITSCSSVD---FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQ-------------RDREIE  337 (452)
Q Consensus       279 i~~l~~l~h~ni-----v~l~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~  337 (452)
                      +.++.+++|.++     ++++++|....   ....+..++||||+++++|.++++......             ......
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876654     56666654321   112346799999999999999997532100             001112


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccc
Q 041632          338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY  417 (452)
Q Consensus       338 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y  417 (452)
                      ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........   .....+|+.|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~---~~~g~~tp~Y  376 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN---PLYGMLDPRY  376 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC---ccccCCCcce
Confidence            24567888999999999999999998   99999999999999999999999999987543221111   1112357899


Q ss_pred             cCccccCCCC--------------------C--CcccceeehhHHHHHHHhCCC-CC
Q 041632          418 VAPEYGLGSE--------------------V--STNGDVYSYGILLLEMVTTKK-PT  451 (452)
Q Consensus       418 ~aPE~~~~~~--------------------~--~~~~DvwSlGv~l~elltg~~-Pf  451 (452)
                      +|||.+....                    +  ..+.||||+||++|||++|.. ||
T Consensus       377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~  433 (507)
T PLN03224        377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV  433 (507)
T ss_pred             eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence            9999865422                    1  124799999999999999875 65

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=243.52  Aligned_cols=196  Identities=26%  Similarity=0.355  Sum_probs=164.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-C-CC----ceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-H-KN----LVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h-~n----iv~l~~~~~~~~~~  303 (452)
                      +.+|.+...+|+|.||.|-.+....++..||||+++.-. ...+..+.|++++.++. + |+    ++++.++     |.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence            678999999999999999999998889999999997432 23356678999999993 2 22    4555555     66


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-  382 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-  382 (452)
                      ..+..|||+|.+ |-|+.+|+....         ...++...+..|+.|++++++|||+.   +++|.||||+|||+.+ 
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~---------y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss  228 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENN---------YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS  228 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCC---------ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence            778899999999 889999998754         35788999999999999999999998   9999999999999942 


Q ss_pred             -------------------CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHH
Q 041632          383 -------------------DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE  443 (452)
Q Consensus       383 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e  443 (452)
                                         +..+||+|||.|++-....       ...+.|..|.|||++.+-.++.++||||+||+|+|
T Consensus       229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E  301 (415)
T KOG0671|consen  229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE  301 (415)
T ss_pred             ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-------ceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence                               3458999999998644222       22467999999999999999999999999999999


Q ss_pred             HHhCCCCC
Q 041632          444 MVTTKKPT  451 (452)
Q Consensus       444 lltg~~Pf  451 (452)
                      +.||..-|
T Consensus       302 lytG~~LF  309 (415)
T KOG0671|consen  302 LYTGETLF  309 (415)
T ss_pred             eeccceec
Confidence            99998765

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=7.1e-30  Score=260.05  Aligned_cols=214  Identities=23%  Similarity=0.263  Sum_probs=145.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCC----CcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeecc-ccCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDED----GTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSS-VDFQ  303 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~-~~~~  303 (452)
                      ..++|+..+.||+|+||.||+|++..+    +..||+|++....  ..+.+..|  .+....+.++..+...+.. ....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457899999999999999999999888    8999999875322  11222222  1222222333322221111 1113


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCc---------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQR---------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK  374 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk  374 (452)
                      .....++|+||+++++|.+++........         .............+..++.|++.||+|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            45678999999999999999875431100         0000011122344667999999999999998   99999999


Q ss_pred             CCCeeecC-CCceEECccccccccccCCCCceeccccccccccccCccccCCC----------------------CCCcc
Q 041632          375 PSNILLDN-DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS----------------------EVSTN  431 (452)
Q Consensus       375 ~~Nill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  431 (452)
                      |+|||+++ ++.+||+|||+|+........   ......+++.|+|||.+...                      .++.+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~---~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY---IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccccc---CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999986 579999999999865422211   11235689999999964321                      23456


Q ss_pred             cceeehhHHHHHHHhCCCCCC
Q 041632          432 GDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       432 ~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||||||++|||+++..|++
T Consensus       360 ~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCc
Confidence            799999999999999877653

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.3e-29  Score=230.12  Aligned_cols=199  Identities=31%  Similarity=0.473  Sum_probs=168.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      |...+.||+|++|.||++....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++.+.     ..+..+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            45668899999999999999877899999999865544 5678999999999999999999998843     33578899


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +||+++++|.+++....          ..+++.....++.+++.+++|||+.   +++|+|++|+||+++.++.++|+||
T Consensus        76 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~  142 (225)
T smart00221       76 MEYCEGGDLFDYLRKKG----------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADF  142 (225)
T ss_pred             EeccCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeC
Confidence            99999999999986543          1178889999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCcccc-CCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG-LGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |.+.........   ......++..|++||.. ....++.++|||+||+++|||++|+.||+
T Consensus       143 g~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      143 GLARFIHRDLAA---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ceeeEecCcccc---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            998866533200   11224578889999998 66678889999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-30  Score=234.96  Aligned_cols=215  Identities=24%  Similarity=0.356  Sum_probs=171.0

Q ss_pred             HHHHhhcCCCCCCceeccCceeEEEEEEcCCC-----cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeec
Q 041632          225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDG-----TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCS  298 (452)
Q Consensus       225 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~  298 (452)
                      ++....++++....+.+|.||+||+|.|++..     +.|-+|.++.... -....+..|.-.+....|||+.++.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            33344466777788999999999999886433     3466676653322 22356788888889999999999999986


Q ss_pred             cccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       299 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                      +    +....+++|.++.-|+|..||...+   .+.....+.++..+...++.|++.|++|||+.   +|||.||.++|+
T Consensus       358 e----~~~~P~V~y~~~~~gNLK~FL~~Cr---~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC  427 (563)
T KOG1024|consen  358 E----DYATPFVLYPATGVGNLKSFLQICR---GDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC  427 (563)
T ss_pred             e----ccCcceEEEeccCcchHHHHHHHhc---cCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence            4    3456788999999999999998544   22334457788899999999999999999998   999999999999


Q ss_pred             eecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       379 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      +||+...+||+|=.+++.+-+.+......  ....+..||+||.+....|+.++|||||||+||||+| |+.|+
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGD--nEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py  499 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGD--NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY  499 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCC--CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc
Confidence            99999999999999988554332221111  1235778999999999999999999999999999999 99987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=7.7e-29  Score=227.36  Aligned_cols=186  Identities=36%  Similarity=0.517  Sum_probs=161.3

Q ss_pred             CceeEEEEEEcCCCcEEEEEEeeccCCcc-HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCCCChh
Q 041632          243 SFGSVYKGVFDEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLE  321 (452)
Q Consensus       243 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~  321 (452)
                      +||.||+|++..+|+.+|+|++....... .+.+.+|++.+++++|+|++++.+.+.     .....++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence            58999999998889999999997655444 678999999999999999999998853     335789999999999999


Q ss_pred             hhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCC
Q 041632          322 KWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS  401 (452)
Q Consensus       322 ~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  401 (452)
                      +++....           .+++..++.++.+++.+++|||+.   +++|+||+|+||++++++.++++|||.+.......
T Consensus        76 ~~~~~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~  141 (244)
T smart00220       76 DLLKKRG-----------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG  141 (244)
T ss_pred             HHHHhcc-----------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc
Confidence            9986432           278889999999999999999998   99999999999999999999999999998655322


Q ss_pred             CCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       402 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                           ......++..|++||......++.++||||+|+++|+|++|..||+
T Consensus       142 -----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~  187 (244)
T smart00220      142 -----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP  187 (244)
T ss_pred             -----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                 1123457889999999888888999999999999999999999984

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4.8e-30  Score=218.21  Aligned_cols=195  Identities=23%  Similarity=0.423  Sum_probs=163.9

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCce
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..++|++.+.+|+|-|++||.|....+.+.++||+++..   ..+...+|+++|..+. ||||++++....+   +....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccC
Confidence            357899999999999999999998878899999999743   2367889999999996 9999999987543   22345


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-Cce
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-LSA  386 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~  386 (452)
                      ..+++||..+.+....-              ++++..+..-++.+++.||+|+|++   ||.|||+||+|++||.. -.+
T Consensus       110 paLiFE~v~n~Dfk~ly--------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY--------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             chhHhhhhccccHHHHh--------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence            67999999888876543              4677778889999999999999999   99999999999999965 469


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|+|||+|.++.+...-..     .+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||
T Consensus       173 rlIDWGLAEFYHp~~eYnV-----RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF  233 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEYNV-----RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  233 (338)
T ss_pred             eeeecchHhhcCCCceeee-----eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence            9999999998876544332     346778899998755 45888999999999999999999998

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-30  Score=253.05  Aligned_cols=197  Identities=31%  Similarity=0.445  Sum_probs=157.5

Q ss_pred             CCCCceeccCcee-EEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEEE
Q 041632          234 SSTNLIGVGSFGS-VYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       234 ~~~~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      ...+++|.|+.|+ ||+|.+  .|+.||||++-.   +..+...+|+..++.- +|||||++++.     -++....||.
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIa  581 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIA  581 (903)
T ss_pred             ccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEE
Confidence            3346789999875 899999  689999998852   3335668999999887 79999999876     4556789999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---C--Cce
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---D--LSA  386 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~--~~~  386 (452)
                      .|.| ..+|.+++....   .+    .........+.+..|++.||++||+.   +||||||||+||||+.   +  ..+
T Consensus       582 lELC-~~sL~dlie~~~---~d----~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra  650 (903)
T KOG1027|consen  582 LELC-ACSLQDLIESSG---LD----VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRA  650 (903)
T ss_pred             ehHh-hhhHHHHHhccc---cc----hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeE
Confidence            9999 789999998641   00    11111145677899999999999997   9999999999999976   3  468


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhC-CCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT-KKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf~  452 (452)
                      +|+|||+++........ ........||-+|+|||++....-+.++||||+||++|+.++| ..||.
T Consensus       651 ~iSDfglsKkl~~~~sS-~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG  716 (903)
T KOG1027|consen  651 KISDFGLSKKLAGGKSS-FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG  716 (903)
T ss_pred             EecccccccccCCCcch-hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence            99999999987644332 2233456699999999999998888899999999999999995 99984

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-29  Score=217.53  Aligned_cols=195  Identities=23%  Similarity=0.368  Sum_probs=158.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .+.|.+.+.+|+|.||.+-++.++++.+.+++|.++.. ....++|.+|..---.+ .|.||+.-++.    .|+..+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~v----aFqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEV----AFQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHH----HhhcCceE
Confidence            35789999999999999999999999999999998633 34457899987654445 58999887655    37777889


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec--CCCce
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD--NDLSA  386 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~  386 (452)
                      ++++||++.|+|..-+...            .+.+....+++.|+++|+.|||+.   .+||||||.+||||-  +...+
T Consensus        98 vF~qE~aP~gdL~snv~~~------------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rv  162 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA------------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRV  162 (378)
T ss_pred             EEeeccCccchhhhhcCcc------------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEE
Confidence            9999999999999866543            466677889999999999999998   999999999999994  34589


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCC-----CCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-----EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |++|||+.+.....-.       ...-+..|.+||+....     ...+.+|+|.||+++|..+||..||
T Consensus       163 KlcDFG~t~k~g~tV~-------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW  225 (378)
T KOG1345|consen  163 KLCDFGLTRKVGTTVK-------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW  225 (378)
T ss_pred             EeeecccccccCceeh-------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence            9999999875432211       12356779999975432     3577899999999999999999998

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=219.69  Aligned_cols=198  Identities=27%  Similarity=0.283  Sum_probs=163.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeec--cCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC-Cce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG-NDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~-~~~  307 (452)
                      .+|.-...+|.|+- .|..+.+.-.++.||+|.+..  ......++..+|...+..++|+|+++++.++....... -..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45667788899988 788888777889999998742  23344577889999999999999999998864432111 124


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+|||+| ..+|.+.+..             .++-.....+..|+++|+.|||+.   +|+||||||+||++..+..+|
T Consensus        96 ~y~v~e~m-~~nl~~vi~~-------------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lK  158 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILM-------------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLK  158 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHH-------------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhhee
Confidence            68999999 7889888762             467778889999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |.|||+|+.-...     .....++.|..|.|||++.+-.+.+.+||||.||++.||++|+.-|
T Consensus       159 i~dfg~ar~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf  217 (369)
T KOG0665|consen  159 ILDFGLARTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF  217 (369)
T ss_pred             eccchhhcccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence            9999999754322     3445678999999999999988999999999999999999998654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=8.1e-29  Score=239.50  Aligned_cols=198  Identities=28%  Similarity=0.423  Sum_probs=170.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.+|.|.||.|||++++.+++..|+|+++........-.+.|+-+++..+||||+.+++.+     ...+..+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-----lr~dklw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-----LRRDKLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-----hhhcCcE
Confidence            46789999999999999999999999999999999988777778889999999999999999999984     4455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +.||||.+|+|.+.-+-.           ..+++.+...+.+...+|++|||++   +-+|||||-.||++++.|.+|++
T Consensus        89 icMEycgggslQdiy~~T-----------gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvkla  154 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVT-----------GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLA  154 (829)
T ss_pred             EEEEecCCCcccceeeec-----------ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeec
Confidence            999999999998765432           3688888888999999999999998   88999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCcccc---CCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG---LGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      |||.+..+.+.    .....+..||+.|||||+-   ..+.|..+||||+.|+...|+-.-+.|
T Consensus       155 Dfgvsaqitat----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp  214 (829)
T KOG0576|consen  155 DFGVSAQITAT----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP  214 (829)
T ss_pred             ccCchhhhhhh----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence            99998755432    2223456799999999974   345789999999999999998776666

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=222.61  Aligned_cols=137  Identities=26%  Similarity=0.419  Sum_probs=115.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-----CC---CceeEeeeeccccC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-----HK---NLVRVITSCSSVDF  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----h~---niv~l~~~~~~~~~  302 (452)
                      .+|.+.++||-|.|++||++....+.+.||+|+.+. ..-..+....||++|++++     |+   .||+++..+.-. .
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs-G  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS-G  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec-C
Confidence            567888999999999999999999999999999973 3334467789999999883     33   589998875432 3


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ..+-+.|+|+|+. |.+|..+|....         -+.++...+.+|+.|++.||.|||..|  ||+|.||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~---------YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSN---------YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhC---------CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            5566899999999 889999987654         356888999999999999999999997  999999999999993

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.7e-26  Score=217.32  Aligned_cols=178  Identities=22%  Similarity=0.221  Sum_probs=133.6

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcC-CCcEEEEEEeecc-----CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDE-DGTVVAIKVINLQ-----RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..++|...+.||+|+||+||+|+++. +++.||||++...     .....+.+.+|++++++++|+|+++.+..     .
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-----~   90 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-----T   90 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-----c
Confidence            45679999999999999999999875 6788899987532     11234568999999999999999853322     1


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc-CCCCeeec
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL-KPSNILLD  381 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~  381 (452)
                         +..++||||+++++|... ...              .   ...++.|+++||+|||+.   ||+|||| ||+|||++
T Consensus        91 ---~~~~LVmE~~~G~~L~~~-~~~--------------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~  146 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLA-RPH--------------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG  146 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHh-Ccc--------------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence               246899999999999632 100              0   135788999999999998   9999999 99999999


Q ss_pred             CCCceEECccccccccccCCCCce----eccccccccccccCccccCCCC------CCccccee
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTV----SSSIGVRGTIGYVAPEYGLGSE------VSTNGDVY  435 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  435 (452)
                      .++.+||+|||+|+.+........    .......+++.|+|||++...+      .+..+|-|
T Consensus       147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999999999997653321111    0112456888999999876532      33446666

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.5e-25  Score=200.64  Aligned_cols=184  Identities=33%  Similarity=0.561  Sum_probs=155.7

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCC
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPN  317 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~  317 (452)
                      ||+|++|.||+++...+++.+++|++...... ..+.+.+|++.++.++|++++++++++.     .....++++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence            68999999999999877999999999754332 3467999999999999999999998843     33578999999999


Q ss_pred             CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CCceEECccccccc
Q 041632          318 GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DLSAHIGDFGLSRF  396 (452)
Q Consensus       318 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~Dfgla~~  396 (452)
                      ++|.+++....          ..+++..++.++.+++.++++||+.   +++|+||+|+||+++. ++.++|+|||.+..
T Consensus        76 ~~l~~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~  142 (215)
T cd00180          76 GSLKDLLKENE----------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKL  142 (215)
T ss_pred             CcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence            99999986431          3578899999999999999999998   9999999999999999 89999999999876


Q ss_pred             cccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHH
Q 041632          397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEM  444 (452)
Q Consensus       397 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~el  444 (452)
                      ......    ......+...|++||..... ..+.++|+|++|+++++|
T Consensus       143 ~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         143 LTSDKS----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             ccCCcc----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            543221    11224478889999998776 788999999999999987

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=4.5e-27  Score=221.43  Aligned_cols=199  Identities=25%  Similarity=0.288  Sum_probs=163.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC------CCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR------HKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~------h~niv~l~~~~~~~~~  302 (452)
                      ...+|.+....|+|-|++|.+|.....|..||||++... ....+.-+.|+++|++++      -.+.++++-.     |
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~-----F  503 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH-----F  503 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH-----h
Confidence            446788888999999999999999888999999999743 233356678999999984      3456666654     6


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ...++.|+|+|-. ..+|.+.|++...        .-.+....+..++.|+.-||..|-..   +|+|.||||+||||++
T Consensus       504 ~hknHLClVFE~L-slNLRevLKKyG~--------nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  504 KHKNHLCLVFEPL-SLNLREVLKKYGR--------NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE  571 (752)
T ss_pred             hhcceeEEEehhh-hchHHHHHHHhCc--------ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence            6677999999988 7799999986541        23466778899999999999999997   9999999999999997


Q ss_pred             C-CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          383 D-LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       383 ~-~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      . ..+||||||.|.......-      ..+.-+..|.|||++.+-+|+..-|+||.||+||||.||+.-|
T Consensus       572 ~k~iLKLCDfGSA~~~~enei------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF  635 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASENEI------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF  635 (752)
T ss_pred             CcceeeeccCccccccccccc------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence            6 4689999999875442211      1234577899999999999999999999999999999999876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=2.8e-26  Score=212.01  Aligned_cols=198  Identities=29%  Similarity=0.444  Sum_probs=163.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC---CCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE---DGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~  305 (452)
                      ...|...++||+|.|++||++....   .++.||+|.+...  .......+|+++|..+ .+.||+++.++     +..+
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~-----~rnn  107 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGC-----FRNN  107 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhh-----hccC
Confidence            4568888999999999999999876   6789999998644  3346789999999999 69999999987     6777


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-C
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-L  384 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~  384 (452)
                      +...+|+||++...-.++..              .++..++..++..+..||+++|..   |||||||||.|+|.+.. +
T Consensus       108 d~v~ivlp~~~H~~f~~l~~--------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~  170 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR--------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQ  170 (418)
T ss_pred             CeeEEEecccCccCHHHHHh--------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccC
Confidence            89999999999999888874              456778889999999999999998   99999999999999854 5


Q ss_pred             ceEECccccccccccCC-----------CCce--------------------e---------ccccccccccccCccccC
Q 041632          385 SAHIGDFGLSRFYQAVS-----------NPTV--------------------S---------SSIGVRGTIGYVAPEYGL  424 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~-----------~~~~--------------------~---------~~~~~~gt~~y~aPE~~~  424 (452)
                      .-.|.|||+|..++...           ....                    .         ......||++|.|||++.
T Consensus       171 rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~  250 (418)
T KOG1167|consen  171 RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLF  250 (418)
T ss_pred             CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHh
Confidence            67899999987221000           0000                    0         001356999999999987


Q ss_pred             CCC-CCcccceeehhHHHHHHHhCCCCC
Q 041632          425 GSE-VSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       425 ~~~-~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +.+ -+.+.||||.||++.-+++++.||
T Consensus       251 k~~~QttaiDiws~GVI~Lslls~~~PF  278 (418)
T KOG1167|consen  251 RCPRQTTAIDIWSAGVILLSLLSRRYPF  278 (418)
T ss_pred             hccCcCCccceeeccceeehhhcccccc
Confidence            754 588999999999999999999998

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=2.4e-24  Score=230.26  Aligned_cols=155  Identities=19%  Similarity=0.306  Sum_probs=113.3

Q ss_pred             cCCC-CCceeEeeeecccc--CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHH
Q 041632          284 NIRH-KNLVRVITSCSSVD--FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL  360 (452)
Q Consensus       284 ~l~h-~niv~l~~~~~~~~--~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  360 (452)
                      .++| +||.++++++....  .......+.++||+ +++|.++|....          ..+++.+++.++.||++||+||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~l   96 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----------RSVDAFECFHVFRQIVEIVNAA   96 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----------ccccHHHHHHHHHHHHHHHHHH
Confidence            4455 57777777642211  11223466778887 779999996422          3588999999999999999999


Q ss_pred             hcCCCCCeEecccCCCCeeecC-------------------CCceEECccccccccccCCC------------Cceeccc
Q 041632          361 HQHCQEPILHCDLKPSNILLDN-------------------DLSAHIGDFGLSRFYQAVSN------------PTVSSSI  409 (452)
Q Consensus       361 H~~~~~~ivH~Dlk~~Nill~~-------------------~~~~kl~Dfgla~~~~~~~~------------~~~~~~~  409 (452)
                      |+.   +|+||||||+||||+.                   ++.+|++|||+++.......            +......
T Consensus        97 H~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (793)
T PLN00181         97 HSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI  173 (793)
T ss_pred             HhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence            998   9999999999999954                   44566777777653221000            0000011


Q ss_pred             cccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       410 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ...||+.|||||++.+..++.++|||||||+||||++|..|++
T Consensus       174 ~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        174 LAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             ccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence            2358899999999999999999999999999999999998874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=5.6e-23  Score=196.74  Aligned_cols=203  Identities=25%  Similarity=0.338  Sum_probs=161.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCC-cEEEEEEeeccCCccHHHHHHHHHHHhcCCC----CCceeEeeeeccccCCCCc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDG-TVVAIKVINLQRQGASKSFMAECKALKNIRH----KNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h----~niv~l~~~~~~~~~~~~~  306 (452)
                      +|.+.+.||+|+||.||.+....++ ..+|+|............+..|+.++..+..    +++..++....    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7899999999999999999987554 5788888875543333367788888888863    57777776521    3556


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC---
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---  383 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---  383 (452)
                      +.++||+.. |.+|.+......         ...++..+..+++.|++.+|+++|+.   |++||||||+|+.+...   
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~---------~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~  161 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNP---------PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRS  161 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCC---------CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCc
Confidence            789999988 889998764321         35789999999999999999999998   99999999999999865   


Q ss_pred             --CceEECcccccc--ccccCCCC---ceec-cccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          384 --LSAHIGDFGLSR--FYQAVSNP---TVSS-SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       384 --~~~kl~Dfgla~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                        ..+.+.|||+++  .+......   .... .....||..|+++....+...+.+.|+||++.++.|++.|..||
T Consensus       162 ~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW  237 (322)
T KOG1164|consen  162 EVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW  237 (322)
T ss_pred             ccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence              468999999998  33222211   1111 22355999999999999999999999999999999999999997

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=1.1e-21  Score=188.08  Aligned_cols=201  Identities=33%  Similarity=0.505  Sum_probs=164.2

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCC-CceeEeeeeccccCCCCcee
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHK-NLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~-niv~l~~~~~~~~~~~~~~~  308 (452)
                      |...+.||.|+||.||++...   ..+++|.+......   ....+.+|+..++.+.|+ +++++....     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            556778999999999999986   78899999754433   357899999999999988 799998874     333447


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-ceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-SAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~k  387 (452)
                      +++++++.++++.+++......        ..+.......++.|++.+++|+|+.   +++|||+||+||+++..+ .++
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~  142 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK--------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVK  142 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEE
Confidence            8999999999999777543210        3678889999999999999999998   899999999999999988 799


Q ss_pred             ECccccccccccCCCCce--eccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTV--SSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++|||.++..........  .......||..|+|||...+   ...+...|+||+|++++++++|..||+
T Consensus       143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~  212 (384)
T COG0515         143 LIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE  212 (384)
T ss_pred             EeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            999999985543222111  12234679999999999887   578889999999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=3.1e-22  Score=175.89  Aligned_cols=139  Identities=18%  Similarity=0.161  Sum_probs=105.5

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--c-------HHH-----------------HHHHHHHHhcCCCCC
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--A-------SKS-----------------FMAECKALKNIRHKN  289 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~ei~~l~~l~h~n  289 (452)
                      .+.||+|++|.||+|... +|+.||||+++.....  .       ...                 ...|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 8999999999754221  1       012                 234999999998777


Q ss_pred             ceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHH-hcCCCCCe
Q 041632          290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL-HQHCQEPI  368 (452)
Q Consensus       290 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i  368 (452)
                      +.......    .   ...++||||++++++.......           ..++..+...++.|++.+|+|+ |+.   +|
T Consensus        81 v~~p~~~~----~---~~~~iVmE~i~g~~l~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~l~H~~---gi  139 (190)
T cd05147          81 IPCPEPIL----L---KSHVLVMEFIGDDGWAAPRLKD-----------APLSESKARELYLQVIQIMRILYQDC---RL  139 (190)
T ss_pred             CCCCcEEE----e---cCCEEEEEEeCCCCCcchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            63322110    1   1237999999887765442211           2578888999999999999999 676   99


Q ss_pred             EecccCCCCeeecCCCceEECcccccccc
Q 041632          369 LHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       369 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                      +||||||+||+++ ++.++|+|||+|...
T Consensus       140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         140 VHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             ccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            9999999999998 478999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=1.8e-22  Score=179.35  Aligned_cols=174  Identities=12%  Similarity=0.118  Sum_probs=130.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHH---------HHHHHHHHhcCCCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS---------FMAECKALKNIRHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~ei~~l~~l~h~niv~l~~~~~~~  300 (452)
                      ..+|...+.+|.|+||.||....  ++..+|+|.++.........         +.+|++.+.+++||+|..+..+....
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999655  46689999997544333322         68999999999999999887663321


Q ss_pred             c---CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCC
Q 041632          301 D---FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSN  377 (452)
Q Consensus       301 ~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  377 (452)
                      .   +......+++|||++|.+|.++..               .+.    ....+++.++..+|+.   |++|||+||+|
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N  165 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN  165 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh---------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence            1   111345789999999999987631               122    2456899999999998   99999999999


Q ss_pred             eeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHH
Q 041632          378 ILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM  444 (452)
Q Consensus       378 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~el  444 (452)
                      |++++++ ++|+|||..+........                ..+.....++.++|+||||+++.-+
T Consensus       166 ili~~~g-i~liDfg~~~~~~e~~a~----------------d~~vler~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        166 FIVSKNG-LRIIDLSGKRCTAQRKAK----------------DRIDLERHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             EEEeCCC-EEEEECCCcccccchhhH----------------HHHHHHhHhcccccccceeEeehHH
Confidence            9999988 999999987644211100                0123445677899999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.8e-22  Score=172.30  Aligned_cols=201  Identities=24%  Similarity=0.371  Sum_probs=160.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCC-CCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRH-KNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h-~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ...|...+.||+|+||.+|.|....+|..||+|.-+....  ..++..|.++.+.++| ..|..+..+     ..+..+.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTEKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccccccc
Confidence            4568899999999999999999999999999998753322  2456778888888865 445555444     4555677


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC---Cc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~  385 (452)
                      .+||+.. |-+|.+...-.          ...++..+++-+|-|++.-++|+|..   +++||||||+|+|..-+   ..
T Consensus        87 vlVMdLL-GPsLEdLfnfC----------~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k  152 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFC----------SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK  152 (341)
T ss_pred             eeeeecc-CccHHHHHHHH----------hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence            8999999 78888776533          24688889999999999999999998   99999999999999644   45


Q ss_pred             eEECccccccccccCC---CCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          386 AHIGDFGLSRFYQAVS---NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +.++|||+|+.+....   .-.........||.+|.+--...+..-+.+.|+=|+|.+|..+--|..||
T Consensus       153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW  221 (341)
T KOG1163|consen  153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW  221 (341)
T ss_pred             EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence            8899999999765322   22223334567999999988877777788899999999999999999998

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-21  Score=175.57  Aligned_cols=200  Identities=22%  Similarity=0.338  Sum_probs=163.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      -.|.+++.||+|.||+++.|+.--+++.||||.-....  ...++..|.+..+.+ ..++|..++-+     .+.+.+-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccchhh
Confidence            36889999999999999999998899999999765332  235677788888777 56888887765     34455678


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-----C
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-----L  384 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-----~  384 (452)
                      +|+|.. |-||.+...-..          .+++...+..+|.|++.-++|+|++   .+|.|||||+|+||..-     .
T Consensus       101 LVidLL-GPSLEDLFD~Cg----------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n  166 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCG----------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDAN  166 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhc----------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCc
Confidence            999998 778877664332          5789999999999999999999998   99999999999999643     3


Q ss_pred             ceEECccccccccccCCC---CceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      .+.++|||+|+.+.....   -......+..||.+||+--...+.+-+.+.|+=|+|-++...+-|..||
T Consensus       167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW  236 (449)
T KOG1165|consen  167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  236 (449)
T ss_pred             eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence            588999999998754322   2223334567999999999999988899999999999999999999998

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.86  E-value=4.9e-22  Score=173.48  Aligned_cols=105  Identities=28%  Similarity=0.319  Sum_probs=91.7

Q ss_pred             CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          318 GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       318 gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                      |+|.+++....          ..+++.+++.++.|++.||+|||+.   +      ||+|||++.++.+|+  ||.++..
T Consensus         1 GsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~   59 (176)
T smart00750        1 VSLADILEVRG----------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFK   59 (176)
T ss_pred             CcHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEee
Confidence            68888886432          3589999999999999999999997   4      999999999999999  9998754


Q ss_pred             ccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       398 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ....         ..||+.|||||++.+..++.++|||||||++|||+||+.||+
T Consensus        60 ~~~~---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~  105 (176)
T smart00750       60 TPEQ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN  105 (176)
T ss_pred             cccc---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence            4211         248999999999999999999999999999999999999984

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.1e-21  Score=170.28  Aligned_cols=139  Identities=19%  Similarity=0.146  Sum_probs=108.1

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--------------------------HHHHHHHHHHHhcCCCCC
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--------------------------SKSFMAECKALKNIRHKN  289 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~ei~~l~~l~h~n  289 (452)
                      .+.||+|++|.||+|+.. +|+.||||+++......                          ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 89999999997542210                          112457899999999998


Q ss_pred             ceeEeeeeccccCCCCceeEEEEeccCCCChhhh-hcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCC
Q 041632          290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW-LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEP  367 (452)
Q Consensus       290 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~  367 (452)
                      +.....+..       ...++||||++++++... +..            ..++..+...++.|++.++.++|+ .   |
T Consensus        81 i~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~~------------~~~~~~~~~~i~~~l~~~l~~lH~~~---g  138 (190)
T cd05145          81 VPVPEPILL-------KKNVLVMEFIGDDGSPAPRLKD------------VPLEEEEAEELYEQVVEQMRRLYQEA---G  138 (190)
T ss_pred             CCCceEEEe-------cCCEEEEEEecCCCchhhhhhh------------ccCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence            743332211       124899999988855433 321            245677889999999999999999 7   9


Q ss_pred             eEecccCCCCeeecCCCceEECccccccccc
Q 041632          368 ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       368 ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                      |+||||||+||+++ ++.++|+|||+++..+
T Consensus       139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999999999 8899999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=9e-23  Score=178.26  Aligned_cols=188  Identities=28%  Similarity=0.485  Sum_probs=148.1

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEe
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      ..+|.+...|+.|+|+|.  |..+++|++...  .....++|..|.-.++.+.||||+++++.|...     ....++..
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq  267 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQ  267 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeee
Confidence            346888999999999996  445677777543  234457899999999999999999999998643     46788999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec-ccCCCCeeecCCCceEEC--c
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHC-DLKPSNILLDNDLSAHIG--D  390 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~-Dlk~~Nill~~~~~~kl~--D  390 (452)
                      ||+.|+|++.|++..         .-..+..++.+++.++|+|++|||+.  .+++-| -|.++.+++|++.+++|+  |
T Consensus       268 ~mp~gslynvlhe~t---------~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad  336 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQT---------SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMAD  336 (448)
T ss_pred             eccchHHHHHHhcCc---------cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheeccc
Confidence            999999999998653         23456678999999999999999997  355544 789999999999998875  3


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCC---cccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVS---TNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      -.++  ++         ..+..-.|.||+||.++..+-+   .++|+|||++++||+.|+..||.
T Consensus       337 ~kfs--fq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa  390 (448)
T KOG0195|consen  337 TKFS--FQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA  390 (448)
T ss_pred             ceee--ee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc
Confidence            2222  11         1122347889999998876543   35999999999999999999994

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=7e-22  Score=200.98  Aligned_cols=198  Identities=24%  Similarity=0.340  Sum_probs=156.6

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHH----HHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASK----SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~----~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ...+.+|.|++|.|+........+..+.|.+...  .....+    .+..|.-+-..+.|||++..+..+...     ..
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~-----~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI-----DG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc-----cc
Confidence            3567899999998888887666665666654311  111222    255677777888999998776654332     23


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      ..-.||||++ +|..++...           ..+...++..++.|+..|++|+|+.   ||.|||+|++|++++.++.+|
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~-----------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lk  460 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN-----------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILK  460 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc-----------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceE
Confidence            3334999999 999988653           2577778889999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcc-cceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTN-GDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||.+..+..............+|+..|+|||++.+..|++. .||||.|+++..|.+|+.||
T Consensus       461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W  525 (601)
T KOG0590|consen  461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW  525 (601)
T ss_pred             EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence            99999998877555544445567889999999999999999776 89999999999999999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.1e-21  Score=200.06  Aligned_cols=196  Identities=22%  Similarity=0.310  Sum_probs=154.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCcee-EeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR-VITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~-l~~~~~~~~~~~~~~~~  309 (452)
                      +.|.+.+.+|+|+||+||+|.... |+.||+|+-+   +...++|..-.+++.+++ +-+.. +..++...-+.  +.-+
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~---P~~~WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~--~~S~  770 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEK---PPNPWEFYICLQVMERLK-PQMLPSIMHISSAHVFQ--NASV  770 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeec---CCCceeeeehHHHHHhhc-hhhhcchHHHHHHHccC--Ccce
Confidence            557777899999999999999975 9999999853   445567766677777776 33222 22222222233  3457


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-------
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-------  382 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-------  382 (452)
                      +|+||.+.|+|.+++...           +.++|.-+..++.|++..++.||..   +|||+||||+|+||..       
T Consensus       771 lv~ey~~~Gtlld~~N~~-----------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTN-----------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             eeeeccccccHHHhhccC-----------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence            999999999999999743           4688888999999999999999998   9999999999999952       


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~  449 (452)
                      ..-++|+|||.+-.+....+  .+.....++|-.+-.+|+..+++++++.|.|.++.+++-|+.|++
T Consensus       837 ~~~l~lIDfG~siDm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ccceEEEecccceeeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            34589999998865443322  234456779999999999999999999999999999999999974

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=4.5e-20  Score=163.67  Aligned_cols=142  Identities=21%  Similarity=0.358  Sum_probs=107.4

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-----CCCCceeEeeeeccccCCCCce
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-----RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-----~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +...+.||+|+||.||.  +..++.. +||++........+.+.+|++.++.+     .||||+++++++....  +.+.
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~   78 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY   78 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence            34457899999999996  6656555 69988765555567899999999999     5799999999854321  1123


Q ss_pred             -eEEEEec--cCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEecccCCCCeeecC-
Q 041632          308 -KAIVYKY--MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL-DYLHQHCQEPILHCDLKPSNILLDN-  382 (452)
Q Consensus       308 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dlk~~Nill~~-  382 (452)
                       ..+|+||  +++|+|.+++.+.            .+++.  ..++.+++.++ +|||+.   +|+||||||+|||++. 
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~------------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~  141 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC------------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRI  141 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc------------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEecc
Confidence             3478999  5579999999642            23333  35677888777 999998   9999999999999974 


Q ss_pred             ---CCceEECc-cccccc
Q 041632          383 ---DLSAHIGD-FGLSRF  396 (452)
Q Consensus       383 ---~~~~kl~D-fgla~~  396 (452)
                         ++.++|+| ||....
T Consensus       142 ~~~~~~~~LiDg~G~~~~  159 (210)
T PRK10345        142 SESEVIPVVCDNIGESTF  159 (210)
T ss_pred             CCCCCcEEEEECCCCcce
Confidence               34799999 554443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.83  E-value=2.3e-22  Score=164.22  Aligned_cols=147  Identities=26%  Similarity=0.333  Sum_probs=138.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ||+|+++ .+|..++.+.+| +.|++++|+|+ .+|.++++|+.|+.|+++.|++. .+|.+|+.++.|+.|||+.|++.
T Consensus        40 LSHNKl~-~vppnia~l~nl-evln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~  115 (264)
T KOG0617|consen   40 LSHNKLT-VVPPNIAELKNL-EVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLN  115 (264)
T ss_pred             cccCcee-ecCCcHHHhhhh-hhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccc
Confidence            6899999 899999999999 99999999999 99999999999999999999998 99999999999999999999986


Q ss_pred             -ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 -GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 -~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                       ..+|..|..++.|+.|+|++|.+.-+||++-++.+|+.|.+..|.+-..|..+|.++.|+.|.+.||+..-
T Consensus       116 e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~v  187 (264)
T KOG0617|consen  116 ENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLTV  187 (264)
T ss_pred             cccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceeee
Confidence             46899999999999999999999999999988888999999999999999999999999999999997644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.5e-20  Score=163.37  Aligned_cols=186  Identities=15%  Similarity=0.062  Sum_probs=134.1

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC----ccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCcee
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ----GASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .+...|++|+||+||.+..  .+..++.+.++....    -..+.+.+|+++|+++. |+++.+++++         +..
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---------~~~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---------DGR   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---------cCE
Confidence            3457899999999997665  577788777764322    11235889999999995 5788888764         235


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc-CCCCeeecCCCceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL-KPSNILLDNDLSAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl-k~~Nill~~~~~~k  387 (452)
                      +++|||++|.+|.+.+..                  ....++.|++.+|+++|+.   ||+|||| ||+|||++.++.++
T Consensus        74 ~lvmeyI~G~~L~~~~~~------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~  132 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPA  132 (218)
T ss_pred             EEEEeeecCccHHhhhhh------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEE
Confidence            899999999898653210                  1134778999999999998   9999999 79999999999999


Q ss_pred             ECccccccccccCCCC----c--eec---cccccccccccCccccCC-CCCC-cccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNP----T--VSS---SIGVRGTIGYVAPEYGLG-SEVS-TNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~----~--~~~---~~~~~gt~~y~aPE~~~~-~~~~-~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||++.........    .  ...   ..-...++.|++|+...- ...+ ...+.++-|.-+|.++||+.|+
T Consensus       133 LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        133 VIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             EEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            9999999854422210    0  000   001225777777775222 1223 4578889999999999998875

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=4.3e-19  Score=161.34  Aligned_cols=144  Identities=19%  Similarity=0.170  Sum_probs=110.3

Q ss_pred             cCCCCCCceeccCceeEEEEE-EcCCCcEEEEEEeeccCCc------------------------cHHHHHHHHHHHhcC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGV-FDEDGTVVAIKVINLQRQG------------------------ASKSFMAECKALKNI  285 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~ei~~l~~l  285 (452)
                      ..|.+.+.||+|++|.||+|. ...+|+.||+|+++.....                        ....+..|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999998 6668999999999743210                        012356899999999


Q ss_pred             CCCC--ceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC
Q 041632          286 RHKN--LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH  363 (452)
Q Consensus       286 ~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  363 (452)
                      .+..  +.++++.         ...++||||++++++..+....           ......+...++.|++.++++||+.
T Consensus       108 ~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~  167 (237)
T smart00090      108 YEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD-----------VEPEEEEEFELYDDILEEMRKLYKE  167 (237)
T ss_pred             HhcCCCCCeeeEe---------cCceEEEEEecCCccccccccc-----------CCcchHHHHHHHHHHHHHHHHHHhc
Confidence            7533  3344332         1247999999998887654221           1234556678999999999999998


Q ss_pred             CCCC-eEecccCCCCeeecCCCceEECccccccccc
Q 041632          364 CQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       364 ~~~~-ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                         + ++||||||+||+++ ++.++|+|||.+....
T Consensus       168 ---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      168 ---GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ---CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence               8 99999999999999 8899999999987543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=3.2e-20  Score=180.54  Aligned_cols=185  Identities=26%  Similarity=0.319  Sum_probs=149.5

Q ss_pred             ceeccCceeEEEEEE---cCCCcEEEEEEeeccCCcc--HHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeEEE
Q 041632          238 LIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      ++|+|+||.|+..+-   ...|+.+|.|..+......  ......|..++...+ ||.++++...     ++.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            378999999986442   2356778888876433211  123456677778885 9999998766     6667788999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      ++|..+|.+...+....           .++......+...++-+++++|+.   +|+|||+|++||+++.+|++|+.||
T Consensus        76 ld~~rgg~lft~l~~~~-----------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdf  141 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKEV-----------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDF  141 (612)
T ss_pred             hhhcccchhhhccccCC-----------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCc
Confidence            99999999998876543           567777788889999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+++..-....        .+||..|||||+..  .+..++|.||||++++||+||..||
T Consensus       142 glske~v~~~~--------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf  191 (612)
T KOG0603|consen  142 GLSKEAVKEKI--------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPF  191 (612)
T ss_pred             hhhhHhHhhhh--------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCC
Confidence            99986542211        27999999999987  5778899999999999999999998

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=5.6e-19  Score=162.38  Aligned_cols=151  Identities=25%  Similarity=0.326  Sum_probs=109.3

Q ss_pred             CCCCceeEeeeeccc----------------------cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCH
Q 041632          286 RHKNLVRVITSCSSV----------------------DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL  343 (452)
Q Consensus       286 ~h~niv~l~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~  343 (452)
                      +|||||++.+++.+.                      ........|+||.-. ..+|.+|+...            ..+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~------------~~s~  340 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR------------HRSY  340 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC------------CCch
Confidence            699999998775431                      011223467888766 56888888643            3556


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec--CCC--ceEECccccccccccCC--CCceeccccccccccc
Q 041632          344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD--NDL--SAHIGDFGLSRFYQAVS--NPTVSSSIGVRGTIGY  417 (452)
Q Consensus       344 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~--~~kl~Dfgla~~~~~~~--~~~~~~~~~~~gt~~y  417 (452)
                      ....-++.|+++|+.|||.+   ||.|||+|++|||+.  +|.  .+.|+|||++---+...  -+-.......-|...-
T Consensus       341 r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~l  417 (598)
T KOG4158|consen  341 RTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKL  417 (598)
T ss_pred             HHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCccee
Confidence            67778999999999999998   999999999999994  333  57899999874222111  1111112234578889


Q ss_pred             cCccccCCCC------CCcccceeehhHHHHHHHhCCCCCC
Q 041632          418 VAPEYGLGSE------VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       418 ~aPE~~~~~~------~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||||+....+      ...|+|.|+.|.+.||+++...||.
T Consensus       418 mAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY  458 (598)
T KOG4158|consen  418 MAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFY  458 (598)
T ss_pred             cchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCccc
Confidence            9999865432      2457999999999999999999983

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.77  E-value=2.7e-19  Score=163.85  Aligned_cols=204  Identities=21%  Similarity=0.283  Sum_probs=127.0

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCC----------CCceeEeeeeccc
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRH----------KNLVRVITSCSSV  300 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h----------~niv~l~~~~~~~  300 (452)
                      ...+.||.|+++.||.+++..+|+.+|+|++.....   ...+++.+|.-....+.+          -.++--++...-.
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            345789999999999999999999999999864432   223566666655444322          1111111111000


Q ss_pred             ---c-C---CCCc-----eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 041632          301 ---D-F---QGND-----FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPI  368 (452)
Q Consensus       301 ---~-~---~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  368 (452)
                         . +   .+..     ..+++|+-+ .++|.+++..-..    .......+....++.+..|+++.+++||+.   |+
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~----~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---Gl  166 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFS----RAQTHSPLAFAARLSLTVQMIRLVANLHSY---GL  166 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHH----HTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhh----cccccchhHHHHHHHHHHHHHHHHHHHhhc---ce
Confidence               0 0   0001     235677766 6788777542110    000012344555677789999999999998   99


Q ss_pred             EecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCC--------CCCCcccceeehhHH
Q 041632          369 LHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--------SEVSTNGDVYSYGIL  440 (452)
Q Consensus       369 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGv~  440 (452)
                      ||+||||+|++++.+|.+.|+||+........     ...  ...+..|.+||....        -.++.+.|.|++|++
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~  239 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT  239 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCce-----eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence            99999999999999999999999876543311     111  234577999997432        247888999999999


Q ss_pred             HHHHHhCCCCCC
Q 041632          441 LLEMVTTKKPTD  452 (452)
Q Consensus       441 l~elltg~~Pf~  452 (452)
                      +|.|++|+.||+
T Consensus       240 ly~lWC~~lPf~  251 (288)
T PF14531_consen  240 LYSLWCGRLPFG  251 (288)
T ss_dssp             HHHHHHSS-STC
T ss_pred             HHHHHHccCCCC
Confidence            999999999996

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.76  E-value=1.9e-18  Score=189.70  Aligned_cols=149  Identities=33%  Similarity=0.530  Sum_probs=111.7

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|++++.+|..+..+++| ++|+|++|++.+.+|..+ .+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+
T Consensus       436 s~N~l~~~~~~~~~~l~~L-~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  513 (968)
T PLN00113        436 SNNNLQGRINSRKWDMPSL-QMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSG  513 (968)
T ss_pred             cCCcccCccChhhccCCCC-cEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCccee
Confidence            3444444444444444444 455555555554444433 34567777777777777888888889999999999999998


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccccCC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      .+|..+..+++|+.|+|++|.+++.+|..+..++ |+.|+|++|++++..| .+..+++|+.+++++|+..+.
T Consensus       514 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~  586 (968)
T PLN00113        514 EIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS  586 (968)
T ss_pred             eCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence            9999999999999999999999998887777665 9999999999987555 457788999999999987663

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=2e-19  Score=183.75  Aligned_cols=198  Identities=21%  Similarity=0.240  Sum_probs=145.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHH--HhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKA--LKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~--l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++...+.||++.|-+|.+|+++ .|. |+||++-..++. ..+.|.++++-  ...++|||.+++.-+     ...+...
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~kAA   96 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDKAA   96 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhHHH
Confidence            4666788999999999999986 554 899998655432 22444443333  455599999998654     3334456


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      |+|-+|. ..+|++.|..+           .-+...+..-|+.|++.|+.-+|..   +|+|||||.+||||+.-.-+.|
T Consensus        97 ylvRqyv-khnLyDRlSTR-----------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~L  161 (1431)
T KOG1240|consen   97 YLVRQYV-KHNLYDRLSTR-----------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYL  161 (1431)
T ss_pred             HHHHHHH-hhhhhhhhccc-----------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhh
Confidence            7777777 66888887543           4577778888999999999999998   9999999999999999999999


Q ss_pred             Ccccccccccc-CCCC---ceeccccccccccccCccccCC----------CC-CCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQA-VSNP---TVSSSIGVRGTIGYVAPEYGLG----------SE-VSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~-~~~~---~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||-..+.... .+++   .....+ ......|.|||.+..          .. .+++.||||+||++.||++ |++||+
T Consensus       162 tDFAsFKPtYLPeDNPadf~fFFDT-SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  162 TDFASFKPTYLPEDNPADFTFFFDT-SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             hcccccCCccCCCCCcccceEEEec-CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            99987664321 1122   111111 223456999997543          12 5778999999999999988 799985

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=6.2e-18  Score=150.39  Aligned_cols=137  Identities=26%  Similarity=0.247  Sum_probs=106.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc----------------------cHHHHHHHHHHHhcCCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG----------------------ASKSFMAECKALKNIRHKN  289 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~ei~~l~~l~h~n  289 (452)
                      -|...+.||+|+||.||++... +|+.||||+++.....                      ....+..|...+..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            3777899999999999999885 7999999987643211                      0123567888888887774


Q ss_pred             --ceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 041632          290 --LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP  367 (452)
Q Consensus       290 --iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  367 (452)
                        +...++.         ...+++|||+++++|......                 .....++.+++.++.++|+.   +
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~-----------------~~~~~~~~~i~~~l~~lh~~---g  145 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL-----------------EDPEEVLDEILEEIVKAYKH---G  145 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhcccc-----------------ccHHHHHHHHHHHHHHHHHC---C
Confidence              3333321         245899999999998764320                 13456889999999999997   9


Q ss_pred             eEecccCCCCeeecCCCceEECccccccccc
Q 041632          368 ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       368 ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                      |+||||||+||++++++.++|+|||.+....
T Consensus       146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         146 IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=4.6e-18  Score=173.68  Aligned_cols=138  Identities=24%  Similarity=0.296  Sum_probs=107.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CC------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQ------GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..|...+.||+|+||+||+|.+...  .+++|+....  ..      ...+.+.+|+++++.++|++++....++.    
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----  406 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV----  406 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE----
Confidence            3456678999999999999998533  3444432111  11      11246889999999999999887665532    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                       .....++||||+++++|.+++.                   ....++.+++.+|+|||+.   +++||||||+||++ +
T Consensus       407 -~~~~~~lv~E~~~g~~L~~~l~-------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~  462 (535)
T PRK09605        407 -DPEEKTIVMEYIGGKDLKDVLE-------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-R  462 (535)
T ss_pred             -eCCCCEEEEEecCCCcHHHHHH-------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-E
Confidence             2235689999999999998773                   3467899999999999998   99999999999999 6


Q ss_pred             CCceEECccccccccc
Q 041632          383 DLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~  398 (452)
                      ++.++|+|||+++...
T Consensus       463 ~~~~~liDFGla~~~~  478 (535)
T PRK09605        463 DDRLYLIDFGLGKYSD  478 (535)
T ss_pred             CCcEEEEeCcccccCC
Confidence            7799999999998643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=6e-18  Score=152.20  Aligned_cols=134  Identities=22%  Similarity=0.339  Sum_probs=107.9

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--------HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--------SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +.||+|++|.||+|++  .|..|++|.........        ...+.+|++.+..++|+++.....++.     +.+..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCC
Confidence            5799999999999998  56789999765322111        235788999999999998765554432     23356


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++|||+++++|.+++....              + ++..++.+++.+|+++|+.   +++|+|++|+||+++ ++.++|
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~--------------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~l  135 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG--------------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYL  135 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc--------------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEE
Confidence            89999999999999875321              1 6788999999999999998   999999999999999 789999


Q ss_pred             Cccccccc
Q 041632          389 GDFGLSRF  396 (452)
Q Consensus       389 ~Dfgla~~  396 (452)
                      +|||.+..
T Consensus       136 iDf~~a~~  143 (211)
T PRK14879        136 IDFGLAEF  143 (211)
T ss_pred             EECCcccC
Confidence            99999875

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=1.1e-19  Score=148.66  Aligned_cols=135  Identities=30%  Similarity=0.437  Sum_probs=124.0

Q ss_pred             ccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccC
Q 041632           13 AIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRG   92 (452)
Q Consensus        13 ~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~   92 (452)
                      +++.+... +.|.||+|+|+ .+|+.+..|.+|+.|++++|+|+ .+|.+++.++.|+.|+++-|++. .+|..|+.++.
T Consensus        28 gLf~~s~I-TrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~  103 (264)
T KOG0617|consen   28 GLFNMSNI-TRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA  103 (264)
T ss_pred             cccchhhh-hhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence            56677888 88999999999 99999999999999999999999 89999999999999999999999 99999999999


Q ss_pred             CCeeecccccccC--CcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           93 IRKLDLSRNNLSG--QIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        93 L~~l~l~~N~l~~--~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      |+.|||.+|+++.  +|..+|-+.+|+.|+|++|.|+-+|+.++.+++|+.|.+.+|..+.
T Consensus       104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~  164 (264)
T KOG0617|consen  104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLS  164 (264)
T ss_pred             hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhh
Confidence            9999999999976  4456666777999999999999999999999999999999886543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=1.5e-17  Score=148.20  Aligned_cols=132  Identities=24%  Similarity=0.329  Sum_probs=102.1

Q ss_pred             ceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--------cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--------ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .||+|++|.||+|.+  +|..|++|........        ...++.+|++++..++|+++.....++.     ..+..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence            489999999999996  5678999986432111        1245778999999998876543332221     223458


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      ++|||+++++|.+++....                 . .++.+++.+|+++|+.   +++|+|++|.||+++ ++.++++
T Consensus        74 lv~e~~~g~~l~~~~~~~~-----------------~-~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~li  131 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGN-----------------D-ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLI  131 (199)
T ss_pred             EEEEEECCccHHHHHhhcH-----------------H-HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEE
Confidence            9999999999998874321                 0 6889999999999998   999999999999999 8899999


Q ss_pred             ccccccccc
Q 041632          390 DFGLSRFYQ  398 (452)
Q Consensus       390 Dfgla~~~~  398 (452)
                      |||++....
T Consensus       132 Dfg~a~~~~  140 (199)
T TIGR03724       132 DFGLGKYSD  140 (199)
T ss_pred             ECCCCcCCC
Confidence            999987543

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.69  E-value=1.2e-17  Score=170.71  Aligned_cols=167  Identities=29%  Similarity=0.393  Sum_probs=122.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+.+++|..|+||.||..+++.+.+.+|.|+=+ +.     .      +     -+||..+.+.           .+
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----l------i-----lRnilt~a~n-----------pf  133 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----L------I-----LRNILTFAGN-----------PF  133 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----h------h-----hhccccccCC-----------cc
Confidence            467999999999999999999998888888884321 10     0      1     1234443321           22


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      .|      |+....++...           .++.        +++.+++|+|+.   +|+|||+||+|.+|+.-|++|+.
T Consensus       134 vv------gDc~tllk~~g-----------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlT  185 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIG-----------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLT  185 (1205)
T ss_pred             ee------chhhhhcccCC-----------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeeccccccc
Confidence            33      55554444322           2222        237899999997   99999999999999999999999


Q ss_pred             ccccccccccCC-----------CCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVS-----------NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~-----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++..-...           ..........+||+.|.|||++....|+..+|.|++|+++||.+.|..||+
T Consensus       186 DfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff  259 (1205)
T KOG0606|consen  186 DFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF  259 (1205)
T ss_pred             chhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence            999987432110           001111234689999999999999999999999999999999999999985

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.69  E-value=3.6e-17  Score=159.36  Aligned_cols=151  Identities=30%  Similarity=0.549  Sum_probs=123.3

Q ss_pred             HhcCCCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHh
Q 041632          282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH  361 (452)
Q Consensus       282 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  361 (452)
                      |+.+.|.|+.+++|.|...     +..++|.+||..|+|.+.+....          ..+++.....+.++++.||+|+|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~----------~~~d~~F~~s~~rdi~~Gl~ylh   65 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNED----------IKLDYFFILSFIRDISKGLAYLH   65 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccc----------cCccHHHHHHHHHHHHHHHHHHh
Confidence            4578999999999997543     57889999999999999997643          57899999999999999999999


Q ss_pred             cCCCCCe-EecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCC-------CCCcccc
Q 041632          362 QHCQEPI-LHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-------EVSTNGD  433 (452)
Q Consensus       362 ~~~~~~i-vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~D  433 (452)
                      +.   +| .|+.++++|+++|....+|++|||+...........  ......-..-|.|||.+...       ..+.+.|
T Consensus        66 ~s---~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~--~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gd  140 (484)
T KOG1023|consen   66 NS---PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPE--AHHPIRKALLWTAPELLRGALSQSLESALTQKGD  140 (484)
T ss_pred             cC---cceeeeeeccccceeeeeEEEEechhhhccccccccccc--ccchhHHHHhccCHHHhcccccccccccccccCC
Confidence            97   44 999999999999999999999999987664211111  11112245669999987663       1466799


Q ss_pred             eeehhHHHHHHHhCCCCCC
Q 041632          434 VYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       434 vwSlGv~l~elltg~~Pf~  452 (452)
                      |||||++++|+++.+.||+
T Consensus       141 iYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen  141 IYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             eehHHHHHHHHHhccCccc
Confidence            9999999999999999986

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2.6e-16  Score=133.32  Aligned_cols=135  Identities=21%  Similarity=0.251  Sum_probs=109.8

Q ss_pred             CCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCC--CCceeEeeeeccccCCCCceeEEEE
Q 041632          235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRH--KNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       235 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h--~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.+.||+|.++.||++...  +..+++|.......  ...+..|+.++..++|  .++.+++.+.     ...+..++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~   72 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLM   72 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEE
Confidence            3467999999999999984  37899999864433  4678899999999976  4888887763     3335789999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||++++.+..+                  +......++.+++++++++|.....+++|+|++|+||++++++.++++|||
T Consensus        73 e~~~g~~~~~~------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~  134 (155)
T cd05120          73 EWIEGETLDEV------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE  134 (155)
T ss_pred             EecCCeecccC------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence            99988777542                  344667789999999999999755589999999999999999999999999


Q ss_pred             cccc
Q 041632          393 LSRF  396 (452)
Q Consensus       393 la~~  396 (452)
                      .++.
T Consensus       135 ~~~~  138 (155)
T cd05120         135 YAGY  138 (155)
T ss_pred             cccC
Confidence            8864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.68  E-value=7.7e-18  Score=161.02  Aligned_cols=127  Identities=31%  Similarity=0.499  Sum_probs=106.5

Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      .+.++.|++|...+|.+||...+        .....++...+.++.|++.|++|   +   +.+|||+||.||+...+..
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~--------~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q  394 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR--------TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQ  394 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC--------cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchh
Confidence            35789999999999999997443        23456777889999999999999   4   8999999999999999999


Q ss_pred             eEECccccccccccCC--CCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh
Q 041632          386 AHIGDFGLSRFYQAVS--NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt  446 (452)
                      +||+|||+........  .+.........||..||+||.+.+..|+.++||||+|++|+|+++
T Consensus       395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            9999999987655332  111222344669999999999999999999999999999999987

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.67  E-value=2.7e-18  Score=157.97  Aligned_cols=141  Identities=26%  Similarity=0.352  Sum_probs=116.3

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ..|+++ .+|++...++.| +.||..+|-++ .+|+.++.|.+|+.|+|.+|+|. .+| +|++|..|.+|+++.|+|. 
T Consensus       168 ~~n~l~-~l~~~~i~m~~L-~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-  241 (565)
T KOG0472|consen  168 EGNKLK-ALPENHIAMKRL-KHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-  241 (565)
T ss_pred             cccchh-hCCHHHHHHHHH-Hhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-
Confidence            356666 444444446676 77777777777 78888888888888888888887 777 7888888888888888888 


Q ss_pred             cCchhhh-cccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           82 SIPSFFR-TSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        82 ~~p~~~~-~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      .+|.... .+++|..|||.+|++...|.+++...+|++||+++|.|++.|++.|++ .|..|.+.|||.
T Consensus       242 ~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl  309 (565)
T KOG0472|consen  242 MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL  309 (565)
T ss_pred             hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence            7887766 789999999999999998888888778999999999999999999999 999999999984

>PLN03150 hypothetical protein; Provisional

Probab=99.67  E-value=1.5e-16  Score=164.45  Aligned_cols=118  Identities=34%  Similarity=0.537  Sum_probs=61.9

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.|+|++|.|+|.+|..++.|++|+.|+|++|+++|.+|..++.+++|+.|+|++|++++.+|+.++.+++|+.|+|++|
T Consensus       421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N  500 (623)
T PLN03150        421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN  500 (623)
T ss_pred             EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence            44555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             cccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCCCCCCCCCCccc
Q 041632          102 NLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCT  163 (452)
Q Consensus       102 ~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~~~~~~~~~~~  163 (452)
                      ++++..|..+..                     .+.++..+++.+|+.+|+.+.   .+.|.
T Consensus       501 ~l~g~iP~~l~~---------------------~~~~~~~l~~~~N~~lc~~p~---l~~C~  538 (623)
T PLN03150        501 SLSGRVPAALGG---------------------RLLHRASFNFTDNAGLCGIPG---LRACG  538 (623)
T ss_pred             cccccCChHHhh---------------------ccccCceEEecCCccccCCCC---CCCCc
Confidence            554444332221                     123445678888999997432   34563

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.66  E-value=4.8e-16  Score=137.01  Aligned_cols=137  Identities=22%  Similarity=0.238  Sum_probs=95.5

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccH--HH----------------------HHHHHHHHhcCCCCC--
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KS----------------------FMAECKALKNIRHKN--  289 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~ei~~l~~l~h~n--  289 (452)
                      .+.||+|+||+||+|... +|+.||||++........  ..                      ...|.+.+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 789999999864322111  11                      134555555553332  


Q ss_pred             ceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCe
Q 041632          290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPI  368 (452)
Q Consensus       290 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i  368 (452)
                      +.+.++.         ...+++|||++++++....-...           ... .+...++.+++.++.++|. .   +|
T Consensus        81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-----------~~~-~~~~~~~~~~~~~l~~lh~~~---~i  136 (187)
T cd05119          81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-----------RLL-EDPEELYDQILELMRKLYREA---GL  136 (187)
T ss_pred             CCceEec---------CCCEEEEEEeCCCCccChhhhhh-----------hhc-ccHHHHHHHHHHHHHHHhhcc---Cc
Confidence            3333322         13589999999865432111000           000 4577899999999999999 6   99


Q ss_pred             EecccCCCCeeecCCCceEECccccccccc
Q 041632          369 LHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       369 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                      +||||||+||+++ ++.++++|||.+....
T Consensus       137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         137 VHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            9999999999999 8999999999986443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.66  E-value=5.5e-18  Score=156.00  Aligned_cols=146  Identities=25%  Similarity=0.369  Sum_probs=136.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ++.|++. ++|..+..+..+++.+.+++|+++ -+|..++.+++|..|+|++|-+. .+|.+++.+..|+.||+++|++.
T Consensus       395 fskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr  471 (565)
T KOG0472|consen  395 FSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR  471 (565)
T ss_pred             cccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence            5789999 999999999999788899999998 99999999999999999999999 89999999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                       .+|..+..+..|+.+-.++|++...++..+..+. |..|||.+|.+..+||.+|+++++++|.++|||+-
T Consensus       472 -~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  472 -MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             -cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence             9999999999999999999999999988555554 99999999999999999999999999999999974

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=2.5e-15  Score=136.99  Aligned_cols=140  Identities=18%  Similarity=0.154  Sum_probs=103.7

Q ss_pred             Ccee-ccCceeEEEEEEcCCCcEEEEEEeeccC-------------CccHHHHHHHHHHHhcCCCCCc--eeEeeeeccc
Q 041632          237 NLIG-VGSFGSVYKGVFDEDGTVVAIKVINLQR-------------QGASKSFMAECKALKNIRHKNL--VRVITSCSSV  300 (452)
Q Consensus       237 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~ei~~l~~l~h~ni--v~l~~~~~~~  300 (452)
                      ..|| .||.|+||....  .+..++||.+....             ......+.+|++++..++|+++  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            5688 899999999887  36789999885211             1122467889999999998885  5566553221


Q ss_pred             cCCCCceeEEEEeccCC-CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          301 DFQGNDFKAIVYKYMPN-GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                      . ......++|+|++++ .+|.+++...            .++..    .+.+++.++++||+.   ||+||||||+|||
T Consensus       115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~------------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NIL  174 (239)
T PRK01723        115 H-GLFYRADILIERIEGARDLVALLQEA------------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNIL  174 (239)
T ss_pred             c-CcceeeeEEEEecCCCCCHHHHHhcC------------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEE
Confidence            1 111123599999997 6898887532            23332    356899999999998   9999999999999


Q ss_pred             ecCCCceEECccccccccc
Q 041632          380 LDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~  398 (452)
                      ++.++.++|+|||.++...
T Consensus       175 v~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        175 LDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             EcCCCCEEEEECCCcccCC
Confidence            9999999999999987543

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.62  E-value=2.2e-17  Score=159.71  Aligned_cols=150  Identities=19%  Similarity=0.272  Sum_probs=129.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ||.|+|. .+|+.+.++.+| +.|+||+|+|+ .+....+...+|+.|+||+|+++ .+|+.++.|+.|+.|++.+|+++
T Consensus       229 lS~N~Lp-~vPecly~l~~L-rrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~  304 (1255)
T KOG0444|consen  229 LSENNLP-IVPECLYKLRNL-RRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT  304 (1255)
T ss_pred             ccccCCC-cchHHHhhhhhh-heeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence            5788888 888888888888 78888888888 77777777888888888888888 78888888999999999888875


Q ss_pred             -ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCCCC
Q 041632           81 -GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGI  154 (452)
Q Consensus        81 -~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~~  154 (452)
                       ..+|+.++.+.+|+.+..++|++.-.|.+...|.+|+.|.|+.|++..+|..+..++.|..|++..||.+--++
T Consensus       305 FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  305 FEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             ccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence             35788889999999999999999888888888888999999999999999988889999999999999877544

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.62  E-value=4.9e-17  Score=157.39  Aligned_cols=147  Identities=20%  Similarity=0.280  Sum_probs=114.1

Q ss_pred             CCCccc-ccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcccc------------------------
Q 041632            2 FENDLS-GTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLS------------------------   56 (452)
Q Consensus         2 ~~N~l~-~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~------------------------   56 (452)
                      +.|.++ +.+|....+++++ ++|.|...+|. .+|++++.|.+|++|.+++|++.                        
T Consensus        15 sgNDFsg~~FP~~v~qMt~~-~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKn   92 (1255)
T KOG0444|consen   15 SGNDFSGDRFPHDVEQMTQM-TWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKN   92 (1255)
T ss_pred             cCCcCCCCcCchhHHHhhhe-eEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccccc
Confidence            456666 3455555555555 55555555555 55555555555555555555543                        


Q ss_pred             ccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccc
Q 041632           57 GEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGI  135 (452)
Q Consensus        57 ~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~  135 (452)
                      .-+|..+..+..|..||||+|+++ ..|..+..-+++-.|+||+|+|..+|...|-.+. |-.|||++|++..+||.+..
T Consensus        93 sGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RR  171 (1255)
T KOG0444|consen   93 SGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRR  171 (1255)
T ss_pred             CCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHH
Confidence            237888889999999999999999 8999999999999999999999999988887776 99999999999999999999


Q ss_pred             cccccccccccccccC
Q 041632          136 FANTSAISVAGCHRLC  151 (452)
Q Consensus       136 ~~~l~~l~~~~n~~~c  151 (452)
                      +..|++|.+++||..-
T Consensus       172 L~~LqtL~Ls~NPL~h  187 (1255)
T KOG0444|consen  172 LSMLQTLKLSNNPLNH  187 (1255)
T ss_pred             HhhhhhhhcCCChhhH
Confidence            9999999999998653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=2.2e-16  Score=160.98  Aligned_cols=203  Identities=30%  Similarity=0.368  Sum_probs=156.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-CCcEEEEEEeeccC--CccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-DGTVVAIKVINLQR--QGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~  306 (452)
                      ..|...+.||+|+|+.|-...... ....+|+|.+....  ....+....|..+-+.+. |+|++++++.     ..+..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCCc
Confidence            457778889999999999877632 34456777665433  222234445777777776 9999999987     55566


Q ss_pred             eeEEEEeccCCCChhhhh-cCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEecccCCCCeeecCCC
Q 041632          307 FKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ..++.++|..++++...+ ....          ...+...+-.+..|+..++.|+| ..   ++.|||+||+|.+++..+
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~----------~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~  161 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDS----------TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESG  161 (601)
T ss_pred             ccccccCcccccccccccccCCc----------cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCC
Confidence            788999999999998877 3221          13444456678999999999999 76   999999999999999999


Q ss_pred             -ceEECccccccccccCCCCceeccccccc-cccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 -SAHIGDFGLSRFYQAVSNPTVSSSIGVRG-TIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 -~~kl~Dfgla~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                       ..+++|||+|..+.... .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++
T Consensus       162 ~~l~~~df~~At~~~~~~-g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~  231 (601)
T KOG0590|consen  162 SALKIADFGLATAYRNKN-GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD  231 (601)
T ss_pred             CcccCCCchhhccccccC-CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence             99999999998766422 22233345668 9999999998874 45778999999999999999999985

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.59  E-value=1.8e-16  Score=152.37  Aligned_cols=128  Identities=22%  Similarity=0.233  Sum_probs=64.2

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ..|+++..-...|..+..+ +.|+|+.|+++..-...+.+|+.|+.|+||+|.|..+-+++|..+++|++|+|++|+|+.
T Consensus       253 qrN~I~kL~DG~Fy~l~km-e~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~  331 (873)
T KOG4194|consen  253 QRNDISKLDDGAFYGLEKM-EHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR  331 (873)
T ss_pred             hhcCcccccCcceeeeccc-ceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence            3455553333344455555 555555555553334445555555555555555555555555555555555555555553


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKV  130 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~  130 (452)
                      ..+..|..|..|+.|+|++|.++.+-...|.+++ |+.|||++|.|+..+
T Consensus       332 l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~I  381 (873)
T KOG4194|consen  332 LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCI  381 (873)
T ss_pred             CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEE
Confidence            3334455555555555555555544444444443 555555555444433

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.58  E-value=1.4e-16  Score=153.14  Aligned_cols=149  Identities=20%  Similarity=0.183  Sum_probs=118.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |+.|+++..-..++++|+.| +.|+||+|.|...-++++.-.++|++|+|++|+|+..-++.|..|.+|++|+|++|.|+
T Consensus       276 L~~N~l~~vn~g~lfgLt~L-~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~  354 (873)
T KOG4194|consen  276 LETNRLQAVNEGWLFGLTSL-EQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID  354 (873)
T ss_pred             cccchhhhhhcccccccchh-hhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence            56788886667788999999 99999999998778889999999999999999999777778888888888888888888


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcc---hhhcccc-cceeeCcccCCCCCCCc-cccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIP---LFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~---~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~  150 (452)
                      ..-..+|..+.+|+.|||++|.|+..+.   ..|+.+. |+.|+|.+|+|..++.. +..|.+|+.|++.+|+..
T Consensus       355 ~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia  429 (873)
T KOG4194|consen  355 HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA  429 (873)
T ss_pred             HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcce
Confidence            5555678888888888888888877654   2344444 88888888888776653 245777777777777644

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.52  E-value=8.7e-16  Score=147.46  Aligned_cols=143  Identities=27%  Similarity=0.376  Sum_probs=126.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |.+|.+. .+|..+.++..| ++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|.|.
T Consensus       105 Ly~n~~r-~ip~~i~~L~~l-t~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~  179 (722)
T KOG0532|consen  105 LYHNCIR-TIPEAICNLEAL-TFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ  179 (722)
T ss_pred             HHhccce-ecchhhhhhhHH-HHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh
Confidence            3567777 788888888888 88888888888 8888887765 888888899988 89999998899999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                       .+|+.++.+.+|+.|.+..|++..+|+... .++|..||+++|++..+|-.+..++.|+.|.+.+||..
T Consensus       180 -slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  180 -SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             -hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCceeecchhhhhhhhheeeeeccCCCC
Confidence             899999999999999999999999888776 78899999999999999999999999999999999853

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=5.7e-14  Score=139.05  Aligned_cols=142  Identities=20%  Similarity=0.243  Sum_probs=99.4

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc----------------------------------------HHHH
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA----------------------------------------SKSF  275 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~  275 (452)
                      .+.||.|++|.||+|+.+ +|+.||||+.+......                                        +-+|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999986 79999999985321000                                        0135


Q ss_pred             HHHHHHHhcC----CCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHH
Q 041632          276 MAECKALKNI----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI  351 (452)
Q Consensus       276 ~~ei~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~  351 (452)
                      .+|++.+.++    +|.+-+.+-..+.+    .....++||||++|++|.++.....          ...   ....++.
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~----------~~~---~~~~ia~  263 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDE----------AGL---DRKALAE  263 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHh----------cCC---CHHHHHH
Confidence            5566655555    34444444444322    2335689999999999988764211          011   2344666


Q ss_pred             HHHH-HHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccc
Q 041632          352 DVAS-ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       352 ~i~~-~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                      .++. .+..+|..   |++|+|++|.||++++++.++++|||++..++
T Consensus       264 ~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       264 NLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            6655 46788887   99999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.51  E-value=1.9e-15  Score=139.24  Aligned_cols=151  Identities=21%  Similarity=0.254  Sum_probs=114.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccC-ccccccCCc------------------
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSN-NGLSGEIPI------------------   61 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~------------------   61 (452)
                      |..|+|+..-|.+|..+.+| +.|||++|+|+.+-|.+|..|++|..|-+-+ |+|+ .+|.                  
T Consensus        74 LdqN~I~~iP~~aF~~l~~L-RrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~  151 (498)
T KOG4237|consen   74 LDQNQISSIPPGAFKTLHRL-RRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANH  151 (498)
T ss_pred             eccCCcccCChhhccchhhh-ceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhh
Confidence            56799994445567788898 8999999999877888999998887775555 7887 4443                  


Q ss_pred             --------------------------------------------------------------------------------
Q 041632           62 --------------------------------------------------------------------------------   61 (452)
Q Consensus        62 --------------------------------------------------------------------------------   61 (452)
                                                                                                      
T Consensus       152 i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl  231 (498)
T KOG4237|consen  152 INCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRL  231 (498)
T ss_pred             hcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHH
Confidence                                                                                            


Q ss_pred             -------------------------------------cccCCCCCCEEEccCccccccCchhhhcccCCCeeeccccccc
Q 041632           62 -------------------------------------ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS  104 (452)
Q Consensus        62 -------------------------------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  104 (452)
                                                           .|..|++|+.|+|++|+|+.+-+.+|.++..++.|+|..|+|.
T Consensus       232 ~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~  311 (498)
T KOG4237|consen  232 YYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLE  311 (498)
T ss_pred             HHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHH
Confidence                                                 1256777888888888888777777888888888888888887


Q ss_pred             CCcchhhcccc-cceeeCcccCCCCCCCcc-cccccccccccccccccCCC
Q 041632          105 GQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus       105 ~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~c~~  153 (452)
                      .+....|..++ |+.|+|.+|+|+...|.. ..+..|.++++-+|||.|..
T Consensus       312 ~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC  362 (498)
T KOG4237|consen  312 FVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC  362 (498)
T ss_pred             HHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence            77777777776 888888888888766633 44566777888888888853

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=1.7e-13  Score=133.89  Aligned_cols=199  Identities=28%  Similarity=0.305  Sum_probs=153.5

Q ss_pred             CCCCCCceec--cCceeEEEEEE--cCCCcEEEEEEee--ccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          232 GFSSTNLIGV--GSFGSVYKGVF--DEDGTVVAIKVIN--LQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       232 ~~~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~--~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      .|.+...+|.  |.+|.||.+..  ..++..+|+|.-+  .........=.+|....+++ .|+|.++....     +.+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence            3556678999  99999999998  8889999999843  33333334445777777777 69999986554     677


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEecccCCCCeee
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS----ALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                      .+..++-+|++ +.+|.++.+...          ..++....+....+..+    |++++|+.   .++|-|+||.||+.
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~----------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~  255 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPC----------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFT  255 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhccc----------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheec
Confidence            78899999999 688888876433          33566677777888888    99999998   99999999999999


Q ss_pred             cCC-CceEECccccccccccCCCCceec-cccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          381 DND-LSAHIGDFGLSRFYQAVSNPTVSS-SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       381 ~~~-~~~kl~Dfgla~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      ..+ ..++++|||+...+.......... .....|...|++||... ..++..+|+||+|.+..|..+|..+
T Consensus       256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~  326 (524)
T KOG0601|consen  256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHL  326 (524)
T ss_pred             ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccc
Confidence            999 889999999988766443222211 12225788899999865 4778899999999999998887654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.3e-14  Score=129.30  Aligned_cols=159  Identities=25%  Similarity=0.394  Sum_probs=119.4

Q ss_pred             HHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHH
Q 041632          281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL  360 (452)
Q Consensus       281 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  360 (452)
                      .+-.+-|.|++++..++.+..+.+.....+++|||..|++.+||++.+       .....+....-.+|+-||..||.||
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-------~~~~a~~~~~wkkw~tqIlsal~yL  192 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-------KNQKALFQKAWKKWCTQILSALSYL  192 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-------HhhhhhhHHHHHHHHHHHHhhhhhh
Confidence            344557999999999987776666777888999999999999998654       1233456666678999999999999


Q ss_pred             hcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceec-cccccccccccCccccCCCCCCcccceeehhH
Q 041632          361 HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS-SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGI  439 (452)
Q Consensus       361 H~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv  439 (452)
                      |+ |.++|+|+++.-+-|+++.++-+|++----. ............ .....+-++|.|||.......+.++|||+||+
T Consensus       193 hs-~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm  270 (458)
T KOG1266|consen  193 HS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM  270 (458)
T ss_pred             hc-cCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence            99 6799999999999999999999998532111 111111110000 11123678999999988778888999999999


Q ss_pred             HHHHHHhCC
Q 041632          440 LLLEMVTTK  448 (452)
Q Consensus       440 ~l~elltg~  448 (452)
                      ...||..|.
T Consensus       271 cAlemailE  279 (458)
T KOG1266|consen  271 CALEMAILE  279 (458)
T ss_pred             HHHHHHHhe
Confidence            999997764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=7.2e-13  Score=132.72  Aligned_cols=146  Identities=16%  Similarity=0.203  Sum_probs=95.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC----------------------------------ccH----
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ----------------------------------GAS----  272 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------------------~~~----  272 (452)
                      ..|+. +.||+|++|+||+|+.+.+|+.||||+.+..-.                                  +..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999986799999999963210                                  001    


Q ss_pred             --HHHHHHHHHHhcC----CCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhh--cCCCCCCcccccccccCCHH
Q 041632          273 --KSFMAECKALKNI----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQKLTLL  344 (452)
Q Consensus       273 --~~~~~ei~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~l~~~  344 (452)
                        -+|.+|+..+.++    .+.+.+.+-.++    +......++||||++|+.+.++-  ....       .....+...
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~~g-------~d~~~la~~  267 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRAAG-------TDMKLLAER  267 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHhcC-------CCHHHHHHH
Confidence              1245555555554    244444443332    22234678999999999998742  2111       001123333


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC----ceEECccccccccc
Q 041632          345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL----SAHIGDFGLSRFYQ  398 (452)
Q Consensus       345 ~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfgla~~~~  398 (452)
                      ....++.|+.       ..   |++|+|++|.||+++.++    .+++.|||++..++
T Consensus       268 ~v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        268 GVEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            3333334433       34   999999999999999888    99999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.39  E-value=2.7e-12  Score=126.76  Aligned_cols=170  Identities=18%  Similarity=0.234  Sum_probs=128.0

Q ss_pred             EEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCC
Q 041632          249 KGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA  328 (452)
Q Consensus       249 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  328 (452)
                      .|..+.++.+|.|...+....+......+-++.|+.++||||++++..     ++..+..|+|+|-+.  .|..+++   
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk---   99 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLK---   99 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHH---
Confidence            466667888999999886665445667788999999999999999987     566668899999884  4555553   


Q ss_pred             CCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceecc
Q 041632          329 IPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS  408 (452)
Q Consensus       329 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~  408 (452)
                                 .+......-.+.||+.||.|||+.|  .++|++|.-+.|+|+..|+.||++|.++...+....    ..
T Consensus       100 -----------~l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~  162 (690)
T KOG1243|consen  100 -----------ELGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PA  162 (690)
T ss_pred             -----------HhHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----cc
Confidence                       2334556667899999999999764  999999999999999999999999998864432221    11


Q ss_pred             ccccccccccCccccCCCCCCcccceeehhHHHHHHHhC
Q 041632          409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT  447 (452)
Q Consensus       409 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg  447 (452)
                      ....--..|..|+.+....  -..|.|-||+++||++.|
T Consensus       163 ~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  163 KSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            1122233466676544322  346999999999999999

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.37  E-value=6.7e-14  Score=124.74  Aligned_cols=135  Identities=20%  Similarity=0.215  Sum_probs=115.2

Q ss_pred             cCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhh
Q 041632            9 TIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFR   88 (452)
Q Consensus         9 ~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~   88 (452)
                      ..-..+..+..| ++||||+|.|+ .+.+++.-++.++.|++|+|.|. .+- ++..|++|+.||||+|.++ .+...-.
T Consensus       275 ~~~~~~dTWq~L-telDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~  349 (490)
T KOG1259|consen  275 SALVSADTWQEL-TELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHL  349 (490)
T ss_pred             ceEEecchHhhh-hhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHh
Confidence            333445567788 89999999999 99999999999999999999998 444 4899999999999999999 7787888


Q ss_pred             cccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCC--Ccccccccccccccccccc
Q 041632           89 TSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKV--PTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        89 ~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~--~~~~~~~~l~~l~~~~n~~  149 (452)
                      .+.+++.|.|+.|.|..+ .+.-++-+|..||+++|+|+..-  ..+|+++.|+.+.+.+||.
T Consensus       350 KLGNIKtL~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl  411 (490)
T KOG1259|consen  350 KLGNIKTLKLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL  411 (490)
T ss_pred             hhcCEeeeehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence            899999999999999863 34445556999999999997653  4579999999999999985

>PLN03150 hypothetical protein; Provisional

Probab=99.37  E-value=8e-13  Score=136.84  Aligned_cols=100  Identities=32%  Similarity=0.555  Sum_probs=90.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+++|.+|..+..+++| +.|+|++|+|+|.+|..++.+++|+.|+|++|++++.+|+.++.+++|+.|+|++|+++
T Consensus       425 L~~n~L~g~ip~~i~~L~~L-~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~  503 (623)
T PLN03150        425 LDNQGLRGFIPNDISKLRHL-QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS  503 (623)
T ss_pred             CCCCCccccCCHHHhCCCCC-CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence            57899999999999999999 99999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCchhhhcc-cCCCeeecccc
Q 041632           81 GSIPSFFRTS-RGIRKLDLSRN  101 (452)
Q Consensus        81 ~~~p~~~~~l-~~L~~l~l~~N  101 (452)
                      |.+|..+..+ .++..+++++|
T Consensus       504 g~iP~~l~~~~~~~~~l~~~~N  525 (623)
T PLN03150        504 GRVPAALGGRLLHRASFNFTDN  525 (623)
T ss_pred             ccCChHHhhccccCceEEecCC
Confidence            9999988753 34445555554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.34  E-value=9.9e-13  Score=112.35  Aligned_cols=124  Identities=24%  Similarity=0.224  Sum_probs=48.8

Q ss_pred             ccccCcccEEEccCCccccCCCcCCc-CCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhh-hcccC
Q 041632           15 FSISYLSNSLNLAENHFVGSIPPRIG-NLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFF-RTSRG   92 (452)
Q Consensus        15 ~~l~~l~~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~   92 (452)
                      .+...+ ++|+|.+|+|+ .+. .++ .+.+|+.|+|++|+|+ .++ .+..+++|+.|++++|+|+ .+++.+ ..+++
T Consensus        16 ~n~~~~-~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~   89 (175)
T PF14580_consen   16 NNPVKL-RELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred             cccccc-ccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence            344567 88999999998 665 566 6889999999999998 555 6888999999999999999 665555 46899


Q ss_pred             CCeeecccccccCCcc-hhh-cccccceeeCcccCCCCCCCc----cccccccccccc
Q 041632           93 IRKLDLSRNNLSGQIP-LFL-EALSLEYLNLSFNDFEGKVPT----KGIFANTSAISV  144 (452)
Q Consensus        93 L~~l~l~~N~l~~~~~-~~~-~~~~L~~l~l~~N~l~~~~~~----~~~~~~l~~l~~  144 (452)
                      |+.|+|++|+|...-. ..+ .+.+|+.|+|.+|.++..+..    +..+++|+.||.
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            9999999999987533 222 344499999999999865432    255677776654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.34  E-value=1.7e-12  Score=134.67  Aligned_cols=76  Identities=17%  Similarity=0.244  Sum_probs=45.9

Q ss_pred             CCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccc
Q 041632           68 SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGC  147 (452)
Q Consensus        68 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n  147 (452)
                      +|+.|+|++|+|+ .+|..   .++|+.|++++|+|+++|. .  ...|+.|++++|+|+.+|..+..+++|..+++++|
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~LssIP~-l--~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N  455 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTSLPM-L--PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGN  455 (788)
T ss_pred             ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCCCCc-c--hhhhhhhhhccCcccccChHHhhccCCCeEECCCC
Confidence            3444444444444 33322   1345566666666665432 1  12366777777777777767777888888888888


Q ss_pred             ccc
Q 041632          148 HRL  150 (452)
Q Consensus       148 ~~~  150 (452)
                      +..
T Consensus       456 ~Ls  458 (788)
T PRK15387        456 PLS  458 (788)
T ss_pred             CCC
Confidence            864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=4.4e-12  Score=109.74  Aligned_cols=130  Identities=15%  Similarity=0.088  Sum_probs=94.3

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCce-eEeeeeccccCCCCceeEEEEecc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV-RVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv-~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      +.++.|.++.||+++..  ++.+++|....... ....+..|+++++.+.+.+++ +++...       ....++||||+
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i   73 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFI   73 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEec
Confidence            56889999999999874  77899998754322 224567899999888655544 344331       11347999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCCeeecCCCceEECcccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC--QEPILHCDLKPSNILLDNDLSAHIGDFGL  393 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  393 (452)
                      ++.++...-               .    .....+.+++.+++.||+..  ..+++|+|++|.||+++ ++.++++|||.
T Consensus        74 ~G~~l~~~~---------------~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          74 EGSELLTED---------------F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             CCCcccccc---------------c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            998876420               0    11235678999999999972  22369999999999999 66899999998


Q ss_pred             ccc
Q 041632          394 SRF  396 (452)
Q Consensus       394 a~~  396 (452)
                      +..
T Consensus       134 a~~  136 (170)
T cd05151         134 AGM  136 (170)
T ss_pred             ccC
Confidence            864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.34  E-value=1.3e-12  Score=136.14  Aligned_cols=91  Identities=25%  Similarity=0.401  Sum_probs=38.6

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++++++ .+|..+.  +.+ +.|+|++|+|+ .+|..+.  .+|+.|++++|+|+ .+|..+.  .+|+.|+|++|++. 
T Consensus       186 ~~~~Lt-sLP~~Ip--~~L-~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-  254 (754)
T PRK15370        186 KILGLT-TIPACIP--EQI-TTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-  254 (754)
T ss_pred             CCCCcC-cCCcccc--cCC-cEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-
Confidence            344444 4444432  233 45555555555 4444332  24555555555544 3443332  23444444444444 


Q ss_pred             cCchhhhcccCCCeeecccccccC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSG  105 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~  105 (452)
                      .+|..+.  .+|+.|+|++|+|+.
T Consensus       255 ~LP~~l~--s~L~~L~Ls~N~L~~  276 (754)
T PRK15370        255 ELPERLP--SALQSLDLFHNKISC  276 (754)
T ss_pred             cCChhHh--CCCCEEECcCCccCc
Confidence            3333332  234444444444443

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.31  E-value=1e-13  Score=140.29  Aligned_cols=149  Identities=28%  Similarity=0.270  Sum_probs=98.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+|+++..+.+| +.|+..+|+|+ .+|..+..+++|+.|.+..|.++ .+|+..+.+++|+.|+|..|+|.
T Consensus       248 is~n~l~-~lp~wi~~~~nl-e~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~  323 (1081)
T KOG0618|consen  248 ISHNNLS-NLPEWIGACANL-EALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP  323 (1081)
T ss_pred             cchhhhh-cchHHHHhcccc-eEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc
Confidence            3566666 556666666666 66666666665 56655555555555555555554 45555555555555555555554


Q ss_pred             -------------------------------------------------ccCchhhhcccCCCeeecccccccCCcchhh
Q 041632           81 -------------------------------------------------GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFL  111 (452)
Q Consensus        81 -------------------------------------------------~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~  111 (452)
                                                                       ...-+.+.+.++|+.|+|++|+|..+|...+
T Consensus       324 ~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~  403 (1081)
T KOG0618|consen  324 SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKL  403 (1081)
T ss_pred             ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHH
Confidence                                                             3333333445778889999999988887777


Q ss_pred             cccc-cceeeCcccCCCCCCCcccccccccccccccccccCCC
Q 041632          112 EALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus       112 ~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      ..+. |++|+|++|+++.+|..+..++.|++|...+|...|-+
T Consensus       404 ~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~~fP  446 (1081)
T KOG0618|consen  404 RKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLLSFP  446 (1081)
T ss_pred             hchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCceeech
Confidence            6665 88999999999888877777777777777777766654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.30  E-value=2e-13  Score=138.33  Aligned_cols=130  Identities=27%  Similarity=0.347  Sum_probs=101.3

Q ss_pred             ccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCc-cccCCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           17 ISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI-ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      +..| +.|+|.+|.|+...=+.+.++++|+.|+|++|+|. .+|+ .+.++..|++|+||+|+|+ .+|+.+..+..|++
T Consensus       358 ~~~L-q~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~t  434 (1081)
T KOG0618|consen  358 HAAL-QELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHT  434 (1081)
T ss_pred             hHHH-HHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHH
Confidence            3445 78888888888776667888889999999999988 5664 4678888999999999998 88888888888999


Q ss_pred             eecccccccCCcchhhcccccceeeCcccCCCCCC-Cccccccccccccccccccc
Q 041632           96 LDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKV-PTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        96 l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~-~~~~~~~~l~~l~~~~n~~~  150 (452)
                      |...+|+|...| ...+...|+.+|++.|.|+... +....-++|+.|+++||.|.
T Consensus       435 L~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  435 LRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             HhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            998888888765 5555556889999998886532 22211278888899988874

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.30  E-value=5.4e-12  Score=131.57  Aligned_cols=134  Identities=19%  Similarity=0.282  Sum_probs=112.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+|..+.  .+| +.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  .+|+.|+|++|+|+
T Consensus       206 Ls~N~Lt-sLP~~l~--~nL-~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~  275 (754)
T PRK15370        206 LDNNELK-SLPENLQ--GNI-KTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS  275 (754)
T ss_pred             ecCCCCC-cCChhhc--cCC-CEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC
Confidence            5789999 7888775  478 99999999999 7887664  48999999999998 7888775  58999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                       .+|..+.  ++|+.|+|++|+|+.+|+...  .+|+.|++++|+++.+|+..  .++|+.|++++|...+
T Consensus       276 -~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l--~~sL~~L~Ls~N~Lt~  339 (754)
T PRK15370        276 -CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSNSLTALPETL--PPGLKTLEAGENALTS  339 (754)
T ss_pred             -ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCCccccCCccc--cccceeccccCCcccc
Confidence             7787664  589999999999998765432  25999999999999887655  5789999999987554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.30  E-value=3.4e-13  Score=129.88  Aligned_cols=126  Identities=28%  Similarity=0.431  Sum_probs=115.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |+.|+++ .+|..++.|+ | +.|-+++|+++ .+|+.++.+..|..||.++|++. .+|..++++.+|+.|.+..|++.
T Consensus       128 ls~NqlS-~lp~~lC~lp-L-kvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~  202 (722)
T KOG0532|consen  128 LSSNQLS-HLPDGLCDLP-L-KVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE  202 (722)
T ss_pred             hccchhh-cCChhhhcCc-c-eeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence            5789999 9999999887 5 89999999999 99999999999999999999999 89999999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTK  133 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~  133 (452)
                       .+|..++.|+ |..||+|+|+++.+|-.+.++..|++|-|.+|.|++.|..+
T Consensus       203 -~lp~El~~Lp-Li~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLqSPPAqI  253 (722)
T KOG0532|consen  203 -DLPEELCSLP-LIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQSPPAQI  253 (722)
T ss_pred             -hCCHHHhCCc-eeeeecccCceeecchhhhhhhhheeeeeccCCCCCChHHH
Confidence             8898888654 99999999999998887777777999999999999766554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.27  E-value=7.6e-11  Score=102.82  Aligned_cols=136  Identities=20%  Similarity=0.142  Sum_probs=94.8

Q ss_pred             CceeccCceeEEEEEEcC------CCcEEEEEEeeccC------------C---------cc-HHHH----HHHHHHHhc
Q 041632          237 NLIGVGSFGSVYKGVFDE------DGTVVAIKVINLQR------------Q---------GA-SKSF----MAECKALKN  284 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~---------~~-~~~~----~~ei~~l~~  284 (452)
                      ..||.|--+.||.|....      .+..+|||+.+...            +         .. .+.+    .+|.+.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999998643      35789999885211            0         01 1222    378888888


Q ss_pred             CCC--CCceeEeeeeccccCCCCceeEEEEeccCCCChhh-hhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHH-
Q 041632          285 IRH--KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEK-WLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL-  360 (452)
Q Consensus       285 l~h--~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-  360 (452)
                      +..  -++...+.+         ...++||||+.++.+.. .++.            ..++..+...+..+++.+|..+ 
T Consensus        83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd------------~~~~~~~~~~i~~~i~~~l~~l~  141 (197)
T cd05146          83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD------------AKLNDEEMKNAYYQVLSMMKQLY  141 (197)
T ss_pred             HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc------------cccCHHHHHHHHHHHHHHHHHHH
Confidence            843  345555543         24589999997654321 1211            1233445667789999999999 


Q ss_pred             hcCCCCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          361 HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       361 H~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                      |+.   ++||+||++.||++++ +.+.|+|||.+...
T Consensus       142 H~~---glVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         142 KEC---NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HhC---CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            776   9999999999999974 67999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.22  E-value=8.3e-12  Score=106.68  Aligned_cols=118  Identities=24%  Similarity=0.239  Sum_probs=41.4

Q ss_pred             ccCCccccCCCcCCcCCCCCCEEEccCccccccCCcccc-CCCCCCEEEccCccccccCchhhhcccCCCeeeccccccc
Q 041632           26 LAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG-LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS  104 (452)
Q Consensus        26 l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  104 (452)
                      |..+.|. .+| .+.+..++++|+|++|+|+ .+ +.++ .+.+|+.|+|++|+|+ .++ .+..++.|+.|++++|+|+
T Consensus         4 lt~~~i~-~~~-~~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    4 LTANMIE-QIA-QYNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             ccccccc-ccc-ccccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence            5556665 555 4556668899999999998 45 4676 5899999999999999 655 5888999999999999999


Q ss_pred             CCcchhhc-ccccceeeCcccCCCCCCC--cccccccccccccccccc
Q 041632          105 GQIPLFLE-ALSLEYLNLSFNDFEGKVP--TKGIFANTSAISVAGCHR  149 (452)
Q Consensus       105 ~~~~~~~~-~~~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~~~n~~  149 (452)
                      .+.+.... +..|+.|++++|+|...-.  .+..+++|+.|++.+||.
T Consensus        78 ~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv  125 (175)
T PF14580_consen   78 SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV  125 (175)
T ss_dssp             S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred             ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence            87665544 4569999999999976543  346788999999999985

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.21  E-value=3.7e-11  Score=124.85  Aligned_cols=110  Identities=25%  Similarity=0.385  Sum_probs=69.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+|+.+..  .+ +.|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|+|++|+|+
T Consensus       208 Ls~~~Lt-sLP~~l~~--~L-~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~  275 (788)
T PRK15387        208 VGESGLT-TLPDCLPA--HI-TTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT  275 (788)
T ss_pred             cCCCCCC-cCCcchhc--CC-CEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCchh
Confidence            5778888 78888764  66 88999999998 67753   578999999999998 56753   356667777777666


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGK  129 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~  129 (452)
                       .+|..+   ++|+.|+|++|+|+.+|..   ..+|+.|+|++|+|+++
T Consensus       276 -~Lp~lp---~~L~~L~Ls~N~Lt~LP~~---p~~L~~LdLS~N~L~~L  317 (788)
T PRK15387        276 -HLPALP---SGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLASL  317 (788)
T ss_pred             -hhhhch---hhcCEEECcCCcccccccc---ccccceeECCCCccccC
Confidence             444322   2344444555554443321   11244444444444443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.20  E-value=2.1e-12  Score=119.31  Aligned_cols=145  Identities=22%  Similarity=0.221  Sum_probs=122.0

Q ss_pred             cccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccC-ccccccC
Q 041632            5 DLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGG-NFFHGSI   83 (452)
Q Consensus         5 ~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~   83 (452)
                      .|+ .+|..+..  .. ++++|..|+|+..-|.+|+.+++|+.||||+|+|+.+-|++|.++++|..|-+-+ |+|+...
T Consensus        57 GL~-eVP~~LP~--~t-veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~  132 (498)
T KOG4237|consen   57 GLT-EVPANLPP--ET-VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLP  132 (498)
T ss_pred             Ccc-cCcccCCC--cc-eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhh
Confidence            455 67766542  34 6799999999944556899999999999999999999999999999988877655 9999444


Q ss_pred             chhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccccCCC
Q 041632           84 PSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus        84 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      -+.|.+|.+|+.|.+.-|++.-+..+.+..++ |..|.+.+|.++.+.. ....+.+++.+.+..||..|-.
T Consensus       133 k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC  204 (498)
T KOG4237|consen  133 KGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC  204 (498)
T ss_pred             hhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence            46899999999999999999999988888776 9999999999998776 4456778889999999988843

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=1.2e-11  Score=121.07  Aligned_cols=196  Identities=23%  Similarity=0.226  Sum_probs=144.6

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEc-CCCcEEEEEEeeccCCccHHH--HHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFD-EDGTVVAIKVINLQRQGASKS--FMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      ...+|..+..||.|.|+.|+....+ .++..+++|.+.........+  -..|+.+...+ .|.++++....     |..
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~~  337 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WSQ  337 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----ccc
Confidence            4467888899999999999987766 678899999886443333222  23555555555 58888886655     444


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-  383 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-  383 (452)
                      ....++-.||++++++...+.           ....+++..++++..|++.++.++|+.   .++|+|+||+||++..+ 
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~-----------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSV-----------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG  403 (524)
T ss_pred             cccccCchhhhcCcchhhhhH-----------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence            456678889999998876652           234677778899999999999999997   99999999999999886 


Q ss_pred             CceEECccccccccccCCCCceeccccccccccc-cCccccCCCCCCcccceeehhHHHHHHHhCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY-VAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~  449 (452)
                      +..+++|||.+..+...      .......+..| .+++......+-.+.|++|||..+.|..+|..
T Consensus       404 ~~~~~~~~~~~t~~~~~------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAFS------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             hhhhcccccccccccee------cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            88899999998642210      11111123334 35556666778889999999999999988764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=4.5e-10  Score=101.57  Aligned_cols=145  Identities=16%  Similarity=0.197  Sum_probs=102.6

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCC--CceeEeeeeccccCCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK--NLVRVITSCSSVDFQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~--niv~l~~~~~~~~~~~~~~~~lv~e  313 (452)
                      +.|+.|..+.||++... +|+.+++|....... .....+..|+++++.+++.  ++.+++.++....  ..+..++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence            56899999999999875 467899998764332 1346788999999998653  3566666533211  1124589999


Q ss_pred             ccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 041632          314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH------------------------------  363 (452)
Q Consensus       314 ~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------  363 (452)
                      |+++.++...+..            ..++..+...++.+++++|++||+.                              
T Consensus        81 ~i~G~~l~~~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (223)
T cd05154          81 RVDGRVLRDRLLR------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA  148 (223)
T ss_pred             EeCCEecCCCCCC------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence            9999888765421            1245555666666777777777642                              


Q ss_pred             -----------------------CCCCeEecccCCCCeeecC--CCceEECccccccc
Q 041632          364 -----------------------CQEPILHCDLKPSNILLDN--DLSAHIGDFGLSRF  396 (452)
Q Consensus       364 -----------------------~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~  396 (452)
                                             ....++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                   1246899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.11  E-value=2.6e-11  Score=125.01  Aligned_cols=205  Identities=27%  Similarity=0.323  Sum_probs=143.0

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ..+++.+.+.+.+|+++.++.+.-...|...+.|......   ....+....+-.++-..+||-+++....     +.-.
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCCC
Confidence            4466777788889999999988876667655665543211   1111222222222222345666654322     3445


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...+++++|..+++|...++...           ..+..-.......+..+.+|||..   .+.|||++|+|.+...++.
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~-----------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh  942 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG-----------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH  942 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC-----------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence            67889999999999998887543           223333444566688899999996   6999999999999999999


Q ss_pred             eEECccccccccccC----CC-----------------------CceeccccccccccccCccccCCCCCCcccceeehh
Q 041632          386 AHIGDFGLSRFYQAV----SN-----------------------PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYG  438 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~----~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG  438 (452)
                      .++.|||........    ..                       ..........||+.|.+||...+......+|.|+.|
T Consensus       943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen  943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred             cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence            999999843321100    00                       000113346699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCC
Q 041632          439 ILLLEMVTTKKPTD  452 (452)
Q Consensus       439 v~l~elltg~~Pf~  452 (452)
                      ++++|.++|..||+
T Consensus      1023 ~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFN 1036 (1205)
T ss_pred             hhhhhhhcCCCCCC
Confidence            99999999999985

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.09  E-value=3.9e-11  Score=118.54  Aligned_cols=145  Identities=27%  Similarity=0.392  Sum_probs=113.5

Q ss_pred             CCCCcccccCCccccccc-CcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSIS-YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~-~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +.+|+++ .+|.....+. +| +.|++++|++. .+|..+..+++|+.|+++.|+++ .+|...+.+++|+.|++++|++
T Consensus       123 l~~n~i~-~i~~~~~~~~~nL-~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i  198 (394)
T COG4886         123 LDNNNIT-DIPPLIGLLKSNL-KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI  198 (394)
T ss_pred             cCCcccc-cCccccccchhhc-ccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCcc
Confidence            4577888 7787777774 88 89999999998 88888899999999999999998 7888777889999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      + .+|.....+..|+.|++++|++...+........+..+.+.+|++...+...+.+++++.+++++|...
T Consensus       199 ~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~  268 (394)
T COG4886         199 S-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS  268 (394)
T ss_pred             c-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhccccccceecccccccc
Confidence            8 788776666678888888886555555555555577777788877765556666777777777777543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.08  E-value=5.2e-11  Score=117.70  Aligned_cols=137  Identities=27%  Similarity=0.375  Sum_probs=118.4

Q ss_pred             CcccccccCcccEEEccCCccccCCCcCCcCCC-CCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhc
Q 041632           11 PEAIFSISYLSNSLNLAENHFVGSIPPRIGNLK-ALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRT   89 (452)
Q Consensus        11 p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~   89 (452)
                      +..+..++.+ +.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.
T Consensus       109 ~~~~~~~~~l-~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~  184 (394)
T COG4886         109 ISELLELTNL-TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN  184 (394)
T ss_pred             chhhhcccce-eEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhh
Confidence            4455566677 99999999999 8998888885 9999999999999 88889999999999999999999 88887778


Q ss_pred             ccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           90 SRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        90 l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      ++.|+.|++++|+++.+++..-....|++|.+++|.+...+.....++++..+.+.+|...+
T Consensus       185 ~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         185 LSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             hhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee
Confidence            89999999999999988775433334999999999777677778889999999888887665

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.05  E-value=1.2e-10  Score=81.92  Aligned_cols=57  Identities=30%  Similarity=0.392  Sum_probs=28.9

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   78 (452)
                      ++|+|++|+|+..-+..|.++++|++|++++|.++...|+.|.++++|++|++++|+
T Consensus         4 ~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    4 ESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             SEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            455555555552222344555555555555555554444455555555555555554

...

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=1.4e-09  Score=91.26  Aligned_cols=141  Identities=26%  Similarity=0.321  Sum_probs=97.3

Q ss_pred             CCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--------ccHHHHHHHHHHHhcCCCCCce--eEeeeeccccCCC
Q 041632          235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--------GASKSFMAECKALKNIRHKNLV--RVITSCSSVDFQG  304 (452)
Q Consensus       235 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv--~l~~~~~~~~~~~  304 (452)
                      ....+-+|+-+.|+++.+  .|+...||.=....-        -..++-.+|++++.++.--.|.  +++       +.+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-------~~D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-------FID   81 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-------EEe
Confidence            567889999999999998  577777774321111        1124567889988887533332  222       222


Q ss_pred             CceeEEEEeccCC-CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          305 NDFKAIVYKYMPN-GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       305 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      ...-.++|||+++ .++.+|+.....         ..-.......++..+-+.+.-||..   +|+|+||..+||++..+
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~---------~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~  149 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTME---------DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSD  149 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHcc---------CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecC
Confidence            3345789999966 478888865431         1111122256788889999999998   99999999999999765


Q ss_pred             C---ceEECccccccc
Q 041632          384 L---SAHIGDFGLSRF  396 (452)
Q Consensus       384 ~---~~kl~Dfgla~~  396 (452)
                      +   .+.++|||++..
T Consensus       150 ~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  150 GNQITPILIDFGLSSV  165 (229)
T ss_pred             CCcCceEEEeecchhc
Confidence            5   358999999864

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.03  E-value=4.3e-11  Score=107.07  Aligned_cols=125  Identities=25%  Similarity=0.249  Sum_probs=104.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ||+|.|+ .+.++.--++.+ +.|+||+|.|. .+.. +..|++|+.||||+|.++ .+-+.-..|-+.+.|.|+.|.|.
T Consensus       291 LS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE  365 (490)
T KOG1259|consen  291 LSGNLIT-QIDESVKLAPKL-RRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE  365 (490)
T ss_pred             ccccchh-hhhhhhhhccce-eEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh
Confidence            6889999 888888878888 99999999998 6554 899999999999999998 66666667899999999999997


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcc-hhhcccc-cceeeCcccCCCCCCCc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIP-LFLEALS-LEYLNLSFNDFEGKVPT  132 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~~~-L~~l~l~~N~l~~~~~~  132 (452)
                       .+ +.+..+-+|..||+++|+|...-. ...+.++ |+.|.|.+|.+.+++..
T Consensus       366 -~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY  417 (490)
T KOG1259|consen  366 -TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY  417 (490)
T ss_pred             -hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence             43 468888999999999999986433 2333445 99999999999988764

>PLN03210 Resistant to P

Probab=99.03  E-value=9.3e-10  Score=122.28  Aligned_cols=112  Identities=24%  Similarity=0.263  Sum_probs=55.4

Q ss_pred             cCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhh
Q 041632            9 TIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFR   88 (452)
Q Consensus         9 ~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~   88 (452)
                      .+|..+ .+.+| +.|+|.+|+|. .+|..+..+++|+.|+|++|...+.+| .++.+++|+.|+|++|.....+|..+.
T Consensus       603 ~lP~~f-~~~~L-~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~  678 (1153)
T PLN03210        603 CMPSNF-RPENL-VKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQ  678 (1153)
T ss_pred             CCCCcC-CccCC-cEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhh
Confidence            344443 23444 55555555555 455555555555555555543222444 255555566666655543335555555


Q ss_pred             cccCCCeeeccccc-ccCCcchhhcccccceeeCcccC
Q 041632           89 TSRGIRKLDLSRNN-LSGQIPLFLEALSLEYLNLSFND  125 (452)
Q Consensus        89 ~l~~L~~l~l~~N~-l~~~~~~~~~~~~L~~l~l~~N~  125 (452)
                      .+++|+.|++++|. +..+|. ...+.+|+.|++++|.
T Consensus       679 ~L~~L~~L~L~~c~~L~~Lp~-~i~l~sL~~L~Lsgc~  715 (1153)
T PLN03210        679 YLNKLEDLDMSRCENLEILPT-GINLKSLYRLNLSGCS  715 (1153)
T ss_pred             ccCCCCEEeCCCCCCcCccCC-cCCCCCCCEEeCCCCC
Confidence            55556666665532 333322 2233335555554443

syringae 6; Provisional

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=2e-09  Score=90.74  Aligned_cols=129  Identities=27%  Similarity=0.327  Sum_probs=90.9

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC---Ccc-----HHHHHHHHHHHhcCCCCCc--eeEeeeeccccCCCCc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGA-----SKSFMAECKALKNIRHKNL--VRVITSCSSVDFQGND  306 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~-----~~~~~~ei~~l~~l~h~ni--v~l~~~~~~~~~~~~~  306 (452)
                      ..+++|+-+.+|.+.+.  |..+++|.=-...   +.-     .++-.+|++++++++--.|  ..++.       .+.+
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d-------vD~~   72 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD-------VDPD   72 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE-------EcCC
Confidence            35789999999999874  4455555321111   111     1345678888888754333  22332       2344


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ...|+|||.+|-.|.+++...                  ...++..+-.-+.-||..   +|+|+||.++||++.++. +
T Consensus        73 ~~~I~me~I~G~~lkd~l~~~------------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i  130 (204)
T COG3642          73 NGLIVMEYIEGELLKDALEEA------------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-I  130 (204)
T ss_pred             CCEEEEEEeCChhHHHHHHhc------------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-E
Confidence            567999999999999888532                  134566677778889998   999999999999998875 8


Q ss_pred             EECccccccc
Q 041632          387 HIGDFGLSRF  396 (452)
Q Consensus       387 kl~Dfgla~~  396 (452)
                      .++|||++..
T Consensus       131 ~~IDfGLg~~  140 (204)
T COG3642         131 YFIDFGLGEF  140 (204)
T ss_pred             EEEECCcccc
Confidence            9999999974

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.03  E-value=2.5e-10  Score=80.36  Aligned_cols=61  Identities=36%  Similarity=0.433  Sum_probs=55.8

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccccc
Q 041632           43 KALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNL  103 (452)
Q Consensus        43 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  103 (452)
                      ++|+.|++++|+|+...++.|.++++|++|++++|+|+...|..|..+++|+.|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999966557899999999999999999977778999999999999999986

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=3.2e-09  Score=102.27  Aligned_cols=181  Identities=20%  Similarity=0.207  Sum_probs=133.8

Q ss_pred             CceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEeccCC-CChh
Q 041632          243 SFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPN-GSLE  321 (452)
Q Consensus       243 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~-gsL~  321 (452)
                      ...+.|++...-+|..+++|+++..+.........-+++++++.|+|+|++.+++....| ++...++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCchHH
Confidence            346789999999999999999964444333334566888999999999999998764433 34568899999986 5777


Q ss_pred             hhhcCCCCCC----cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          322 KWLHPDAIPQ----RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       322 ~~l~~~~~~~----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                      ++-.......    ..........++...|.++.|++.||.++|+.   |..-+-|.+.+|+++.+.+++|+..|.....
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence            6544332211    11123345678899999999999999999998   9999999999999999999999988876554


Q ss_pred             ccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCC
Q 041632          398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK  448 (452)
Q Consensus       398 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~  448 (452)
                      .....                  |.+.+   -.+-|.=.||.++.-|.||.
T Consensus       444 ~~d~~------------------~~le~---~Qq~D~~~lG~ll~aLAt~~  473 (655)
T KOG3741|consen  444 QEDPT------------------EPLES---QQQNDLRDLGLLLLALATGT  473 (655)
T ss_pred             cCCCC------------------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence            42220                  11111   13568888999999999983

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.00  E-value=5e-11  Score=114.25  Aligned_cols=137  Identities=21%  Similarity=0.166  Sum_probs=67.7

Q ss_pred             CcccccccCcccEEEccCCcccc------CCCcCCcCCCCCCEEEccCccccccCCccccCCCC---CCEEEccCccccc
Q 041632           11 PEAIFSISYLSNSLNLAENHFVG------SIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSS---LEDIYLGGNFFHG   81 (452)
Q Consensus        11 p~~~~~l~~l~~~L~l~~n~l~~------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~   81 (452)
                      ++.+...+.+ +.|+++++.+.+      .++..+..+++|+.|++++|.+.+..+..+..+.+   |++|++++|++.+
T Consensus        44 ~~~l~~~~~l-~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~  122 (319)
T cd00116          44 ASALRPQPSL-KELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD  122 (319)
T ss_pred             HHHHhhCCCc-eEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccch
Confidence            3444444555 566666665541      12334455566666666666665444444444433   6666666666552


Q ss_pred             ----cCchhhhcc-cCCCeeecccccccCCc----chhhc-ccccceeeCcccCCCCC-----CCccccccccccccccc
Q 041632           82 ----SIPSFFRTS-RGIRKLDLSRNNLSGQI----PLFLE-ALSLEYLNLSFNDFEGK-----VPTKGIFANTSAISVAG  146 (452)
Q Consensus        82 ----~~p~~~~~l-~~L~~l~l~~N~l~~~~----~~~~~-~~~L~~l~l~~N~l~~~-----~~~~~~~~~l~~l~~~~  146 (452)
                          .+...+..+ ++|+.|++++|.+++..    +..+. +..|+.|++++|.+++.     +.....+++|+.|++++
T Consensus       123 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~  202 (319)
T cd00116         123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN  202 (319)
T ss_pred             HHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccC
Confidence                122334444 56666666666665321    11122 12366666666666531     11112233566666665


Q ss_pred             cc
Q 041632          147 CH  148 (452)
Q Consensus       147 n~  148 (452)
                      |.
T Consensus       203 n~  204 (319)
T cd00116         203 NG  204 (319)
T ss_pred             Cc
Confidence            54

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.95  E-value=9.7e-11  Score=112.23  Aligned_cols=139  Identities=20%  Similarity=0.278  Sum_probs=104.1

Q ss_pred             CCcccccccCcccEEEccCCccccCCCcCCcCCCC---CCEEEccCccccc----cCCccccCC-CCCCEEEccCccccc
Q 041632           10 IPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKA---LRSFDVSNNGLSG----EIPIELGLC-SSLEDIYLGGNFFHG   81 (452)
Q Consensus        10 ~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~   81 (452)
                      ++..+..+.+| +.|+|++|.+.+..+..+..+.+   |+.|++++|++++    .+...+..+ ++|+.|+|++|.+++
T Consensus        73 ~~~~l~~~~~L-~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~  151 (319)
T cd00116          73 LLQGLTKGCGL-QELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEG  151 (319)
T ss_pred             HHHHHHhcCce-eEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCc
Confidence            45567778888 99999999998667777766666   9999999999873    344456677 899999999999984


Q ss_pred             c----CchhhhcccCCCeeecccccccCCc-----chhhcccccceeeCcccCCCCCCC-----cccccccccccccccc
Q 041632           82 S----IPSFFRTSRGIRKLDLSRNNLSGQI-----PLFLEALSLEYLNLSFNDFEGKVP-----TKGIFANTSAISVAGC  147 (452)
Q Consensus        82 ~----~p~~~~~l~~L~~l~l~~N~l~~~~-----~~~~~~~~L~~l~l~~N~l~~~~~-----~~~~~~~l~~l~~~~n  147 (452)
                      .    ++..+..+++|+.|++++|.+++..     ........|++|++++|.+++...     .+..+++|+.|++++|
T Consensus       152 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n  231 (319)
T cd00116         152 ASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN  231 (319)
T ss_pred             hHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCC
Confidence            3    3446677788999999999998521     112233359999999999874322     2345678999999988


Q ss_pred             cc
Q 041632          148 HR  149 (452)
Q Consensus       148 ~~  149 (452)
                      +.
T Consensus       232 ~l  233 (319)
T cd00116         232 NL  233 (319)
T ss_pred             cC
Confidence            64

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=98.94  E-value=3.1e-09  Score=118.21  Aligned_cols=141  Identities=18%  Similarity=0.222  Sum_probs=111.5

Q ss_pred             cccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCc
Q 041632            5 DLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIP   84 (452)
Q Consensus         5 ~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p   84 (452)
                      ++...+|+++..++.-++.|++.+|.++ .+|..| .+.+|+.|++++|++. .+|.++..+++|+.|+|++|.....+|
T Consensus       575 ~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip  651 (1153)
T PLN03210        575 EVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP  651 (1153)
T ss_pred             cceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC
Confidence            4455678888887654499999999998 899887 5799999999999998 789999999999999999876444777


Q ss_pred             hhhhcccCCCeeecccccccCCcchhhc-ccccceeeCccc-CCCCCCCccccccccccccccccccc
Q 041632           85 SFFRTSRGIRKLDLSRNNLSGQIPLFLE-ALSLEYLNLSFN-DFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        85 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~-~~~L~~l~l~~N-~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      . ++.+++|+.|+|++|......|..+. +.+|+.|++++| .++.+|... .+++|+.|++++|..+
T Consensus       652 ~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L  717 (1153)
T PLN03210        652 D-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRL  717 (1153)
T ss_pred             c-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCc
Confidence            4 88899999999998764444444444 445999999986 566555544 6888999999887543

syringae 6; Provisional

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=1e-08  Score=89.22  Aligned_cols=124  Identities=25%  Similarity=0.318  Sum_probs=78.4

Q ss_pred             eEEEEEEcCCCcEEEEEEeeccCC-------------c--------c-----HHHHHHHHHHHhcCCCC--CceeEeeee
Q 041632          246 SVYKGVFDEDGTVVAIKVINLQRQ-------------G--------A-----SKSFMAECKALKNIRHK--NLVRVITSC  297 (452)
Q Consensus       246 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~--------~-----~~~~~~ei~~l~~l~h~--niv~l~~~~  297 (452)
                      .||.|... +|..+|+|+.+....             .        .     .....+|.+.|.++..-  ++.+.+.+ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38888874 788999998853110             0        0     12467899999999765  45555543 


Q ss_pred             ccccCCCCceeEEEEeccC--CCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEecccC
Q 041632          298 SSVDFQGNDFKAIVYKYMP--NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDY-LHQHCQEPILHCDLK  374 (452)
Q Consensus       298 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dlk  374 (452)
                              +..++||||++  |..+.......             ++......++.+++..+.. +|..   ||+|+|+.
T Consensus        79 --------~~~~ivME~I~~~G~~~~~l~~~~-------------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs  134 (188)
T PF01163_consen   79 --------NRNVIVMEYIGEDGVPLPRLKDVD-------------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLS  134 (188)
T ss_dssp             --------ETTEEEEE--EETTEEGGCHHHCG-------------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-S
T ss_pred             --------eCCEEEEEecCCCccchhhHHhcc-------------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCC
Confidence                    13479999998  44444332211             1122345677778886666 4676   99999999


Q ss_pred             CCCeeecCCCceEECccccccc
Q 041632          375 PSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       375 ~~Nill~~~~~~kl~Dfgla~~  396 (452)
                      +.||+++++ .+.|+|||.+..
T Consensus       135 ~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  135 EYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             TTSEEEETT-CEEE--GTTEEE
T ss_pred             hhhEEeecc-eEEEEecCccee
Confidence            999999988 999999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=2.6e-08  Score=91.96  Aligned_cols=146  Identities=14%  Similarity=0.054  Sum_probs=96.7

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-----------cHHHHHHHHHHHhcCCCCCc--eeEeeeeccccCC
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-----------ASKSFMAECKALKNIRHKNL--VRVITSCSSVDFQ  303 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~ei~~l~~l~h~ni--v~l~~~~~~~~~~  303 (452)
                      +.+-......|++..+  +|+.+.||........           ....+.+|.+.+.++...+|  .+.+++.......
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4444444455777766  6788999976322110           01147788888877743332  2233332111111


Q ss_pred             CCceeEEEEeccCCC-ChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          304 GNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       304 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      .....++|+|++++- +|.+++....         ....+...+..++.+++..++-||..   ||+|+|+++.|||++.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~---------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA---------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHL  173 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEec
Confidence            123468999999876 8988874311         12344556778999999999999998   9999999999999985


Q ss_pred             -------CCceEECccccccc
Q 041632          383 -------DLSAHIGDFGLSRF  396 (452)
Q Consensus       383 -------~~~~kl~Dfgla~~  396 (452)
                             ++.+.++||+.+..
T Consensus       174 ~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        174 PFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cccCCCCCceEEEEECCcccc
Confidence                   46899999998853

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.85  E-value=1.5e-10  Score=91.93  Aligned_cols=125  Identities=17%  Similarity=0.217  Sum_probs=98.3

Q ss_pred             cEEEccCCccccCCCcCCcC---CCCCCEEEccCccccccCCccccCC-CCCCEEEccCccccccCchhhhcccCCCeee
Q 041632           22 NSLNLAENHFVGSIPPRIGN---LKALRSFDVSNNGLSGEIPIELGLC-SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLD   97 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~---l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~   97 (452)
                      -.|+|++++|. -++++...   ...|+..+|++|.+. .+|+.|... +.++.|+|++|+|+ .+|..+..++.|+.|+
T Consensus        30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            56899999997 77776554   445666699999998 788888755 58999999999999 8898999999999999


Q ss_pred             cccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccc-ccccccccc
Q 041632           98 LSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSA-ISVAGCHRL  150 (452)
Q Consensus        98 l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~-l~~~~n~~~  150 (452)
                      ++.|.|...+..++.+.+|-.|+..+|.+..++-.. ..+.+.. ..+.++||.
T Consensus       107 l~~N~l~~~p~vi~~L~~l~~Lds~~na~~eid~dl-~~s~~~al~~lgnepl~  159 (177)
T KOG4579|consen  107 LRFNPLNAEPRVIAPLIKLDMLDSPENARAEIDVDL-FYSSLPALIKLGNEPLG  159 (177)
T ss_pred             cccCccccchHHHHHHHhHHHhcCCCCccccCcHHH-hccccHHHHHhcCCccc
Confidence            999999988888888767999999999988766553 2233333 344555553

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.83  E-value=5.6e-08  Score=91.57  Aligned_cols=200  Identities=16%  Similarity=0.174  Sum_probs=128.1

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC--CCCceeEE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF--QGNDFKAI  310 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~--~~~~~~~l  310 (452)
                      ...+.||+|+-+.+|-.-.-   ...+.|+..........+.   ++.|... .||-+..=+.+-...-+  .......+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34578999999999963321   1235577765444333222   3334444 56654431222111111  11222456


Q ss_pred             EEeccCCC-ChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          311 VYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       311 v~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|...++. .+..+....     .+...-....|...++++..++.+.+-||+.   |.+-+|+.++|+||++++.+.+.
T Consensus        88 lmP~v~g~~pI~~~y~p~-----tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LV  159 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPA-----TRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLV  159 (637)
T ss_pred             ecccCCCccchhhhcCch-----hhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEE
Confidence            67666554 233333211     1122335678999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhC-CCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTT-KKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg-~~Pf~  452 (452)
                      |-..-..   ..+...  ....+|...|++||...     +..-+...|-|.+||++++++.| +.||.
T Consensus       160 dsDsfqi---~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys  223 (637)
T COG4248         160 DSDSFQI---NANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS  223 (637)
T ss_pred             cccceee---ccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence            8543221   112111  12356899999999744     23456779999999999999886 99984

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=8.6e-08  Score=83.90  Aligned_cols=144  Identities=16%  Similarity=0.137  Sum_probs=103.0

Q ss_pred             ceeccCceeEEEEEEcCCCcEEEEEEeeccC------CccHHHHHHHHHHHhcCCCCC--ceeEeeeeccccCCCCceeE
Q 041632          238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQR------QGASKSFMAECKALKNIRHKN--LVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~ei~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~  309 (452)
                      --|+||.+.|++-.+  .|+.+-+|+-....      +-....|.+|...+.++..-+  +.+.+ ++...........+
T Consensus        25 N~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~  101 (216)
T PRK09902         25 NYRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL  101 (216)
T ss_pred             CcCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence            357899999999887  45578888764111      223468999999998884333  34443 22211112233467


Q ss_pred             EEEeccCC-CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc--e
Q 041632          310 IVYKYMPN-GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS--A  386 (452)
Q Consensus       310 lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~  386 (452)
                      ||+|-+++ -+|.+++....         ..+.+..++..+..+++..++-||+.   |+.|+|+.+.||+++.++.  +
T Consensus       102 LVTe~L~g~~~L~~~l~~~~---------~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v  169 (216)
T PRK09902        102 LVTEDMAGFISIADWYAQHA---------VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEA  169 (216)
T ss_pred             EEEEeCCCCccHHHHHhcCC---------cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeE
Confidence            99997754 58988885432         23456677789999999999999998   9999999999999986666  9


Q ss_pred             EECccccccc
Q 041632          387 HIGDFGLSRF  396 (452)
Q Consensus       387 kl~Dfgla~~  396 (452)
                      +++||.-++.
T Consensus       170 ~lIDlEk~r~  179 (216)
T PRK09902        170 GFLDLEKSRR  179 (216)
T ss_pred             EEEEhhccch
Confidence            9999987653

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=6.6e-08  Score=86.65  Aligned_cols=133  Identities=24%  Similarity=0.279  Sum_probs=92.5

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC----------------C-cc-----HHHHHHHHHHHhcCCCC--C
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR----------------Q-GA-----SKSFMAECKALKNIRHK--N  289 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~-~~-----~~~~~~ei~~l~~l~h~--n  289 (452)
                      .++..||-|--+.||.|... .|.++|||.=+.-.                . .+     ....++|.++|.++...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34578999999999999985 78899999543110                0 11     12457889999998544  5


Q ss_pred             ceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 041632          290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL  369 (452)
Q Consensus       290 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  369 (452)
                      +.+.+++         +..++|||+++|--|...-                ++....-.++..|++-+.-.-..   |||
T Consensus       173 VP~P~~~---------nRHaVvMe~ieG~eL~~~r----------------~~~en~~~il~~il~~~~~~~~~---GiV  224 (304)
T COG0478         173 VPKPIAW---------NRHAVVMEYIEGVELYRLR----------------LDVENPDEILDKILEEVRKAYRR---GIV  224 (304)
T ss_pred             CCCcccc---------ccceeeeehcccceeeccc----------------CcccCHHHHHHHHHHHHHHHHHc---Ccc
Confidence            5555443         4678999999886665321                11223334444555554444454   999


Q ss_pred             ecccCCCCeeecCCCceEECcccccc
Q 041632          370 HCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       370 H~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      |+|+.+-||++++||.+.++||--+.
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCcccc
Confidence            99999999999999999999997654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.71  E-value=3e-10  Score=112.71  Aligned_cols=129  Identities=20%  Similarity=0.250  Sum_probs=95.8

Q ss_pred             cCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCch-hhhcccCCCee
Q 041632           18 SYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKL   96 (452)
Q Consensus        18 ~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l   96 (452)
                      ..| ...+.++|+|. .+..++.-++.|+.|||++|+++ ... .+..|+.|++|||+.|+++ .+|. ....+. |+.|
T Consensus       164 n~L-~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L  237 (1096)
T KOG1859|consen  164 NKL-ATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLL  237 (1096)
T ss_pred             hhH-hhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heee
Confidence            345 56788888888 77888888888888888888887 333 7888888888888888888 6664 334444 8888


Q ss_pred             ecccccccCCcchhhcccccceeeCcccCCCCCCC--cccccccccccccccccccCCC
Q 041632           97 DLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVP--TKGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus        97 ~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      .+++|-++.+ -++-++.+|+.||+++|-|.+...  .++.+..|..|++.|||.-|.+
T Consensus       238 ~lrnN~l~tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  238 NLRNNALTTL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             eecccHHHhh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            8888888764 334445558888888888876543  2366788888888898876653

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.68  E-value=1.3e-09  Score=86.60  Aligned_cols=117  Identities=19%  Similarity=0.280  Sum_probs=92.4

Q ss_pred             cCCccccccc---CcccEEEccCCccccCCCcCCcC-CCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCc
Q 041632            9 TIPEAIFSIS---YLSNSLNLAENHFVGSIPPRIGN-LKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIP   84 (452)
Q Consensus         9 ~~p~~~~~l~---~l~~~L~l~~n~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p   84 (452)
                      .+++....+.   .| +..+|++|.+. ..|+.|.. ++.++.|+|++|+|+ .+|+++..++.|+.|++++|.|. ..|
T Consensus        41 ~i~davy~l~~~~el-~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p  116 (177)
T KOG4579|consen   41 YIADAVYMLSKGYEL-TKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEP  116 (177)
T ss_pred             HHHHHHHHHhCCceE-EEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cch
Confidence            4555544444   44 55799999999 78877765 559999999999999 89999999999999999999999 889


Q ss_pred             hhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCC
Q 041632           85 SFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGK  129 (452)
Q Consensus        85 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~  129 (452)
                      ..+..|.+|-.|+..+|.+..++-+.+-....-..++.++.+.+-
T Consensus       117 ~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~  161 (177)
T KOG4579|consen  117 RVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDE  161 (177)
T ss_pred             HHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCccccc
Confidence            989889999999999999998776644332234445566666543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.64  E-value=2.8e-07  Score=82.20  Aligned_cols=109  Identities=25%  Similarity=0.281  Sum_probs=79.6

Q ss_pred             HHHHHHHHHHhcCCCCC--ceeEeeeeccccCCCCceeEEEEeccCCC-ChhhhhcCCCCCCcccccccccCCHHHHHHH
Q 041632          273 KSFMAECKALKNIRHKN--LVRVITSCSSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISI  349 (452)
Q Consensus       273 ~~~~~ei~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i  349 (452)
                      ....+|.+.+..+....  +.+.+++...... .....++|+|++++. +|.+++....           ..+......+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~-----------~~~~~~~~~l  123 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWE-----------QLDPSQRREL  123 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhc-----------ccchhhHHHH
Confidence            45677777777664322  3344444322111 113458999999874 8999886432           2455567789


Q ss_pred             HHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC---ceEECccccccc
Q 041632          350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDFGLSRF  396 (452)
Q Consensus       350 ~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Dfgla~~  396 (452)
                      +.+++..++-||+.   ||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       124 l~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  124 LRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999998   999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=2e-08  Score=100.20  Aligned_cols=98  Identities=21%  Similarity=0.426  Sum_probs=75.0

Q ss_pred             HHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCC-----CceeccccccccccccCccccC
Q 041632          350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN-----PTVSSSIGVRGTIGYVAPEYGL  424 (452)
Q Consensus       350 ~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~  424 (452)
                      +.+++.|+.|+|..  .++||++|.|++|.++.++..||+.|+.+........     .+..-..-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34566999999997  7999999999999999999999999998754332111     0000011123567899999999


Q ss_pred             CCCCCcccceeehhHHHHHHHhCCC
Q 041632          425 GSEVSTNGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       425 ~~~~~~~~DvwSlGv~l~elltg~~  449 (452)
                      ....+.++|+||+||++|.+..|..
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk  207 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGK  207 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCc
Confidence            8888999999999999999985443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.56  E-value=2.8e-09  Score=106.04  Aligned_cols=121  Identities=27%  Similarity=0.296  Sum_probs=96.3

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCc-cccCCCCCCEEEccCcccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI-ELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~   80 (452)
                      +.|+|. .+.+++.=++.+ +.|||++|+++ ... .+..|+.|++|||+.|++. .+|. ...++. |+.|.|+||-++
T Consensus       172 syN~L~-~mD~SLqll~al-e~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~  245 (1096)
T KOG1859|consen  172 SYNRLV-LMDESLQLLPAL-ESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT  245 (1096)
T ss_pred             chhhHH-hHHHHHHHHHHh-hhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH
Confidence            457777 666777777788 99999999998 444 8899999999999999999 6774 334555 999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcc--hhhcccccceeeCcccCCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKV  130 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~--~~~~~~~L~~l~l~~N~l~~~~  130 (452)
                       .+- .+.+|.+|+.|||++|-|++.-.  ..+.+..|+.|+|.+|.+..-|
T Consensus       246 -tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  246 -TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             -hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence             544 57889999999999999987432  2333445999999999997554

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.55  E-value=1.5e-08  Score=100.55  Aligned_cols=128  Identities=23%  Similarity=0.232  Sum_probs=64.9

Q ss_pred             ccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCee
Q 041632           17 ISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKL   96 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l   96 (452)
                      +..+ +.+++..|.|. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+.. . .+..++.|+.|
T Consensus        71 l~~l-~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i-~-~l~~l~~L~~L  145 (414)
T KOG0531|consen   71 LTSL-KELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL-E-GLSTLTLLKEL  145 (414)
T ss_pred             hHhH-Hhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc-c-chhhccchhhh
Confidence            3444 45555556555 33334555566666666666665 3333355556666666666665522 2 23344445666


Q ss_pred             ecccccccCCcchhhcccccceeeCcccCCCCCCCc-cccccccccccccccccc
Q 041632           97 DLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRL  150 (452)
Q Consensus        97 ~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~  150 (452)
                      ++++|.|+.+.. .-....|+.+++++|++..+.+. ...+.++..+.+.+|...
T Consensus       146 ~l~~N~i~~~~~-~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~  199 (414)
T KOG0531|consen  146 NLSGNLISDISG-LESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR  199 (414)
T ss_pred             eeccCcchhccC-CccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence            666666554321 11122355666666665554442 233555555555555443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=4.9e-07  Score=90.50  Aligned_cols=141  Identities=19%  Similarity=0.242  Sum_probs=90.6

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccC----------------------Cc------------------cHHHHH
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR----------------------QG------------------ASKSFM  276 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------------~~------------------~~~~~~  276 (452)
                      +.|+.++-|.||+|+.. +|+.||||+.+..-                      +.                  .+-++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68999999999999997 69999999875211                      00                  001355


Q ss_pred             HHHHHHhcC----CCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHH
Q 041632          277 AECKALKNI----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID  352 (452)
Q Consensus       277 ~ei~~l~~l----~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~  352 (452)
                      +|...+.++    +...-+.+-.++    ++......++|||++|-.+.+......          ...+...   ++..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~----------~g~d~k~---ia~~  272 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKS----------AGIDRKE---LAEL  272 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceee----hhccCCcEEEEEeeCCEecccHHHHHh----------cCCCHHH---HHHH
Confidence            566555554    222233343333    344456789999999988887742211          1233222   2222


Q ss_pred             HHHH-HHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccc
Q 041632          353 VASA-LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       353 i~~~-l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                      ++++ +..+-..   |++|.|..|.||+++.++.+.+.|||+...++
T Consensus       273 ~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         273 LVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            2221 1122223   99999999999999999999999999987554

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.51  E-value=6e-08  Score=95.92  Aligned_cols=183  Identities=18%  Similarity=0.142  Sum_probs=127.7

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC-ceeEeeeeccccCCCCceeEEEE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN-LVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      ...+-+++|+++++||.+-..+. ....+.+...     ....-++++|.+++||| .++.++.     .+..++.++++
T Consensus       245 ~~fh~fvK~altknpKkRptaek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~  313 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPM  313 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhh-heeceeeccc-----hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhh
Confidence            33456889999999998875443 3336665422     44567889999999999 5555543     45566788999


Q ss_pred             eccCCC-ChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          313 KYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       313 e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      +++..+ +-..-..          .....+...+...+...-+++++|+|+.   .=+|||    ||+.++ +..|..||
T Consensus       314 ~i~s~~rs~~~~~~----------~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~  375 (829)
T KOG0576|consen  314 RICSTGRSSALEMT----------VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDF  375 (829)
T ss_pred             hhhcCCccccccCC----------hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccc
Confidence            999776 2221110          1112233334444556677899999986   458888    777665 67899999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      +....+....     ......+|+.|+|||+.....+....|+|+.|+-..++--|-.|
T Consensus       376 ~v~~~L~~~~-----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  376 AVPPQLTRTM-----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCCcccCccc-----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            9887665433     12235689999999999999999999999999877777767665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=1.6e-06  Score=76.36  Aligned_cols=141  Identities=16%  Similarity=0.183  Sum_probs=89.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHH---------HHHHHHHHhcCC---CCCceeEeeee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS---------FMAECKALKNIR---HKNLVRVITSC  297 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~ei~~l~~l~---h~niv~l~~~~  297 (452)
                      ..+|...+++-......|.+-..  +|+.+++|..+.......+.         ..+++..+.+++   -.....++.++
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            35677667777666666666555  67889999876433222222         233334333332   22222322222


Q ss_pred             ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCC
Q 041632          298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSN  377 (452)
Q Consensus       298 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  377 (452)
                      .-..+......+++|||++|..|.++..               ++.    .++..+++++.-+|+.   |++|+|..|.|
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgN  165 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGN  165 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh---------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCc
Confidence            2222333445678999999988876531               222    2455677889999998   99999999999


Q ss_pred             eeecCCCceEECcccccc
Q 041632          378 ILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       378 ill~~~~~~kl~Dfgla~  395 (452)
                      +++++++ ++++||+..+
T Consensus       166 Flv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  166 FLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEEECCc-EEEEECcccc
Confidence            9999665 8999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.42  E-value=5.1e-08  Score=96.79  Aligned_cols=141  Identities=22%  Similarity=0.271  Sum_probs=99.5

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ..|.+. .+-..+..+.++ +.|++.+|+|. .+...+..+++|++|++++|+|+. +. .+..++.|+.|++++|.|+ 
T Consensus        80 ~~n~i~-~~~~~l~~~~~l-~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~-i~-~l~~l~~L~~L~l~~N~i~-  153 (414)
T KOG0531|consen   80 RQNLIA-KILNHLSKLKSL-EALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITK-LE-GLSTLTLLKELNLSGNLIS-  153 (414)
T ss_pred             chhhhh-hhhcccccccce-eeeeccccchh-hcccchhhhhcchheecccccccc-cc-chhhccchhhheeccCcch-
Confidence            345555 333457778888 88999999998 665557888999999999999983 33 4677777999999999988 


Q ss_pred             cCchhhhcccCCCeeecccccccCCcch-hhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPL-FLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      .+. .+..++.|+.+++++|++..+.+. .-.+..++.+++.+|.+.... ....+..+..+++..|...
T Consensus       154 ~~~-~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  154 DIS-GLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             hcc-CCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc-chHHHHHHHHhhcccccce
Confidence            444 355578889999999999876663 234445888899999887432 2333444555566666543

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.42  E-value=2.1e-07  Score=60.07  Aligned_cols=36  Identities=33%  Similarity=0.517  Sum_probs=20.2

Q ss_pred             CCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632           44 ALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus        44 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +|++|++++|+|+ .+|..+++|++|+.|++++|+|+
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            5566666666665 45555666666666666666655

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.41  E-value=2e-07  Score=60.16  Aligned_cols=37  Identities=27%  Similarity=0.442  Sum_probs=18.4

Q ss_pred             CCCEEEccCccccccCchhhhcccCCCeeecccccccC
Q 041632           68 SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG  105 (452)
Q Consensus        68 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  105 (452)
                      +|++|+|++|+|+ .+|+.+.+|++|+.|++++|+|+.
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            4555555555555 444445555555555555555554

...

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.34  E-value=9.2e-08  Score=90.26  Aligned_cols=135  Identities=20%  Similarity=0.172  Sum_probs=86.0

Q ss_pred             ccccccCcccEEEccCCccccCCC--cCCcCCCCCCEEEccCccccccCCccc-cCCCCCCEEEccCccccc-cCchhhh
Q 041632           13 AIFSISYLSNSLNLAENHFVGSIP--PRIGNLKALRSFDVSNNGLSGEIPIEL-GLCSSLEDIYLGGNFFHG-SIPSFFR   88 (452)
Q Consensus        13 ~~~~l~~l~~~L~l~~n~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~-~~p~~~~   88 (452)
                      -...++++ +.|||+.|-|..-.|  .-...|++|+.|+|+.|++.-...... ..++.|+.|.|+.+.|+- .+-....
T Consensus       141 ~~k~~~~v-~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~  219 (505)
T KOG3207|consen  141 YSKILPNV-RDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILL  219 (505)
T ss_pred             hhhhCCcc-eeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHH
Confidence            34467777 788888888763222  234568888888888888762222222 245778888888887761 1222344


Q ss_pred             cccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCC--Cccccccccccccccccc
Q 041632           89 TSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKV--PTKGIFANTSAISVAGCH  148 (452)
Q Consensus        89 ~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~--~~~~~~~~l~~l~~~~n~  148 (452)
                      .+|+|+.|+|..|....+-......+. |++|||++|++...+  +..+.|+.|..|+++.+.
T Consensus       220 ~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tg  282 (505)
T KOG3207|consen  220 TFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTG  282 (505)
T ss_pred             hCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccC
Confidence            568888888888863333333334444 888888888887666  345777777777776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.32  E-value=8e-06  Score=73.83  Aligned_cols=145  Identities=12%  Similarity=0.173  Sum_probs=79.0

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCc--eeEeeeeccccCCCCceeEEEEec
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL--VRVITSCSSVDFQGNDFKAIVYKY  314 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~  314 (452)
                      ..||+|..+.||+.    .|..+++|......  ......+|.++++.+..-.+  .+.+.++     ...+...+|||+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~   75 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYEL   75 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeee
Confidence            46899999999983    24457788875422  33556889998887753333  3444442     223345789999


Q ss_pred             cCCCC-hhhhhcCC----------------CCCCcccccccccCCHHHHHHHHH----------HH-HHHHHHHhcC-CC
Q 041632          315 MPNGS-LEKWLHPD----------------AIPQRDREIEIQKLTLLQRISIAI----------DV-ASALDYLHQH-CQ  365 (452)
Q Consensus       315 ~~~gs-L~~~l~~~----------------~~~~~~~~~~~~~l~~~~~~~i~~----------~i-~~~l~~LH~~-~~  365 (452)
                      ++|.+ +...+...                +.+....  ....+... ...+..          .+ ....++|... ..
T Consensus        76 i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~--~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~  152 (226)
T TIGR02172        76 IVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC--DTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT  152 (226)
T ss_pred             cCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC--CCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence            98863 22111110                0000000  00000000 000000          00 0112222211 13


Q ss_pred             CCeEecccCCCCeeecCCCceEECccccccc
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                      +.++|+|+.|.||++++++ +.|+||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            4678999999999999988 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	452
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-35
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-33
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-25
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-25
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-23
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-22
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-21
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		8e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-17
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-16
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-13
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-13
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-11
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		9e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-10
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		8e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		9e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		6e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-06
3soa_A	444	Full-Length Human Camkii Length = 444		5e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-06
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		3e-05
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		7e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/236 (37%), Positives = 128/236 (54%), Gaps = 17/236 (7%)
Query: 218 LLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFM 276
           L + S + L  A+D FS+ N++G G FG VYKG    DGT+VA+K +  +R QG    F 
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERXQGGELQFQ 83
Query: 277 AECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI 336
            E + +    H+NL+R+   C +        + +VY YM NGS+   L       R+R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCL-------RERPE 131
Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF 396
               L   +R  IA+  A  L YLH HC   I+H D+K +NILLD +  A +GDFGL++ 
Sbjct: 132 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191
Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              +          VRGTIG++APEY    + S   DV+ YG++LLE++T ++  D
Sbjct: 192 ---MDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 85/236 (36%), Positives = 125/236 (52%), Gaps = 17/236 (7%)
Query: 218 LLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFM 276
           L + S + L  A+D F + N++G G FG VYKG    DG +VA+K +  +R QG    F 
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL-ADGXLVAVKRLKEERTQGGELQFQ 75
Query: 277 AECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI 336
            E + +    H+NL+R+   C +        + +VY YM NGS+   L       R+R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCL-------RERPE 123
Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF 396
               L   +R  IA+  A  L YLH HC   I+H D+K +NILLD +  A +GDFGL++ 
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              +          VRG IG++APEY    + S   DV+ YG++LLE++T ++  D
Sbjct: 184 ---MDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/223 (34%), Positives = 115/223 (51%), Gaps = 18/223 (8%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI 285
           L +AT+ F    LIG G FG VYKGV   DG  VA+K    +     + F  E + L   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           RH +LV +I  C     + N+   ++YKYM NG+L++ L+   +P      E       Q
Sbjct: 93  RHPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWE-------Q 140
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
           R+ I I  A  L YLH      I+H D+K  NILLD +    I DFG+S+    +    +
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHL 197
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
                V+GT+GY+ PEY +   ++   DVYS+G++L E++  +
Sbjct: 198 XXV--VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/223 (34%), Positives = 115/223 (51%), Gaps = 18/223 (8%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI 285
           L +AT+ F    LIG G FG VYKGV   DG  VA+K    +     + F  E + L   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           RH +LV +I  C     + N+   ++YKYM NG+L++ L+   +P      E       Q
Sbjct: 93  RHPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWE-------Q 140
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
           R+ I I  A  L YLH      I+H D+K  NILLD +    I DFG+S+    +    +
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
                V+GT+GY+ PEY +   ++   DVYS+G++L E++  +
Sbjct: 198 XXV--VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/215 (34%), Positives = 115/215 (53%), Gaps = 27/215 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIK----VINLQRQGASKSFMAECKALKNIRHKNLVR 292
           N +G G FG VYKG  +   T VA+K    ++++  +   + F  E K +   +H+NLV 
Sbjct: 37  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLTLLQRISIAI 351
           ++   S     G+D   +VY YMPNGSL   L   D  P          L+   R  IA 
Sbjct: 95  LLGFSSD----GDDL-CLVYVYMPNGSLLDRLSCLDGTP---------PLSWHMRCKIAQ 140
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
             A+ +++LH++     +H D+K +NILLD   +A I DFGL+R  +  +   + S I  
Sbjct: 141 GAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRI-- 195
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            GT  Y+APE  L  E++   D+YS+G++LLE++T
Sbjct: 196 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 114/215 (53%), Gaps = 27/215 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIK----VINLQRQGASKSFMAECKALKNIRHKNLVR 292
           N +G G FG VYKG  +   T VA+K    ++++  +   + F  E K +   +H+NLV 
Sbjct: 37  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLTLLQRISIAI 351
           ++   S     G+D   +VY YMPNGSL   L   D  P          L+   R  IA 
Sbjct: 95  LLGFSSD----GDDL-CLVYVYMPNGSLLDRLSCLDGTP---------PLSWHMRCKIAQ 140
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
             A+ +++LH++     +H D+K +NILLD   +A I DFGL+R  +  +   +   I  
Sbjct: 141 GAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRI-- 195
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            GT  Y+APE  L  E++   D+YS+G++LLE++T
Sbjct: 196 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 114/215 (53%), Gaps = 27/215 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIK----VINLQRQGASKSFMAECKALKNIRHKNLVR 292
           N +G G FG VYKG  +   T VA+K    ++++  +   + F  E K +   +H+NLV 
Sbjct: 31  NKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLTLLQRISIAI 351
           ++   S     G+D   +VY YMPNGSL   L   D  P          L+   R  IA 
Sbjct: 89  LLGFSSD----GDDL-CLVYVYMPNGSLLDRLSCLDGTP---------PLSWHMRCKIAQ 134
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
             A+ +++LH++     +H D+K +NILLD   +A I DFGL+R  +  +   +   I  
Sbjct: 135 GAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRI-- 189
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            GT  Y+APE  L  E++   D+YS+G++LLE++T
Sbjct: 190 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 223

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/214 (33%), Positives = 115/214 (53%), Gaps = 22/214 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+V++  +   G+ VA+K++  Q   A +   F+ E   +K +RH N+V  + +
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +    Q  +  +IV +Y+  GSL + LH        RE    +L   +R+S+A DVA  
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLHKSGA----RE----QLDERRRLSMAYDVAKG 149
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YLH     PI+H +LK  N+L+D   +  + DFGLSR   +    T  SS    GT  
Sbjct: 150 MNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAAGTPE 204
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE       +   DVYS+G++L E+ T ++P
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 22/214 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+V++  +   G+ VA+K++  Q   A +   F+ E   +K +RH N+V  + +
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +    Q  +  +IV +Y+  GSL + LH        RE    +L   +R+S+A DVA  
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLHKSGA----RE----QLDERRRLSMAYDVAKG 149
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YLH     PI+H DLK  N+L+D   +  + DFGLSR   +        S    GT  
Sbjct: 150 MNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS----XFLXSKXAAGTPE 204
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE       +   DVYS+G++L E+ T ++P
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 74/215 (34%), Positives = 110/215 (51%), Gaps = 27/215 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIK----VINLQRQGASKSFMAECKALKNIRHKNLVR 292
           N  G G FG VYKG  +   T VA+K    ++++  +   + F  E K     +H+NLV 
Sbjct: 28  NKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVE 85
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-DAIPQRDREIEIQKLTLLQRISIAI 351
           ++   S     G+D   +VY Y PNGSL   L   D  P          L+   R  IA 
Sbjct: 86  LLGFSSD----GDDL-CLVYVYXPNGSLLDRLSCLDGTP---------PLSWHXRCKIAQ 131
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
             A+ +++LH++     +H D+K +NILLD   +A I DFGL+R  +  +     S I  
Sbjct: 132 GAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRI-- 186
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            GT  Y APE  L  E++   D+YS+G++LLE++T
Sbjct: 187 VGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIIT 220

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/238 (33%), Positives = 118/238 (49%), Gaps = 38/238 (15%)
Query: 222 SYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKA 281
           SY   ++A++   ST  IG GSFG+VYKG +  D  V  +KV++   +   ++F  E   
Sbjct: 28  SYYWEIEASEVMLSTR-IGSGSFGTVYKGKWHGDVAVKILKVVDPTPE-QFQAFRNEVAV 85
Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L+  RH N++  +       +   D  AIV ++    SL K LH          ++  K 
Sbjct: 86  LRKTRHVNILLFM------GYMTKDNLAIVTQWCEGSSLYKHLH----------VQETKF 129
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL----SRF- 396
            + Q I IA   A  +DYLH    + I+H D+K +NI L   L+  IGDFGL    SR+ 
Sbjct: 130 QMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186
Query: 397 -YQAVSNPTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Q V  PT        G++ ++APE       +  S   DVYSYGI+L E++T + P
Sbjct: 187 GSQQVEQPT--------GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 299 -SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F       IV +YMP G+L  +L         RE   +++T +  + +A  ++SA+
Sbjct: 99  LEPPFY------IVTEYMPYGNLLDYL---------RECNREEVTAVVLLYMATQISSAM 143
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           +YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I +
Sbjct: 144 EYLEK---KNFIHRDLAARNCLVGENHVVKVADFGLSRL---MTGDTYTAHAGAKFPIKW 197
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE    +  S   DV+++G+LL E+ T
Sbjct: 198 TAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 85  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 128
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 182
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 30  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 88  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 131
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 132 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 185
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 186 TAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 29  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 87  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 130
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 131 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 184
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 185 TAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 31  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 89  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 132
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 133 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 186
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 187 TAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 79  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 122
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 176
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 27  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 85  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 128
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 129 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 182
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 183 TAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 26  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 84  QEPI------YIITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 127
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 128 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 181
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 182 TAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 23  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 81  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 124
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 125 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 178
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 179 TAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 22  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 80  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 123
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 124 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 177
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 178 TAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 79  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 122
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEXTAREGAKFPIKW 176
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 113/220 (51%), Gaps = 33/220 (15%)
Query: 237 NLIGVGSFGSVYKGVFDEDG---TVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNL 290
            +IG G FG V +G     G   + VAIK +     +RQ   + F++E   +    H N+
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ--RREFLSEASIMGQFEHPNI 77
Query: 291 VR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           +R   V+T+   V         I+ ++M NG+L+ +L           +   + T++Q +
Sbjct: 78  IRLEGVVTNSMPV--------MILTEFMENGALDSFLR----------LNDGQFTVIQLV 119
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA-VSNPTVS 406
            +   +AS + YL +      +H DL   NIL++++L   + DFGLSRF +   S+PT +
Sbjct: 120 GMLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYT 176
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           SS+G +  I + APE     + ++  D +SYGI++ E+++
Sbjct: 177 SSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 21  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 79  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 122
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 176
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 16  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 74  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 117
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 118 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 171
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 172 TAPEAINYGTFTIKSDVWSFGILLTEIVT 200

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 33/219 (15%)
Query: 238 LIGVGSFGSVYKGVFDEDG---TVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLV 291
           +IG G FG V +G     G   + VAIK +     +RQ   + F++E   +    H N++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ--RREFLSEASIMGQFEHPNII 80
Query: 292 R---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           R   V+T+   V         I+ ++M NG+L+ +L           +   + T++Q + 
Sbjct: 81  RLEGVVTNSMPV--------MILTEFMENGALDSFLR----------LNDGQFTVIQLVG 122
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA-VSNPTVSS 407
           +   +AS + YL +      +H DL   NIL++++L   + DFGLSRF +   S+PT +S
Sbjct: 123 MLRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETS 179
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           S+G +  I + APE     + ++  D +SYGI++ E+++
Sbjct: 180 SLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 78  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 123
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTXTAHAGAKFPIKWT 177
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            ++         AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 73  STAPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 116
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 171
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 43  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 100 STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 143
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 144 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 198
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 144
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 145 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 199
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 115/224 (51%), Gaps = 20/224 (8%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNI 285
           + ++  F     +G G++ +VYKG+    G  VA+K + L   +G   + + E   +K +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H+N+VR+     +      +   +V+++M N  L+K++    +    R +E+  +   Q
Sbjct: 61  KHENIVRLYDVIHT-----ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                  +   L + H++    ILH DLKP N+L++      +GDFGL+R +    N T 
Sbjct: 115 -----WQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TF 165
Query: 406 SSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTK 448
           SS +    T+ Y AP+  +GS   ST+ D++S G +L EM+T K
Sbjct: 166 SSEV---VTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 18  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 75  STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 118
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 119 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 173
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 121
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 122 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 176
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++ + T VAIK +      + +SF+ E + +K ++H  LV++    S
Sbjct: 17  LGNGQFGEVWMGTWNGN-TKVAIKTLKPGTM-SPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L         ++ E + L L   + +A  VA+ + 
Sbjct: 75  EEPI------YIVTEYMNKGSLLDFL---------KDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+ N L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 120 YIERMN---YIHRDLRSANILVGNGLICKIADFGLARL---IEDNEXTARQGAKFPIKWT 173
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+VT
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVT 201

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 73  STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 116
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 171
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 21  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 78  STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 121
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 122 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 176
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 78  ----REPPFYIII-EFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 123
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTXTAHAGAKFPIKWT 177
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 78  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 123
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTFTAHAGAKFPIKWT 177
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 178 APESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 80  ----REPPFYIII-EFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 80  ----REPPFYIII-EFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 101 STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 144
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 145 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS--GSIL 199
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 16  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 74  EEPI------XIVTEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMA 118
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 119 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEXTARQGAKFPIKWT 172
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 173 APEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTXTAHAGAKFPIKWT 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 85  ----REPPFYIII-EFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 36  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 93  STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 136
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 137 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS--GSIL 191
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 115/223 (51%), Gaps = 22/223 (9%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALK 283
           K  ++ TD  +  + +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K
Sbjct: 8   KWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMK 65
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
            I+H NLV+++  C+    +   F  I+ ++M  G+L  +L         RE   Q++  
Sbjct: 66  EIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNLLDYL---------RECNRQEVNA 111
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           +  + +A  ++SA++YL +   +  +H DL   N L+  +    + DFGLSR    ++  
Sbjct: 112 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGD 165
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           T ++  G +  I + APE    ++ S   DV+++G+LL E+ T
Sbjct: 166 TXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 84  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 129
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 130 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 183
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 17  LGAGQFGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 75  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 118
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H +L+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 119 AFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIKW 172
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 173 TAPEAINYGTFTIKSDVWSFGILLTEIVT 201

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 82  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 127
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 128 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAPAGAKFPIKWT 181
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 93  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 138
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 139 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 192
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 193 APESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 80  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 115/223 (51%), Gaps = 22/223 (9%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALK 283
           K  ++ TD  +  + +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K
Sbjct: 9   KWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMK 66
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
            I+H NLV+++  C+    +   F  I+ ++M  G+L  +L         RE   Q++  
Sbjct: 67  EIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNA 112
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           +  + +A  ++SA++YL +   +  +H DL   N L+  +    + DFGLSR    ++  
Sbjct: 113 VVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGD 166
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           T ++  G +  I + APE    ++ S   DV+++G+LL E+ T
Sbjct: 167 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 81  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 126
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 127 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAPAGAKFPIKWT 180
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 181 APESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K IRH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 82  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 127
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 128 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 181
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 182 APESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 16  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH          I   K  +++ I IA   A  
Sbjct: 73  STKPQL------AIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTAQG 116
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  DL+  IGDFGL+      S       +   G+I 
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS--GSIL 171
Query: 417 YVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 85  ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H DL   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 185 APESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 275 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 333 EEPIY------IVTEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMA 377
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 378 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 431
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 19  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 77  EEPIY------IVTEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMA 121
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 122 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 175
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 176 APEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G  G V+ G ++   T VA+K +  Q   +  +F+AE   +K ++H+ LVR+    +
Sbjct: 21  LGAGQAGEVWMGYYN-GHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLH-PDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                      I+ +YM NGSL  +L  P  I          KLT+ + + +A  +A  +
Sbjct: 79  QEPIY------IITEYMENGSLVDFLKTPSGI----------KLTINKLLDMAAQIAEGM 122
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I +
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDAEXTAREGAKFPIKW 176
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE       +   DV+S+GILL E+VT
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMA 294
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 295 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 348
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMA 294
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 295 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 348
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVIEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEXTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 17  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 75  EEPI------YIVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 119
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 120 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 173
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 15  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 73  EEPI------YIVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 117
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 118 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 171
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 172 APEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVIEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 192 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 250 EEPI------YIVGEYMSKGSLLDFLKGETG---------KYLRLPQLVDMAAQIASGMA 294
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 295 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 348
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVCEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH       + + E++KL     I IA   A  
Sbjct: 77  STKPQL------AIVTQWCEGSSLYHHLHAS-----ETKFEMKKL-----IDIARQTARG 120
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  D +  IGDFGL+      S       +   G+I 
Sbjct: 121 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLS--GSIL 175
Query: 417 YVAPE---YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE       +  S   DVY++GI+L E++T + P
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 193 LGQGCFGEVWMGTWN-GTTRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 251 EEPI------YIVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 295
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL R    + +   ++  G +  I + 
Sbjct: 296 YVERM---NYVHRDLRAANILVGENLVCKVADFGLGRL---IEDNEYTARQGAKFPIKWT 349
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 350 APEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            ++         AIV ++    SL   LH       + + E++KL     I IA   A  
Sbjct: 89  STAPQL------AIVTQWCEGSSLYHHLHAS-----ETKFEMKKL-----IDIARQTARG 132
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  D +  IGDFGL+      S       +   G+I 
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS--GSIL 187
Query: 417 YVAPE---YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE       +  S   DVY++GI+L E++T + P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA++
Sbjct: 287 ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSAME 332
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H +L   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 333 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 386
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+VYKG +  D   VA+K++N+      +  +F  E   L+  RH N++  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +          AIV ++    SL   LH       + + E++KL     I IA   A  
Sbjct: 89  STKPQL------AIVTQWCEGSSLYHHLHAS-----ETKFEMKKL-----IDIARQTARG 132
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +DYLH    + I+H DLK +NI L  D +  IGDFGL+      S       +   G+I 
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS--GSIL 187
Query: 417 YVAPE---YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE       +  S   DVY++GI+L E++T + P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + ++  +AS + 
Sbjct: 81  EEPI------YIVTEYMNKGSLLDFLKGETG---------KYLRLPQLVDMSAQIASGMA 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 126 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVTEYMSKGSLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL  +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERMN---YVHRDLAAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 23  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  GSL  +L  +           + L L Q + ++  +AS + 
Sbjct: 81  EEPI------YIVTEYMNKGSLLDFLKGETG---------KYLRLPQLVDMSAQIASGMA 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 126 YVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEWTARQGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 180 APEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 108/208 (51%), Gaps = 21/208 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G +G VY+GV+ +    VA+K +  +     + F+ E   +K I+H NLV+++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +   F  I+ ++M  G+L  +L         RE   Q++  +  + +A  ++SA++
Sbjct: 326 ----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVNAVVLLYMATQISSAME 371
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL +   +  +H +L   N L+  +    + DFGLSR    ++  T ++  G +  I + 
Sbjct: 372 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWT 425
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE    ++ S   DV+++G+LL E+ T
Sbjct: 426 APESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 27/227 (11%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIR 286
           AT  +     IGVG++G+VYK      G  VA+K + +    +G   S + E   L+ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 287 ---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
              H N+VR++  C++          +V++++ +  L  +L  D  P      E  K  +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVS 401
            Q +         LD+LH +C   I+H DLKP NIL+ +  +  + DFGL+R   YQ   
Sbjct: 119 RQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           +P V        T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 169 DPVVV-------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  G L  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVMEYMSKGCLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++   T VAIK +      + ++F+ E + +K +RH+ LV++    S
Sbjct: 26  LGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      IV +YM  G L  +L  +           + L L Q + +A  +AS + 
Sbjct: 84  EEPI------YIVTEYMSKGCLLDFLKGEMG---------KYLRLPQLVDMAAQIASGMA 128
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I + 
Sbjct: 129 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIKWT 182
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE  L    +   DV+S+GILL E+ T
Sbjct: 183 APEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 82  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 128
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 129 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 184
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 185 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 109 GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 155
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 156 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 211
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 83  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 129
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 130 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 185
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 186 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 124
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 180
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 85  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 131
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 132 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 187
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 188 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 84  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 130
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 131 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 186
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 187 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 142
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 198
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 77  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 123
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 124 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 179
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 180 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 127
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 183
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 76  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 122
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 123 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 178
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 179 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 142
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 143 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 198
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 199 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 124
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 180
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 27/221 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + +     +G G++G VYK   D  G +VA+K I L  + +G   + + E   LK + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N+V +I    S          +V+++M    L+K L  +    +D +I+I    LL+ ++
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
                     + HQH    ILH DLKP N+L+++D +  + DFGL+R   A   P  S +
Sbjct: 134 ----------HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR---AFGIPVRSYT 177
Query: 409 IGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
             V  T+ Y AP+  +GS + ST+ D++S G +  EM+T K
Sbjct: 178 HEV-VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 107/221 (48%), Gaps = 20/221 (9%)
Query: 239 IGVGSFGSV-----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V     Y     +D  +VA+K +      A K F  E + L N++H+++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQK--LTLLQRIS 348
              C        D   +V++YM +G L K+L    PDA+   D +    K  L L Q + 
Sbjct: 83  YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           IA  +AS + YL     +  +H DL   N L+  +L   IGDFG+SR   +     V   
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
             +   I ++ PE  +  + +T  DV+S+G++L E+ T  K
Sbjct: 195 TML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 233

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 113/221 (51%), Gaps = 27/221 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + +     +G G++G VYK   D  G +VA+K I L  + +G   + + E   LK + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N+V +I    S          +V+++M    L+K L  +    +D +I+I    LL+ ++
Sbjct: 80  NIVSLIDVIHS-----ERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
                     + HQH    ILH DLKP N+L+++D +  + DFGL+R   A   P  S +
Sbjct: 134 ----------HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR---AFGIPVRSYT 177
Query: 409 IGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
             V  T+ Y AP+  +GS + ST+ D++S G +  EM+T K
Sbjct: 178 HEV-VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIR 286
           AT  +     IGVG++G+VYK      G  VA+K + +    +G   S + E   L+ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 287 ---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
              H N+VR++  C++          +V++++ +  L  +L  D  P      E  K  +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVS 401
            Q +         LD+LH +C   I+H DLKP NIL+ +  +  + DFGL+R   YQ   
Sbjct: 119 RQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
            P V        T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 169 APVVV-------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 79  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 125
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF------YQAVSNPTVSSS 408
             ++YL     +  +H +L   NIL++N+    IGDFGL++       Y  V  P  S  
Sbjct: 126 KGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP- 181
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 182 ------IFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L   A         I  + LLQ  S    + 
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHA-------ERIDHIKLLQYTS---QIC 127
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 183
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 31/219 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDGT---VVAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR 292
            +IG G FG V  G     G     VAIK +     +   + F++E   +    H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTLLQRIS 348
              V+T  + V         I+ ++M NGSL+ +L      Q D +   IQ + +L+ I+
Sbjct: 99  LEGVVTKSTPV--------MIITEFMENGSLDSFLR-----QNDGQFTVIQLVGMLRGIA 145
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA-VSNPTVSS 407
             +   + ++Y+H+         DL   NIL++++L   + DFGLSRF +   S+PT +S
Sbjct: 146 AGMKYLADMNYVHR---------DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 196
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           ++G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 197 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +++P GSL ++L      Q+ +E  I  + LLQ  S    + 
Sbjct: 81  GVCYSA---GRRNLKLIMEFLPYGSLREYL------QKHKE-RIDHIKLLQYTS---QIC 127
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             ++YL     +  +H DL   NIL++N+    IGDFGL++              G    
Sbjct: 128 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG-ESP 183
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 184 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 27/227 (11%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIR 286
           AT  +     IGVG++G+VYK      G  VA+K + +    +G   S + E   L+ + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 287 ---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
              H N+VR++  C++          +V++++ +  L  +L  D  P      E  K  +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVS 401
            Q +         LD+LH +C   I+H DLKP NIL+ +  +  + DFGL+R   YQ   
Sbjct: 119 RQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
            P V        T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 169 FPVVV-------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 33/218 (15%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E  I  + LLQ  S    + 
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYL------QKHKE-RIDHIKLLQYTS---QIC 124
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF------YQAVSNPTVSSS 408
             ++YL     +  +H DL   NIL++N+    IGDFGL++       +  V  P  S  
Sbjct: 125 KGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP- 180
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 I + APE    S+ S   DV+S+G++L E+ T
Sbjct: 181 ------IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 69
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 70  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 114
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS+G +  
Sbjct: 115 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 168
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 71  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 115
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS+G +  
Sbjct: 116 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 169
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 239 IGVGSFGSV-----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V     Y    ++D  +VA+K +      A K F  E + L N++H+++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQKLTLLQRISIA 350
              C        D   +V++YM +G L K+L    PDA+   +     + LT  Q + IA
Sbjct: 81  YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTE-LTQSQMLHIA 134
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             +A+ + YL     +  +H DL   N L+  +L   IGDFG+SR   +     V     
Sbjct: 135 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 191
Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           +   I ++ PE  +  + +T  DV+S G++L E+ T  K
Sbjct: 192 L--PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 86  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 130
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS+G +  
Sbjct: 131 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 184
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 66  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 110
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS+G +  
Sbjct: 111 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 164
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 76
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 77  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS+G +  
Sbjct: 122 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFP 175
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 86  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 130
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS+G +  
Sbjct: 131 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEETSSVGSKFP 184
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNI-RHKNLVR 292
           ++IG G+FG V K    +DG  +   +  ++   +    + F  E + L  +  H N++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-----LTLLQRI 347
           ++ +C   + +G  + AI  +Y P+G+L  +L    + + D    I       L+  Q +
Sbjct: 81  LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 135
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A DVA  +DYL    Q+  +H DL   NIL+  +  A I DFGLSR  +     T+  
Sbjct: 136 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 191
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               R  + ++A E    S  +TN DV+SYG+LL E+V+
Sbjct: 192 ----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNI-RHKNLVR 292
           ++IG G+FG V K    +DG  +   +  ++   +    + F  E + L  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-----LTLLQRI 347
           ++ +C   + +G  + AI  +Y P+G+L  +L    + + D    I       L+  Q +
Sbjct: 91  LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A DVA  +DYL    Q+  +H DL   NIL+  +  A I DFGLSR  +     T+  
Sbjct: 146 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 201
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               R  + ++A E    S  +TN DV+SYG+LL E+V+
Sbjct: 202 ----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM--------AECK 280
           AT  +     IGVG++G+VYK      G  VA+K + +   G     +        A  +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            L+   H N+VR++  C++          +V++++ +  L  +L  D  P      E  K
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL--DKAPPPGLPAETIK 123
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQ 398
             + Q +         LD+LH +C   I+H DLKP NIL+ +  +  + DFGL+R   YQ
Sbjct: 124 DLMRQFLR-------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
               P V        T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 174 MALTPVVV-------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 96  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 141
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKL 198
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    ++G +D     VAIK+I  +   +   F+ E K + N+ H+ LV++ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLY 70
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    Q   F  I+ +YM NG L  +L         RE+   +    Q + +  DV 
Sbjct: 71  GVCTK---QRPIF--IITEYMANGCLLNYL---------REMR-HRFQTQQLLEMCKDVC 115
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            A++YL     +  LH DL   N L+++     + DFGLSR+   V +   +SS G +  
Sbjct: 116 EAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSRGSKFP 169
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           + +  PE  + S+ S+  D++++G+L+ E+ +  K
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 204

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNI-RHKNLVR 292
           ++IG G+FG V K    +DG  +   +  ++   +    + F  E + L  +  H N++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-----LTLLQRI 347
           ++ +C   + +G  + AI  +Y P+G+L  +L    + + D    I       L+  Q +
Sbjct: 88  LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 142
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A DVA  +DYL    Q+  +H +L   NIL+  +  A I DFGLSR  +     T+  
Sbjct: 143 HFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG- 198
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               R  + ++A E    S  +TN DV+SYG+LL E+V+
Sbjct: 199 ----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 237 NLIGVGSFGSVYKG-VFDEDGTV--VAIKVINLQR--QGASKSFMAECKALKNIRHKNLV 291
            ++G G FGSV +G +  EDGT   VA+K + L    Q   + F++E   +K+  H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R++  C  +  QG     ++  +M  G L  +L    +    + I +Q L     +   +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL-----LKFMV 154
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           D+A  ++YL        LH DL   N +L +D++  + DFGLS+  +  S          
Sbjct: 155 DIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYRQGRIA 209
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  + ++A E       ++  DV+++G+ + E+ T
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 237 NLIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVR 292
            +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++  C     +      +V  YM +G L  ++            E    T+   I   + 
Sbjct: 94  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQ 139
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G +
Sbjct: 140 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 115 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 160
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 161 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 217
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 26/219 (11%)
Query: 234 SSTNLIGVGSFGSVYKGVFD----EDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHK 288
           +   +IG G FG VYKG+      +    VAIK +        +  F+ E   +    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRI 347
           N++R+    S           I+ +YM NG+L+K+L      ++D E  + +L  +L+ I
Sbjct: 107 NIIRLEGVISKYKPM-----MIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLRGI 156
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           +  +   + ++Y+H+         DL   NIL++++L   + DFGLSR  +     T ++
Sbjct: 157 AAGMKYLANMNYVHR---------DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           S G +  I + APE     + ++  DV+S+GI++ E++T
Sbjct: 208 S-GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 237 NLIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVR 292
            +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++  C     +      +V  YM +G L  ++            E    T+   I   + 
Sbjct: 88  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQ 133
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G +
Sbjct: 134 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDGT---VVAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR 292
            +IG G FG V  G     G     VAIK +     +   + F++E   +    H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTLLQRIS 348
              V+T  + V         I+ ++M NGSL+ +L      Q D +   IQ + +L+ I+
Sbjct: 73  LEGVVTKSTPV--------MIITEFMENGSLDSFLR-----QNDGQFTVIQLVGMLRGIA 119
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA-VSNPTVSS 407
             +   + ++Y+H+          L   NIL++++L   + DFGLSRF +   S+PT +S
Sbjct: 120 AGMKYLADMNYVHRA---------LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 170
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           ++G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 171 ALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 237 NLIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVR 292
            +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++  C     +      +V  YM +G L  ++            E    T+   I   + 
Sbjct: 91  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQ 136
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G +
Sbjct: 137 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
            ++G G+FG V K  +      VAIK I  + +   K+F+ E + L  + H N+V++  +
Sbjct: 14  EVVGRGAFGVVCKAKWRAKD--VAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C +          +V +Y   GSL   LH  A P       +   T    +S  +  +  
Sbjct: 70  CLNP-------VCLVMEYAEGGSLYNVLH-GAEP-------LPYYTAAHAMSWCLQCSQG 114
Query: 357 LDYLHQHCQEPILHCDLKPSNILL-DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           + YLH    + ++H DLKP N+LL        I DFG +   Q       +     +G+ 
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSA 167
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            ++APE   GS  S   DV+S+GI+L E++T +KP D
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 116 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 161
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 162 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 218
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 142
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 96  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 141
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 198
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 237 NLIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVR 292
            +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++  C     +      +V  YM +G L  ++            E    T+   I   + 
Sbjct: 93  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQ 138
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G +
Sbjct: 139 VAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
            ++G G+FG V K  +      VAIK   ++ +   K+F+ E + L  + H N+V++  +
Sbjct: 15  EVVGRGAFGVVCKAKWRAKD--VAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C +          +V +Y   GSL   LH  A P       +   T    +S  +  +  
Sbjct: 71  CLNP-------VCLVMEYAEGGSLYNVLH-GAEP-------LPYYTAAHAMSWCLQCSQG 115
Query: 357 LDYLHQHCQEPILHCDLKPSNILL-DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           + YLH    + ++H DLKP N+LL        I DFG +   Q       +     +G+ 
Sbjct: 116 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSA 168
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            ++APE   GS  S   DV+S+GI+L E++T +KP D
Sbjct: 169 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 142
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 29/230 (12%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL-QRQGASKSFMAECKALKNIRHKNLV 291
           F     +G G FG V++     D    AIK I L  R+ A +  M E KAL  + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 292 RVITSC----SSVDFQGNDFKAIVYKYMP---NGSLEKWLHPD-AIPQRDREIEIQKLTL 343
           R   +     ++   Q +  K  +Y  M      +L+ W++    I +R+R + +     
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH---- 122
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL------SRFY 397
                I + +A A+++LH    + ++H DLKPSNI    D    +GDFGL          
Sbjct: 123 -----IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 398 QAVSN--PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           Q V    P  +   G  GT  Y++PE   G+  S   D++S G++L E++
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++ + T VA+K +        ++F+ E   +K ++H  LVR+    +
Sbjct: 21  LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                  +   I+ +YM  GSL  +L  D         E  K+ L + I  +  +A  + 
Sbjct: 79  R-----EEPIYIITEYMAKGSLLDFLKSD---------EGGKVLLPKLIDFSAQIAEGMA 124
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +   +  +H DL+ +N+L+   L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 125 YIER---KNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWT 178
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           APE       +   DV+S+GILL E+VT  K
Sbjct: 179 APEAINFGCFTIKSDVWSFGILLYEIVTYGK 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA--ECKALKN 284
            ++ + +     IG GSFG        EDG    IK IN+ R  + +   +  E   L N
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           ++H N+V+   S     F+ N    IV  Y   G L K             I  QK  L 
Sbjct: 80  MKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFK------------RINAQKGVLF 122
Query: 345 QRISIA---IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
           Q   I    + +  AL ++H      ILH D+K  NI L  D +  +GDFG++R    V 
Sbjct: 123 QEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR----VL 175
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           N TV  +    GT  Y++PE       +   D+++ G +L E+ T K
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V+       + ++D  +VA+K +    + A + F  E + L  ++H+++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDA-IPQRDREIEIQKLTLLQRISI 349
              C+    +G     +V++YM +G L ++L    PDA +     ++    L L Q +++
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A  VA+ + YL        +H DL   N L+   L   IGDFG+SR   +     V    
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            +   I ++ PE  L  + +T  DV+S+G++L E+ T  K
Sbjct: 221 ML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+   +++  T VA+K +        ++F+AE   +K ++H  LV++    +
Sbjct: 23  LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      I+ ++M  GSL  +L  D         E  K  L + I  +  +A  + 
Sbjct: 81  KEPIY------IITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQIAEGMA 125
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           ++ Q      +H DL+ +NIL+   L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 126 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWT 179
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE       +   DV+S+GILL+E+VT
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGV-FDEDGTVVAIKVINLQ--RQGASKSFMA 277
           M    L +A   +     IG G++G V+K       G  VA+K + +Q   +G   S + 
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 278 ECKALKNIR---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           E   L+++    H N+VR+   C+           +V++++ +  L  +L  D +P+   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGV 117
Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
             E  K  + Q       +   LD+LH H    ++H DLKP NIL+ +     + DFGL+
Sbjct: 118 PTETIKDMMFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           R Y   S     +S+ V  T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 168 RIY---SFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGV-FDEDGTVVAIKVINLQ--RQGASKSFMA 277
           M    L +A   +     IG G++G V+K       G  VA+K + +Q   +G   S + 
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 278 ECKALKNIR---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           E   L+++    H N+VR+   C+           +V++++ +  L  +L  D +P+   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGV 117
Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
             E  K  + Q       +   LD+LH H    ++H DLKP NIL+ +     + DFGL+
Sbjct: 118 PTETIKDMMFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           R Y   S     +S+ V  T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 168 RIY---SFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V+       + ++D  +VA+K +    + A + F  E + L  ++H+++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDA-IPQRDREIEIQKLTLLQRISI 349
              C+    +G     +V++YM +G L ++L    PDA +     ++    L L Q +++
Sbjct: 80  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A  VA+ + YL        +H DL   N L+   L   IGDFG+SR   +     V    
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 191
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            +   I ++ PE  L  + +T  DV+S+G++L E+ T  K
Sbjct: 192 ML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGV-FDEDGTVVAIKVINLQ--RQGASKSFMA 277
           M    L +A   +     IG G++G V+K       G  VA+K + +Q   +G   S + 
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 278 ECKALKNIR---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           E   L+++    H N+VR+   C+           +V++++ +  L  +L  D +P+   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL--DKVPEPGV 117
Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
             E  K  + Q       +   LD+LH H    ++H DLKP NIL+ +     + DFGL+
Sbjct: 118 PTETIKDMMFQ-------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           R Y   S     +S+ V  T+ Y APE  L S  +T  D++S G +  EM   K
Sbjct: 168 RIY---SFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 98  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 143
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 144 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 200
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 102 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 147
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 148 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 204
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 156 LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 201
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 202 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 142
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 143 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 95  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 140
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 141 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 197
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 19/220 (8%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V+       + ++D  +VA+K +    + A + F  E + L  ++H+++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDA-IPQRDREIEIQKLTLLQRISI 349
              C+    +G     +V++YM +G L ++L    PDA +     ++    L L Q +++
Sbjct: 86  FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A  VA+ + YL        +H DL   N L+   L   IGDFG+SR   +     V    
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 197
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            +   I ++ PE  L  + +T  DV+S+G++L E+ T  K
Sbjct: 198 ML--PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+   +++  T VA+K +        ++F+AE   +K ++H  LV++    +
Sbjct: 196 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      I+ ++M  GSL  +L  D         E  K  L + I  +  +A  + 
Sbjct: 254 KEPIY------IITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQIAEGMA 298
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           ++ Q      +H DL+ +NIL+   L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 299 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWT 352
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE       +   DV+S+GILL+E+VT
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 97  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 142
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 143 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 21/217 (9%)
Query: 238 LIGVGSFGSVYKG-VFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRV 293
           +IG G FG VY G + D DG  +   V +L R    G    F+ E   +K+  H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     +      +V  YM +G L  ++            E    T+   I   + V
Sbjct: 98  LGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQV 143
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + +L     +  +H DL   N +LD   +  + DFGL+R        +V +  G + 
Sbjct: 144 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL 200
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG V  G  D  G  VA+K I  +    +++F+AE   +  +RH NLV+++    
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 83
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+ +G  +  IV +YM  GSL      D +  R R + +    LL+    ++DV  A++
Sbjct: 84  -VEEKGGLY--IVTEYMAKGSL-----VDYLRSRGRSV-LGGDCLLK---FSLDVCEAME 131
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL  +     +H DL   N+L+  D  A + DFGL++     S+   +  + V+ T    
Sbjct: 132 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT---- 181
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE     + ST  DV+S+GILL E+ +
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 30/234 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQRQG--ASKSFMAEC 279
           +LK T+      ++G G+FG+VYKG++  +G      VAIK++N +  G  A+  FM E 
Sbjct: 34  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 91
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
             + ++ H +LVR++  C S   Q      +V + MP+G L +++H     +    I  Q
Sbjct: 92  LIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH-----EHKDNIGSQ 140
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L     ++  + +A  + YL +     ++H DL   N+L+ +     I DFGL+R  + 
Sbjct: 141 LL-----LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
             +    ++ G +  I ++A E     + +   DV+SYG+ + E++T   KP D
Sbjct: 193 --DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG V  G  D  G  VA+K I  +    +++F+AE   +  +RH NLV+++    
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 68
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+ +G  +  IV +YM  GSL      D +  R R + +    LL+    ++DV  A++
Sbjct: 69  -VEEKGGLY--IVTEYMAKGSL-----VDYLRSRGRSV-LGGDCLLK---FSLDVCEAME 116
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL  +     +H DL   N+L+  D  A + DFGL++     S+   +  + V+ T    
Sbjct: 117 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT---- 166
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEM 444
           APE     + ST  DV+S+GILL E+
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEI 192

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 118/234 (50%), Gaps = 30/234 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQRQG--ASKSFMAEC 279
           +LK T+      ++G G+FG+VYKG++  +G      VAIK++N +  G  A+  FM E 
Sbjct: 11  ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEA 68
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
             + ++ H +LVR++  C S   Q      +V + MP+G L +++H     +    I  Q
Sbjct: 69  LIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLEYVH-----EHKDNIGSQ 117
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L     ++  + +A  + YL +     ++H DL   N+L+ +     I DFGL+R  + 
Sbjct: 118 LL-----LNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 169
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
             +    ++ G +  I ++A E     + +   DV+SYG+ + E++T   KP D
Sbjct: 170 --DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG V  G  D  G  VA+K I  +    +++F+AE   +  +RH NLV+++    
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 255
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+ +G  +  IV +YM  GSL  +L       R R   +     L + S+  DV  A++
Sbjct: 256 -VEEKGGLY--IVTEYMAKGSLVDYL-------RSRGRSVLGGDCLLKFSL--DVCEAME 303
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL  +     +H DL   N+L+  D  A + DFGL++     S+   +  + V+ T    
Sbjct: 304 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT---- 353
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEM 444
           APE     + ST  DV+S+GILL E+
Sbjct: 354 APEALREKKFSTKSDVWSFGILLWEI 379

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G + K              E
Sbjct: 63  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPRGEVYK--------------E 103
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S
Sbjct: 104 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 160
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 161 -----VHAPS-SRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG V  G  D  G  VA+K I  +    +++F+AE   +  +RH NLV+++    
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI- 74
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+ +G  +  IV +YM  GSL  +L       R R   +     L + S+  DV  A++
Sbjct: 75  -VEEKGGLY--IVTEYMAKGSLVDYL-------RSRGRSVLGGDCLLKFSL--DVCEAME 122
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YL  +     +H DL   N+L+  D  A + DFGL++     S+   +  + V+ T    
Sbjct: 123 YLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT---- 172
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEM 444
           APE    +  ST  DV+S+GILL E+
Sbjct: 173 APEALREAAFSTKSDVWSFGILLWEI 198

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G + K              E
Sbjct: 63  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPRGEVYK--------------E 103
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S
Sbjct: 104 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 160
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 161 -----VHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 237 NLIGVGSFGSVYKGVF--DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
            +IG+G FG VY+  +  DE     A    +       ++   E K    ++H N++ + 
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C            +V ++   G L + L    IP            +L  ++ A+ +A
Sbjct: 73  GVCLK-----EPNLCLVMEFARGGPLNRVLSGKRIPP----------DIL--VNWAVQIA 115
Query: 355 SALDYLHQHCQEPILHCDLKPSNILL-----DNDLS---AHIGDFGLSRFYQAVSNPTVS 406
             ++YLH     PI+H DLK SNIL+     + DLS     I DFGL+R +        +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR------T 169
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + +   G   ++APE    S  S   DV+SYG+LL E++T + P
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 113/254 (44%), Gaps = 35/254 (13%)
Query: 203 SRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIK 262
           S P   P E +  K   + S K    A + F     +G G FG+VY     +   ++A+K
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQW-ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK 65
Query: 263 VI---NLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGS 319
           V+    L++ G       E +   ++RH N++R+        F       ++ +Y P G+
Sbjct: 66  VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGT 120
Query: 320 LEKWLHPDAIPQRDREIEIQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPS 376
           + +              E+QKL+    QR +  I ++A+AL Y H    + ++H D+KP 
Sbjct: 121 VYR--------------ELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPE 163
Query: 377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYS 436
           N+LL +     I DFG S     V  P+ S    + GT+ Y+ PE   G       D++S
Sbjct: 164 NLLLGSAGELKIADFGWS-----VHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWS 217
Query: 437 YGILLLEMVTTKKP 450
            G+L  E +  K P
Sbjct: 218 LGVLCYEFLVGKPP 231

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDGT---VVAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR 292
            +IGVG FG V  G     G     VAIK +         + F++E   +    H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
              V+T C  V         I+ +YM NGSL+ +L  +            + T++Q + +
Sbjct: 95  LEGVVTKCKPV--------MIITEYMENGSLDAFLRKND----------GRFTVIQLVGM 136
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-SS 408
              + S + YL        +H DL   NIL++++L   + DFG+SR  +   +P  + ++
Sbjct: 137 LRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLE--DDPEAAYTT 191
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 192 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRV 293
           + +GVG+FG V  G     G  VA+K++N Q+            E + LK  RH +++++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
               S+      DF  +V +Y+  G L      D I +  R  E++   L Q+I      
Sbjct: 77  YQVIST----PTDF-FMVMEYVSGGELF-----DYICKHGRVEEMEARRLFQQI------ 120
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            SA+DY H+H    ++H DLKP N+LLD  ++A I DFGLS           S      G
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----G 172
Query: 414 TIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD 452
           +  Y APE   G        D++S G++L  ++    P D
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 102
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 103 PLIK--SYLFQLLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 154
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 155 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 102
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 103 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 154
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 155 VPVRTYTHEV-VTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 39/232 (16%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKN 284
           L + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 285 IRHKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           + H N+V+++    +        +F   D K    K+M   +L        IP       
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP------- 104
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
              L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +
Sbjct: 105 ---LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 156
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                      +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 GVPVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+ G ++ + T VA+K +        ++F+ E   +K ++H  LVR+    +
Sbjct: 20  LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSV-QAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                  +   I+ ++M  GSL  +L  D         E  K+ L + I  +  +A  + 
Sbjct: 78  K-----EEPIYIITEFMAKGSLLDFLKSD---------EGGKVLLPKLIDFSAQIAEGMA 123
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           Y+ +   +  +H DL+ +N+L+   L   I DFGL+R    + +   ++  G +  I + 
Sbjct: 124 YIER---KNYIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWT 177
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
           APE       +   +V+S+GILL E+VT  K
Sbjct: 178 APEAINFGCFTIKSNVWSFGILLYEIVTYGK 208

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 109
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 110 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 161
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 162 VPVRTYTHEVV-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 39/232 (16%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKN 284
           L + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK 
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 285 IRHKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           + H N+V+++    +        +F   D K    K+M   +L        IP       
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP------- 105
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
              L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +
Sbjct: 106 ---LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 157
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                      +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 158 GVPVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 102
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 103 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 154
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 155 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 101
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 102 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 153
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 154 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 34/223 (15%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRV 293
           + +GVG+FG V  G     G  VA+K++N Q+            E + LK  RH +++++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
               S+      DF  +V +Y+  G L      D I +  R  E++   L Q+I      
Sbjct: 77  YQVIST----PTDF-FMVMEYVSGGELF-----DYICKHGRVEEMEARRLFQQI------ 120
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            SA+DY H+H    ++H DLKP N+LLD  ++A I DFGLS          +S    +R 
Sbjct: 121 LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--------MSDGEFLRD 169
Query: 414 TIG---YVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD 452
           + G   Y APE   G        D++S G++L  ++    P D
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 101
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 102 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 153
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 154 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 102
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 103 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-G 155
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
           V   T +  +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 VPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDGT---VVAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR 292
            +IGVG FG V  G     G     VAIK +         + F++E   +    H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
              V+T C  V         I+ +YM NGSL+ +L  +            + T++Q + +
Sbjct: 74  LEGVVTKCKPV--------MIITEYMENGSLDAFLRKND----------GRFTVIQLVGM 115
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-SS 408
              + S + YL        +H DL   NIL++++L   + DFG+SR  +   +P  + ++
Sbjct: 116 LRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLE--DDPEAAYTT 170
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 171 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 109
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 110 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 161
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 162 VPVRTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V+   +++  T VA+K +        ++F+AE   +K ++H  LV++    +
Sbjct: 190 LGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 247
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                      I+ ++M  GSL  +L  D         E  K  L + I  +  +A  + 
Sbjct: 248 KEPI------YIITEFMAKGSLLDFLKSD---------EGSKQPLPKLIDFSAQIAEGMA 292
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           ++ Q      +H DL+ +NIL+   L   I DFGL+R             +G +  I + 
Sbjct: 293 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR-------------VGAKFPIKWT 336
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVT 446
           APE       +   DV+S+GILL+E+VT
Sbjct: 337 APEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDGT---VVAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR 292
            +IGVG FG V  G     G     VAIK +         + F++E   +    H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
              V+T C  V         I+ +YM NGSL+ +L  +            + T++Q + +
Sbjct: 80  LEGVVTKCKPV--------MIITEYMENGSLDAFLRKND----------GRFTVIQLVGM 121
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-SS 408
              + S + YL        +H DL   NIL++++L   + DFG+SR  +   +P  + ++
Sbjct: 122 LRGIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLE--DDPEAAYTT 176
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE     + ++  DV+SYGI++ E+++
Sbjct: 177 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 102
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 103 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 154
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 155 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 106
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  V 
Sbjct: 107 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVP 160
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
             T +  +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 161 VRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 113/254 (44%), Gaps = 35/254 (13%)
Query: 203 SRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIK 262
           S P   P E +  K   + S K    A + F     +G G FG+VY     +   ++A+K
Sbjct: 7   SAPENNPEEELASKQKNEESKKRQW-ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK 65
Query: 263 VI---NLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGS 319
           V+    L++ G       E +   ++RH N++R+        F       ++ +Y P G+
Sbjct: 66  VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGT 120
Query: 320 LEKWLHPDAIPQRDREIEIQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPS 376
           + +              E+QKL+    QR +  I ++A+AL Y H    + ++H D+KP 
Sbjct: 121 VYR--------------ELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPE 163
Query: 377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYS 436
           N+LL +     I DFG S     V  P+ S    + GT+ Y+ PE   G       D++S
Sbjct: 164 NLLLGSAGELKIADFGWS-----VHAPS-SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWS 217
Query: 437 YGILLLEMVTTKKP 450
            G+L  E +  K P
Sbjct: 218 LGVLCYEFLVGKPP 231

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 104/232 (44%), Gaps = 39/232 (16%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKN 284
           L + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 285 IRHKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           + H N+V+++    +        +F   D K    K+M   +L        IP       
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLK----KFMDASALT------GIP------- 104
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
              L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +
Sbjct: 105 ---LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAF 156
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                      +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 GVPVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 239 IGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVIT 295
           IG G FG V+ G + ++D   VAIK I   R+GA   + F+ E + +  + H  LV++  
Sbjct: 18  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C            +V+++M +G L  +L       R +       TLL    + +DV  
Sbjct: 73  VCLE-----QAPICLVFEFMEHGCLSDYL-------RTQRGLFAAETLL---GMCLDVCE 117
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  +
Sbjct: 118 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPV 171
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            + +PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 172 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 103
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 104 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 157
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 158 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRVITSC 297
           IG G+FG V+ G    D T+VA+K          K+ F+ E + LK   H N+VR+I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
           +           IV + +  G    +L  +    R +       TLLQ +    D A+ +
Sbjct: 182 TQ-----KQPIYIVMELVQGGDFLTFLRTEGARLRVK-------TLLQMVG---DAAAGM 226
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT-IG 416
           +YL   C    +H DL   N L+       I DFG+SR     ++   ++S G+R   + 
Sbjct: 227 EYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQVPVK 280
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + APE       S+  DV+S+GILL E
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 103
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 104 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 158 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G FG V    +KG +D     VA+K+I  +   +   F  E + +  + H  LV+  
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----VAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 295 TSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             CS       ++   IV +Y+ NG L  +L              + L   Q + +  DV
Sbjct: 70  GVCS------KEYPIYIVTEYISNGCLLNYLRSHG----------KGLEPSQLLEMCYDV 113
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              + +L  H     +H DL   N L+D DL   + DFG++R+   V +    SS+G + 
Sbjct: 114 CEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKF 167
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT-KKPTD 452
            + + APE     + S+  DV+++GIL+ E+ +  K P D
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 239 IGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVIT 295
           IG G FG V+ G + ++D   VAIK I   R+GA   + F+ E + +  + H  LV++  
Sbjct: 13  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C            +V+++M +G L  +L       R +       TLL    + +DV  
Sbjct: 68  VCLE-----QAPICLVFEFMEHGCLSDYL-------RTQRGLFAAETLL---GMCLDVCE 112
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  +
Sbjct: 113 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPV 166
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            + +PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 167 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 101
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 102 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 103
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 104 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 157
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 158 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 239 IGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVIT 295
           IG G FG V+ G + ++D   VAIK I   R+GA   + F+ E + +  + H  LV++  
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C            +V+++M +G L  +L       R +       TLL    + +DV  
Sbjct: 70  VCLE-----QAPICLVFEFMEHGCLSDYL-------RTQRGLFAAETLL---GMCLDVCE 114
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  +
Sbjct: 115 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPV 168
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            + +PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVRVI 294
           IG GSF +VYKG+  E  T V +    LQ +  +KS    F  E + LK ++H N+VR  
Sbjct: 34  IGRGSFKTVYKGLDTE--TTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S  S   +G     +V +   +G+L+ +L         +  ++ K+ +L+  S    + 
Sbjct: 92  DSWEST-VKGKKCIVLVTELXTSGTLKTYL---------KRFKVXKIKVLR--SWCRQIL 139
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDL-SAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
             L +LH     PI+H DLK  NI +     S  IGD GL+   +A      S +  V G
Sbjct: 140 KGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA------SFAKAVIG 192
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  + APE     +   + DVY++G   LE  T++ P
Sbjct: 193 TPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRVITSC 297
           IG G+FG V+ G    D T+VA+K          K+ F+ E + LK   H N+VR+I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
           +           IV + +  G    +L  +    R +       TLLQ +    D A+ +
Sbjct: 182 TQ-----KQPIYIVMELVQGGDFLTFLRTEGARLRVK-------TLLQMVG---DAAAGM 226
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT-IG 416
           +YL   C    +H DL   N L+       I DFG+SR     ++   ++S G+R   + 
Sbjct: 227 EYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQVPVK 280
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + APE       S+  DV+S+GILL E
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 102
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 103 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 156
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 101
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 102 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 101
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +    
Sbjct: 102 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                  +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 RTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 102
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 103 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 156
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 45/237 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F    LIG G FG V+K     DG    I+ +    + A +    E KAL  + H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 293 VITSCSSVDF---------QGNDFKA---------------IVYKYMPNGSLEKWLHPDA 328
                   D+         + +D+                 I  ++   G+LE+W+    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 329 IPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI 388
             + D+   +  L L ++I+        +DY+H    + ++H DLKPSNI L +     I
Sbjct: 130 GEKLDK---VLALELFEQIT------KGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKI 177
Query: 389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           GDFGL    +     T S     +GT+ Y++PE     +     D+Y+ G++L E++
Sbjct: 178 GDFGLVTSLKNDGKRTRS-----KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 104
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 105 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 159 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F    LIG G FG V+K     DG    IK +    + A +    E KAL  + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 293 VITSCSSVDFQ-----GNDFKA------IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
                   D+       N  ++      I  ++   G+LE+W+      + D+   +  L
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK---VLAL 125
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L ++I+        +DY+H    + +++ DLKPSNI L +     IGDFGL       S
Sbjct: 126 ELFEQIT------KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGL-----VTS 171
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
                     +GT+ Y++PE     +     D+Y+ G++L E++
Sbjct: 172 LKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 101
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 102 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G++ +              E
Sbjct: 61  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------E 101
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S
Sbjct: 102 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 -----VHAPS-SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP--------- 101
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 102 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 101
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +    
Sbjct: 102 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                  +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 RTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G++ +              E
Sbjct: 61  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------E 101
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S
Sbjct: 102 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 -----VHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G++ +              E
Sbjct: 61  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------E 101
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S
Sbjct: 102 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 -----VHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G++ +              E
Sbjct: 63  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------E 103
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S
Sbjct: 104 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS 160
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 161 -----VHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 103
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +    
Sbjct: 104 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                  +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 159 RTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           +     +G GSFG V        G  VA+K+IN   L +         E   L+ +RH +
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++++     S      D   +V +Y  N         D I QRD+  E +     Q+I  
Sbjct: 76  IIKLYDVIKS-----KDEIIMVIEYAGNELF------DYIVQRDKMSEQEARRFFQQI-- 122
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                SA++Y H+H    I+H DLKP N+LLD  L+  I DFGLS      +    S   
Sbjct: 123 ----ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-- 173
Query: 410 GVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD 452
              G+  Y APE   G        DV+S G++L  M+  + P D
Sbjct: 174 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY         ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F  +    ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K    K+M   +L        IP         
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSMDLK----KFMDASALT------GIP--------- 102
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 103 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 156
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 111
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 112 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 163
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 164 PS-SRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           +     +G GSFG V        G  VA+K+IN   L +         E   L+ +RH +
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++++     S      D   +V +Y  N         D I QRD+  E +     Q+I  
Sbjct: 75  IIKLYDVIKS-----KDEIIMVIEYAGNELF------DYIVQRDKMSEQEARRFFQQI-- 121
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                SA++Y H+H    I+H DLKP N+LLD  L+  I DFGLS      +    S   
Sbjct: 122 ----ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-- 172
Query: 410 GVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD 452
              G+  Y APE   G        DV+S G++L  M+  + P D
Sbjct: 173 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 109
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 110 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 161
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 162 PS-SRRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 29/224 (12%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           +     +G GSFG V        G  VA+K+IN   L +         E   L+ +RH +
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++++     S      D   +V +Y  N         D I QRD+  E +     Q+I  
Sbjct: 66  IIKLYDVIKS-----KDEIIMVIEYAGNELF------DYIVQRDKMSEQEARRFFQQI-- 112
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                SA++Y H+H    I+H DLKP N+LLD  L+  I DFGLS      +    S   
Sbjct: 113 ----ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-- 163
Query: 410 GVRGTIGYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
              G+  Y APE   G   +    DV+S G++L  M+  + P D
Sbjct: 164 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 102/239 (42%), Gaps = 48/239 (20%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI----- 285
           D      LIG G +G+VYKG  DE    VA+KV +   +   ++F+ E    KNI     
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANR---QNFINE----KNIYRVPL 63
Query: 286 -RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
             H N+ R I     V   G     +V +Y PNGSL K+L             +     +
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------------SLHTSDWV 111
Query: 345 QRISIAIDVASALDYLH------QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
               +A  V   L YLH       H +  I H DL   N+L+ ND +  I DFGLS   +
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS--MR 169
Query: 399 AVSNPTV------SSSIGVRGTIGYVAPEYGLGS-------EVSTNGDVYSYGILLLEM 444
              N  V      +++I   GTI Y+APE   G+             D+Y+ G++  E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 29/224 (12%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           +     +G GSFG V        G  VA+K+IN   L +         E   L+ +RH +
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++++     S      D   +V +Y  N         D I QRD+  E +     Q+I  
Sbjct: 70  IIKLYDVIKS-----KDEIIMVIEYAGNELF------DYIVQRDKMSEQEARRFFQQI-- 116
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                SA++Y H+H    I+H DLKP N+LLD  L+  I DFGLS      +    S   
Sbjct: 117 ----ISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC-- 167
Query: 410 GVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD 452
              G+  Y APE   G        DV+S G++L  M+  + P D
Sbjct: 168 ---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 107
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 108 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 159
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 160 PS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G  VA+K +  +  G        E + L+N+ H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C+  +  GN  K I+ +++P+GSL+++L  +            K+ L Q++  A+ +
Sbjct: 89  KGICT--EDGGNGIKLIM-EFLPSGSLKEYLPKNK----------NKINLKQQLKYAVQI 135
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              +DYL        +H DL   N+L++++    IGDFGL++  +       +       
Sbjct: 136 CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEXXTVKDDRDS 191
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + + APE  + S+     DV+S+G+ L E++T
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 66  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 106
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 107 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 65  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 105
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 106 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 157
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 158 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 110
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 111 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 162
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 163 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 71  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 111
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 112 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 163
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 164 PS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G  VA+K +  +  G        E + L+N+ H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C+  +  GN  K I+ +++P+GSL+++L  +            K+ L Q++  A+ +
Sbjct: 77  KGICT--EDGGNGIKLIM-EFLPSGSLKEYLPKNK----------NKINLKQQLKYAVQI 123
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              +DYL        +H DL   N+L++++    IGDFGL++  +       +       
Sbjct: 124 CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEXXTVKDDRDS 179
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + + APE  + S+     DV+S+G+ L E++T
Sbjct: 180 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 83  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 123
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 124 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 175
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 176 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 63  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 103
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 104 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 155
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 156 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 108
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 109 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 160
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 161 PS-SRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 107
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S    +   
Sbjct: 108 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR 164
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            T+S      GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 165 TTLS------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 31/226 (13%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA---IPQRDREIEIQKLTL 343
           H N+V+++    +      +   +V++++ +  L+K++   A   IP          L L
Sbjct: 64  HPNIVKLLDVIHT-----ENKLYLVFEHV-DQDLKKFMDASALTGIP----------LPL 107
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           ++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +      
Sbjct: 108 IK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 163 YXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 40  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 141
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 142 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 196
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 197 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 30  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 131
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 132 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 186
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 187 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+  I L  + +G   + + E   LK + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 102
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 103 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 154
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 155 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+  I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 289 NLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           N+V+++    +        +F   D K    K+M   +L        IP          L
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLK----KFMDASALT------GIP----------L 101
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
            L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R   A  
Sbjct: 102 PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR---AFG 153
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
            P  + +  V  T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 154 VPVRTYTHEV-VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 29/219 (13%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL-----QRQGASKSFMAECKALKNIRH 287
           +   + +G G F +VYK        +VAIK I L      + G +++ + E K L+ + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N++ ++ +     F      ++V+ +M    LE  +  +++      I+   L  LQ  
Sbjct: 72  PNIIGLLDA-----FGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQ-- 123
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                    L+YLHQH    ILH DLKP+N+LLD +    + DFGL++ + + +      
Sbjct: 124 --------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMV 445
            +    T  Y APE   G+ +   G D+++ G +L E++
Sbjct: 173 VV----TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 114
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 115 -FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLE- 169
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 170 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 69  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 109
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 110 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 161
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 162 PS-SRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 67  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 107
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I DFG S     V  
Sbjct: 108 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-----VHA 159
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 160 PS-SRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 239 IGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVIT 295
           IG G FG V+ G + ++D   VAIK I   R+GA   + F+ E + +  + H  LV++  
Sbjct: 16  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C            +V ++M +G L  +L       R +       TLL    + +DV  
Sbjct: 71  VCLE-----QAPICLVTEFMEHGCLSDYL-------RTQRGLFAAETLL---GMCLDVCE 115
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPV 169
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            + +PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMA 277
           M  K    A + F     +G G FG+VY     +   ++A+KV+    L++ G       
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E +   ++RH N++R+        F       ++ +Y P G++ +              E
Sbjct: 61  EVEIQSHLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------E 101
Query: 338 IQKLTLL--QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           +QKL+    QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I +FG S
Sbjct: 102 LQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS 158
Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                V  P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 159 -----VHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K     +M   +L        IP         
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDLKT----FMDASALT------GIP--------- 104
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 105 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 158
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 159 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 39/232 (16%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKN 284
           L + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK 
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 285 IRHKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           + H N+V+++    +        +F   D K     +M   +L        IP       
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLK----DFMDASALT------GIP------- 103
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
              L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +
Sbjct: 104 ---LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 155
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                      +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 GVPVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 39/232 (16%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKN 284
           L + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK 
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 285 IRHKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           + H N+V+++    +        +F   D K     +M   +L        IP       
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFLSMDLK----DFMDASALT------GIP------- 104
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
              L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +
Sbjct: 105 ---LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF 156
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                      +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 157 GVPVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASK 273
           AL +M  +      D F     +G G FG+VY     ++  ++A+KV+    L+++G   
Sbjct: 2   ALAEMPKRKF--TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH 59
Query: 274 SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD 333
               E +   ++RH N++R+        F       ++ ++ P G L K L      +  
Sbjct: 60  QLRREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQ-----KHG 109
Query: 334 REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL 393
           R  E +  T ++      ++A AL Y H+     ++H D+KP N+L+       I DFG 
Sbjct: 110 RFDEQRSATFME------ELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGW 160
Query: 394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           S     V  P++       GT+ Y+ PE   G       D++  G+L  E +    P D
Sbjct: 161 S-----VHAPSLRRRXMC-GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 39/230 (16%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIR 286
           + + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 287 HKNLVRVITSCSS-------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           H N+V+++    +        +F   D K     +M   +L        IP         
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLK----DFMDASALT------GIP--------- 101
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L L++  S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  
Sbjct: 102 -LPLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGV 155
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
                    +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 156 PVRTYXHEVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGL+R  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 33/218 (15%)
Query: 238 LIGVGSFGSVYKGVFDEDGTV---VAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR- 292
           +IG G FG V  G     G     VAIK + +   +   + F+ E   +    H N++  
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 293 --VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTLLQRISI 349
             V+T    V         IV +YM NGSL+ +L      + D +   IQ + +L+ IS 
Sbjct: 89  EGVVTKSKPV--------MIVTEYMENGSLDTFLK-----KNDGQFTVIQLVGMLRGISA 135
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-SS 408
            +   S + Y+H+         DL   NIL++++L   + DFGLSR  +   +P  + ++
Sbjct: 136 GMKYLSDMGYVHR---------DLAARNILINSNLVCKVSDFGLSRVLE--DDPEAAYTT 184
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE     + ++  DV+SYGI++ E+V+
Sbjct: 185 RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 103/239 (43%), Gaps = 30/239 (12%)
Query: 217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASK 273
           AL +M  +      D F     +G G FG+VY     ++  ++A+KV+    L+++G   
Sbjct: 3   ALAEMPKRKF--TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH 60
Query: 274 SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD 333
               E +   ++RH N++R+        F       ++ ++ P G L K L      +  
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQ-----KHG 110
Query: 334 REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL 393
           R  E +  T ++      ++A AL Y H+     ++H D+KP N+L+       I DFG 
Sbjct: 111 RFDEQRSATFME------ELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGW 161
Query: 394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           S     V  P++       GT+ Y+ PE   G       D++  G+L  E +    P D
Sbjct: 162 S-----VHAPSLRRRXMC-GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/131 (37%), Positives = 70/131 (53%), Gaps = 2/131 (1%)
Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N  +G IP  + + S L  SL+L+ N+  G+IP  +G+L  LR   +  N L GEIP EL
Sbjct: 401 NGFTGKIPPTLSNCSELV-SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 459
Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
               +LE + L  N   G IPS       +  + LS N L+G+IP ++  L +L  L LS
Sbjct: 460 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 519
Query: 123 FNDFEGKVPTK 133
            N F G +P +
Sbjct: 520 NNSFSGNIPAE 530

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV +YM NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGL R  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNI 285
           A + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL- 344
           RH N++R+        F       ++ +Y P G++ +              E+QKL+   
Sbjct: 68  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSKFD 108
Query: 345 -QRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
            QR +  I ++A+AL Y H    + ++H D+KP N+LL +     I +FG S     V  
Sbjct: 109 EQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-----VHA 160
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           P+ S    + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 161 PS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
            ++G G FG   K    E G V+ +K +    +   ++F+ E K ++ + H N+++ I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI-- 73
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
              V ++      I  +Y+  G+L        I   D +         QR+S A D+AS 
Sbjct: 74  --GVLYKDKRLNFIT-EYIKGGTLR-----GIIKSMDSQYPWS-----QRVSFAKDIASG 120
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY----------QAVSNPTVS 406
           + YLH      I+H DL   N L+  + +  + DFGL+R            +++  P   
Sbjct: 121 MAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
               V G   ++APE   G       DV+S+GI+L E++
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGA-SKSFMAECKALKNIR 286
           +D +    ++G G    V+      D   VA+KV+  +L R  +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H  +V V  +  + +        IV +Y+   +L   +H +             +T  + 
Sbjct: 71  HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG-----------PMTPKRA 118
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I +  D   AL++ HQ+    I+H D+KP+NI++    +  + DFG++R      N +V+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVT 174
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +  V GT  Y++PE   G  V    DVYS G +L E++T + P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGA-SKSFMAECKALKNIR 286
           +D +    ++G G    V+      D   VA+KV+  +L R  +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H  +V V  +  + +        IV +Y+   +L   +H +             +T  + 
Sbjct: 71  HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG-----------PMTPKRA 118
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I +  D   AL++ HQ+    I+H D+KP+NI++    +  + DFG++R      N +V+
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVT 174
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +  V GT  Y++PE   G  V    DVYS G +L E++T + P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 109/224 (48%), Gaps = 31/224 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA---IPQRDREIEIQKLTLLQ 345
           N+V+++    +      +   +V++++ +  L+ ++   A   IP          L L++
Sbjct: 62  NIVKLLDVIHT-----ENKLYLVFEHV-HQDLKTFMDASALTGIP----------LPLIK 105
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
             S    +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +  V   T 
Sbjct: 106 --SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTY 159
Query: 406 SSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTK 448
           +  +    T+ Y APE  LG +  ST  D++S G +  EMVT +
Sbjct: 160 THEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/131 (37%), Positives = 70/131 (53%), Gaps = 2/131 (1%)
Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N  +G IP  + + S L  SL+L+ N+  G+IP  +G+L  LR   +  N L GEIP EL
Sbjct: 404 NGFTGKIPPTLSNCSELV-SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
               +LE + L  N   G IPS       +  + LS N L+G+IP ++  L +L  L LS
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 123 FNDFEGKVPTK 133
            N F G +P +
Sbjct: 523 NNSFSGNIPAE 533

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 25/212 (11%)
Query: 239 IGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           IG G FG V+ G + ++D   VAIK I  +   +   F+ E + +  + H  LV++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKDK--VAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                       +V+++M +G L  +L       R +       TLL    + +DV   +
Sbjct: 92  LE-----QAPICLVFEFMEHGCLSDYL-------RTQRGLFAAETLL---GMCLDVCEGM 136
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  + +
Sbjct: 137 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVKW 190
Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            +PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 191 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGA-SKSFMAECKALKNIR 286
           +D +    ++G G    V+      D   VA+KV+  +L R  +    F  E +    + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H  +V V  +  + +        IV +Y+   +L   +H +             +T  + 
Sbjct: 71  HPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEG-----------PMTPKRA 118
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I +  D   AL++ HQ+    I+H D+KP+NIL+    +  + DFG++R   A S  +V 
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVX 174
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +  V GT  Y++PE   G  V    DVYS G +L E++T + P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 77  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 130
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R       
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE--- 184
Query: 403 PTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 185 -TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 21/226 (9%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 68  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 121
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R       
Sbjct: 122 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE--- 175
Query: 403 PTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 176 -TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 74  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 127
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 128 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 181
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 182 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 70  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 123
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 177
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 178 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 83  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 136
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 137 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 190
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 191 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 76  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 129
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 183
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 184 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 40/226 (17%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVR- 292
           + +GVG+FG V  G  +  G  VA+K++N Q+            E + LK  RH ++++ 
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 293 --VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
             VI++ S +         +V +Y+  G L      D I +  R  E +   L Q+I   
Sbjct: 82  YQVISTPSDI--------FMVMEYVSGGELF-----DYICKNGRLDEKESRRLFQQI--- 125
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
               S +DY H+H    ++H DLKP N+LLD  ++A I DFGLS          +S    
Sbjct: 126 ---LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM--------MSDGEF 171
Query: 411 VRGTIG---YVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD 452
           +R + G   Y APE   G        D++S G++L  ++    P D
Sbjct: 172 LRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 77  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 130
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 131 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 184
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 185 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G G FG+VY     +   ++A+KV+    L++ G       E +   ++RH N++R+  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL--QRISIAI-D 352
                 F       ++ +Y P G++ +              E+QKL+    QR +  I +
Sbjct: 80  Y-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSRFDEQRTATYITE 120
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A+AL Y H    + ++H D+KP N+LL ++    I DFG S     V  P+ S    + 
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-----VHAPS-SRRTTLC 171
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT+ Y+ PE   G       D++S G+L  E +    P
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 105 KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 158
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 159 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 212
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 213 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 239 IGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVIT 295
           IG G FG V+ G + ++D   VAIK I   R+GA   + F+ E + +  + H  LV++  
Sbjct: 15  IGSGQFGLVHLGYWLNKDK--VAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
            C            +V+++M +G L  +L       R +       TLL    + +DV  
Sbjct: 70  VCLE-----QAPICLVFEFMEHGCLSDYL-------RTQRGLFAAETLL---GMCLDVCE 114
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            + YL +     ++H DL   N L+  +    + DFG++RF   V +   +SS G +  +
Sbjct: 115 GMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPV 168
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
            + +PE    S  S+  DV+S+G+L+ E+ +  K
Sbjct: 169 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           ++G G++G VY G    +   +AIK I  +    S+    E    K+++HKN+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F  N F  I  + +P GSL   L     P +D E  I   T          +   L
Sbjct: 88  ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK--------QILEGL 135
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSA--HIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            YLH +    I+H D+K  N+L+ N  S    I DFG S+    + NP   +     GT+
Sbjct: 136 KYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGI-NPCTET---FTGTL 187
Query: 416 GYVAPE--------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y+APE        YG  +      D++S G  ++EM T K P
Sbjct: 188 QYMAPEIIDKGPRGYGKAA------DIWSLGCTIIEMATGKPP 224

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 109/227 (48%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 76  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 129
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 130 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 183
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 184 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR 286
           L   D +     +G G+FG VYK    E   + A KVI+ + +   + +M E   L +  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-LTLLQ 345
           H N+V+++ +     F   +   I+ ++   G++      DA+      +E+++ LT  Q
Sbjct: 93  HPNIVKLLDA-----FYYENNLWILIEFCAGGAV------DAVM-----LELERPLTESQ 136
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
              +      AL+YLH +    I+H DLK  NIL   D    + DFG+S    A +  T+
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTI 189
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTN------GDVYSYGILLLEMVTTKKP 450
                  GT  ++APE  +  E S +       DV+S GI L+EM   + P
Sbjct: 190 QRRDSFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV + M NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           ++G G++G VY G    +   +AIK I  +    S+    E    K+++HKN+V+ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 73
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F  N F  I  + +P GSL   L     P +D E  I   T          +   L
Sbjct: 74  ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK--------QILEGL 121
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSA--HIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            YLH +    I+H D+K  N+L+ N  S    I DFG S+    + NP   +     GT+
Sbjct: 122 KYLHDN---QIVHRDIKGDNVLI-NTYSGVLKISDFGTSKRLAGI-NPCTET---FTGTL 173
Query: 416 GYVAPEY------GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y+APE       G G       D++S G  ++EM T K P
Sbjct: 174 QYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 210

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+  ED  + VA+K++        K + M+E K + ++ +H+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            ++ +C+     G     ++ +Y   G L  +L   A    D+E + + L L   +  + 
Sbjct: 106 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKE-DGRPLELRDLLHFSS 159
Query: 352 DVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            VA  + +L  ++C    +H D+   N+LL N   A IGDFGL+R     SN  V  +  
Sbjct: 160 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 213
Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 214 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++        + IR   +
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--------QIIRELQV 76
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 77  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 126
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 127 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 182
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 183 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 41/229 (17%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL-QRQGAS------KSFMAECKALKNIRHKNLV 291
           IG G FG V+KG   +D +VVAIK + L   +G +      + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++           ++   +V +++P G L   L   A P          +    ++ + +
Sbjct: 87  KLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKAHP----------IKWSVKLRLML 129
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDN-----DLSAHIGDFGLSRFYQAVSNPTVS 406
           D+A  ++Y+ Q+   PI+H DL+  NI L +      + A + DFGLS+        +V 
Sbjct: 130 DIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------QSVH 181
Query: 407 SSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKPTD 452
           S  G+ G   ++APE  +G+E    +   D YS+ ++L  ++T + P D
Sbjct: 182 SVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 235 STNLIGVGSFGSVYKGVF-DEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNL 290
           S  +IG G FG VY G + D+    +   + +L R       ++F+ E   ++ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           + +I     +         ++  YM +G L +++     PQR+        T+   IS  
Sbjct: 85  LALI----GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNP-------TVKDLISFG 130
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + VA  ++YL    ++  +H DL   N +LD   +  + DFGL+R        +V     
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            R  + + A E       +T  DV+S+G+LL E++T   P
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++ +        IR   +
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 84
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 85  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 134
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 135 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 191 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++        + IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--------QIIRELQV 57
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 107
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 108 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 164 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++        + IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--------QIIRELQV 57
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 107
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 108 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 164 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++        + IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--------QIIRELQV 57
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 107
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 108 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 164 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++        + IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--------QIIRELQV 57
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 107
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 108 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 164 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 34/218 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G G FG+VY     +   ++A+KV+    L++ G       E +   ++RH N++R+  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL--QRISIAI-D 352
                 F       ++ +Y P G++ +              E+QKL+    QR +  I +
Sbjct: 80  Y-----FHDATRVYLILEYAPLGTVYR--------------ELQKLSRFDEQRTATYITE 120
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A+AL Y H    + ++H D+KP N+LL ++    I DFG S     V  P+ S    + 
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-----VHAPS-SRRDTLC 171
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT+ Y+ PE   G       D++S G+L  E +    P
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 20/216 (9%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+  ED  + VA+K++        K + M+E K + ++ +H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            ++ +C+     G     ++ +Y   G L  +L   A    D+E + + L L   +  + 
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKE-DGRPLELRDLLHFSS 167
Query: 352 DVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            VA  + +L  ++C    +H D+   N+LL N   A IGDFGL+R     SN  V  +  
Sbjct: 168 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN-- 221
Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 222 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 42  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV + M NGSL+ +L         R+ + Q
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFL---------RKHDAQ 143
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 144 -FTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLE- 198
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 199 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++ +        IR   +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 57
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 58  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 107
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 108 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 164 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 110/228 (48%), Gaps = 32/228 (14%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINL-QRQGASKSFMAECKAL 282
           L AT+  S   ++G G FG V  G      +    VAIK + +   +   + F+ E   +
Sbjct: 13  LDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 283 KNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
               H N++R   V+T    V         IV + M NGSL+ +L         R+ + Q
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFL---------RKHDAQ 114
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
             T++Q + +   +AS + YL        +H DL   NIL++++L   + DFGLSR  + 
Sbjct: 115 -FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLE- 169
Query: 400 VSNPTVS-SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +P  + ++ G +  I + +PE     + ++  DV+SYGI+L E+++
Sbjct: 170 -DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++ +        IR   +
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI--------IRELQV 119
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 120 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 169
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 170 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 225
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 226 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P+ +    +   +
Sbjct: 70  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPS 123
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N  +  D +  IGDFG++R  Y+   
Sbjct: 124 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE--- 177
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 178 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V+K      G V+A K+I+L+ + A ++        + IR   +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--------QIIRELQV 60
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP++          +L 
Sbjct: 61  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ----------ILG 110
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  +  I+H D+KPSNIL+++     + DFG+S +    ++N  
Sbjct: 111 KVSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF 166
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 167 V-------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           + F   NL+G GSF  VY+      G  VAIK+I+   + + G  +    E K    ++H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            +++ +        F+ +++  +V +   NG + ++L     P  + E            
Sbjct: 71  PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR---------- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                + + + YLH H    ILH DL  SN+LL  +++  I DFGL+   +       + 
Sbjct: 116 HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT- 171
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              + GT  Y++PE    S      DV+S G +   ++  + P D
Sbjct: 172 ---LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 36/252 (14%)
Query: 205 PSRQPSEPMIRKALL-KMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIK- 262
           P  QP     +KAL   M Y +L      F     IG G F  VY+     DG  VA+K 
Sbjct: 14  PQFQP-----QKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 263 --VINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSL 320
             + +L    A    + E   LK + H N+++   S     F  ++   IV +    G L
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGDL 119
Query: 321 EKWLHPDAIPQRDREIEIQKLTLLQRI--SIAIDVASALDYLHQHCQEPILHCDLKPSNI 378
            + +         +  + QK  + +R      + + SAL+++H      ++H D+KP+N+
Sbjct: 120 SRMI---------KHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANV 167
Query: 379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYG 438
            +       +GD GL RF+ +      +++  + GT  Y++PE    +  +   D++S G
Sbjct: 168 FITATGVVKLGDLGLGRFFSS----KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG 223
Query: 439 ILLLEMVTTKKP 450
            LL EM   + P
Sbjct: 224 CLLYEMAALQSP 235

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 86
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 87  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALE 131
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 132 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGTPYWM 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EM+  + P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P       +   +
Sbjct: 83  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPS 136
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 137 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 190
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 191 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 86  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALE 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGTPYWM 183
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EM+  + P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 86  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALE 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWM 183
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EM+  + P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 86  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALE 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H D+K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSEMVGTPYWM 183
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EM+  + P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR 286
           L   D +     +G G+FG VYK    E   + A KVI+ + +   + +M E   L +  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-LTLLQ 345
           H N+V+++ +     F   +   I+ ++   G++      DA+      +E+++ LT  Q
Sbjct: 93  HPNIVKLLDA-----FYYENNLWILIEFCAGGAV------DAVM-----LELERPLTESQ 136
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
              +      AL+YLH +    I+H DLK  NIL   D    + DFG+S    A +   +
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXI 189
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTN------GDVYSYGILLLEMVTTKKP 450
                  GT  ++APE  +  E S +       DV+S GI L+EM   + P
Sbjct: 190 QRRDSFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDG---TVVAIKVINL-QRQGASKSFMAECKALKNIRHKNLVR 292
            +IG G FG V  G     G     VAIK + +   +   + F+ E   +    H N+V 
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVH 108
Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
              V+T    V         IV ++M NG+L+ +L      + D      + T++Q + +
Sbjct: 109 LEGVVTRGKPV--------MIVIEFMENGALDAFLR-----KHD-----GQFTVIQLVGM 150
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP-TVSSS 408
              +A+ + YL        +H DL   NIL++++L   + DFGLSR  +   +P  V ++
Sbjct: 151 LRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIE--DDPEAVYTT 205
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  + + APE     + ++  DV+SYGI++ E+++
Sbjct: 206 TGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G +VA+K +        +S +  E   L+ + H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C     QG     +V +Y+P GSL      D +P+         + L Q +  A  +
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLR-----DYLPR-------HSIGLAQLLLFAQQI 126
Query: 354 ASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
              + YLH QH     +H +L   N+LLDND    IGDFGL++     + P       VR
Sbjct: 127 CEGMAYLHSQH----YIHRNLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVR 177
Query: 413 ----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 + + APE     +     DV+S+G+ L E++T
Sbjct: 178 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 41/229 (17%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL-QRQGAS------KSFMAECKALKNIRHKNLV 291
           IG G FG V+KG   +D +VVAIK + L   +G +      + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++           ++   +V +++P G L   L   A P          +    ++ + +
Sbjct: 87  KLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKAHP----------IKWSVKLRLML 129
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDN-----DLSAHIGDFGLSRFYQAVSNPTVS 406
           D+A  ++Y+ Q+   PI+H DL+  NI L +      + A + DFG        S  +V 
Sbjct: 130 DIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG-------TSQQSVH 181
Query: 407 SSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKPTD 452
           S  G+ G   ++APE  +G+E    +   D YS+ ++L  ++T + P D
Sbjct: 182 SVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G +VA+K +        +S +  E   L+ + H+++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C     QG     +V +Y+P GSL      D +P+         + L Q +  A  +
Sbjct: 82  KGCCED---QGEKSLQLVMEYVPLGSLR-----DYLPR-------HSIGLAQLLLFAQQI 126
Query: 354 ASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
              + YLH QH     +H +L   N+LLDND    IGDFGL++     + P       VR
Sbjct: 127 CEGMAYLHAQH----YIHRNLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYYRVR 177
Query: 413 ----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 + + APE     +     DV+S+G+ L E++T
Sbjct: 178 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR 286
           L   D +     +G G+FG VYK    E   + A KVI+ + +   + +M E   L +  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-LTLLQ 345
           H N+V+++ +     F   +   I+ ++   G++      DA+      +E+++ LT  Q
Sbjct: 93  HPNIVKLLDA-----FYYENNLWILIEFCAGGAV------DAVM-----LELERPLTESQ 136
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
              +      AL+YLH +    I+H DLK  NIL   D    + DFG+S    A +   +
Sbjct: 137 IQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXI 189
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTN------GDVYSYGILLLEMVTTKKP 450
                  GT  ++APE  +  E S +       DV+S GI L+EM   + P
Sbjct: 190 QRRDXFIGTPYWMAPEVVM-CETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 23/227 (10%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASK-SFMAECKAL 282
           A +  + +  +G GSFG VY+GV      DE  T VAIK +N       +  F+ E   +
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 283 KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           K     ++VR++   S    QG     ++ + M  G L+ +L     P       +   +
Sbjct: 73  KEFNCHHVVRLLGVVS----QGQP-TLVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPS 126
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVS 401
           L + I +A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R  Y+   
Sbjct: 127 LSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--- 180
Query: 402 NPTVSSSIGVRG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             T     G +G   + +++PE       +T  DV+S+G++L E+ T
Sbjct: 181 --TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/248 (29%), Positives = 111/248 (44%), Gaps = 47/248 (18%)
Query: 215 RKALLKMSYKSLLKATDG-FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI----NLQRQ 269
           R+ L K+   SL K  +  F     +G GS+GSVYK +  E G +VAIK +    +LQ  
Sbjct: 12  RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEI 71
Query: 270 GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWLH 325
               S M +C                S   V + G+ FK     IV +Y   GS+     
Sbjct: 72  IKEISIMQQCD---------------SPHVVKYYGSYFKNTDLWIVMEYCGAGSVS---- 112
Query: 326 PDAIPQRDREI-EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL 384
            D I  R++ + E +  T+LQ           L+YLH   +   +H D+K  NILL+ + 
Sbjct: 113 -DIIRLRNKTLTEDEIATILQ------STLKGLEYLHFMRK---IHRDIKAGNILLNTEG 162
Query: 385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTN--GDVYSYGILLL 442
            A + DFG++          ++    V GT  ++APE  +  E+  N   D++S GI  +
Sbjct: 163 HAKLADFGVA----GQLTDXMAKRNXVIGTPFWMAPE--VIQEIGYNCVADIWSLGITAI 216
Query: 443 EMVTTKKP 450
           EM   K P
Sbjct: 217 EMAEGKPP 224

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 19/195 (9%)
Query: 259 VAIKVI--NLQRQGA-SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
           VA+KV+  +L R  +    F  E +    + H  +V V  +  + +        IV +Y+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEA-ETPAGPLPYIVMEYV 98
Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
              +L   +H +             +T  + I +  D   AL++ HQ+    I+H D+KP
Sbjct: 99  DGVTLRDIVHTEG-----------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKP 144
Query: 376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
           +NI++    +  + DFG++R   A S  +V+ +  V GT  Y++PE   G  V    DVY
Sbjct: 145 ANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 436 SYGILLLEMVTTKKP 450
           S G +L E++T + P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRV 293
           +G G FG V    Y    D  G +VA+K +        +S +  E   L+ + H+++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C      G     +V +Y+P GSL      D +P+         + L Q +  A  +
Sbjct: 99  KGCCEDA---GAASLQLVMEYVPLGSLR-----DYLPR-------HSIGLAQLLLFAQQI 143
Query: 354 ASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
              + YLH QH     +H DL   N+LLDND    IGDFGL++     + P       VR
Sbjct: 144 CEGMAYLHAQH----YIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEXYRVR 194
Query: 413 ----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 + + APE     +     DV+S+G+ L E++T
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 35/226 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D F   + +G G+ G V K      G ++A K+I+L+ + A ++ +        IR   +
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQI--------IRELQV 67
Query: 291 VRVITSCSSVDFQGNDFK----AIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLLQ 345
           +    S   V F G  +     +I  ++M  GSL++ L     IP+           +L 
Sbjct: 68  LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE----------ILG 117
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPT 404
           ++SIA  V   L YL +  Q  I+H D+KPSNIL+++     + DFG+S +   +++N  
Sbjct: 118 KVSIA--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 173
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V       GT  Y+APE   G+  S   D++S G+ L+E+   + P
Sbjct: 174 V-------GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 41/229 (17%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL-QRQGAS------KSFMAECKALKNIRHKNLV 291
           IG G FG V+KG   +D +VVAIK + L   +G +      + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++           ++   +V +++P G L   L   A P          +    ++ + +
Sbjct: 87  KLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKAHP----------IKWSVKLRLML 129
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDN-----DLSAHIGDFGLSRFYQAVSNPTVS 406
           D+A  ++Y+ Q+   PI+H DL+  NI L +      + A + DF LS+        +V 
Sbjct: 130 DIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-------QSVH 181
Query: 407 SSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKPTD 452
           S  G+ G   ++APE  +G+E    +   D YS+ ++L  ++T + P D
Sbjct: 182 SVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 19/195 (9%)
Query: 259 VAIKVI--NLQRQGA-SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
           VA+KV+  +L R  +    F  E +    + H  +V V  +  + +        IV +Y+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 98
Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
              +L   +H +             +T  + I +  D   AL++ HQ+    I+H D+KP
Sbjct: 99  DGVTLRDIVHTEG-----------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKP 144
Query: 376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
           +NI++    +  + DFG++R      N +V+ +  V GT  Y++PE   G  V    DVY
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 436 SYGILLLEMVTTKKP 450
           S G +L E++T + P
Sbjct: 204 SLGCVLYEVLTGEPP 218

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+        + +            + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----------IT 57
Query: 293 VITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L P  +       E Q  T+L+
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILR 111
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                 ++   LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 112 ------EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI 159
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 160 KRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 28/238 (11%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSF 275
           M+   +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  
Sbjct: 3   MALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 276 MAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDRE 335
           + E   + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDN 110
Query: 336 IEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           I  Q L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++
Sbjct: 111 IGSQYL-----LNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 162
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
              A      +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 163 LLGAEEKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 209 PSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR 268
           PS     +ALL+     +LK T+ F    ++G G+FG+VYKG++  +G  V I V  ++ 
Sbjct: 33  PSGEAPNQALLR-----ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMEL 86
Query: 269 QGAS-----KSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW 323
           + A+     K  + E   + ++ + ++ R++  C +   Q      ++ + MP G L   
Sbjct: 87  REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-- 138
Query: 324 LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND 383
              D + +    I  Q L     ++  + +A  ++YL       ++H DL   N+L+   
Sbjct: 139 ---DYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP 187
Query: 384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
               I DFGL++   A      +   G +  I ++A E  L    +   DV+SYG+ + E
Sbjct: 188 QHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 245
Query: 444 MVT-TKKPTD 452
           ++T   KP D
Sbjct: 246 LMTFGSKPYD 255

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 116/250 (46%), Gaps = 33/250 (13%)
Query: 209 PSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQ 267
           PS     +ALL+     +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   
Sbjct: 3   PSGEAPNQALLR-----ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL 56
Query: 268 RQG----ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW 323
           R+     A+K  + E   + ++ + ++ R++  C +   Q      ++ + MP G L   
Sbjct: 57  REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-- 108
Query: 324 LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND 383
              D + +    I  Q L     ++  + +A  ++YL       ++H DL   N+L+   
Sbjct: 109 ---DYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTP 157
Query: 384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
               I DFGL++   A      +   G +  I ++A E  L    +   DV+SYG+ + E
Sbjct: 158 QHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 215
Query: 444 MVT-TKKPTD 452
           ++T   KP D
Sbjct: 216 LMTFGSKPYD 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+        + +            + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----------IT 57
Query: 293 VITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L P  +       E Q  T+L+
Sbjct: 58  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILR 111
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                 ++   LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 112 ------EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI 159
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 160 KRNXFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 19/195 (9%)
Query: 259 VAIKVI--NLQRQGA-SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
           VA+KV+  +L R  +    F  E +    + H  +V V  +  + +        IV +Y+
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLPYIVMEYV 115
Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
              +L   +H +             +T  + I +  D   AL++ HQ+    I+H D+KP
Sbjct: 116 DGVTLRDIVHTEG-----------PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKP 161
Query: 376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
           +NI++    +  + DFG++R   A S  +V+ +  V GT  Y++PE   G  V    DVY
Sbjct: 162 ANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 220
Query: 436 SYGILLLEMVTTKKP 450
           S G +L E++T + P
Sbjct: 221 SLGCVLYEVLTGEPP 235

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 14/214 (6%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG GS+G   K     DG ++  K ++     +   +  ++E   L+ ++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
              +D + N    IV +Y   G L        I +  +E +      + R+   + +A  
Sbjct: 74  I--ID-RTNTTLYIVMEYCEGGDL-----ASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
             +        +LH DLKP+N+ LD   +  +GDFGL+R    + N   S +    GT  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKAFVGTPY 181
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y++PE       +   D++S G LL E+     P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 114/245 (46%), Gaps = 44/245 (17%)
Query: 225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKN 284
           SL  A+D F    ++G G+FG V K     D    AIK I    +  S + ++E   L +
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLAS 58
Query: 285 IRHKNLVR----------VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           + H+ +VR           +   ++V  +   F  I  +Y  NG+L   +H + + Q+  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLF--IQMEYCENGTLYDLIHSENLNQQRD 116
Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           E       L ++I        AL Y+H    + I+H DLKP NI +D   +  IGDFGL+
Sbjct: 117 EY----WRLFRQI------LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 395 R-FYQAV------------SNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGIL 440
           +  ++++            S+  ++S+I   GT  YVA E   G+   +   D+YS GI+
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAI---GTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 441 LLEMV 445
             EM+
Sbjct: 221 FFEMI 225

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 86
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +Y+  GSL   +    + +             Q  ++  +   AL+
Sbjct: 87  ---YLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQALE 131
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           +LH +    ++H ++K  NILL  D S  + DFG    + A   P  S    + GT  ++
Sbjct: 132 FLHSN---QVIHRNIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWM 184
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+ +EM+  + P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDG---TVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNL 290
            +IG G  G V  G     G     VAIK +     +RQ   + F++E   +    H N+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ--RRDFLSEASIMGQFDHPNI 112
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRISI 349
           +R+      V  +G     IV +YM NGSL+ +L        D +  I +L  +L+ +  
Sbjct: 113 IRL----EGVVTRGR-LAMIVTEYMENGSLDTFLR-----THDGQFTIMQLVGMLRGVGA 162
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-SS 408
            +   S L Y+H+         DL   N+L+D++L   + DFGLSR  +   +P  + ++
Sbjct: 163 GMRYLSDLGYVHR---------DLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAXTT 211
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE       S+  DV+S+G+++ E++ 
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 31/228 (13%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+  ED  + VA+K++        K + M+E K + ++ +H+N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSL--------EKWLHPDAIPQRDRE----IEIQ 339
            ++ +C+     G     ++ +Y   G L        E  L P   P +D E     + +
Sbjct: 99  NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGR 153
Query: 340 KLTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
            L L   +  +  VA  + +L  ++C    +H D+   N+LL N   A IGDFGL+R   
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIM 209
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             SN  V  +   R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 210 NDSNYIVKGN--ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+        + +            + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----------IT 72
Query: 293 VITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L P  +       E Q  T+L+
Sbjct: 73  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILR 126
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                 ++   LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 127 ------EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI 174
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 175 KRNXFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNL 290
           +G G FG V    Y    D  G +VA+K +   ++G        +  E + L+ + H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V+    C     QG     +V +Y+P GSL      D +P+         + L Q +  A
Sbjct: 73  VKYKGCCED---QGEKSVQLVMEYVPLGSLR-----DYLPR-------HCVGLAQLLLFA 117
Query: 351 IDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             +   + YLH QH     +H  L   N+LLDND    IGDFGL++     + P      
Sbjct: 118 QQICEGMAYLHAQH----YIHRALAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYY 168
Query: 410 GVR----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            VR      + + APE     +     DV+S+G+ L E++T
Sbjct: 169 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 237 NLIGVGSFGSVYKGVFDEDG---TVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNL 290
            +IG G  G V  G     G     VAIK +     +RQ   + F++E   +    H N+
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ--RRDFLSEASIMGQFDHPNI 112
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRISI 349
           +R+      V  +G     IV +YM NGSL+ +L        D +  I +L  +L+ +  
Sbjct: 113 IRL----EGVVTRGR-LAMIVTEYMENGSLDTFLR-----THDGQFTIMQLVGMLRGVGA 162
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-SS 408
            +   S L Y+H+         DL   N+L+D++L   + DFGLSR  +   +P  + ++
Sbjct: 163 GMRYLSDLGYVHR---------DLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTT 211
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            G +  I + APE       S+  DV+S+G+++ E++ 
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 40/221 (18%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNL 290
           +G G FG V    Y    D  G +VA+K +   ++G        +  E + L+ + H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKAL---KEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V+    C     QG     +V +Y+P GSL      D +P+         + L Q +  A
Sbjct: 74  VKYKGCCED---QGEKSVQLVMEYVPLGSLR-----DYLPR-------HCVGLAQLLLFA 118
Query: 351 IDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             +   + YLH QH     +H  L   N+LLDND    IGDFGL++     + P      
Sbjct: 119 QQICEGMAYLHAQH----YIHRALAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEYY 169
Query: 410 GVR----GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            VR      + + APE     +     DV+S+G+ L E++T
Sbjct: 170 RVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G+V+K    E   +VA+K + L    +G   S + E   LK ++HKN+VR+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--- 66
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
               D   +D K  +     +  L+K+   D+    D + EI K  L Q       +   
Sbjct: 67  ---HDVLHSDKKLTLVFEFCDQDLKKYF--DSC-NGDLDPEIVKSFLFQ-------LLKG 113
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           L + H      +LH DLKP N+L++ +    + DFGL+R   A   P    S  V  T+ 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLAR---AFGIPVRCYSAEV-VTLW 166
Query: 417 YVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           Y  P+   G+++ ST+ D++S G +  E+    +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 37/225 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+        + +            + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE-----------IT 77
Query: 293 VITSCSS---VDFQGNDFK----AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L P  +       E Q  T+L+
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD------ETQIATILR 131
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            I         LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 132 EI------LKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDTQI 179
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 180 KRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGV 411
           +A  + YL+    +  +H DL   N ++ +D +  IGDFG++R  Y+     T     G 
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TAYYRKGG 190
Query: 412 RG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 121
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 122 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 174 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 119
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 120 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 172 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 118
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 119 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 171 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 12  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGXLL-----DYVREHKDNIGSQY 119
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 120 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 172 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 14/214 (6%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG GS+G   K     DG ++  K ++     +   +  ++E   L+ ++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
              +D + N    IV +Y   G L        I +  +E +      + R+   + +A  
Sbjct: 74  I--ID-RTNTTLYIVMEYCEGGDL-----ASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
             +        +LH DLKP+N+ LD   +  +GDFGL+R    + N   S +    GT  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDTSFAKTFVGTPY 181
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y++PE       +   D++S G LL E+     P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+  ED  + VA+K++        K + M+E K + ++ +H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQR--IS 348
            ++ +C+     G     ++ +Y   G L  +L   + + + D    I   TL  R  + 
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            +  VA  + +L     +  +H D+   N+LL N   A IGDFGL+R     SN  V  +
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
              R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 226 --ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 76/164 (46%), Gaps = 13/164 (7%)
Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N +SG IP++  S S L  S+ ++ N   G IPP   NL  L   D+S N L G+  +  
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLF 217
Query: 64  GLCSSLEDIYLGGN---FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYL 119
           G   + + I+L  N   F  G +      S+ +  LDL  N + G +P  L  L  L  L
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKV----GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 120 NLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCT 163
           N+SFN+  G++P  G        + A    LCG      LP CT
Sbjct: 274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS----PLPACT 313

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 118
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 119 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 171 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 121
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 122 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 174 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 120
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 121 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 173 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 21  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 128
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 129 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 181 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 121
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 122 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 174 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 125
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 126 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 178 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 14  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 121
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 122 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 174 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 17  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 124
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 125 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 176
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 177 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 118
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 119 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 171 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 112
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 113 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 165 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 120
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 121 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 173 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 239 IGVGSFGSVYKGVFDEDGTV---VAIKVINL---QRQGASKSFMAECKALKNIRHKNLVR 292
           +G G   +VY     ED  +   VAIK I +   +++   K F  E      + H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +I     VD + +D   +V +Y+   +L +++                L++   I+    
Sbjct: 76  MI----DVD-EEDDCYYLVMEYIEGPTLSEYIESHG-----------PLSVDTAINFTNQ 119
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   + + H      I+H D+KP NIL+D++ +  I DFG+++   A+S  +++ +  V 
Sbjct: 120 ILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVL 173
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT+ Y +PE   G       D+YS GI+L EM+  + P
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGXLL-----DYVREHKDNIGSQY 118
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 119 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 171 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 36  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 143
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 144 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 196 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A  + YL+    +  +H DL   N ++ +D +  IGDFG++R        T     G +
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE----TDXXRKGGK 191
Query: 413 G--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 82  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A  + YL+    +  +H DL   N ++ +D +  IGDFG++R        T     G +
Sbjct: 136 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE----TDXXRKGGK 188
Query: 413 G--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 189 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A  + YL+    +  +H DL   N ++ +D +  IGDFG++R        T     G +
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE----TDXXRKGGK 191
Query: 413 G--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 104/234 (44%), Gaps = 16/234 (6%)
Query: 219 LKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGASKS--- 274
           LK   + +L     F+   ++G G FGSV +     EDG+ V + V  L+    + S   
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 275 -FMAECKALKNIRHKNLVRVITSCSSVDFQGN-DFKAIVYKYMPNGSLEKWLHPDAIPQR 332
            F+ E   +K   H ++ +++        +G      ++  +M +G L  +L    I + 
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 333 DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG 392
              + +Q L     +   +D+A  ++YL        +H DL   N +L  D++  + DFG
Sbjct: 131 PFNLPLQTL-----VRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFG 182
Query: 393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           LSR  +  S          +  + ++A E    +  + + DV+++G+ + E++T
Sbjct: 183 LSR--KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 84  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGV 411
           +A  + YL+    +  +H DL   N ++ +D +  IGDFG++R  Y+     T     G 
Sbjct: 138 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TDYYRKGG 189
Query: 412 RG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 190 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKN 289
           D +    +IG G+   V           VAIK INL++ Q +    + E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V   TS     F   D   +V K +  GS+      D I     + E  K  +L   +I
Sbjct: 75  IVSYYTS-----FVVKDELWLVMKLLSGGSV-----LDIIKHIVAKGE-HKSGVLDESTI 123
Query: 350 AI---DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           A    +V   L+YLH++ Q   +H D+K  NILL  D S  I DFG+S F     + T +
Sbjct: 124 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 407 SSIGVR----GTIGYVAPEYGLGSEVST---NGDVYSYGILLLEMVTTKKP 450
               VR    GT  ++APE  +  +V       D++S+GI  +E+ T   P
Sbjct: 181 K---VRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGV 411
           +A  + YL+    +  +H DL   N ++ +D +  IGDFG++R  Y+     T     G 
Sbjct: 139 IADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-----TDYYRKGG 190
Query: 412 RG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKN 289
           D +    +IG G+   V           VAIK INL++ Q +    + E +A+    H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V   TS     F   D   +V K +  GS+      D I     + E  K  +L   +I
Sbjct: 70  IVSYYTS-----FVVKDELWLVMKLLSGGSV-----LDIIKHIVAKGE-HKSGVLDESTI 118
Query: 350 AI---DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           A    +V   L+YLH++ Q   +H D+K  NILL  D S  I DFG+S F     + T +
Sbjct: 119 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 175
Query: 407 SSIGVR----GTIGYVAPEYGLGSEVST---NGDVYSYGILLLEMVTTKKP 450
               VR    GT  ++APE  +  +V       D++S+GI  +E+ T   P
Sbjct: 176 K---VRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+  + IG GSFG VYKG+ +    VVAIK+I+L+        + +            + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQE-----------IT 69
Query: 293 VITSCSS---VDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K+    I+ +Y+  GS    L P  +       E    T+L+
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLE------ETYIATILR 123
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                 ++   LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 124 ------EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQI 171
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S      D++S GI  +E+   + P
Sbjct: 172 KRNXFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+  ED  + VA+K++        K + M+E K + ++ +H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            ++ +C+     G     ++ +Y   G L  +L      ++ R +E          +IA 
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLR-----RKSRVLETDPA-----FAIAN 158
Query: 352 DVASALDYLHQHCQ----------EPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
             AS  D LH   Q          +  +H D+   N+LL N   A IGDFGL+R     S
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           N  V  +   R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 219 NYIVKGN--ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA---ECKALKNIRHKNLVR--- 292
           +G GSFG V      +    VA+K I+ Q    S   M    E   LK +RH ++++   
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           VIT+ + +         +V +Y   G L      D I ++ R  E +     Q+I  AI+
Sbjct: 77  VITTPTDI--------VMVIEY-AGGELF-----DYIVEKKRMTEDEGRRFFQQIICAIE 122
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
                 Y H+H    I+H DLKP N+LLD++L+  I DFGLS      +    S      
Sbjct: 123 ------YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----- 168
Query: 413 GTIGYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
           G+  Y APE   G   +    DV+S GI+L  M+  + P D
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+FG V+K    + G  VA+K + ++  ++G   + + E K L+ ++H+N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 297 CSSVDFQGNDFKAIVY------KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           C +     N  KA +Y      ++   G L   L               K TL +   + 
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL--------------VKFTLSEIKRVM 131
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             + + L Y+H++    ILH D+K +N+L+  D    + DFGL+R +    N   +    
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 411 VRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
              T+ Y  PE  LG  +     D++  G ++ EM T
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIR 286
           +D +    ++G GSFG V        G   A+KVI    ++++   +S + E + LK + 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N++++        F+   +  +V +    G L      D I  R R  E+    ++++
Sbjct: 91  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-----FDEIISRKRFSEVDAARIIRQ 140
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
                 V S + Y+H++    I+H DLKP N+LL++   D +  I DFGLS  ++A  + 
Sbjct: 141 ------VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SK 189
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            +   I   GT  Y+APE   G+      DV+S G++L
Sbjct: 190 KMKDKI---GTAYYIAPEVLHGT-YDEKCDVWSTGVIL 223

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           + S L++LHQ     I++ DLKP N+LLD+D +  I D GL+   +A    T     G  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK----GYA 350
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT G++APE  LG E   + D ++ G+ L EM+  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           + S L++LHQ     I++ DLKP N+LLD+D +  I D GL+   +A    T     G  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK----GYA 350
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT G++APE  LG E   + D ++ G+ L EM+  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           + S L++LHQ     I++ DLKP N+LLD+D +  I D GL+   +A    T     G  
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK----GYA 350
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT G++APE  LG E   + D ++ G+ L EM+  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           + S L++LHQ     I++ DLKP N+LLD+D +  I D GL+   +A    T     G  
Sbjct: 298 IVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK----GYA 350
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT G++APE  LG E   + D ++ G+ L EM+  + P
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F+    IG GSFG V+KG+ +    VVAIK+I+L+        + +            + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE-----------IT 73
Query: 293 VITSCSS---VDFQGNDFKA----IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           V++ C S     + G+  K     I+ +Y+  GS    L            E Q  T+L+
Sbjct: 74  VLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD------EFQIATMLK 127
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            I         LDYLH    E  +H D+K +N+LL       + DFG++     +++  +
Sbjct: 128 EI------LKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA---GQLTDTQI 175
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  V GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 176 KRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 19/218 (8%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQKLTLLQRIS 348
            ++ +C+     G     IV ++   G+L  +L     + +P +  ++    LTL   I 
Sbjct: 97  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            +  VA  +++L        +H DL   NILL       I DFGL+R      +P     
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRK 207
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
              R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G+V+K    E   +VA+K + L    +G   S + E   LK ++HKN+VR+   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--- 66
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
               D   +D K  +     +  L+K+   D+    D + EI K  L Q       +   
Sbjct: 67  ---HDVLHSDKKLTLVFEFCDQDLKKYF--DSC-NGDLDPEIVKSFLFQ-------LLKG 113
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           L + H      +LH DLKP N+L++ +    + +FGL+R   A   P    S  V  T+ 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLAR---AFGIPVRCYSAEV-VTLW 166
Query: 417 YVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           Y  P+   G+++ ST+ D++S G +  E+    +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           +D +    ++G GSFG V        G   A+KVI+   ++++   +S + E + LK + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N++++        F+   +  +V +    G L      D I  R R  E+    ++++
Sbjct: 85  HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-----FDEIISRKRFSEVDAARIIRQ 134
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
                 V S + Y+H++    I+H DLKP N+LL++   D +  I DFGLS  ++A  + 
Sbjct: 135 ------VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SK 183
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            +   I   GT  Y+APE   G+      DV+S G++L
Sbjct: 184 KMKDKI---GTAYYIAPEVLHGT-YDEKCDVWSTGVIL 217

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 32/220 (14%)
Query: 239 IGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVR 292
           +G G+FGSV +GV+   +    VAIKV+   +QG  K+     M E + +  + +  +VR
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRISIAI 351
           +I  C +          +V +    G L K+L    + +R+ EI +  +  LL ++S+ +
Sbjct: 75  LIGVCQAEALM------LVMEMAGGGPLHKFL----VGKRE-EIPVSNVAELLHQVSMGM 123
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
                 +++H+         DL   N+LL N   A I DFGLS+   A  +   + S G 
Sbjct: 124 KYLEEKNFVHR---------DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG- 173
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT-KKP 450
           +  + + APE     + S+  DV+SYG+ + E ++  +KP
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           +D +    ++G GSFG V        G   A+KVI+   ++++   +S + E + LK + 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N++++        F+   +  +V +    G L      D I  R R  E+    ++++
Sbjct: 108 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-----FDEIISRKRFSEVDAARIIRQ 157
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
                 V S + Y+H++    I+H DLKP N+LL++   D +  I DFGLS  ++A  + 
Sbjct: 158 ------VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SK 206
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            +   I   GT  Y+APE   G+      DV+S G++L
Sbjct: 207 KMKDKI---GTAYYIAPEVLHGT-YDEKCDVWSTGVIL 240

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+FG V+K    + G  VA+K + ++  ++G   + + E K L+ ++H+N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 297 CSSVDFQGNDFKAIVY------KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           C +     N  K  +Y      ++   G L   L               K TL +   + 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------VKFTLSEIKRVM 131
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             + + L Y+H++    ILH D+K +N+L+  D    + DFGL+R +    N   +    
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 411 VRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
              T+ Y  PE  LG  +     D++  G ++ EM T
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 120
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFG ++   A 
Sbjct: 121 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 173 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 35/215 (16%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVR---VI 294
           +G G++ +VYKG       +VA+K I L+  +GA  + + E   LK+++H N+V    +I
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP--DAIPQRDREIEIQKLTLLQRISIAID 352
            +  S+         +V++Y+ +  L+++L    + I   +      KL L Q       
Sbjct: 70  HTEKSL--------TLVFEYL-DKDLKQYLDDCGNIINMHN-----VKLFLFQ------- 108
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   L Y H+   + +LH DLKP N+L++      + DFGL+R   A S PT +    V 
Sbjct: 109 LLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEV- 161
Query: 413 GTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
            T+ Y  P+  LGS + ST  D++  G +  EM T
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 15  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 122
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFG ++   A 
Sbjct: 123 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 174
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 175 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 120
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFG ++   A 
Sbjct: 121 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 173 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           +D +    ++G GSFG V        G   A+KVI+   ++++   +S + E + LK + 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N++++        F+   +  +V +    G L      D I  R R  E+    ++++
Sbjct: 109 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGEL-----FDEIISRKRFSEVDAARIIRQ 158
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
                 V S + Y+H++    I+H DLKP N+LL++   D +  I DFGLS  ++A  + 
Sbjct: 159 ------VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SK 207
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            +   I   GT  Y+APE   G+      DV+S G++L
Sbjct: 208 KMKDKI---GTAYYIAPEVLHGT-YDEKCDVWSTGVIL 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 43/243 (17%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR 286
           L+    F    ++G G+FG V K     D    AIK I    +  S + ++E   L ++ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLN 60
Query: 287 HKNLVR----------VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI 336
           H+ +VR           +   ++V  +   F  I  +Y  N +L   +H + + Q+  E 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLF--IQMEYCENRTLYDLIHSENLNQQRDEY 118
Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR- 395
                 L ++I        AL Y+H    + I+H DLKP NI +D   +  IGDFGL++ 
Sbjct: 119 ----WRLFRQI------LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 396 FYQAV------------SNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLL 442
            ++++            S+  ++S+I   GT  YVA E   G+   +   D+YS GI+  
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAI---GTAMYVATEVLDGTGHYNEKIDMYSLGIIFF 222
Query: 443 EMV 445
           EM+
Sbjct: 223 EMI 225

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++  G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLL-----DYVREHKDNIGSQY 125
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 126 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 178 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+FG V+K    + G  VA+K + ++  ++G   + + E K L+ ++H+N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 297 CSSVDFQGNDFKAIVY------KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           C +     N  K  +Y      ++   G L   L               K TL +   + 
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------VKFTLSEIKRVM 130
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             + + L Y+H++    ILH D+K +N+L+  D    + DFGL+R +    N   +    
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 411 VRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
              T+ Y  PE  LG  +     D++  G ++ EM T
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 18  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 125
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFG ++   A 
Sbjct: 126 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 178 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 14/214 (6%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG GS+G   K     DG ++  K ++     +   +  ++E   L+ ++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
              +D + N    IV +Y   G L        I +  +E +      + R+   + +A  
Sbjct: 74  I--ID-RTNTTLYIVMEYCEGGDL-----ASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
             +        +LH DLKP+N+ LD   +  +GDFGL+R    + N     +    GT  
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR----ILNHDEDFAKEFVGTPY 181
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y++PE       +   D++S G LL E+     P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 33/243 (13%)
Query: 216 KALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG---- 270
           +ALL+     +LK T+      ++G G+FG+VYKG++  DG  V I V I + R+     
Sbjct: 8   QALLR-----ILKETE-LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK 61
Query: 271 ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIP 330
           A+K  + E   +  +    + R++  C +   Q      +V + MP G L      D + 
Sbjct: 62  ANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ------LVTQLMPYGCLL-----DHVR 110
Query: 331 QRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD 390
           +    +  Q L     ++  + +A  + YL       ++H DL   N+L+ +     I D
Sbjct: 111 ENRGRLGSQDL-----LNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITD 162
Query: 391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKK 449
           FGL+R      + T   + G +  I ++A E  L    +   DV+SYG+ + E++T   K
Sbjct: 163 FGLARLLDI--DETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAK 220
Query: 450 PTD 452
           P D
Sbjct: 221 PYD 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+FG VYK    E G + A KVI  + +   + ++ E + L    H  +V+++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 84
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK-LTLLQRISIAIDVASAL 357
              +  +    I+ ++ P G++      DAI      +E+ + LT  Q   +   +  AL
Sbjct: 85  ---YYHDGKLWIMIEFCPGGAV------DAI-----MLELDRGLTEPQIQVVCRQMLEAL 130
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           ++LH    + I+H DLK  N+L+  +    + DFG+S    A +  T+       GT  +
Sbjct: 131 NFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYW 183
Query: 418 VAPEYGLGSEVST-----NGDVYSYGILLLEMVTTKKP 450
           +APE  +   +         D++S GI L+EM   + P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++  G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 18  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 125
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 126 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 178 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 13  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 120
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFG ++   A 
Sbjct: 121 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 173 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRH 287
           D F     +G G FG+VY     +   +VA+KV+    ++++G       E +   ++ H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N++R+        F       ++ +Y P G L K L      Q+    + Q+       
Sbjct: 83  PNILRLYNY-----FYDRRRIYLILEYAPRGELYKEL------QKSCTFDEQRTA----- 126
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           +I  ++A AL Y H    + ++H D+KP N+LL       I DFG S    ++   T+  
Sbjct: 127 TIMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC- 182
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT+ Y+ PE   G   +   D++  G+L  E++    P
Sbjct: 183 -----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+FG V+K    + G  VA+K + ++  ++G   + + E K L+ ++H+N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 297 CSSVDFQGNDFKAIVY------KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           C +     N  K  +Y      ++   G L   L               K TL +   + 
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--------------VKFTLSEIKRVM 131
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             + + L Y+H++    ILH D+K +N+L+  D    + DFGL+R +    N   +    
Sbjct: 132 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 411 VRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT 446
              T+ Y  PE  LG  +     D++  G ++ EM T
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 86  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGV 411
           +A  + YL+    +  +H +L   N ++ +D +  IGDFG++R  Y+     T     G 
Sbjct: 140 IADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-----TDYYRKGG 191
Query: 412 RG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 192 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 34/224 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           D +     +G G++G VYK +       VAIK I L  + +G   + + E   LK ++H+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N++ +     SV    N    ++++Y  N  L+K++  D  P  D  + + K  L Q I 
Sbjct: 94  NIIEL----KSV-IHHNHRLHLIFEYAEN-DLKKYM--DKNP--DVSMRVIKSFLYQLI- 142
Query: 349 IAIDVASALDYLH-QHCQEPILHCDLKPSNILLD-NDLSA----HIGDFGLSRFYQAVSN 402
                 + +++ H + C    LH DLKP N+LL  +D S      IGDFGL+R +     
Sbjct: 143 ------NGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
                 I    T+ Y  PE  LGS   ST+ D++S   +  EM+
Sbjct: 193 QFTHEII----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++G G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 11  ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 118
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFG ++   A 
Sbjct: 119 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 171 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+FG VYK    E G + A KVI  + +   + ++ E + L    H  +V+++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA-- 76
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIP-QRDREIEIQKLTLLQRISIAIDVASAL 357
              +  +    I+ ++ P G++      DAI  + DR +   ++ ++ R      +  AL
Sbjct: 77  ---YYHDGKLWIMIEFCPGGAV------DAIMLELDRGLTEPQIQVVCR-----QMLEAL 122
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           ++LH    + I+H DLK  N+L+  +    + DFG+S    A +  T+       GT  +
Sbjct: 123 NFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYW 175
Query: 418 VAPEYGLGSEVST-----NGDVYSYGILLLEMVTTKKP 450
           +APE  +   +         D++S GI L+EM   + P
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKAL-KNIRHK 288
           F    +IG GSFG V       +    A+KV+    + ++   K  M+E   L KN++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
            LV +  S     FQ  D    V  Y+  G L   L      QR+R        L  R  
Sbjct: 100 FLVGLHFS-----FQTADKLYFVLDYINGGELFYHL------QRER------CFLEPRAR 142
Query: 349 I-AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A ++ASAL YLH      I++ DLKP NILLD+     + DFGL +  + + + + +S
Sbjct: 143 FYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTS 197
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           +    GT  Y+APE           D +  G +L EM+
Sbjct: 198 TFC--GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR 292
           +G GSFG VY+G     +  E  T VA+K +N       +  F+ E   +K     ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   S           +V + M +G L+ +L     P+ +        TL + I +A +
Sbjct: 85  LLGVVSK-----GQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGV 411
           +A  + YL+    +  +H +L   N ++ +D +  IGDFG++R  Y+     T     G 
Sbjct: 139 IADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-----TDYYRKGG 190
Query: 412 RG--TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +G   + ++APE       +T+ D++S+G++L E+ +
Sbjct: 191 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKV-INLQRQG----ASKSFMAECK 280
           +LK T+ F    ++  G+FG+VYKG++  +G  V I V I   R+     A+K  + E  
Sbjct: 11  ILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            + ++ + ++ R++  C +   Q      ++ + MP G L      D + +    I  Q 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLL-----DYVREHKDNIGSQY 118
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L     ++  + +A  ++YL       ++H DL   N+L+       I DFGL++   A 
Sbjct: 119 L-----LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD 452
                +   G +  I ++A E  L    +   DV+SYG+ + E++T   KP D
Sbjct: 171 EKEYHAE--GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P ++   ++ K  LTL   
Sbjct: 97  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 153 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 207
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 208 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQKLTLLQRIS 348
            ++ +C+     G     IV ++   G+L  +L     + +P +D   +   LTL   I 
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDF--LTLEHLIX 148
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            +  VA  +++L        +H DL   NILL       I DFGL+R      +P     
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR--DIYKDPDYVRK 203
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
              R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 242 GSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD 301
           G FG V+K     D   VA+K+  LQ + + +S   E  +   ++H+NL++ I +    +
Sbjct: 26  GRFGCVWKAQLMND--FVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAA----E 78
Query: 302 FQGNDFKA---IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            +G++ +    ++  +   GSL  +L  + I            T  +   +A  ++  L 
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGNII------------TWNELCHVAETMSRGLS 126
Query: 359 YLHQHC--------QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           YLH+          +  I H D K  N+LL +DL+A + DFGL+  ++    P    + G
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPP--GDTHG 184
Query: 411 VRGTIGYVAPEYGLGS-----EVSTNGDVYSYGILLLEMVTTKKPTD 452
             GT  Y+APE   G+     +     D+Y+ G++L E+V+  K  D
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 239 IGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVR 292
           +G G+FGSV +GV+   +    VAIKV+   +QG  K+     M E + +  + +  +VR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT-LLQRISIAI 351
           +I  C +          +V +    G L K+L    + +R+ EI +  +  LL ++S+ +
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFL----VGKRE-EIPVSNVAELLHQVSMGM 449
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
                 +++H+         +L   N+LL N   A I DFGLS+   A  +   + S G 
Sbjct: 450 KYLEEKNFVHR---------NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG- 499
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  + + APE     + S+  DV+SYG+ + E ++
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+  ED  + VA+K++        K + M+E K + ++ +H+N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAI-----PQRDREIEIQKLTL 343
            ++ +C+     G     ++ +Y   G L  +L    P  +     P  + E ++    L
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           L     +  VA  + +L     +  +H D+   N+LL N   A IGDFGL+R     SN 
Sbjct: 169 LH---FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            V  +   R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 223 IVKGN--ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASKS----FMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IIHLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVR--- 292
           ++G GSFG V K          A+KVIN    +   + + + E + LK + H N+++   
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   SS          IV +    G L      D I +R R  E     ++++      
Sbjct: 89  ILEDSSSF--------YIVGELYTGGEL-----FDEIIKRKRFSEHDAARIIKQ------ 129
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           V S + Y+H+H    I+H DLKP NILL++   D    I DFGLS  +Q   N  +   I
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE   G+      DV+S G++L  +++   P
Sbjct: 185 ---GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R    +   
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNID-- 211
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               +   R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 27/220 (12%)
Query: 234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           S T ++G G FG V+K      G  +A K+I  +     +    E   +  + H NL+++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI-EIQKLTLLQRISIAID 352
             +     F+  +   +V +Y+  G L            DR I E   LT L  I     
Sbjct: 152 YDA-----FESKNDIVLVMEYVDGGEL-----------FDRIIDESYNLTELDTILFMKQ 195
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVSSSIG 410
           +   + ++HQ     ILH DLKP NIL  N  +  I   DFGL+R Y+      V+    
Sbjct: 196 ICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--- 249
Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT  ++APE      VS   D++S G++   +++   P
Sbjct: 250 --GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQKLTLLQRIS 348
            ++ +C+     G     IV ++   G+L  +L     + +P +D   +   LTL   I 
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKDF--LTLEHLIC 148
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            +  VA  +++L        +H DL   NILL       I DFGL+R      +P     
Sbjct: 149 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRK 203
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
              R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 204 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 233 FSSTNLIGVGSFGSVY---KGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           F    ++G GSFG V+   K    + G + A+KV+    L+ +   ++ M E   L ++ 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILADVN 88
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAI-PQRDREIEIQKLTLLQ 345
           H  +V++  +     FQ      ++  ++  G L   L  + +  + D +  + +L L  
Sbjct: 89  HPFVVKLHYA-----FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL-- 141
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                      LD+LH      I++ DLKP NILLD +    + DFGLS+  +A+ +   
Sbjct: 142 ----------GLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKK 186
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + S    GT+ Y+APE       S + D +SYG+L+ EM+T   P
Sbjct: 187 AYSFC--GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASKSFMA---ECKALKNIRHKNLV 291
            ++G G FG+V+KGV+  +G  + I V    ++ +   +SF A      A+ ++ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R++  C     Q      +V +Y+P GSL      D + Q    +  Q L     ++  +
Sbjct: 79  RLLGLCPGSSLQ------LVTQYLPLGSLL-----DHVRQHRGALGPQLL-----LNWGV 122
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +A  + YL +H    ++H +L   N+LL +     + DFG++          + S    
Sbjct: 123 QIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--A 177
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I ++A E     + +   DV+SYG+ + E++T
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IITLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R    +   
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNID-- 211
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               +   R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRVITSC 297
           +G G FG V + +  + G  VAIK    +    ++  +  E + +K + H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 298 SSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +     ND   +  +Y   G L K+L+        +E  I+  TLL       D++SA
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR--TLLS------DISSA 134
Query: 357 LDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           L YLH++    I+H DLKP NI+L      L   I D G   + + +    + +     G
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGELCTEFV--G 186
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T+ Y+APE     + +   D +S+G L  E +T  +P
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 21/217 (9%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRVITSC 297
           +G G FG V + +  + G  VAIK    +    ++  +  E + +K + H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 298 SSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +     ND   +  +Y   G L K+L+        +E  I+  TLL       D++SA
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR--TLLS------DISSA 133
Query: 357 LDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           L YLH++    I+H DLKP NI+L      L   I D G   + + +    + +     G
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGELCTEFV--G 185
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T+ Y+APE     + +   D +S+G L  E +T  +P
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G  VA+K ++L++Q   +    E   +++  H N+V + +S  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS-- 110
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L      D +          ++   Q  ++ + V  AL 
Sbjct: 111 ---YLVGDELWVVMEFLEGGALT-----DIVTH-------TRMNEEQIATVCLSVLRALS 155
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YLH    + ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 156 YLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSK-EVPKRKXLVGTPYWM 208
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE        T  D++S GI+++EM+  + P
Sbjct: 209 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVR--- 292
           ++G GSFG V K          A+KVIN    +   + + + E + LK + H N+++   
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   SS          IV +    G L      D I +R R  E     ++++      
Sbjct: 89  ILEDSSSF--------YIVGELYTGGEL-----FDEIIKRKRFSEHDAARIIKQ------ 129
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           V S + Y+H+H    I+H DLKP NILL++   D    I DFGLS  +Q   N  +   I
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE   G+      DV+S G++L  +++   P
Sbjct: 185 ---GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASKSFMA---ECKALKNIRHKNLV 291
            ++G G FG+V+KGV+  +G  + I V    ++ +   +SF A      A+ ++ H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R++  C     Q      +V +Y+P GSL      D + Q    +  Q L     ++  +
Sbjct: 97  RLLGLCPGSSLQ------LVTQYLPLGSLL-----DHVRQHRGALGPQLL-----LNWGV 140
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +A  + YL +H    ++H +L   N+LL +     + DFG++          + S    
Sbjct: 141 QIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE--A 195
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I ++A E     + +   DV+SYG+ + E++T
Sbjct: 196 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVR--- 292
           ++G GSFG V K          A+KVIN    +   + + + E + LK + H N+++   
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++   SS          IV +    G L      D I +R R  E     ++++      
Sbjct: 89  ILEDSSSF--------YIVGELYTGGEL-----FDEIIKRKRFSEHDAARIIKQ------ 129
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           V S + Y+H+H    I+H DLKP NILL++   D    I DFGLS  +Q   N  +   I
Sbjct: 130 VFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI 184
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE   G+      DV+S G++L  +++   P
Sbjct: 185 ---GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KNTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 112/263 (42%), Gaps = 62/263 (23%)
Query: 222 SYKSLLKATDGFSSTNLI-----GVGSFGSVYKGV-FDEDG----TVVAIKVINLQRQGA 271
           ++K L      F   NL+     G G FG V K   F   G    T VA+K++   ++ A
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENA 65
Query: 272 SKS----FMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--- 324
           S S     ++E   LK + H +++++  +CS    Q      IV +Y   GSL  +L   
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPLLLIV-EYAKYGSLRGFLRES 120
Query: 325 --------------------HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
                               HPD           + LT+   IS A  ++  + YL    
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDE----------RALTMGDLISFAWQISQGMQYL---A 167
Query: 365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGVRGTIGYVAPEYG 423
           +  ++H DL   NIL+       I DFGLSR  Y+   +  V  S G R  + ++A E  
Sbjct: 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE--EDSXVKRSQG-RIPVKWMAIESL 224
Query: 424 LGSEVSTNGDVYSYGILLLEMVT 446
                +T  DV+S+G+LL E+VT
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 231 DGFSSTNLIGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKAL 282
           D  +    +G G FG V        D+D    A+ V + + +  A++      ++E + +
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 283 KNI-RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI--- 338
           K I +HKN++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I   
Sbjct: 82  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 339 --QKLTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
             +++T    +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLAR 192
Query: 396 ------FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 +Y+  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 193 DINNIDYYKKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 92  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 147 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 203 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 231 DGFSSTNLIGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASKS----FMAECKAL 282
           D  +    +G G FG V        D+D    A+ V + + +  A++      ++E + +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 283 KNI-RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI--- 338
           K I +HKN++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I   
Sbjct: 141 KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 339 --QKLTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
             +++T    +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 396 ------FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 +Y+  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 252 DINNIDYYKKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G +VA+K +        + F  E + LK +    +V+  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 73
Query: 295 TSCSSVDF-QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR-EIEIQKLTLLQRISIAID 352
                V +  G     +V +Y+P+G L  +L      QR R  ++  +L L      +  
Sbjct: 74  ---RGVSYGPGRPELRLVMEYLPSGCLRDFL------QRHRARLDASRLLL-----YSSQ 119
Query: 353 VASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           +   ++YL  + C    +H DL   NIL++++    I DFGL++      +  V    G 
Sbjct: 120 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG- 174
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I + APE    +  S   DV+S+G++L E+ T
Sbjct: 175 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 112/263 (42%), Gaps = 62/263 (23%)
Query: 222 SYKSLLKATDGFSSTNLI-----GVGSFGSVYKGV-FDEDG----TVVAIKVINLQRQGA 271
           ++K L      F   NL+     G G FG V K   F   G    T VA+K++   ++ A
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENA 65
Query: 272 SKS----FMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--- 324
           S S     ++E   LK + H +++++  +CS    Q      IV +Y   GSL  +L   
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPLLLIV-EYAKYGSLRGFLRES 120
Query: 325 --------------------HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
                               HPD           + LT+   IS A  ++  + YL +  
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDE----------RALTMGDLISFAWQISQGMQYLAEMS 170
Query: 365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGVRGTIGYVAPEYG 423
              ++H DL   NIL+       I DFGLSR  Y+   +  V  S G R  + ++A E  
Sbjct: 171 ---LVHRDLAARNILVAEGRKMKISDFGLSRDVYE--EDSXVKRSQG-RIPVKWMAIESL 224
Query: 424 LGSEVSTNGDVYSYGILLLEMVT 446
                +T  DV+S+G+LL E+VT
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 112/263 (42%), Gaps = 62/263 (23%)
Query: 222 SYKSLLKATDGFSSTNLI-----GVGSFGSVYKGV-FDEDG----TVVAIKVINLQRQGA 271
           ++K L      F   NL+     G G FG V K   F   G    T VA+K++   ++ A
Sbjct: 9   AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENA 65
Query: 272 SKS----FMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--- 324
           S S     ++E   LK + H +++++  +CS    Q      IV +Y   GSL  +L   
Sbjct: 66  SPSELRDLLSEFNVLKQVNHPHVIKLYGACS----QDGPLLLIV-EYAKYGSLRGFLRES 120
Query: 325 --------------------HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
                               HPD           + LT+   IS A  ++  + YL    
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDE----------RALTMGDLISFAWQISQGMQYL---A 167
Query: 365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGVRGTIGYVAPEYG 423
           +  ++H DL   NIL+       I DFGLSR  Y+   +  V  S G R  + ++A E  
Sbjct: 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE--EDSYVKRSQG-RIPVKWMAIESL 224
Query: 424 LGSEVSTNGDVYSYGILLLEMVT 446
                +T  DV+S+G+LL E+VT
Sbjct: 225 FDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 245 GSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG 304
           G ++KG +  +  VV +  +       S+ F  EC  L+   H N++ V+ +C S     
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PP 80
Query: 305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
                ++  +MP GSL   LH       D+          Q +  A+D+A  + +L  H 
Sbjct: 81  APHPTLITHWMPYGSLYNVLHEGTNFVVDQS---------QAVKFALDMARGMAFL--HT 129
Query: 365 QEPIL-HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG 423
            EP++    L   ++++D D++A I    +   +Q         S G      +VAPE  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEAL 180
Query: 424 LGSEVSTN---GDVYSYGILLLEMVTTKKP 450
                 TN    D++S+ +LL E+VT + P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV  Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-AYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +   +I     +++T  
Sbjct: 95  IINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 150 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 206 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 34/246 (13%)
Query: 211 EPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG 270
           EP + K    +  K  LK  D F    ++G GSFG V+   F +     AIK   L++  
Sbjct: 1   EPELNKERPSLQIK--LKIED-FELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDV 55
Query: 271 ASKSFMAECKALKN------IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL 324
                  EC  ++         H  L  +  +     FQ  +    V +Y+  G L   +
Sbjct: 56  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKENLFFVMEYLNGGDLMYHI 110
Query: 325 HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL 384
                          K  L +    A ++   L +LH    + I++ DLK  NILLD D 
Sbjct: 111 Q-----------SCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDG 156
Query: 385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
              I DFG+ +        T        GT  Y+APE  LG + + + D +S+G+LL EM
Sbjct: 157 HIKIADFGMCKENMLGDAKTNEFC----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 212
Query: 445 VTTKKP 450
           +  + P
Sbjct: 213 LIGQSP 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 86  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXV 196
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXV 205
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 132 NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 242
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 243 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 205
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 25/223 (11%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           D F    ++G GSFG V      E G + A+KV+    + +    +  M E + L   R+
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
              +  +  C    FQ  D    V +++  G L   +      Q+ R  +  +       
Sbjct: 83  HPFLTQLFCC----FQTPDRLFFVMEFVNGGDLMFHI------QKSRRFDEARARFY--- 129
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A ++ SAL +LH    + I++ DLK  N+LLD++    + DFG+ +  + + N   ++
Sbjct: 130 --AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTA 182
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +    GT  Y+APE           D ++ G+LL EM+    P
Sbjct: 183 TFC--GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYKGV---FDEDGTVVAIKV-INLQRQGASK----SFMAECKALKNI-RHKN 289
           +G G+FG V        D+D    A+ V + + +  A++      ++E + +K I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV  Y   G+L ++L     P  +   +I     +++T  
Sbjct: 103 IINLLGACT----QDGPLYVIV-GYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R      +Y
Sbjct: 158 DLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  +N         R  + ++APE       +   DV+S+G+L+ E+ T
Sbjct: 214 KKTTNG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 95  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDXV 205
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 25/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  S     FQ +D    V +Y   G L   L  + +   DR           R   
Sbjct: 213 LTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYG 257
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++ SALDYLH   ++ +++ DLK  N++LD D    I DFGL +  + + +     + 
Sbjct: 258 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTF 312
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 313 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 233 FSSTNLIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNI 285
           F    ++G G +G V+   K      G + A+KV+     ++    +    AE   L+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H  +V +I +     FQ      ++ +Y+  G L   L  + I   D          L 
Sbjct: 79  KHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYLA 128
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            IS+A      L +LHQ   + I++ DLKP NI+L++     + DFGL +  +++ + TV
Sbjct: 129 EISMA------LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTV 177
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + +    GTI Y+APE  + S  +   D +S G L+ +M+T   P
Sbjct: 178 THTFC--GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 216
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L               +   ++   Q  ++ + V  AL 
Sbjct: 217 ---YLVGDELWVVMEFLEGGALTDI------------VTHTRMNEEQIAAVCLAVLQALS 261
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH      ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 262 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSK-EVPRRKXLVGTPYWM 314
Query: 419 APE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE       G EV    D++S GI+++EMV  + P
Sbjct: 315 APELISRLPYGPEV----DIWSLGIMVIEMVDGEPP 346

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIK--VINLQRQGASKSFMAECKALKN 284
            ++ + + +  L+G GS+G V K    + G +VAIK  + +   +   K  M E K LK 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW-LHPDAIPQRDREIEIQKLTL 343
           +RH+NLV ++  C            +V++++ +  L+   L P+ +     + ++ +  L
Sbjct: 81  LRHENLVNLLEVCKK-----KKRWYLVFEFVDHTILDDLELFPNGL-----DYQVVQKYL 130
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
            Q       + + + + H H    I+H D+KP NIL+       + DFG +R   A    
Sbjct: 131 FQ-------IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGE 179
Query: 404 TVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEM 444
                +  R    Y APE  +G  +     DV++ G L+ EM
Sbjct: 180 VYDDEVATR---WYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G +VA+K +        + F  E + LK +    +V+  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 76
Query: 295 TSCSSVDF-QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR-EIEIQKLTLLQRISIAID 352
                V +  G     +V +Y+P+G L  +L      QR R  ++  +L L      +  
Sbjct: 77  ---RGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARLDASRLLL-----YSSQ 122
Query: 353 VASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           +   ++YL  + C    +H DL   NIL++++    I DFGL++      +  V    G 
Sbjct: 123 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG- 177
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I + APE    +  S   DV+S+G++L E+ T
Sbjct: 178 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 25/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  S     FQ +D    V +Y   G L   L  + +   DR           R   
Sbjct: 210 LTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYG 254
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++ SALDYLH   ++ +++ DLK  N++LD D    I DFGL +  + + +     + 
Sbjct: 255 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTF 309
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 310 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRH 287
           D F     IG GSFG V     ++   + A+K +N Q+   +   ++   E + ++ + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV +  S     FQ  +   +V   +  G L   L      Q++   + + + L    
Sbjct: 75  PFLVNLWYS-----FQDEEDMFMVVDLLLGGDLRYHL------QQNVHFKEETVKLF--- 120
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
               ++  ALDYL     + I+H D+KP NILLD     HI DF +     A   P  + 
Sbjct: 121 --ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNI-----AAMLPRETQ 170
Query: 408 SIGVRGTIGYVAPEY---GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT  Y+APE      G+  S   D +S G+   E++  ++P
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     IV ++   G+L  +L     + +P +  E ++ K  LTL   
Sbjct: 96  NLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPE-DLYKDFLTLEHL 150
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXV 205
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G +VA+K +        + F  E + LK +    +V+  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 77
Query: 295 TSCSSVDF-QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR-EIEIQKLTLLQRISIAID 352
                V +  G     +V +Y+P+G L  +L      QR R  ++  +L L      +  
Sbjct: 78  ---RGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARLDASRLLL-----YSSQ 123
Query: 353 VASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           +   ++YL  + C    +H DL   NIL++++    I DFGL++      +  V    G 
Sbjct: 124 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG- 178
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I + APE    +  S   DV+S+G++L E+ T
Sbjct: 179 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 239 IGVGSFGSV----YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    Y  + D  G +VA+K +        + F  E + LK +    +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY- 89
Query: 295 TSCSSVDF-QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR-EIEIQKLTLLQRISIAID 352
                V +  G     +V +Y+P+G L  +L      QR R  ++  +L L      +  
Sbjct: 90  ---RGVSYGPGRQSLRLVMEYLPSGCLRDFL------QRHRARLDASRLLL-----YSSQ 135
Query: 353 VASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           +   ++YL  + C    +H DL   NIL++++    I DFGL++      +  V    G 
Sbjct: 136 ICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG- 190
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I + APE    +  S   DV+S+G++L E+ T
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVR 292
           +G   FG VYKG        E    VAIK +  + +G   + F  E      ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLLQRI 347
           ++   +      +   ++++ Y  +G L ++L     H D     D       L     +
Sbjct: 94  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVS 401
            +   +A+ ++YL  H    ++H DL   N+L+ + L+  I D GL R      +Y+ + 
Sbjct: 149 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           N  +         I ++APE  +  + S + D++SYG++L E+ +
Sbjct: 206 NSLLP--------IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 139
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L               +   ++   Q  ++ + V  AL 
Sbjct: 140 ---YLVGDELWVVMEFLEGGALTDI------------VTHTRMNEEQIAAVCLAVLQALS 184
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH      ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 185 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSK-EVPRRKXLVGTPYWM 237
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+++EMV  + P
Sbjct: 238 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           +D +    ++G GSFG V        G   A+KVI+   ++++   +S + E + LK + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N+ ++        F+   +  +V +    G L      D I  R R  E+    ++++
Sbjct: 85  HPNIXKLYEF-----FEDKGYFYLVGEVYTGGEL-----FDEIISRKRFSEVDAARIIRQ 134
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
                 V S + Y H++    I+H DLKP N+LL++   D +  I DFGLS  ++A  + 
Sbjct: 135 ------VLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SK 183
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
                I   GT  Y+APE   G+      DV+S G++L
Sbjct: 184 KXKDKI---GTAYYIAPEVLHGT-YDEKCDVWSTGVIL 217

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 31/229 (13%)
Query: 238 LIGVGSFGSVYKGV---FDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNI-RHKNL 290
           ++G G+FG V         + G  + + V  L+ +  S   ++ M+E K +  +  H+N+
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK---------- 340
           V ++ +C+     G  +  ++++Y   G L  +L        + EIE +           
Sbjct: 112 VNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 341 --LTLLQRISIAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
             LT    +  A  VA  +++L  + C    +H DL   N+L+ +     I DFGL+R  
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + SN  V  +   R  + ++APE       +   DV+SYGILL E+ +
Sbjct: 223 MSDSNYVVRGN--ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 126
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 181
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 182 -----TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 126
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 181
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 182 -----TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  S     FQ +D    V +Y   G L   L  + +   DR           R   
Sbjct: 71  LTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYG 115
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++ SALDYLH   ++ +++ DLK  N++LD D    I DFGL +  + + +       
Sbjct: 116 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF 170
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 171 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  S     FQ +D    V +Y   G L   L  + +   DR           R   
Sbjct: 70  LTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYG 114
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++ SALDYLH   ++ +++ DLK  N++LD D    I DFGL +  + + +       
Sbjct: 115 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF 169
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 170 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 33/225 (14%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGA-SKSFMAECKALKNIRHKNLVR 292
           +G   FG VYKG        E    VAIK +  + +G   + F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLLQRI 347
           ++   +      +   ++++ Y  +G L ++L     H D     D       L     +
Sbjct: 77  LLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVS 401
            +   +A+ ++YL  H    ++H DL   N+L+ + L+  I D GL R      +Y+ + 
Sbjct: 132 HLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           N  +         I ++APE  +  + S + D++SYG++L E+ +
Sbjct: 189 NSLL--------PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 126
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 181
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 182 -----TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  S     FQ +D    V +Y   G L   L  + +   DR           R   
Sbjct: 72  LTALKYS-----FQTHDRLCFVMEYANGGELFFHLSRERVFSEDR----------ARFYG 116
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++ SALDYLH   ++ +++ DLK  N++LD D    I DFGL +  + + +       
Sbjct: 117 A-EIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF 171
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 172 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 94
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L      D +          ++   Q  ++ + V  AL 
Sbjct: 95  ---YLVGDELWVVMEFLEGGALT-----DIVTH-------TRMNEEQIAAVCLAVLQALS 139
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH      ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 140 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSK-EVPRRKXLVGTPYWM 192
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+++EMV  + P
Sbjct: 193 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 96
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L      D +          ++   Q  ++ + V  AL 
Sbjct: 97  ---YLVGDELWVVMEFLEGGALT-----DIVTH-------TRMNEEQIAAVCLAVLQALS 141
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH      ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 142 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSK-EVPRRKXLVGTPYWM 194
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+++EMV  + P
Sbjct: 195 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L +   +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 85
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L      D +          ++   Q  ++ + V  AL 
Sbjct: 86  ---YLVGDELWVVMEFLEGGALT-----DIVTH-------TRMNEEQIAAVCLAVLQALS 130
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH      ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 131 VLHAQG---VIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSK-EVPRRKXLVGTPYWM 183
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+++EMV  + P
Sbjct: 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +          ++L+  
Sbjct: 137 IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 249 KTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G +VA+K ++L++Q   +    E   +++ +H+N+V +  S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-- 89
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              +   D   +V +++  G+L      D +          ++   Q  ++ + V  AL 
Sbjct: 90  ---YLVGDELWVVMEFLEGGALT-----DIVTH-------TRMNEEQIAAVCLAVLQALS 134
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
            LH    + ++H D+K  +ILL +D    + DFG   F   VS   V     + GT  ++
Sbjct: 135 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSK-EVPRRKXLVGTPYWM 187
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE           D++S GI+++EMV  + P
Sbjct: 188 APELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 233 FSSTNLIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNI 285
           F    ++G G +G V+   K      G + A+KV+     ++    +    AE   L+ +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H  +V +I +     FQ      ++ +Y+  G L   L  + I   D          L 
Sbjct: 79  KHPFIVDLIYA-----FQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYLA 128
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            IS+A      L +LHQ   + I++ DLKP NI+L++     + DFGL +  +++ + TV
Sbjct: 129 EISMA------LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTV 177
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +      GTI Y+APE  + S  +   D +S G L+ +M+T   P
Sbjct: 178 THXFC--GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + IG G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 124
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH-- 179
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 180 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAI-----PQRDREIEIQKL 341
           ++ ++ +C+    Q      IV +Y   G+L ++L    P  +     P  + E   ++L
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPE---EQL 147
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
           +    +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R    + 
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                 +   R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 205 --XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  +A+K ++   Q    +K    E + 
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T  +S++ + ND   + +  +    L            +  ++ 
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLE-EFNDVYLVTH--LMGADL------------NNIVKC 148
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 149 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 203
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 204 -----TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 24/232 (10%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAEC 279
           M  + +   +  F   +L+G G++G V        G +VAIK I    +   +   + E 
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           K LK+ +H+N++ +        F+  +   I+ + M        LH        R I  Q
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LH--------RVISTQ 107
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L+             A+  LH      ++H DLKPSN+L++++    + DFGL+R    
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 400 V----SNPTVSSS--IGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEM 444
                S PT   S  +    T  Y APE  L S + S   DV+S G +L E+
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +          ++L+  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 208 KTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G VYK   +  G   A+K I L+++  G   + + E   LK ++H N+V++   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V++++ +  L+K L    + +   E    K  LLQ       + + 
Sbjct: 69  IHT-----KKRLVLVFEHL-DQDLKKLLD---VCEGGLESVTAKSFLLQ-------LLNG 112
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + Y H      +LH DLKP N+L++ +    I DFGL+R +           +    T+ 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLW 165
Query: 417 YVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
           Y AP+  +GS + ST  D++S G +  EMV
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     ++ ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 86  NLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 196
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G VYK   +  G   A+K I L+++  G   + + E   LK ++H N+V++   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V++++ +  L+K L    + +   E    K  LLQ       + + 
Sbjct: 69  IHT-----KKRLVLVFEHL-DQDLKKLLD---VCEGGLESVTAKSFLLQ-------LLNG 112
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + Y H      +LH DLKP N+L++ +    I DFGL+R +           +    T+ 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLW 165
Query: 417 YVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
           Y AP+  +GS + ST  D++S G +  EMV
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     ++ ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 86  NLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXV 196
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)
Query: 239 IGVGSFGSVYKG-VFDEDGTVVAIKV-INLQRQGAS----KSFMAECKALKNI-RHKNLV 291
           +G G+FG V +   F  D T     V + + ++GA+    ++ M+E K L +I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP---DAIPQRDREIEIQK--LTLLQR 346
            ++ +C+     G     ++ ++   G+L  +L     + +P +    ++ K  LTL   
Sbjct: 86  NLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P   
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYV 196
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 197 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +          ++L+  
Sbjct: 85  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 197 KTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 85  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 123
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R    V++P
Sbjct: 124 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLAR----VADP 176
Query: 404 TVSSS---IGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
               +        T  Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 177 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 105/233 (45%), Gaps = 41/233 (17%)
Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVR 292
           IG G+FG V++      +  E  T+VA+K++  +     ++ F  E   +    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL------------HPD-AIPQRDREIEIQ 339
           ++  C+           ++++YM  G L ++L            H D +   R       
Sbjct: 115 LLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR---- 395
            L+  +++ IA  VA+ + YL +      +H DL   N L+  ++   I DFGLSR    
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 396 --FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +Y+A  N  +         I ++ PE    +  +T  DV++YG++L E+ +
Sbjct: 227 ADYYKADGNDAIP--------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +          ++L+  
Sbjct: 88  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 200 KTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +          ++L+  
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 208 KTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 94/230 (40%), Gaps = 32/230 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKN-- 284
           LK  D F    ++G GSFG V+   F +     AIK   L++         EC  ++   
Sbjct: 14  LKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRV 70
Query: 285 ----IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
                 H  L  +  +     FQ  +    V +Y+  G L   +               K
Sbjct: 71  LSLAWEHPFLTHMFCT-----FQTKENLFFVMEYLNGGDLMYHIQ-----------SCHK 114
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
             L +    A ++   L +LH    + I++ DLK  NILLD D    I DFG+ +     
Sbjct: 115 FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              T        GT  Y+APE  LG + + + D +S+G+LL EM+  + P
Sbjct: 172 DAKTNXFC----GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 36/228 (15%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLTLL 344
           ++ ++ +C+    Q      IV +Y   G+L ++L     P  +          ++L+  
Sbjct: 89  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQ 398
             +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      +Y+
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 201 KTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMX--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 125
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 180
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 181 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++   L+ LH+   E I++ DLKP NILLD+     I D GL     AV  P   +  
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL-----AVHVPEGQTIK 343
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           G  GT+GY+APE       + + D ++ G LL EM+  + P
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 85  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 123
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 124 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 181 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 121
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 176
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 177 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 105 GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 143
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 144 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 200
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 201 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 42/231 (18%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAI-----PQRDREIEIQKL 341
           ++ ++ +C+    Q      IV +Y   G+L ++L    P  +     P  + E   ++L
Sbjct: 81  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPE---EQL 132
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------ 395
           +    +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      
Sbjct: 133 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +Y+  +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 190 YYKKTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITS 296
           IG G++G VYK   +  G   A+K I L+++  G   + + E   LK ++H N+V++   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V++++ +  L+K L    + +   E    K  LLQ       + + 
Sbjct: 69  IHT-----KKRLVLVFEHL-DQDLKKLLD---VCEGGLESVTAKSFLLQ-------LLNG 112
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + Y H      +LH DLKP N+L++ +    I DFGL+R +           +    T+ 
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLW 165
Query: 417 YVAPEYGLGS-EVSTNGDVYSYGILLLEMV 445
           Y AP+  +GS + ST  D++S G +  EMV
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 85  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 123
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 124 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 180
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 181 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 115
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 171 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 85  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 123
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 124 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 181 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 42/231 (18%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSF---MAECKALKNI-RHKN 289
           +G G+FG V          D+   V  + V  L+     K     ++E + +K I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAI-----PQRDREIEIQKL 341
           ++ ++ +C+    Q      IV +Y   G+L ++L    P  +     P  + E   ++L
Sbjct: 96  IINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPE---EQL 147
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------ 395
           +    +S A  VA  ++YL     +  +H DL   N+L+  D    I DFGL+R      
Sbjct: 148 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +Y+  +N         R  + ++APE       +   DV+S+G+LL E+ T
Sbjct: 205 YYKKTTNG--------RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 124
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH-- 179
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 180 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           A ++   L+ LH+   E I++ DLKP NILLD+     I D GL     AV  P   +  
Sbjct: 292 AAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL-----AVHVPEGQTIK 343
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           G  GT+GY+APE       + + D ++ G LL EM+  + P
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 125
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 180
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 181 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 124
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 179
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 180 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 124
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 125 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 179
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 180 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 139
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 194
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 195 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 139
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 194
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 195 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 118
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 119 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 173
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 174 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 89  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKCQHLSN 127
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 128 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 185 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS G V        G  VA+K+++L++Q   +    E   +++ +H N+V +  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY- 111
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                G +   ++ +++  G+L      D + Q        +L   Q  ++   V  AL 
Sbjct: 112 ---LVGEEL-WVLMEFLQGGALT-----DIVSQ-------VRLNEEQIATVCEAVLQALA 155
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV 418
           YLH    + ++H D+K  +ILL  D    + DFG    + A  +  V     + GT  ++
Sbjct: 156 YLH---AQGVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKXLVGTPYWM 208
Query: 419 APEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           APE    S  +T  D++S GI+++EMV  + P
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 102/237 (43%), Gaps = 33/237 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECK 280
           K +    + F    +IG G+FG V          V A+K++N   + ++  +  F  E  
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH--PDAIPQRDREIEI 338
            L N   K +  +  +     FQ ++   +V  Y   G L   L    D +P+     E+
Sbjct: 127 VLVNGDSKWITTLHYA-----FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE-----EM 176
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
            +  L + + IAID    L Y+H+         D+KP NIL+D +    + DFG     +
Sbjct: 177 ARFYLAEMV-IAIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSC--LK 224
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + + TV SS+ V GT  Y++PE      G         D +S G+ + EM+  + P
Sbjct: 225 LMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 121
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 176
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 177 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 87  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 125
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 126 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 183 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKX 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 126
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 127 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 181
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 182 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 89  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 127
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 128 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 185 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 115
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 171 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKX 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 138
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 193
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 194 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 121
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 176
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 177 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 83  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 121
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 122 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 179 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 115
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 116 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 171 -----TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 117
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 118 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 172
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 173 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 93  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 131
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 132 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 188
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 189 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 85  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 123
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 124 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 180
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 181 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 116
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 171
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 172 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 83  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 121
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 122 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 178
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 179 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 142
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 197
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 198 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 131
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 186
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 187 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 116
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 117 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 171
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 172 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 139
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 140 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 194
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 195 -----TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 131
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 186
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 187 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 138
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 139 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 193
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 194 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 125
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 180
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 181 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 90  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 128
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 129 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 185
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 186 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 130
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 185
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 186 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 130
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 131 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARH-- 185
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 186 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 91  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 129
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 130 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 186
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 187 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 82  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 120
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 121 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 177
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 178 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 89  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 127
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 128 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 185 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 89  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 127
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 128 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDH 184
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 185 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 238 LIGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA---SKSFMAECKALKNIRHKNLVRV 293
           ++G G FG VY+GV+ +  G  + + V   ++       + FM+E   +KN+ H ++V++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I           +   I+ +  P G L  +L      +R++      L +L  +  ++ +
Sbjct: 79  IGIIEE------EPTWIIMELYPYGELGHYL------ERNK----NSLKVLTLVLYSLQI 122
Query: 354 ASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
             A+ YL   +C    +H D+   NIL+ +     +GDFGLSR+   + +     +   R
Sbjct: 123 CKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTR 175
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
             I +++PE       +T  DV+ + + + E+++  K
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 212

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/217 (23%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 238 LIGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA---SKSFMAECKALKNIRHKNLVRV 293
           ++G G FG VY+GV+ +  G  + + V   ++       + FM+E   +KN+ H ++V++
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I           +   I+ +  P G L  +L      +R++      L +L  +  ++ +
Sbjct: 91  IGIIEE------EPTWIIMELYPYGELGHYL------ERNK----NSLKVLTLVLYSLQI 134
Query: 354 ASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
             A+ YL   +C    +H D+   NIL+ +     +GDFGLSR+   + +     +   R
Sbjct: 135 CKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY---IEDEDYYKASVTR 187
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
             I +++PE       +T  DV+ + + + E+++  K
Sbjct: 188 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 224

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 142
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 143 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 197
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 198 -----TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 104/226 (46%), Gaps = 28/226 (12%)
Query: 229 ATDGFSSTNLIGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGA---SKSFMAECKALKN 284
           A +      ++G G FG VY+GV+ +  G  + + V   ++       + FM+E   +KN
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H ++V++I           +   I+ +  P G L  +L      +R++      L +L
Sbjct: 66  LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYL------ERNK----NSLKVL 109
Query: 345 QRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             +  ++ +  A+ YL   +C    +H D+   NIL+ +     +GDFGLSR+   + + 
Sbjct: 110 TLVLYSLQICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRY---IEDE 162
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK 449
               +   R  I +++PE       +T  DV+ + + + E+++  K
Sbjct: 163 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGK 208

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 89  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 127
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R    V++P
Sbjct: 128 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADP 180
Query: 404 TVSSS---IGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
               +        T  Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 181 DHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 41/229 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 90  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 128
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R    V++P
Sbjct: 129 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADP 181
Query: 404 TVSSS---IGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
               +        T  Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 182 DHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 131
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 132 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 186
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 187 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 87  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 125
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 126 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 182
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 183 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           ++    IG G++G V         T VAIK I+  + Q   +  + E + L   RH+N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 292 --RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
             R I   S+++   + +  IV   M                   E ++ KL   Q++S 
Sbjct: 105 GIRDILRASTLEAMRDVY--IVQDLM-------------------ETDLYKLLKSQQLSN 143
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+L++      I DFGL+R      + 
Sbjct: 144 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDH 200
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 201 TGFLTEXVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMX--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            +  I    +++ Q  D   + +  +    L K L            + Q L+       
Sbjct: 105 GINDIIRAPTIE-QMKDVYLVTH--LMGADLYKLL------------KTQHLSNDHICYF 149
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT--VSS 407
              +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + T  ++ 
Sbjct: 150 LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 206
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
            +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 207 YVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 111/245 (45%), Gaps = 44/245 (17%)
Query: 225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKN 284
           SL  A+D F    ++G G+FG V K     D    AIK I    +  S + ++E   L +
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLAS 58
Query: 285 IRHKNLVR----------VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           + H+ +VR           +   ++V  +   F  I  +Y  N +L   +H + + Q+  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLF--IQXEYCENRTLYDLIHSENLNQQRD 116
Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
           E       L ++I        AL Y+H    + I+H +LKP NI +D   +  IGDFGL+
Sbjct: 117 EY----WRLFRQI------LEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLA 163
Query: 395 R-FYQAV------------SNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGIL 440
           +  ++++            S+  ++S+I   GT  YVA E   G+   +   D YS GI+
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAI---GTAXYVATEVLDGTGHYNEKIDXYSLGII 220
Query: 441 LLEMV 445
             E +
Sbjct: 221 FFEXI 225

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + +   +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 129
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 130 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 184
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 185 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 121
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 122 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARH-- 176
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 177 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAEC 279
           M  + +   +  F   +L+G G++G V        G +VAIK I    +   +   + E 
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           K LK+ +H+N++ +        F+  +   I+ + M        LH        R I  Q
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LH--------RVISTQ 107
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L+             A+  LH      ++H DLKPSN+L++++    + DFGL+R    
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 400 V----SNPTVSSS--IGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEM 444
                S PT   S       T  Y APE  L S + S   DV+S G +L E+
Sbjct: 165 SAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 98/232 (42%), Gaps = 24/232 (10%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAEC 279
           M  + +   +  F   +L+G G++G V        G +VAIK I    +   +   + E 
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           K LK+ +H+N++ +        F+  +   I+ + M        LH        R I  Q
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LH--------RVISTQ 107
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
            L+             A+  LH      ++H DLKPSN+L++++    + DFGL+R    
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 400 V----SNPTVSSS--IGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEM 444
                S PT   S       T  Y APE  L S + S   DV+S G +L E+
Sbjct: 165 SAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 39/226 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F     +G GSFG V+      +G   A+KV  L+++   +        LK + H N  R
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVR--------LKQVEHTNDER 57
Query: 293 VITSCSSV--------DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           ++ S  +          FQ      ++  Y+  G L   L            + Q+    
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----------KSQRFPNP 106
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
                A +V  AL+YLH    + I++ DLKP NILLD +    I DFG +++      P 
Sbjct: 107 VAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PD 158
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           V+  +   GT  Y+APE       + + D +S+GIL+ EM+    P
Sbjct: 159 VTYXLC--GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 125
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 126 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARH-- 180
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 181 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 64  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 113
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 114 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 163
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 164 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAI+ I+  + Q   +  + E K L   RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 89  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 127
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 128 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 185 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 38/227 (16%)
Query: 242 GSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITS---C 297
           G FG V+K     +   VA+K+  +Q +Q     +  E  +L  ++H+N+++ I +    
Sbjct: 35  GRFGCVWKAQLLNE--YVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRG 90
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
           +SVD        ++  +   GSL  +L  + +               +   IA  +A  L
Sbjct: 91  TSVDVD----LWLITAFHEKGSLSDFLKANVVSWN------------ELCHIAETMARGL 134
Query: 358 DYLHQHC-------QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            YLH+         +  I H D+K  N+LL N+L+A I DFGL+  ++A    +   + G
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA--GKSAGDTHG 192
Query: 411 VRGTIGYVAPEYGLGS-----EVSTNGDVYSYGILLLEMVTTKKPTD 452
             GT  Y+APE   G+     +     D+Y+ G++L E+ +     D
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 102/239 (42%), Gaps = 56/239 (23%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVI--------NLQRQGASKSFMAECKALKNIRHKNL 290
           +G G++G V+K +    G VVA+K I        + QR       + E    +NI   NL
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI--VNL 74
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           + V+ + +  D        +V+ YM     E  LH          I    L  + +  + 
Sbjct: 75  LNVLRADNDRDV------YLVFDYM-----ETDLHA--------VIRANILEPVHKQYVV 115
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY---QAVSN----- 402
             +   + YLH      +LH D+KPSNILL+ +    + DFGLSR +   + V+N     
Sbjct: 116 YQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 403 ------------PTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
                       P ++  +  R    Y APE  LGS   T G D++S G +L E++  K
Sbjct: 173 INENTENFDDDQPILTDYVATR---WYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I D+GL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGT--VVAIKVIN---LQRQGASKSFMAECKA 281
           +K TD F+   ++G GSFG V   + D  GT  + AIK++    + +    +  M E + 
Sbjct: 16  VKLTD-FNFLMVLGKGSFGKVM--LADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRV 72
Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L  +     +  + SC    FQ  D    V +Y+  G L   +            ++ K 
Sbjct: 73  LALLDKPPFLTQLHSC----FQTVDRLYFVMEYVNGGDLMYHIQ-----------QVGKF 117
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
              Q +  A +++  L +LH+     I++ DLK  N++LD++    I DFG+ + +    
Sbjct: 118 KEPQAVFYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG 174
Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             T        GT  Y+APE         + D ++YG+LL EM+  + P D
Sbjct: 175 VTTREFC----GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 39/228 (17%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLV 291
           +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L   RH+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 292 RV--ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS- 348
            +  I    +++ Q  D    VY                I Q   E ++ KL   Q +S 
Sbjct: 87  GINDIIRAPTIE-QMKD----VY----------------IVQDLMETDLYKLLKTQHLSN 125
Query: 349 -----IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 126 DHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDH 182
Query: 404 T--VSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           T  ++  +  R    Y APE  L S+  T   D++S G +L EM++ +
Sbjct: 183 TGFLTEYVATR---WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 130
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 131 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 184
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 185 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++S   
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF-- 194
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE       S + D+++ G ++ ++V    P
Sbjct: 195 VGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 7/99 (7%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++A ALD+LH      I++ DLKP NILLD +    + DFGLS+  +++ +   + S   
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFC- 187
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT+ Y+APE       + + D +S+G+L+ EM+T   P
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 130
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 131 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 184
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 185 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 7/99 (7%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++A ALD+LH      I++ DLKP NILLD +    + DFGLS+  +++ +   + S   
Sbjct: 135 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFC- 188
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT+ Y+APE       + + D +S+G+L+ EM+T   P
Sbjct: 189 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 7/99 (7%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++A ALD+LH      I++ DLKP NILLD +    + DFGLS+  +++ +   + S   
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFC- 187
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT+ Y+APE       + + D +S+G+L+ EM+T   P
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 78
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 131
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 132 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 185
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 186 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  +LE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
             +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  +LE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKTLEEFQDVYLV------MELMDANLXQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
             +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 81
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 134
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 135 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 188
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 189 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 142
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 143 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 196
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 197 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 96
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 149
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 150 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 203
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 204 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F    ++G G+F  V+       G + A+K I         S   E   LK I+H+N+V 
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +        ++      +V + +  G L ++ L      ++D  + IQ+           
Sbjct: 71  L-----EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ----------- 114
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            V SA+ YLH++    I+H DLKP N+L    + +    I DFGLS+  Q   N  +S++
Sbjct: 115 -VLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTA 167
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            G   T GYVAPE       S   D +S G++
Sbjct: 168 CG---TPGYVAPEVLAQKPYSKAVDCWSIGVI 196

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 89
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 142
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 143 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 196
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 197 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 83  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLXQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 85
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 138
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 139 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 192
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 193 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 130
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 131 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 184
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 185 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +  + H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 149
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 150 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 207 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +  + H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 163
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 221 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 79  GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 122 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHG-KWP 177
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 437 GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 479
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 480 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP 535
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 536 VKWYAPECINYYKFSSKSDVWSFGVLMWE 564

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 90
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 143
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 144 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 197
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 198 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 163
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 164 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 221 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 164
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 165 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC 218
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 219 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 82
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 135
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 136 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 189
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 190 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     IG GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +YMP G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYMPGGDMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 140
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 141 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 197
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 198 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     IG GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +YMP G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYMPGGDMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 438 GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 480
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 481 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP 536
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 537 VKWYAPECINYYKFSSKSDVWSFGVLMWE 565

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L     +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 70  L-----TALKYAFQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 113
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+     + 
Sbjct: 114 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 168
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 169 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L     +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 67  L-----TALKYAFQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 110
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+     + 
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 166 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 148
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 206 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM-AECKALKNIRHKNLV 291
           ++ T +IG GSFG VY+    + G +VAIK +    QG  K+F   E + ++ + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 292 RV-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           R+     SS + +   +  +V  Y+P        H     Q    I + KL + Q     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ----- 130
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSI 409
             +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I
Sbjct: 131 --LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYI 183
Query: 410 GVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
             R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 184 CSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 149
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 206
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 207 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 209
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 210 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 263
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 264 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 163
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 164 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 220
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 221 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 148
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 149 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 205
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 206 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 208 QPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ 267
           +P E  + + LL +  K L             G G+FG+V KG +     V  + V  L+
Sbjct: 17  RPKEVYLDRKLLTLEDKEL-------------GSGNFGTVKKGYYQMKKVVKTVAVKILK 63
Query: 268 RQGASKSF----MAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW 323
            +    +     +AE   ++ + +  +VR+I  C +  +       +V +    G L K+
Sbjct: 64  NEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKY 117
Query: 324 LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND 383
           L      Q++R ++ + +     I +   V+  + YL +      +H DL   N+LL   
Sbjct: 118 L------QQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQ 163
Query: 384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
             A I DFGLS+  +A  N   + + G +  + + APE     + S+  DV+S+G+L+ E
Sbjct: 164 HYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 208 QPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ 267
           +P E  + + LL +  K L             G G+FG+V KG +     V  + V  L+
Sbjct: 17  RPKEVYLDRKLLTLEDKEL-------------GSGNFGTVKKGYYQMKKVVKTVAVKILK 63
Query: 268 RQGASKSF----MAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW 323
            +    +     +AE   ++ + +  +VR+I  C +  +       +V +    G L K+
Sbjct: 64  NEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKY 117
Query: 324 LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND 383
           L      Q++R ++ + +     I +   V+  + YL +      +H DL   N+LL   
Sbjct: 118 L------QQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQ 163
Query: 384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
             A I DFGLS+  +A  N   + + G +  + + APE     + S+  DV+S+G+L+ E
Sbjct: 164 HYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 105 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 155
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 156 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 212
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 213 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L     +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 67  L-----TALKYAFQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 110
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+     + 
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 166 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKS 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 93  GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 135
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 136 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP 191
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 192 VKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM-AECKALKNIRHKNLV 291
           ++ T +IG GSFG VY+    + G +VAIK +    QG  K+F   E + ++ + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 292 RV-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           R+     SS + +   +  +V  Y+P        H     Q    I + KL + Q     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ----- 130
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSI 409
             +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I
Sbjct: 131 --LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYI 183
Query: 410 GVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
             R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 184 CSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 208 QPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ 267
           +P E  + + LL +  K L             G G+FG+V KG +     V  + V  L+
Sbjct: 7   RPKEVYLDRKLLTLEDKEL-------------GSGNFGTVKKGYYQMKKVVKTVAVKILK 53
Query: 268 RQGASKSF----MAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW 323
            +    +     +AE   ++ + +  +VR+I  C +  +       +V +    G L K+
Sbjct: 54  NEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM------LVMEMAELGPLNKY 107
Query: 324 LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND 383
           L      Q++R ++ + +     I +   V+  + YL +      +H DL   N+LL   
Sbjct: 108 L------QQNRHVKDKNI-----IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQ 153
Query: 384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
             A I DFGLS+  +A  N   + + G +  + + APE     + S+  DV+S+G+L+ E
Sbjct: 154 HYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 77
Query: 293 VITSCSSVDFQGNDFKAIVY-----KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           +        +   + K +VY      Y+P        H     Q    I + KL + Q  
Sbjct: 78  L----RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ-- 130
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVS 406
                +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      
Sbjct: 131 -----LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNV 180
Query: 407 SSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
           S I  R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 181 SXICSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 76  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLXQVI 112
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 113 QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAG 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 171 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D +     +G G+FG V++      G   A K +    +   ++   E + +  +RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           V +  +     F+ ++   ++Y++M  G L EK              E  K++  + +  
Sbjct: 111 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVAD-----------EHNKMSEDEAVEY 154
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVSS 407
              V   L ++H++     +H DLKP NI+     S  +   DFGL+    A  +P  S 
Sbjct: 155 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT----AHLDPKQSV 207
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            +   GT  + APE   G  V    D++S G+L
Sbjct: 208 KVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVL 239

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 79  GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 122 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP 177
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 178 VKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 105
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 158
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 159 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 212
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 213 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 115 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 165
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 166 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 222
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 223 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 164
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 165 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 218
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 219 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 83  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLXQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 99/218 (45%), Gaps = 35/218 (16%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKN---LVRV 293
           +G G++G+V   V    G  VAIK +    Q +  +K    E + LK++RH+N   L+ V
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 294 ITSCSSVDFQGNDFKAIVYKYMP--NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            T   ++D    DF    Y  MP     L K +  + + + DR   IQ L          
Sbjct: 93  FTPDETLD----DFTDF-YLVMPFMGTDLGKLMKHEKLGE-DR---IQFLV--------Y 135
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +   L Y+H      I+H DLKP N+ ++ D    I DFGL+R  QA S        G 
Sbjct: 136 QMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSE-----MXGX 185
Query: 412 RGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
             T  Y APE  L     T   D++S G ++ EM+T K
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM-AECKALKNIRHKNLV 291
           ++ T +IG GSFG VY+    + G +VAIK +    QG  K+F   E + ++ + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQG--KAFKNRELQIMRKLDHCNIV 76
Query: 292 RV-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           R+     SS + +   +  +V  Y+P        H     Q    I + KL + Q     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYV-KLYMYQ----- 130
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSI 409
             +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I
Sbjct: 131 --LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXI 183
Query: 410 GVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
             R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 184 CSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 115
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
            KLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R   
Sbjct: 116 AKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 171 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 77  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 113
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 171
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 172 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+ G V        G  VA+K ++   Q Q  +K    E   LK + HKN++ ++  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                            + P  +LE++     +      +E+    L Q I + +D    
Sbjct: 92  -----------------FTPQKTLEEFQDVYLV------MELMDANLCQVIHMELDHERM 128
Query: 357 LDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
              L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A +N  ++  +
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYV 186
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             R    Y APE  LG   + N D++S G ++ E+V
Sbjct: 187 VTR---YYRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 84  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 120
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 178
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 179 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 83  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 76  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 112
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 170
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 171 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 113
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 166
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 167 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 220
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 221 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 84  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 120
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 178
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 179 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 73  GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 115
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 116 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP 171
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 172 VKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 82  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 118
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 119 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 176
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 177 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 83  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  +LE++     +      +E+    L Q I + +D 
Sbjct: 127 LNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVIQMELDH 163
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 221
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
             +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 222 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 115
Query: 293 V-ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H     Q    I + KL + Q      
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ------ 168
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V      S I 
Sbjct: 169 -LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC 222
Query: 411 VRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
            R    Y APE   G ++ +++ DV+S G +L E++
Sbjct: 223 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  +LE++     +      +E+    L Q I
Sbjct: 77  KNIISLLNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVI 113
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 171
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 172 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 43/222 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  V D +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  +LE++     +      +E+    L Q I + +D 
Sbjct: 127 LNV-----------------FTPQKTLEEFQDVYLV------MELMDANLCQVIQMELDH 163
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 221
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
             +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 222 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 125 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRET----RPRPSQPSSLAMLDLLHVARD 175
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 176 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCA 232
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 233 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF----MAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +     V  + V  L+ +    +     +AE   ++ + +  +VR+I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L      Q++R ++ + +     I +   V+
Sbjct: 75  GICEAESWM------LVMEMAELGPLNKYL------QQNRHVKDKNI-----IELVHQVS 117
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G +  
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWP 173
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
           + + APE     + S+  DV+S+G+L+ E
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 139 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 189
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 190 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 246
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 247 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 118
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE-HR 174
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D +     +G G+FG V++      G   A K +    +   ++   E + +  +RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           V +  +     F+ ++   ++Y++M  G L EK              E  K++  + +  
Sbjct: 217 VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVAD-----------EHNKMSEDEAVEY 260
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVSS 407
              V   L ++H++     +H DLKP NI+     S  +   DFGL+    A  +P  S 
Sbjct: 261 MRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT----AHLDPKQSV 313
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            +   GT  + APE   G  V    D++S G+L
Sbjct: 314 KV-TTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 116 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 166
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG++R  Y+A        +
Sbjct: 167 IACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCA 223
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 224 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKFSLDLASLILYAYQLS 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+ +  +    S     +  
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG---KLP 175
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G+ G V   V       VA+K+++++R     ++   E    K + H+
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 65  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 114
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 115 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 164
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKN 289
           D F     +G G+FG V+       G    IK IN  R Q   +   AE + LK++ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           ++++        F+      IV +    G L E+ +   A   R + +    +  L +  
Sbjct: 82  IIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQA---RGKALSEGYVAELMK-- 131
Query: 349 IAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAH----IGDFGLSRFYQAVSNP 403
               + +AL Y H QH    ++H DLKP NIL   D S H    I DFGL+  +++  + 
Sbjct: 132 ---QMMNALAYFHSQH----VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           T ++     GT  Y+APE     +V+   D++S G+++  ++T
Sbjct: 184 TNAA-----GTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLT 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 175
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 106 GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 149
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 150 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 203
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 128
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 129 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQE-HR 184
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHK 288
            + +     +G G++G V   V       VA+K+++++R     ++   E      + H+
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPD-AIPQRDREIEIQKLTLLQRI 347
           N+V+          +GN  + +  +Y   G L   + PD  +P+ D +    +L      
Sbjct: 66  NVVKFYGHRR----EGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----- 115
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                  + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +
Sbjct: 116 -------AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            +   GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 166 KMC--GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L     +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 67  L-----TALKYAFQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 110
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+       
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 165
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 166 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I DF L+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VAIK+I+  +   +  +    E + +K + H N+V++   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          ++ +Y   G +  +L       R +E E +        S    + SA
Sbjct: 80  IET-----EKTLYLIMEYASGGEVFDYLVAHG---RMKEKEAR--------SKFRQIVSA 123
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GTI 415
           + Y HQ   + I+H DLK  N+LLD D++  I DFG S  +      TV   +    G+ 
Sbjct: 124 VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF------TVGGKLDTFCGSP 174
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 175 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 67  LTALKYA-----FQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 110
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+       
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 165
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 166 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L     +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 67  L-----TALKYAFQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 110
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+       
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 165
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 166 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++S   
Sbjct: 137 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF-- 191
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 80  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 123
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 124 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 177
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 111/230 (48%), Gaps = 32/230 (13%)
Query: 231 DGFSSTNLIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALK 283
           + F    ++G G++G V+   K    + G + A+KV+     +Q+   ++    E + L+
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
           +IR    +  +       FQ      ++  Y+  G L  + H   + QR+R  E      
Sbjct: 114 HIRQSPFLVTLHYA----FQTETKLHLILDYINGGEL--FTH---LSQRERFTE------ 158
Query: 344 LQRISIAI-DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
              + I + ++  AL++LH+     I++ D+K  NILLD++    + DFGLS+ +  V++
Sbjct: 159 -HEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF--VAD 212
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNG--DVYSYGILLLEMVTTKKP 450
            T   +    GTI Y+AP+   G +   +   D +S G+L+ E++T   P
Sbjct: 213 ET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 83  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 126
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 127 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 180
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 81  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 124
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 125 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 178
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 75  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 118
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 119 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 172
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKYSLDLASLILYAYQLS 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 175
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++S   
Sbjct: 141 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF-- 195
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 196 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 26/221 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    L+G G+FG V        G   A+K++  +   A       + E + L+N RH  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           L  +  +     FQ +D    V +Y   G L  + H      R+R    ++         
Sbjct: 72  LTALKYA-----FQTHDRLCFVMEYANGGEL--FFHL----SRERVFTEERARFY----- 115
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
             ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +  + +S+       
Sbjct: 116 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXF 170
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 171 C--GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I  FGL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I D GL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I D GL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 32/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKA 281
           K+  +    + S   +G G++GSV   +    G  VAIK ++   Q +  +K    E   
Sbjct: 35  KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 94
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T  SS+     DF    Y  MP      ++  D       E   
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLR-NFYDF----YLVMP------FMQTDLQKIMGMEFSE 143
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           +K+  L        +   L Y+H      ++H DLKP N+ ++ D    I DFGL+R   
Sbjct: 144 EKIQYL-----VYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD 195
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           A          G   T  Y APE  L     +   D++S G ++ EM+T K
Sbjct: 196 A-------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 128
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 129 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HR 184
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKN 284
           K  + F    ++G GSF +V            AIK++   ++ ++        E   +  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H   V++  +     FQ ++       Y  NG L K++         R+I     T  
Sbjct: 67  LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC- 111
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
            R   A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S   
Sbjct: 112 TRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 167
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++     GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 168 RANXFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 118
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HR 174
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VAIK+I+  +   +  +    E + +K + H N+V++   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          ++ +Y   G +  +L       R +E E +        S    + SA
Sbjct: 83  IET-----EKTLYLIMEYASGGEVFDYLVAHG---RMKEKEAR--------SKFRQIVSA 126
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI-GVRGTI 415
           + Y HQ   + I+H DLK  N+LLD D++  I DFG S  +      TV   +    G  
Sbjct: 127 VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF------TVGGKLDAFCGAP 177
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 118
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 119 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HR 174
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKN 284
           K  + F    ++G GSF +V            AIK++   ++ ++        E   +  
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 63
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H   V++  +     FQ ++       Y  NG L K++         R+I     T  
Sbjct: 64  LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC- 108
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
            R   A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S   
Sbjct: 109 TRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 164
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++     GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 165 RANXFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKN 284
           K  + F    ++G GSF +V            AIK++   ++ ++        E   +  
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 65
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H   V++  +     FQ ++       Y  NG L K++         R+I     T  
Sbjct: 66  LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC- 110
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
            R   A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S   
Sbjct: 111 TRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 166
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++     GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 167 RANXFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKN 284
           K  + F    ++G GSF +V            AIK++   ++ ++        E   +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H   V++  +     FQ ++       Y  NG L K++         R+I     T  
Sbjct: 65  LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC- 109
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
            R   A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S   
Sbjct: 110 TRFYTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++     GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 166 RANXFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 122
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 123 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HR 178
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 24/240 (10%)
Query: 217 ALLKM-SYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASK 273
           ALLK  S+       D +     IG G++G V        G  VAIK I         +K
Sbjct: 39  ALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAK 98
Query: 274 SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI-VYKYMPNGSLEKWLHPDAIPQR 332
             + E K LK+ +H N++  I           +FK++ V   +    L + +H       
Sbjct: 99  RTLRELKILKHFKHDNII-AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS----- 152
Query: 333 DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG 392
                 Q LTL         +   L Y+H      ++H DLKPSN+L++ +    IGDFG
Sbjct: 153 ------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203
Query: 393 LSRFYQAVSNPTVSSSIGVR--GTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKK 449
           ++R     ++P            T  Y APE  L   E +   D++S G +  EM+  ++
Sbjct: 204 MAR--GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 39/233 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           +   ++IG G    V + V    G   A+K++ +  +  S   + E +     R  +++R
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR-RETHILR 154
Query: 293 VITSCSSV-----DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            +     +      ++ + F  +V+  M  G L  +L            E   L+  +  
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-----------TEKVALSEKETR 203
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           SI   +  A+ +LH +    I+H DLKP NILLD+++   + DFG S   +         
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR--- 257
Query: 408 SIGVRGTIGYVAPEY----------GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT GY+APE           G G EV    D+++ G++L  ++    P
Sbjct: 258 --ELCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPP 304

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDG--TV-VAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D     TV VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS-IAI 351
           +     +   +      +V +  P GSL            DR  + Q   LL  +S  A+
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSL-----------LDRLRKHQGHFLLGTLSRYAV 122
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            VA  + YL     +  +H DL   N+LL       IGDFGL R      +  V      
Sbjct: 123 QVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HR 178
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +    + APE       S   D + +G+ L EM T
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEYS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEYS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 11/107 (10%)
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL------SRFYQAV 400
           + I I +A A+++LH    + ++H DLKPSNI    D    +GDFGL          Q V
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 401 SN--PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
               P  ++  G  GT  Y++PE   G+  S   D++S G++L E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+K+I+  +  +S  +    E + +K + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V +Y   G +  +L       R +E E +        +    + SA
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHG---RMKEKEAR--------AKFRQIVSA 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GTI 415
           + Y HQ     I+H DLK  N+LLD D++  I DFG S  +      T  + +    G+ 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF------TFGNKLDTFCGSP 176
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEYS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 35/238 (14%)
Query: 225 SLLKATD------GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFM 276
           S+  ATD       +     IG G+F  V        G  VA+K+I+  +   +  +   
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 277 AECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI 336
            E + +K + H N+V++     +          +V +Y   G +  +L       R +E 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIET-----EKTLYLVMEYASGGEVFDYLVAHG---RMKEK 114
Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF 396
           E +        +    + SA+ Y HQ     I+H DLK  N+LLD D++  I DFG S  
Sbjct: 115 EAR--------AKFRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNE 163
Query: 397 YQAVSNPTVSSSIGVR-GTIGYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
           +      TV + +    G+  Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 164 F------TVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     IG GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+K+I+  +  +S  +    E + +K + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V +Y   G +  +L       R +E E +        +    + SA
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHG---RMKEKEAR--------AKFRQIVSA 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GTI 415
           + Y HQ     I+H DLK  N+LLD D++  I DFG S  +      T  + +    G+ 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF------TFGNKLDTFCGSP 176
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + 
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           LK+++H+N   L+ V T   S++ + ND   + +  +    L            +  ++ 
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLE-EFNDVYLVTH--LMGADL------------NNIVKC 119
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           QKLT      +   +   L Y+H      I+H DLKPSN+ ++ D    I D GL+R   
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARH-- 174
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
                T     G   T  Y APE  L     +   D++S G ++ E++T +
Sbjct: 175 -----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 99/240 (41%), Gaps = 24/240 (10%)
Query: 217 ALLKM-SYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASK 273
           ALLK  S+       D +     IG G++G V        G  VAIK I         +K
Sbjct: 40  ALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAK 99
Query: 274 SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI-VYKYMPNGSLEKWLHPDAIPQR 332
             + E K LK+ +H N++  I           +FK++ V   +    L + +H       
Sbjct: 100 RTLRELKILKHFKHDNII-AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS----- 153
Query: 333 DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG 392
                 Q LTL         +   L Y+H      ++H DLKPSN+L++ +    IGDFG
Sbjct: 154 ------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 204
Query: 393 LSRFYQAVSNPTVSSSIGVR--GTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKK 449
           ++R     ++P            T  Y APE  L   E +   D++S G +  EM+  ++
Sbjct: 205 MAR--GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 94  PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 137
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 138 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 187
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 188 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 122 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 165
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 166 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 215
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 216 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    +++   
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF-- 192
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 99/226 (43%), Gaps = 34/226 (15%)
Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
            LIG G FG VY G +  +   VAI++I+++R      K+F  E  A +  RH+N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            +C S         AI+       +L   +       RD +I    L + +   IA ++ 
Sbjct: 96  GACMS-----PPHLAIITSLCKGRTLYSVV-------RDAKI---VLDVNKTRQIAQEIV 140
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-G 413
             + YLH    + ILH DLK  N+  DN     I DFGL      +        + ++ G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 414 TIGYVAPE--YGLGSEV-------STNGDVYSYGILLLEMVTTKKP 450
            + ++APE    L  +        S + DV++ G +  E+   + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFL----------QVRKFSLDLASLILYAYQLS 501
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+ ++    +GDFGLSR+   + + T   +   +  
Sbjct: 502 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLP 555
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 83  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  +   +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 178 TSFMMEPEVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVR 292
           +G G+FG VY+G       D     VA+K +  +  +     F+ E   +    H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  V  Q    + I+ + M  G L+ +L       R R  +   L +L  + +A D
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHVARD 149
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSR-FYQAVSNPTVSSS 408
           +A    YL ++     +H D+   N LL        A IGDFG+++  Y+A        +
Sbjct: 150 IACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCA 206
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +     + ++ PE  +    ++  D +S+G+LL E+ +
Sbjct: 207 M---LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVITS 296
           IG G+ G V        G  VA+K ++   Q Q  +K    E   LK + HKN++ ++  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                            + P  +LE++     +      +E+    L Q I + +D    
Sbjct: 90  -----------------FTPQKTLEEFQDVYLV------MELMDANLCQVIHMELDHERM 126
Query: 357 LDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
              L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A +N  ++  +
Sbjct: 127 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYV 184
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             R    Y APE  LG     N D++S G ++ E+V
Sbjct: 185 VTR---YYRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIR 286
           +D +     +G G++G V        G   AIK+I   ++     S + + E   LK + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N++++        F+      +V +    G L            D  I  QK + +  
Sbjct: 80  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGEL-----------FDEIILRQKFSEVDA 123
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
             I   V S   YLH+H    I+H DLKP N+LL++   D    I DFGLS  ++     
Sbjct: 124 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE----- 175
Query: 404 TVSSSIGVR-GTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            V   +  R GT  Y+APE  L  +     DV+S G++L
Sbjct: 176 -VGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 212

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRH 287
           TD +     IG G+F  V + V    G   A K+IN ++  A   +    E +  + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+VR+  S S        F  +V+  +  G L      + I  R+   E      +Q+I
Sbjct: 63  SNIVRLHDSISE-----EGFHYLVFDLVTGGEL-----FEDIVAREYYSEADASHCIQQI 112
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDFGLSRFYQAVSNPT 404
             A+        LH H Q  ++H DLKP N+LL +     +  + DFGL+   Q      
Sbjct: 113 LEAV--------LHCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ-- 161
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  G  GT GY++PE           D+++ G++L  ++    P
Sbjct: 162 --AWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+K+I+  +  +S  +    E + +K + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V +Y   G +  +L       R +E E +        +    + SA
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHG---RMKEKEAR--------AKFRQIVSA 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GTI 415
           + Y HQ     I+H DLK  N+LLD D++  I DFG S  +      T  + +    G  
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF------TFGNKLDAFCGAP 176
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 190 VMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYK 249
           V+V  +    H   R  +  +E +          K +    + F    +IG G+FG V  
Sbjct: 49  VLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAV 108
Query: 250 GVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND 306
                   + A+K++N   + ++  +  F  E   L N       + IT+     FQ  +
Sbjct: 109 VKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN----GDCQWITALHYA-FQDEN 163
Query: 307 FKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
              +V  Y   G L   L    D +P+      I ++ L      AID    L Y+H+  
Sbjct: 164 HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL------AIDSIHQLHYVHR-- 215
Query: 365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEY-- 422
                  D+KP N+LLD +    + DFG     +   + TV SS+ V GT  Y++PE   
Sbjct: 216 -------DIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAV-GTPDYISPEILQ 265
Query: 423 ----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               G+G +     D +S G+ + EM+  + P
Sbjct: 266 AMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 296

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIRHKN 289
           FS    IG GSFG+VY      +  VVAIK ++    Q     +  + E + L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            ++    C    +       +V +Y   GS    L     P ++ EI       LQ    
Sbjct: 116 TIQY-RGC----YLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQ---- 165
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                  L YLH H    ++H D+K  NILL       +GDFG S    A +N  V    
Sbjct: 166 ------GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFV---- 211
Query: 410 GVRGTIGYVAPEYGLG-SEVSTNG--DVYSYGILLLEMVTTKKP 450
              GT  ++APE  L   E   +G  DV+S GI  +E+   K P
Sbjct: 212 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I +       
Sbjct: 94  PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFXEPHAR 137
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 138 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 187
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 188 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKA 281
           +K      D +   +++G G+F  V          +VAIK I  +  +G   S   E   
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L  I+H N+V +        ++      ++ + +  G L            DR +E    
Sbjct: 70  LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-----------FDRIVEKGFY 113
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL---LDNDLSAHIGDFGLSRFYQ 398
           T      +   V  A+ YLH      I+H DLKP N+L   LD D    I DFGLS+   
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--- 167
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            + +P    S    GT GYVAPE       S   D +S G++
Sbjct: 168 -MEDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKA 281
           +K      D +   +++G G+F  V          +VAIK I  +  +G   S   E   
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L  I+H N+V +        ++      ++ + +  G L            DR +E    
Sbjct: 70  LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-----------FDRIVEKGFY 113
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL---LDNDLSAHIGDFGLSRFYQ 398
           T      +   V  A+ YLH      I+H DLKP N+L   LD D    I DFGLS+   
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--- 167
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            + +P    S    GT GYVAPE       S   D +S G++
Sbjct: 168 -MEDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 122 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 177
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 178 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNI 285
           K +D +     +G G+F  V + V    G   A K+IN ++  A   +    E +  + +
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H N+VR+  S      Q   F  +V+  +  G L      + I  R+   E      +Q
Sbjct: 62  QHPNIVRLHDS-----IQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQ 111
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LSAHIGDFGLSRFYQAVSN 402
           +I        ++ Y H +    I+H +LKP N+LL +     +  + DFGL     A+  
Sbjct: 112 QI------LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL-----AIEV 157
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               +  G  GT GY++PE       S   D+++ G++L  ++    P
Sbjct: 158 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNI 285
           K +D +     +G G+F  V + V    G   A K+IN ++  A   +    E +  + +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H N+VR+  S      Q   F  +V+  +  G L      + I  R+   E      +Q
Sbjct: 63  QHPNIVRLHDS-----IQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQ 112
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LSAHIGDFGLSRFYQAVSN 402
           +I        ++ Y H +    I+H +LKP N+LL +     +  + DFGL     A+  
Sbjct: 113 QI------LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL-----AIEV 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               +  G  GT GY++PE       S   D+++ G++L  ++    P
Sbjct: 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G FG V++G +   G  VA+K+ + + +   +S+  E +  + +  RH+N++  I +
Sbjct: 12  IGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 66
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +  +        +V  Y  +GSL  +L+   +            T+   I +A+  AS 
Sbjct: 67  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTV------------TVEGMIKLALSTASG 113
Query: 357 LDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL     AV + + + +I +
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-----AVRHDSATDTIDI 168
Query: 412 R-----GTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMV 445
                 GT  Y+APE    S      E     D+Y+ G++  E+ 
Sbjct: 169 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 194
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 195 VGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 45/228 (19%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G++GSV K V    G ++A+K I        +S + E +  + +   ++V   + C 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--------RSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 299 S-VDFQGNDFKA----IVYKYMPNGSLEKWLH------PDAIPQRDREIEIQKLTLLQRI 347
             V F G  F+     I  + M + S +K+         D IP+           +L +I
Sbjct: 82  YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEE----------ILGKI 130
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           ++A     AL++L ++ +  I+H D+KPSNILLD   +  + DFG+S   Q V +   + 
Sbjct: 131 TLA--TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG--QLVDSIAKTR 184
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNG-----DVYSYGILLLEMVTTKKP 450
             G R    Y+APE  +    S  G     DV+S GI L E+ T + P
Sbjct: 185 DAGCR---PYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 29/228 (12%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNI 285
           K +D +     +G G+F  V + V    G   A K+IN ++  A   +    E +  + +
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H N+VR+  S      Q   F  +V+  +  G L      + I  R+   E      +Q
Sbjct: 63  QHPNIVRLHDS-----IQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQ 112
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LSAHIGDFGLSRFYQAVSN 402
           +I        ++ Y H +    I+H +LKP N+LL +     +  + DFGL     A+  
Sbjct: 113 QI------LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL-----AIEV 158
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               +  G  GT GY++PE       S   D+++ G++L  ++    P
Sbjct: 159 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRH 287
           + F    ++G GSF +V            AIK++   ++ ++        E   +  + H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
              V++  +     FQ ++       Y  NG L K++         R+I     T   R 
Sbjct: 92  PFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC-TRF 136
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++
Sbjct: 137 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 193 XF--VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 87  PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 130
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG   F + V   T + 
Sbjct: 131 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGRTWT- 183
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 184 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 194
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 192
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 194
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 192
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G FG V++G +   G  VA+K+ + + +   +S+  E +  + +  RH+N++  I +
Sbjct: 50  IGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 104
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +  +        +V  Y  +GSL  +L+   +            T+   I +A+  AS 
Sbjct: 105 DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTV------------TVEGMIKLALSTASG 151
Query: 357 LDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL     AV + + + +I +
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-----AVRHDSATDTIDI 206
Query: 412 R-----GTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMV 445
                 GT  Y+APE    S      E     D+Y+ G++  E+ 
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRH 287
           + F    ++G GSF +V            AIK++   ++ ++        E   +  + H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
              V++  +     FQ ++       Y  NG L K++         R+I     T   R 
Sbjct: 95  PFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC-TRF 139
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++
Sbjct: 140 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 196 XF--VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRH 287
           TD +     +G G+F  V + V        A K+IN ++  A   +    E +  + ++H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+VR+  S S        F  +V+  +  G L      + I  R+   E      + +I
Sbjct: 90  PNIVRLHDSISE-----EGFHYLVFDLVTGGELF-----EDIVAREYYSEADASHCIHQI 139
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDFGLSRFYQAVSNPT 404
                   +++++HQH    I+H DLKP N+LL +     +  + DFGL+   Q      
Sbjct: 140 ------LESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQ-- 188
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +  G  GT GY++PE           D+++ G++L  ++    P
Sbjct: 189 --AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 110/272 (40%), Gaps = 35/272 (12%)
Query: 190 VMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYK 249
           V+V  +    H   R  +  +E +          K +    + F    +IG G+FG V  
Sbjct: 33  VLVCLYTECSHSALRRDKYVAEFLEWAKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAV 92
Query: 250 GVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND 306
                   + A+K++N   + ++  +  F  E   L N       + IT+     FQ  +
Sbjct: 93  VKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN----GDCQWITALHYA-FQDEN 147
Query: 307 FKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
              +V  Y   G L   L    D +P+      I ++ L      AID    L Y+H+  
Sbjct: 148 HLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL------AIDSIHQLHYVHR-- 199
Query: 365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEY-- 422
                  D+KP N+LLD +    + DFG     +   + TV SS+ V GT  Y++PE   
Sbjct: 200 -------DIKPDNVLLDVNGHIRLADFGSC--LKMNDDGTVQSSVAV-GTPDYISPEILQ 249
Query: 423 ----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               G+G +     D +S G+ + EM+  + P
Sbjct: 250 AMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 194
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 195 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 145 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 199
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 200 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 137 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 191
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 192 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 24/223 (10%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRH 287
           + F    ++G GSF +V            AIK++   ++ ++        E   +  + H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
              V++  +     FQ ++       Y  NG L K++         R+I     T   R 
Sbjct: 93  PFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYI---------RKIGSFDETC-TRF 137
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++
Sbjct: 138 YTA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 193
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 194 XF--VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+K+I+  +  +S  +    E + +K + H N+V++   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA-IPQRDREIEIQKLTLLQRISIAIDVAS 355
             +          +V +Y   G +  +L     + +++   + ++            + S
Sbjct: 75  IET-----EKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQ------------IVS 117
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GT 414
           A+ Y HQ     I+H DLK  N+LLD D++  I DFG S  +      T  + +    G+
Sbjct: 118 AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF------TFGNKLDTFCGS 168
Query: 415 IGYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
             Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKA 281
           +K      D +   +++G G+F  V          +VAIK I  +  +G   S   E   
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L  I+H N+V +        ++      ++ + +  G L            DR +E    
Sbjct: 70  LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-----------FDRIVEKGFY 113
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL---LDNDLSAHIGDFGLSRFYQ 398
           T      +   V  A+ YLH      I+H DLKP N+L   LD D    I DFGLS+   
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--- 167
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            + +P    S    GT GYVAPE       S   D +S G++
Sbjct: 168 -MEDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+++I+  +  +S  +    E + +K + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V +Y   G +  +L       R +E E +        +    + SA
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHG---RMKEKEAR--------AKFRQIVSA 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GTI 415
           + Y HQ     I+H DLK  N+LLD D++  I DFG S  +      T  + +    G+ 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF------TFGNKLDTFCGSP 176
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++ SAL+YLH    + I+H DLKP NILL+ D+   I DFG ++     S    ++    
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF-- 192
Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 95/224 (42%), Gaps = 33/224 (14%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIRHKN 289
           FS    IG GSFG+VY      +  VVAIK ++    Q     +  + E + L+ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            ++    C    +       +V +Y   GS    L     P ++ EI       LQ    
Sbjct: 77  TIQY-RGC----YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQ---- 126
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                  L YLH H    ++H D+K  NILL       +GDFG S    A +N  V    
Sbjct: 127 ------GLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFV---- 172
Query: 410 GVRGTIGYVAPEYGLG-SEVSTNG--DVYSYGILLLEMVTTKKP 450
              GT  ++APE  L   E   +G  DV+S GI  +E+   K P
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG   F + V   T + 
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGRTWT- 198
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 199 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 83  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  +   +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 178 TSFMMEPEVVTR---YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 88  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 124
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 125 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 182
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 183 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G FG V++G +   G  VA+K+ + + +   +S+  E +  + +  RH+N++  I +
Sbjct: 14  IGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 68
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +  +        +V  Y  +GSL  +L+   +            T+   I +A+  AS 
Sbjct: 69  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTV------------TVEGMIKLALSTASG 115
Query: 357 LDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL     AV + + + +I +
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-----AVRHDSATDTIDI 170
Query: 412 R-----GTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMV 445
                 GT  Y+APE    S      E     D+Y+ G++  E+ 
Sbjct: 171 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 28/222 (12%)
Query: 223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKA 281
           +K      D +   +++G G+F  V          +VAIK I  +  +G   S   E   
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L  I+H N+V +        ++      ++ + +  G L            DR +E    
Sbjct: 70  LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGEL-----------FDRIVEKGFY 113
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL---LDNDLSAHIGDFGLSRFYQ 398
           T      +   V  A+ YLH      I+H DLKP N+L   LD D    I DFGLS+   
Sbjct: 114 TERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--- 167
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            + +P    S    GT GYVAPE       S   D +S G++
Sbjct: 168 -MEDPGSVLSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G FG V++G +   G  VA+K+ + + +   +S+  E +  + +  RH+N++  I +
Sbjct: 17  IGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 71
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +  +        +V  Y  +GSL  +L+   +            T+   I +A+  AS 
Sbjct: 72  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTV------------TVEGMIKLALSTASG 118
Query: 357 LDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL     AV + + + +I +
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-----AVRHDSATDTIDI 173
Query: 412 R-----GTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMV 445
                 GT  Y+APE    S      E     D+Y+ G++  E+ 
Sbjct: 174 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G FG V++G +   G  VA+K+ + + +   +S+  E +  + +  RH+N++  I +
Sbjct: 37  IGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 91
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +  +        +V  Y  +GSL  +L+   +            T+   I +A+  AS 
Sbjct: 92  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTV------------TVEGMIKLALSTASG 138
Query: 357 LDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL     AV + + + +I +
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-----AVRHDSATDTIDI 193
Query: 412 R-----GTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMV 445
                 GT  Y+APE    S      E     D+Y+ G++  E+ 
Sbjct: 194 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIR 286
           +D +     +G G++G V        G   AIK+I   ++     S + + E   LK + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N++++        F+      +V +    G L      D I  R      QK + +  
Sbjct: 63  HPNIMKLYEF-----FEDKRNYYLVMEVYRGGEL-----FDEIILR------QKFSEVDA 106
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNP 403
             I   V S   YLH+H    I+H DLKP N+LL++   D    I DFGLS  ++     
Sbjct: 107 AVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE----- 158
Query: 404 TVSSSIGVR-GTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            V   +  R GT  Y+APE  L  +     DV+S G++L
Sbjct: 159 -VGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVIL 195

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G FG V++G +   G  VA+K+ + + +   +S+  E +  + +  RH+N++  I +
Sbjct: 11  IGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAA 65
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +  +        +V  Y  +GSL  +L+   +            T+   I +A+  AS 
Sbjct: 66  DNKDNGTWTQL-WLVSDYHEHGSLFDYLNRYTV------------TVEGMIKLALSTASG 112
Query: 357 LDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL     AV + + + +I +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL-----AVRHDSATDTIDI 167
Query: 412 R-----GTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEM 444
                 GT  Y+APE    S      E     D+Y+ G++  E+
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKA 281
           K+  +    + S   +G G++GSV   +    G  VAIK ++   Q +  +K    E   
Sbjct: 17  KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLL 76
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAIVYKYMP--NGSLEKWLHPDAIPQRDREI 336
           LK+++H+N   L+ V T  SS+     DF    Y  MP     L+K      +  +  E 
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLR-NFYDF----YLVMPFMQTDLQK-----IMGLKFSEE 126
Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF 396
           +IQ L           +   L Y+H      ++H DLKP N+ ++ D    I DFGL+R 
Sbjct: 127 KIQYLVY--------QMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175
Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
             A          G   T  Y APE  L     +   D++S G ++ EM+T K
Sbjct: 176 ADA-------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 110/234 (47%), Gaps = 55/234 (23%)
Query: 233 FSSTNLIGVGSFGS-VYKGVFDEDGTVVAIKVINLQRQGASKSFMAEC-----KALKNIR 286
           F   +++G G+ G+ VY+G+FD              R  A K  + EC     + ++ +R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFD-------------NRDVAVKRILPECFSFADREVQLLR 72
Query: 287 ----HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-REIEIQKL 341
               H N++R    C+  D Q   F+ I  + +   +L+++     + Q+D   + ++ +
Sbjct: 73  ESDEHPNVIRYF--CTEKDRQ---FQYIAIE-LCAATLQEY-----VEQKDFAHLGLEPI 121
Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-----NDLSAHIGDFGLSRF 396
           TLLQ+ +      S L +LH      I+H DLKP NIL+        + A I DFGL + 
Sbjct: 122 TLLQQTT------SGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG----DVYSYGILLLEMVT 446
             AV   + S   GV GT G++APE  L  +   N     D++S G +   +++
Sbjct: 173 L-AVGRHSFSRRSGVPGTEGWIAPEM-LSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 78  GVIT------ENPVWIIMELCTLGELRSFL----------QVRKFSLDLASLILYAYQLS 121
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+       +GDFGLSR+   + + T   +   +  
Sbjct: 122 TALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRY---MEDSTYYKASKGKLP 175
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 77  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 113
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 114 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 171
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
           ++  ++  +  R    Y APE  LG     N D++S G ++ EMV  K
Sbjct: 172 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVVAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLSQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             +  R    Y APE  LG     N D++S G+++ EM+
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 83  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           ++  ++  +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 178 TSFMMTPEVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNI 285
           K +D +     +G G+F  V + V    G   A K+IN ++  A   +    E +  + +
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H N+VR+  S      Q   F  +V+  +  G L      + I  R+   E      +Q
Sbjct: 86  QHPNIVRLHDS-----IQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQ 135
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LSAHIGDFGLSRFYQAVSN 402
           +I        ++ Y H +    I+H +LKP N+LL +     +  + DFGL     A+  
Sbjct: 136 QI------LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL-----AIEV 181
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
               +  G  GT GY++PE       S   D+++ G++L
Sbjct: 182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+++D      + DFGL++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 27/210 (12%)
Query: 245 GSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG 304
           G ++KG +  +  VV +  +       S+ F  EC  L+   H N++ V+ +C S     
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS---PP 80
Query: 305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC 364
                ++  + P GSL   LH       D+          Q +  A+D A    +L  H 
Sbjct: 81  APHPTLITHWXPYGSLYNVLHEGTNFVVDQS---------QAVKFALDXARGXAFL--HT 129
Query: 365 QEPIL-HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG 423
            EP++    L   ++ +D D +A I    +   +Q         S G      +VAPE  
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQ---------SPGRXYAPAWVAPEAL 180
Query: 424 LGSEVSTN---GDVYSYGILLLEMVTTKKP 450
                 TN    D +S+ +LL E+VT + P
Sbjct: 181 QKKPEDTNRRSADXWSFAVLLWELVTREVP 210

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 43/219 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLSQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             +  R    Y APE  LG     N D++S G+++ EM+
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+++I+  +  +S  +    E + +K + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V +Y   G +  +L       R +E E +        +    + SA
Sbjct: 82  IET-----EKTLYLVMEYASGGEVFDYLVAHG---RMKEKEAR--------AKFRQIVSA 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG-VRGTI 415
           + Y HQ     I+H DLK  N+LLD D++  I DFG S  +      T  + +    G+ 
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF------TFGNKLDEFCGSP 176
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/140 (32%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID-VASALDYLHQHCQEPI 368
           I+Y+YM N S+ K+     +  ++    I     +Q I   I  V ++  Y+H   ++ I
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIP----IQVIKCIIKSVLNSFSYIHN--EKNI 173
Query: 369 LHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI-GVRGTIGYVAPEYGLGSE 427
            H D+KPSNIL+D +    + DFG S +        V   I G RGT  ++ PE+   +E
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFGESEY-------MVDKKIKGSRGTYEFMPPEF-FSNE 225
Query: 428 VSTNG---DVYSYGILLLEM 444
            S NG   D++S GI L  M
Sbjct: 226 SSYNGAKVDIWSLGICLYVM 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I +       
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFXEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+++D      + DFGL++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFXEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 51/229 (22%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           +G G +G V++G++   G  VA+K+ + + +   +S+  E +    +  RH N++  I S
Sbjct: 16  VGKGRYGEVWRGLWH--GESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          I + Y  +GSL  +L              Q+ TL   +++ + V++A
Sbjct: 71  DMTSRNSSTQLWLITH-YHEHGSLYDFL--------------QRQTLEPHLALRLAVSAA 115
Query: 357 LDYLHQHCQ-------EPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS-------N 402
               H H +         I H D K  N+L+ ++L   I D GL+  +   S       N
Sbjct: 116 CGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNN 175
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTN-------GDVYSYGILLLEM 444
           P V       GT  Y+APE  L  ++ T+        D++++G++L E+
Sbjct: 176 PRV-------GTKRYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +       +   I+ +    G L  +L          ++    L L   I  A  ++
Sbjct: 458 GVITE------NPVWIIMELCTLGELRSFL----------QVRKFSLDLASLILYAYQLS 501
Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           +AL YL     +  +H D+   N+L+       +GDFGLSR+   + + T   +   +  
Sbjct: 502 TALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRY---MEDSTYYKASKGKLP 555
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           I ++APE       ++  DV+ +G+ + E++
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+P G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVPGGEMFSHLR-----------RIGRFXEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQK----------VVKLKQIEHTLN 91
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R++ + +          F+ N    +V +Y P G +   L             I + +
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFS 140
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+++D      + DFG ++  +    
Sbjct: 141 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG--- 194
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 ----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 5/108 (4%)
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
           + +T+   IS +  VA  +++L        +H DL   NILL  +    I DFGL+R   
Sbjct: 194 EPITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLAR--D 248
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
              NP        R  + ++APE       ST  DV+SYG+LL E+ +
Sbjct: 249 IYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 84  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 120
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 121 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 178
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           ++  ++  +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 179 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 41/255 (16%)
Query: 208 QPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-- 265
           Q +EP++      +  K +    D F    +IG G+F  V      + G V A+K++N  
Sbjct: 44  QWAEPIV------VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW 97
Query: 266 -LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL 324
            + ++G    F  E   L N   + + ++  +     FQ  ++  +V +Y   G L   L
Sbjct: 98  DMLKRGEVSCFREERDVLVNGDRRWITQLHFA-----FQDENYLYLVMEYYVGGDLLTLL 152
Query: 325 HP--DAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN 382
               + IP      E+ +  L + I +AID    L Y+H+         D+KP NILLD 
Sbjct: 153 SKFGERIPA-----EMARFYLAE-IVMAIDSVHRLGYVHR---------DIKPDNILLDR 197
Query: 383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE-------YGLGSEVSTNGDVY 435
                + DFG     +A  + TV S + V GT  Y++PE                  D +
Sbjct: 198 CGHIRLADFGSCLKLRA--DGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 436 SYGILLLEMVTTKKP 450
           + G+   EM   + P
Sbjct: 255 ALGVFAYEMFYGQTP 269

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 83  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           ++  ++  +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 83  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 119
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A 
Sbjct: 120 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAG 177
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           ++  ++  +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 178 TSFMMTPYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           +G G +G V++G +   G  VA+K+ + + +   KS+  E +    +  RH+N++  I S
Sbjct: 45  VGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 99
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          I + Y   GSL  +L            ++  L  +  + I + +AS 
Sbjct: 100 DMTSRHSSTQLWLITH-YHEMGSLYDYL------------QLTTLDTVSCLRIVLSIASG 146
Query: 357 LDYLH-----QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  +    I D GL+  +   +N     +   
Sbjct: 147 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 206
Query: 412 RGTIGYVAPEYGLGSEVSTNG-------DVYSYGILLLEM 444
            GT  Y+APE  L   +  +        D++++G++L E+
Sbjct: 207 VGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 233 FSSTNLIGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
           + +   IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + H
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
           KN++ ++                   + P  SLE++     +      +E+    L Q I
Sbjct: 85  KNIIGLLNV-----------------FTPQKSLEEFQDVYIV------MELMDANLCQVI 121
Query: 348 SIAIDVASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
            + +D       L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R     
Sbjct: 122 QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----- 176
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           +  T    +    T  Y APE  LG     N D++S G ++ EM+
Sbjct: 177 TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 30/228 (13%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLV 291
           F    L+G G++G VYKG   + G + AIKV+++      +    E   LK    H+N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 84
Query: 292 RVITSCSSVDFQGNDFK-AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
               +    +  G D +  +V ++   GS+               I+  K   L+   IA
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL------------IKNTKGNTLKEEWIA 132
Query: 351 I---DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
               ++   L +LHQH    ++H D+K  N+LL  +    + DFG+S    A  + TV  
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGR 185
Query: 408 SIGVRGTIGYVAPEYGLGSE-----VSTNGDVYSYGILLLEMVTTKKP 450
                GT  ++APE     E          D++S GI  +EM     P
Sbjct: 186 RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 95/231 (41%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 72  MKAED-YDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L   +    +P++  +    ++ L
Sbjct: 131 FANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 185
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                       ALD +H      ++H D+KP N+LLD      + DFG           
Sbjct: 186 ------------ALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 404 TVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +++   GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 231 HCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 88/228 (38%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQK----------VVKLKQIEHTLN 91
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R+  + +          F+ N    +V +Y P G +   L             I + +
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLR-----------RIGRFS 140
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +    
Sbjct: 141 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG--- 194
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 ----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK----------VVKLKQIEHTLN 90
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R++ + +          F+ N    +V +Y+  G +   L             I + +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFS 139
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +    
Sbjct: 140 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 194 ----RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/239 (22%), Positives = 104/239 (43%), Gaps = 32/239 (13%)
Query: 217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM 276
           ++++  +++ ++ TDG+     IGVGS+    + +        A+K+I+  ++  ++   
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE 67
Query: 277 AECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGS-LEKWLHPDAIPQRDRE 335
                L+  +H N++ +        +    +  +V + M  G  L+K L      +R+  
Sbjct: 68  I---LLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119
Query: 336 IEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDF 391
                       ++   +   ++YLH    + ++H DLKPSNIL      N  S  I DF
Sbjct: 120 ------------AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           G ++  +A +   ++       T  +VAPE           D++S G+LL  M+T   P
Sbjct: 165 GFAKQLRAENGLLMTPCY----TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+++D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+ G V+K  F + G V+A+K   ++R G  +        L  +   +    I  C 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVK--QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 299 SVDFQGND-FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                  D F A+         L+K +    IP+R          +L ++++AI    AL
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPER----------ILGKMTVAI--VKAL 137
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
            YL +  +  ++H D+KPSNILLD      + DFG+S   + V +     S G      Y
Sbjct: 138 YYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGC---AAY 190
Query: 418 VAPEY-----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +APE          +     DV+S GI L+E+ T + P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           +G G +G V++G +   G  VA+K+ + + +   KS+  E +    +  RH+N++  I S
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          I + Y   GSL  +L            ++  L  +  + I + +AS 
Sbjct: 71  DMTSRHSSTQLWLITH-YHEMGSLYDYL------------QLTTLDTVSCLRIVLSIASG 117
Query: 357 LDYLH-----QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  +    I D GL+  +   +N     +   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 412 RGTIGYVAPEYGLGSEVSTNG-------DVYSYGILLLEM 444
            GT  Y+APE  L   +  +        D++++G++L E+
Sbjct: 178 VGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           +G G +G V++G +   G  VA+K+ + + +   KS+  E +    +  RH+N++  I S
Sbjct: 16  VGKGRYGEVWRGSWQ--GENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIAS 70
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          I + Y   GSL  +L            ++  L  +  + I + +AS 
Sbjct: 71  DMTSRHSSTQLWLITH-YHEMGSLYDYL------------QLTTLDTVSCLRIVLSIASG 117
Query: 357 LDYLH-----QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  +    I D GL+  +   +N     +   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 412 RGTIGYVAPEYGLGSEVSTNG-------DVYSYGILLLEM 444
            GT  Y+APE  L   +  +        D++++G++L E+
Sbjct: 178 VGTKRYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK----------VVKLKQIEHTLN 90
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R++ + +          F+ N    +V +Y+  G +   L             I + +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFS 139
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +    
Sbjct: 140 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 194 ----RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLSQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 29/218 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G+F  V        G  VA+K+I+  +  +S  +    E +  K + H N+V++   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             +          +V +Y   G +  +L       R +E E +        +    + SA
Sbjct: 82  IET-----EKTLYLVXEYASGGEVFDYLVAHG---RXKEKEAR--------AKFRQIVSA 125
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-GTI 415
           + Y HQ     I+H DLK  N+LLD D +  I DFG S  +      T  + +    G  
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF------TFGNKLDAFCGAP 176
Query: 416 GYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD 452
            Y APE   G +      DV+S G++L  +V+   P D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 122 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 165
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG   F + V   T + 
Sbjct: 166 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG---FAKRVKGATWT- 218
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 219 ---LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLSQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLSQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK----------VVKLKQIEHTLN 91
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R++ + +          F+ N    +V +Y P G +   L             I + +
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFS 140
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+++D      + DFG ++  +    
Sbjct: 141 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG--- 194
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 ----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 34/170 (20%)
Query: 278 ECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE 337
           E   LK++ H N++++        F+   +  +V ++   G L      + I  R +  E
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGEL-----FEQIINRHKFDE 145
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LSAHIGDFGLS 394
                ++++I       S + YLH+H    I+H D+KP NILL+N    L+  I DFGLS
Sbjct: 146 CDAANIMKQI------LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 395 RFYQAVSNPTVSSSIGVR---GTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
            F+        S    +R   GT  Y+APE  L  + +   DV+S G+++
Sbjct: 197 SFF--------SKDYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIM 237

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 43/219 (19%)
Query: 239 IGVGSFGSV---YKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRV 293
           IG G+ G V   Y  + + +   VAIK ++   Q Q  +K    E   +K + HKN++ +
Sbjct: 32  IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +                   + P  SLE++     +      +E+    L Q I + +D 
Sbjct: 89  LNV-----------------FTPQKSLEEFQDVYIV------MELMDANLSQVIQMELDH 125
Query: 354 ASALDYLHQ------HCQEP-ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
                 L+Q      H     I+H DLKPSNI++ +D +  I DFGL+R   A ++  ++
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMT 183
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
             +  R    Y APE  LG     N D++S G ++ EM+
Sbjct: 184 PYVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK----------VVKLKQIEHTLN 91
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R++ + +          F+ N    +V +Y P G +   L             I + +
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFS 140
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+++D      + DFG ++  +    
Sbjct: 141 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG--- 194
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 ----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y P G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+++D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 98/245 (40%), Gaps = 41/245 (16%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQRQGASKSFMAECKALKNIRHK 288
           D +   +LIG GS+G V +     +  VVAIK I    +     K  + E   L  + H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           ++V+V+      D +  D   +V + + +   +K       P    E+ I+  TLL  + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFR---TPVYLTELHIK--TLLYNLL 166
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           + +       Y+H      ILH DLKP+N L++ D S  + DFGL+R      N      
Sbjct: 167 VGVK------YVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 409 IGVRG-----------------------TIGYVAPEYGLGSEVSTNG-DVYSYGILLLEM 444
           I  R                        T  Y APE  L  E  T   DV+S G +  E+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 445 VTTKK 449
           +   K
Sbjct: 278 LNMIK 282

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 88  PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 131
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 132 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-------R 181
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 182 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/228 (23%), Positives = 88/228 (38%), Gaps = 39/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-N 289
           D F     +G GSFG V      E G   A+K+++ Q+             LK I H  N
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQK----------VVKLKQIEHTLN 91
Query: 290 LVRVITSCS-------SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
             R++ + +          F+ N    +V +Y P G +   L             I +  
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFX 140
Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                  A  +    +YLH      +++ DLKP N+++D      + DFG ++  +    
Sbjct: 141 EPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG--- 194
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 ----RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 51/247 (20%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--------------------------L 266
           ++  + IG GS+G V     + D T  A+KV++                          +
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 267 QRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP 326
           Q +G  +    E   LK + H N+V+++     +D    D   +V++ +  G + +    
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLV---EVLDDPNEDHLYMVFELVNQGPVME---- 127
Query: 327 DAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA 386
             +P      E Q     Q      D+   ++YLH    + I+H D+KPSN+L+  D   
Sbjct: 128 --VPTLKPLSEDQARFYFQ------DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHI 176
Query: 387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG---DVYSYGILLLE 443
            I DFG+S  ++  S+  +S+++   GT  ++APE    +    +G   DV++ G+ L  
Sbjct: 177 KIADFGVSNEFKG-SDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 444 MVTTKKP 450
            V  + P
Sbjct: 233 FVFGQCP 239

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 102 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 145
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 146 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 195
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 196 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y P G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYAPGGEMFSHLR-----------RIGRFXEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+++D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFAEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 30/226 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           + FS   +IG G FG VY     + G + A+K ++ +R    K    E  AL      +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 291 VRV----ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           V         C S  F   D  + +   M  G L   L    +            +    
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----------FSEADM 294
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPTV 405
              A ++   L+++H      +++ DLKP+NILLD      I D GL+  F +   + +V
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 351
Query: 406 SSSIGVRGTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                  GT GY+APE    G    ++ D +S G +L +++    P
Sbjct: 352 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 30/226 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           + FS   +IG G FG VY     + G + A+K ++ +R    K    E  AL      +L
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 244
Query: 291 VRV----ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           V         C S  F   D  + +   M  G L   L    +            +    
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----------FSEADM 293
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPTV 405
              A ++   L+++H      +++ DLKP+NILLD      I D GL+  F +   + +V
Sbjct: 294 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV 350
Query: 406 SSSIGVRGTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                  GT GY+APE    G    ++ D +S G +L +++    P
Sbjct: 351 -------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLV 291
           F     +G G+F  V        G + A+K I  +  +G   S   E   L+ I+H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            +        ++  +   +V + +  G L      D I ++    E    TL+++     
Sbjct: 84  ALEDI-----YESPNHLYLVMQLVSGGEL-----FDRIVEKGFYTEKDASTLIRQ----- 128
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
            V  A+ YLH+     I+H DLKP N+L    D +    I DFGLS+         +S++
Sbjct: 129 -VLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTA 182
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
            G   T GYVAPE       S   D +S G++
Sbjct: 183 CG---TPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 28/225 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           + FS   +IG G FG VY     + G + A+K ++ +R    K    E  AL      +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 291 VRV----ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           V         C S  F   D  + +   M  G L   L    +            +    
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----------FSEADM 294
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
              A ++   L+++H      +++ DLKP+NILLD      I D GL+  +   S     
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPH 348
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +S+   GT GY+APE    G    ++ D +S G +L +++    P
Sbjct: 349 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFXEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 92/225 (40%), Gaps = 28/225 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           + FS   +IG G FG VY     + G + A+K ++ +R    K    E  AL      +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 291 VRV----ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           V         C S  F   D  + +   M  G L   L    +            +    
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-----------FSEADM 294
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
              A ++   L+++H      +++ DLKP+NILLD      I D GL+  +   S     
Sbjct: 295 RFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPH 348
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +S+   GT GY+APE    G    ++ D +S G +L +++    P
Sbjct: 349 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I +       
Sbjct: 96  PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFXEPHAR 139
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 140 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 189
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 190 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFXEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I +       
Sbjct: 122 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFXEPHAR 165
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 166 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 215
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 216 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I +       
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFXEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G+F  V + V    G   A K+IN ++  A   +    E +  + ++H N+VR+  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            S    +G+ +  +++  +  G L      + I  R+   E      +Q+I  A+     
Sbjct: 90  ISE---EGHHY--LIFDLVTGGELF-----EDIVAREYYSEADASHCIQQILEAV----- 134
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
              LH H Q  ++H DLKP N+LL + L   +  + DFGL+   +        +  G  G
Sbjct: 135 ---LHCH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ----AWFGFAG 186
Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T GY++PE           D+++ G++L  ++    P
Sbjct: 187 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRH 287
           + +     IG GS+G V+K    + G +VAIK   L+ +      K  + E + LK ++H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            NLV ++       F+      +V++Y  +  L    H     QR     + K       
Sbjct: 62  PNLVNLLEV-----FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVK------- 105
Query: 348 SIAIDVASALDYLHQH-CQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           SI      A+++ H+H C    +H D+KP NIL+       + DFG +R     S+    
Sbjct: 106 SITWQTLQAVNFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YYD 160
Query: 407 SSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVT 446
             +  R    Y +PE  +G ++     DV++ G +  E+++
Sbjct: 161 DEVATR---WYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 106/245 (43%), Gaps = 58/245 (23%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---------QRQGASKSFMAECKA 281
           + +    ++G G    V + +        A+K+I++         + Q   ++ + E   
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 282 LKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
           L+ +  H N++++  +     ++ N F  +V+  M  G L  +L              +K
Sbjct: 77  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL-------------TEK 118
Query: 341 LTLLQR-----ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           +TL ++     +   ++V  AL  L+      I+H DLKP NILLD+D++  + DFG S 
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS- 171
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEY----------GLGSEVSTNGDVYSYGILLLEMV 445
             Q      + S   V GT  Y+APE           G G EV    D++S G+++  ++
Sbjct: 172 -CQLDPGEKLRS---VCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLL 223
Query: 446 TTKKP 450
               P
Sbjct: 224 AGSPP 228

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 96/227 (42%), Gaps = 30/227 (13%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRH 287
           TD +     +G G+F  V + +    G   A K+IN ++  A   +    E +  + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+VR+  S S        F  +V+  +  G L      + I  R+   E      +Q+I
Sbjct: 63  PNIVRLHDSISE-----EGFHYLVFDLVTGGELF-----EDIVAREYYSEADASHCIQQI 112
Query: 348 SIAIDVASALDYLHQHCQ-EPILHCDLKPSNILLDND---LSAHIGDFGLSRFYQAVSNP 403
             +++          HC    I+H DLKP N+LL +     +  + DFGL+   Q     
Sbjct: 113 LESVN----------HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ- 161
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +  G  GT GY++PE           D+++ G++L  ++    P
Sbjct: 162 ---AWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRH 287
           TD +     +G G+F  V + +    G   A K+IN ++  A   +    E +  + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+VR+  S S        F  +V+  +  G L      + I  R+   E      +Q+I
Sbjct: 63  PNIVRLHDSISE-----EGFHYLVFDLVTGGELF-----EDIVAREYYSEADASHCIQQI 112
Query: 348 SIAIDVASALDYLHQHCQ-EPILHCDLKPSNILLDND---LSAHIGDFGLSRFYQAVSNP 403
             +++          HC    I+H DLKP N+LL +     +  + DFGL+   Q     
Sbjct: 113 LESVN----------HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ- 161
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
              +  G  GT GY++PE           D+++ G++L
Sbjct: 162 ---AWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 71  MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L   +    +P++           
Sbjct: 130 FANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----------- 173
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             R   A +V  ALD +H       +H D+KP N+LLD      + DFG           
Sbjct: 174 WARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 404 TVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +++   GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 230 RCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 66  MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L   +    +P++           
Sbjct: 125 FANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----------- 168
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             R   A +V  ALD +H       +H D+KP N+LLD      + DFG           
Sbjct: 169 WARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 404 TVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +++   GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 225 RCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    +IG GS+  V      +   + A+KV+  +     +       E    +   +  
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            +  + SC    FQ       V +Y+  G L   +      QR R++  +          
Sbjct: 67  FLVGLHSC----FQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFY----- 111
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           + +++ AL+YLH+     I++ DLK  N+LLD++    + D+G+ +  + +     +S  
Sbjct: 112 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXF 166
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE   G +   + D ++ G+L+ EM+  + P D
Sbjct: 167 C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  L    +   D ++ G+L+ +M     P
Sbjct: 195 TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/263 (22%), Positives = 119/263 (45%), Gaps = 36/263 (13%)
Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVA 260
           ++ + S  P   +  KA + +  ++     D       +G G++G V K      G ++A
Sbjct: 21  EQPQTSSTPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMA 80
Query: 261 IKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA----IVYKYMP 316
           +K I      A+ +   + + L ++     +R +    +V F G  F+     I  + M 
Sbjct: 81  VKRIR-----ATVNSQEQKRLLMDLDIS--MRTVDCPFTVTFYGALFREGDVWICMELM- 132
Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQRI--SIAIDVASALDYLHQHCQEPILHCDLK 374
           + SL+K+          +++  +  T+ + I   IA+ +  AL++LH      ++H D+K
Sbjct: 133 DTSLDKFY---------KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVK 181
Query: 375 PSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-- 432
           PSN+L++      + DFG+S +       T+ +     G   Y+APE  +  E++  G  
Sbjct: 182 PSNVLINALGQVKMCDFGISGYLVDSVAKTIDA-----GCKPYMAPER-INPELNQKGYS 235
Query: 433 ---DVYSYGILLLEMVTTKKPTD 452
              D++S GI ++E+   + P D
Sbjct: 236 VKSDIWSLGITMIELAILRFPYD 258

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 71  MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L   +    +P++           
Sbjct: 130 FANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----------- 173
Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
             R   A +V  ALD +H       +H D+KP N+LLD      + DFG           
Sbjct: 174 WARFYTA-EVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 404 TVSSSIGVRGTIGYVAPEY----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +++   GT  Y++PE     G         D +S G+ L EM+    P
Sbjct: 230 RCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHK 288
           +    +IG GSFG V K    +    VA+K++       RQ A      E + L+++R +
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQ 153
Query: 289 ---NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
              N + VI    +  F+ +         M    L K            + + Q  +L  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK------------KNKFQGFSLPL 201
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNP 403
               A  +   LD LH++    I+HCDLKP NILL     + I   DFG S +       
Sbjct: 202 VRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + S         Y APE  LG+      D++S G +L E++T
Sbjct: 259 XIQSRF-------YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 36/223 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHK 288
           +    +IG GSFG V K    +    VA+K++       RQ A      E + L+++R +
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQ 153
Query: 289 ---NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
              N + VI    +  F+ +         M    L K            + + Q  +L  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK------------KNKFQGFSLPL 201
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNP 403
               A  +   LD LH++    I+HCDLKP NILL     + I   DFG S +       
Sbjct: 202 VRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + S         Y APE  LG+      D++S G +L E++T
Sbjct: 259 XIQSRF-------YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+   D  + VA+K++        + + M+E K L  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--------- 342
            ++ +C+     G     ++ +Y   G L  +L      +R R+  I   T         
Sbjct: 114 NLLGACT---IGGPTL--VITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 162
Query: 343 ----LLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
               L   +S +  VA  + +L  ++C    +H DL   NILL +     I DFGL+R  
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHI 218
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  SN  V  +   R  + ++APE       +   DV+SYGI L E+ +
Sbjct: 219 KNDSNYVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 58/103 (56%), Gaps = 7/103 (6%)
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           + +++ AL+YLH+     I++ DLK  N+LLD++    + D+G+ +  + +     +S+ 
Sbjct: 159 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTF 213
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE   G +   + D ++ G+L+ EM+  + P D
Sbjct: 214 C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    +IG GS+  V      +   + A+KV+  +     +       E    +   +  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            +  + SC    FQ       V +Y+  G L   +      QR R++  +          
Sbjct: 71  FLVGLHSC----FQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFY----- 115
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           + +++ AL+YLH+     I++ DLK  N+LLD++    + D+G+ +  + +     +S  
Sbjct: 116 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXF 170
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE   G +   + D ++ G+L+ EM+  + P D
Sbjct: 171 C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 25/223 (11%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRHKN 289
           F    +IG GS+  V      +   + A+KV+  +     +       E    +   +  
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            +  + SC    FQ       V +Y+  G L   +      QR R++  +          
Sbjct: 82  FLVGLHSC----FQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFY----- 126
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           + +++ AL+YLH+     I++ DLK  N+LLD++    + D+G+ +  + +     +S  
Sbjct: 127 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXF 181
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE   G +   + D ++ G+L+ EM+  + P D
Sbjct: 182 C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+   D  + VA+K++        + + M+E K L  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--------- 342
            ++ +C+     G     ++ +Y   G L  +L      +R R+  I   T         
Sbjct: 91  NLLGACT---IGGPTL--VITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 139
Query: 343 ----LLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
               L   +S +  VA  + +L  ++C    +H DL   NILL +     I DFGL+R  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  SN  V  +   R  + ++APE       +   DV+SYGI L E+ +
Sbjct: 196 KNDSNYVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+++D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+APE  +    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G  G V+  V ++    VAIK I L    + K  + E K ++ + H N+V+V     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPD---AIPQRDREIEIQKLTLLQRISIAIDVAS 355
               Q  D    + +      +++++  D    + Q     E  +L + Q       +  
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ-------LLR 131
Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDN-DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            L Y+H      +LH DLKP+N+ ++  DL   IGDFGL+R      +     S G+  T
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-T 187
Query: 415 IGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
             Y +P   L     T   D+++ G +  EM+T K
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+   D  + VA+K++        + + M+E K L  +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--------- 342
            ++ +C+     G     ++ +Y   G L  +L      +R R+  I   T         
Sbjct: 107 NLLGACT---IGGPTL--VITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 155
Query: 343 ----LLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
               L   +S +  VA  + +L  ++C    +H DL   NILL +     I DFGL+R  
Sbjct: 156 LALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  SN  V  +   R  + ++APE       +   DV+SYGI L E+ +
Sbjct: 212 KNDSNYVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---------QRQGASKSFMAECKA 281
           + +    ++G G    V + +        A+K+I++         + Q   ++ + E   
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 282 LKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
           L+ +  H N++++  +     ++ N F  +V+  M  G L  +L              +K
Sbjct: 77  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL-------------TEK 118
Query: 341 LTLLQR-----ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           +TL ++     +   ++V  AL  L+      I+H DLKP NILLD+D++  + DFG S 
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS- 171
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEY----------GLGSEVSTNGDVYSYGILLLEMV 445
                 +P       V GT  Y+APE           G G EV    D++S G+++  ++
Sbjct: 172 ---CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLL 223
Query: 446 TTKKP 450
               P
Sbjct: 224 AGSPP 228

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+   D  + VA+K++        + + M+E K L  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--------- 342
            ++ +C+     G     ++ +Y   G L  +L      +R R+  I   T         
Sbjct: 114 NLLGACT---IGGPTL--VITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 162
Query: 343 ----LLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
               L   +S +  VA  + +L  ++C    +H DL   NILL +     I DFGL+R  
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  SN  V  +   R  + ++APE       +   DV+SYGI L E+ +
Sbjct: 219 KNDSNYVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 239 IGVGSFGSVYK----GVFDEDGTV-VAIKVINLQRQGASK-SFMAECKALKNI-RHKNLV 291
           +G G+FG V +    G+   D  + VA+K++        + + M+E K L  +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--------- 342
            ++ +C+     G     ++ +Y   G L  +L      +R R+  I   T         
Sbjct: 109 NLLGACT---IGGPTL--VITEYCCYGDLLNFL------RRKRDSFICSKTSPAIMEDDE 157
Query: 343 ----LLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
               L   +S +  VA  + +L  ++C    +H DL   NILL +     I DFGL+R  
Sbjct: 158 LALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  SN  V  +   R  + ++APE       +   DV+SYGI L E+ +
Sbjct: 214 KNDSNYVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 105/245 (42%), Gaps = 58/245 (23%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---------QRQGASKSFMAECKA 281
           + +    ++G G    V + +        A+K+I++         + Q   ++ + E   
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 282 LKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
           L+ +  H N++++  +     ++ N F  +V+  M  G L  +L              +K
Sbjct: 64  LRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL-------------TEK 105
Query: 341 LTLLQR-----ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           +TL ++     +   ++V  AL  L+      I+H DLKP NILLD+D++  + DFG S 
Sbjct: 106 VTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS- 158
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEY----------GLGSEVSTNGDVYSYGILLLEMV 445
                 +P       V GT  Y+APE           G G EV    D++S G+++  ++
Sbjct: 159 ---CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLL 210
Query: 446 TTKKP 450
               P
Sbjct: 211 AGSPP 215

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT  Y+AP   L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +          +G G++GSV           VA+K ++   Q    ++    E + 
Sbjct: 13  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 72
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAI-VYKYMPNGSLEKWLHPDAIPQRDREIE 337
           LK+++H+N   L+ V T  +S++    DF  + +   +    L   +   A+   D  ++
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIE----DFSEVYLVTTLMGADLNNIVKCQALS--DEHVQ 126
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
                LL+           L Y+H      I+H DLKPSN+ ++ D    I DFGL+R  
Sbjct: 127 FLVYQLLR----------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-- 171
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           QA    T     G   T  Y APE  L     +   D++S G ++ E++  K
Sbjct: 172 QADEEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 97/247 (39%), Gaps = 39/247 (15%)
Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKN 284
           +K  D +   +LIG GS+G VY          VAIK +N   +     K  + E   L  
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           ++   ++R+       D    D   IV + + +  L+K                  LT  
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIF-----------LTEQ 131
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
              +I  ++     ++H+     I+H DLKP+N LL+ D S  I DFGL+R   +  +  
Sbjct: 132 HVKTILYNLLLGEKFIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIH 188
Query: 405 VSSSIGVRG---------------------TIGYVAPEYGLGSEVSTNG-DVYSYGILLL 442
           + + +  +                      T  Y APE  L  E  TN  D++S G +  
Sbjct: 189 IVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFA 248
Query: 443 EMVTTKK 449
           E++   K
Sbjct: 249 ELLNMMK 255

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKA 281
           K++ +          +G G++GSV           VA+K ++   Q    ++    E + 
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAI-VYKYMPNGSLEKWLHPDAIPQRDREIE 337
           LK+++H+N   L+ V T  +S++    DF  + +   +    L   +   A+   D  ++
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIE----DFSEVYLVTTLMGADLNNIVKSQALS--DEHVQ 134
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
                LL+           L Y+H      I+H DLKPSN+ ++ D    I DFGL+R  
Sbjct: 135 FLVYQLLR----------GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-- 179
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           QA    T     G   T  Y APE  L     +   D++S G ++ E++  K
Sbjct: 180 QADEEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHK 288
           +    +IG G FG V K    +    VA+K++       RQ A      E + L+++R +
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQ 153
Query: 289 ---NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
              N + VI    +  F+ +         M    L K            + + Q  +L  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK------------KNKFQGFSLPL 201
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNP 403
               A  +   LD LH++    I+HCDLKP NILL     + I   DFG S +       
Sbjct: 202 VRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYX 258
Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + S         Y APE  LG+      D++S G +L E++T
Sbjct: 259 XIQSRF-------YRAPEVILGARYGMPIDMWSLGCILAELLT 294

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 41/224 (18%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITS 296
           IG G +G V+ G +   G  VA+KV     +    S+  E +  + +  RH+N++  I  
Sbjct: 45  IGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI-- 97
Query: 297 CSSVDFQGNDFKAIVY---KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             + D +G      +Y    Y  NGSL  +L    +  +              + +A   
Sbjct: 98  --AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM------------LKLAYSS 143
Query: 354 ASALDYLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVSNPTVSS 407
            S L +LH        +  I H DLK  NIL+  + +  I D GL+ +F    +   +  
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTN-------GDVYSYGILLLEM 444
           +  V GT  Y+ PE  L   ++ N        D+YS+G++L E+
Sbjct: 204 NTRV-GTKRYMPPEV-LDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 105/256 (41%), Gaps = 48/256 (18%)
Query: 225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKS---FMAEC 279
           SLL+    +     IG GS+G V   + ++   + AIK++N    RQ   K       E 
Sbjct: 20  SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV 79
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP-----------DA 328
           + +K + H N+ R+        ++   +  +V +    G L   L+            D 
Sbjct: 80  RLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 329 I-------PQRDREIE-------IQKLTLLQR----ISIAIDVASALDYLHQHCQEPILH 370
           +       P+ + E          + L  +QR     +I   + SAL YLH    + I H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICH 191
Query: 371 CDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV 428
            D+KP N L   + S  I   DFGLS+ +  ++N          GT  +VAPE  L +  
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-LNTTN 250
Query: 429 STNG---DVYSYGILL 441
            + G   D +S G+LL
Sbjct: 251 ESYGPKCDAWSAGVLL 266

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKA 281
           K++ +          +G G++GSV           VA+K ++   Q    ++    E + 
Sbjct: 21  KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 282 LKNIRHKN---LVRVITSCSSVDFQGNDFKAI-VYKYMPNGSLEKWLHPDAIPQRDREIE 337
           LK+++H+N   L+ V T  +S++    DF  + +   +    L   +   A+   D  ++
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIE----DFSEVYLVTTLMGADLNNIVKCQALS--DEHVQ 134
Query: 338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY 397
                LL+           L Y+H      I+H DLKPSN+ ++ D    I DFGL+R  
Sbjct: 135 FLVYQLLR----------GLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-- 179
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK 448
           QA    T     G   T  Y APE  L     +   D++S G ++ E++  K
Sbjct: 180 QADEEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 29/223 (13%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSF---MAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144
Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------R 194
Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT   +APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
            +++  +IG GSFG V++    E   V   KV+  +R         E + ++ ++H N+V
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-----ELQIMRIVKHPNVV 95
Query: 292 RVIT-SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
            +     S+ D +   F  +V +Y+P        H   + Q    + I KL + Q     
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI-KLYMYQ----- 149
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSI 409
             +  +L Y+H      I H D+KP N+LLD       + DFG ++   A   P V S I
Sbjct: 150 --LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GEPNV-SXI 202
Query: 410 GVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMV 445
             R    Y APE   G +  +TN D++S G ++ E++
Sbjct: 203 CSR---YYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-R 286
           K  D +   +LIG GSFG V K     +   VAIK+I  ++   +++   E + L+ + +
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-QIEVRLLELMNK 109
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H   ++         F   +   +V++ M + +L   L         R    + ++L   
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLL---------RNTNFRGVSLNLT 159
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN--DLSAHIGDFGLS-----RFYQA 399
              A  + +AL +L    +  I+HCDLKP NILL N    +  I DFG S     R YQ 
Sbjct: 160 RKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX 218
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + +              Y +PE  LG       D++S G +L+EM T
Sbjct: 219 IQSRF------------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 28/235 (11%)
Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAE 278
           M+  +  + T+ +     +G G+F  V + V    G   A  +IN ++  A   +    E
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 279 CKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
            +  + ++H N+VR+  S S    +G+ +  +++  +  G L      + I  R+   E 
Sbjct: 61  ARICRLLKHPNIVRLHDSISE---EGHHY--LIFDLVTGGELF-----EDIVAREYYSEA 110
Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDFGLSR 395
                +Q+I  A+        LH H Q  ++H +LKP N+LL + L   +  + DFGL+ 
Sbjct: 111 DASHCIQQILEAV--------LHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +        +  G  GT GY++PE           D+++ G++L  ++    P
Sbjct: 162 EVEGEQQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 334 REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL------DNDLSAH 387
           ++ E + + L+    I+  +   LDY+H+ C   I+H D+KP N+L+      +N +   
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIK 178
Query: 388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I D G + +Y    +   ++SI  R    Y +PE  LG+      D++S   L+ E++T
Sbjct: 179 IADLGNACWY----DEHYTNSIQTR---EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-R 286
           K  D +   +LIG GSFG V K     +   VAIK+I  ++   +++   E + L+ + +
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-QIEVRLLELMNK 109
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H   ++         F   +   +V++ M + +L   L         R    + ++L   
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLL---------RNTNFRGVSLNLT 159
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLS-----RFYQA 399
              A  + +AL +L    +  I+HCDLKP NILL N   + I   DFG S     R YQ 
Sbjct: 160 RKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX 218
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + +              Y +PE  LG       D++S G +L+EM T
Sbjct: 219 IQSRF------------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/119 (27%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 334 REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL------DNDLSAH 387
           ++ E + + L+    I+  +   LDY+H+ C   I+H D+KP N+L+      +N +   
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIK 178
Query: 388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I D G + +Y    +   ++SI  R    Y +PE  LG+      D++S   L+ E++T
Sbjct: 179 IADLGNACWY----DEHYTNSIQTR---EYRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 99/227 (43%), Gaps = 32/227 (14%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-R 286
           K  D +   +LIG GSFG V K     +   VAIK+I  ++   +++   E + L+ + +
Sbjct: 32  KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-QIEVRLLELMNK 90
Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H   ++         F   +   +V++ M + +L   L         R    + ++L   
Sbjct: 91  HDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLL---------RNTNFRGVSLNLT 140
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLS-----RFYQA 399
              A  + +AL +L    +  I+HCDLKP NILL N   + I   DFG S     R YQ 
Sbjct: 141 RKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX 199
Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + +              Y +PE  LG       D++S G +L+EM T
Sbjct: 200 IQSRF------------YRSPEVLLGMPYDLAIDMWSLGCILVEMHT 234

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV---RVIT 295
           +G G++G VYK    +        +  ++  G S S   E   L+ ++H N++   +V  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 296 SCSS------VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           S +        D+  +D   I+  +  + + +K   P  +P+           +++  S+
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK---PVQLPR----------GMVK--SL 133
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDND----LSAHIGDFGLSRFYQAVSNPTV 405
              +   + YLH +    +LH DLKP+NIL+  +        I D G +R + +   P +
Sbjct: 134 LYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP-L 189
Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
           +    V  T  Y APE  LG+   T   D+++ G +  E++T++
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           F   + +G GS+G V+K    EDG + A+K      +G         + L  +     V 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD----RARKLAEVGSHEKVG 114
Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
               C  ++ Q  +   I+Y       L+  L   ++ Q+  E     L   Q      D
Sbjct: 115 QHPCCVRLE-QAWEEGGILY-------LQTELCGPSL-QQHCEAWGASLPEAQVWGYLRD 165
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
              AL +LH    + ++H D+KP+NI L       +GDFGL      V   T  +     
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGL-----LVELGTAGAGEVQE 217
Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMV 445
           G   Y+APE   GS   T  DV+S G+ +LE+ 
Sbjct: 218 GDPRYMAPELLQGS-YGTAADVFSLGLTILEVA 249

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 43/234 (18%)
Query: 235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRV 293
           ++ L+G G++  V   V  ++G   A+K+I  Q   +      E + L   + +KN++ +
Sbjct: 17  TSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILEL 76
Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I       F+ +    +V++ +  GS+       A  Q+ +    ++ + + R     DV
Sbjct: 77  IEF-----FEDDTRFYLVFEKLQGGSIL------AHIQKQKHFNEREASRVVR-----DV 120
Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLS---AHIGDFGLSRFYQ------AVSNPT 404
           A+ALD+LH    + I H DLKP NIL ++        I DF L    +       ++ P 
Sbjct: 121 AAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE 177
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNG--------DVYSYGILLLEMVTTKKP 450
           +++     G+  Y+APE     EV T+         D++S G++L  M++   P
Sbjct: 178 LTTPC---GSAEYMAPEV---VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           LTL   I  +  VA  +++L        +H DL   NILL       I DFGL+R     
Sbjct: 190 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIY 244
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +P        R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           LTL   I  +  VA  +++L        +H DL   NILL       I DFGL+R     
Sbjct: 188 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIY 242
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +P        R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 243 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 101/239 (42%), Gaps = 32/239 (13%)
Query: 217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFM 276
           ++++  +++ ++ TDG+     IGVGS+    + +        A+K+I+  ++  ++   
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE 67
Query: 277 AECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGS-LEKWLHPDAIPQRDRE 335
                L+  +H N++ +        +    +  +V +    G  L+K L      +R+  
Sbjct: 68  I---LLRYGQHPNIITLKDV-----YDDGKYVYVVTELXKGGELLDKILRQKFFSEREAS 119
Query: 336 IEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDF 391
                       ++   +   ++YLH    + ++H DLKPSNIL      N  S  I DF
Sbjct: 120 ------------AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           G ++  +A +    +       T  +VAPE           D++S G+LL   +T   P
Sbjct: 165 GFAKQLRAENGLLXTPCY----TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           LTL   I  +  VA  +++L        +H DL   NILL       I DFGL+R     
Sbjct: 195 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIY 249
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +P        R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 250 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 50/93 (53%), Gaps = 12/93 (12%)
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           V S + YLH+H    I+H DLKP N+LL++   D    I DFGLS  ++  +   +   +
Sbjct: 145 VLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERL 199
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLL 442
              GT  Y+APE  L  +     DV+S G++L 
Sbjct: 200 ---GTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 98/233 (42%), Gaps = 32/233 (13%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVY----KGVFDEDGTVVAIKVINLQRQGASKSFMAEC 279
           +  +K TD F+   ++G GSFG V     KG  DE   V  +K   + +    +  M E 
Sbjct: 14  RDRMKLTD-FNFLMVLGKGSFGKVMLSERKGT-DELYAVKILKKDVVIQDDDVECTMVEK 71
Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           + L        +  + SC    FQ  D    V +Y+  G L   +            ++ 
Sbjct: 72  RVLALPGKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQ-----------QVG 116
Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--FY 397
           +      +  A ++A  L +L     + I++ DLK  N++LD++    I DFG+ +   +
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173
Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             V+           GT  Y+APE         + D +++G+LL EM+  + P
Sbjct: 174 DGVTTKXFC------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN 289
           +DG+     IGVGS+    + V        A+KVI+  ++  S+        L+  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPN 82
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGS-LEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           ++ +        +       +V + M  G  L+K L      +R+    +          
Sbjct: 83  IITLKDV-----YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT-------- 129
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDFGLSRFYQAVSNPT 404
               +   ++YLH    + ++H DLKPSNIL      N     I DFG ++  +A +   
Sbjct: 130 ----IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++       T  +VAPE           D++S GILL  M+    P
Sbjct: 183 MTPCY----TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 111/263 (42%), Gaps = 36/263 (13%)
Query: 198 SWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATD-------GFSSTNL-IGVGSFGSVYK 249
           +W  R   SR+PS        + ++ K  LK  D        +++  L +G GSFG V++
Sbjct: 54  TWAARGSRSREPSPKTEDNEGVLLTEK--LKPVDYEYREEVHWATHQLRLGRGSFGEVHR 111
Query: 250 GVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA 309
               + G   A+K + L+   A +  MA C  L + R   L   +     V+        
Sbjct: 112 MEDKQTGFQCAVKKVRLEVFRAEE-LMA-CAGLTSPRIVPLYGAVREGPWVN-------- 161
Query: 310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL 369
           I  + +  GSL + +        DR         L  +  A++    L+YLH      IL
Sbjct: 162 IFMELLEGGSLGQLVKEQGCLPEDR--------ALYYLGQALE---GLEYLHS---RRIL 207
Query: 370 HCDLKPSNILLDNDLS-AHIGDFGLSRFYQAVS-NPTVSSSIGVRGTIGYVAPEYGLGSE 427
           H D+K  N+LL +D S A + DFG +   Q      ++ +   + GT  ++APE  LG  
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 428 VSTNGDVYSYGILLLEMVTTKKP 450
                DV+S   ++L M+    P
Sbjct: 268 CDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           LTL   I  +  VA  +++L        +H DL   NILL       I DFGL+R     
Sbjct: 197 LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIY 251
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +P        R  + ++APE       +   DV+S+G+LL E+ +
Sbjct: 252 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 96/232 (41%), Gaps = 30/232 (12%)
Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECK 280
           +  +K TD F+   ++G GSFG V          + A+K++      +    +  M E +
Sbjct: 335 RDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 393
Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            L        +  + SC    FQ  D    V +Y+  G L   +            ++ +
Sbjct: 394 VLALPGKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDLMYHIQ-----------QVGR 438
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR--FYQ 398
                 +  A ++A  L +L     + I++ DLK  N++LD++    I DFG+ +   + 
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            V+           GT  Y+APE         + D +++G+LL EM+  + P
Sbjct: 496 GVTTKXFC------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN 289
           +DG+     IGVGS+    + V        A+KVI+  ++  S+        L+  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEI---LLRYGQHPN 82
Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGS-LEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           ++ +        +       +V + M  G  L+K L      +R+    +          
Sbjct: 83  IITLKDV-----YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT-------- 129
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDFGLSRFYQAVSNPT 404
               +   ++YLH    + ++H DLKPSNIL      N     I DFG ++  +A +   
Sbjct: 130 ----IGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++       T  +VAPE           D++S GILL  M+    P
Sbjct: 183 MTPCY----TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 239 IGVGSFGSVYKGVFDEDG-------TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
           +G G+F  ++KGV  E G       T V +KV++   +  S+SF      +  + HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
                C        D   +V +++  GSL+ +L  +             + +L ++ +A 
Sbjct: 76  LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNK----------NCINILWKLEVAK 120
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +A+A+ +L ++    ++H ++   NILL  +     G+    +      + TV     +
Sbjct: 121 QLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 412 RGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVT 446
           +  I +V PE     + ++   D +S+G  L E+ +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           IA+ +  AL++LH      ++H D+KPSN+L++      + DFG+S +        V+  
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD----DVAKD 167
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNG-----DVYSYGILLLEMVTTKKPTD 452
           I   G   Y+APE  +  E++  G     D++S GI ++E+   + P D
Sbjct: 168 IDA-GCKPYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 239 IGVGSFGSVYKGVFDEDG-------TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
           +G G+F  ++KGV  E G       T V +KV++   +  S+SF      +  + HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
                C    F G D   +V +++  GSL+ +L  +             + +L ++ +A 
Sbjct: 76  LNYGVC----FCG-DENILVQEFVKFGSLDTYLKKNK----------NCINILWKLEVAK 120
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +A A+ +L ++    ++H ++   NILL  +     G+    +      + TV     +
Sbjct: 121 QLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 412 RGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVT 446
           +  I +V PE     + ++   D +S+G  L E+ +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 110/263 (41%), Gaps = 36/263 (13%)
Query: 198 SWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATD-------GFSSTNL-IGVGSFGSVYK 249
           +W  R   SR+PS        + ++ K  LK  D        +++  L +G GSFG V++
Sbjct: 35  TWAARGSRSREPSPKTEDNEGVLLTEK--LKPVDYEYREEVHWATHQLRLGRGSFGEVHR 92
Query: 250 GVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA 309
               + G   A+K + L+   A +  MA C  L + R   L   +     V+        
Sbjct: 93  MEDKQTGFQCAVKKVRLEVFRAEE-LMA-CAGLTSPRIVPLYGAVREGPWVN-------- 142
Query: 310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL 369
           I  + +  GSL + +        DR         L  +  A++    L+YLH      IL
Sbjct: 143 IFMELLEGGSLGQLVKEQGCLPEDR--------ALYYLGQALE---GLEYLHS---RRIL 188
Query: 370 HCDLKPSNILLDNDLS-AHIGDFGLSRFYQAVS-NPTVSSSIGVRGTIGYVAPEYGLGSE 427
           H D+K  N+LL +D S A + DFG +   Q       + +   + GT  ++APE  LG  
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 428 VSTNGDVYSYGILLLEMVTTKKP 450
                DV+S   ++L M+    P
Sbjct: 249 CDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 93/236 (39%), Gaps = 36/236 (15%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHK 288
           D +   +LIG GS+G VY          VAIK +N   +     K  + E   L  ++  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
            ++R+       D    D   IV + + +  L+K                  LT     +
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIF-----------LTEEHIKT 133
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           I  ++    +++H+     I+H DLKP+N LL+ D S  + DFGL+R   +  +  + + 
Sbjct: 134 ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 409 IGVRGTIG------------------YVAPEYGLGSEVSTNG-DVYSYGILLLEMV 445
           +      G                  Y APE  L  E  T   D++S G +  E++
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 22/151 (14%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ NDF  +V +     SL + LH     +R    E +    L++I +         YLH
Sbjct: 86  FEDNDFVFVVLELCRRRSLLE-LHK----RRKALTEPEARYYLRQIVLGCQ------YLH 134
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVSNPTVSSSIGVRGTIGYVA 419
           ++    ++H DLK  N+ L+ DL   IGDFGL+    Y      T+       GT  Y+A
Sbjct: 135 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC------GTPNYIA 185
Query: 420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           PE       S   DV+S G ++  ++  K P
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 22/151 (14%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ NDF  +V +     SL + LH     +R    E +    L++I +         YLH
Sbjct: 90  FEDNDFVFVVLELCRRRSLLE-LHK----RRKALTEPEARYYLRQIVLGCQ------YLH 138
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVSNPTVSSSIGVRGTIGYVA 419
           ++    ++H DLK  N+ L+ DL   IGDFGL+    Y      T+       GT  Y+A
Sbjct: 139 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC------GTPNYIA 189
Query: 420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           PE       S   DV+S G ++  ++  K P
Sbjct: 190 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 22/151 (14%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ NDF  +V +     SL + LH     +R    E +    L++I +         YLH
Sbjct: 86  FEDNDFVFVVLELCRRRSLLE-LHK----RRKALTEPEARYYLRQIVLGCQ------YLH 134
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVSNPTVSSSIGVRGTIGYVA 419
           ++    ++H DLK  N+ L+ DL   IGDFGL+    Y      T+       GT  Y+A
Sbjct: 135 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC------GTPNYIA 185
Query: 420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           PE       S   DV+S G ++  ++  K P
Sbjct: 186 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 33/232 (14%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG +Y           A  V+ ++ Q     F +E K  + +  K+ ++      
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIERK 103
Query: 299 SVDFQG---------NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            +D+ G          +FK   Y++M    +E+ L  D      +    +K T+LQ   +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFM---VMER-LGIDLQKISGQNGTFKKSTVLQ---L 156
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILL--DNDLSAHIGDFGLSRFY-------QAV 400
            I +   L+Y+H++     +H D+K +N+LL   N    ++ D+GLS  Y       Q  
Sbjct: 157 GIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            NP      G  GTI + + +   G  +S   DV   G  +L  +  K P +
Sbjct: 214 ENPRK----GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/228 (22%), Positives = 93/228 (40%), Gaps = 41/228 (17%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D +     +G G +  V++ +   +   V +K++   ++   K    E K L+N+R    
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLR--GG 91
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
             +IT    V    +   A+V++++ N   ++                Q LT        
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--------------QTLTDYDIRFYM 137
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSI 409
            ++  ALDY H      I+H D+KP N+++D++     + D+GL+ FY            
Sbjct: 138 YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP------GQEY 188
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSY-------GILLLEMVTTKKP 450
            VR     VA  Y  G E+  +  +Y Y       G +L  M+  K+P
Sbjct: 189 NVR-----VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 231

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 30/216 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSC 297
           +G GSF    K V  +     A+K+I+ + +  ++    E  ALK    H N+V++    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F       +V + +  G L      + I ++    E +   +++++       SA+
Sbjct: 75  ----FHDQLHTFLVMELLNGGEL-----FERIKKKKHFSETEASYIMRKL------VSAV 119
Query: 358 DYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            ++H      ++H DLKP N+L    +++L   I DFG +R     + P  +       T
Sbjct: 120 SHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF----T 172
Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + Y APE    +    + D++S G++L  M++ + P
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 117 KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 157
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 158 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 407 SSIGVRGTIGYVAPEYGLG-SEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 214 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 70  KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 110
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 111 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 166
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 167 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 73  KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 113
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 114 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 169
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 170 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 222

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 89  KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 129
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 130 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 185
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 186 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-- 285
           + T  F     IG G FGSV+K V   DG + AIK       G+    + E  AL+ +  
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS----VDEQNALREVYA 63
Query: 286 -----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
                +H ++VR  ++ +      +D   I  +Y   GSL      DAI +  R +   K
Sbjct: 64  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL-----ADAISENYRIMSYFK 113
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL 380
              L+   + + V   L Y+H      ++H D+KPSNI +
Sbjct: 114 EAELK--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFI 148

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-- 285
           + T  F     IG G FGSV+K V   DG + AIK       G+    + E  AL+ +  
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS----VDEQNALREVYA 59
Query: 286 -----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
                +H ++VR  ++ +      +D   I  +Y   GSL      DAI +  R +   K
Sbjct: 60  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL-----ADAISENYRIMSYFK 109
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL 380
              L+   + + V   L Y+H      ++H D+KPSNI +
Sbjct: 110 EAELK--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFI 144

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLE--KWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+++   WL      ++ + I+       +R
Sbjct: 117 KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 157
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 158 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 214 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-- 285
           + T  F     IG G FGSV+K V   DG + AIK       G+    + E  AL+ +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS----VDEQNALREVYA 61
Query: 286 -----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
                +H ++VR  ++ +      +D   I  +Y   GSL      DAI +  R +   K
Sbjct: 62  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL-----ADAISENYRIMSYFK 111
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL 380
              L+   + + V   L Y+H      ++H D+KPSNI +
Sbjct: 112 EAELK--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 69  KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 109
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 110 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 165
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 166 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 218

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-- 285
           + T  F     IG G FGSV+K V   DG + AIK       G+    + E  AL+ +  
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS----VDEQNALREVYA 61
Query: 286 -----RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
                +H ++VR  ++ +      +D   I  +Y   GSL      DAI +  R +   K
Sbjct: 62  HAVLGQHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSL-----ADAISENYRIMSYFK 111
Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL 380
              L+   + + V   L Y+H      ++H D+KPSNI +
Sbjct: 112 EAELK--DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFI 146

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ NDF  +V +     SL + LH     +R    E +    L++I +         YLH
Sbjct: 84  FEDNDFVFVVLELCRRRSLLE-LHK----RRKALTEPEARYYLRQIVLGCQ------YLH 132
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-----GTIG 416
           ++    ++H DLK  N+ L+ DL   IGDFGL+         T     G R     GT  
Sbjct: 133 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTPN 180
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y+APE       S   DV+S G ++  ++  K P
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 11/91 (12%)
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           +  A+ YLH++    I+H DLKP N+L      D    I DFGLS+    V +  +  ++
Sbjct: 157 ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTV 210
Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
              GT GY APE   G       D++S GI+
Sbjct: 211 C--GTPGYCAPEILRGCAYGPEVDMWSVGII 239

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ NDF  +V +     SL + LH     +R    E +    L++I +         YLH
Sbjct: 108 FEDNDFVFVVLELCRRRSLLE-LHK----RRKALTEPEARYYLRQIVLGCQ------YLH 156
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-----GTIG 416
           ++    ++H DLK  N+ L+ DL   IGDFGL+         T     G R     GT  
Sbjct: 157 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTPN 204
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y+APE       S   DV+S G ++  ++  K P
Sbjct: 205 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 22/151 (14%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ +DF  +V +     SL + LH     +R + +   +     R +I       + YLH
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LH-----KRRKAVTEPEARYFMRQTI-----QGVQYLH 159
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--YQAVSNPTVSSSIGVRGTIGYVA 419
            +    ++H DLK  N+ L++D+   IGDFGL+    +      T+       GT  Y+A
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC------GTPNYIA 210
Query: 420 PEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           PE       S   D++S G +L  ++  K P
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 237 NLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
           +L+G GS+G V K V D +        +  K    +      +   E + L+ +RHKN++
Sbjct: 11  DLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++      VD   N+ K  +Y  M           D++P++       +  + Q      
Sbjct: 70  QL------VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-------RFPVCQAHGYFC 116
Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIG 410
            +   L+YLH    + I+H D+KP N+LL    +  I   G++   +   ++ T  +S  
Sbjct: 117 QLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-- 171
Query: 411 VRGTIGYVAPEY--GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +G+  +  PE   GL +      D++S G+ L  + T   P
Sbjct: 172 -QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 68/154 (44%), Gaps = 28/154 (18%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ NDF  +V +     SL + LH     +R    E +    L++I +         YLH
Sbjct: 110 FEDNDFVFVVLELCRRRSLLE-LHK----RRKALTEPEARYYLRQIVLGCQ------YLH 158
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-----GTIG 416
           ++    ++H DLK  N+ L+ DL   IGDFGL+         T     G R     GT  
Sbjct: 159 RN---RVIHRDLKLGNLFLNEDLEVKIGDFGLA---------TKVEYDGERKKVLCGTPN 206
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y+APE       S   DV+S G ++  ++  K P
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ +DF  +V +     SL + LH     +R + +   +     R +I       + YLH
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LH-----KRRKAVTEPEARYFMRQTI-----QGVQYLH 159
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE 421
            +    ++H DLK  N+ L++D+   IGDFGL+   +            + GT  Y+APE
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE----RKKDLCGTPNYIAPE 212
Query: 422 YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                  S   D++S G +L  ++  K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ +DF  +V +     SL + LH     +R + +   +     R +I       + YLH
Sbjct: 95  FEDDDFVYVVLEICRRRSLLE-LH-----KRRKAVTEPEARYFMRQTI-----QGVQYLH 143
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE 421
            +    ++H DLK  N+ L++D+   IGDFGL+   +            + GT  Y+APE
Sbjct: 144 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE----RKKDLCGTPNYIAPE 196
Query: 422 YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                  S   D++S G +L  ++  K P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSC 297
           +G G FG V++ V          K + ++  G  +  + +  ++ NI RH+N++ +  S 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F+  +   ++++++    + + ++  A    +REI          +S    V  AL
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERINTSAFELNEREI----------VSYVHQVCEAL 115
Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVSSSIGVRGTI 415
            +LH H    I H D++P NI+     S+ I   +FG +R  +   N  +  +       
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP----- 167
Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y APE      VST  D++S G L+  +++   P
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G F  V       DG   A+K I    Q   +    E    +   H N++R++  C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC- 95
Query: 299 SVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRDREI-EIQKLTLLQRISIAIDVASA 356
            +  +G   +A ++  +   G+L  W   + +  +   + E Q L LL  I   ++   A
Sbjct: 96  -LRERGAKHEAWLLLPFFKRGTL--WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG--------LSRFYQAVSNPTVSSS 408
             Y H+         DLKP+NILL ++    + D G        +    QA+   T+   
Sbjct: 153 KGYAHR---------DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL---TLQDW 200
Query: 409 IGVRGTIGYVAPE-YGLGSE--VSTNGDVYSYGILLLEMVTTKKPTD 452
              R TI Y APE + + S   +    DV+S G +L  M+  + P D
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 67/149 (44%), Gaps = 18/149 (12%)
Query: 302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH 361
           F+ +DF  +V +     SL + LH     +R + +   +     R +I       + YLH
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LH-----KRRKAVTEPEARYFMRQTI-----QGVQYLH 159
Query: 362 QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE 421
            +    ++H DLK  N+ L++D+   IGDFGL+   +            + GT  Y+APE
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE----RKKXLCGTPNYIAPE 212
Query: 422 YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                  S   D++S G +L  ++  K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D +     +G G+FG V++ V    G V   K IN        +   E   +  + H  L
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           + +  +     F+      ++ +++  G L      D I   D      K++  + I+  
Sbjct: 111 INLHDA-----FEDKYEMVLILEFLSGGELF-----DRIAAED-----YKMSEAEVINYM 155
Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDL--SAHIGDFGLSRFYQAVSNPTVSSS 408
                 L ++H+H    I+H D+KP NI+ +     S  I DFGL+       NP     
Sbjct: 156 RQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLA----TKLNPDEIVK 208
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL 440
           +    T  + APE      V    D+++ G+L
Sbjct: 209 VTT-ATAEFAAPEIVDREPVGFYTDMWAIGVL 239

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 89  KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 129
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q      V 
Sbjct: 130 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVK 185
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    GT+ Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 186 DS--QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 40/224 (17%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK-NLVRVITSC 297
           +G G F  V + +    G   A K +  +R+G       +C+A   I H+  ++ +  SC
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ------DCRA--EILHEIAVLELAKSC 88
Query: 298 SSV-----DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
             V      ++      ++ +Y   G +     P+ + +   E ++        I +   
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDV--------IRLIKQ 139
Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDFGLSRFYQAVSNPTVSSSI 409
           +   + YLHQ+    I+H DLKP NILL +        I DFG+SR         +  + 
Sbjct: 140 ILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR--------KIGHAC 188
Query: 410 GVR---GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +R   GT  Y+APE      ++T  D+++ GI+   ++T   P
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           IA+ +  AL++LH      ++H D+KPSN+L++        DFG+S +        V+  
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVD----DVAKD 194
Query: 409 IGVRGTIGYVAPEYGLGSEVSTNG-----DVYSYGILLLEMVTTKKPTD 452
           I   G   Y APE  +  E++  G     D++S GI  +E+   + P D
Sbjct: 195 IDA-GCKPYXAPER-INPELNQKGYSVKSDIWSLGITXIELAILRFPYD 241

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 43/235 (18%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKN- 289
           +S    IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 290 -LVRVITSCSSVDFQGNDFKAIVYKYMPNGS--LEKWLHPDAIPQRDREIEIQKLTLLQR 346
            ++R+       D++  D    +Y  M  G+  L  WL      ++ + I+       +R
Sbjct: 117 KIIRL------YDYEITD--QYIYMVMECGNIDLNSWL------KKKKSID-----PWER 157
Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            S   ++  A+  +HQH    I+H DLKP+N L+ + +   I DFG++   Q  +   V 
Sbjct: 158 KSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVK 213
Query: 407 SSIGVRGTIGYVAPE-YGLGSEVSTNG----------DVYSYGILLLEMVTTKKP 450
            S    G + Y+ PE     S    NG          DV+S G +L  M   K P
Sbjct: 214 DS--QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 31/155 (20%)
Query: 310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL 369
           +V++ M  GS+   +H     +R    E++   ++Q      DVASALD+LH    + I 
Sbjct: 88  LVFEKMRGGSILSHIH-----KRRHFNELEASVVVQ------DVASALDFLH---NKGIA 133
Query: 370 HCDLKPSNILLD--NDLS-AHIGDFGLSRFYQ------AVSNPTVSSSIGVRGTIGYVAP 420
           H DLKP NIL +  N +S   I DFGL    +       +S P + +     G+  Y+AP
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPC---GSAEYMAP 190
Query: 421 EY--GLGSEVS---TNGDVYSYGILLLEMVTTKKP 450
           E       E S      D++S G++L  +++   P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G GSFG V++    + G   A+K + L+     +  +  C  L + R   L   +    
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPRIVPLYGAVREGP 123
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+        I  + +  GSL + +        DR         L  +  A++    L+
Sbjct: 124 WVN--------IFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALE---GLE 164
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLS-AHIGDFGLSRFYQAVS-NPTVSSSIGVRGTIG 416
           YLH      ILH D+K  N+LL +D S A + DFG +   Q      ++ +   + GT  
Sbjct: 165 YLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE  +G       D++S   ++L M+    P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 32/227 (14%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--------QGASKSFMAECKALKN 284
           +S+ + +G G+FG V+  V  E    V +K I  ++                 E   L  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H N+++V+       F+   F  +V +   +G L+ +   D  P+ D  +        
Sbjct: 86  VEHANIIKVLDI-----FENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPL-------- 131
Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
               I   + SA+ YL     + I+H D+K  NI++  D +  + DFG + + +      
Sbjct: 132 -ASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-----R 182
Query: 405 VSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
                   GTI Y APE  +G+       +++S G+ L  +V  + P
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 42/81 (51%), Gaps = 3/81 (3%)
Query: 370 HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVS 429
           H D+KP NIL+  D  A++ DFG++    A ++  ++      GT+ Y APE    S  +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTLYYXAPERFSESHAT 213
Query: 430 TNGDVYSYGILLLEMVTTKKP 450
              D+Y+   +L E +T   P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G GSFG V++    + G   A+K + L+     +  +  C  L + R   L   +    
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPRIVPLYGAVREGP 137
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+        I  + +  GSL + +        DR         L  +  A++    L+
Sbjct: 138 WVN--------IFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALE---GLE 178
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLS-AHIGDFGLSRFYQAVS-NPTVSSSIGVRGTIG 416
           YLH      ILH D+K  N+LL +D S A + DFG +   Q      ++ +   + GT  
Sbjct: 179 YLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 235
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE  +G       D++S   ++L M+    P
Sbjct: 236 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G GSFG V++    + G   A+K + L+     +  +  C  L + R   L   +    
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE--LVACAGLSSPRIVPLYGAVREGP 139
Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
            V+        I  + +  GSL + +        DR         L  +  A++    L+
Sbjct: 140 WVN--------IFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALE---GLE 180
Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLS-AHIGDFGLSRFYQAVS-NPTVSSSIGVRGTIG 416
           YLH      ILH D+K  N+LL +D S A + DFG +   Q      ++ +   + GT  
Sbjct: 181 YLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 237
Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE  +G       D++S   ++L M+    P
Sbjct: 238 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GSFG +Y G   +    VAIK+ N++ +      + E K  +      +++  T   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYR------ILQGGTGIP 66
Query: 299 SVDFQG--NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           +V + G   D+  +V   +   SLE   +             +KL+L   + +A  + + 
Sbjct: 67  NVRWFGVEGDYNVLVMDLL-GPSLEDLFN----------FCSRKLSLKTVLMLADQMINR 115
Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSA---HIGDFGLSRFYQAVSNPT---VSSSIG 410
           ++++H       LH D+KP N L+     A   +I DFGL++ Y+  S         +  
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172
Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLL 442
           + GT  Y +    LG E S   D+ S G +L+
Sbjct: 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 98/224 (43%), Gaps = 27/224 (12%)
Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-----KSFMAECKALKNI 285
           D +    +IG G+F  V + +  E G   A+K++++ +  +S     +    E      +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +H ++V ++ + SS     +    +V+++M        L  + + + D      +     
Sbjct: 84  KHPHIVELLETYSS-----DGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASH 134
Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSN 402
            +     +  AL Y H +    I+H D+KP N+LL   +N     +GDFG++   Q   +
Sbjct: 135 YMR---QILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGES 186
Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             V+   G  GT  ++APE           DV+  G++L  +++
Sbjct: 187 GLVAG--GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           ++++G G+  +V++G   + G + AIKV  N+         M E + LK + HKN+V++ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                   +    K ++ ++ P GSL   L     P     +   +  ++ R     DV 
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLR-----DVV 122
Query: 355 SALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDFGLSR 395
             +++L ++    I+H ++KP NI+     D      + DFG +R
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           ++++G G+  +V++G   + G + AIKV  N+         M E + LK + HKN+V++ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                   +    K ++ ++ P GSL   L     P     +   +  ++ R     DV 
Sbjct: 74  AIEEETTTR---HKVLIMEFCPCGSLYTVLEE---PSNAYGLPESEFLIVLR-----DVV 122
Query: 355 SALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDFGLSR 395
             +++L ++    I+H ++KP NI+     D      + DFG +R
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 34/173 (19%)
Query: 273 KSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR 332
           + F+AE      + H ++V++       D  G+    IV +Y+   SL++          
Sbjct: 130 RQFLAE------VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR---------- 173
Query: 333 DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG 392
               + QKL + + I+  +++  AL YLH      +++ DLKP NI+L  +    I D G
Sbjct: 174 ---SKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEEQLKLI-DLG 226
Query: 393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEM 444
                 AVS   ++S   + GT G+ APE    G  V+T  D+Y+ G  L  +
Sbjct: 227 ------AVSR--INSFGYLYGTPGFQAPEIVRTGPTVAT--DIYTVGRTLAAL 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 34/215 (15%)
Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVV--AIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           ++  N IG GS+G V   V  + GT +  A K I          F  E + +K++ H N+
Sbjct: 28  YTLENTIGRGSWGEVKIAV--QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 85
Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +R+  +     F+ N    +V +    G L E+ +H     + D               I
Sbjct: 86  IRLYET-----FEDNTDIYLVMELCTGGELFERVVHKRVFRESDA------------ARI 128
Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVS 406
             DV SA+ Y H+     + H DLKP N L      D    + DFGL+    A   P   
Sbjct: 129 MKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA----ARFKPGKM 181
Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
               V GT  YV+P+  L        D +S G+++
Sbjct: 182 MRTKV-GTPYYVSPQV-LEGLYGPECDEWSAGVMM 214

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	452
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-79
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-74
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-63
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-55
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-52
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-50
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-49
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-48
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-48
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-44
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-21
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-40
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	9e-34
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-23
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-15
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-04
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-35
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-32
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-32
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-30
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-30
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-29
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-28
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-28
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	8e-27
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-26
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-26
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-25
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-09
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-25
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-24
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-23
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-19
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-10
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-21
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-21
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-21
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-21
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-20
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-15
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-09
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-16
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-10
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-12
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-10
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-10
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-08
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-04
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-08
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-10
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-08
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-08
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-10
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-07
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-07
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-09
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-08
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-08
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-06
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-07
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-07
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-07
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-05
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-07
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-06
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-05
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-06
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-04
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-06
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-05
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-05
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-04
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-05
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  249 bits (637), Expect = 1e-79
 Identities = 86/232 (37%), Positives = 127/232 (54%), Gaps = 17/232 (7%)

Query: 222 SYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECK 280
           S + L  A+D FS+ N++G G FG VYKG    DGT+VA+K +  +  QG    F  E +
Sbjct: 21  SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
            +    H+NL+R+   C        + + +VY YM NGS+   L        +R      
Sbjct: 80  MISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLR-------ERPESQPP 127

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L   +R  IA+  A  L YLH HC   I+H D+K +NILLD +  A +GDFGL++     
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-Y 186

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            +  V++   VRGTIG++APEY    + S   DV+ YG++LLE++T ++  D
Sbjct: 187 KDTHVTT--AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  234 bits (599), Expect = 4e-74
 Identities = 81/257 (31%), Positives = 126/257 (49%), Gaps = 20/257 (7%)

Query: 197 FSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDG 256
           +S    S      S  ++     ++    L +AT+ F    LIG G FG VYKGV   DG
Sbjct: 5   YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DG 63

Query: 257 TVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
             VA+K    +  QG  + F  E + L   RH +LV +I  C        +   ++YKYM
Sbjct: 64  AKVALKRRTPESSQGI-EEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYM 117

Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
            NG+L++ L+         ++    ++  QR+ I I  A  L YLH      I+H D+K 
Sbjct: 118 ENGNLKRHLY-------GSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKS 167

Query: 376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
            NILLD +    I DFG+S+    +    +S+   V+GT+GY+ PEY +   ++   DVY
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLST--VVKGTLGYIDPEYFIKGRLTEKSDVY 225

Query: 436 SYGILLLEMVTTKKPTD 452
           S+G++L E++  +    
Sbjct: 226 SFGVVLFEVLCARSAIV 242

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  206 bits (526), Expect = 2e-63
 Identities = 76/241 (31%), Positives = 116/241 (48%), Gaps = 31/241 (12%)

Query: 222 SYKSLLKATDGFSS------TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--- 272
           S+  L   T+ F         N +G G FG VYKG  +   T VA+K +       +   
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEEL 73

Query: 273 -KSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQ 331
            + F  E K +   +H+NLV ++   S       D   +VY YMPNGSL   L       
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLS------ 122

Query: 332 RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF 391
                    L+   R  IA   A+ +++LH++     +H D+K +NILLD   +A I DF
Sbjct: 123 --CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177

Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT 451
           GL+R  +  +   ++S   + GT  Y+APE   G E++   D+YS+G++LLE++T     
Sbjct: 178 GLARASEKFAQTVMTSR--IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234

Query: 452 D 452
           D
Sbjct: 235 D 235

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  197 bits (503), Expect = 7e-60
 Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 32/247 (12%)

Query: 219 LKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAE 278
           + +  ++L   +       +   G FG V+K         VA+K+  +Q    S     E
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-DKQSWQNEYE 68

Query: 279 CKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
             +L  ++H+N+++ I +         D   ++  +   GSL  +L              
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA------------ 115

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQE-------PILHCDLKPSNILLDNDLSAHIGDF 391
             ++  +   IA  +A  L YLH+            I H D+K  N+LL N+L+A I DF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMV 445
           GL+  ++  +  +   + G  GT  Y+APE  L   ++         D+Y+ G++L E+ 
Sbjct: 176 GLALKFE--AGKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELA 232

Query: 446 TTKKPTD 452
           +     D
Sbjct: 233 SRCTAAD 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  190 bits (484), Expect = 4e-57
 Identities = 70/214 (32%), Positives = 114/214 (53%), Gaps = 22/214 (10%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG GSFG+V++  +   G+ VA+K++  Q   A     F+ E   +K +RH N+V  + +
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +    Q  +  +IV +Y+  GSL + LH        +    ++L   +R+S+A DVA  
Sbjct: 103 VT----QPPNL-SIVTEYLSRGSLYRLLH--------KSGAREQLDERRRLSMAYDVAKG 149

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YLH     PI+H +LK  N+L+D   +  + DFGLSR   +    T  SS    GT  
Sbjct: 150 MNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS----TFLSSKSAAGTPE 204

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE       +   DVYS+G++L E+ T ++P
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  183 bits (467), Expect = 4e-55
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 35/220 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITS 296
           +     G ++KG +   G  + +KV+ ++      S+ F  EC  L+   H N++ V+ +
Sbjct: 18  LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C S          ++  +MP GSL   LH         E     +   Q +  A+D+A  
Sbjct: 76  CQS---PPAPHPTLITHWMPYGSLYNVLH---------EGTNFVVDQSQAVKFALDMARG 123

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + +LH   +  I    L   ++++D D++A I    +   +Q         S G      
Sbjct: 124 MAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAPA 173

Query: 417 YVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +VAPE             +   D++S+ +LL E+VT + P
Sbjct: 174 WVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  184 bits (469), Expect = 5e-55
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G+FG V K  +      VAIK I  + +   K+F+ E + L  + H N+V++  +C 
Sbjct: 16  VGRGAFGVVCKAKWR--AKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGACL 71

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
                 N    +V +Y   GSL   LH                T    +S  +  +  + 
Sbjct: 72  ------NPV-CLVMEYAEGGSLYNVLHGAEPLP--------YYTAAHAMSWCLQCSQGVA 116

Query: 359 YLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           YLH    + ++H DLKP N+LL        I DFG +   Q       +     +G+  +
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ-------THMTNNKGSAAW 169

Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +APE   GS  S   DV+S+GI+L E++T +KP
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  180 bits (458), Expect = 3e-53
 Identities = 65/247 (26%), Positives = 96/247 (38%), Gaps = 36/247 (14%)

Query: 219 LKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAE 278
           ++ +        D      LIG G +G+VYKG  D     VA+KV +       ++F+ E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA---NRQNFINE 55

Query: 279 CK--ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI 336
                +  + H N+ R I     V   G     +V +Y PNGSL K+L            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---------- 105

Query: 337 EIQKLTLLQRISIAIDVASALDYLHQ------HCQEPILHCDLKPSNILLDNDLSAHIGD 390
                  +    +A  V   L YLH       H +  I H DL   N+L+ ND +  I D
Sbjct: 106 --HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 391 FGLSRFYQ----AVSNPTVSSSIGVRGTIGYVAPEY-------GLGSEVSTNGDVYSYGI 439
           FGLS               +++I   GTI Y+APE                  D+Y+ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 440 LLLEMVT 446
           +  E+  
Sbjct: 224 IYWEIFM 230

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  178 bits (453), Expect = 4e-53
 Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 37/224 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ----GASKSFMAECKALKNIRHKNLVRVI 294
           IG+G FG VY+  +   G  VA+K              ++   E K    ++H N++ + 
Sbjct: 15  IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C     +  +   +V ++   G L + L              +++     ++ A+ +A
Sbjct: 73  GVCL----KEPNL-CLVMEFARGGPLNRVLSG------------KRIPPDILVNWAVQIA 115

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAH--------IGDFGLSRFYQAVSNPTVS 406
             ++YLH     PI+H DLK SNIL+   +           I DFGL+R        T  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKM 172

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S+    G   ++APE    S  S   DV+SYG+LL E++T + P
Sbjct: 173 SAA---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  177 bits (452), Expect = 9e-53
 Identities = 73/259 (28%), Positives = 112/259 (43%), Gaps = 44/259 (16%)

Query: 198 SWHKRSRPSRQPSEP-MIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDG 256
             H     SR  ++   I    + +  +              IG GSFG+VYKG +  D 
Sbjct: 4   GHHHHHHGSRDAADDWEIPDGQITVGQR--------------IGSGSFGTVYKGKWHGD- 48

Query: 257 TVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKY 314
             VA+K++N+        ++F  E   L+  RH N++  +   ++         AIV ++
Sbjct: 49  --VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIVTQW 100

Query: 315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK 374
               SL   LH         E    K  + + I IA   A  +DYLH      I+H DLK
Sbjct: 101 CEGSSLYHHLH-------ASET---KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLK 147

Query: 375 PSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE---YGLGSEVSTN 431
            +NI L  D +  IGDFGL+      S         + G+I ++APE       +  S  
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE--QLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 432 GDVYSYGILLLEMVTTKKP 450
            DVY++GI+L E++T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  177 bits (450), Expect = 2e-52
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 39/226 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-------KSFMAECKALKNIRHKNLV 291
           IG G FG V+KG   +D +VVAIK + L             + F  E   + N+ H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++            +   +V +++P G L   L   A P          +    ++ + +
Sbjct: 87  KLYGLMH-------NPPRMVMEFVPCGDLYHRLLDKAHP----------IKWSVKLRLML 129

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDN-----DLSAHIGDFGLSRFYQAVSNPTVS 406
           D+A  ++Y+      PI+H DL+  NI L +      + A + DFGLS+        +V 
Sbjct: 130 DIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-------SVH 181

Query: 407 SSIGVRGTIGYVAPE--YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S  G+ G   ++APE         +   D YS+ ++L  ++T + P
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  169 bits (431), Expect = 3e-49
 Identities = 59/226 (26%), Positives = 93/226 (41%), Gaps = 34/226 (15%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
            LIG G FG VY G +  +   VAI++I+++R      K+F  E  A +  RH+N+V  +
Sbjct: 39  ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            +C S         AI+       +L   +        D +I    L + +   IA ++ 
Sbjct: 96  GACMS-----PPHLAIITSLCKGRTLYSVVR-------DAKI---VLDVNKTRQIAQEIV 140

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI-GVRG 413
             + YLH      ILH DLK  N+  DN     I DFGL      +        +    G
Sbjct: 141 KGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196

Query: 414 TIGYVAPE---------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            + ++APE                S + DV++ G +  E+   + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  168 bits (428), Expect = 4e-49
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 31/229 (13%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECK--ALKNIRHKNLVRVI 294
             +G G +G V++G +   G  VA+K+ + +     KS+  E +      +RH+N++  I
Sbjct: 14  ECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFI 68

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S  +          ++  Y   GSL  +L                L  +  + I + +A
Sbjct: 69  ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQL------------TTLDTVSCLRIVLSIA 115

Query: 355 SALDYLH-----QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           S L +LH        +  I H DLK  NIL+  +    I D GL+  +   +N     + 
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 410 GVRGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              GT  Y+APE           +     D++++G++L E+        
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  167 bits (426), Expect = 1e-48
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 28/222 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG   K    E G V+ +K +    +   ++F+ E K ++ + H N+++ I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
               +       + +Y+  G+L   +          +    +    QR+S A D+AS + 
Sbjct: 78  ----KDKRL-NFITEYIKGGTLRGIIK-------SMDS---QYPWSQRVSFAKDIASGMA 122

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF----------YQAVSNPTVSSS 408
           YLH      I+H DL   N L+  + +  + DFGL+R            +++  P     
Sbjct: 123 YLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             V G   ++APE   G       DV+S+GI+L E++     
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (424), Expect = 4e-48
 Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 27/221 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             IG G +G V+ G +   G  VA+KV     + AS     E      +RH+N++  I +
Sbjct: 43  KQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAA 99

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                        ++  Y  NGSL  +L                L     + +A    S 
Sbjct: 100 DIKGTGSWTQL-YLITDYHENGSLYDYLKS------------TTLDAKSMLKLAYSSVSG 146

Query: 357 LDYLH-----QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           L +LH        +  I H DLK  NIL+  + +  I D GL+  + + +N         
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206

Query: 412 RGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVT 446
            GT  Y+ PE    S    +       D+YS+G++L E+  
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  166 bits (423), Expect = 6e-48
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 31/223 (13%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECK--ALKNIRHKNLVRVI 294
             IG G FG V++G +   G  VA+K+ + + +   +S+  E +      +RH+N++  I
Sbjct: 48  ESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            + +  +        +V  Y  +GSL  +L+               +T+   I +A+  A
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTA 149

Query: 355 SALDYLHQHCQE-----PILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           S L +LH           I H DLK  NIL+  + +  I D GL+  + + ++    +  
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 410 GVRGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVT 446
              GT  Y+APE    S    +       D+Y+ G++  E+  
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  164 bits (417), Expect = 3e-44
 Identities = 56/174 (32%), Positives = 74/174 (42%), Gaps = 7/174 (4%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            +  G   E +  +S   N  N+    + G   P   N  ++   D+S N LSG IP E+
Sbjct: 594 LEFQGIRSEQLNRLSTR-NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
           G    L  + LG N   GSIP      RG+  LDLS N L G+IP  + AL  L  ++LS
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712

Query: 123 FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKC-TENKSSNQRISRS 175
            N+  G +P  G F             LCG      LP+C   N        RS
Sbjct: 713 NNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPRCDPSNADGYAHHQRS 762

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  136 bits (344), Expect = 1e-34
 Identities = 53/157 (33%), Positives = 76/157 (48%), Gaps = 6/157 (3%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           +  N LSGTIP ++ S+S L   L L  N   G IP  +  +K L +  +  N L+GEIP
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLR-DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP 483

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
             L  C++L  I L  N   G IP +      +  L LS N+ SG IP  L    SL +L
Sbjct: 484 SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543

Query: 120 NLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPE 156
           +L+ N F G +P   +F  +  I+    + + G    
Sbjct: 544 DLNTNLFNGTIPA-AMFKQSGKIAA---NFIAGKRYV 576

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  134 bits (339), Expect = 5e-34
 Identities = 46/134 (34%), Positives = 64/134 (47%), Gaps = 2/134 (1%)

Query: 1   MFENDLSGTIPEAIFSISYLS-NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEI 59
           +  N+ SG I   +      +   L L  N F G IPP + N   L S  +S N LSG I
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEY 118
           P  LG  S L D+ L  N   G IP      + +  L L  N+L+G+IP  L    +L +
Sbjct: 435 PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNW 494

Query: 119 LNLSFNDFEGKVPT 132
           ++LS N   G++P 
Sbjct: 495 ISLSNNRLTGEIPK 508

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  134 bits (339), Expect = 5e-34
 Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 8/199 (4%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           +  N  +G IP  + + S L  SL+L+ N+  G+IP  +G+L  LR   +  N L GEIP
Sbjct: 401 LQNNGFTGKIPPTLSNCSELV-SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYL 119
            EL    +LE + L  N   G IPS       +  + LS N L+G+IP ++  L  L  L
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAIL 519

Query: 120 NLSFNDFEGKVP-TKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQ---RISRS 175
            LS N F G +P   G   +   + +   +   G IP   + K +   ++N    +    
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNT-NLFNGTIPA-AMFKQSGKIAANFIAGKRYVY 577

Query: 176 LKILISIVSIFLGIVMVSF 194
           +K             ++ F
Sbjct: 578 IKNDGMKKECHGAGNLLEF 596

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  133 bits (338), Expect = 7e-34
 Identities = 48/131 (36%), Positives = 74/131 (56%), Gaps = 3/131 (2%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGN--LKALRSFDVSNNGLSGEIPI 61
           N+ SG +PE++ ++S    +L+L+ N+F G I P +       L+   + NNG +G+IP 
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLN 120
            L  CS L  ++L  N+  G+IPS   +   +R L L  N L G+IP  L  + +LE L 
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472

Query: 121 LSFNDFEGKVP 131
           L FND  G++P
Sbjct: 473 LDFNDLTGEIP 483

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (325), Expect = 3e-32
 Identities = 49/136 (36%), Positives = 69/136 (50%), Gaps = 9/136 (6%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           EN  +G IP+ +           L+L+ NHF G++PP  G+   L S  +S+N  SGE+P
Sbjct: 278 ENKFTGEIPDFLSGA--CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 61  IE-LGLCSSLEDIYLGGNFFHGSIP-SFFRTSRGIRKLDLSRNNLSGQIPLFL---EALS 115
           ++ L     L+ + L  N F G +P S    S  +  LDLS NN SG I   L      +
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 116 LEYLNLSFNDFEGKVP 131
           L+ L L  N F GK+P
Sbjct: 396 LQELYLQNNGFTGKIP 411

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (325), Expect = 4e-32
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 9/157 (5%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N +SG                 L ++ N   G +   +     L   DVS+N  S  IP 
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP- 217

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
            LG CS+L+ + + GN   G       T   ++ L++S N   G IP      SL+YL+L
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP-LKSLQYLSL 276

Query: 122 SFNDFEGKVPT--KGIFANTSAISVAGCHRLCGGIPE 156
           + N F G++P    G     + + ++G H   G +P 
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNH-FYGAVPP 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (324), Expect = 5e-32
 Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 6/134 (4%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPP-RIGNLKALRSFDVSNNGLSGEIPI 61
            N   G +P    S S L  SL L+ N+F G +P   +  ++ L+  D+S N  SGE+P 
Sbjct: 303 GNHFYGAVPPFFGSCSLLE-SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361

Query: 62  ELG-LCSSLEDIYLGGNFFHGSIPSFF--RTSRGIRKLDLSRNNLSGQIPLFLEALS-LE 117
            L  L +SL  + L  N F G I           +++L L  N  +G+IP  L   S L 
Sbjct: 362 SLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV 421

Query: 118 YLNLSFNDFEGKVP 131
            L+LSFN   G +P
Sbjct: 422 SLHLSFNYLSGTIP 435

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (323), Expect = 6e-32
 Identities = 49/136 (36%), Positives = 71/136 (52%), Gaps = 6/136 (4%)

Query: 1   MFENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKA-LRSFDVSNNGLSGE 58
           +  N+ SG +P + +  +  L   L+L+ N F G +P  + NL A L + D+S+N  SG 
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLK-VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383

Query: 59  IPIELGLC--SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS- 115
           I   L     ++L+++YL  N F G IP        +  L LS N LSG IP  L +LS 
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSK 443

Query: 116 LEYLNLSFNDFEGKVP 131
           L  L L  N  EG++P
Sbjct: 444 LRDLKLWLNMLEGEIP 459

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  126 bits (318), Expect = 3e-31
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 16/166 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N +SG +      +S   N   L+++ N+F   IP  +G+  AL+  D+S N LSG+   
Sbjct: 188 NKISGDVD-----VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSR 241

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL--SLEYL 119
            +  C+ L+ + +  N F G IP     S  ++ L L+ N  +G+IP FL     +L  L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTGEIPDFLSGACDTLTGL 299

Query: 120 NLSFNDFEGKVPTKGIFANTS--AISVAGCHRLCGGIPELQLPKCT 163
           +LS N F G VP     + +   +++++  +   G +P   L K  
Sbjct: 300 DLSGNHFYGAVP-PFFGSCSLLESLALSSNN-FSGELPMDTLLKMR 343

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  115 bits (291), Expect = 9e-28
 Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 11/161 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP--I 61
           N     +  ++ S++ L  SL L+ +H  GS+        +L S D+S N LSG +    
Sbjct: 63  NVGFSAVSSSLLSLTGL-ESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLT 120

Query: 62  ELGLCSSLEDIYLGGNFFHGSIP-SFFRTSRGIRKLDLSRNNLSGQIPLFLEAL----SL 116
            LG CS L+ + +  N        S       +  LDLS N++SG   +          L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180

Query: 117 EYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPEL 157
           ++L +S N   G V       N   + V+  +    GIP L
Sbjct: 181 KHLAISGNKISGDVDV-SRCVNLEFLDVSSNN-FSTGIPFL 219

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  110 bits (277), Expect = 4e-26
 Identities = 36/132 (27%), Positives = 52/132 (39%), Gaps = 8/132 (6%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNG--LSGEIP 60
            N  +GTIP A+F       S  +A N   G     I N    +    + N     G   
Sbjct: 547 TNLFNGTIPAAMFK-----QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
            +L   S+     +    + G     F  +  +  LD+S N LSG IP  + ++  L  L
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661

Query: 120 NLSFNDFEGKVP 131
           NL  ND  G +P
Sbjct: 662 NLGHNDISGSIP 673

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.5 bits (241), Expect = 2e-21
 Identities = 29/150 (19%), Positives = 62/150 (41%), Gaps = 13/150 (8%)

Query: 23  SLNLAENHF---VGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF 79
           S++L+         ++   + +L  L S  +SN+ ++G +       +SL  + L  N  
Sbjct: 54  SIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSL 112

Query: 80  HGSIPSFFRTSR--GIRKLDLSRNNLSGQIPL--FLEALSLEYLNLSFNDFEGKVPTKGI 135
            G + +        G++ L++S N L     +   L+  SLE L+LS N   G      +
Sbjct: 113 SGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWV 172

Query: 136 FANT----SAISVAGCHRLCGGIPELQLPK 161
            ++       ++++G   + G +   +   
Sbjct: 173 LSDGCGELKHLAISGNK-ISGDVDVSRCVN 201

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.9 bits (177), Expect = 2e-13
 Identities = 22/95 (23%), Positives = 41/95 (43%), Gaps = 4/95 (4%)

Query: 40  GNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLS 99
             + ++       N     +   L   + LE ++L  +  +GS+  F  ++  +  LDLS
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS-LTSLDLS 108

Query: 100 RNNLSGQIPLFLE---ALSLEYLNLSFNDFEGKVP 131
           RN+LSG +           L++LN+S N  +    
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK 143

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  144 bits (367), Expect = 4e-40
 Identities = 47/186 (25%), Positives = 74/186 (39%), Gaps = 31/186 (16%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKAL-RSFDVSNNGLSGEIPI 61
            N LSGT+P +I S+  L   +    N   G+IP   G+   L  S  +S N L+G+IP 
Sbjct: 134 YNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
                + L  + L  N   G     F + +  +K+ L++N+L+  +     + +L  L+L
Sbjct: 193 TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL 251

Query: 122 S------------------------FNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPEL 157
                                    FN+  G++P  G        + A    LCG     
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP--- 308

Query: 158 QLPKCT 163
            LP CT
Sbjct: 309 -LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  128 bits (323), Expect = 9e-34
 Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 6/136 (4%)

Query: 1   MFENDLSGT--IPEAIFSISYLSNSLNLA-ENHFVGSIPPRIGNLKALRSFDVSNNGLSG 57
           +   +L     IP ++ ++ YL+  L +   N+ VG IPP I  L  L    +++  +SG
Sbjct: 57  LSGLNLPKPYPIPSSLANLPYLN-FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 58  EIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-- 115
            IP  L    +L  +    N   G++P    +   +  +    N +SG IP    + S  
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175

Query: 116 LEYLNLSFNDFEGKVP 131
              + +S N   GK+P
Sbjct: 176 FTSMTISRNRLTGKIP 191

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 98.0 bits (245), Expect = 5e-23
 Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 4/116 (3%)

Query: 21  SNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI--ELGLCSSLEDIYLGG-N 77
             + +     ++G +         + + D+S   L    PI   L     L  +Y+GG N
Sbjct: 28  LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGIN 87

Query: 78  FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT 132
              G IP        +  L ++  N+SG IP FL  +  L  L+ S+N   G +P 
Sbjct: 88  NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPP 143

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 24/84 (28%), Positives = 37/84 (44%), Gaps = 3/84 (3%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           + +N L+  + + +     L N L+L  N   G++P  +  LK L S +VS N L GEIP
Sbjct: 228 LAKNSLAFDLGK-VGLSKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 61  IELGLCSSLEDIYLGGNFFHGSIP 84
            + G     +      N      P
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 42.5 bits (101), Expect = 2e-04
 Identities = 19/72 (26%), Positives = 27/72 (37%), Gaps = 4/72 (5%)

Query: 65  LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQ--IPLFLEALS-LEYLNL 121
           L S L         + G +      +  +  LDLS  NL     IP  L  L  L +L +
Sbjct: 24  LSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI 83

Query: 122 S-FNDFEGKVPT 132
              N+  G +P 
Sbjct: 84  GGINNLVGPIPP 95

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (349), Expect = 1e-37
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVIT 295
            IG GSF +VYKG+  E    VA   +  ++   S  + F  E + LK ++H N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
           S  S          +V + M +G+L+ +L              + + +    S    +  
Sbjct: 93  SWESTVKGKKCI-VLVTELMTSGTLKTYLK-----------RFKVMKIKVLRSWCRQILK 140

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            L +LH     PI+H DLK  NI +     S  IGD GL+   +A           V GT
Sbjct: 141 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIGT 193

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             ++APE     +   + DVY++G+ +LEM T++ P
Sbjct: 194 PEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  141 bits (357), Expect = 3e-37
 Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 25/212 (11%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
           + +G G +G VY+GV+ +    VA+K +   ++     + F+ E   +K I+H NLV+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+    +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++
Sbjct: 283 GVCT----REPPFY-IITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQIS 328

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           SA++YL +      +H +L   N L+  +    + DFGLSR        T ++  G +  
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFP 382

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE    ++ S   DV+++G+LL E+ T
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (343), Expect = 1e-36
 Identities = 61/251 (24%), Positives = 107/251 (42%), Gaps = 30/251 (11%)

Query: 203 SRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIK 262
             P  QP + +       M Y +L      F     IG G F  VY+     DG  VA+K
Sbjct: 12  PVPQFQPQKALRPD----MGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALK 63

Query: 263 VINLQRQGASK---SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGS 319
            + +     +K     + E   LK + H N+++   S     F  ++   IV +    G 
Sbjct: 64  KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGD 118

Query: 320 LEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL 379
           L + +       + ++  I + T+       + + SAL+++H      ++H D+KP+N+ 
Sbjct: 119 LSRMIKH----FKKQKRLIPERTVW---KYFVQLCSALEHMHSRR---VMHRDIKPANVF 168

Query: 380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGI 439
           +       +GD GL RF+ + +    S    + GT  Y++PE    +  +   D++S G 
Sbjct: 169 ITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGC 224

Query: 440 LLLEMVTTKKP 450
           LL EM   + P
Sbjct: 225 LLYEMAALQSP 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (333), Expect = 2e-35
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           ++G G++G VY G    +   +AIK I  +    S+    E    K+++HKN+V+ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS- 87

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F  N F  I  + +P GSL   L     P +D E  I   T          +   L
Sbjct: 88  ----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK--------QILEGL 135

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDL-SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
            YLH +    I+H D+K  N+L++       I DFG S+    ++  T +      GT+ 
Sbjct: 136 KYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET----FTGTLQ 188

Query: 417 YVAPE--YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y+APE             D++S G  ++EM T K P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (340), Expect = 4e-35
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 29/209 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVITSC 297
           IG G FG V  G +   G  VA+K I   +  A+ ++F+AE   +  +RH NLV+++   
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                +      IV +YM  GSL  +L         R      L     +  ++DV  A+
Sbjct: 256 V----EEKGGLYIVTEYMAKGSLVDYL---------RSRGRSVLGGDCLLKFSLDVCEAM 302

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           +YL  +     +H DL   N+L+  D  A + DFGL++          S+    +  + +
Sbjct: 303 EYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKW 352

Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            APE     + ST  DV+S+GILL E+ +
Sbjct: 353 TAPEALREKKFSTKSDVWSFGILLWEIYS 381

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  130 bits (329), Expect = 6e-35
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 25/210 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G +G VY+GV+ +    VA+K +   ++     + F+ E   +K I+H NLV+++  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+    +   F  I+ ++M  G+L  +L         RE   Q+++ +  + +A  ++SA
Sbjct: 78  CT----REPPF-YIITEFMTYGNLLDYL---------RECNRQEVSAVVLLYMATQISSA 123

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YL +      +H DL   N L+  +    + DFGLSR        T ++  G +  I 
Sbjct: 124 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIK 177

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + APE    ++ S   DV+++G+LL E+ T
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  130 bits (330), Expect = 9e-35
 Identities = 57/265 (21%), Positives = 97/265 (36%), Gaps = 41/265 (15%)

Query: 197 FSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKAT---DGFSSTNLIGVGSFGSVYKGVFD 253
           F    + +P R        + L    Y      +     F   + +G GS+G V+K    
Sbjct: 20  FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79

Query: 254 EDGTVVAIKVINLQRQGAS--KSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAI 310
           EDG + A+K      +G       +AE  + + + +H   VR+  +     ++      +
Sbjct: 80  EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEEGGILYL 134

Query: 311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILH 370
             +     SL++     A      E ++             D   AL +LH      ++H
Sbjct: 135 QTELC-GPSLQQHCE--AWGASLPEAQVWG--------YLRDTLLALAHLHSQ---GLVH 180

Query: 371 CDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE-----YGLG 425
            D+KP+NI L       +GDFGL      +            G   Y+APE     YG  
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEV--QEGDPRYMAPELLQGSYGTA 235

Query: 426 SEVSTNGDVYSYGILLLEMVTTKKP 450
           +      DV+S G+ +LE+    + 
Sbjct: 236 A------DVFSLGLTILEVACNMEL 254

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (326), Expect = 2e-34
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 32/225 (14%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
            LIG G FG V+K     DG    IK +    + A +    E KAL  + H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHYNGC 72

Query: 297 CSSVDFQGNDFKA-----------IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
               D+                  I  ++   G+LE+W+      ++  ++   +     
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDKVLALE----- 126

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
              +   +   +DY+H      +++ DLKPSNI L +     IGDFGL     ++ N   
Sbjct: 127 ---LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGK 177

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +    +GT+ Y++PE     +     D+Y+ G++L E++     
Sbjct: 178 RTR--SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (335), Expect = 2e-34
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
             +G G FG V+   ++   T VA+K +   + G+   ++F+AE   +K ++H  LV++ 
Sbjct: 194 KKLGAGQFGEVWMATYN-KHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              +           I+ ++M  GSL  +L         +  E  K  L + I  +  +A
Sbjct: 250 AVVTKEPIY------IITEFMAKGSLLDFL---------KSDEGSKQPLPKLIDFSAQIA 294

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + ++ Q      +H DL+ +NIL+   L   I DFGL+R    + +   ++  G +  
Sbjct: 295 EGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV---IEDNEYTAREGAKFP 348

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE       +   DV+S+GILL+E+VT
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  130 bits (330), Expect = 3e-34
 Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 37/217 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVRVI 294
           IG G+FG V+ G    D T+VA+K     R+         F+ E + LK   H N+VR+I
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C+           IV + +  G    +L       R       +L +   + +  D A
Sbjct: 179 GVCT-----QKQPIYIVMELVQGGDFLTFL-------RTEG---ARLRVKTLLQMVGDAA 223

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG---- 410
           + ++YL        +H DL   N L+       I DFG+SR     ++   ++S G    
Sbjct: 224 AGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE---EADGVYAASGGLRQV 277

Query: 411 -VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            V+ T    APE       S+  DV+S+GILL E  +
Sbjct: 278 PVKWT----APEALNYGRYSSESDVWSFGILLWETFS 310

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (327), Expect = 3e-34
 Identities = 52/253 (20%), Positives = 95/253 (37%), Gaps = 28/253 (11%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVA 260
           +R  P  + +E ++    LK       +     +    +G GSFG V++    + G   A
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87

Query: 261 IKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSL 320
           +K + L+          E  A   +    +V +  +      +   +  I  + +  GSL
Sbjct: 88  VKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGSL 137

Query: 321 EKWL-HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL 379
            + +     +P    E                     L+YLH      ILH D+K  N+L
Sbjct: 138 GQLIKQMGCLP----EDRALYYLG--------QALEGLEYLHTRR---ILHGDVKADNVL 182

Query: 380 LDND-LSAHIGDFGLS-RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSY 437
           L +D   A + DFG +          ++ +   + GT  ++APE  +G       D++S 
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242

Query: 438 GILLLEMVTTKKP 450
             ++L M+    P
Sbjct: 243 CCMMLHMLNGCHP 255

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  128 bits (323), Expect = 4e-34
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 31/212 (14%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVIT 295
             IG G FG V  G +   G  VA+K I   +  A+ ++F+AE   +  +RH NLV+++ 
Sbjct: 27  QTIGKGEFGDVMLGDYR--GNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
                  +      IV +YM  GSL  +L         R      L     +  ++DV  
Sbjct: 82  VIV----EEKGGLYIVTEYMAKGSLVDYL---------RSRGRSVLGGDCLLKFSLDVCE 128

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR-FYQAVSNPTVSSSIGVRGT 414
           A++YL  +     +H DL   N+L+  D  A + DFGL++           +  + V+ T
Sbjct: 129 AMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWT 181

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               APE     + ST  DV+S+GILL E+ +
Sbjct: 182 ----APEALREKKFSTKSDVWSFGILLWEIYS 209

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (319), Expect = 1e-33
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 27/210 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G FG V+ G +    T VA+K +   +QG+    +F+AE   +K ++H+ LVR+   
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +       +   I+ +YM NGSL  +L         +     KLT+ + + +A  +A  
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFL---------KTPSGIKLTINKLLDMAAQIAEG 121

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I 
Sbjct: 122 MAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIK 175

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + APE       +   DV+S+GILL E+VT
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  130 bits (328), Expect = 2e-33
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS--FMAECKALKNIRHKNLVRVI 294
             +G G FG V+ G ++    V AIK +   + G      F+ E + +K +RH+ LV++ 
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRV-AIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              S           IV +YM  GSL  +L         +    + L L Q + +A  +A
Sbjct: 246 AVVSEEPIY------IVTEYMSKGSLLDFL---------KGETGKYLRLPQLVDMAAQIA 290

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           S + Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFP 344

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE  L    +   DV+S+GILL E+ T
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  126 bits (318), Expect = 3e-33
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 27/225 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVRVITS 296
            +G G FG V++     D    AIK I L  +  ++   M E KAL  + H  +VR   +
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 297 -------CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
                            +  I  +     +L+ W++      R    E ++   L    I
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-----GRCTIEERERSVCLH---I 123

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF--------YQAVS 401
            + +A A+++LH      ++H DLKPSNI    D    +GDFGL                
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            P  +   G  GT  Y++PE   G+  S   D++S G++L E++ 
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (320), Expect = 4e-33
 Identities = 62/218 (28%), Positives = 90/218 (41%), Gaps = 29/218 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVIT 295
            IG GSFG        EDG    IK IN+ R  +   +    E   L N++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL---QRISIAID 352
           S     F+ N    IV  Y   G L K             I  QK  L    Q +   + 
Sbjct: 91  S-----FEENGSLYIVMDYCEGGDLFKR------------INAQKGVLFQEDQILDWFVQ 133

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +  AL ++H      ILH D+K  NI L  D +  +GDFG++R   +      +      
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA----CI 186

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT  Y++PE       +   D+++ G +L E+ T K  
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  129 bits (327), Expect = 5e-33
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS--FMAECKALKNIRHKNLVRVI 294
             +G G FG V+ G ++    V AIK +   + G      F+ E + +K +RH+ LV++ 
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRV-AIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
              S           IV +YM  GSL  +L         +    + L L Q + +A  +A
Sbjct: 329 AVVSEEPIY------IVTEYMSKGSLLDFL---------KGETGKYLRLPQLVDMAAQIA 373

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           S + Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFP 427

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           I + APE  L    +   DV+S+GILL E+ T
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (316), Expect = 5e-33
 Identities = 57/220 (25%), Positives = 83/220 (37%), Gaps = 38/220 (17%)

Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +         VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +     +   +      +V +  P GSL   L       R  +       L      A+ 
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRL-------RKHQ---GHFLLGTLSRYAVQ 129

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG-- 410
           VA  + YL        +H DL   N+LL       IGDFGL R      +  V       
Sbjct: 130 VAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 411 -VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
                    APE       S  S   D + +G+ L EM T
Sbjct: 187 PFAWC----APESLKTRTFSHAS---DTWMFGVTLWEMFT 219

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (314), Expect = 1e-32
 Identities = 59/234 (25%), Positives = 92/234 (39%), Gaps = 45/234 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           ++G G+FG V K     D    AIK I    +    + ++E   L ++ H+ +VR   + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 298 SSVDFQGNDFKA--------IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
                      A        I  +Y  NG+L   +H     +   +   +   L ++I  
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS----ENLNQQRDEYWRLFRQI-- 125

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                 AL Y+H      I+H DLKP NI +D   +  IGDFGL++      +     S 
Sbjct: 126 ----LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 410 GVR----------GTIGYVAPE-------YGLGSEVSTNGDVYSYGILLLEMVT 446
            +           GT  YVA E       Y    ++    D+YS GI+  EM+ 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIY 226

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (326), Expect = 2e-32
 Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 30/216 (13%)

Query: 238 LIGVGSFGSVYKGVFDE--DGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVI 294
            I  G  G +Y  + D   +G  V +K +       A    MAE + L  + H ++V++ 
Sbjct: 87  CIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                 D  G+    IV +Y+   SL             +  + QKL + + I+  +++ 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSL-------------KRSKGQKLPVAEAIAYLLEIL 192

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            AL YLH      +++ DLKP NI+L  +    + D G            ++S   + GT
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--------RINSFGYLYGT 240

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            G+ APE       +   D+Y+ G  L  +      
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (314), Expect = 2e-32
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 41/221 (18%)

Query: 239 IGVGSFGSVYKGVFDEDG---TVVAIKVINLQRQGAS----KSFMAECKALKNIRHKNLV 291
           IG G  G V  G     G     VAIK +   + G +    + F++E   +    H N++
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R+    +    +G     IV +YM NGSL+ +L       R  +    + T++Q + +  
Sbjct: 114 RLEGVVT----RGRLA-MIVTEYMENGSLDTFL-------RTHD---GQFTIMQLVGMLR 158

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG- 410
            V + + YL        +H DL   N+L+D++L   + DFGLSR  +   +   +++ G 
Sbjct: 159 GVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215

Query: 411 --VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
             +R T    APE   +   S  S   DV+S+G+++ E++ 
Sbjct: 216 IPIRWT----APEAIAFRTFSSAS---DVWSFGVVMWEVLA 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  122 bits (309), Expect = 3e-32
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 27/210 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           IG G FG V+ G +  +   VAIK I   R+GA   + F+ E + +  + H  LV++   
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C            +V ++M +G L  +L       R +            + + +DV   
Sbjct: 72  CLE-----QAPICLVTEFMEHGCLSDYL-------RTQR---GLFAAETLLGMCLDVCEG 116

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  + 
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 170

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + +PE    S  S+  DV+S+G+L+ E+ +
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  125 bits (315), Expect = 3e-32
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 43/231 (18%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNL--VR 292
             IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  +   +R
Sbjct: 62  KQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 293 VITSCSSVDFQGNDFKAIVYKYM--PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +       D++  D    +Y  M   N  L  WL            + + +   +R S  
Sbjct: 121 LY------DYEITDQY--IYMVMECGNIDLNSWLK-----------KKKSIDPWERKSYW 161

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++  A+  +HQH    I+H DLKP+N L+ +     + DFG++   Q  +   V  S  
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ- 216

Query: 411 VRGTIGYVAPE-----------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             G + Y+ PE               S++S   DV+S G +L  M   K P
Sbjct: 217 -VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (310), Expect = 5e-32
 Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 45/228 (19%)

Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLV 291
           +G G FGSV +G     D     VA+K   ++   +S+     F++E   +K+  H N++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R++  C  +  QG     ++  +M  G L  +L          E   + + L   +   +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-----YSRLETGPKHIPLQTLLKFMV 154

Query: 352 DVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVSN-- 402
           D+A  ++YL +++     LH DL   N +L +D++  + DFGLS+      +Y+      
Sbjct: 155 DIALGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210

Query: 403 -PTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
            P       V+      A E     +    ++  DV+++G+ + E+ T
Sbjct: 211 MP-------VKWI----AIESLADRV---YTSKSDVWAFGVTMWEIAT 244

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  121 bits (307), Expect = 6e-32
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G FG V  G +      VA+K+I   ++G+     F  E + +  + H  LV+    
Sbjct: 16  LGSGQFGVVKLGKWK-GQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           CS    +      IV +Y+ NG L  +L       R      + L   Q + +  DV   
Sbjct: 72  CS----KEYPI-YIVTEYISNGCLLNYL-------RSHG---KGLEPSQLLEMCYDVCEG 116

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + +L  H     +H DL   N L+D DL   + DFG++R+   V +    SS+G +  + 
Sbjct: 117 MAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY---VLDDQYVSSVGTKFPVK 170

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           + APE     + S+  DV+++GIL+ E+ +
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (311), Expect = 6e-32
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 43/231 (18%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNL--VR 292
             IG G    V++   +E   + AIK +NL+        S+  E   L  ++  +   +R
Sbjct: 15  KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 293 VITSCSSVDFQGNDFKAIVYKYM--PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +       D++  D    +Y  M   N  L  WL            + + +   +R S  
Sbjct: 74  LY------DYEITDQY--IYMVMECGNIDLNSWLK-----------KKKSIDPWERKSYW 114

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++  A+  +HQH    I+H DLKP+N L+ +     + DFG++   Q  +   V  S  
Sbjct: 115 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ- 169

Query: 411 VRGTIGYVAPE-----------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT+ Y+ PE               S++S   DV+S G +L  M   K P
Sbjct: 170 -VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  123 bits (310), Expect = 7e-32
 Identities = 50/219 (22%), Positives = 100/219 (45%), Gaps = 38/219 (17%)

Query: 239 IGVGSFGSVYKGVFDEDG----TVVAIKVINLQRQGASKS----FMAECKALKNIRHKNL 290
           +G G+FG+VYKG++  +G      VAIK +   R+  S       + E   + ++ + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASVDNPHV 79

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
            R++  C +   Q      ++ + MP G L  ++       R+ +     +     ++  
Sbjct: 80  CRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK---DNIGSQYLLNWC 123

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + +A  ++YL       ++H DL   N+L+       I DFGL++   A      +   G
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--G 178

Query: 411 VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
            +  I ++A E   + + +  S   DV+SYG+ + E++T
Sbjct: 179 GKVPIKWMALESILHRIYTHQS---DVWSYGVTVWELMT 214

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  121 bits (306), Expect = 1e-31
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 27/210 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G FG V  G +      VAIK+I   ++G+     F+ E K + N+ H+ LV++   
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+           I+ +YM NG L  +L       R+      +    Q + +  DV  A
Sbjct: 88  CTK-----QRPIFIITEYMANGCLLNYL-------REMR---HRFQTQQLLEMCKDVCEA 132

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YL        LH DL   N L+++     + DFGLSR+   V +   +SS+G +  + 
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVR 186

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  PE  + S+ S+  D++++G+L+ E+ +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  122 bits (309), Expect = 1e-31
 Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 42/222 (18%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGAS----KSFMAECKALKNIRHKNL 290
           IG G FG VYKG+      +    VAIK +   + G +      F+ E   +    H N+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +R+    S    +      I+ +YM NG+L+K+L       R+++    + ++LQ + + 
Sbjct: 109 IRLEGVIS----KYKPM-MIITEYMENGALDKFL-------REKD---GEFSVLQLVGML 153

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             +A+ + YL        +H DL   NIL++++L   + DFGLSR  +     T ++S G
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210

Query: 411 ---VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
              +R T    APE   Y    + ++  DV+S+GI++ E++T
Sbjct: 211 KIPIRWT----APEAISYR---KFTSASDVWSFGIVMWEVMT 245

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (308), Expect = 1e-31
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNL--VR 292
             IG G    V++ V +E   + AIK +NL+        S+  E   L  ++  +   +R
Sbjct: 34  KQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 293 VITSCSSVDFQGNDFKAIVYKYM--PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +       D++  D    +Y  M   N  L  WL            + + +   +R S  
Sbjct: 93  LY------DYEITDQY--IYMVMECGNIDLNSWLK-----------KKKSIDPWERKSYW 133

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++  A+  +HQH    I+H DLKP+N L+ +     + DFG++   Q  +   V  S  
Sbjct: 134 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ- 188

Query: 411 VRGTIGYVAPE-----------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT+ Y+ PE               S++S   DV+S G +L  M   K P
Sbjct: 189 -VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  122 bits (308), Expect = 1e-31
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 27/215 (12%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    +    D  G +VA+K +        + F  E + LK +    +V+  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                    G     +V +Y+P+G L  +L      QR R     +L   + +  +  + 
Sbjct: 91  GVSYG---PGRQSLRLVMEYLPSGCLRDFL------QRHR----ARLDASRLLLYSSQIC 137

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG---V 411
             ++YL        +H DL   NIL++++    I DFGL++      +  V    G   +
Sbjct: 138 KGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPI 194

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                  APE    +  S   DV+S+G++L E+ T
Sbjct: 195 FWY----APESLSDNIFSRQSDVWSFGVVLYELFT 225

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  121 bits (305), Expect = 2e-31
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    +    D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L       +  +   +++  ++ +     + 
Sbjct: 78  GVCYS---AGRRNLKLIMEYLPYGSLRDYL-------QKHK---ERIDHIKLLQYTSQIC 124

Query: 355 SALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG--- 410
             ++YL  +      +H DL   NIL++N+    IGDFGL++              G   
Sbjct: 125 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +       APE    S+ S   DV+S+G++L E+ T
Sbjct: 181 IFWY----APESLTESKFSVASDVWSFGVVLYELFT 212

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (303), Expect = 2e-31
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 30/223 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVIT 295
            IG GS+G   K     DG ++  K ++      +  +  ++E   L+ ++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
               +D        IV +Y   G L   +      +  + ++ + +     + +   +  
Sbjct: 73  RI--IDRTNTTLY-IVMEYCEGGDLASVI--TKGTKERQYLDEEFV-----LRVMTQLTL 122

Query: 356 ALDYLHQHCQEP--ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           AL   H+       +LH DLKP+N+ LD   +  +GDFGL+R     ++   +      G
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT----FVG 178

Query: 414 TIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y++PE      Y   S      D++S G LL E+     P
Sbjct: 179 TPYYMSPEQMNRMSYNEKS------DIWSLGCLLYELCALMPP 215

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  121 bits (305), Expect = 2e-31
 Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 25/224 (11%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            +G G F  V       DG   A+K I    Q   +    E    +   H N++R++  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                  ++   ++  +   G+L   +          + +   LT  Q + + + +   L
Sbjct: 96  LRERGAKHEAW-LLLPFFKRGTLWNEI-------ERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ-----AVSNPTVSSSIGVR 412
           + +H        H DLKP+NILL ++    + D G           +    T+      R
Sbjct: 148 EAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 413 GTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            TI Y APE      + +  E +   DV+S G +L  M+  + P
Sbjct: 205 CTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP 245

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (305), Expect = 2e-31
 Identities = 53/220 (24%), Positives = 101/220 (45%), Gaps = 36/220 (16%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNL 290
           +G G FG V    +    D  G  VA+K +   +  +  +       E + L+N+ H+N+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSL---KPESGGNHIADLKKEIEILRNLYHENI 85

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V+    C+     G +   ++ +++P+GSL+++L          +    K+ L Q++  A
Sbjct: 86  VKYKGICTE---DGGNGIKLIMEFLPSGSLKEYL-------PKNK---NKINLKQQLKYA 132

Query: 351 IDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
           + +   +DYL  +      +H DL   N+L++++    IGDFGL++  +           
Sbjct: 133 VQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188

Query: 410 G---VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               V       APE  + S+     DV+S+G+ L E++T
Sbjct: 189 RDSPVFWY----APECLMQSKFYIASDVWSFGVTLHELLT 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  120 bits (304), Expect = 3e-31
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 37/218 (16%)

Query: 239 IGVGSFGSVYKGVFDEDG--TVVAIKVI--NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FG+V KG +        VA+K++             +AE   ++ + +  +VR+I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C +  +       +V +    G L K+L       +      + +     I +   V+
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYL-------QQN----RHVKDKNIIELVHQVS 127

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG---V 411
             + YL +      +H DL   N+LL     A I DFGLS+  +A  N   + + G   V
Sbjct: 128 MGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184

Query: 412 RGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           +      APE   Y    + S+  DV+S+G+L+ E  +
Sbjct: 185 KWY----APECINYY---KFSSKSDVWSFGVLMWEAFS 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  120 bits (303), Expect = 3e-31
 Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 38/218 (17%)

Query: 239 IGVGSFGSVYKGVFDEDG---TVVAIKVINLQRQGAS----KSFMAECKALKNIRHKNLV 291
           IG G FG V++G++         VAIK     +   S    + F+ E   ++   H ++V
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++I   +           I+ +    G L  +L       + R+     L L   I  A 
Sbjct: 80  KLIGVITENPVW------IIMELCTLGELRSFL-------QVRK---YSLDLASLILYAY 123

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +++AL YL        +H D+   N+L+ ++    +GDFGLSR+   + + T   +   
Sbjct: 124 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKG 177

Query: 412 RGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I ++APE   +   +  S   DV+ +G+ + E++ 
Sbjct: 178 KLPIKWMAPESINFRRFTSAS---DVWMFGVCMWEILM 212

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  120 bits (302), Expect = 4e-31
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 41/220 (18%)

Query: 239 IGVGSFGSVYKGVFDEDG--TVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVR 292
           +G G+FGSV +GV+        VAIKV+   +QG  K+     M E + +  + +  +VR
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +I  C +          +V +    G L K+L         +    +++ +     +   
Sbjct: 75  LIGVCQAEALM------LVMEMAGGGPLHKFL-------VGKR---EEIPVSNVAELLHQ 118

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG-- 410
           V+  + YL +      +H DL   N+LL N   A I DFGLS+   A  +   + S G  
Sbjct: 119 VSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175

Query: 411 -VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
            ++      APE   +   S  S   DV+SYG+ + E ++
Sbjct: 176 PLKWY----APECINFRKFSSRS---DVWSYGVTMWEALS 208

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  122 bits (307), Expect = 4e-31
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 35/218 (16%)

Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGAS----KSFMAECKALKNIRHKNLV 291
           +G G FG V  G      +    VAIK +   + G +    + F+ E   +    H N++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           R+    +      +    IV +YM NGSL+ +L       R  +    + T++Q + +  
Sbjct: 110 RLEGVVTK-----SKPVMIVTEYMENGSLDSFL-------RKHD---AQFTVIQLVGMLR 154

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG- 410
            +AS + YL        +H DL   NIL++++L   + DFGL R  +       ++  G 
Sbjct: 155 GIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 411 --VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             +R T    +PE     + ++  DV+SYGI+L E+++
Sbjct: 212 IPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (304), Expect = 5e-31
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           +G G+FGSV    +    D  G VVA+K +    +   + F  E + LK+++H N+V+  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             C S    G     ++ +Y+P GSL  +L      Q+ +E    ++  ++ +     + 
Sbjct: 109 GVCYS---AGRRNLKLIMEYLPYGSLRDYL------QKHKE----RIDHIKLLQYTSQIC 155

Query: 355 SALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG--- 410
             ++YL  +      +H DL   NIL++N+    IGDFGL++              G   
Sbjct: 156 KGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +       APE    S+ S   DV+S+G++L E+ T
Sbjct: 212 IFWY----APESLTESKFSVASDVWSFGVVLYELFT 243

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  120 bits (302), Expect = 6e-31
 Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 43/225 (19%)

Query: 237 NLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGAS----KSFMAECKALKNIRHKN 289
            +IG G FG VY G +    ++    AIK ++   +       ++F+ E   ++ + H N
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPN 83

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++ +I               ++  YM +G L +++       R  +   +  T+   IS 
Sbjct: 84  VLALIGIML----PPEGLPHVLLPYMCHGDLLQFI-------RSPQ---RNPTVKDLISF 129

Query: 350 AIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF-YQAVSNPTVSS 407
            + VA  ++YL  Q      +H DL   N +LD   +  + DFGL+R             
Sbjct: 130 GLQVARGMEYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH 185

Query: 408 SIG---VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
                 V+ T    A E          +T  DV+S+G+LL E++T
Sbjct: 186 RHARLPVKWT----ALESLQTYR---FTTKSDVWSFGVLLWELLT 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  119 bits (301), Expect = 7e-31
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 43/225 (19%)

Query: 237 NLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
            +IG G FG VY G     D      A+K +N   +         F+ E   +K+  H N
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++ ++  C   +        +V  YM +G L  ++       R+        T+   I  
Sbjct: 88  VLSLLGICLRSEGS----PLVVLPYMKHGDLRNFI-------RNET---HNPTVKDLIGF 133

Query: 350 AIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF-YQAVSNPTVSS 407
            + VA  + YL  +      +H DL   N +LD   +  + DFGL+R  Y        + 
Sbjct: 134 GLQVAKGMKYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 408 SIG---VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           +     V+      A E       +  S   DV+S+G+LL E++T
Sbjct: 190 TGAKLPVKWM----ALESLQTQKFTTKS---DVWSFGVLLWELMT 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  119 bits (300), Expect = 7e-31
 Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 38/218 (17%)

Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLV 291
           +G G FG VY+GV+     +   VA+K     ++  +      FM+E   +KN+ H ++V
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++I               I+ +  P G L  +L          +     L +L  +  ++
Sbjct: 77  KLIGIIEEEPTW------IIMELYPYGELGHYL-------ERNK---NSLKVLTLVLYSL 120

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +  A+ YL        +H D+   NIL+ +     +GDFGLSR    + +     +   
Sbjct: 121 QICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVT 174

Query: 412 RGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           R  I +++PE   +      +T  DV+ + + + E+++
Sbjct: 175 RLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILS 209

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (301), Expect = 8e-31
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 29/218 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVI 294
            +G G   +VY          VAIK I +  +      K F  E      + H+N+V +I
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 295 TSCSSVDFQGNDFKA--IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
                 D    +     +V +Y+   +L +++                L++   I+    
Sbjct: 78  ------D-VDEEDDCYYLVMEYIEGPTLSEYIE-----------SHGPLSVDTAINFTNQ 119

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +   + + H      I+H D+KP NIL+D++ +  I DFG+++   A+S  +++ +  V 
Sbjct: 120 ILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVL 173

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT+ Y +PE   G       D+YS GI+L EM+  + P
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  120 bits (302), Expect = 9e-31
 Identities = 49/224 (21%), Positives = 96/224 (42%), Gaps = 36/224 (16%)

Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVI--NLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G FGSV +      D     VA+K++  ++      + F+ E   +K   H ++ ++
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 294 ITSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +        +G      ++  +M +G L  +L    I +         L L   +   +D
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-----FNLPLQTLVRFMVD 145

Query: 353 VASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVSNPTV 405
           +A  ++YL  ++     +H DL   N +L  D++  + DFGLSR      +Y+       
Sbjct: 146 IACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA--- 198

Query: 406 SSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
            S + V+      A E     L    + + DV+++G+ + E++T
Sbjct: 199 -SKLPVKWL----ALESLADNL---YTVHSDVWAFGVTMWEIMT 234

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  119 bits (301), Expect = 1e-30
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 26/213 (12%)

Query: 239 IGVGSFGSVYKGVFDEDG----TVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRV 293
           +G G FG+V+KGV+  +G      V IKVI  +    S         A+ ++ H ++VR+
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           +  C     Q      +V +Y+P GSL   +       R        L     ++  + +
Sbjct: 81  LGLCPGSSLQ------LVTQYLPLGSLLDHV-------RQHR---GALGPQLLLNWGVQI 124

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A  + YL +H    ++H +L   N+LL +     + DFG++       +         + 
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP--PDDKQLLYSEAKT 179

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            I ++A E     + +   DV+SYG+ + E++T
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  120 bits (303), Expect = 1e-30
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 43/225 (19%)

Query: 237 NLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
            +IG G FG VY G     D      A+K +N   +         F+ E   +K+  H N
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++ ++  C     +G+    +V  YM +G L  ++       R+        T+   I  
Sbjct: 152 VLSLLGICL--RSEGSPL--VVLPYMKHGDLRNFI-------RNET---HNPTVKDLIGF 197

Query: 350 AIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF-YQAVSNPTVSS 407
            + VA  + +L  +      +H DL   N +LD   +  + DFGL+R  Y    +   + 
Sbjct: 198 GLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253

Query: 408 SIG---VRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           +     V+      A E          +T  DV+S+G+LL E++T
Sbjct: 254 TGAKLPVKWM----ALESLQTQK---FTTKSDVWSFGVLLWELMT 291

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (294), Expect = 5e-30
 Identities = 54/248 (21%), Positives = 92/248 (37%), Gaps = 60/248 (24%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNI-RHKN 289
           F     IG G FGSV+K V   DG + AIK       G+   ++ + E  A   + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLLQRIS 348
           +VR  ++     +  +D   I  +Y   GSL   +     I    +E E++ L L     
Sbjct: 73  VVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL----- 122

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-------------------LSAHIG 389
               V   L Y+H      ++H D+KPSNI +                      +   IG
Sbjct: 123 ---QVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE-------YGLGSEVSTNGDVYSYGILLL 442
           D G       +S+P V       G   ++A E       +   +      D+++  + ++
Sbjct: 177 DLGHVT---RISSPQV-----EEGDSRFLANEVLQENYTHLPKA------DIFALALTVV 222

Query: 443 EMVTTKKP 450
                +  
Sbjct: 223 CAAGAEPL 230

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  116 bits (293), Expect = 8e-30
 Identities = 57/232 (24%), Positives = 97/232 (41%), Gaps = 47/232 (20%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G   FG VYKG        E    VAIK +   +  A       F  E      ++H N
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLL 344
           +V ++   +    +     ++++ Y  +G L ++L     H D     D       L   
Sbjct: 74  VVCLLGVVT----KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FY 397
             + +   +A+ ++YL   H     +H DL   N+L+ + L+  I D GL R      +Y
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY 184

Query: 398 QAVSNPTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
           + + N    S + +R      APE   YG     S + D++SYG++L E+ +
Sbjct: 185 KLLGN----SLLPIRWM----APEAIMYGK---FSIDSDIWSYGVVLWEVFS 225

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  117 bits (295), Expect = 8e-30
 Identities = 50/216 (23%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 239 IGVGSFGSVYKGVFDEDG----TVVAIKVINLQRQGASKS----FMAECKALKNIRHKNL 290
           +G G+FG+VYKG++  +G      VAIK +   R+  S       + E   + ++ + ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASVDNPHV 79

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
            R++  C +   Q      ++ + MP G L  ++       R+ +     +     ++  
Sbjct: 80  CRLLGICLTSTVQ------LITQLMPFGCLLDYV-------REHK---DNIGSQYLLNWC 123

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
           + +A  ++YL       ++H DL   N+L+       I DFGL++   A      +   G
Sbjct: 124 VQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--G 178

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +  I ++A E  L    +   DV+SYG+ + E++T
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  117 bits (294), Expect = 1e-29
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 41/226 (18%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G GSFG VY+GV      DE  T VAIK +N   + AS      F+ E   +K     +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +VR++   S    QG     ++ + M  G L+ +L     P       +   +L + I +
Sbjct: 90  VVRLLGVVS----QGQPT-LVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPSLSKMIQM 143

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVSNP 403
           A ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R      +Y+     
Sbjct: 144 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK- 199

Query: 404 TVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
                + VR      +PE    G+    +T  DV+S+G++L E+ T
Sbjct: 200 ---GLLPVRWM----SPESLKDGV---FTTYSDVWSFGVVLWEIAT 235

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  120 bits (302), Expect = 2e-29
 Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 239 IGVGSFGSVYKGVF---DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLV 291
           IG G FG V++G++   +     VAIK     +   S S    F+ E   ++   H ++V
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           ++I   +           I+ +    G L  +L       + R+     L L   I  A 
Sbjct: 455 KLIGVITENPVW------IIMELCTLGELRSFL-------QVRK---FSLDLASLILYAY 498

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +++AL YL        +H D+   N+L+ ++    +GDFGLSR    + + T   +   
Sbjct: 499 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKG 552

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +  I ++APE       ++  DV+ +G+ + E++ 
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  120 bits (302), Expect = 2e-29
 Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 239 IGVGSFGSVYKGVFDEDG--TVVAIKVINLQRQGASKS----FMAECKALKNIRHKNLVR 292
           +G G+FGSV +GV+        VAIKV+   +QG  K+     M E + +  + +  +VR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL---KQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +I  C +          +V +    G L K+L         +    +++ +     +   
Sbjct: 401 LIGVCQAEALM------LVMEMAGGGPLHKFL-------VGKR---EEIPVSNVAELLHQ 444

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           V+  + YL +      +H +L   N+LL N   A I DFGLS+   A  +   ++    +
Sbjct: 445 VSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGK 500

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             + + APE     + S+  DV+SYG+ + E ++
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  115 bits (289), Expect = 4e-29
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 32/217 (14%)

Query: 239 IGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLVRV 293
           +G G FG V    +    D  G +VA+K +        +S +  E   L+ + H+++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
              C            +V +Y+P GSL  +L       R        + L Q +  A  +
Sbjct: 99  KGCCEDAGAASL---QLVMEYVPLGSLRDYL------PRHS------IGLAQLLLFAQQI 143

Query: 354 ASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG-- 410
              + YLH QH     +H DL   N+LLDND    IGDFGL++              G  
Sbjct: 144 CEGMAYLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

Query: 411 -VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            V       APE     +     DV+S+G+ L E++T
Sbjct: 200 PVFWY----APECLKEYKFYYASDVWSFGVTLYELLT 232

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 4e-29
 Identities = 47/225 (20%), Positives = 91/225 (40%), Gaps = 44/225 (19%)

Query: 239 IGVGSFGSVYKGVF-------DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV 291
           +G G+F  ++KGV            T V +KV++   +  S+SF      +  + HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
                C        D   +V +++  GSL+ +L       +  +     + +L ++ +A 
Sbjct: 76  LNYGVCVC-----GDENILVQEFVKFGSLDTYL-------KKNK---NCINILWKLEVAK 120

Query: 352 DVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAH--------IGDFGLSRFYQAVSN 402
            +A+A+ +L         +H ++   NILL  +            + D G+S        
Sbjct: 121 QLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------ 170

Query: 403 PTVSSSIGVRGTIGYVAPE-YGLGSEVSTNGDVYSYGILLLEMVT 446
             V     ++  I +V PE       ++   D +S+G  L E+ +
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  115 bits (289), Expect = 5e-29
 Identities = 57/260 (21%), Positives = 89/260 (34%), Gaps = 56/260 (21%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVITS 296
            +G G FG V++     D    AIK I L  +  + +  M E KAL  + H  +VR   +
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE------------------- 337
                 +    +          +      P  +     +I                    
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 338 -----IQ-----KLTLLQRIS---------------IAIDVASALDYLHQHCQEPILHCD 372
                IQ     K  L   ++               I I +A A+++LH      ++H D
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRD 189

Query: 373 LKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR--------GTIGYVAPEYGL 424
           LKPSNI    D    +GDFGL              +            GT  Y++PE   
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249

Query: 425 GSEVSTNGDVYSYGILLLEM 444
           G+  S   D++S G++L E+
Sbjct: 250 GNNYSHKVDIFSLGLILFEL 269

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  114 bits (288), Expect = 5e-29
 Identities = 52/243 (21%), Positives = 98/243 (40%), Gaps = 34/243 (13%)

Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAEC 279
           M  +S       +  ++++G G+  +V++G   + G + AIKV N           M E 
Sbjct: 1   MGSQSTSN--HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF 58

Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           + LK + HKN+V++    +  +      K ++ ++ P GSL   L   +      E E  
Sbjct: 59  EVLKKLNHKNIVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDFGLSR 395
            +          DV   +++L ++    I+H ++KP NI+     D      + DFG +R
Sbjct: 116 IVLR--------DVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG--------DVYSYGILLLEMVTT 447
             +   +    S     GT  Y+ P+    + +  +         D++S G+      T 
Sbjct: 165 ELE--DDEQFVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

Query: 448 KKP 450
             P
Sbjct: 220 SLP 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  114 bits (287), Expect = 8e-29
 Identities = 58/235 (24%), Positives = 94/235 (40%), Gaps = 50/235 (21%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNI-RHK 288
           +G G+FG V +      +  +    VA+K++   +  A  +     M+E K L  +  H 
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-------HPDAIPQRDREIEIQKL 341
           N+V ++ +C+     G     ++ +Y   G L  +L                 E +   L
Sbjct: 88  NIVNLLGACT----IGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 342 TLLQRISIAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR----- 395
            L   +S +  VA  + +L  ++C    +H DL   NILL +     I DFGL+R     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 396 -FYQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             Y    N   P       V+      APE       +   DV+SYGI L E+ +
Sbjct: 199 SNYVVKGNARLP-------VKWM----APESIFNCVYTFESDVWSYGIFLWELFS 242

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  114 bits (288), Expect = 8e-29
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 46/233 (19%)

Query: 237 NLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNI-R 286
             +G G+FG V +        ++    VA+K++   +  A        M+E K + ++ +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQ 108

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---PDAIPQRDREIEIQKLTL 343
           H+N+V ++ +C+     G     ++ +Y   G L  +L              I     + 
Sbjct: 109 HENIVNLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 344 LQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------F 396
              +  +  VA  + +L  ++C    +H D+   N+LL N   A IGDFGL+R       
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

Query: 397 YQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           Y    N   P       V+      APE       +   DV+SYGILL E+ +
Sbjct: 220 YIVKGNARLP-------VKWM----APESIFDCVYTVQSDVWSYGILLWEIFS 261

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  113 bits (286), Expect = 9e-29
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 38/227 (16%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V+          +D  +VA+K +      A K F  E + L N++H+++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLLQRIS 348
              C      G+    +V++YM +G L K+L         +          +L L Q + 
Sbjct: 83  YGVCG----DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVSN 402
           IA  +AS + YL        +H DL   N L+  +L   IGDFG+SR      +Y+   +
Sbjct: 138 IASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 403 PTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
               + + +R       PE   Y      +T  DV+S+G++L E+ T
Sbjct: 195 ----TMLPIRWM----PPESIMYRK---FTTESDVWSFGVILWEIFT 230

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (286), Expect = 1e-28
 Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 37/222 (16%)

Query: 238 LIGVGSFGSVYKGVFDED---GTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLV 291
           L+G G  G VY+    ED     +VA+K+++               E +    ++  ++V
Sbjct: 41  LVGRGGMGDVYEA---EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 292 RVITSCSSVDF---QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
            +       DF    G  +  +  + +    L   L                L   + ++
Sbjct: 98  PIH------DFGEIDGQLY--VDMRLINGVDLAAMLRRQG-----------PLAPPRAVA 138

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           I   + SALD  H        H D+KP NIL+  D  A++ DFG++    A ++  ++  
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQL 192

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               GT+ Y+APE    S  +   D+Y+   +L E +T   P
Sbjct: 193 GNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (287), Expect = 1e-28
 Identities = 46/228 (20%), Positives = 85/228 (37%), Gaps = 25/228 (10%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITS 296
           ++  G F  VY+      G   A+K +    +  +++ + E   +K +  H N+V+  ++
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 297 CSSVDFQGNDFKAIVYKYM--PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S    + +  +A          G L ++L             + K        I     
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--------IFYQTC 146

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY--------QAVSNPTVS 406
            A+ ++H+  + PI+H DLK  N+LL N  +  + DFG +            A     V 
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 407 SSIGVRGTIGYVAPE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             I    T  Y  PE    Y     +    D+++ G +L  +   + P
Sbjct: 206 EEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP 252

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  117 bits (294), Expect = 2e-28
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 25/219 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK-SFMAECKALKNIRHKNLVR---VI 294
           +G G FG V + +  + G  VAIK    +    ++  +  E + +K + H N+V    V 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                     ND   +  +Y   G L K+L+        +E  I+   LL       D++
Sbjct: 82  DGLQ--KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT--LLS------DIS 131

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           SAL YLH++    I+H DLKP NI+L      L   I D G ++          +  +  
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV-- 184

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT+ Y+APE     + +   D +S+G L  E +T  +P
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  115 bits (288), Expect = 2e-28
 Identities = 34/272 (12%), Positives = 76/272 (27%), Gaps = 42/272 (15%)

Query: 202 RSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAI 261
            S       +P   ++ L    ++L++         ++G     +  +    E G    +
Sbjct: 56  VSTSLWNTGQPFRVESELGERPRTLVRG-------TVLGQEDPYAYLEATDQETGESFEV 108

Query: 262 KVINLQRQGAS---KSFMAECKALKNIRH----------------KNLVRVITSCSSVDF 302
            V     +  S   K    E   L+ +R                  +LV+       +  
Sbjct: 109 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 168

Query: 303 QGNDFKAIVYKY---MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDY 359
           + ++    V       P          + +       +   L    R+ + + V   L  
Sbjct: 169 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIRLLAS 226

Query: 360 LHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVA 419
           LH +    ++H  L+P +I+LD      +  F       A +   +             A
Sbjct: 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF---APPETTA 280

Query: 420 PEYGLGSEVSTNG-----DVYSYGILLLEMVT 446
                  +          D ++ G+ +  +  
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  113 bits (284), Expect = 2e-28
 Identities = 61/243 (25%), Positives = 95/243 (39%), Gaps = 61/243 (25%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G G FG V K            T VA+K++   ++ AS S     ++E   LK + H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNHPH 87

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-------------HPDAIPQRDREI 336
           ++++  +CS    Q      ++ +Y   GSL  +L                         
Sbjct: 88  VIKLYGACS----QDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 337 EIQKLTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           + + LT+   IS A  ++  + YL         +H DL   NIL+       I DFGLSR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSR 198

Query: 396 ------FYQAVSN---PTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLE 443
                  Y   S    P       V+      A E     +    +T  DV+S+G+LL E
Sbjct: 199 DVYEEDSYVKRSQGRIP-------VKWM----AIESLFDHI---YTTQSDVWSFGVLLWE 244

Query: 444 MVT 446
           +VT
Sbjct: 245 IVT 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  113 bits (284), Expect = 2e-28
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 49/230 (21%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G G+FG VY+G       D     VA+K +    +  S+     F+ E   +    H+N
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQN 94

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +VR I        Q      I+ + M  G L+ +L       R R  +   L +L  + +
Sbjct: 95  IVRCIGVSL----QSLPR-FILMELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHV 145

Query: 350 AIDVASALDYL-HQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSR------FYQA 399
           A D+A    YL   H     +H D+   N LL        A IGDFG++R      +Y+ 
Sbjct: 146 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201

Query: 400 VSNPTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
                  + + V+       PE    G+    ++  D +S+G+LL E+ +
Sbjct: 202 GGC----AMLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFS 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  112 bits (282), Expect = 4e-28
 Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 47/233 (20%)

Query: 239 IGVGSFGSVYKG-----VFDEDGTVVAIKVINLQRQGASKS----FMAECKALKNI-RHK 288
           +G G+FG V +              VA+K++    +GA+ S     M+E K L +I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTL 343
           N+V ++ +C+    +      ++ ++   G+L  +L               ++    LTL
Sbjct: 92  NVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147

Query: 344 LQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------F 396
              I  +  VA  +++L  + C    +H DL   NILL       I DFGL+R       
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203

Query: 397 YQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           Y    +   P       ++      APE       +   DV+S+G+LL E+ +
Sbjct: 204 YVRKGDARLP-------LKWM----APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (286), Expect = 4e-28
 Identities = 51/239 (21%), Positives = 97/239 (40%), Gaps = 34/239 (14%)

Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAEC 279
           M  +S       +  ++++G G+  +V++G   + G + AIKV N           M E 
Sbjct: 1   MGSQSTSN--HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREF 58

Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           + LK + HKN+V++    +  +      K ++ ++ P GSL   L   +      E E  
Sbjct: 59  EVLKKLNHKNIVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLSAHIGDFGLSR 395
            +          DV   +++L ++    I+H ++KP NI+     D      + DFG +R
Sbjct: 116 IVL--------RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG--------DVYSYGILLLEMVT 446
             +   +    S     GT  Y+ P+    + +  +         D++S G+      T
Sbjct: 165 ELE--DDEQFVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  112 bits (282), Expect = 5e-28
 Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 37/226 (16%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV 293
           +G G+FG V+         ++D  +VA+K +    + A + F  E + L  ++H+++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL----HPDAIPQRDREIEIQKLTLLQRISI 349
              C+    +G     +V++YM +G L ++L        +     ++    L L Q +++
Sbjct: 109 FGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR------FYQAVSNP 403
           A  VA+ + YL        +H DL   N L+   L   IGDFG+SR      +Y+     
Sbjct: 164 ASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR- 219

Query: 404 TVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
              + + +R       PE   Y      +T  DV+S+G++L E+ T
Sbjct: 220 ---TMLPIRWM----PPESILYRK---FTTESDVWSFGVVLWEIFT 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  112 bits (282), Expect = 7e-28
 Identities = 28/238 (11%), Positives = 56/238 (23%), Gaps = 39/238 (16%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVI 294
            + VG    V+     E     A+KV        +   +       A   +  ++     
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 295 TSC------------------SSVDFQGNDFKAIVYKYMP--NGSLEKWLHPDAIPQRDR 334
                                     Q +   A     MP  +  LE            R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
                   +L    +   +      L       ++H    P N+ +  D    +GD    
Sbjct: 189 G----DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA- 240

Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEY--GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                    T   +      + Y   E+     +  +   + +  G+ +  +     P
Sbjct: 241 ----LWKVGTRGPASS--VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  111 bits (281), Expect = 8e-28
 Identities = 53/235 (22%), Positives = 103/235 (43%), Gaps = 50/235 (21%)

Query: 239 IGVGSFGSVYKGV-------FDEDGTVVAIKVINLQRQGASKS----FMAECKALKNI-R 286
           +G G+FG V             ++   VA+K++   +  A++      ++E + +K I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 99

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKL 341
           HKN++ ++ +C+    Q      ++ +Y   G+L ++L                +  +++
Sbjct: 100 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 342 TLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR----- 395
           T    +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R     
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 210

Query: 396 -FYQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +Y+  +N   P       V+      APE       +   DV+S+G+L+ E+ T
Sbjct: 211 DYYKKTTNGRLP-------VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  111 bits (280), Expect = 9e-28
 Identities = 66/226 (29%), Positives = 100/226 (44%), Gaps = 36/226 (15%)

Query: 237 NLIGVGSFGSVYKGVFDEDG--TVVAIKVINLQRQGASKS----FMAECKALKNI-RHKN 289
           ++IG G+FG V K    +DG     AIK +   ++ ASK     F  E + L  +  H N
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPN 87

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKLTLL 344
           ++ ++ +C         +  +  +Y P+G+L  +L                     L+  
Sbjct: 88  IINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 345 QRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR---FYQAV 400
           Q +  A DVA  +DYL  +      +H DL   NIL+  +  A I DFGLSR    Y   
Sbjct: 143 QLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +       + VR      A E    S  +TN DV+SYG+LL E+V+
Sbjct: 199 TM----GRLPVRWM----AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  110 bits (277), Expect = 2e-27
 Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 36/228 (15%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHK 288
             +     IG G++G+V+K    E   +VA+K + L    +G   S + E   LK ++HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 289 NLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--L 343
           N+VR   V+ S   +         +V+++     L+K+   D+         ++     L
Sbjct: 62  NIVRLHDVLHSDKKL--------TLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQL 110

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           L+           L + H      +LH DLKP N+L++ +    + +FGL+R +  +   
Sbjct: 111 LK----------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVR 156

Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
             S+ + V  T+ Y  P+   G+++ ST+ D++S G +  E+    +P
Sbjct: 157 CYSAEV-V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  110 bits (276), Expect = 2e-27
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++    IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
            + S     +   D   +V +Y+  GSL   +    +     E +I         ++  +
Sbjct: 82  YLDS-----YLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIA--------AVCRE 124

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
              AL++LH +    ++H D+K  NILL  D S  + DFG      A   P  S    + 
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMV 177

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GT  ++APE           D++S GI+ +EM+  + P
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  111 bits (279), Expect = 3e-27
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 49/230 (21%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           +G G+FG VY+G       D     VA+K +    +  S+     F+ E   +    H+N
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +VR I        Q      I+ + M  G L+ +L       R R  +   L +L  + +
Sbjct: 136 IVRCIGVSL----QSLPR-FILLELMAGGDLKSFLRE----TRPRPSQPSSLAMLDLLHV 186

Query: 350 AIDVASALDYL-HQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSR------FYQA 399
           A D+A    YL   H     +H D+   N LL        A IGDFG++R      +Y+ 
Sbjct: 187 ARDIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242

Query: 400 VSNPTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLEMVT 446
                  + + V+       PE    G+    ++  D +S+G+LL E+ +
Sbjct: 243 GGC----AMLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFS 281

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (276), Expect = 3e-27
 Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 31/222 (13%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVI--NLQR-QGASKSFMAECKALKNIRHKNLVRVI 294
           ++G G    V+      D   VA+KV+  +L R       F  E +    + H  +V V 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 295 TSCSSVDFQGNDFKA------IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
                 D  G           IV +Y+   +L   +H               +T  + I 
Sbjct: 79  ------D-TGEAETPAGPLPYIVMEYVDGVTLRDIVH-----------TEGPMTPKRAIE 120

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           +  D   AL++ HQ+    I+H D+KP+NI++    +  + DFG++R      N    ++
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             V GT  Y++PE   G  V    DVYS G +L E++T + P
Sbjct: 178 A-VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 3e-27
 Identities = 32/242 (13%), Positives = 69/242 (28%), Gaps = 46/242 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRH------- 287
           ++G     +  +    E G    + V     +    A K    E   L+ +R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 288 ---------KNLVRVITSCSSVDFQGNDFKAIVYKY---MPNGSLEKWLHPDAIPQRDRE 335
                     +LV+       +  + ++    V       P          + +      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 336 IEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
            +   L    R+ + + V   L  LH +    ++H  L+P +I+LD      +  F    
Sbjct: 200 HK--SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 396 FYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-----------DVYSYGILLLEM 444
              A    +         + G+  PE        +             D ++ G+++  +
Sbjct: 255 RDGARVVSS--------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

Query: 445 VT 446
             
Sbjct: 307 WC 308

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  110 bits (277), Expect = 3e-27
 Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 55/240 (22%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGAS----KSFMAECKALKNI-RHK 288
           +G G+FG V                VA+K++   ++ A     ++ M+E K +  +  H+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHE 109

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL------------HPDAIPQRDREI 336
           N+V ++ +C+           ++++Y   G L  +L              +   + + E 
Sbjct: 110 NIVNLLGACT----LSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 337 EIQKLTLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
           ++  LT    +  A  VA  +++L  + C    +H DL   N+L+ +     I DFGL+R
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLAR 220

Query: 396 ------FYQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
                  Y    N   P       V+      APE       +   DV+SYGILL E+ +
Sbjct: 221 DIMSDSNYVVRGNARLP-------VKWM----APESLFEGIYTIKSDVWSYGILLWEIFS 269

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (278), Expect = 4e-27
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 50/235 (21%)

Query: 239 IGVGSFGSVYKGV-------FDEDGTVVAIKVINLQRQGASKS----FMAECKALKNI-R 286
           +G G+FG V                T VA+K++      A++      ++E + +K I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKL 341
           HKN++ ++ +C+    Q      IV +Y   G+L ++L                   ++L
Sbjct: 134 HKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 342 TLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR----- 395
           +    +S A  VA  ++YL  + C    +H DL   N+L+  D    I DFGL+R     
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

Query: 396 -FYQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +Y+  +N   P       V+      APE       +   DV+S+G+LL E+ T
Sbjct: 245 DYYKKTTNGRLP-------VKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  110 bits (278), Expect = 4e-27
 Identities = 53/235 (22%), Positives = 102/235 (43%), Gaps = 50/235 (21%)

Query: 239 IGVGSFGSVYKGV-------FDEDGTVVAIKVINLQRQGASKS----FMAECKALKNI-R 286
           +G G FG V             ++   VA+K++   +  A++      ++E + +K I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGK 145

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-----HPDAIPQRDREIEIQKL 341
           HKN++ ++ +C+    Q      ++ +Y   G+L ++L                +  +++
Sbjct: 146 HKNIINLLGACT----QDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 342 TLLQRISIAIDVASALDYL-HQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR----- 395
           T    +S    +A  ++YL  Q C    +H DL   N+L+  +    I DFGL+R     
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 396 -FYQAVSN---PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            +Y+  +N   P       V+      APE       +   DV+S+G+L+ E+ T
Sbjct: 257 DYYKKTTNGRLP-------VKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (274), Expect = 7e-27
 Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 32/253 (12%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATD---GFSSTNLIGVGSFGSVYKGVFDEDGT 257
                S   +    + AL     + ++   D      S   IG GS G V        G 
Sbjct: 17  NLYFQSGVVTHEQFKAAL-----RMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71

Query: 258 VVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPN 317
            VA+K+++L++Q   +    E   +++ +H N+V +  S     +   +   ++ +++  
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-----YLVGEELWVLMEFLQG 126

Query: 318 GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSN 377
           G+L   +    +     E +I         ++   V  AL YLH      ++H D+K  +
Sbjct: 127 GALTDIVSQVRL----NEEQIA--------TVCEAVLQALAYLHAQ---GVIHRDIKSDS 171

Query: 378 ILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSY 437
           ILL  D    + DFG      A  +  V     + GT  ++APE    S  +T  D++S 
Sbjct: 172 ILLTLDGRVKLSDFGFC----AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227

Query: 438 GILLLEMVTTKKP 450
           GI+++EMV  + P
Sbjct: 228 GIMVIEMVDGEPP 240

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  109 bits (274), Expect = 8e-27
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 61/243 (25%)

Query: 239 IGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQGASKS----FMAECKALKNIRHKN 289
           IG G+FG V++         E  T+VA+K++   ++ AS      F  E   +    + N
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDNPN 111

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-------------HPDAIPQRDREI 336
           +V+++  C+     G     ++++YM  G L ++L                +   R    
Sbjct: 112 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 337 EIQKLTLLQRISIAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
               L+  +++ IA  VA+ + YL  +      +H DL   N L+  ++   I DFGLSR
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSR 222

Query: 396 ------FYQAVSN---PTVSSSIGVRGTIGYVAPE---YGLGSEVSTNGDVYSYGILLLE 443
                 +Y+A  N   P       +R       PE   Y      +T  DV++YG++L E
Sbjct: 223 NIYSADYYKADGNDAIP-------IRWM----PPESIFYNR---YTTESDVWAYGVVLWE 268

Query: 444 MVT 446
           + +
Sbjct: 269 IFS 271

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  108 bits (273), Expect = 9e-27
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 32/225 (14%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKN 289
           + +   + +G G++ +VYKG       +VA+K I L+ + GA  + + E   LK+++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 290 LVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           +V    +I +  S+         +V++Y+    L+++L           +   KL L Q 
Sbjct: 62  IVTLHDIIHTEKSL--------TLVFEYLDK-DLKQYLDDCGNIINMHNV---KLFLFQL 109

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           +         L Y H+     +LH DLKP N+L++      + DFGL+R    +   T  
Sbjct: 110 L-------RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYD 158

Query: 407 SSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           + + V  T+ Y  P+  LGS   ST  D++  G +  EM  T +P
Sbjct: 159 NEV-V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA-TGRP 199

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (271), Expect = 9e-27
 Identities = 68/233 (29%), Positives = 101/233 (43%), Gaps = 34/233 (14%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKN 289
           D +    +IG G+   V           VAIK INL++   S    + E +A+    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V   TS     F   D   +V K +  GS+      D I     + E +   L +   I
Sbjct: 75  IVSYYTS-----FVVKDELWLVMKLLSGGSVL-----DIIKHIVAKGEHKSGVLDEST-I 123

Query: 350 AI---DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           A    +V   L+YLH++ Q   +H D+K  NILL  D S  I DFG+S F     + T +
Sbjct: 124 ATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 407 SSIGVRGT-IG---YVAPE-----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                R T +G   ++APE      G   +     D++S+GI  +E+ T   P
Sbjct: 181 KV---RKTFVGTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAP 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  110 bits (277), Expect = 1e-26
 Identities = 59/230 (25%), Positives = 101/230 (43%), Gaps = 39/230 (16%)

Query: 233 FSSTNLIGVGSFGS-VYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNI-RHKN 289
           F   +++G G+ G+ VY+G+FD     VA+K I  +    A +    E + L+    H N
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFADR----EVQLLRESDEHPN 79

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-REIEIQKLTLLQRIS 348
           ++R   +      +   F+ I  +     +L+     + + Q+D   + ++ +TLLQ   
Sbjct: 80  VIRYFCT-----EKDRQFQYIAIELCA-ATLQ-----EYVEQKDFAHLGLEPITLLQ--- 125

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-----DLSAHIGDFGLSRFYQAVSNP 403
                 S L +LH      I+H DLKP NIL+        + A I DFGL +        
Sbjct: 126 ---QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRH 178

Query: 404 TVSSSIGVRGTIGYVAPEY---GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + S   GV GT G++APE          +   D++S G +   +++    
Sbjct: 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  107 bits (270), Expect = 2e-26
 Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 44/225 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVI 294
            +G G F   ++    +   V A K++    L +    +    E    +++ H+++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                  F+ NDF  +V +     SL      +   +R    E +    L++I       
Sbjct: 82  GF-----FEDNDFVFVVLELCRRRSLL-----ELHKRRKALTEPEARYYLRQI------V 125

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-- 412
               YLH++    ++H DLK  N+ L+ DL   IGDFGL+   +             R  
Sbjct: 126 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---------RKK 173

Query: 413 ---GTIGYVAPE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              GT  Y+APE     G   EV    DV+S G ++  ++  K P
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (272), Expect = 2e-26
 Identities = 56/263 (21%), Positives = 98/263 (37%), Gaps = 54/263 (20%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVV 259
              + P  +    ++     +  Y    +          +G G F   ++    +   V 
Sbjct: 20  APAAAPPAKEIPEVLVDPRSRRRYV-RGR---------FLGKGGFAKCFEISDADTKEVF 69

Query: 260 AIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMP 316
           A K++    L +    +    E    +++ H+++V          F+ NDF  +V +   
Sbjct: 70  AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCR 124

Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS 376
             SL      +   +R    E +    L++I           YLH++    ++H DLK  
Sbjct: 125 RRSLL-----ELHKRRKALTEPEARYYLRQI------VLGCQYLHRNR---VIHRDLKLG 170

Query: 377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR-----GTIGYVAPEY----GLGSE 427
           N+ L+ DL   IGDFGL+   +             R     GT  Y+APE     G   E
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGE---------RKKVLCGTPNYIAPEVLSKKGHSFE 221

Query: 428 VSTNGDVYSYGILLLEMVTTKKP 450
           V    DV+S G ++  ++  K P
Sbjct: 222 V----DVWSIGCIMYTLLVGKPP 240

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (268), Expect = 2e-26
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR-- 292
           L+G GSF  VY+      G  VAIK+I+   + + G  +    E K    ++H +++   
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 293 -VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI-EIQKLTLLQRISIA 350
                 + V         +V +   NG + ++L       R +   E +    + +I   
Sbjct: 78  NYFEDSNYV--------YLVLEMCHNGEMNRYLK-----NRVKPFSENEARHFMHQI--- 121

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP--TVSSS 408
               + + YLH H    ILH DL  SN+LL  +++  I DFGL+   +       T+   
Sbjct: 122 ---ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-- 173

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               GT  Y++PE    S      DV+S G +   ++  + P
Sbjct: 174 ----GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (266), Expect = 4e-26
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 28/217 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRV 293
             +G G FG+VY     +   ++A+KV+    L++ G       E +   ++RH N++R+
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
                   F       ++ +Y P G++ + L       +  E                ++
Sbjct: 75  YGY-----FHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTAT--------YITEL 118

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           A+AL Y H      ++H D+KP N+LL +     I DFG S    +     +       G
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC------G 169

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  106 bits (267), Expect = 6e-26
 Identities = 68/231 (29%), Positives = 118/231 (51%), Gaps = 31/231 (13%)

Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL-QRQGASKSFMAECKALKNI 285
           + ++  F     +G G++ +VYKG+    G  VA+K + L   +G   + + E   +K +
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60

Query: 286 RHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL--HPDAIPQRDREIEIQK 340
           +H+N+VR   VI + + +         +V+++M N  L+K++         R  E+ + K
Sbjct: 61  KHENIVRLYDVIHTENKL--------TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
               Q       +   L + H++    ILH DLKP N+L++      +GDFGL+R +  +
Sbjct: 112 YFQWQ-------LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG-I 160

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
              T SS + V  T+ Y AP+  +GS   ST+ D++S G +L EM+ T KP
Sbjct: 161 PVNTFSSEV-V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKP 207

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (266), Expect = 7e-26
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 34/226 (15%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHK 288
           + +     +G G++G VYK   D  G +VA+K I L    +G   + + E   LK + H 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79

Query: 289 NLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           N+V    VI S   +         +V+++M    L+K L  D      ++ +I+   L Q
Sbjct: 80  NIVSLIDVIHSERCL--------TLVFEFMEK-DLKKVL--DENKTGLQDSQIKIY-LYQ 127

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                  +   + + HQH    ILH DLKP N+L+++D +  + DFGL+R +     P  
Sbjct: 128 -------LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF---GIPVR 174

Query: 406 SSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           S +  V  T+ Y AP+  +GS+  ST+ D++S G +  EM+ T KP
Sbjct: 175 SYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI-TGKP 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  107 bits (268), Expect = 1e-25
 Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 42/241 (17%)

Query: 233 FSSTNLIGVGSFGSV-YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL-KNIRHKNL 290
             S  ++G GS G+V ++G F   G  VA+K + +         + E K L ++  H N+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV 71

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTLLQRISI 349
           +R   S        + F  I  +   N +L+     D +  ++   E ++       IS+
Sbjct: 72  IRYYCS-----ETTDRFLYIALELC-NLNLQ-----DLVESKNVSDENLKLQKEYNPISL 120

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDN-------------DLSAHIGDFGLSRF 396
              +AS + +LH      I+H DLKP NIL+               +L   I DFGL + 
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 397 YQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-------DVYSYGILLLEMVTTKK 449
             +  +   ++     GT G+ APE    S             D++S G +   +++  K
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 450 P 450
            
Sbjct: 238 H 238

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  104 bits (262), Expect = 2e-25
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 38/228 (16%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHK 288
           + +     IG G++G VYK   +  G   A+K I L+   +G   + + E   LK ++H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 289 NLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--L 343
           N+V+   VI +   +         +V++++    L+K L  D        +  +     L
Sbjct: 61  NIVKLYDVIHTKKRL--------VLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQL 109

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
           L            + Y H      +LH DLKP N+L++ +    I DFGL+R +  +   
Sbjct: 110 LN----------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVR 155

Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
             +  I V  T+ Y AP+  +GS+  ST  D++S G +  EMV    P
Sbjct: 156 KYTHEI-V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTP 199

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 3e-25
 Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 25/219 (11%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS-FMAECKALKNIRHKNLV 291
           F+    IG GSFG V+KG+ +    VVAIK+I+L+           E   L       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +   S     +  +    I+ +Y+  GS    L P  +     E +I         +I  
Sbjct: 84  KYYGS-----YLKDTKLWIIMEYLGGGSALDLLEPGPLD----ETQIA--------TILR 126

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
           ++   LDYLH       +H D+K +N+LL       + DFG++         T       
Sbjct: 127 EILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRNTF 179

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  ++APE    S   +  D++S GI  +E+   + P
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (263), Expect = 3e-25
 Identities = 36/237 (15%), Positives = 73/237 (30%), Gaps = 32/237 (13%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQGASKSFMAECKALKN 284
           +      +L+G G+F  VY+         ++     +KV                + LK 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
                 ++  ++         +   +V +    G+L      +AI    +    + +   
Sbjct: 124 SMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLL-----NAI-NLYKNTPEKVMPQG 172

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH-----------IGDFGL 393
             IS A+ +   ++ +H      I+H D+KP N +L N                + D G 
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S   +    P  +       T G+   E       +   D +     +  M+     
Sbjct: 230 SIDMKLF--PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (259), Expect = 4e-25
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 28/216 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVI 294
            +G G FG+VY     ++  ++A+KV+    L+++G       E +   ++RH N++R+ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                  F       ++ ++ P G L K L       R  E                ++A
Sbjct: 81  NY-----FHDRKRIYLMLEFAPRGELYKELQKH---GRFDEQRSAT--------FMEELA 124

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            AL Y H+     ++H D+KP N+L+       I DFG S    ++   T+       GT
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------GT 175

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + Y+ PE   G       D++  G+L  E +    P
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  107 bits (268), Expect = 4e-25
 Identities = 32/129 (24%), Positives = 49/129 (37%), Gaps = 4/129 (3%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPI 61
                         +S L   L +A N F  +  P I   L+ L   D+S   L    P 
Sbjct: 430 HTHTRVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL--SLEYL 119
                SSL+ + +  N F       ++    ++ LD S N++       L+    SL +L
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548

Query: 120 NLSFNDFEG 128
           NL+ NDF  
Sbjct: 549 NLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 99.3 bits (248), Expect = 2e-22
 Identities = 24/133 (18%), Positives = 46/133 (34%), Gaps = 6/133 (4%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEI-P 60
           ++L      ++F    L N   L+++  H   +       L +L    ++ N       P
Sbjct: 406 SNLKQMSEFSVFL--SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
                  +L  + L         P+ F +   ++ L++S NN         + L SL+ L
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 523

Query: 120 NLSFNDFEGKVPT 132
           + S N        
Sbjct: 524 DYSLNHIMTSKKQ 536

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.4 bits (243), Expect = 8e-22
 Identities = 30/143 (20%), Positives = 49/143 (34%), Gaps = 9/143 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            ++      A  S+S+LS +L L  N            L +L+        L+      +
Sbjct: 62  CEIQTIEDGAYQSLSHLS-TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 64  GLCSSLEDIYLGGNFFHG-SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-----LE 117
           G   +L+++ +  N      +P +F     +  LDLS N +       L  L        
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 118 YLNLSFNDFEGKVPTKGIFANTS 140
            L+LS N      P  G F    
Sbjct: 181 SLDLSLNPMNFIQP--GAFKEIR 201

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 95.1 bits (237), Expect = 4e-21
 Identities = 44/207 (21%), Positives = 73/207 (35%), Gaps = 14/207 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGL-SGEIPIE 62
           N +      A   +S L   L   E +        IG+LK L+  +V++N + S ++P  
Sbjct: 86  NPIQSLALGAFSGLSSLQ-KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIR----KLDLSRNNLSGQIPLFLEALSLEY 118
               ++LE + L  N       +  R    +      LDLS N ++   P   + + L  
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHK 204

Query: 119 LNLSFNDFEGKVPTKGIFANTSAISV----AGCHRLCGGIPEL---QLPKCTENKSSNQR 171
           L L  N     V  K      + + V     G  R  G + +     L           R
Sbjct: 205 LTLRNNFDSLNVM-KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 172 ISRSLKILISIVSIFLGIVMVSFFIFS 198
           ++     L  I+ +F  +  VS F   
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLV 290

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 92.4 bits (230), Expect = 3e-20
 Identities = 21/107 (19%), Positives = 38/107 (35%), Gaps = 1/107 (0%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
           +L+L+ N           +   L+  D+S   +           S L  + L GN     
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEG 128
               F     ++KL     NL+      +  L +L+ LN++ N  + 
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 88.2 bits (219), Expect = 7e-19
 Identities = 32/131 (24%), Positives = 53/131 (40%), Gaps = 5/131 (3%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
           +  N +  T+      +  L   L+   ++        +  +L+ L   D+S+       
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLE-HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 60  PIELGLCSSLEDIYLGGNFFHGSI-PSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLE 117
                  SSLE + + GN F  +  P  F   R +  LDLS+  L    P    +L SL+
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 118 YLNLSFNDFEG 128
            LN+S N+F  
Sbjct: 498 VLNMSHNNFFS 508

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 29/122 (23%), Positives = 48/122 (39%), Gaps = 4/122 (3%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             L    P A  S+S L   LN++ N+F          L +L+  D S N +      EL
Sbjct: 480 CQLEQLSPTAFNSLSSL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538

Query: 64  G-LCSSLEDIYLGGNFFHGSIPS--FFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
               SSL  + L  N F  +     F +  +  R+L +    +    P   + + +  LN
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLN 598

Query: 121 LS 122
           ++
Sbjct: 599 IT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 32/138 (23%), Positives = 49/138 (35%), Gaps = 10/138 (7%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L     E +   SY      L L    F G  P     LK+L+    ++N   G     
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVNCKF-GQFPT--LKLKSLKRLTFTSN--KGGNAFS 342

Query: 63  LGLCSSLEDIYLGGNF--FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
                SLE + L  N   F G        +  ++ LDLS N +      FL    LE+L+
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLD 402

Query: 121 LSFNDFEGKVPTKGIFAN 138
              ++ +       +F +
Sbjct: 403 FQHSNLKQMSE-FSVFLS 419

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 18/162 (11%), Positives = 40/162 (24%), Gaps = 39/162 (24%)

Query: 4   NDLSGTIPEAIFSISYLSN---SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           N +       +  +  +     SL+L+ N      P     ++ L    + NN  S  + 
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVM 217

Query: 61  ----------------------------IELGLCSSLEDIYLGGN------FFHGSIPSF 86
                                        +      L ++ +         ++   I   
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277

Query: 87  FRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEG 128
           F     +    L    +  ++  F      ++L L    F  
Sbjct: 278 FNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQ 318

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 18/129 (13%), Positives = 44/129 (34%), Gaps = 7/129 (5%)

Query: 16  SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLG 75
           +++     L    ++++  I      L  + SF + +  +              + + L 
Sbjct: 256 NLTIEEFRLAYL-DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELV 312

Query: 76  GNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGI 135
              F        ++   +++L  + N         ++  SLE+L+LS N    K      
Sbjct: 313 NCKFGQFPTLKLKS---LKRLTFTSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 136 FANTSAISV 144
              T+++  
Sbjct: 369 DFGTTSLKY 377

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  103 bits (259), Expect = 5e-25
 Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 27/223 (12%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           +     +G G+FG VYK    E G + A KVI  + +   + ++ E + L    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++ +     +  +    I+ ++ P G+++  +        + +I++          +   
Sbjct: 81  LLGA-----YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV----------VCRQ 125

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +  AL++LH      I+H DLK  N+L+  +    + DFG+S    A +  T+       
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFI 178

Query: 413 GTIGYVAPEYGLGSEVSTNG-----DVYSYGILLLEMVTTKKP 450
           GT  ++APE  +   +         D++S GI L+EM   + P
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (260), Expect = 6e-25
 Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 25/236 (10%)

Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGV-FDEDGTVVAIKVINLQ--RQGASKSFMA 277
           M    L +A   +     IG G++G V+K       G  VA+K + +Q   +G   S + 
Sbjct: 1   MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60

Query: 278 ECKALKNIR---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           E   L+++    H N+VR+   C+           +V++++    L  +L  D +P+   
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGV 117

Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
             E  K  + Q       +   LD+LH H    ++H DLKP NIL+ +     + DFGL+
Sbjct: 118 PTETIKDMMFQ-------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167

Query: 395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           R Y   S     +S+ V  T+ Y APE  L S  +T  D++S G +  EM   +KP
Sbjct: 168 RIY---SFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 217

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (258), Expect = 9e-25
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 27/231 (11%)

Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL-QRQGASKSF----MAECKAL 282
            AT  +     IGVG++G+VYK      G  VA+K + +    G         + E   L
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 283 KNIR---HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           + +    H N+VR++  C++          +V++++    L  +L  D  P      E  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETI 122

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
           K  + Q           LD+LH +C   I+H DLKP NIL+ +  +  + DFGL+R Y  
Sbjct: 123 KDLMRQ-------FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-- 170

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            S     + + V  T+ Y APE  L S  +T  D++S G +  EM   +KP
Sbjct: 171 -SYQMALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 217

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  103 bits (258), Expect = 1e-24
 Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 39/262 (14%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVV 259
           H                  + +S      + D +     +G G++G VYK +       V
Sbjct: 3   HHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETV 62

Query: 260 AIKVINLQ--RQGASKSFMAECKALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKY 314
           AIK I L+   +G   + + E   LK ++H+N++    VI     +         ++++Y
Sbjct: 63  AIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL--------HLIFEY 114

Query: 315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK 374
             N  L+K++  D  P       I+   L Q       + + +++ H       LH DLK
Sbjct: 115 AEN-DLKKYM--DKNPDVS-MRVIKSF-LYQ-------LINGVNFCHSRR---CLHRDLK 159

Query: 375 PSNILLDNDLSAH-----IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV- 428
           P N+LL    ++      IGDFGL+R +  +     +  I +  T+ Y  PE  LGS   
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEI-I--TLWYRPPEILLGSRHY 215

Query: 429 STNGDVYSYGILLLEMVTTKKP 450
           ST+ D++S   +  EM+  K P
Sbjct: 216 STSVDIWSIACIWAEML-MKTP 236

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  103 bits (258), Expect = 1e-24
 Identities = 66/257 (25%), Positives = 111/257 (43%), Gaps = 37/257 (14%)

Query: 202 RSRPSRQPSEPMIRK--ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVV 259
           +     +  E   ++  A L    K      D F   + +G G+ G V+K      G V+
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 260 AIKVINLQRQGAS-KSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA----IVYKY 314
           A K+I+L+ + A     + E + L       +V          F G  +      I  ++
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---------FYGAFYSDGEISICMEH 112

Query: 315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK 374
           M  GSL++ L       R  E  + K        ++I V   L YL +  +  I+H D+K
Sbjct: 113 MDGGSLDQVLK---KAGRIPEQILGK--------VSIAVIKGLTYLREKHK--IMHRDVK 159

Query: 375 PSNILLDNDLSAHIGDFGLS-RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGD 433
           PSNIL+++     + DFG+S +   +++N  V       GT  Y++PE   G+  S   D
Sbjct: 160 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------GTRSYMSPERLQGTHYSVQSD 212

Query: 434 VYSYGILLLEMVTTKKP 450
           ++S G+ L+EM   + P
Sbjct: 213 IWSMGLSLVEMAVGRYP 229

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  103 bits (258), Expect = 1e-24
 Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 45/231 (19%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN-----------------LQRQGASKSFMAECKA 281
           +  G F  +      +D    A+K                    +  +     F  E + 
Sbjct: 39  LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 282 LKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           + +I+++  +    +IT+   V      +  I+Y+YM N S+ K+           +   
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEV------Y--IIYEYMENDSILKFDEYF---FVLDKNYT 145

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
             + +     I   V ++  Y+H      I H D+KPSNIL+D +    + DFG S +  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEY-- 201

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG---DVYSYGILLLEMVT 446
            + +  +  S   RGT  ++ PE+   +E S NG   D++S GI L  M  
Sbjct: 202 -MVDKKIKGS---RGTYEFMPPEF-FSNESSYNGAKVDIWSLGICLYVMFY 247

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (259), Expect = 2e-24
 Identities = 46/237 (19%), Positives = 78/237 (32%), Gaps = 40/237 (16%)

Query: 230 TDGFSSTNLIGVG--SFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNI 285
              +    +IG G     +V    +   G  V ++ INL+            E    K  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 286 RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLE---KWLHPDAIPQRDREIEIQKLT 342
            H N+V    +     F  ++   +V  +M  GS +        D +     E+ I    
Sbjct: 84  NHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTHFMDGMN----ELAIA--- 131

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS-RFYQAVS 401
                 I   V  ALDY+H       +H  +K S+IL+  D   ++     +        
Sbjct: 132 -----YILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 402 NPTVSSSIGVR--GTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              V           + +++PE       G  ++     D+YS GI   E+     P
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVP 236

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (256), Expect = 2e-24
 Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 36/221 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS---FMA--ECKALKNIRHKNLVR- 292
           +G G F +VYK        +VAIK I L  +  +K      A  E K L+ + H N++  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 293 --VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
                  S++        ++V+ +M    LE  +  +++      I   K  +L      
Sbjct: 78  LDAFGHKSNI--------SLVFDFMET-DLEVIIKDNSLVLTPSHI---KAYMLM----- 120

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
                 L+YLHQH    ILH DLKP+N+LLD +    + DFGL++ +    N   +  + 
Sbjct: 121 --TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQV- 173

Query: 411 VRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           V  T  Y APE   G+ +     D+++ G +L E++  + P
Sbjct: 174 V--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LRVP 211

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (256), Expect = 3e-24
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 25/228 (10%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA--ECKALKNIRHK 288
             +     IG G+FG V+K    + G  VA+K + ++ +       A  E K L+ ++H+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 289 NLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           N+V    +  + +S   +      +V+ +  +  L   L    +     EI   K  +  
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI---KRVMQM 132

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                  + + L Y+H++    ILH D+K +N+L+  D    + DFGL+R +    N   
Sbjct: 133 -------LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182

Query: 406 S--SSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
           +  ++  V  T+ Y  PE  LG        D++  G ++ EM  T+ P
Sbjct: 183 NRYTNRVV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW-TRSP 227

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  100 bits (252), Expect = 6e-24
 Identities = 60/252 (23%), Positives = 104/252 (41%), Gaps = 32/252 (12%)

Query: 210 SEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ 269
           +     ++L ++   +L      F    L+G G++G VYKG   + G + AIKV+++   
Sbjct: 3   ASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62

Query: 270 GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKA-IVYKYMPNGSLEKWLHPD 327
              +    E   LK    H+N+     +    +  G D +  +V ++   GS+   +   
Sbjct: 63  -EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN- 120

Query: 328 AIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH 387
                 +E  I          I  ++   L +LHQH    ++H D+K  N+LL  +    
Sbjct: 121 TKGNTLKEEWIA--------YICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 388 IGDFGLSRFYQAVSNPTVSSSIGVRGT-IG---YVAPEYGLGSEVSTNG-----DVYSYG 438
           + DFG+S          +  ++G R T IG   ++APE     E          D++S G
Sbjct: 170 LVDFGVSA--------QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

Query: 439 ILLLEMVTTKKP 450
           I  +EM     P
Sbjct: 222 ITAIEMAEGAPP 233

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (252), Expect = 6e-24
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 39/221 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITS 296
           IG GS+G V+K    + G +VAIK            K  + E + LK ++H NLV ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL-- 68

Query: 297 CSSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--LLQRISIAIDV 353
               + F+      +V++Y  + ++   L  D   +   E  ++ +T   LQ        
Sbjct: 69  ----EVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQ-------- 113

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP-T--VSSSIG 410
             A+++ H+H     +H D+KP NIL+       + DFG +R     S+     V+    
Sbjct: 114 --AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---- 164

Query: 411 VRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
              T  Y +PE  +G        DV++ G +  E++ +  P
Sbjct: 165 ---TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL-SGVP 201

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  102 bits (255), Expect = 7e-24
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 26/222 (11%)

Query: 239 IGVGSFGSVYKGVFDEDGT--VVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR---V 293
           +G G++G VYK    +       A+K I     G S S   E   L+ ++H N++    V
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             S +           +++ Y  +  L   +            +  +L      S+   +
Sbjct: 87  FLSHADRKV------WLLFDYAEH-DLWHII--KFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH----IGDFGLSRFYQAVSNPTVSSSI 409
              + YLH +    +LH DLKP+NIL+  +        I D G +R + +   P      
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 410 GVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
            V  T  Y APE  LG+   +   D+++ G +  E++ T +P
Sbjct: 195 VVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEP 234

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 25/244 (10%)

Query: 207 RQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL 266
           +  + P  +   L        +  + F     +G GS+GSVYK +  E G +VAIK + +
Sbjct: 6   QLRNPPRRQLKKLD-EDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV 64

Query: 267 QRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHP 326
           +     +  + E   ++     ++V+   S     +  N    IV +Y   GS+   +  
Sbjct: 65  ESD--LQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSVSDIIRL 117

Query: 327 DAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA 386
                 + EI            I       L+YLH       +H D+K  NILL+ +  A
Sbjct: 118 RNKTLTEDEIAT----------ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHA 164

Query: 387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + DFG++         T++    V GT  ++APE       +   D++S GI  +EM  
Sbjct: 165 KLADFGVA----GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220

Query: 447 TKKP 450
            K P
Sbjct: 221 GKPP 224

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 39/223 (17%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHKNLVRVI 294
            L+G GS+G V K    + G +VAIK        +   K  M E K LK +RH+NLV ++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 295 TSCSSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--LLQRISIAI 351
                 +  +      +V++++ + ++   L  +  P       +QK    ++       
Sbjct: 91  ------EVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIIN------ 135

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP---TVSSS 408
                + + H H    I+H D+KP NIL+       + DFG +R   A        V+  
Sbjct: 136 ----GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-- 186

Query: 409 IGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
                T  Y APE  +G        DV++ G L+ EM    +P
Sbjct: 187 -----TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF-MGEP 223

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 50/247 (20%), Positives = 89/247 (36%), Gaps = 29/247 (11%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSST----NLIGVGSFGSVYKGVFDEDG 256
           K   P     +        K   + +                +G G+FG V++ V    G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 257 TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMP 316
            V   K IN        +   E   +  + H  L+ +  +     F+      ++ +++ 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMVLILEFLS 131

Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS 376
            G L      D I   D      K++  + I+        L ++H+H    I+H D+KP 
Sbjct: 132 GGELF-----DRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 178

Query: 377 NILLDNDLSAH--IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDV 434
           NI+ +   ++   I DFGL+       NP     +    T  + APE      V    D+
Sbjct: 179 NIMCETKKASSVKIIDFGLATKL----NPDEIVKVTT-ATAEFAAPEIVDREPVGFYTDM 233

Query: 435 YSYGILL 441
           ++ G+L 
Sbjct: 234 WAIGVLG 240

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (251), Expect = 8e-23
 Identities = 23/146 (15%), Positives = 54/146 (36%), Gaps = 12/146 (8%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGL-------- 55
                T      ++  L++ + +     +  +P  +  L  ++  +V+ N          
Sbjct: 235 AQQYKTEDLKWDNLKDLTD-VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293

Query: 56  SGEIPIELGLCSSLEDIYLGGN-FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL 114
             +   +  +   ++ IY+G N      + +  +  + +  L+   N L G++P F   +
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEI 353

Query: 115 SLEYLNLSFNDFEGKVPTKGIFANTS 140
            L  LNL++N     +P       T 
Sbjct: 354 KLASLNLAYNQITE-IP-ANFCGFTE 377

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 93.6 bits (233), Expect = 2e-20
 Identities = 23/139 (16%), Positives = 43/139 (30%), Gaps = 16/139 (11%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           +                  + N        +   +  NLK L   +V N     ++P  L
Sbjct: 216 SPFVAENICE------AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269

Query: 64  GLCSSLEDIYLGGNFFH--------GSIPSFFRTSRGIRKLDLSRNNL-SGQIPLFLEAL 114
                ++ I +  N               +       I+ + +  NNL +  +   L+ +
Sbjct: 270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKM 329

Query: 115 -SLEYLNLSFNDFEGKVPT 132
             L  L   +N  EGK+P 
Sbjct: 330 KKLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 19/138 (13%), Positives = 48/138 (34%), Gaps = 12/138 (8%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFV--------GSIPPRIGNLKALRSFDVSN 52
           ++       +P  + ++  +   +N+A N  +                  + ++   +  
Sbjct: 256 VYNCPNLTKLPTFLKALPEM-QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314

Query: 53  NGL-SGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFL 111
           N L +  +   L     L  +    N   G +P+F    + +  L+L+ N ++     F 
Sbjct: 315 NNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIK-LASLNLAYNQITEIPANFC 373

Query: 112 EAL-SLEYLNLSFNDFEG 128
                +E L+ + N  + 
Sbjct: 374 GFTEQVENLSFAHNKLKY 391

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.2 bits (219), Expect = 8e-19
 Identities = 20/139 (14%), Positives = 39/139 (28%), Gaps = 9/139 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVG----SIPPRIGNLKALRSFDVSNNGLSGEI 59
              SG +P+AI  ++ L   L L  +          P  I    +               
Sbjct: 91  FGASGRVPDAIGQLTELE-VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTF 149

Query: 60  PIELGL--CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SL 116
                    S L    +  +    SI    R +    ++    NN++  +   +  L  L
Sbjct: 150 VDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKL 208

Query: 117 EYLNLSFNDFEGKVPTKGI 135
               +  + F  +   +  
Sbjct: 209 RQFYMGNSPFVAENICEAW 227

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 18/141 (12%), Positives = 47/141 (33%), Gaps = 8/141 (5%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           +    +I ++          +    N+    +   +  L  LR F + N+    E   E 
Sbjct: 169 DPQQKSIKKSSRITLKD-TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEA 226

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
               + E         + +    +   + +  +++       ++P FL+AL  ++ +N++
Sbjct: 227 WENENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA 281

Query: 123 FNDFEGKVPTKGIFANTSAIS 143
            N        K  +   +   
Sbjct: 282 CNRGISGEQLKDDWQALADAP 302

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.4 bits (217), Expect = 1e-18
 Identities = 30/147 (20%), Positives = 49/147 (33%), Gaps = 22/147 (14%)

Query: 1   MFENDLSGTIPEAIFSISYLSN--SLNLAENHFVG-------SIPPRIGNLKALRSFDVS 51
              N L   IP  IF    +S   +++ + N            + P       + S ++S
Sbjct: 384 FAHNKLK-YIPN-IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLS 441

Query: 52  NNGLSGEIPIELGLCSSLEDIYLGGNFFHG-------SIPSFFRTSRGIRKLDLSRNNLS 104
           NN +S          S L  I L GN                F+ +  +  +DL  N L+
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT 501

Query: 105 GQIP---LFLEALSLEYLNLSFNDFEG 128
             +           L  ++LS+N F  
Sbjct: 502 K-LSDDFRATTLPYLVGIDLSYNSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 25/143 (17%), Positives = 51/143 (35%), Gaps = 17/143 (11%)

Query: 7   SGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL-GL 65
           +  +  ++  +  L   L    N   G   P  G+   L S +++ N ++  IP    G 
Sbjct: 319 TFPVETSLQKMKKLG-MLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGF 375

Query: 66  CSSLEDIYLGGNFFHGSIPS--FFRTSRGIRKLDLSRNNLSGQIPLFLEAL--------S 115
              +E++    N     IP+    ++   +  +D S N +        + L        +
Sbjct: 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434

Query: 116 LEYLNLSFNDFEGKVPTKGIFAN 138
           +  +NLS N          +F+ 
Sbjct: 435 VSSINLSNNQISKFPK--ELFST 455

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 22/139 (15%), Positives = 43/139 (30%), Gaps = 13/139 (9%)

Query: 2   FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPP--RIGNLKALRSFDVSNNGLSGEI 59
              +      E   +   L+ S++L  N     +    R   L  L   D+S N  S   
Sbjct: 472 IPKNSLKDENENFKNTYLLT-SIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-F 528

Query: 60  PIELGLCSSLEDIYLG------GNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEA 113
           P +    S+L+   +       GN      P        + +L +  N++          
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP- 587

Query: 114 LSLEYLNLSFNDFEGKVPT 132
            ++  L++  N       +
Sbjct: 588 -NISVLDIKDNPNISIDLS 605

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 26/130 (20%), Positives = 42/130 (32%), Gaps = 15/130 (11%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSN------NGL 55
           N L+    +  F  + L     ++L+ N F    P +  N   L+ F + N      N  
Sbjct: 498 NKLTKLSDD--FRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRT 554

Query: 56  SGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP-LFLEAL 114
             E P  + LC SL  + +G N               I  LD+  N             +
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRKVNEKITP---NISVLDIKDNPNISIDLSYVCPYI 611

Query: 115 SLEYLNLSFN 124
                 L ++
Sbjct: 612 EAGMYMLFYD 621

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 13/106 (12%), Positives = 29/106 (27%), Gaps = 9/106 (8%)

Query: 4   NDLSGTIPEAIFSIS-----YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           N  S   P    + S      + N  +   N  +   P  I    +L    + +N +   
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK- 580

Query: 59  IPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
             +   +  ++  + +  N       S+           L  +   
Sbjct: 581 --VNEKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 13/117 (11%), Positives = 34/117 (29%), Gaps = 7/117 (5%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG- 81
           + N   + +       + +   +    +   G SG +P  +G  + LE + LG +     
Sbjct: 61  NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120

Query: 82  ---SIPSFFRTSRGIRKLDLSRNNLSGQIP---LFLEALSLEYLNLSFNDFEGKVPT 132
                P     +    +    R +            +   L    ++ +  +  +  
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.0 bits (244), Expect = 9e-23
 Identities = 50/240 (20%), Positives = 83/240 (34%), Gaps = 44/240 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-----KSFMAECKALKNIRHKNLVRV 293
           IG GS+G V   + ++   + AIK++N  +         +    E + +K + H N+ R+
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 294 ITSCSSVDF---------QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
                   +          G+    +      +                 E   + +   
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 345 QRI---------------SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH-- 387
                             +I   + SAL YLH      I H D+KP N L   + S    
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE------YGLGSEVSTNGDVYSYGILL 441
           + DFGLS+ +  ++N          GT  +VAPE         G +     D +S G+LL
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAGVLL 266

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 61/260 (23%), Positives = 95/260 (36%), Gaps = 34/260 (13%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSST----NLIGVGSFGSVYKGVFDED 255
           H     S        +  L       +       S        +G G++G V        
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 256 GTVVAIKVINLQRQGASK--SFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK 313
               AIK+I       S     + E   LK + H N++++        F+      +V +
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVME 116

Query: 314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL 373
               G L            D  I   K   +    I   V S + YLH+H    I+H DL
Sbjct: 117 CYKGGEL-----------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDL 162

Query: 374 KPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVST 430
           KP N+LL++   D    I DFGLS  ++  +   +   +   GT  Y+APE  L  +   
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERL---GTAYYIAPEV-LRKKYDE 216

Query: 431 NGDVYSYGILLLEMVTTKKP 450
             DV+S G++L  ++    P
Sbjct: 217 KCDVWSIGVILFILLAGYPP 236

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 40/215 (18%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           ++G G+F  V+       G + A+K I         S   E   LK I+H+N+V +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               ++      +V + +  G L            DR +E    T      +   V SA+
Sbjct: 75  ----YESTTHYYLVMQLVSGGEL-----------FDRILERGVYTEKDASLVIQQVLSAV 119

Query: 358 DYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            YLH++    I+H DLKP N+L    + +    I DFGLS+  Q   N  +S++    GT
Sbjct: 120 KYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTAC---GT 170

Query: 415 IGYVAPE----YGLGSEVSTNGDVYSYG----ILL 441
            GYVAPE          V    D +S G    ILL
Sbjct: 171 PGYVAPEVLAQKPYSKAV----DCWSIGVITYILL 201

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 25/211 (11%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
            S T ++G G FG V+K      G  +A K+I  +     +    E   +  + H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +  +     F+  +   +V +Y+  G L      D I           LT L  I     
Sbjct: 151 LYDA-----FESKNDIVLVMEYVDGGELF-----DRIIDES-----YNLTELDTILFMKQ 195

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIG 410
           +   + ++HQ     ILH DLKP NIL  N  +  I   DFGL+R Y+      V     
Sbjct: 196 ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV----- 247

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
             GT  ++APE      VS   D++S G++ 
Sbjct: 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 48/223 (21%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR---------QGASKSFMAECKALKNI-RHK 288
           +G G    V + +        A+K+I++           Q   ++ + E   L+ +  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N++++  +     ++ N F  +V+  M  G L            D   E   L+  +   
Sbjct: 85  NIIQLKDT-----YETNTFFFLVFDLMKKGEL-----------FDYLTEKVTLSEKETRK 128

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
           I   +   +  LH+     I+H DLKP NILLD+D++  + DFG S              
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---- 181

Query: 409 IGVRGTIGYVAPE----------YGLGSEVSTNGDVYSYGILL 441
             V GT  Y+APE           G G EV    D++S G+++
Sbjct: 182 -EVCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 35/223 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECK-ALKNIRHKNLVRVITS 296
           IG G++GSV K V    G ++A+K I         K  + +    +++     +V+   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLH--PDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                F+  D   I  + M + S +K+       +     E  + K        I +   
Sbjct: 90  L----FREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--------ITLATV 135

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            AL++L ++ +  I+H D+KPSNILLD   +  + DFG+S          +  SI     
Sbjct: 136 KALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISG--------QLVDSIAKTRD 185

Query: 415 IG---YVAPE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            G   Y+APE               DV+S GI L E+ T + P
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 38/211 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG GS+G V   V        A K I          F  E + +K++ H N++R+  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              F+ N    +V +    G L      + +  +    E     +++ +       SA+ 
Sbjct: 75  ---FEDNTDIYLVMELCTGGELF-----ERVVHKRVFRESDAARIMKDV------LSAVA 120

Query: 359 YLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           Y H+     + H DLKP N L      D    + DFGL+  ++      + + +   GT 
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK--PGKMMRTKV---GTP 172

Query: 416 GYVAPE-----YGLGSEVSTNGDVYSYGILL 441
            YV+P+     YG   E     D +S G+++
Sbjct: 173 YYVSPQVLEGLYGP--EC----DEWSAGVMM 197

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 28/219 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS-KSFMAECK-ALKNIRHKNLVRVITS 296
           +G G++G V K      G ++A+K I         K  + +   +++ +     V    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
                F+  D   I  + M + SL+K+        Q   E  + K        IA+ +  
Sbjct: 75  L----FREGDVW-ICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--------IAVSIVK 120

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           AL++LH      ++H D+KPSN+L++      + DFG+S     V +          G  
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDA---GCK 173

Query: 416 GYVAPE----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y+APE           S   D++S GI ++E+   + P
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 40/229 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA----ECKALKNIRHKNLVR- 292
           L+G GS+G V + +  E     A+K++  ++     +  A    E + L+ +RHKN+++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 293 --VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
             V+ +             +V +Y   G  E     D++P++ R    Q      ++   
Sbjct: 72  VDVLYNEEKQKM------YMVMEYCVCGMQEML---DSVPEK-RFPVCQAHGYFCQL--- 118

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
                 L+YLH      I+H D+KP N+LL    +  I   G++      +      +  
Sbjct: 119 ---IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-- 170

Query: 411 VRGTIGYVAPE-------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            +G+  +  PE       +  G +V    D++S G+ L  + T   P +
Sbjct: 171 SQGSPAFQPPEIANGLDTF-SGFKV----DIWSAGVTLYNITTGLYPFE 214

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 41/228 (17%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS---KSFMAECKALKNIRHKN 289
           FS    IG GSFG+VY      +  VVAIK ++   + ++   +  + E + L+ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            ++         +       +V +Y   GS    L     P ++ EI            +
Sbjct: 116 TIQYRGC-----YLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA----------V 159

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                  L YLH H    ++H D+K  NILL       +GDFG             +S +
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG------------SASIM 204

Query: 410 GVRGT-IG---YVAPEYGLGSEVSTNG---DVYSYGILLLEMVTTKKP 450
               + +G   ++APE  L  +        DV+S GI  +E+   K P
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR-- 292
            +GVG+FG V  G     G  VA+K++N   ++          E + LK  RH ++++  
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 293 -VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            VI++ +           +V +Y+  G L      D I +  R  E++   L Q+I    
Sbjct: 78  QVISTPTDF--------FMVMEYVSGGELF-----DYICKHGRVEEMEARRLFQQI---- 120

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
              SA+DY H+H    ++H DLKP N+LLD  ++A I DFGLS          + +S   
Sbjct: 121 --LSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-- 171

Query: 412 RGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            G+  Y APE      Y  G EV    D++S G++L  ++    P D
Sbjct: 172 -GSPNYAAPEVISGRLY-AGPEV----DIWSCGVILYALLCGTLPFD 212

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 54/225 (24%), Positives = 92/225 (40%), Gaps = 39/225 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVR---V 293
            +G G++G V   V       VA+K+++++R     ++   E    K + H+N+V+    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
               +           +  +Y   G L      D I       E        ++      
Sbjct: 74  RREGNIQ--------YLFLEYCSGGELF-----DRIEPDIGMPEPDAQRFFHQL------ 114

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +   + G
Sbjct: 115 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK--MCG 169

Query: 414 TIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
           T+ YVAPE      +     V    DV+S GI+L  M+  + P D
Sbjct: 170 TLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELPWD 209

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 31/209 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
           +G GSFG V        G   A+KVI+   ++++   +S + E + LK + H N++++  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
                 F+   +  +V +    G L            D  I  ++ + +    I   V S
Sbjct: 94  F-----FEDKGYFYLVGEVYTGGEL-----------FDEIISRKRFSEVDAARIIRQVLS 137

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
            + Y+H++    I+H DLKP N+LL++   D +  I DFGLS  ++  ++  +   I   
Sbjct: 138 GITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKI--- 189

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
           GT  Y+APE  L        DV+S G++L
Sbjct: 190 GTAYYIAPEV-LHGTYDEKCDVWSTGVIL 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 41/216 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G+F  V + V    G   A K+IN ++  A   +    E +  + ++H N+VR+  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                 Q   F  +V+  +  G L      + I  R+   E      +Q+I        +
Sbjct: 74  -----IQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQI------LES 117

Query: 357 LDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + Y H +    I+H +LKP N+LL       +  + DFGL+               G  G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-----GFAG 169

Query: 414 TIGYVAPE----YGLGSEVSTNGDVYSYG----ILL 441
           T GY++PE          V    D+++ G    ILL
Sbjct: 170 TPGYLSPEVLKKDPYSKPV----DIWACGVILYILL 201

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 53/223 (23%), Positives = 86/223 (38%), Gaps = 51/223 (22%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--------LQRQGASKSFMAECKALKNIRHKNL 290
           +G G+ G V      +    VAI++I+         +    + +   E + LK + H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDR--EIEIQKLTLLQRIS 348
           +++     + D+       IV + M  G L      D +    R  E   +         
Sbjct: 203 IKIKNFFDAEDYY------IVLELMEGGELF-----DKVVGNKRLKEATCKLYFY----- 246

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTV 405
               +  A+ YLH++    I+H DLKP N+LL   + D    I DFG S+     S    
Sbjct: 247 ---QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR- 299

Query: 406 SSSIGVRGTIGYVAPE-------YGLGSEVSTNGDVYSYGILL 441
                + GT  Y+APE        G    V    D +S G++L
Sbjct: 300 ----TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 334

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 57/241 (23%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMA----------------- 277
            IG GS+G V     + D T  A+KV++   L RQ                         
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 278 ------ECKALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA 328
                 E   LK + H N+V+   V+   +           +V++ +  G + +      
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY------MVFELVNQGPVME------ 127

Query: 329 IPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI 388
           +P      E Q     Q      D+   ++YLH      I+H D+KPSN+L+  D    I
Sbjct: 128 VPTLKPLSEDQARFYFQ------DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKI 178

Query: 389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG---DVYSYGILLLEMV 445
            DFG+S  ++  S+  +S+++   GT  ++APE    +    +G   DV++ G+ L   V
Sbjct: 179 ADFGVSNEFKG-SDALLSNTV---GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234

Query: 446 T 446
            
Sbjct: 235 F 235

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 61/217 (28%), Positives = 89/217 (41%), Gaps = 44/217 (20%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           +G GSFG V K          A+KVIN        + + + E + LK + H N++++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                 + +    IV +    G L            D  I+ ++ +      I   V S 
Sbjct: 90  -----LEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSG 133

Query: 357 LDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + Y+H+H    I+H DLKP NILL   + D    I DFGLS  +Q  +           G
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK-----DRIG 185

Query: 414 TIGYVAPE-----YGLGSEVSTNGDVYSYG----ILL 441
           T  Y+APE     Y    +     DV+S G    ILL
Sbjct: 186 TAYYIAPEVLRGTYDE--KC----DVWSAGVILYILL 216

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 42/222 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMA-----ECKALKNIRHKNL 290
           +G G+FG V+  V  E    V +K I    +      +         E   L  + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           ++V+       F+   F  +V +   +G L+ +     I +  R  E     + +++   
Sbjct: 92  IKVLDI-----FENQGFFQLVMEKHGSG-LDLF---AFIDRHPRLDEPLASYIFRQL--- 139

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
               SA+ YL       I+H D+K  NI++  D +  + DFG + + +        +   
Sbjct: 140 ---VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC- 190

Query: 411 VRGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVT 446
             GTI Y APE      Y  G E+    +++S G+ L  +V 
Sbjct: 191 --GTIEYCAPEVLMGNPY-RGPEL----EMWSLGVTLYTLVF 225

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 30/239 (12%)

Query: 221 MSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAEC 279
           M  + +   +  F   +L+G G++G V        G +VAIK I    +   +   + E 
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60

Query: 280 KALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI 336
           K LK+ +H+N++    +    S  +F  N+   I+ + M     +  LH        R I
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENF--NEV-YIIQELM-----QTDLH--------RVI 104

Query: 337 EIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF 396
             Q L+             A+  LH      ++H DLKPSN+L++++    + DFGL+R 
Sbjct: 105 STQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 397 YQAVSNPTVSSSIGVRGTIGYV------APEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
               +      +    G + +V      APE  L S   +   DV+S G +L E+   +
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.9 bits (231), Expect = 6e-21
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 55/268 (20%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSST----NLIGVGSFGSVYKGVFDEDG 256
           K +    + +E +  +++          A   F       ++IG G    V + V    G
Sbjct: 60  KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119

Query: 257 TVVAIKVINLQR--------QGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDF 307
              A+K++ +          +   ++   E   L+ +  H +++ +I S     ++ + F
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESSSF 174

Query: 308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP 367
             +V+  M  G L            D   E   L+  +  SI   +  A+ +LH +    
Sbjct: 175 MFLVFDLMRKGEL-----------FDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--- 220

Query: 368 ILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE------ 421
           I+H DLKP NILLD+++   + DFG S   +            + GT GY+APE      
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR-----ELCGTPGYLAPEILKCSM 275

Query: 422 ----YGLGSEVSTNGDVYSYG----ILL 441
                G G EV    D+++ G     LL
Sbjct: 276 DETHPGYGKEV----DLWACGVILFTLL 299

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 94.0 bits (234), Expect = 7e-21
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 40/213 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           +G GSFG V K          A+KVIN        + + + E + LK + H N++++   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                 + +    IV +    G L            D  I+ ++ +      I   V S 
Sbjct: 90  -----LEDSSSFYIVGELYTGGEL-----------FDEIIKRKRFSEHDAARIIKQVFSG 133

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + Y+H+H    I+H DLKP NILL++   D    I DFGLS  +Q   N  +   I   G
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRI---G 185

Query: 414 TIGYVAPE-----YGLGSEVSTNGDVYSYGILL 441
           T  Y+APE     Y    +     DV+S G++L
Sbjct: 186 TAYYIAPEVLRGTY--DEKC----DVWSAGVIL 212

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 52/219 (23%), Positives = 89/219 (40%), Gaps = 39/219 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVR---V 293
            +G G++G V   V       VA+K+++++R     ++   E    K + H+N+V+    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
               +           +  +Y   G L      D I       E        ++      
Sbjct: 74  RREGNIQ--------YLFLEYCSGGELF-----DRIEPDIGMPEPDAQRFFHQL------ 114

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +   + G
Sbjct: 115 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK--MCG 169

Query: 414 TIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVT 446
           T+ YVAPE      +     V    DV+S GI+L  M+ 
Sbjct: 170 TLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLA 203

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.0 bits (229), Expect = 7e-21
 Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 47/221 (21%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--------LQRQGASKSFMAECKALKNIRHKNL 290
           +G G+ G V      +    VAIK+I+         +    + +   E + LK + H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           +++     + D+       IV + M  G L      D +    R  E        ++   
Sbjct: 78  IKIKNFFDAEDYY------IVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQM--- 123

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSS 407
                A+ YLH++    I+H DLKP N+LL   + D    I DFG S+     S      
Sbjct: 124 ---LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--- 174

Query: 408 SIGVRGTIGYVAPE-------YGLGSEVSTNGDVYSYGILL 441
              + GT  Y+APE        G    V    D +S G++L
Sbjct: 175 --TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVR---V 293
           IG G+F  V        G  VAIK+I+  +   +  +    E + +K + H N+V+   V
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I +  ++         ++ +Y   G +      D +    R  E +  +  ++I      
Sbjct: 83  IETEKTL--------YLIMEYASGGEVF-----DYLVAHGRMKEKEARSKFRQI------ 123

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
            SA+ Y HQ     I+H DLK  N+LLD D++  I DFG S  +       + +     G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFC---G 175

Query: 414 TIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              Y APE      Y  G EV    DV+S G++L  +V+   P D
Sbjct: 176 APPYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLPFD 215

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 31/210 (14%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSC 297
           +G G+FG V+       G    IK IN  R Q   +   AE + LK++ H N++++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F+      IV +    G L      + I       +   L+      +   + +AL
Sbjct: 89  ----FEDYHNMYIVMETCEGGELL-----ERIVSAQARGK--ALSEGYVAELMKQMMNAL 137

Query: 358 DYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            Y H      ++H DLKP NIL  +        I DFGL+  ++  S+   +++    GT
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA---GT 189

Query: 415 IGYVAPE---YGLGSEVSTNGDVYSYGILL 441
             Y+APE     +  +     D++S G+++
Sbjct: 190 ALYMAPEVFKRDVTFKC----DIWSAGVVM 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 59/266 (22%), Positives = 98/266 (36%), Gaps = 54/266 (20%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSY---KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDG 256
           H     S        +   +       K   K  + +     +G G++G V         
Sbjct: 2   HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGH 61

Query: 257 TVVAIKVINLQR-------------QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ 303
           +  AIKVI   +             +   +    E   LK++ H N++++        F+
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FE 116

Query: 304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH 363
              +  +V ++   G L            ++ I   K       +I   + S + YLH+H
Sbjct: 117 DKKYFYLVTEFYEGGEL-----------FEQIINRHKFDECDAANIMKQILSGICYLHKH 165

Query: 364 CQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAP 420
               I+H D+KP NILL+N    L+  I DFGLS F+               GT  Y+AP
Sbjct: 166 N---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR-----DRLGTAYYIAP 217

Query: 421 E-----YGLGSEVSTNGDVYSYGILL 441
           E     Y    +     DV+S G+++
Sbjct: 218 EVLKKKY--NEKC----DVWSCGVIM 237

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 55/249 (22%), Positives = 96/249 (38%), Gaps = 32/249 (12%)

Query: 210 SEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ 269
                +   L +  +      +   +   +G G+ G V+K  F + G V+A+K +     
Sbjct: 4   GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63

Query: 270 GAS-KSFMAECKAL-KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLE-KWLHP 326
               K  + +   + K+     +V+   +         D   I  + M   + + K    
Sbjct: 64  KEENKRILMDLDVVLKSHDCPYIVQCFGTF----ITNTDVF-IAMELMGTCAEKLKKRMQ 118

Query: 327 DAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA 386
             IP    E  + K        + + +  AL YL +  +  ++H D+KPSNILLD     
Sbjct: 119 GPIP----ERILGK--------MTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQI 164

Query: 387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE-----YGLGSEVSTNGDVYSYGILL 441
            + DFG+S   + V     +      G   Y+APE          +     DV+S GI L
Sbjct: 165 KLCDFGISG--RLVD--DKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219

Query: 442 LEMVTTKKP 450
           +E+ T + P
Sbjct: 220 VELATGQFP 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 42/226 (18%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           F    ++G GSF +V            AIK++    + ++        E   +  + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            V++  +     FQ ++       Y  NG L                    L  +++I  
Sbjct: 92  FVKLYFT-----FQDDEKLYFGLSYAKNGEL--------------------LKYIRKIGS 126

Query: 350 ---------AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
                      ++ SAL+YLH      I+H DLKP NILL+ D+   I DFG ++     
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           S    ++S    GT  YV+PE         + D+++ G ++ ++V 
Sbjct: 184 SKQARANSFV--GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 227

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.4 bits (232), Expect = 1e-20
 Identities = 48/247 (19%), Positives = 94/247 (38%), Gaps = 29/247 (11%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSST----NLIGVGSFGSVYKGVFDEDG 256
           +         +  +     +   + +    D           +G G+FG V++      G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182

Query: 257 TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMP 316
              A K +    +   ++   E + +  +RH  LV +  +     F+ ++   ++Y++M 
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMS 237

Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS 376
            G L      + +          K++  + +     V   L ++H++     +H DLKP 
Sbjct: 238 GGELF-----EKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPE 284

Query: 377 NILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDV 434
           NI+     S  +   DFGL+       +P  S  +   GT  + APE   G  V    D+
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHL----DPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDM 339

Query: 435 YSYGILL 441
           +S G+L 
Sbjct: 340 WSVGVLS 346

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 26/205 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           +G G FG V++ V          K + + +         E   L   RH+N++ +  S  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHES-- 69

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
              F+  +   ++++++    +      + I          +L   + +S    V  AL 
Sbjct: 70  ---FESMEELVMIFEFISGLDIF-----ERINTSA-----FELNEREIVSYVHQVCEALQ 116

Query: 359 YLHQHCQEPILHCDLKPSNILLDNDLSAH--IGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           +LH H    I H D++P NI+     S+   I +FG +R       P  +  +       
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL----KPGDNFRLLF-TAPE 168

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILL 441
           Y APE      VST  D++S G L+
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 33/223 (14%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNL 290
           + +   IG G+ G V           VAIK ++   Q Q  +K    E   +K + HKN+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 291 VR---VITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           +    V T   S++    +F+ +  V + M   +L + +  +   +R   +  Q L    
Sbjct: 87  IGLLNVFTPQKSLE----EFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQML---- 137

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
                      + +LH      I+H DLKPSNI++ +D +  I DFGL+R        T 
Sbjct: 138 ---------CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT- 184

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
                   T  Y APE  LG     N D++S G ++ EM+   
Sbjct: 185 ----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 41/216 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVITS 296
           +G G+F  V + V    G   A K+IN ++  A   +    E +  + ++H N+VR+  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                 Q   F  +V+  +  G L      + I  R+   E      +Q+I        +
Sbjct: 97  -----IQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQI------LES 140

Query: 357 LDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + Y H +    I+H +LKP N+LL       +  + DFGL+               G  G
Sbjct: 141 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-----GFAG 192

Query: 414 TIGYVAPE----YGLGSEVSTNGDVYSYG----ILL 441
           T GY++PE          V    D+++ G    ILL
Sbjct: 193 TPGYLSPEVLKKDPYSKPV----DIWACGVILYILL 224

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 53/253 (20%), Positives = 98/253 (38%), Gaps = 45/253 (17%)

Query: 213 MIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS 272
           M+       + +   K  D F    + G G+FG+V  G     G  VAIK +    +  +
Sbjct: 5   MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN 64

Query: 273 KSFMAECKALKNIRHKNLVR---VITSCSSVDFQGND-FKAIVYKYMPNGSLEKWL-HPD 327
           +      + L  + H N+V+      +    D    D +  +V +Y+P+ +L +   +  
Sbjct: 65  RELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDR--RDIYLNVVMEYVPD-TLHRCCRNYY 120

Query: 328 AIPQRDREIEIQKLT--LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD---N 382
                   I I+     L++          ++  LH      + H D+KP N+L++    
Sbjct: 121 RRQVAPPPILIKVFLFQLIR----------SIGCLHLPSVN-VCHRDIKPHNVLVNEADG 169

Query: 383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYV------APEYGLGS-EVSTNGDVY 435
            L   + DFG ++       P V+          Y+      APE   G+   +T  D++
Sbjct: 170 TLK--LCDFGSAKKLSPS-EPNVA----------YICSRYYRAPELIFGNQHYTTAVDIW 216

Query: 436 SYGILLLEMVTTK 448
           S G +  EM+  +
Sbjct: 217 SVGCIFAEMMLGE 229

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 91.4 bits (227), Expect = 5e-20
 Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 44/227 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR-- 292
            +GVG+FG V  G  +  G  VA+K++N   ++          E + LK  RH ++++  
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 293 -VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            VI++ S +         +V +Y+  G L      D I +  R  E +   L Q+I    
Sbjct: 83  QVISTPSDI--------FMVMEYVSGGELF-----DYICKNGRLDEKESRRLFQQI---- 125

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
              S +DY H+H    ++H DLKP N+LLD  ++A I DFGLS          + +S   
Sbjct: 126 --LSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-- 176

Query: 412 RGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
            G+  Y APE      Y  G EV    D++S G++L  ++    P D
Sbjct: 177 -GSPNYAAPEVISGRLY-AGPEV----DIWSSGVILYALLCGTLPFD 217

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.6 bits (228), Expect = 6e-20
 Identities = 31/126 (24%), Positives = 49/126 (38%), Gaps = 2/126 (1%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L           S L+ SL++  N      P     L  L+  ++ +N LS       
Sbjct: 35  NQLRRLPAANFTRYSQLT-SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
             C++L +++L  N       + F   + +  LDLS N LS         L +L+ L LS
Sbjct: 94  AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153

Query: 123 FNDFEG 128
            N  + 
Sbjct: 154 NNKIQA 159

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.2 bits (227), Expect = 7e-20
 Identities = 29/142 (20%), Positives = 48/142 (33%), Gaps = 9/142 (6%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N +             L  +L+L+ N    +       L+ L+   +SNN +      E
Sbjct: 106 SNSIQKIKNNPFVKQKNL-ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164

Query: 63  LGLC--SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP----LFLEALSL 116
           L +   SSL+ + L  N      P  F     +  L L+   L   +     L L   S+
Sbjct: 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSI 224

Query: 117 EYLNLSFNDFEGKVPTKGIFAN 138
             L+LS +       +   F  
Sbjct: 225 RNLSLSNSQLST--TSNTTFLG 244

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 91.2 bits (227), Expect = 9e-20
 Identities = 28/138 (20%), Positives = 43/138 (31%), Gaps = 6/138 (4%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N +S   PE    +  L   LNL  N               L    + +N +        
Sbjct: 59  NTISKLEPELCQKLPMLK-VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL---SLEYLN 120
               +L  + L  N    +          +++L LS N +       L+     SL+ L 
Sbjct: 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177

Query: 121 LSFNDFEGKVPTKGIFAN 138
           LS N  +   P  G F  
Sbjct: 178 LSSNQIKEFSP--GCFHA 193

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.3 bits (222), Expect = 3e-19
 Identities = 27/144 (18%), Positives = 53/144 (36%), Gaps = 9/144 (6%)

Query: 4   NDLSGTIPEAIFSISYL------SNSL-NLAENHFVGSIPPRIGNLKALRSFDVSNNGLS 56
           N+++    + +  +  L       N+L  L ++   G     +  L  L   ++ +NG  
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD 549

Query: 57  GEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-- 114
                       L+ I LG N  +    S F     ++ L+L +N ++            
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609

Query: 115 SLEYLNLSFNDFEGKVPTKGIFAN 138
           +L  L++ FN F+    +   F N
Sbjct: 610 NLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.5 bits (207), Expect = 3e-17
 Identities = 25/127 (19%), Positives = 41/127 (32%), Gaps = 5/127 (3%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
              L+  +P+ + +   ++  LNL  N               L S DV  N +S   P  
Sbjct: 13  HLKLT-QVPDDLPT--NIT-VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNL 121
                 L+ + L  N         F     + +L L  N++            +L  L+L
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128

Query: 122 SFNDFEG 128
           S N    
Sbjct: 129 SHNGLSS 135

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 30/132 (22%), Positives = 48/132 (36%), Gaps = 7/132 (5%)

Query: 4   NDLS-GTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           +  S  T+    F     S    LNL +N            L  L   D+  N +  E+ 
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 61  I-ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG--QIPLFLEAL-SL 116
             E     ++ +IYL  N +     + F     +++L L R  L      P   + L +L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482

Query: 117 EYLNLSFNDFEG 128
             L+LS N+   
Sbjct: 483 TILDLSNNNIAN 494

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.0 bits (198), Expect = 4e-16
 Identities = 23/139 (16%), Positives = 43/139 (30%), Gaps = 15/139 (10%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNN---------G 54
           N+L+    ++   +  L     L  N+        +  L  +R  ++  +          
Sbjct: 258 NNLNVVGNDSFAWLPQLE-YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316

Query: 55  LSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP-----L 109
           L             LE + +  N   G   + F     ++ L LS +  S +       +
Sbjct: 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFV 376

Query: 110 FLEALSLEYLNLSFNDFEG 128
            L    L  LNL+ N    
Sbjct: 377 SLAHSPLHILNLTKNKISK 395

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 79.3 bits (196), Expect = 6e-16
 Identities = 29/152 (19%), Positives = 47/152 (30%), Gaps = 14/152 (9%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHF--VGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N        +   +  L   L L       V S P     L+ L   D+SNN ++     
Sbjct: 440 NKYLQLTRNSFALVPSLQ-RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498

Query: 62  ELGLCSSLEDIYLGGN--------FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEA 113
            L     LE + L  N           G    F +    +  L+L  N          + 
Sbjct: 499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD 558

Query: 114 L-SLEYLNLSFNDFEGKVPTKGIFANTSAISV 144
           L  L+ ++L  N+         +F N  ++  
Sbjct: 559 LFELKIIDLGLNNLNTLPA--SVFNNQVSLKS 588

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.9 bits (195), Expect = 8e-16
 Identities = 29/139 (20%), Positives = 47/139 (33%), Gaps = 14/139 (10%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLK--ALRSFDVSNNGLSGEI 59
             L  ++ E +      ++  +L+L+ +    +       LK   L   D+S N L+   
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPL---------- 109
                    LE  +L  N               +R L+L R+     I L          
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324

Query: 110 FLEALSLEYLNLSFNDFEG 128
           F     LE+LN+  ND  G
Sbjct: 325 FQWLKCLEHLNMEDNDIPG 343

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 25/147 (17%), Positives = 45/147 (30%), Gaps = 9/147 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             L      +   +  L   LN+ +N   G        L  L+   +SN+  S       
Sbjct: 315 ASLPKIDDFSFQWLKCL-EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE 373

Query: 64  GLC----SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLE 117
                  S L  + L  N         F     +  LDL  N +  ++    +    ++ 
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433

Query: 118 YLNLSFNDFEGKVPTKGIFANTSAISV 144
            + LS+N +         FA   ++  
Sbjct: 434 EIYLSYNKYLQLTR--NSFALVPSLQR 458

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 44/218 (20%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           +G G+F  V + V    G   A  +IN ++      +    E +  + ++H N+VR+  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                        +++  +  G L            +  +  +  +          +  A
Sbjct: 79  -----ISEEGHHYLIFDLVTGGEL-----------FEDIVAREYYSEADASHCIQQILEA 122

Query: 357 LDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + + HQ     ++H +LKP N+LL       +  + DFGL+   +           G  G
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF----GFAG 175

Query: 414 TIGYVAPE------YGLGSEVSTNGDVYSYG----ILL 441
           T GY++PE      YG    V    D+++ G    ILL
Sbjct: 176 TPGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 38/223 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRVI 294
            IG GSFG V     ++   + A+K +N      +   ++   E + ++ + H  LV + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            S     FQ  +   +V   +  G L   L      Q++   + + +    ++ I  ++ 
Sbjct: 82  YS-----FQDEEDMFMVVDLLLGGDLRYHL------QQNVHFKEETV----KLFIC-ELV 125

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            ALDYL       I+H D+KP NILLD     HI DF ++           + +    GT
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMA----GT 177

Query: 415 IGYVAPE-------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Y+APE        G    V    D +S G+   E++  ++P
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 60/246 (24%), Positives = 95/246 (38%), Gaps = 56/246 (22%)

Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           L+  D F    +IG G+F  V      + G V A+K++N   + ++G    F  E   L 
Sbjct: 58  LQRDD-FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116

Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
           N   + + ++  +     FQ  ++  +V +Y   G L                    LTL
Sbjct: 117 NGDRRWITQLHFA-----FQDENYLYLVMEYYVGGDL--------------------LTL 151

Query: 344 LQRISIAID----------VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDF 391
           L +    I           +  A+D +H+      +H D+KP NILLD     HI   DF
Sbjct: 152 LSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADF 206

Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY-------SYGILLLEM 444
           G     +  ++ TV S + V GT  Y++PE             Y       + G+   EM
Sbjct: 207 GSCL--KLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

Query: 445 VTTKKP 450
              + P
Sbjct: 264 FYGQTP 269

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 53/238 (22%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           F    +IG G+FG V          V A+K++N   + ++  +  F  E   L N   K 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +  +  +     FQ ++   +V  Y   G L                    LTLL +   
Sbjct: 136 ITTLHYA-----FQDDNNLYLVMDYYVGGDL--------------------LTLLSKFED 170

Query: 350 AID----------VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFY 397
            +           +  A+D +HQ      +H D+KP NIL+D +   HI   DFG     
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGSCL-- 223

Query: 398 QAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-----DVYSYGILLLEMVTTKKP 450
           + + + TV SS+ V GT  Y++PE     E          D +S G+ + EM+  + P
Sbjct: 224 KLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 33/226 (14%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
              + +   IG G+ G V           VAIK ++   Q Q  +K    E   +K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 288 KNLVR---VITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           KN++    V T   +++    +F+ +  V + M   +L + +  +   +R   +  Q L 
Sbjct: 121 KNIISLLNVFTPQKTLE----EFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQML- 174

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                         + +LH      I+H DLKPSNI++ +D +  I DFGL+R       
Sbjct: 175 ------------CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 219

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK 448
            T         T  Y APE  LG     N D++S G ++ EMV  K
Sbjct: 220 MT-----PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 35/209 (16%)

Query: 229 ATDGFSST---------NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAEC 279
           +TD FS           +++G G+   V   +        A+K+I  Q          E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 280 KALKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI 338
           + L   + H+N++ +I       F+  D   +V++ M  GS+                + 
Sbjct: 62  EMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSI-----------LSHIHKR 105

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSR 395
           +    L+   +  DVASALD+LH      I H DLKP NIL    +      I DF L  
Sbjct: 106 RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162

Query: 396 FYQAVSNPTVSSSIGVR---GTIGYVAPE 421
             +   + +  S+  +    G+  Y+APE
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPE 191

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 45/213 (21%), Positives = 79/213 (37%), Gaps = 34/213 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS------FMAECKALKNIRHKNLVR 292
           +G G F  V K      G   A K I  ++  AS+          E   L+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +        ++      ++ + +  G L            D   + + L+  +  S    
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQ 123

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH----IGDFGLSRFYQAVSNPTVSSS 408
           +   ++YLH      I H DLKP NI+L +         + DFGL+   +          
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--- 177

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
             + GT  +VAPE      +    D++S G++ 
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 44/215 (20%), Positives = 87/215 (40%), Gaps = 35/215 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR-----QGASKSFMAECKALKNIRHKNLVRV 293
           IG G F  V + +  E G   A+K++++ +       +++    E      ++H ++V +
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           + +     +  +    +V+++M    L        I +R         +          +
Sbjct: 92  LET-----YSSDGMLYMVFEFMDGADLC-----FEIVKRAD--AGFVYSEAVASHYMRQI 139

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             AL Y H +    I+H D+KP  +LL   +N     +G FG++     +    + +  G
Sbjct: 140 LEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ---LGESGLVAG-G 192

Query: 411 VRGTIGYVAPE----YGLGSEVSTNGDVYSYGILL 441
             GT  ++APE       G  V    DV+  G++L
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPV----DVWGCGVIL 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 63/254 (24%), Positives = 103/254 (40%), Gaps = 30/254 (11%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVV 259
           H         +          M    +      +++ + IG G++G V     + +   V
Sbjct: 1   HHHHHHMAAAAAAGPE-----MVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRV 55

Query: 260 AIKVIN-LQRQGASKSFMAECKALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYM 315
           AIK I+  + Q   +  + E K L   RH+N++    +I + +       D   IV   M
Sbjct: 56  AIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM--KDV-YIVQDLM 112

Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
                E  L+        + ++ Q L+          +   L Y+H      +LH DLKP
Sbjct: 113 -----ETDLY--------KLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKP 156

Query: 376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DV 434
           SN+LL+      I DFGL+R      + T   +  V  T  Y APE  L S+  T   D+
Sbjct: 157 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDI 215

Query: 435 YSYGILLLEMVTTK 448
           +S G +L EM++ +
Sbjct: 216 WSVGCILAEMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 57/227 (25%), Positives = 92/227 (40%), Gaps = 28/227 (12%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           +     +G G  G V+  V ++    VAIK I L    + K  + E K ++ + H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 293 VI-------TSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
           V        +  +       +  ++  V +YM     E  L           +E   L  
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLA--------NVLEQGPLLE 119

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSN 402
                    +   L Y+H      +LH DLKP+N+ ++  DL   IGDFGL+R      +
Sbjct: 120 EHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
                S G+  T  Y +P   L     T   D+++ G +  EM+T K
Sbjct: 177 HKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 48/222 (21%), Positives = 97/222 (43%), Gaps = 45/222 (20%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVR---VI 294
           +G G +  V++ +   +   V +K++   ++   K    E K L+N+R   N++    ++
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT--LLQRISIAID 352
               S         A+V++++ N   ++        Q   + +I+     +L+       
Sbjct: 101 KDPVS----RTP--ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILK------- 141

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSI 409
              ALDY H      I+H D+KP N+++D+    L   + D+GL+ FY       V    
Sbjct: 142 ---ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR--LIDWGLAEFYHPGQEYNVR--- 190

Query: 410 GVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
            V  +  +  PE  +  ++   + D++S G +L  M+  K+P
Sbjct: 191 -V-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 45/213 (21%), Positives = 79/213 (37%), Gaps = 34/213 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK------SFMAECKALKNIRHKNLVR 292
           +G G F  V K      G   A K I  ++  AS+          E   L+ + H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +        ++      ++ + +  G L            D   + + L+  +  S    
Sbjct: 80  LHDV-----YENRTDVVLILELVSGGEL-----------FDFLAQKESLSEEEATSFIKQ 123

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH----IGDFGLSRFYQAVSNPTVSSS 408
           +   ++YLH      I H DLKP NI+L +         + DFGL+   +          
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--- 177

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
             + GT  +VAPE      +    D++S G++ 
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 61/257 (23%), Positives = 91/257 (35%), Gaps = 45/257 (17%)

Query: 200 HKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSST----NLIGVGSFGSVYKGVFDED 255
                 S   +      A L   Y       D  S      + +G G+   VY+      
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 256 GTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
               A+KV+   +    K    E   L  + H N++++        F+     ++V + +
Sbjct: 78  QKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELV 130

Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
             G L            DR +E    +          +  A+ YLH++    I+H DLKP
Sbjct: 131 TGGEL-----------FDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKP 176

Query: 376 SNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE----YGLGSEV 428
            N+L      D    I DFGLS+  +            V GT GY APE       G EV
Sbjct: 177 ENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-----TVCGTPGYCAPEILRGCAYGPEV 231

Query: 429 STNGDVYSYG----ILL 441
               D++S G    ILL
Sbjct: 232 ----DMWSVGIITYILL 244

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 40/229 (17%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
              + S   +G G++GSV   +    G  VAIK ++   Q +  +K    E   LK+++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 288 KNLVR---VITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           +N++    V T  SS+     +F     V  +M     +  L    +  +  E +IQ L 
Sbjct: 83  ENVIGLLDVFTPASSLR----NFYDFYLVMPFM-----QTDLQ-KIMGLKFSEEKIQYLV 132

Query: 343 --LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
             +L+           L Y+H      ++H DLKP N+ ++ D    I DFGL+R   A 
Sbjct: 133 YQMLK----------GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
               V        T  Y APE  L         D++S G ++ EM+T K
Sbjct: 180 MTGYVV-------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 73/229 (31%), Positives = 106/229 (46%), Gaps = 49/229 (21%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA-----ECKALKNIRHKNLVR 292
            +G GSFG V      +    VA+K I+  RQ   KS M      E   LK +RH ++++
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFIS--RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73

Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
              VIT+ + +         +V +Y   G L      D I ++ R  E +     Q+I  
Sbjct: 74  LYDVITTPTDI--------VMVIEYA-GGELF-----DYIVEKKRMTEDEGRRFFQQI-- 117

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
                 A++Y H+H    I+H DLKP N+LLD++L+  I DFGLS          + +S 
Sbjct: 118 ----ICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC 168

Query: 410 GVRGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
              G+  Y APE      Y  G EV    DV+S GI+L  M+  + P D
Sbjct: 169 ---GSPNYAAPEVINGKLY-AGPEV----DVWSCGIVLYVMLVGRLPFD 209

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 87.4 bits (217), Expect = 5e-19
 Identities = 59/220 (26%), Positives = 86/220 (39%), Gaps = 44/220 (20%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR---VI 294
            IG G+FG            +VA+K I  +     ++   E    +++RH N+VR   VI
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
            + + +        AI+ +Y   G L      + I    R  E +     Q++       
Sbjct: 86  LTPTHL--------AIIMEYASGGELY-----ERICNAGRFSEDEARFFFQQL------L 126

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAH--IGDFGLSRFYQAVSNPTVSSSIGVR 412
           S + Y H      I H DLK  N LLD   +    I DFG S+     S P  +      
Sbjct: 127 SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 178

Query: 413 GTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVT 446
           GT  Y+APE      Y  G       DV+S G+ L  M+ 
Sbjct: 179 GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLV 213

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 34/226 (15%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   ++  ++    E + ++ + H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 111

Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL-HPDAIPQRDREIEIQKLT--LLQR 346
                   SS + +   +  +V  Y+P  ++ +   H     Q    I ++     L + 
Sbjct: 112 LRYFFY--SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR- 167

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA-HIGDFGLSRFYQAVSNPTV 405
                    +L Y+H      I H D+KP N+LLD D +   + DFG ++  Q V     
Sbjct: 168 ---------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPN 213

Query: 406 SSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
            S I  R    Y APE   G+   +++ DV+S G +L E++   +P
Sbjct: 214 VSYICSR---YYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQP 255

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 45/209 (21%), Positives = 80/209 (38%), Gaps = 28/209 (13%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRH-KNLVRVIT 295
           +G G F  V + +    G   A K +  +R+G       + E   L+  +    ++ +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVAS 355
                 ++      ++ +Y   G +              E     ++    I +   +  
Sbjct: 97  V-----YENTSEIILILEYAAGGEIF-----SLCLPELAE----MVSENDVIRLIKQILE 142

Query: 356 ALDYLHQHCQEPILHCDLKPSNILLDNDLSAH---IGDFGLSRFYQAVSNPTVSSSIGVR 412
            + YLHQ+    I+H DLKP NILL +        I DFG+SR               + 
Sbjct: 143 GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE-----IM 194

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
           GT  Y+APE      ++T  D+++ GI+ 
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 85.9 bits (213), Expect = 8e-19
 Identities = 57/234 (24%), Positives = 81/234 (34%), Gaps = 52/234 (22%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMA------ECKALKNIRHK--N 289
           L+G G FGSVY G+   D   VAIK +   R               E   LK +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 290 LVR---VITSCSSVDFQGNDFKAIVYKY-MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
           ++R                D   ++ +   P   L      D I +R    E    +   
Sbjct: 110 VIRLLDWFER--------PDSFVLILERPEPVQDLF-----DFITERGALQEELARSFFW 156

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPT 404
           ++        A+ + H      +LH D+K  NIL+D N     + DFG     +  +  T
Sbjct: 157 QV------LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYT 206

Query: 405 VSSSIGVRGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
                   GT  Y  PE      Y  G        V+S GILL +MV    P +
Sbjct: 207 DFD-----GTRVYSPPEWIRYHRY-HGRSA----AVWSLGILLYDMVCGDIPFE 250

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 87.9 bits (218), Expect = 9e-19
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 26/225 (11%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIR 286
           D F    ++G G FG V+       G + A K +N     +R+G  +  M E K L  + 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVH 243

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
            + +V  +       F+      +V   M  G +    H   + + +   +  +      
Sbjct: 244 SRFIVS-LAYA----FETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRA----I 292

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
              A  + S L++LHQ     I++ DLKP N+LLD+D +  I D GL     AV      
Sbjct: 293 FYTA-QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL-----AVELKAGQ 343

Query: 407 SSIGVR-GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +      GT G++APE  LG E   + D ++ G+ L EM+  + P
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVR---V 293
           +G G++G+V   V    G  VAIK +    Q +  +K    E + LK++RH+N++    V
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92

Query: 294 ITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            T   ++D    DF     V  +M        L         + ++ +KL   +   +  
Sbjct: 93  FTPDETLD----DFTDFYLVMPFM-----GTDLG--------KLMKHEKLGEDRIQFLVY 135

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +   L Y+H      I+H DLKP N+ ++ D    I DFGL+R   +     V      
Sbjct: 136 QMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----- 187

Query: 412 RGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
             T  Y APE  L     T   D++S G ++ EM+T K
Sbjct: 188 --TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 84.9 bits (211), Expect = 9e-19
 Identities = 50/213 (23%), Positives = 81/213 (38%), Gaps = 34/213 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK------SFMAECKALKNIRHKNLVR 292
           +G G F  V K      G   A K I  +R  +S+          E   L+ IRH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +        F+      ++ + +  G L            D   E + LT  +       
Sbjct: 73  LHDI-----FENKTDVVLILELVSGGEL-----------FDFLAEKESLTEDEATQFLKQ 116

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN--DLSAHI--GDFGLSRFYQAVSNPTVSSS 408
           +   + YLH      I H DLKP NI+L +    +  I   DFG++   +A +       
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--- 170

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
             + GT  +VAPE      +    D++S G++ 
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 49/213 (23%), Positives = 79/213 (37%), Gaps = 34/213 (15%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKS------FMAECKALKNIRHKNLVR 292
           +G G F  V K      G   A K I  +R  +S+          E   LK I+H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +        ++      ++ + +  G L            D   E + LT  +       
Sbjct: 79  LHEV-----YENKTDVILILELVAGGEL-----------FDFLAEKESLTEEEATEFLKQ 122

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDN--DLSAHI--GDFGLSRFYQAVSNPTVSSS 408
           + + + YLH      I H DLKP NI+L +       I   DFGL+      +       
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--- 176

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILL 441
             + GT  +VAPE      +    D++S G++ 
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 51/241 (21%)

Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALK 283
           +KA D +    +IG G+FG V          V A+K+++   + ++  S  F  E   + 
Sbjct: 66  MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124

Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
                 +V++  +     FQ + +  +V +YMP G L                    + L
Sbjct: 125 FANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDL--------------------VNL 159

Query: 344 LQRISIAIDVA--------SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGL 393
           +    +    A         ALD +H       +H D+KP N+LLD     H+   DFG 
Sbjct: 160 MSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGT 214

Query: 394 SRFYQAVSNPTVSSSIGVRGTIGYVAPE--YGLGSEVSTNGDV--YSYGILLLEMVTTKK 449
               +      V     V GT  Y++PE     G +     +   +S G+ L EM+    
Sbjct: 215 CM--KMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

Query: 450 P 450
           P
Sbjct: 272 P 272

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 35/227 (15%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRH 287
            + + + + +G G++GSV      + G  VA+K ++   Q    +K    E + LK+++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 288 KNLVR---VITSCSSVDFQGNDFKAI--VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
           +N++    V T   S++    +F  +  V   M        L+          ++ QKLT
Sbjct: 88  ENVIGLLDVFTPARSLE----EFNDVYLVTHLM-----GADLN--------NIVKCQKLT 130

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
                 +   +   L Y+H      I+H DLKPSN+ ++ D    I DFGL+R       
Sbjct: 131 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
             V+       T  Y APE  L         D++S G ++ E++T +
Sbjct: 188 GYVA-------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 23/126 (18%), Positives = 40/126 (31%), Gaps = 3/126 (2%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPI 61
             +           ++ L N+L +A N F  +    +  N   L   D+S   L      
Sbjct: 433 YTNTKIDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLN 120
                  L+ + +  N       S +     +  LD S N +     +      SL + N
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551

Query: 121 LSFNDF 126
           L+ N  
Sbjct: 552 LTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 25/129 (19%), Positives = 44/129 (34%), Gaps = 4/129 (3%)

Query: 3   ENDLSGTIPEAIF-SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
            + L      + F S+  L   L+++  +           L +L +  ++ N        
Sbjct: 408 HSTLKRVTEFSAFLSLEKLL-YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466

Query: 62  E-LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
                 ++L  + L            F T   ++ L++S NNL          L SL  L
Sbjct: 467 NVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526

Query: 120 NLSFNDFEG 128
           + SFN  E 
Sbjct: 527 DCSFNRIET 535

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 22/127 (17%), Positives = 48/127 (37%), Gaps = 3/127 (2%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L      +  + S L   L+L+              L  L +  ++ N +    P   
Sbjct: 42  NPLKILKSYSFSNFSELQ-WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG-QIPLFLEAL-SLEYLNL 121
              +SLE++                    ++KL+++ N +   ++P +   L +L +++L
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160

Query: 122 SFNDFEG 128
           S+N  + 
Sbjct: 161 SYNYIQT 167

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 23/142 (16%), Positives = 48/142 (33%), Gaps = 6/142 (4%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG-EIPIE 62
           N +    P +   ++ L  +L   E          IG L  L+  +V++N +   ++P  
Sbjct: 90  NPIQSFSPGSFSGLTSLE-NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFR----TSRGIRKLDLSRNNLSGQIPLFLEALSLEY 118
               ++L  + L  N+      +  +      +    LD+S N +        + + L  
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208

Query: 119 LNLSFNDFEGKVPTKGIFANTS 140
           L L  N     +    +     
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAG 230

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 24/146 (16%), Positives = 44/146 (30%), Gaps = 11/146 (7%)

Query: 5   DLSG----TIPEAIF-SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEI 59
                    +P+ I  S   +    +L+ N           N   L+  D+S   +    
Sbjct: 17  QCMDQKLSKVPDDIPSSTKNI----DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEY 118
                    L ++ L GN      P  F     +  L      L+      +  L +L+ 
Sbjct: 73  DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK 132

Query: 119 LNLSFNDFEGKVPTKGIFANTSAISV 144
           LN++ N           F+N + +  
Sbjct: 133 LNVAHNFIHS-CKLPAYFSNLTNLVH 157

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 21/133 (15%), Positives = 42/133 (31%), Gaps = 10/133 (7%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           DLS           +S    ++   L+L+ N  +  +      L+ L+  D  ++ L   
Sbjct: 356 DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRV 414

Query: 59  IPIE-LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALS 115
                      L  + +            F     +  L ++ N+        +F    +
Sbjct: 415 TEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN 474

Query: 116 LEYLNLSFNDFEG 128
           L +L+LS    E 
Sbjct: 475 LTFLDLSKCQLEQ 487

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 16/103 (15%), Positives = 34/103 (33%), Gaps = 4/103 (3%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N         +F+    +N   L+L++             L  L+  ++S+N L      
Sbjct: 458 NSFKDNTLSNVFA--NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
                 SL  +    N    S        + +   +L+ N+++
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 21/137 (15%), Positives = 43/137 (31%), Gaps = 15/137 (10%)

Query: 5   DLSG----TIPEAIFSISYLSNSLNLAENHFVGSIPPR-IGNLKALRSFDVSNNGLSGEI 59
           D+S      I +  F    L   L L  N    +I    + NL  L    +       E 
Sbjct: 187 DMSLNPIDFIQDQAFQGIKLH-ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245

Query: 60  PIEL-------GLCS-SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFL 111
            +E+       GLC  ++++  L            F     +  + L+  ++   +    
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVP 304

Query: 112 EALSLEYLNLSFNDFEG 128
           +    + L++     + 
Sbjct: 305 KHFKWQSLSIIRCQLKQ 321

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 16/126 (12%), Positives = 41/126 (32%), Gaps = 7/126 (5%)

Query: 4   NDLSGTIPEAIFSISYLS-NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            +L    P  +  +  ++ +   L   +       +   L  + +  ++   +   +  +
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-D 302

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           +      + + +         P+       ++ L L+ N  S      +   SL YL+LS
Sbjct: 303 VPKHFKWQSLSIIRCQLK-QFPTLDLPF--LKSLTLTMNKGS-ISFKKVALPSLSYLDLS 358

Query: 123 FNDFEG 128
            N    
Sbjct: 359 RNALSF 364

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 27/127 (21%), Positives = 42/127 (33%), Gaps = 11/127 (8%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            +           ++ +S +++LA           +      +S  +    L        
Sbjct: 271 TNDFSDDIVKFHCLANVS-AMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPT 324

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPL---FLEALSLEYLN 120
                L+ + L  N   GSI         +  LDLSRN LS         L   SL +L+
Sbjct: 325 LDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 121 LSFNDFE 127
           LSFN   
Sbjct: 383 LSFNGAI 389

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 49/211 (23%), Positives = 86/211 (40%), Gaps = 38/211 (18%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSC 297
           +G GSF    K V  +     A+K+I+ + +    +   E  ALK    H N+V++    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITALKLCEGHPNIVKLHEV- 74

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F       +V + +  G L            +R  + +  +  +   I   + SA+
Sbjct: 75  ----FHDQLHTFLVMELLNGGEL-----------FERIKKKKHFSETEASYIMRKLVSAV 119

Query: 358 DYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
            ++H      ++H DLKP N+L    +++L   I DFG +R      N  + +      T
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPC---FT 172

Query: 415 IGYVAPE----YGLGSEVSTNGDVYSYGILL 441
           + Y APE     G         D++S G++L
Sbjct: 173 LHYAAPELLNQNGYDESC----DLWSLGVIL 199

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 28/247 (11%)

Query: 208 QPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-- 265
             S    R    K   +  +     F    ++G G FG V        G + A K +   
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTKNT-FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220

Query: 266 --LQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKW 323
              +R+G     + E + L+ +  + +V +  +     ++  D   +V   M  G L+  
Sbjct: 221 RIKKRKGE-AMALNEKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLKFH 274

Query: 324 LHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND 383
           +          +         + +  A ++   L+ LH+     I++ DLKP NILLD+ 
Sbjct: 275 I------YHMGQ---AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDH 322

Query: 384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE 443
               I D GL+         T+   +   GT+GY+APE       + + D ++ G LL E
Sbjct: 323 GHIRISDLGLAV--HVPEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYE 377

Query: 444 MVTTKKP 450
           M+  + P
Sbjct: 378 MIAGQSP 384

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.9 bits (210), Expect = 5e-18
 Identities = 61/279 (21%), Positives = 101/279 (36%), Gaps = 47/279 (16%)

Query: 202 RSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAI 261
           +    ++      +         S  +  D +   +LIG GS+G V +     +  VVAI
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 262 KVINL--QRQGASKSFMAECKALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMP 316
           K I    +     K  + E   L  + H ++V+   ++       F  ++   +V +   
Sbjct: 84  KKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF--DEL-YVVLEIAD 140

Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS 376
           +   +K                  LT L   ++  ++   + Y+H      ILH DLKP+
Sbjct: 141 S-DFKKLFRTP-----------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPA 185

Query: 377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI-----------------GYV- 418
           N L++ D S  + DFGL+R      N      I  R                    G+V 
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245

Query: 419 -----APEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPT 451
                APE  L  E  T   DV+S G +  E++   K  
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 61/257 (23%), Positives = 114/257 (44%), Gaps = 38/257 (14%)

Query: 202 RSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAI 261
           +  P   P++ +   A      K+  +    +++  +IG GSFG V++    E    VAI
Sbjct: 14  KLNPLDDPNKVIKVLA---SDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVAI 69

Query: 262 KVINLQRQGASKSFMAECKALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNG 318
           K +   ++  ++    E + ++ ++H N+V       S  + D +   F  +V +Y+P  
Sbjct: 70  KKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS--NGDKKDEVFLNLVLEYVPE- 122

Query: 319 SLEKWL-HPDAIPQRDREIEIQKLT--LLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
           ++ +   H   + Q    + I+     LL+          +L Y+H      I H D+KP
Sbjct: 123 TVYRASRHYAKLKQTMPMLLIKLYMYQLLR----------SLAYIHSIG---ICHRDIKP 169

Query: 376 SNILLDNDLSA-HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGD 433
            N+LLD       + DFG ++    ++     S I  R    Y APE   G+   +TN D
Sbjct: 170 QNLLLDPPSGVLKLIDFGSAK--ILIAGEPNVSYICSR---YYRAPELIFGATNYTTNID 224

Query: 434 VYSYGILLLEMVTTKKP 450
           ++S G ++ E++   +P
Sbjct: 225 IWSTGCVMAELM-QGQP 240

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 49/243 (20%), Positives = 97/243 (39%), Gaps = 48/243 (19%)

Query: 214 IRKALLKMSYKSLLKATDGFSST----NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ 269
           ++   +    + L + +  F+        IGVGS+    + +        A+K+I+  ++
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60

Query: 270 GASKSFMAECKAL-KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA 328
             ++    E + L +  +H N++ +        +    +  +V + M  G L        
Sbjct: 61  DPTE----EIEILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGEL-------- 103

Query: 329 IPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDL 384
               D+ +  +  +  +  ++   +   ++YLH      ++H DLKPSNIL      N  
Sbjct: 104 ---LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157

Query: 385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE------YGLGSEVSTNGDVYSYG 438
           S  I DFG ++  +A +   +        T  +VAPE      Y          D++S G
Sbjct: 158 SIRICDFGFAKQLRAENGLLM----TPCYTANFVAPEVLERQGYDA--AC----DIWSLG 207

Query: 439 ILL 441
           +LL
Sbjct: 208 VLL 210

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 56/269 (20%), Positives = 96/269 (35%), Gaps = 69/269 (25%)

Query: 239 IGVGSFGSVYKGV-----FDEDGTVVAIKVINLQRQGAS----KSFMAECKALKNI-RHK 288
           +G G+FG V +              VA+K++   ++GA+    ++ M+E K L +I  H 
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHL 86

Query: 289 NLVRVITSCSSVDF------------------------------------QGNDFKAIVY 312
           N+V ++ +C+                                        QG D+   + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 313 KYMPNGS---------------LEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
             +                    EK L      +   ++    LTL   I  +  VA  +
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGY 417
           ++L        +H DL   NILL       I DFGL+R      +         R  + +
Sbjct: 207 EFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG--DARLPLKW 261

Query: 418 VAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           +APE       +   DV+S+G+LL E+ +
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 81.7 bits (202), Expect = 1e-17
 Identities = 27/218 (12%), Positives = 56/218 (25%), Gaps = 59/218 (27%)

Query: 238 LIGVGSFGSVYKGVFDED-GTVVAIKVINLQRQGASKS---FMAECKALKNIRHKNLVRV 293
             G       ++ + D      VA+  ++ Q           ++    L  I    + RV
Sbjct: 38  FHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 294 ITSCSSVDF-QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +      D         +V +++  GSL++       P                I     
Sbjct: 97  L------DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-------------AIRAMQS 137

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           +A+A D  H+     +      PS + +  D    +                        
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP--------------------- 173

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                         + +   D+   G  L  ++  + P
Sbjct: 174 ----------ATMPDANPQDDIRGIGASLYALLVNRWP 201

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 36/212 (16%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL-KNIRHKNLVRVITS 296
           ++G+G  G V +      G   A+K++       S     E     +     ++V ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVCILDV 90

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             ++         I+ + M  G L        I +R      Q  T  +   I  D+ +A
Sbjct: 91  YENMHHGKRCL-LIIMECMEGGELF-----SRIQERGD----QAFTEREAAEIMRDIGTA 140

Query: 357 LDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + +LH H    I H D+KP N+L    + D    + DFG ++     +   + +      
Sbjct: 141 IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQTPC---Y 191

Query: 414 TIGYVAPE----YGLGSEVSTNGDVYSYGILL 441
           T  YVAPE               D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKSC----DMWSLGVIM 219

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 64/257 (24%), Positives = 109/257 (42%), Gaps = 26/257 (10%)

Query: 198 SWHKRSRPSRQPSEPMIRKALLKMSYKSLLKAT-DGFSSTNLIGVGSFGSVYKGVFDEDG 256
           +  +    S  PS+    + +     K   + T + F    L+G G+FG V        G
Sbjct: 114 AAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATG 173

Query: 257 TVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYK 313
              A+K++    +  +      + E + L+N RH  L  +  S     FQ +D    V +
Sbjct: 174 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFVME 228

Query: 314 YMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL 373
           Y   G L   L  + +   DR           R   A ++ SALDYLH   ++ +++ DL
Sbjct: 229 YANGGELFFHLSRERVFSEDR----------ARFYGA-EIVSALDYLHS--EKNVVYRDL 275

Query: 374 KPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGD 433
           K  N++LD D    I DFGL +  + + +     +    GT  Y+APE    ++     D
Sbjct: 276 KLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFC--GTPEYLAPEVLEDNDYGRAVD 331

Query: 434 VYSYGILLLEMVTTKKP 450
            +  G+++ EM+  + P
Sbjct: 332 WWGLGVVMYEMMCGRLP 348

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 56/242 (23%), Positives = 87/242 (35%), Gaps = 54/242 (22%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMA---------E 278
              ++    I  GS+G+V  GV D +G  VAIK +   +                    E
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 279 CKALKNIRHKNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDRE 335
            + L +  H N++    +           +    +V + M    L + +H   I      
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAM--HKL-YLVTELMRT-DLAQVIHDQRIVISP-- 133

Query: 336 IEIQKLT--LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGL 393
             IQ     +L            L  LH+     ++H DL P NILL ++    I DF L
Sbjct: 134 QHIQYFMYHILL----------GLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNL 180

Query: 394 SRFYQAVSNPTVSSSIGVRGTIGYV------APEYGLGSEVSTNG-DVYSYGILLLEMVT 446
           +R   A +N T            YV      APE  +  +  T   D++S G ++ EM  
Sbjct: 181 AREDTADANKT-----------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

Query: 447 TK 448
            K
Sbjct: 230 RK 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 45/227 (19%), Positives = 94/227 (41%), Gaps = 40/227 (17%)

Query: 238 LIGVGSFGSVYKGVFD-EDGTVVAIKVI-NLQRQGASKSFMAECKALKNIR--------H 287
            +G G F +V+    D  + T VA+K++   +     ++   E K L+ +          
Sbjct: 26  KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDS 82

Query: 288 KNLVRVITSCSSVDFQGNDFK--AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ 345
                ++      + +G +     +V++ +   +L   +         ++ E + + L+ 
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALI---------KKYEHRGIPLIY 132

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH------IGDFGLSRFYQA 399
              I+  +   LDY+H+ C   I+H D+KP N+L++   S        I D G + +Y  
Sbjct: 133 VKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
               ++ +         Y +PE  LG+      D++S   L+ E++T
Sbjct: 191 HYTNSIQTRE-------YRSPEVLLGAPWGCGADIWSTACLIFELIT 230

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 52/222 (23%), Positives = 74/222 (33%), Gaps = 38/222 (17%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
           L+G G FG+V+ G    D   VAIKVI   R                +     V      
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 298 SSV----DFQGNDFKA-IVYKY-MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
             V    D+        +V +  +P   L      D I ++    E        ++    
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLF-----DYITEKGPLGEGPSRCFFGQV---- 148

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDND-LSAHIGDFGLSRFYQAVSNPTVSSSIG 410
              +A+ + H      ++H D+K  NIL+D     A + DFG           T      
Sbjct: 149 --VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-EPYTDFD--- 199

Query: 411 VRGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVT 446
             GT  Y  PE      Y           V+S GILL +MV 
Sbjct: 200 --GTRVYSPPEWISRHQY-HALPA----TVWSLGILLYDMVC 234

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 19/135 (14%), Positives = 35/135 (25%), Gaps = 17/135 (12%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           +  +                 N        +      NLK L   ++ N     ++P  L
Sbjct: 458 SPFTYDNIAV------DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511

Query: 64  GLCSSLEDIYLGGNFFHG---------SIPSFFRTSRGIRKLDLSRNNLSG-QIPLFLEA 113
                L+ + +  N              +     T   I+   +  NNL        L+ 
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571

Query: 114 L-SLEYLNLSFNDFE 127
           +  L  L+   N   
Sbjct: 572 MVKLGLLDCVHNKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 26/137 (18%), Positives = 47/137 (34%), Gaps = 20/137 (14%)

Query: 3   ENDLSGTIPEAIF-----SISYLSN--SLNLAENHFVGSIPPRI--GNLKALRSFDVSNN 53
            N ++ +IPE        +        +++L  N    S+        L  L + DVS N
Sbjct: 706 NNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYN 763

Query: 54  GLSGEIPIELGLCSSLEDIYL------GGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQI 107
             S   P +    S L+   +       GN      P+   T   + +L +  N++    
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVD 822

Query: 108 PLFLEALSLEYLNLSFN 124
                   L  L+++ N
Sbjct: 823 EKLTP--QLYILDIADN 837

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 21/126 (16%), Positives = 41/126 (32%), Gaps = 6/126 (4%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N      P    S   L ++      + +  I   I  L  L+    +N+  + +     
Sbjct: 409 NRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI--- 465

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLS 122
                 ED        + +    +   + +  ++L       Q+P FL  L  L+ LN++
Sbjct: 466 --AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523

Query: 123 FNDFEG 128
            N    
Sbjct: 524 CNRGIS 529

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 25/140 (17%), Positives = 42/140 (30%), Gaps = 17/140 (12%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPR--IGNLKALRSFDVSNNGLSG---E 58
           N +   IPE   + +     L  + N     IP      ++  + S D S N +      
Sbjct: 605 NQIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662

Query: 59  IPIELGL--CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS-------GQIPL 109
           I   +      +   + L  N         F T   I  + LS N ++            
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722

Query: 110 FLEAL-SLEYLNLSFNDFEG 128
             +    L  ++L FN    
Sbjct: 723 NYKNTYLLTTIDLRFNKLTS 742

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 74.9 bits (184), Expect = 2e-14
 Identities = 19/126 (15%), Positives = 40/126 (31%), Gaps = 10/126 (7%)

Query: 8   GTIPEAIFSISYLSNSLNLAENHFVGSIPPR--IGNLKALRSFDVSNNGLSGEIPIELGL 65
             + +   +   +     +  N+     P    +  +  L   D  +N +   +    G 
Sbjct: 538 TRLADDEDTGPKIQ-IFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGT 593

Query: 66  CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEAL-SLEYLNLS 122
              L D+ L  N        F   +  +  L  S N L   IP     +++  +  ++ S
Sbjct: 594 NVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFS 652

Query: 123 FNDFEG 128
           +N    
Sbjct: 653 YNKIGS 658

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 15/107 (14%), Positives = 33/107 (30%), Gaps = 11/107 (10%)

Query: 4   NDLSGTIPEAIFSIS-----YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           N  S + P    + S      + +  +   N  +   P  I    +L    + +N +  +
Sbjct: 763 NCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-K 820

Query: 59  IPIELGLCSSLEDIYLGGN-FFHGSIPSFFRTSR-GIRKLDLSRNNL 103
           +  +  L   L  + +  N      + S       G+  L   +   
Sbjct: 821 VDEK--LTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 18/140 (12%), Positives = 42/140 (30%), Gaps = 6/140 (4%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
           + N   + +       + N   +    ++  G  G +P  +G  + L+ +  G +    S
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQI-PLFLEAL-SLEYLNLSFNDF----EGKVPTKGIF 136
              F          +  ++ +      +FL+    L   +L  +      E K   K   
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 137 ANTSAISVAGCHRLCGGIPE 156
            +     +         I +
Sbjct: 423 ISLKDTQIGNLTNRITFISK 442

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 18/132 (13%), Positives = 40/132 (30%), Gaps = 9/132 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEI-PIE 62
               G +P+AI  ++ L   L+   +    S              +   + +      + 
Sbjct: 333 FGAKGRVPDAIGQLTELK-VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391

Query: 63  LGLCSSLEDIYLGGNFFH-----GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SL 116
           L     L    L  +  +       I    R S    ++    N ++  I   ++ L  L
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKL 450

Query: 117 EYLNLSFNDFEG 128
           + +  + + F  
Sbjct: 451 QIIYFANSPFTY 462

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 17/138 (12%), Positives = 37/138 (26%), Gaps = 2/138 (1%)

Query: 33  GSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRG 92
             I           + D  N               +  +     + +          +  
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGR 324

Query: 93  IRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC 151
           +  L L+     G++P  +  L+ L+ L+   +         G    T  +S    HR+ 
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 152 GGIPELQLPKCTENKSSN 169
               ++ L        S+
Sbjct: 385 MHYKKMFLDYDQRLNLSD 402

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.0 bits (201), Expect = 4e-17
 Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 36/223 (16%)

Query: 238 LIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHKNL 290
           ++G G +G V+   K      G + A+KV+     ++    +    AE   L+ ++H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RISI 349
           V +I +     FQ      ++ +Y+  G L   L      +R+                +
Sbjct: 84  VDLIYA-----FQTGGKLYLILEYLSGGELFMQL------EREG-----IFMEDTACFYL 127

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSS 407
           A +++ AL +LHQ     I++ DLKP NI+L++    H+   DFGL +  +++ + TV+ 
Sbjct: 128 A-EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCK--ESIHDGTVTH 179

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +    GTI Y+APE  + S  +   D +S G L+ +M+T   P
Sbjct: 180 TFC--GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 47/243 (19%), Positives = 91/243 (37%), Gaps = 39/243 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           +S    +G GSFG V +    E G   A+K +    +  ++    E   +K + H N+++
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIK 64

Query: 293 ---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE---IQKL--TLL 344
                 +    + +         K     +     H   I    +      I +     L
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 345 QRISIAIDVAS-----------------ALDYLHQHCQEPILHCDLKPSNILLD-NDLSA 386
            ++  +   +                  A+ ++H      I H D+KP N+L++  D + 
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTL 181

Query: 387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMV 445
            + DFG ++  + + +    + I  R    Y APE  LG+   T   D++S G +  E++
Sbjct: 182 KLCDFGSAK--KLIPSEPSVAYICSR---FYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 446 TTK 448
             K
Sbjct: 237 LGK 239

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 29/144 (20%), Positives = 47/144 (32%), Gaps = 5/144 (3%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             L     ++ F   +L   LNL+ +    S       L AL+  ++  N        + 
Sbjct: 410 TRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

Query: 64  GL---CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
                   LE + L            F + + +  +DLS N L+      L  L   YLN
Sbjct: 470 NSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLN 529

Query: 121 LSFNDFEGKVPTKGIFANTSAISV 144
           L+ N     +P   +    S    
Sbjct: 530 LASNHISIILP--SLLPILSQQRT 551

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 33/177 (18%), Positives = 55/177 (31%), Gaps = 7/177 (3%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             +     +   S   L ++L L  N  +      +   KAL+       G+S    I L
Sbjct: 67  CQIYWIHEDTFQSQHRL-DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPL---FLEALSLEYLN 120
               +LE +YLG N            +  ++ LD   N +          L+  +   LN
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185

Query: 121 LSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPEL---QLPKCTENKSSNQRISR 174
           L+ ND  G  P     A   +++  G   L      L    +         +     
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 18/126 (14%), Positives = 37/126 (29%), Gaps = 2/126 (1%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L          +  L+  L+L              +   L +  ++ N L       L
Sbjct: 43  NVLPTIQNTTFSRLINLT-FLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG-QIPLFLEALSLEYLNLS 122
               +L+ ++                 + +  L L  N++S  ++P       L+ L+  
Sbjct: 102 SGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161

Query: 123 FNDFEG 128
            N    
Sbjct: 162 NNAIHY 167

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 28/129 (21%), Positives = 44/129 (34%), Gaps = 6/129 (4%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIG---NLKALRSFDVSNNGLSGEIP 60
           + L  +  +    +  L   LNL  NHF      +      L  L    +S   LS    
Sbjct: 435 SLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
                   +  + L  N    S        +GI  L+L+ N++S  +P  L  L     +
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTI 552

Query: 120 NLSFNDFEG 128
           NL  N  + 
Sbjct: 553 NLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 19/123 (15%), Positives = 37/123 (30%), Gaps = 5/123 (4%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
              L+  IP  + +    +  L  + N            L  L   D++   +       
Sbjct: 21  NLGLN-EIPGTLPN---STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNL 121
                 L+ + L  N       +     + ++ L   +  +S    + L    +LE L L
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 122 SFN 124
             N
Sbjct: 137 GSN 139

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 28/146 (19%), Positives = 48/146 (32%), Gaps = 10/146 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           +             S L   L+L   H    +P  +  L  L+   +S N       I  
Sbjct: 264 HYFFNISSNTFHCFSGLQ-ELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISA 321

Query: 64  GLCSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSGQIPLFLEAL----SLEY 118
               SL  + + GN     + +        +R+LDLS +++          L     L+ 
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQS 380

Query: 119 LNLSFNDFEGKVPTKGIFANTSAISV 144
           LNLS+N+          F     + +
Sbjct: 381 LNLSYNEPLSLKT--EAFKECPQLEL 404

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 28/142 (19%), Positives = 52/142 (36%), Gaps = 8/142 (5%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPR-IGNLKALRSFDVSNNGL--SGEIP 60
           N        +  +   L+  L++  N     +    + NL+ LR  D+S++ +  S    
Sbjct: 311 NKFENLCQISASNFPSLT-HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEY 118
           ++L   S L+ + L  N         F+    +  LDL+   L  +     F     L+ 
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 119 LNLSFNDFEGKVPTKGIFANTS 140
           LNLS +  +       +F    
Sbjct: 430 LNLSHSLLDISSE--QLFDGLP 449

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 33/130 (25%), Positives = 55/130 (42%), Gaps = 8/130 (6%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGN--LKALRSFDVSNNGLSGEIPI 61
           ND++  I    F  +    SLN      +  I   + N  +++L      +       P 
Sbjct: 189 NDIA-GIEPGAFDSAVF-QSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246

Query: 62  ELGLCS--SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEY 118
                   S+E I L  ++F     + F    G+++LDL+  +LS ++P  L  L +L+ 
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK 305

Query: 119 LNLSFNDFEG 128
           L LS N FE 
Sbjct: 306 LVLSANKFEN 315

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 25/126 (19%), Positives = 48/126 (38%), Gaps = 14/126 (11%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
            DLS     A  S+  ++  ++L+ N    S    + +LK +   ++++N +S  +P  L
Sbjct: 486 CDLSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLL 543

Query: 64  GLCSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSG------QIPLFLEALSL 116
            + S    I L  N    +  + +F           +   L        + P  L  + L
Sbjct: 544 PILSQQRTINLRQNPLDCTCSNIYFL-----EWYKENMQKLEDTEDTLCENPPLLRGVRL 598

Query: 117 EYLNLS 122
             + LS
Sbjct: 599 SDVTLS 604

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 54/247 (21%), Positives = 96/247 (38%), Gaps = 44/247 (17%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRH 287
            D +   +LIG GS+G VY          VAIK +N   +     K  + E   L  ++ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 288 KNLVR---VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE-IQKLTL 343
             ++R   +I     + F  ++   IV +       +  L         +  +    LT 
Sbjct: 85  DYIIRLYDLIIPDDLLKF--DEL-YIVLEIA-----DSDLK--------KLFKTPIFLTE 128

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
               +I  ++    +++H+     I+H DLKP+N LL+ D S  + DFGL+R   +  + 
Sbjct: 129 EHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185

Query: 404 TVSSSIGVRGTI------------GYV------APEYGLGSEVSTNG-DVYSYGILLLEM 444
            + + +                   +V      APE  L  E  T   D++S G +  E+
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 445 VTTKKPT 451
           +   +  
Sbjct: 246 LNMLQSH 252

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 54/232 (23%), Positives = 92/232 (39%), Gaps = 47/232 (20%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q   +    +  + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S     F+ N    +V +Y+  G +                     + L+RI
Sbjct: 101 PFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--------------------FSHLRRI 135

Query: 348 SI---------AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
                      A  +    +YLH      +++ DLKP N+L+D      + DFG ++   
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--- 189

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            V   T +    + GT   +APE  L    +   D ++ G+L+ EM     P
Sbjct: 190 RVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 62/237 (26%), Positives = 100/237 (42%), Gaps = 40/237 (16%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIR-HKN 289
           +     +G G++G V+K +    G VVA+K I    Q    ++    E   L  +  H+N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V ++    + +    D   +V+ YM     E  LH          I    L  + +  +
Sbjct: 71  IVNLLNVLRADND--RDV-YLVFDYM-----ETDLH--------AVIRANILEPVHKQYV 114

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
              +   + YLH      +LH D+KPSNILL+ +    + DFGLSR +  +   T +  +
Sbjct: 115 VYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171

Query: 410 GVRGTI-----------GYV------APEYGLGSEVSTNG-DVYSYGILLLEMVTTK 448
            +                YV      APE  LGS   T G D++S G +L E++  K
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 70/353 (19%), Positives = 120/353 (33%), Gaps = 59/353 (16%)

Query: 110 FLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSN 169
           F E +  +Y      + E  V ++ IF       +  C        +  +     +    
Sbjct: 85  FYEEIK-KY-EKLETEEERLVCSREIFDTYIMKELLAC---SHPFSKSAIEHVQGHLVKK 139

Query: 170 QRISRSLKILISIVSIFLGIVMVSFFIFSWHKRSRPSRQPSEPMIRKALLKMSYKSLLKA 229
           Q      +  I  +   L   +   FI S         +  E       L M+  S+ + 
Sbjct: 140 QVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVE---LNIHLTMNDFSVHR- 195

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNI 285
                   +IG G FG VY     + G + A+K ++      +QG     + E   L  +
Sbjct: 196 --------IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-TLALNERIMLSLV 246

Query: 286 RHKN---LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLT 342
              +   +V +  +     F   D  + +   M  G L   L       +        + 
Sbjct: 247 STGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEADM- 294

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
              R   A ++   L+++H      +++ DLKP+NILLD      I D GL+        
Sbjct: 295 ---RFYAA-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC--DFSKK 345

Query: 403 PTVSSSIGVRGTIGYVAPE-----YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              +S     GT GY+APE         S      D +S G +L +++    P
Sbjct: 346 KPHASV----GTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 46/230 (20%)

Query: 238 LIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHKN- 289
           ++G G++G V+   K    + G + A+KV+     +Q+   ++    E + L++IR    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RIS 348
           LV +  +     FQ      ++  Y+  G L   L       +       + T  + +I 
Sbjct: 121 LVTLHYA-----FQTETKLHLILDYINGGELFTHL------SQRE-----RFTEHEVQIY 164

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVS 406
           +  ++  AL++LH+     I++ D+K  NILLD++   H+   DFGLS+ + A       
Sbjct: 165 VG-EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAY 218

Query: 407 SSIGVRGTIGYVAPE------YGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                 GTI Y+AP+       G    V    D +S G+L+ E++T   P
Sbjct: 219 DFC---GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 51/228 (22%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKN 289
           F     +G GSFG V+      +G   A+KV+    + R    +    E   L  + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++R+  +     FQ      ++  Y+  G L                     +LL++   
Sbjct: 68  IIRMWGT-----FQDAQQIFMIMDYIEGGEL--------------------FSLLRKSQR 102

Query: 350 ---------AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQ 398
                    A +V  AL+YLH      I++ DLKP NILLD +   HI   DFG ++   
Sbjct: 103 FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAK--- 154

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            V + T +    + GT  Y+APE       + + D +S+GIL+ EM+ 
Sbjct: 155 YVPDVTYT----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 38/223 (17%)

Query: 238 LIGVGSFGSVY---KGVFDEDGTVVAIKVIN----LQRQGASKSFMAECKALKNIRHKNL 290
           ++G GSFG V+   K    +   + A+KV+       R         E   L  + H  +
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTKMERDILVEVNHPFI 88

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RISI 349
           V++  +     FQ      ++  ++  G L   L       ++        T    +  +
Sbjct: 89  VKLHYA-----FQTEGKLYLILDFLRGGDLFTRL------SKEV-----MFTEEDVKFYL 132

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSS 407
           A ++A ALD+LH      I++ DLKP NILLD +   HI   DFGLS+  +++ +   + 
Sbjct: 133 A-ELALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK--ESIDHEKKAY 184

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S    GT+ Y+APE       + + D +S+G+L+ EM+T   P
Sbjct: 185 SFC--GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKALKNIRHKNLVRVI 294
           L+G G+FG V        G   A+K++    +  +      + E + L+N RH  L  + 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RISIAIDV 353
            +     FQ +D    V +Y   G L   L       R+R       T  + R   A ++
Sbjct: 72  YA-----FQTHDRLCFVMEYANGGELFFHL------SRER-----VFTEERARFYGA-EI 114

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIGV 411
            SAL+YLH      +++ D+K  N++LD D   HI   DFGL +  + +S+     +   
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK--EGISDGATMKTFC- 166

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 47/253 (18%), Positives = 89/253 (35%), Gaps = 43/253 (16%)

Query: 203 SRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNL----IGVGSFGSVYKGVFDEDGTV 258
             P++ P  P  +     +     +K         +    +G+G  G V +         
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 259 VAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPN 317
            A+K++             E +      +  ++VR++    +  + G     IV + +  
Sbjct: 90  FALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDG 143

Query: 318 GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSN 377
           G L        I  R      Q  T  +   I   +  A+ YLH      I H D+KP N
Sbjct: 144 GELF-----SRIQDRGD----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191

Query: 378 ILL---DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPE------YGLGSEV 428
           +L      +    + DFG ++   +  + ++++      T  YVAPE      Y      
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC---YTPYYVAPEVLGPEKYDK--SC 244

Query: 429 STNGDVYSYGILL 441
               D++S G+++
Sbjct: 245 ----DMWSLGVIM 253

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 38/219 (17%)

Query: 238 LIGVGSFGSVYKGVFD-EDGTVVAIKVI----NLQRQGASKSFMAECKALKNIRHK---N 289
           +IG GSFG V K  +D +    VA+K++       RQ        E + L+++R +   N
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQA-----AEEIRILEHLRKQDKDN 157

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
            + VI    +  F+ +    + ++ + + +L + +         ++ + Q  +L      
Sbjct: 158 TMNVIHMLENFTFRNHIC--MTFELL-SMNLYELI---------KKNKFQGFSLPLVRKF 205

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSS 407
           A  +   LD LH++    I+HCDLKP NILL     + I   DFG S +     +  V +
Sbjct: 206 AHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYT 258

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            I  R    Y APE  LG+      D++S G +L E++T
Sbjct: 259 YIQSR---FYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 75/257 (29%), Positives = 110/257 (42%), Gaps = 34/257 (13%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVA 260
           +    +  P     ++  L  S     K +D F    +IG GSFG V       +    A
Sbjct: 9   ELMNANPAPPPAPSQQINLGPSSNPHAKPSD-FHFLKVIGKGSFGKVLLARHKAEEVFYA 67

Query: 261 IKVI---NLQRQGASKSFMAECKAL-KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMP 316
           +KV+    + ++   K  M+E   L KN++H  LV +  S     FQ  D    V  Y+ 
Sbjct: 68  VKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYFVLDYIN 122

Query: 317 NGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RISIAIDVASALDYLHQHCQEPILHCDLKP 375
            G L   L      QR+R          + R   A ++ASAL YLH      I++ DLKP
Sbjct: 123 GGELFYHL------QRER-----CFLEPRARFYAA-EIASALGYLHSL---NIVYRDLKP 167

Query: 376 SNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGD 433
            NILLD+    HI   DFGL +  + + + + +S+    GT  Y+APE           D
Sbjct: 168 ENILLDSQ--GHIVLTDFGLCK--ENIEHNSTTSTFC--GTPEYLAPEVLHKQPYDRTVD 221

Query: 434 VYSYGILLLEMVTTKKP 450
            +  G +L EM+    P
Sbjct: 222 WWCLGAVLYEMLYGLPP 238

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 31/219 (14%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKAL-KNIRHKNLVRV 293
           ++G GSFG V+   F +     AIK +    +      +  M E + L     H  L  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             +     FQ  +    V +Y+  G L   +      Q        K  L +    A ++
Sbjct: 84  FCT-----FQTKENLFFVMEYLNGGDLMYHI------QSCH-----KFDLSRATFYAAEI 127

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIGV 411
              L +LH      I++ DLK  NILLD D   HI   DFG+ +  + +     +++   
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK--ENMLGDAKTNTFC- 179

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  Y+APE  LG + + + D +S+G+LL EM+  + P
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 59/246 (23%), Positives = 103/246 (41%), Gaps = 28/246 (11%)

Query: 209 PSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI---N 265
           P E       + ++  + L   + F    ++G GSFG V      E G + A+KV+    
Sbjct: 2   PKESSKEGNGIGVNSSNRLGIDN-FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDV 60

Query: 266 LQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWL 324
           + +    +  M E + L     H  L ++        FQ  D    V +++  G L   +
Sbjct: 61  ILQDDDVECTMTEKRILSLARNHPFLTQLFCC-----FQTPDRLFFVMEFVNGGDLMFHI 115

Query: 325 HPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL 384
                 Q+ R     +    +    A ++ SAL +LH      I++ DLK  N+LLD++ 
Sbjct: 116 ------QKSR-----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEG 161

Query: 385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEM 444
              + DFG+ +  + + N   +++    GT  Y+APE           D ++ G+LL EM
Sbjct: 162 HCKLADFGMCK--EGICNGVTTATFC--GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217

Query: 445 VTTKKP 450
           +    P
Sbjct: 218 LCGHAP 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 55/255 (21%), Positives = 103/255 (40%), Gaps = 30/255 (11%)

Query: 201 KRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVA 260
            +   + +               +  +K TD F+   ++G GSFG V          + A
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTD-FNFLMVLGKGSFGKVMLSERKGTDELYA 370

Query: 261 IKVIN----LQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAIVYKYM 315
           +K++     +Q     +  M E + L    +   L + + SC    FQ  D    V +Y+
Sbjct: 371 VKILKKDVVIQDDDV-ECTMVEKRVLALPGKPPFLTQ-LHSC----FQTMDRLYFVMEYV 424

Query: 316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP 375
             G L   +      Q+       +      +  A ++A  L +L       I++ DLK 
Sbjct: 425 NGGDLMYHI------QQVG-----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKL 470

Query: 376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVY 435
            N++LD++    I DFG+ +  + + +   + +    GT  Y+APE         + D +
Sbjct: 471 DNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFC--GTPDYIAPEIIAYQPYGKSVDWW 526

Query: 436 SYGILLLEMVTTKKP 450
           ++G+LL EM+  + P
Sbjct: 527 AFGVLLYEMLAGQAP 541

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 32/125 (25%), Positives = 52/125 (41%), Gaps = 11/125 (8%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLC----SSLEDIYLGGNF 78
            L++A+ H +     ++    AL + D+S+N   GE  +   LC     +L+ + L    
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212

Query: 79  FH---GSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPTK 133
                G   +       ++ LDLS N+L              L  LNLSF   + +VP K
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP-K 270

Query: 134 GIFAN 138
           G+ A 
Sbjct: 271 GLPAK 275

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 24/110 (21%), Positives = 32/110 (29%), Gaps = 8/110 (7%)

Query: 23  SLNLAENHF---VGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGL-CSSLEDIYLGGNF 78
            L L         G           L+  D+S+N L            S L  + L    
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 79  FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEG 128
               +P        +  LDLS N L    P   E   +  L+L  N F  
Sbjct: 265 LK-QVPKG--LPAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 24/126 (19%), Positives = 39/126 (30%), Gaps = 12/126 (9%)

Query: 13  AIFSISYLSNSLNLAENHFVGSIPPRIGNL--KALRSFDVSNNGLSGEIP----IELGLC 66
            +  IS L   L L      G+ PP +       L   ++ N   +        ++  L 
Sbjct: 90  RVLGISGLQE-LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148

Query: 67  SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-----SLEYLNL 121
             L+ + +             R    +  LDLS N   G+  L          +L+ L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 122 SFNDFE 127
                E
Sbjct: 209 RNAGME 214

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 58/220 (26%), Positives = 89/220 (40%), Gaps = 34/220 (15%)

Query: 236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVI----NLQRQGASKSFMAECKALKNIRHK--- 288
            +LIG GSFG V K     +   VAIK+I        Q        E + L+ +      
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-----QIEVRLLELMNKHDTE 113

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
               ++       F+ +    +V++ + + +L   L         R    + ++L     
Sbjct: 114 MKYYIVHLKRHFMFRNHLC--LVFEML-SYNLYDLL---------RNTNFRGVSLNLTRK 161

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG--DFGLSRFYQAVSNPTVS 406
            A  + +AL +L    +  I+HCDLKP NILL N   + I   DFG S          + 
Sbjct: 162 FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIY 216

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
             I  R    Y +PE  LG       D++S G +L+EM T
Sbjct: 217 QYIQSR---FYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKAL-KNIRHKNLVRV 293
           ++G GSFG V          + A+K++    + +    +  M E + L    +   L ++
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
            +      FQ  D    V +Y+  G L   +      Q+       +      +  A ++
Sbjct: 87  HSC-----FQTMDRLYFVMEYVNGGDLMYHI------QQVG-----RFKEPHAVFYAAEI 130

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIGV 411
           A  L +L       I++ DLK  N++LD++   HI   DFG+ +  + + +   + +   
Sbjct: 131 AIGLFFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK--ENIWDGVTTKTFC- 182

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            GT  Y+APE         + D +++G+LL EM+  + P
Sbjct: 183 -GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 30/257 (11%)

Query: 199 WHKRSRPSRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTV 258
           + + +  S    E             S L   D F    +IG GS+  V      +   +
Sbjct: 21  YFQGAMGSGIEEEKEAMNTRESGKASSSLGLQD-FDLLRVIGRGSYAKVLLVRLKKTDRI 79

Query: 259 VAIKVI---NLQRQGASKSFMAECKAL-KNIRHKNLVRVITSCSSVDFQGNDFKAIVYKY 314
            A++V+    +           E     +   H  LV + +      FQ       V +Y
Sbjct: 80  YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC-----FQTESRLFFVIEY 134

Query: 315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RISIAIDVASALDYLHQHCQEPILHCDL 373
           +  G L   +      QR R     KL     R   A +++ AL+YLH+     I++ DL
Sbjct: 135 VNGGDLMFHM------QRQR-----KLPEEHARFYSA-EISLALNYLHER---GIIYRDL 179

Query: 374 KPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGD 433
           K  N+LLD++    + D+G+ +  + +     +S+    GT  Y+APE   G +   + D
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFC--GTPNYIAPEILRGEDYGFSVD 235

Query: 434 VYSYGILLLEMVTTKKP 450
            ++ G+L+ EM+  + P
Sbjct: 236 WWALGVLMFEMMAGRSP 252

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVI---NLQRQGASKSFMAECKAL-KNIRHKNLVRV 293
           +IG GS+  V      +   + A+KV+    +           E     +   H  LV +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ-RISIAID 352
            +      FQ       V +Y+  G L   +      QR R     KL     R   A +
Sbjct: 76  HSC-----FQTESRLFFVIEYVNGGDLMFHM------QRQR-----KLPEEHARFYSA-E 118

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSSIG 410
           ++ AL+YLH+     I++ DLK  N+LLD++   HI   D+G+ +  + +     +S+  
Sbjct: 119 ISLALNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK--EGLRPGDTTSTFC 171

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             GT  Y+APE   G +   + D ++ G+L+ EM+  + P
Sbjct: 172 --GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 21/112 (18%), Positives = 42/112 (37%), Gaps = 13/112 (11%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
           +L L         P +   L  L+   +   GL  E+P  +   + LE + L  N    +
Sbjct: 85  ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-A 141

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL----------SLEYLNLSFN 124
           +P+   +   +R+L +       ++P  L +           +L+ L L + 
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 25/134 (18%), Positives = 50/134 (37%), Gaps = 22/134 (16%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
            +       +P+   ++   +   +L LA N    ++P  I +L  LR   +       E
Sbjct: 110 TIDAAGLMELPD---TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTE 165

Query: 59  IPIELGLCS---------SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPL 109
           +P  L             +L+ + L       S+P+     + ++ L +  + LS  +  
Sbjct: 166 LPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP 223

Query: 110 FLEAL-SLEYLNLS 122
            +  L  LE L+L 
Sbjct: 224 AIHHLPKLEELDLR 237

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 18/114 (15%), Positives = 39/114 (34%), Gaps = 6/114 (5%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
            + LS  +     +I +L     L+L     + + PP  G    L+   + +      +P
Sbjct: 215 NSPLS-ALGP---AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLP 270

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL 114
           +++   + LE + L G      +PS          + +  +  +        A 
Sbjct: 271 LDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 12/107 (11%), Positives = 29/107 (27%), Gaps = 7/107 (6%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
           +L    +  +      +   +   + D +    +          ++ +     G     +
Sbjct: 16  NLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGRALKAT 71

Query: 83  IPSFFR-TSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFE 127
                  T  G   L+L    L  Q P     L  L+++ +      
Sbjct: 72  ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 34/177 (19%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS- 296
            IG G FG +Y           A  V+ ++ Q     F  E K  + +  K+ ++     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIER 102

Query: 297 -------------CSSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLT 342
                            +F+G  ++ +V + +  G  L+K    +               
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQN-----------GTFK 149

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD--NDLSAHIGDFGLSRFY 397
               + + I +   L+Y+H++     +H D+K +N+LL   N    ++ D+GLS  Y
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 1e-11
 Identities = 36/203 (17%), Positives = 63/203 (31%), Gaps = 34/203 (16%)

Query: 225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI--------NLQRQGASKSFM 276
           S    T+       IG G FG V++ +   D T VAIK+I        N   Q   +  +
Sbjct: 14  SHCLPTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 277 AE---CKALKNIRHKNLVRVITSCSSVDF---QGNDFKAIVYKYMPNGSLEKWLHPDAIP 330
            E    K L  +  +   R             QG+    ++  +    S +   +     
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 331 QRDREIEI----------------QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLK 374
            +D ++ I                +  +L    SI   + ++L       +    H DL 
Sbjct: 132 FKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189

Query: 375 PSNILLDNDLSAHIGDFGLSRFY 397
             N+LL       +      +  
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSS 212

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 22/114 (19%), Positives = 44/114 (38%), Gaps = 9/114 (7%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
           +  ++ LS    L +  N    S    + +L  L+  +V +N +S      L   S L  
Sbjct: 236 LSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNS 291

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFN 124
           ++L  N               +  L LS+N+++   P  L +L  ++  + +  
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 62.6 bits (153), Expect = 7e-11
 Identities = 27/122 (22%), Positives = 49/122 (40%), Gaps = 8/122 (6%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            ++G    +I  I YL+N   LNL  N  +  I P + NL  L +  +  N ++      
Sbjct: 50  VVAGEKVASIQGIEYLTNLEYLNLNGNQ-ITDISP-LSNLVKLTNLYIGTNKIT--DISA 105

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           L   ++L ++YL  +      P        +  L+L  N+    +        L YL ++
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVT 163

Query: 123 FN 124
            +
Sbjct: 164 ES 165

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 24/123 (19%), Positives = 44/123 (35%), Gaps = 10/123 (8%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L+      I  ++ L+   SLNL  NH +  + P + N+  L    V+ + +    PI 
Sbjct: 116 YLNEDNISDISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPI- 173

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNL 121
               + L  + L  N      P    +   +       N ++   P  +  +  L  L +
Sbjct: 174 -ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKI 228

Query: 122 SFN 124
             N
Sbjct: 229 GNN 231

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 59.5 bits (145), Expect = 6e-10
 Identities = 26/129 (20%), Positives = 48/129 (37%), Gaps = 9/129 (6%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L+    E I  ++ L++        N      P  + N+  L S  + NN ++   P  
Sbjct: 183 SLNYNQIEDISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-- 238

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           L   S L  + +G N    S  +  +    ++ L++  N +S  I +      L  L L+
Sbjct: 239 LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLN 295

Query: 123 FNDFEGKVP 131
            N    +  
Sbjct: 296 NNQLGNEDM 304

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.9 bits (133), Expect = 2e-08
 Identities = 20/102 (19%), Positives = 39/102 (38%), Gaps = 6/102 (5%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           ++       I ++  L+    LN+  N  +  I   + NL  L S  ++NN L  E    
Sbjct: 249 EIGTNQISDINAVKDLTKLKMLNVGSNQ-ISDISV-LNNLSQLNSLFLNNNQLGNEDMEV 306

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
           +G  ++L  ++L  N      P    +   +   D +   + 
Sbjct: 307 IGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 46.8 bits (112), Expect = 8e-06
 Identities = 18/103 (17%), Positives = 35/103 (33%), Gaps = 9/103 (8%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
           +L       +  I P   +L       +    ++  +  E     S+  + + G     S
Sbjct: 4   TLATLPAP-INQIFP-DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-S 58

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFN 124
           I      +  +  L+L+ N ++   P  L  L  L  L +  N
Sbjct: 59  IQGIEYLTN-LEYLNLNGNQITDISP--LSNLVKLTNLYIGTN 98

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 28/124 (22%), Positives = 49/124 (39%), Gaps = 18/124 (14%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
             LS ++PE    +     SL  + N     +P    +LK+L   + +   LS       
Sbjct: 81  LGLS-SLPELPPHL----ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS------- 127

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
            L   LE + +  N     +P     S  ++ +D+  N+L  ++P      SLE++    
Sbjct: 128 DLPPLLEYLGVSNNQLE-KLPELQN-SSFLKIIDVDNNSLK-KLPDLPP--SLEFIAAGN 182

Query: 124 NDFE 127
           N  E
Sbjct: 183 NQLE 186

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 30/125 (24%), Positives = 48/125 (38%), Gaps = 18/125 (14%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N L   +P+   S+     S+    N       P + NL  L +    NN L   +P  
Sbjct: 204 NNSLK-KLPDLPLSLE----SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDL 255

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
                SLE + +  N+    +P   ++   +  LD+S N  S  +       +L YLN S
Sbjct: 256 PP---SLEALNVRDNYLT-DLPELPQS---LTFLDVSENIFS-GLSELPP--NLYYLNAS 305

Query: 123 FNDFE 127
            N+  
Sbjct: 306 SNEIR 310

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 29/125 (23%), Positives = 43/125 (34%), Gaps = 16/125 (12%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N L   +P+   S+ ++        N       P + NL  L +    NN L  ++P  
Sbjct: 162 NNSLK-KLPDLPPSLEFI----AAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDL 213

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
                SLE I  G N     +P        +  +    N L   +P      SLE LN+ 
Sbjct: 214 PL---SLESIVAGNNILE-ELPELQNLPF-LTTIYADNNLLK-TLPDLPP--SLEALNVR 265

Query: 123 FNDFE 127
            N   
Sbjct: 266 DNYLT 270

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 21/131 (16%), Positives = 42/131 (32%), Gaps = 21/131 (16%)

Query: 10  IPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG----- 64
           I     S ++L        ++    +P    N+K+   +  + +      P   G     
Sbjct: 3   INPRNVSNTFL-QEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 65  --------LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-S 115
                   L     ++ L       S+P        +  L  S N+L+ ++P   ++L S
Sbjct: 61  AVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKS 115

Query: 116 LEYLNLSFNDF 126
           L   N +    
Sbjct: 116 LLVDNNNLKAL 126

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 25/122 (20%), Positives = 40/122 (32%), Gaps = 21/122 (17%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N L   +P     +  L      + NH    +P    NLK L    V  N L  E P  
Sbjct: 326 NNKLI-ELPALPPRLERL----IASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDI 375

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
                 L          +  +       + +++L +  N L  + P   E  S+E L ++
Sbjct: 376 PESVEDLR--------MNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPE--SVEDLRMN 424

Query: 123 FN 124
             
Sbjct: 425 SE 426

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 21/106 (19%), Positives = 42/106 (39%), Gaps = 18/106 (16%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
            LN++ N  +  +P     L+ L     S N L+ E+P       +L+ +++  N     
Sbjct: 321 ELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-E 371

Query: 83  IPSFFRTSRGIRKL-DLSRNNLSGQIPLFLEALSLEYLNLSFNDFE 127
            P           + DL  N+   ++P   +  +L+ L++  N   
Sbjct: 372 FPD------IPESVEDLRMNSHLAEVPELPQ--NLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 27/127 (21%), Positives = 57/127 (44%), Gaps = 20/127 (15%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           + +N L+  +PE   S+++L  S N+        +     NL  L   + S+N +   + 
Sbjct: 264 VRDNYLT-DLPELPQSLTFLDVSENIFS-----GLSELPPNLYYL---NASSNEIR-SLC 313

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
               L  SLE++ +  N     +P+       + +L  S N+L+ ++P   +  +L+ L+
Sbjct: 314 ---DLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ--NLKQLH 363

Query: 121 LSFNDFE 127
           + +N   
Sbjct: 364 VEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 30/124 (24%), Positives = 49/124 (39%), Gaps = 20/124 (16%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L  T+P+   S+     +LN+ +N+    +P    +L  L   +   +GLS   P   
Sbjct: 247 NLLK-TLPDLPPSLE----ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP--- 297

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
               +L  +    N     I S       + +L++S N L  ++P       LE L  SF
Sbjct: 298 ----NLYYLNASSN----EIRSLCDLPPSLEELNVSNNKLI-ELPALPP--RLERLIASF 346

Query: 124 NDFE 127
           N   
Sbjct: 347 NHLA 350

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.9 bits (112), Expect = 9e-06
 Identities = 20/102 (19%), Positives = 32/102 (31%), Gaps = 14/102 (13%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N L    P+   S+  L  + +L        +P    NLK L    V  N L  E P  
Sbjct: 366 YNPLR-EFPDIPESVEDLRMNSHL------AEVPELPQNLKQL---HVETNPLR-EFPDI 414

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
                S+ED+ +              T+  +       ++  
Sbjct: 415 PE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 15/93 (16%), Positives = 28/93 (30%), Gaps = 11/93 (11%)

Query: 35  IPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIR 94
           I PR  +   L+     ++ L+ E+P+E     S  + Y   + +  + P      R + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 95  KLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFE 127
              L                    L L+     
Sbjct: 62  VSRLRDCLD----------RQAHELELNNLGLS 84

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 42/230 (18%)

Query: 238 LIGVGSFGSVYKGVFD--EDGTVVAIKVI-NLQR---QGASKSFMAECKALKNIRHK--- 288
            +G G+FG V +   D     + VA+K+I N+ +            E   LK I+ K   
Sbjct: 26  NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLKKIKEKDKE 79

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N    +      +F G+    I ++ +   +  ++L         +E   Q   L     
Sbjct: 80  NKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFL---------KENNFQPYPLPHVRH 127

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS-- 406
           +A  +  AL +LH++    + H DLKP NIL  N     + +   S   ++V N ++   
Sbjct: 128 MAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184

Query: 407 ---SSIGVRGTIGYV-------APEYGLGSEVSTNGDVYSYGILLLEMVT 446
              S+         +        PE  L    +   DV+S G +L E   
Sbjct: 185 DFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 32/139 (23%), Positives = 54/139 (38%), Gaps = 10/139 (7%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGL-SGEIP 60
           N +  ++    FS   LS+   L   E +        IG+LK L+  +V++N + S ++P
Sbjct: 86  NPIQ-SLALGAFS--GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 61  IELGLCSSLEDIYLGGNFFH----GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSL 116
                 ++LE + L  N         +    +       LDLS N ++   P   + + L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202

Query: 117 EYLNLSFNDFEGKVPTKGI 135
             L L  N     V    I
Sbjct: 203 HKLTLRNNFDSLNVMKTCI 221

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 23/131 (17%), Positives = 48/131 (36%), Gaps = 10/131 (7%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           DLS      +    F          L+L+             +L  L +  ++ N +   
Sbjct: 34  DLSFNPLRHLGSYSFF--SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 59  IPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNL-SGQIPLFLEAL-SL 116
                   SSL+ +                  + +++L+++ N + S ++P +   L +L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 117 EYLNLSFNDFE 127
           E+L+LS N  +
Sbjct: 152 EHLDLSSNKIQ 162

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 19/126 (15%), Positives = 44/126 (34%), Gaps = 2/126 (1%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            ++L      ++F        L+++  H   +       L +L    ++ N        +
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464

Query: 63  -LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLN 120
                 +L  + L         P+ F +   ++ L+++ N L        + L SL+ + 
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524

Query: 121 LSFNDF 126
           L  N +
Sbjct: 525 LHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 21/129 (16%), Positives = 43/129 (33%), Gaps = 10/129 (7%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           DLS            S    ++   L+L+ N  + ++      L+ L   D  ++ L   
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 59  IPIE-LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALS 115
                     +L  + +       +    F     +  L ++ N+        +F E  +
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471

Query: 116 LEYLNLSFN 124
           L +L+LS  
Sbjct: 472 LTFLDLSQC 480

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 1/103 (0%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
           +L+L+ N           +   L+  D+S   +           S L  + L GN     
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFN 124
               F     ++KL     NL+      +  L +L+ LN++ N
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN 134

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 30/126 (23%), Positives = 51/126 (40%), Gaps = 8/126 (6%)

Query: 15  FSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYL 74
           FS ++    L L    F G  P     LK+L+    ++N        E+ L  SLE + L
Sbjct: 300 FSYNFGWQHLELVNCKF-GQFPT--LKLKSLKRLTFTSNKGG-NAFSEVDL-PSLEFLDL 354

Query: 75  GGNFFH--GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT 132
             N     G        +  ++ LDLS N +      FL    LE+L+   ++ + ++  
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSE 413

Query: 133 KGIFAN 138
             +F +
Sbjct: 414 FSVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 26/107 (24%), Positives = 39/107 (36%), Gaps = 9/107 (8%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           D+S          IF+   LS+   L +A N F  +  P I   L+ L   D+S   L  
Sbjct: 427 DISHTHTRVAFNGIFN--GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484

Query: 58  EIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
             P      SSL+ + +  N         F     ++K+ L  N   
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 5/93 (5%)

Query: 34  SIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI 93
            IP  +    + ++ D+S N L             L+ + L            +++   +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 94  RKLDLSRNNLSGQIP--LFLEALSLEYLNLSFN 124
             L L+ N +   +    F    SL+ L     
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 18/127 (14%), Positives = 46/127 (36%), Gaps = 7/127 (5%)

Query: 16  SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLG 75
           +++     L    ++++  I      L  + SF + +  +   +  +       + + L 
Sbjct: 256 NLTIEEFRLAY-LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELV 312

Query: 76  GNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGI 135
              F        ++   +++L  + N         ++  SLE+L+LS N    K      
Sbjct: 313 NCKFGQFPTLKLKS---LKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 136 FANTSAI 142
              T+++
Sbjct: 369 DFGTTSL 375

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 8/86 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
           N         IF+   L N   L+L++      + P    +L +L+  ++++N L   +P
Sbjct: 455 NSFQENFLPDIFT--ELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMASNQLK-SVP 510

Query: 61  IE-LGLCSSLEDIYLGGNFFHGSIPS 85
                  +SL+ I+L  N +  S P 
Sbjct: 511 DGIFDRLTSLQKIWLHTNPWDCSCPR 536

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 47/244 (19%), Positives = 85/244 (34%), Gaps = 70/244 (28%)

Query: 238 LIGVGSFGSVYKGVFD--EDGTVVAIKVI-NLQR---QGASKSFMAECKALKNIRHK--- 288
            +G G+FG V +   D    G  VA+K++ N+ R           +E + L+++      
Sbjct: 21  TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEIQVLEHLNTTDPN 74

Query: 289 NLVRVITSCSSVDFQGN-------------DF-KAIVYKYMPNGSLEKWLHPDAIPQRDR 334
           +  R +      +  G+             DF K   +                      
Sbjct: 75  STFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFR------------------ 116

Query: 335 EIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS 394
                 L  ++++  A  +  ++++LH +    + H DLKP NIL          +  + 
Sbjct: 117 ------LDHIRKM--AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165

Query: 395 RFYQAVSNPTV------SSSIGVRGTIGYV------APEYGLGSEVSTNGDVYSYGILLL 442
           R  + + NP +      S++         V      APE  L    S   DV+S G +L+
Sbjct: 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILI 225

Query: 443 EMVT 446
           E   
Sbjct: 226 EYYL 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 32/161 (19%), Positives = 58/161 (36%), Gaps = 26/161 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSC 297
           +G+G  G V +          A+K++             E +      +  ++VR++   
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREI--EIQKLTLLQRISIAIDVAS 355
            +  + G     IV + +  G L        I  R  +   E +   +++ I        
Sbjct: 81  EN-LYAGRKCLLIVMECLDGGELF-----SRIQDRGDQAFTEREASEIMKSI------GE 128

Query: 356 ALDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGL 393
           A+ YLH      I H D+KP N+L      +    + DFG 
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 26/117 (22%), Positives = 47/117 (40%), Gaps = 9/117 (7%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
           +  ++ L+    L+++ N    S    +  L  L S   +NN +S   P  LG+ ++L++
Sbjct: 170 LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEG 128
           + L GN           +   +  LDL+ N +S  +        L  L L  N    
Sbjct: 226 LSLNGNQL--KDIGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISN 279

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 30/127 (23%), Positives = 50/127 (39%), Gaps = 11/127 (8%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L+G   + I +++ L+N   L+LA N      P  +  L  L    +  N +S   P  
Sbjct: 227 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-- 282

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNL 121
           L   ++L ++ L  N      P      + +  L L  NN+S   P  + +L  L+ L  
Sbjct: 283 LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 338

Query: 122 SFNDFEG 128
             N    
Sbjct: 339 YNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 28/118 (23%), Positives = 43/118 (36%), Gaps = 11/118 (9%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
           I  ++ L+   +L L EN      P  I NLK L    +  N +S   P  +   + L+ 
Sbjct: 280 ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEG 128
           ++   N    S  S       I  L    N +S   P  L  L  +  L L+   +  
Sbjct: 336 LFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 18/114 (15%), Positives = 40/114 (35%), Gaps = 11/114 (9%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
           IF+ + L+      L + +   ++     +L  + +      G+       +   ++L  
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQ 72

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFN 124
           I    N      P   +    +  + ++ N ++   P  L  L +L  L L  N
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNN 122

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 27/122 (22%), Positives = 38/122 (31%), Gaps = 9/122 (7%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L  T      S + L    +L              +  L  L   + SNN L+   P  
Sbjct: 30  VLGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP-- 85

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           L   + L DI +  N      P        +  L L  N ++  I       +L  L LS
Sbjct: 86  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELS 142

Query: 123 FN 124
            N
Sbjct: 143 SN 144

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 27/126 (21%), Positives = 49/126 (38%), Gaps = 10/126 (7%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            ++      I  ++ L+N   L L  N      P  + NL  L   ++S+N +S      
Sbjct: 96  LMNNNQIADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISA 151

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           L   +SL+ +  G      +          + +LD+S N +S  I +  +  +LE L  +
Sbjct: 152 LSGLTSLQQLSFGNQV---TDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIAT 207

Query: 123 FNDFEG 128
            N    
Sbjct: 208 NNQISD 213

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 17/123 (13%), Positives = 39/123 (31%), Gaps = 12/123 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N++S   P     +S L+    L    N    S    + NL  +      +N +S   P+
Sbjct: 319 NNISDISP-----VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTPL 371

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
                + +  + L    +  +  ++      I     +            +  S    ++
Sbjct: 372 --ANLTRITQLGLNDQAWTNAPVNYKANVS-IPNTVKNVTGALIAPATISDGGSYTEPDI 428

Query: 122 SFN 124
           ++N
Sbjct: 429 TWN 431

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 11/127 (8%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N ++  +   +     L+  L L  N+   +    + N   L   D+S N L  +I   
Sbjct: 214 HNSIN-VVRGPVNV--ELT-ILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYH 266

Query: 63  -LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLN 120
                  LE +Y+  N    ++  + +    ++ LDLS N+L   +         LE L 
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 324

Query: 121 LSFNDFE 127
           L  N   
Sbjct: 325 LDHNSIV 331

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 10/103 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N+L   I    F    +     L ++ N  V ++      +  L+  D+S+N L   +  
Sbjct: 258 NELE-KIMYHPFV--KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
                  LE++YL  N    ++     T   ++ L LS N+  
Sbjct: 313 NQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 28/124 (22%), Positives = 51/124 (41%), Gaps = 17/124 (13%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
           NDLS ++P  IF         +L+++ N+    I         +L++  +S+N L+    
Sbjct: 127 NDLS-SLPRGIFH--NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH--- 179

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
           ++L L  SL    +  N       S       + +LD S N+++  +   +    L  L 
Sbjct: 180 VDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILK 232

Query: 121 LSFN 124
           L  N
Sbjct: 233 LQHN 236

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 24/133 (18%), Positives = 44/133 (33%), Gaps = 8/133 (6%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE-LGLCS 67
            I   +       + +++               L   +     N+ +  ++P   L    
Sbjct: 12  CIDSNLQYDCVFYD-VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 69

Query: 68  SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFND 125
            +E + L            F  +  I+KL +  N +   +P  +F     L  L L  ND
Sbjct: 70  QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 128

Query: 126 FEGKVPTKGIFAN 138
               +P +GIF N
Sbjct: 129 LS-SLP-RGIFHN 139

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 27/127 (21%), Positives = 48/127 (37%), Gaps = 15/127 (11%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
             +   I    F+  Y      L +  N     +PP +  N+  L    +  N LS  +P
Sbjct: 79  LQIE-EIDTYAFA--YAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLP 133

Query: 61  IEL--GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLE 117
             +       L  + +  N         F+ +  ++ L LS N L+  +   L  + SL 
Sbjct: 134 RGIFHNT-PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLF 189

Query: 118 YLNLSFN 124
           + N+S+N
Sbjct: 190 HANVSYN 196

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 47/237 (19%), Positives = 85/237 (35%), Gaps = 52/237 (21%)

Query: 238 LIGVGSFGSVYKGVFD-EDGTVVAIKVI-NLQR---QGASKSFMAECKALKNIRH----- 287
            +G G+FG V       ++    A+KV+ N+++            E   LK I++     
Sbjct: 42  KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADILKKIQNDDINN 95

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N+V+         +  +    ++++ +   SL + +                  +    
Sbjct: 96  NNIVKYH---GKFMYYDHMC--LIFEPL-GPSLYEII---------TRNNYNGFHIEDIK 140

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
              I++  AL+YL +     + H DLKP NILLD+                       + 
Sbjct: 141 LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 408 SIGVR----G--------------TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
           S G++    G              T  Y APE  L      + D++S+G +L E+ T
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 15/137 (10%)

Query: 3   ENDLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIG-NLKALRSFDVSNNGL 55
              +           ++S   L     + +  +     +P     +LK+L   D+S N +
Sbjct: 290 RLHIPQFYLFYDLSTVYS--LLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLSENLM 346

Query: 56  SGEI---PIELGLCSSLEDIYLGGNFFH--GSIPSFFRTSRGIRKLDLSRNNLSGQIPLF 110
             E        G   SL+ + L  N             T + +  LD+SRN         
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSC 406

Query: 111 LEALSLEYLNLSFNDFE 127
                + +LNLS     
Sbjct: 407 QWPEKMRFLNLSSTGIR 423

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 30/143 (20%), Positives = 61/143 (42%), Gaps = 14/143 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N L  ++ +    +  L N  SL+++ N F   +P      + +R  ++S+ G+   +  
Sbjct: 371 NHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVK- 426

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
              +  +LE + +  N    ++ SF      +++L +SRN L   +P       L  + +
Sbjct: 427 -TCIPQTLEVLDVSNN----NLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMKI 480

Query: 122 SFNDFEGKVPTKGIFANTSAISV 144
           S N    K    GIF   +++  
Sbjct: 481 SRNQL--KSVPDGIFDRLTSLQK 501

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 26/127 (20%), Positives = 47/127 (37%), Gaps = 15/127 (11%)

Query: 5   DLSG----TIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           D+S      +P++      +   LNL+       +       + L   DVSNN L     
Sbjct: 393 DISRNTFHPMPDSCQWPEKMR-FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFS 447

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
           + L     L+++Y+  N       +       +  + +SRN L        + L SL+ +
Sbjct: 448 LFL---PRLQELYISRNKLKTLPDASLFPV--LLVMKISRNQLKSVPDGIFDRLTSLQKI 502

Query: 120 NLSFNDF 126
            L  N +
Sbjct: 503 WLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 32/120 (26%), Positives = 55/120 (45%), Gaps = 7/120 (5%)

Query: 21  SNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH 80
           S   +     F  SIP  +    A++S D+S N ++     +L  C++L+ + L  +  +
Sbjct: 7   SGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63

Query: 81  GSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPTKGIFAN 138
                 F +   +  LDLS N+LS  +    F    SL+YLNL  N ++  +    +F N
Sbjct: 64  TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 23/133 (17%), Positives = 41/133 (30%), Gaps = 4/133 (3%)

Query: 10  IPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSL 69
           + E  F    L+   +   +               +R   +    L  ++     L   +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312

Query: 70  EDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQI---PLFLEAL-SLEYLNLSFND 125
           + I +  +       SF +  + +  LDLS N +  +         A  SL+ L LS N 
Sbjct: 313 KRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNH 372

Query: 126 FEGKVPTKGIFAN 138
                 T  I   
Sbjct: 373 LRSMQKTGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 25/165 (15%), Positives = 45/165 (27%), Gaps = 7/165 (4%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPR-IGNLKALRSFDVSNNGLSGEIPI 61
            N        ++F       +L +        I       L +L   ++    L      
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
            L     +  + L  +     +  F      +R L+L   NL+         +      +
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR-FQFSPLPVDEVSSPM 225

Query: 122 SFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENK 166
               F G V T   F     +      R    + E++   CT N 
Sbjct: 226 KKLAFRGSVLTDESFNELLKL-----LRYILELSEVEFDDCTLNG 265

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 58.4 bits (142), Expect = 4e-10
 Identities = 25/122 (20%), Positives = 43/122 (35%), Gaps = 4/122 (3%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L+      +  I Y  N   L +   H   +  P I  L  L    +    ++ +    
Sbjct: 50  TLANINVTDLTGIEYAHNIKDLTINNIH-ATNYNP-ISGLSNLERLRIMGKDVTSDKIPN 107

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
           L   +SL  + +  +    SI +   T   +  +DLS N     I        L+ LN+ 
Sbjct: 108 LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQ 167

Query: 123 FN 124
           F+
Sbjct: 168 FD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 2e-08
 Identities = 21/123 (17%), Positives = 40/123 (32%), Gaps = 6/123 (4%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            ++         IS LSN   L +          P +  L +L   D+S++     I  +
Sbjct: 72  TINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNL 121
           +     +  I L  N     I    +T   ++ L++  + +       +E    L  L  
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188

Query: 122 SFN 124
              
Sbjct: 189 FSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 16/107 (14%), Positives = 34/107 (31%), Gaps = 21/107 (19%)

Query: 39  IGNLKALRSFDVSNNGLSGEIPIE--------------------LGLCSSLEDIYLGGNF 78
              + +L    ++N  ++    IE                    +   S+LE + + G  
Sbjct: 40  EAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNPISGLSNLERLRIMGKD 99

Query: 79  FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFN 124
                         +  LD+S +     I   +  L  +  ++LS+N
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 39.6 bits (93), Expect = 7e-04
 Identities = 16/74 (21%), Positives = 32/74 (43%), Gaps = 4/74 (5%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           +    +I   I ++  + NS++L+ N  +  I P +  L  L+S ++  +G+     IE 
Sbjct: 122 SAHDDSILTKINTLPKV-NSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE- 178

Query: 64  GLCSSLEDIYLGGN 77
                L  +Y    
Sbjct: 179 DF-PKLNQLYAFSQ 191

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 21/124 (16%), Positives = 43/124 (34%), Gaps = 4/124 (3%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N++       + + S     LNL  N     +  ++     L++ D+S+N L+  +  E 
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEF 210

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
              + +  I L  N     I    R S+ +   DL  N           + +     ++ 
Sbjct: 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK 269

Query: 124 NDFE 127
              +
Sbjct: 270 QTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.9 bits (145), Expect = 7e-10
 Identities = 22/115 (19%), Positives = 44/115 (38%), Gaps = 7/115 (6%)

Query: 10  IPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSL 69
           I E   + +       + ++    ++     +   ++  D+S N LS     +L   + L
Sbjct: 2   IHEIKQNGNRY-KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 70  EDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
           E + L  N  +         S  +R LDL+ N +   +       S+E L+ + N
Sbjct: 61  ELLNLSSNVLY-ETLDLESLST-LRTLDLNNNYVQELLVGP----SIETLHAANN 109

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 22/106 (20%), Positives = 38/106 (35%), Gaps = 3/106 (2%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG-EIPIELGLCSSLEDIYLGGNFFHG 81
           ++ LA N          G    ++  D+  N +             +LE + L  NF + 
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183

Query: 82  SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFE 127
                      ++ LDLS N L+   P F  A  + +++L  N   
Sbjct: 184 VKGQVVFAK--LKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 16/91 (17%), Positives = 34/91 (37%), Gaps = 1/91 (1%)

Query: 34  SIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI 93
           +I     N    +   V+++ L   +        +++++ L GN       +       +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 94  RKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
             L+LS N L  +        +L  L+L+ N
Sbjct: 61  ELLNLSSNVLY-ETLDLESLSTLRTLDLNNN 90

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 12/115 (10%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
              +  LS   +L+L  N+        +    ++ +   +NN +S    +        ++
Sbjct: 73  TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKN 124

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG-QIPLFLEAL-SLEYLNLSFN 124
           IYL  N               ++ LDL  N +          +  +LE+LNL +N
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 23/129 (17%), Positives = 43/129 (33%), Gaps = 11/129 (8%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           DL      T+  A    +       LNL  N     +  ++     L++ D+S+N L+  
Sbjct: 150 DLKLNEIDTVNFAEL-AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-F 205

Query: 59  IPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEY 118
           +  E    + +  I L  N     I    R S+ +   DL  N           + +   
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 119 LNLSFNDFE 127
             ++    +
Sbjct: 265 QTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 22/116 (18%), Positives = 44/116 (37%), Gaps = 9/116 (7%)

Query: 10  IPEAIFSISYLSNSLNLAENHFVGSIPPRIG-NLKALRSFDVSNNGLSGEIPIELGLCSS 68
           I E   + +       + ++         +  +   ++  D+S N LS     +L   + 
Sbjct: 2   IHEIKQNGNRY-KIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 69  LEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
           LE + L  N  +         S  +R LDL+ N +  ++       S+E L+ + N
Sbjct: 60  LELLNLSSNVLY-ETLDLESLST-LRTLDLNNNYVQ-ELL---VGPSIETLHAANN 109

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 24/121 (19%), Positives = 46/121 (38%), Gaps = 11/121 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N +   +   +      +   +L+L+ N     + P   +   +    + NN L   I  
Sbjct: 179 NFIY-DVKGQVV----FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK 231

Query: 62  ELGLCSSLEDIYLGGNFFH-GSIPSFFRTSRGIRKLDLSRN-NLSGQIPLFLEALSLEYL 119
            L    +LE   L GN FH G++  FF  ++ ++ +       L+GQ        +L + 
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291

Query: 120 N 120
            
Sbjct: 292 G 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 16/91 (17%), Positives = 34/91 (37%), Gaps = 1/91 (1%)

Query: 34  SIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI 93
           +I     N    +   V+++ L   +        +++++ L GN       +       +
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 94  RKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
             L+LS N L  +        +L  L+L+ N
Sbjct: 61  ELLNLSSNVLY-ETLDLESLSTLRTLDLNNN 90

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 56.2 bits (136), Expect = 6e-09
 Identities = 31/145 (21%), Positives = 51/145 (35%), Gaps = 30/145 (20%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           DLSG     I  A  +    +    LNL+ N         + +L  LR+ D++NN +  E
Sbjct: 40  DLSGNPLSQISAADLA--PFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-E 94

Query: 59  IP-----------------IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN 101
           +                  +        ++IYL  N               ++ LDL  N
Sbjct: 95  LLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154

Query: 102 NLSG-QIPLFLEAL-SLEYLNLSFN 124
            +          +  +LE+LNL +N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYN 179

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 11/124 (8%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            N ++  +   +     L+  L L  N+   +    + N   L   D+S N L  +I   
Sbjct: 220 HNSIN-VVRGPVNV--ELT-ILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYH 272

Query: 63  -LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLN 120
                  LE +Y+  N    ++  + +    ++ LDLS N+L   +         LE L 
Sbjct: 273 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLY 330

Query: 121 LSFN 124
           L  N
Sbjct: 331 LDHN 334

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 30/159 (18%), Positives = 61/159 (38%), Gaps = 10/159 (6%)

Query: 23  SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG 81
            ++L+ N     I       ++ L    +SNN L   + +      +L+ + L  N    
Sbjct: 258 EVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL- 314

Query: 82  SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTKGIFANTS 140
            +         +  L L  N++   + L      +L+ L LS ND++     + +F N +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHNDWDC-NSLRALFRNVA 370

Query: 141 AISVAGCHRLCGGIPELQLPKCTENKSSNQRISRSLKIL 179
             +V    + C    +L+   C +  S    + R L+ +
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKE-SDKPYLDRLLQYI 408

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.5 bits (136), Expect = 9e-09
 Identities = 29/139 (20%), Positives = 54/139 (38%), Gaps = 19/139 (13%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N+L   I +  F     ++  +L L+ N     +      + +L   +VS N LS     
Sbjct: 157 NNLE-RIEDDTFQ--ATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS----- 205

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
            L +  ++E++    N  +  +      +  +  L L  NNL+      L    L  ++L
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDL 261

Query: 122 SFNDFEGKVPTKGIFANTS 140
           S+N+ E K+     F    
Sbjct: 262 SYNELE-KIM-YHPFVKMQ 278

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 28/130 (21%), Positives = 50/130 (38%), Gaps = 18/130 (13%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           +L+      I    F+  Y      L +  N     +PP +  N+  L    +  N LS 
Sbjct: 81  NLNDLQIEEIDTYAFA--YAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 58  EIPIEL--GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL- 114
            +P  +       L  + +  N         F+ +  ++ L LS N L+  +   L  + 
Sbjct: 137 SLPRGIFHNT-PKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 192

Query: 115 SLEYLNLSFN 124
           SL + N+S+N
Sbjct: 193 SLFHANVSYN 202

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 8/109 (7%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L   +      I  L   L+L+ NH +  +         L +  + +N +     ++L
Sbjct: 288 NRLV-ALNLYGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKL 341

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLE 112
               +L+++ L  N +  +  S     R + +  +   +   +I   LE
Sbjct: 342 STHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDADQHCKIDYQLE 388

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 25/138 (18%), Positives = 46/138 (33%), Gaps = 14/138 (10%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
                TI +  F    L N   L+L  +     + P     L  L    +   GLS  + 
Sbjct: 58  QYTPLTIDKEAFR--NLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVL 114

Query: 61  IELGLC--SSLEDIYLGGNFFHG-SIPSFFRTSRGIRKLDLSRNNLSGQIP----LFLEA 113
            +       +L  + L  N      +   F     ++ +D S N +   +       L+ 
Sbjct: 115 KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQG 173

Query: 114 LSLEYLNLSFNDFEGKVP 131
            +L + +L+ N    +V 
Sbjct: 174 KTLSFFSLAANSLYSRVS 191

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 25/140 (17%), Positives = 52/140 (37%), Gaps = 12/140 (8%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIE 62
            +L+  +P+ + +   L     L+ N+   ++       L+ L+  ++ +      I  E
Sbjct: 14  CNLT-QVPQVLNTTERL----LLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKE 67

Query: 63  -LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQI--PLFLEAL-SLEY 118
                 +L  + LG +  +   P  F+    + +L L    LS  +    +   L +L  
Sbjct: 68  AFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127

Query: 119 LNLSFNDFEGKVPTKGIFAN 138
           L+LS N     +     F  
Sbjct: 128 LDLSKNQIR-SLYLHPSFGK 146

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 34/173 (19%), Positives = 57/173 (32%), Gaps = 22/173 (12%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPR--IGNLKALRSFDVSNNGLS 56
           DL       +    F    L +   L L       ++       NLKAL   D+S N + 
Sbjct: 79  DLGSSKIYFLHPDAFQ--GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136

Query: 57  G-EIPIELGLCSSLEDIYLGGNFFHGSIPSFFR--TSRGIRKLDLSRNNLSGQIPLF--- 110
              +    G  +SL+ I    N               + +    L+ N+L  ++ +    
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196

Query: 111 ----LEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQL 159
                  + LE L++S N +   +   G F+N  + S A    L   I     
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDIT--GNFSNAISKSQAFSLILAHHIMGAGF 247

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 35/159 (22%), Positives = 57/159 (35%), Gaps = 16/159 (10%)

Query: 5   DLSGTIPEAIFSISYLSN-----SLNLAENHFVGSIPPR--IGNLKALRSFDVSNNGLSG 57
            LS    E +  + +L        L L +N F  S           +L    +  N L  
Sbjct: 407 HLSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 58  EIPIELGL-----CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLE 112
               EL        S L+ +YL  N+ +   P  F     +R L L+ N L+  +     
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL 524

Query: 113 ALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC 151
             +LE L++S N      P   +F + S + +     +C
Sbjct: 525 PANLEILDISRNQL--LAPNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 24/112 (21%), Positives = 38/112 (33%), Gaps = 7/112 (6%)

Query: 34  SIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSI-PSFFRTSRG 92
            +P  +   + L    +S N +             L+ + LG  +   +I    FR    
Sbjct: 18  QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 93  IRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAI 142
           +R LDL  + +   +    F     L  L L F      V   G F N  A+
Sbjct: 75  LRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 39/177 (22%), Positives = 59/177 (33%), Gaps = 15/177 (8%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           DLS     ++   +F    L +   LNLA N     I       L  L+  ++S N L  
Sbjct: 272 DLSHGFVFSLNSRVFE--TLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGE 328

Query: 58  EIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLE 117
                      +  I L  N         F+    ++ LDL  N L+  I       S+ 
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFI---PSIP 384

Query: 118 YLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENKSSNQRISR 174
            + LS N     +P   + AN   +S      L      L++P       +  R S 
Sbjct: 385 DIFLSGNKLV-TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS 440

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 20/129 (15%), Positives = 42/129 (32%), Gaps = 4/129 (3%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLK--ALRSFDVSNNGLSGE 58
            F N +S +   ++    ++        ++           L   ++R  D+S+  +   
Sbjct: 223 NFSNAISKSQAFSLILAHHIM-GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSL 281

Query: 59  IPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLE 117
                     L+ + L  N  +      F     ++ L+LS N L          L  + 
Sbjct: 282 NSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVA 341

Query: 118 YLNLSFNDF 126
           Y++L  N  
Sbjct: 342 YIDLQKNHI 350

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 6/78 (7%)

Query: 49  DVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP 108
                 L+ ++P  L   ++ E + L  N+      S F     ++ L+L        I 
Sbjct: 10  FYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 109 --LFLEALSLEYLNLSFN 124
              F    +L  L+L  +
Sbjct: 66  KEAFRNLPNLRILDLGSS 83

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 12/131 (9%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
                      IF+   LS+   L +A N F  +  P I   L+ L   D+S   L  ++
Sbjct: 135 HTHTR-VAFNGIFN--GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QL 190

Query: 60  PIEL--GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL--S 115
                  L SSL+ + +  N F       ++    ++ LD S N++       L+    S
Sbjct: 191 SPTAFNSL-SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSS 249

Query: 116 LEYLNLSFNDF 126
           L +LNL+ NDF
Sbjct: 250 LAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 23/131 (17%), Positives = 48/131 (36%), Gaps = 11/131 (8%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N LS        S    ++   L+L+ N  + ++      L+ L   D  ++ L  ++  
Sbjct: 62  NGLS-FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS- 117

Query: 62  ELGL---CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSL 116
           E  +     +L  + +       +    F     +  L ++ N+        +F E  +L
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177

Query: 117 EYLNLSFNDFE 127
            +L+LS    E
Sbjct: 178 TFLDLSQCQLE 188

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 20/120 (16%), Positives = 41/120 (34%), Gaps = 6/120 (5%)

Query: 21  SNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF- 79
              +         S+P  I    +    ++ +N L           + L  + L  N   
Sbjct: 9   GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS 65

Query: 80  HGSIPSF-FRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFAN 138
                S     +  ++ LDLS N +      FL    LE+L+   ++ + ++    +F +
Sbjct: 66  FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 124

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 20/124 (16%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N+L+ ++P     +     +L ++ N    S+P     L  L  F      L        
Sbjct: 71  NNLT-SLPALPPELR----TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALP---- 120

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSF 123
              S L  +++ GN    S+P       G+++L +S N L+  +P       L  L    
Sbjct: 121 ---SGLCKLWIFGNQLT-SLPVLP---PGLQELSVSDNQLA-SLPALPS--ELCKLWAYN 170

Query: 124 NDFE 127
           N   
Sbjct: 171 NQLT 174

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 28/124 (22%), Positives = 54/124 (43%), Gaps = 20/124 (16%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
            + N L+ ++P     +      L++++N    S+P     L  L      NN L+  +P
Sbjct: 168 AYNNQLT-SLPMLPSGL----QELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLP 217

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
               L S L+++ + GN    S+P        +++L +S N L+  +P+      L  L+
Sbjct: 218 ---ALPSGLKELIVSGNRL-TSLPVLP---SELKELMVSGNRLT-SLPMLPS--GLLSLS 267

Query: 121 LSFN 124
           +  N
Sbjct: 268 VYRN 271

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 14/116 (12%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L+ ++P     +      L ++ N    S+P     LK L    VS N L+  +P+  
Sbjct: 211 NRLT-SLPALPSGLK----ELIVSGNRL-TSLPVLPSELKEL---MVSGNRLT-SLPMLP 260

Query: 64  GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYL 119
                L  + +  N     +P           ++L  N LS +    L  ++    
Sbjct: 261 S---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPG 312

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 24/180 (13%), Positives = 63/180 (35%), Gaps = 39/180 (21%)

Query: 239 IGVGSFGSVYKGVFDEDGTV--------VAIKV----------INLQRQGASKSFMAECK 280
               + G +Y+       T          ++K+           N  ++ A    + + K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 281 ALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQ 339
            L +     +   +          + ++ +V   +  G SL+      A+    + +  +
Sbjct: 110 KLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL--GRSLQ-----SALDVSPKHVLSE 158

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL--DNDLSAHIGDFGLSRFY 397
           +  L     +A  +  AL++LH++     +H ++   NI +  ++     +  +G +  Y
Sbjct: 159 RSVLQ----VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 29/166 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRH-KNLVRVITSC 297
           IG G+FG +  G        VAIK+     +  +     E +  K +     + +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 298 SSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                    + A+V + +  G SLE     D     DR       +L   + IAI + S 
Sbjct: 75  -----PCGKYNAMVLELL--GPSLE-----DLFDLCDR-----TFSLKTVLMIAIQLISR 117

Query: 357 LDYLHQHCQEPILHCDLKPSNILL-----DNDLSAHIGDFGLSRFY 397
           ++Y+H      +++ D+KP N L+           HI DF L++ Y
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 4e-09
 Identities = 32/180 (17%), Positives = 64/180 (35%), Gaps = 37/180 (20%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIK---VINLQRQGASKSFMAECKALKNIRHKNLVRVI 294
            IG G FG +Y          V      V+ ++       F  E K  +       ++  
Sbjct: 42  PIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFT-ELKFYQRAAKPEQIQKW 99

Query: 295 TSCSSVDFQG---------NDFKAIVYKYM------PNGSLEKWLHPDAIPQRDREIEIQ 339
                + + G         +D     Y++M          L+            +     
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQ-----KIYEANAK----- 147

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD--NDLSAHIGDFGLSRFY 397
           + +    + +++ +   L+Y+H+H     +H D+K SN+LL+  N    ++ D+GL+  Y
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 52/274 (18%), Positives = 81/274 (29%), Gaps = 96/274 (35%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-----HKNLVRV 293
           +G G F +V+     +    VA+KV+         + + E + LK++R       N   V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNG------------SLEKWLHPDAIPQRDREIEIQKL 341
           +         G            NG             L KW+       +   +   K 
Sbjct: 104 VQLLDDFKISG-----------VNGTHICMVFEVLGHHLLKWII--KSNYQGLPLPCVKK 150

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL--------------------- 380
            + Q       V   LDYLH  C+  I+H D+KP NILL                     
Sbjct: 151 IIQQ-------VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 381 ----------------------------DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
                                          L   I D G + +        +       
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ------ 255

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            T  Y + E  +GS  +T  D++S   +  E+ T
Sbjct: 256 -TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 42/164 (25%), Positives = 66/164 (40%), Gaps = 27/164 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV-RVITSC 297
           IG GSFG +Y G     G  VAIK+     +        E K  K ++    +  +    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 298 SSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                   D+  +V + +  G SLE     D      R     K +L   + +A  + S 
Sbjct: 75  -----AEGDYNVMVMELL--GPSLE-----DLFNFCSR-----KFSLKTVLLLADQMISR 117

Query: 357 LDYLHQHCQEPILHCDLKPSNILL---DNDLSAHIGDFGLSRFY 397
           ++Y+H       +H D+KP N L+         +I DFGL++ Y
Sbjct: 118 IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 24/126 (19%), Positives = 42/126 (33%), Gaps = 10/126 (7%)

Query: 2   FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           F N +SGT  +   +           EN        +   +       ++   LS  +P 
Sbjct: 18  FYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPD 76

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
            L     +  + +  N    S+P        +  LD   N LS  +P      SL++L++
Sbjct: 77  NLP--PQITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-TLPELPA--SLKHLDV 127

Query: 122 SFNDFE 127
             N   
Sbjct: 128 DNNQLT 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 24/123 (19%), Positives = 46/123 (37%), Gaps = 21/123 (17%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
           N+    + E +     ++    L L   +   S+P  +     +   +++ N L   +P 
Sbjct: 47  NEAVSLLKECL-----INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPE 97

Query: 62  ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNL 121
                 SLE +    N    ++P        ++ LD+  N L+  +P       LEY+N 
Sbjct: 98  LPA---SLEYLDACDNRLS-TLPELPA---SLKHLDVDNNQLT-MLPELPA--LLEYINA 147

Query: 122 SFN 124
             N
Sbjct: 148 DNN 150

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 27/125 (21%), Positives = 42/125 (33%), Gaps = 15/125 (12%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N L+  +PE     + L   L++  N     +P    +L+AL   DVS N L   +P   
Sbjct: 150 NQLT-MLPE---LPTSLE-VLSVRNNQL-TFLPELPESLEAL---DVSTNLLE-SLPAVP 199

Query: 64  GLCSSLED----IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYL 119
                 E+         N     IP    +      + L  N LS +I   L   + +  
Sbjct: 200 VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD 258

Query: 120 NLSFN 124
                
Sbjct: 259 YHGPR 263

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 19/115 (16%), Positives = 33/115 (28%), Gaps = 7/115 (6%)

Query: 3   ENDLSGTIPEAIFSISYLSNS---LNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEI 59
            N L  ++P       +   +       EN     IP  I +L    +  + +N LS  I
Sbjct: 189 TNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL 114
              L   ++  D +    +F  S        R     D             +  +
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQNTLHR--PLADAVTAWFPENKQSDVSQI 299

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 29/166 (17%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV-RVITSC 297
           IG GSFG +++G    +   VAIK     R+  +     E +  K +     +  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 298 SSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                Q      +V   +  G SLE     D +    R     K ++      A  + + 
Sbjct: 76  -----QEGLHNVLVIDLL--GPSLE-----DLLDLCGR-----KFSVKTVAMAAKQMLAR 118

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSA-----HIGDFGLSRFY 397
           +  +H+     +++ D+KP N L+    S      ++ DFG+ +FY
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 12/133 (9%)

Query: 1   MFENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           + +NDL   I    FS   L++   L L + +   SIP     +L  L    + +  ++ 
Sbjct: 135 VGDNDLV-YISHRAFS--GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN- 189

Query: 58  EIPIE-LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEAL 114
            I          L+ + +    +  ++         +  L ++  NL+  +P       +
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248

Query: 115 SLEYLNLSFNDFE 127
            L +LNLS+N   
Sbjct: 249 YLRFLNLSYNPIS 261

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 34/132 (25%), Positives = 56/132 (42%), Gaps = 19/132 (14%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           DL      T+ +  F+     +   L L EN  V ++ P    NL  LR+  + +N L  
Sbjct: 38  DLGKNRIKTLNQDEFA--SFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRSNRLK- 93

Query: 58  EIPIEL--GLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQIP--LFLE 112
            IP+ +  GL S+L  + +  N     +  + F+    ++ L++  N+L   I    F  
Sbjct: 94  LIPLGVFTGL-SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSG 150

Query: 113 ALSLEYLNLSFN 124
             SLE L L   
Sbjct: 151 LNSLEQLTLEKC 162

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 53.6 bits (129), Expect = 8e-08
 Identities = 25/122 (20%), Positives = 49/122 (40%), Gaps = 14/122 (11%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL--GL 65
            +PE I +    +  L+L +N    ++      +   L   +++ N +S  +       L
Sbjct: 25  AVPEGIPT---ETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNL 79

Query: 66  CSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLS 122
             +L  + L  N     IP   F     + KLD+S N +   +   +F +  +L+ L + 
Sbjct: 80  -FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVG 136

Query: 123 FN 124
            N
Sbjct: 137 DN 138

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 30/130 (23%), Positives = 54/130 (41%), Gaps = 12/130 (9%)

Query: 3   ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPR-IGNLKALRSFDVSNNGLSGEIPI 61
                 T+         L+ SL++   +   ++P   + +L  LR  ++S N +S  I  
Sbjct: 209 HWPYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEG 265

Query: 62  EL--GLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQIP--LFLEALSL 116
            +   L   L++I L G      +  + FR    +R L++S N L+  +   +F    +L
Sbjct: 266 SMLHEL-LRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNL 322

Query: 117 EYLNLSFNDF 126
           E L L  N  
Sbjct: 323 ETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 20/98 (20%), Positives = 36/98 (36%), Gaps = 8/98 (8%)

Query: 46  RSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG 105
           R+           +P   G+ +    + LG N         F +   + +L+L+ N +S 
Sbjct: 14  RAVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS- 69

Query: 106 QIP--LFLEALSLEYLNLSFNDFEGKVPTKGIFANTSA 141
            +    F    +L  L L  N  +  +P  G+F   S 
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLK-LIP-LGVFTGLSN 105

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 27/164 (16%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLV-RVITSC 297
           IG GSFG +Y G   +    VAIK+ N   +      + E K  + ++    +  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLEN--VKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 298 SSVDFQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                   D+  +V   +  G SLE                 +KL+L   + +A  + + 
Sbjct: 73  -----VEGDYNVLVMDLL--GPSLEDL----------FNFCSRKLSLKTVLMLADQMINR 115

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAH---IGDFGLSRFY 397
           ++++H       LH D+KP N L+     A+   I DFGL++ Y
Sbjct: 116 VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 16/142 (11%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
            ND+S  + +  F    L +  +L L  N     I  +    L+ L+   +S N L  EI
Sbjct: 63  NNDIS-ELRKDDFK--GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EI 117

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQI--PLFLEALSL 116
           P    L SSL ++ +  N     +P   F   R +  +++  N L      P   + L L
Sbjct: 118 P--PNLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKL 174

Query: 117 EYLNLSFNDFEGKVPTKGIFAN 138
            YL +S       +P K +   
Sbjct: 175 NYLRISEAKLT-GIP-KDLPET 194

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 25/155 (16%), Positives = 52/155 (33%), Gaps = 20/155 (12%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
           + E  L+  IP+ +     L N L+L  N    +I          L    + +N +    
Sbjct: 179 ISEAKLT-GIPKDLPE--TL-NELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM-- 231

Query: 60  PIELGL---CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS-------GQIPL 109
            IE G      +L +++L  N     +P+     + ++ + L  NN++         +  
Sbjct: 232 -IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289

Query: 110 FLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISV 144
            ++      ++L  N           F   +    
Sbjct: 290 GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 37/141 (26%), Positives = 56/141 (39%), Gaps = 13/141 (9%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
            N +  TI    F+   L+N  +L L +N  + +IP      L  L+   + NN +   I
Sbjct: 97  RNHIR-TIEIGAFN--GLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE-SI 151

Query: 60  PIEL-GLCSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSGQIPLFLEALSLE 117
           P        SL  + LG       I    F     +R L+L+  NL  +IP     + L+
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLD 210

Query: 118 YLNLSFNDFEGKVPTKGIFAN 138
            L+LS N     +   G F  
Sbjct: 211 ELDLSGNHLS-AIR-PGSFQG 229

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 32/122 (26%), Positives = 50/122 (40%), Gaps = 14/122 (11%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL--GL 65
            +P+ I +    +  LNL EN     I      +L+ L    +S N +   I I    GL
Sbjct: 57  EVPDGIST---NTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGL 111

Query: 66  CSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLS 122
            ++L  + L  N    +IP+  F     +++L L  N +   IP   F    SL  L+L 
Sbjct: 112 -ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168

Query: 123 FN 124
             
Sbjct: 169 EL 170

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 37/127 (29%), Positives = 56/127 (44%), Gaps = 14/127 (11%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
             LS  I E  F    LSN   LNLA  +    IP  +  L  L   D+S N LS  I  
Sbjct: 171 KRLS-YISEGAFE--GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRP 224

Query: 62  EL--GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLE 117
               GL   L+ +++  +       + F   + + +++L+ NNL+  +P  LF     LE
Sbjct: 225 GSFQGL-MHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLE 282

Query: 118 YLNLSFN 124
            ++L  N
Sbjct: 283 RIHLHHN 289

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 4e-07
 Identities = 59/381 (15%), Positives = 111/381 (29%), Gaps = 145/381 (38%)

Query: 107 IPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCTENK 166
           + +F +A      N    D +     K I +                I  +         
Sbjct: 22  LSVFEDAFVD---NFDCKDVQDM--PKSILSKEE----------IDHI--IMSK------ 58

Query: 167 SSNQRISRSLKILI-------SIVSIFLGIVMVSFFIFSWHKRSRPSRQPSEPM------ 213
                +S +L++          +V  F+  V+   + F         RQPS         
Sbjct: 59  ---DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQ 115

Query: 214 ------------------------IRKALLKMSYKSLLKATDGFSSTNLI--GVGSFGSV 247
                                   +R+ALL++             + N++  GV   G  
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR-----------PAKNVLIDGVLGSG-- 162

Query: 248 YKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV----ITSCSSVDFQ 303
            K       T VA+ V               C + K ++ K   ++    + +C+S +  
Sbjct: 163 -K-------TWVALDV---------------CLSYK-VQCKMDFKIFWLNLKNCNSPETV 198

Query: 304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQ----RISIAI--DVASA- 356
               + ++Y+  PN +  +  H   I  R   I+ +   LL+       + +  +V +A 
Sbjct: 199 LEMLQKLLYQIDPNWT-SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK 257

Query: 357 -LDYLHQHCQEPIL------------------HCDLKPSNILLDNDLS-------AHIGD 390
             +  +  C+  IL                  H  L   ++ L  D              
Sbjct: 258 AWNAFNLSCK--ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP 315

Query: 391 FGLSRFYQAVS-NPTVSSSIG 410
             L R  + ++ NP   S I 
Sbjct: 316 QDLPR--EVLTTNPRRLSIIA 334

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 25/135 (18%), Positives = 50/135 (37%), Gaps = 20/135 (14%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
           + + +++ TIP+ +     L+  L+L  N     +       L  L    +S N +S   
Sbjct: 178 IADTNIT-TIPQGLPP--SLT-ELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISA-- 230

Query: 60  PIELGL---CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS-------GQIPL 109
            ++ G       L +++L  N     +P      + I+ + L  NN+S            
Sbjct: 231 -VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 288

Query: 110 FLEALSLEYLNLSFN 124
             +  S   ++L  N
Sbjct: 289 NTKKASYSGVSLFSN 303

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 19/134 (14%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
           N ++  +  A      L+N   L L+ N  + ++      N   LR   ++NN L  ++P
Sbjct: 202 NKIT-KVDAASLK--GLNNLAKLGLSFNS-ISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPS-------FFRTSRGIRKLDLSRNNLS-GQIP--LF 110
             L     ++ +YL  N    +I S       +         + L  N +   +I    F
Sbjct: 257 GGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 315

Query: 111 LEALSLEYLNLSFN 124
                   + L   
Sbjct: 316 RCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 27/135 (20%), Positives = 52/135 (38%), Gaps = 15/135 (11%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL--GL 65
            +P+ +      +  L+L  N     I      NLK L +  + NN +S +I       L
Sbjct: 45  KVPKDLPP---DTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPL 99

Query: 66  CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSF 123
              LE +YL  N     +P   +  + +++L +  N ++ ++   +F     +  + L  
Sbjct: 100 -VKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGT 154

Query: 124 NDFEGKVPTKGIFAN 138
           N  +      G F  
Sbjct: 155 NPLKSSGIENGAFQG 169

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 34/152 (22%), Positives = 52/152 (34%), Gaps = 39/152 (25%)

Query: 5   DLSG----TIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           DL       I +  F    L N  +L L  N     I P     L  L    +S N L  
Sbjct: 58  DLQNNKITEIKDGDFK--NLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK- 113

Query: 58  EIPIEL-----------------------GLCSSLEDIYLGGNFFHGSI--PSFFRTSRG 92
           E+P ++                       GL + +  + LG N    S      F+  + 
Sbjct: 114 ELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGMKK 172

Query: 93  IRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
           +  + ++  N++  IP  L   SL  L+L  N
Sbjct: 173 LSYIRIADTNIT-TIPQGLPP-SLTELHLDGN 202

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 22/82 (26%), Positives = 33/82 (40%), Gaps = 6/82 (7%)

Query: 45  LRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS 104
           LR    S+ GL  ++P +L        + L  N         F+  + +  L L  N +S
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 105 GQIP--LFLEALSLEYLNLSFN 124
            +I    F   + LE L LS N
Sbjct: 90  -KISPGAFAPLVKLERLYLSKN 110

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 32/130 (24%), Positives = 49/130 (37%), Gaps = 11/130 (8%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
            N +   I    F+   L++  +L L +N  +  IP      L  LR   + NN +   I
Sbjct: 108 RNSIR-QIEVGAFN--GLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE-SI 162

Query: 60  PIE-LGLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQIPLFLEALSLE 117
           P        SL  + LG       I    F     ++ L+L   N+   +P     + LE
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLE 221

Query: 118 YLNLSFNDFE 127
            L +S N F 
Sbjct: 222 ELEMSGNHFP 231

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 34/120 (28%), Positives = 50/120 (41%), Gaps = 14/120 (11%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL--GL 65
            +P+ I S    +  LNL EN+    I      +L  L    +  N +  +I +    GL
Sbjct: 68  EVPQGIPS---NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGL 122

Query: 66  CSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLS 122
            +SL  + L  N+    IPS  F     +R+L L  N +   IP   F    SL  L+L 
Sbjct: 123 -ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLG 179

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 36/128 (28%), Positives = 51/128 (39%), Gaps = 16/128 (12%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI 61
             L   I E  F    L N   LNL   +      P +  L  L   ++S N    EI  
Sbjct: 182 KKLE-YISEGAFE--GLFNLKYLNLGMCNI--KDMPNLTPLVGLEELEMSGNHFP-EIRP 235

Query: 62  EL--GLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQIP--LFLEALSL 116
               GL SSL+ +++  +     I    F     + +L+L+ NNLS  +P  LF     L
Sbjct: 236 GSFHGL-SSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYL 292

Query: 117 EYLNLSFN 124
             L+L  N
Sbjct: 293 VELHLHHN 300

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 19/111 (17%), Positives = 41/111 (36%), Gaps = 12/111 (10%)

Query: 16  SISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIY 73
           S   L+   SL+   +     +   I  L  L     ++N ++    ++L   ++L  + 
Sbjct: 37  SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT---LDLSQNTNLTYLA 91

Query: 74  LGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
              N    ++         +  L+   N L+ ++    +   L YLN + N
Sbjct: 92  CDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD-VSQNPLLTYLNCARN 137

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 9/109 (8%), Positives = 30/109 (27%), Gaps = 7/109 (6%)

Query: 16  SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLG 75
            +++ +  +              + +   L   D    G++    ++L     L  +YL 
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLN 326

Query: 76  GNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
                  +      +  ++ L     ++        +  +L     +  
Sbjct: 327 NTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 18/110 (16%), Positives = 36/110 (32%), Gaps = 8/110 (7%)

Query: 15  FSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYL 74
             +S+ +    L  +         +     L + D S N ++    +++     L  +  
Sbjct: 142 IDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNC 198

Query: 75  GGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
             N     +      +  +  LD S N L+ +I        L Y + S N
Sbjct: 199 DTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID-VTPLTQLTYFDCSVN 243

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 15/111 (13%), Positives = 30/111 (27%), Gaps = 12/111 (10%)

Query: 16  SISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIY 73
            ++       L+ + N     I   +  L  L  FD S N L+    +++   S L  ++
Sbjct: 207 DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLH 260

Query: 74  LGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
                    I      +  +            +         L  L+    
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRKI-KELDVTHNTQLYLLDCQAA 307

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 32/130 (24%), Positives = 50/130 (38%), Gaps = 16/130 (12%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
              L   +   +F    L+    L L +N    ++P     +L  L    +  N +S  +
Sbjct: 114 RCGLQ-ELGPGLFR--GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SV 168

Query: 60  PIEL--GLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQIP--LFLEAL 114
           P     GL  SL+ + L  N     +    FR    +  L L  NNLS  +P        
Sbjct: 169 PERAFRGL-HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLR 225

Query: 115 SLEYLNLSFN 124
           +L+YL L+ N
Sbjct: 226 ALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 29/122 (23%), Positives = 45/122 (36%), Gaps = 13/122 (10%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL--GL 65
            +P  I +    S  + L  N     +P       + L    + +N L+  I      GL
Sbjct: 25  AVPVGIPA---ASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGL 79

Query: 66  CSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLS 122
            + LE + L  N    S+    F     +  L L R  L  ++   LF    +L+YL L 
Sbjct: 80  -ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQ 137

Query: 123 FN 124
            N
Sbjct: 138 DN 139

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 31/122 (25%), Positives = 54/122 (44%), Gaps = 13/122 (10%)

Query: 23  SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL--GLCSSLEDIYLGGNFF 79
           + +L+++    ++   +  +   L    ++ N ++ +I      GL + L  + L  NF 
Sbjct: 279 TCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL-THLLKLNLSQNFL 335

Query: 80  HGSIPSF-FRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPTKGIF 136
            GSI S  F     +  LDLS N++   +    FL   +L+ L L  N  +  VP  GIF
Sbjct: 336 -GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVP-DGIF 391

Query: 137 AN 138
             
Sbjct: 392 DR 393

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 31/132 (23%), Positives = 42/132 (31%), Gaps = 16/132 (12%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGL-SGEI 59
                 I    F    LS+   L L  N F+  +       L  L    ++   L    +
Sbjct: 64  QTPGLVIRNNTFR--GLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVL 120

Query: 60  PIEL--GLCSSLEDIYLGGNFFHGSIP-SFFRTSRGIRKLDLSRNNLSGQIP----LFLE 112
                  L +SLE + L  N      P SFF   R    LDL+ N +   I     L  +
Sbjct: 121 SGNFFKPL-TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQ 178

Query: 113 ALSLEYLNLSFN 124
                 L LS  
Sbjct: 179 GKHFTLLRLSSI 190

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 21/110 (19%), Positives = 38/110 (34%), Gaps = 10/110 (9%)

Query: 32  VGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPS-FFRTS 90
           V  +P  +  +      D+S N ++            L+ + +        I +  FR  
Sbjct: 25  VPELPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL 78

Query: 91  RGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPTKGIFAN 138
             +  L L  N    Q+    F    +LE L L+  + +G V +   F  
Sbjct: 79  SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 22/130 (16%), Positives = 41/130 (31%), Gaps = 12/130 (9%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
            +     +    F    LS    + +     +  I P     L  L+   + N GL    
Sbjct: 64  IDVTLQQLESHSFY--NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120

Query: 60  P--IELGLCSSLEDIYLGGNFFHGSIP--SFFRTSRGIRKLDLSRNNLSGQIPLF-LEAL 114
           P   ++        + +  N +  SIP  +F         L L  N  +  +  +     
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT 179

Query: 115 SLEYLNLSFN 124
            L+ + L+ N
Sbjct: 180 KLDAVYLNKN 189

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.8 bits (113), Expect = 4e-06
 Identities = 19/104 (18%), Positives = 39/104 (37%), Gaps = 8/104 (7%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
            L+      +  +  L     L+L+ N    ++PP +  L+ L     S+N L   +   
Sbjct: 447 HLAHKDLTVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-G 503

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSF--FRTSRGIRKLDLSRNNLS 104
           +     L+++ L  N       +     +   +  L+L  N+L 
Sbjct: 504 VANLPRLQELLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.3 bits (109), Expect = 1e-05
 Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 4/97 (4%)

Query: 28  ENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFF 87
            + F+            +R   +++  L+  +   L     +  + L  N    ++P   
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPAL 482

Query: 88  RTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
              R +  L  S N L   +        L+ L L  N
Sbjct: 483 AALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNN 518

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 22/113 (19%), Positives = 48/113 (42%), Gaps = 10/113 (8%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
           +F    L+N    NL +   V  +      L  +++F+  N+ +   +   +   ++L++
Sbjct: 12  VFPDPGLANAVKQNLGKQS-VTDLVS-QKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKE 67

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
           ++L  N    S  S  +    + +L ++RN L   +   + +  L  L L  N
Sbjct: 68  LHLSHN--QISDLSPLKDLTKLEELSVNRNRLK-NLN-GIPSACLSRLFLDNN 116

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 22/122 (18%), Positives = 46/122 (37%), Gaps = 10/122 (8%)

Query: 5   DLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE 62
           +   +  +++  + + +N   L+L+ N  +  + P + +L  L    V+ N L     + 
Sbjct: 47  NGDNSNIQSLAGMQFFTNLKELHLSHNQ-ISDLSP-LKDLTKLEELSVNRNRLKN---LN 101

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
               + L  ++L  N             + +  L +  N L   I +      LE L+L 
Sbjct: 102 GIPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLH 158

Query: 123 FN 124
            N
Sbjct: 159 GN 160

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 14/128 (10%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIG---NLKALRSFDVSNNGLSGEIP 60
           N L+ T+ E    ++ L  +L L  N     +         +K+L+  D+S N +S +  
Sbjct: 334 NLLTDTVFENCGHLTEL-ETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391

Query: 61  IELGLCS---SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SL 116
              G CS   SL  + +  N    +I  F      I+ LDL  N +   IP  +  L +L
Sbjct: 392 K--GDCSWTKSLLSLNMSSNILTDTI--FRCLPPRIKVLDLHSNKIK-SIPKQVVKLEAL 446

Query: 117 EYLNLSFN 124
           + LN++ N
Sbjct: 447 QELNVASN 454

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 27/118 (22%), Positives = 53/118 (44%), Gaps = 6/118 (5%)

Query: 21  SNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH 80
              ++ ++N  +  +P  +   +     ++S N +S     ++   S L  + +  N   
Sbjct: 2   EFLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ 58

Query: 81  GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFAN 138
               S F+ ++ +  LDLS N L   I      ++L++L+LSFN F+  +P    F N
Sbjct: 59  YLDISVFKFNQELEYLDLSHNKLVK-IS-CHPTVNLKHLDLSFNAFD-ALPICKEFGN 113

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 24/149 (16%), Positives = 49/149 (32%), Gaps = 16/149 (10%)

Query: 1   MFENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSG 57
           +   D    I    F+   L+    L +  +    S  P+   +++ +    +       
Sbjct: 156 VGNMDTFTKIQRKDFA--GLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL 212

Query: 58  EIPIELGLCSSLEDIYLGGNFFHG----SIPSF----FRTSRGIRKLDLSRNNLSGQIPL 109
            + I + + SS+E + L            + +            R + ++  +L   + L
Sbjct: 213 LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272

Query: 110 FLEALSLEYLNLSFNDFEGKVPTKGIFAN 138
             +   L  L  S N  +  VP  GIF  
Sbjct: 273 LNQISGLLELEFSRNQLKS-VP-DGIFDR 299

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 15/138 (10%), Positives = 40/138 (28%), Gaps = 14/138 (10%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEI 59
           +  N        ++FS       L +        I  +    L  L   ++  + L    
Sbjct: 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SY 189

Query: 60  PIE-LGLCSSLEDIYLGGNFFHGSIPS-FFRTSRGIRKLDLSRNNL---------SGQIP 108
             + L    ++  + L        +   F   +  +  L+L   +L         +G+  
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETN 248

Query: 109 LFLEALSLEYLNLSFNDF 126
             ++  +   + ++    
Sbjct: 249 SLIKKFTFRNVKITDESL 266

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 24/119 (20%), Positives = 45/119 (37%), Gaps = 11/119 (9%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIELGLCS 67
            +P  +      +  L+L+EN    +           L   ++    L+ ++ ++  L  
Sbjct: 24  ALPPDLPK---DTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTL-P 77

Query: 68  SLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFN 124
            L  + L  N    S+P   +T   +  LD+S N L+  +P         L+ L L  N
Sbjct: 78  VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGN 134

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 18/132 (13%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
           N+LS    E   +   L+N  SL L+ NH +  I       +  LR  D+S+N L   + 
Sbjct: 49  NNLSRLRAEWTPT--RLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-TLD 104

Query: 61  IEL--GLCSSLEDIYLGGNFFHGSIPSF-FRTSRGIRKLDLSRNNLSGQIP--LF--LEA 113
             L   L  +LE + L  N     +    F     ++KL LS+N +S + P  L      
Sbjct: 105 EFLFSDL-QALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161

Query: 114 L-SLEYLNLSFN 124
           L  L  L+LS N
Sbjct: 162 LPKLMLLDLSSN 173

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 31/159 (19%), Positives = 54/159 (33%), Gaps = 33/159 (20%)

Query: 1   MFENDLSGTIPEAIFSIS-YLSN-----SLNLAENHF----VGSIPPRIGNLKALRSFDV 50
           +F   +   IPEA+  +   L       ++ L++N F       +   +     L    +
Sbjct: 70  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 129

Query: 51  SNNGLSGE-------------IPIELGLCSSLEDIYLGGNFFHG----SIPSFFRTSRGI 93
            NNGL  +             +  +      L  I  G N             F++ R +
Sbjct: 130 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 189

Query: 94  RKLDLSRNNLS--GQIPLFLEAL----SLEYLNLSFNDF 126
             + + +N +   G   L LE L     L+ L+L  N F
Sbjct: 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 23/124 (18%), Positives = 46/124 (37%), Gaps = 20/124 (16%)

Query: 23  SLNLAENHF----VGSIPPRIGNLKALRSFDVSNNGLSGE---IPIELGL--CSSLEDIY 73
           S+    N      +        + + L +  +  NG+  E     +  GL  C  L+ + 
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222

Query: 74  LGGNFFHG----SIPSFFRTSRGIRKLDLSRNNLSGQ-IPLFLEAL------SLEYLNLS 122
           L  N F      ++    ++   +R+L L+   LS +     ++A        L+ L L 
Sbjct: 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 282

Query: 123 FNDF 126
           +N+ 
Sbjct: 283 YNEI 286

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 3/95 (3%)

Query: 34  SIPPRIGNLKALRSFDVSNNGLSGEIPIE-LGLCSSLEDIYLGGNFFHGSIPSF-FRTSR 91
                +   + L    + N      + +  L     L ++ +  +     +    F  + 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 92  GIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDF 126
            + +L+LS N L       ++ LSL+ L LS N  
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 23/116 (19%), Positives = 42/116 (36%), Gaps = 12/116 (10%)

Query: 14  IFSISYLSN-----SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSS 68
           I  ++ L+       L L  N  + +I P +  L  L+   + N  +S   P  L   S 
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQ-ITNISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSK 174

Query: 69  LEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
           L  +    N     I S   +   + ++ L  N +S  +       +L  + L+  
Sbjct: 175 LTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 23/125 (18%), Positives = 49/125 (39%), Gaps = 11/125 (8%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           +     +      + + L    +L+      V +I   +  L  L   ++ +N ++ ++ 
Sbjct: 23  KIAAGKSNVTDTVTQADLDGITTLSAFGTG-VTTIEG-VQYLNNLIGLELKDNQIT-DLA 79

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYL 119
             L   + + ++ L GN       S     + I+ LDL+   ++   P  L  L +L+ L
Sbjct: 80  -PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134

Query: 120 NLSFN 124
            L  N
Sbjct: 135 YLDLN 139

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 20/113 (17%), Positives = 46/113 (40%), Gaps = 9/113 (7%)

Query: 14  IFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLED 71
           +  +  L+    L L+ N  + ++   I  L+++++ D+++  ++   P  L   S+L+ 
Sbjct: 78  LAPLKNLTKITELELSGNP-LKNVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQV 133

Query: 72  IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
           +YL  N    +I         ++ L +    +S  +        L  L    N
Sbjct: 134 LYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDN 183

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 28/142 (19%), Positives = 48/142 (33%), Gaps = 14/142 (9%)

Query: 4   NDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIP 60
           N+L   I    F    L N   L ++       +P     +       D+ +N     I 
Sbjct: 90  NNLL-YINPEAFQ--NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145

Query: 61  IEL--GLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP--LFLEALSL 116
                GL      ++L  N     I +       + +L+LS NN   ++P  +F  A   
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGP 204

Query: 117 EYLNLSFNDFEGKVPTKGIFAN 138
             L++S       +P+     N
Sbjct: 205 VILDISRTRIH-SLPS-YGLEN 224

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.6 bits (102), Expect = 1e-04
 Identities = 24/126 (19%), Positives = 49/126 (38%), Gaps = 13/126 (10%)

Query: 3   ENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           +++L         + + L++   +    +  + S+   I  L  +    ++ N L+ +I 
Sbjct: 25  KDNLKKKSVTDAVTQNELNSIDQIIANNSD-IKSVQG-IQYLPNVTKLFLNGNKLT-DIK 81

Query: 61  IELGLCSSLEDIYLGGNFFHGSIP--SFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEY 118
             L    +L  ++L  N     I   S  +  + ++ L L  N +S  I   +    LE 
Sbjct: 82  -PLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLES 135

Query: 119 LNLSFN 124
           L L  N
Sbjct: 136 LYLGNN 141

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 30/126 (23%), Positives = 52/126 (41%), Gaps = 10/126 (7%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPP---RIGNLKALRSFDVSNNGL-SGEI 59
           N  + ++ +   ++  L  +L L  N    +         N+ +L + DVS N L S   
Sbjct: 363 NVFTDSVFQGCSTLKRLQ-TLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAY 420

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEY 118
                   S+  + L  N   GS+  F      ++ LDL  N +   IP  +  L +L+ 
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSV--FRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQE 477

Query: 119 LNLSFN 124
           LN++ N
Sbjct: 478 LNVASN 483

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	452
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.87
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.87
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.86
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.85
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.84
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.84
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.82
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.82
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.82
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.81
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.81
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.81
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.81
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.8
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.8
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.79
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.79
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.79
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.77
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.77
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.77
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.77
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.77
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.77
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.77
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.76
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.76
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.75
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.75
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.75
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.74
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.74
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.74
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.74
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.74
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.74
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.74
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.74
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.73
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.73
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.73
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.73
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.73
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.73
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.72
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.72
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.72
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.72
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.72
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.72
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.72
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.71
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.71
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.71
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.71
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.71
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.7
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.7
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.7
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.7
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.7
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.69
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.69
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.69
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.69
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.69
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.69
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.69
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.68
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.68
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.68
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.68
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.68
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.67
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.67
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.67
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.66
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.66
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.66
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.65
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.65
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.65
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.65
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.64
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.64
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.64
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.63
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.63
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.63
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.62
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.62
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.6
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.59
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.59
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.58
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.55
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.55
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.54
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.54
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.53
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.52
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.51
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.51
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.5
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.48
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.48
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.46
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.45
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.45
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.29
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.25
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.14
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.04
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.02
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.99
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.74
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.71
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.7
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.69
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.62
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.58
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.56
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.48
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.47
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.44
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.43
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.4
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.38
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.26
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.13
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.9
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.82
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.69
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.55
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.55
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.54
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.38
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.38
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.37
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.32
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.31
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.31
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.24
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.2
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.04
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.04
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.0
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.96
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.91
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.84
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.42
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.84
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.95
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.02
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.06
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	86.66
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	84.61
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.93
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.36

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.3e-52  Score=387.95  Aligned_cols=201  Identities=25%  Similarity=0.410  Sum_probs=179.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+++|++++|||||+++++     +++++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-----EEeCCE
Confidence            5799999999999999999999999999999999743   34455789999999999999999999998     556678


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+|||||++|+|.+++...           ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+|
T Consensus       107 ~yivmEy~~gG~L~~~i~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vK  172 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKI-----------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ  172 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEE
Confidence            99999999999999999643           3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+.+......  ......+||+.|||||++.+..|+.++||||+||++|||+||+.||+
T Consensus       173 l~DFGla~~~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  235 (311)
T 4aw0_A          173 ITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR  235 (311)
T ss_dssp             ECCCTTCEECCTTTTC--CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEcCCceecCCCCCc--ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999876533222  12334689999999999999999999999999999999999999995

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-51  Score=392.28  Aligned_cols=198  Identities=25%  Similarity=0.375  Sum_probs=178.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++     .+.+..|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            4588889999999999999999999999999999877666667899999999999999999999984     45568999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |||||++|+|.+++..            ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       149 vmEy~~gg~L~~~l~~------------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             EECCCTTEEHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEeCCCCCcHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEec
Confidence            9999999999999863            2589999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+.+.....    .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.
T Consensus       214 FGla~~~~~~~~----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  271 (346)
T 4fih_A          214 FGFCAQVSKEVP----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  271 (346)
T ss_dssp             CTTCEECCSSSC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CcCceecCCCCC----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            999987653322    1234679999999999999999999999999999999999999994

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-51  Score=392.90  Aligned_cols=201  Identities=29%  Similarity=0.410  Sum_probs=170.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++....  ...+.+.+|+++|++++|||||++++++     ++++..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECCEE
Confidence            679999999999999999999999999999999975432  2346789999999999999999999984     456689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      |+|||||++|+|.++|...+         ...+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        99 yiVmEy~~gg~L~~~i~~~~---------~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl  166 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQK---------GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL  166 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTT---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEE
T ss_pred             EEEEeCCCCCcHHHHHHHcC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEE
Confidence            99999999999999996432         23578889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+.....    .......+||+.|||||++.+..|+.++||||+||++|||+||+.||+
T Consensus       167 ~DFGla~~~~~~----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~  226 (350)
T 4b9d_A          167 GDFGIARVLNST----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE  226 (350)
T ss_dssp             CSTTEESCCCHH----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccceeecCC----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            999999865421    111234579999999999999999999999999999999999999995

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-51  Score=386.09  Aligned_cols=212  Identities=28%  Similarity=0.428  Sum_probs=174.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|.+.+.||+|+||+||+|++.     .+++.||||+++.......++|.+|+++|++++|||||+++++|.     ++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence            45777889999999999999975     357899999998665555678999999999999999999999964     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCC--cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQ--RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +..++|||||++|+|.++|+......  .........++|.+++.++.|+|.||+|||+.   +|+||||||+|||++++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence            57899999999999999997542100  00112235799999999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +.+||+|||+|+........  .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~--~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~  232 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY  232 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCE--EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CcEEECCcccceecCCCCce--eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999865432221  12223468999999999999999999999999999999999 999995

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=393.88  Aligned_cols=198  Identities=25%  Similarity=0.375  Sum_probs=178.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|+.++|||||++++++     .+.+..|+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEEEE
Confidence            4689999999999999999999999999999999877666667899999999999999999999984     44568999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      |||||++|+|.++++.            ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       226 VmEy~~gG~L~~~i~~------------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~D  290 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH------------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD  290 (423)
T ss_dssp             EEECCTTEEHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECC
T ss_pred             EEeCCCCCcHHHHHhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEec
Confidence            9999999999999863            2488999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+.+.....    .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.
T Consensus       291 FGla~~~~~~~~----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~  348 (423)
T 4fie_A          291 FGFCAQVSKEVP----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF  348 (423)
T ss_dssp             CTTCEECCSSCC----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CccceECCCCCc----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            999987653322    1234679999999999999999999999999999999999999994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-50  Score=385.05  Aligned_cols=212  Identities=27%  Similarity=0.438  Sum_probs=169.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|...+.||+|+||+||+|+++     .+++.||||+++.......++|.+|+++|++++|||||+++++|.     +.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            34666788999999999999975     357899999998665555678999999999999999999999964     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCc----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQR----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      +..++|||||++|+|.++++.......    ........++|.+++.|+.|+|.||+|||+.   +|+||||||+|||++
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence            578999999999999999986542211    1112335699999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++++||+|||+|+.........  ......||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~  262 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY  262 (329)
T ss_dssp             TTTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             CCCcEEEcccccceeccCCCcce--ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCC
Confidence            99999999999998654332211  1223569999999999999999999999999999999999 999995

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-50  Score=377.75  Aligned_cols=199  Identities=35%  Similarity=0.530  Sum_probs=165.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .+++.+.+.||+|+||+||+|++..   .||||+++....  ...+.|.+|++++++++|||||+++++|..      +.
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------DN  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------Ce
Confidence            4577888999999999999999752   599999974432  334689999999999999999999998632      35


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|||||++|+|.++|+...          ..+++.++..|+.|+|.||+|||+.   +||||||||+|||+++++++|
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~----------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~K  172 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE----------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVK  172 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEE
T ss_pred             EEEEEEcCCCCCHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEE
Confidence            789999999999999997543          3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+........  .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||+
T Consensus       173 i~DFGla~~~~~~~~~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~  238 (307)
T 3omv_A          173 IGDFGLATVKSRWSGS--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS  238 (307)
T ss_dssp             ECCCSSCBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EeeccCceecccCCcc--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence            9999999865432221  12234579999999999854   468999999999999999999999995

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-50  Score=373.42  Aligned_cols=199  Identities=31%  Similarity=0.462  Sum_probs=168.4

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      ...+.||+|+||+||+|+++.+++.||+|++.....  ...+.|.+|++++++++|||||++++++... ....+..++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE-ETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec-cCCCcEEEEE
Confidence            455679999999999999999999999999975432  2346799999999999999999999986432 1234568999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CCceEECc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DLSAHIGD  390 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~D  390 (452)
                      ||||++|+|.+++...           ..+++.++..++.|++.||+|||++ .++|+||||||+|||+++ ++.+||+|
T Consensus       108 mEy~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF-----------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             EeCCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEe
Confidence            9999999999999643           3689999999999999999999997 123999999999999985 78999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+.....      .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.
T Consensus       176 FGla~~~~~~------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~  230 (290)
T 3fpq_A          176 LGLATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             TTGGGGCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CcCCEeCCCC------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999854321      1224679999999999865 69999999999999999999999994

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-50  Score=382.67  Aligned_cols=198  Identities=24%  Similarity=0.301  Sum_probs=168.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +.|+..+.||+|+||+||+|+++.+|+.||||+++....     ..+|+++++.++|||||++++++     .+++..|+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~-----~~~~~~~i  127 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV-----REGPWVNI  127 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            456777889999999999999999999999999975432     24799999999999999999984     44568999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-ceEEC
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-SAHIG  389 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~  389 (452)
                      |||||++|+|.++|+..           ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++ .+||+
T Consensus       128 vmEy~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~  193 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQM-----------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC  193 (336)
T ss_dssp             EECCCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred             EEeccCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence            99999999999999643           3689999999999999999999998   999999999999999987 69999


Q ss_pred             ccccccccccCCCCc-eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPT-VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+|+......... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||+
T Consensus       194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~  257 (336)
T 4g3f_A          194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT  257 (336)
T ss_dssp             CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence            999998765332211 112223579999999999999999999999999999999999999995

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.5e-50  Score=370.07  Aligned_cols=197  Identities=29%  Similarity=0.457  Sum_probs=161.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|+++...   ....+.+.+|++++++++||||++++++     +++.+.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-----IKSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE-----EECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE-----EEECCE
Confidence            67999999999999999999999999999999997432   3345679999999999999999999998     455678


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||+ +|+|.+++.+.           ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++++|
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vk  152 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQR-----------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVK  152 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHS-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEE
T ss_pred             EEEEEeCC-CCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEE
Confidence            99999999 78999998643           3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+......     .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||+
T Consensus       153 l~DFGla~~~~~~~-----~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~  213 (275)
T 3hyh_A          153 IADFGLSNIMTDGN-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD  213 (275)
T ss_dssp             ECCSSCC--------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeecCCCeecCCCC-----ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC
Confidence            99999998654322     1223679999999999998876 578999999999999999999995

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.8e-50  Score=378.37  Aligned_cols=211  Identities=24%  Similarity=0.369  Sum_probs=173.3

Q ss_pred             CCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++++.+.||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|..     +
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence            3556788999999999999974     356899999997543 3345789999999999999999999999643     4


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                      +..++|||||++|+|.++|........     ........++|.+++.++.|+|.||+|||+.   +||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence            568999999999999999976432111     1112235699999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++++++||+|||+|+.........  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~--~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYK--LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBC--SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCCCEEECCcccceeccCCCcee--EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence            999999999999998664332211  1223569999999999999999999999999999999999 899984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-50  Score=378.24  Aligned_cols=199  Identities=27%  Similarity=0.361  Sum_probs=166.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|++.+.||+|+||+||+|+..   .+++.||||+++...  ......+.+|+++|++++|||||++++++     +++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----QTE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----EET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            57999999999999999999873   467899999997432  22234688999999999999999999984     456


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..|+|||||++|+|.+++...           ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~  164 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKE-----------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGH  164 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCC
Confidence            6899999999999999999643           3689999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+|+.......    .....+||+.|||||++.+..|+.++||||+||++|||+||+.||+
T Consensus       165 vKl~DFGla~~~~~~~~----~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~  227 (304)
T 3ubd_A          165 IKLTDFGLSKESIDHEK----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ  227 (304)
T ss_dssp             EEEESSEEEEC-----C----CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEecccccceeccCCCc----cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence            99999999986432221    1234679999999999999999999999999999999999999995

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.4e-49  Score=371.92  Aligned_cols=204  Identities=27%  Similarity=0.347  Sum_probs=163.6

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +|...+.||+|+||+||+|++  +|+.||||+++... .....+..|+..+.+++|||||+++++|...+ ......++|
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            466678999999999999998  58999999996432 22233445666677899999999999986432 122367999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecccCCCCeeecCCCce
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH-----CQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ||||++|+|.++|+.            ..++|.++.+++.|++.||+|||+.     +.++|+||||||+|||+++++++
T Consensus        80 ~Ey~~~gsL~~~l~~------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EECCTTCBHHHHHHH------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             ecCCCCCcHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence            999999999999964            2589999999999999999999985     24699999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCC------CCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+|+.................||+.|||||++.+.      .++.++|||||||++|||+||+.||
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~  218 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCC
Confidence            9999999987664433322233346799999999998754      4678999999999999999998765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3e-48  Score=365.11  Aligned_cols=208  Identities=28%  Similarity=0.457  Sum_probs=163.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccC-------
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDF-------  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-------  302 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+++|++++|||||++++++...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3588899999999999999999999999999999755433 34678999999999999999999998754321       


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ......|+|||||++|+|.+++....        .....++..++.++.|++.||+|||++   +|+||||||+|||++.
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~  153 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC--------TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTM  153 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC--------SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC--------CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECC
Confidence            12335789999999999999997543        123456677889999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCc--------eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPT--------VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+|+.........        .......+||+.|||||++.+..|+.++|||||||++|||++   ||.
T Consensus       154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~  228 (299)
T 4g31_A          154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS  228 (299)
T ss_dssp             TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred             CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence            9999999999998765332111        112234579999999999999999999999999999999997   663

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-48  Score=374.69  Aligned_cols=220  Identities=24%  Similarity=0.349  Sum_probs=179.2

Q ss_pred             HHHHHhhcCCCCCCceeccCceeEEEEEEcCC-----CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCC-CCceeEeee
Q 041632          224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQ-GASKSFMAECKALKNIRH-KNLVRVITS  296 (452)
Q Consensus       224 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h-~niv~l~~~  296 (452)
                      +.++...++|++.+.||+|+||+||+|++...     ++.||||.++.... ...+.|.+|+++|++++| ||||+++++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            44555567899999999999999999998643     36899999975433 234679999999999965 899999999


Q ss_pred             eccccCCCCceeEEEEeccCCCChhhhhcCCCCCC-----cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041632          297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQ-----RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHC  371 (452)
Q Consensus       297 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  371 (452)
                      |.    ..++..++|||||++|+|.++|+......     .........+++.+++.++.|||.||+|||+.   +||||
T Consensus       137 ~~----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR  209 (353)
T 4ase_A          137 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  209 (353)
T ss_dssp             EC----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EE----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence            74    33456899999999999999997543110     00112235689999999999999999999998   99999


Q ss_pred             ccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCC
Q 041632          372 DLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKP  450 (452)
Q Consensus       372 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~P  450 (452)
                      ||||+|||+++++.+||+|||+|+........  .......||+.|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCc--eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            99999999999999999999999866533222  22334579999999999999999999999999999999998 9999


Q ss_pred             CC
Q 041632          451 TD  452 (452)
Q Consensus       451 f~  452 (452)
                      |+
T Consensus       288 f~  289 (353)
T 4ase_A          288 YP  289 (353)
T ss_dssp             ST
T ss_pred             CC
Confidence            94

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=370.74  Aligned_cols=208  Identities=27%  Similarity=0.357  Sum_probs=175.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccc-cCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSV-DFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~-~~~~~~  306 (452)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++....  ...+.+.+|+++|+.++|||||++++++... .+.+.+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            3579999999999999999999999999999999974432  2346788999999999999999999986543 244556


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+|||||+ |+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~-----------~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~  197 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS-----------QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCEL  197 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCE
T ss_pred             EEEEEEeCCC-CCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCE
Confidence            7899999995 7899999654           3689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+|+.+..............+||+.|||||++.+. .++.++||||+||++|||+||+.||.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~  264 (398)
T 4b99_A          198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP  264 (398)
T ss_dssp             EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence            9999999987653322222233457899999999998775 46899999999999999999999994

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-45  Score=374.95  Aligned_cols=197  Identities=24%  Similarity=0.362  Sum_probs=170.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHH---HHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFM---AECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|+++...   ........   .++.+++.++|||||+++++     +++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f~~  263 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FHT  263 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EEC
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----EEE
Confidence            67999999999999999999999999999999997432   22223333   34677788899999999998     566


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..|+|||||+||+|.++|...           ..+++.++..++.||+.||+|||+.   +||||||||+|||++.+|
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~-----------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G  329 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQH-----------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG  329 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCC
Confidence            77899999999999999999643           3689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++||+|||+|+.+....      ....+||+.|||||++.+ ..|+.++|+||+||++|||+||+.||.
T Consensus       330 ~vKL~DFGlA~~~~~~~------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~  392 (689)
T 3v5w_A          330 HVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  392 (689)
T ss_dssp             CEEECCCTTCEECSSCC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CEEecccceeeecCCCC------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999998665322      234679999999999865 579999999999999999999999994

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.6e-45  Score=351.99  Aligned_cols=199  Identities=26%  Similarity=0.355  Sum_probs=167.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      ..+.|++.+.||+|+||+||+|+++   .+++.||+|.+...  ....++.+|+++++.+ +||||++++++     +++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~-----~~~   91 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYC-----FRK   91 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEE-----EEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEE-----EEE
Confidence            4578999999999999999999874   45789999998643  3446788999999998 69999999988     455


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-  383 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-  383 (452)
                      .+..++||||+++|+|.+++.              .+++.++..++.|++.||+|||+.   +|+||||||+|||++.+ 
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~--------------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~  154 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN--------------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRL  154 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT--------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred             CCEEEEEEeCCCcccHHHHHc--------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCC
Confidence            678999999999999999883              478889999999999999999998   99999999999999877 


Q ss_pred             CceEECccccccccccCCCCc------------------------eeccccccccccccCccccCCC-CCCcccceeehh
Q 041632          384 LSAHIGDFGLSRFYQAVSNPT------------------------VSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYG  438 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG  438 (452)
                      +.+||+|||+|+.........                        .......+||+.|||||++.+. .++.++||||+|
T Consensus       155 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG  234 (361)
T 4f9c_A          155 KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG  234 (361)
T ss_dssp             TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH
Confidence            799999999998654221100                        0111235799999999998775 489999999999


Q ss_pred             HHHHHHHhCCCCC
Q 041632          439 ILLLEMVTTKKPT  451 (452)
Q Consensus       439 v~l~elltg~~Pf  451 (452)
                      |++|||+||+.||
T Consensus       235 ~il~ell~G~~Pf  247 (361)
T 4f9c_A          235 VIFLSLLSGRYPF  247 (361)
T ss_dssp             HHHHHHHHTCSSS
T ss_pred             HHHHHHHHCCCCC
Confidence            9999999999998

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.7e-45  Score=371.23  Aligned_cols=199  Identities=24%  Similarity=0.398  Sum_probs=177.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++........+.+.+|+++|+.++||||++++++     +++.+..++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-----~~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEE-----EECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEEE
Confidence            679999999999999999999999999999999976655556788999999999999999999998     556678999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC--CceEE
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND--LSAHI  388 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl  388 (452)
                      |||||++|+|.++|....          ..+++.++..++.|++.||+|||++   +|+||||||+|||++.+  +.+||
T Consensus       232 v~E~~~gg~L~~~i~~~~----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl  298 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEH----------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL  298 (573)
T ss_dssp             EEECCCCCBHHHHHTCTT----------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEeecCCCcHHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEE
Confidence            999999999999996432          3688999999999999999999998   99999999999999854  89999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+.+....     .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.
T Consensus       299 ~DFG~a~~~~~~~-----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~  357 (573)
T 3uto_A          299 IDFGLTAHLDPKQ-----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG  357 (573)
T ss_dssp             CCCSSCEECCTTS-----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             eeccceeEccCCC-----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999998765322     1223579999999999999999999999999999999999999994

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1e-42  Score=344.90  Aligned_cols=209  Identities=24%  Similarity=0.309  Sum_probs=178.4

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeecc
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSS  299 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~  299 (452)
                      ++++....++|+..+.||+|+||+||+|+++.+++.||+|+++..   .......+.+|+.++..++||||+++++++  
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--  143 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF--  143 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE--
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--
Confidence            444555678899999999999999999999989999999999742   122234588999999999999999999984  


Q ss_pred             ccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          300 VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       300 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                         .+.+..++||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||
T Consensus       144 ---~~~~~~~lV~Ey~~gg~L~~~l~~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NIL  207 (437)
T 4aw2_A          144 ---QDDNNLYLVMDYYVGGDLLTLLSKFE----------DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNIL  207 (437)
T ss_dssp             ---ECSSEEEEEECCCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             ---eeCCEEEEEEecCCCCcHHHHHHHcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHee
Confidence               44568999999999999999997532          3689999999999999999999998   9999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.++.+||+|||+++.......   ......+||+.|+|||++.     ...++.++|||||||++|||+||+.||.
T Consensus       208 l~~~g~vkL~DFGla~~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~  282 (437)
T 4aw2_A          208 MDMNGHIRLADFGSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY  282 (437)
T ss_dssp             ECTTSCEEECCCTTCEECCTTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EcCCCCEEEcchhhhhhcccCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence            99999999999999976543221   1223357999999999986     5678999999999999999999999994

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-41  Score=321.25  Aligned_cols=199  Identities=27%  Similarity=0.390  Sum_probs=177.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||+||+|++..+|+.||+|++........+.+.+|+.+++.++||||+++++++.     ..+..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence            467999999999999999999998899999999998776667788999999999999999999999854     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++...            .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        94 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~  158 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT  158 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEECCCCCCHHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEe
Confidence            999999999999998632            478899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.........    .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       159 Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  217 (297)
T 3fxz_A          159 DFGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (297)
T ss_dssp             CCTTCEECCSTTCC----BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             eCCCceecCCcccc----cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99998765433221    223569999999999999999999999999999999999999984

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-41  Score=325.93  Aligned_cols=200  Identities=26%  Similarity=0.361  Sum_probs=174.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|+..+.||+|+||+||+|+.+.+|+.||+|+++..   .......+.+|+++++.++||||+++++++     .+.+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            35788899999999999999999999999999999743   234457789999999999999999999984     4456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|..++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v  144 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE-----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI  144 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCE
Confidence            899999999999999998643           3688999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......    .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       145 kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  206 (337)
T 1o6l_A          145 KITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  206 (337)
T ss_dssp             EECCCTTCBCSCCTTC----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEeeccchhhcccCCC----cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCC
Confidence            9999999975332211    1234579999999999999999999999999999999999999984

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-41  Score=325.23  Aligned_cols=199  Identities=27%  Similarity=0.422  Sum_probs=174.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|.+.+.||+|+||.||+|++..+|+.||||++.....  ...+.+.+|+++++.++||||+++++++     ...+.
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCE
Confidence            4679999999999999999999988999999999975432  3346788999999999999999999985     34567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~k  154 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAH-----------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIK  154 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             EEEEEECCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEE
Confidence            89999999999999998543           3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCC-cccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVS-TNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++......     ......||+.|+|||++.+..++ .++||||+||++|||+||+.||+
T Consensus       155 l~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  215 (328)
T 3fe3_A          155 IADFGFSNEFTVGG-----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD  215 (328)
T ss_dssp             ECSTTCCGGGSSSC-----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeeccCceecCCCC-----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence            99999997654322     12345799999999999887765 78999999999999999999995

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-41  Score=334.83  Aligned_cols=205  Identities=24%  Similarity=0.342  Sum_probs=175.9

Q ss_pred             HHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       225 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      ++....++|++.+.||+|+||+||+|+++.+++.||+|+++..   .....+.+.+|+++++.++||||+++++++    
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~----  138 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF----  138 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE----
Confidence            3444567899999999999999999999999999999999642   223335688999999999999999999984    


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                       .+.+..++||||+++|+|.+++...            .+++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       139 -~~~~~~~lV~E~~~gg~L~~~l~~~------------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~  202 (410)
T 3v8s_A          139 -QDDRYLYMVMEYMPGGDLVNLMSNY------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLD  202 (410)
T ss_dssp             -ECSSEEEEEECCCTTEEHHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             -EECCEEEEEEeCCCCCcHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeEC
Confidence             4566899999999999999998532            478899999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCC----CCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE----VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++.+||+|||+++......   .......+||+.|+|||++.+..    ++.++|||||||++|||+||+.||.
T Consensus       203 ~~g~ikL~DFG~a~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  274 (410)
T 3v8s_A          203 KSGHLKLADFGTCMKMNKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  274 (410)
T ss_dssp             TTSCEEECCCTTCEECCTTS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCEEEeccceeEeeccCC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence            99999999999998654321   12223467999999999987655    7899999999999999999999994

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=329.05  Aligned_cols=200  Identities=27%  Similarity=0.384  Sum_probs=170.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++..   .....+.+.+|.++++.+ +||||+++++++     .+.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence            46899999999999999999999999999999999743   223446788999999988 799999999984     455


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~  162 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS-----------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGH  162 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCC
Confidence            6899999999999999998643           3689999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......    ......+||+.|+|||++.+..++.++||||+||++|||++|+.||+
T Consensus       163 ikL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~  225 (353)
T 3txo_A          163 CKLADFGMCKEGICNG----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE  225 (353)
T ss_dssp             EEECCCTTCBCSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEccccceeecccCC----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCC
Confidence            9999999997533221    12234579999999999988889999999999999999999999995

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-41  Score=330.30  Aligned_cols=200  Identities=24%  Similarity=0.363  Sum_probs=173.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++....   ...+.+.+|..++.++ +||||+++++++     .+.
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~  125 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE  125 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----ECS
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EEC
Confidence            3578999999999999999999999999999999975432   2234678899999877 899999999984     456


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~  191 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQ-----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGH  191 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCC
Confidence            6899999999999999998643           3689999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.......    .....+||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       192 ikL~DFGla~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          192 IKLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             EEECCCTTCBCCCCTTC----CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             EEEeecceeeecccCCC----ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            99999999975322211    1234679999999999999999999999999999999999999994

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-40  Score=317.56  Aligned_cols=209  Identities=26%  Similarity=0.344  Sum_probs=179.6

Q ss_pred             ccChHHHHHhhcC----------CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC
Q 041632          220 KMSYKSLLKATDG----------FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN  289 (452)
Q Consensus       220 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n  289 (452)
                      .++++++..+++.          |...+.||+|+||.||+|+...+|+.||||+++.......+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3455555555433          556678999999999999998899999999998766666788999999999999999


Q ss_pred             ceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 041632          290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL  369 (452)
Q Consensus       290 iv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  369 (452)
                      |+++++++..     .+..++||||+++|+|.+++...            .+++.++..++.|++.||+|||+.   +|+
T Consensus       104 iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~------------~l~~~~~~~i~~qi~~~L~~LH~~---~iv  163 (321)
T 2c30_A          104 VVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQV------------RLNEEQIATVCEAVLQALAYLHAQ---GVI  163 (321)
T ss_dssp             BCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTTC------------CCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             cceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence            9999998543     45789999999999999998642            488999999999999999999998   999


Q ss_pred             ecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCC
Q 041632          370 HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       370 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~  449 (452)
                      ||||||+||+++.++.+||+|||+++........    .....||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~  239 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP  239 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCccc----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865432211    123569999999999999899999999999999999999999


Q ss_pred             CCC
Q 041632          450 PTD  452 (452)
Q Consensus       450 Pf~  452 (452)
                      ||.
T Consensus       240 pf~  242 (321)
T 2c30_A          240 PYF  242 (321)
T ss_dssp             TTT
T ss_pred             CCC
Confidence            984

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-40  Score=322.87  Aligned_cols=199  Identities=23%  Similarity=0.332  Sum_probs=175.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc------cHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG------ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .+.|++.+.||+|+||+||+|+++.+|+.||+|+++.....      ..+.+.+|+.+++.++||||+++++++     .
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----E   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----E
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----E
Confidence            46789999999999999999999999999999999754322      347899999999999999999999984     4


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++++
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~  151 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQK-----------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK  151 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTC-----------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCC
Confidence            556889999999999999999653           3689999999999999999999998   99999999999999887


Q ss_pred             C----ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 L----SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~----~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +    .+||+|||+++.......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       152 ~~~~~~vkl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~  219 (361)
T 2yab_A          152 NIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  219 (361)
T ss_dssp             TSSSCCEEECCCSSCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCCccCEEEEecCCceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            7    799999999986653221     123569999999999998899999999999999999999999994

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-41  Score=319.26  Aligned_cols=196  Identities=30%  Similarity=0.416  Sum_probs=173.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+++...+|+.||+|+++..   .....+.+.+|+.+++.++||||+++++++     .+...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCCE
Confidence            5688899999999999999999999999999999743   234456788999999999999999999984     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k  146 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKS-----------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK  146 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHT-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEE
Confidence            89999999999999999643           3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.....       .....||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       147 L~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  204 (318)
T 1fot_A          147 ITDFGFAKYVPDV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  204 (318)
T ss_dssp             ECCCSSCEECSSC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EeecCcceecCCc-------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            9999999865421       123569999999999999999999999999999999999999984

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.8e-41  Score=317.95  Aligned_cols=205  Identities=25%  Similarity=0.431  Sum_probs=175.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|...+.||+|+||+||+|++..+++.||+|.+........+.+.+|++++++++||||+++++++.     +++..+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeE
Confidence            357888899999999999999999899999999986555556678999999999999999999999854     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  150 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD----------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVA  150 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEEC
T ss_pred             EEEEecCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEe
Confidence            9999999999999997532          4689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCce----------eccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTV----------SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++..........          .......||+.|+|||++.+..++.++||||||+++|||++|..||.
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~  223 (310)
T 3s95_A          151 DFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP  223 (310)
T ss_dssp             CCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSST
T ss_pred             ecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCc
Confidence            9999986643222110          01113569999999999999999999999999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=324.68  Aligned_cols=198  Identities=27%  Similarity=0.392  Sum_probs=173.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||++++..+++.||+|++...   .....+.+.+|+++++.++||||+++++++     .+.+.
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~   89 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEED   89 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence            5688999999999999999999999999999999743   234457889999999999999999999884     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|..++...           ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk  155 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQN-----------VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH  155 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence            89999999999999999754           3589999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++......     ......||+.|+|||++..   ..++.++|||||||++|||+||+.||+
T Consensus       156 L~DFG~a~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          156 ITDFNIAAMLPRET-----QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             ECCCTTCEECCTTC-----CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeccceeeeccCCC-----ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence            99999998654322     1234579999999999864   458999999999999999999999994

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.4e-41  Score=323.34  Aligned_cols=201  Identities=28%  Similarity=0.428  Sum_probs=174.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      ..++|...+.||+|+||+||+|+++.+|+.||+|+++...   ....+.+..|.+++..+ +||||+++++++     .+
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence            4578999999999999999999999999999999997532   34456788899999877 999999999984     45


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g  155 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQSC-----------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDG  155 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCC
Confidence            56899999999999999998642           3688999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.......    .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       156 ~vkL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  219 (345)
T 1xjd_A          156 HIKIADFGMCKENMLGDA----KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH  219 (345)
T ss_dssp             CEEECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CEEEeEChhhhhcccCCC----cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCC
Confidence            999999999975432211    1234579999999999999999999999999999999999999984

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=332.92  Aligned_cols=209  Identities=24%  Similarity=0.336  Sum_probs=177.4

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeecc
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSS  299 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~  299 (452)
                      .++.....++|++.+.||+|+||+||+++.+.+|+.||+|+++...   ....+.+.+|++++..++||||+++++++  
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~--  130 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF--  130 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE--
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE--
Confidence            3444455688999999999999999999999899999999997422   22234588999999999999999999984  


Q ss_pred             ccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          300 VDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       300 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                         ++.+..++||||+++|+|.+++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||
T Consensus       131 ---~~~~~~~lVmE~~~gg~L~~~l~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NIL  194 (412)
T 2vd5_A          131 ---QDENYLYLVMEYYVGGDLLTLLSKFG----------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNIL  194 (412)
T ss_dssp             ---ECSSEEEEEECCCCSCBHHHHHHHHS----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             ---eeCCEEEEEEcCCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHee
Confidence               45668999999999999999996421          3688999999999999999999998   9999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccC-------CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-------GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.++++||+|||+++.......   ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.
T Consensus       195 ld~~g~vkL~DFGla~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  271 (412)
T 2vd5_A          195 LDRCGHIRLADFGSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY  271 (412)
T ss_dssp             ECTTSCEEECCCTTCEECCTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ecCCCCEEEeechhheeccCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence            99999999999999986543221   1222357999999999986       4578999999999999999999999994

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-40  Score=318.59  Aligned_cols=212  Identities=36%  Similarity=0.610  Sum_probs=180.9

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..++...+++|+..+.||+|+||.||+|++. +|+.||||++........+.+.+|+++++.++||||+++++++     
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----  104 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----  104 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence            3344556789999999999999999999975 7899999999766666678899999999999999999999984     


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      .+.+..++||||+++|+|.+++....       .....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~  174 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSD-------LPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE  174 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSC-------CCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECT
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccC-------CCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECC
Confidence            44567899999999999999996543       1224689999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++.........  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       175 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~  242 (321)
T 2qkw_B          175 NFVPKITDFGISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV  242 (321)
T ss_dssp             TCCEEECCCTTCEECSSSSCCC--CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred             CCCEEEeecccccccccccccc--cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence            9999999999997644222111  1223458999999999988899999999999999999999999984

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.5e-41  Score=322.73  Aligned_cols=199  Identities=25%  Similarity=0.368  Sum_probs=173.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|+..+.||+|+||.||+|+++.+++.||+|+++....   ...+.+.+|+.++.++ +||||+++++++     .+.+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeCC
Confidence            568889999999999999999999999999999975432   2235678999999888 899999999984     4456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~  149 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQ-----------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHI  149 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCE
Confidence            899999999999999998642           3589999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......    .....+||+.|+|||++.+..++.++||||+||++|||++|+.||+
T Consensus       150 kL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  211 (345)
T 3a8x_A          150 KLTDYGMCKEGLRPGD----TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  211 (345)
T ss_dssp             EECCGGGCBCSCCTTC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEEeccccccccCCCC----cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence            9999999975332211    1233579999999999999999999999999999999999999994

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=9.4e-41  Score=320.02  Aligned_cols=220  Identities=39%  Similarity=0.666  Sum_probs=186.8

Q ss_pred             hhcccChHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEee
Q 041632          217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVIT  295 (452)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~  295 (452)
                      ....++.+++....++|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+++++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            3567888999999999999999999999999999864 689999999975432 22347899999999999999999999


Q ss_pred             eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       296 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                      ++.     ..+..++||||+++|+|.+++....       .....+++..++.++.|++.||+|||+.+.++|+||||||
T Consensus        95 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp  162 (326)
T 3uim_A           95 FCM-----TPTERLLVYPYMANGSVASCLRERP-------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA  162 (326)
T ss_dssp             EEC-----CSSCCEEEEECCTTCBHHHHHHCCS-------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred             EEe-----cCCceEEEEEeccCCCHHHHHHhcc-------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence            853     4456799999999999999997643       1234589999999999999999999997777999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++++.+||+|||+++........   ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          163 ANILLDEEFEAVVGDFGLAKLMDYKDTH---VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             GGEEECTTCCEEECCCSSCEECCSSSSC---EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             hhEEECCCCCEEeccCccccccCccccc---ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            9999999999999999999866433222   1223459999999999988889999999999999999999999984

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-40  Score=314.58  Aligned_cols=201  Identities=26%  Similarity=0.437  Sum_probs=170.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||.||+|++..+++.||+|.+......   ..+.+.+|++++++++||||+++++++     .+.+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            35788999999999999999999989999999998644332   236789999999999999999999984     4456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~  150 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESH-----------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL  150 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             eEEEEEeCCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence            889999999999999998643           3689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......   .......||+.|+|||.+.+..++.++||||+|+++|||+||+.||+
T Consensus       151 kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  213 (294)
T 4eqm_A          151 KIFDFGIAKALSETSL---TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN  213 (294)
T ss_dssp             EECCCSSSTTC----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEeCCCccccccccc---cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            9999999986543221   11223569999999999999899999999999999999999999995

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.9e-41  Score=322.49  Aligned_cols=200  Identities=24%  Similarity=0.338  Sum_probs=174.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|+..+.||+|+||+||+|+++.+|+.||+|+++..   .....+.+..|.+++..+ +||||++++++     +++.
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~-----~~~~   93 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQTM   93 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE-----EECS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE-----EEcC
Confidence            46799999999999999999999988999999999743   234456788999999988 89999999988     4455


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  159 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQV-----------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH  159 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCc
Confidence            6899999999999999998642           3588999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.......    .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       160 vkL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~  222 (353)
T 2i0e_A          160 IKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE  222 (353)
T ss_dssp             EEECCCTTCBCCCCTTC----CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEEeCCcccccccCCc----ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCC
Confidence            99999999975332211    1234579999999999999999999999999999999999999984

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=316.94  Aligned_cols=199  Identities=23%  Similarity=0.322  Sum_probs=174.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|.+.+.||+|+||+||+|++..+++.||+|.+... ......+.+|+++++.++||||+++++++     .+.+..+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCEEE
Confidence            46788999999999999999999999999999999743 33446788999999999999999999985     3455889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC--CCceE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN--DLSAH  387 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~k  387 (452)
                      +||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.  ++.+|
T Consensus        78 lv~e~~~g~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~k  144 (321)
T 1tki_A           78 MIFEFISGLDIFERINTSA----------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIK  144 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred             EEEEeCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEE
Confidence            9999999999999996532          3588999999999999999999998   9999999999999997  78999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......     .....||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       145 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  204 (321)
T 1tki_A          145 IIEFGQARQLKPGDN-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL  204 (321)
T ss_dssp             ECCCTTCEECCTTCE-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEECCCCeECCCCCc-----cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            999999987653221     123568999999999998889999999999999999999999984

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.9e-40  Score=320.46  Aligned_cols=196  Identities=25%  Similarity=0.368  Sum_probs=174.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||.||++++..+|+.||+|+++..   .....+.+.+|+++++.++||||+++++++     .+.+.
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcCCE
Confidence            5788899999999999999999989999999999743   234457789999999999999999999884     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~k  181 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRI-----------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             EEEEEcCCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEE
Confidence            89999999999999998643           3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.....       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       182 L~DFg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  239 (350)
T 1rdq_E          182 VTDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             ECCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EcccccceeccCC-------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCC
Confidence            9999999865421       123569999999999999999999999999999999999999984

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=314.53  Aligned_cols=198  Identities=25%  Similarity=0.342  Sum_probs=173.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc------cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG------ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      +.|...+.||+|+||.||+|++..+|+.||+|+++.....      ..+.+.+|++++++++||||+++++++     .+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~   85 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN   85 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            4588889999999999999999989999999999754321      357899999999999999999999984     44


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~  151 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEK-----------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN  151 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTS-----------SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc-----------CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence            56789999999999999999643           3588999999999999999999998   999999999999999887


Q ss_pred             ----ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 ----SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ----~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                          .+||+|||+++.......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  218 (326)
T 2y0a_A          152 VPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  218 (326)
T ss_dssp             SSSCCEEECCCTTCEECCTTSC-----CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCCCCEEEEECCCCeECCCCCc-----cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence                899999999986643221     123469999999999998899999999999999999999999984

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-40  Score=321.43  Aligned_cols=200  Identities=22%  Similarity=0.325  Sum_probs=174.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+|+...+|+.||+|++..........+.+|+++++.++||||+++++++     .+.+..+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEEE
Confidence            35789999999999999999999999999999999765444556789999999999999999999984     4456889


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC--CCceE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN--DLSAH  387 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~k  387 (452)
                      +||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.  ++.+|
T Consensus       125 lv~E~~~gg~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vk  191 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAED----------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVK  191 (387)
T ss_dssp             EEEECCCCCBHHHHTTCTT----------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEE
T ss_pred             EEEEcCCCCcHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceE
Confidence            9999999999999986532          3589999999999999999999998   9999999999999974  57899


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       192 L~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  251 (387)
T 1kob_A          192 IIDFGLATKLNPDEI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA  251 (387)
T ss_dssp             ECCCTTCEECCTTSC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             EEecccceecCCCcc-----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence            999999986643221     122469999999999999899999999999999999999999984

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.8e-40  Score=317.18  Aligned_cols=198  Identities=29%  Similarity=0.421  Sum_probs=171.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|.+.+.||+|+||+||+|++..+|+.||+|++...   .......+.+|+++++.++||||+++++++     ...+
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~   82 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPT   82 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCC
Confidence            36788999999999999999999989999999999743   223346789999999999999999999985     3455


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+ +|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~  147 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEK-----------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNV  147 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCE
T ss_pred             EEEEEEECC-CCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCE
Confidence            789999999 78999988543           3689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++........     .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+
T Consensus       148 kl~DFG~s~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  209 (336)
T 3h4j_B          148 KIADFGLSNIMTDGNF-----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD  209 (336)
T ss_dssp             EECCSSCTBTTTTSBT-----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred             EEEEeccceeccCCcc-----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence            9999999986543221     123569999999999988776 789999999999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-40  Score=316.89  Aligned_cols=202  Identities=26%  Similarity=0.414  Sum_probs=171.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++     .+.+..
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            3678999999999999999999998999999999974432 2346788999999999999999999985     345678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl  146 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  146 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT-----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEcCCCCcHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEE
Confidence            9999999999999998654           3589999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.+......  .......||+.|+|||++.+..+ +.++|||||||++|||+||+.||+
T Consensus       147 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  209 (323)
T 3tki_A          147 SDFGLATVFRYNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  209 (323)
T ss_dssp             CCCTTCEECEETTEE--CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             EEeeccceeccCCcc--cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence            999999865432211  11223569999999999887765 778999999999999999999995

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.7e-40  Score=318.32  Aligned_cols=199  Identities=24%  Similarity=0.397  Sum_probs=172.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|+++....  ...+.+.+|+++++.++||||+++++++     .+.+.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            4578999999999999999999998999999999975433  2336788999999999999999999984     44568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC---
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL---  384 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---  384 (452)
                      .++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++   
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~  168 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAR-----------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA  168 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTC-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred             EEEEEecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence            89999999999999998653           3588999999999999999999998   999999999999998654   


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||++........     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       169 ~~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~  231 (362)
T 2bdw_A          169 AVKLADFGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  231 (362)
T ss_dssp             CEEECCCTTCBCCTTCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CEEEeecCcceEecCCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            599999999986553221     123569999999999999899999999999999999999999984

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-40  Score=322.28  Aligned_cols=200  Identities=31%  Similarity=0.381  Sum_probs=165.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHH-HhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKA-LKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~-l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||+||+|+++.+++.||+|+++....   ...+.+..|..+ ++.++||||+++++++     .+.
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~~  111 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTA  111 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----ECS
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EeC
Confidence            3578899999999999999999999999999999975432   233456677776 5778999999999884     455


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  177 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRE-----------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGH  177 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence            6899999999999999998643           3578889999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.......    .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       178 ikL~DFG~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~  240 (373)
T 2r5t_A          178 IVLTDFGLCKENIEHNS----TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY  240 (373)
T ss_dssp             EEECCCCBCGGGBCCCC----CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEEeeCccccccccCCC----ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99999999985332211    1234579999999999999999999999999999999999999984

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.5e-40  Score=320.25  Aligned_cols=203  Identities=21%  Similarity=0.329  Sum_probs=172.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-----CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-----QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +.|++.+.||+|+||+||+|+++.+|+.||||+++...     ....+.+.+|+++++.++||||+++++++.     +.
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~   98 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----SD   98 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            46888999999999999999999999999999996421     224578999999999999999999999853     45


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++....       .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        99 ~~~~lv~e~~~g~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~  168 (351)
T 3c0i_A           99 GMLYMVFEFMDGADLCFEIVKRA-------DAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKEN  168 (351)
T ss_dssp             TEEEEEEECCSSCBHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSST
T ss_pred             CEEEEEEeCCCCCCHHHHHHHhc-------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCC
Confidence            67899999999999988875321       1123588999999999999999999998   9999999999999987655


Q ss_pred             ---eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 ---AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ---~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                         +||+|||+++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       169 ~~~vkl~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (351)
T 3c0i_A          169 SAPVKLGGFGVAIQLGESGL----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY  234 (351)
T ss_dssp             TCCEEECCCTTCEECCTTSC----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcEEEecCcceeEecCCCe----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence               99999999986653221    1123569999999999999899999999999999999999999984

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6e-40  Score=311.90  Aligned_cols=202  Identities=33%  Similarity=0.522  Sum_probs=164.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ..++|++.+.||+|+||+||+|++  +|+.||||++.....  ...+.+.+|++++++++||||+++++++     .+.+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~  107 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPP  107 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTT
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence            346788899999999999999988  588999999975432  2235789999999999999999999985     3455


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCCeeecCCC
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP--ILHCDLKPSNILLDNDL  384 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~  384 (452)
                      ..++||||+++|+|.+++....        ....+++.+++.++.|++.||+|||+.   +  |+||||||+||+++.++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~  176 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSG--------AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKY  176 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTT--------HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTC
T ss_pred             ceEEEEecCCCCcHHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCC
Confidence            7899999999999999997542        123489999999999999999999998   7  99999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.......    ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       177 ~~kL~Dfg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          177 TVKVCDFGLSRLKASTFL----SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             CEEECCCC---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred             cEEECCCCCCcccccccc----ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999975432211    1223569999999999999999999999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.8e-40  Score=330.91  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=176.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|...+.||+|+||+||+|+++.+|+.||+|++....   ....+.+.+|++++++++||||+++++++     .+.+.
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~~  259 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKTD  259 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCCE
Confidence            67888899999999999999999899999999997432   33456789999999999999999999884     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....       .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~-------~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vk  329 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVD-------EDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR  329 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSS-------TTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred             EEEEEEeccCCCHHHHHHHhh-------cccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEE
Confidence            899999999999999986542       1124689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........    ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       330 L~DFGla~~~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~  390 (543)
T 3c4z_A          330 ISDLGLAVELKAGQTK----TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR  390 (543)
T ss_dssp             ECCCTTCEECCTTCCC----BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeecceeeeccCCCcc----cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence            9999999865432211    123579999999999999999999999999999999999999994

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=319.81  Aligned_cols=203  Identities=16%  Similarity=0.179  Sum_probs=169.4

Q ss_pred             hcCCCCCCceeccCceeEEEEE-----EcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC---CCCceeEeeeecccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGV-----FDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR---HKNLVRVITSCSSVD  301 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~---h~niv~l~~~~~~~~  301 (452)
                      .++|.+.+.||+|+||+||+|+     ...+++.||+|+++..   ..+++..|+++++.++   |+||+++++++.   
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~---  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL---  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE---
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee---
Confidence            4678888999999999999994     5567899999998643   4567888888888886   999999999853   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                        ..+..++||||+++|+|.+++....      ......+++.+++.++.|++.||+|||+.   +|+||||||+|||++
T Consensus       138 --~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          138 --FQNGSVLVGELYSYGTLLNAINLYK------NTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG  206 (365)
T ss_dssp             --CSSCEEEEECCCCSCBHHHHHHHHH------TSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC
T ss_pred             --cCCCcEEEEeccCCCcHHHHHHHhh------cccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEec
Confidence              3457899999999999999996321      01124689999999999999999999998   999999999999999


Q ss_pred             C-----------CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCC
Q 041632          382 N-----------DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       382 ~-----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      .           ++.+||+|||+++.........  ......||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  284 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT--IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM  284 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTE--EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCc--eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence            8           8999999999997654332221  22346799999999999999999999999999999999999999


Q ss_pred             C
Q 041632          451 T  451 (452)
Q Consensus       451 f  451 (452)
                      |
T Consensus       285 f  285 (365)
T 3e7e_A          285 K  285 (365)
T ss_dssp             C
T ss_pred             c
Confidence            8

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=307.63  Aligned_cols=201  Identities=26%  Similarity=0.387  Sum_probs=167.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--------------------------ccHHHHHHHHHHHh
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--------------------------GASKSFMAECKALK  283 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~ei~~l~  283 (452)
                      .++|+..+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3678899999999999999999998999999999964321                          11256889999999


Q ss_pred             cCCCCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC
Q 041632          284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH  363 (452)
Q Consensus       284 ~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  363 (452)
                      +++||||+++++++..   ...+..++||||+++++|.+++..            ..+++.+++.++.|++.||+|||+.
T Consensus        92 ~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~  156 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPTL------------KPLSEDQARFYFQDLIKGIEYLHYQ  156 (298)
T ss_dssp             TCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSCS------------SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            9999999999998643   224578999999999999876532            3589999999999999999999998


Q ss_pred             CCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCC---CCcccceeehhHH
Q 041632          364 CQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGIL  440 (452)
Q Consensus       364 ~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~  440 (452)
                         +|+||||||+|||++.++.+||+|||+++.......    ......||+.|+|||.+.+..   ++.++|||||||+
T Consensus       157 ---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~  229 (298)
T 2zv2_A          157 ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT  229 (298)
T ss_dssp             ---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHH
T ss_pred             ---CeeccCCCHHHEEECCCCCEEEecCCCccccccccc----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHH
Confidence               999999999999999999999999999986543221    112356999999999987655   4778999999999


Q ss_pred             HHHHHhCCCCCC
Q 041632          441 LLEMVTTKKPTD  452 (452)
Q Consensus       441 l~elltg~~Pf~  452 (452)
                      +|||++|+.||.
T Consensus       230 l~~l~~g~~pf~  241 (298)
T 2zv2_A          230 LYCFVFGQCPFM  241 (298)
T ss_dssp             HHHHHHSSCSSC
T ss_pred             HHHHHHCCCCCC
Confidence            999999999984

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.3e-40  Score=332.35  Aligned_cols=201  Identities=25%  Similarity=0.383  Sum_probs=175.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|+..+.||+|+||.||+|+++.+|+.||+|++...   .......+.+|+++++.++||||+++++++     .+.+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeCC
Confidence            45688899999999999999999999999999999743   234456788999999999999999999884     4556


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~---------~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~v  325 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMG---------QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI  325 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSS---------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCe
Confidence            8999999999999999986532         13489999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       326 KL~DFGla~~~~~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~  386 (576)
T 2acx_A          326 RISDLGLAVHVPEGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ  386 (576)
T ss_dssp             EECCCTTCEECCTTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSS
T ss_pred             EEEecccceecccCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCc
Confidence            9999999986543221     123579999999999999899999999999999999999999995

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-39  Score=311.81  Aligned_cols=210  Identities=27%  Similarity=0.431  Sum_probs=172.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-------
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-------  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-------  302 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++.....       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56888999999999999999999899999999997543 3345789999999999999999999998744221       


Q ss_pred             ---------------------------------------------CCCceeEEEEeccCCCChhhhhcCCCCCCcccccc
Q 041632          303 ---------------------------------------------QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIE  337 (452)
Q Consensus       303 ---------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~  337 (452)
                                                                   ......++||||+++|+|.+++....        .
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~  157 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--------S  157 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--------S
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--------C
Confidence                                                         11224799999999999999997653        2


Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCc--------eeccc
Q 041632          338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT--------VSSSI  409 (452)
Q Consensus       338 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~  409 (452)
                      ....++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........        .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT  234 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccc
Confidence            23457778899999999999999998   99999999999999999999999999998765332111        01123


Q ss_pred             cccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       410 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       235 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             SCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred             ccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence            356999999999999989999999999999999999998875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.4e-39  Score=310.63  Aligned_cols=205  Identities=28%  Similarity=0.480  Sum_probs=159.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|+..+.||+|+||+||+|++..+|+.||+|+++... ....+.+.+|++++++++||||+++++++     .+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeE
Confidence            467999999999999999999999899999999997543 33447889999999999999999999984     445688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||++ |+|.+++.....     ......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl  149 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTV-----GNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKL  149 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHS-----SSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecC-CCHHHHHHhccc-----cccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEE
Confidence            99999997 699998864221     11123588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++........    .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||+
T Consensus       150 ~Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  210 (317)
T 2pmi_A          150 GDFGLARAFGIPVNT----FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP  210 (317)
T ss_dssp             CCCSSCEETTSCCCC----CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcCccceecCCCccc----CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999865432211    123468999999999876 468999999999999999999999984

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-40  Score=314.81  Aligned_cols=207  Identities=27%  Similarity=0.437  Sum_probs=168.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc---HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA---SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||+||+|++..+++.||||+++......   ...+.+|++++++++||||+++++++.... ....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence            467899999999999999999998899999999997543322   357889999999999999999999865432 1223


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  155 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE-----------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAV  155 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCE
T ss_pred             ccEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCE
Confidence            458999999999999998642           3589999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       156 kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  220 (311)
T 3ork_A          156 KVMDFGIARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT  220 (311)
T ss_dssp             EECCCSCC-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEeeccCcccccccccc-cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            99999999865432221 112233568999999999999899999999999999999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=314.39  Aligned_cols=203  Identities=27%  Similarity=0.477  Sum_probs=169.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCC---cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|.+.+.||+|+||+||+|++..++   ..||||+++.... ...+.+.+|++++++++||||+++++++.     +.+
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  123 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RGR  123 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GGG
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            56888899999999999999997554   4599999975432 33467999999999999999999999853     445


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHD----------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC  190 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence            7899999999999999996542          3689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++.......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       191 kl~Dfg~a~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  256 (325)
T 3kul_A          191 KVSDFGLSRVLEDDPDAAY-TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW  256 (325)
T ss_dssp             EECCCSSCEECC----CCE-ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EECCCCcccccccCcccee-eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            9999999987653322221 2223446889999999988889999999999999999999 999984

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=323.76  Aligned_cols=200  Identities=22%  Similarity=0.327  Sum_probs=172.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++     .+.+.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~   84 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH   84 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence            4678999999999999999999999999999999975433  2345789999999999999999999984     45568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec---CCC
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD---NDL  384 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~  384 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++   +++
T Consensus        85 ~~lv~E~~~gg~L~~~i~~~-----------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~  150 (444)
T 3soa_A           85 HYLIFDLVTGGELFEDIVAR-----------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA  150 (444)
T ss_dssp             EEEEECCCBCCBHHHHHHHC-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTC
T ss_pred             EEEEEEeCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCC
Confidence            89999999999999988643           3589999999999999999999998   999999999999998   467


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.......    ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       151 ~vkL~DFG~a~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          151 AVKLADFGLAIEVEGEQQ----AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CEEECCCSSCBCCCTTCC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cEEEccCceeEEecCCCc----eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            899999999976543221    1223569999999999999899999999999999999999999984

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=310.95  Aligned_cols=203  Identities=24%  Similarity=0.379  Sum_probs=173.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|.+.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++..   ......+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCceEE
Confidence            56888999999999999999999889999999997543 3345778899999999999999999998642   2334679


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee----cCCCc
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLS  385 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~  385 (452)
                      +||||+++|+|.+++....        ....+++.+++.++.|++.||+|||+.   +|+||||||+|||+    +.++.
T Consensus        86 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  154 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPS--------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV  154 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGG--------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEE
T ss_pred             EEEeCCCCCCHHHHHHHhc--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCce
Confidence            9999999999999997532        123489999999999999999999998   99999999999999    78888


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccC--------CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL--------GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++........     ....||+.|+|||++.        +..++.++|||||||++|||+||+.||+
T Consensus       155 ~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  224 (319)
T 4euu_A          155 YKLTDFGAARELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (319)
T ss_dssp             EEECCCTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred             EEEccCCCceecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999866533221     2346999999999875        5678999999999999999999999983

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.7e-40  Score=314.19  Aligned_cols=200  Identities=26%  Similarity=0.364  Sum_probs=163.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR----QGASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      .++|+..+.||+|+||.||+++..   .+|+.||+|+++...    ......+.+|+++++.++||||+++++++     
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   90 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-----   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence            357889999999999999999984   578999999997432    22345678999999999999999999984     


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ...+..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~  156 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLERE-----------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNH  156 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECT
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECC
Confidence            3456789999999999999998642           3578889999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  222 (327)
T 3a62_A          157 QGHVKLTDFGLCKESIHDGT----VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT  222 (327)
T ss_dssp             TSCEEECCCSCC--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCcEEEEeCCcccccccCCc----cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCC
Confidence            99999999999875432211    1223569999999999998899999999999999999999999994

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8e-40  Score=317.97  Aligned_cols=221  Identities=24%  Similarity=0.325  Sum_probs=180.8

Q ss_pred             CCCCChhHHHhhhcccChHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC
Q 041632          206 SRQPSEPMIRKALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI  285 (452)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l  285 (452)
                      .+..+..........++++......++|.+.+.||+|+||+||+|++..+++.||||+++.. ....+.+..|+++++.+
T Consensus        10 ~~~~~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l   88 (360)
T 3llt_A           10 GRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKI   88 (360)
T ss_dssp             ----------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHT
T ss_pred             cccceeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHh
Confidence            33334444445566677777777778999999999999999999999989999999999632 23346678899999988


Q ss_pred             C-----CCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHH
Q 041632          286 R-----HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYL  360 (452)
Q Consensus       286 ~-----h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  360 (452)
                      +     ||||+++++++.     ..+..++||||+ +++|.+++....         ...+++.++..++.|++.||+||
T Consensus        89 ~~~~~~h~~iv~~~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~L  153 (360)
T 3llt_A           89 QNDDINNNNIVKYHGKFM-----YYDHMCLIFEPL-GPSLYEIITRNN---------YNGFHIEDIKLYCIEILKALNYL  153 (360)
T ss_dssp             CCCSTTGGGBCCEEEEEE-----ETTEEEEEECCC-CCBHHHHHHHTT---------TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCCCeecccceee-----ECCeeEEEEcCC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHH
Confidence            6     999999999854     345789999999 999999986432         13588999999999999999999


Q ss_pred             hcCCCCCeEecccCCCCeeecC-------------------------CCceEECccccccccccCCCCceeccccccccc
Q 041632          361 HQHCQEPILHCDLKPSNILLDN-------------------------DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI  415 (452)
Q Consensus       361 H~~~~~~ivH~Dlk~~Nill~~-------------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~  415 (452)
                      |+.   +|+||||||+|||++.                         ++.+||+|||+++......       ....||+
T Consensus       154 H~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~  223 (360)
T 3llt_A          154 RKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTR  223 (360)
T ss_dssp             HHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCG
T ss_pred             HHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcc
Confidence            998   9999999999999975                         7899999999998644221       1246899


Q ss_pred             cccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       416 ~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       224 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          224 QYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             GGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999999999999999999999984

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=318.08  Aligned_cols=194  Identities=27%  Similarity=0.372  Sum_probs=164.9

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      .+.||+|+||.||+|+...+|+.||+|+++.......+.+.+|++++++++||||+++++++.     +.+..++||||+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~  168 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVMEYV  168 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEECC
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEeCC
Confidence            567999999999999999899999999998655555678999999999999999999999853     456789999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee--cCCCceEECcccc
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL--DNDLSAHIGDFGL  393 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill--~~~~~~kl~Dfgl  393 (452)
                      ++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+  ++++.+||+|||+
T Consensus       169 ~~~~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~  235 (373)
T 2x4f_A          169 DGGELFDRIIDES----------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGL  235 (373)
T ss_dssp             TTCEEHHHHHHTG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred             CCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence            9999999885432          4688999999999999999999998   99999999999999  5678999999999


Q ss_pred             ccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          394 SRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       394 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+.....     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       236 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  289 (373)
T 2x4f_A          236 ARRYKPREK-----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL  289 (373)
T ss_dssp             CEECCTTCB-----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ceecCCccc-----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            986653221     122459999999999998899999999999999999999999984

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-39  Score=325.22  Aligned_cols=203  Identities=29%  Similarity=0.378  Sum_probs=159.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  ...+.+.+|+++++.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            4679999999999999999999999999999999964322  23467899999999999999999999976555556677


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||+ +|+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~k  196 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-----------VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVK  196 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEE
T ss_pred             EEEEEecc-ccchhhhcccC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEe
Confidence            89999998 68999988643           3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCce-----------------------eccccccccccccCcccc-CCCCCCcccceeehhHHHHH
Q 041632          388 IGDFGLSRFYQAVSNPTV-----------------------SSSIGVRGTIGYVAPEYG-LGSEVSTNGDVYSYGILLLE  443 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~-----------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~e  443 (452)
                      |+|||+++..........                       ......+||+.|+|||++ ....++.++|||||||++||
T Consensus       197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e  276 (458)
T 3rp9_A          197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE  276 (458)
T ss_dssp             ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence            999999987643221100                       122346789999999975 45679999999999999999


Q ss_pred             HHhC
Q 041632          444 MVTT  447 (452)
Q Consensus       444 lltg  447 (452)
                      |+||
T Consensus       277 lltg  280 (458)
T 3rp9_A          277 LLNM  280 (458)
T ss_dssp             HHTT
T ss_pred             HHHh
Confidence            9993

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-39  Score=317.51  Aligned_cols=213  Identities=23%  Similarity=0.435  Sum_probs=173.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-------CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-------EDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|.+.+.||+|+||+||+|++.       .++..||||+++.... ...+.+.+|+++++++ +||||++++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            367888899999999999999974       3456899999975432 2346789999999999 8999999999853  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         +.+..++||||+++|+|.+++.........     .......+++.+++.++.|++.||+|||+.   +|+||||||
T Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  231 (370)
T 2psq_A          158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  231 (370)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred             ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence               445789999999999999999764321100     011234689999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||++.++.+||+|||+++.........  ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYK--KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTC--TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hhEEECCCCCEEEccccCCcccCccccee--cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999998654322111  1223457889999999999899999999999999999999 999984

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=306.84  Aligned_cols=206  Identities=30%  Similarity=0.427  Sum_probs=171.7

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-----ccHHHHHHHHHHHhcCC---CCCceeEeeeeccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-----GASKSFMAECKALKNIR---HKNLVRVITSCSSV  300 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~ei~~l~~l~---h~niv~l~~~~~~~  300 (452)
                      ..++|++.+.||+|+||+||+|++..+|+.||+|+++....     .....+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35789999999999999999999988999999999974331     22356778888777764   99999999997654


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                      ........++||||+. |+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~  153 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP---------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILV  153 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence            3333336789999996 69999997543         13489999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.++.+||+|||+++.......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       154 ~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  220 (308)
T 3g33_A          154 TSGGTVKLADFGLARIYSYQMA-----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC  220 (308)
T ss_dssp             CTTSCEEECSCSCTTTSTTCCC-----SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred             cCCCCEEEeeCccccccCCCcc-----cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999986543222     223568999999999998999999999999999999999999984

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.1e-39  Score=306.92  Aligned_cols=201  Identities=27%  Similarity=0.434  Sum_probs=166.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhc--CCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKN--IRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~--l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++  +|+.||||++...   ....+..|.+++..  ++||||+++++++... ......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~-~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS-RHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE-ETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc-cCCCce
Confidence            46799999999999999999998  6899999998643   33555666666655  7999999999986543 233456


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecccCCCCee
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH--------QHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlk~~Nil  379 (452)
                      .++||||+++|+|.++++.            ..+++.+++.++.|++.||+|||        +.   +|+||||||+|||
T Consensus        81 ~~lv~e~~~~g~L~~~l~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nil  145 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNIL  145 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEE
T ss_pred             eEEehhhccCCCHHHHHhh------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEE
Confidence            8999999999999999953            25889999999999999999999        65   9999999999999


Q ss_pred             ecCCCceEECccccccccccCCCCceeccccccccccccCccccCCC------CCCcccceeehhHHHHHHHhC------
Q 041632          380 LDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMVTT------  447 (452)
Q Consensus       380 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg------  447 (452)
                      ++.++.+||+|||+++.................||+.|+|||++.+.      .++.++|||||||++|||+||      
T Consensus       146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~  225 (301)
T 3q4u_A          146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI  225 (301)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence            99999999999999986654333222222334699999999998776      456789999999999999999      


Q ss_pred             ----CCCC
Q 041632          448 ----KKPT  451 (452)
Q Consensus       448 ----~~Pf  451 (452)
                          +.||
T Consensus       226 ~~~~~~pf  233 (301)
T 3q4u_A          226 VEDYKPPF  233 (301)
T ss_dssp             CCCCCCTT
T ss_pred             cccccccc
Confidence                7887

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.5e-40  Score=310.76  Aligned_cols=206  Identities=27%  Similarity=0.468  Sum_probs=170.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||+||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++...   +.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HH
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence            35688899999999999999994    567899999999765555567899999999999999999999986432   12


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~  152 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK----------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR  152 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc----------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCe
Confidence            35789999999999999996432          3589999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......... .......++..|+|||.+.+..++.++||||||+++|||+||..||.
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          153 VKIGDFGLTKVLPQDKEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             EEECCCCSCC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             EEEccCcccccccCCccee-eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence            9999999998664322111 11223457888999999988899999999999999999999998874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1e-39  Score=313.48  Aligned_cols=202  Identities=23%  Similarity=0.350  Sum_probs=172.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||+||+|+...+|+.||||++.....  .+.+.+|+++++++ +||||+++++++.     ..+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            3578899999999999999999988999999999875432  34688999999999 9999999999853     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc---
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS---  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---  385 (452)
                      ++||||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.   
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~  146 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCD----------RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQ  146 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCT
T ss_pred             EEEEEeC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCC
Confidence            9999999 999999986432          4689999999999999999999998   9999999999999999887   


Q ss_pred             --eEECccccccccccCCCCce---eccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 --AHIGDFGLSRFYQAVSNPTV---SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 --~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                        +||+|||+++.+........   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       147 ~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~  218 (330)
T 2izr_A          147 QVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQ  218 (330)
T ss_dssp             TSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcc
Confidence              99999999987643322111   11234579999999999999999999999999999999999999994

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4e-40  Score=329.16  Aligned_cols=200  Identities=27%  Similarity=0.356  Sum_probs=164.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|+..+.||+|+||.||+|+...+|+.||||+++..   .......+.+|+++++.++||||+++++++.     ..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence            35788999999999999999999999999999999743   2333456789999999999999999999854     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCCeeecCCCc
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ..++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+ .   +|+||||||+|||++.++.
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~  287 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRE-----------RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGH  287 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSC
T ss_pred             EEEEEEeeCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCC
Confidence            789999999999999998543           368999999999999999999998 7   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......    .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       288 ~kl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  350 (446)
T 4ejn_A          288 IKITDFGLCKEGIKDG----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  350 (446)
T ss_dssp             EEECCCCCCCTTCC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEccCCCceeccCCC----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence            9999999997533221    12234679999999999999999999999999999999999999984

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=314.15  Aligned_cols=198  Identities=25%  Similarity=0.338  Sum_probs=158.7

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++.     +.+..
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence            3467889999999999999999999889999999997543  3467889999999999999999999853     45678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---CCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~  385 (452)
                      ++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.   ++.
T Consensus       124 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~  189 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEK-----------GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAP  189 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTC-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCC
T ss_pred             EEEEEeCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCC
Confidence            9999999999999998654           2588999999999999999999998   9999999999999975   889


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       190 ~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  251 (349)
T 2w4o_A          190 LKIADFGLSKIVEHQVL-----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY  251 (349)
T ss_dssp             EEECCCC---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEEccCccccccCcccc-----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            99999999986542211     123568999999999999899999999999999999999999984

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.8e-39  Score=304.93  Aligned_cols=198  Identities=26%  Similarity=0.439  Sum_probs=167.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||+||+|++..+|+.||+|+++....  ...+.+.+|++++++++||||+++++++.     +.+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            468888999999999999999999999999999975433  33467889999999999999999999853     45678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++ ++.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        77 ~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl  142 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSCN----------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKL  142 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCC-CHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            999999965 5555554321          3689999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||+++........    .....||+.|+|||++.+.. ++.++||||+||++|||+||..||
T Consensus       143 ~Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          143 ANFGLARAFGIPVRC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CCCTTCEECCSCCSC----CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             eecccceecCCcccc----ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            999999865422211    12346899999999987765 799999999999999999998885

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-39  Score=323.64  Aligned_cols=199  Identities=28%  Similarity=0.454  Sum_probs=173.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|.+.+.||+|+||.||+|++..+|+.||||+++...   ....+.+.+|+++++.++||||+++++++     ...+
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~   89 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS   89 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            357888999999999999999999899999999997432   23456789999999999999999999985     3455


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~v  155 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKN-----------GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNA  155 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSS-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEEEeCCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCe
Confidence            789999999999999999643           3589999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......     ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+
T Consensus       156 kL~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~  217 (476)
T 2y94_A          156 KIADFGLSNMMSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD  217 (476)
T ss_dssp             EECCCSSCEECCTTCC-----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEeccchhhcccccc-----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence            9999999986543221     123569999999999988765 689999999999999999999995

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.2e-39  Score=307.26  Aligned_cols=199  Identities=30%  Similarity=0.457  Sum_probs=167.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++.....  ...+.+.+|++++++++||||+++++++     .+.+.
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   93 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSERC   93 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSSC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCCE
Confidence            467899999999999999999986 689999999974432  3346788999999999999999999984     44567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||++ |+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        94 ~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~k  159 (311)
T 3niz_A           94 LTLVFEFME-KDLKKVLDENK----------TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALK  159 (311)
T ss_dssp             EEEEEECCS-EEHHHHHHTCT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEcCCC-CCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEE
Confidence            899999997 58888876543          3588999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||+
T Consensus       160 l~Dfg~a~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  221 (311)
T 3niz_A          160 LADFGLARAFGIPVRS----YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP  221 (311)
T ss_dssp             ECCCTTCEETTSCCC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EccCcCceecCCCccc----ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence            9999999865432211    123468999999999876 568999999999999999999999984

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-39  Score=318.04  Aligned_cols=204  Identities=27%  Similarity=0.495  Sum_probs=160.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||+||+|++.   .++..||||.++.... ...+.|.+|++++++++||||+++++++.     +.
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence            357999999999999999999986   4577899999975432 33467999999999999999999999853     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  185 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHD----------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLV  185 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             CceEEEEeCCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCC
Confidence            57899999999999999997543          3689999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++.......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       186 ~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~  252 (373)
T 2qol_A          186 CKVSDFGLGRVLEDDPEAAY-TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW  252 (373)
T ss_dssp             EEECCC-----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred             EEECcCccccccccCCccce-eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            99999999986653222111 1122345788999999988899999999999999999998 999983

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.3e-40  Score=312.56  Aligned_cols=205  Identities=27%  Similarity=0.398  Sum_probs=169.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+|++.  ++.||||+++... .....+..|+.++++++||||+++++++.... ......+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~   98 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW   98 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence            467889999999999999999984  7899999996443 23355677999999999999999999975432 1134579


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC-------CCCCeEecccCCCCeeecC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH-------CQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~ivH~Dlk~~Nill~~  382 (452)
                      +||||+++|+|.++++..            .+++.+++.++.|++.||+|||+.       +.++|+||||||+|||++.
T Consensus        99 lv~e~~~~g~L~~~l~~~------------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN------------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             EEEecCCCCCHHHHHHhc------------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence            999999999999999642            488999999999999999999985       1348999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++........  .......||+.|+|||++.+     ..++.++|||||||++|||+||+.||+
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~  239 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKSA--GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD  239 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSCC--CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred             CCeEEEccCCcccccccccCc--cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence            999999999999866533221  12233569999999999876     356778999999999999999999984

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.2e-39  Score=323.35  Aligned_cols=201  Identities=26%  Similarity=0.277  Sum_probs=166.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~  306 (452)
                      .++|+..+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+++++.++||||+++++++..... .+..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999999999999999999743  23335678899999999999999999998754321 3345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++ ++.+.+.             ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~-------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~  203 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  203 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             eEEEEEeCCCC-CHHHHHh-------------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCE
Confidence            67999999965 5666653             2478889999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++......     ......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       204 kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~  264 (464)
T 3ttj_A          204 KILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  264 (464)
T ss_dssp             EECCCCCC-----CC-----CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEEEEeeeecCCCc-----ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999998654321     1223579999999999999999999999999999999999999994

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-39  Score=313.37  Aligned_cols=218  Identities=25%  Similarity=0.318  Sum_probs=172.9

Q ss_pred             HHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc-----CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-----RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       227 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      ....++|++.+.||+|+||+||+|++..+++.||+|++...     .....+.+.+|++++++++||||+++++++    
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~----   97 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY----   97 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh----
Confidence            34556799999999999999999999999999999999743     234457899999999999999999999985    


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCc-----------------------------ccccccccCCHHHHHHHHHH
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-----------------------------DREIEIQKLTLLQRISIAID  352 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----------------------------~~~~~~~~l~~~~~~~i~~~  352 (452)
                       .+.+..++||||+++|+|.+++........                             ........+++..++.++.|
T Consensus        98 -~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  176 (345)
T 3hko_A           98 -EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ  176 (345)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHH
T ss_pred             -ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHH
Confidence             445688999999999999999853110000                             00011223467788899999


Q ss_pred             HHHHHHHHhcCCCCCeEecccCCCCeeecCCC--ceEECccccccccccCCCCceeccccccccccccCccccCC--CCC
Q 041632          353 VASALDYLHQHCQEPILHCDLKPSNILLDNDL--SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEV  428 (452)
Q Consensus       353 i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~  428 (452)
                      ++.||+|||+.   +|+||||||+||+++.++  .+||+|||+++.+...............||+.|+|||++.+  ..+
T Consensus       177 i~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          177 IFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            99999999998   999999999999998776  89999999998765433332223334569999999999865  678


Q ss_pred             CcccceeehhHHHHHHHhCCCCCC
Q 041632          429 STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       429 ~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.++|||||||++|||++|+.||+
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~  277 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFP  277 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCC
Confidence            999999999999999999999984

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.1e-39  Score=317.14  Aligned_cols=207  Identities=20%  Similarity=0.242  Sum_probs=174.6

Q ss_pred             hhcCCCCCCceecc--CceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          229 ATDGFSSTNLIGVG--SFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       229 ~~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ..++|++.+.||+|  +||.||+|++..+|+.||||+++....  ...+.+.+|+++++.++||||+++++++.     +
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~   97 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----A   97 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----E
Confidence            35679999999999  999999999999999999999975532  33467888999999999999999999854     4


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++|+|.+++....         ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  165 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHF---------MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDG  165 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTC---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhc---------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            557899999999999999986432         13588999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCC---ceeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNP---TVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||.+.........   .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  238 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK  238 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCC
Confidence            9999999988654321110   1111122468999999999887  578999999999999999999999984

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-39  Score=315.02  Aligned_cols=198  Identities=27%  Similarity=0.338  Sum_probs=164.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+++...+++.||+|++.... ...+.+.+|+.+++.++||||+++++++     .+.+..+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVI-----LTPTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEE-----eeCCEEE
Confidence            467999999999999999999999999999999997443 3346789999999999999999999985     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc--eE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS--AH  387 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--~k  387 (452)
                      +||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.  +|
T Consensus        93 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k  158 (361)
T 3uc3_A           93 IIMEYASGGELYERICNA-----------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK  158 (361)
T ss_dssp             EEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred             EEEEeCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence            999999999999998532           3689999999999999999999998   9999999999999987765  99


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcc-cceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTN-GDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++......     ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||+
T Consensus       159 l~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  219 (361)
T 3uc3_A          159 ICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE  219 (361)
T ss_dssp             ECCCCCC--------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EeecCccccccccC-----CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence            99999987433221     1123469999999999888777665 899999999999999999994

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7e-39  Score=306.74  Aligned_cols=191  Identities=24%  Similarity=0.352  Sum_probs=150.4

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeEEEEec
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKY  314 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~  314 (452)
                      .+.||+|+||+||+|++..+|+.||||++...   ....+.+|+++++.+. ||||+++++++     .+....++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEEEEEEc
Confidence            47899999999999999989999999999643   3467889999999996 99999999985     445688999999


Q ss_pred             cCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC---ceEECcc
Q 041632          315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL---SAHIGDF  391 (452)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---~~kl~Df  391 (452)
                      +++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++   .+||+||
T Consensus        88 ~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df  153 (325)
T 3kn6_A           88 LNGGELFERIKKK-----------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDF  153 (325)
T ss_dssp             CCSCBHHHHHHHC-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCC
T ss_pred             cCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecc
Confidence            9999999999643           3689999999999999999999998   999999999999998765   8999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       154 g~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  210 (325)
T 3kn6_A          154 GFARLKPPDNQ----PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ  210 (325)
T ss_dssp             TTCEECCC--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccceecCCCCC----cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            99986543221    1223468999999999999999999999999999999999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6e-39  Score=300.18  Aligned_cols=198  Identities=25%  Similarity=0.314  Sum_probs=174.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|.+.+.||+|+||.||+|++..++..||+|.+........+.+.+|++++++++||||+++++++     .+.+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence            35688899999999999999999989999999999876666678899999999999999999999985     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~  386 (452)
                      +||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||++   +.++.+
T Consensus        83 lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~  148 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK-----------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPL  148 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred             EEEeccCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcE
Confidence            999999999999988543           3588999999999999999999998   99999999999999   788999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++........     .....||+.|+|||.+.+ .++.++||||||+++|||+||+.||+
T Consensus       149 ~l~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  208 (277)
T 3f3z_A          149 KLIDFGLAARFKPGKM-----MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS  208 (277)
T ss_dssp             EECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEecccceeccCccc-----hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCC
Confidence            9999999976553221     123468999999999765 48999999999999999999999984

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5e-39  Score=335.53  Aligned_cols=201  Identities=24%  Similarity=0.336  Sum_probs=175.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~  304 (452)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..   .....+.+..|.+++..+ +||+|++++++     +++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----FQT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----CBC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----EEe
Confidence            346789999999999999999999999999999999743   234456788999999988 79999999988     566


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..|+||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g  479 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQV-----------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG  479 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSS
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCC
Confidence            67899999999999999999643           3689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       480 ~ikL~DFGla~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~  543 (674)
T 3pfq_A          480 HIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE  543 (674)
T ss_dssp             CEEECCCTTCEECCCTTC----CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cEEEeecceeeccccCCc----ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence            999999999985432221    1234679999999999999999999999999999999999999995

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=7e-39  Score=306.36  Aligned_cols=199  Identities=23%  Similarity=0.333  Sum_probs=173.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc------cHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG------ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|++.+.||+|+||.||+|++..+|+.||+|+++.....      ..+.+.+|++++++++||||+++++++     .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----E   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence            35688899999999999999999989999999999754322      357899999999999999999999985     3


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~  151 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQK-----------ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDK  151 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC-----------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCT
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecC
Confidence            456789999999999999999653           2578899999999999999999998   99999999999999988


Q ss_pred             C----ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 L----SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~----~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +    .+||+|||+++.......     .....||+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus       152 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  219 (321)
T 2a2a_A          152 NIPIPHIKLIDFGLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  219 (321)
T ss_dssp             TSSSCCEEECCCTTCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             CCCcCCEEEccCccceecCcccc-----ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence            8    799999999986553221     123468999999999998899999999999999999999999984

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.6e-39  Score=300.40  Aligned_cols=200  Identities=26%  Similarity=0.462  Sum_probs=171.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||.||+|++. +++.||+|++.... ...+++.+|++++++++||||+++++++     .+.+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   81 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   81 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence            357888899999999999999987 57789999997443 3457899999999999999999999985     3455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  148 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVS  148 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEEC
T ss_pred             EEEEeCCCCcHHHHHHhcC----------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEec
Confidence            9999999999999996543          3588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++.....   .........+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||+
T Consensus       149 Dfg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~  209 (269)
T 4hcu_A          149 DFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE  209 (269)
T ss_dssp             CTTGGGGBCCH---HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccccccc---ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence            99999755321   1112223457889999999988889999999999999999999 999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.8e-40  Score=320.29  Aligned_cols=203  Identities=28%  Similarity=0.408  Sum_probs=171.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|...+.||+|+||+||+|++..+++.||||.++.... ...+.+.+|++++++++||||++++++|.     ..+..
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCCc
Confidence            4568888999999999999999988899999999874432 22356889999999999999999999963     34568


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...          ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       188 ~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl  254 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTE----------GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKI  254 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHH----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEcCCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEE
Confidence            9999999999999998642          23588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++......  .........+++.|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       255 ~DfG~s~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~  317 (377)
T 3cbl_A          255 SDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP  317 (377)
T ss_dssp             CCGGGCEECTTSE--EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CcCCCceecCCCc--eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999997543211  0111112236788999999988889999999999999999999 999984

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8e-39  Score=299.51  Aligned_cols=201  Identities=26%  Similarity=0.464  Sum_probs=154.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|.+.+.||+|+||.||+|+...+|+.||+|+++...   ....+.+.+|++++++++||||+++++++     .+.+
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence            356888999999999999999998899999999996432   23347889999999999999999999985     3456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|+||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~  151 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRV----------KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNI  151 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCS----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence            7899999999999999997542          4688999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++.........    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       152 kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  213 (278)
T 3cok_A          152 KIADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD  213 (278)
T ss_dssp             EECCCTTCEECC--------------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEeecceeeccCCCCc----ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999865422211    123468999999999998889999999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.9e-39  Score=315.61  Aligned_cols=204  Identities=26%  Similarity=0.408  Sum_probs=162.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...  .....+.+.+|+.+++.+. ||||+++++++..   .+..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---TTSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---CCCC
Confidence            46799999999999999999999999999999998533  2233466789999999997 9999999998643   2344


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||++ |+|.+++..            ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA------------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH------------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             EEEEEecccC-cCHHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCE
Confidence            6899999996 689988853            2588889999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCC-----------------ceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCC
Q 041632          387 HIGDFGLSRFYQAVSNP-----------------TVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTK  448 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~  448 (452)
                      ||+|||+++.+......                 .........||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  228 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK  228 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence            99999999865421110                 0111234579999999999876 67899999999999999999999


Q ss_pred             CCCC
Q 041632          449 KPTD  452 (452)
Q Consensus       449 ~Pf~  452 (452)
                      .||.
T Consensus       229 ~pf~  232 (388)
T 3oz6_A          229 PIFP  232 (388)
T ss_dssp             CSCC
T ss_pred             CCCC
Confidence            9994

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.6e-39  Score=315.58  Aligned_cols=222  Identities=24%  Similarity=0.354  Sum_probs=178.4

Q ss_pred             ChHHHHHhhcCCCCCCceeccCceeEEEEE-----EcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEe
Q 041632          222 SYKSLLKATDGFSSTNLIGVGSFGSVYKGV-----FDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVI  294 (452)
Q Consensus       222 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~  294 (452)
                      ....+....++|++.+.||+|+||.||+|+     ...+++.||||+++.... ...+.+.+|+++++++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            344455567889999999999999999999     445678999999975433 2336799999999999 899999999


Q ss_pred             eeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCc------------------------------------------
Q 041632          295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR------------------------------------------  332 (452)
Q Consensus       295 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------  332 (452)
                      +++..    .+...++||||+++|+|.+++........                                          
T Consensus        93 ~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           93 GACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             EEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            98643    33457999999999999999976532100                                          


Q ss_pred             -------------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccccccc
Q 041632          333 -------------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA  399 (452)
Q Consensus       333 -------------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  399 (452)
                                   ........+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                         0000122389999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       400 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||+| |+.||+
T Consensus       246 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  297 (359)
T 3vhe_A          246 DPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  297 (359)
T ss_dssp             CTTC--EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cccc--hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence            2221  22234568999999999988899999999999999999999 999984

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.4e-39  Score=303.76  Aligned_cols=198  Identities=28%  Similarity=0.443  Sum_probs=165.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||+||+|+. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.     +.+..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeE
Confidence            4688889999999999999998 578999999996443  223477889999999999999999999853     44578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||++ ++|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  141 (288)
T 1ob3_A           76 VLVFEHLD-QDLKKLLDVCE----------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKI  141 (288)
T ss_dssp             EEEEECCS-EEHHHHHHTST----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             EEEEEecC-CCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            99999996 49998886532          3588899999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.......    ......||+.|+|||++.+. .++.++||||+||++|||+||+.||+
T Consensus       142 ~Dfg~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  202 (288)
T 1ob3_A          142 ADFGLARAFGIPVR----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP  202 (288)
T ss_dssp             CCTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eECccccccCcccc----ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999986542211    11234589999999998764 58999999999999999999999984

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7.2e-39  Score=315.14  Aligned_cols=199  Identities=22%  Similarity=0.307  Sum_probs=162.8

Q ss_pred             cCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHh-cCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALK-NIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~-~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|.+. +.||+|+||+||++++..+|+.||||+++.     ...+.+|++++. ..+||||+++++++... +.+....
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcEE
Confidence            456655 689999999999999999999999999963     256778888874 45899999999986432 2345678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---CCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~  385 (452)
                      ++||||+++|+|.+++....         ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.   ++.
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~  202 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG---------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI  202 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC------------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCC
T ss_pred             EEEEEeCCCCcHHHHHHHhC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCcc
Confidence            99999999999999997542         23589999999999999999999998   9999999999999997   789


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       203 ~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  264 (400)
T 1nxk_A          203 LKLTDFGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_dssp             EEECCCTTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEEEecccccccCCCC-----ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence            9999999998654221     1123568999999999999999999999999999999999999984

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.2e-38  Score=300.89  Aligned_cols=215  Identities=35%  Similarity=0.564  Sum_probs=181.3

Q ss_pred             hhcccChHHHHHhhcCCCCC------CceeccCceeEEEEEEcCCCcEEEEEEeeccC----CccHHHHHHHHHHHhcCC
Q 041632          217 ALLKMSYKSLLKATDGFSST------NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR----QGASKSFMAECKALKNIR  286 (452)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~  286 (452)
                      ....+++.++..++++|...      +.||+|+||.||+|++  +++.||||++....    ....+.+.+|+++++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            45678889999999888777      8999999999999987  57899999986432    233578999999999999


Q ss_pred             CCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 041632          287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQE  366 (452)
Q Consensus       287 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  366 (452)
                      ||||+++++++.     +.+..++||||+++|+|.+++....        ....+++..++.++.|++.||+|||+.   
T Consensus        89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lH~~---  152 (307)
T 2nru_A           89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLD--------GTPPLSWHMRCKIAQGAANGINFLHEN---  152 (307)
T ss_dssp             CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGG--------GCCCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHhcC---
Confidence            999999999853     4457899999999999999986432        124689999999999999999999998   


Q ss_pred             CeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh
Q 041632          367 PILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       367 ~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt  446 (452)
                      +|+||||||+||++++++.+||+|||+++.........  ......||+.|+|||.+.+ .++.++||||||+++|||+|
T Consensus       153 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~  229 (307)
T 2nru_A          153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV--MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT  229 (307)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE--ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeecccccccccccccc--cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH
Confidence            99999999999999999999999999998654322211  1223568999999998765 58899999999999999999


Q ss_pred             CCCCCC
Q 041632          447 TKKPTD  452 (452)
Q Consensus       447 g~~Pf~  452 (452)
                      |+.||+
T Consensus       230 g~~p~~  235 (307)
T 2nru_A          230 GLPAVD  235 (307)
T ss_dssp             CCCSBC
T ss_pred             CCCCcc
Confidence            999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.3e-39  Score=298.54  Aligned_cols=200  Identities=29%  Similarity=0.474  Sum_probs=172.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||+|++. ++..||+|+++... ...+++.+|++++++++||||+++++++     .+....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            457888999999999999999886 67789999997443 3457799999999999999999999985     3455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++...          ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~  146 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH----------GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVS  146 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH----------GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEc
Confidence            999999999999998642          23589999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||++.......   ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       147 Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  207 (268)
T 3sxs_A          147 DFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD  207 (268)
T ss_dssp             CTTCEEECCTTC---EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cCccceecchhh---hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcc
Confidence            999998654321   122234457788999999988889999999999999999999 999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.7e-39  Score=309.96  Aligned_cols=199  Identities=25%  Similarity=0.393  Sum_probs=172.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--------cHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--------ASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      .++|+..+.||+|+||+||+|++..+++.||||+++.....        ..+.+.+|++++++++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            45789999999999999999999999999999999754321        224577899999999999999999984    


Q ss_pred             CCCCceeEEEEeccCCC-ChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          302 FQGNDFKAIVYKYMPNG-SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                       .+.+..++||||+.+| +|.+++....           .+++..++.++.|++.||+|||+.   +|+||||||+|||+
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  163 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFIDRHP-----------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVI  163 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHHTCC-----------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEE
Confidence             4456889999999777 9999987543           589999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.++.+||+|||+++........     ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus       164 ~~~~~~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  231 (335)
T 3dls_A          164 AEDFTIKLIDFGSAAYLERGKLF-----YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC  231 (335)
T ss_dssp             CTTSCEEECCCTTCEECCTTCCB-----CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             cCCCcEEEeecccceECCCCCce-----eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence            99999999999999866533221     23569999999999888776 789999999999999999999984

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.4e-39  Score=317.73  Aligned_cols=207  Identities=26%  Similarity=0.342  Sum_probs=170.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  ...+.+.+|+++++.++||||+++++++....+.....
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            4679999999999999999999999999999999974322  33467899999999999999999999976544444467


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||++ |+|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-----------~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~k  169 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-----------IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVK  169 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEE
Confidence            899999995 6999998653           3589999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCce------------------eccccccccccccCcccc-CCCCCCcccceeehhHHHHHHHhCC
Q 041632          388 IGDFGLSRFYQAVSNPTV------------------SSSIGVRGTIGYVAPEYG-LGSEVSTNGDVYSYGILLLEMVTTK  448 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~  448 (452)
                      |+|||+++..........                  .......||+.|+|||++ ....++.++||||+||++|||++|.
T Consensus       170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred             EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence            999999987653321100                  112456799999999985 5567999999999999999999866


Q ss_pred             CCC
Q 041632          449 KPT  451 (452)
Q Consensus       449 ~Pf  451 (452)
                      .||
T Consensus       250 ~p~  252 (432)
T 3n9x_A          250 QSH  252 (432)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            554

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-38  Score=308.44  Aligned_cols=209  Identities=26%  Similarity=0.403  Sum_probs=173.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccC---CC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDF---QG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~---~~  304 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++....  ......+.+|+++++.++||||+++++++.....   ..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            357889999999999999999999899999999986443  2334678899999999999999999998765321   11


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||++ |+|.+.+....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~  161 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNVL----------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDG  161 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred             CceEEEEEeccC-CCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCC
Confidence            456899999996 57777775432          3589999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.+...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||+
T Consensus       162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  230 (351)
T 3mi9_A          162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ  230 (351)
T ss_dssp             CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999998765333332233344668999999998876 458999999999999999999999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=316.98  Aligned_cols=208  Identities=25%  Similarity=0.387  Sum_probs=169.6

Q ss_pred             cCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|.+.+.||+|+||+||+|++     ..+++.||||+++... ......+.+|+.++++++||||+++++++     .+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~  145 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-----LQ  145 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----ec
Confidence            4688889999999999999995     3467789999996432 23345788999999999999999999985     34


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      ....++||||+++|+|.+++.....    .......+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  218 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRP----RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPG  218 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSC----CSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSS
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhcc----ccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCC
Confidence            4567999999999999999975331    112234689999999999999999999998   999999999999999554


Q ss_pred             ---ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 ---SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ---~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                         .+||+|||+++.........  ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       219 ~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~  288 (367)
T 3l9p_A          219 PGRVAKIGDFGMARDIYRAGYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP  288 (367)
T ss_dssp             TTCCEEECCCHHHHHHHHHSSCT--TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCceEEECCCccccccccccccc--cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence               59999999998653222111  1123457999999999988899999999999999999998 999984

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-38  Score=298.66  Aligned_cols=196  Identities=29%  Similarity=0.473  Sum_probs=167.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc-------HHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA-------SKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      .++|+..+.||+|+||+||+|++..+++.||+|++.......       .+.+.+|++++++++||||+++++++..   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   94 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---   94 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---
Confidence            367888999999999999999999899999999996443222       1678999999999999999999998532   


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCCeee
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP--ILHCDLKPSNILL  380 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill  380 (452)
                        .  .++||||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +  |+||||||+||++
T Consensus        95 --~--~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~  157 (287)
T 4f0f_A           95 --P--PRMVMEFVPCGDLYHRLLDKA----------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFL  157 (287)
T ss_dssp             --T--TEEEEECCTTCBHHHHHHCTT----------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEE
T ss_pred             --C--CeEEEEecCCCCHHHHHhccc----------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEE
Confidence              2  269999999999999886543          4689999999999999999999998   7  9999999999999


Q ss_pred             cCCCc-----eEECccccccccccCCCCceeccccccccccccCccccC--CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          381 DNDLS-----AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL--GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~~~~~-----~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.++.     +||+|||+++....       ......||+.|+|||++.  ...++.++|||||||++|||++|+.||+
T Consensus       158 ~~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  229 (287)
T 4f0f_A          158 QSLDENAPVCAKVADFGLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD  229 (287)
T ss_dssp             SCCCTTCSCCEEECCCTTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             eccCCCCceeEEeCCCCccccccc-------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCc
Confidence            88776     99999999974332       112356899999999983  4567899999999999999999999984

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.6e-39  Score=299.85  Aligned_cols=199  Identities=26%  Similarity=0.436  Sum_probs=171.0

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      +.++|++.+.||+|+||+||+|++..+++.||+|++....   ....+.+.+|++++++++||||+++++++     .+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   81 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA   81 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecC
Confidence            3467889999999999999999999999999999996432   23346789999999999999999999985     345


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~  147 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL-----------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGE  147 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSC
T ss_pred             CEEEEEEecCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCC
Confidence            6789999999999999998543           3588999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++.......      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       148 ~~l~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  208 (279)
T 3fdn_A          148 LKIADFGWSVHAPSSR------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE  208 (279)
T ss_dssp             EEECSCCEESCC--------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEEEeccccccCCccc------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCC
Confidence            9999999986443221      123468999999999999899999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.1e-39  Score=309.64  Aligned_cols=201  Identities=26%  Similarity=0.481  Sum_probs=164.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcE----EEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|+..+.||+|+||+||+|++..+++.    ||+|.+... .....+.+.+|++++++++||||++++++|..      
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------   88 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   88 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence            5688889999999999999998777765    577877533 23455789999999999999999999998753      


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++++||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~  155 (327)
T 3poz_A           89 STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHST----------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred             CCeEEEEEecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCC
Confidence            23678999999999999996533          4688999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++.........  ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       156 ~kl~Dfg~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  221 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             EEECCTTHHHHHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEEccCcceeEccCCcccc--cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence            9999999998765332221  2223457889999999998899999999999999999999 999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.3e-39  Score=313.31  Aligned_cols=208  Identities=19%  Similarity=0.314  Sum_probs=168.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC-----CcEEEEEEeeccCCcc-----------HHHHHHHHHHHhcCCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED-----GTVVAIKVINLQRQGA-----------SKSFMAECKALKNIRHKNLVRV  293 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~ei~~l~~l~h~niv~l  293 (452)
                      .++|.+.+.||+|+||+||+|++..+     ++.||||++.......           ...+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45799999999999999999998754     5789999987443211           1234456667788899999999


Q ss_pred             eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeccc
Q 041632          294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDL  373 (452)
Q Consensus       294 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dl  373 (452)
                      ++++... ..+....++||||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||
T Consensus       114 ~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDl  178 (364)
T 3op5_A          114 WGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANA----------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDI  178 (364)
T ss_dssp             EEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             Eeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecC
Confidence            9987543 12235689999999 999999986432          4689999999999999999999998   9999999


Q ss_pred             CCCCeeec--CCCceEECccccccccccCCCCc---eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCC
Q 041632          374 KPSNILLD--NDLSAHIGDFGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK  448 (452)
Q Consensus       374 k~~Nill~--~~~~~kl~Dfgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~  448 (452)
                      ||+|||++  .++.+||+|||+++.+.......   ........||+.|+|||++.+..++.++|||||||++|||+||+
T Consensus       179 kp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~  258 (364)
T 3op5_A          179 KASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH  258 (364)
T ss_dssp             CGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999  88999999999998665322111   11113345999999999999989999999999999999999999


Q ss_pred             CCCC
Q 041632          449 KPTD  452 (452)
Q Consensus       449 ~Pf~  452 (452)
                      .||+
T Consensus       259 ~Pf~  262 (364)
T 3op5_A          259 LPWE  262 (364)
T ss_dssp             CTTG
T ss_pred             CCcc
Confidence            9994

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-39  Score=305.35  Aligned_cols=203  Identities=26%  Similarity=0.361  Sum_probs=166.9

Q ss_pred             cCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +.|.+. +.||+|+||+||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++.     +.+..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDRF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEE
Confidence            567774 7899999999999999889999999999876666678899999999885 7999999999853     45688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc---
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS---  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---  385 (452)
                      ++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.   
T Consensus        87 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~  152 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKR-----------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSP  152 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCS
T ss_pred             EEEEEcCCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCc
Confidence            9999999999999998642           3588999999999999999999998   9999999999999998776   


Q ss_pred             eEECccccccccccCCCCc---eeccccccccccccCccccCC-----CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLG-----SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.........   ........||+.|+|||++..     ..++.++|||||||++|||+||+.||.
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  227 (316)
T 2ac3_A          153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV  227 (316)
T ss_dssp             EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCc
Confidence            9999999987654221110   111123459999999999764     458899999999999999999999984

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.8e-39  Score=301.83  Aligned_cols=201  Identities=28%  Similarity=0.491  Sum_probs=169.7

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|++.+.||+|+||+||++++. ++..||+|+++... ...+++.+|++++++++||||+++++++     .+.+..
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            4567888999999999999999986 67889999997443 3457899999999999999999999985     345578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl  161 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR----------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV  161 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG----------GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEE
T ss_pred             EEEEeccCCCcHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEE
Confidence            99999999999999996532          4689999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++.....   .........+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||+
T Consensus       162 ~Dfg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~  223 (283)
T 3gen_A          162 SDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE  223 (283)
T ss_dssp             CSTTGGGGBCCH---HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cccccccccccc---ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            999999765321   1112223457889999999988889999999999999999998 999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.1e-39  Score=309.02  Aligned_cols=196  Identities=26%  Similarity=0.399  Sum_probs=167.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|+..+.||+|+||+||+++++.+|+.||+|+++.....    ..+|++++.++ +||||+++++++     .+.+..
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY-----DDGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEE
Confidence            46789999999999999999999999999999999754432    35688888887 799999999984     456688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC----C
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND----L  384 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~----~  384 (452)
                      ++||||+++|+|.+++....           .+++.++..++.|++.||+|||+.   +|+||||||+|||+.++    +
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~-----------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~  157 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK-----------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPE  157 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT-----------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGG
T ss_pred             EEEEeCCCCCcHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcC
Confidence            99999999999999986543           589999999999999999999998   99999999999998543    3


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++........    .....||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       158 ~~kl~Dfg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~  221 (342)
T 2qr7_A          158 SIRICDFGFAKQLRAENGL----LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA  221 (342)
T ss_dssp             GEEECCCTTCEECBCTTCC----BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eEEEEECCCcccCcCCCCc----eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence            5999999999866533221    123568999999999888789999999999999999999999984

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.8e-38  Score=299.99  Aligned_cols=202  Identities=22%  Similarity=0.309  Sum_probs=172.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||.||+|++..+|+.||||++....  ..+.+.+|++.++.+ +|+|++++++++     .+....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCcee
Confidence            457899999999999999999998899999999986433  235678999999999 899999999884     345578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc---
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS---  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---  385 (452)
                      ++||||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.   
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~  147 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG----------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNA  147 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTT
T ss_pred             EEEEEec-CCCHHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCC
Confidence            9999999 999999996432          3589999999999999999999998   9999999999999987776   


Q ss_pred             --eEECccccccccccCCCCce---eccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 --AHIGDFGLSRFYQAVSNPTV---SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 --~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                        +||+|||+++..........   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  219 (298)
T 1csn_A          148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  219 (298)
T ss_dssp             TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcc
Confidence              99999999987654322111   11234569999999999999899999999999999999999999984

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-38  Score=295.75  Aligned_cols=202  Identities=26%  Similarity=0.409  Sum_probs=173.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++.     +.+..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence            356888999999999999999999899999999997543 334578899999999999999999999853     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  146 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  146 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTT-----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCcHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEE
Confidence            9999999999999998643           3588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+.........  .......||+.|+|||.+.+..+ +.++||||||+++|||+||+.||+
T Consensus       147 ~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  209 (276)
T 2yex_A          147 SDFGLATVFRYNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  209 (276)
T ss_dssp             CCCTTCEECEETTEE--CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred             eeCCCccccCCCcch--hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence            999999865432211  11223568999999999887665 778999999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2e-38  Score=297.72  Aligned_cols=198  Identities=25%  Similarity=0.441  Sum_probs=173.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||.||+|+...+++.||+|++...   .....+.+.+|+++++.++||||+++++++.     +.+
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   87 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRK   87 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCC
Confidence            35788899999999999999999989999999999643   2334578899999999999999999999853     456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  153 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKH-----------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGEL  153 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCE
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCE
Confidence            789999999999999998643           3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++.......      .....|++.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus       154 kl~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  213 (284)
T 2vgo_A          154 KIADFGWSVHAPSLR------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD  213 (284)
T ss_dssp             EECCCTTCEECSSSC------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEecccccccCcccc------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence            999999987544221      123468999999999999899999999999999999999999985

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-38  Score=318.29  Aligned_cols=196  Identities=30%  Similarity=0.469  Sum_probs=167.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||+||+|.+.  |+.||||+++...  ..+.|.+|++++++++||||+++++++..    .....+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~  263 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY  263 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceE
Confidence            456888899999999999999984  7899999997543  45789999999999999999999998643    334689


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       264 iv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~  331 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVS  331 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC---------TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCcHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEe
Confidence            9999999999999996432         12468889999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++......       ....+++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       332 DfG~a~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~  388 (450)
T 1k9a_A          332 DFGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  388 (450)
T ss_dssp             CCTTCEECC-------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             eCCCcccccccc-------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999997543211       11247889999999999999999999999999999999 999984

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.6e-39  Score=323.99  Aligned_cols=202  Identities=27%  Similarity=0.489  Sum_probs=174.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||.||+|++..++..||||.++... ...++|.+|+++|++++||||++++++|.     ..+..+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~  292 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY  292 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEE
Confidence            456788899999999999999998889999999997543 34678999999999999999999999964     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       293 lv~E~~~~g~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~  360 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN---------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVA  360 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEccCCCCHHHHHHhcC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEe
Confidence            9999999999999996432         24588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++.....   .........++..|+|||++....++.++|||||||++|||+| |+.||.
T Consensus       361 DFG~a~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~  421 (495)
T 1opk_A          361 DFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  421 (495)
T ss_dssp             CTTCEECCTTC---CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ecccceeccCC---ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCC
Confidence            99999865422   1122223456789999999988889999999999999999999 999984

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.8e-38  Score=296.64  Aligned_cols=199  Identities=24%  Similarity=0.395  Sum_probs=172.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ...+.+.+|++++++++||||+++++++     .+.+.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence            4678999999999999999999998999999999975433  2336788999999999999999999985     34567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc--
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS--  385 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~--  385 (452)
                      .++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.  
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~  145 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR-----------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA  145 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTC
T ss_pred             EEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCC
Confidence            89999999999999888532           3589999999999999999999998   9999999999999986655  


Q ss_pred             -eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 -AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 -~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                       +||+|||++........     .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.
T Consensus       146 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          146 AVKLADFGLAIEVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             CEEECCCTTCEECCSSCB-----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cEEEeeceeeEEcccCcc-----ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence             99999999976543221     123568999999999999999999999999999999999999983

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-39  Score=312.43  Aligned_cols=204  Identities=26%  Similarity=0.472  Sum_probs=158.8

Q ss_pred             CCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .|...+.||+|+||+||+|++..+   +..||+|.++... ....+.+.+|++++++++||||++++++|.    ...+.
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence            356678899999999999997533   2468999986433 344578999999999999999999999863    33456


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k  232 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVK  232 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             eEEEEECCCCCCHHHHHhhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEE
Confidence            789999999999999997543          3578889999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |+|||+++.................+|+.|+|||.+.+..++.++|||||||++|||+| |..||+
T Consensus       233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~  298 (373)
T 3c1x_A          233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP  298 (373)
T ss_dssp             ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCC
Confidence            99999998654322222222233457889999999988899999999999999999999 677773

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=302.21  Aligned_cols=199  Identities=25%  Similarity=0.366  Sum_probs=166.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||+||+|++..+|+.||+|++......  ..+.+.+|++++++++||||+++++++.     +.+..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence            5788899999999999999999989999999998644332  2466889999999999999999999854     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        78 ~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl  143 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQ-----------RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKL  143 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTS-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEEeCCCchHHHHHhhh-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEE
Confidence            9999999999999887643           3588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++........    .....||+.|+|||++.+ ..++.++||||+|+++|||+||+.||+
T Consensus       144 ~Dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  204 (311)
T 4agu_A          144 CDFGFARLLTGPSDY----YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWP  204 (311)
T ss_dssp             CCCTTCEECC----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eeCCCchhccCcccc----cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            999999865432211    123468999999999876 568999999999999999999999984

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.6e-38  Score=298.53  Aligned_cols=200  Identities=24%  Similarity=0.327  Sum_probs=173.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|...+.||+|+||.||++++..+++.||+|++.....   ...+.+.+|+++++.++||||+++++++.     +.+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   88 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND   88 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCC
Confidence            3568889999999999999999998999999999975432   33467889999999999999999999853     455


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        89 ~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  154 (294)
T 2rku_A           89 FVFVVLELCRRRSLLELHKRR-----------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV  154 (294)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             EEEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCE
Confidence            789999999999999988532           3688999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++........    .....||+.|+|||.+.+..++.++||||||+++|||+||+.||+
T Consensus       155 kl~dfg~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  216 (294)
T 2rku_A          155 KIGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE  216 (294)
T ss_dssp             EECCCTTCEECCSTTCC----BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEEeccCceecccCccc----cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999865432221    123468999999999998889999999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7e-39  Score=306.89  Aligned_cols=201  Identities=24%  Similarity=0.426  Sum_probs=167.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcE----EEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|+..+.||+|+||+||+|++..+++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++.      +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence            5688889999999999999999877765    7777775332 233356789999999999999999999863      2


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++|+||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~  153 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHR----------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQ  153 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSG----------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHcc----------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCe
Confidence            35789999999999999997542          3678889999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++.........  ......||..|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       154 ~kl~Dfg~a~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~  219 (325)
T 3kex_A          154 VQVADFGVADLLPPDDKQL--LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA  219 (325)
T ss_dssp             EEECSCSGGGGSCCCTTCC--C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEECCCCcccccCcccccc--cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence            9999999998765332221  1223457889999999988899999999999999999999 999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-38  Score=308.17  Aligned_cols=195  Identities=29%  Similarity=0.398  Sum_probs=167.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +.|+..+.||+|+||+||+|+...+|+.||||++......   ..+.+.+|++++++++||||+++++++.     +.+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence            3477888999999999999999889999999999754332   2357889999999999999999999854     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||++ |++.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  194 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK  194 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred             EEEEEecCC-CCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEE
Confidence            899999996 78888775322          4689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.....        ....||+.|+|||++.   ...++.++|||||||++|||+||+.||.
T Consensus       195 L~DfG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  254 (348)
T 1u5q_A          195 LGDFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  254 (348)
T ss_dssp             ECCCTTCBSSSSB--------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EeeccCceecCCC--------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999765421        1246899999999874   5678999999999999999999999984

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.9e-38  Score=314.15  Aligned_cols=199  Identities=25%  Similarity=0.348  Sum_probs=162.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--------ccHHHHHHHHHHHhcCCCCCceeEeeeeccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--------GASKSFMAECKALKNIRHKNLVRVITSCSSV  300 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~  300 (452)
                      ..++|.+.+.||+|+||+||+|++..+++.||||++.....        .....+.+|++++++++||||+++++++.  
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            35689999999999999999999999999999999974321        11235789999999999999999998852  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                          .+..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+
T Consensus       211 ----~~~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll  272 (419)
T 3i6u_A          211 ----AEDYYIVLELMEGGELFDKVVGN-----------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL  272 (419)
T ss_dssp             ----SSEEEEEEECCTTCBGGGGTSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred             ----cCceEEEEEcCCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEE
Confidence                23478999999999999988643           3689999999999999999999998   99999999999999


Q ss_pred             cCCC---ceEECccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          381 DNDL---SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.++   .+||+|||+++......     ......||+.|+|||++.+   ..++.++|||||||++|||+||+.||.
T Consensus       273 ~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~  345 (419)
T 3i6u_A          273 SSQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS  345 (419)
T ss_dssp             SSSSSSCCEEECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecCCCcceEEEeecccceecCCCc-----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            7544   59999999998654221     1223569999999999753   568889999999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=309.11  Aligned_cols=200  Identities=28%  Similarity=0.366  Sum_probs=164.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~~  306 (452)
                      .++|+..+.||+|+||.||+|++..+|+.||||++.....  ...+.+.+|+++++.++||||+++++++.... ..+..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4578889999999999999999998999999999964322  23467889999999999999999999865432 11224


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+ +++|.+++..            ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~------------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  167 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH------------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL  167 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             eEEEEEecC-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCE
Confidence            569999999 8899999853            2578899999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.....       .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus       168 kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  227 (367)
T 1cm8_A          168 KILDFGLARQADSE-------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  227 (367)
T ss_dssp             EECCCTTCEECCSS-------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEeeecccccccc-------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999865422       123568999999999877 679999999999999999999999984

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-38  Score=304.61  Aligned_cols=200  Identities=24%  Similarity=0.330  Sum_probs=174.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|...+.||+|+||.||++++..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     +.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            356888999999999999999999899999999997543   233467889999999999999999999853     456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  180 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR-----------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV  180 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred             eEEEEEecCCCCCHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCE
Confidence            789999999999999988532           3688999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++........    .....||+.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus       181 kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  242 (335)
T 2owb_A          181 KIGDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE  242 (335)
T ss_dssp             EECCCTTCEECCSTTCC----BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEeeccCceecccCccc----ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence            99999999865432221    123568999999999998889999999999999999999999985

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=302.53  Aligned_cols=196  Identities=27%  Similarity=0.343  Sum_probs=161.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--cHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||+||+|++..+|+.||||++......  ....+..|+..+.++ +||||++++++|.     +.+.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            4688889999999999999999989999999998643322  223455566655555 9999999999854     4567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~k  197 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWG----------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK  197 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEE
T ss_pred             EEEEEecc-CCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEE
Confidence            89999999 789998886432          4689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||++........     .....||+.|+|||++.+ .++.++|||||||++|||++|..|+
T Consensus       198 l~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~  255 (311)
T 3p1a_A          198 LGDFGLLVELGTAGA-----GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELP  255 (311)
T ss_dssp             ECCCTTCEECC-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred             EccceeeeecccCCC-----CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999876543221     123458999999999876 7899999999999999999997665

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-38  Score=301.21  Aligned_cols=198  Identities=28%  Similarity=0.363  Sum_probs=169.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|.+.+.||+|+||.||+++...+|+.||+|+++.......+.+.+|++++++++||||+++++++     .+.+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEEE
Confidence            35688899999999999999999989999999999865554556789999999999999999999984     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~  386 (452)
                      +||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||++   ++++.+
T Consensus        83 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~  148 (304)
T 2jam_A           83 LVMQLVSGGELFDRILER-----------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKI  148 (304)
T ss_dssp             EEECCCCSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCE
T ss_pred             EEEEcCCCccHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCE
Confidence            999999999999988532           3588999999999999999999998   99999999999999   788999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.....      ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus       149 kl~Dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  208 (304)
T 2jam_A          149 MITDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY  208 (304)
T ss_dssp             EBCSCSTTCCCCCB------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEccCCcceecCCC------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999998754321      1122458999999999999899999999999999999999999984

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-39  Score=307.07  Aligned_cols=199  Identities=25%  Similarity=0.429  Sum_probs=162.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|...+.||+|+||+||+|++..+++.||+|++...... ....+.+|+++++.++||||+++++++     .+.+..+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEEE
Confidence            4688889999999999999999989999999999644322 122456799999999999999999985     3455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||++ |+|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~  142 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG----------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLA  142 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEEC
T ss_pred             EEecccc-cCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEc
Confidence            9999996 69998886432          3588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.......    ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||+
T Consensus       143 Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  202 (324)
T 3mtl_A          143 DFGLARAKSIPTK----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP  202 (324)
T ss_dssp             SSSEEECC----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCcccccccCCcc----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999975442211    1123468999999999876 568999999999999999999999984

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-38  Score=300.44  Aligned_cols=201  Identities=22%  Similarity=0.284  Sum_probs=163.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|.+.+.||+|+||.||+|++..+++.||+|++......   ..+.+.+|++++++++||||+++++++.     ..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence            46799999999999999999999889999999999754322   2367899999999999999999999853     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|+||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~  173 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQ-----------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA  173 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             eEEEEEEecCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence            789999999999999998642           3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++........   .......||+.|+|||.+.+..++.++||||||+++|||+||+.||+
T Consensus       174 kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (309)
T 2h34_A          174 YLVDFGIASATTDEKL---TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ  236 (309)
T ss_dssp             EECSCCC-------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEecCccCcccccccc---ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence            9999999876543221   11223468999999999999899999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.6e-39  Score=300.97  Aligned_cols=194  Identities=25%  Similarity=0.422  Sum_probs=167.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCC-------cEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDG-------TVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      ++|.+.+.||+|+||+||+|++..++       ..||+|+++.......+.+.+|++++++++||||+++++++.     
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   82 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV-----   82 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-----
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----
Confidence            56888899999999999999987666       479999998766666788999999999999999999999853     


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNK----------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence            4457799999999999999996432          3488999999999999999999998   99999999999999988


Q ss_pred             Cc--------eEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCC
Q 041632          384 LS--------AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       384 ~~--------~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      +.        +||+|||++.....        .....||+.|+|||++.+ ..++.++|||||||++|||+||..|
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~  217 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLP--------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK  217 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSC--------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CcccccccceeeeccCcccccccC--------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence            87        99999999864431        112458899999999887 6789999999999999999995444

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-38  Score=295.99  Aligned_cols=198  Identities=24%  Similarity=0.353  Sum_probs=170.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ------GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|++.+.||+|+||.||+|+...+|+.||+|+++....      ...+.+.+|++++++++||||+++++++.     +
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            468888999999999999999998999999999975432      23578999999999999999999999853     4


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~  145 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK-----------ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKN  145 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCC
Confidence            55789999999999999998532           3689999999999999999999998   999999999999999877


Q ss_pred             ----ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 ----SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ----~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                          .+||+|||++........     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       146 ~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          146 VPNPRIKLIDFGIAHKIEAGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  212 (283)
T ss_dssp             SSSCCEEECCCTTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCceEEEecccceeccCCCc-----ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence                899999999986543221     123458999999999998899999999999999999999999984

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-38  Score=298.16  Aligned_cols=201  Identities=27%  Similarity=0.373  Sum_probs=167.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|.+.+.||+|+||+||+++...+++.||+|++.... ....+.+.+|++++++++||||+++++++     .+....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeEE
Confidence            46888899999999999999999899999999997554 33457899999999999999999999985     3455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~  386 (452)
                      +||||+++|+|.+++....       .....+++..++.++.|++.||+|||+.   +|+||||||+||++   +.++.+
T Consensus        97 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~  166 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQ-------ARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPI  166 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCE
T ss_pred             EEEEeCCCCcHHHHHHhhh-------hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCE
Confidence            9999999999999885321       1124689999999999999999999998   99999999999999   456789


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......     .....||+.|+|||++. ..++.++||||||+++|||++|+.||+
T Consensus       167 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~  226 (285)
T 3is5_A          167 KIIDFGLAELFKSDEH-----STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT  226 (285)
T ss_dssp             EECCCCCCCC---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEeeecceecCCccc-----CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence            9999999976543221     12346899999999875 578999999999999999999999984

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=307.71  Aligned_cols=214  Identities=24%  Similarity=0.407  Sum_probs=173.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..++|+..+.||+|+||.||+|++.     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.    
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence            4578999999999999999999986     3458999999975433 33467899999999999999999999853    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCC-------------cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQ-------------RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL  369 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  369 (452)
                       +.+..++||||+++|+|.+++.......             +........+++.+++.++.|++.||+|||+.   +|+
T Consensus       121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv  196 (343)
T 1luf_A          121 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV  196 (343)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             -cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence             3457899999999999999997542110             00011125789999999999999999999998   999


Q ss_pred             ecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CC
Q 041632          370 HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TK  448 (452)
Q Consensus       370 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~  448 (452)
                      ||||||+||+++.++.+||+|||+++........  .......+|+.|+|||.+.+..++.++||||||+++|||+| |+
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            9999999999999999999999999865432211  11123458899999999888889999999999999999999 99


Q ss_pred             CCCC
Q 041632          449 KPTD  452 (452)
Q Consensus       449 ~Pf~  452 (452)
                      .||.
T Consensus       275 ~p~~  278 (343)
T 1luf_A          275 QPYY  278 (343)
T ss_dssp             CTTT
T ss_pred             CcCC
Confidence            9984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.9e-38  Score=306.53  Aligned_cols=207  Identities=27%  Similarity=0.334  Sum_probs=174.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..++|+..+.||+|+||.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++++..........
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            34679999999999999999999998999999999974332 23367899999999999999999999876554455567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||++ |+|.+++..            ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       105 ~~iv~e~~~-~~L~~~l~~------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~k  168 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK  168 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             EEEEEcccC-cCHHHHHHh------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEE
Confidence            899999996 699998853            2488999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++......... .......||+.|+|||++.+ ..++.++||||+||++|||+||+.||+
T Consensus       169 l~Dfg~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  233 (364)
T 3qyz_A          169 ICDFGLARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP  233 (364)
T ss_dssp             ECCCTTCEECCGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEeCcceEecCCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCC
Confidence            99999998655322211 11223569999999998654 458999999999999999999999984

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=298.91  Aligned_cols=196  Identities=32%  Similarity=0.515  Sum_probs=162.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||+||+|++  .++.||+|.+..  ....+.+.+|++++++++||||+++++++.       +..++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~l   76 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCL   76 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEE
Confidence            4688889999999999999998  478899999853  334578999999999999999999998853       23689


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc-eEEC
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS-AHIG  389 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~-~kl~  389 (452)
                      ||||+++|+|.+++....        ....+++.+++.++.|++.||+|||+.+..+|+||||||+||+++.++. +||+
T Consensus        77 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~  148 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAE--------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC  148 (307)
T ss_dssp             EEECCTTCBHHHHHHCSS--------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEcCCCCCHHHHHhccC--------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence            999999999999997543        1235788899999999999999999943349999999999999998886 7999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.......       ....||+.|+|||++.+..++.++||||||+++|||+||+.||+
T Consensus       149 Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~  204 (307)
T 2eva_A          149 DFGTACDIQTHM-------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD  204 (307)
T ss_dssp             CCCC-------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred             cccccccccccc-------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCch
Confidence            999997544211       12358999999999999899999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=305.59  Aligned_cols=214  Identities=25%  Similarity=0.417  Sum_probs=171.8

Q ss_pred             hhcCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      ..++|.+.+.||+|+||.||+|++     ..+++.||+|+++... ....+.+.+|+++++++ +||||+++++++.   
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            346788899999999999999997     3456789999997432 23447899999999999 9999999999853   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCc------------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR------------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPIL  369 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  369 (452)
                        ..+..++||||+++|+|.+++........            ........+++.+++.++.|++.||+|||+.   +|+
T Consensus       120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv  194 (344)
T 1rjb_A          120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV  194 (344)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence              34578999999999999999976531100            0011124589999999999999999999998   999


Q ss_pred             ecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CC
Q 041632          370 HCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TK  448 (452)
Q Consensus       370 H~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~  448 (452)
                      ||||||+||+++.++.+||+|||++..........  ......||+.|+|||.+.+..++.++|||||||++|||+| |+
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccce--eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999998665433221  2223457889999999988889999999999999999998 99


Q ss_pred             CCCC
Q 041632          449 KPTD  452 (452)
Q Consensus       449 ~Pf~  452 (452)
                      .||+
T Consensus       273 ~p~~  276 (344)
T 1rjb_A          273 NPYP  276 (344)
T ss_dssp             CSST
T ss_pred             CCcc
Confidence            9984

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-39  Score=314.32  Aligned_cols=203  Identities=24%  Similarity=0.380  Sum_probs=171.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|.+.+.||+|+||+||+|++..+|+.||||+++... ....+.+.+|++++++++||||+++++++..   ......+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCCeeE
Confidence            56888999999999999999999899999999997433 2345778899999999999999999998642   2234679


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee----cCCCc
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDLS  385 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~~  385 (452)
                      +||||+++|+|.+++....        ....+++.+++.++.|++.||+|||+.   +|+||||||+|||+    +.++.
T Consensus        86 lv~e~~~~g~L~~~l~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  154 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPS--------NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSV  154 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGG--------GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEE
T ss_pred             EEEecCCCCCHHHHHHhhh--------cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCcee
Confidence            9999999999999996532        123389999999999999999999998   99999999999999    77888


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCC--------CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--------SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......     ......||+.|+|||++.+        ..++.++|||||||++|||+||+.||.
T Consensus       155 ~kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~  224 (396)
T 4eut_A          155 YKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (396)
T ss_dssp             EEECCGGGCEECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred             EEEecCCCceEccCCC-----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999999998654321     1123569999999998764        467889999999999999999999983

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-38  Score=305.58  Aligned_cols=204  Identities=24%  Similarity=0.402  Sum_probs=175.3

Q ss_pred             cCCCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++..   .+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCCc
Confidence            5788899999999999999994    56789999999976655556779999999999999999999988642   3456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~  166 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR----------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHV  166 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred             eEEEEEeecCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCE
Confidence            7899999999999999986422          3589999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+++........ ........||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       167 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~  230 (327)
T 3lxl_A          167 KIADFGLAKLLPLDKDY-YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS  230 (327)
T ss_dssp             EECCGGGCEECCTTCSE-EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             EEcccccceecccCCcc-ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            99999999876533221 12223355888999999998888999999999999999999999997

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.6e-38  Score=318.17  Aligned_cols=201  Identities=28%  Similarity=0.499  Sum_probs=171.0

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|...+.||+|+||+||+|++. ++..||||.++... ...+.|.+|++++++++||||+++++++.      .+..
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~  257 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPI  257 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCcc
Confidence            3466888899999999999999996 57889999997543 44688999999999999999999999853      2357


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl  325 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE---------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI  325 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH---------HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEE
T ss_pred             EEEEeecCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEE
Confidence            99999999999999996431         23578889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++......   ........+|+.|+|||++....++.++|||||||++|||+| |+.||+
T Consensus       326 ~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~  387 (454)
T 1qcf_A          326 ADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP  387 (454)
T ss_dssp             CSTTGGGGBCCHH---HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             eeCCCceEcCCCc---eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence            9999998654211   111122346889999999988889999999999999999999 999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.5e-38  Score=295.98  Aligned_cols=198  Identities=28%  Similarity=0.417  Sum_probs=173.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      +.|+..+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.     +.+..+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence            56888899999999999999998899999999997543 344578999999999999999999999854     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++..            ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        97 lv~e~~~~~~L~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  161 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP------------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA  161 (303)
T ss_dssp             EEEECCTTEEHHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEeCCCCcHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence            99999999999999863            2588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++........    ......||+.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus       162 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  220 (303)
T 3a7i_A          162 DFGVAGQLTDTQI----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS  220 (303)
T ss_dssp             CCTTCEECBTTBC----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ecccceecCcccc----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence            9999976543221    1123468999999999998899999999999999999999999984

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.3e-38  Score=305.54  Aligned_cols=201  Identities=27%  Similarity=0.442  Sum_probs=162.9

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ...++|++.+.||+|+||+||+|++..+++.||||+++....  ...+.+.+|++++++++||||+++++++.     +.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence            345789999999999999999999999999999999974432  22456789999999999999999999853     45


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec----
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD----  381 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~----  381 (452)
                      +..++||||++ |+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++    
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~-----------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKN-----------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHC-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred             CEEEEEEecCC-CCHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence            67899999996 5999998643           2588999999999999999999998   999999999999994    


Q ss_pred             -CCCceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 -NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                       +++.+||+|||+++.......    ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  239 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIPIR----QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFP  239 (329)
T ss_dssp             --CCEEEECCTTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CccceEEECcCCCccccCCccc----ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence             455699999999986542221    12234589999999998774 48999999999999999999999984

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-38  Score=319.36  Aligned_cols=197  Identities=28%  Similarity=0.457  Sum_probs=172.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|+..+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|++++++++||||+++++++     .+.+.
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  100 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKGY  100 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence            56888999999999999999999999999999997442   34457899999999999999999999984     44568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCC
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDL  384 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~  384 (452)
                      .++|+||+.+|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+   +.++
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  166 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISR-----------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA  166 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-----------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred             EEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCC
Confidence            89999999999999998654           3588999999999999999999998   99999999999999   5678


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.+.....     .....||+.|+|||++.+ .++.++||||+||++|||++|+.||.
T Consensus       167 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  228 (484)
T 3nyv_A          167 NIRIIDFGLSTHFEASKK-----MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFN  228 (484)
T ss_dssp             CEEECCTTHHHHBCCCCS-----HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cEEEEeeeeeEEcccccc-----cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCC
Confidence            999999999986653221     223569999999999876 68999999999999999999999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-38  Score=304.81  Aligned_cols=201  Identities=27%  Similarity=0.428  Sum_probs=164.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-----cHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-----ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      ..++|+..+.||+|+||.||+|++..+|+.||||++......     ..+.+.+|+++++.++||||+++++++     .
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~   82 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----G   82 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----e
Confidence            346799999999999999999999888999999999743221     124688999999999999999999984     4


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..++||||+++ +|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        83 ~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~  148 (346)
T 1ua2_A           83 HKSNISLVFDFMET-DLEVIIKDNS----------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN  148 (346)
T ss_dssp             CTTCCEEEEECCSE-EHHHHHTTCC----------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             eCCceEEEEEcCCC-CHHHHHHhcC----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCC
Confidence            45678999999975 8988886543          3577788999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||+++.......    ......||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus       149 ~~~kl~Dfg~a~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~  214 (346)
T 1ua2_A          149 GVLKLADFGLAKSFGSPNR----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP  214 (346)
T ss_dssp             CCEEECCCGGGSTTTSCCC----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCEEEEecccceeccCCcc----cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999986543221    12235689999999998664 58899999999999999999999984

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.9e-38  Score=300.87  Aligned_cols=213  Identities=25%  Similarity=0.377  Sum_probs=173.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|.+.+.||+|+||.||+|++.     .+++.||+|+++.... ...+.+.+|++++++++||||+++++++     .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----S   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----e
Confidence            457888899999999999999973     4568999999975432 3346789999999999999999999985     3


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCc-------------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQR-------------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILH  370 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  370 (452)
                      +.+..++||||+++|+|.+++........             ........+++.+++.++.|++.||+|||+.   +|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcc
Confidence            45578999999999999999975431100             0001124589999999999999999999998   9999


Q ss_pred             cccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCC
Q 041632          371 CDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKK  449 (452)
Q Consensus       371 ~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~  449 (452)
                      |||||+||++++++.+||+|||+++.......  ........+|+.|+|||.+.+..++.++|||||||++|||+| |+.
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccchheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999986543221  112223457889999999988889999999999999999999 999


Q ss_pred             CCC
Q 041632          450 PTD  452 (452)
Q Consensus       450 Pf~  452 (452)
                      ||+
T Consensus       252 p~~  254 (314)
T 2ivs_A          252 PYP  254 (314)
T ss_dssp             SST
T ss_pred             CCC
Confidence            984

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-38  Score=304.62  Aligned_cols=214  Identities=21%  Similarity=0.412  Sum_probs=158.7

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCc---EEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGT---VVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      ..++|++.+.||+|+||+||+|++..++.   .||||+++..  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45679999999999999999999876664   8999999754  334457899999999999999999999986543211


Q ss_pred             C-CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          304 G-NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       304 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      . ....++|+||+++|+|.+++.....     ......+++.+++.++.|++.||+|||+.   +|+||||||+|||+++
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~  172 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRI-----GENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE  172 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC--------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhc-----cccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence            1 1123899999999999999864321     01123589999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++.+||+|||+++........  .......+++.|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  241 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA  241 (323)
T ss_dssp             TSCEEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCEEEeeccccccccccccc--cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            999999999999865432211  11223457889999999988889999999999999999999 999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.8e-38  Score=304.17  Aligned_cols=210  Identities=24%  Similarity=0.289  Sum_probs=170.6

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-----------cHHHHHHHHHHHhcCCCCCce
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-----------ASKSFMAECKALKNIRHKNLV  291 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~ei~~l~~l~h~niv  291 (452)
                      .+++....++|...+.||+|+||.||+|+.. +|+.||||++......           ..+.+.+|++++++++||||+
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            4566777899999999999999999999986 5899999999643221           126789999999999999999


Q ss_pred             eEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEec
Q 041632          292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHC  371 (452)
Q Consensus       292 ~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  371 (452)
                      ++++++...........++||||++ |+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~  158 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----------IVISPQHIQYFMYHILLGLHVLHEA---GVVHR  158 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHHC---cCEec
Confidence            9999875544344557899999996 78888886432          3689999999999999999999998   99999


Q ss_pred             ccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCC
Q 041632          372 DLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       372 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      ||||+||+++.++.+||+|||+++.......     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTADAN-----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCChHHEEEcCCCCEEEEecCcccccccccc-----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            9999999999999999999999975432221     123468999999998876 6789999999999999999999999


Q ss_pred             CC
Q 041632          451 TD  452 (452)
Q Consensus       451 f~  452 (452)
                      |+
T Consensus       234 f~  235 (362)
T 3pg1_A          234 FR  235 (362)
T ss_dssp             CC
T ss_pred             CC
Confidence            84

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-37  Score=293.10  Aligned_cols=199  Identities=31%  Similarity=0.443  Sum_probs=169.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .|.+.+.||+|+||.||+|.+..++..||+|.+.....  ...+.+.+|+++++.++||||+++++++... ..+....+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc-cCCCceEE
Confidence            36677789999999999999999999999999975432  3346789999999999999999999986543 23456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCCeeec-CCCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP--ILHCDLKPSNILLD-NDLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~  386 (452)
                      +||||+++|+|.+++...           ..+++..++.++.|++.||+|||+.   +  |+||||||+||+++ +++.+
T Consensus       106 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~  171 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF-----------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSV  171 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCE
T ss_pred             EEEEecCCCCHHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCE
Confidence            999999999999998642           3588999999999999999999997   7  99999999999998 78999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++.......      .....||+.|+|||++.+ .++.++||||+|+++|||++|+.||.
T Consensus       172 kl~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~  230 (290)
T 1t4h_A          172 KIGDLGLATLKRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  230 (290)
T ss_dssp             EECCTTGGGGCCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEeeCCCcccccccc------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence            999999997543221      123468999999998764 68999999999999999999999984

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.4e-39  Score=300.53  Aligned_cols=203  Identities=27%  Similarity=0.487  Sum_probs=175.4

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|++.+.||+|+||+||+|++..+++.||+|.+... ....+.+.+|++++++++||||+++++++     .+.+..
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            456788899999999999999999988999999999743 33457899999999999999999999985     345578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++++|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l  152 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECN---------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV  152 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCC---------TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEEcCCCCcHHHHHHhcc---------cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEE
Confidence            99999999999999996432         24589999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||++........   .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||+
T Consensus       153 ~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~  214 (288)
T 3kfa_A          153 ADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  214 (288)
T ss_dssp             CCCCGGGTSCSSSS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccCccceeccCCcc---ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999986543221   22233457889999999988889999999999999999999 999984

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.8e-38  Score=293.71  Aligned_cols=198  Identities=29%  Similarity=0.510  Sum_probs=158.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC----ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ----GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|+..+.||+|+||.||+|++  +|+.||||++.....    ...+.+.+|+++++.++||||+++++++     .+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            35788889999999999999998  488999999864432    2346789999999999999999999985     345


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---  382 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---  382 (452)
                      +..++||||+++++|.+++..            ..+++.+++.++.|++.||+|||+....+|+||||||+||+++.   
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~  146 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE  146 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred             CceEEEEEcCCCCCHHHHhhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence            578999999999999999853            35889999999999999999999982222999999999999986   


Q ss_pred             -----CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 -----DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                           ++.+||+|||+++.......      ....||+.|+|||.+.+..++.++||||||+++|||+||+.||.
T Consensus       147 ~~~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  215 (271)
T 3dtc_A          147 NGDLSNKILKITDFGLAREWHRTTK------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR  215 (271)
T ss_dssp             SSCCSSCCEEECCCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred             cccccCcceEEccCCcccccccccc------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                 67899999999976543221      13458999999999988889999999999999999999999984

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.4e-38  Score=309.19  Aligned_cols=199  Identities=27%  Similarity=0.406  Sum_probs=172.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|+..+.||+|+||+||+|++..+++.||+|++..... ...+.+.+|+++++.++||||+++++++.     ..+..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence            3578899999999999999999998999999999975432 33467899999999999999999999854     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++++|.+++...           ..+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+||
T Consensus       107 ~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl  173 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKA-----------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL  173 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEECCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEE
Confidence            9999999999999998643           3588999999999999999999983  18999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++.......      .....||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       174 ~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  231 (360)
T 3eqc_A          174 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP  231 (360)
T ss_dssp             CCCCCCHHHHHHC----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred             EECCCCccccccc------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999987553221      122468999999999999999999999999999999999999984

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.1e-38  Score=305.38  Aligned_cols=201  Identities=26%  Similarity=0.270  Sum_probs=163.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~~  306 (452)
                      .++|+..+.||+|+||.||+|+...+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.... ..+..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            3678999999999999999999998999999999975322  33467889999999999999999999865432 22334


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||++ |+|.+++.             ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             ceEEEEEcCC-CCHHHHHh-------------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCE
Confidence            7899999996 57888774             2478889999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       167 kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  227 (371)
T 2xrw_A          167 KILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP  227 (371)
T ss_dssp             EECCCCC---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEEeeccccccccc-----ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            999999997654221     1123568999999999999899999999999999999999999984

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.7e-38  Score=298.02  Aligned_cols=204  Identities=26%  Similarity=0.475  Sum_probs=166.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ..|++.+.||+|+||+||+|++..+   +..||+|.+..... ...+.+.+|++++++++||||++++++|.    ..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence            4578889999999999999997533   33689998864332 33467899999999999999999999863    3445


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  167 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV  167 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTT----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred             ceEEEEeCCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCE
Confidence            6789999999999999997533          4578899999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      ||+|||+++.................+|+.|+|||.+.+..++.++||||+|+++|||++ |.+||
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  233 (298)
T 3f66_A          168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  233 (298)
T ss_dssp             EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999998654332222222334568899999999988899999999999999999999 55565

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.1e-38  Score=317.34  Aligned_cols=197  Identities=29%  Similarity=0.431  Sum_probs=169.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|++.+.||+|+||+||+|++..+++.||||++...  .......+.+|++++++++||||+++++++     .+....
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~   96 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF   96 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCEE
Confidence            5688999999999999999999989999999999643  234457899999999999999999999985     445688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec---CCCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD---NDLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~  385 (452)
                      ++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++   .++.
T Consensus        97 ~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  162 (486)
T 3mwu_A           97 YIVGELYTGGELFDEIIKR-----------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCD  162 (486)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCC
T ss_pred             EEEEEcCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCC
Confidence            9999999999999988543           3689999999999999999999998   999999999999995   4567


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......     ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.
T Consensus       163 ~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  223 (486)
T 3mwu_A          163 IKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (486)
T ss_dssp             EEECSCSCTTTBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEEECCcCeECCCCC-----ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999998654322     1223569999999999875 58999999999999999999999984

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.7e-38  Score=306.16  Aligned_cols=205  Identities=23%  Similarity=0.323  Sum_probs=165.8

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-----
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-----  302 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-----  302 (452)
                      ...++|+..+.||+|+||+||+|++..+|+.||||++......    ..+|+++++.++||||+++++++.....     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            3457899999999999999999999999999999998644322    2479999999999999999998744221     


Q ss_pred             ----------------------------CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHH
Q 041632          303 ----------------------------QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA  354 (452)
Q Consensus       303 ----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~  354 (452)
                                                  .+....++||||++ |+|.+.+....       .....+++..++.++.|++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-------RSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-------hcCCCCCHHHHHHHHHHHH
Confidence                                        33445889999997 68777764211       1124689999999999999


Q ss_pred             HHHHHHhcCCCCCeEecccCCCCeeec-CCCceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCccc
Q 041632          355 SALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNG  432 (452)
Q Consensus       355 ~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  432 (452)
                      .||+|||+.   +|+||||||+||+++ .++.+||+|||+++.......     .....||+.|+|||++.+. .++.++
T Consensus       152 ~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~  223 (383)
T 3eb0_A          152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAPELMLGATEYTPSI  223 (383)
T ss_dssp             HHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-----CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred             HHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-----CcCcccCCCccCHHHhcCCCCCCcch
Confidence            999999998   999999999999998 688999999999986543222     1235689999999988765 489999


Q ss_pred             ceeehhHHHHHHHhCCCCCC
Q 041632          433 DVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       433 DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||||+||++|||++|+.||.
T Consensus       224 DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          224 DLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             HHHHHHHHHHHHHHSSCSSC
T ss_pred             hhhhHHHHHHHHHhCCCCCC
Confidence            99999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-38  Score=307.25  Aligned_cols=200  Identities=26%  Similarity=0.370  Sum_probs=154.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccc-cCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSV-DFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~-~~~~~~  306 (452)
                      .++|+..+.||+|+||.||+|++..+|+.||||++....  ....+.+.+|+++++.++||||+++++++... ......
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            467999999999999999999999999999999996432  23346788999999999999999999986432 112235


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|+|++ +++|.+++..            ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~------------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~  171 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC------------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  171 (367)
T ss_dssp             CCEEEEECC-CEECC-----------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred             eEEEEeccc-CCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCE
Confidence            679999999 7899888753            3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.....       .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus       172 kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  231 (367)
T 2fst_X          172 KILDFGLARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  231 (367)
T ss_dssp             EECC----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEeecccccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999764321       123568999999999876 678999999999999999999999984

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.2e-38  Score=299.73  Aligned_cols=208  Identities=23%  Similarity=0.341  Sum_probs=172.9

Q ss_pred             hHHHHHhhcCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcC-CCCCceeEeeeec
Q 041632          223 YKSLLKATDGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNI-RHKNLVRVITSCS  298 (452)
Q Consensus       223 ~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l-~h~niv~l~~~~~  298 (452)
                      ++......+.|.+. +.||+|+||.||+|+...+|+.||+|++.....  .....+.+|+.+++.+ .||||+++++++ 
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-   98 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-   98 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-
Confidence            33334445566666 889999999999999998999999999975432  3357889999999999 569999999984 


Q ss_pred             cccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       299 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                          .+.+..++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||
T Consensus        99 ----~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NI  162 (327)
T 3lm5_A           99 ----ENTSEIILILEYAAGGEIFSLCLPEL---------AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNI  162 (327)
T ss_dssp             ----ECSSEEEEEEECCTTEEGGGGGSSCC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             ----EeCCeEEEEEEecCCCcHHHHHHHhc---------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHE
Confidence                44567899999999999999986432         24689999999999999999999998   999999999999


Q ss_pred             eecC---CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          379 LLDN---DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       379 ll~~---~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.   ++.+||+|||+++.......     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       163 l~~~~~~~~~~kL~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  234 (327)
T 3lm5_A          163 LLSSIYPLGDIKIVDFGMSRKIGHACE-----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV  234 (327)
T ss_dssp             EESCBTTBCCEEECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEecCCCCCcEEEeeCccccccCCccc-----cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9998   78999999999986543221     123469999999999999999999999999999999999999984

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=305.55  Aligned_cols=206  Identities=22%  Similarity=0.324  Sum_probs=166.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC---CCcEEEEEEeeccCCc-----------cHHHHHHHHHHHhcCCCCCceeEeee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE---DGTVVAIKVINLQRQG-----------ASKSFMAECKALKNIRHKNLVRVITS  296 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~ei~~l~~l~h~niv~l~~~  296 (452)
                      ++|.+.+.||+|+||.||+|++..   ++..||+|++......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            568889999999999999999976   7789999998754321           12346788889999999999999998


Q ss_pred             eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       297 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                      +... +.+....++||||+ +++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus       117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~  180 (345)
T 2v62_A          117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQN-----------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAA  180 (345)
T ss_dssp             EEEE-SSSCEEEEEEEECE-EEEHHHHCBGG-----------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             cccc-cCCCcEEEEEEecc-CCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHH
Confidence            7542 34467889999999 99999998643           2689999999999999999999998   9999999999


Q ss_pred             CeeecCCC--ceEECccccccccccCCCC---ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          377 NILLDNDL--SAHIGDFGLSRFYQAVSNP---TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       377 Nill~~~~--~~kl~Dfgla~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||++.++  .+||+|||+++.+......   .........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999887  9999999999876432211   111123456999999999999989999999999999999999999999


Q ss_pred             C
Q 041632          452 D  452 (452)
Q Consensus       452 ~  452 (452)
                      +
T Consensus       261 ~  261 (345)
T 2v62_A          261 E  261 (345)
T ss_dssp             G
T ss_pred             c
Confidence            3

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=303.50  Aligned_cols=205  Identities=32%  Similarity=0.477  Sum_probs=164.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHH--HhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKA--LKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~--l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+|++  +++.||||+++...   ...+..|.++  +..++||||+++++.+......+...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46788999999999999999987  68999999997432   2444444444  45589999999998766555566667


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEecccCCCCeeec
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC------QEPILHCDLKPSNILLD  381 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dlk~~Nill~  381 (452)
                      .++||||+++|+|.+++...            ..++..++.++.|++.||+|||+.+      .++|+||||||+|||++
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~------------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~  154 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH------------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK  154 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC------------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC
T ss_pred             EEEEEecCCCCcHHHHHhhc------------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc
Confidence            89999999999999999643            3578899999999999999999852      23899999999999999


Q ss_pred             CCCceEECccccccccccCCCC----ceeccccccccccccCccccCC-------CCCCcccceeehhHHHHHHHhCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNP----TVSSSIGVRGTIGYVAPEYGLG-------SEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      .++.+||+|||+++.+......    .........||+.|+|||++.+       ..++.++|||||||++|||+||..|
T Consensus       155 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p  234 (336)
T 3g2f_A          155 NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD  234 (336)
T ss_dssp             TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGG
T ss_pred             CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCc
Confidence            9999999999999866432211    1111223569999999999876       4567789999999999999999776


Q ss_pred             C
Q 041632          451 T  451 (452)
Q Consensus       451 f  451 (452)
                      |
T Consensus       235 ~  235 (336)
T 3g2f_A          235 L  235 (336)
T ss_dssp             G
T ss_pred             C
Confidence            5

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.3e-38  Score=317.76  Aligned_cols=197  Identities=26%  Similarity=0.382  Sum_probs=166.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||+||+|++..++..||+|++....  ......+.+|+++++.++||||+++++++     .+....
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~  111 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY  111 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence            46888999999999999999999999999999997543  33357889999999999999999999985     445678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC---Cc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---LS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~~  385 (452)
                      ++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.+   +.
T Consensus       112 ~lv~e~~~~g~L~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  177 (494)
T 3lij_A          112 YLVMECYKGGELFDEIIHR-----------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDAL  177 (494)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred             EEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCc
Confidence            9999999999999888532           3688999999999999999999998   99999999999999764   45


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++.+.....     .....||+.|+|||++. ..++.++||||+||++|||++|+.||.
T Consensus       178 ~kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~  238 (494)
T 3lij_A          178 IKIVDFGLSAVFENQKK-----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG  238 (494)
T ss_dssp             EEECCCTTCEECBTTBC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEEEECCCCeECCCCcc-----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999986653221     22356999999999876 479999999999999999999999984

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-38  Score=299.39  Aligned_cols=204  Identities=25%  Similarity=0.462  Sum_probs=170.0

Q ss_pred             cCCCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ..|+..+.||+|+||.||+|++    ..+++.||+|+++... ....+.+.+|+++++.++||||+++++++..   .+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCC
Confidence            3477889999999999999994    5678999999997443 3345789999999999999999999998653   223


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK----------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCC
Confidence            56789999999999999985332          3589999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +||+|||+++........ ........||..|+|||.+.+..++.++||||+|+++|||+||..|+
T Consensus       165 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEY-YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             EEECCCTTCEECCTTCCE-EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             EEECcccccccccCCCcc-eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            999999999876533221 12223456888999999998888999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.1e-38  Score=303.83  Aligned_cols=201  Identities=25%  Similarity=0.440  Sum_probs=171.6

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--------cHHHHHHHHHHHhcC-CCCCceeEeeeec
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--------ASKSFMAECKALKNI-RHKNLVRVITSCS  298 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~ei~~l~~l-~h~niv~l~~~~~  298 (452)
                      ...++|.+.+.||+|+||.||+|++..+|+.||||+++.....        ..+.+.+|+++++++ +||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3446799999999999999999999888999999999754321        135678999999999 8999999999853


Q ss_pred             cccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       299 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                           ..+..++||||+++++|.+++...           ..+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus       171 -----~~~~~~lv~e~~~g~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NI  231 (365)
T 2y7j_A          171 -----SSSFMFLVFDLMRKGELFDYLTEK-----------VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI  231 (365)
T ss_dssp             -----BSSEEEEEECCCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             -----eCCEEEEEEEeCCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence                 456789999999999999998632           3689999999999999999999998   999999999999


Q ss_pred             eecCCCceEECccccccccccCCCCceeccccccccccccCccccCC------CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG------SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       379 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.++.+||+|||++........     .....||+.|+|||++.+      ..++.++|||||||++|||+||+.||.
T Consensus       232 l~~~~~~ikl~DfG~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  306 (365)
T 2y7j_A          232 LLDDNMQIRLSDFGFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW  306 (365)
T ss_dssp             EECTTCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EECCCCCEEEEecCcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence            999999999999999986653221     123569999999998752      358899999999999999999999984

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.1e-38  Score=301.67  Aligned_cols=200  Identities=27%  Similarity=0.390  Sum_probs=167.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|+..+.||+|+||.||+|++..+|+.||+|++.......  .+.+.+|++++++++||||+++++++.     +.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   98 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKR   98 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCE
Confidence            357888999999999999999999899999999986543322  356789999999999999999999854     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++...           ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~k  164 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP-----------NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVK  164 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEecCCcchHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEE
Confidence            89999999999998886543           3589999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........    .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       165 l~Dfg~~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (331)
T 4aaa_A          165 LCDFGFARTLAAPGEV----YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP  226 (331)
T ss_dssp             ECCCTTC----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEeCCCceeecCCccc----cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999765432211    1234589999999998775 68999999999999999999999984

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-38  Score=297.40  Aligned_cols=201  Identities=24%  Similarity=0.410  Sum_probs=159.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|++.+.||+|+||.||+|++..+   +..||+|.++.... ...+.+.+|+.++++++||||+++++++.      .
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence            45788889999999999999998643   45799999865332 33467899999999999999999999852      2


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  154 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRK----------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC  154 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred             CccEEEEecCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCC
Confidence            35789999999999999996432          3588999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++........   ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||+
T Consensus       155 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~  219 (281)
T 1mp8_A          155 VKLGDFGLSRYMEDSTYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ  219 (281)
T ss_dssp             EEECC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEECccccccccCccccc---ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence            999999999866432211   1122347889999999988889999999999999999997 999984

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.7e-38  Score=296.22  Aligned_cols=204  Identities=26%  Similarity=0.391  Sum_probs=169.2

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|++.+.||+|+||+||+|++..+++.||||++.....  ...+.+|+++++.++|++++..+..+.    ...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCCCce
Confidence            45789999999999999999999988999999998764332  245789999999999999888777653    334678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~  385 (452)
                      ++||||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+   ++++.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~  146 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL  146 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTC
T ss_pred             EEEEEcc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCe
Confidence            9999999 999999986432          3589999999999999999999998   99999999999999   78899


Q ss_pred             eEECccccccccccCCCCce---eccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTV---SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++..........   .......||+.|+|||.+.+..++.++|||||||++|||++|+.||+
T Consensus       147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 4hgt_A          147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCc
Confidence            99999999987654322111   11224569999999999999999999999999999999999999994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.4e-38  Score=303.23  Aligned_cols=207  Identities=26%  Similarity=0.370  Sum_probs=172.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|...+.||+|+||.||+|++..+|+.||||+++.... .....+.+|++++++++||||+++++++....+......
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            4678899999999999999999998999999999964332 234578899999999999999999998766555566788


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|+||++ |+|.+++..            ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        90 ~lv~e~~~-~~L~~~~~~------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST------------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred             EEEEeccC-ccHHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEE
Confidence            99999996 699988853            2588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCce------eccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTV------SSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++..........      .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  224 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP  224 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999986643221110      01223468999999998654 678999999999999999999999984

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-38  Score=305.84  Aligned_cols=213  Identities=25%  Similarity=0.410  Sum_probs=174.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC-------CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE-------DGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|.+.+.||+|+||+||+|++..       .+..||||+++.... ...+.+.+|+++++++ +||||+++++++.  
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence            3578888999999999999999743       335799999975433 2346789999999999 9999999999853  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         ..+..++||||+++|+|.+++........     ........+++.+++.++.|++.||+|||+.   +|+||||||
T Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  219 (382)
T 3tt0_A          146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  219 (382)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence               44578999999999999999976432110     1112235689999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||++.++.+||+|||+++.........  ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTC--CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccc--cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999998654322111  1223457899999999999899999999999999999999 999984

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=301.99  Aligned_cols=212  Identities=23%  Similarity=0.244  Sum_probs=172.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||.||+++...+|+.||||++........+.+.+|+++++.++||||+++++++... .......+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRE-RGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE-ETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec-cCCCceeE
Confidence            45788999999999999999999889999999999765555567899999999999999999999986532 12345788


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +|+||+++|+|.+++....       .....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       107 lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLK-------DKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHH-------TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEeCCCCcHHHHHHHHH-------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999986421       1124689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCce-----eccccccccccccCccccCCCC---CCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTV-----SSSIGVRGTIGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++...........     .......||+.|+|||++.+..   ++.++||||||+++|||++|+.||+
T Consensus       177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  247 (317)
T 2buj_A          177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD  247 (317)
T ss_dssp             CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred             ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence            9998875432111000     0011244799999999987654   6889999999999999999999983

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=308.41  Aligned_cols=200  Identities=26%  Similarity=0.383  Sum_probs=167.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEc---CCCcEEEEEEeeccC----CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFD---EDGTVVAIKVINLQR----QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      ++|++.+.||+|+||+||+++..   .+|+.||||+++...    ....+.+.+|+++++.+ +||||+++++++.    
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  129 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----  129 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe----
Confidence            56888999999999999999984   478999999986432    23345677899999999 7999999998853    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                       ..+..++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.
T Consensus       130 -~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  194 (355)
T 1vzo_A          130 -TETKLHLILDYINGGELFTHLSQR-----------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS  194 (355)
T ss_dssp             -ETTEEEEEECCCCSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             -eCceEEEEeecCCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence             345789999999999999998642           3588999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++.+.....   .......||+.|+|||++.+  ..++.++|||||||++|||+||+.||.
T Consensus       195 ~~~~kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~  263 (355)
T 1vzo_A          195 NGHVVLTDFGLSKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT  263 (355)
T ss_dssp             TSCEEESCSSEEEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CCcEEEeeCCCCeecccCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            99999999999986542211   12233569999999999875  347889999999999999999999984

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=294.30  Aligned_cols=202  Identities=29%  Similarity=0.393  Sum_probs=168.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|.....||+|+||.||+|++..+++.||+|.++.......+.+.+|+.+++.++||||+++++++.     ..+..++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEE
Confidence            34555669999999999999999899999999998766666688999999999999999999999854     3457899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-CCceEEC
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-DLSAHIG  389 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-~~~~kl~  389 (452)
                      ||||+++++|.+++....        ....+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+
T Consensus        97 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~  165 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKW--------GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKIS  165 (295)
T ss_dssp             EEECCSEEEHHHHHHHTT--------CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEEC
T ss_pred             EEEeCCCCCHHHHHHhhc--------cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEe
Confidence            999999999999986432        123467888999999999999999998   9999999999999987 8999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCC--CCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE--VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.......    ......||+.|+|||++.+..  ++.++||||||+++|||++|+.||.
T Consensus       166 Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  226 (295)
T 2clq_A          166 DFGTSKRLAGINP----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY  226 (295)
T ss_dssp             CTTTCEESCC---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred             ecccccccCCCCC----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            9999976542211    112346899999999986643  7889999999999999999999983

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.4e-38  Score=292.18  Aligned_cols=199  Identities=28%  Similarity=0.450  Sum_probs=165.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|++...   .....+.+.+|++.++.++||||+++++++     ...+
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT   84 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence            36788899999999999999999889999999999643   233456889999999999999999999985     3456


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  150 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKH-----------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNA  150 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCE
T ss_pred             eEEEEEeccCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCE
Confidence            789999999999999998643           3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++........     .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+
T Consensus       151 ~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  212 (276)
T 2h6d_A          151 KIADFGLSNMMSDGEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD  212 (276)
T ss_dssp             EECCCCGGGCCCC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEeecccccccCCCcc-----eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            9999999976543211     123458999999999887765 689999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.3e-39  Score=315.60  Aligned_cols=207  Identities=16%  Similarity=0.209  Sum_probs=162.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHH---HHHhcCCCCCceeEeeeecccc--
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAEC---KALKNIRHKNLVRVITSCSSVD--  301 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei---~~l~~l~h~niv~l~~~~~~~~--  301 (452)
                      .++|...+.||+|+||+||+|++..+|+.||||++...   .....+.+.+|+   +.++.++||||+++++.+....  
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35688889999999999999999888999999999743   334457889999   5566668999999884432100  


Q ss_pred             CCCC------------c-----eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC
Q 041632          302 FQGN------------D-----FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC  364 (452)
Q Consensus       302 ~~~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  364 (452)
                      +++.            +     ..++||||+ +|+|.+++....    ........+++..++.++.|++.||+|||+. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~----~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-  225 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL----SHSSTHKSLVHHARLQLTLQVIRLLASLHHY-  225 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH----HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc----ccccccccccHHHHHHHHHHHHHHHHHHHhC-
Confidence            1111            1     278999999 689999996421    0001113455688889999999999999998 


Q ss_pred             CCCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCC-----------CCCcccc
Q 041632          365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-----------EVSTNGD  433 (452)
Q Consensus       365 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D  433 (452)
                        +|+||||||+|||++.++.+||+|||+++....       ......| +.|+|||++.+.           .++.++|
T Consensus       226 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D  295 (377)
T 3byv_A          226 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD  295 (377)
T ss_dssp             --TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred             --CeecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence              999999999999999999999999999975321       1123457 999999998877           7999999


Q ss_pred             eeehhHHHHHHHhCCCCCC
Q 041632          434 VYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       434 vwSlGv~l~elltg~~Pf~  452 (452)
                      ||||||++|||+||+.||.
T Consensus       296 vwSlG~il~elltg~~Pf~  314 (377)
T 3byv_A          296 AWALGLVIYWIWCADLPIT  314 (377)
T ss_dssp             HHHHHHHHHHHHHSSCCC-
T ss_pred             HHHHHHHHHHHHHCCCCCc
Confidence            9999999999999999984

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.2e-37  Score=316.10  Aligned_cols=198  Identities=26%  Similarity=0.411  Sum_probs=169.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-------------ccHHHHHHHHHHHhcCCCCCceeEeee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-------------GASKSFMAECKALKNIRHKNLVRVITS  296 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~ei~~l~~l~h~niv~l~~~  296 (452)
                      .++|.+.+.||+|+||+||+|+++.+++.||+|++.....             ...+.+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4679999999999999999999999999999999974321             234678999999999999999999998


Q ss_pred             eccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       297 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                      +     .+....++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus       115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~  175 (504)
T 3q5i_A          115 F-----EDKKYFYLVTEFYEGGELFEQIINR-----------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPE  175 (504)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred             E-----EcCCEEEEEEecCCCCcHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHH
Confidence            5     4456889999999999999988542           3689999999999999999999998   9999999999


Q ss_pred             CeeecCCC---ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          377 NILLDNDL---SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       377 Nill~~~~---~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.++   .+||+|||+++.......     .....||+.|+|||++. ..++.++||||+||++|||++|+.||.
T Consensus       176 Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~  248 (504)
T 3q5i_A          176 NILLENKNSLLNIKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFG  248 (504)
T ss_dssp             GEEESSTTCCSSEEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HEEEecCCCCccEEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence            99999776   699999999986653221     12356999999999976 468999999999999999999999994

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-38  Score=299.15  Aligned_cols=201  Identities=25%  Similarity=0.397  Sum_probs=168.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .+.|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+++++.++||||+++++++.     ..+..+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeEE
Confidence            467889999999999999999999889999999998666666788999999999999999999999853     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        93 lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  159 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELD----------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLA  159 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred             EEEEeCCCCcHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEE
Confidence            9999999999999885422          3588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCcccc-----CCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG-----LGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||++.......    .......||+.|+|||++     ....++.++||||||+++|||++|+.||+
T Consensus       160 Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  223 (302)
T 2j7t_A          160 DFGVSAKNLKTL----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH  223 (302)
T ss_dssp             CCHHHHHHHHHH----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ECCCCccccccc----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence            999876432110    011224589999999987     46678999999999999999999999984

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.8e-38  Score=295.03  Aligned_cols=203  Identities=26%  Similarity=0.393  Sum_probs=171.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||.||+|++..+|+.||||++.....  .+.+.+|+++++.++|++++..+..+.    ...+..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCCceE
Confidence            4679999999999999999999988999999999865433  356889999999999999877776653    2345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~  386 (452)
                      +||||+ +++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+   ++++.+
T Consensus        82 lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~  147 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred             EEEEec-CCCHHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeE
Confidence            999999 999999986332          3589999999999999999999998   99999999999999   488899


Q ss_pred             EECccccccccccCCCCce---eccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTV---SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++..........   .......||+.|+|||.+.+..++.++|||||||++|||+||+.||+
T Consensus       148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 3uzp_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            9999999987654322110   11234569999999999999899999999999999999999999984

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-37  Score=294.93  Aligned_cols=203  Identities=26%  Similarity=0.438  Sum_probs=166.8

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCc---EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGT---VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .|...+.||+|+||+||+|++..+++   .||+|.+..... ...+.+.+|++++++++||||+++++++..    .+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence            35556889999999999999755444   799999874333 334678999999999999999999998632    2334


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++++||+.+|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+|
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~k  164 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSPQ----------RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVK  164 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred             cEEEEecccCCCHHHHHhccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence            589999999999999997532          4678899999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||+++.................+|+.|+|||.+.+..++.++||||||+++|||+||..|+
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~  228 (298)
T 3pls_A          165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP  228 (298)
T ss_dssp             ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred             eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence            9999999755432211122223456899999999999999999999999999999999965553

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=296.77  Aligned_cols=200  Identities=28%  Similarity=0.382  Sum_probs=168.7

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|.+....  ..+.+.+|+++++.++||||+++++++.     ..+..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence            3467899999999999999999999889999999997543  3478899999999999999999999854     34578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++++|.+++...          ...+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus       100 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  166 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLR----------NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKL  166 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHH----------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEeecCCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEE
Confidence            9999999999999998532          24688999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||++........    ......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       167 ~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  226 (314)
T 3com_A          167 ADFGVAGQLTDTMA----KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA  226 (314)
T ss_dssp             CCCTTCEECBTTBS----CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             eecccchhhhhhcc----ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999976543211    1223468999999999998899999999999999999999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=301.86  Aligned_cols=202  Identities=26%  Similarity=0.479  Sum_probs=164.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcE----EEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTV----VAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      .++|+..+.||+|+||+||+|++..+++.    ||+|.+... .....+.+.+|++++++++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            35788999999999999999999877765    466766432 34456789999999999999999999998643     


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                       +..++++||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~  154 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ  154 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETT
T ss_pred             -CCceEEEEecCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCC
Confidence             23688999999999999986533          4588999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++.........  ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||+
T Consensus       155 ~~kL~DfG~a~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  221 (327)
T 3lzb_A          155 HVKITDFGLAKLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             EEEECCTTC------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CEEEccCcceeEccCccccc--cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999998664322211  1223457889999999998899999999999999999999 999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.4e-38  Score=296.36  Aligned_cols=206  Identities=26%  Similarity=0.406  Sum_probs=171.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+++...+|+.||+|.++....  ...+.+.+|++++++++||||+++++++..   .....
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence            3578889999999999999999998999999999975432  234678999999999999999999997642   22457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEecccCCCCeeecC
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP-----ILHCDLKPSNILLDN  382 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dlk~~Nill~~  382 (452)
                      .++||||+++++|.+++....       .....+++.+++.++.|++.||+|||+.   +     |+||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~  151 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGT-------KERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDG  151 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECS
T ss_pred             EEEEEeCCCCCCHHHHHHhhc-------ccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcC
Confidence            899999999999999986421       1223589999999999999999999997   7     999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++.......    ......||+.|+|||.+.+..++.++||||||+++|||+||+.||+
T Consensus       152 ~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  217 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHDTS----FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT  217 (279)
T ss_dssp             SSCEEECCCCHHHHC---CH----HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCEEEecCchheeeccccc----cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            99999999999976542211    1123468999999999988889999999999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.1e-38  Score=291.56  Aligned_cols=200  Identities=26%  Similarity=0.453  Sum_probs=171.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||.||+|++. +++.||+|++..... ..+.+.+|++++++++||||+++++++.     +.+..+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   79 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeE
Confidence            356888899999999999999986 678899999975433 3478999999999999999999999853     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        80 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~  146 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVS  146 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEEC
T ss_pred             EEEeCCCCCcHHHHHhhCc----------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEc
Confidence            9999999999999996432          3578999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++.....   .........+++.|+|||++.+..++.++||||||+++|||++ |+.||+
T Consensus       147 dfg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  207 (267)
T 3t9t_A          147 DFGMTRFVLDD---QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE  207 (267)
T ss_dssp             CTTGGGGBCCH---HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccccccc---cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCC
Confidence            99999765321   1111223457889999999988889999999999999999999 899984

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.9e-38  Score=299.86  Aligned_cols=213  Identities=26%  Similarity=0.387  Sum_probs=173.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|...+.||+|+||.||+|++     ..+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   97 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence            45788899999999999999985     34678999999975433 2346789999999999 9999999999853    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCc-------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                       ..+..++||||+++|+|.+++........       ........+++.+++.++.|++.||+|||+.   +|+||||||
T Consensus        98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  173 (313)
T 1t46_A           98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (313)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCcc
Confidence             34578999999999999999975431100       0011223589999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+++.++.+||+|||+++.........  ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ceEEEcCCCCEEEccccccccccccccce--eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999998665432221  1223457889999999888889999999999999999999 999984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.8e-38  Score=310.30  Aligned_cols=202  Identities=26%  Similarity=0.377  Sum_probs=163.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  309 (452)
                      .+|+..+.||+|+||+||+|++..+|+.||||++.....    ...+|+++++.++||||+++++++..... .+....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            357888999999999999999998999999999864322    23479999999999999999988754321 2233467


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-CceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-LSAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl  388 (452)
                      +||||+++ ++.+.+....       .....+++..++.++.|++.||+|||+.   +|+||||||+|||++.+ +.+||
T Consensus       130 lv~e~~~~-~l~~~~~~~~-------~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl  198 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYS-------RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL  198 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred             eehhcccc-cHHHHHHHHh-------hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEe
Confidence            99999965 6665553210       1124689999999999999999999998   99999999999999965 57899


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.......     .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus       199 ~DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~  258 (420)
T 1j1b_A          199 CDFGSAKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP  258 (420)
T ss_dssp             CCCTTCEECCTTCC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccchhhhhcccCCC-----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99999986543221     1235689999999998764 78999999999999999999999994

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.8e-38  Score=295.62  Aligned_cols=201  Identities=27%  Similarity=0.487  Sum_probs=171.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-------
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-------  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-------  302 (452)
                      ..+|+..+.||+|+||.||+|++..+|+.||+|+++...    +.+.+|++++++++||||+++++++...++       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            356888999999999999999998899999999997543    356789999999999999999998654221       


Q ss_pred             ----CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          303 ----QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       303 ----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                          ......++||||+++|+|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Ni  153 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---------GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI  153 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGG---------GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHE
Confidence                12345789999999999999996421         24688999999999999999999998   999999999999


Q ss_pred             eecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       379 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ++++++.+||+|||++........     .....||+.|+|||.+.+..++.++||||||+++|||++|..||
T Consensus       154 l~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~  221 (284)
T 2a19_B          154 FLVDTKQVKIGDFGLVTSLKNDGK-----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA  221 (284)
T ss_dssp             EEEETTEEEECCCTTCEESSCCSC-----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSH
T ss_pred             EEcCCCCEEECcchhheecccccc-----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcc
Confidence            999999999999999986553221     12345899999999999889999999999999999999999886

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2e-37  Score=297.38  Aligned_cols=194  Identities=23%  Similarity=0.371  Sum_probs=168.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++.   ...+.+.+|++++++++ ||||+++++++..   ......
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~  108 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTP  108 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCce
Confidence            3678899999999999999999998999999999863   33578899999999997 9999999998643   224567


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-ceE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-SAH  387 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~k  387 (452)
                      ++||||+++++|.+++.              .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++ .+|
T Consensus       109 ~lv~e~~~~~~l~~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~k  171 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ--------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLR  171 (330)
T ss_dssp             EEEEECCCCCCHHHHGG--------------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEEeccCchhHHHHHH--------------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEE
Confidence            99999999999999873              478889999999999999999998   999999999999999776 899


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |+|||+++........     ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus       172 l~Dfg~a~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~  231 (330)
T 3nsz_A          172 LIDWGLAEFYHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF  231 (330)
T ss_dssp             ECCCTTCEECCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             EEeCCCceEcCCCCcc-----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence            9999999865533221     22468999999999877 67899999999999999999999998

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.3e-38  Score=300.98  Aligned_cols=211  Identities=20%  Similarity=0.271  Sum_probs=160.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeecccc---CCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVD---FQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~---~~~~  305 (452)
                      ..+|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++....   ....
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            356888999999999999999999899999999997665555678899999999995 999999999874221   1345


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCCeeecCC
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP--ILHCDLKPSNILLDND  383 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~  383 (452)
                      ...++++||+. |+|.+++....        ....+++.+++.++.|++.||+|||+.   +  |+||||||+|||++.+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME--------SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH--------TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh--------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCC
Confidence            56899999995 89999885311        123589999999999999999999997   7  9999999999999999


Q ss_pred             CceEECccccccccccCCCCce--------eccccccccccccCcccc---CCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTV--------SSSIGVRGTIGYVAPEYG---LGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||+++..........        .......||+.|+|||++   .+..++.++|||||||++|||+||+.||+
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            9999999999986653222110        011134589999999998   56678999999999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=296.59  Aligned_cols=206  Identities=26%  Similarity=0.359  Sum_probs=165.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeecccc--------
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD--------  301 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~--------  301 (452)
                      .++|...+.||+|+||.||+|++..+|+.||+|++........+.+.+|++++++++||||+++++++....        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357888999999999999999999889999999998665555678999999999999999999998864321        


Q ss_pred             -CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          302 -FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       302 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                       +.+....++||||++ |+|.+++..            ..+++.+++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  153 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ------------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFI  153 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc------------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEE
Confidence             234567899999997 699999854            2478889999999999999999998   99999999999999


Q ss_pred             c-CCCceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          381 D-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      + +++.+||+|||+++......... .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||+
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  226 (320)
T 2i6l_A          154 NTEDLVLKIGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA  226 (320)
T ss_dssp             ETTTTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCCeEEEccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC
Confidence            7 56799999999998654321111 11223457999999998765 678999999999999999999999984

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8e-38  Score=297.90  Aligned_cols=215  Identities=23%  Similarity=0.425  Sum_probs=164.4

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcC---CCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDE---DGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ...++|.+.+.||+|+||.||+|++..   +++.||+|.++....  ...+.+.+|++++++++||||+++++++.....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345678888999999999999998864   455899999975432  234678999999999999999999998765433


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ......++|+||+++|+|.+++.....     ......+++.+++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~  182 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRL-----ETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD  182 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTB-----TTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhh-----hcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence            333456999999999999999854321     11234689999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ++.+||+|||+++........  .......+++.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  251 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYP  251 (313)
T ss_dssp             TSCEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCcEEEeecCcceeccccccc--CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence            999999999999865432211  11223457889999999998899999999999999999999 888884

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-37  Score=290.11  Aligned_cols=197  Identities=25%  Similarity=0.423  Sum_probs=166.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|...+.||+|+||.||+|+++  ++.||||++.....  ...+.+.+|++++++++||||+++++++...   ..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~   83 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH   83 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence            357888999999999999999984  88999999975432  3346799999999999999999999986432   2357


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEecccCCCCeeecCCCc
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP--ILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dlk~~Nill~~~~~  385 (452)
                      .++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+.   +  |+||||||+||++++++.
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~  151 (271)
T 3kmu_A           84 PTLITHWMPYGSLYNVLHEGT---------NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMT  151 (271)
T ss_dssp             CEEEEECCTTCBHHHHHHSCS---------SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSC
T ss_pred             eEeeecccCCCcHHHHHhhcc---------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcc
Confidence            799999999999999997542         13589999999999999999999997   7  999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCc---ccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVST---NGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++|+|||++.....         ....||+.|+|||.+.+..++.   ++||||||+++|||+||+.||+
T Consensus       152 ~~l~~~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  212 (271)
T 3kmu_A          152 ARISMADVKFSFQS---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA  212 (271)
T ss_dssp             EEEEGGGSCCTTSC---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred             eeEEeccceeeecc---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            99999988754221         1235899999999988765544   7999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=300.22  Aligned_cols=212  Identities=25%  Similarity=0.359  Sum_probs=170.7

Q ss_pred             HHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       224 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      ..+....++|++.+.||+|+||.||+|++..+|+.||+|+++... ...+.+.+|+++++++ +||||+++++++.....
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            333445678999999999999999999998899999999997543 3457889999999999 89999999998754321


Q ss_pred             C-CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          303 Q-GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       303 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      . ..+..++||||+++|+|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK---------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT  163 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence            1 1457899999999999999986432         24688999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++.+||+|||++........    ......||+.|+|||++.     +..++.++|||||||++|||+||+.||.
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  235 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTVG----RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC  235 (326)
T ss_dssp             TTCCEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCCCEEEeeCcCceecCcCcc----ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            999999999999876542211    112346899999999986     5678999999999999999999999984

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-38  Score=300.68  Aligned_cols=203  Identities=29%  Similarity=0.500  Sum_probs=162.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCC----cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDG----TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|...+.||+|+||+||+|++..++    ..||+|.++.... .....+.+|++++++++||||+++++++     .+.
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SKY  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ecC
Confidence            45667789999999999999986443    4699999975432 2345789999999999999999999985     345


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~  185 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKD----------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV  185 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCc
Confidence            57899999999999999986432          4688999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+++......... .......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  252 (333)
T 1mqb_A          186 CKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW  252 (333)
T ss_dssp             EEECCCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEECCCCcchhhccccccc-cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcc
Confidence            9999999998665322211 11122346889999999988899999999999999999999 999983

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-38  Score=299.95  Aligned_cols=204  Identities=27%  Similarity=0.474  Sum_probs=172.1

Q ss_pred             cCCCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||.||++++    ..+|+.||||++........+.+.+|++++++++||||+++++++..   .+..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe---cCCC
Confidence            4688889999999999999994    55789999999986666666789999999999999999999998642   2234


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  184 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK----------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRV  184 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST----------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred             ceEEEEECCCCCCHHHHHHhcc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcE
Confidence            6789999999999999996532          3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+++........ ........++..|+|||.+.+..++.++||||||+++|||+||..||
T Consensus       185 kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~  248 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS  248 (326)
T ss_dssp             EECCCTTCEECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred             EEecCcchhhccccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence            99999999876533221 11122345788899999998888999999999999999999999886

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-37  Score=293.82  Aligned_cols=199  Identities=34%  Similarity=0.514  Sum_probs=157.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++.   ..||+|+++....  ...+.+.+|++++++++||||+++++++.      .+.
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~   93 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQ   93 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCc
Confidence            467899999999999999999874   3599999975433  23467899999999999999999998642      345


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~k  160 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE----------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK  160 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC-------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred             cEEEEEecCCCcHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence            789999999999999996543          4688999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.........  ......||+.|+|||.+.   +..++.++||||||+++|||++|+.||+
T Consensus       161 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  226 (289)
T 3og7_A          161 IGDFGLATEKSRWSGSH--QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS  226 (289)
T ss_dssp             ECCCC--------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             Eccceeccccccccccc--cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence            99999997554222111  122356899999999986   5678889999999999999999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.3e-37  Score=291.01  Aligned_cols=205  Identities=21%  Similarity=0.380  Sum_probs=169.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC----CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR----QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|.+.+.||+|+||.||++++..+++.||+|+++...    ....+.+.+|++++++++||||+++++++..   .+.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            468999999999999999999998899999999997432    3345789999999999999999999998632   334


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++||||++++ |.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~---------~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~  147 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVP---------EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGT  147 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHST---------TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             CeEEEEehhccCC-HHHHHHhCc---------ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCc
Confidence            5789999999776 767665322         24688999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCC--CCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE--VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++..........  ......||+.|+|||++.+..  ++.++||||||+++|||++|+.||+
T Consensus       148 ~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  214 (305)
T 2wtk_C          148 LKISALGVAEALHPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE  214 (305)
T ss_dssp             EEECCCTTCEECCTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEeeccccccccCcccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999998654322221  122356899999999987644  4779999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-37  Score=298.87  Aligned_cols=213  Identities=23%  Similarity=0.440  Sum_probs=171.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-------CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-------EDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|.+.+.||+|+||+||+|++.       .+++.||+|+++.... ...+.+.+|+++++++ +||||+++++++.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            467888999999999999999975       3567899999975432 2346789999999999 9999999999853  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         ..+..++||||+++|+|.+++.........     .......+++.+++.++.|++.||+|||+.   +|+||||||
T Consensus       112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp  185 (334)
T 2pvf_A          112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA  185 (334)
T ss_dssp             ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence               345789999999999999999765421110     011234589999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+++.++.+||+|||+++.......  ........+|+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceEEEcCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999999999999999986543221  112223457889999999888889999999999999999999 999984

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-38  Score=303.06  Aligned_cols=199  Identities=27%  Similarity=0.401  Sum_probs=161.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--cHHHHHHHHHHHhcCCC--CCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--ASKSFMAECKALKNIRH--KNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~ei~~l~~l~h--~niv~l~~~~~~~~~~~~  305 (452)
                      .+.|++.+.||+|+||.||++... +++.||||++......  ..+.+.+|++++++++|  |||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            356888999999999999999985 6889999999754332  23678999999999976  99999999853     45


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      ...++||| +.+++|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++ ++.
T Consensus        82 ~~~~lv~e-~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~  145 (343)
T 3dbq_A           82 QYIYMVME-CGNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGM  145 (343)
T ss_dssp             SEEEEEEC-CCSEEHHHHHHHS-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTE
T ss_pred             CEEEEEEe-CCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCc
Confidence            58899999 5588999999643           3688999999999999999999998   999999999999997 578


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCC-----------CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----------SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++........  .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||+
T Consensus       146 ~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  221 (343)
T 3dbq_A          146 LKLIDFGIANQMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  221 (343)
T ss_dssp             EEECCCSSSCCC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEEeecccccccCccccc--ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence            999999999866432211  11223569999999999754           678899999999999999999999984

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-37  Score=292.57  Aligned_cols=199  Identities=23%  Similarity=0.339  Sum_probs=168.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||+||+|++..+++.||+|+++...  ......+.+|+..+..+ +||||+++++++.     +.+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~~   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----EDD   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ETT
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCC
Confidence            456889999999999999999999899999999997543  33456788999999999 9999999999853     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC----
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN----  382 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~----  382 (452)
                      ..++||||+++++|.+++....       .....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.    
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~  154 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENY-------RIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP  154 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred             eEEEEEEecCCCcHHHHHHhhc-------ccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence            8899999999999999986421       1124589999999999999999999998   9999999999999984    


Q ss_pred             ---------------CCceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHh
Q 041632          383 ---------------DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       383 ---------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ellt  446 (452)
                                     ...+||+|||.+.......        ...||+.|+|||.+.+. .++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (289)
T 1x8b_A          155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAG  226 (289)
T ss_dssp             ---------------CCCEEECCCTTCEETTCSC--------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccCCceEEEEcccccccccCCcc--------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhc
Confidence                           4479999999998654321        13489999999998765 56789999999999999999


Q ss_pred             CCCCC
Q 041632          447 TKKPT  451 (452)
Q Consensus       447 g~~Pf  451 (452)
                      |..|+
T Consensus       227 ~~~~~  231 (289)
T 1x8b_A          227 AEPLP  231 (289)
T ss_dssp             CCCCC
T ss_pred             CCCCC
Confidence            99875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.5e-38  Score=313.90  Aligned_cols=201  Identities=31%  Similarity=0.529  Sum_probs=165.9

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|...+.||+|+||+||+|++. .+..||||+++... ...++|.+|++++++++||||+++++++..      +..
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~  253 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  253 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cce
Confidence            3456788899999999999999997 45679999997543 345789999999999999999999998632      357


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...         ....+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus       254 ~iv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl  321 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGE---------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  321 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHH---------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEehhhcCCCHHHHHHhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEE
Confidence            8999999999999999632         123588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++.......   .......+|..|+|||.+....++.++|||||||++|||+| |+.||.
T Consensus       322 ~DfG~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~  383 (452)
T 1fmk_A          322 ADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  383 (452)
T ss_dssp             CCCCTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCCccceecCCCce---ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence            99999986543211   11223447889999999988899999999999999999999 999984

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.2e-37  Score=292.65  Aligned_cols=200  Identities=24%  Similarity=0.388  Sum_probs=171.6

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---------ccHHHHHHHHHHHhcCC-CCCceeEeeeec
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---------GASKSFMAECKALKNIR-HKNLVRVITSCS  298 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~ei~~l~~l~-h~niv~l~~~~~  298 (452)
                      ..++|+..+.||+|+||.||+|++..+|+.||||+++....         ...+.+.+|+++++++. ||||+++++++ 
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~-   93 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   93 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence            34678999999999999999999998999999999975431         12356789999999995 99999999985 


Q ss_pred             cccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       299 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                          ...+..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||
T Consensus        94 ----~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Ni  155 (298)
T 1phk_A           94 ----ETNTFFFLVFDLMKKGELFDYLTEK-----------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENI  155 (298)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             ----ccCCeEEEEEeccCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceE
Confidence                4456889999999999999998642           3688999999999999999999998   999999999999


Q ss_pred             eecCCCceEECccccccccccCCCCceeccccccccccccCccccC------CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL------GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       379 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++.++.+||+|||++........     .....||+.|+|||++.      ...++.++||||||+++|||++|+.||.
T Consensus       156 l~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          156 LLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             EECTTCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EEcCCCcEEEecccchhhcCCCcc-----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence            999999999999999986543221     12346899999999874      4568899999999999999999999984

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.5e-38  Score=298.33  Aligned_cols=221  Identities=24%  Similarity=0.356  Sum_probs=177.1

Q ss_pred             hHHHHHhhcCCCCCCceeccCceeEEEEEE-----cCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEee
Q 041632          223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVIT  295 (452)
Q Consensus       223 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~  295 (452)
                      ...+....++|.+.+.||+|+||+||+|++     ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            334444567899999999999999999985     34678999999975433 2345789999999999 7999999999


Q ss_pred             eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 041632          296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILH  370 (452)
Q Consensus       296 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  370 (452)
                      ++..    .+...++||||+++|+|.+++.........     .......+++.+++.++.|++.||+|||+.   +|+|
T Consensus        99 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H  171 (316)
T 2xir_A           99 ACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  171 (316)
T ss_dssp             EECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence            8642    234589999999999999999765421000     001123378999999999999999999998   9999


Q ss_pred             cccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCC
Q 041632          371 CDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKK  449 (452)
Q Consensus       371 ~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~  449 (452)
                      |||||+||+++.++.+||+|||+++........  .......||+.|+|||++.+..++.++||||||+++|||+| |+.
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccc--eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999865432221  22233557899999999988889999999999999999998 999


Q ss_pred             CCC
Q 041632          450 PTD  452 (452)
Q Consensus       450 Pf~  452 (452)
                      ||+
T Consensus       250 p~~  252 (316)
T 2xir_A          250 PYP  252 (316)
T ss_dssp             SST
T ss_pred             CCc
Confidence            984

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-37  Score=308.63  Aligned_cols=197  Identities=25%  Similarity=0.359  Sum_probs=167.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC------CCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI------RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l------~h~niv~l~~~~~~~~~~  303 (452)
                      ..+|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.+      +|+||+++++++.     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-----  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-----  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence            35688999999999999999999989999999999643 22335677888887766      6779999999854     


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      ..+..++||||+. ++|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~  236 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNK---------FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ  236 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTT---------TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC
Confidence            3457899999995 79999886543         23589999999999999999999998   99999999999999998


Q ss_pred             Cc--eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LS--AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~--~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.  +||+|||+++.....       .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       237 ~~~~vkL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          237 GRSGIKVIDFGSSCYEHQR-------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             TSCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcceEEeecccceecCCc-------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence            87  999999999754321       123468999999999999999999999999999999999999984

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1e-37  Score=296.77  Aligned_cols=204  Identities=25%  Similarity=0.405  Sum_probs=162.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|.+.+.||+|+||.||+|+...+|+.||+|+++...   ....+.+.+|++++++++||||+++++++.     ..+
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~  105 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDN  105 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETT
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCC
Confidence            356889999999999999999998899999999997532   233467889999999999999999999854     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++....       .....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~  175 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFK-------KQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV  175 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             cEEEEEecCCCCCHHHHHHHhc-------ccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence            7899999999999999985321       1124588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.......    ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       176 kl~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  237 (310)
T 2wqm_A          176 KLGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY  237 (310)
T ss_dssp             EECCC----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EEEeccceeeecCCCc----cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            9999999876543221    1123468999999999998899999999999999999999999984

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-37  Score=305.73  Aligned_cols=198  Identities=26%  Similarity=0.398  Sum_probs=162.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCC--CCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIR--HKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~--h~niv~l~~~~~~~~~~~~~  306 (452)
                      ..|++.+.||+|+||+||++... +++.||||++.....  ...+.+.+|++++++++  ||||+++++++.     ..+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence            45888999999999999999986 489999999975432  23467899999999996  599999999854     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||| +.+++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++ ++.+
T Consensus       130 ~~~lv~E-~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~  193 (390)
T 2zmd_A          130 YIYMVME-CGNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGML  193 (390)
T ss_dssp             EEEEEEE-CCSEEHHHHHHHC-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCE
T ss_pred             EEEEEEe-cCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeE
Confidence            7899999 5689999998643           2578889999999999999999998   999999999999995 5799


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-----------CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----------SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.+......  .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||+
T Consensus       194 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  268 (390)
T 2zmd_A          194 KLIDFGIANQMQPDTTS--VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  268 (390)
T ss_dssp             EECCCSSSCCC-----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEEecCccccccCCCcc--ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence            99999999866432211  11223569999999999764           368899999999999999999999984

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.7e-38  Score=307.49  Aligned_cols=200  Identities=11%  Similarity=0.054  Sum_probs=149.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHH---HHHhcCCCCCceeEeeeec------
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAEC---KALKNIRHKNLVRVITSCS------  298 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei---~~l~~l~h~niv~l~~~~~------  298 (452)
                      ..|...+.||+|+||+||+|++..+|+.||||++.....   ...+.+.+|+   +.++. +||||++++..+.      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            347888999999999999999998999999999986543   2235677784   45555 7999888553221      


Q ss_pred             -cccC------------CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHH------HHHHHHHHHHHHH
Q 041632          299 -SVDF------------QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR------ISIAIDVASALDY  359 (452)
Q Consensus       299 -~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~  359 (452)
                       ....            ......++||||++ |+|.+++....          ..+.+..+      +.++.|++.||+|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------~~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----------FVYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----------HSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----------cccchhhhhhhhhHHHHHHHHHHHHHH
Confidence             1000            00144799999998 99999996431          12333344      6788999999999


Q ss_pred             HhcCCCCCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCC--CCCCcccceeeh
Q 041632          360 LHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSY  437 (452)
Q Consensus       360 LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSl  437 (452)
                      ||+.   +|+||||||+|||++.++.+||+|||+++.....       .....+|+.|+|||++.+  ..++.++|||||
T Consensus       210 LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl  279 (371)
T 3q60_A          210 LQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAPREFLNASTATFTHALNAWQL  279 (371)
T ss_dssp             HHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred             HHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence            9998   9999999999999999999999999999855311       112457799999999987  679999999999


Q ss_pred             hHHHHHHHhCCCCCC
Q 041632          438 GILLLEMVTTKKPTD  452 (452)
Q Consensus       438 Gv~l~elltg~~Pf~  452 (452)
                      ||++|||+||+.||+
T Consensus       280 G~il~elltg~~Pf~  294 (371)
T 3q60_A          280 GLSIYRVWCLFLPFG  294 (371)
T ss_dssp             HHHHHHHHHSSCSTT
T ss_pred             HHHHHHHHhCCCCCC
Confidence            999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-37  Score=297.14  Aligned_cols=198  Identities=25%  Similarity=0.353  Sum_probs=165.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--------ccHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--------GASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      .++|.+.+.||+|+||.||+|++..+++.||||++.....        .....+.+|++++++++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            3568899999999999999999998999999999864321        122458899999999999999999998532  


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                         . ..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        87 ---~-~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  148 (322)
T 2ycf_A           87 ---E-DYYIVLELMEGGELFDKVVGN-----------KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLS  148 (322)
T ss_dssp             ---S-SEEEEEECCTTEETHHHHSTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred             ---C-ceEEEEecCCCCcHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEe
Confidence               2 379999999999999998643           3688999999999999999999998   999999999999998


Q ss_pred             CCCc---eEECccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 NDLS---AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~~~~---~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .++.   +||+|||+++......     ......||+.|+|||++.   ...++.++|||||||++|||++|+.||+
T Consensus       149 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  220 (322)
T 2ycf_A          149 SQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS  220 (322)
T ss_dssp             SSSSSCCEEECCCTTCEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCCCeEEEccCccceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            7664   9999999997654211     112346899999999863   5678999999999999999999999984

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6e-38  Score=295.64  Aligned_cols=202  Identities=26%  Similarity=0.428  Sum_probs=166.9

Q ss_pred             hcCCCCCC-ceeccCceeEEEEEE--cCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          230 TDGFSSTN-LIGVGSFGSVYKGVF--DEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       230 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      .++|.+.+ .||+|+||+||+|.+  ..+++.||||+++....  ...+.+.+|+++++.++||||+++++++.      
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------   88 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------   88 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence            35677777 899999999999954  45678999999975432  23467999999999999999999999862      


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~  154 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQN-----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH  154 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHC-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence            24578999999999999999643           2588999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++........ ........+++.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       155 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  222 (291)
T 1xbb_A          155 YAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  222 (291)
T ss_dssp             EEEECCCTTCEECCTTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             cEEEccCCcceeeccCCCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence            9999999999866533221 112223346789999999988889999999999999999999 999984

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-37  Score=320.68  Aligned_cols=195  Identities=27%  Similarity=0.452  Sum_probs=161.8

Q ss_pred             ceeccCceeEEEEEEc--CCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEEec
Q 041632          238 LIGVGSFGSVYKGVFD--EDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKY  314 (452)
Q Consensus       238 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~  314 (452)
                      .||+|+||.||+|.++  .++..||||+++... ....+++.+|++++++++||||++++++|..      +..++||||
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~~lv~E~  416 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EALMLVMEM  416 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSEEEEEEC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCeEEEEEe
Confidence            6999999999999875  356689999997543 3456789999999999999999999998642      347999999


Q ss_pred             cCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccc
Q 041632          315 MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLS  394 (452)
Q Consensus       315 ~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  394 (452)
                      +++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||++
T Consensus       417 ~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla  483 (613)
T 2ozo_A          417 AGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS  483 (613)
T ss_dssp             CTTCBHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred             CCCCcHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence            99999999996543          4689999999999999999999998   9999999999999999999999999999


Q ss_pred             cccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          395 RFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       395 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +........ ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       484 ~~~~~~~~~-~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~  541 (613)
T 2ozo_A          484 KALGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  541 (613)
T ss_dssp             TTCC---------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccCCCce-eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            865432211 111122346789999999988899999999999999999998 999984

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-37  Score=289.54  Aligned_cols=200  Identities=31%  Similarity=0.528  Sum_probs=170.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||.||+|++. +++.||+|.+.... ...+.+.+|++++++++||||+++++++.      .+..+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~   83 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIY   83 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcE
Confidence            456888899999999999999986 67789999997443 34578999999999999999999998853      23478


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.+||+
T Consensus        84 ~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS---------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH---------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEecCCCCCHHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEEC
Confidence            9999999999999986421         23588999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++......   ........+++.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       152 Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  212 (279)
T 1qpc_A          152 DFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP  212 (279)
T ss_dssp             CCTTCEECSSSC---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCcccccccCcc---cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence            999998654321   112223457889999999988889999999999999999999 999984

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-37  Score=292.03  Aligned_cols=202  Identities=27%  Similarity=0.448  Sum_probs=168.5

Q ss_pred             cCCCCCC-ceeccCceeEEEEEEc--CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTN-LIGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|.+.+ .||+|+||.||+|++.  .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.      .+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence            3455555 8999999999999864  4678899999975432 33567899999999999999999999862      23


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~  149 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA  149 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCC----------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCE
Confidence            5799999999999999996432          4589999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++........ ........+|+.|+|||++.+..++.++||||||+++|||+| |+.||+
T Consensus       150 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  215 (287)
T 1u59_A          150 KISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  215 (287)
T ss_dssp             EECCCTTCEECTTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EECcccceeeeccCcce-eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999866432211 111223457899999999988889999999999999999999 999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-37  Score=297.92  Aligned_cols=212  Identities=21%  Similarity=0.310  Sum_probs=159.4

Q ss_pred             HHHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-
Q 041632          224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-  302 (452)
Q Consensus       224 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-  302 (452)
                      .......++|.+.+.||+|+||+||+|++..+|+.||||++.... .....+.++++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            344556788999999999999999999999899999999986433 233466788888899999999999998755332 


Q ss_pred             -CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHh--cCCCCCeEecccCCCCee
Q 041632          303 -QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH--QHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       303 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dlk~~Nil  379 (452)
                       ......++||||+++ +|...+....       .....+++..+..++.|++.||+|||  +.   +|+||||||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIl  163 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYY-------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVL  163 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHH-------TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHh-------hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEE
Confidence             223347899999975 5444332100       11246788899999999999999999  76   9999999999999


Q ss_pred             ecC-CCceEECccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LDN-DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++. ++.+||+|||+++.......     .....||+.|+|||++.+.. ++.++|||||||++|||+||+.||.
T Consensus       164 l~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  233 (360)
T 3e3p_A          164 VNEADGTLKLCDFGSAKKLSPSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR  233 (360)
T ss_dssp             EETTTTEEEECCCTTCBCCCTTSC-----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeCCCCcEEEeeCCCceecCCCCC-----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence            997 89999999999986553221     12346899999999986644 8999999999999999999999984

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.6e-38  Score=293.34  Aligned_cols=201  Identities=25%  Similarity=0.450  Sum_probs=166.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcC---CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDE---DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|...+.||+|+||+||+|++..   ++..||+|.+..... ...+.+.+|++++++++||||+++++++..      
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE------   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS------
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC------
Confidence            4678889999999999999999753   334699999975432 345778999999999999999999998532      


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++++|.+++....          ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  151 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK----------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPEC  151 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTE
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc----------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCc
Confidence            34589999999999999986432          3588999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||++.........   ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       152 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~  216 (281)
T 3cc6_A          152 VKLGDFGLSRYIEDEDYY---KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF  216 (281)
T ss_dssp             EEECCCCGGGCC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEeCccCCCccccccccc---ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence            999999999865432211   1123457889999999988889999999999999999998 999984

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-38  Score=298.01  Aligned_cols=213  Identities=29%  Similarity=0.367  Sum_probs=154.5

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ..++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++.     ..+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence            4578999999999999999999998889999999986443 234467889999999999999999999854     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++.....   ........+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVA---KGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHH---TTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred             cEEEehhccCCchHHHHHHHhh---ccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence            8999999999999999863110   0001124589999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCc-eeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPT-VSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||++.......... ........||+.|+|||++.+ ..++.++||||||+++|||+||+.||+
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  228 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH  228 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            99999987654322111 111123468999999998765 468999999999999999999999984

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-37  Score=299.67  Aligned_cols=215  Identities=25%  Similarity=0.393  Sum_probs=173.4

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCc-----EEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGT-----VVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      ...++|...+.||+|+||.||+|++..+++     .||+|.+..... ...+.+.+|+++++.+ +||||+++++++.  
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence            345678889999999999999999876554     799999975432 3346789999999999 8999999999853  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCC---CcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIP---QRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSN  377 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~N  377 (452)
                         ..+..++||||+++|+|.+++......   ..........+++.+++.++.|++.||+|||+.   +|+||||||+|
T Consensus       121 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  194 (333)
T 2i1m_A          121 ---HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN  194 (333)
T ss_dssp             ---SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence               445789999999999999998642100   000001134679999999999999999999998   99999999999


Q ss_pred             eeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          378 ILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       378 ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |+++.++.+||+|||+++.........  ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||+
T Consensus       195 Il~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          195 VLLTNGHVAKIGDFGLARDIMNDSNYI--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             CEEEGGGEEEBCCCGGGCCGGGCTTSE--ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             EEECCCCeEEECcccccccccccccee--ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence            999999999999999998654332221  1223457889999999888889999999999999999999 999984

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.7e-37  Score=297.73  Aligned_cols=204  Identities=23%  Similarity=0.318  Sum_probs=169.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc-----------------HHHHHHHHHHHhcCCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA-----------------SKSFMAECKALKNIRHKNLVR  292 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~ei~~l~~l~h~niv~  292 (452)
                      .++|.+.+.||+|+||.||+|++  +|+.||+|++.......                 .+.+.+|++++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36799999999999999999999  89999999997432111                 178999999999999999999


Q ss_pred             EeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEec
Q 041632          293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPILHC  371 (452)
Q Consensus       293 l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~  371 (452)
                      +++++.     +.+..++||||+++|+|.+++.....-.   ......+++..++.++.|++.||+|||+ .   +|+||
T Consensus       108 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~  176 (348)
T 2pml_X          108 CEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLD---KNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHR  176 (348)
T ss_dssp             CSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSC---SSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECC
T ss_pred             EEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhh---hccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeec
Confidence            999853     3458899999999999999943210000   0113568999999999999999999998 7   99999


Q ss_pred             ccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCc-ccceeehhHHHHHHHhCCC
Q 041632          372 DLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVST-NGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       372 Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGv~l~elltg~~  449 (452)
                      ||||+||+++.++.+||+|||.+......      ......||+.|+|||++.+. .++. ++||||||+++|||++|+.
T Consensus       177 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          177 DVKPSNILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCChHhEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999865422      12235689999999998877 6666 9999999999999999999


Q ss_pred             CCC
Q 041632          450 PTD  452 (452)
Q Consensus       450 Pf~  452 (452)
                      ||+
T Consensus       251 pf~  253 (348)
T 2pml_X          251 PFS  253 (348)
T ss_dssp             SSC
T ss_pred             CCC
Confidence            984

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-37  Score=298.09  Aligned_cols=209  Identities=25%  Similarity=0.387  Sum_probs=166.2

Q ss_pred             hcCCCCCCceeccCceeEEEEE-----EcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGV-----FDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|.+.+.||+|+||.||+|+     ...+++.||||.+.... .....++.+|+.++++++||||+++++++.     
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence            3578899999999999999999     44567899999996432 233467899999999999999999999853     


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-  382 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-  382 (452)
                      ..+..++||||+++|+|.+++.....    .......+++.+++.++.|++.||+|||+.   +|+||||||+||+++. 
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRP----RPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP  176 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSC----CSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCS
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcc----cccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecC
Confidence            34567999999999999999975431    111224589999999999999999999998   9999999999999994 


Q ss_pred             --CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          383 --DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       383 --~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                        +..+||+|||+++.........  ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  247 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYR--KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP  247 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCcceEEECccccccccccccccc--cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence              4569999999997554222111  1223457899999999988889999999999999999998 999984

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.2e-37  Score=307.66  Aligned_cols=203  Identities=26%  Similarity=0.394  Sum_probs=169.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|.+.+.||+|+||.||+|++..+++.||||++......  .++..|+++++.++|++.+..+..+.    ...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG----VEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEE----EETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCEEE
Confidence            46799999999999999999999889999999998654332  45789999999998755554444432    2345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee---cCCCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL---DNDLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill---~~~~~~  386 (452)
                      +||||+ +++|.+++....          ..+++.+++.++.||+.||+|||+.   +|+||||||+|||+   +.++.+
T Consensus        80 lvme~~-g~sL~~ll~~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~v  145 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQV  145 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCE
T ss_pred             EEEECC-CCCHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeE
Confidence            999999 999999986432          3689999999999999999999998   99999999999999   688999


Q ss_pred             EECccccccccccCCCCc---eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.+.......   ........||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~  214 (483)
T 3sv0_A          146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ  214 (483)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            999999998765432211   111224569999999999999999999999999999999999999984

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-37  Score=291.63  Aligned_cols=196  Identities=30%  Similarity=0.474  Sum_probs=161.4

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||.||++++  +|+.||||+++..  ...+.+.+|++++++++||||+++++++.    ...+..+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~   91 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLY   91 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCE
T ss_pred             hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCceE
Confidence            35788899999999999999998  4889999999643  34578999999999999999999999853    2334679


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++++|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~  159 (278)
T 1byg_A           92 IVTEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVS  159 (278)
T ss_dssp             EEECCCTTEEHHHHHHHHH---------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             EEEecCCCCCHHHHHHhcc---------cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEe
Confidence            9999999999999986321         12478899999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||++.......       ....+++.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       160 Dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  216 (278)
T 1byg_A          160 DFGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  216 (278)
T ss_dssp             CCCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             eccccccccccc-------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            999987544221       12347889999999988889999999999999999998 999984

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.4e-38  Score=298.92  Aligned_cols=215  Identities=25%  Similarity=0.406  Sum_probs=173.3

Q ss_pred             HHhhcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccc
Q 041632          227 LKATDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSV  300 (452)
Q Consensus       227 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~  300 (452)
                      ....++|+..+.||+|+||.||+|++.     .+++.||+|.+..... .....+.+|+++++.++||||+++++++   
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---   97 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV---   97 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE---
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE---
Confidence            344567889999999999999999876     3578899999974432 2335688999999999999999999985   


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                        .+.+..++||||+++|+|.+++...... .........+++.+++.++.|++.||+|||+.   +|+||||||+||++
T Consensus        98 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           98 --SQGQPTLVIMELMTRGDLKSYLRSLRPA-MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             --CSSSSCEEEEECCTTCBHHHHHHHHHHH-HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             --ccCCccEEEEEeCCCCcHHHHHHHhchh-hccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence              3445789999999999999998642100 00001123568999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +.++.+||+|||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||+
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  242 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  242 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             cCCCeEEECcCccccccccccc--cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccc
Confidence            9999999999999976543221  112223457889999999988889999999999999999999 899984

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.1e-37  Score=294.58  Aligned_cols=206  Identities=28%  Similarity=0.428  Sum_probs=171.1

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEc-CCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcC---CCCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFD-EDGTVVAIKVINLQRQ--GASKSFMAECKALKNI---RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l---~h~niv~l~~~~~~~~~  302 (452)
                      +.++|++.+.||+|+||.||+|++. .+|+.||+|+++....  .....+.+|+++++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999984 6789999999974432  2234566777777666   89999999998754333


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ......++||||++ |+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~  155 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP---------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS  155 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC---------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcC
Confidence            34567899999997 79999986432         13488999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++......     ......||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       156 ~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  220 (326)
T 1blx_A          156 SGQIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  220 (326)
T ss_dssp             TCCEEECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCEEEecCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence            9999999999997554221     1223568999999999998899999999999999999999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-37  Score=294.16  Aligned_cols=200  Identities=27%  Similarity=0.389  Sum_probs=159.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC--CCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI--RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l--~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+|+++  |+.||||++...   ....+..|.+++...  +||||+++++++.... .....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  109 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQ  109 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCc
Confidence            467999999999999999999984  899999998643   234455566665554  9999999999865431 11257


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEecccCCCCeeecC
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC-----QEPILHCDLKPSNILLDN  382 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~  382 (452)
                      .++||||+++|+|.++++.            ..+++.+++.++.|++.||+|||+.+     .++|+||||||+|||++.
T Consensus       110 ~~lv~e~~~~g~L~~~l~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~  177 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK  177 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             eEEEEeccCCCcHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence            8999999999999999953            25889999999999999999999851     348999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcc------cceeehhHHHHHHHhC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTN------GDVYSYGILLLEMVTT  447 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGv~l~elltg  447 (452)
                      ++.+||+|||+++.+...............||+.|+|||++.+...+.+      +|||||||++|||+||
T Consensus       178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            9999999999997665333222222234569999999999887766665      9999999999999999

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-37  Score=296.77  Aligned_cols=209  Identities=31%  Similarity=0.482  Sum_probs=168.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEE--EEEEeecc-CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVV--AIKVINLQ-RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|+..+.||+|+||.||+|++..++..+  |+|.++.. .....+.+.+|+++++++ +||||+++++++.     +.+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence            57888999999999999999998788755  99988643 233446789999999999 9999999999853     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcc-----cccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ..++||||+++|+|.+++.........     .......+++.+++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence            789999999999999999764310000     001224689999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .++.+||+|||+++......     ......+++.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  243 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  243 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCCeEEEcccCcCccccccc-----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence            99999999999987433211     1122347889999999988889999999999999999998 999984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.2e-37  Score=298.74  Aligned_cols=199  Identities=27%  Similarity=0.353  Sum_probs=165.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC-CCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ-GND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~-~~~  306 (452)
                      .++|...+.||+|+||+||+|++..+|+.||||++.....  ...+.+.+|+++++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4578889999999999999999999999999999975432  2246788999999999999999999986543211 111


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+. ++|.+++.             ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-------------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             eEEEEEcccc-ccHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCE
Confidence            3489999996 78888763             2488999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.....       .....||+.|+|||++.+ ..++.++|||||||++|||+||+.||+
T Consensus       184 kL~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  243 (371)
T 4exu_A          184 KILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK  243 (371)
T ss_dssp             EECSTTCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEEecCcccccccC-------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            99999999754422       123468999999999877 678999999999999999999999995

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.5e-37  Score=320.53  Aligned_cols=195  Identities=27%  Similarity=0.447  Sum_probs=161.4

Q ss_pred             CceeccCceeEEEEEE--cCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVF--DEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|.+  +.+++.||||+++....  ...+++.+|++++++++||||++++++|..      +..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence            3699999999999965  44568999999975432  335789999999999999999999998632      3478999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||+|||
T Consensus       449 E~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFG  514 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN-----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  514 (635)
T ss_dssp             ECCTTEEHHHHHHHC-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTT
T ss_pred             EccCCCCHHHHHhhC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcC
Confidence            999999999999643           3688999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++.+....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus       515 la~~~~~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~  574 (635)
T 4fl3_A          515 LSKALRADENYY-KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  574 (635)
T ss_dssp             HHHHTTC--------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CccccccCcccc-ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            998765332211 11223447889999999988899999999999999999998 999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.7e-37  Score=290.78  Aligned_cols=203  Identities=24%  Similarity=0.286  Sum_probs=155.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||+|+++......  .+.+.++...++.++||||+++++++.     +.+.
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence            467889999999999999999999899999999997543222  233455555688889999999999854     4457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||++ |+|.+++....       .....+++..++.++.|++.||+|||+.  .+|+||||||+||+++.++.+|
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~-------~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~k  150 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVI-------DKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVK  150 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHH-------HTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEE
T ss_pred             EEEEEehhc-cchHHHHHHHH-------hcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEE
Confidence            899999996 58887775311       1224689999999999999999999984  2899999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCcccc----CCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG----LGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........     ....||+.|+|||.+    .+..++.++||||+|+++|||+||+.||+
T Consensus       151 l~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  214 (290)
T 3fme_A          151 MCDFGISGYLVDDVAK-----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD  214 (290)
T ss_dssp             BCCC--------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             EeecCCcccccccccc-----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            9999999765432211     223589999999995    55678999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=304.34  Aligned_cols=209  Identities=25%  Similarity=0.356  Sum_probs=154.2

Q ss_pred             CCCC-CCceeccCceeEEEEEEc--CCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSS-TNLIGVGSFGSVYKGVFD--EDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .|++ .++||+|+||+||+|+++  .+++.||+|++...  .....+.+|++++++++||||+++++++..   ......
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLS---HADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeE
Confidence            3555 568999999999999976  46889999999643  334678899999999999999999998642   335678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee----cCCC
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL----DNDL  384 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill----~~~~  384 (452)
                      ++||||++ |+|.+++......  ........+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  169 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRAS--KANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG  169 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHH--C-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred             EEEEeCCC-CCHHHHHHHhccc--cccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence            99999995 6888877532100  0001123589999999999999999999998   99999999999999    6788


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++........ ........||+.|+|||++.+. .++.++|||||||++|||+||+.||+
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          170 RVKIADMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             CEEECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cEEEEECCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence            9999999999866532211 1122345689999999998774 58999999999999999999999994

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-37  Score=294.53  Aligned_cols=201  Identities=26%  Similarity=0.442  Sum_probs=168.1

Q ss_pred             CCCCCceeccCceeEEEEEE----cCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          233 FSSTNLIGVGSFGSVYKGVF----DEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      |+..+.||+|+||+||++.+    ..+++.||||+++.... ...+.+.+|++++++++||||+++++++..   .+...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence            47889999999999988865    34688999999975432 334678999999999999999999998653   22457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...            .+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~------------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~k  174 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH------------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVK  174 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEecccCCcHHHHHhhC------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEE
Confidence            89999999999999998642            488999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++........ ........+|+.|+|||++.+..++.++||||||+++|||+||+.||.
T Consensus       175 l~Dfg~a~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~  238 (318)
T 3lxp_A          175 IGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ  238 (318)
T ss_dssp             ECCGGGCEECCTTCSE-EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ECCccccccccccccc-cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence            9999999876533221 112233458889999999988889999999999999999999999973

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.4e-37  Score=302.05  Aligned_cols=201  Identities=25%  Similarity=0.342  Sum_probs=160.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~  309 (452)
                      .+|...+.||+|+||+||+|++..+++ ||+|++......    ..+|+++++.++||||+++++++..... .+....+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            468889999999999999999975554 888887543222    2379999999999999999998754332 3344578


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec-CCCceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl  388 (452)
                      +||||++++.+.......        .....+++..++.++.|++.||+|||+.   +|+||||||+|||++ .++.+||
T Consensus       115 lv~e~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL  183 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYA--------KLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKL  183 (394)
T ss_dssp             EEEECCSEEHHHHHHHHH--------HTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeccCccHHHHHHHHH--------hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEE
Confidence            999999765443322110        1124688999999999999999999998   999999999999999 7999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.......     .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       184 ~DFG~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  243 (394)
T 4e7w_A          184 IDFGSAKILIAGEP-----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP  243 (394)
T ss_dssp             CCCTTCEECCTTCC-----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eeCCCcccccCCCC-----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999986543221     1235689999999998764 58999999999999999999999994

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=316.91  Aligned_cols=201  Identities=31%  Similarity=0.529  Sum_probs=169.9

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|++.+.||+|+||+||+|++. .+..||||+++... ...++|.+|+++|++++||||+++++++..      +..
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  336 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI  336 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred             chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccc
Confidence            3456788899999999999999996 45679999997543 345789999999999999999999998632      357


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...         ....+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus       337 ~lv~e~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl  404 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGE---------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  404 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHH---------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             eEeeehhcCCcHHHHHhhc---------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEE
Confidence            8999999999999999632         123588999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||+++.....   .........++..|+|||++....++.++|||||||++|||+| |+.||.
T Consensus       405 ~DFG~a~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~  466 (535)
T 2h8h_A          405 ADFGLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  466 (535)
T ss_dssp             CCTTSTTTCCCH---HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred             cccccceecCCC---ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999865421   1111123447889999999988899999999999999999999 999984

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.7e-38  Score=302.35  Aligned_cols=200  Identities=15%  Similarity=0.229  Sum_probs=165.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC--------CCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeE---------
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE--------DGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRV---------  293 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l---------  293 (452)
                      ++|.+.+.||+|+||.||+|++..        +++.||+|++...     +.+.+|++++++++||||+++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578899999999999999999986        4789999998743     467899999999999999984         


Q ss_pred             ------eeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 041632          294 ------ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEP  367 (452)
Q Consensus       294 ------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  367 (452)
                            ++++.    ..+...++||||+ +++|.+++....         ...+++.+++.++.|++.||+|||+.   +
T Consensus       117 ~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~---~  179 (352)
T 2jii_A          117 LAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP---------KHVLSERSVLQVACRLLDALEFLHEN---E  179 (352)
T ss_dssp             CSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG---------GGCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             cCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC---------cCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence                  33321    2346789999999 999999996431         24689999999999999999999998   9


Q ss_pred             eEecccCCCCeeecCCC--ceEECccccccccccCCCCce---eccccccccccccCccccCCCCCCcccceeehhHHHH
Q 041632          368 ILHCDLKPSNILLDNDL--SAHIGDFGLSRFYQAVSNPTV---SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLL  442 (452)
Q Consensus       368 ivH~Dlk~~Nill~~~~--~~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~  442 (452)
                      |+||||||+|||++.++  .+||+|||+++.+........   .......||+.|+|||++.+..++.++|||||||++|
T Consensus       180 ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  259 (352)
T 2jii_A          180 YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML  259 (352)
T ss_dssp             CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence            99999999999999998  999999999986653221110   1112346999999999999989999999999999999


Q ss_pred             HHHhCCCCCC
Q 041632          443 EMVTTKKPTD  452 (452)
Q Consensus       443 elltg~~Pf~  452 (452)
                      ||+||+.||+
T Consensus       260 el~~g~~pf~  269 (352)
T 2jii_A          260 KWLYGFLPWT  269 (352)
T ss_dssp             HHHHSCCTTG
T ss_pred             HHHhCCCCcc
Confidence            9999999984

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.3e-37  Score=302.48  Aligned_cols=201  Identities=25%  Similarity=0.368  Sum_probs=167.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC--------CCCceeEeeeeccccC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR--------HKNLVRVITSCSSVDF  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~--------h~niv~l~~~~~~~~~  302 (452)
                      ++|.+.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.++        |+||+++++++.... 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            5788999999999999999999989999999999633 233467889999999885        788999999864321 


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ......++||||+ ++++.+++....         ...+++.+++.++.|++.||+|||+.+  +|+||||||+|||++.
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~  182 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN---------YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSV  182 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT---------TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECC
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc---------cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEec
Confidence            2445789999999 667766664321         135899999999999999999999852  8999999999999997


Q ss_pred             CC-------------------------------------------------ceEECccccccccccCCCCceeccccccc
Q 041632          383 DL-------------------------------------------------SAHIGDFGLSRFYQAVSNPTVSSSIGVRG  413 (452)
Q Consensus       383 ~~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~~~g  413 (452)
                      ++                                                 .+||+|||+++......       ....|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------~~~~g  255 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------TEDIQ  255 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------CSCCS
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------ccCCC
Confidence            75                                                 79999999998654321       22458


Q ss_pred             cccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       414 t~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  294 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE  294 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence            999999999999899999999999999999999999994

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-36  Score=293.76  Aligned_cols=198  Identities=28%  Similarity=0.420  Sum_probs=163.2

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhc--CCCCCceeEeeeeccccCCCCc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKN--IRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~--l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ..++|.+.+.||+|+||.||+|++  +|+.||||++...   ..+.+.+|++++..  ++||||+++++++.... ....
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~  113 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT  113 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cccc
Confidence            446799999999999999999998  5899999998643   34677888888877  79999999999864322 1113


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHh--------cCCCCCeEecccCCCCe
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLH--------QHCQEPILHCDLKPSNI  378 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dlk~~Ni  378 (452)
                      ..++||||+++|+|.+++..            ..+++.+++.++.|++.||+|||        +.   +|+||||||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI  178 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI  178 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred             eeEEEEeecCCCcHHHHHhc------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence            68999999999999999953            24889999999999999999999        65   999999999999


Q ss_pred             eecCCCceEECccccccccccCCCCceeccccccccccccCccccCCC------CCCcccceeehhHHHHHHHhC
Q 041632          379 LLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMVTT  447 (452)
Q Consensus       379 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg  447 (452)
                      +++.++.+||+|||+++.................||+.|+|||++.+.      .++.++|||||||++|||+||
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999999987654332211122345699999999998765      334689999999999999999

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=295.29  Aligned_cols=199  Identities=27%  Similarity=0.361  Sum_probs=165.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~  306 (452)
                      .++|...+.||+|+||.||+|++..+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3678889999999999999999998999999999964332  224678899999999999999999998643221 1112


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||++ ++|.+++.             ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-------------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~  165 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-------------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCEL  165 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCE
T ss_pred             eEEEEecccc-CCHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcE
Confidence            3589999996 68887763             2478999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++.....       .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||+
T Consensus       166 kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  225 (353)
T 3coi_A          166 KILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK  225 (353)
T ss_dssp             EECSTTCTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred             EEeecccccCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999754321       123468999999999876 678999999999999999999999984

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-36  Score=287.96  Aligned_cols=203  Identities=28%  Similarity=0.413  Sum_probs=163.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeecccc--------
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVD--------  301 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~--------  301 (452)
                      .++|+..+.||+|+||.||+|++..+|+.||+|++... ....+.+.+|++++++++||||+++++++....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45688899999999999999999889999999999643 233467899999999999999999999865321        


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ....+..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN----------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFID  150 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC----------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc----------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEc
Confidence            123467899999999999999996432          3577889999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCC----------ceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHh
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNP----------TVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~ellt  446 (452)
                      .++.+||+|||+++........          .........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            9999999999999765422100          01112235689999999998764 68999999999999999998

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-36  Score=285.51  Aligned_cols=198  Identities=29%  Similarity=0.417  Sum_probs=169.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||.||+|+...+++.||+|++....  ....+.+.+|++++++++||||+++++++.     +.+.
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            357899999999999999999998899999999997442  344578999999999999999999999853     4567


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC---C
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND---L  384 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~---~  384 (452)
                      .++|+||+++++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.+   +
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~  161 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKR-----------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC  161 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred             EEEEEEccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcc
Confidence            89999999999999888532           3588999999999999999999998   99999999999999764   4


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||++........     .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||.
T Consensus       162 ~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~  223 (287)
T 2wei_A          162 DIKIIDFGLSTCFQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY  223 (287)
T ss_dssp             CEEECSTTGGGTBCCCSS-----CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cEEEeccCcceeecCCCc-----cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence            799999999986543221     122458999999998765 58999999999999999999999984

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.9e-37  Score=293.23  Aligned_cols=197  Identities=22%  Similarity=0.343  Sum_probs=166.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEE-cCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC------ceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVF-DEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN------LVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n------iv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||+||+|+. ..+++.||||+++.. ....+.+.+|+++++.++|++      ++++++++     
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~-----   86 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF-----   86 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE-----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc-----
Confidence            35789999999999999999998 557899999999643 233467889999998886654      89998884     


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      ...+..++||||+ +++|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+|||++.
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~  153 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENG---------FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQ  153 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT---------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESC
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcC---------CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEec
Confidence            3445889999999 899999986432         13578999999999999999999998   9999999999999987


Q ss_pred             -------------------CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHH
Q 041632          383 -------------------DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE  443 (452)
Q Consensus       383 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e  443 (452)
                                         ++.+||+|||+++......       ....||+.|+|||++.+..++.++|||||||++||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  226 (339)
T 1z57_A          154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE  226 (339)
T ss_dssp             CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHH
T ss_pred             cccccccCCccccccccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHH
Confidence                               6689999999997643221       12468999999999999899999999999999999


Q ss_pred             HHhCCCCCC
Q 041632          444 MVTTKKPTD  452 (452)
Q Consensus       444 lltg~~Pf~  452 (452)
                      |+||+.||.
T Consensus       227 l~~g~~pf~  235 (339)
T 1z57_A          227 YYLGFTVFP  235 (339)
T ss_dssp             HHHSSCSCC
T ss_pred             HHhCCCCCC
Confidence            999999984

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.5e-37  Score=289.45  Aligned_cols=202  Identities=28%  Similarity=0.404  Sum_probs=159.8

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-CC--cEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-DG--TVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|++.+.||+|+||+||+|++.. ++  ..||+|+++..   .....+.+.+|++++++++||||+++++++..     
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   92 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   92 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-----
Confidence            568889999999999999999743 33  36899998743   23345788999999999999999999998532     


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      . ..++|+||+++++|.+++...          ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        93 ~-~~~~v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~  158 (291)
T 1u46_A           93 P-PMKMVTELAPLGSLLDRLRKH----------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD  158 (291)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH----------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred             C-CceeeEecccCCCHHHHHHhc----------cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence            2 378999999999999998642          14588999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++........ ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  226 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  226 (291)
T ss_dssp             EEEECCCTTCEECCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CEEEccccccccccccccc-hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            9999999999866533221 112223457889999999988889999999999999999999 999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.9e-36  Score=296.47  Aligned_cols=200  Identities=28%  Similarity=0.329  Sum_probs=166.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CC-----CceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HK-----NLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~-----niv~l~~~~~~~~~  302 (452)
                      ..++|++.+.||+|+||+||+|+...+++.||||+++.. ......+..|+++++.++ |+     +++++.+++.    
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~----  126 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM----  126 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec----
Confidence            356899999999999999999999989999999999732 223466778888888874 55     3888888743    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec-
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-  381 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-  381 (452)
                       ..+..++||||++ |+|.+++....         ...+++..+..++.|++.||+|||++ ..+|+||||||+|||++ 
T Consensus       127 -~~~~~~lv~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~  194 (382)
T 2vx3_A          127 -FRNHLCLVFEMLS-YNLYDLLRNTN---------FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCN  194 (382)
T ss_dssp             -ETTEEEEEEECCC-CBHHHHHHHTT---------TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESS
T ss_pred             -cCCceEEEEecCC-CCHHHHHhhcC---------cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEec
Confidence             3458899999995 69999986532         13588999999999999999999952 24999999999999995 


Q ss_pred             -CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          382 -NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                       .++.+||+|||+++.....       .....||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       195 ~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          195 PKRSAIKIVDFGSSCQLGQR-------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             TTSCCEEECCCTTCEETTCC-------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCcEEEEeccCceecccc-------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence             4788999999999865422       123468999999999999999999999999999999999999995

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.8e-36  Score=290.14  Aligned_cols=200  Identities=23%  Similarity=0.324  Sum_probs=147.8

Q ss_pred             hcCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|.+. +.||+|+||+||+|++..+|+.||||++...    .....+....++.++||||+++++++.... .+....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceE
Confidence            4678875 4699999999999999989999999998642    122223333456679999999999865421 234568


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---CCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~  385 (452)
                      ++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++.
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~---------~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG---------DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC----------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred             EEEEeccCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCce
Confidence            99999999999999997542         23689999999999999999999998   9999999999999986   455


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++......      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       170 ~kl~Dfg~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (336)
T 3fhr_A          170 LKLTDFGFAKETTQNA------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY  230 (336)
T ss_dssp             EEECCCTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             EEEeccccceeccccc------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999997554221      122458999999999988889999999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-36  Score=310.10  Aligned_cols=206  Identities=27%  Similarity=0.398  Sum_probs=172.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeecccc-CCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVD-FQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~-~~~~~~~  308 (452)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|++++++++||||+++++++.... +...+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999998899999999986542 233467899999999999999999999865422 2335678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc---
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS---  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~---  385 (452)
                      ++||||+++|+|.+++....        ....+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.   
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~--------~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~  162 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE--------NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLI  162 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS--------CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCE
T ss_pred             EEEEEeCCCCCHHHHHHhcc--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCcee
Confidence            99999999999999997542        123577888999999999999999998   9999999999999997765   


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++........     .....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus       163 vKL~DFG~a~~~~~~~~-----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~  224 (676)
T 3qa8_A          163 HKIIDLGYAKELDQGEL-----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL  224 (676)
T ss_dssp             EEECSCCCCCBTTSCCC-----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEcccccccccccccc-----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence            99999999986543221     123568999999999999999999999999999999999999983

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.7e-37  Score=292.93  Aligned_cols=199  Identities=26%  Similarity=0.345  Sum_probs=168.8

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc------cHHHHHHHHHHHhcCC--CCCceeEeeeeccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG------ASKSFMAECKALKNIR--HKNLVRVITSCSSV  300 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~--h~niv~l~~~~~~~  300 (452)
                      ..++|++.+.||+|+||.||+|++..+++.||||+++.....      ..+.+.+|++++++++  ||||+++++++   
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~---  117 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---  117 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence            456799999999999999999999989999999999754322      2245678999999996  59999999985   


Q ss_pred             cCCCCceeEEEEeccCC-CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          301 DFQGNDFKAIVYKYMPN-GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                        ...+..++|+|++.+ ++|.+++...           ..+++..++.++.|++.||+|||+.   +|+||||||+|||
T Consensus       118 --~~~~~~~lv~e~~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl  181 (320)
T 3a99_A          118 --ERPDSFVLILERPEPVQDLFDFITER-----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENIL  181 (320)
T ss_dssp             --ECSSEEEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             --ecCCcEEEEEEcCCCCccHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEE
Confidence              345678999999976 8999998642           3688999999999999999999998   9999999999999


Q ss_pred             ec-CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++ +++.+||+|||+++......      .....||+.|+|||++.+..+ +.++||||||+++|||+||+.||+
T Consensus       182 l~~~~~~~kL~Dfg~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  250 (320)
T 3a99_A          182 IDLNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  250 (320)
T ss_dssp             EETTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EeCCCCCEEEeeCcccccccccc------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCC
Confidence            99 78999999999998654321      122458999999999876665 678999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-37  Score=291.28  Aligned_cols=200  Identities=26%  Similarity=0.335  Sum_probs=162.8

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc------cHHHHHHHHHHHhcC----CCCCceeEeeee
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG------ASKSFMAECKALKNI----RHKNLVRVITSC  297 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l----~h~niv~l~~~~  297 (452)
                      ...++|.+.+.||+|+||.||+|++..+++.||||+++.....      ....+.+|++++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999999889999999999754321      223456788888888    899999999984


Q ss_pred             ccccCCCCceeEEEEec-cCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          298 SSVDFQGNDFKAIVYKY-MPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       298 ~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                           ...+..++|+|+ +.+++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus       108 -----~~~~~~~~v~e~~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~  168 (312)
T 2iwi_A          108 -----ETQEGFMLVLERPLPAQDLFDYITEK-----------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDE  168 (312)
T ss_dssp             ----------CEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGG
T ss_pred             -----ecCCeEEEEEEecCCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChh
Confidence                 445578999999 7899999998642           3589999999999999999999998   9999999999


Q ss_pred             Ceeec-CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          377 NILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       377 Nill~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+++ +++.+||+|||+++......      .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||+
T Consensus       169 Nil~~~~~~~~kl~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  240 (312)
T 2iwi_A          169 NILIDLRRGCAKLIDFGSGALLHDEP------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE  240 (312)
T ss_dssp             GEEEETTTTEEEECCCSSCEECCSSC------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             hEEEeCCCCeEEEEEcchhhhcccCc------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCC
Confidence            99999 88999999999998655321      123458999999999876665 458999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.8e-36  Score=287.41  Aligned_cols=204  Identities=25%  Similarity=0.312  Sum_probs=148.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHH-HHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECK-ALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~-~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|...+.||+|+||.||+|++..+|+.||||+++.... .....+..|+. +++.++||||+++++++.     ..+.
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~   95 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGD   95 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCc
Confidence            3678889999999999999999988999999999975432 22345556665 777889999999999853     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||++ |+|.+++....      ......+++..+..++.|++.||+|||+.  .+|+||||||+||+++.++.+|
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           96 CWICMELMS-TSFDKFYKYVY------SVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             EEEEECCCS-EEHHHHHHHHH------HTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEE
T ss_pred             eEEEEeecC-CChHHHHHHHH------hhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEE
Confidence            899999997 58877764210      01124688999999999999999999984  3899999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCcccc----CCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG----LGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......     .....||+.|+|||++    .+..++.++|||||||++|||++|+.||+
T Consensus       167 l~Dfg~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (327)
T 3aln_A          167 LCDFGISGQLVDSIA-----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYP  230 (327)
T ss_dssp             ECCCSSSCC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSS
T ss_pred             EccCCCceecccccc-----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            999999976542211     1123589999999998    45678999999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-36  Score=291.28  Aligned_cols=197  Identities=25%  Similarity=0.348  Sum_probs=164.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC-cEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC------ceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG-TVVAIKVINLQRQGASKSFMAECKALKNIRHKN------LVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n------iv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||+||+|+...++ +.||+|+++.. ....+.+.+|+++++.++|++      ++.+.+++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~-----   91 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF-----   91 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE-----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee-----
Confidence            367899999999999999999997666 78999999632 233467888999999887766      78877764     


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee--
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL--  380 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill--  380 (452)
                      ...+..++||||+ ++++.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+|||+  
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~---------~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~  158 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENN---------FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVN  158 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT---------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESC
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEec
Confidence            3345789999999 777777775432         13588999999999999999999998   99999999999999  


Q ss_pred             -----------------cCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHH
Q 041632          381 -----------------DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLE  443 (452)
Q Consensus       381 -----------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e  443 (452)
                                       +.++.+||+|||+++......       ....||+.|+|||++.+..++.++|||||||++||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE  231 (355)
T ss_dssp             CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence                             567899999999997543221       22468999999999999899999999999999999


Q ss_pred             HHhCCCCCC
Q 041632          444 MVTTKKPTD  452 (452)
Q Consensus       444 lltg~~Pf~  452 (452)
                      |+||+.||+
T Consensus       232 l~~g~~pf~  240 (355)
T 2eu9_A          232 YYRGFTLFQ  240 (355)
T ss_dssp             HHHSSCSCC
T ss_pred             HHhCCCCCC
Confidence            999999994

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.9e-36  Score=298.91  Aligned_cols=204  Identities=25%  Similarity=0.335  Sum_probs=152.0

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .|...+.||+|+||+||.+.. .+|+.||||++...   ..+.+.+|+++++++ +||||+++++++     .+.+..++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l   86 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI   86 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence            344567899999999986544 47999999998643   345678999999876 899999999874     44568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC-------
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND-------  383 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-------  383 (452)
                      ||||+. |+|.+++.......    ......++..++.++.|++.||+|||+.   +|+||||||+|||++.+       
T Consensus        87 v~E~~~-gsL~~~l~~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~  158 (434)
T 2rio_A           87 ALELCN-LNLQDLVESKNVSD----ENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQ  158 (434)
T ss_dssp             EECCCS-EEHHHHHHTC----------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCC
T ss_pred             EEecCC-CCHHHHHhccCCCc----hhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccccc
Confidence            999995 79999997653110    0011123345678999999999999998   99999999999999754       


Q ss_pred             ------CceEECccccccccccCCCCceeccccccccccccCccccCC-------CCCCcccceeehhHHHHHHHh-CCC
Q 041632          384 ------LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-------SEVSTNGDVYSYGILLLEMVT-TKK  449 (452)
Q Consensus       384 ------~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~  449 (452)
                            +.+||+|||+++.................||+.|+|||++.+       ..++.++|||||||++|||+| |+.
T Consensus       159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~  238 (434)
T 2rio_A          159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH  238 (434)
T ss_dssp             TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence                  489999999998765332211111223569999999999865       568999999999999999999 999


Q ss_pred             CCC
Q 041632          450 PTD  452 (452)
Q Consensus       450 Pf~  452 (452)
                      ||+
T Consensus       239 Pf~  241 (434)
T 2rio_A          239 PFG  241 (434)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-36  Score=293.56  Aligned_cols=202  Identities=21%  Similarity=0.342  Sum_probs=168.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-----------CCCceeEeeeec
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-----------HKNLVRVITSCS  298 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----------h~niv~l~~~~~  298 (452)
                      .++|.+.+.||+|+||+||+|++..+++.||||++... ....+.+.+|++++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35788999999999999999999889999999999632 223467889999998886           899999999865


Q ss_pred             cccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCe
Q 041632          299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNI  378 (452)
Q Consensus       299 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Ni  378 (452)
                      ... .+....++||||+ +++|.+++....         ...+++..++.++.|++.||+|||+.  .+|+||||||+||
T Consensus        97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NI  163 (373)
T 1q8y_A           97 HKG-PNGVHVVMVFEVL-GENLLALIKKYE---------HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENV  163 (373)
T ss_dssp             EEE-TTEEEEEEEECCC-CEEHHHHHHHTT---------TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGE
T ss_pred             ccC-CCCceEEEEEecC-CCCHHHHHHHhh---------ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHe
Confidence            422 2233688999999 999999986432         23588999999999999999999994  2899999999999


Q ss_pred             eec------CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          379 LLD------NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       379 ll~------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++      ..+.+||+|||+++......       ....||+.|+|||++.+..++.++|||||||++|||+||+.||+
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  236 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  236 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             EEeccCCCcCcceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            994      44589999999998654321       12458999999999999899999999999999999999999995

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.3e-36  Score=288.52  Aligned_cols=203  Identities=27%  Similarity=0.397  Sum_probs=162.6

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ...++|++.+.||+|+||.||+|++..   .||+|.++...  ....+.+.+|++++++++||||+++++++.     +.
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SP  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CS
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence            345789999999999999999999853   48999987432  233356789999999999999999999854     34


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++|+||+++++|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++ ++.
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~  167 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDAK----------IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGK  167 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSSC----------CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---C
T ss_pred             CceEEEeecccCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCC
Confidence            56899999999999999996532          3578899999999999999999998   999999999999998 679


Q ss_pred             eEECccccccccccCCCC-ceeccccccccccccCccccCC---------CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNP-TVSSSIGVRGTIGYVAPEYGLG---------SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+++........ .........||+.|+|||++..         ..++.++||||||+++|||+||+.||+
T Consensus       168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  244 (319)
T 2y4i_B          168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK  244 (319)
T ss_dssp             CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred             EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999998754321111 1111223458999999998764         357889999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.4e-36  Score=311.68  Aligned_cols=200  Identities=25%  Similarity=0.412  Sum_probs=165.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||+||+|++..+   +..||+|.++.... ...+.+.+|+.++++++||||+++++++.      ++
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~  463 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN  463 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------SS
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------cC
Confidence            4567778899999999999998543   46799999864332 33467899999999999999999999853      23


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++....          ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v  530 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK----------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV  530 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT----------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence            5789999999999999996432          3588999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++........   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       531 kL~DFG~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~  594 (656)
T 2j0j_A          531 KLGDFGLSRYMEDSTYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ  594 (656)
T ss_dssp             EECCCCCCCSCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEEecCCCeecCCCcce---eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence            99999999865432211   1122447889999999988899999999999999999997 999984

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.1e-37  Score=294.33  Aligned_cols=195  Identities=22%  Similarity=0.208  Sum_probs=159.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--------CccHHHHHHHHHHHhcCC---------CCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--------QGASKSFMAECKALKNIR---------HKNLVR  292 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~ei~~l~~l~---------h~niv~  292 (452)
                      .++|+..+.||+|+||+||+|++  +|+.||||+++...        ....+.+.+|+++++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35688889999999999999998  68999999997543        223378889999988885         777777


Q ss_pred             Eeeeeccc-------------------------cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHH
Q 041632          293 VITSCSSV-------------------------DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI  347 (452)
Q Consensus       293 l~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~  347 (452)
                      +.+.+...                         ++.+.+..++||||+++|++.+.+..            ..+++.+++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------------~~~~~~~~~  164 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------------KLSSLATAK  164 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------------TCCCHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------------cCCCHHHHH
Confidence            76653211                         01235678999999999977766632            247899999


Q ss_pred             HHHHHHHHHHHHHh-cCCCCCeEecccCCCCeeecCCC--------------------ceEECccccccccccCCCCcee
Q 041632          348 SIAIDVASALDYLH-QHCQEPILHCDLKPSNILLDNDL--------------------SAHIGDFGLSRFYQAVSNPTVS  406 (452)
Q Consensus       348 ~i~~~i~~~l~~LH-~~~~~~ivH~Dlk~~Nill~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~  406 (452)
                      .++.|++.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....      
T Consensus       165 ~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            99999999999999 87   999999999999999887                    8999999999865421      


Q ss_pred             ccccccccccccCccccCCCCCCcccceeehhHH-HHHHHhCCCCC
Q 041632          407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGIL-LLEMVTTKKPT  451 (452)
Q Consensus       407 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~-l~elltg~~Pf  451 (452)
                         ...||+.|+|||++.+.. +.++||||+|++ .+++++|..||
T Consensus       236 ---~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~  277 (336)
T 2vuw_A          236 ---IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY  277 (336)
T ss_dssp             ---EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred             ---cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence               236999999999998766 889999998777 88899999997

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.2e-36  Score=286.84  Aligned_cols=203  Identities=26%  Similarity=0.383  Sum_probs=163.1

Q ss_pred             HHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCC--CCCceeEeeeecccc
Q 041632          226 LLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIR--HKNLVRVITSCSSVD  301 (452)
Q Consensus       226 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~--h~niv~l~~~~~~~~  301 (452)
                      +....++|++.+.||+|+||.||+++.. +++.||||++.....  ...+.+.+|++++++++  ||||+++++++.   
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~---   98 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI---   98 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE---
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee---
Confidence            3344567999999999999999999985 688999999975432  23467899999999997  599999999853   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                        +.+..++||| +.+++|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++
T Consensus        99 --~~~~~~lv~e-~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           99 --TDQYIYMVME-CGNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV  161 (313)
T ss_dssp             --CSSEEEEEEC-CCSEEHHHHHHHC-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE
T ss_pred             --cCCEEEEEEe-cCCCcHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE
Confidence              3457899999 5689999998643           3578899999999999999999998   999999999999996


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCC-----------CCCCcccceeehhHHHHHHHhCCCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-----------SEVSTNGDVYSYGILLLEMVTTKKP  450 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~P  450 (452)
                      + +.+||+|||+++........  .......||+.|+|||.+.+           ..++.++||||||+++|||++|+.|
T Consensus       162 ~-~~~kL~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (313)
T 3cek_A          162 D-GMLKLIDFGIANQMQPDTTS--VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP  238 (313)
T ss_dssp             T-TEEEECCCSSSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             C-CeEEEeeccccccccCcccc--ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCc
Confidence            5 89999999999865432211  11123468999999999765           4688899999999999999999999


Q ss_pred             CC
Q 041632          451 TD  452 (452)
Q Consensus       451 f~  452 (452)
                      |+
T Consensus       239 f~  240 (313)
T 3cek_A          239 FQ  240 (313)
T ss_dssp             TT
T ss_pred             hh
Confidence            84

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-35  Score=312.20  Aligned_cols=196  Identities=24%  Similarity=0.360  Sum_probs=164.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcC-CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDE-DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|.+.+.||+|+||+||+|++.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+.......
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            679999999999999999999975 689999999864332 334578899999999999999999998765443233346


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      |+||||+++++|.+++..             .+++.+++.++.|++.||+|||+.   +|+||||||+|||++.+ .+||
T Consensus       160 ~lv~E~~~g~~L~~~~~~-------------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl  222 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-------------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKL  222 (681)
T ss_dssp             EEEEECCCCEECC----C-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEE
T ss_pred             EEEEEeCCCCcHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEE
Confidence            999999999999887642             588999999999999999999998   99999999999999986 9999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++.....        ....||+.|+|||++.+. ++.++|||||||++|||++|..||.
T Consensus       223 ~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~  277 (681)
T 2pzi_A          223 IDLGAVSRINSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRN  277 (681)
T ss_dssp             CCCTTCEETTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred             EecccchhcccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCc
Confidence            999999865432        224599999999988664 4889999999999999999998863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=283.03  Aligned_cols=199  Identities=26%  Similarity=0.335  Sum_probs=148.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCcc--HHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGA--SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|+..+.||+|+||.||+|++..+|+.||||++.......  .+.+.++..+++.++||||+++++++.     +.+.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence            456888899999999999999999899999999997543322  233445556788889999999999853     4457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEecccCCCCeeecCCCce
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQ-HCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      .++||||+ ++.+..+....          ...+++..++.++.|++.||+|||+ .   +|+||||||+||+++.++.+
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~  164 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRM----------QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQI  164 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHH----------TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCE
T ss_pred             EEEEEecc-CCcHHHHHHHh----------ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCE
Confidence            89999999 55555544321          2468899999999999999999998 4   89999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||++........     .....||+.|+|||++.     ...++.++|||||||++|||++|+.||+
T Consensus       165 kl~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  230 (318)
T 2dyl_A          165 KLCDFGISGRLVDDKA-----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK  230 (318)
T ss_dssp             EECCCTTC-------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EEEECCCchhccCCcc-----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCC
Confidence            9999999976543221     12245899999999984     4568899999999999999999999984

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=292.72  Aligned_cols=198  Identities=26%  Similarity=0.372  Sum_probs=151.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .+|...+.||+|+||+||.... .+|+.||||++.....   ..+.+|+++++.+ +||||+++++++     .+....+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~~   94 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQY   94 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEEE
Confidence            4578889999999999654333 4789999999864322   2356899999999 899999999884     3455789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-----CC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-----DL  384 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~  384 (452)
                      +||||++ |+|.+++....          ....+.+++.++.|++.||+|||+.   +|+||||||+|||++.     ..
T Consensus        95 lv~E~~~-g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~  160 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKD----------FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKI  160 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSS----------CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBC
T ss_pred             EEEECCC-CCHHHHHHhcC----------CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCce
Confidence            9999995 69999997543          1233335678999999999999998   9999999999999953     33


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccC---CCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL---GSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++........ ........||+.|+|||++.   ...++.++|||||||++|||+| |..||.
T Consensus       161 ~~kL~DFG~a~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~  231 (432)
T 3p23_A          161 KAMISDFGLCKKLAVGRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG  231 (432)
T ss_dssp             CEEECCTTEEECC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred             eEEEecccceeeccCCCcc-eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence            5889999999866532211 11223456999999999987   4567889999999999999999 999983

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-35  Score=289.45  Aligned_cols=206  Identities=17%  Similarity=0.191  Sum_probs=154.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCC-CCceeEeee---------e
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRH-KNLVRVITS---------C  297 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h-~niv~l~~~---------~  297 (452)
                      ..|...+.||+|+||+||+|++..+|+.||||++.....   ...+.+.+|+.+++.++| +|.......         +
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            346677899999999999999998999999999873332   225789999999999987 322111100         0


Q ss_pred             ------------ccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCC
Q 041632          298 ------------SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQ  365 (452)
Q Consensus       298 ------------~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  365 (452)
                                  ...........+++|+++ +++|.+++....    ........+++..++.++.|++.||+|||+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~----~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  230 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL----SHSSTHKSLVHHARLQLTLQVIRLLASLHHY--  230 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHH----HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhh----cccccCCCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence                        000000012346666665 789998884210    0001124578889999999999999999998  


Q ss_pred             CCeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCcccc----------CCCCCCccccee
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYG----------LGSEVSTNGDVY  435 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvw  435 (452)
                       +|+||||||+|||++.++.+||+|||+++.....       .....| +.|+|||++          .+..++.++|||
T Consensus       231 -~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw  301 (413)
T 3dzo_A          231 -GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW  301 (413)
T ss_dssp             -TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred             -CcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence             9999999999999999999999999998754422       223457 999999998          566788999999


Q ss_pred             ehhHHHHHHHhCCCCCC
Q 041632          436 SYGILLLEMVTTKKPTD  452 (452)
Q Consensus       436 SlGv~l~elltg~~Pf~  452 (452)
                      ||||++|||+||+.||+
T Consensus       302 SlGvil~elltg~~Pf~  318 (413)
T 3dzo_A          302 TLGLAIYWIWCADLPNT  318 (413)
T ss_dssp             HHHHHHHHHHHSSCCCC
T ss_pred             HHHHHHHHHHHCCCCCC
Confidence            99999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.7e-34  Score=271.07  Aligned_cols=170  Identities=14%  Similarity=0.136  Sum_probs=147.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||.||+|++..+|+.||||++......   ..+.+.+|++.+++++||||+++++++.     +.+.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECCc
Confidence            5699999999999999999999888999999999754332   2367899999999999999999999853     3457


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++++|.+++...             ....++..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~-------------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~k  169 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS-------------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV  169 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC-------------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEE
T ss_pred             EEEEEEecCCCCHHHHHhcC-------------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEE
Confidence            89999999999999998531             34556888999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++++                        |++       .++.++|||||||++|||+||+.||+
T Consensus       170 l~~~~------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~  203 (286)
T 3uqc_A          170 LAYPA------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLP  203 (286)
T ss_dssp             ECSCC------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSC
T ss_pred             EEecc------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCC
Confidence            98543                        222       36789999999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2e-33  Score=265.69  Aligned_cols=178  Identities=21%  Similarity=0.367  Sum_probs=151.1

Q ss_pred             cCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHH-hcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKAL-KNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l-~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|.+. +.||+|+||.||++++..+++.||+|+++.     ...+.+|++++ +..+||||+++++++... ..+....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCceE
Confidence            456666 789999999999999998999999999963     25677888887 566999999999986532 2335678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---CCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~  385 (452)
                      ++||||+++|+|.+++....         ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.   ++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~  158 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG---------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAI  158 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT---------TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred             EEEEeecCCCcHHHHHHhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCc
Confidence            99999999999999996532         23589999999999999999999998   9999999999999998   789


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||++....                          +..++.++|||||||++|||+||+.||.
T Consensus       159 ~kl~Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~  199 (299)
T 3m2w_A          159 LKLTDFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY  199 (299)
T ss_dssp             EEECCCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEEeccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999885322                          2356789999999999999999999984

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.6e-32  Score=280.63  Aligned_cols=184  Identities=15%  Similarity=0.040  Sum_probs=128.1

Q ss_pred             eeccCceeEEEEEEcCCCcEEEEEEeeccCC----------ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ----------GASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       239 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .+.|+.|.+..++....|+.+|+|++.....          ...++|.+|+++|+++ .|+||++++++     ++++..
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GENAQS  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EECSSE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEECCE
Confidence            4566666666666555688999999974321          2235699999999999 79999999998     667779


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .||||||++|++|.++|....           .++..   +|+.||+.||+|+|++   |||||||||+|||+++++.+|
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~-----------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vK  379 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGE-----------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHAR  379 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTC-----------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEE
T ss_pred             EEEEEecCCCCcHHHHHHhCC-----------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEE
Confidence            999999999999999997543           34443   4889999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKK  449 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~  449 (452)
                      |+|||+|+.......    .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus       380 L~DFGlAr~~~~~~~----~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          380 LIDFGSIVTTPQDCS----WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ECCCTTEESCC---C----CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             EeecccCeeCCCCCc----cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            999999986543221    2234679999999999875 56778999999999888876643

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=6.7e-29  Score=252.42  Aligned_cols=187  Identities=19%  Similarity=0.170  Sum_probs=140.8

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc--------cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG--------ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ...+.||+|+||+||+|+.  .++.+++|........        ..+.+.+|++++++++||||+++..++.     ..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DL  411 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ET
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eC
Confidence            3457899999999999965  5788999987532211        1245899999999999999995444432     12


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++++|.+++..                   +..++.|++.||+|||+.   +|+||||||+|||+++  .
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~-------------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~  467 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED-------------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--D  467 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT-------------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--S
T ss_pred             CccEEEEECCCCCCHHHHHHH-------------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--e
Confidence            345999999999999999853                   447999999999999998   9999999999999999  9


Q ss_pred             eEECccccccccccCCCCce---eccccccccccccCccccCC--CCCCcccceeehhHHHHHHHhCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTV---SSSIGVRGTIGYVAPEYGLG--SEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +||+|||+++..........   .......||+.|||||++..  ..|+..+|+||..+-..+-+.++.+|
T Consensus       468 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          468 LYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999999987643211000   01124679999999999876  56888899999999999988888776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.2e-25  Score=208.16  Aligned_cols=163  Identities=18%  Similarity=0.128  Sum_probs=125.8

Q ss_pred             HHHHhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC------------------ccHHHHHHHHHHHhcCC
Q 041632          225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ------------------GASKSFMAECKALKNIR  286 (452)
Q Consensus       225 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~ei~~l~~l~  286 (452)
                      .+......|.+.+.||+|+||.||+|++ .+|+.||+|.++....                  .....+.+|++++++++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3344455677779999999999999999 7899999999964321                  12356899999999998


Q ss_pred             CCCceeEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 041632          287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQE  366 (452)
Q Consensus       287 h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  366 (452)
                      |   +++.+++.      .+..++||||+++|+|.+ +...                 +...++.|++.||+|||+.   
T Consensus       163 ~---~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~~-----------------~~~~i~~qi~~~l~~lH~~---  212 (282)
T 1zar_A          163 G---LAVPKVYA------WEGNAVLMELIDAKELYR-VRVE-----------------NPDEVLDMILEEVAKFYHR---  212 (282)
T ss_dssp             T---SSSCCEEE------EETTEEEEECCCCEEGGG-CCCS-----------------CHHHHHHHHHHHHHHHHHT---
T ss_pred             C---CCcCeEEe------ccceEEEEEecCCCcHHH-cchh-----------------hHHHHHHHHHHHHHHHHHC---
Confidence            4   45544321      134699999999999998 4211                 2346999999999999998   


Q ss_pred             CeEecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCC----------CCCCcccceee
Q 041632          367 PILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG----------SEVSTNGDVYS  436 (452)
Q Consensus       367 ~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS  436 (452)
                      +|+||||||+|||++ ++.+||+|||+++.                 +..++|||++.+          ..++..+|+|.
T Consensus       213 giiHrDlkp~NILl~-~~~vkl~DFG~a~~-----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-----------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             TEECSCCSTTSEEEE-TTEEEECCCTTCEE-----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CCEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999999999999 99999999999862                 345788887653          45667777765

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.88  E-value=1.3e-22  Score=215.77  Aligned_cols=153  Identities=37%  Similarity=0.509  Sum_probs=132.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCC-----------------------------------------
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRI-----------------------------------------   39 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~-----------------------------------------   39 (452)
                      |++|+++|.+|..+..+++| ++|+|++|+++|.+|..+                                         
T Consensus       521 L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  599 (768)
T 3rgz_A          521 LSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI  599 (768)
T ss_dssp             CCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTC
T ss_pred             CCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccc
Confidence            46777777778777778777 788888887777666543                                         


Q ss_pred             -----------------------------cCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcc
Q 041632           40 -----------------------------GNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTS   90 (452)
Q Consensus        40 -----------------------------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l   90 (452)
                                                   +.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.|+.+
T Consensus       600 ~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L  679 (768)
T 3rgz_A          600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDL  679 (768)
T ss_dssp             CGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred             cchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCC
Confidence                                         335678888999999999999999999999999999999999999999999


Q ss_pred             cCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccccCCCC
Q 041632           91 RGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGI  154 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~~  154 (452)
                      ++|+.|||++|++++.+|..+..++ |++|++++|+++|.+|..+.|.++....+.|||++||.+
T Consensus       680 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             TTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence            9999999999999998888777665 999999999999999998999999999999999999864

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.87  E-value=6.4e-22  Score=181.76  Aligned_cols=151  Identities=21%  Similarity=0.254  Sum_probs=126.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..|..+..+++| ++|+|++|+|++..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|+
T Consensus        42 L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  120 (251)
T 3m19_A           42 LQSTGLATLSDATFRGLTKL-TWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK  120 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ccCCCcCccCHhHhcCcccC-CEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC
Confidence            57888887777788888888 89999999998777777888999999999999998666677888899999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      +..+..|..+++|+.|+|++|+|+++++..+..+ +|++|+|++|++++.++. +..+++|+.+++++|++.|.
T Consensus       121 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          121 SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            6666667888999999999999998888666554 499999999999888773 56788888999999998875

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.87  E-value=6.3e-22  Score=177.95  Aligned_cols=148  Identities=22%  Similarity=0.215  Sum_probs=132.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+|..+.  +.+ +.|+|++|+|++..+..|..+++|+.|+|++|+|++..|+.|.++++|++|+|++|+|+
T Consensus        18 c~~~~l~-~iP~~l~--~~l-~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~   93 (220)
T 2v9t_B           18 CRGKGLT-EIPTNLP--ETI-TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT   93 (220)
T ss_dssp             CTTSCCS-SCCSSCC--TTC-CEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred             cCCCCcC-cCCCccC--cCC-CEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence            4678888 7888775  577 99999999999767779999999999999999999888999999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ...+..|..+++|+.|+|++|+|+++++..+..++ |+.|+|++|+|+++++. +..+++|+.+++++|+|.|.
T Consensus        94 ~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B           94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            55556689999999999999999999888777665 99999999999999885 57789999999999999984

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.86  E-value=4.4e-22  Score=188.97  Aligned_cols=152  Identities=30%  Similarity=0.463  Sum_probs=97.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCC-CCCEEEccCcccccc---------------------
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLK-ALRSFDVSNNGLSGE---------------------   58 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~---------------------   58 (452)
                      |++|++++.+|..+..+++| ++|+|++|+|++.+|..++.++ +|+.|++++|++++.                     
T Consensus       132 Ls~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~  210 (313)
T 1ogq_A          132 FSYNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEE
T ss_pred             CCCCccCCcCChHHhcCCCC-CeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCccc
Confidence            34555555555555555555 5555555555555555555555 555555555555544                     


Q ss_pred             --CCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccc
Q 041632           59 --IPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGI  135 (452)
Q Consensus        59 --~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~  135 (452)
                        .|..+..+++|+.|+|++|++++.+|. +..+++|+.|+|++|++++..|..+..++ |++|+|++|++++.+|..+.
T Consensus       211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~  289 (313)
T 1ogq_A          211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcc
Confidence              444555555566666666655533333 55666777777777777766665555444 88888888888877777777


Q ss_pred             cccccccccccccccCCCC
Q 041632          136 FANTSAISVAGCHRLCGGI  154 (452)
Q Consensus       136 ~~~l~~l~~~~n~~~c~~~  154 (452)
                      +++|+.+++.+|+++|+.+
T Consensus       290 l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          290 LQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTT
T ss_pred             ccccChHHhcCCCCccCCC
Confidence            8888888899999888753

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.86  E-value=3.7e-21  Score=174.08  Aligned_cols=149  Identities=16%  Similarity=0.109  Sum_probs=131.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+|..+.  ++| ++|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+
T Consensus        26 c~~~~l~-~ip~~~~--~~L-~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~  101 (229)
T 3e6j_A           26 CRSKRHA-SVPAGIP--TNA-QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT  101 (229)
T ss_dssp             CTTSCCS-SCCSCCC--TTC-SEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ccCCCcC-ccCCCCC--CCC-CEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC
Confidence            3577888 8888775  778 99999999999888999999999999999999998555566899999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCc-ccccccccccccccccccCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      +..+..|..+++|+.|+|++|+|+.++..+..+.+|+.|+|++|+|++.++. +..+++|+.+++.+||+.|..
T Consensus       102 ~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          102 VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             ccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            6666778999999999999999998877776666799999999999998875 577899999999999999853

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=2.6e-21  Score=173.95  Aligned_cols=148  Identities=22%  Similarity=0.238  Sum_probs=130.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCC-cCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIP-PRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +++|+++ .+|..+..  .+ ++|+|++|+|++..| ..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus        18 ~s~n~l~-~iP~~~~~--~~-~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l   93 (220)
T 2v70_A           18 CSNQKLN-KIPEHIPQ--YT-AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL   93 (220)
T ss_dssp             CCSSCCS-SCCSCCCT--TC-SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             eCCCCcc-cCccCCCC--CC-CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCcc
Confidence            5788998 78987643  44 899999999996655 4589999999999999999977777999999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccccCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ++..|..|..+++|+.|+|++|+|++++|..+..++ |++|+|++|+|++.+| .+..+++|+.|++++|++.|.
T Consensus        94 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A           94 ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            977788899999999999999999999887776655 9999999999999865 557899999999999999985

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.85  E-value=4.3e-21  Score=179.97  Aligned_cols=135  Identities=27%  Similarity=0.263  Sum_probs=84.3

Q ss_pred             cccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           16 SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        16 ~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      .+++| ++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.
T Consensus        75 ~l~~L-~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           75 TLPVL-GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             CCTTC-CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCcC-CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            34444 45555555555 55555666666666666666666444455666666666666666666444455666666666


Q ss_pred             eecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632           96 LDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        96 l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      |+|++|+|+++++..+..++ |+.|+|++|+|+.+|+....+.+|+.+++.+|||.|.
T Consensus       153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             EECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence            66666666666666555333 6667777777666666665566667777777777663

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.84  E-value=1.9e-20  Score=173.90  Aligned_cols=146  Identities=19%  Similarity=0.182  Sum_probs=71.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..+..+..+++| ++|+|++|+|++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+++
T Consensus        44 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  122 (270)
T 2o6q_A           44 LQSNKLSSLPSKAFHRLTKL-RLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK  122 (270)
T ss_dssp             CCSSCCSCCCTTSSSSCTTC-CEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC
T ss_pred             CcCCCCCeeCHHHhcCCCCC-CEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC
Confidence            34555554333455555555 55666666555322333455555555555555555433344455555555555555555


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCc-ccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGC  147 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n  147 (452)
                      +..+..|..+++|+.|+|++|+++++++..+..++ |++|+|++|++++.++. +..+++|+.|++++|
T Consensus       123 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (270)
T 2o6q_A          123 SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN  191 (270)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence            44444444555555555555555544444333222 44444444444444432 233444444444444

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.84  E-value=2.3e-20  Score=173.47  Aligned_cols=149  Identities=19%  Similarity=0.161  Sum_probs=120.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++ + +.+..+++| ++|+|++|+|++..|..|..+++|++|++++|++++..|..|+.+++|++|+|++|+++
T Consensus        70 l~~n~l~~-~-~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  146 (272)
T 3rfs_A           70 LGGNKLHD-I-SALKELTNL-TYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ  146 (272)
T ss_dssp             CTTSCCCC-C-GGGTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCC-c-hhhcCCCCC-CEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccC
Confidence            56788874 3 477888888 88888888888666667888888888888888888666666888888999999888888


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      +..+..|..+++|+.|++++|+++++++..+... +|++|++++|++++.++. ++.+++|+.|++++|++.|.
T Consensus       147 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  220 (272)
T 3rfs_A          147 SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  220 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc
Confidence            6666677888889999999998888887766554 488999999988888775 36788888888998888775

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.83  E-value=2.6e-23  Score=209.34  Aligned_cols=146  Identities=21%  Similarity=0.159  Sum_probs=106.3

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCcccc-CCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG-LCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l   79 (452)
                      |++|+|++..+.   .+++| +.|+|++|+|++..|..++.+++|+.|+|++|.+++..|..+. .+++|+.|+|++|.|
T Consensus       106 L~~N~l~~~~~~---~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l  181 (487)
T 3oja_A          106 AANNNISRVSCS---RGQGK-KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (487)
T ss_dssp             CCSSCCCCEEEC---CCSSC-EEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             CcCCcCCCCCcc---ccCCC-CEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence            456666644333   24566 7788888888766677777788888888888888877777775 678888888888888


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ++. |. +..+++|+.|+|++|+|+++++.+..+.+|+.|+|++|.|+++|+.++.+++|+.+++++|++.|+
T Consensus       182 ~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          182 YDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             CEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             ccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence            744 32 334777888888888888877775555558888888888887777777777888888888887775

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=6.2e-21  Score=175.79  Aligned_cols=137  Identities=18%  Similarity=0.178  Sum_probs=104.7

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcE--EEEEEeeccCCc------------------------cHHHHHHHHHHHhcCC
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTV--VAIKVINLQRQG------------------------ASKSFMAECKALKNIR  286 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~ei~~l~~l~  286 (452)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++.....                        ....+.+|++.+.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998668888  999987533111                        0136789999999998


Q ss_pred             CCCc--eeEeeeeccccCCCCceeEEEEeccCC-C----ChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHH
Q 041632          287 HKNL--VRVITSCSSVDFQGNDFKAIVYKYMPN-G----SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDY  359 (452)
Q Consensus       287 h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~  359 (452)
                      |+++  ..++..         +..++||||+.+ |    +|.++...              .++.++..++.|++.||+|
T Consensus       129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~--------------~~~~~~~~i~~qi~~~l~~  185 (258)
T 1zth_A          129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE--------------LKELDVEGIFNDVVENVKR  185 (258)
T ss_dssp             HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG--------------GGGSCHHHHHHHHHHHHHH
T ss_pred             hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc--------------cChHHHHHHHHHHHHHHHH
Confidence            8764  333321         245899999942 4    56555321              1233567899999999999


Q ss_pred             Hh-cCCCCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          360 LH-QHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       360 LH-~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                      || +.   +|+||||||+|||+++  .++|+|||+|...
T Consensus       186 lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          186 LYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99 87   9999999999999998  9999999999754

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=1.4e-20  Score=182.34  Aligned_cols=151  Identities=23%  Similarity=0.161  Sum_probs=118.6

Q ss_pred             CCCCcccccCCcccc-cccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIF-SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~-~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+|++..+..+. .+++| ++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus        46 Ls~N~l~~l~~~~~~~~l~~L-~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  124 (361)
T 2xot_A           46 LSHNNLSRLRAEWTPTRLTNL-HSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHI  124 (361)
T ss_dssp             CCSSCCCEECTTSSSSCCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCCCCCCccChhhhhhccccc-CEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcc
Confidence            577888865555665 78888 8888888888866667788888888888888888866666788888888888888888


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhc----ccccceeeCcccCCCCCCCc-cccccc--ccccccccccccCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLE----ALSLEYLNLSFNDFEGKVPT-KGIFAN--TSAISVAGCHRLCG  152 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~L~~l~l~~N~l~~~~~~-~~~~~~--l~~l~~~~n~~~c~  152 (452)
                      ++..|..|..+++|+.|+|++|+|+++++..+.    +.+|+.|+|++|+|+.+++. +..++.  ++.|++.+|||.|.
T Consensus       125 ~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          125 VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD  204 (361)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred             cEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence            877778888888888888888888888777652    33488888888888877653 244444  36788888988885

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=8.5e-20  Score=162.55  Aligned_cols=148  Identities=17%  Similarity=0.156  Sum_probs=127.9

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|.++ .+|..+.  +++ ++|+|++|+|++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+|++
T Consensus        15 ~~~~l~-~~p~~~~--~~l-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~   90 (208)
T 2o6s_A           15 YSQGRT-SVPTGIP--AQT-TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS   90 (208)
T ss_dssp             CSSCCS-SCCSCCC--TTC-SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             cCCCcc-CCCCCCC--CCC-cEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCc
Confidence            567777 7787664  477 999999999996666678999999999999999996656668999999999999999996


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-ccccccccccccccccccCCC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      ..+..|..+++|+.|+|++|+++++++..+... +|++|++++|++++.++. +..+++|+.+++++|++.|..
T Consensus        91 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  164 (208)
T 2o6s_A           91 LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  164 (208)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred             cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecCC
Confidence            666678999999999999999999988876655 599999999999998886 477899999999999998753

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.82  E-value=1e-20  Score=179.48  Aligned_cols=146  Identities=32%  Similarity=0.490  Sum_probs=127.7

Q ss_pred             CCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccccc
Q 041632            3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS   82 (452)
Q Consensus         3 ~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~   82 (452)
                      .|++++.+|+.+.++++| ++|+|++|++++.+|..|.++++|++|+|++|++++.+|..++.+++|++|+|++|++++.
T Consensus        86 ~n~l~~~~p~~l~~l~~L-~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  164 (313)
T 1ogq_A           86 INNLVGPIPPAIAKLTQL-HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA  164 (313)
T ss_dssp             ETTEESCCCGGGGGCTTC-SEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred             CCcccccCChhHhcCCCC-CEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCc
Confidence            388888899999999998 8999999999888999999999999999999999988999999999999999999999988


Q ss_pred             Cchhhhccc-CCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCc-ccccccccccccccccc
Q 041632           83 IPSFFRTSR-GIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHR  149 (452)
Q Consensus        83 ~p~~~~~l~-~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~  149 (452)
                      +|..+..++ +|+.|+|++|++++..|..+...+|++|++++|++++.++. ++.+++|+.|++++|..
T Consensus       165 ~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  233 (313)
T 1ogq_A          165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL  233 (313)
T ss_dssp             CCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred             CCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCce
Confidence            999999888 89999999999988777777766799999999998876654 46788888888888865

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.82  E-value=6.1e-20  Score=170.99  Aligned_cols=151  Identities=18%  Similarity=0.216  Sum_probs=88.1

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|++++..+..+..+++| ++|+|++|+|++..|..|.++++|++|++++|++++..+..++.+++|++|+|++|++++
T Consensus        60 ~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  138 (276)
T 2z62_A           60 SRCEIQTIEDGAYQSLSHL-STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS  138 (276)
T ss_dssp             TTCCCCEECTTTTTTCTTC-CEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred             CCCcCCccCHHHccCCcCC-CEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccce
Confidence            4555554444455555555 555555555554444455555555555555555553333345555555555555555543


Q ss_pred             c-CchhhhcccCCCeeecccc----------------------------cccCCcchhhcccccceeeCcccCCCCCCCc
Q 041632           82 S-IPSFFRTSRGIRKLDLSRN----------------------------NLSGQIPLFLEALSLEYLNLSFNDFEGKVPT  132 (452)
Q Consensus        82 ~-~p~~~~~l~~L~~l~l~~N----------------------------~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~  132 (452)
                      . +|..|..+++|+.|+|++|                            +++++++..+...+|++|++++|++++.++.
T Consensus       139 ~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~  218 (276)
T 2z62_A          139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDG  218 (276)
T ss_dssp             CCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTT
T ss_pred             ecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHh
Confidence            1 3445555555555555555                            4444444444444678888888888888775


Q ss_pred             c-cccccccccccccccccCCC
Q 041632          133 K-GIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus       133 ~-~~~~~l~~l~~~~n~~~c~~  153 (452)
                      . ..+++|+.+++++|++.|..
T Consensus       219 ~~~~l~~L~~L~l~~N~~~c~c  240 (276)
T 2z62_A          219 IFDRLTSLQKIWLHTNPWDCSC  240 (276)
T ss_dssp             TTTTCCSCCEEECCSSCBCCCT
T ss_pred             HhcccccccEEEccCCcccccC
Confidence            4 66888888899999888854

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.82  E-value=4.6e-20  Score=172.66  Aligned_cols=147  Identities=20%  Similarity=0.210  Sum_probs=84.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCc-cccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENH-FVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|++++..|..+..+++| ++|+|++|+ ++...|..|..+++|++|++++|++++..|..+..+++|++|+|++|++
T Consensus        63 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  141 (285)
T 1ozn_A           63 LHSNVLARIDAAAFTGLALL-EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL  141 (285)
T ss_dssp             CCSSCCCEECTTTTTTCTTC-CEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCCCccceeCHhhcCCccCC-CEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcc
Confidence            35566665556666666666 666666665 5534455666666666666666666655555566666666666666666


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCC-ccccccccccccccccc
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCH  148 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~  148 (452)
                      ++..+..|..+++|+.|+|++|+++++++..+... +|++|++++|++++.++ .+..+++|+.|++++|.
T Consensus       142 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  212 (285)
T 1ozn_A          142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN  212 (285)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             cccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCc
Confidence            64444445566666666666666665555434333 25555555555555432 33445555555555553

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.81  E-value=1.3e-19  Score=166.32  Aligned_cols=146  Identities=17%  Similarity=0.148  Sum_probs=131.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+|..+.  +.+ +.|+|++|+|++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|+
T Consensus        21 ~~~~~l~-~~p~~~~--~~l-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   96 (251)
T 3m19_A           21 CQGKSLD-SVPSGIP--ADT-EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA   96 (251)
T ss_dssp             CTTCCCS-SCCSCCC--TTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             cCCCCcc-ccCCCCC--CCC-CEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc
Confidence            4678888 8888776  577 99999999999888889999999999999999999888888999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-cccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~  150 (452)
                      +..+..|..+++|+.|+|++|+|+++++..+..+ +|++|+|++|+|++.++. ++.+++|+.|++++|...
T Consensus        97 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  168 (251)
T 3m19_A           97 SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ  168 (251)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCC
Confidence            7777889999999999999999999998877655 499999999999999884 678899999999999754

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.81  E-value=5.6e-20  Score=161.58  Aligned_cols=151  Identities=24%  Similarity=0.269  Sum_probs=117.3

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCc-CCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPP-RIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +++|+|+ .+|..+..  .+ ++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus        15 ~s~~~l~-~ip~~~~~--~l-~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l   90 (192)
T 1w8a_A           15 CTGRGLK-EIPRDIPL--HT-TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             CTTSCCS-SCCSCCCT--TC-SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             cCCCCcC-cCccCCCC--CC-CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcC
Confidence            4678887 78887755  67 8899999999855543 488899999999999999987788899999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccccCCCCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIP  155 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~~~  155 (452)
                      ++..|..|..+++|+.|+|++|+|++++|..+..++ |++|+|++|.+++..+.......+....+.++...|+.+.
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~  167 (192)
T 1w8a_A           91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             CccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence            977777888899999999999999988777776554 9999999999987654322222344445556666676544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.81  E-value=4.8e-20  Score=176.01  Aligned_cols=147  Identities=14%  Similarity=0.272  Sum_probs=127.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+|+.+++++.| ++|+|++|+|+ .+|..++++++|++|+|++|+++ .+|..++.+++|++|+|++|++.
T Consensus        88 L~~n~l~-~lp~~l~~l~~L-~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~  163 (328)
T 4fcg_A           88 LRSVPLP-QFPDQAFRLSHL-QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL  163 (328)
T ss_dssp             EESSCCS-SCCSCGGGGTTC-SEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred             ccCCCch-hcChhhhhCCCC-CEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence            4678888 889999999998 99999999999 89999999999999999999998 88999999999999999998888


Q ss_pred             ccCchhhhc---------ccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 GSIPSFFRT---------SRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~---------l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      +.+|..+..         +++|+.|+|++|+++.++..+..+.+|++|+|++|+++++|+.++.+++|+.|++++|+...
T Consensus       164 ~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~  243 (328)
T 4fcg_A          164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALR  243 (328)
T ss_dssp             CCCCSCSEEEC-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCC
T ss_pred             cccChhHhhccchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchh
Confidence            788887664         89999999999999976665555556999999999999888888888999999999887543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.81  E-value=7.9e-20  Score=194.32  Aligned_cols=84  Identities=43%  Similarity=0.699  Sum_probs=46.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++.+|..+..+++| ++|+|++|++++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++|+++
T Consensus       473 L~~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~  551 (768)
T 3rgz_A          473 LDFNDLTGEIPSGLSNCTNL-NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN  551 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTC-CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred             ecCCcccCcCCHHHhcCCCC-CEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccC
Confidence            34555555555555555555 55555555555555555555555555555555555555555555555555555555554


Q ss_pred             ccCch
Q 041632           81 GSIPS   85 (452)
Q Consensus        81 ~~~p~   85 (452)
                      |.+|.
T Consensus       552 g~ip~  556 (768)
T 3rgz_A          552 GTIPA  556 (768)
T ss_dssp             SBCCG
T ss_pred             CcCCh
Confidence            44443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.80  E-value=4.2e-19  Score=164.73  Aligned_cols=144  Identities=19%  Similarity=0.260  Sum_probs=85.1

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|+++ .+|..+.  +.+ +.|+|++|+|++..+.+|.++++|++|+|++|+++...+..|..+++|++|+|++|++++
T Consensus        24 ~~~~l~-~ip~~~~--~~l-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~   99 (270)
T 2o6q_A           24 SSKKLT-AIPSNIP--ADT-KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA   99 (270)
T ss_dssp             TTSCCS-SCCSCCC--TTC-SEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCC
T ss_pred             cCCCCC-ccCCCCC--CCC-CEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCc
Confidence            455566 4555543  345 666666666664444456666666666666666663333344566666666666666664


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCc-ccccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHR  149 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~  149 (452)
                      ..+..|..+++|+.|+|++|+++++++..+..++ |++|+|++|++++.++. ++.+++|+.|++++|..
T Consensus       100 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l  169 (270)
T 2o6q_A          100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL  169 (270)
T ss_dssp             CCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcC
Confidence            4444556666666666666666666655554333 66666666666665554 34556666666666643

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.80  E-value=2.2e-19  Score=168.35  Aligned_cols=146  Identities=21%  Similarity=0.199  Sum_probs=115.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|..+..+++| ++|+|++|+|+ .+|.. +.+++|++|+|++|+++ .+|..+..+++|++|+|++|+|+
T Consensus        38 L~~N~l~~~~~~~~~~l~~L-~~L~L~~n~l~-~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~  113 (290)
T 1p9a_G           38 LSENLLYTFSLATLMPYTRL-TQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT  113 (290)
T ss_dssp             CTTSCCSEEEGGGGTTCTTC-CEEECTTSCCC-EEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCC
T ss_pred             cCCCcCCccCHHHhhcCCCC-CEEECCCCccC-cccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCc
Confidence            56777876667778888887 78888888887 44433 77888888888888887 78888888888888888888888


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-ccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~  150 (452)
                      +..|..|..+++|+.|+|++|+|+++++..+..++ |+.|+|++|+|+++++.. ..+++|+.|++++|...
T Consensus       114 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~  185 (290)
T 1p9a_G          114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY  185 (290)
T ss_dssp             CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence            66667788888888888888888888887776554 888888888888887754 56788888888888654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.79  E-value=1.8e-19  Score=186.68  Aligned_cols=152  Identities=17%  Similarity=0.142  Sum_probs=133.3

Q ss_pred             CCCCcccccCC-cccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccc-cCCccccCCCCCCEEEccCcc
Q 041632            1 MFENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG-EIPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus         1 l~~N~l~~~~p-~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~   78 (452)
                      |++|++++..| ..+..+++| ++|+|++|++++..|..+..+++|++|++++|++++ .+|..++.+++|+.|+|++|+
T Consensus       406 l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  484 (606)
T 3vq2_A          406 FQHSTLKRVTEFSAFLSLEKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ  484 (606)
T ss_dssp             CTTSEEESTTTTTTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             CCCCccCCccChhhhhccccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCc
Confidence            56788887766 678888888 899999999988888889999999999999999987 478899999999999999999


Q ss_pred             ccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccc-cccccccccccccCCC
Q 041632           79 FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFA-NTSAISVAGCHRLCGG  153 (452)
Q Consensus        79 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~-~l~~l~~~~n~~~c~~  153 (452)
                      +++..|..|..+++|+.|+|++|++++.+|..+..++ |+.|++++|+|+.+|+.+..++ +|+.+++++||+.|..
T Consensus       485 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c  561 (606)
T 3vq2_A          485 LEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACIC  561 (606)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred             CCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCC
Confidence            9988888999999999999999999998887776555 9999999999998888777776 5999999999999854

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.79  E-value=1.9e-19  Score=171.90  Aligned_cols=146  Identities=22%  Similarity=0.282  Sum_probs=129.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccC---------CCCCCE
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGL---------CSSLED   71 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---------l~~L~~   71 (452)
                      |++|+|+ .+|+.+..+++| ++|+|++|+|+ .+|..++++++|++|+|++|++.+.+|..++.         +++|++
T Consensus       111 L~~n~l~-~lp~~~~~l~~L-~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~  187 (328)
T 4fcg_A          111 IDAAGLM-ELPDTMQQFAGL-ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS  187 (328)
T ss_dssp             EESSCCC-CCCSCGGGGTTC-SEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCE
T ss_pred             CCCCCcc-chhHHHhccCCC-CEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCE
Confidence            4689999 899999999999 99999999999 88999999999999999998888899988765         999999


Q ss_pred             EEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCC-ccccccccccccccccccc
Q 041632           72 IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        72 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~~  150 (452)
                      |+|++|+|+ .+|..+..+++|+.|+|++|+++++++.+..+.+|++|++++|++.+..| .++.+++|+.|++++|+..
T Consensus       188 L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~  266 (328)
T 4fcg_A          188 LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL  266 (328)
T ss_dssp             EEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTC
T ss_pred             EECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCch
Confidence            999999999 88999999999999999999999988776556669999999988877665 4578899999999988654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.79  E-value=3.2e-19  Score=168.69  Aligned_cols=145  Identities=23%  Similarity=0.265  Sum_probs=66.1

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCC-cCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIP-PRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ++|+++ .+|..+..+++| ++|+|++|++++..+ ..+..+++|++|++++|.+++..|..+..+++|++|+|++|.++
T Consensus        86 s~n~i~-~l~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  163 (306)
T 2z66_A           86 SFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ  163 (306)
T ss_dssp             CSCSEE-EEEEEEETCTTC-CEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred             CCCccc-cChhhcCCCCCC-CEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence            444544 344444455554 455555555542222 24444455555555555444444444444444444444444444


Q ss_pred             c-cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC-ccccccccccccccccc
Q 041632           81 G-SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCH  148 (452)
Q Consensus        81 ~-~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~  148 (452)
                      + .+|..+..+++|+.|+|++|++++.+|..+...+ |++|++++|++++.++ .+..+++|+.|++++|+
T Consensus       164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  234 (306)
T 2z66_A          164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH  234 (306)
T ss_dssp             GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSC
T ss_pred             cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCC
Confidence            3 2444444444444444444444444443333222 4444444444444433 22334444444444443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.79  E-value=1.6e-19  Score=180.40  Aligned_cols=136  Identities=15%  Similarity=0.143  Sum_probs=124.9

Q ss_pred             cCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeee
Q 041632           18 SYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLD   97 (452)
Q Consensus        18 ~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~   97 (452)
                      ++| +.|+|++|++++..|..++.+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+
T Consensus       275 ~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  353 (455)
T 3v47_A          275 SGV-KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD  353 (455)
T ss_dssp             SCC-CEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred             cCc-eEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence            467 9999999999988999999999999999999999988899999999999999999999988889999999999999


Q ss_pred             cccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-cccccccccccccccccCCCC
Q 041632           98 LSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRLCGGI  154 (452)
Q Consensus        98 l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~c~~~  154 (452)
                      |++|++++++|..+...+ |++|++++|++++.++.. ..+++|+.|++++|++.|..+
T Consensus       354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            999999999887766555 999999999999988865 778999999999999998643

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=1.1e-19  Score=163.31  Aligned_cols=130  Identities=18%  Similarity=0.160  Sum_probs=117.1

Q ss_pred             CCCCcccccCCc-ccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPE-AIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~-~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+|++..|. .+..+++| ++|+|++|+|++..|.+|.++++|++|+|++|++++..|..|..+++|++|+|++|+|
T Consensus        39 L~~N~l~~~~~~~~~~~l~~L-~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  117 (220)
T 2v70_A           39 LNNNEFTVLEATGIFKKLPQL-RKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRI  117 (220)
T ss_dssp             CCSSCCCEECCCCCGGGCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCC
T ss_pred             cCCCcCCccCchhhhccCCCC-CEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcC
Confidence            689999976554 47899999 9999999999977777999999999999999999977777899999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP  131 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~  131 (452)
                      ++..|..|..+++|+.|+|++|+|++++|..+..++ |+.|+|++|.+....+
T Consensus       118 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          118 TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             CCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             CeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            988899999999999999999999999887777655 9999999999986544

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=2.2e-19  Score=161.33  Aligned_cols=128  Identities=19%  Similarity=0.181  Sum_probs=116.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|..|..+++| ++|+|++|+|++..|.+|.++++|++|+|++|+|+...+..|..+++|++|+|++|+|+
T Consensus        39 l~~n~i~~i~~~~~~~l~~L-~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~  117 (220)
T 2v9t_B           39 LEQNTIKVIPPGAFSPYKKL-RRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN  117 (220)
T ss_dssp             CCSSCCCEECTTSSTTCTTC-CEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCcCCCcCHhHhhCCCCC-CEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCC
Confidence            67899997767789999999 99999999999888999999999999999999999555555789999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGK  129 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~  129 (452)
                      +..|..|..+++|+.|+|++|+|+++++..+...+ |+.|+|++|.+...
T Consensus       118 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            88889999999999999999999999988777554 99999999999753

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.78  E-value=5.5e-19  Score=165.32  Aligned_cols=145  Identities=19%  Similarity=0.115  Sum_probs=65.4

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcc-ccccCCccccCCCCCCEEEccCcccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNG-LSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ++|++++..++.+..+++| ++|+|++|+|++..|..|..+++|++|++++|. ++...|..+..+++|++|+|++|+++
T Consensus        40 ~~n~i~~~~~~~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~  118 (285)
T 1ozn_A           40 HGNRISHVPAASFRACRNL-TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ  118 (285)
T ss_dssp             TTSCCCEECTTTTTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             eCCcCCccCHHHcccCCCC-CEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCC
Confidence            3444443333344444444 444444444443334444444444444444443 44333444444444444444444444


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-ccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGC  147 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n  147 (452)
                      +..|..|..+++|+.|++++|+++++++..+... +|++|++++|++++.++. +..+++|+.|++++|
T Consensus       119 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  187 (285)
T 1ozn_A          119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN  187 (285)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence            3334444444444444444444444444333322 244444444444444432 333444444444444

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=9.9e-19  Score=154.24  Aligned_cols=142  Identities=15%  Similarity=0.164  Sum_probs=117.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+++ .+| .+..+++| ++|+|++|+++ .+ ..+..+++|++|++++|++++..|..++.+++|++|+|++|+++
T Consensus        51 l~~n~i~-~l~-~l~~l~~L-~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~  125 (197)
T 4ezg_A           51 LANINVT-DLT-GIEYAHNI-KDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD  125 (197)
T ss_dssp             EESSCCS-CCT-TGGGCTTC-SEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCB
T ss_pred             ccCCCcc-ChH-HHhcCCCC-CEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccC
Confidence            3578888 777 68888888 89999999776 44 47888999999999999998778888999999999999999999


Q ss_pred             ccCchhhhcccCCCeeeccccc-ccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNN-LSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      +..|..+..+++|+.|+|++|+ ++.++ ....+.+|++|++++|+++..+ .+..+++|+.|++++|+.
T Consensus       126 ~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          126 DSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             GGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC--
T ss_pred             cHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCccc
Confidence            7788889999999999999998 66654 4445556999999999998765 667788999999998864

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.77  E-value=1.1e-18  Score=153.39  Aligned_cols=127  Identities=20%  Similarity=0.204  Sum_probs=106.4

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.+++++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            56888999988 7887664  58899999999988 78888888999999999999998776778888899999999999


Q ss_pred             cccCCcchhhcccc-cceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632          102 NLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus       102 ~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      +|+++++..+..++ |++|+|++|+|+.+++. +..+++|+.+++++|+|.|.
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            99888887776554 99999999999888775 46688888899999999884

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.77  E-value=1.4e-18  Score=173.43  Aligned_cols=84  Identities=20%  Similarity=0.230  Sum_probs=49.7

Q ss_pred             CCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-ccccccccccccc
Q 041632           69 LEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIFANTSAISVAG  146 (452)
Q Consensus        69 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~  146 (452)
                      |+.|+|++|+|++..|..|..+++|+.|+|++|+++++++..+..++ |+.|+|++|+|++.++.. ..+++|+.|++++
T Consensus       220 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  299 (452)
T 3zyi_A          220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH  299 (452)
T ss_dssp             CCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCS
T ss_pred             ccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccC
Confidence            33333444444444445555555566666666666555555554443 777777777777666543 5567777777777


Q ss_pred             ccccCC
Q 041632          147 CHRLCG  152 (452)
Q Consensus       147 n~~~c~  152 (452)
                      |||.|.
T Consensus       300 Np~~Cd  305 (452)
T 3zyi_A          300 NPWNCD  305 (452)
T ss_dssp             SCEECS
T ss_pred             CCcCCC
Confidence            777774

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.77  E-value=5.5e-19  Score=179.61  Aligned_cols=149  Identities=20%  Similarity=0.209  Sum_probs=121.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCcccc--CCCcCCcCCCCCCEEEccCccccccCCcc-ccCCCCCCEEEccCc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVG--SIPPRIGNLKALRSFDVSNNGLSGEIPIE-LGLCSSLEDIYLGGN   77 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~l~~N   77 (452)
                      |++|++++.+|..+..+++| ++|+|++|+|++  .+|..+..+++|++|++++|++++.+|.. +..+++|++|+|++|
T Consensus       331 Ls~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N  409 (520)
T 2z7x_B          331 FSNNLLTDTVFENCGHLTEL-ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN  409 (520)
T ss_dssp             CCSSCCCTTTTTTCCCCSSC-CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSS
T ss_pred             eECCccChhhhhhhccCCCC-CEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCC
Confidence            57788887788888888888 888888888885  45667888888888888888888646654 778888888888888


Q ss_pred             cccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632           78 FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        78 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ++++..|..+.  ++|+.|+|++|+|+.+++..+.+.+|++|++++|+|+.+|+. +..+++|+.+++++|++.|.
T Consensus       410 ~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          410 ILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             CCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence            88777776654  688999999999988777777666699999999999988776 67788889999999998884

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.77  E-value=5.5e-19  Score=155.24  Aligned_cols=124  Identities=25%  Similarity=0.275  Sum_probs=112.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+|+ .+|..+.  ..+ ++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus        17 ~~~~~l~-~ip~~~~--~~l-~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~   91 (193)
T 2wfh_A           17 CSNKGLK-VLPKGIP--RDV-TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR   91 (193)
T ss_dssp             CTTSCCS-SCCSCCC--TTC-CEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCCCCCC-cCCCCCC--CCC-CEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccC
Confidence            4688998 8898775  477 99999999999 89999999999999999999999777788999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGK  129 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~  129 (452)
                      +..|..|..+++|+.|+|++|+|+.+++..+..++ |+.|+|++|.+...
T Consensus        92 ~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           92 CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            87788999999999999999999999988776554 99999999999754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.77  E-value=7.1e-19  Score=180.52  Aligned_cols=149  Identities=18%  Similarity=0.195  Sum_probs=127.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCcccc--CCCcCCcCCCCCCEEEccCccccccCCc-cccCCCCCCEEEccCc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVG--SIPPRIGNLKALRSFDVSNNGLSGEIPI-ELGLCSSLEDIYLGGN   77 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N   77 (452)
                      |++|++++.+|..+..+++| ++|+|++|+|++  .+|..+.++++|++|++++|++++.+|. .+..+++|++|+|++|
T Consensus       360 l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n  438 (562)
T 3a79_B          360 FTQNVFTDSVFQGCSTLKRL-QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN  438 (562)
T ss_dssp             CCSSCCCTTTTTTCCSCSSC-CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSS
T ss_pred             CCCCccccchhhhhcccCCC-CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCC
Confidence            57899998889999999998 999999999985  2346789999999999999999874665 4788899999999999


Q ss_pred             cccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632           78 FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        78 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ++++..|..+.  ++|+.|+|++|+|+.+++..+.+.+|++|+|++|+|+.+|+. +..+++|+.+++++|||.|.
T Consensus       439 ~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          439 MLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             CCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             CCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence            99877776554  689999999999998888888666699999999999988887 67889999999999999884

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.77  E-value=1.7e-18  Score=154.14  Aligned_cols=142  Identities=18%  Similarity=0.168  Sum_probs=121.5

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..+..+..+++| ++|+|++|+|++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|+
T Consensus        35 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  113 (208)
T 2o6s_A           35 LETNSLKSLPNGVFDELTSL-TQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ  113 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTC-SEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCCCccCcCChhhhcccccC-cEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCc
Confidence            57899996555667899999 99999999999555567899999999999999999666666899999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      +..+..|..+++|+.|+|++|+++++++..+... +|++|++++|.+.+.      +++++.++++.|..
T Consensus       114 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~------~~~l~~L~~~~n~~  177 (208)
T 2o6s_A          114 SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT------CPGIRYLSEWINKH  177 (208)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC------TTTTHHHHHHHHHC
T ss_pred             ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC------CCCHHHHHHHHHhC
Confidence            6666778999999999999999999988876655 499999999998754      45667777777754

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=1.7e-18  Score=156.44  Aligned_cols=131  Identities=18%  Similarity=0.189  Sum_probs=117.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|..+..+++| ++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus        47 Ls~n~i~~~~~~~~~~l~~L-~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~  125 (229)
T 3e6j_A           47 LHDNQITKLEPGVFDSLINL-KELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT  125 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCCCccCccCHHHhhCccCC-cEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc
Confidence            68999998889999999999 99999999998555567899999999999999999666667899999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK  133 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~  133 (452)
                       .+|..+..+++|+.|+|++|+|+++++..+..++ |+.|+|++|.+....+.+
T Consensus       126 -~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  178 (229)
T 3e6j_A          126 -ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDI  178 (229)
T ss_dssp             -SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGGG
T ss_pred             -ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcchh
Confidence             8899999999999999999999999887777554 999999999998765533

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.77  E-value=1.2e-18  Score=168.66  Aligned_cols=146  Identities=18%  Similarity=0.148  Sum_probs=127.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCc-CCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIG-NLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +++|+|+ .+|..+..  .+ +.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|..+++|++|+|++|+|
T Consensus        25 c~~~~l~-~iP~~~~~--~l-~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l  100 (361)
T 2xot_A           25 CSKQQLP-NVPQSLPS--YT-ALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHL  100 (361)
T ss_dssp             CCSSCCS-SCCSSCCT--TC-SEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             eCCCCcC-ccCccCCC--CC-CEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcC
Confidence            4678898 78987653  45 8999999999977777787 999999999999999977778899999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc----ccccccccccccccccc
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK----GIFANTSAISVAGCHRL  150 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~----~~~~~l~~l~~~~n~~~  150 (452)
                      ++..+..|..+++|+.|+|++|+|+++++..+..++ |+.|+|++|+|+++++..    ..+++|+.|++++|...
T Consensus       101 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A          101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            977777899999999999999999999888777665 999999999999988865    46899999999998653

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.77  E-value=1.2e-18  Score=173.47  Aligned_cols=150  Identities=21%  Similarity=0.233  Sum_probs=112.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCc-------------------------CCcCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPP-------------------------RIGNLKALRSFDVSNNGL   55 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~-------------------------~~~~l~~L~~L~l~~N~l   55 (452)
                      |++|+|++..+..+..+++| ++|+|++|+|++..+.                         .|.++++|++|+|++|++
T Consensus       119 L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l  197 (440)
T 3zyj_A          119 LFDNRLTTIPNGAFVYLSKL-KELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL  197 (440)
T ss_dssp             CCSSCCSSCCTTTSCSCSSC-CEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred             CCCCcCCeeCHhHhhccccC-ceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence            46677774444456667776 7777777776633333                         355566666666666666


Q ss_pred             cccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-
Q 041632           56 SGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-  133 (452)
Q Consensus        56 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-  133 (452)
                      + .+| .+..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+++++++..+..++ |+.|+|++|+|++.++.. 
T Consensus       198 ~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  275 (440)
T 3zyj_A          198 R-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF  275 (440)
T ss_dssp             S-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             c-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHh
Confidence            6 455 367777888888888888877788888888999999999999888887776555 999999999999888764 


Q ss_pred             cccccccccccccccccCCC
Q 041632          134 GIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus       134 ~~~~~l~~l~~~~n~~~c~~  153 (452)
                      ..+++|+.|++++|||.|..
T Consensus       276 ~~l~~L~~L~L~~Np~~CdC  295 (440)
T 3zyj_A          276 TPLHHLERIHLHHNPWNCNC  295 (440)
T ss_dssp             SSCTTCCEEECCSSCEECSS
T ss_pred             ccccCCCEEEcCCCCccCCC
Confidence            66889999999999999853

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.76  E-value=5.5e-19  Score=183.76  Aligned_cols=144  Identities=20%  Similarity=0.277  Sum_probs=73.8

Q ss_pred             CCcccccCCcccccccCcccEEEccCCccccC-----------------CCcCCc--CCCCCCEEEccCccccccCCccc
Q 041632            3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVGS-----------------IPPRIG--NLKALRSFDVSNNGLSGEIPIEL   63 (452)
Q Consensus         3 ~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~   63 (452)
                      .|+|+| +|++++++++| ++|+|++|+|++.                 +|..++  ++++|++|+|++|++.+.+|+.|
T Consensus       192 ~n~l~~-ip~~l~~l~~L-~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l  269 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKL-RQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL  269 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTC-CEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTT
T ss_pred             cCCCcc-CCHHHhcccCC-CEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHH
Confidence            345554 55555555555 5555555555543                 555555  55555555555555555555555


Q ss_pred             cCCCCCCEEEccCcc-ccc-cCchhhhcc------cCCCeeecccccccCCcc--hhhcccccceeeCcccCCCCCCCcc
Q 041632           64 GLCSSLEDIYLGGNF-FHG-SIPSFFRTS------RGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPTK  133 (452)
Q Consensus        64 ~~l~~L~~L~l~~N~-l~~-~~p~~~~~l------~~L~~l~l~~N~l~~~~~--~~~~~~~L~~l~l~~N~l~~~~~~~  133 (452)
                      +++++|++|+|++|+ +++ .+|..+..+      ++|+.|+|++|+++.+|+  .+..+.+|++|++++|+++|..|.+
T Consensus       270 ~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~  349 (636)
T 4eco_A          270 KALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF  349 (636)
T ss_dssp             TTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECCCC
T ss_pred             hcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchhhh
Confidence            555555555555554 554 455555444      555555555555553333  2222223555555555555322344


Q ss_pred             ccccccccccccccc
Q 041632          134 GIFANTSAISVAGCH  148 (452)
Q Consensus       134 ~~~~~l~~l~~~~n~  148 (452)
                      +.+++|+.|++++|.
T Consensus       350 ~~l~~L~~L~L~~N~  364 (636)
T 4eco_A          350 GSEIKLASLNLAYNQ  364 (636)
T ss_dssp             EEEEEESEEECCSSE
T ss_pred             CCCCCCCEEECCCCc
Confidence            445555555555554

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=1.7e-18  Score=152.01  Aligned_cols=128  Identities=20%  Similarity=0.232  Sum_probs=114.7

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCc-cccCCCCCCEEEccCccccccCchhhhcccCCCeeeccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI-ELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSR  100 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~  100 (452)
                      +.|++++|+|+ .+|..+..  +|+.|++++|+|++..+. .|+.+++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            68999999998 89987765  999999999999965554 489999999999999999988899999999999999999


Q ss_pred             ccccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccccCC
Q 041632          101 NNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus       101 N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      |+|+++++..+..++ |++|+|++|+|++.+| .+..+++|+.+++++|++.|.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            999999988776554 9999999999998866 457889999999999999885

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.76  E-value=7.1e-19  Score=182.93  Aligned_cols=148  Identities=19%  Similarity=0.284  Sum_probs=134.5

Q ss_pred             CCCCccccc-----------------CCcccc--cccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcc-ccc-cC
Q 041632            1 MFENDLSGT-----------------IPEAIF--SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNG-LSG-EI   59 (452)
Q Consensus         1 l~~N~l~~~-----------------~p~~~~--~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~   59 (452)
                      |++|+|+|.                 +|+.++  ++++| ++|+|++|++.+.+|..|+++++|++|++++|+ +++ .+
T Consensus       213 Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L-~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~l  291 (636)
T 4eco_A          213 MGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDL-TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL  291 (636)
T ss_dssp             EESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC-CEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHH
T ss_pred             CcCCccccccccccccccccchhcccCchhhhhcccCCC-CEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccc
Confidence            468899975                 999999  99999 999999999999999999999999999999998 998 89


Q ss_pred             CccccCC------CCCCEEEccCccccccCch--hhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCC
Q 041632           60 PIELGLC------SSLEDIYLGGNFFHGSIPS--FFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVP  131 (452)
Q Consensus        60 p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~  131 (452)
                      |..++.+      ++|++|+|++|+++ .+|.  .+..+++|+.|++++|++++..|.+..+.+|++|++++|+++.+|.
T Consensus       292 p~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N~l~~lp~  370 (636)
T 4eco_A          292 KDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPA  370 (636)
T ss_dssp             HHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSSEEEECCT
T ss_pred             hHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCCccccccH
Confidence            9999887      99999999999999 8898  9999999999999999999666643334459999999999998888


Q ss_pred             ccccccc-cccccccccccc
Q 041632          132 TKGIFAN-TSAISVAGCHRL  150 (452)
Q Consensus       132 ~~~~~~~-l~~l~~~~n~~~  150 (452)
                      .++.+++ |+.|++++|...
T Consensus       371 ~l~~l~~~L~~L~Ls~N~l~  390 (636)
T 4eco_A          371 NFCGFTEQVENLSFAHNKLK  390 (636)
T ss_dssp             TSEEECTTCCEEECCSSCCS
T ss_pred             hhhhhcccCcEEEccCCcCc
Confidence            8888999 999999999864

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.76  E-value=4.7e-18  Score=157.80  Aligned_cols=145  Identities=17%  Similarity=0.199  Sum_probs=126.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|.++ .++ ++..+++| ++|+|++|++++ + +.+..+++|++|++++|++++..|..++.+++|++|+|++|+++
T Consensus        48 l~~~~i~-~~~-~l~~l~~L-~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  122 (272)
T 3rfs_A           48 ANNSDIK-SVQ-GIQYLPNV-RYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ  122 (272)
T ss_dssp             CTTSCCC-CCT-TGGGCTTC-CEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred             eCCCCcc-ccc-ccccCCCC-cEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCC
Confidence            4567777 444 58889999 999999999984 4 48999999999999999999777777899999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCcc-ccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~  150 (452)
                      +..+..|..+++|+.|+|++|+++++++..+... +|+.|++++|++++.++.. +.+++|+.|++++|...
T Consensus       123 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (272)
T 3rfs_A          123 SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK  194 (272)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence            7777779999999999999999999998877655 4999999999999988864 77899999999999754

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.75  E-value=2.9e-18  Score=159.57  Aligned_cols=149  Identities=16%  Similarity=0.116  Sum_probs=126.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..+..+.++++| ++|+|++|++++..+..|.++++|++|+|++|++++..|..|..+++|++|++++|+++
T Consensus        35 ls~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  113 (276)
T 2z62_A           35 LSFNPLRHLGSYSFFSFPEL-QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA  113 (276)
T ss_dssp             CTTCCCCEECTTTTTTCTTC-SEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred             CCCCcccccCHhHhccccCC-cEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCcc
Confidence            57899997767789999999 99999999999777779999999999999999999887889999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCc-chhhccc-ccceeeCcccCCCCCCCc-cccccccc----cccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQI-PLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTS----AISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~----~l~~~~n~~~  150 (452)
                      +..+..+..+++|+.|++++|++++.. |..+..+ +|++|++++|++++.++. +..+.+++    .+++++|+..
T Consensus       114 ~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~  190 (276)
T 2z62_A          114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN  190 (276)
T ss_dssp             CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC
T ss_pred             ccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc
Confidence            666668999999999999999999843 5555544 599999999999987653 44555665    6677777643

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.75  E-value=3.1e-18  Score=161.84  Aligned_cols=151  Identities=17%  Similarity=0.205  Sum_probs=112.5

Q ss_pred             CCCCcccccCC-cccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccc-cCCccccCCCCCCEEEccCcc
Q 041632            1 MFENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG-EIPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus         1 l~~N~l~~~~p-~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~   78 (452)
                      |++|++++..+ ..+..+++| ++|+|++|++++..|..+..+++|++|++++|.+++ .+|..+..+++|++|+|++|+
T Consensus       108 l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  186 (306)
T 2z66_A          108 FQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ  186 (306)
T ss_dssp             CTTSEEESSTTTTTTTTCTTC-CEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred             CCCCcccccccchhhhhccCC-CEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence            46777774433 467777777 788888888877777778888888888888888875 577778888888888888888


Q ss_pred             ccccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-cccc-ccccccccccccccCC
Q 041632           79 FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIF-ANTSAISVAGCHRLCG  152 (452)
Q Consensus        79 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~-~~l~~l~~~~n~~~c~  152 (452)
                      +++..|..|..+++|+.|+|++|++++.++..+... +|++|++++|++++.++. +..+ ++|+.|++++|++.|.
T Consensus       187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            886667778888888888888888887776555544 388888888888776653 3555 4778888888887774

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.75  E-value=9.8e-19  Score=185.88  Aligned_cols=114  Identities=16%  Similarity=0.187  Sum_probs=54.9

Q ss_pred             CCcCCcCCCCCCEEEccCccccc-----------------cCCcccc--CCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           35 IPPRIGNLKALRSFDVSNNGLSG-----------------EIPIELG--LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        35 ~p~~~~~l~~L~~L~l~~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      +|..|++|++|+.|+|++|+|++                 .+|+.++  ++++|++|+|++|++.+.+|..|.++++|+.
T Consensus       440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~  519 (876)
T 4ecn_A          440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS  519 (876)
T ss_dssp             ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred             hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence            44445555555555555555554                 1455544  5555555555555555455555555555555


Q ss_pred             eeccccc-ccC-Ccc-hhhccc-------ccceeeCcccCCCCCCC--ccccccccccccccccc
Q 041632           96 LDLSRNN-LSG-QIP-LFLEAL-------SLEYLNLSFNDFEGKVP--TKGIFANTSAISVAGCH  148 (452)
Q Consensus        96 l~l~~N~-l~~-~~~-~~~~~~-------~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~~~n~  148 (452)
                      |+|++|+ +++ ..| .+..+.       +|+.|+|++|+++.+|+  .++.+++|+.|++++|.
T Consensus       520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~  584 (876)
T 4ecn_A          520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNK  584 (876)
T ss_dssp             EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSC
T ss_pred             EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCC
Confidence            5555554 444 222 222221       35555555555554443  34445555555555444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.74  E-value=4.6e-18  Score=176.13  Aligned_cols=150  Identities=21%  Similarity=0.199  Sum_probs=111.0

Q ss_pred             CCCCcccccCCcc-cccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcccccc---CCccccCCCCCCEEEccC
Q 041632            1 MFENDLSGTIPEA-IFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE---IPIELGLCSSLEDIYLGG   76 (452)
Q Consensus         1 l~~N~l~~~~p~~-~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~l~~   76 (452)
                      |++|++++..|.. +..+++| ++|+|++|++++..|..+..+++|++|++++|.+++.   .+..+..+++|+.|+|++
T Consensus       407 l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~  485 (606)
T 3t6q_A          407 LAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF  485 (606)
T ss_dssp             CTTCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTT
T ss_pred             CCCCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCC
Confidence            3566666555443 5666666 6777777777766666777777777777777777652   235577777888888888


Q ss_pred             ccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-cccccccccccccccccCC
Q 041632           77 NFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        77 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~c~  152 (452)
                      |++++..|..|..+++|+.|+|++|++++.+|..+..++ | +|++++|++++.+|.. ..+++|+.+++++||+.|.
T Consensus       486 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          486 CDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             CccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            888777777888888888888888888887777666655 7 8888888888877753 6678888899999998884

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.74  E-value=5.3e-18  Score=178.06  Aligned_cols=151  Identities=21%  Similarity=0.191  Sum_probs=124.0

Q ss_pred             CCCccc--ccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCC--------ccccCCCCCCE
Q 041632            2 FENDLS--GTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP--------IELGLCSSLED   71 (452)
Q Consensus         2 ~~N~l~--~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~L~~   71 (452)
                      ++|+++  +.+|..+..+++| ++|+|++|+|++..|..|..+++|++|++++|++++..+        ..+.++++|+.
T Consensus       462 ~~n~l~~~~~~p~~~~~l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~  540 (680)
T 1ziw_A          462 RRVALKNVDSSPSPFQPLRNL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI  540 (680)
T ss_dssp             TTSCCBCTTCSSCTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCE
T ss_pred             ccccccccccCCcccccCCCC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCE
Confidence            345544  4677888888888 899999999986666778999999999999999885422        23788899999


Q ss_pred             EEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-c-cccccccccccccc
Q 041632           72 IYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-G-IFANTSAISVAGCH  148 (452)
Q Consensus        72 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~-~~~~l~~l~~~~n~  148 (452)
                      |+|++|+|+...+..|..+++|+.|+|++|+++++++..+...+ |+.|+|++|+|++.++.. + .+++|+.+++++||
T Consensus       541 L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~  620 (680)
T 1ziw_A          541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNP  620 (680)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCC
T ss_pred             EECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCC
Confidence            99999999944445789999999999999999999888876554 999999999999888764 3 58899999999999


Q ss_pred             ccCCC
Q 041632          149 RLCGG  153 (452)
Q Consensus       149 ~~c~~  153 (452)
                      |.|..
T Consensus       621 ~~c~c  625 (680)
T 1ziw_A          621 FDCTC  625 (680)
T ss_dssp             CCBCC
T ss_pred             cccCC
Confidence            99964

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.74  E-value=6.3e-18  Score=168.70  Aligned_cols=147  Identities=20%  Similarity=0.249  Sum_probs=103.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|+.|.++++| ++|+|++|+|++..|..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|+
T Consensus        82 L~~n~i~~~~~~~~~~l~~L-~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  160 (452)
T 3zyi_A           82 LMENNIQMIQADTFRHLHHL-EVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE  160 (452)
T ss_dssp             CCSSCCCEECTTTTTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCC
T ss_pred             CcCCcCceECHHHcCCCCCC-CEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcc
Confidence            46777776667777777777 77777777777666677777777777777777777555555777777777777777777


Q ss_pred             ccCchhhhcccCCCeeeccc-ccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSR-NNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      ...+..|..+++|+.|+|++ |.+..+++..+..++ |++|+|++|++++. |.+..+++|+.|++++|..
T Consensus       161 ~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l  230 (452)
T 3zyi_A          161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHF  230 (452)
T ss_dssp             EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCC
T ss_pred             eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcC
Confidence            55555677777777777776 455555555555444 77777777777765 3455677777777777754

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.74  E-value=2.1e-18  Score=183.37  Aligned_cols=145  Identities=17%  Similarity=0.135  Sum_probs=128.0

Q ss_pred             CCcccccCCcccccccCcccEEEccCCcccc-----------------CCCcCCc--CCCCCCEEEccCccccccCCccc
Q 041632            3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVG-----------------SIPPRIG--NLKALRSFDVSNNGLSGEIPIEL   63 (452)
Q Consensus         3 ~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~~p~~~   63 (452)
                      .|+|++ +|+++.++++| ++|+|++|+|++                 .+|..++  ++++|++|+|++|++.+.+|..|
T Consensus       434 ~N~L~~-IP~~l~~L~~L-~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l  511 (876)
T 4ecn_A          434 TNRITF-ISKAIQRLTKL-QIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL  511 (876)
T ss_dssp             SCEEEE-ECGGGGGCTTC-CEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGG
T ss_pred             cCcccc-hhHHHhcCCCC-CEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHH
Confidence            588997 89999999999 999999999997                 3999988  99999999999999999999999


Q ss_pred             cCCCCCCEEEccCcc-ccc-cCchhhhccc-------CCCeeecccccccCCcc--hhhcccccceeeCcccCCCCCCCc
Q 041632           64 GLCSSLEDIYLGGNF-FHG-SIPSFFRTSR-------GIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPT  132 (452)
Q Consensus        64 ~~l~~L~~L~l~~N~-l~~-~~p~~~~~l~-------~L~~l~l~~N~l~~~~~--~~~~~~~L~~l~l~~N~l~~~~~~  132 (452)
                      +++++|+.|+|++|+ +++ .+|..+..++       +|+.|+|++|+++.+|+  .+..+.+|+.|+|++|+++.+| .
T Consensus       512 ~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~~lp-~  590 (876)
T 4ecn_A          512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-A  590 (876)
T ss_dssp             GGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCCBCC-C
T ss_pred             hCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcccch-h
Confidence            999999999999998 998 7998888877       99999999999996665  4444555999999999999655 7


Q ss_pred             cccccccccccccccccc
Q 041632          133 KGIFANTSAISVAGCHRL  150 (452)
Q Consensus       133 ~~~~~~l~~l~~~~n~~~  150 (452)
                      ++.+++|+.|++++|...
T Consensus       591 ~~~L~~L~~L~Ls~N~l~  608 (876)
T 4ecn_A          591 FGTNVKLTDLKLDYNQIE  608 (876)
T ss_dssp             CCTTSEESEEECCSSCCS
T ss_pred             hcCCCcceEEECcCCccc
Confidence            788899999999988754

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.74  E-value=3.6e-18  Score=183.41  Aligned_cols=84  Identities=26%  Similarity=0.383  Sum_probs=47.3

Q ss_pred             CCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccc
Q 041632           67 SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAG  146 (452)
Q Consensus        67 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~  146 (452)
                      ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++++..+. .+|+.|+|++|+|++.+|..  |.+|+.+++++
T Consensus       480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~  556 (844)
T 3j0a_A          480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDV--FVSLSVLDITH  556 (844)
T ss_dssp             CCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEE
T ss_pred             ccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhH--hCCcCEEEecC
Confidence            3344444444444433334444455555555555555554444433 33555555555555555533  67888999999


Q ss_pred             ccccCCC
Q 041632          147 CHRLCGG  153 (452)
Q Consensus       147 n~~~c~~  153 (452)
                      ||+.|..
T Consensus       557 Np~~C~c  563 (844)
T 3j0a_A          557 NKFICEC  563 (844)
T ss_dssp             ECCCCSS
T ss_pred             CCccccc
Confidence            9999954

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.74  E-value=5.9e-18  Score=145.23  Aligned_cols=130  Identities=17%  Similarity=0.123  Sum_probs=115.1

Q ss_pred             ccCcccEEEccCCccc-cCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           17 ISYLSNSLNLAENHFV-GSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      .+.+ +.|+|++|+++ +.+|..+..+++|+.|++++|.+++.  ..++.+++|++|+|++|++++.+|..+..+++|+.
T Consensus        23 ~~~L-~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           23 PAAV-RELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             TTSC-SEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             cccC-CEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            4677 99999999998 78999999999999999999999954  78999999999999999999778988888999999


Q ss_pred             eecccccccCCcc-hhhc-ccccceeeCcccCCCCCCC----cccccccccccccccccc
Q 041632           96 LDLSRNNLSGQIP-LFLE-ALSLEYLNLSFNDFEGKVP----TKGIFANTSAISVAGCHR  149 (452)
Q Consensus        96 l~l~~N~l~~~~~-~~~~-~~~L~~l~l~~N~l~~~~~----~~~~~~~l~~l~~~~n~~  149 (452)
                      |+|++|++++++. ..+. +.+|++|++++|.+++.++    .+..+++|+.|++.+|..
T Consensus       100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~  159 (168)
T 2ell_A          100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED  159 (168)
T ss_dssp             EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred             EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence            9999999999763 3444 4459999999999999887    567899999999998865

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.74  E-value=6.5e-18  Score=175.60  Aligned_cols=144  Identities=17%  Similarity=0.116  Sum_probs=118.9

Q ss_pred             CCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccccc
Q 041632            3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS   82 (452)
Q Consensus         3 ~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~   82 (452)
                      +.+|+ .+|..+.  +++ ++|+|++|+|++..|.+|.++++|++|+|++|+|++..|+.|.+|++|++|+|++|+|++.
T Consensus        40 ~~~l~-~vP~~lp--~~~-~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l  115 (635)
T 4g8a_A           40 ELNFY-KIPDNLP--FST-KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL  115 (635)
T ss_dssp             TSCCS-SCCSSSC--TTC-CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             CCCcC-ccCCCCC--cCC-CEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCC
Confidence            44677 7787663  356 8999999999966667899999999999999999976677899999999999999999966


Q ss_pred             CchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCC--Cccccccccccccccccccc
Q 041632           83 IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKV--PTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        83 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~--~~~~~~~~l~~l~~~~n~~~  150 (452)
                      .+..|.++++|+.|+|++|+|+++++..+..++ |++|+|++|.+++..  ...+.+++|+.|++++|...
T Consensus       116 ~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  186 (635)
T 4g8a_A          116 ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  186 (635)
T ss_dssp             CGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccc
Confidence            667889999999999999999998887666554 999999999997643  34577889999999988653

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.74  E-value=1.1e-18  Score=165.60  Aligned_cols=146  Identities=16%  Similarity=0.157  Sum_probs=76.1

Q ss_pred             CCCcccccCCccc--ccccCcccEEEccCCccccCCCcCCcCC-----CCCCEEEccCccccccCCccccCCCCCCEEEc
Q 041632            2 FENDLSGTIPEAI--FSISYLSNSLNLAENHFVGSIPPRIGNL-----KALRSFDVSNNGLSGEIPIELGLCSSLEDIYL   74 (452)
Q Consensus         2 ~~N~l~~~~p~~~--~~l~~l~~~L~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   74 (452)
                      ++|++++.+|..+  ..+++| ++|+|++|+|++. |..++.+     ++|++|+|++|++++..|+.|+.+++|++|+|
T Consensus       103 ~~n~l~~~~~~~~~~~~l~~L-~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  180 (312)
T 1wwl_A          103 ENLEVTGTAPPPLLEATGPDL-NILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL  180 (312)
T ss_dssp             EEEBCBSCCCCCSSSCCSCCC-SEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEEC
T ss_pred             cCCcccchhHHHHHHhcCCCc-cEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEEC
Confidence            3455555555554  455555 5555555555533 5555444     55566666666555444455556666666666


Q ss_pred             cCcccccc--Cchhh--hcccCCCeeecccccccCCc---chhhcc-cccceeeCcccCCCCCCC--ccccccccccccc
Q 041632           75 GGNFFHGS--IPSFF--RTSRGIRKLDLSRNNLSGQI---PLFLEA-LSLEYLNLSFNDFEGKVP--TKGIFANTSAISV  144 (452)
Q Consensus        75 ~~N~l~~~--~p~~~--~~l~~L~~l~l~~N~l~~~~---~~~~~~-~~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~  144 (452)
                      ++|++.+.  +|..+  ..+++|+.|+|++|+|++++   ...+.. .+|++|++++|++++.++  ....+++|+.|++
T Consensus       181 s~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L  260 (312)
T 1wwl_A          181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL  260 (312)
T ss_dssp             CSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEEC
T ss_pred             CCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEEC
Confidence            66655433  23333  55555666666666555322   122222 236666666666655442  2233455566666


Q ss_pred             ccccc
Q 041632          145 AGCHR  149 (452)
Q Consensus       145 ~~n~~  149 (452)
                      ++|..
T Consensus       261 s~N~l  265 (312)
T 1wwl_A          261 SFTGL  265 (312)
T ss_dssp             TTSCC
T ss_pred             CCCcc
Confidence            55543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.73  E-value=7.7e-18  Score=141.43  Aligned_cols=126  Identities=17%  Similarity=0.152  Sum_probs=110.8

Q ss_pred             ccCcccEEEccCCccc-cCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           17 ISYLSNSLNLAENHFV-GSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      .+++ +.|++++|+++ +.+|..+..+++|+.|++++|++++.  ..++.+++|++|+|++|++++.+|..+..+++|+.
T Consensus        16 ~~~l-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           16 PSDV-KELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             GGGC-SEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CccC-eEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            4677 99999999998 88999999999999999999999954  78999999999999999999779999999999999


Q ss_pred             eecccccccCCc-chhhc-ccccceeeCcccCCCCCCC----cccccccccccccc
Q 041632           96 LDLSRNNLSGQI-PLFLE-ALSLEYLNLSFNDFEGKVP----TKGIFANTSAISVA  145 (452)
Q Consensus        96 l~l~~N~l~~~~-~~~~~-~~~L~~l~l~~N~l~~~~~----~~~~~~~l~~l~~~  145 (452)
                      |++++|++++.+ +..+. +.+|++|++++|.+++.++    .++.+++|+.|+++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            999999999864 24444 4459999999999999887    45778888888775

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.73  E-value=5.2e-18  Score=170.54  Aligned_cols=148  Identities=18%  Similarity=0.133  Sum_probs=107.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|..|.++++| ++|+|++|+|++..|.+|.++++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus        39 L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~  117 (477)
T 2id5_A           39 LGKNRIKTLNQDEFASFPHL-EELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV  117 (477)
T ss_dssp             CCSSCCCEECTTTTTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCC
T ss_pred             CCCCccceECHhHccCCCCC-CEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccc
Confidence            46777776667777777777 77888888887666777778888888888888777444455677788888888888777


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCc-ccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~  149 (452)
                      +..|..|..+++|+.|+|++|+++++.+..+..++ |+.|++++|++++.++. +..+++|+.|++++|..
T Consensus       118 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i  188 (477)
T 2id5_A          118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI  188 (477)
T ss_dssp             EECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCC
T ss_pred             cCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcC
Confidence            66677777777778888877777777665555444 77777777777776653 35567777777776654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.73  E-value=8.5e-18  Score=144.23  Aligned_cols=128  Identities=17%  Similarity=0.226  Sum_probs=113.8

Q ss_pred             CCCCccc-ccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLS-GTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~-~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+++ +.+|..+..+++| ++|+|++|+|++.  ..+..+++|++|+|++|++++.+|..+..+++|++|+|++|+|
T Consensus        31 l~~n~l~~~~i~~~~~~l~~L-~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  107 (168)
T 2ell_A           31 LDNCKSNDGKIEGLTAEFVNL-EFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKL  107 (168)
T ss_dssp             CCSCBCBTTBCSSCCGGGGGC-CEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSC
T ss_pred             CCCCCCChhhHHHHHHhCCCC-CEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCcc
Confidence            5789998 7899999999999 9999999999954  7899999999999999999977888888899999999999999


Q ss_pred             cccCc--hhhhcccCCCeeecccccccCCcc---hhhccc-ccceeeCcccCCCCCCCc
Q 041632           80 HGSIP--SFFRTSRGIRKLDLSRNNLSGQIP---LFLEAL-SLEYLNLSFNDFEGKVPT  132 (452)
Q Consensus        80 ~~~~p--~~~~~l~~L~~l~l~~N~l~~~~~---~~~~~~-~L~~l~l~~N~l~~~~~~  132 (452)
                      + .+|  ..+..+++|+.|++++|++++.++   ..+..+ +|++|++++|.++..|..
T Consensus       108 ~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~  165 (168)
T 2ell_A          108 K-DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS  165 (168)
T ss_dssp             C-SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred             C-cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence            9 444  789999999999999999999887   455544 599999999999877654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.73  E-value=1e-17  Score=144.97  Aligned_cols=126  Identities=21%  Similarity=0.244  Sum_probs=71.1

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|+++ .+|..+.  +++ ++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+|++
T Consensus        15 ~~~~l~-~~p~~~~--~~l-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~   90 (177)
T 2o6r_A           15 NSKGLT-SVPTGIP--SSA-TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS   90 (177)
T ss_dssp             CSSCCS-SCCTTCC--TTC-SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             cCCCCc-cCCCCCC--CCC-cEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccc
Confidence            445555 4554433  345 566666666664444445666666666666666664434445666666666666666664


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVP  131 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~  131 (452)
                      ..+..|..+++|+.|+|++|+++++++..+... +|++|++++|.+++..+
T Consensus        91 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           91 LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            444445566666666666666666555544433 36666666666655443

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.73  E-value=2.9e-18  Score=156.09  Aligned_cols=144  Identities=13%  Similarity=0.068  Sum_probs=77.6

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCc-cccCCCcCCcCCCCCCEEEccC-ccccccCCccccCCCCCCEEEccCccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENH-FVGSIPPRIGNLKALRSFDVSN-NGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      ++|+|++..+..+..+++| ++|+|++|+ +++..+.+|.++++|++|++++ |++++..+..|..+++|++|++++|++
T Consensus        39 ~~n~l~~i~~~~~~~l~~L-~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l  117 (239)
T 2xwt_C           39 IETHLRTIPSHAFSNLPNI-SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL  117 (239)
T ss_dssp             ESCCCSEECTTTTTTCTTC-CEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECC
T ss_pred             eCCcceEECHHHccCCCCC-cEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCC
Confidence            4555554434455555665 566666664 5533334555666666666665 566544444555666666666666665


Q ss_pred             cccCchhhhcccCCC---eeecccc-cccCCcchhhcccc-cc-eeeCcccCCCCCCCccccccccccccccccc
Q 041632           80 HGSIPSFFRTSRGIR---KLDLSRN-NLSGQIPLFLEALS-LE-YLNLSFNDFEGKVPTKGIFANTSAISVAGCH  148 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~---~l~l~~N-~l~~~~~~~~~~~~-L~-~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~  148 (452)
                      + .+|+ |..+++|+   .|++++| +++++++..+...+ |+ .|++++|+++.+++.....++|+.|++++|+
T Consensus       118 ~-~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~  190 (239)
T 2xwt_C          118 K-MFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK  190 (239)
T ss_dssp             C-SCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCT
T ss_pred             c-cccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCC
Confidence            5 3444 55555555   5555555 55555554444332 55 5666666555544443223455555555553

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.73  E-value=7.7e-18  Score=173.03  Aligned_cols=151  Identities=21%  Similarity=0.247  Sum_probs=131.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCC-cCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIP-PRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+++ .+|..+..+++| ++|+|++|++++..| ..+.++++|++|++++|++++..|..+..+++|++|+|++|++
T Consensus       380 l~~n~l~-~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  457 (570)
T 2z63_A          380 LSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF  457 (570)
T ss_dssp             CCSCSEE-EEEEEEETCTTC-CEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred             CCCCccc-cccccccccCCC-CEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcC
Confidence            4677887 445558888998 899999999986666 5789999999999999999988999999999999999999999


Q ss_pred             c-ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-ccccccccccccccccccCCC
Q 041632           80 H-GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus        80 ~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      + +.+|..+..+++|+.|+|++|++++.+|..+... +|++|++++|++++.++. +..+++|+.+++++|++.|..
T Consensus       458 ~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  534 (570)
T 2z63_A          458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  534 (570)
T ss_dssp             GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             ccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCC
Confidence            7 5789999999999999999999999877766655 499999999999998875 477899999999999999864

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.72  E-value=1.5e-17  Score=165.43  Aligned_cols=147  Identities=22%  Similarity=0.251  Sum_probs=106.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..+..|.++++| ++|+|++|+|++..+.+|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus        71 L~~n~i~~~~~~~~~~l~~L-~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~  149 (440)
T 3zyj_A           71 LHENQIQIIKVNSFKHLRHL-EILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE  149 (440)
T ss_dssp             CCSCCCCEECTTTTSSCSSC-CEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCC
T ss_pred             ccCCcCCeeCHHHhhCCCCC-CEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCccc
Confidence            56777776666777777877 78888888887666677788888888888888887554556777888888888888887


Q ss_pred             ccCchhhhcccCCCeeeccc-ccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSR-NNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      ...+..|..+++|+.|+|++ |.+..+++..+..++ |++|+|++|+++.+| .+..+++|+.|++++|..
T Consensus       150 ~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~l~~L~~L~Ls~N~l  219 (440)
T 3zyj_A          150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP-NLTPLIKLDELDLSGNHL  219 (440)
T ss_dssp             EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-CCTTCSSCCEEECTTSCC
T ss_pred             ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-ccCCCcccCEEECCCCcc
Confidence            55556777777777777777 445555555555444 888888888877554 456677777777777753

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.72  E-value=5e-18  Score=160.95  Aligned_cols=146  Identities=19%  Similarity=0.162  Sum_probs=121.3

Q ss_pred             CCCCcccccCCcccccc-----cCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcccccc--CCccc--cCCCCCCE
Q 041632            1 MFENDLSGTIPEAIFSI-----SYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE--IPIEL--GLCSSLED   71 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l-----~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~   71 (452)
                      |++|++++. |..+..+     ++| ++|+|++|+|++..|..|+.+++|++|+|++|++.+.  +|..+  +.+++|++
T Consensus       128 Ls~N~l~~~-~~~~~~l~~~~~~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~  205 (312)
T 1wwl_A          128 LRNVSWATR-DAWLAELQQWLKPGL-KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV  205 (312)
T ss_dssp             EESCBCSSS-SSHHHHHHTTCCTTC-CEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCE
T ss_pred             ccCCCCcch-hHHHHHHHHhhcCCC-cEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCE
Confidence            478999966 8888887     888 9999999999977779999999999999999998765  34455  89999999


Q ss_pred             EEccCccccc--cCc-hhhhcccCCCeeecccccccCCcc-hhhc-ccccceeeCcccCCCCCCCccccccccccccccc
Q 041632           72 IYLGGNFFHG--SIP-SFFRTSRGIRKLDLSRNNLSGQIP-LFLE-ALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAG  146 (452)
Q Consensus        72 L~l~~N~l~~--~~p-~~~~~l~~L~~l~l~~N~l~~~~~-~~~~-~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~  146 (452)
                      |+|++|+|++  .++ ..+..+++|+.|+|++|++++.+| ..+. ..+|++|+|++|+|+.+|..+.  ++|+.|++++
T Consensus       206 L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~  283 (312)
T 1wwl_A          206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSY  283 (312)
T ss_dssp             EECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCS
T ss_pred             EECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCC
Confidence            9999999982  222 345678999999999999999774 3444 3459999999999998877664  8999999999


Q ss_pred             cccc
Q 041632          147 CHRL  150 (452)
Q Consensus       147 n~~~  150 (452)
                      |...
T Consensus       284 N~l~  287 (312)
T 1wwl_A          284 NRLD  287 (312)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            8653

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.72  E-value=1.9e-17  Score=172.13  Aligned_cols=151  Identities=16%  Similarity=0.204  Sum_probs=131.3

Q ss_pred             CCCcccccCC-cccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccc-cccCCccccCCCCCCEEEccCccc
Q 041632            2 FENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGL-SGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         2 ~~N~l~~~~p-~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l-~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +.|++....+ ..+..+..+ +.++++.|++++..|..+..+++|+.|++++|.+ .+..|+.|..+++|++|+|++|+|
T Consensus       428 ~~~~~~~~~~~~~~~~l~~l-~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L  506 (635)
T 4g8a_A          428 QHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL  506 (635)
T ss_dssp             TTSEEESTTSSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCC
T ss_pred             hhcccccccccccccccccc-ccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCcc
Confidence            3455554444 456678888 8999999999988899999999999999999974 456889999999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-ccc-ccccccccccccccCCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIF-ANTSAISVAGCHRLCGG  153 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~-~~l~~l~~~~n~~~c~~  153 (452)
                      ++..|..|.++++|+.|+|++|+|+++++..+..++ |++|+|++|+|++.+|.. ..+ ++|+.|++++|||.|.+
T Consensus       507 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          507 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             CEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             CCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            988899999999999999999999999998887665 999999999999998854 445 68999999999999953

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.72  E-value=3.3e-17  Score=141.80  Aligned_cols=128  Identities=16%  Similarity=0.153  Sum_probs=113.7

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.+++++|+++ .+|..+.  ++|+.|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            68999999999 7886554  79999999999999666667899999999999999999666677899999999999999


Q ss_pred             cccCCcchhhccc-ccceeeCcccCCCCCCCcc-cccccccccccccccccCC
Q 041632          102 NLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRLCG  152 (452)
Q Consensus       102 ~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~c~  152 (452)
                      +|+++++..+... +|++|++++|++++.++.. ..+++|+.+++++|++.|.
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            9999998877655 4999999999999998865 6789999999999999874

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.72  E-value=5e-17  Score=155.27  Aligned_cols=147  Identities=17%  Similarity=0.161  Sum_probs=114.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCcccc--CCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVG--SIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   78 (452)
                      |++|++++..+..+..+++| ++|+|++|+++.  ..+..+.++++|+.|++++|+++ .+|..+.  ++|++|+|++|+
T Consensus       128 l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~  203 (330)
T 1xku_A          128 VHENEITKVRKSVFNGLNQM-IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNK  203 (330)
T ss_dssp             CCSSCCCBBCHHHHTTCTTC-CEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSC
T ss_pred             CCCCcccccCHhHhcCCccc-cEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCc
Confidence            56788886666677888888 888888888853  66777888888888888888887 5776654  788888888888


Q ss_pred             ccccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           79 FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        79 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      +++..|..|..+++|+.|+|++|++++.++..+... +|++|++++|+++.+|..+..+++|+.|++++|+...
T Consensus       204 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~  277 (330)
T 1xku_A          204 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA  277 (330)
T ss_dssp             CCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             CCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCc
Confidence            887777788888888888888888888777555544 4888888888888777777777888888888887644

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.72  E-value=4.1e-18  Score=161.90  Aligned_cols=146  Identities=21%  Similarity=0.158  Sum_probs=107.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCcccc-CCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG-LCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l   79 (452)
                      |++|++++..+..   +++| ++|+|++|++++..|..+..+++|++|++++|++++..|..+. .+++|++|+|++|+|
T Consensus       106 l~~n~l~~~~~~~---~~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l  181 (317)
T 3o53_A          106 AANNNISRVSCSR---GQGK-KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI  181 (317)
T ss_dssp             CCSSCCSEEEECC---CSSC-EEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred             CCCCccCCcCccc---cCCC-CEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcC
Confidence            4566666443332   4566 7888888888866666788888888888888888866666664 678888888888888


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ++. |. ...+++|+.|+|++|+++++++.+..+.+|+.|+|++|+|+.+|+.+..+++|+.+++++|++.|+
T Consensus       182 ~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          182 YDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             CEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             ccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence            743 43 234788888888888888877775555568888888888887777777778888888888888764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=4e-17  Score=150.67  Aligned_cols=140  Identities=16%  Similarity=0.244  Sum_probs=101.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+| ++..+++| ++|+|++|+|+ .+|. +..+++|+.|+|++|+++ .+|....  ++|+.|+|++|+|+
T Consensus        48 l~~n~i~-~l~-~l~~l~~L-~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~~N~l~  119 (263)
T 1xeu_A           48 GDNSNIQ-SLA-GMQFFTNL-KELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLDNNELR  119 (263)
T ss_dssp             CTTSCCC-CCT-TGGGCTTC-CEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEECCSSCCS
T ss_pred             CcCCCcc-cch-HHhhCCCC-CEEECCCCccC-CChh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEccCCccC
Confidence            4667777 566 67777777 78888888887 4444 777888888888888887 3554333  77888888888887


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      + ++ .+..+++|+.|+|++|++++++ ....+.+|+.|++++|++++. +.+..+++|+.|++++|+..|.
T Consensus       120 ~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          120 D-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             B-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred             C-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence            3 44 5778888888888888888764 343444588888888888876 5566778888888888876554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.72  E-value=2e-17  Score=166.32  Aligned_cols=150  Identities=19%  Similarity=0.128  Sum_probs=134.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..|..|.++++| ++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+++
T Consensus        63 L~~n~i~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~  141 (477)
T 2id5_A           63 LNENIVSAVEPGAFNNLFNL-RTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV  141 (477)
T ss_dssp             CTTSCCCEECTTTTTTCTTC-CEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC
T ss_pred             CCCCccCEeChhhhhCCccC-CEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc
Confidence            57899998889999999999 99999999999555567899999999999999999888999999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccccC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~~c  151 (452)
                      +..|..|..+++|+.|+|++|+++++++..+...+ |+.|++++|.+++.++ .+..+++|+.|++++|+...
T Consensus       142 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~  214 (477)
T 2id5_A          142 YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD  214 (477)
T ss_dssp             EECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCC
T ss_pred             eeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccc
Confidence            88888999999999999999999999887776555 9999999999998776 45778899999999886543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.71  E-value=6.9e-18  Score=153.57  Aligned_cols=147  Identities=15%  Similarity=0.153  Sum_probs=128.0

Q ss_pred             CCCCc-ccccCCcccccccCcccEEEccC-CccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCC---EEEcc
Q 041632            1 MFEND-LSGTIPEAIFSISYLSNSLNLAE-NHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLE---DIYLG   75 (452)
Q Consensus         1 l~~N~-l~~~~p~~~~~l~~l~~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---~L~l~   75 (452)
                      |++|+ +++..+..|..+++| ++|+|++ |+|++..+..|.++++|++|++++|+++ .+|+ +..+++|+   +|+++
T Consensus        62 l~~n~~l~~i~~~~f~~l~~L-~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~~L~l~  138 (239)
T 2xwt_C           62 VSIDVTLQQLESHSFYNLSKV-THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDIFFILEIT  138 (239)
T ss_dssp             EECCSSCCEECTTTEESCTTC-CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCSEEEEEEE
T ss_pred             CCCCCCcceeCHhHcCCCcCC-cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-cccccccccccEEECC
Confidence            46786 885555688899999 9999999 9999666678999999999999999999 4887 99999998   99999


Q ss_pred             Cc-cccccCchhhhcccCCC-eeecccccccCCcchhhcccccceeeCcccC-CCCCCCc-cccc-cccccccccccccc
Q 041632           76 GN-FFHGSIPSFFRTSRGIR-KLDLSRNNLSGQIPLFLEALSLEYLNLSFND-FEGKVPT-KGIF-ANTSAISVAGCHRL  150 (452)
Q Consensus        76 ~N-~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~-l~~~~~~-~~~~-~~l~~l~~~~n~~~  150 (452)
                      +| ++++..+..|..+++|+ .|++++|+++.+++..+...+|+.|++++|+ ++.+++. ...+ ++|+.|++++|+..
T Consensus       139 ~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~  218 (239)
T 2xwt_C          139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT  218 (239)
T ss_dssp             SCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred             CCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc
Confidence            99 99966667899999999 9999999999888888887669999999995 9988765 4667 89999999998764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.71  E-value=5.8e-18  Score=170.31  Aligned_cols=145  Identities=22%  Similarity=0.161  Sum_probs=86.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCc----------------ccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI----------------ELG   64 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----------------~~~   64 (452)
                      |++|+|++..|..|..+++| ++|+|++|.|++..|  +..+++|++|+|++|.|++..+.                ...
T Consensus        41 Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~  117 (487)
T 3oja_A           41 LSGNPLSQISAADLAPFTKL-ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS  117 (487)
T ss_dssp             CCSSCCCCCCGGGGTTCTTC-CEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEEC
T ss_pred             eeCCcCCCCCHHHHhCCCCC-CEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCcc
Confidence            57889997777888899998 899999999986554  88888888888777777632111                001


Q ss_pred             CCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhc------------------------ccccceee
Q 041632           65 LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLE------------------------ALSLEYLN  120 (452)
Q Consensus        65 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~------------------------~~~L~~l~  120 (452)
                      .+++|+.|+|++|.|++..|..|..+++|+.|+|++|.+++.+|..+.                        +.+|+.|+
T Consensus       118 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~  197 (487)
T 3oja_A          118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLD  197 (487)
T ss_dssp             CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEE
T ss_pred             ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccccccCCCCCEEE
Confidence            234445555555555544444555555555555555555554433322                        22355555


Q ss_pred             CcccCCCCCCCccccccccccccccccc
Q 041632          121 LSFNDFEGKVPTKGIFANTSAISVAGCH  148 (452)
Q Consensus       121 l~~N~l~~~~~~~~~~~~l~~l~~~~n~  148 (452)
                      |++|+|++.|+.++.+++|+.|++++|.
T Consensus       198 Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~  225 (487)
T 3oja_A          198 LSSNKLAFMGPEFQSAAGVTWISLRNNK  225 (487)
T ss_dssp             CCSSCCCEECGGGGGGTTCSEEECTTSC
T ss_pred             CCCCCCCCCCHhHcCCCCccEEEecCCc
Confidence            5555555555555555555555555554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.71  E-value=2.6e-18  Score=162.75  Aligned_cols=146  Identities=18%  Similarity=0.154  Sum_probs=118.7

Q ss_pred             CCCCcccccCC----cccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcccccc--C--CccccCCCCCCEE
Q 041632            1 MFENDLSGTIP----EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE--I--PIELGLCSSLEDI   72 (452)
Q Consensus         1 l~~N~l~~~~p----~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L   72 (452)
                      |++|++++..|    ..+..+++| ++|+|++|+|++..|..|+.+++|++|+|++|++.+.  +  +..++.+++|++|
T Consensus       124 Ls~n~i~~~~~~~~~~~~~~~~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L  202 (310)
T 4glp_A          124 LRNVSWATGRSWLAELQQWLKPGL-KVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNL  202 (310)
T ss_dssp             EESCCCSSTTSSHHHHHTTBCSCC-CEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSC
T ss_pred             eecccccchhhhhHHHHhhhccCC-CEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEE
Confidence            46888887665    345678898 9999999999978888999999999999999998642  3  2334789999999


Q ss_pred             EccCccccccCch----hhhcccCCCeeecccccccCCcc-hhhcc---cccceeeCcccCCCCCCCccccccccccccc
Q 041632           73 YLGGNFFHGSIPS----FFRTSRGIRKLDLSRNNLSGQIP-LFLEA---LSLEYLNLSFNDFEGKVPTKGIFANTSAISV  144 (452)
Q Consensus        73 ~l~~N~l~~~~p~----~~~~l~~L~~l~l~~N~l~~~~~-~~~~~---~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~  144 (452)
                      +|++|+|+ .+|.    .+..+++|+.|+|++|+|++..| ....+   .+|++|+|++|+|+.+|...  +++|+.|++
T Consensus       203 ~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~--~~~L~~L~L  279 (310)
T 4glp_A          203 ALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGL--PAKLRVLDL  279 (310)
T ss_dssp             BCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCC--CSCCSCEEC
T ss_pred             ECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhh--cCCCCEEEC
Confidence            99999998 5454    35788999999999999999844 44444   25999999999999887766  489999999


Q ss_pred             cccccc
Q 041632          145 AGCHRL  150 (452)
Q Consensus       145 ~~n~~~  150 (452)
                      ++|...
T Consensus       280 s~N~l~  285 (310)
T 4glp_A          280 SSNRLN  285 (310)
T ss_dssp             CSCCCC
T ss_pred             CCCcCC
Confidence            999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=1e-17  Score=160.38  Aligned_cols=136  Identities=20%  Similarity=0.237  Sum_probs=96.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--------------ccHHHH--------HHHHHHHhcCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--------------GASKSF--------MAECKALKNIRHK  288 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~ei~~l~~l~h~  288 (452)
                      .-|++.+.||+|++|.||+|... +|+.||||+++....              ......        ..|...|.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34888999999999999999985 799999998753210              011122        2345555555333


Q ss_pred             Cce--eEeeeeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 041632          289 NLV--RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQE  366 (452)
Q Consensus       289 niv--~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  366 (452)
                      ++.  ..+..         ...++||||+++++|..+....                 ....++.|++.+|.|||+.   
T Consensus       174 gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~~-----------------~~~~l~~qll~~l~~lH~~---  224 (397)
T 4gyi_A          174 GFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSVP-----------------DPASLYADLIALILRLAKH---  224 (397)
T ss_dssp             TCSCCCEEEE---------ETTEEEEECCSCEEGGGCCCCS-----------------CHHHHHHHHHHHHHHHHHT---
T ss_pred             CCCCCeeeec---------cCceEEEEecCCccHhhhcccH-----------------HHHHHHHHHHHHHHHHHHC---
Confidence            321  11111         1247999999988887654211                 2346789999999999998   


Q ss_pred             CeEecccCCCCeeecCCC----------ceEECccccccc
Q 041632          367 PILHCDLKPSNILLDNDL----------SAHIGDFGLSRF  396 (452)
Q Consensus       367 ~ivH~Dlk~~Nill~~~~----------~~kl~Dfgla~~  396 (452)
                      |||||||||.|||+++++          .+.|+||+-+..
T Consensus       225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999999999998876          389999997754

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.71  E-value=4.1e-17  Score=155.84  Aligned_cols=142  Identities=18%  Similarity=0.205  Sum_probs=78.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccc--cCCccccCCCCCCEEEccCcc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG--EIPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~   78 (452)
                      |++|+|+ .+|..++  ++| ++|++++|++++..+..|.++++|+.|++++|.++.  ..|..+..+++|++|++++|+
T Consensus       107 Ls~n~l~-~l~~~~~--~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP--KTL-QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             CCSSCCS-BCCSSCC--TTC-CEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             CCCCcCC-ccChhhc--ccc-cEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            3455555 4555443  455 566666666654444455666666666666666532  445555666666666666666


Q ss_pred             ccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccc
Q 041632           79 FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHR  149 (452)
Q Consensus        79 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~  149 (452)
                      ++ .+|..+.  ++|+.|++++|++++.++..+...+ |++|++++|++++.++ .+..+++|+.|++++|..
T Consensus       183 l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  252 (330)
T 1xku_A          183 IT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL  252 (330)
T ss_dssp             CC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             cc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence            65 4444332  5566666666666655544444333 6666666666655544 334555666666666543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.71  E-value=2.5e-17  Score=164.49  Aligned_cols=133  Identities=18%  Similarity=0.152  Sum_probs=123.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++.+|..+..+++| ++|+|++|++++..|..|..+++|++|+|++|++++..|..|+.+++|++|+|++|+++
T Consensus       282 l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  360 (455)
T 3v47_A          282 LSKSKIFALLKSVFSHFTDL-EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR  360 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCC
T ss_pred             ecCccccccchhhcccCCCC-CEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCccc
Confidence            57899998899999999999 99999999999888999999999999999999999888899999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKG  134 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~  134 (452)
                      +..|..|..+++|+.|+|++|+|+++++..+..++ |++|++++|++++..|...
T Consensus       361 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          361 ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             ccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            88899999999999999999999999988776554 9999999999998877553

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.71  E-value=9.3e-18  Score=161.94  Aligned_cols=146  Identities=16%  Similarity=0.180  Sum_probs=123.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+|..+..  ++ ++|+|++|+|++..+..|.++++|++|++++|++++..|..|+.+++|++|+|++|+|+
T Consensus        38 ~~~~~l~-~iP~~~~~--~L-~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  113 (353)
T 2z80_A           38 GSSGSLN-SIPSGLTE--AV-KSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS  113 (353)
T ss_dssp             CCSTTCS-SCCTTCCT--TC-CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCCcc-cccccccc--cC-cEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC
Confidence            3678888 88987763  77 99999999999666668999999999999999999877888999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcc-hhhccc-ccceeeCccc-CCCCCCC-ccccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIP-LFLEAL-SLEYLNLSFN-DFEGKVP-TKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~~~-~L~~l~l~~N-~l~~~~~-~~~~~~~l~~l~~~~n~~~  150 (452)
                      +..+..|..+++|+.|+|++|+++++++ ..+... +|++|++++| .++..++ .++.+++|+.|++++|...
T Consensus       114 ~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~  187 (353)
T 2z80_A          114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ  187 (353)
T ss_dssp             SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred             cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence            5555569999999999999999998877 455544 5999999999 5776655 4577899999999998753

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.70  E-value=3.9e-17  Score=169.07  Aligned_cols=141  Identities=18%  Similarity=0.158  Sum_probs=64.7

Q ss_pred             CCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccccc
Q 041632            3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS   82 (452)
Q Consensus         3 ~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~   82 (452)
                      +++++ .+|..+.  +.+ ++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++.
T Consensus        20 ~~~l~-~ip~~~~--~~l-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~   95 (606)
T 3vq2_A           20 DQKLS-KVPDDIP--SST-KNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF   95 (606)
T ss_dssp             TSCCS-SCCTTSC--TTC-CEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCC
T ss_pred             CCCcc-cCCCCCC--CCc-CEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccccc
Confidence            34444 4444332  333 4455555555444444444455555555555554444444444455555555555554444


Q ss_pred             CchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCC--CCCcccccccccccccccc
Q 041632           83 IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEG--KVPTKGIFANTSAISVAGC  147 (452)
Q Consensus        83 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~--~~~~~~~~~~l~~l~~~~n  147 (452)
                      .|..|.++++|+.|+|++|+++++++..+..+. |++|++++|++++  .|..++.+++|+.|++++|
T Consensus        96 ~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n  163 (606)
T 3vq2_A           96 SPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN  163 (606)
T ss_dssp             CTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred             ChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence            444444455555555555554444433333222 4555555554443  2333444444444444444

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.70  E-value=1.9e-17  Score=171.38  Aligned_cols=148  Identities=13%  Similarity=0.059  Sum_probs=97.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|..|.++++| ++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|+|++|+++
T Consensus        40 Ls~n~i~~~~~~~~~~l~~L-~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~  118 (606)
T 3t6q_A           40 FSFNVLPTIQNTTFSRLINL-TFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS  118 (606)
T ss_dssp             CTTCCCSEECTTTSTTCTTC-SEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS
T ss_pred             ccCCccCcCChhHhccCccc-eEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcc
Confidence            46677776666677777776 77777777776666667777777777777777777666667777777777777777777


Q ss_pred             ccCchhhhcccCCCeeecccccccCCc-chhhcccccceeeCcccCCCCCCCc-cccccccc--ccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQI-PLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTS--AISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~--~l~~~~n~~  149 (452)
                      +..|..|..+++|+.|+|++|+++++. |..+.+.+|++|++++|++++.++. ++.+++++  .+++++|..
T Consensus       119 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l  191 (606)
T 3t6q_A          119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI  191 (606)
T ss_dssp             CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCC
T ss_pred             cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCcc
Confidence            544566677777777777777776643 4444444477777777777665443 34555665  556666643

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.70  E-value=5.5e-17  Score=152.07  Aligned_cols=138  Identities=20%  Similarity=0.243  Sum_probs=90.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+| .+..+++| ++|+|++|+++ .++. +..+++|++|++++|++++ +| .+..+++|++|+|++|+++
T Consensus        53 l~~~~i~-~~~-~~~~l~~L-~~L~L~~n~l~-~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~  125 (291)
T 1h6t_A           53 ANNSDIK-SVQ-GIQYLPNV-TKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS  125 (291)
T ss_dssp             CTTSCCC-CCT-TGGGCTTC-CEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC
T ss_pred             ccCCCcc-cCh-hHhcCCCC-CEEEccCCccC-CCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCC
Confidence            3566666 444 36667777 77777777777 3443 7777777777777777763 43 3777777777777777776


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      + + +.+..+++|+.|++++|+++++ +.+..+.+|+.|++++|++++.++ +..+++|+.|++++|..
T Consensus       126 ~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          126 D-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             C-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred             C-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcC
Confidence            3 3 3566677777777777777765 333344447777777777776655 55666777777776654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.70  E-value=5.7e-17  Score=167.44  Aligned_cols=105  Identities=16%  Similarity=0.113  Sum_probs=72.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++..|..|..+++| ++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+.+++|++|+|++|.|+
T Consensus        82 L~~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~  160 (597)
T 3oja_B           82 LNDLQIEEIDTYAFAYAHTI-QKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE  160 (597)
T ss_dssp             CTTSCCCEECTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCCCChHHhcCCCCC-CEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCC
Confidence            46677776666677777777 77777777777666666777777777777777777433334577777777777777777


Q ss_pred             ccCchhhhcccCCCeeecccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQ  106 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~  106 (452)
                      +..|..|..+++|+.|+|++|.+++.
T Consensus       161 ~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          161 RIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             BCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             CCChhhhhcCCcCcEEECcCCCCCCc
Confidence            66666677777777777777766654

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.70  E-value=6.2e-17  Score=154.74  Aligned_cols=140  Identities=16%  Similarity=0.206  Sum_probs=86.3

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|+++ .+|..+.  +.+ ++|+|++|+|++..|..|.++++|++|+|++|++++..|..|+.+++|++|+|++|+++ 
T Consensus        41 ~~~~l~-~ip~~~~--~~l-~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-  115 (332)
T 2ft3_A           41 SDLGLK-AVPKEIS--PDT-TLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-  115 (332)
T ss_dssp             CSSCCS-SCCSCCC--TTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-
T ss_pred             CCCCcc-ccCCCCC--CCC-eEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-
Confidence            455666 5666553  355 66777777776555566777777777777777776655666777777777777777776 


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCC--CCC-cccccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEG--KVP-TKGIFANTSAISVAGCHR  149 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~--~~~-~~~~~~~l~~l~~~~n~~  149 (452)
                      .+|..+.  ++|+.|++++|+++++++..+...+ |+.|++++|.++.  ..+ ....+ +|+.|++++|..
T Consensus       116 ~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          116 EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            5554443  5667777777777666665554433 6777777766642  222 22333 566666666643

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.69  E-value=1.6e-17  Score=157.34  Aligned_cols=149  Identities=14%  Similarity=0.109  Sum_probs=123.3

Q ss_pred             CCCCcccccCCccc--ccccCcccEEEccCCccccCCC----cCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEc
Q 041632            1 MFENDLSGTIPEAI--FSISYLSNSLNLAENHFVGSIP----PRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYL   74 (452)
Q Consensus         1 l~~N~l~~~~p~~~--~~l~~l~~~L~l~~n~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   74 (452)
                      |++|++++..|..+  ..+++| ++|+|++|++++..|    ..+..+++|++|+|++|++++..|..|+.+++|++|+|
T Consensus        98 l~~n~l~~~~~~~~~~~~~~~L-~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  176 (310)
T 4glp_A           98 LEDLKITGTMPPLPLEATGLAL-SSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDL  176 (310)
T ss_dssp             EESCCCBSCCCCCSSSCCCBCC-SSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEEC
T ss_pred             eeCCEeccchhhhhhhccCCCC-CEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEEC
Confidence            46899999999988  889999 999999999997665    44567999999999999999888889999999999999


Q ss_pred             cCcccccc--Cc--hhhhcccCCCeeecccccccCCcch---hhcc-cccceeeCcccCCCCC-CCccccc---cccccc
Q 041632           75 GGNFFHGS--IP--SFFRTSRGIRKLDLSRNNLSGQIPL---FLEA-LSLEYLNLSFNDFEGK-VPTKGIF---ANTSAI  142 (452)
Q Consensus        75 ~~N~l~~~--~p--~~~~~l~~L~~l~l~~N~l~~~~~~---~~~~-~~L~~l~l~~N~l~~~-~~~~~~~---~~l~~l  142 (452)
                      ++|++.+.  ++  ..+..+++|+.|+|++|+++.+++.   .+.. .+|++|+|++|++++. |+..+.+   ++|+.|
T Consensus       177 s~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L  256 (310)
T 4glp_A          177 SDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSL  256 (310)
T ss_dssp             CSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCE
T ss_pred             CCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEE
Confidence            99998742  32  2346889999999999999865543   3333 4599999999999998 5555555   699999


Q ss_pred             cccccccc
Q 041632          143 SVAGCHRL  150 (452)
Q Consensus       143 ~~~~n~~~  150 (452)
                      ++++|...
T Consensus       257 ~Ls~N~l~  264 (310)
T 4glp_A          257 NLSFAGLE  264 (310)
T ss_dssp             ECCSSCCC
T ss_pred             ECCCCCCC
Confidence            99999764

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.69  E-value=5.1e-17  Score=156.71  Aligned_cols=146  Identities=19%  Similarity=0.166  Sum_probs=94.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..++.+.++++| ++|+|++|+|++..|..|.++++|++|++++|++++..+..++.+++|++|+|++|+++
T Consensus        59 l~~n~i~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  137 (353)
T 2z80_A           59 LSNNRITYISNSDLQRCVNL-QALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK  137 (353)
T ss_dssp             CTTSCCCEECTTTTTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS
T ss_pred             CCCCcCcccCHHHhccCCCC-CEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc
Confidence            45677775444466777777 77777777777555666777777777777777776332233667777777777777777


Q ss_pred             ccCch--hhhcccCCCeeecccc-cccCCcchhhcccc-cceeeCcccCCCCCCC-ccccccccccccccccc
Q 041632           81 GSIPS--FFRTSRGIRKLDLSRN-NLSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCH  148 (452)
Q Consensus        81 ~~~p~--~~~~l~~L~~l~l~~N-~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~  148 (452)
                       .+|.  .|..+++|+.|++++| .+..+++..+...+ |++|++++|++++.++ .++.+++|+.|++++|.
T Consensus       138 -~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~  209 (353)
T 2z80_A          138 -TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ  209 (353)
T ss_dssp             -SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred             -ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence             4443  5667777777777776 46665555554443 7777777777766533 44566667777776664

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.69  E-value=8.5e-17  Score=152.08  Aligned_cols=139  Identities=16%  Similarity=0.288  Sum_probs=103.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+++ .+|. +..+++| ++|+|++|+|+ .+| .+..+++|++|++++|++++ +|. +..+++|++|+|++|+++
T Consensus        70 L~~n~i~-~~~~-~~~l~~L-~~L~L~~n~l~-~~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~  142 (308)
T 1h6u_A           70 LKDNQIT-DLAP-LKNLTKI-TELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQIT  142 (308)
T ss_dssp             CCSSCCC-CCGG-GTTCCSC-CEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred             ccCCcCC-CChh-HccCCCC-CEEEccCCcCC-Cch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccC
Confidence            5678888 4444 7888888 88888888887 444 68888888888888888874 443 788888888888888887


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      + ++. +..+++|+.|+|++|+++++++ ...+.+|+.|++++|++++.++ +..+++|+.|++++|+..
T Consensus       143 ~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          143 N-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             C-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCC
T ss_pred             c-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccC
Confidence            3 443 7778888888888888887665 3334448888888888877655 566777777777777653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.69  E-value=1.6e-16  Score=148.96  Aligned_cols=140  Identities=26%  Similarity=0.340  Sum_probs=87.5

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++ ++. +..+++| ++|+|++|+++ .+| .+..+++|++|++++|++++ + +.+..+++|+.|+|++|+++
T Consensus        75 L~~n~l~~-~~~-l~~l~~L-~~L~l~~n~l~-~~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~  147 (291)
T 1h6t_A           75 LNGNKLTD-IKP-LANLKNL-GWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT  147 (291)
T ss_dssp             CCSSCCCC-CGG-GTTCTTC-CEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCC
T ss_pred             ccCCccCC-Ccc-cccCCCC-CEEECCCCcCC-CCh-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCC
Confidence            45666663 333 6666666 67777777766 333 36667777777777777663 3 35666677777777777766


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      + + +.+..+++|+.|+|++|+++++++ ...+.+|+.|++++|.++..+ .+..+++|+.|++++|+..+
T Consensus       148 ~-~-~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          148 D-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             C-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEEEEC
T ss_pred             c-c-hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCcccC
Confidence            3 3 456666777777777777766555 333334777777777776553 35556666667777665443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.69  E-value=1.4e-16  Score=150.70  Aligned_cols=138  Identities=17%  Similarity=0.312  Sum_probs=117.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+| ++..+++| ++|+|++|+++ .++. +..+++|++|+|++|++++ +| .+..+++|++|+|++|+++
T Consensus        48 l~~~~i~-~l~-~~~~l~~L-~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~  120 (308)
T 1h6u_A           48 AFGTGVT-TIE-GVQYLNNL-IGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQIT  120 (308)
T ss_dssp             CTTSCCC-CCT-TGGGCTTC-CEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCC
T ss_pred             eeCCCcc-Cch-hhhccCCC-CEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCC
Confidence            4678888 566 68889999 99999999998 5555 9999999999999999984 54 7999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                       .+|. +..+++|+.|++++|+++++++ ...+..|++|++++|++++.++ +..+++|+.|++++|..
T Consensus       121 -~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          121 -DVTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             -CCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred             -Cchh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCcc
Confidence             4554 8999999999999999998766 4444459999999999998776 77789999999998865

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.69  E-value=4.3e-17  Score=136.86  Aligned_cols=120  Identities=18%  Similarity=0.246  Sum_probs=106.3

Q ss_pred             CCCCccc-ccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLS-GTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~-~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +++|+++ +.+|..+..+++| ++|+|++|+|++.  ..++.+++|++|++++|++++.+|..++.+++|++|++++|++
T Consensus        24 l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i  100 (149)
T 2je0_A           24 LDNSRSNEGKLEGLTDEFEEL-EFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI  100 (149)
T ss_dssp             CTTCBCBTTBCCSCCTTCTTC-CEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCC
T ss_pred             ccCCcCChhHHHHHHhhcCCC-cEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcC
Confidence            5789998 8899999999999 9999999999955  7899999999999999999977888888899999999999999


Q ss_pred             ccc-CchhhhcccCCCeeecccccccCCcc---hhhccc-ccceeeCcc
Q 041632           80 HGS-IPSFFRTSRGIRKLDLSRNNLSGQIP---LFLEAL-SLEYLNLSF  123 (452)
Q Consensus        80 ~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~---~~~~~~-~L~~l~l~~  123 (452)
                      ++. .+..+..+++|+.|++++|++++.++   ..+... +|+.|++++
T Consensus       101 ~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          101 KDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            953 34889999999999999999999887   455544 599999874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.69  E-value=2.7e-17  Score=168.28  Aligned_cols=144  Identities=14%  Similarity=0.143  Sum_probs=104.4

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|+++ .+|+.++  +.+ ++|+|++|+|++..|.+|.++++|++|+|++|++++..|+.|+.+++|++|+|++|++++
T Consensus        13 ~~~~l~-~ip~~~~--~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~   88 (549)
T 2z81_A           13 RSRSFT-SIPSGLT--AAM-KSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS   88 (549)
T ss_dssp             TTSCCS-SCCSCCC--TTC-CEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCS
T ss_pred             CCCccc-cccccCC--CCc-cEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCc
Confidence            467777 7777664  566 788888888876677778888888888888888887777778888888888888888886


Q ss_pred             cCchhhhcccCCCeeecccccccCC-cchhhc-ccccceeeCcccC-CCCCCC-cccccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQ-IPLFLE-ALSLEYLNLSFND-FEGKVP-TKGIFANTSAISVAGCHR  149 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~-~~~~~~-~~~L~~l~l~~N~-l~~~~~-~~~~~~~l~~l~~~~n~~  149 (452)
                      ..|..|..+++|+.|+|++|++++. .|..+. +.+|++|++++|+ +...++ .+..+++|+.|++++|..
T Consensus        89 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           89 LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            6666688888888888888888753 233333 3348888888887 444443 356677777777777754

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.69  E-value=8.5e-17  Score=153.81  Aligned_cols=147  Identities=16%  Similarity=0.105  Sum_probs=98.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccc--cCCccccCC------------
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG--EIPIELGLC------------   66 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l------------   66 (452)
                      |++|+++ .+|..++  ++| ++|+|++|++++..+..|..+++|+.|++++|.++.  ..|..+..+            
T Consensus       109 L~~n~l~-~l~~~~~--~~L-~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l  184 (332)
T 2ft3_A          109 ISKNHLV-EIPPNLP--SSL-VELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL  184 (332)
T ss_dssp             CCSSCCC-SCCSSCC--TTC-CEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBC
T ss_pred             CCCCcCC-ccCcccc--ccC-CEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCC
Confidence            3556666 5555544  455 566666666653333445666666666666665532  334444333            


Q ss_pred             --------CCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccc
Q 041632           67 --------SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFA  137 (452)
Q Consensus        67 --------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~  137 (452)
                              ++|++|+|++|++++..|..|..+++|+.|+|++|++++.++..+...+ |++|++++|+++.+|+.+..++
T Consensus       185 ~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~  264 (332)
T 2ft3_A          185 TGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLK  264 (332)
T ss_dssp             SSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCT
T ss_pred             CccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCc
Confidence                    5677777777777766667788888888888888888887776555444 8888888888887777777788


Q ss_pred             cccccccccccccC
Q 041632          138 NTSAISVAGCHRLC  151 (452)
Q Consensus       138 ~l~~l~~~~n~~~c  151 (452)
                      +|+.|++++|+...
T Consensus       265 ~L~~L~l~~N~l~~  278 (332)
T 2ft3_A          265 LLQVVYLHTNNITK  278 (332)
T ss_dssp             TCCEEECCSSCCCB
T ss_pred             cCCEEECCCCCCCc
Confidence            88888888887644

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.68  E-value=1.8e-16  Score=155.03  Aligned_cols=125  Identities=18%  Similarity=0.166  Sum_probs=69.6

Q ss_pred             CCcccccCCcc-cccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            3 ENDLSGTIPEA-IFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         3 ~N~l~~~~p~~-~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      +|.++ .+|.. +..+++| ++|+|++|++++..|..|..+++|++|+|++|++++..|..|+.+++|++|+|++|+++.
T Consensus        54 ~~~l~-~l~~~~~~~l~~L-~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  131 (390)
T 3o6n_A           54 NSTMR-KLPAALLDSFRQV-ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS  131 (390)
T ss_dssp             SCEES-EECTHHHHHCCCC-SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCchh-hCChhHhcccccC-cEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCc
Confidence            44455 34433 3455555 666666666654444556666666666666666665445555666666666666666662


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGK  129 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~  129 (452)
                      ..+..|..+++|+.|++++|+++++++..+...+ |++|++++|++++.
T Consensus       132 l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          132 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence            2223345566666666666666655555444333 66666666665543

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.68  E-value=6.5e-17  Score=167.05  Aligned_cols=144  Identities=16%  Similarity=0.105  Sum_probs=121.1

Q ss_pred             CCCcccccCCc-ccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            2 FENDLSGTIPE-AIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         2 ~~N~l~~~~p~-~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ++|.++ .+|. .+..++.| ++|+|++|.|++..|..|+.+++|+.|+|++|.+++..|..|+++++|++|+|++|.|+
T Consensus        59 ~~~~l~-~lp~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  136 (597)
T 3oja_B           59 KNSTMR-KLPAALLDSFRQV-ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS  136 (597)
T ss_dssp             SSCEES-EECTHHHHHCCCC-SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             eCCCCC-CcCHHHHccCCCC-cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC
Confidence            567777 4554 46778898 99999999999777789999999999999999999877788899999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      +..+..|..+++|+.|+|++|.+++++|..+..++ |++|+|++|.+++.+.  +.+++|+.+++++|..
T Consensus       137 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~L~~L~l~~n~l  204 (597)
T 3oja_B          137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL--SLIPSLFHANVSYNLL  204 (597)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCG--GGCTTCSEEECCSSCC
T ss_pred             CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcCh--hhhhhhhhhhcccCcc
Confidence            55555679999999999999999999887666554 9999999999998753  5588888888887754

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.68  E-value=8.6e-17  Score=139.06  Aligned_cols=133  Identities=15%  Similarity=0.096  Sum_probs=112.0

Q ss_pred             cccccccCcccEEEccCCccccCCCcCCcCCC-CCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcc
Q 041632           12 EAIFSISYLSNSLNLAENHFVGSIPPRIGNLK-ALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTS   90 (452)
Q Consensus        12 ~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l   90 (452)
                      ..+..+.+| ++|+|++|+|+ .+|. +..+. +|++|++++|++++ + +.++.+++|++|+|++|+|++..|..|..+
T Consensus        13 ~~~~~~~~L-~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l   87 (176)
T 1a9n_A           13 AQYTNAVRD-RELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQAL   87 (176)
T ss_dssp             CEEECTTSC-EEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHC
T ss_pred             HhcCCcCCc-eEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcC
Confidence            345678888 99999999999 6664 55555 99999999999995 4 689999999999999999996555666999


Q ss_pred             cCCCeeecccccccCCcc--hhhcccccceeeCcccCCCCCCCc----ccccccccccccccccc
Q 041632           91 RGIRKLDLSRNNLSGQIP--LFLEALSLEYLNLSFNDFEGKVPT----KGIFANTSAISVAGCHR  149 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~--~~~~~~~L~~l~l~~N~l~~~~~~----~~~~~~l~~l~~~~n~~  149 (452)
                      ++|+.|+|++|+|+.+++  ....+.+|+.|++++|.++..++.    +..+++|+.+++++|..
T Consensus        88 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           88 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             CCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence            999999999999988765  343444599999999999988775    67899999999988753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.68  E-value=2e-17  Score=157.07  Aligned_cols=144  Identities=22%  Similarity=0.203  Sum_probs=86.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCc----------------ccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI----------------ELG   64 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~----------------~~~   64 (452)
                      |++|+|++..|+.+..+++| ++|+|++|++++..|  +..+++|++|++++|++++..+.                ...
T Consensus        41 L~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~  117 (317)
T 3o53_A           41 LSGNPLSQISAADLAPFTKL-ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCS  117 (317)
T ss_dssp             CTTSCCCCCCHHHHTTCTTC-CEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEEC
T ss_pred             CcCCccCcCCHHHhhCCCcC-CEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCcc
Confidence            57888887666788888888 888898888885443  88888888888888877642110                011


Q ss_pred             CCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhc--ccccceeeCcccCCCCCCCccccccccccc
Q 041632           65 LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLE--ALSLEYLNLSFNDFEGKVPTKGIFANTSAI  142 (452)
Q Consensus        65 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l  142 (452)
                      .+++|++|++++|++++..|..+..+++|+.|+|++|++++.++..+.  +..|++|+|++|++++.+... .+++|+.|
T Consensus       118 ~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~l~~L~~L  196 (317)
T 3o53_A          118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQV-VFAKLKTL  196 (317)
T ss_dssp             CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCC-CCTTCCEE
T ss_pred             ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccccc-ccccCCEE
Confidence            234455555555555544444556666666666666666655444331  223555555555555443222 24555555


Q ss_pred             cccccc
Q 041632          143 SVAGCH  148 (452)
Q Consensus       143 ~~~~n~  148 (452)
                      ++++|.
T Consensus       197 ~Ls~N~  202 (317)
T 3o53_A          197 DLSSNK  202 (317)
T ss_dssp             ECCSSC
T ss_pred             ECCCCc
Confidence            555553

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.68  E-value=4.1e-17  Score=165.80  Aligned_cols=134  Identities=18%  Similarity=0.149  Sum_probs=103.9

Q ss_pred             ccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccc--cCCccccCCCCCCEEEccCccccccCch-hhhccc
Q 041632           15 FSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG--EIPIELGLCSSLEDIYLGGNFFHGSIPS-FFRTSR   91 (452)
Q Consensus        15 ~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~   91 (452)
                      ..+++| ++|+|++|++++.+|..++.+++|++|++++|++++  .+|..++.+++|++|+|++|++++.+|. .+..++
T Consensus       321 ~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  399 (520)
T 2z7x_B          321 SKISPF-LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK  399 (520)
T ss_dssp             SSCCCC-CEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred             hhCCcc-cEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence            456677 788888888887778888888888888888888875  4566788888888888888888864665 477778


Q ss_pred             CCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           92 GIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        92 ~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      +|+.|++++|++++..|..+. ..|+.|++++|+++.+|+.+..+++|+.|++++|+..
T Consensus       400 ~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~  457 (520)
T 2z7x_B          400 SLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK  457 (520)
T ss_dssp             TCCEEECCSSCCCGGGGGSCC-TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             cCCEEECcCCCCCcchhhhhc-ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC
Confidence            888888888888765554433 3588999999999888777778888999999888654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.68  E-value=6.8e-17  Score=169.63  Aligned_cols=148  Identities=21%  Similarity=0.194  Sum_probs=97.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..|..|.+++.| ++|+|++|++++..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|+++
T Consensus        32 Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~  110 (680)
T 1ziw_A           32 LTHNQLRRLPAANFTRYSQL-TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ  110 (680)
T ss_dssp             CCSSCCCCCCGGGGGGGTTC-SEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC
T ss_pred             CCCCCCCCcCHHHHhCCCcC-cEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccC
Confidence            45667775555566777777 77777777777666666777777777777777776433335777777777777777777


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCcc---cccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTK---GIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~---~~~~~l~~l~~~~n~~  149 (452)
                      +..|..|..+++|+.|+|++|++++.++..+..+ +|++|++++|++++.++..   ..+++|+.|++++|..
T Consensus       111 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l  183 (680)
T 1ziw_A          111 KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI  183 (680)
T ss_dssp             CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCC
T ss_pred             ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcc
Confidence            5555667777777777777777776666555433 3777777777776665532   1235667777776643

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.67  E-value=1.1e-16  Score=156.62  Aligned_cols=133  Identities=13%  Similarity=0.195  Sum_probs=112.5

Q ss_pred             cccCcccEEEccCCccccCCCc-CCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCC
Q 041632           16 SISYLSNSLNLAENHFVGSIPP-RIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIR   94 (452)
Q Consensus        16 ~l~~l~~~L~l~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   94 (452)
                      .+.++ +.|++++|.++ .+|. .+..+++|++|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|+
T Consensus        43 ~l~~l-~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  120 (390)
T 3o6n_A           43 TLNNQ-KIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT  120 (390)
T ss_dssp             GGCCC-SEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             ccCCc-eEEEecCCchh-hCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence            46778 89999999998 5554 468899999999999999877777899999999999999999977778889999999


Q ss_pred             eeecccccccCCcchhhccc-ccceeeCcccCCCCCCCc-cccccccccccccccccc
Q 041632           95 KLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRL  150 (452)
Q Consensus        95 ~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~  150 (452)
                      .|+|++|+++.+++..+... +|++|++++|++++.++. +..+++|+.|++++|...
T Consensus       121 ~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  178 (390)
T 3o6n_A          121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT  178 (390)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred             EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence            99999999998888776544 499999999999888765 577889999999988754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.67  E-value=7.4e-17  Score=165.50  Aligned_cols=134  Identities=23%  Similarity=0.206  Sum_probs=114.1

Q ss_pred             ccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccc--cCCccccCCCCCCEEEccCccccccCch-hhhccc
Q 041632           15 FSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG--EIPIELGLCSSLEDIYLGGNFFHGSIPS-FFRTSR   91 (452)
Q Consensus        15 ~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~   91 (452)
                      ..+++| ++|+|++|++++.+|..+.++++|++|++++|++++  .+|..++.+++|++|+|++|++++.+|. .+..++
T Consensus       350 ~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~  428 (562)
T 3a79_B          350 PSPSSF-TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE  428 (562)
T ss_dssp             SSCCCC-CEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred             cCCCCc-eEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence            566788 899999999998889999999999999999999985  3346789999999999999999974664 588889


Q ss_pred             CCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           92 GIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        92 ~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      +|+.|+|++|++++..+..+. .+|++|+|++|+|+.+|+....+++|+.|++++|...
T Consensus       429 ~L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~  486 (562)
T 3a79_B          429 SILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK  486 (562)
T ss_dssp             TCCEEECCSSCCCGGGGSSCC-TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC
T ss_pred             cCCEEECCCCCCCcchhhhhc-CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC
Confidence            999999999999876555433 4599999999999998888888999999999998764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.67  E-value=1.4e-16  Score=162.91  Aligned_cols=148  Identities=17%  Similarity=0.153  Sum_probs=130.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++..|..+.++++| ++|+|++|+|++..|.+|+++++|++|+|++|++++..|..|+.+++|++|+|++|+++
T Consensus        33 Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~  111 (549)
T 2z81_A           33 LSFNKITYIGHGDLRACANL-QVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ  111 (549)
T ss_dssp             CCSSCCCEECSSTTSSCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCS
T ss_pred             CcCCccCccChhhhhcCCcc-cEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCccc
Confidence            68899998888999999999 99999999999888899999999999999999999766667999999999999999998


Q ss_pred             c-cCchhhhcccCCCeeeccccc-ccCCcchhhcccc-cceeeCcccCCCCCCC-cccccccccccccccccc
Q 041632           81 G-SIPSFFRTSRGIRKLDLSRNN-LSGQIPLFLEALS-LEYLNLSFNDFEGKVP-TKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~-~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~-~~~~~~~l~~l~~~~n~~  149 (452)
                      + ..|..+..+++|+.|++++|+ +..+++..+..++ |++|++++|++++..| .++.+++|+.|++.+|..
T Consensus       112 ~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~  184 (549)
T 2z81_A          112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES  184 (549)
T ss_dssp             SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred             ccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence            6 357789999999999999998 5656655566555 9999999999998544 567889999999988763

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.66  E-value=4.1e-16  Score=160.16  Aligned_cols=135  Identities=19%  Similarity=0.241  Sum_probs=63.4

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|+|+ .+| .+..+++| +.|+|++|+|++ +|. +..|++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++
T Consensus        51 ~~n~i~-~l~-~l~~l~~L-~~L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~  123 (605)
T 1m9s_A           51 NNSDIK-SVQ-GIQYLPNV-TKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD  123 (605)
T ss_dssp             TTCCCC-CCT-TGGGCTTC-CEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCC
T ss_pred             cCCCCC-CCh-HHccCCCC-CEEEeeCCCCCC-Chh-hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCC
Confidence            444444 333 34555555 555555555552 222 555555555555555554 222 45555555555555555542


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGC  147 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n  147 (452)
                       ++ .+..+++|+.|+|++|+|+++ +.+..+.+|+.|+|++|+|++.++ +..+++|+.|++++|
T Consensus       124 -l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N  185 (605)
T 1m9s_A          124 -IN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN  185 (605)
T ss_dssp             -CG-GGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             -Cc-cccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCC
Confidence             22 344455555555555555443 222222235555555555544444 344444444444444

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.66  E-value=2.1e-16  Score=162.29  Aligned_cols=127  Identities=17%  Similarity=0.123  Sum_probs=61.4

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.|+|++|++++..+.+|.++++|++|+|++|++++..|+.|+++++|++|+|++|++++..|..|..+++|+.|++++|
T Consensus        31 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  110 (570)
T 2z63_A           31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  110 (570)
T ss_dssp             CEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccc
Confidence            45555555555444444555555555555555555444444555555555555555555444445555555555555555


Q ss_pred             cccCCcchhhccc-ccceeeCcccCCCC--CCCccccccccccccccccc
Q 041632          102 NLSGQIPLFLEAL-SLEYLNLSFNDFEG--KVPTKGIFANTSAISVAGCH  148 (452)
Q Consensus       102 ~l~~~~~~~~~~~-~L~~l~l~~N~l~~--~~~~~~~~~~l~~l~~~~n~  148 (452)
                      +++++++..+..+ +|++|++++|.+++  .|..++.+++|+.|++++|.
T Consensus       111 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~  160 (570)
T 2z63_A          111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  160 (570)
T ss_dssp             CCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred             ccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCc
Confidence            5554444222222 25555555555543  23334444555555555443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.66  E-value=3.5e-17  Score=172.10  Aligned_cols=143  Identities=17%  Similarity=0.160  Sum_probs=109.2

Q ss_pred             CCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccccc
Q 041632            3 ENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS   82 (452)
Q Consensus         3 ~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~   82 (452)
                      .|++. ..|+.+..+..| +.|+|++|+|. .+|..+.++++|++|+|++|.|+ .+|..|+.|++|++|+|++|+|+ .
T Consensus       210 ~n~~~-~~~~~~~~l~~L-~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~  284 (727)
T 4b8c_D          210 ENRMV-MPKDSKYDDQLW-HALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S  284 (727)
T ss_dssp             -------------CCCCC-CEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred             cccee-cChhhhccCCCC-cEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence            34444 557788888988 89999999998 88888889999999999999998 89999999999999999999999 8


Q ss_pred             CchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccc-ccc-ccccccccccccc
Q 041632           83 IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKG-IFA-NTSAISVAGCHRL  150 (452)
Q Consensus        83 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~-~~~-~l~~l~~~~n~~~  150 (452)
                      +|..|..|++|+.|+|++|.|+.+|..+..+.+|+.|+|++|+|++.+|... .+. .+..+++.+|...
T Consensus       285 lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~  354 (727)
T 4b8c_D          285 LPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPE  354 (727)
T ss_dssp             CCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             cChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCccc
Confidence            8999999999999999999998777665455569999999999998777542 111 1223567777653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.65  E-value=1.7e-16  Score=170.36  Aligned_cols=148  Identities=19%  Similarity=0.108  Sum_probs=105.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCC-CcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSI-PPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+|++..|..|.++++| ++|+|++|.+.+.+ |.+|.++++|++|+|++|.+++..|+.|+++++|++|+|++|.+
T Consensus        31 Ls~N~i~~i~~~~~~~l~~L-~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l  109 (844)
T 3j0a_A           31 LSFNYIRTVTASSFPFLEQL-QLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL  109 (844)
T ss_dssp             EESCCCCEECSSSCSSCCSC-SEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCC
T ss_pred             CCCCcCCccChhHCcccccC-eEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCC
Confidence            46777777777777788887 78888887555455 66778888888888888888777777888888888888888888


Q ss_pred             cccCchh--hhcccCCCeeecccccccCCcc-hhhccc-ccceeeCcccCCCCCCCc-cccc--ccccccccccccc
Q 041632           80 HGSIPSF--FRTSRGIRKLDLSRNNLSGQIP-LFLEAL-SLEYLNLSFNDFEGKVPT-KGIF--ANTSAISVAGCHR  149 (452)
Q Consensus        80 ~~~~p~~--~~~l~~L~~l~l~~N~l~~~~~-~~~~~~-~L~~l~l~~N~l~~~~~~-~~~~--~~l~~l~~~~n~~  149 (452)
                      ++.+|..  |..+++|+.|+|++|.+++..+ ..+..+ +|++|+|++|.+++..+. ++.+  ++|+.|++++|+.
T Consensus       110 ~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l  186 (844)
T 3j0a_A          110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL  186 (844)
T ss_dssp             SSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBS
T ss_pred             CcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcc
Confidence            7655554  7778888888888888877643 344433 488888888887765543 3333  5666666666653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.65  E-value=4.2e-16  Score=133.86  Aligned_cols=109  Identities=17%  Similarity=0.179  Sum_probs=95.3

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.|++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            78999999998 7887774  89999999999999777888999999999999999999666667899999999999999


Q ss_pred             cccCCcchhhccc-ccceeeCcccCCCCCCCcc
Q 041632          102 NLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTK  133 (452)
Q Consensus       102 ~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~  133 (452)
                      +|+++++..+..+ +|++|+|++|.++...+.+
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l  121 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI  121 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence            9999988777655 4999999999998776644

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.65  E-value=2.9e-16  Score=144.85  Aligned_cols=139  Identities=16%  Similarity=0.235  Sum_probs=117.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+++ .++ .+..+++| ++|++++|+|+ .+| .+..+++|+.|+|++|++++ +|. +..+++|+.|+|++|+|+
T Consensus        26 l~~~~i~-~~~-~~~~l~~L-~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~   98 (263)
T 1xeu_A           26 LGKQSVT-DLV-SQKELSGV-QNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLK   98 (263)
T ss_dssp             HTCSCTT-SEE-CHHHHTTC-SEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCS
T ss_pred             hcCCCcc-ccc-chhhcCcC-cEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccC
Confidence            3567887 445 68889999 99999999999 777 79999999999999999995 555 999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                       .+|... . ++|+.|+|++|++++++ ....+.+|+.|++++|++++.+ .+..+++|+.|++++|+...
T Consensus        99 -~l~~~~-~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           99 -NLNGIP-S-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             -CCTTCC-C-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTSCCCB
T ss_pred             -CcCccc-c-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCCcCcc
Confidence             455433 3 89999999999999864 4445556999999999999875 67789999999999997654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.65  E-value=2.4e-18  Score=151.89  Aligned_cols=124  Identities=21%  Similarity=0.237  Sum_probs=71.8

Q ss_pred             CCCcccccCCc------ccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEcc
Q 041632            2 FENDLSGTIPE------AIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLG   75 (452)
Q Consensus         2 ~~N~l~~~~p~------~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   75 (452)
                      +.|+++|.+|.      .+..+++| ++|+|++|+|+ .+| .+..+++|++|++++|+++ .+|..+..+++|++|+|+
T Consensus        26 ~~~~l~~~~~~l~~l~~~~~~l~~L-~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~  101 (198)
T 1ds9_A           26 EKVELHGMIPPIEKMDATLSTLKAC-KHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             SEEECCBCCTTCCCCHHHHHHTTTC-SEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEE
T ss_pred             heeEeccccCcHhhhhHHHhcCCCC-CEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECc
Confidence            34455555554      56666666 66666666666 355 5666666666666666665 556555555666666666


Q ss_pred             CccccccCchhhhcccCCCeeecccccccCCcc-hhh-cccccceeeCcccCCCCCCC
Q 041632           76 GNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP-LFL-EALSLEYLNLSFNDFEGKVP  131 (452)
Q Consensus        76 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~-~~~~L~~l~l~~N~l~~~~~  131 (452)
                      +|+|+ .+| .+..+++|+.|+|++|++++.++ ..+ .+.+|++|++++|.+++.+|
T Consensus       102 ~N~l~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  157 (198)
T 1ds9_A          102 YNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             EEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred             CCcCC-cCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence            66666 334 45666666666666666665443 222 23336666666666655433

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.64  E-value=4.9e-16  Score=133.90  Aligned_cols=112  Identities=19%  Similarity=0.221  Sum_probs=96.2

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.+++++|+|+ .+|..+.  ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            67999999998 8888775  89999999999999877889999999999999999999655566789999999999999


Q ss_pred             cccCCcchhhccc-ccceeeCcccCCCCCCCccccc
Q 041632          102 NLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTKGIF  136 (452)
Q Consensus       102 ~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~~~~  136 (452)
                      +|+++++..+..+ +|++|+|++|.+...++.+..+
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l  127 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYL  127 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHH
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcccccccHHHH
Confidence            9999888766655 4999999999998777655333

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.64  E-value=6.8e-16  Score=158.53  Aligned_cols=141  Identities=24%  Similarity=0.316  Sum_probs=122.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++. |. +..+++| +.|+|++|+|+ .+| .+..+++|+.|+|++|+|++ + +.+..|++|+.|+|++|+|+
T Consensus        72 Ls~N~l~~~-~~-l~~l~~L-~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~  144 (605)
T 1m9s_A           72 LNGNKLTDI-KP-LTNLKNL-GWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKIT  144 (605)
T ss_dssp             CTTSCCCCC-GG-GGGCTTC-CEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCC
T ss_pred             eeCCCCCCC-hh-hccCCCC-CEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccC
Confidence            678999954 44 8999999 99999999998 555 79999999999999999984 4 46999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      +.  +.+..+++|+.|+|++|+|++++| +..+.+|+.|+|++|+|+++ +.+..+++|+.|++++|+....
T Consensus       145 ~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          145 DI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             CC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred             Cc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence            54  679999999999999999999887 44555699999999999986 5677899999999999986543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.64  E-value=7.1e-17  Score=169.80  Aligned_cols=126  Identities=29%  Similarity=0.403  Sum_probs=64.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|. .+|..++.++.| ++|+|++|+|+ .+|..|++|++|+.|+|++|+|+ .+|..|+.|++|++|+|++|.|+
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFL-TRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT  306 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSC-SCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC
T ss_pred             CCCCCCC-CCChhhcCCCCC-CEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC
Confidence            3445555 455555555555 55555555555 55555555555555555555555 44555555555555555555554


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc--cceeeCcccCCCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS--LEYLNLSFNDFEGKVP  131 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~--L~~l~l~~N~l~~~~~  131 (452)
                       .+|..|..+++|+.|+|++|+|++.+|..+...+  +..|+|++|.+++.+|
T Consensus       307 -~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p  358 (727)
T 4b8c_D          307 -TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP  358 (727)
T ss_dssp             -CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             -ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence             4454455555555555555555555544443322  2234555555554433

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.63  E-value=5.8e-16  Score=136.41  Aligned_cols=130  Identities=13%  Similarity=0.138  Sum_probs=114.2

Q ss_pred             cccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCC
Q 041632           14 IFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI   93 (452)
Q Consensus        14 ~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   93 (452)
                      ...++.+ ++|++++|+|+ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..+..+++|
T Consensus        40 ~~~l~~L-~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           40 EAQMNSL-TYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             HHHHHTC-CEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             hhhcCCc-cEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            3677888 99999999999 788 7999999999999999886  34589999999999999999998788899999999


Q ss_pred             CeeecccccccCCcchhhccc-ccceeeCcccC-CCCCCCcccccccccccccccccc
Q 041632           94 RKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFND-FEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        94 ~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~-l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      +.|+|++|++++..+..+..+ .|++|++++|+ ++..+ .+..+++|+.|++++|+.
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i  171 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV  171 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCC
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCC
Confidence            999999999998666655555 49999999998 76654 678899999999999875

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.63  E-value=7.1e-16  Score=156.79  Aligned_cols=131  Identities=21%  Similarity=0.221  Sum_probs=80.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++ +|. +.+  +| ++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|+
T Consensus       107 Ls~N~l~~-ip~-l~~--~L-~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          107 ACDNRLST-LPE-LPA--SL-KHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             CCSSCCSC-CCC-CCT--TC-CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred             ccCCCCCC-cch-hhc--CC-CEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence            34555553 454 433  44 556666666653 554   45666666666666663 554   4566777777777776


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhccccc-------ceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSL-------EYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L-------~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      + +|. |.  ++|+.|+|++|+|+.+|+ +..  +|       +.|+|++|+|+.+|+.+..+++|+.|++++|+..+
T Consensus       174 ~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~  244 (571)
T 3cvr_A          174 F-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSS  244 (571)
T ss_dssp             C-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCH
T ss_pred             C-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCC
Confidence            3 555 44  677777777777776555 222  45       77777777777777666667777777777776543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.63  E-value=1.2e-15  Score=146.68  Aligned_cols=138  Identities=20%  Similarity=0.277  Sum_probs=65.8

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++|+++ .++. +..+++| +.|++++|++++ ++. +..+++|+.|++++|++++ +|. +..+++|++|++++|++++
T Consensus       185 ~~n~l~-~~~~-~~~l~~L-~~L~l~~n~l~~-~~~-~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~  257 (347)
T 4fmz_A          185 NYNQIE-DISP-LASLTSL-HYFTAYVNQITD-ITP-VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD  257 (347)
T ss_dssp             TTSCCC-CCGG-GGGCTTC-CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC
T ss_pred             cCCccc-cccc-ccCCCcc-ceeecccCCCCC-Cch-hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC
Confidence            455555 3332 4455555 555555555552 222 4555555555555555552 232 5555555555555555552


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCc-ccccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHR  149 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~  149 (452)
                       + +.+..+++|+.|++++|+++++ +....+.+|+.|++++|++++.++. ++.+++|+.|++++|+.
T Consensus       258 -~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l  323 (347)
T 4fmz_A          258 -I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI  323 (347)
T ss_dssp             -C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred             -C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence             2 2344555555555555555543 2222222355555555555444332 23445555555555543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.62  E-value=1.6e-15  Score=130.23  Aligned_cols=104  Identities=18%  Similarity=0.186  Sum_probs=93.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+|+ .+|..+.  +.+ ++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|+
T Consensus        16 ~s~n~l~-~ip~~~~--~~l-~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~   91 (170)
T 3g39_A           16 CSGKSLA-SVPTGIP--TTT-QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK   91 (170)
T ss_dssp             CTTSCCS-SCCSCCC--TTC-SEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             eCCCCcC-ccCccCC--CCC-cEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccC
Confidence            5789999 7898774  677 99999999999777889999999999999999999666667899999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIP  108 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~  108 (452)
                      +..+..|..+++|+.|+|++|+++...+
T Consensus        92 ~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           92 SIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             EeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            6666679999999999999999987654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.62  E-value=2e-15  Score=130.10  Aligned_cols=105  Identities=16%  Similarity=0.148  Sum_probs=92.5

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+|+ .+|..+.  +.| ++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus        19 ~~~n~l~-~iP~~~~--~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~   94 (174)
T 2r9u_A           19 CQNIRLA-SVPAGIP--TDK-QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK   94 (174)
T ss_dssp             CCSSCCS-SCCSCCC--TTC-SEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             eCCCCCC-ccCCCcC--CCC-cEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccc
Confidence            5788997 8898875  677 99999999999788899999999999999999999655556789999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcch
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPL  109 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  109 (452)
                      +..+..|..+++|+.|+|++|++...++.
T Consensus        95 ~l~~~~~~~l~~L~~L~L~~N~~~c~~~~  123 (174)
T 2r9u_A           95 SIPRGAFDNLKSLTHIYLYNNPWDCECRD  123 (174)
T ss_dssp             CCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred             eeCHHHhccccCCCEEEeCCCCccccccc
Confidence            55555699999999999999999976653

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.61  E-value=1.2e-15  Score=155.79  Aligned_cols=116  Identities=22%  Similarity=0.214  Sum_probs=80.4

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.|+|++|+|+ .+|. |+.+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|+ .+| .|..+++|+.|+|++|
T Consensus       444 ~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp-~l~~l~~L~~L~Ls~N  518 (567)
T 1dce_A          444 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN  518 (567)
T ss_dssp             SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             eEEEecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCC-CCc-ccCCCCCCcEEECCCC
Confidence            67777777777 4665 777777777777777777 67777777777777777777777 356 6777777777777777


Q ss_pred             cccCCc-chhhc-ccccceeeCcccCCCCCCCcccc----ccccccc
Q 041632          102 NLSGQI-PLFLE-ALSLEYLNLSFNDFEGKVPTKGI----FANTSAI  142 (452)
Q Consensus       102 ~l~~~~-~~~~~-~~~L~~l~l~~N~l~~~~~~~~~----~~~l~~l  142 (452)
                      +|++++ |..+. +.+|+.|+|++|+|++.|+....    +++|+.|
T Consensus       519 ~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L  565 (567)
T 1dce_A          519 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  565 (567)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCcc
Confidence            777764 44443 33477777777777777665422    4555544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=1.3e-15  Score=131.57  Aligned_cols=122  Identities=11%  Similarity=0.132  Sum_probs=102.9

Q ss_pred             CCCCcccccCCccccccc-CcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSIS-YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~-~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+++ .+|. +..+. +| ++|+|++|+|++.  +.+..+++|++|+|++|+|++..|..+..+++|++|+|++|+|
T Consensus        26 l~~n~l~-~i~~-~~~~~~~L-~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  100 (176)
T 1a9n_A           26 LRGYKIP-VIEN-LGATLDQF-DAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL  100 (176)
T ss_dssp             CTTSCCC-SCCC-GGGGTTCC-SEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCC
T ss_pred             eeCCCCc-hhHH-hhhcCCCC-CEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcC
Confidence            5789999 5654 66666 88 9999999999954  6899999999999999999954334459999999999999999


Q ss_pred             cccCch--hhhcccCCCeeecccccccCCcch----hhcccccceeeCcccCCCC
Q 041632           80 HGSIPS--FFRTSRGIRKLDLSRNNLSGQIPL----FLEALSLEYLNLSFNDFEG  128 (452)
Q Consensus        80 ~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~----~~~~~~L~~l~l~~N~l~~  128 (452)
                      + .+|.  .+..+++|+.|++++|+++..++.    +..+..|+.||+++|.+..
T Consensus       101 ~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~  154 (176)
T 1a9n_A          101 V-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE  154 (176)
T ss_dssp             C-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred             C-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence            8 6776  899999999999999999987764    4445559999999998753

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.60  E-value=2.5e-15  Score=150.48  Aligned_cols=138  Identities=22%  Similarity=0.267  Sum_probs=76.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++ + +.+..+++| +.|+|++|++++..|  +..+++|+.|++++|++++ +|. +..+++|+.|+|++|+++
T Consensus       228 l~~n~l~~-~-~~l~~l~~L-~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~  300 (466)
T 1o6v_A          228 LNGNQLKD-I-GTLASLTNL-TDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLE  300 (466)
T ss_dssp             CCSSCCCC-C-GGGGGCTTC-SEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCS
T ss_pred             CCCCCccc-c-hhhhcCCCC-CEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCccc
Confidence            35566663 3 345566666 666666666663332  6666666666666666663 332 556666666666666666


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      +. +. +..+++|+.|+|++|++++.+| ...+.+|+.|++++|++++. +.+..+++|+.|++++|+.
T Consensus       301 ~~-~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l  365 (466)
T 1o6v_A          301 DI-SP-ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQI  365 (466)
T ss_dssp             CC-GG-GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCC
T ss_pred             Cc-hh-hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCcc
Confidence            33 22 5556666666666666665544 22233355666665555554 3344455555555555543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.59  E-value=3.4e-15  Score=152.42  Aligned_cols=115  Identities=18%  Similarity=0.285  Sum_probs=103.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+|. +..+++| +.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|+
T Consensus       448 Ls~n~l~-~lp~-~~~l~~L-~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~  521 (567)
T 1dce_A          448 LAHKDLT-VLCH-LEQLLLV-THLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ  521 (567)
T ss_dssp             CTTSCCS-SCCC-GGGGTTC-CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC
T ss_pred             ecCCCCC-CCcC-ccccccC-cEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCC
Confidence            6899999 5787 9999999 99999999999 999999999999999999999995 78 8999999999999999999


Q ss_pred             ccC-chhhhcccCCCeeecccccccCCcchhhc----ccccceeeC
Q 041632           81 GSI-PSFFRTSRGIRKLDLSRNNLSGQIPLFLE----ALSLEYLNL  121 (452)
Q Consensus        81 ~~~-p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----~~~L~~l~l  121 (452)
                      +.. |..|..+++|+.|+|++|+|++.++....    +.+|+.|++
T Consensus       522 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          522 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            666 99999999999999999999998875432    234888864

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.59  E-value=5.6e-15  Score=150.19  Aligned_cols=126  Identities=21%  Similarity=0.269  Sum_probs=71.1

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++ +|..++  ++| ++|+|++|+|+ .+|   ..+++|+.|+|++|+|++ +|. +..  +|+.|+|++|+|+
T Consensus        66 Ls~n~L~~-lp~~l~--~~L-~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~  133 (571)
T 3cvr_A           66 LNRLNLSS-LPDNLP--PQI-TVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLT  133 (571)
T ss_dssp             CCSSCCSC-CCSCCC--TTC-SEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCS
T ss_pred             eCCCCCCc-cCHhHc--CCC-CEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCC
Confidence            45666663 666553  455 66777777666 566   345666666666666663 555 443  6666666666666


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCH  148 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~  148 (452)
                      + +|.   .+++|+.|+|++|+|+++++   ...+|+.|+|++|+|+++|+ ++  ++|+.|++++|.
T Consensus       134 ~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~  191 (571)
T 3cvr_A          134 M-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNL  191 (571)
T ss_dssp             C-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSC
T ss_pred             C-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCC
Confidence            3 444   45556666666666555443   22235555555555555444 32  455555555553

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.58  E-value=4e-15  Score=143.01  Aligned_cols=130  Identities=18%  Similarity=0.137  Sum_probs=107.0

Q ss_pred             EEEccCC-ccccCCCcCCcCCCCCCEEEccC-ccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeeccc
Q 041632           23 SLNLAEN-HFVGSIPPRIGNLKALRSFDVSN-NGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSR  100 (452)
Q Consensus        23 ~L~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~  100 (452)
                      .++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            5789998 998 7998 99999999999996 999977778899999999999999999988888999999999999999


Q ss_pred             ccccCCcchhhcccccceeeCcccCCCCCCCcccccc---cccccccccccccCCCCC
Q 041632          101 NNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFA---NTSAISVAGCHRLCGGIP  155 (452)
Q Consensus       101 N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~---~l~~l~~~~n~~~c~~~~  155 (452)
                      |+|+++++..+..++|+.|+|++|.|..... +..|.   ......+..+...|..+.
T Consensus        90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c~-l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           90 NALESLSWKTVQGLSLQELVLSGNPLHCSCA-LRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SCCSCCCSTTTCSCCCCEEECCSSCCCCCGG-GHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CccceeCHHHcccCCceEEEeeCCCccCCCc-cHHHHHHHHhCcccccccCCCCCCCh
Confidence            9999999998888889999999999986543 21222   222334455667775443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=6e-17  Score=142.85  Aligned_cols=133  Identities=19%  Similarity=0.214  Sum_probs=116.5

Q ss_pred             cccccCcccEEEccCCccccCCCc------CCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhh
Q 041632           14 IFSISYLSNSLNLAENHFVGSIPP------RIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFF   87 (452)
Q Consensus        14 ~~~l~~l~~~L~l~~n~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~   87 (452)
                      +.....+ +.++|+.|.++|.+|.      .+..+++|++|++++|++++ +| .+..+++|++|+|++|+|+ .+|..+
T Consensus        14 ~~~~~~l-~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~   89 (198)
T 1ds9_A           14 FEERKSV-VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD   89 (198)
T ss_dssp             HHHTTCC-CCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred             HHhcccc-cCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence            4556677 7889999999988887      89999999999999999994 88 9999999999999999999 889888


Q ss_pred             hcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCC--cccccccccccccccccccC
Q 041632           88 RTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVP--TKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        88 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~~~n~~~c  151 (452)
                      ..+++|+.|+|++|++++++ .+..+.+|++|++++|+++..++  .+..+++|+.+++++|+..|
T Consensus        90 ~~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~  154 (198)
T 1ds9_A           90 AVADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred             hcCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence            88999999999999999854 44455569999999999997654  56778999999999998755

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.55  E-value=1.9e-14  Score=144.10  Aligned_cols=140  Identities=24%  Similarity=0.354  Sum_probs=113.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|++++..|  +..+++| ++|+|++|+++ .++ .+..+++|+.|++++|.+++..|  +..+++|+.|++++|+++
T Consensus       206 l~~n~l~~~~~--~~~l~~L-~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  278 (466)
T 1o6v_A          206 ATNNQISDITP--LGILTNL-DELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS  278 (466)
T ss_dssp             CCSSCCCCCGG--GGGCTTC-CEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC
T ss_pred             ecCCccccccc--ccccCCC-CEEECCCCCcc-cch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccC
Confidence            56788885544  7778888 89999999998 443 68889999999999999985443  888999999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLC  151 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c  151 (452)
                      + +|. +..+++|+.|++++|++++.++ ...+.+|+.|++++|++++.++ ...+++|+.|++++|+...
T Consensus       279 ~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~  345 (466)
T 1o6v_A          279 N-ISP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSD  345 (466)
T ss_dssp             C-CGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred             c-ccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCC
Confidence            4 444 8888999999999999998766 3344459999999999998876 6678899999999886543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.55  E-value=2.8e-14  Score=137.08  Aligned_cols=139  Identities=19%  Similarity=0.319  Sum_probs=90.5

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+|. +..+++| ++|+|++|+++ .+|. +..+++|++|++++|.++ .+| .+..+++|++|++++|+++
T Consensus        51 l~~~~i~-~~~~-~~~~~~L-~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l~~n~i~  123 (347)
T 4fmz_A           51 VAGEKVA-SIQG-IEYLTNL-EYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLNEDNIS  123 (347)
T ss_dssp             CCSSCCC-CCTT-GGGCTTC-CEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECTTSCCC
T ss_pred             EeCCccc-cchh-hhhcCCc-cEEEccCCccc-cchh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEECcCCccc
Confidence            3456665 4443 6667777 77777777776 4444 777777777777777776 343 5777777777777777777


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                       .+|. +..+++|+.|++++|.....++....+..|++|++++|.+++.++ +..+++|+.+++++|..
T Consensus       124 -~~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n~l  189 (347)
T 4fmz_A          124 -DISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYNQI  189 (347)
T ss_dssp             -CCGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTSCC
T ss_pred             -Cchh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCCcc
Confidence             3443 667777777777777554445544444457777777777766554 55667777777776653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.54  E-value=3.8e-14  Score=141.25  Aligned_cols=132  Identities=13%  Similarity=0.123  Sum_probs=68.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++ +| ++..+++| ++|+|++|+|++ +|  ++.+++|++|++++|++++ +|  ++.+++|++|+|++|+++
T Consensus        49 Ls~n~l~~-~~-~l~~l~~L-~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~  119 (457)
T 3bz5_A           49 CHNSSITD-MT-GIEKLTGL-TKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT  119 (457)
T ss_dssp             CCSSCCCC-CT-TGGGCTTC-SEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCS
T ss_pred             ccCCCccc-Ch-hhcccCCC-CEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCC
Confidence            35566663 34 45666666 666666666663 33  5666666666666666663 33  566666666666666666


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGC  147 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n  147 (452)
                      + +|  +..+++|+.|++++|++++++  ...+..|++|++++|...+.. .++.+++|+.|++++|
T Consensus       120 ~-l~--~~~l~~L~~L~l~~N~l~~l~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n  180 (457)
T 3bz5_A          120 K-LD--VSQNPLLTYLNCARNTLTEID--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFN  180 (457)
T ss_dssp             C-CC--CTTCTTCCEEECTTSCCSCCC--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSS
T ss_pred             e-ec--CCCCCcCCEEECCCCccceec--cccCCcCCEEECCCCCccccc-ccccCCcCCEEECCCC
Confidence            3 33  555666666666666665542  112222444444444322222 1233444444444444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.54  E-value=1.1e-15  Score=147.76  Aligned_cols=149  Identities=22%  Similarity=0.203  Sum_probs=119.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCC----cCCcCCC-CCCEEEccCccccccCCccccCC-----CCCC
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIP----PRIGNLK-ALRSFDVSNNGLSGEIPIELGLC-----SSLE   70 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~   70 (452)
                      |+.|+++|.+|+.+....+| ++|+|++|+|++..+    ..+..++ +|++|+|++|++++..+..+..+     ++|+
T Consensus         5 ls~n~~~~~~~~~~~~~~~L-~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGV-TSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTC-CEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             cccccchHHHHHHHhCCCCc-eEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            67899998888877766678 999999999996655    7788898 99999999999997777777775     9999


Q ss_pred             EEEccCccccccCchhhhcc-----cCCCeeecccccccCCcchhhc----c--cccceeeCcccCCCCCCCc-----cc
Q 041632           71 DIYLGGNFFHGSIPSFFRTS-----RGIRKLDLSRNNLSGQIPLFLE----A--LSLEYLNLSFNDFEGKVPT-----KG  134 (452)
Q Consensus        71 ~L~l~~N~l~~~~p~~~~~l-----~~L~~l~l~~N~l~~~~~~~~~----~--~~L~~l~l~~N~l~~~~~~-----~~  134 (452)
                      +|+|++|+|++..+..+...     ++|+.|+|++|++++..+..+.    .  .+|++|+|++|+++.....     +.
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~  163 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA  163 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence            99999999997777755554     8999999999999988765443    1  3599999999999853321     12


Q ss_pred             cc-cccccccccccccc
Q 041632          135 IF-ANTSAISVAGCHRL  150 (452)
Q Consensus       135 ~~-~~l~~l~~~~n~~~  150 (452)
                      .+ ++|+.|++++|...
T Consensus       164 ~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          164 AIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             TSCTTCCEEECTTSCGG
T ss_pred             cCCccccEeeecCCCCc
Confidence            33 38999999988653

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.53  E-value=3.8e-14  Score=145.79  Aligned_cols=77  Identities=18%  Similarity=0.211  Sum_probs=45.8

Q ss_pred             CCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccc
Q 041632           67 SSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAG  146 (452)
Q Consensus        67 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~  146 (452)
                      ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|+|+.+++   ...+|+.|+|++|+|+.+|+.+..+++|+.|++++
T Consensus       221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCS
T ss_pred             CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecC
Confidence            45555555555555 344   234556666666666665544   22346667777777766665566666677777776


Q ss_pred             cccc
Q 041632          147 CHRL  150 (452)
Q Consensus       147 n~~~  150 (452)
                      |+..
T Consensus       294 N~l~  297 (622)
T 3g06_A          294 NPLS  297 (622)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            6643

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.52  E-value=1.3e-14  Score=139.73  Aligned_cols=143  Identities=11%  Similarity=0.048  Sum_probs=96.9

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCC-ccccCCCCCCE-EEccCccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP-IELGLCSSLED-IYLGGNFF   79 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~l~~N~l   79 (452)
                      ++|+|+ .+|..+.  +++ ++|+|++|+|+..-+.+|.+|++|++|+|++|++.+.+| +.|.++++|++ +++++|+|
T Consensus        17 ~~~~Lt-~iP~~l~--~~l-~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l   92 (350)
T 4ay9_X           17 QESKVT-EIPSDLP--RNA-IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL   92 (350)
T ss_dssp             ESTTCC-SCCTTCC--TTC-SEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTC
T ss_pred             cCCCCC-ccCcCcC--CCC-CEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcc
Confidence            467788 7887773  466 888899998883334578888899999998888765565 45778877765 56677888


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhh-cccccceeeCcc-cCCCCCCCcc-ccc-cccccccccccc
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFL-EALSLEYLNLSF-NDFEGKVPTK-GIF-ANTSAISVAGCH  148 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~-~~~~L~~l~l~~-N~l~~~~~~~-~~~-~~l~~l~~~~n~  148 (452)
                      +...|..|..+++|+.|++++|+++.+++..+ ....+..|++.+ |++..+++.. ..+ ..++.|++++|.
T Consensus        93 ~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~  165 (350)
T 4ay9_X           93 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG  165 (350)
T ss_dssp             CEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred             cccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence            86667788888888888888888887766433 233356666643 4555444432 112 234555666554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.51  E-value=7.1e-14  Score=139.26  Aligned_cols=132  Identities=15%  Similarity=0.123  Sum_probs=78.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++ +|  +..+++| ++|+|++|+|++ +|  ++.+++|++|++++|++++ +|  ++.+++|++|++++|+..
T Consensus        92 Ls~N~l~~-~~--~~~l~~L-~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~  161 (457)
T 3bz5_A           92 CDSNKLTN-LD--VTPLTKL-TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKI  161 (457)
T ss_dssp             CCSSCCSC-CC--CTTCTTC-CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCC
T ss_pred             CcCCCCce-ee--cCCCCcC-CEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCcc
Confidence            56788884 44  7778887 888888888874 54  7788888888888888875 33  566666666666666433


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCH  148 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~  148 (452)
                      +.+  .+..+++|+.|++++|++++++  ...+..|+.|++++|++++.  .++.+++|+.|++++|.
T Consensus       162 ~~~--~~~~l~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~  223 (457)
T 3bz5_A          162 TKL--DVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNK  223 (457)
T ss_dssp             CCC--CCTTCTTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSC
T ss_pred             ccc--ccccCCcCCEEECCCCccceec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCc
Confidence            333  2445555555555555555543  22222355555555555443  13344444445544443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.51  E-value=1.5e-15  Score=145.34  Aligned_cols=147  Identities=15%  Similarity=0.148  Sum_probs=107.3

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccC-CCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCc-c
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGS-IPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGN-F   78 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~   78 (452)
                      +++|.+++..| .++.+++| ++|+|++|.+++. +|..+..+++|++|+|++|++++..|..++.+++|++|+|++| .
T Consensus        77 l~~n~l~~~~~-~~~~~~~L-~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~  154 (336)
T 2ast_B           77 CPRSFMDQPLA-EHFSPFRV-QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG  154 (336)
T ss_dssp             CTTCEECSCCC-SCCCCBCC-CEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBS
T ss_pred             cCCccccccch-hhccCCCC-CEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCC
Confidence            46777875544 46678888 8888888888755 7777888888888888888888777888888888888888888 6


Q ss_pred             ccc-cCchhhhcccCCCeeecccc-cccCC--cchhhccc-ccceeeCcccC--CC--CCCCcccccccccccccccccc
Q 041632           79 FHG-SIPSFFRTSRGIRKLDLSRN-NLSGQ--IPLFLEAL-SLEYLNLSFND--FE--GKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        79 l~~-~~p~~~~~l~~L~~l~l~~N-~l~~~--~~~~~~~~-~L~~l~l~~N~--l~--~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      +++ .++..+..+++|+.|++++| .+++.  +.....+. +|++|++++|.  ++  +.+.....+++|+.|++++|..
T Consensus       155 l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~  234 (336)
T 2ast_B          155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM  234 (336)
T ss_dssp             CCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred             CCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCc
Confidence            775 36667778888888888888 77753  33344455 68888888884  33  2233345677788888877763

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.50  E-value=1.8e-15  Score=144.66  Aligned_cols=142  Identities=18%  Similarity=0.239  Sum_probs=112.3

Q ss_pred             CCCcccccCCcccccc--cCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcccccc-CCccccCCCCCCEEEccCcc
Q 041632            2 FENDLSGTIPEAIFSI--SYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE-IPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l--~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~   78 (452)
                      ++|++.   |..+..+  ..+ +.|++++|.+++..| .+..+++|++|++++|.+++. +|..+..+++|++|+|++|+
T Consensus        55 ~~~~~~---~~~~~~~~~~~l-~~L~l~~n~l~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~  129 (336)
T 2ast_B           55 TGKNLH---PDVTGRLLSQGV-IAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR  129 (336)
T ss_dssp             TTCBCC---HHHHHHHHHTTC-SEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred             ccccCC---HHHHHhhhhccc-eEEEcCCccccccch-hhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcc
Confidence            455555   5556666  777 899999999985555 467899999999999998865 88888899999999999999


Q ss_pred             ccccCchhhhcccCCCeeecccc-cccCC-cchhhc-ccccceeeCccc-CCCC--CCCcccccc-ccccccccccc
Q 041632           79 FHGSIPSFFRTSRGIRKLDLSRN-NLSGQ-IPLFLE-ALSLEYLNLSFN-DFEG--KVPTKGIFA-NTSAISVAGCH  148 (452)
Q Consensus        79 l~~~~p~~~~~l~~L~~l~l~~N-~l~~~-~~~~~~-~~~L~~l~l~~N-~l~~--~~~~~~~~~-~l~~l~~~~n~  148 (452)
                      +++..|..+..+++|+.|+|++| .+++. .+..+. +.+|++|++++| .+++  .+.....++ +|+.|++++|.
T Consensus       130 l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~  206 (336)
T 2ast_B          130 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR  206 (336)
T ss_dssp             CCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred             cCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence            98888888999999999999999 67752 444344 445999999999 8875  333456788 89999999885

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.49  E-value=2e-15  Score=147.42  Aligned_cols=147  Identities=16%  Similarity=0.139  Sum_probs=71.5

Q ss_pred             CCCCcccc----cCCcccccccCcccEEEccCCccccCCCcCCc----CC---------CCCCEEEccCcccc-ccCC--
Q 041632            1 MFENDLSG----TIPEAIFSISYLSNSLNLAENHFVGSIPPRIG----NL---------KALRSFDVSNNGLS-GEIP--   60 (452)
Q Consensus         1 l~~N~l~~----~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~-~~~p--   60 (452)
                      |++|+|++    .+|..+..+++| ++|+|++|.|++..+..+.    .+         ++|++|+|++|+++ +.+|  
T Consensus       101 Ls~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l  179 (386)
T 2ca6_A          101 LSDNAFGPTAQEPLIDFLSKHTPL-EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW  179 (386)
T ss_dssp             CCSCCCCTTTHHHHHHHHHHCTTC-CEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH
T ss_pred             CCCCcCCHHHHHHHHHHHHhCCCC-CEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHH
Confidence            45666664    355566666666 6666666666432222222    22         56666666666554 2233  


Q ss_pred             -ccccCCCCCCEEEccCccccc-----cCchhhhcccCCCeeeccccccc----CCcchhhc-ccccceeeCcccCCCCC
Q 041632           61 -IELGLCSSLEDIYLGGNFFHG-----SIPSFFRTSRGIRKLDLSRNNLS----GQIPLFLE-ALSLEYLNLSFNDFEGK  129 (452)
Q Consensus        61 -~~~~~l~~L~~L~l~~N~l~~-----~~p~~~~~l~~L~~l~l~~N~l~----~~~~~~~~-~~~L~~l~l~~N~l~~~  129 (452)
                       ..+..+++|+.|+|++|+|+.     ..|..+..+++|+.|+|++|.++    ...+..+. +.+|++|+|++|.+++.
T Consensus       180 ~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~  259 (386)
T 2ca6_A          180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  259 (386)
T ss_dssp             HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             HHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence             344455555555555555541     12224555555555555555553    22222222 22355555555555432


Q ss_pred             -----CCcc--ccccccccccccccc
Q 041632          130 -----VPTK--GIFANTSAISVAGCH  148 (452)
Q Consensus       130 -----~~~~--~~~~~l~~l~~~~n~  148 (452)
                           +..+  +.+++|+.|++++|+
T Consensus       260 ~~~~l~~~l~~~~~~~L~~L~L~~n~  285 (386)
T 2ca6_A          260 GAAAVVDAFSKLENIGLQTLRLQYNE  285 (386)
T ss_dssp             HHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred             hHHHHHHHHhhccCCCeEEEECcCCc
Confidence                 1111  224555555555554

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.49  E-value=1.4e-13  Score=137.01  Aligned_cols=118  Identities=25%  Similarity=0.230  Sum_probs=71.0

Q ss_pred             CcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeec
Q 041632           19 YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDL   98 (452)
Q Consensus        19 ~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l   98 (452)
                      +| ++|+|++|+++ .+| +|+++++|++|++++|+++ .+|..+   .+|++|++++|++++ +| .+..+++|+.|++
T Consensus       132 ~L-~~L~L~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~-~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          132 LL-EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TC-CEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CC-CEEECcCCCCC-CCc-ccCCCCCCCEEECCCCcCc-ccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            44 56666666666 355 4666666666666666666 355433   366666666666663 44 4666666666666


Q ss_pred             ccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           99 SRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        99 ~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      ++|++++++...   .+|++|++++|+++.+| .++.+++|+.|++++|..
T Consensus       203 ~~N~l~~l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l  249 (454)
T 1jl5_A          203 DNNSLKKLPDLP---LSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLL  249 (454)
T ss_dssp             CSSCCSSCCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCC
T ss_pred             CCCcCCcCCCCc---CcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcC
Confidence            666666643321   24666777777666544 355666777777766644

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.48  E-value=1.8e-13  Score=136.25  Aligned_cols=132  Identities=19%  Similarity=0.208  Sum_probs=105.7

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++++ +| ++.++++| ++|++++|+++ .+|..+   .+|++|++++|++++ +| .++.+++|++|++++|+++
T Consensus       138 L~~n~l~~-lp-~~~~l~~L-~~L~l~~N~l~-~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~  208 (454)
T 1jl5_A          138 VSNNQLEK-LP-ELQNSSFL-KIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK  208 (454)
T ss_dssp             CCSSCCSS-CC-CCTTCTTC-CEEECCSSCCS-CCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred             CcCCCCCC-Cc-ccCCCCCC-CEEECCCCcCc-ccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCC
Confidence            57899994 88 59999999 99999999999 577544   589999999999985 77 6999999999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      + +|...   ++|+.|++++|+++.++ .+..+..|++|++++|++++.|+.   +++|+.|++++|..
T Consensus       209 ~-l~~~~---~~L~~L~l~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l  269 (454)
T 1jl5_A          209 K-LPDLP---LSLESIVAGNNILEELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYL  269 (454)
T ss_dssp             S-CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCC
T ss_pred             c-CCCCc---CcccEEECcCCcCCccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcc
Confidence            4 55432   57889999999988655 444444589999999998876542   47788888888764

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.48  E-value=1.6e-13  Score=141.07  Aligned_cols=112  Identities=26%  Similarity=0.394  Sum_probs=79.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+|+ .+|..+.  ++| ++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|.   .+++|++|+|++|+|+
T Consensus        47 ls~n~L~-~lp~~l~--~~L-~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~  114 (622)
T 3g06_A           47 VGESGLT-TLPDCLP--AHI-TTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT  114 (622)
T ss_dssp             CCSSCCS-CCCSCCC--TTC-SEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC
T ss_pred             ecCCCcC-ccChhhC--CCC-cEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC
Confidence            5678888 7888776  677 88888888888 6775   5678888888888887 5666   6678888888888887


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVP  131 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~  131 (452)
                       .+|.   .+++|+.|++++|+|+++++.   ..+|++|+|++|++++++.
T Consensus       115 -~l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~l~~  158 (622)
T 3g06_A          115 -HLPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLASLPA  158 (622)
T ss_dssp             -CCCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSCCCC
T ss_pred             -CCCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCcCCCcCC
Confidence             4554   456677777777777665542   1346666666666665543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.47  E-value=5.3e-14  Score=135.37  Aligned_cols=147  Identities=16%  Similarity=0.082  Sum_probs=107.4

Q ss_pred             CCCCcccccCC-cccccccCcccEEEccCCccccCCC-cCCcCCCCCCE-EEccCccccccCCccccCCCCCCEEEccCc
Q 041632            1 MFENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIP-PRIGNLKALRS-FDVSNNGLSGEIPIELGLCSSLEDIYLGGN   77 (452)
Q Consensus         1 l~~N~l~~~~p-~~~~~l~~l~~~L~l~~n~l~~~~p-~~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   77 (452)
                      |++|+|+ .+| +.|.++++| ++|+|++|++.+.+| .+|.++++|+. +.+++|+++...|+.|..+++|++|++++|
T Consensus        37 Ls~N~i~-~i~~~~f~~l~~L-~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n  114 (350)
T 4ay9_X           37 FVLTKLR-VIQKGAFSGFGDL-EKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT  114 (350)
T ss_dssp             EESCCCS-EECTTSSTTCTTC-CEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEE
T ss_pred             ccCCcCC-CcCHHHHcCCCCC-CEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccc
Confidence            5789999 555 568899999 999999999876666 46889998876 667789999777888999999999999999


Q ss_pred             cccccCchhhhccc--------------------------CCCeeecccccccCCcchhhcccccceeeCc-ccCCCCCC
Q 041632           78 FFHGSIPSFFRTSR--------------------------GIRKLDLSRNNLSGQIPLFLEALSLEYLNLS-FNDFEGKV  130 (452)
Q Consensus        78 ~l~~~~p~~~~~l~--------------------------~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~-~N~l~~~~  130 (452)
                      +|+...+..+....                          .++.|+|++|+|+.+++..+...+|+.|++. +|.++.++
T Consensus       115 ~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~  194 (350)
T 4ay9_X          115 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELP  194 (350)
T ss_dssp             CCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCC
T ss_pred             ccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCC
Confidence            99854443333222                          3556677777777666666666666677665 35666666


Q ss_pred             Ccc-cccccccccccccccc
Q 041632          131 PTK-GIFANTSAISVAGCHR  149 (452)
Q Consensus       131 ~~~-~~~~~l~~l~~~~n~~  149 (452)
                      +.. ..+++|+.|++++|..
T Consensus       195 ~~~f~~l~~L~~LdLs~N~l  214 (350)
T 4ay9_X          195 NDVFHGASGPVILDISRTRI  214 (350)
T ss_dssp             TTTTTTEECCSEEECTTSCC
T ss_pred             HHHhccCcccchhhcCCCCc
Confidence            543 5567777777777654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.46  E-value=8.3e-14  Score=133.81  Aligned_cols=102  Identities=18%  Similarity=0.181  Sum_probs=90.1

Q ss_pred             CCC-cccccCCcccccccCcccEEEccC-CccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            2 FEN-DLSGTIPEAIFSISYLSNSLNLAE-NHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         2 ~~N-~l~~~~p~~~~~l~~l~~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      ++| +|+ .+|. +..+++| ++|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|
T Consensus        16 ~~~n~l~-~ip~-l~~~~~L-~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l   92 (347)
T 2ifg_A           16 TRDGALD-SLHH-LPGAENL-TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL   92 (347)
T ss_dssp             CSSCCCT-TTTT-SCSCSCC-SEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCC
T ss_pred             CCCCCCC-ccCC-CCCCCCe-eEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCcc
Confidence            455 898 7899 9999999 9999996 999977778999999999999999999998888999999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCc
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQI  107 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~  107 (452)
                      ++..+..|..++ |+.|+|++|++...-
T Consensus        93 ~~~~~~~~~~~~-L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           93 ESLSWKTVQGLS-LQELVLSGNPLHCSC  119 (347)
T ss_dssp             SCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred             ceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence            965555666665 999999999998643

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.45  E-value=5.2e-15  Score=144.40  Aligned_cols=148  Identities=16%  Similarity=0.168  Sum_probs=110.5

Q ss_pred             CCCCcccccCC----cccccccCcccEEEccCC---ccccCCCcCC-------cCCCCCCEEEccCccccc----cCCcc
Q 041632            1 MFENDLSGTIP----EAIFSISYLSNSLNLAEN---HFVGSIPPRI-------GNLKALRSFDVSNNGLSG----EIPIE   62 (452)
Q Consensus         1 l~~N~l~~~~p----~~~~~l~~l~~~L~l~~n---~l~~~~p~~~-------~~l~~L~~L~l~~N~l~~----~~p~~   62 (452)
                      |++|+|++..+    ..+..+++| ++|+|++|   ++++.+|..+       ..+++|++|+|++|.+++    .+|..
T Consensus        39 L~~n~i~~~~~~~l~~~l~~~~~L-~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~  117 (386)
T 2ca6_A           39 LSGNTIGTEAARWLSENIASKKDL-EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF  117 (386)
T ss_dssp             CTTSEECHHHHHHHHHTTTTCTTC-CEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHHhCCCc-cEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHH
Confidence            57788886644    446678888 89999985   5555666655       688999999999999986    47888


Q ss_pred             ccCCCCCCEEEccCccccccCchh----hhcc---------cCCCeeeccccccc-CCcc---hhh-cccccceeeCccc
Q 041632           63 LGLCSSLEDIYLGGNFFHGSIPSF----FRTS---------RGIRKLDLSRNNLS-GQIP---LFL-EALSLEYLNLSFN  124 (452)
Q Consensus        63 ~~~l~~L~~L~l~~N~l~~~~p~~----~~~l---------~~L~~l~l~~N~l~-~~~~---~~~-~~~~L~~l~l~~N  124 (452)
                      +..+++|++|+|++|.|+...+..    +..+         ++|+.|+|++|+++ ...+   ..+ .+.+|++|+|++|
T Consensus       118 l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n  197 (386)
T 2ca6_A          118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN  197 (386)
T ss_dssp             HHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSS
T ss_pred             HHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCC
Confidence            889999999999999987544443    4444         89999999999997 2333   233 3345999999999


Q ss_pred             CCC--C---CCC-cccccccccccccccccc
Q 041632          125 DFE--G---KVP-TKGIFANTSAISVAGCHR  149 (452)
Q Consensus       125 ~l~--~---~~~-~~~~~~~l~~l~~~~n~~  149 (452)
                      +++  +   ..+ .+..+++|+.|++++|..
T Consensus       198 ~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l  228 (386)
T 2ca6_A          198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  228 (386)
T ss_dssp             CCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             CCCHhHHHHHHHHHhhcCCCccEEECcCCCC
Confidence            987  2   223 556788899999988875

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.45  E-value=1.3e-14  Score=140.32  Aligned_cols=148  Identities=22%  Similarity=0.181  Sum_probs=113.9

Q ss_pred             CCCCcccccCC----ccccccc-CcccEEEccCCccccCCCcCCcCC-----CCCCEEEccCccccccCCcccc----CC
Q 041632            1 MFENDLSGTIP----EAIFSIS-YLSNSLNLAENHFVGSIPPRIGNL-----KALRSFDVSNNGLSGEIPIELG----LC   66 (452)
Q Consensus         1 l~~N~l~~~~p----~~~~~l~-~l~~~L~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~----~l   66 (452)
                      |++|+|++..+    +.+..++ +| ++|+|++|+|++..+..+..+     ++|++|+|++|++++..+..+.    .+
T Consensus        29 Ls~n~l~~~~~~~l~~~l~~~~~~L-~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~  107 (362)
T 3goz_A           29 LSLNNLYSISTVELIQAFANTPASV-TSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI  107 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHTCCTTC-CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTS
T ss_pred             ccCCCCChHHHHHHHHHHHhCCCce-eEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhC
Confidence            57899986655    6777788 78 999999999997777777775     9999999999999866666444    44


Q ss_pred             -CCCCEEEccCccccccCchhhhc-----ccCCCeeecccccccCCcchh----h-ccc-ccceeeCcccCCCCCCCc-c
Q 041632           67 -SSLEDIYLGGNFFHGSIPSFFRT-----SRGIRKLDLSRNNLSGQIPLF----L-EAL-SLEYLNLSFNDFEGKVPT-K  133 (452)
Q Consensus        67 -~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~~~~~~----~-~~~-~L~~l~l~~N~l~~~~~~-~  133 (452)
                       ++|++|+|++|+|++..+..+..     .++|+.|+|++|++++.....    + ... +|++|+|++|++++..+. +
T Consensus       108 ~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  187 (362)
T 3goz_A          108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAEL  187 (362)
T ss_dssp             CTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred             CCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHH
Confidence             89999999999999766666554     368999999999998644322    2 233 599999999999876542 1


Q ss_pred             ----ccc-ccccccccccccc
Q 041632          134 ----GIF-ANTSAISVAGCHR  149 (452)
Q Consensus       134 ----~~~-~~l~~l~~~~n~~  149 (452)
                          ..+ ++|+.|++++|..
T Consensus       188 ~~~l~~~~~~L~~L~Ls~N~i  208 (362)
T 3goz_A          188 AKFLASIPASVTSLDLSANLL  208 (362)
T ss_dssp             HHHHHTSCTTCCEEECTTSCG
T ss_pred             HHHHHhCCCCCCEEECCCCCC
Confidence                233 5899999998864

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=2.3e-12  Score=118.59  Aligned_cols=145  Identities=14%  Similarity=0.086  Sum_probs=108.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|.....++.|+.+.||+...  .++.+++|+...........+.+|+++++.+. +..+.++++++.     ..+..
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~   85 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWS   85 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCce
Confidence            45687778888888899999875  36789999987532233356889999998884 666777887743     24578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC------------------------
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC------------------------  364 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------  364 (452)
                      ++||||++|.+|.+.+...                .+...++.+++.+++.||+..                        
T Consensus        86 ~lv~e~i~G~~l~~~~~~~----------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           86 NLLMSEADGVLCSEEYEDE----------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             EEEEECCSSEEHHHHCCTT----------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCeehhhccCCc----------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence            9999999999998753211                123467889999999999821                        


Q ss_pred             --------------------------------CCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          365 --------------------------------QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       365 --------------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                                                      ...++|+|++|.||+++++..+.|+||+.+...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g  214 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA  214 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence                                            135899999999999987666779999987643

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.29  E-value=8.2e-14  Score=139.09  Aligned_cols=148  Identities=16%  Similarity=0.125  Sum_probs=95.6

Q ss_pred             CCCCccccc----CCcccccccCcccEEEccCCccccCC-----CcCCcCCCCCCEEEccCcccccc----CCccccCCC
Q 041632            1 MFENDLSGT----IPEAIFSISYLSNSLNLAENHFVGSI-----PPRIGNLKALRSFDVSNNGLSGE----IPIELGLCS   67 (452)
Q Consensus         1 l~~N~l~~~----~p~~~~~l~~l~~~L~l~~n~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~   67 (452)
                      |++|++++.    +|..+..+++| ++|+|++|++++.-     +..+..+++|++|++++|+++..    +|..+..++
T Consensus       206 L~~n~l~~~~~~~l~~~l~~~~~L-~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~  284 (461)
T 1z7x_W          206 LESCGVTSDNCRDLCGIVASKASL-RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE  284 (461)
T ss_dssp             CTTSCCBTTHHHHHHHHHHHCTTC-CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCT
T ss_pred             ccCCCCcHHHHHHHHHHHHhCCCc-cEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCC
Confidence            467777753    56777778888 88888888886432     22233578888888888888743    677777788


Q ss_pred             CCCEEEccCccccccCchhhhcc-----cCCCeeecccccccCCc----chhhc-ccccceeeCcccCCCCCCCc-ccc-
Q 041632           68 SLEDIYLGGNFFHGSIPSFFRTS-----RGIRKLDLSRNNLSGQI----PLFLE-ALSLEYLNLSFNDFEGKVPT-KGI-  135 (452)
Q Consensus        68 ~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~l~l~~N~l~~~~----~~~~~-~~~L~~l~l~~N~l~~~~~~-~~~-  135 (452)
                      +|++|+|++|.+++..+..+...     ++|+.|+|++|.+++..    +..+. +.+|++|++++|+++...+. +.. 
T Consensus       285 ~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~  364 (461)
T 1z7x_W          285 SLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG  364 (461)
T ss_dssp             TCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHH
T ss_pred             CcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHH
Confidence            88888888888775544444433     57777777777776542    22222 23477777777776543221 111 


Q ss_pred             ----cccccccccccccc
Q 041632          136 ----FANTSAISVAGCHR  149 (452)
Q Consensus       136 ----~~~l~~l~~~~n~~  149 (452)
                          .++|+.|++++|..
T Consensus       365 l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          365 LGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HTSTTCCCCEEECTTSCC
T ss_pred             HcCCCCceEEEECCCCCC
Confidence                44677777776643

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.25  E-value=4.7e-13  Score=133.54  Aligned_cols=126  Identities=21%  Similarity=0.222  Sum_probs=69.8

Q ss_pred             CCCcccc----cCCcccccccCcccEEEccCCccccCCCcCCc-CCC----CCCEEEccCccccc----cCCccccCCCC
Q 041632            2 FENDLSG----TIPEAIFSISYLSNSLNLAENHFVGSIPPRIG-NLK----ALRSFDVSNNGLSG----EIPIELGLCSS   68 (452)
Q Consensus         2 ~~N~l~~----~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~-~l~----~L~~L~l~~N~l~~----~~p~~~~~l~~   68 (452)
                      ++|++++    .+|+.+..+++| ++|+|++|++++..+..+. .++    +|++|+|++|+++.    .+|..+..+++
T Consensus        36 ~~~~l~~~~~~~l~~~l~~~~~L-~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~  114 (461)
T 1z7x_W           36 DDCGLTEARCKDISSALRVNPAL-AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPT  114 (461)
T ss_dssp             ESSCCCHHHHHHHHHHHHTCTTC-CEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTT
T ss_pred             cCCCCCHHHHHHHHHHHHhCCCc-CEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCc
Confidence            4455553    235555566666 6777777776543333322 233    57777777777662    45666666777


Q ss_pred             CCEEEccCccccccCchhhhc-----ccCCCeeecccccccCCc----chhhc-ccccceeeCcccCCCC
Q 041632           69 LEDIYLGGNFFHGSIPSFFRT-----SRGIRKLDLSRNNLSGQI----PLFLE-ALSLEYLNLSFNDFEG  128 (452)
Q Consensus        69 L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~~~----~~~~~-~~~L~~l~l~~N~l~~  128 (452)
                      |++|+|++|.+++..+..+..     .++|+.|+|++|++++..    +..+. +.+|++|++++|.++.
T Consensus       115 L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  184 (461)
T 1z7x_W          115 LQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE  184 (461)
T ss_dssp             CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             eeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcch
Confidence            777777777666443333332     345666666666665532    22222 2236666666666543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.19  E-value=2.4e-11  Score=111.39  Aligned_cols=138  Identities=17%  Similarity=0.090  Sum_probs=94.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC--ceeEeeeeccccCCCCceeE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN--LVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++......+.|..+.||+... .+|+.+++|+....   ....+.+|+++++.+.+.+  +.+++++..     ..+..+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~   91 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDW   91 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEE
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCE
Confidence            344333334556699999875 36778999987533   2245788999988885444  445666532     234579


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC-------------------------
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC-------------------------  364 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------  364 (452)
                      +||||++|.++.  ...              .+   ...++.+++..++.||+..                         
T Consensus        92 ~v~e~i~G~~l~--~~~--------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH--------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGL  152 (264)
T ss_dssp             EEEECCSSEETT--TSC--------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTC
T ss_pred             EEEEecCCcccC--cCc--------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCC
Confidence            999999998884  211              11   1246677777777777642                         


Q ss_pred             ------------------------------CCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          365 ------------------------------QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       365 ------------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                                                    ...++|+|++|.||+++++..+.|+|||.+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          153 VDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             CCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             ccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                          123999999999999988766789999987643

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.14  E-value=1.1e-12  Score=126.82  Aligned_cols=148  Identities=13%  Similarity=0.097  Sum_probs=103.5

Q ss_pred             CCCCcccccCCcccccc-----cCcccEEEccCCccccCCCcCC-cCCCCCCEEEccCccccccCCccc-----cCCCCC
Q 041632            1 MFENDLSGTIPEAIFSI-----SYLSNSLNLAENHFVGSIPPRI-GNLKALRSFDVSNNGLSGEIPIEL-----GLCSSL   69 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l-----~~l~~~L~l~~n~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~L   69 (452)
                      |++|+|+..-...+...     ..| ++|+|++|.|+..-...+ ..+++|+.|+|++|+|+..-...+     ...++|
T Consensus        79 Ls~n~l~~~~~~~l~~~L~~~~~~L-~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L  157 (372)
T 3un9_A           79 LAGVRMTPVKCTVVAAVLGSGRHAL-DEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQI  157 (372)
T ss_dssp             CTTSCCCHHHHHHHHHHHSSCSSCE-EEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCC
T ss_pred             ecCCCCCHHHHHHHHHHHhhCCCCc-eEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCcc
Confidence            56777775444444433     577 899999999874333333 346789999999999975433443     346889


Q ss_pred             CEEEccCccccc----cCchhhhcccCCCeeecccccccCCc----chhhc-ccccceeeCcccCCCCCCC-----cccc
Q 041632           70 EDIYLGGNFFHG----SIPSFFRTSRGIRKLDLSRNNLSGQI----PLFLE-ALSLEYLNLSFNDFEGKVP-----TKGI  135 (452)
Q Consensus        70 ~~L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~~~~----~~~~~-~~~L~~l~l~~N~l~~~~~-----~~~~  135 (452)
                      +.|+|++|.|+.    .++..+..+++|+.|+|++|.|+...    ...+. ..+|+.|+|++|.|+....     .+..
T Consensus       158 ~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~  237 (372)
T 3un9_A          158 TTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAARE  237 (372)
T ss_dssp             CEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHH
T ss_pred             ceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHh
Confidence            999999999874    24556677899999999999987632    22333 3359999999999874321     1234


Q ss_pred             cccccccccccccc
Q 041632          136 FANTSAISVAGCHR  149 (452)
Q Consensus       136 ~~~l~~l~~~~n~~  149 (452)
                      .++|+.|++++|+.
T Consensus       238 ~~~L~~L~Ls~N~i  251 (372)
T 3un9_A          238 HPSLELLHLYFNEL  251 (372)
T ss_dssp             CSSCCEEECTTSSC
T ss_pred             CCCCCEEeccCCCC
Confidence            57889999998864

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.04  E-value=5.8e-10  Score=106.03  Aligned_cols=82  Identities=13%  Similarity=0.002  Sum_probs=65.8

Q ss_pred             CCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cc-eeeCcccCCCCCCCcc-ccccccccc
Q 041632           66 CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LE-YLNLSFNDFEGKVPTK-GIFANTSAI  142 (452)
Q Consensus        66 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~-~l~l~~N~l~~~~~~~-~~~~~l~~l  142 (452)
                      +++|+.|+|++|+++.+.+.+|.+|++|+.|+|++| ++.+.+..|.... |+ .+++.+ .++.+.+.. ..+++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            678999999999998566668999999999999988 8888888887766 98 999988 777666543 556788888


Q ss_pred             ccccccc
Q 041632          143 SVAGCHR  149 (452)
Q Consensus       143 ~~~~n~~  149 (452)
                      ++.+|..
T Consensus       303 ~l~~n~i  309 (329)
T 3sb4_A          303 LATGDKI  309 (329)
T ss_dssp             EECSSCC
T ss_pred             EeCCCcc
Confidence            8876654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=6.7e-10  Score=106.96  Aligned_cols=145  Identities=12%  Similarity=0.188  Sum_probs=103.4

Q ss_pred             CCCceeccCceeEEEEEEcCCCcEEEEEEee--ccC-CccHHHHHHHHHHHhcCC--CCCceeEeeeeccccCCCCceeE
Q 041632          235 STNLIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQR-QGASKSFMAECKALKNIR--HKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       235 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~ei~~l~~l~--h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ..+.++.|.++.||+....  +..+++|+..  ... ......+.+|+++++.+.  +..+.+++..+....  ..+..+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeE
Confidence            3467899999999998864  4578888775  222 122356788999998886  445777777754321  113578


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC-------------------------
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC-------------------------  364 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------  364 (452)
                      +||||++|..+.+..             ...++..++..++.+++..|+.||+..                         
T Consensus       118 ~vme~v~G~~l~~~~-------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS-------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK  184 (359)
T ss_dssp             EEEECCCCBCCCCTT-------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCc-------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence            999999988775321             124677788889999999999999731                         


Q ss_pred             ------------------------------CCCeEecccCCCCeeecCCCc--eEECccccccc
Q 041632          365 ------------------------------QEPILHCDLKPSNILLDNDLS--AHIGDFGLSRF  396 (452)
Q Consensus       365 ------------------------------~~~ivH~Dlk~~Nill~~~~~--~kl~Dfgla~~  396 (452)
                                                    ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                          257999999999999997753  68999998874

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.02  E-value=3e-10  Score=107.99  Aligned_cols=127  Identities=13%  Similarity=0.128  Sum_probs=90.0

Q ss_pred             ccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc----c------------
Q 041632           17 ISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF----H------------   80 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l----~------------   80 (452)
                      +++| +.|+|.+ +++..-+.+|.++++|+.|++++|.+....+..|.++.++..+.++.+..    .            
T Consensus       100 ~~~L-~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~  177 (329)
T 3sb4_A          100 KQTL-EKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP  177 (329)
T ss_dssp             CTTC-CC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred             cCCC-cEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence            7888 8888888 78745556788889999999988888766667788777777776655321    0            


Q ss_pred             ----------ccCch---------------------------hh-hcccCCCeeecccccccCCcchhhcccc-cceeeC
Q 041632           81 ----------GSIPS---------------------------FF-RTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNL  121 (452)
Q Consensus        81 ----------~~~p~---------------------------~~-~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l  121 (452)
                                +.++.                           .+ ..+++|+.|+|++|+++.+++..|.... |+.|+|
T Consensus       178 L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l  257 (329)
T 3sb4_A          178 LETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL  257 (329)
T ss_dssp             CEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred             cceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence                      00111                           00 1378899999999999988888887664 999999


Q ss_pred             cccCCCCCCCcc-ccccccc-cccccc
Q 041632          122 SFNDFEGKVPTK-GIFANTS-AISVAG  146 (452)
Q Consensus       122 ~~N~l~~~~~~~-~~~~~l~-~l~~~~  146 (452)
                      .+| ++.+++.. ..+++|+ .+++.+
T Consensus       258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~  283 (329)
T 3sb4_A          258 PHN-LKTIGQRVFSNCGRLAGTLELPA  283 (329)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred             Ccc-cceehHHHhhCChhccEEEEEcc
Confidence            988 77666643 4566676 776655

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=2.1e-10  Score=107.79  Aligned_cols=192  Identities=16%  Similarity=0.120  Sum_probs=116.5

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCC--ceeEeeeeccccCCCCceeEEEE
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKN--LVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~n--iv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      .+.++.|....||+..     ..+++|+....  .....+.+|.++++.+ .+..  +.+++..+...  ......|+||
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEE
Confidence            4668999999999853     35788875422  3346788999999887 3333  33344332110  1112357899


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH-----------------------------  363 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------------------------  363 (452)
                      |+++|.++.....             ..++..++..++.+++..++.||+.                             
T Consensus        96 ~~i~G~~l~~~~~-------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (304)
T 3sg8_A           96 TKIKGVPLTPLLL-------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLS  162 (304)
T ss_dssp             ECCCCEECCHHHH-------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHT
T ss_pred             cccCCeECCcccc-------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhc
Confidence            9999988764321             2356666777777777777777751                             


Q ss_pred             --------------------------CCCCeEecccCCCCeeecC--CCceEECccccccccccCCCCceecc-------
Q 041632          364 --------------------------CQEPILHCDLKPSNILLDN--DLSAHIGDFGLSRFYQAVSNPTVSSS-------  408 (452)
Q Consensus       364 --------------------------~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~~~~~~~~~~~~-------  408 (452)
                                                ..+.++|+|++|.||++++  +..+.|+||+.+...+...+......       
T Consensus       163 ~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~  242 (304)
T 3sg8_A          163 RELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGM  242 (304)
T ss_dssp             TTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCH
T ss_pred             ccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCH
Confidence                                      1246899999999999998  45678999998864332100000000       


Q ss_pred             ---ccccccccccC-ccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          409 ---IGVRGTIGYVA-PEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       409 ---~~~~gt~~y~a-PE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                         .......+... |+...  ......+.|++|.++|++.+|..||
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               00000000111 11111  1122258999999999999998765

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.99  E-value=4.5e-11  Score=115.48  Aligned_cols=127  Identities=18%  Similarity=0.191  Sum_probs=96.4

Q ss_pred             CCCCcccccCCcccc-cccCcccEEEccCCccccCCCcCC-----cCCCCCCEEEccCccccc----cCCccccCCCCCC
Q 041632            1 MFENDLSGTIPEAIF-SISYLSNSLNLAENHFVGSIPPRI-----GNLKALRSFDVSNNGLSG----EIPIELGLCSSLE   70 (452)
Q Consensus         1 l~~N~l~~~~p~~~~-~l~~l~~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~   70 (452)
                      |++|+|+..-...+. .+.+| +.|+|++|+|+..-...+     ...++|+.|+|++|.|+.    .++..+..+++|+
T Consensus       108 Ls~n~l~~~~~~~l~~~L~~L-~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~  186 (372)
T 3un9_A          108 LASCQLDPAGLRTLLPVFLRA-RKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT  186 (372)
T ss_dssp             CTTCCCCHHHHHHTHHHHHTE-EEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCC
T ss_pred             ecCCCCCHHHHHHHHHHHHhc-cHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcC
Confidence            578888754334443 46778 999999999975433444     356899999999999974    3555668899999


Q ss_pred             EEEccCcccccc----CchhhhcccCCCeeecccccccCCcch----hh-cccccceeeCcccCCCC
Q 041632           71 DIYLGGNFFHGS----IPSFFRTSRGIRKLDLSRNNLSGQIPL----FL-EALSLEYLNLSFNDFEG  128 (452)
Q Consensus        71 ~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~----~~-~~~~L~~l~l~~N~l~~  128 (452)
                      +|+|++|+|++.    ++..+...++|+.|+|++|.|+.....    .+ .+.+|++|+|++|.|+.
T Consensus       187 ~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          187 HLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             EEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             EEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            999999999843    356677889999999999999864322    22 23459999999999874

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.74  E-value=3.6e-09  Score=96.37  Aligned_cols=103  Identities=20%  Similarity=0.215  Sum_probs=70.3

Q ss_pred             cccccCcccE--EEccCCccccCCCc----CCcCCCCCCEEEccCccccc--cCCccccCCCCCCEEEccCccccccCch
Q 041632           14 IFSISYLSNS--LNLAENHFVGSIPP----RIGNLKALRSFDVSNNGLSG--EIPIELGLCSSLEDIYLGGNFFHGSIPS   85 (452)
Q Consensus        14 ~~~l~~l~~~--L~l~~n~l~~~~p~----~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~   85 (452)
                      +...+.| ..  ++++.|+.. .++.    ...++++|+.|+|++|+|++  .+|+.+..+++|+.|+|++|+|++.  .
T Consensus       137 l~~dp~L-~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~  212 (267)
T 3rw6_A          137 LRSDPDL-VAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--R  212 (267)
T ss_dssp             GGGCHHH-HHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--G
T ss_pred             cCCCcch-hhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--h
Confidence            4455555 44  677888544 3332    22568889999999999886  4556777889999999999998844  3


Q ss_pred             hhhccc--CCCeeecccccccCCcc-------hhhccc-ccceee
Q 041632           86 FFRTSR--GIRKLDLSRNNLSGQIP-------LFLEAL-SLEYLN  120 (452)
Q Consensus        86 ~~~~l~--~L~~l~l~~N~l~~~~~-------~~~~~~-~L~~l~  120 (452)
                      .+..+.  +|+.|+|++|.+.+..|       ..+... +|+.||
T Consensus       213 ~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          213 ELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             GGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             hhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            344444  88999999999886443       223333 377775

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.71  E-value=1.6e-09  Score=111.36  Aligned_cols=132  Identities=12%  Similarity=0.081  Sum_probs=97.8

Q ss_pred             ccccCcccEEEccCCccccC----CCcCCcCCCCCCEEEccCcccc----ccCCccccCCCCCCEEEccCccccccCchh
Q 041632           15 FSISYLSNSLNLAENHFVGS----IPPRIGNLKALRSFDVSNNGLS----GEIPIELGLCSSLEDIYLGGNFFHGSIPSF   86 (452)
Q Consensus        15 ~~l~~l~~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~   86 (452)
                      ..+++| ++|+|++|.+++.    ++..+..+++|+.|++++|.++    +.++..+..+++|+.|+|++|.+. .+|..
T Consensus       161 ~~~~~L-~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~  238 (592)
T 3ogk_B          161 THCRKI-KTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGF  238 (592)
T ss_dssp             HHCTTC-SEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHH
T ss_pred             hhCCCC-CEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHH
Confidence            367888 9999999998755    3445567899999999999997    345556678999999999999998 57889


Q ss_pred             hhcccCCCeeecccccccC----CcchhhcccccceeeCcccCCCCCCCccccccccccccccccc
Q 041632           87 FRTSRGIRKLDLSRNNLSG----QIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCH  148 (452)
Q Consensus        87 ~~~l~~L~~l~l~~N~l~~----~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~  148 (452)
                      +..+++|+.|+++++....    .......+.+|+.|+++++.....+.....+++|+.|++++|.
T Consensus       239 ~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~  304 (592)
T 3ogk_B          239 FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYAL  304 (592)
T ss_dssp             HHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCC
T ss_pred             HhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCc
Confidence            9999999999998643221    1112222334778888776655555555667788888887776

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.70  E-value=5.2e-09  Score=107.57  Aligned_cols=145  Identities=12%  Similarity=0.078  Sum_probs=104.5

Q ss_pred             CCCcccccCCcccccc-c-CcccEEEccCCc-ccc-CCCcCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEE
Q 041632            2 FENDLSGTIPEAIFSI-S-YLSNSLNLAENH-FVG-SIPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSSLEDIY   73 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l-~-~l~~~L~l~~n~-l~~-~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~   73 (452)
                      ++|.+++..+..+... + +| ++|+|++|. ++. .++....++++|++|+|++|.+++.    ++..+..+++|+.|+
T Consensus       120 ~~~~i~~~~~~~l~~~~~~~L-~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~  198 (592)
T 3ogk_B          120 RRMIVSDLDLDRLAKARADDL-ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLN  198 (592)
T ss_dssp             ESCBCCHHHHHHHHHHHGGGC-CEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEE
T ss_pred             eccEecHHHHHHHHHhccccC-cEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEE
Confidence            4566666666666664 3 47 999999987 321 1233335789999999999998755    444556789999999


Q ss_pred             ccCcccc----ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCC----CCCCcccccccccccccc
Q 041632           74 LGGNFFH----GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFE----GKVPTKGIFANTSAISVA  145 (452)
Q Consensus        74 l~~N~l~----~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~----~~~~~~~~~~~l~~l~~~  145 (452)
                      |++|.++    +.++..+..+++|+.|+|++|.+.+++.....+.+|++|+++.+...    ..+..+..+++|+.+.++
T Consensus       199 L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~  278 (592)
T 3ogk_B          199 FYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLS  278 (592)
T ss_dssp             CTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEET
T ss_pred             eeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcc
Confidence            9999997    35566677899999999999999986655445555999999864322    122234667788888776


Q ss_pred             cc
Q 041632          146 GC  147 (452)
Q Consensus       146 ~n  147 (452)
                      ++
T Consensus       279 ~~  280 (592)
T 3ogk_B          279 YM  280 (592)
T ss_dssp             TC
T ss_pred             cc
Confidence            64

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.69  E-value=3.1e-09  Score=91.98  Aligned_cols=113  Identities=13%  Similarity=0.216  Sum_probs=67.9

Q ss_pred             cccccCcccEEEccCC-cccc----CCCcCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEEccCcccccc--
Q 041632           14 IFSISYLSNSLNLAEN-HFVG----SIPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSSLEDIYLGGNFFHGS--   82 (452)
Q Consensus        14 ~~~l~~l~~~L~l~~n-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--   82 (452)
                      +...+.| ++|+|++| .|..    .+...+...++|++|+|++|+|...    +.+.+...++|++|+|++|.|+..  
T Consensus        32 l~~~~~L-~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           32 QNNDPDL-EEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HTTCTTC-CEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HhcCCCC-CEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            3345566 77777777 6652    1334455667777777777777532    344455566777777777777632  


Q ss_pred             --CchhhhcccCCCeeec--ccccccCCc----chhh-cccccceeeCcccCCC
Q 041632           83 --IPSFFRTSRGIRKLDL--SRNNLSGQI----PLFL-EALSLEYLNLSFNDFE  127 (452)
Q Consensus        83 --~p~~~~~l~~L~~l~l--~~N~l~~~~----~~~~-~~~~L~~l~l~~N~l~  127 (452)
                        +...+...++|+.|+|  ++|.|...-    ...+ ...+|++|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              3445556667777777  667776421    1111 2234777777777653

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.67  E-value=2.7e-09  Score=97.18  Aligned_cols=119  Identities=18%  Similarity=0.139  Sum_probs=82.8

Q ss_pred             EEccCCccccCCCc-CCcCCCCCCE--EEccCccccccCCcc----ccCCCCCCEEEccCccccc--cCchhhhcccCCC
Q 041632           24 LNLAENHFVGSIPP-RIGNLKALRS--FDVSNNGLSGEIPIE----LGLCSSLEDIYLGGNFFHG--SIPSFFRTSRGIR   94 (452)
Q Consensus        24 L~l~~n~l~~~~p~-~~~~l~~L~~--L~l~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~   94 (452)
                      |...+|.-++.++- .|...+.|..  ++++.|+.. .++..    ..++++|+.|+|++|+|++  .+|..+..+++|+
T Consensus       121 l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~  199 (267)
T 3rw6_A          121 MSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK  199 (267)
T ss_dssp             HHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCC
T ss_pred             HHhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCC
Confidence            44455555444442 2555555665  678888554 34432    3568999999999999996  4567888999999


Q ss_pred             eeecccccccCCcc-hhhcccccceeeCcccCCCCCCCc--------ccccccccccc
Q 041632           95 KLDLSRNNLSGQIP-LFLEALSLEYLNLSFNDFEGKVPT--------KGIFANTSAIS  143 (452)
Q Consensus        95 ~l~l~~N~l~~~~~-~~~~~~~L~~l~l~~N~l~~~~~~--------~~~~~~l~~l~  143 (452)
                      .|+|++|+|++... ..+..+.|++|+|++|.+++..|.        ...|++|+.|+
T Consensus       200 ~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          200 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             EEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             EEECCCCccCCchhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            99999999998622 222223799999999999875442        35577777664

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.58  E-value=1.3e-07  Score=92.04  Aligned_cols=61  Identities=10%  Similarity=0.094  Sum_probs=30.9

Q ss_pred             chhhhcccCCCeeeccccccc-----CCcchhhccc-ccceeeCcccCCCCCCCcc-cccccccccccc
Q 041632           84 PSFFRTSRGIRKLDLSRNNLS-----GQIPLFLEAL-SLEYLNLSFNDFEGKVPTK-GIFANTSAISVA  145 (452)
Q Consensus        84 p~~~~~l~~L~~l~l~~N~l~-----~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~  145 (452)
                      +.+|.+|++|+.+++.+|.+.     .+.+..|... +|+.++|. |.++.+.... ..+++|+.+.+.
T Consensus       264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp  331 (401)
T 4fdw_A          264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIP  331 (401)
T ss_dssp             TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEEC
T ss_pred             hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEEC
Confidence            445666666666666666554     3444444433 36666665 3344443322 223445555443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.56  E-value=2.6e-09  Score=109.90  Aligned_cols=129  Identities=16%  Similarity=0.199  Sum_probs=67.9

Q ss_pred             ccCcccEEEccCCccccCCCcCCc-CCCCCCEEEcc--C----ccccccCC------ccccCCCCCCEEEccCccccccC
Q 041632           17 ISYLSNSLNLAENHFVGSIPPRIG-NLKALRSFDVS--N----NGLSGEIP------IELGLCSSLEDIYLGGNFFHGSI   83 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~~~~p------~~~~~l~~L~~L~l~~N~l~~~~   83 (452)
                      +++| +.|+++.|++++..+..+. .+++|+.|+++  +    |.++ ..|      .-+..+++|+.|+|++ .+++..
T Consensus       371 ~~~L-~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~  447 (594)
T 2p1m_B          371 CPKL-ESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV  447 (594)
T ss_dssp             CTTC-CEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred             chhH-HHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence            4555 6666666666544444443 35666666666  3    4444 121      1144566666666655 454444


Q ss_pred             chhhhc-ccCCCeeecccccccCCcchhh-c-ccccceeeCcccCCCCCCC--ccccccccccccccccc
Q 041632           84 PSFFRT-SRGIRKLDLSRNNLSGQIPLFL-E-ALSLEYLNLSFNDFEGKVP--TKGIFANTSAISVAGCH  148 (452)
Q Consensus        84 p~~~~~-l~~L~~l~l~~N~l~~~~~~~~-~-~~~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~~~n~  148 (452)
                      +..+.. +++|+.|+|++|.+++.....+ . +.+|+.|+|++|.++....  ....+++|+.|++++|+
T Consensus       448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~  517 (594)
T 2p1m_B          448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS  517 (594)
T ss_dssp             HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred             HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence            444444 6666777776666654322211 2 3346777777766632211  12335666666666654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.48  E-value=1.6e-08  Score=103.98  Aligned_cols=86  Identities=16%  Similarity=0.247  Sum_probs=44.7

Q ss_pred             cccCcccEEEccCCccccCCCcCCc-CCCCCCEEEccCc-ccccc-CCccccCCCCCCEEEccCccccccCchhhh----
Q 041632           16 SISYLSNSLNLAENHFVGSIPPRIG-NLKALRSFDVSNN-GLSGE-IPIELGLCSSLEDIYLGGNFFHGSIPSFFR----   88 (452)
Q Consensus        16 ~l~~l~~~L~l~~n~l~~~~p~~~~-~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~----   88 (452)
                      .+++| ++|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+.    
T Consensus       103 ~~~~L-~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~  181 (594)
T 2p1m_B          103 SYTWL-EEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD  181 (594)
T ss_dssp             HCTTC-CEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred             hCCCC-CeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence            34555 6666666666544444443 4566666666665 34321 333333556666666666665543333332    


Q ss_pred             cccCCCeeeccccc
Q 041632           89 TSRGIRKLDLSRNN  102 (452)
Q Consensus        89 ~l~~L~~l~l~~N~  102 (452)
                      .+++|+.|++++|.
T Consensus       182 ~~~~L~~L~l~~~~  195 (594)
T 2p1m_B          182 TYTSLVSLNISCLA  195 (594)
T ss_dssp             TCCCCCEEECTTCC
T ss_pred             cCCcCcEEEecccC
Confidence            34455666665554

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.47  E-value=3.6e-07  Score=88.92  Aligned_cols=122  Identities=10%  Similarity=0.119  Sum_probs=62.0

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      +.+.|.+ .++..-+.+|.++++|+.++|++|+++ .+|.....+.+|+.+.|.+| ++..-..+|.+|++|+.+++.+|
T Consensus       160 ~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~  236 (401)
T 4fdw_A          160 QEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN  236 (401)
T ss_dssp             CEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT
T ss_pred             eEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC
Confidence            4555543 444233345555566666666655555 33333223455666666533 44344445666666666666553


Q ss_pred             cccCCcchhhcccccceeeCcccCCCCCCCcc-ccccccccccccccc
Q 041632          102 NLSGQIPLFLEALSLEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCH  148 (452)
Q Consensus       102 ~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~  148 (452)
                       ++.+....|...+|+.+.+ .|.++.+.... ..+++|+.+.+.+|.
T Consensus       237 -l~~I~~~aF~~~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~  282 (401)
T 4fdw_A          237 -VSTIGQEAFRESGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGST  282 (401)
T ss_dssp             -CCEECTTTTTTCCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSC
T ss_pred             -ccCccccccccCCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcc
Confidence             4445555555544666666 33344443322 334555555555543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.44  E-value=6.8e-08  Score=92.52  Aligned_cols=83  Identities=14%  Similarity=0.139  Sum_probs=38.4

Q ss_pred             cccccccCcccEEEccCCccc---------cCCCcCCcCCCCCCEEEccCcc-ccccCCccccCCCCCCEEEccCccccc
Q 041632           12 EAIFSISYLSNSLNLAENHFV---------GSIPPRIGNLKALRSFDVSNNG-LSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus        12 ~~~~~l~~l~~~L~l~~n~l~---------~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      +++..+++| +.|.+..+...         +.++..+..+++|+.|+|++|. +  .++. +. +++|+.|+|..|.+..
T Consensus       133 ~s~~~l~~L-~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l--~l~~-~~-~~~L~~L~L~~~~l~~  207 (362)
T 2ra8_A          133 ENKEKFAHF-EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL--SIGK-KP-RPNLKSLEIISGGLPD  207 (362)
T ss_dssp             TTHHHHTTC-SEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC--BCCS-CB-CTTCSEEEEECSBCCH
T ss_pred             Hhhhhcchh-hheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc--eecc-cc-CCCCcEEEEecCCCCh
Confidence            334455555 56655443321         1122334455566666665552 2  1222 22 5556666665555542


Q ss_pred             cCchhhh--cccCCCeeecc
Q 041632           82 SIPSFFR--TSRGIRKLDLS   99 (452)
Q Consensus        82 ~~p~~~~--~l~~L~~l~l~   99 (452)
                      .....+.  .+++|+.|+|+
T Consensus       208 ~~l~~l~~~~lp~L~~L~L~  227 (362)
T 2ra8_A          208 SVVEDILGSDLPNLEKLVLY  227 (362)
T ss_dssp             HHHHHHHHSBCTTCCEEEEE
T ss_pred             HHHHHHHHccCCCCcEEEEe
Confidence            2222332  45555555553

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.43  E-value=4.7e-08  Score=84.48  Aligned_cols=114  Identities=12%  Similarity=0.091  Sum_probs=83.1

Q ss_pred             CCcCCcCCCCCCEEEccCc-cccc----cCCccccCCCCCCEEEccCcccccc----CchhhhcccCCCeeecccccccC
Q 041632           35 IPPRIGNLKALRSFDVSNN-GLSG----EIPIELGLCSSLEDIYLGGNFFHGS----IPSFFRTSRGIRKLDLSRNNLSG  105 (452)
Q Consensus        35 ~p~~~~~l~~L~~L~l~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~  105 (452)
                      +...+...+.|++|+|++| .+..    .+...+...++|++|+|++|+|...    +...+...++|+.|+|++|.|..
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            3445678899999999999 8874    2556677889999999999999742    34566677899999999999986


Q ss_pred             Cc----chhhc-ccccceeeC--cccCCCCCC-----Cccccccccccccccccc
Q 041632          106 QI----PLFLE-ALSLEYLNL--SFNDFEGKV-----PTKGIFANTSAISVAGCH  148 (452)
Q Consensus       106 ~~----~~~~~-~~~L~~l~l--~~N~l~~~~-----~~~~~~~~l~~l~~~~n~  148 (452)
                      .-    ...+. ..+|++|+|  ++|.|...-     ..+...++|+.|++++|.
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~  162 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  162 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence            31    22223 345999999  889986421     112334678888887664

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.40  E-value=9.3e-07  Score=81.15  Aligned_cols=137  Identities=16%  Similarity=0.081  Sum_probs=90.6

Q ss_pred             ceeccCce-eEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeEEEEecc
Q 041632          238 LIGVGSFG-SVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       238 ~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      .+..|..+ .||+.....++..+++|+-..   +...++.+|.+.|+.+. +--+.++++++.     +.+..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEee
Confidence            45556555 689887766777889998652   34467888999888773 222455666543     235679999999


Q ss_pred             CCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 041632          316 PNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC-------------------------------  364 (452)
Q Consensus       316 ~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  364 (452)
                      ++.++.+.....               ......++.+++..|+-||+..                               
T Consensus       103 ~G~~~~~~~~~~---------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (272)
T 4gkh_A          103 PGKTAFQVLEEY---------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF  167 (272)
T ss_dssp             CSEEHHHHHHHC---------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred             CCccccccccCC---------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence            988876543211               0112234444555555555321                               


Q ss_pred             ------------------------CCCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          365 ------------------------QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       365 ------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                                              ...++|+|+.+.||++++++.+-|+||+.+...
T Consensus       168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                                    124799999999999998877789999988643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.38  E-value=1.2e-06  Score=82.10  Aligned_cols=139  Identities=15%  Similarity=0.126  Sum_probs=88.7

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCC---CceeEeeeeccccCCCCceeEEEE
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK---NLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      .+.++.|....||+.     |..+++|+-.  .......+.+|.++++.+.+.   .+.+++.++.    ...+..+++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~   92 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGY   92 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEE
Confidence            356788888899986     3557888742  223346788999999998653   2445554432    1234568999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH-----------------------------  363 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------------------------  363 (452)
                      ||++|.++.....             ..++..+...++.+++..|+.||+.                             
T Consensus        93 e~i~G~~l~~~~~-------------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~  159 (306)
T 3tdw_A           93 RKVQGQILGEDGM-------------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQ  159 (306)
T ss_dssp             ECCCSEECHHHHH-------------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHH
T ss_pred             eccCCeECchhhh-------------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHh
Confidence            9999988865321             1122333333444444444444432                             


Q ss_pred             ----------------------------CCCCeEecccCCCCeeecC---CCc-eEECccccccccc
Q 041632          364 ----------------------------CQEPILHCDLKPSNILLDN---DLS-AHIGDFGLSRFYQ  398 (452)
Q Consensus       364 ----------------------------~~~~ivH~Dlk~~Nill~~---~~~-~kl~Dfgla~~~~  398 (452)
                                                  ..+.++|+|+++.||+++.   ++. +.|+||+.+..-+
T Consensus       160 ~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          160 VFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             TGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             cccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                        2346799999999999997   455 4899999876443

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.14  E-value=9.2e-07  Score=84.64  Aligned_cols=136  Identities=15%  Similarity=0.153  Sum_probs=92.3

Q ss_pred             CCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCcccc--CCCCCCEEEccC--cccccc---
Q 041632           10 IPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG--LCSSLEDIYLGG--NFFHGS---   82 (452)
Q Consensus        10 ~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~---   82 (452)
                      ++..+..+++| +.|+|++|.-. .++. +. +++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.   
T Consensus       164 L~~ll~~~P~L-~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          164 LSPVLDAMPLL-NNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             CHHHHHTCTTC-CEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred             HHHHHhcCCCC-cEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence            33445667888 99999988412 3443 43 89999999999988754444444  789999999863  322111   


Q ss_pred             --Cchhh--hcccCCCeeecccccccCCcch-hh---cccccceeeCcccCCCCC-----CCcccccccccccccccccc
Q 041632           83 --IPSFF--RTSRGIRKLDLSRNNLSGQIPL-FL---EALSLEYLNLSFNDFEGK-----VPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        83 --~p~~~--~~l~~L~~l~l~~N~l~~~~~~-~~---~~~~L~~l~l~~N~l~~~-----~~~~~~~~~l~~l~~~~n~~  149 (452)
                        +...+  ..+++|+.|+|++|.+....+. ..   .+..|++|+|+.|.++..     +..+..+++|+.|++++|+.
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i  319 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL  319 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence              11222  2478999999999998753322 22   233599999999998752     22335678999999987753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.13  E-value=4.3e-06  Score=80.00  Aligned_cols=84  Identities=7%  Similarity=-0.053  Sum_probs=52.3

Q ss_pred             Cce-eccCceeEEEEEEc--C----CCcEEEEEEeeccC---CccHHHHHHHHHHHhcCC-C--CCceeEeeeeccccCC
Q 041632          237 NLI-GVGSFGSVYKGVFD--E----DGTVVAIKVINLQR---QGASKSFMAECKALKNIR-H--KNLVRVITSCSSVDFQ  303 (452)
Q Consensus       237 ~~l-g~G~~g~Vy~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~ei~~l~~l~-h--~niv~l~~~~~~~~~~  303 (452)
                      +.| +.|....+|+....  .    +++.+++|+.....   ......+.+|+++++.+. +  -.+.+++.++..... 
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~-  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV-  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence            456 78888999987753  1    15678888765322   111245678888887773 2  245666665432211 


Q ss_pred             CCceeEEEEeccCCCChhh
Q 041632          304 GNDFKAIVYKYMPNGSLEK  322 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~  322 (452)
                       .+..++||||++|..+.+
T Consensus       105 -~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 -LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             -TSSCEEEEECCCCBCCCB
T ss_pred             -cCCceEEEEecCCCChhh
Confidence             134579999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=7.6e-06  Score=79.55  Aligned_cols=76  Identities=18%  Similarity=0.115  Sum_probs=47.4

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-------ccHHHHHHHHHHHhcCCC--CC-ceeEeeeeccccCCCC
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-------GASKSFMAECKALKNIRH--KN-LVRVITSCSSVDFQGN  305 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~ei~~l~~l~h--~n-iv~l~~~~~~~~~~~~  305 (452)
                      .+.+|.|..+.||++....+++.++||.......       ...+.+..|.++++.+..  |. +.+++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            4578999999999997655677899998642211       123456788888887632  33 33454431       1


Q ss_pred             ceeEEEEeccCCC
Q 041632          306 DFKAIVYKYMPNG  318 (452)
Q Consensus       306 ~~~~lv~e~~~~g  318 (452)
                      +..++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2357999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.90  E-value=4.7e-05  Score=72.11  Aligned_cols=43  Identities=21%  Similarity=0.148  Sum_probs=34.1

Q ss_pred             HHHHHHHHhc----------CCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          353 VASALDYLHQ----------HCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       353 i~~~l~~LH~----------~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      +..++++|++          .....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       199 ~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          199 GLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4446666653          123589999999999999888899999999875

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.82  E-value=6.1e-06  Score=69.73  Aligned_cols=83  Identities=11%  Similarity=0.044  Sum_probs=44.7

Q ss_pred             CCCCEEEccCccccccCCccccCCCCCCEEEccCcc-ccccCchhhhcc----cCCCeeeccccc-ccCCc-chhhcccc
Q 041632           43 KALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNF-FHGSIPSFFRTS----RGIRKLDLSRNN-LSGQI-PLFLEALS  115 (452)
Q Consensus        43 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~l~l~~N~-l~~~~-~~~~~~~~  115 (452)
                      .+|+.||++++.++..--..+..|++|+.|+|+++. |++.--..++.+    ++|+.|+|+++. ++..- .....+.+
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356666776666654433445666777777776663 553222334332    357777776653 54421 11223334


Q ss_pred             cceeeCcccC
Q 041632          116 LEYLNLSFND  125 (452)
Q Consensus       116 L~~l~l~~N~  125 (452)
                      |++|+++++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777777654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.73  E-value=6.5e-05  Score=72.85  Aligned_cols=107  Identities=14%  Similarity=0.157  Sum_probs=57.9

Q ss_pred             cccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCC
Q 041632           14 IFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI   93 (452)
Q Consensus        14 ~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   93 (452)
                      |..+..| +.+.+.++..+ .-..+|.++++|+.+.+. +.++..-...|.+|.+|+.++|..| ++.+-..+|.+|.+|
T Consensus       261 F~~c~~L-~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L  336 (394)
T 4gt6_A          261 FDSCAYL-ASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL  336 (394)
T ss_dssp             TTTCSSC-CEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred             eeecccc-cEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence            4444555 56666554443 444556666666666664 3344233445666666666666544 442334566666666


Q ss_pred             CeeecccccccCCcchhhccc-ccceeeCcccC
Q 041632           94 RKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFND  125 (452)
Q Consensus        94 ~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~  125 (452)
                      +.+.+..+ ++.+....|... +|+.+++.+|.
T Consensus       337 ~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          337 ERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             CEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred             CEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence            66666433 555555555433 36666665553

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.69  E-value=0.00013  Score=67.29  Aligned_cols=78  Identities=14%  Similarity=0.132  Sum_probs=54.9

Q ss_pred             CCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCC---CceeEeeeeccccCCCCceeE
Q 041632          233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHK---NLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       233 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~---niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ....+.+|.|..+.||+.+.. +|+.|++|+-..........|..|.+.|+.+.-.   -+.++++..         ..+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~   86 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT   86 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence            344567899999999999885 7899999987654444446788999888877321   234444431         237


Q ss_pred             EEEeccCCCCh
Q 041632          310 IVYKYMPNGSL  320 (452)
Q Consensus       310 lv~e~~~~gsL  320 (452)
                      +||||.+++..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            89999987654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.55  E-value=2e-05  Score=67.88  Aligned_cols=63  Identities=19%  Similarity=0.236  Sum_probs=27.6

Q ss_pred             CCCCCEEEccCc-cccc----cCCccccCCCCCCEEEccCcccccc----CchhhhcccCCCeeeccccccc
Q 041632           42 LKALRSFDVSNN-GLSG----EIPIELGLCSSLEDIYLGGNFFHGS----IPSFFRTSRGIRKLDLSRNNLS  104 (452)
Q Consensus        42 l~~L~~L~l~~N-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~  104 (452)
                      -+.|++|+|++| +|..    .+.+.+..-+.|+.|+|++|+|...    +-..+..-+.|+.|+|++|.|.
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            344555555443 4431    1233344444555555555555421    1223333345555555555554

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.55  E-value=4.8e-05  Score=64.20  Aligned_cols=83  Identities=8%  Similarity=0.021  Sum_probs=49.5

Q ss_pred             CcccEEEccCCccccCCCcCCcCCCCCCEEEccCcc-ccccCCccccCC----CCCCEEEccCc-cccccCchhhhcccC
Q 041632           19 YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNG-LSGEIPIELGLC----SSLEDIYLGGN-FFHGSIPSFFRTSRG   92 (452)
Q Consensus        19 ~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N-~l~~~~p~~~~~l~~   92 (452)
                      .| +.|||+++.|+..-=..+..+++|+.|+|+++. ++..-=..+..+    ++|++|+|+++ +|+..--..+..+++
T Consensus        62 ~L-~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           62 KI-QAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CE-EEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             eE-eEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            45 677777777664433456677777777777763 553222234433    35777777776 365433345566777


Q ss_pred             CCeeeccccc
Q 041632           93 IRKLDLSRNN  102 (452)
Q Consensus        93 L~~l~l~~N~  102 (452)
                      |+.|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777777654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.54  E-value=0.00042  Score=64.61  Aligned_cols=146  Identities=15%  Similarity=0.089  Sum_probs=88.3

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC---CCCceeEeeeeccccCCCCceeEEEE
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR---HKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~---h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      .+.|+.|....+|+...  ++..+++|+....   ....+..|.+.|+.+.   ...+.+++.++..     .+..++||
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvm  110 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLL  110 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEE
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEE
Confidence            45789999999999875  4667888987532   3567888988888773   2456677766432     34689999


Q ss_pred             eccCCCChhh-----------hhcCCCC-CC--cccc--------cccccCCHHHHH---HHHH----------------
Q 041632          313 KYMPNGSLEK-----------WLHPDAI-PQ--RDRE--------IEIQKLTLLQRI---SIAI----------------  351 (452)
Q Consensus       313 e~~~~gsL~~-----------~l~~~~~-~~--~~~~--------~~~~~l~~~~~~---~i~~----------------  351 (452)
                      ||+++..+..           .|+.... ..  ....        .....-+|....   ++..                
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            9999886521           1222111 00  0000        001122444321   1111                


Q ss_pred             HHH-HHHHHHhc-CCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          352 DVA-SALDYLHQ-HCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       352 ~i~-~~l~~LH~-~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      .++ .....|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111 11223432 2357899999999999999887 8899984

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.38  E-value=0.00025  Score=56.93  Aligned_cols=55  Identities=18%  Similarity=0.231  Sum_probs=23.3

Q ss_pred             EEEccCCccc-cCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632           23 SLNLAENHFV-GSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus        23 ~L~l~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      .++.++++|+ ..+|..+.  ++|+.|+|++|+|+..-++.|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            3455555553 23443221  1344444444444422223334444444444444433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.38  E-value=0.00035  Score=67.64  Aligned_cols=109  Identities=13%  Similarity=0.182  Sum_probs=76.4

Q ss_pred             cccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhccc
Q 041632           12 EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSR   91 (452)
Q Consensus        12 ~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~   91 (452)
                      .+|.++..| +.+.+. +.++..-..+|.++.+|+.++|..| ++..-..+|.+|.+|+.+.|..+ ++.+-..+|.+|+
T Consensus       282 ~aF~~c~~L-~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~  357 (394)
T 4gt6_A          282 GAFMNCPAL-QDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCT  357 (394)
T ss_dssp             TTTTTCTTC-CEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCT
T ss_pred             ccccccccc-ccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCC
Confidence            356677888 899996 5566355578999999999999875 66455678999999999999866 6645567999999


Q ss_pred             CCCeeecccccccCCcchhhcccccceeeCcccCC
Q 041632           92 GIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDF  126 (452)
Q Consensus        92 ~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l  126 (452)
                      +|+.+++.+|....  ..++.+..|+.+.+..|.+
T Consensus       358 ~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          358 ALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TCCEEEESSCHHHH--HTCBCCCCC----------
T ss_pred             CCCEEEECCceeeh--hhhhccCCCCEEEeCCCCE
Confidence            99999999886542  2344455588887766654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.37  E-value=0.00028  Score=68.92  Aligned_cols=31  Identities=19%  Similarity=0.387  Sum_probs=27.5

Q ss_pred             CCeEecccCCCCeeecCCCceEECcccccccc
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSRFY  397 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  397 (452)
                      ..++|+|+++.|||++.++ ++|+||+.+..-
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            5899999999999999876 999999988643

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.32  E-value=0.00037  Score=55.89  Aligned_cols=57  Identities=19%  Similarity=0.347  Sum_probs=47.6

Q ss_pred             CEEEccCcccc-ccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeeccccccc
Q 041632           46 RSFDVSNNGLS-GEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLS  104 (452)
Q Consensus        46 ~~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  104 (452)
                      ..++.++++++ ..+|..+.  ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            47899999986 35776554  57999999999999555667899999999999999875

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.31  E-value=0.00099  Score=63.97  Aligned_cols=127  Identities=12%  Similarity=0.080  Sum_probs=76.4

Q ss_pred             cccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCC
Q 041632           14 IFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI   93 (452)
Q Consensus        14 ~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   93 (452)
                      +.....+ +.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-..+|.+|.+|
T Consensus       213 f~~~~~l-~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L  288 (379)
T 4h09_A          213 FSYGKNL-KKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL  288 (379)
T ss_dssp             TTTCSSC-SEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred             ccccccc-ceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence            3444555 56666544 33244556777777777777665 44344556777777777777654 442444567777778


Q ss_pred             CeeecccccccCCcchhhccc-ccceeeCcccCCCCCCCcc-cccccccccccc
Q 041632           94 RKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFNDFEGKVPTK-GIFANTSAISVA  145 (452)
Q Consensus        94 ~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~  145 (452)
                      +.+.+.++.++.+.+..|... +|+.+.|..+ ++.+.... ..+++|+.+.+.
T Consensus       289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            887777777777666666543 4777777643 44343322 234455555543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.31  E-value=0.00068  Score=65.10  Aligned_cols=110  Identities=13%  Similarity=0.173  Sum_probs=86.7

Q ss_pred             CcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcc
Q 041632           11 PEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTS   90 (452)
Q Consensus        11 p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l   90 (452)
                      ...+..+..| +.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-...|.+|.+|+.+.+.++.++..-+.+|.+|
T Consensus       233 ~~~f~~~~~L-~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c  309 (379)
T 4h09_A          233 DGAFYGMKAL-DEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDC  309 (379)
T ss_dssp             TTTTTTCSSC-CEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTC
T ss_pred             cccccCCccc-eEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCC
Confidence            3456677888 89999876 66355678999999999999765 553555678999999999999999985666799999


Q ss_pred             cCCCeeecccccccCCcchhhcc-cccceeeCccc
Q 041632           91 RGIRKLDLSRNNLSGQIPLFLEA-LSLEYLNLSFN  124 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~~~~~~-~~L~~l~l~~N  124 (452)
                      .+|+.+.|.++ ++.+....|.. .+|+.+.+..+
T Consensus       310 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          310 VKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             TTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             CCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            99999999765 77777777765 45998887644

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.26  E-value=0.0011  Score=64.18  Aligned_cols=123  Identities=14%  Similarity=0.070  Sum_probs=68.3

Q ss_pred             cccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           16 SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        16 ~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      .+..+ +.+.+..+..+ .-..+|..+..|+.+.+..+.+   ....|..+.+|+.+.+.++ ++.+-..+|.+|.+|+.
T Consensus       251 ~~~~l-~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~  324 (394)
T 4fs7_A          251 GCTDL-ESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVS  324 (394)
T ss_dssp             TCSSC-CEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred             ccccc-eeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCE
Confidence            34444 45555544433 3444555555555555544432   2234666777777777654 44344556777777777


Q ss_pred             eecccccccCCcchhhcc-cccceeeCcccCCCCCCCcc-ccccccccccccc
Q 041632           96 LDLSRNNLSGQIPLFLEA-LSLEYLNLSFNDFEGKVPTK-GIFANTSAISVAG  146 (452)
Q Consensus        96 l~l~~N~l~~~~~~~~~~-~~L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~  146 (452)
                      ++|.++ ++.+....|.. .+|+.+++..| ++.+.... ..+++|+.+++..
T Consensus       325 i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~  375 (394)
T 4fs7_A          325 IDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK  375 (394)
T ss_dssp             ECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred             EEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence            777543 66666666654 34777777655 55444332 3345566665543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.24  E-value=0.0013  Score=60.93  Aligned_cols=31  Identities=29%  Similarity=0.329  Sum_probs=26.0

Q ss_pred             CCCeEecccCCCCeeecCCCceEECccccccc
Q 041632          365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       365 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                      ...++|+|+.+.||+ .+++.+.++||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            346899999999999 5667789999998764

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.20  E-value=0.00082  Score=64.96  Aligned_cols=107  Identities=12%  Similarity=0.050  Sum_probs=82.8

Q ss_pred             CcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcc
Q 041632           11 PEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTS   90 (452)
Q Consensus        11 p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l   90 (452)
                      ...+.....+ +.+.+..+.+.   ..+|..+.+|+.+.+..+ ++..-..+|.+|.+|+.++|.++ ++.+-..+|.+|
T Consensus       269 ~~~F~~~~~l-~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c  342 (394)
T 4fs7_A          269 GSLFYNCSGL-KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC  342 (394)
T ss_dssp             SCTTTTCTTC-CEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred             cccccccccc-ceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence            3455666777 77877776554   457889999999999876 66455677999999999999765 664556799999


Q ss_pred             cCCCeeecccccccCCcchhhccc-ccceeeCccc
Q 041632           91 RGIRKLDLSRNNLSGQIPLFLEAL-SLEYLNLSFN  124 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~~~~~~~-~L~~l~l~~N  124 (452)
                      .+|+.+++..| ++.+....|... +|+.+++..+
T Consensus       343 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          343 TSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             TTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             CCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            99999999877 777777777654 5999988654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.04  E-value=0.0025  Score=62.76  Aligned_cols=74  Identities=15%  Similarity=0.067  Sum_probs=45.5

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCc-eeEeeeeccccCCCCceeEEEEecc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL-VRVITSCSSVDFQGNDFKAIVYKYM  315 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~~lv~e~~  315 (452)
                      +.|+.|-...+|+......+..+++|+........ -+..+|..+++.+...++ .++++.+     . +   ..|+||+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~e~I  183 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-----T-N---GRIEEFM  183 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEEEee
Confidence            46778888999999875434788888874322111 122578888888854444 4565542     1 1   3599999


Q ss_pred             CCCCh
Q 041632          316 PNGSL  320 (452)
Q Consensus       316 ~~gsL  320 (452)
                      +|.++
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87555

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.04  E-value=0.0014  Score=64.06  Aligned_cols=73  Identities=16%  Similarity=0.246  Sum_probs=47.4

Q ss_pred             CceeccCceeEEEEEEcC-------CCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCc-eeEeeeeccccCCCCcee
Q 041632          237 NLIGVGSFGSVYKGVFDE-------DGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL-VRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni-v~l~~~~~~~~~~~~~~~  308 (452)
                      +.|+.|....+|+.....       +++.+++|+....  ...+.+..|..+++.+...++ .++++.+     .+    
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            467888889999998742       2568889987421  222556688888887743333 4555542     11    


Q ss_pred             EEEEeccCCCCh
Q 041632          309 AIVYKYMPNGSL  320 (452)
Q Consensus       309 ~lv~e~~~~gsL  320 (452)
                      .+|+||++|.++
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            378999976444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.00  E-value=0.0018  Score=62.06  Aligned_cols=144  Identities=14%  Similarity=0.168  Sum_probs=80.2

Q ss_pred             CceeccCceeEEEEEEcC-------CCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCcee
Q 041632          237 NLIGVGSFGSVYKGVFDE-------DGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +.+..|-...+|+.....       +++.+++|+.... ........+|.++++.+. +.-..++++.+.     +    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~-----~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP-----E----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET-----T----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC-----C----
Confidence            467778888999988742       3468889886322 223456678988887773 222345555431     1    


Q ss_pred             EEEEeccCCCChhhh-----------------hcCCCCCCcccccccccCC--HHHHHHHHHHHH---------------
Q 041632          309 AIVYKYMPNGSLEKW-----------------LHPDAIPQRDREIEIQKLT--LLQRISIAIDVA---------------  354 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~-----------------l~~~~~~~~~~~~~~~~l~--~~~~~~i~~~i~---------------  354 (452)
                      .+|+||++|.++..-                 |+.....      ......  +.+..++..++.               
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~------~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~  199 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMP------FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEM  199 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS------SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC------CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhh
Confidence            288999987665321                 1111100      001111  233344443321               


Q ss_pred             ----HHHHHH----hc-CCCCCeEecccCCCCeeecCC----CceEECccccccc
Q 041632          355 ----SALDYL----HQ-HCQEPILHCDLKPSNILLDND----LSAHIGDFGLSRF  396 (452)
Q Consensus       355 ----~~l~~L----H~-~~~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~  396 (452)
                          ..++.|    .. .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       200 ~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          200 YSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             TTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                122232    22 123478999999999999876    7899999998873

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.96  E-value=0.0005  Score=59.10  Aligned_cols=108  Identities=19%  Similarity=0.234  Sum_probs=69.6

Q ss_pred             ccCcccEEEccCC-cccc----CCCcCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEEccCcccccc----C
Q 041632           17 ISYLSNSLNLAEN-HFVG----SIPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSSLEDIYLGGNFFHGS----I   83 (452)
Q Consensus        17 l~~l~~~L~l~~n-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~   83 (452)
                      -+.| ++|+|++| +|..    .+-+++..-+.|+.|+|++|+|...    +.+.+..-+.|+.|+|+.|+|+..    +
T Consensus        40 n~~L-~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al  118 (197)
T 1pgv_A           40 DTDL-KEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL  118 (197)
T ss_dssp             CSSC-CEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCc-cEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence            4567 89999985 7753    2455667778899999999999743    334455678899999999998843    2


Q ss_pred             chhhhcccCCCeeeccccc---ccCC----cchhhc-ccccceeeCcccC
Q 041632           84 PSFFRTSRGIRKLDLSRNN---LSGQ----IPLFLE-ALSLEYLNLSFND  125 (452)
Q Consensus        84 p~~~~~l~~L~~l~l~~N~---l~~~----~~~~~~-~~~L~~l~l~~N~  125 (452)
                      -.++..-+.|+.|+|++|.   +...    +...+. ..+|+.|+++.|.
T Consensus       119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~  168 (197)
T 1pgv_A          119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  168 (197)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence            2334444668888887653   3221    111222 2337777766554

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.91  E-value=0.0079  Score=56.23  Aligned_cols=80  Identities=10%  Similarity=0.120  Sum_probs=47.1

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC--ceeEeeeecccc-CCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN--LVRVITSCSSVD-FQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~l~~~~~~~~-~~~~~~~~lv~e  313 (452)
                      ..++ |....||+.... +|+.+++|...... .....+..|..+++.+....  +.+++.. .... ....+..++++|
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEE
Confidence            3466 778899987653 56678999886321 23456777888777763222  3333332 1100 011345678999


Q ss_pred             ccCCCCh
Q 041632          314 YMPNGSL  320 (452)
Q Consensus       314 ~~~~gsL  320 (452)
                      |++|..+
T Consensus       108 ~i~G~~~  114 (328)
T 1zyl_A          108 SVGGRQF  114 (328)
T ss_dssp             CCCCEEC
T ss_pred             ecCCCCC
Confidence            9987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.91  E-value=0.0048  Score=57.62  Aligned_cols=155  Identities=12%  Similarity=0.066  Sum_probs=77.0

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC--ceeEeeeecccc-CCCCceeEEEEe
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN--LVRVITSCSSVD-FQGNDFKAIVYK  313 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~l~~~~~~~~-~~~~~~~~lv~e  313 (452)
                      +.|+.|....+|+.... +| .+++|+....  ...+.+..|++++..+...+  +.+++....... ....+..+++++
T Consensus        28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            34666878899998764 34 5788987642  12234566777776663222  233332110000 011235688999


Q ss_pred             ccCCCChhh--------------hhcCC--CCCCcccccccccCCHHHHHH------------HHHHHHHHHHHHhcC--
Q 041632          314 YMPNGSLEK--------------WLHPD--AIPQRDREIEIQKLTLLQRIS------------IAIDVASALDYLHQH--  363 (452)
Q Consensus       314 ~~~~gsL~~--------------~l~~~--~~~~~~~~~~~~~l~~~~~~~------------i~~~i~~~l~~LH~~--  363 (452)
                      |++|..+..              .++..  ....... .......|.....            +...+...++++++.  
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~-~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRP-NALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCB-CTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCccc-CccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            998865421              01100  0000000 0000001111000            001133445555431  


Q ss_pred             --CCCCeEecccCCCCeeecCCCceEECccccccc
Q 041632          364 --CQEPILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       364 --~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                        ...+++|+|+.+.||+++++..+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              235799999999999999876668999997753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.84  E-value=0.0082  Score=56.36  Aligned_cols=33  Identities=18%  Similarity=0.240  Sum_probs=28.2

Q ss_pred             CCCeEecccCCCCeeecCC----CceEECcccccccc
Q 041632          365 QEPILHCDLKPSNILLDND----LSAHIGDFGLSRFY  397 (452)
Q Consensus       365 ~~~ivH~Dlk~~Nill~~~----~~~kl~Dfgla~~~  397 (452)
                      ...++|+|+.+.||+++.+    ..+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3589999999999999875    67899999988643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.42  E-value=0.0044  Score=59.20  Aligned_cols=29  Identities=31%  Similarity=0.346  Sum_probs=24.8

Q ss_pred             CCeEecccCCCCeeecCCCceEECcccccc
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ..++|+|+.+.|||++++. +.|+||+.+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            4789999999999998665 8999999776

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.017  Score=54.32  Aligned_cols=31  Identities=26%  Similarity=0.358  Sum_probs=27.8

Q ss_pred             CCeEecccCCCCeeecCCCceEECccccccc
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.95  E-value=0.029  Score=54.44  Aligned_cols=30  Identities=23%  Similarity=0.337  Sum_probs=26.8

Q ss_pred             CCeEecccCCCCeeecCCCceEECccccccc
Q 041632          366 EPILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       366 ~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                      ..++|+|+.+.||+ +.++.+.++||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            46899999999999 8888999999998873

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.02  E-value=0.054  Score=46.86  Aligned_cols=98  Identities=18%  Similarity=0.142  Sum_probs=62.6

Q ss_pred             ChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccccccccc
Q 041632          319 SLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ  398 (452)
Q Consensus       319 sL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~  398 (452)
                      +|.+.|...          ..+++++++|.++.|.+.+|.-+-..-  .-..+=+.|..|++..+|.|...+ +.+.   
T Consensus        34 SL~eIL~~~----------~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---   97 (229)
T 2yle_A           34 SLEEILRLY----------NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---   97 (229)
T ss_dssp             EHHHHHHHH----------TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------
T ss_pred             cHHHHHHHc----------CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---
Confidence            677777643          368999999999999999987762110  001223456889999999988764 2110   


Q ss_pred             cCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh
Q 041632          399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT  446 (452)
Q Consensus       399 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt  446 (452)
                                   .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                         0123466888753 345677889999999998765

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.06  E-value=0.074  Score=52.29  Aligned_cols=60  Identities=7%  Similarity=0.007  Sum_probs=16.7

Q ss_pred             CCCceeccCceeEEEEEEcCCCcEEEE------EEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeee
Q 041632          235 STNLIGVGSFGSVYKGVFDEDGTVVAI------KVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSC  297 (452)
Q Consensus       235 ~~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~  297 (452)
                      ..+.+|   ||+||+|.+.....+|||      |..+...  .+....+.+|..+++..+|||+++..++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            445666   999999999755567888      6654221  12234688899999999999999987764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=86.66  E-value=0.33  Score=29.99  Aligned_cols=13  Identities=23%  Similarity=0.324  Sum_probs=6.9

Q ss_pred             eeehhHHHHHHHH
Q 041632          177 KILISIVSIFLGI  189 (452)
Q Consensus       177 ~i~i~~~~~~~~~  189 (452)
                      .|+.+++++++++
T Consensus        12 ~IA~gVVgGv~~~   24 (44)
T 2ks1_B           12 SIATGMVGALLLL   24 (44)
T ss_dssp             SSTHHHHHHHHHH
T ss_pred             eEEeehhHHHHHH
Confidence            3556666544443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=84.61  E-value=0.4  Score=29.55  Aligned_cols=12  Identities=8%  Similarity=0.191  Sum_probs=6.0

Q ss_pred             eehhHHHHHHHH
Q 041632          178 ILISIVSIFLGI  189 (452)
Q Consensus       178 i~i~~~~~~~~~  189 (452)
                      |+.+++++++++
T Consensus        12 IA~gVVgGv~~v   23 (44)
T 2l2t_A           12 IAAGVIGGLFIL   23 (44)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             EEEeehHHHHHH
Confidence            555555544443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.93  E-value=2.2  Score=36.74  Aligned_cols=53  Identities=13%  Similarity=0.206  Sum_probs=45.1

Q ss_pred             cccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          338 IQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       338 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ....+...+++++..++....++++.     +|--|.|+|+++|.++.+++.-.|+-.
T Consensus        75 ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~  127 (215)
T 4ann_A           75 IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQN  127 (215)
T ss_dssp             GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETT
T ss_pred             HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCcc
Confidence            35788899999999999988777654     677899999999999999999888643

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.36  E-value=2.3  Score=36.67  Aligned_cols=52  Identities=27%  Similarity=0.364  Sum_probs=43.4

Q ss_pred             ccCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          339 QKLTLLQRISIAIDVASALD-YLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       339 ~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ..++..++++++..++.... ++++     -+|--+.|+|+++|.++.+++.-.|+-.
T Consensus        80 ~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A           80 RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEECTTCCEEESCCEETT
T ss_pred             HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence            46788899999999888777 6655     3677899999999999999999888643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	452
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-51
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-50
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-49
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-48
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-47
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-46
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-46
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-45
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-44
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-43
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-42
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-42
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-37
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-36
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	9e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-55
 Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 29/219 (13%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKALKNIRHKNLVRVI 294
             IG GSFG+VYKG +  D   VA+K++N+        ++F  E   L+  RH N++  +
Sbjct: 14  QRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
                  +      AIV ++    SL   LH          I   K  +++ I IA   A
Sbjct: 71  ------GYSTAPQLAIVTQWCEGSSLYHHLH----------IIETKFEMIKLIDIARQTA 114

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             +DYLH      I+H DLK +NI L  DL+  IGDFGL+      S         + G+
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ--LSGS 169

Query: 415 IGYVAPEYGLGSE---VSTNGDVYSYGILLLEMVTTKKP 450
           I ++APE     +    S   DVY++GI+L E++T + P
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-53
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 25/223 (11%)

Query: 229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-RQGASKSFMAECKALKNIRH 287
             D F   + +G G+ G V+K      G V+A K+I+L+ +       + E + L     
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             +V    +  S     +   +I  ++M  GSL++ L            +  ++      
Sbjct: 64  PYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK-----------KAGRIPEQILG 107

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
            ++I V   L YL +     I+H D+KPSNIL+++     + DFG+S         ++++
Sbjct: 108 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 161

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S    GT  Y++PE   G+  S   D++S G+ L+EM   + P
Sbjct: 162 SF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (446), Expect = 3e-52
 Identities = 60/243 (24%), Positives = 113/243 (46%), Gaps = 32/243 (13%)

Query: 222 SYKSLLKATDGFSST---------NLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQR- 268
           +++   +A   F+            +IG G FG V  G     G     VAIK +     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 269 QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDA 328
           +   + F++E   +    H N++ +    +      +    I+ ++M NGSL+ +L  + 
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND 122

Query: 329 IPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI 388
                        T++Q + +   +A+ + YL        +H DL   NIL++++L   +
Sbjct: 123 GQF----------TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKV 169

Query: 389 GDFGLSRFYQ-AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT 447
            DFGLSRF +   S+PT +S++G +  I + APE     + ++  DV+SYGI++ E+++ 
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229

Query: 448 KKP 450
            + 
Sbjct: 230 GER 232

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-51
 Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 18/224 (8%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHK 288
           + +     IG GS+G   K     DG ++  K ++     +   +  ++E   L+ ++H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N+VR          + N    IV +Y   G L   +            E Q L     + 
Sbjct: 64  NIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVIT-------KGTKERQYLDEEFVLR 113

Query: 349 IAIDVASALDYLHQH--CQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           +   +  AL   H+       +LH DLKP+N+ LD   +  +GDFGL+R      N   S
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTS 169

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +    GT  Y++PE       +   D++S G LL E+     P
Sbjct: 170 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 5e-50
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             +G G FG V+ G      T VA+K +         +F+AE   +K ++H+ LVR+   
Sbjct: 19  ERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            +       +   I+ +YM NGSL  +L               KLT+ + + +A  +A  
Sbjct: 77  VT------QEPIYIITEYMENGSLVDFLK---------TPSGIKLTINKLLDMAAQIAEG 121

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + ++ +      +H DL+ +NIL+ + LS  I DFGL+R    + +   ++  G +  I 
Sbjct: 122 MAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL---IEDNEYTAREGAKFPIK 175

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + APE       +   DV+S+GILL E+VT  + 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 7e-50
 Identities = 55/231 (23%), Positives = 101/231 (43%), Gaps = 24/231 (10%)

Query: 224 KSLLKATDGFSSTNL-IGVGSFGSVYKGVF--DEDGTVVAIKVINLQ-RQGASKSFMAEC 279
           K L    D     ++ +G G+FGSV +GV+   +    VAIKV+     +  ++  M E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 280 KALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQ 339
           + +  + +  +VR+I  C +          +V +    G L K+L              +
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR----------E 104

Query: 340 KLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQA 399
           ++ +     +   V+  + YL +      +H DL   N+LL N   A I DFGLS+   A
Sbjct: 105 EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161

Query: 400 VSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +   ++    +  + + APE     + S+  DV+SYG+ + E ++  + 
Sbjct: 162 -DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 211

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 7e-49
 Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 23/215 (10%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITS 296
           IG GSF +VYKG+  E    VA   +  ++  +   + F  E + LK ++H N+VR   S
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             S   +G     +V + M +G+L+ +L              + + +    S    +   
Sbjct: 77  WES-TVKGKKCIVLVTELMTSGTLKTYLK-----------RFKVMKIKVLRSWCRQILKG 124

Query: 357 LDYLHQHCQEPILHCDLKPSNILL-DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
           L +LH     PI+H DLK  NI +     S  IGD GL+   +A      S +  V GT 
Sbjct: 125 LQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA------SFAKAVIGTP 177

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++APE     +   + DVY++G+ +LEM T++ P
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 211

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-48
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             +G G FG V+ G      T VAIK +        ++F+ E + +K +RH+ LV++   
Sbjct: 23  VKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
            S       +   IV +YM  GSL  +L  +                 Q + +A  +AS 
Sbjct: 81  VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP---------QLVDMAAQIASG 125

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + Y+ +      +H DL+ +NIL+  +L   + DFGL+R    + +   ++  G +  I 
Sbjct: 126 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL---IEDNEYTARQGAKFPIK 179

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + APE  L    +   DV+S+GILL E+ T  + 
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 7e-48
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 28/223 (12%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           + F     +G G FG+VY     +   ++A+KV+    L++ G       E +   ++RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N++R+                ++ +Y P G++ + L            ++ K    +  
Sbjct: 66  PNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQ-----------KLSKFDEQRTA 109

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
           +   ++A+AL Y H      ++H D+KP N+LL +     I DFG S    +      S 
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------SR 160

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
              + GT+ Y+ PE   G       D++S G+L  E +  K P
Sbjct: 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-47
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             IG G FG V  G +   G  VA+K I       +++F+AE   +  +RH NLV+++  
Sbjct: 13  QTIGKGEFGDVMLGDYR--GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                 +      IV +YM  GSL  +L                L     +  ++DV  A
Sbjct: 69  I----VEEKGGLYIVTEYMAKGSLVDYLR---------SRGRSVLGGDCLLKFSLDVCEA 115

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YL  +     +H DL   N+L+  D  A + DFGL++          S+    +  + 
Sbjct: 116 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVK 165

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + APE     + ST  DV+S+GILL E+ +  + 
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 3e-47
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)

Query: 239 IGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCS 298
           IG G FG V++G +   G  VA+K+ +  R+  S    AE      +RH+N++  I + +
Sbjct: 11  IGKGRFGEVWRGKWR--GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 299 SVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALD 358
             +        +V  Y  +GSL  +L+               +T+   I +A+  AS L 
Sbjct: 68  KDNGTWTQL-WLVSDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTASGLA 114

Query: 359 YLHQHC-----QEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           +LH        +  I H DLK  NIL+  + +  I D GL+  + + ++    +     G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 414 TIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE    S      E     D+Y+ G++  E+      
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 3e-47
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 23/214 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             IG G FG V+ G    +   VAIK I        + F+ E + +  + H  LV++   
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 68

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C            +V+++M +G L  +L                      + + +DV   
Sbjct: 69  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAE----------TLLGMCLDVCEG 113

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           + YL + C   ++H DL   N L+  +    + DFG++RF   V +   +SS G +  + 
Sbjct: 114 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQYTSSTGTKFPVK 167

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + +PE    S  S+  DV+S+G+L+ E+ +  K 
Sbjct: 168 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 7e-47
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 23/214 (10%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             +G G FG V  G        VAIK+I          F+ E K + N+ H+ LV++   
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 67

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
           C+           I+ +YM NG L  +L               +    Q + +  DV  A
Sbjct: 68  CTK-----QRPIFIITEYMANGCLLNYLRE----------MRHRFQTQQLLEMCKDVCEA 112

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           ++YL        LH DL   N L+++     + DFGLSR+   V +   +SS+G +  + 
Sbjct: 113 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY---VLDDEYTSSVGSKFPVR 166

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  PE  + S+ S+  D++++G+L+ E+ +  K 
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 9e-47
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 21/218 (9%)

Query: 237 NLIGVGSFGSVYKGVFDED---GTVVAIKVIN-LQRQGASKSFMAECKALKNIRHKNLVR 292
            +IG G FG VY G   ++       A+K +N +   G    F+ E   +K+  H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           ++  C     +      +V  YM +G L  ++            E    T+   I   + 
Sbjct: 93  LLGIC----LRSEGSPLVVLPYMKHGDLRNFIRN----------ETHNPTVKDLIGFGLQ 138

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  +        +  +H DL   N +LD   +  + DFGL+R        +V +  G +
Sbjct: 139 VAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 195

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             + ++A E     + +T  DV+S+G+LL E++T   P
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 1e-46
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 27/229 (11%)

Query: 227 LKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR 286
           L   D +     +G G+FG VYK    E   + A KVI+ + +   + +M E   L +  
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N+V+++ +         +   I+ ++   G+++  +      + +R      LT  Q 
Sbjct: 68  HPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVML-----ELER-----PLTESQI 112

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
             +      AL+YLH +    I+H DLK  NIL   D    + DFG+S         T+ 
Sbjct: 113 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN----TRTIQ 165

Query: 407 SSIGVRGTIGYVAPEY-----GLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                 GT  ++APE                DV+S GI L+EM   + P
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 23/224 (10%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKN 289
           + +     +G G++G V   V       VA+K+++++R     ++   E    K + H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           +V+          +  + + +  +Y   G L   + PD             +        
Sbjct: 65  VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRF 108

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSI 409
              + + + YLH      I H D+KP N+LLD   +  I DFGL+  ++  +   + +  
Sbjct: 109 FHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK- 164

Query: 410 GVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKPTD 452
            + GT+ YVAPE     E      DV+S GI+L  M+  + P D
Sbjct: 165 -MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-46
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 25/218 (11%)

Query: 237 NLIGVGSFGSVYKGVF--DEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVR 292
             +G G+FG+V KG +   +    VA+K++  +          +AE   ++ + +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +I  C        +   +V +    G L K+L  +           + +     I +   
Sbjct: 73  MIGICE------AESWMLVMEMAELGPLNKYLQQN-----------RHVKDKNIIELVHQ 115

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           V+  + YL +      +H DL   N+LL     A I DFGLS+  +A       +    +
Sbjct: 116 VSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGK 171

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             + + APE     + S+  DV+S+G+L+ E  +  + 
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (407), Expect = 2e-46
 Identities = 54/227 (23%), Positives = 86/227 (37%), Gaps = 33/227 (14%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---QRQGASKSFMAECKALKNIR 286
              FS    IG GSFG+VY      +  VVAIK ++    Q     +  + E + L+ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H N ++                 +V +Y    + +                 + L  ++ 
Sbjct: 74  HPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHK-----------KPLQEVEI 117

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
            ++       L YLH H    ++H D+K  NILL       +GDFG +            
Sbjct: 118 AAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------- 166

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNG---DVYSYGILLLEMVTTKKP 450
            +    GT  ++APE  L  +        DV+S GI  +E+   K P
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-46
 Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 29/232 (12%)

Query: 238 LIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQ-RQGASKSFMAECKALKNI-RHKNL 290
           ++G G+FG V                VA+K++  +      ++ M+E K +  +  H+N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH------------PDAIPQRDREIEI 338
           V ++ +C+      +    ++++Y   G L  +L              +   + + E ++
Sbjct: 104 VNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 339 QKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQ 398
             LT    +  A  VA  +++L        +H DL   N+L+ +     I DFGL+R   
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 399 AVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           + SN  V      R  + ++APE       +   DV+SYGILL E+ +    
Sbjct: 216 SDSNYVVRG--NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 4e-46
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 24/214 (11%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITS 296
             IG G+ G+VY  +    G  VAI+ +NLQ+Q   +  + E   ++  ++ N+V  + S
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
                    D   +V +Y+  GSL   +    + +             Q  ++  +   A
Sbjct: 86  Y-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG------------QIAAVCRECLQA 128

Query: 357 LDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           L++LH +    ++H D+K  NILL  D S  + DFG         +   +    + GT  
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST----MVGTPY 181

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++APE           D++S GI+ +EM+  + P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 2e-45
 Identities = 53/248 (21%), Positives = 100/248 (40%), Gaps = 29/248 (11%)

Query: 222 SYKSLLKATDGFSSTNLIGVGSFGSVYKG-----VFDEDGTVVAIKVINLQ-RQGASKSF 275
              SL    +       IG G+FG V++      +  E  T+VA+K++  +        F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 276 MAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH---------- 325
             E   +    + N+V+++  C+           ++++YM  G L ++L           
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 326 ---PDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN 382
                +   R        L+  +++ IA  VA+ + YL +      +H DL   N L+  
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175

Query: 383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLL 442
           ++   I DFGLSR   +        +      I ++ PE    +  +T  DV++YG++L 
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGN--DAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233

Query: 443 EMVTTKKP 450
           E+ +    
Sbjct: 234 EIFSYGLQ 241

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-45
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 22/229 (9%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGT--VVAIKVIN-LQRQGASKSFMAECKALKNI-R 286
           +     ++IG G+FG V K    +DG     AIK +     +   + F  E + L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRD-----REIEIQKL 341
           H N++ ++ +C     +   +  +  +Y P+G+L  +L    + + D            L
Sbjct: 70  HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
           +  Q +  A DVA  +DYL Q      +H DL   NIL+  +  A I DFGLSR  +   
Sbjct: 125 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             T+      R  + ++A E    S  +TN DV+SYG+LL E+V+    
Sbjct: 182 KKTM-----GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 24/226 (10%)

Query: 228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKN 284
           K  + F    ++G GSF +V            AIK++    + ++        E   +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           + H   V++  +     FQ ++       Y  NG L K++            +I      
Sbjct: 65  LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIR-----------KIGSFDET 108

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
                  ++ SAL+YLH      I+H DLKP NILL+ D+   I DFG ++     S   
Sbjct: 109 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165

Query: 405 VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            ++S    GT  YV+PE         + D+++ G ++ ++V    P
Sbjct: 166 RANS--FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 21/220 (9%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
              +  + +G G +G VY+GV+ +    VA+K +        + F+ E   +K I+H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V+++  C+           I+ ++M  G+L  +L          E   Q+++ +  + +A
Sbjct: 76  VQLLGVCTR-----EPPFYIITEFMTYGNLLDYLR---------ECNRQEVSAVVLLYMA 121

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
             ++SA++YL +      +H DL   N L+  +    + DFGLSR     +  T ++  G
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAG 175

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +  I + APE    ++ S   DV+++G+LL E+ T    
Sbjct: 176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 215

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  156 bits (395), Expect = 2e-44
 Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 25/222 (11%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D +     +G G+FG V++      G   A K +    +   ++   E + +  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           V +  +     F+ ++   ++Y++M  G L + +            E  K++  + +   
Sbjct: 86  VNLHDA-----FEDDNEMVMIYEFMSGGELFEKVAD----------EHNKMSEDEAVEYM 130

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSS 408
             V   L ++H++     +H DLKP NI+     S  +   DFGL+            S 
Sbjct: 131 RQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-----PKQSV 182

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               GT  + APE   G  V    D++S G+L   +++   P
Sbjct: 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-44
 Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 24/230 (10%)

Query: 237 NLIGVGSFGSVYKGVF-----DEDGTVVAIKVINL-QRQGASKSFMAECKALKNI-RHKN 289
             +G G+FG V +         +    VA+K++         ++ M+E K L  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH-------PDAIPQRDREIEIQKLT 342
           +V ++ +C+           ++ +Y   G L  +L                 E +   L 
Sbjct: 89  IVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
           L   +S +  VA  + +L        +H DL   NILL +     I DFGL+R  +  SN
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD 452
             V  +   R  + ++APE       +   DV+SYGI L E+ +      
Sbjct: 201 YVVKGN--ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 54/239 (22%), Positives = 104/239 (43%), Gaps = 32/239 (13%)

Query: 217 ALLKMSYKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVI-----NLQRQGA 271
           ALL+     +LK T+ F    ++G G+FG+VYKG++  +G  V I V            A
Sbjct: 1   ALLR-----ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54

Query: 272 SKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQ 331
           +K  + E   + ++ + ++ R++  C +   Q      ++ + MP G L  ++       
Sbjct: 55  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI 108

Query: 332 RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF 391
             +            ++  + +A  ++YL       ++H DL   N+L+       I DF
Sbjct: 109 GSQY----------LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDF 155

Query: 392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           GL++     +      + G +  I ++A E  L    +   DV+SYG+ + E++T    
Sbjct: 156 GLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-42
 Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDG----TVVAIKVINLQR-QGASKSFMAECKALKNIRH 287
            +   +IG G FG VYKG+           VAIK +     +     F+ E   +    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
            N++R+    S           I+ +YM NG+L+K+L               + ++LQ +
Sbjct: 69  HNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKD----------GEFSVLQLV 113

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
            +   +A+ + YL        +H DL   NIL++++L   + DFGLSR  +     T ++
Sbjct: 114 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           S G +  I + APE     + ++  DV+S+GI++ E++T  + 
Sbjct: 171 S-GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 212

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 19/224 (8%)

Query: 230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIR 286
           +D +    ++G G    V+          VA+KV+     +       F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H  +V V  +  +    G     IV +Y+   +L   +H               +T  + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVH-----------TEGPMTPKRA 113

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
           I +  D   AL++ HQ+    I+H D+KP+NI++    +  + DFG++R      N    
Sbjct: 114 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           ++  V GT  Y++PE   G  V    DVYS G +L E++T + P
Sbjct: 171 TA-AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (381), Expect = 3e-42
 Identities = 44/222 (19%), Positives = 85/222 (38%), Gaps = 25/222 (11%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL 290
           D +     +G G+FG V++ V    G V   K IN        +   E   +  + H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           + +  +     F+      ++ +++  G L   +            E  K++  + I+  
Sbjct: 89  INLHDA-----FEDKYEMVLILEFLSGGELFDRIAA----------EDYKMSEAEVINYM 133

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI--GDFGLSRFYQAVSNPTVSSS 408
                 L ++H+H    I+H D+KP NI+ +   ++ +   DFGL+              
Sbjct: 134 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-----PDEIV 185

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                T  + APE      V    D+++ G+L   +++   P
Sbjct: 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 7e-42
 Identities = 56/218 (25%), Positives = 84/218 (38%), Gaps = 26/218 (11%)

Query: 239 IGVGSFGSVYKGVFDED---GTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVR 292
           +G GSFG V +G +D        VA+K +    L +  A   F+ E  A+ ++ H+NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 293 VITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAID 352
           +     +   +      +V +  P GSL   L                  L      A+ 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----------GHFLLGTLSRYAVQ 119

Query: 353 VASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVR 412
           VA  + YL        +H DL   N+LL       IGDFGL R      +  V      +
Sbjct: 120 VAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRK 175

Query: 413 GTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               + APE       S   D + +G+ L EM T  + 
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 3e-41
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 238 LIGVGSFGSVYKGVF---DEDGTVVAIKVI-NLQRQGASKSFMAECKALKNIRHKNLVRV 293
            IG G FG V++G++   +     VAIK   N       + F+ E   ++   H ++V++
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
           I   +       +   I+ +    G L  +L           +    L L   I  A  +
Sbjct: 74  IGVIT------ENPVWIIMELCTLGELRSFLQ----------VRKYSLDLASLILYAYQL 117

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           ++AL YL        +H D+   N+L+ ++    +GDFGLSR+   + + T   +   + 
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKL 171

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            I ++APE       ++  DV+ +G+ + E++     
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 208

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-41
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 17/220 (7%)

Query: 237 NLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNL 290
             +G GSFG VY+GV      DE  T VAIK +N          F+ E   +K     ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIA 350
           VR++               ++ + M  G L+ +L     P       +   +L + I +A
Sbjct: 86  VRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLR-PAMANNPVLAPPSLSKMIQMA 139

Query: 351 IDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIG 410
            ++A  + YL+ +     +H DL   N ++  D +  IGDFG++R               
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGK 194

Query: 411 VRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
               + +++PE       +T  DV+S+G++L E+ T  + 
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 51/236 (21%), Positives = 95/236 (40%), Gaps = 40/236 (16%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL---------QRQGASKSFMAECKA 281
           + +    ++G G    V + +        A+K+I++         + Q   ++ + E   
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 282 LKNIR-HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQK 340
           L+ +  H N++++        ++ N F  +V+  M  G L  +L            E   
Sbjct: 63  LRKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLT-----------EKVT 106

Query: 341 LTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAV 400
           L+  +   I   +   +  LH+     I+H DLKP NILLD+D++  + DFG S      
Sbjct: 107 LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 163

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNG------DVYSYGILLLEMVTTKKP 450
                     V GT  Y+APE    S    +       D++S G+++  ++    P
Sbjct: 164 EKLR-----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 3e-39
 Identities = 51/229 (22%), Positives = 79/229 (34%), Gaps = 22/229 (9%)

Query: 223 YKSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKA 281
           +K      D +   +++G G+F  V          +VAIK I  +  +G   S   E   
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L  I+H N+V +        ++      ++ + +  G L   +            E    
Sbjct: 61  LHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIV-----------EKGFY 104

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
           T      +   V  A+ YLH                  LD D    I DFGLS+     S
Sbjct: 105 TERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             +        GT GYVAPE       S   D +S G++   ++    P
Sbjct: 165 VLS-----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 19/225 (8%)

Query: 237 NLIGVGSFGSVYKGVF-----DEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNL 290
             +G G+FG V +              VA+K++         ++ M+E K L +I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 291 VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLH-----PDAIPQRDREIEIQKLTLLQ 345
           V  +        +      ++ ++   G+L  +L               ++    LTL  
Sbjct: 79  VVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 346 RISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTV 405
            I  +  VA  +++L        +H DL   NILL       I DFGL+R      +P  
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY--KDPDY 190

Query: 406 SSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                 R  + ++APE       +   DV+S+G+LL E+ +    
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 2e-38
 Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 26/215 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            +G G FG V++ V          K + ++          E   L   RH+N++ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHES- 69

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
               F+  +   ++++++    + + ++  A            L   + +S    V  AL
Sbjct: 70  ----FESMEELVMIFEFISGLDIFERINTSAFE----------LNEREIVSYVHQVCEAL 115

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAH--IGDFGLSRFYQAVSNPTVSSSIGVRGTI 415
            +LH H    I H D++P NI+     S+   I +FG +R  +   N  +     +    
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-----LFTAP 167

Query: 416 GYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            Y APE      VST  D++S G L+  +++   P
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 8e-38
 Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 19/228 (8%)

Query: 225 SLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN-LQRQGASKSFMAECKALK 283
            +      +++ + IG G++G V     + +   VAIK I+  + Q   +  + E K L 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
             RH+N++ +     +   +      +V  ++    L K L              Q L+ 
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKT------------QHLSN 108

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
                    +   L Y+H      +LH DLKPSN+LL+      I DFGL+R      + 
Sbjct: 109 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP-DHD 164

Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTN-GDVYSYGILLLEMVTTKKP 450
                     T  Y APE  L S+  T   D++S G +L EM++ +  
Sbjct: 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 27/224 (12%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKAL-KNIR 286
           + F    ++G GSFG V+   F +     AIK +    +      +  M E + L     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
           H  L  +  +      Q  +    V +Y+  G L   +               K  L + 
Sbjct: 62  HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQ-----------SCHKFDLSRA 105

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVS 406
              A ++   L +LH      I++ DLK  NILLD D    I DFG+ +          +
Sbjct: 106 TFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM----LGDA 158

Query: 407 SSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
            +    GT  Y+APE  LG + + + D +S+G+LL EM+  + P
Sbjct: 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-37
 Identities = 52/228 (22%), Positives = 96/228 (42%), Gaps = 24/228 (10%)

Query: 237 NLIGVGSFGSVYKGV-------FDEDGTVVAIKVINLQR-QGASKSFMAECKALKNI-RH 287
             +G G+FG V                T VA+K++     +      ++E + +K I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEI-----QKLT 342
           KN++ ++ +C+      +    ++ +Y   G+L ++L     P  +          ++L+
Sbjct: 79  KNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 343 LLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSN 402
               +S A  VA  ++YL        +H DL   N+L+  D    I DFGL+R       
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH--HI 188

Query: 403 PTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +   R  + ++APE       +   DV+S+G+LL E+ T    
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-36
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 20/220 (9%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVI 294
             IG G+FG V+K    + G  VA+K + ++  ++G   + + E K L+ ++H+N+V +I
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 295 TSCSSVDFQGNDFKA---IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
             C +     N  K    +V+ +  +       +            + K TL +   +  
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----------VLVKFTLSEIKRVMQ 124

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
            +   L+ L+   +  ILH D+K +N+L+  D    + DFGL+R +    N   +     
Sbjct: 125 ML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 412 RGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKP 450
             T+ Y  PE  LG  +     D++  G ++ EM T    
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  134 bits (339), Expect = 3e-36
 Identities = 49/229 (21%), Positives = 85/229 (37%), Gaps = 32/229 (13%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL------QRQGASKSFMAECKALKN 284
           + FS   +IG G FG VY     + G + A+K ++       Q +  + +       +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
                +V +  +     F   D  + +   M  G L   L    +               
Sbjct: 64  GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----------- 107

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPT 404
                A ++   L+++H      +++ DLKP+NILLD      I D GL+  +       
Sbjct: 108 DMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK----- 159

Query: 405 VSSSIGVRGTIGYVAPEYGL-GSEVSTNGDVYSYGILLLEMVTTKKPTD 452
                   GT GY+APE    G    ++ D +S G +L +++    P  
Sbjct: 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  133 bits (334), Expect = 4e-36
 Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 26/215 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            IG GSFG +Y G     G  VAIK+  ++ +        E K  K ++    +  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                   D+  +V + +     + +               +K +L   + +A  + S +
Sbjct: 72  ----GAEGDYNVMVMELLGPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRI 116

Query: 358 DYLHQHCQEPILHCDLKPSNIL---LDNDLSAHIGDFGLSRFY---QAVSNPTVSSSIGV 411
           +Y+H       +H D+KP N L          +I DFGL++ Y   +   +     +  +
Sbjct: 117 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 412 RGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            GT  Y +    LG E S   D+ S G +L+    
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (333), Expect = 9e-36
 Identities = 56/217 (25%), Positives = 89/217 (41%), Gaps = 29/217 (13%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRHKNLVRV 293
             +G GSFG V+      +G   A+KV+    + R    +    E   L  + H  ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 294 ITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDV 353
             +      Q      ++  Y+  G L   L              Q+         A +V
Sbjct: 70  WGTF-----QDAQQIFMIMDYIEGGELFSLLRKS-----------QRFPNPVAKFYAAEV 113

Query: 354 ASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
             AL+YLH      I++ DLKP NILLD +    I DFG +++           +  + G
Sbjct: 114 CLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-------DVTYTLCG 163

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  Y+APE       + + D +S+GIL+ EM+    P
Sbjct: 164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 9e-36
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 23/221 (10%)

Query: 233 FSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVR 292
           ++ T +IG GSFG VY+    + G +VAIK +   +    +    E + ++ + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 293 VITSC-SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
           +     SS + +   +  +V  Y+P        H             Q L ++       
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--------YSRAKQTLPVIYVKLYMY 129

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH-IGDFGLSRFYQAVSNPTVSSSIG 410
            +  +L Y+H      I H D+KP N+LLD D +   + DFG ++    V      S I 
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYIC 184

Query: 411 VRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKP 450
            R    Y APE   G+   T+  DV+S G +L E++  +  
Sbjct: 185 SR---YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-35
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 29/220 (13%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ-----RQGASKSFMAECKALKNIRHKNLV 291
           + +G G F +VYK        +VAIK I L      + G +++ + E K L+ + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 292 RVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAI 351
            ++ +            ++V+ +M                         LT     +  +
Sbjct: 64  GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNS-----------LVLTPSHIKAYML 107

Query: 352 DVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGV 411
                L+YLHQH    ILH DLKP+N+LLD +    + DFGL++ +         +    
Sbjct: 108 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF----GSPNRAYTHQ 160

Query: 412 RGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKP 450
             T  Y APE   G+ +     D+++ G +L E++     
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 4e-35
 Identities = 42/217 (19%), Positives = 82/217 (37%), Gaps = 27/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITS 296
           ++G+G  G V +          A+K++             E +      +  ++VR++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73

Query: 297 CSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASA 356
             ++ + G     IV + +  G L   +          +   Q  T  +   I   +  A
Sbjct: 74  YENL-YAGRKCLLIVMECLDGGELFSRIQ---------DRGDQAFTEREASEIMKSIGEA 123

Query: 357 LDYLHQHCQEPILHCDLKPSNILLD---NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRG 413
           + YLH      I H D+KP N+L      +    + DFG ++        + +S      
Sbjct: 124 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-----TSHNSLTTPCY 175

Query: 414 TIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           T  YVAPE     +   + D++S G+++  ++    P
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-35
 Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 24/229 (10%)

Query: 228 KATDGFSSTNLIGVGSFGSVYKGV-FDEDGTVVAIKVINLQ--RQGASKSFMAE---CKA 281
           +A   +     IG G++G V+K       G  VA+K + +Q   +G   S + E    + 
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           L+   H N+VR+   C+           +V++++                    +    +
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK----------VPEPGV 113

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
                  +   +   LD+LH H    ++H DLKP NIL+ +     + DFGL+R Y    
Sbjct: 114 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             T      V  T+ Y APE  L S  +T  D++S G +  EM   K  
Sbjct: 171 ALT-----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 9e-34
 Identities = 51/230 (22%), Positives = 87/230 (37%), Gaps = 34/230 (14%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS------KSFMAECKALKN 284
           D + +   +G G F  V K      G   A K I  +R  +S      +    E   LK 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 285 IRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLL 344
           I+H N++ +        ++      ++ + +  G L  +L            E + LT  
Sbjct: 70  IQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLA-----------EKESLTEE 113

Query: 345 QRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND----LSAHIGDFGLSRFYQAV 400
           +       + + + YLH      I H DLKP NI+L +         I DFGL+      
Sbjct: 114 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-- 168

Query: 401 SNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                +    + GT  +VAPE      +    D++S G++   +++   P
Sbjct: 169 ---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 39/217 (17%), Positives = 77/217 (35%), Gaps = 28/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            IG GSFG +++G    +   VAIK     R+  +     E +  K +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
                Q      +V   +     +                 +K ++      A  + + +
Sbjct: 70  ----GQEGLHNVLVIDLLGPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARV 114

Query: 358 DYLHQHCQEPILHCDLKPSNILLDNDLSAHIG-----DFGLSRFYQAVSNPTVSSSI--- 409
             +H+     +++ D+KP N L+    S +       DFG+ +FY+              
Sbjct: 115 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 410 GVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT 446
            + GT  Y++    LG E S   D+ + G + +  + 
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR 208

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 5e-33
 Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 25/223 (11%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINL--QRQGASKSFMAECKALKNIRHK 288
           + F     IG G++G VYK      G VVA+K I L  + +G   + + E   LK + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 289 NLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRIS 348
           N+V+++           +   +V++++               +      +  + L    S
Sbjct: 62  NIVKLLDVI-----HTENKLYLVFEFLHQDLK----------KFMDASALTGIPLPLIKS 106

Query: 349 IAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSS 408
               +   L + H H    +LH DLKP N+L++ + +  + DFGL+R +       V + 
Sbjct: 107 YLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTY 159

Query: 409 IGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKP 450
                T+ Y APE  LG +  ST  D++S G +  EMVT +  
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 4e-32
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 26/223 (11%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVIN---LQRQGASKSFMAECKALKNIRH 287
           + F    L+G G+FG V        G   A+K++    +  +      + E + L+N RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             L  +  +      Q +D    V +Y   G L   L  +           +  T  +  
Sbjct: 65  PFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRE-----------RVFTEERAR 108

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
               ++ SAL+YLH      +++ D+K  N++LD D    I DFGL +   +        
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--- 162

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                GT  Y+APE    ++     D +  G+++ EM+  + P
Sbjct: 163 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 4e-32
 Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 24/216 (11%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVI 294
             IG G++G+V+K    E   +VA+K + L    +G   S + E   LK ++HKN+VR+ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
               S     +    +V+++      + +   +     +              S    + 
Sbjct: 68  DVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPE-----------IVKSFLFQLL 111

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L + H      +LH DLKP N+L++ +    + +FGL+R +     P    S  V   
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF---GIPVRCYSAEVVTL 165

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
                         ST+ D++S G +  E+    +P
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 6e-32
 Identities = 52/223 (23%), Positives = 73/223 (32%), Gaps = 34/223 (15%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQR------QGASKSFMAECKALKNIR--HKN 289
           L+G G FGSVY G+   D   VAIK +   R               E   LK +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++R++           D   ++ +                       E   L      S 
Sbjct: 71  VIRLLDWFER-----PDSFVLILERPEPVQDLFDFI----------TERGALQEELARSF 115

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSS 408
              V  A+ + H      +LH D+K  NIL+D N     + DFG     +          
Sbjct: 116 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---- 168

Query: 409 IGVRGTIGYVAPEYGLGSEVSTNG-DVYSYGILLLEMVTTKKP 450
               GT  Y  PE+            V+S GILL +MV    P
Sbjct: 169 --FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (306), Expect = 9e-32
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 29/223 (13%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASK---SFMAECKALKNIRH 287
           D F     +G GSFG V      E G   A+K+++ Q+    K     + E + L+ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 288 KNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRI 347
             LV++  S      + N    +V +Y+  G +   L             I + +     
Sbjct: 101 PFLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSHLR-----------RIGRFSEPHAR 144

Query: 348 SIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSS 407
             A  +    +YLH      +++ DLKP N+L+D      + DFG ++  +         
Sbjct: 145 FYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GR 194

Query: 408 SIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           +  + GT   +APE  L    +   D ++ G+L+ EM     P
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  117 bits (294), Expect = 1e-30
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 27/217 (12%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVI 294
             IG G++G VYK   +  G   A+K I L++  +G   + + E   LK ++H N+V++ 
Sbjct: 8   EKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66

Query: 295 TSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
               +          +V++++     +     +             L  +   S  + + 
Sbjct: 67  DVIHT-----KKRLVLVFEHLDQDLKKLLDVCE-----------GGLESVTAKSFLLQLL 110

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
           + + Y H      +LH DLKP N+L++ +    I DFGL+R +       V        T
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVT 163

Query: 415 IGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKP 450
           + Y AP+  +GS+  ST  D++S G +  EMV     
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (297), Expect = 1e-30
 Identities = 46/223 (20%), Positives = 93/223 (41%), Gaps = 31/223 (13%)

Query: 231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKN 289
           D +     +G G +  V++ +   +   V +K++   ++   K    E K L+N+R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91

Query: 290 LVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISI 349
           ++ +           +   A+V++++ N   ++                Q LT       
Sbjct: 92  IITLADIV---KDPVSRTPALVFEHVNNTDFKQL--------------YQTLTDYDIRFY 134

Query: 350 AIDVASALDYLHQHCQEPILHCDLKPSNILLDND-LSAHIGDFGLSRFYQAVSNPTVSSS 408
             ++  ALDY H      I+H D+KP N+++D++     + D+GL+ FY       V   
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--- 188

Query: 409 IGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKP 450
                +  +  PE  +  +    + D++S G +L  M+  K+P
Sbjct: 189 --RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 3e-30
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 27/217 (12%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
            +G G++G+V   V    G  VAIK +    Q +  +K    E + LK++RH+N++ ++ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 296 SCSSVDFQGNDFK-AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             +  +   +     +V  +M                  + ++ +KL   +   +   + 
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTD-------------LGKLMKHEKLGEDRIQFLVYQML 131

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             L Y+H        H DLKP N+ ++ D    I DFGL+R   +     V        T
Sbjct: 132 KGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-------VT 181

Query: 415 IGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKP 450
             Y APE  L     +   D++S G ++ EM+T K  
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (293), Expect = 7e-30
 Identities = 40/214 (18%), Positives = 89/214 (41%), Gaps = 6/214 (2%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSC 297
            +G G F +V+      + T VA+K++    +  +++   E K L+ +   +  +  +  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 298 SSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASAL 357
           ++   +  D          +  +   +  + +    ++ E + + L+    I+  +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 358 DYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIG 416
           DY+H+ C   I+H D+KP N+L++  D   ++    ++    A              T  
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTRE 194

Query: 417 YVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
           Y +PE  LG+      D++S   L+ E++T    
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 4e-29
 Identities = 51/230 (22%), Positives = 94/230 (40%), Gaps = 25/230 (10%)

Query: 224 KSLLKATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGAS--KSFMAECKA 281
           K++ +  + + + + +G G++GSV      + G  VA+K ++   Q     K    E + 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70

Query: 282 LKNIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKL 341
           LK+++H+N++ ++   +            +  ++    L   +              QKL
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC------------QKL 118

Query: 342 TLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVS 401
           T      +   +   L Y+H        H DLKPSN+ ++ D    I DFGL+R      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

Query: 402 NPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKP 450
                   G   T  Y APE  L     +   D++S G ++ E++T +  
Sbjct: 176 T-------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 6e-29
 Identities = 52/216 (24%), Positives = 81/216 (37%), Gaps = 25/216 (11%)

Query: 238 LIGVGSFGSVYKGVFDEDGTVVAIKVIN--LQRQGASKSFMAECKALKNIRHKNLVRVIT 295
            IG G+ G V           VAIK ++   Q Q  +K    E   +K + HKN++ ++ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 296 SCSSVD-FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVA 354
             +     +      +V + M     +                       +   +   + 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------------DHERMSYLLYQML 129

Query: 355 SALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGT 414
             + +LH        H DLKPSNI++ +D +  I DFGL+R        T         T
Sbjct: 130 CGIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-----YVVT 181

Query: 415 IGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKP 450
             Y APE  LG     N D++S G ++ EMV  K  
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-28
 Identities = 53/229 (23%), Positives = 102/229 (44%), Gaps = 30/229 (13%)

Query: 231 DGFSSTNLIGVGSFGSVYKG---VFDEDGTVVAIKVIN----LQRQGASKSFMAECKALK 283
           + F    ++G G++G V+        + G + A+KV+     +Q+   ++    E + L+
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 284 NIRHKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTL 343
           +IR    +  +       FQ      ++  Y+  G L   L            + ++ T 
Sbjct: 84  HIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLS-----------QRERFTE 128

Query: 344 LQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNP 403
            +      ++  AL++LH+     I++ D+K  NILLD++    + DFGLS+ + A    
Sbjct: 129 HEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET- 184

Query: 404 TVSSSIGVRGTIGYVAPEYGLGSEVSTNG--DVYSYGILLLEMVTTKKP 450
               +    GTI Y+AP+   G +   +   D +S G+L+ E++T   P
Sbjct: 185 --ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.8 bits (196), Expect = 5e-18
 Identities = 21/169 (12%), Positives = 45/169 (26%), Gaps = 34/169 (20%)

Query: 237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINL----------QRQGASKSFMAECKALKNIR 286
            L+G G   +V+     E      +K   +          +R      F           
Sbjct: 6   KLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 287 HKNLVRVITSCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQR 346
            + L ++    +       +  A++ + +    L +                        
Sbjct: 65  FRALQKLQ-GLAVPKVYAWEGNAVLMELIDAKELYRVRVE------------------NP 105

Query: 347 ISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFGLSR 395
             +   +   +   +      I+H DL   N+L+  +    I DF  S 
Sbjct: 106 DEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.6 bits (153), Expect = 9e-12
 Identities = 21/63 (33%), Positives = 28/63 (44%), Gaps = 1/63 (1%)

Query: 22  NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG 81
           N L+L  N   G++P  +  LK L S +VS N L GEIP + G     +      N    
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLC 305

Query: 82  SIP 84
             P
Sbjct: 306 GSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.8 bits (130), Expect = 6e-09
 Identities = 15/64 (23%), Positives = 21/64 (32%), Gaps = 1/64 (1%)

Query: 46  RSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG 105
              D+ NN + G +P  L     L  + +  N   G IP      R       + N    
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR-FDVSAYANNKCLC 305

Query: 106 QIPL 109
             PL
Sbjct: 306 GSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 54.0 bits (128), Expect = 1e-08
 Identities = 21/68 (30%), Positives = 34/68 (50%), Gaps = 6/68 (8%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNN-GLSGEI 59
           +  N + GT+P+ +  + +L  SLN++ N+  G IP   GNL+       +NN  L G  
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLH-SLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG-- 306

Query: 60  PIELGLCS 67
              L  C+
Sbjct: 307 -SPLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 53.6 bits (127), Expect = 2e-08
 Identities = 21/98 (21%), Positives = 33/98 (33%), Gaps = 27/98 (27%)

Query: 66  CSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFND 125
             +L  + L  N  +G++P      + +  L++S NNL G+IP        +    + N 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

Query: 126 FEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLPKCT 163
                                   LCG      LP CT
Sbjct: 303 C-----------------------LCGS----PLPACT 313

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 61.6 bits (148), Expect = 5e-11
 Identities = 26/120 (21%), Positives = 39/120 (32%), Gaps = 5/120 (4%)

Query: 5   DLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELG 64
            L       I  ++ L+   NL  N         I NLK L    +  N +S   P+   
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV--S 326

Query: 65  LCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFN 124
             + L+ ++   N    S  S       I  L    N +S   PL      +  L L+  
Sbjct: 327 SLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTPLA-NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.9 bits (141), Expect = 5e-10
 Identities = 36/184 (19%), Positives = 60/184 (32%), Gaps = 30/184 (16%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
              N +S   P  I +     + L+L  N         + +L  L   D++NN +S   P
Sbjct: 204 ATNNQISDITPLGILTNL---DELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 258

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGI--------------------RKLDLSR 100
             L   + L ++ LG N      P    T+                         L L  
Sbjct: 259 --LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 316

Query: 101 NNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIPELQLP 160
           NN+S   P+      L+ L  + N     V +     N + +S     ++    P   L 
Sbjct: 317 NNISDISPVS-SLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN-QISDLTPLANLT 373

Query: 161 KCTE 164
           + T+
Sbjct: 374 RITQ 377

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 3e-08
 Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 11/79 (13%)

Query: 1   MFENDLSGTIPEAIFSISYLSN--SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE 58
           ++ N++S   P     +S L+    L  A N    S    + NL  +      +N +S  
Sbjct: 314 LYFNNISDISP-----VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDL 366

Query: 59  IPIELGLCSSLEDIYLGGN 77
            P  L   + +  + L   
Sbjct: 367 TP--LANLTRITQLGLNDQ 383

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.1 bits (136), Expect = 1e-09
 Identities = 25/128 (19%), Positives = 45/128 (35%), Gaps = 4/128 (3%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           +  N +S     A   +  L     L +N      P    +L  L +  +  N LS    
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
             L    +L+ + L  N +     +    +  ++K   S + +   +P  L    L    
Sbjct: 219 EALAPLRALQYLRLNDNPWVCDCRARPLWAW-LQKFRGSSSEVPCSLPQRLAGRDL--KR 275

Query: 121 LSFNDFEG 128
           L+ ND +G
Sbjct: 276 LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.5 bits (124), Expect = 3e-08
 Identities = 21/131 (16%), Positives = 37/131 (28%), Gaps = 1/131 (0%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           + +N L     +    +  L   L L  N            L +L    +  N ++   P
Sbjct: 136 LQDNALQALPDDTFRDLGNL-THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
                   L  +YL  N             R ++ L L+ N              L+   
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254

Query: 121 LSFNDFEGKVP 131
            S ++    +P
Sbjct: 255 GSSSEVPCSLP 265

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (87), Expect = 0.001
 Identities = 30/183 (16%), Positives = 56/183 (30%), Gaps = 25/183 (13%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
           + +N    ++  A F      ++L+L         P     L AL+   + +N L     
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPD 146

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEAL------ 114
                  +L  ++L GN         FR    + +L L +N ++   P     L      
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206

Query: 115 -------------------SLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIP 155
                              +L+YL L+ N +      + ++A       +     C    
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266

Query: 156 ELQ 158
            L 
Sbjct: 267 RLA 269

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 1e-07
 Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 7/108 (6%)

Query: 24  LNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSI 83
           L+LA      ++   +  L  +   D+S+N L    P  L     LE +    +      
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57

Query: 84  PSFFRTSRGIRKLDLSRNNL-SGQIPLFLEAL-SLEYLNLSFNDFEGK 129
                    +++L L  N L        L +   L  LNL  N    +
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.4 bits (116), Expect = 4e-07
 Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 11/94 (11%)

Query: 29  NHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFR 88
           N     I        +L   +VSNN L  E+P        LE +    N     +P   +
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPELPQ 324

Query: 89  TSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLS 122
               +++L +  N L  + P   E  S+E L ++
Sbjct: 325 N---LKQLHVEYNPLR-EFPDIPE--SVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.7 bits (101), Expect = 3e-05
 Identities = 18/78 (23%), Positives = 35/78 (44%), Gaps = 7/78 (8%)

Query: 51  SNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLF 110
             N  S EI     L  SLE++ +  N     +P+       + +L  S N+L+ ++P  
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPEL 322

Query: 111 LEALSLEYLNLSFNDFEG 128
            +  +L+ L++ +N    
Sbjct: 323 PQ--NLKQLHVEYNPLRE 338

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 4e-07
 Identities = 18/93 (19%), Positives = 31/93 (33%), Gaps = 11/93 (11%)

Query: 45  LRSFDVSNNGLSGEIPIEL-GLCSSLEDIYLGGNFFHG----SIPSFFRTSRGIRKLDLS 99
           ++S D+    LS     EL  L    + + L            I S  R +  + +L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 100 RNNLSGQIP------LFLEALSLEYLNLSFNDF 126
            N L           L   +  ++ L+L     
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 3e-06
 Identities = 21/126 (16%), Positives = 41/126 (32%), Gaps = 23/126 (18%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHF----VGSIPPRIGNLKALRSFDVSNNGLS 56
             E+     + + +     +   L LA+         S+   +    +LR  D+SNN L 
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410

Query: 57  GEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSL 116
               ++  L  S+                       + +L L     S ++   L+AL  
Sbjct: 411 DAGILQ--LVESVRQ-----------------PGCLLEQLVLYDIYWSEEMEDRLQALEK 451

Query: 117 EYLNLS 122
           +  +L 
Sbjct: 452 DKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (83), Expect = 0.004
 Identities = 9/86 (10%), Positives = 22/86 (25%), Gaps = 9/86 (10%)

Query: 4  NDLSGTIPEAIFSISYLSNSLNLAENHF----VGSIPPRIGNLKALRSFDVSNNGLSGEI 59
           +LS      +  +      + L +          I   +    AL   ++ +N L    
Sbjct: 12 EELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVG 71

Query: 60 PIELG-----LCSSLEDIYLGGNFFH 80
             +          ++ + L      
Sbjct: 72 VHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 44.3 bits (103), Expect = 1e-05
 Identities = 22/128 (17%), Positives = 43/128 (33%), Gaps = 4/128 (3%)

Query: 1   MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP 60
                 SG    A   +  LS    +A+ +   +IP   G   +L    +  N ++    
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYI-RIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDA 188

Query: 61  IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLN 120
             L   ++L  + L  N            +  +R+L L+ N L        +   ++ + 
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY 248

Query: 121 LSFNDFEG 128
           L  N+   
Sbjct: 249 LHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 43.9 bits (102), Expect = 2e-05
 Identities = 20/151 (13%), Positives = 38/151 (25%), Gaps = 26/151 (17%)

Query: 4   NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIEL 63
           N ++        ++  L ++L L  N      P     L  L    +S N L        
Sbjct: 41  NKITEIKDGDFKNLKNL-HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP 99

Query: 64  GLCSSLE-----------------------DIYLGGNFFHGSIPSFFRTSRGIRKLDLSR 100
                L                        ++        G     F+  + +  + ++ 
Sbjct: 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 159

Query: 101 NNLSGQIPLFLEALSLEYLNLSFNDFEGKVP 131
            N++          SL  L+L  N       
Sbjct: 160 TNITTIPQGLPP--SLTELHLDGNKITKVDA 188

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 42.7 bits (99), Expect = 5e-05
 Identities = 30/152 (19%), Positives = 48/152 (31%), Gaps = 3/152 (1%)

Query: 23  SLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS 82
            L+L  N           NLK L +  + NN +S   P        LE +YL  N     
Sbjct: 35  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 94

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAI 142
                +T + +R  +     +   +   L  + +  L  +     G     G F     +
Sbjct: 95  PEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN--GAFQGMKKL 152

Query: 143 SVAGCHRL-CGGIPELQLPKCTENKSSNQRIS 173
           S           IP+   P  TE      +I+
Sbjct: 153 SYIRIADTNITTIPQGLPPSLTELHLDGNKIT 184

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 23/123 (18%), Positives = 39/123 (31%), Gaps = 11/123 (8%)

Query: 9   TIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSS 68
           TIP+ +         L+L  N         +  L  L    +S N +S      L     
Sbjct: 164 TIPQGLPP---SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220

Query: 69  LEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSG-------QIPLFLEALSLEYLNL 121
           L +++L  N             + I+ + L  NN+S              +  S   ++L
Sbjct: 221 LRELHLNNNKLVKVPGGLADH-KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

Query: 122 SFN 124
             N
Sbjct: 280 FSN 282

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 1e-04
 Identities = 21/106 (19%), Positives = 38/106 (35%), Gaps = 3/106 (2%)

Query: 5   DLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSG--EIPIE 62
           DL G   +       +   LN   +    ++     N+  L S ++SNN L    ++   
Sbjct: 28  DLKGLRSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI 86

Query: 63  LGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIP 108
           +    +L+ + L GN               + +L L  N+LS    
Sbjct: 87  VQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 5e-04
 Identities = 16/95 (16%), Positives = 28/95 (29%), Gaps = 4/95 (4%)

Query: 13  AIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSS 68
           A FSI   S  L+        S+   +    +++   +S N +  E    +   +     
Sbjct: 1   ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60

Query: 69  LEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNL 103
           LE       F            R + +  L    L
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (89), Expect = 7e-04
 Identities = 9/56 (16%), Positives = 21/56 (37%), Gaps = 1/56 (1%)

Query: 74  LGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGK 129
           L G   H  +      S+G+      R+ +   +        +++++LS +  E  
Sbjct: 7   LTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.4 bits (85), Expect = 0.002
 Identities = 11/52 (21%), Positives = 18/52 (34%), Gaps = 1/52 (1%)

Query: 29  NHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH 80
           N+        +  L+ L +  +  N L   IP        L   +L GN + 
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.003
 Identities = 12/63 (19%), Positives = 21/63 (33%), Gaps = 3/63 (4%)

Query: 60  PIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYL 119
              L   S L  +    N      P    +   + ++ L  N +S   PL     +L  +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA-NTSNLFIV 222

Query: 120 NLS 122
            L+
Sbjct: 223 TLT 225

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.1 bits (82), Expect = 0.003
 Identities = 8/44 (18%), Positives = 15/44 (34%), Gaps = 1/44 (2%)

Query: 83  IPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDF 126
              +    R  R+LDL    +     L       + ++ S N+ 
Sbjct: 11  AAQYTNAVR-DRELDLRGYKIPVIENLGATLDQFDAIDFSDNEI 53

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	452
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.82
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.82
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.78
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.75
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.74
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.73
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.7
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.69
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.66
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.65
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.64
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.63
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.6
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.57
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.56
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.56
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.56
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.55
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.54
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.52
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.5
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.49
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.48
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.36
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.35
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.31
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.11
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.96
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.91
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.79
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.66
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.57
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.54
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.52
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.48
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.42
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.19
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.9
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.77
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.63
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.53
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.32
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.51
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.05
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.63

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=370.19  Aligned_cols=198  Identities=27%  Similarity=0.393  Sum_probs=177.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|+..+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++||||+++++++     .+.+..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCEEEE
Confidence            4699999999999999999999999999999999877666678899999999999999999999984     44568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.+++..            ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++++||+|
T Consensus        95 vmEy~~gg~L~~~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~D  159 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE------------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  159 (293)
T ss_dssp             EEECCTTCBHHHHHHH------------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEecCCCcHHHHhhc------------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeecc
Confidence            9999999999998753            2588999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+.+......    .....||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus       160 FG~a~~~~~~~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  217 (293)
T d1yhwa1         160 FGFCAQITPEQSK----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL  217 (293)
T ss_dssp             CTTCEECCSTTCC----BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             chhheeecccccc----ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCC
Confidence            9999876533222    223569999999999999999999999999999999999999994

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=370.18  Aligned_cols=202  Identities=26%  Similarity=0.414  Sum_probs=173.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||+++++++     .+++..
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCcee
Confidence            3578999999999999999999999999999999975432 3346789999999999999999999984     445688


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        79 ~ivmEy~~gg~L~~~l~~~-----------~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL  144 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD-----------IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  144 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT-----------TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEE
T ss_pred             EEEEeccCCCcHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEE
Confidence            9999999999999999654           3689999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+........  ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||+
T Consensus       145 ~DFG~a~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~  207 (271)
T d1nvra_         145 SDFGLATVFRYNNRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  207 (271)
T ss_dssp             CCCTTCEECEETTEE--CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             ccchhheeeccCCcc--ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence            999999876533211  12234679999999999988776 578999999999999999999995

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=364.88  Aligned_cols=197  Identities=26%  Similarity=0.438  Sum_probs=175.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||+|++...   .....+.+.+|++++++++||||+++++++     .+++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence            5788999999999999999999999999999999632   344567889999999999999999999984     45668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~-----------~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~k  146 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKL-----------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK  146 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeecCCCcHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEe
Confidence            99999999999999998643           3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+......      .....||+.|||||++.+..++.++|||||||++|||+||+.||+
T Consensus       147 l~DFG~a~~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  205 (263)
T d2j4za1         147 IADFGWSVHAPSSR------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE  205 (263)
T ss_dssp             ECCCCSCSCCCCCC------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ecccceeeecCCCc------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence            99999997654221      123569999999999999999999999999999999999999995

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=365.63  Aligned_cols=208  Identities=26%  Similarity=0.402  Sum_probs=165.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||.++....  ...+.+.+|++++++++||||+++++++.+   +.++..
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCEE
Confidence            579999999999999999999999999999999975432  234568999999999999999999998642   234567


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEecccCCCCeeecCCCce
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC--QEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ++||||+++|+|.+++....       .....+++.+++.++.|++.||+|||+..  ..+|+||||||+|||+++++.+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~-------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~v  153 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGT-------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV  153 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHH-------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCE
T ss_pred             EEEEecCCCCcHHHHHHhcc-------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcE
Confidence            99999999999999985321       12346899999999999999999999861  1249999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+|+.......    ......||+.|||||++.+..++.++|||||||++|||+||+.||+
T Consensus       154 kl~DFG~a~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         154 KLGDFGLARILNHDTS----FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             EECCHHHHHHC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEeeccceeecccCCC----ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence            9999999987653221    1223579999999999999999999999999999999999999995

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=366.08  Aligned_cols=201  Identities=25%  Similarity=0.410  Sum_probs=174.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|++++++++||||++++++     +.+++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~-----~~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE-----EECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE-----EEECCE
Confidence            5799999999999999999999989999999999743   23445789999999999999999999998     445668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vk  148 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI-----------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ  148 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred             EEEEEEccCCCCHHHhhhcc-----------CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEE
Confidence            99999999999999988643           3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+.+......  .......||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus       149 l~DFG~a~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (288)
T d1uu3a_         149 ITDFGTAKVLSPESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR  211 (288)
T ss_dssp             ECCCTTCEECC------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecccccceecccCCcc--cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC
Confidence            9999999876533221  12234579999999999999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=367.45  Aligned_cols=200  Identities=28%  Similarity=0.404  Sum_probs=174.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      +.|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++||||+++++++.     +.+..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence            46888999999999999999999999999999998766666788999999999999999999999853     4568899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.+++....          ..+++.++..++.|++.||+|||++   +|+||||||+|||++.++++||+|
T Consensus        87 vmEy~~~g~L~~~~~~~~----------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~D  153 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE----------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLAD  153 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEe
Confidence            999999999999875322          3689999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccC-----CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL-----GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+......    .......||+.|+|||++.     ...|+.++|||||||++|||+||+.||+
T Consensus       154 FG~a~~~~~~~----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~  216 (288)
T d2jfla1         154 FGVSAKNTRTI----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH  216 (288)
T ss_dssp             CTTCEECHHHH----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             chhhhccCCCc----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC
Confidence            99997543211    1122356999999999873     4568999999999999999999999994

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=373.54  Aligned_cols=199  Identities=27%  Similarity=0.404  Sum_probs=174.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC-CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR-QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|+++... ....+.+.+|+++|++++|||||++++++     .+.+..
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            567999999999999999999999999999999997543 33356789999999999999999999985     455689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++.+.           ..+++..+..++.|++.||+|||+.  .+|+||||||+|||+++++++||
T Consensus        80 ~iVmEy~~gg~L~~~l~~~-----------~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl  146 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKA-----------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKL  146 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEcCCCCcHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEE
Confidence            9999999999999999643           3689999999999999999999973  18999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+......      ....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.
T Consensus       147 ~DFGla~~~~~~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~  204 (322)
T d1s9ja_         147 CDFGVSGQLIDSM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP  204 (322)
T ss_dssp             CCCCCCHHHHHHT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred             eeCCCccccCCCc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999998664321      123579999999999999999999999999999999999999994

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=357.82  Aligned_cols=199  Identities=34%  Similarity=0.525  Sum_probs=165.7

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|++.+.||+|+||+||+|+++   ..||||+++...  ....+.|.+|++++++++||||+++++++..      +.
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            467999999999999999999874   359999997443  3445789999999999999999999998532      35


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++....          ..+++.++..++.|+++||+|||+.   +|+||||||+|||+++++.+|
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~K  144 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIE----------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVK  144 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEE
T ss_pred             EEEEEecCCCCCHHHHHhhcc----------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEE
Confidence            789999999999999996543          3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+........  .......||+.|||||++.+   ..++.++|||||||++|||+||+.||+
T Consensus       145 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~  210 (276)
T d1uwha_         145 IGDFGLATVKSRWSGS--HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS  210 (276)
T ss_dssp             ECCCCCSCC--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             EccccceeeccccCCc--ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence            9999999865432221  12234569999999999864   358899999999999999999999995

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=364.37  Aligned_cols=199  Identities=27%  Similarity=0.377  Sum_probs=177.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+++|++++||||++++++     +++.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-----~~~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-----FQTHDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-----EECSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-----eccccc
Confidence            5799999999999999999999999999999999743   33455788999999999999999999998     556678


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|.+++...           ..+++.+++.++.|++.||+|||++   +|+||||||+|||++.++.+|
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~-----------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vk  145 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRE-----------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIK  145 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred             cccceeccCCCchhhhhhcc-----------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEE
Confidence            99999999999999998643           3688999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+.......    .....+||+.|+|||++.+..|+.++||||+||++|||+||+.||.
T Consensus       146 l~DFG~a~~~~~~~~----~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~  206 (337)
T d1o6la_         146 ITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY  206 (337)
T ss_dssp             ECCCTTCBCSCCTTC----CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeecccccccccCCc----ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCC
Confidence            999999986543222    1234679999999999999999999999999999999999999984

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=353.75  Aligned_cols=199  Identities=31%  Similarity=0.460  Sum_probs=168.3

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +..+.||+|+||+||+|+++.+++.||+|.+.....  ...+.+.+|+++|++++||||+++++++... ..+....++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE-SSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec-cccCCEEEEE
Confidence            455689999999999999999999999999975432  2346789999999999999999999986542 2345678999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec-CCCceEECc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD-NDLSAHIGD  390 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~-~~~~~kl~D  390 (452)
                      |||+++|+|.+++...           ..+++.++..++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|
T Consensus        91 mE~~~~g~L~~~l~~~-----------~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-----------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             EECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EeCCCCCcHHHHHhcc-----------ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEee
Confidence            9999999999999643           3689999999999999999999997 12399999999999997 578999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+.....      ......||+.|||||++.+ .++.++|||||||++|||+||+.||.
T Consensus       159 FGla~~~~~~------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~  213 (270)
T d1t4ha_         159 LGLATLKRAS------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS  213 (270)
T ss_dssp             TTGGGGCCTT------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCcceeccCC------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCC
Confidence            9999854321      1123579999999999865 69999999999999999999999994

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-48  Score=362.23  Aligned_cols=199  Identities=28%  Similarity=0.370  Sum_probs=160.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++||||++++++     +.+++..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~-----~~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEE-----EECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEE
Confidence            4568999999999999999999999999999999975432 334568899999999999999999998     4556789


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec---CCCc
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD---NDLS  385 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~  385 (452)
                      ++||||+++|+|.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++   +++.
T Consensus        83 ~lvmE~~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~  148 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK-----------GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSK  148 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred             EEEEeccCCCcHHHhhhcc-----------cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCce
Confidence            9999999999999999754           3689999999999999999999998   999999999999995   5789


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +||+|||+|+.......     ....+||+.|||||++.+..++.++||||+||++|||+||+.||.
T Consensus       149 vkl~DFG~a~~~~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  210 (307)
T d1a06a_         149 IMISDFGLSKMEDPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY  210 (307)
T ss_dssp             EEECCC-----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EEEeccceeEEccCCCe-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence            99999999986543221     223569999999999999999999999999999999999999994

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-48  Score=361.86  Aligned_cols=202  Identities=27%  Similarity=0.480  Sum_probs=175.0

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ..++|+..+.||+|+||+||+|+++.+|+.||||+++.+. ...++|.+|+++|++++||||++++++|.     +.+..
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~   88 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   88 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCee
Confidence            4467888899999999999999999889999999997543 34578999999999999999999999853     44578


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+++|+|.+++....         ...+++..++.++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~---------~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl  156 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECN---------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV  156 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSC---------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEeecccCcchHHHhhhcc---------ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEE
Confidence            99999999999999986432         24689999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||+|+.......   .......||+.|+|||++.+..++.++|||||||++|||+||..||
T Consensus       157 ~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~  216 (287)
T d1opja_         157 ADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  216 (287)
T ss_dssp             CCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccceeecCCCCc---eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence            99999986653222   2223345899999999999999999999999999999999977765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.5e-47  Score=364.88  Aligned_cols=199  Identities=23%  Similarity=0.343  Sum_probs=176.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++.......+.+.+|++++++++||||++++++     +.+++..++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE-----EECSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEE-----EEECCEEEE
Confidence            579999999999999999999999999999999986554555678899999999999999999998     455678999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec--CCCceEE
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD--NDLSAHI  388 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl  388 (452)
                      |||||++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++  .++.+||
T Consensus       104 vmE~~~gg~L~~~~~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL  170 (352)
T d1koba_         104 ILEFLSGGELFDRIAAED----------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKI  170 (352)
T ss_dssp             EEECCCCCBHHHHTTCTT----------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEE
T ss_pred             EEEcCCCChHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEE
Confidence            999999999998876443          4689999999999999999999998   999999999999998  6789999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+.+.....     .....||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus       171 ~DFGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  229 (352)
T d1koba_         171 IDFGLATKLNPDEI-----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA  229 (352)
T ss_dssp             CCCTTCEECCTTSC-----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             eecccceecCCCCc-----eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence            99999987653322     123569999999999999999999999999999999999999994

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-47  Score=360.19  Aligned_cols=196  Identities=30%  Similarity=0.429  Sum_probs=175.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|++++++++||||++++++     +.+.+.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-----~~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-----FQDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-----EECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee-----EeeCCe
Confidence            5688999999999999999999999999999999743   33455789999999999999999999998     445668


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++||||+++|+|..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vk  144 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKS-----------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK  144 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHT-----------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred             eeeEeeecCCcccccccccc-----------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEE
Confidence            99999999999999988654           3678888999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+.....       ....+||+.|||||++.+..++.++||||+||++|||+||+.||+
T Consensus       145 L~DFG~a~~~~~~-------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~  202 (316)
T d1fota_         145 ITDFGFAKYVPDV-------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY  202 (316)
T ss_dssp             ECCCSSCEECSSC-------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EecCccceEeccc-------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCC
Confidence            9999999865422       123579999999999999999999999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-47  Score=366.06  Aligned_cols=199  Identities=23%  Similarity=0.382  Sum_probs=176.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|++++++++||||+++++++     .+.+..++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEEE
Confidence            5799999999999999999999999999999999765555567889999999999999999999984     44568999


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC--CCceEE
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN--DLSAHI  388 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl  388 (452)
                      |||||++|+|.+++....          ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.  ++.+||
T Consensus       101 vmE~~~gg~L~~~l~~~~----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL  167 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH----------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKL  167 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT----------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEE
T ss_pred             EEEcCCCCCHHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEE
Confidence            999999999999986432          3689999999999999999999998   9999999999999964  578999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+.......     .....||+.|||||++.+..++.++||||+||++|||+||+.||.
T Consensus       168 ~DFG~a~~~~~~~~-----~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~  226 (350)
T d1koaa2         168 IDFGLTAHLDPKQS-----VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG  226 (350)
T ss_dssp             CCCTTCEECCTTSC-----EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eecchheecccccc-----cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence            99999987653322     123569999999999999999999999999999999999999994

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=352.45  Aligned_cols=199  Identities=26%  Similarity=0.459  Sum_probs=162.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||+||+|++. +++.||||+++.. ....++|.+|++++++++||||++++++|.     +.+..+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~   76 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC   76 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceE
Confidence            357888899999999999999986 6788999999753 344578999999999999999999999964     345689


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....          ..+++..++.++.|+|.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        77 lv~E~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~  143 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQR----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVS  143 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEEC
T ss_pred             EEEEecCCCcHHHHhhccc----------cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEec
Confidence            9999999999999987543          4688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhC-CCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT-KKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf  451 (452)
                      |||+++........   ......||+.|+|||++.+..++.++|||||||++|||+|+ ++||
T Consensus       144 DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~  203 (263)
T d1sm2a_         144 DFGMTRFVLDDQYT---SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY  203 (263)
T ss_dssp             SCC---------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccchheeccCCCce---eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCC
Confidence            99999866533221   22235689999999999999999999999999999999995 5555

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-47  Score=359.24  Aligned_cols=204  Identities=28%  Similarity=0.502  Sum_probs=160.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc---EEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT---VVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||+||+|+++.+++   .||||.+..... ...++|.+|+++|++++|||||+++++|.     +.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence            456777899999999999999976654   688998864433 33467999999999999999999999963     345


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++|||||++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++++
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~----------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~  167 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQND----------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVC  167 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             EEEEEEEecCCCcceeeecccc----------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcE
Confidence            7899999999999999887543          4689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCC-ceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNP-TVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++........ .........||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~  235 (299)
T d1jpaa_         168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW  235 (299)
T ss_dssp             EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence            99999999876533221 1222233568999999999999999999999999999999998 899984

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-47  Score=358.14  Aligned_cols=194  Identities=27%  Similarity=0.374  Sum_probs=169.4

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      .|+..+.||+|+||+||+|++..+|+.||||+++.....   ..+.+.+|+++|++++|||||++++++.     +++..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence            488889999999999999999999999999999755432   2356889999999999999999999853     45678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++|||||++|++..++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++.+||
T Consensus        91 ~iv~E~~~~g~l~~~~~~~-----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl  156 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHK-----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL  156 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred             EEEEEecCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEE
Confidence            9999999999998776432           3689999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC---CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG---SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+.....        ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.
T Consensus       157 ~DFG~a~~~~~~--------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         157 GDFGSASIMAPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             CCCTTCBSSSSB--------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             eecccccccCCC--------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence            999999864421        23469999999999754   468999999999999999999999984

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=352.54  Aligned_cols=199  Identities=25%  Similarity=0.337  Sum_probs=174.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC------ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ------GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||+++....      ...+.+.+|+++|++++||||+++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            3579999999999999999999999999999999974321      2357899999999999999999999984     4


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..++|||||++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~-----------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~  149 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEK-----------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDR  149 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCS
T ss_pred             ECCEEEEEEEcCCCccccchhccc-----------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecC
Confidence            566899999999999999998643           3689999999999999999999998   99999999999999877


Q ss_pred             C----ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 L----SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~----~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +    .+|++|||+|+.......     .....||+.|+|||++.+..++.++||||+||++|||+||+.||.
T Consensus       150 ~~~~~~vkl~DfG~a~~~~~~~~-----~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  217 (293)
T d1jksa_         150 NVPKPRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL  217 (293)
T ss_dssp             SSSSCCEEECCCTTCEECTTSCB-----CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCcccceEecchhhhhhcCCCcc-----ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence            6    499999999987653322     223568999999999999899999999999999999999999994

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=352.02  Aligned_cols=202  Identities=27%  Similarity=0.455  Sum_probs=169.8

Q ss_pred             cCCCCCCc-eeccCceeEEEEEEcC--CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNL-IGVGSFGSVYKGVFDE--DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|...+. ||+|+||+||+|.++.  ++..||||+++.... ...++|.+|+++|++++|||||+++++|..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            44555564 9999999999998753  455899999975433 334789999999999999999999998642      2


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+++|+|.+++...+          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~  148 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGKR----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA  148 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEE
T ss_pred             eEEEEEEeCCCCcHHHHhhccc----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCce
Confidence            4789999999999999986543          4689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||+| |+.||+
T Consensus       149 Kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~  214 (285)
T d1u59a_         149 KISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  214 (285)
T ss_dssp             EECCCTTCEECTTCSCE-ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             eeccchhhhcccccccc-cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence            99999999876533221 122233568999999999988899999999999999999998 999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=350.61  Aligned_cols=199  Identities=30%  Similarity=0.521  Sum_probs=170.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|++++++++|||||+++++|..      +..+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~~   83 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPIY   83 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCeE
Confidence            356888899999999999999986 67889999997443 345789999999999999999999998632      3468


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....         ...+++.+++.++.|+++||+|||+.   +|+||||||+|||+++++.+||+
T Consensus        84 iv~Ey~~~g~L~~~~~~~~---------~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~  151 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPS---------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIA  151 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHH---------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEeCCCCcHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeec
Confidence            9999999999999875432         24589999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||+|+......   ........||+.|+|||++.+..++.++|||||||++|||+||..|+
T Consensus       152 DFGla~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         152 DFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             CCTTCEECSSSC---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccceEEccCCc---cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            999998765322   12223456899999999998889999999999999999999965554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=343.01  Aligned_cols=200  Identities=29%  Similarity=0.494  Sum_probs=175.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|+..+.||+|+||+||+|+++ +++.||||.++... ...++|.+|++++++++||||++++++|.     +++..+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~   75 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceE
Confidence            468999999999999999999995 78899999998543 34578999999999999999999999964     345789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|.+++....          ..+++..+++++.|+++||+|||+.   +|+||||||+||++++++.+||+
T Consensus        76 iv~Ey~~~g~l~~~~~~~~----------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~  142 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMR----------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS  142 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGG----------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEccCCCcHHHhhhccc----------cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEEC
Confidence            9999999999999976432          4688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      |||+++........   ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       143 DfG~a~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~  203 (258)
T d1k2pa_         143 DFGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE  203 (258)
T ss_dssp             CCSSCCBCSSSSCC---CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cchhheeccCCCce---eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCC
Confidence            99999866543222   2233568999999999998999999999999999999998 899985

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-46  Score=359.80  Aligned_cols=196  Identities=26%  Similarity=0.381  Sum_probs=175.3

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+.+|+++|+.++||||++++++     +.+...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-----~~~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS-----FKDNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE-----EECSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccc-----cccccc
Confidence            5799999999999999999999999999999999743   33445788999999999999999999998     445568


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .++|+||+.+|+|..++...           ..+++.+++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~-----------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ik  181 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRI-----------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQ  181 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             cccccccccccchhhhHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEE
Confidence            89999999999999998643           3689999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+|+......       ....||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus       182 L~DFG~a~~~~~~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  239 (350)
T d1rdqe_         182 VTDFGFAKRVKGRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             ECCCTTCEECSSCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eeeceeeeeccccc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCC
Confidence            99999998765221       23569999999999999999999999999999999999999995

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=347.55  Aligned_cols=195  Identities=27%  Similarity=0.442  Sum_probs=163.7

Q ss_pred             CceeccCceeEEEEEEcC--CCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEEE
Q 041632          237 NLIGVGSFGSVYKGVFDE--DGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIVY  312 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  312 (452)
                      +.||+|+||+||+|.+..  +++.||||+++...  ....++|.+|+++|++++||||++++++|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            469999999999998753  45789999996432  3334689999999999999999999998632      2468999


Q ss_pred             eccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECccc
Q 041632          313 KYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDFG  392 (452)
Q Consensus       313 e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  392 (452)
                      ||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        87 E~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFG  152 (277)
T d1xbba_          87 EMAELGPLNKYLQQN-----------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG  152 (277)
T ss_dssp             ECCTTEEHHHHHHHC-----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EcCCCCcHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchh
Confidence            999999999998643           3689999999999999999999998   99999999999999999999999999


Q ss_pred             cccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          393 LSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       393 la~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +++........ ........||+.|||||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       153 la~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~  212 (277)
T d1xbba_         153 LSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  212 (277)
T ss_dssp             TCEECCTTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             hhhhccccccc-cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence            99876533222 222334568999999999998899999999999999999998 899984

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=351.75  Aligned_cols=199  Identities=29%  Similarity=0.449  Sum_probs=173.4

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc---CCccHHHHHHHHHHHh-cCCCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ---RQGASKSFMAECKALK-NIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~ei~~l~-~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||+||+|+++.+|+.||||+++..   .....+.+..|+.++. .++||||++++++     +.+++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~-----~~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT-----FQTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEE-----EECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEE-----EccCC
Confidence            5789999999999999999999999999999999743   2344456777777665 6899999999998     45567


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+||||+++|+|.+++...           ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~-----------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~  142 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSC-----------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHI  142 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred             ceeEEEeecCCCcHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCce
Confidence            899999999999999999643           3688999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+++........    .....||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus       143 kl~DFG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~  204 (320)
T d1xjda_         143 KIADFGMCKENMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH  204 (320)
T ss_dssp             EECCCTTCBCCCCTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eccccchhhhccccccc----ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence            99999999865432221    223569999999999999999999999999999999999999995

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.8e-46  Score=357.24  Aligned_cols=198  Identities=24%  Similarity=0.360  Sum_probs=169.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC---CccHHHHH---HHHHHHhcCCCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR---QGASKSFM---AECKALKNIRHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~ei~~l~~l~h~niv~l~~~~~~~~~~  303 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...   ......+.   +|+++++.++||||++++++     +.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~-----~~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----FH   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----EE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEE-----EE
Confidence            367999999999999999999999999999999996322   12223333   44777888899999999998     44


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      +.+..|+||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~-----------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~  143 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQH-----------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEH  143 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhc-----------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCC
Confidence            566899999999999999999643           3678899999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||+|+.+....      .....||+.|+|||++.. ..++.++|||||||++|||+||+.||+
T Consensus       144 g~iKl~DFGla~~~~~~~------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  207 (364)
T d1omwa3         144 GHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             SCEEECCCTTCEECSSSC------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcEEEeeeceeeecCCCc------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence            999999999998665322      123569999999999865 568999999999999999999999995

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=353.64  Aligned_cols=213  Identities=25%  Similarity=0.414  Sum_probs=171.6

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCc-----EEEEEEeecc-CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGT-----VVAIKVINLQ-RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|++.+.||+|+||+||+|++...++     .||+|.+... .......+.+|+.++.++ +|||||++++++.    
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence            3578889999999999999999865443     6999998643 233446789999999998 8999999999953    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCc------------ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQR------------DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILH  370 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  370 (452)
                       +.+..++||||+++|+|.++|+..+....            ........+++.+++.++.|++.||+|||+.   +|+|
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH  187 (325)
T d1rjba_         112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH  187 (325)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence             45578999999999999999976531100            0112234689999999999999999999998   9999


Q ss_pred             cccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCC
Q 041632          371 CDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKK  449 (452)
Q Consensus       371 ~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~  449 (452)
                      |||||+|||++.++.+||+|||+|+.........  ......||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~  265 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN  265 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCcee--eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence            9999999999999999999999998765433322  2233568999999999999999999999999999999998 899


Q ss_pred             CCC
Q 041632          450 PTD  452 (452)
Q Consensus       450 Pf~  452 (452)
                      ||+
T Consensus       266 Pf~  268 (325)
T d1rjba_         266 PYP  268 (325)
T ss_dssp             SST
T ss_pred             CCC
Confidence            984

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=346.45  Aligned_cols=203  Identities=29%  Similarity=0.493  Sum_probs=162.8

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC----cEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG----TVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++.|+..++||+|+||+||+|+++.++    ..||||+++.... ....+|.+|++++++++|||||+++++|.     +
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----c
Confidence            356788899999999999999987554    4799999975433 33457899999999999999999999964     3


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||+.+|++.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||||+.++
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~  147 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKD----------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNL  147 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred             CCceEEEEEecccCcchhhhhccc----------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCC
Confidence            457899999999999998876432          4689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      .+||+|||+++......... .......||+.|||||++.+..++.++|||||||++|||+||..|+
T Consensus       148 ~~Kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~  213 (283)
T d1mqba_         148 VCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP  213 (283)
T ss_dssp             CEEECCCCC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             eEEEcccchhhcccCCCccc-eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence            99999999998765332221 1223356899999999999999999999999999999999976654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.1e-46  Score=344.69  Aligned_cols=207  Identities=27%  Similarity=0.422  Sum_probs=169.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC---ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ---GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~  306 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....   ...+.+.+|+++++.++||||+++++++...+ ....
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence            4679999999999999999999999999999999975433   22357899999999999999999999865432 2334


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..|+||||+++|+|.+++...           ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++..
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~-----------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~  150 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE-----------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAV  150 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCE
T ss_pred             eEEEEEECCCCCEehhhhccc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccc
Confidence            578999999999999988543           3689999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +++|||.+......... ........||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus       151 ~l~d~~~~~~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  215 (277)
T d1o6ya_         151 KVMDFGIARAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT  215 (277)
T ss_dssp             EECCCTTCEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eeehhhhhhhhcccccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence            99999998765433221 122334679999999999999999999999999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=347.97  Aligned_cols=199  Identities=23%  Similarity=0.334  Sum_probs=173.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++... .....+.+|+++|+.++||||++++++     +++++..|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~-----~~~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES-----FESMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEE-----EEETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEE-----EEECCEEE
Confidence            467899999999999999999999999999999997543 234568899999999999999999998     44566899


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC--CceE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND--LSAH  387 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~k  387 (452)
                      +|||||++|+|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.+  ..+|
T Consensus        78 lvmE~~~gg~L~~~i~~~~----------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ik  144 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA----------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIK  144 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred             EEEecCCCCcHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEE
Confidence            9999999999999997543          3589999999999999999999998   99999999999999854  5899


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+|||+++.......     .....+|+.|+|||...+..++.++||||+||++|||++|+.||.
T Consensus       145 l~DFG~~~~~~~~~~-----~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~  204 (321)
T d1tkia_         145 IIEFGQARQLKPGDN-----FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL  204 (321)
T ss_dssp             ECCCTTCEECCTTCE-----EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EcccchhhccccCCc-----ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence            999999986543221     123568999999999999999999999999999999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-45  Score=339.70  Aligned_cols=198  Identities=25%  Similarity=0.421  Sum_probs=172.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc---------cHHHHHHHHHHHhcCC-CCCceeEeeeeccc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG---------ASKSFMAECKALKNIR-HKNLVRVITSCSSV  300 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~  300 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.....         ..+.+.+|++++++++ ||||++++++    
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~----   78 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT----   78 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE----
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee----
Confidence            5789999999999999999999999999999999754321         1246889999999996 9999999998    


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeee
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILL  380 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill  380 (452)
                       +.+++..|+||||+++|+|.++++..           ..+++.++..++.|++.||+|||++   +|+||||||+|||+
T Consensus        79 -~~~~~~~~ivmE~~~~g~L~~~l~~~-----------~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill  143 (277)
T d1phka_          79 -YETNTFFFLVFDLMKKGELFDYLTEK-----------VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILL  143 (277)
T ss_dssp             -EECSSEEEEEEECCTTCBHHHHHHHH-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             -cccCcceEEEEEcCCCchHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEE
Confidence             45567899999999999999999643           3689999999999999999999998   99999999999999


Q ss_pred             cCCCceEECccccccccccCCCCceeccccccccccccCccccC------CCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          381 DNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGL------GSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       381 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.++.+||+|||+++.......     .....||+.|+|||.+.      ...++.++||||+||++|||+||+.||.
T Consensus       144 ~~~~~~kl~DFG~a~~~~~~~~-----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~  216 (277)
T d1phka_         144 DDDMNIKLTDFGFSCQLDPGEK-----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  216 (277)
T ss_dssp             CTTCCEEECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCCCeEEccchheeEccCCCc-----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC
Confidence            9999999999999987653222     22356999999999864      3457889999999999999999999995

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=347.53  Aligned_cols=201  Identities=26%  Similarity=0.481  Sum_probs=166.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc----EEEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT----VVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      ++|+..+.||+|+||+||+|++..+|+    .||+|.++.. .....++|.+|++++++++|||||+++++|.+      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            468999999999999999999987775    5888888643 34456789999999999999999999999753      


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++++||+.+|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+|||++.++.
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~  149 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREHK----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH  149 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTS----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred             CCeeEEEEeccCCcccccccccc----------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCC
Confidence            24678899999999999886443          5689999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+|+.........  ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+
T Consensus       150 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~  215 (317)
T d1xkka_         150 VKITDFGLAKLLGAEEKEY--HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  215 (317)
T ss_dssp             EEECCCSHHHHTTTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             eEeeccccceecccccccc--cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence            9999999998765332221  1223468999999999999999999999999999999999 899985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-45  Score=347.06  Aligned_cols=200  Identities=22%  Similarity=0.305  Sum_probs=169.8

Q ss_pred             hcCCCCC-CceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSST-NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      .++|.+. +.||+|+||+||+|++..+|+.||||+++.     ...+.+|++++.++ +||||+++++++... ......
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence            3578776 469999999999999998999999999863     25678899987655 899999999986432 233467


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---CC
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DL  384 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~  384 (452)
                      .|+|||||++|+|.+++....         ...+++.++..++.|++.||+|||+.   +|+||||||+|||+++   ++
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~---------~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~  151 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRG---------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA  151 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCS---------CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTC
T ss_pred             EEEEEECCCCCcHHHHHHhcC---------CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccc
Confidence            899999999999999997532         24689999999999999999999998   9999999999999985   56


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+|+.......     .....||+.|||||++.+..|+.++||||+||++|||+||+.||.
T Consensus       152 ~~Kl~DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~  214 (335)
T d2ozaa1         152 ILKLTDFGFAKETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY  214 (335)
T ss_dssp             CEEECCCTTCEECCCCCC-----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred             cccccccceeeeccCCCc-----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence            799999999986653322     223569999999999999999999999999999999999999994

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=344.30  Aligned_cols=199  Identities=31%  Similarity=0.526  Sum_probs=164.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+|+++ +++.||||+++... ...+.|.+|+.++++++|||||+++++|..      +..+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~~   87 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY   87 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec------CCeE
Confidence            467889999999999999999997 45679999997443 345789999999999999999999998632      3468


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEEC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIG  389 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  389 (452)
                      +||||+++|+|..++...         ....+++.+++.++.|++.||+|||+.   +|+||||||+|||+++++++||+
T Consensus        88 lv~Ey~~~g~l~~~~~~~---------~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~  155 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGE---------TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA  155 (285)
T ss_dssp             EEECCCTTCBHHHHHSHH---------HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEecCCCchhhhhhhc---------ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEc
Confidence            999999999999988632         124589999999999999999999998   99999999999999999999999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      |||+++.......   .......||+.|+|||++....++.++|||||||++|||+||..|+
T Consensus       156 DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~  214 (285)
T d1fmka3         156 DFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP  214 (285)
T ss_dssp             CCCTTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccchhhhccCCCc---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence            9999986543222   1223356899999999999999999999999999999999976665

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=340.57  Aligned_cols=194  Identities=27%  Similarity=0.407  Sum_probs=162.3

Q ss_pred             CCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc-----cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          236 TNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG-----ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      .+.||+|+||+||+|+++.+|+.||||+++.....     ..+.+.+|++++++++||||++++++     +.+++..++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~-----~~~~~~~~i   77 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA-----FGHKSNISL   77 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE-----ECCTTCCEE
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEee-----eccCCceee
Confidence            46899999999999999999999999999644321     23468899999999999999999998     455667899


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+.++++..+....           ..+++.++..++.|++.||+|||+.   +|+||||||+|||+++++.+||+|
T Consensus        78 vmE~~~~~~~~~~~~~~-----------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~D  143 (299)
T d1ua2a_          78 VFDFMETDLEVIIKDNS-----------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD  143 (299)
T ss_dssp             EEECCSEEHHHHHTTCC-----------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             hhhhhcchHHhhhhhcc-----------cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccccc
Confidence            99999888777665432           3577888999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|+........    .....||+.|+|||++... .++.++||||+||++|||+||+.||.
T Consensus       144 FG~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~  202 (299)
T d1ua2a_         144 FGLAKSFGSPNRA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP  202 (299)
T ss_dssp             CGGGSTTTSCCCC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CccccccCCCccc----ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence            9999865533221    2235699999999987654 57999999999999999999999984

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=335.39  Aligned_cols=195  Identities=30%  Similarity=0.477  Sum_probs=161.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAI  310 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l  310 (452)
                      ++|++.+.||+|+||.||+|++  .|+.||||+++.+  ...+.|.+|++++++++||||++++++|.    .+.+..++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~~l   78 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYI   78 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CCEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcEEE
Confidence            5677889999999999999998  4789999999643  34578999999999999999999999863    23345799


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECc
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGD  390 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~D  390 (452)
                      ||||+++|+|.+++....         ...+++..+++++.|++.||+|||+.   +|+||||||+|||++.++.+|++|
T Consensus        79 v~ey~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~d  146 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRG---------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD  146 (262)
T ss_dssp             EECCCTTEEHHHHHHHHH---------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             EEeccCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecc
Confidence            999999999999996421         23589999999999999999999998   999999999999999999999999


Q ss_pred             cccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          391 FGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       391 fgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      ||+++......       ....+|..|+|||++.+..++.++|||||||++|||+| |+.||+
T Consensus       147 fg~s~~~~~~~-------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~  202 (262)
T d1byga_         147 FGLTKEASSTQ-------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  202 (262)
T ss_dssp             CCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             cccceecCCCC-------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence            99998654221       12347899999999988899999999999999999998 788874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-44  Score=337.71  Aligned_cols=200  Identities=27%  Similarity=0.494  Sum_probs=168.8

Q ss_pred             CCceeccCceeEEEEEEcCCC---cEEEEEEeecc-CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          236 TNLIGVGSFGSVYKGVFDEDG---TVVAIKVINLQ-RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       236 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      .++||+|+||+||+|++..++   ..||||+++.. .....++|.+|+++|++++||||++++++|..    .++..++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence            468999999999999986543   36999999743 33344789999999999999999999998743    23568999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEECcc
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHIGDF  391 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  391 (452)
                      ||||++|+|.+++....          ...++.+++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+||
T Consensus       108 ~E~~~~g~l~~~~~~~~----------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNET----------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             EECCTTCBHHHHHHCTT----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred             EEEeecCchhhhhcccc----------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecc
Confidence            99999999999987543          4577888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          392 GLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       392 gla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |+++.................||+.|+|||.+....++.++||||||+++|||+||+.||.
T Consensus       175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~  235 (311)
T d1r0pa_         175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY  235 (311)
T ss_dssp             GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence            9998765443333333344668999999999998999999999999999999999888873

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=337.90  Aligned_cols=200  Identities=30%  Similarity=0.503  Sum_probs=167.0

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      |+|++.+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|++++++++||||+++++++     .+.+..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence            578999999999999999999999999999999964432  3357899999999999999999999984     445689


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++||||+.++ +.+++....         ...+++.++..++.|++.||+|||+.   +||||||||+|||++.++.+||
T Consensus        77 ~iv~e~~~~~-~~~~~~~~~---------~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl  143 (298)
T d1gz8a_          77 YLVFEFLHQD-LKKFMDASA---------LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKL  143 (298)
T ss_dssp             EEEEECCSEE-HHHHHHHTT---------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             eEEEeecCCc-hhhhhhhhc---------ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCccee
Confidence            9999999654 444443211         24689999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.|+.......    ......||+.|+|||++.... ++.++||||+||++|||++|+.||+
T Consensus       144 ~DFG~a~~~~~~~~----~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~  204 (298)
T d1gz8a_         144 ADFGLARAFGVPVR----TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP  204 (298)
T ss_dssp             CSTTHHHHHCCCSB----CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccCCcceeccCCcc----cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence            99999986543221    222356999999999877665 5789999999999999999999994

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=338.49  Aligned_cols=204  Identities=27%  Similarity=0.347  Sum_probs=163.3

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeEEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKAIV  311 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv  311 (452)
                      +|...+.||+|+||+||+|++  +|+.||||+++... ........|+..+..++||||++++++|.... ......++|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            455678899999999999997  68899999996432 11222344555666789999999999986543 223467999


Q ss_pred             EeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEecccCCCCeeecCCCce
Q 041632          312 YKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQH-----CQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       312 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ||||++|+|.++++.            ..++|.+++.++.|+|.||+|+|+.     +.++|+||||||+||||++++.+
T Consensus        80 ~Ey~~~g~L~~~l~~------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             EECCTTCBHHHHHHH------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             EecccCCCHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence            999999999999964            2589999999999999999999973     23599999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCC------CCCcccceeehhHHHHHHHhCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS------EVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ||+|||+++.................||+.|+|||++.+.      .++.++|||||||++|||+||..||
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~  218 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence            9999999987765443333333456799999999997654      2677899999999999999998876

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=334.99  Aligned_cols=201  Identities=24%  Similarity=0.410  Sum_probs=160.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC---CcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED---GTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGN  305 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~  305 (452)
                      .++|+..+.||+|+||+||+|++..+   +..||||.++..... ..+.|.+|++++++++||||+++++++.      .
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence            35788899999999999999998644   357899988644333 3467999999999999999999999863      2


Q ss_pred             ceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCc
Q 041632          306 DFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLS  385 (452)
Q Consensus       306 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~  385 (452)
                      +..++||||+++|+|.+++....          ..+++.+++.++.|++.||+|||+.   +|+||||||+||++++++.
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~  146 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRK----------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDC  146 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTT----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTE
T ss_pred             CeEEEEEEeccCCcHHhhhhccC----------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCc
Confidence            35799999999999999875432          4689999999999999999999998   9999999999999999999


Q ss_pred             eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          386 AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       386 ~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +||+|||+|+........   ......||+.|+|||++.+..++.++|||||||++|||+| |+.||+
T Consensus       147 ~Kl~DfG~a~~~~~~~~~---~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~  211 (273)
T d1mp8a_         147 VKLGDFGLSRYMEDSTYY---KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ  211 (273)
T ss_dssp             EEECC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             EEEccchhheeccCCcce---eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCC
Confidence            999999999866532221   2223458999999999998999999999999999999998 899985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-44  Score=337.79  Aligned_cols=205  Identities=27%  Similarity=0.407  Sum_probs=170.9

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCC-CcEEEEEEeeccC--CccHHHHHHHHHHHhcC---CCCCceeEeeeeccccCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDED-GTVVAIKVINLQR--QGASKSFMAECKALKNI---RHKNLVRVITSCSSVDFQ  303 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l---~h~niv~l~~~~~~~~~~  303 (452)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++...  ......+.+|+.+++.+   +||||+++++++......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999655 6789999997432  22234566777776655   899999999998655555


Q ss_pred             CCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCC
Q 041632          304 GNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDND  383 (452)
Q Consensus       304 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  383 (452)
                      .....++++||++++++........          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~  152 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE----------PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS  152 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             cCceEEEEEEeccCCchhhhhhccC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCC
Confidence            6678899999998887765543322          4688999999999999999999998   99999999999999999


Q ss_pred             CceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          384 LSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       384 ~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +.+||+|||+++......     ......||+.|+|||++.+..++.++||||+||++|||+||+.||+
T Consensus       153 ~~~kl~dfg~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~  216 (305)
T d1blxa_         153 GQIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  216 (305)
T ss_dssp             CCEEECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCeeecchhhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence            999999999987543221     2234679999999999999999999999999999999999999995

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-44  Score=338.61  Aligned_cols=215  Identities=24%  Similarity=0.396  Sum_probs=173.3

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCCc-cHHHHHHHHHHHhcCCCCCceeEeeeecccc
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQG-ASKSFMAECKALKNIRHKNLVRVITSCSSVD  301 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~  301 (452)
                      ...++|+..+.||+|+||+||+|+++.     +++.||||+++..... ..++|.+|++++++++||||++++++|.   
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~---   86 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA---   86 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec---
Confidence            345789999999999999999999853     4578999999754333 3467999999999999999999999964   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCC-------------cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQ-------------RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPI  368 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  368 (452)
                        ..+..+++|||+++|+|.+++.......             .........+++.+++.++.|++.||+|||+.   +|
T Consensus        87 --~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          87 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             --cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence              3457899999999999999996432110             01112235689999999999999999999998   99


Q ss_pred             EecccCCCCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCC
Q 041632          369 LHCDLKPSNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK  448 (452)
Q Consensus       369 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~  448 (452)
                      +||||||+|||+|.++++||+|||+|+.........  ......||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence            999999999999999999999999998654332211  222356899999999999999999999999999999999986


Q ss_pred             -CCCC
Q 041632          449 -KPTD  452 (452)
Q Consensus       449 -~Pf~  452 (452)
                       .||.
T Consensus       240 ~~p~~  244 (301)
T d1lufa_         240 LQPYY  244 (301)
T ss_dssp             CCTTT
T ss_pred             CCCCC
Confidence             5663

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=332.93  Aligned_cols=202  Identities=28%  Similarity=0.403  Sum_probs=161.2

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCC-C--cEEEEEEeecc---CCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDED-G--TVVAIKVINLQ---RQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQG  304 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~--~~vavK~~~~~---~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~  304 (452)
                      ++|++.+.||+|+||+||+|++..+ +  ..||||+++..   .....++|.+|++++++++||||++++++|..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4688889999999999999997533 2  47899998643   23334689999999999999999999998642     


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                       +..++||||+++|++.+++...          ...+++..++.++.|+|.||+|||+.   +|+||||||+||+++.++
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~----------~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~  148 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKH----------QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD  148 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHH----------GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred             -cchheeeeeecCcchhhhhhcc----------cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccc
Confidence             2468999999999999887543          24689999999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      .+||+|||+++........ ........||..|+|||.+.+..++.++|||||||++|||+| |+.||.
T Consensus       149 ~vkl~DfGl~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~  216 (273)
T d1u46a_         149 LVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  216 (273)
T ss_dssp             EEEECCCTTCEECCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ceeeccchhhhhcccCCCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence            9999999999876533322 222334558899999999999999999999999999999998 899984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=334.52  Aligned_cols=197  Identities=26%  Similarity=0.352  Sum_probs=166.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCc------cHHHHHHHHHHHhcCC--CCCceeEeeeeccccC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQG------ASKSFMAECKALKNIR--HKNLVRVITSCSSVDF  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~ei~~l~~l~--h~niv~l~~~~~~~~~  302 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.....      ....+.+|+.++++++  ||||++++++     +
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~-----~   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-----F   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE-----E
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE-----E
Confidence            5789999999999999999999999999999999743221      1234678999999986  8999999998     4


Q ss_pred             CCCceeEEEEeccCC-CChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          303 QGNDFKAIVYKYMPN-GSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      .+.+..++||||+.+ +++.+++...           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++
T Consensus        79 ~~~~~~~lv~e~~~~~~~l~~~~~~~-----------~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~  144 (273)
T d1xwsa_          79 ERPDSFVLILERPEPVQDLFDFITER-----------GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID  144 (273)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH-----------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred             eeCCeEEEEEEeccCcchHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEe
Confidence            556688999999976 5777777532           3689999999999999999999998   999999999999998


Q ss_pred             C-CCceEECccccccccccCCCCceeccccccccccccCccccCCCCC-CcccceeehhHHHHHHHhCCCCCC
Q 041632          382 N-DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEV-STNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       382 ~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      . ++.+||+|||+|+......      .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||+
T Consensus       145 ~~~~~vkl~DFG~a~~~~~~~------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~  211 (273)
T d1xwsa_         145 LNRGELKLIDFGSGALLKDTV------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE  211 (273)
T ss_dssp             TTTTEEEECCCTTCEECCSSC------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCCCeEEECccccceeccccc------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence            5 5799999999998654321      123569999999999887665 567999999999999999999995

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-44  Score=335.39  Aligned_cols=215  Identities=25%  Similarity=0.375  Sum_probs=163.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeecccc
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVD  301 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~  301 (452)
                      ..++|++.+.||+|+||+||+|++..     +++.||||+++.... ...+.+.+|.+.+.++ +|+||+.+++++.   
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~---   87 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT---   87 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec---
Confidence            34678999999999999999999753     357899999974433 3345678888888777 7899999998863   


Q ss_pred             CCCCceeEEEEeccCCCChhhhhcCCCCCC-----cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCC
Q 041632          302 FQGNDFKAIVYKYMPNGSLEKWLHPDAIPQ-----RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPS  376 (452)
Q Consensus       302 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~  376 (452)
                       .++...++|||||++|+|.++++......     .........+++.+++.++.|++.||+|||+.   +|+||||||+
T Consensus        88 -~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          88 -KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             -STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             -cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence             34456899999999999999997543110     00111234689999999999999999999998   9999999999


Q ss_pred             CeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhC-CCCCC
Q 041632          377 NILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTT-KKPTD  452 (452)
Q Consensus       377 Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~Pf~  452 (452)
                      |||+++++++||+|||+|+........  .......||+.|+|||++.+..++.++|||||||++|||+|| ..||+
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTS--CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceeECCCCcEEEccCcchhhccccccc--cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999865433222  122345699999999999999999999999999999999996 45774

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-43  Score=331.56  Aligned_cols=209  Identities=25%  Similarity=0.387  Sum_probs=169.5

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeecc--CCccHHHHHHHHHHHhcCCCCCceeEeeeecccc---CCC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ--RQGASKSFMAECKALKNIRHKNLVRVITSCSSVD---FQG  304 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~---~~~  304 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+++|++++|||++++++++....   ...
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36789999999999999999999999999999998643  3344578999999999999999999999875432   122


Q ss_pred             CceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC
Q 041632          305 NDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL  384 (452)
Q Consensus       305 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  384 (452)
                      .+..++||||++++.+..+....           ..+++.+++.++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~-----------~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~  154 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL-----------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDG  154 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTS
T ss_pred             CceEEEEEeccCCCccchhhhcc-----------cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCC
Confidence            44689999999877776554332           4688889999999999999999998   999999999999999999


Q ss_pred             ceEECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+++.+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||+
T Consensus       155 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~  223 (318)
T d3blha1         155 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ  223 (318)
T ss_dssp             CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence            999999999987654333322333346799999999998765 68999999999999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-43  Score=328.77  Aligned_cols=213  Identities=25%  Similarity=0.409  Sum_probs=170.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCC-------cEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDG-------TVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSV  300 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~  300 (452)
                      .++|++.+.||+|+||+||+|+....+       ..||||+++.... ....++.+|...+.++ +||||++++++|.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence            467888899999999999999975443       4799999975443 2346788899999888 8999999999964  


Q ss_pred             cCCCCceeEEEEeccCCCChhhhhcCCCCCCc-----ccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          301 DFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQR-----DREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                         +++..++||||+++|+|.+++........     ........+++.+++.++.|++.||+|||+.   +||||||||
T Consensus        90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp  163 (299)
T d1fgka_          90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA  163 (299)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence               34578999999999999999976643211     1223346789999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPTD  452 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf~  452 (452)
                      +|||++.++.+||+|||+++.........  ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||+
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cceeecCCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            99999999999999999998766443322  2234568999999999999999999999999999999998 788874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=331.52  Aligned_cols=208  Identities=30%  Similarity=0.473  Sum_probs=168.5

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCc--EEEEEEeecc-CCccHHHHHHHHHHHhcC-CCCCceeEeeeeccccCCCCc
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGT--VVAIKVINLQ-RQGASKSFMAECKALKNI-RHKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~~~~~  306 (452)
                      ++|++.+.||+|+||+||+|+++.+|.  .||||.++.. .....+.|.+|+++|+++ +||||++++++|..     .+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence            578888999999999999999987776  4677877533 333456799999999999 79999999999653     45


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCC-----cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeec
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQ-----RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLD  381 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~  381 (452)
                      ..++||||+++|+|.++|+......     .........+++.+++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence            7899999999999999997642100     00112345789999999999999999999998   999999999999999


Q ss_pred             CCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCC-CCC
Q 041632          382 NDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK-KPT  451 (452)
Q Consensus       382 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~Pf  451 (452)
                      .++.+||+|||+++........     ....||..|+|||.+.+..++.++|||||||++|||++|. .||
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~  227 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  227 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEccccccccccccccc-----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCC
Confidence            9999999999999865432221     2345899999999999999999999999999999999975 466

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=332.60  Aligned_cols=206  Identities=26%  Similarity=0.331  Sum_probs=169.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      +++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|+.++||||+++++++....+......
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            4568899999999999999999999999999999975432 334678999999999999999999999866554444455


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      +++ +|+.+|+|.+++..            ..+++.++..++.|++.||+|||++   +|+||||||+|||+++++.+||
T Consensus        87 ~l~-~~~~~g~L~~~l~~------------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl  150 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKT------------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKI  150 (345)
T ss_dssp             EEE-EECCCEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEE
T ss_pred             EEE-EeecCCchhhhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEE
Confidence            555 55669999999853            2589999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+++......... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||+
T Consensus       151 ~DfG~a~~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~  214 (345)
T d1pmea_         151 CDFGLARVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP  214 (345)
T ss_dssp             CCCTTCEECCGGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccCceeeccCCCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence            9999998654332211 12234569999999999755 457889999999999999999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.6e-43  Score=326.29  Aligned_cols=198  Identities=26%  Similarity=0.417  Sum_probs=166.6

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|+..+.||+|+||+||+|+++ +|+.||||+++...  ....+.+.+|+.+|++++||||+++++++     .+.+..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence            57888999999999999999986 78999999996542  33357899999999999999999999884     455678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++++||+.++.+..+....           ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+|+
T Consensus        76 ~i~~e~~~~~~~~~~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl  141 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCE-----------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKI  141 (286)
T ss_dssp             EEEEECCSEEHHHHHHTST-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeehhhhHHHHHhhc-----------CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEe
Confidence            9999999877776665433           4699999999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||.+........    ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||+
T Consensus       142 ~DfG~a~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~  202 (286)
T d1ob3a_         142 ADFGLARAFGIPVR----KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP  202 (286)
T ss_dssp             CCTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccceecccCcc----ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence            99999987653322    12234689999999998754 56899999999999999999999994

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-43  Score=328.79  Aligned_cols=212  Identities=25%  Similarity=0.408  Sum_probs=172.3

Q ss_pred             hhcCCCCCCceeccCceeEEEEEEcC-----CCcEEEEEEeeccCC-ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC
Q 041632          229 ATDGFSSTNLIGVGSFGSVYKGVFDE-----DGTVVAIKVINLQRQ-GASKSFMAECKALKNIRHKNLVRVITSCSSVDF  302 (452)
Q Consensus       229 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~  302 (452)
                      ..++|+..+.||+|+||+||+|.+..     +++.||||+++.... .....|.+|++++++++||||++++++|.    
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----   93 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   93 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC----
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe----
Confidence            34678888999999999999999842     357899999975433 22356899999999999999999999964    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                       ..+..++||||+++|+|.+++...... .........+++.++..++.|+|+||+|||+.   +|+||||||+|||+++
T Consensus        94 -~~~~~~lv~e~~~~g~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          94 -QGQPTLVIMELMTRGDLKSYLRSLRPA-MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  168 (308)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHHHHH-HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             -cCCceeEEEeecCCCCHHHHHHhcccc-cccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence             345789999999999999998642100 00111224578999999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCC-CCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTK-KPT  451 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~Pf  451 (452)
                      ++++||+|||+|+.......  ........||+.|+|||.+.+..++.++|||||||++|||+||. .||
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~  236 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY  236 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             CceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCC
Confidence            99999999999986653322  12223346899999999999999999999999999999999985 666

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=325.72  Aligned_cols=212  Identities=26%  Similarity=0.386  Sum_probs=173.2

Q ss_pred             hcCCCCCCceeccCceeEEEEEEc-----CCCcEEEEEEeeccCC-ccHHHHHHHHHHHhcC-CCCCceeEeeeeccccC
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFD-----EDGTVVAIKVINLQRQ-GASKSFMAECKALKNI-RHKNLVRVITSCSSVDF  302 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~ei~~l~~l-~h~niv~l~~~~~~~~~  302 (452)
                      .++|+..+.||+|+||.||+|++.     .+++.||||+++.... .....|.+|+.+++++ +|||||+++++|.    
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~----   97 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe----
Confidence            467888899999999999999873     4567999999975443 3345789999999999 7999999999964    


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCC-------cccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQ-------RDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                       +.+..++||||+++|+|.++++......       .........+++.++..++.||+.||+|||++   +++||||||
T Consensus        98 -~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp  173 (311)
T d1t46a_          98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA  173 (311)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence             3456899999999999999997543211       01122345789999999999999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHh-CCCCC
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVT-TKKPT  451 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~Pf  451 (452)
                      +||+++.++.+|++|||.++........  .......||+.|+|||++.+..++.++|||||||++|||+| |++||
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTS--EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ccccccccCcccccccchheeccCCCcc--eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            9999999999999999999876543322  22334679999999999998899999999999999999999 55555

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.5e-42  Score=320.57  Aligned_cols=201  Identities=21%  Similarity=0.311  Sum_probs=169.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCC-CCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRH-KNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h-~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+.+|++.++.++| +|++.+++++     ..+...+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~~~   77 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLHNV   77 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCCccE
Confidence            578899999999999999999999999999999864432  2457788899999965 8899888874     3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC-----CC
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN-----DL  384 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~  384 (452)
                      +||||+ +++|.+++....          ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.     ++
T Consensus        78 ~vme~~-~~~l~~~~~~~~----------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~  143 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCG----------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN  143 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred             EEEEec-CCCHHHHHHhhc----------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence            999999 789999886433          4688999999999999999999998   9999999999999974     57


Q ss_pred             ceEECccccccccccCCCCc---eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          385 SAHIGDFGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       385 ~~kl~Dfgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      .+||+|||+|+.+.......   ........||+.|||||++.+..++.++|||||||++|||+||+.||+
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            89999999998765332211   112234579999999999999999999999999999999999999994

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=326.79  Aligned_cols=201  Identities=26%  Similarity=0.379  Sum_probs=163.1

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCceeEE
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGNDFKAI  310 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~~~~l  310 (452)
                      +|+..++||+|+||+||+|++..+|+.||||++.....    ...+|+++|++++||||+++++++..... .+..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            47778899999999999999999999999999975432    23479999999999999999998754322 33446789


Q ss_pred             EEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-ceEEC
Q 041632          311 VYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-SAHIG  389 (452)
Q Consensus       311 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~  389 (452)
                      ||||++++.+......        ......+++.++..++.|++.||+|||+.   +|+||||||+|||++.++ .+||+
T Consensus        97 v~Ey~~~~~~~~l~~~--------~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          97 VLDYVPETVYRVARHY--------SRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             EEECCSEEHHHHHHHH--------HHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEEC
T ss_pred             EEeccCCccHHHHHhh--------hhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEe
Confidence            9999976643333211        01234689999999999999999999998   999999999999999775 89999


Q ss_pred             ccccccccccCCCCceeccccccccccccCccccCC-CCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          390 DFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLG-SEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       390 Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |||+++.......     .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.
T Consensus       166 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~  224 (350)
T d1q5ka_         166 DFGSAKQLVRGEP-----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP  224 (350)
T ss_dssp             CCTTCEECCTTSC-----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             cccchhhccCCcc-----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCC
Confidence            9999986643222     123569999999998765 568999999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-42  Score=320.81  Aligned_cols=203  Identities=26%  Similarity=0.388  Sum_probs=167.1

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCceeE
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  .+++..|+++++.++|+|++..+..|.    .+.+..+
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~~~   79 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDYNV   79 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCEEE
Confidence            3579999999999999999999998999999999875432  245789999999998888776666553    3456789


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC---CCce
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN---DLSA  386 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~  386 (452)
                      +||||+ ++++..++....          ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.   +..+
T Consensus        80 ivme~~-~~~l~~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~v  145 (299)
T d1ckia_          80 MVMELL-GPSLEDLFNFCS----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV  145 (299)
T ss_dssp             EEEECC-CCBHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred             EEEEEc-CCchhhhhhhcc----------CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCcee
Confidence            999999 666666654322          4689999999999999999999998   9999999999999864   5579


Q ss_pred             EECccccccccccCCCCc---eeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPT---VSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ||+|||+|+.+.......   ........||+.|||||.+.+..++.++|||||||++|||+||+.||.
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~  214 (299)
T d1ckia_         146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ  214 (299)
T ss_dssp             EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence            999999999775332211   112234579999999999999999999999999999999999999984

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=326.39  Aligned_cols=200  Identities=28%  Similarity=0.356  Sum_probs=164.3

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCc
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGND  306 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~  306 (452)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++....  ...+.+.+|+++|+.++|||||++++++...+. ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4678899999999999999999999999999999974322  234678899999999999999999998754332 2334


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCce
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSA  386 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~  386 (452)
                      ..++||||+ +.+|..+.+.            ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~  160 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH------------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCEL  160 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             eEEEEEecc-cccHHHHHHh------------ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccc
Confidence            579999999 6677776642            3589999999999999999999998   99999999999999999999


Q ss_pred             EECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          387 HIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       387 kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      |++|||+|+......       ....||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       161 kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~  220 (346)
T d1cm8a_         161 KILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK  220 (346)
T ss_dssp             EECCCTTCEECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ccccccceeccCCcc-------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence            999999998654321       235699999999998764 56899999999999999999999984

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-41  Score=320.73  Aligned_cols=194  Identities=23%  Similarity=0.362  Sum_probs=167.1

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCceeE
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGNDFKA  309 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~  309 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++.   ...+++.+|+++|+.++ ||||+++++++..   ......+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCcee
Confidence            679999999999999999999999999999999863   23577899999999995 9999999988542   3345689


Q ss_pred             EEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCC-ceEE
Q 041632          310 IVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDL-SAHI  388 (452)
Q Consensus       310 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl  388 (452)
                      +||||+++++|..+.              +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||
T Consensus       109 ~v~e~~~~~~L~~~~--------------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl  171 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY--------------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRL  171 (328)
T ss_dssp             EEEECCCSCBGGGTT--------------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEEeecCCCcHHHHh--------------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeee
Confidence            999999999998764              3588999999999999999999998   999999999999998655 6999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      +|||+|+........     ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus       172 ~DFG~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~  231 (328)
T d3bqca1         172 IDWGLAEFYHPGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  231 (328)
T ss_dssp             CCGGGCEECCTTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             cccccceeccCCCcc-----cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence            999999876533222     235689999999997765 47999999999999999999999983

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=315.62  Aligned_cols=198  Identities=25%  Similarity=0.411  Sum_probs=171.7

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccC--CccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCcee
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQR--QGASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~~  308 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++...  ......+.+|+.+++.++||||+++++++     .+.+..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            47889999999999999999999999999999997543  33457899999999999999999999984     445678


Q ss_pred             EEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceEE
Q 041632          309 AIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAHI  388 (452)
Q Consensus       309 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  388 (452)
                      ++++|++.++++..++...           ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        77 ~iv~~~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl  142 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN-----------GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKL  142 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             eEEeeeccccccccccccc-----------cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceee
Confidence            9999999999998887654           3678889999999999999999998   9999999999999999999999


Q ss_pred             CccccccccccCCCCceeccccccccccccCccccCCCC-CCcccceeehhHHHHHHHhCCCCC
Q 041632          389 GDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSE-VSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       389 ~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      +|||.++.........    ....+++.|+|||.+.... ++.++||||+||++|||++|+.||
T Consensus       143 ~DFG~a~~~~~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  202 (292)
T d1unla_         143 ANFGLARAFGIPVRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             CCCTTCEECCSCCSCC----CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             eecchhhcccCCCccc----eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCC
Confidence            9999998765333222    2345788999999987655 689999999999999999999996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=324.85  Aligned_cols=200  Identities=27%  Similarity=0.412  Sum_probs=168.2

Q ss_pred             cCCCCCCceeccCceeEEEEEE---cCCCcEEEEEEeeccC----CccHHHHHHHHHHHhcCCC-CCceeEeeeeccccC
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVF---DEDGTVVAIKVINLQR----QGASKSFMAECKALKNIRH-KNLVRVITSCSSVDF  302 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~ei~~l~~l~h-~niv~l~~~~~~~~~  302 (452)
                      ++|++.+.||+|+||+||+|+.   +.+|+.||||+++...    ....+.+.+|++++++++| |||++++++     +
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~-----~   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA-----F   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE-----E
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee-----e
Confidence            5699999999999999999987   3468999999986332    2334678899999999976 899999988     4


Q ss_pred             CCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecC
Q 041632          303 QGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDN  382 (452)
Q Consensus       303 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~  382 (452)
                      .+....++++||+.+|+|.+++...           ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~-----------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~  164 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQR-----------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS  164 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             ccCCceeeeeecccccHHHHHHHhc-----------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC
Confidence            4456899999999999999998643           3567888999999999999999998   9999999999999999


Q ss_pred             CCceEECccccccccccCCCCceeccccccccccccCccccCCC--CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          383 DLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS--EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       383 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.+||+|||+++.+.....   .......|++.|+|||.+.+.  .++.++||||+||++|||+||+.||.
T Consensus       165 ~~~vkL~DFG~a~~~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~  233 (322)
T d1vzoa_         165 NGHVVLTDFGLSKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT  233 (322)
T ss_dssp             TSCEEESCSSEEEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             CCCEEEeeccchhhhccccc---ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            99999999999986543221   122345799999999998764  46889999999999999999999994

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-41  Score=322.85  Aligned_cols=201  Identities=25%  Similarity=0.344  Sum_probs=167.0

Q ss_pred             hcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccCCCCce
Q 041632          230 TDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDFQGNDF  307 (452)
Q Consensus       230 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~~~~~~  307 (452)
                      +++|++.+.||+|+||+||+|++..+|+.||||+++....  ...+.+.+|+++++.++|||++++++++......+...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            5679999999999999999999999999999999975433  23457889999999999999999998865443333344


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .+++++|+.+|+|.+++...            .+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~------------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             eEEEEEeecCCchhhhcccc------------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccc
Confidence            56667788899999998542            589999999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCC-CCCcccceeehhHHHHHHHhCCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGS-EVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++|||++......       .....||+.|+|||...+. .++.++||||+||++|||++|+.||.
T Consensus       162 l~dfg~a~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         162 ILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             ECCC----CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccchhcccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence            9999998754321       2235699999999986665 46889999999999999999999984

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=319.67  Aligned_cols=199  Identities=26%  Similarity=0.269  Sum_probs=160.9

Q ss_pred             cCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC--ccHHHHHHHHHHHhcCCCCCceeEeeeeccccC-CCCce
Q 041632          231 DGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ--GASKSFMAECKALKNIRHKNLVRVITSCSSVDF-QGNDF  307 (452)
Q Consensus       231 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~ei~~l~~l~h~niv~l~~~~~~~~~-~~~~~  307 (452)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....  ....++.+|+.++++++||||+++++++..... +....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            578999999999999999999999999999999975432  233568899999999999999999998754332 34578


Q ss_pred             eEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCeeecCCCceE
Q 041632          308 KAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNILLDNDLSAH  387 (452)
Q Consensus       308 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~k  387 (452)
                      .|+||||+.++.+. .+.             ..+++.++..++.|++.||+|||+.   ||+||||||+|||++.++.+|
T Consensus        97 ~~iv~Ey~~~~l~~-~~~-------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~k  159 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQ-------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_dssp             EEEEEECCSEEHHH-HHT-------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             eEEEEeccchHHHH-hhh-------------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccccccee
Confidence            89999999665544 432             2578899999999999999999998   999999999999999999999


Q ss_pred             ECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCC
Q 041632          388 IGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPT  451 (452)
Q Consensus       388 l~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf  451 (452)
                      ++|||+++......     ......+|+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       160 l~df~~~~~~~~~~-----~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF  218 (355)
T d2b1pa1         160 ILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF  218 (355)
T ss_dssp             ECCCCC--------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             eechhhhhcccccc-----ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence            99999987554322     223356899999999999999999999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-35  Score=286.47  Aligned_cols=199  Identities=22%  Similarity=0.335  Sum_probs=156.9

Q ss_pred             CCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-----------CCCceeEeeeeccc
Q 041632          232 GFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-----------HKNLVRVITSCSSV  300 (452)
Q Consensus       232 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-----------h~niv~l~~~~~~~  300 (452)
                      +|++.+.||+|+||+||+|+...+|+.||||+++... ...+.+.+|+++++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~-   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH-   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE-
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee-
Confidence            4899999999999999999999999999999997432 23467788999888775           5778888877542 


Q ss_pred             cCCCCceeEEEEeccCCCCh-hhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCCCCee
Q 041632          301 DFQGNDFKAIVYKYMPNGSL-EKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKPSNIL  379 (452)
Q Consensus       301 ~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~~Nil  379 (452)
                        ......+++++++..+.. ......         .....+++..+..++.|++.||+|||+.  .+|+||||||+|||
T Consensus        92 --~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIl  158 (362)
T d1q8ya_          92 --KGPNGVHVVMVFEVLGENLLALIKK---------YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVL  158 (362)
T ss_dssp             --EETTEEEEEEEECCCCEEHHHHHHH---------TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEE
T ss_pred             --ccccceeeeeeeccccccccccccc---------ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHee
Confidence              223445566666554432 222211         1235688889999999999999999983  29999999999999


Q ss_pred             ecCCCc------eEECccccccccccCCCCceeccccccccccccCccccCCCCCCcccceeehhHHHHHHHhCCCCCC
Q 041632          380 LDNDLS------AHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAPEYGLGSEVSTNGDVYSYGILLLEMVTTKKPTD  452 (452)
Q Consensus       380 l~~~~~------~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~Pf~  452 (452)
                      ++.++.      +|++|||.+.......       ....||+.|+|||++....++.++||||+||+++||++|+.||+
T Consensus       159 l~~~~~~~~~~~~kl~dfg~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         159 MEIVDSPENLIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             EEEEETTTTEEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             eeccCcccccceeeEeeccccccccccc-------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence            986653      9999999987554222       22469999999999999999999999999999999999999984

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.90  E-value=4.8e-25  Score=191.74  Aligned_cols=162  Identities=17%  Similarity=0.137  Sum_probs=116.7

Q ss_pred             CCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCC------------------ccHHHHHHHHHHHhcCCCCCceeEee
Q 041632          234 SSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQ------------------GASKSFMAECKALKNIRHKNLVRVIT  295 (452)
Q Consensus       234 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~ei~~l~~l~h~niv~l~~  295 (452)
                      .+.+.||+|+||+||+|+.. +|+.||||+++....                  ........|...+.++.|++++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34678999999999999985 789999998753211                  00123456888999999999988775


Q ss_pred             eeccccCCCCceeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCCCCCeEecccCC
Q 041632          296 SCSSVDFQGNDFKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHCQEPILHCDLKP  375 (452)
Q Consensus       296 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dlk~  375 (452)
                      ..         ..+++|||++++.+.+                  ++......++.|++.+++|||+.   +|+||||||
T Consensus        82 ~~---------~~~lvme~~~~~~~~~------------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP  131 (191)
T d1zara2          82 WE---------GNAVLMELIDAKELYR------------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQ  131 (191)
T ss_dssp             EE---------TTEEEEECCCCEEGGG------------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             ec---------CCEEEEEeeccccccc------------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCCh
Confidence            41         2379999998765543                  22233567899999999999998   999999999


Q ss_pred             CCeeecCCCceEECccccccccccCCCCceeccccccccccccCc------cccCCCCCCcccceeehhHH
Q 041632          376 SNILLDNDLSAHIGDFGLSRFYQAVSNPTVSSSIGVRGTIGYVAP------EYGLGSEVSTNGDVYSYGIL  440 (452)
Q Consensus       376 ~Nill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DvwSlGv~  440 (452)
                      +|||++++ .++|+|||.|........            ..|...      |. ....|+.++|+||..--
T Consensus       132 ~NILv~~~-~~~liDFG~a~~~~~~~~------------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         132 YNVLVSEE-GIWIIDFPQSVEVGEEGW------------REILERDVRNIITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TSEEEETT-EEEECCCTTCEETTSTTH------------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHH
T ss_pred             hheeeeCC-CEEEEECCCcccCCCCCc------------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHH
Confidence            99999965 589999999875431111            011110      11 13567889999997543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=3.3e-20  Score=169.54  Aligned_cols=148  Identities=22%  Similarity=0.204  Sum_probs=112.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCc---
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGN---   77 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N---   77 (452)
                      |++|+|++..+..|.++++| ++|+|++|+|+ .+| .++.+++|++|+|++|+++ ..|..+..+++|+.|++++|   
T Consensus        38 Ls~N~i~~l~~~~f~~l~~L-~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~  113 (266)
T d1p9ag_          38 LSENLLYTFSLATLMPYTRL-TQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT  113 (266)
T ss_dssp             CTTSCCSEEEGGGGTTCTTC-CEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCC
T ss_pred             CcCCcCCCcCHHHhhccccc-ccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccc
Confidence            57788885445667778887 78888888887 554 3567777777777777776 45556666666666555555   


Q ss_pred             ---------------------cccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccc
Q 041632           78 ---------------------FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGI  135 (452)
Q Consensus        78 ---------------------~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~  135 (452)
                                           .++...+..+..+++|+.|++++|+|+++++..+..++ |++|+|++|+|+.+|+.+..
T Consensus       114 ~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~  193 (266)
T d1p9ag_         114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFG  193 (266)
T ss_dssp             CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             eeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCC
Confidence                                 44433445566778899999999999998888777655 99999999999988888888


Q ss_pred             cccccccccccccccCC
Q 041632          136 FANTSAISVAGCHRLCG  152 (452)
Q Consensus       136 ~~~l~~l~~~~n~~~c~  152 (452)
                      +++|+.|++++|||.|.
T Consensus       194 ~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         194 SHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             TCCCSEEECCSCCBCCS
T ss_pred             CCCCCEEEecCCCCCCC
Confidence            89999999999999995

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.82  E-value=1.5e-20  Score=163.07  Aligned_cols=151  Identities=24%  Similarity=0.265  Sum_probs=126.8

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCC-CcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSI-PPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      +++|+|+ .+|.++.  +.+ ++|+|++|+|++.+ +..|.++++|+.|+|++|++....++.|..+++|++|+|++|+|
T Consensus        15 Cs~~~L~-~iP~~lp--~~l-~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l   90 (192)
T d1w8aa_          15 CTGRGLK-EIPRDIP--LHT-TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             CTTSCCS-SCCSCCC--TTC-SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             EeCCCcC-ccCCCCC--CCC-CEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccc
Confidence            4688999 8898875  577 89999999998655 45678999999999999999988889999999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccccCCCCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGGIP  155 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~~~  155 (452)
                      +...|..|.++++|+.|+|++|+|++++++.|...+ |++|+|++|.+....+.......+....+..|...|..+.
T Consensus        91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh
Confidence            977788899999999999999999999998887665 9999999999987655433344566667777777776543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.78  E-value=2.4e-19  Score=167.83  Aligned_cols=156  Identities=31%  Similarity=0.506  Sum_probs=120.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCC-CEEEccCccccc----------------------
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKAL-RSFDVSNNGLSG----------------------   57 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L-~~L~l~~N~l~~----------------------   57 (452)
                      ++.|++.+.+|.++.+++.+ +.+++++|.+++.+|..+..+..+ +.+++++|++++                      
T Consensus       132 l~~N~~~~~~p~~l~~l~~L-~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEE
T ss_pred             cccccccccCchhhccCccc-ceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            35566666777777777776 677777777776777766666654 566666666554                      


Q ss_pred             -cCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccc
Q 041632           58 -EIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGI  135 (452)
Q Consensus        58 -~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~  135 (452)
                       .+|..+..+++|+.+++++|.+.+.+ +.+..+++|+.|+|++|+|++.+|..+..++ |++|+|++|+|+|.+|..+.
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~  289 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN  289 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred             ccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence             45555677888999999999998554 4688899999999999999987666555554 99999999999988888888


Q ss_pred             cccccccccccccccCCCCCCCCCCcc
Q 041632          136 FANTSAISVAGCHRLCGGIPELQLPKC  162 (452)
Q Consensus       136 ~~~l~~l~~~~n~~~c~~~~~~~~~~~  162 (452)
                      +++|+.+++.+|+.+||.+    +|.|
T Consensus       290 L~~L~~l~l~~N~~l~g~p----lp~c  312 (313)
T d1ogqa_         290 LQRFDVSAYANNKCLCGSP----LPAC  312 (313)
T ss_dssp             GGGSCGGGTCSSSEEESTT----SSCC
T ss_pred             CCCCCHHHhCCCccccCCC----CCCC
Confidence            9999999999999999864    3566

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.2e-18  Score=158.83  Aligned_cols=150  Identities=18%  Similarity=0.199  Sum_probs=133.7

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ..|+++...|..+.++++| ++|+|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|+|++
T Consensus        89 ~~~~~~~l~~~~~~~l~~L-~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~  167 (284)
T d1ozna_          89 DNAQLRSVDPATFHGLGRL-HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS  167 (284)
T ss_dssp             SCTTCCCCCTTTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred             cccccccccchhhcccccC-CEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc
Confidence            3566775557788899999 999999999986677788899999999999999996666789999999999999999998


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCc-ccccccccccccccccccCC
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPT-KGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~-~~~~~~l~~l~~~~n~~~c~  152 (452)
                      ..+..|.++++|+.+++++|+++++.|..+...+ |++|++++|++++.++. ++.+++|+.+++++|||.|.
T Consensus       168 l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             cchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            8888999999999999999999999888887765 99999999999998875 46789999999999999985

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.74  E-value=3e-18  Score=148.36  Aligned_cols=150  Identities=15%  Similarity=0.147  Sum_probs=126.4

Q ss_pred             CCCCcccccC-CcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccc
Q 041632            1 MFENDLSGTI-PEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFF   79 (452)
Q Consensus         1 l~~N~l~~~~-p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   79 (452)
                      |++|+|++.+ +..|..+++| +.|+|++|++++..+..|..+++|++|+|++|+|+...|+.|.++++|++|+|++|+|
T Consensus        36 Ls~N~i~~~~~~~~f~~l~~L-~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l  114 (192)
T d1w8aa_          36 LNDNELGRISSDGLFGRLPHL-VKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI  114 (192)
T ss_dssp             CCSCCCCSBCCSCSGGGCTTC-CEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCC
T ss_pred             eCCCCCcccccccccCCCceE-eeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccc
Confidence            6899998656 4556789999 9999999999988889999999999999999999977778899999999999999999


Q ss_pred             cccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccccCCC
Q 041632           80 HGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCGG  153 (452)
Q Consensus        80 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~~  153 (452)
                      ++..|+.|..+++|+.|+|++|.+....+..+-...++.+.+..|.++...|.  .+..++.+++..|...|..
T Consensus       115 ~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C~~  186 (192)
T d1w8aa_         115 SCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             CEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCCCC
T ss_pred             cccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcCCC
Confidence            97778899999999999999999987654333222377778888888765453  3677788889988888854

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=5.5e-18  Score=154.61  Aligned_cols=140  Identities=21%  Similarity=0.201  Sum_probs=105.0

Q ss_pred             CCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccc
Q 041632            2 FENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHG   81 (452)
Q Consensus         2 ~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~   81 (452)
                      ++++|+ .+|+.+.  +++ ++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .++.+++|++|+|++|+++ 
T Consensus        18 ~~~~L~-~iP~~lp--~~l-~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-   90 (266)
T d1p9ag_          18 DKRNLT-ALPPDLP--KDT-TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-   90 (266)
T ss_dssp             TTSCCS-SCCSCCC--TTC-CEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-
T ss_pred             cCCCCC-eeCcCcC--cCC-CEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-
Confidence            678899 7898875  467 99999999999555578999999999999999998 565 4678999999999999999 


Q ss_pred             cCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcc-ccccccccccccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTK-GIFANTSAISVAGCH  148 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~  148 (452)
                      ..+..+..+++|+.|++++|.+.++++..+.... ++.|++++|.++.+++.. ..+++++.+++++|.
T Consensus        91 ~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~  159 (266)
T d1p9ag_          91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN  159 (266)
T ss_dssp             SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence            6677888888888888888777776655544433 555555555555554433 334455555555553

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.70  E-value=3.2e-17  Score=130.74  Aligned_cols=104  Identities=22%  Similarity=0.239  Sum_probs=82.9

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRN  101 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  101 (452)
                      ++|+|++|+|+ .+| .+..+++|++|++++|+|+ .+|+.++.+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            46888999988 666 4888888999999999888 67888888889999999999888 555 4888888999999999


Q ss_pred             cccCCcc-hhh-cccccceeeCcccCCCCCC
Q 041632          102 NLSGQIP-LFL-EALSLEYLNLSFNDFEGKV  130 (452)
Q Consensus       102 ~l~~~~~-~~~-~~~~L~~l~l~~N~l~~~~  130 (452)
                      +|+..+. ..+ .+..|+.|++++|+++..+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~  106 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  106 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence            8887653 333 3445888888888887654

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.69  E-value=1e-17  Score=156.56  Aligned_cols=131  Identities=27%  Similarity=0.449  Sum_probs=98.2

Q ss_pred             CCCcccc--cCCcccccccCcccEEEccC-CccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcc
Q 041632            2 FENDLSG--TIPEAIFSISYLSNSLNLAE-NHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNF   78 (452)
Q Consensus         2 ~~N~l~~--~~p~~~~~l~~l~~~L~l~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   78 (452)
                      ++|+++|  .+|+++++++.| ++|+|++ |+++|.+|.+|++|++|++|+|++|++.+..|..+..+.+|+.+++++|+
T Consensus        58 ~~~~l~g~~~lp~~l~~L~~L-~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~  136 (313)
T d1ogqa_          58 SGLNLPKPYPIPSSLANLPYL-NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             ECCCCSSCEECCGGGGGCTTC-SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCCCCCCCChHHhcCccc-cccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence            4566766  467788888887 7888875 77877788888888888888888888887777777788888888888888


Q ss_pred             ccccCchhhhcccCCCeeecccccccCCcchhhc-ccc-cceeeCcccCCCCCCCcc
Q 041632           79 FHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLE-ALS-LEYLNLSFNDFEGKVPTK  133 (452)
Q Consensus        79 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~-~~~-L~~l~l~~N~l~~~~~~~  133 (452)
                      +.+.+|..+..++.|+.+++++|.+.+..|..+. ... ++.+++++|++++.++..
T Consensus       137 ~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~  193 (313)
T d1ogqa_         137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT  193 (313)
T ss_dssp             EESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGG
T ss_pred             ccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccc
Confidence            7777788888888888888888888765554443 334 477788888877766543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.66  E-value=8.7e-17  Score=134.59  Aligned_cols=127  Identities=17%  Similarity=0.103  Sum_probs=105.2

Q ss_pred             ccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccC
Q 041632           13 AIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRG   92 (452)
Q Consensus        13 ~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~   92 (452)
                      .+.+...+ ++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .+..+++|++|++++|+|+...+..+..+++
T Consensus        13 ~~~n~~~l-r~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~   88 (162)
T d1a9na_          13 QYTNAVRD-RELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD   88 (162)
T ss_dssp             EEECTTSC-EEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hccCcCcC-cEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence            35677788 99999999999 77877788999999999999999 564 6999999999999999999655566788999


Q ss_pred             CCeeecccccccCCcc-hhhc-ccccceeeCcccCCCCCCC----cccccccccccc
Q 041632           93 IRKLDLSRNNLSGQIP-LFLE-ALSLEYLNLSFNDFEGKVP----TKGIFANTSAIS  143 (452)
Q Consensus        93 L~~l~l~~N~l~~~~~-~~~~-~~~L~~l~l~~N~l~~~~~----~~~~~~~l~~l~  143 (452)
                      |+.|++++|+|+.... ..+. +.+|++|++++|.++..+.    .+..+++|+.|+
T Consensus        89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            9999999999998654 3344 4459999999999987764    235567777665

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.65  E-value=3.1e-16  Score=124.91  Aligned_cols=100  Identities=19%  Similarity=0.349  Sum_probs=89.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+| .+.+++.| ++|+|++|+|+ .+|+.++.+++|+.|++++|+|+ .+| +++.+++|++|++++|+|+
T Consensus         5 Ls~n~l~-~l~-~l~~l~~L-~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~   78 (124)
T d1dcea3           5 LAHKDLT-VLC-HLEQLLLV-THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ   78 (124)
T ss_dssp             CTTSCCS-SCC-CGGGGTTC-CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC
T ss_pred             cCCCCCC-CCc-ccccCCCC-CEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccC
Confidence            6899999 766 58999999 99999999999 88999999999999999999999 566 5999999999999999999


Q ss_pred             ccCc--hhhhcccCCCeeecccccccCCc
Q 041632           81 GSIP--SFFRTSRGIRKLDLSRNNLSGQI  107 (452)
Q Consensus        81 ~~~p--~~~~~l~~L~~l~l~~N~l~~~~  107 (452)
                       .+|  ..+..+++|+.|++++|+++..+
T Consensus        79 -~~~~~~~l~~~~~L~~L~l~~N~i~~~~  106 (124)
T d1dcea3          79 -QSAAIQPLVSCPRLVLLNLQGNSLCQEE  106 (124)
T ss_dssp             -SSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             -CCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence             444  57899999999999999997653

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1.6e-16  Score=146.11  Aligned_cols=151  Identities=21%  Similarity=0.186  Sum_probs=127.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|++.+..+..+....+| +.+++++|+|++..+..|..+++|+.|++++|++++..|..|.++++|+.+++++|+++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L-~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~  190 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA  190 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             cCCcccccccccccchhccc-chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccc
Confidence            57788885556677778888 99999999999666678999999999999999999877889999999999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      +..|..|..+++|+.|++++|++.++++..+.... |++|++++|.+...-+.......++......+...|.
T Consensus       191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~  263 (284)
T d1ozna_         191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCS  263 (284)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEE
T ss_pred             ccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeC
Confidence            88899999999999999999999999998886555 9999999999986554333334556556666666664

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.63  E-value=1.1e-15  Score=141.99  Aligned_cols=147  Identities=21%  Similarity=0.196  Sum_probs=106.6

Q ss_pred             CCCCcccccCC-cccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCcc-----------------
Q 041632            1 MFENDLSGTIP-EAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIE-----------------   62 (452)
Q Consensus         1 l~~N~l~~~~p-~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-----------------   62 (452)
                      |++|+|+ .+| .+|.++++| ++|++++|.++...|.+|.++++|+.|++++|+++ .+|..                 
T Consensus        38 Ls~N~i~-~l~~~~f~~l~~L-~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~  114 (305)
T d1xkua_          38 LQNNKIT-EIKDGDFKNLKNL-HTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK  114 (305)
T ss_dssp             CCSSCCC-CBCTTTTTTCTTC-CEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCB
T ss_pred             CcCCcCC-CcChhHhhccccc-cccccccccccccchhhhhCCCccCEecccCCccC-cCccchhhhhhhhhccccchhh
Confidence            5778888 454 467788888 88888888888666778888888888888888776 34331                 


Q ss_pred             -------------------------------cc---------------------CCCCCCEEEccCccccccCchhhhcc
Q 041632           63 -------------------------------LG---------------------LCSSLEDIYLGGNFFHGSIPSFFRTS   90 (452)
Q Consensus        63 -------------------------------~~---------------------~l~~L~~L~l~~N~l~~~~p~~~~~l   90 (452)
                                                     +.                     .+++|+.|++++|.+++..+..|..+
T Consensus       115 l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~  194 (305)
T d1xkua_         115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGL  194 (305)
T ss_dssp             BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGGTTC
T ss_pred             hhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHhhcc
Confidence                                           11                     23445555555555555556667777


Q ss_pred             cCCCeeecccccccCCcchhhcccc-cceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           91 RGIRKLDLSRNNLSGQIPLFLEALS-LEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                      +.++.|++++|.++++++..+...+ |++|+|++|+|+.+|+.+..+++|+.|++++|...
T Consensus       195 ~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccC
Confidence            7788888888888887777666554 88888888888888777777888888888887643

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.60  E-value=3e-15  Score=129.86  Aligned_cols=138  Identities=21%  Similarity=0.307  Sum_probs=102.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .+ +++..+++| ++|+|++|+|+ .+++ ++++++|++|++++|.+. .+| .++++++|+.|++++|.+.
T Consensus        47 l~~~~i~-~l-~~l~~l~nL-~~L~Ls~N~l~-~~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~  119 (199)
T d2omxa2          47 ADRLGIK-SI-DGVEYLNNL-TQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQIT  119 (199)
T ss_dssp             CTTSCCC-CC-TTGGGCTTC-CEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCC
T ss_pred             CCCCCCC-Cc-cccccCCCc-CcCcccccccc-Cccc-ccCCcccccccccccccc-ccc-ccccccccccccccccccc
Confidence            4566776 44 357778888 88888888887 4443 788888888888888887 454 4778888888888888877


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                       .+ +.+..+++|+.|++++|++..+ +....+.+|++|++++|++++.++ ++.+++|+.|++++|+.
T Consensus       120 -~~-~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         120 -DI-DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKV  184 (199)
T ss_dssp             -CC-GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred             -cc-cccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccCCcc-ccCCCCCCEEECCCCCC
Confidence             33 3477788888888888888764 344455568888888888887654 56788888888888853

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.57  E-value=9.5e-15  Score=135.52  Aligned_cols=142  Identities=15%  Similarity=0.116  Sum_probs=122.4

Q ss_pred             cCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhh
Q 041632            9 TIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFR   88 (452)
Q Consensus         9 ~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~   88 (452)
                      ..+..+..++.| +++++++|+++ .+|..+  +++|+.|++++|.+++..+..|..++.++.|++++|++++..+..|.
T Consensus       141 ~~~~~~~~l~~L-~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~  216 (305)
T d1xkua_         141 IENGAFQGMKKL-SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA  216 (305)
T ss_dssp             BCTTGGGGCTTC-CEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGG
T ss_pred             CCcccccccccc-CccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccc
Confidence            445677788888 99999999998 777654  68999999999999989999999999999999999999988888999


Q ss_pred             cccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcc-------cccccccccccccccccCCCC
Q 041632           89 TSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTK-------GIFANTSAISVAGCHRLCGGI  154 (452)
Q Consensus        89 ~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~-------~~~~~l~~l~~~~n~~~c~~~  154 (452)
                      ++++|+.|+|++|+|+.+++.+..+..|++|+|++|+|+.++...       ....+|+.+++.+|||.+...
T Consensus       217 ~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~  289 (305)
T d1xkua_         217 NTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  289 (305)
T ss_dssp             GSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             ccccceeeecccccccccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence            999999999999999988766655666999999999999875432       345778899999999977543

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=1e-14  Score=120.96  Aligned_cols=109  Identities=18%  Similarity=0.111  Sum_probs=97.6

Q ss_pred             ccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCc-cccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCe
Q 041632           17 ISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNN-GLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRK   95 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   95 (452)
                      .... +.++.+++++. ..|..+..+++|+.|++++| .|+..-++.|.++++|+.|+|++|+|+...|.+|..+++|+.
T Consensus         7 c~~~-~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           7 PHGS-SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CSSS-SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             cCCC-CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            3445 67999999998 88999999999999999876 588655678999999999999999999777889999999999


Q ss_pred             eecccccccCCcchhhcccccceeeCcccCCC
Q 041632           96 LDLSRNNLSGQIPLFLEALSLEYLNLSFNDFE  127 (452)
Q Consensus        96 l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~  127 (452)
                      |+|++|+|+.+++..+...+|+.|+|++|.+.
T Consensus        85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred             eeccCCCCcccChhhhccccccccccCCCccc
Confidence            99999999999999998888999999999986

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.56  E-value=1.3e-14  Score=126.98  Aligned_cols=138  Identities=19%  Similarity=0.224  Sum_probs=99.2

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+++ .++ ++..+++| ++|+|++|+|+ .++ .++.+++|++|++++|+++ .+| .+..+++|+.|++++|.+.
T Consensus        53 l~~~~i~-~l~-~l~~l~~L-~~L~L~~n~i~-~l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~  125 (210)
T d1h6ta2          53 ANNSDIK-SVQ-GIQYLPNV-TKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS  125 (210)
T ss_dssp             CTTSCCC-CCT-TGGGCTTC-CEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC
T ss_pred             CcCCCCC-Cch-hHhhCCCC-CEEeCCCcccc-Ccc-ccccCcccccccccccccc-ccc-ccccccccccccccccccc
Confidence            3566666 333 46777787 78888888887 444 3677888888888888887 455 4777888888888888776


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                       .++ .+..++.|+.+++++|.+++.. ....+.+|+.+++++|+++++++ +..+++|+.|++++|..
T Consensus       126 -~~~-~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i  190 (210)
T d1h6ta2         126 -DIN-GLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI  190 (210)
T ss_dssp             -CCG-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred             -ccc-cccccccccccccccccccccc-ccccccccccccccccccccccc-ccCCCCCCEEECCCCCC
Confidence             443 5777788888888888877643 33344458888888888887654 56688888888888754

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.56  E-value=3.1e-15  Score=124.95  Aligned_cols=116  Identities=12%  Similarity=0.160  Sum_probs=96.4

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+|..+..+++| +.|+|++|+|+ .++ .|..+++|++|++++|+++...+..+..+++|+.|++++|+|+
T Consensus        25 L~~n~I~-~i~~~~~~l~~L-~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~  100 (162)
T d1a9na_          25 LRGYKIP-VIENLGATLDQF-DAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV  100 (162)
T ss_dssp             CTTSCCC-SCCCGGGGTTCC-SEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC
T ss_pred             CCCCCCC-ccCccccccccC-CEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc
Confidence            6889999 778777789999 99999999999 665 5999999999999999999544444678999999999999998


Q ss_pred             ccCc--hhhhcccCCCeeecccccccCCcc---hhhc-ccccceeeC
Q 041632           81 GSIP--SFFRTSRGIRKLDLSRNNLSGQIP---LFLE-ALSLEYLNL  121 (452)
Q Consensus        81 ~~~p--~~~~~l~~L~~l~l~~N~l~~~~~---~~~~-~~~L~~l~l  121 (452)
                       .++  ..+..+++|+.|++++|.++..+.   ..+. +.+|++||-
T Consensus       101 -~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_         101 -ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             -CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             -ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence             555  468899999999999999987663   2333 345988873

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.55  E-value=1.1e-14  Score=127.36  Aligned_cols=135  Identities=26%  Similarity=0.367  Sum_probs=113.9

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++ ++ .+..+++| ++|++++|+|+ .+| .+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.++
T Consensus        75 L~~n~i~~-l~-~~~~l~~L-~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~  147 (210)
T d1h6ta2          75 LNGNKLTD-IK-PLANLKNL-GWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT  147 (210)
T ss_dssp             CCSSCCCC-CG-GGTTCTTC-CEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCC
T ss_pred             CCCccccC-cc-ccccCccc-ccccccccccc-ccc-ccccccccccccccccccc-cc-cccccccccccccccccccc
Confidence            57899994 55 47889999 99999999998 666 6899999999999999987 44 46889999999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAG  146 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~  146 (452)
                       .+ ..+..+++|+.+++++|+++++++ ...+.+|+.|+|++|+|+.++ .+..+++|+.|++++
T Consensus       148 -~~-~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         148 -DI-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -CC-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEE
T ss_pred             -cc-cccccccccccccccccccccccc-ccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEccC
Confidence             33 357889999999999999998654 444556999999999999764 577789999998864

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.54  E-value=2.2e-14  Score=124.29  Aligned_cols=131  Identities=21%  Similarity=0.312  Sum_probs=109.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|++ +++ +.++++| ++|++++|.+. .+| .+.++++|+.|++++|.+.. + +.+..+++|+.|++++|++.
T Consensus        69 Ls~N~l~~-~~~-l~~l~~L-~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~  141 (199)
T d2omxa2          69 FSNNQLTD-ITP-LKNLTKL-VDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS  141 (199)
T ss_dssp             CCSSCCCC-CGG-GTTCTTC-CEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred             cccccccC-ccc-ccCCccc-ccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhHHhhhhhhhhc
Confidence            67899994 443 8899999 99999999998 666 48999999999999999873 3 45889999999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAI  142 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l  142 (452)
                       .++ .+..+++|+.|++++|+++++++ ...+.+|++|++++|+++.++ .++.+++|+.|
T Consensus       142 -~~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~i~~i~-~l~~L~~L~~L  199 (199)
T d2omxa2         142 -DIS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNKVSDIS-VLAKLTNLESL  199 (199)
T ss_dssp             -CCG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG-GGGGCTTCSEE
T ss_pred             -ccc-cccccccccccccccccccCCcc-ccCCCCCCEEECCCCCCCCCc-cccCCCCCCcC
Confidence             555 58899999999999999998654 445556999999999999764 45567766643

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=1.6e-14  Score=119.76  Aligned_cols=112  Identities=17%  Similarity=0.165  Sum_probs=98.6

Q ss_pred             cCCCCCCEEEccCccccccCCccccCCCCCCEEEccCc-cccccCchhhhcccCCCeeecccccccCCcchhhcccc-cc
Q 041632           40 GNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGN-FFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALS-LE  117 (452)
Q Consensus        40 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~-L~  117 (452)
                      ......+.++.+++++. ..|..+..+++|++|++++| .|+...+++|.++++|+.|+|++|+|+.+++..|..++ |+
T Consensus         5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence            44556678999999998 78999999999999999876 59966677899999999999999999999998887766 99


Q ss_pred             eeeCcccCCCCCCCcccccccccccccccccccCC
Q 041632          118 YLNLSFNDFEGKVPTKGIFANTSAISVAGCHRLCG  152 (452)
Q Consensus       118 ~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~c~  152 (452)
                      +|+|++|+|+.+++......+++.|++++|||.|.
T Consensus        84 ~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          84 RLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (156)
T ss_dssp             EEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             ceeccCCCCcccChhhhccccccccccCCCcccCC
Confidence            99999999999998775566899999999999984

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.50  E-value=1.5e-16  Score=137.82  Aligned_cols=113  Identities=21%  Similarity=0.242  Sum_probs=60.7

Q ss_pred             CcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcc
Q 041632           11 PEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTS   90 (452)
Q Consensus        11 p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l   90 (452)
                      |.++..+++| +.|+|++|+|+ .++ .+..|++|+.|+|++|+|+ .+|..+..+++|++|++++|+|+ .++ .+..+
T Consensus        41 ~~sl~~L~~L-~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l  114 (198)
T d1m9la_          41 DATLSTLKAC-KHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKL  114 (198)
T ss_dssp             HHHHHHTTTC-CEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHH
T ss_pred             hhHHhccccc-ceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccc
Confidence            3445555565 56666666665 443 3555666666666666665 45544444455666666666665 332 35555


Q ss_pred             cCCCeeecccccccCCcc-hhhccc-ccceeeCcccCCCCC
Q 041632           91 RGIRKLDLSRNNLSGQIP-LFLEAL-SLEYLNLSFNDFEGK  129 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~-~~~~~~-~L~~l~l~~N~l~~~  129 (452)
                      ++|+.|++++|+|+.+.. ..+..+ +|+.|+|++|.++..
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccccC
Confidence            666666666666655432 222222 366666666655433

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.49  E-value=4.4e-14  Score=134.98  Aligned_cols=126  Identities=22%  Similarity=0.269  Sum_probs=70.0

Q ss_pred             ccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccC-------------
Q 041632           17 ISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSI-------------   83 (452)
Q Consensus        17 l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-------------   83 (452)
                      ..+| +.|++++|+++ .+| .+..+++|+.|++++|++++ ++ .++.+++|+.|++++|++++..             
T Consensus       218 ~~~L-~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~-~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~  292 (384)
T d2omza2         218 LTNL-DELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISN-LA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLEL  292 (384)
T ss_dssp             CTTC-CEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEEC
T ss_pred             cCCC-CEEECCCCCCC-Ccc-hhhcccccchhccccCccCC-CC-cccccccCCEeeccCcccCCCCccccccccccccc
Confidence            3444 44555555544 222 34444455555555554442 21 1444444444444444443211             


Q ss_pred             -------chhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCcccccccccccccccccc
Q 041632           84 -------PSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        84 -------p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~  149 (452)
                             ...+..+++++.|++++|+++++++ +-.+.+|+.|++++|+|++++ .++.+++|+.|++++|+.
T Consensus       293 ~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l  363 (384)
T d2omza2         293 NENQLEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQI  363 (384)
T ss_dssp             CSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCC
T ss_pred             cccccccccccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcC
Confidence                   1235666777888888888877653 333444888888888877643 466677788888877753

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.48  E-value=1e-13  Score=122.60  Aligned_cols=140  Identities=18%  Similarity=0.273  Sum_probs=108.6

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      +++|+|+ .+ +++..+++| ++|+|++|++++ ++ .+..+++|+.+++++|.++ .++ .+..+++|+.+++++|...
T Consensus        48 l~~~~i~-~l-~~l~~l~~L-~~L~ls~n~i~~-~~-~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~  120 (227)
T d1h6ua2          48 AFGTGVT-TI-EGVQYLNNL-IGLELKDNQITD-LA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT  120 (227)
T ss_dssp             CTTSCCC-CC-TTGGGCTTC-CEEECCSSCCCC-CG-GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCC
T ss_pred             CCCCCCC-cc-hhHhcCCCC-cEeecCCceeec-cc-ccccccccccccccccccc-ccc-ccccccccccccccccccc
Confidence            4678888 56 468889998 899999999984 33 3888899999999998887 454 5778888888888888765


Q ss_pred             ccCc--------------------hhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccc
Q 041632           81 GSIP--------------------SFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTS  140 (452)
Q Consensus        81 ~~~p--------------------~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~  140 (452)
                      +..+                    ..+..+++|+.|++++|.+....+ +..+.+|+.|+|++|+++++++ +..+++|+
T Consensus       121 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~  198 (227)
T d1h6ua2         121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP-LASLPNLI  198 (227)
T ss_dssp             CCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCC
T ss_pred             ccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchh-hcccccceecccCCCccCCChh-hcCCCCCC
Confidence            3211                    235667889999999999987554 4445569999999999997654 67789999


Q ss_pred             ccccccccc
Q 041632          141 AISVAGCHR  149 (452)
Q Consensus       141 ~l~~~~n~~  149 (452)
                      .|++++|+.
T Consensus       199 ~L~Ls~N~l  207 (227)
T d1h6ua2         199 EVHLKNNQI  207 (227)
T ss_dssp             EEECTTSCC
T ss_pred             EEECcCCcC
Confidence            999999863

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=3.8e-15  Score=128.81  Aligned_cols=124  Identities=18%  Similarity=0.214  Sum_probs=103.4

Q ss_pred             cEEEccCC--ccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeecc
Q 041632           22 NSLNLAEN--HFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLS   99 (452)
Q Consensus        22 ~~L~l~~n--~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~   99 (452)
                      +.+++..+  .++ .+|.+++.|++|++|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|+++
T Consensus        26 ~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~  101 (198)
T d1m9la_          26 EKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWIS  101 (198)
T ss_dssp             SCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECS
T ss_pred             ceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccc
Confidence            45666554  455 66778999999999999999999 565 6999999999999999999 778777777899999999


Q ss_pred             cccccCCcchhhcccccceeeCcccCCCCCCC--ccccccccccccccccccc
Q 041632          100 RNNLSGQIPLFLEALSLEYLNLSFNDFEGKVP--TKGIFANTSAISVAGCHRL  150 (452)
Q Consensus       100 ~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~--~~~~~~~l~~l~~~~n~~~  150 (452)
                      +|+++.+ +....+.+|+.|++++|+|+..+.  .+..+++|+.|++++||..
T Consensus       102 ~N~i~~l-~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         102 YNQIASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             EEECCCH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccc-ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            9999975 445555669999999999987653  4577899999999999753

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.36  E-value=1.7e-12  Score=123.74  Aligned_cols=138  Identities=17%  Similarity=0.250  Sum_probs=91.5

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCC--------------------
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP--------------------   60 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p--------------------   60 (452)
                      +++|+++ .+ +.+..++++ +.|++++|++++ ++ .++.+++|+.|++++|++++..|                    
T Consensus       226 l~~n~l~-~~-~~l~~l~~L-~~L~l~~n~l~~-~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~  300 (384)
T d2omza2         226 LNGNQLK-DI-GTLASLTNL-TDLDLANNQISN-LA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI  300 (384)
T ss_dssp             CCSSCCC-CC-GGGGGCTTC-SEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCC
T ss_pred             CCCCCCC-Cc-chhhccccc-chhccccCccCC-CC-cccccccCCEeeccCcccCCCCccccccccccccccccccccc
Confidence            3456666 33 356677777 778888887773 33 36777777877777777663211                    


Q ss_pred             ccccCCCCCCEEEccCccccccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccc
Q 041632           61 IELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTS  140 (452)
Q Consensus        61 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~  140 (452)
                      ..+..+++++.|++++|+|++ ++ .+..+++|+.|++++|+|++++ .+..+.+|++|++++|+|++++| +..+++|+
T Consensus       301 ~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~  376 (384)
T d2omza2         301 SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQISDLTP-LANLTRIT  376 (384)
T ss_dssp             GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCS
T ss_pred             cccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCC
Confidence            234556777777777777774 33 2677777888888888777643 33344447888888888777665 55677777


Q ss_pred             ccccccc
Q 041632          141 AISVAGC  147 (452)
Q Consensus       141 ~l~~~~n  147 (452)
                      .|++++|
T Consensus       377 ~L~L~~N  383 (384)
T d2omza2         377 QLGLNDQ  383 (384)
T ss_dssp             EEECCCE
T ss_pred             EeeCCCC
Confidence            7777766

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.35  E-value=1.7e-12  Score=114.53  Aligned_cols=139  Identities=14%  Similarity=0.251  Sum_probs=111.0

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      ++.+++++.+  .+..+.+| +.|++.+|+|+ .++ .+..|++|+.|++++|++++..  .+..+++|+.+++++|.++
T Consensus        26 l~~~~~~d~~--~~~~l~~L-~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~~   98 (227)
T d1h6ua2          26 AGKSNVTDTV--TQADLDGI-TTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPLK   98 (227)
T ss_dssp             TTCSSTTSEE--CHHHHHTC-CEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCCS
T ss_pred             hCCCCcCCcC--CHHHcCCc-CEEECCCCCCC-cch-hHhcCCCCcEeecCCceeeccc--ccccccccccccccccccc
Confidence            3456666543  45678899 99999999999 665 6999999999999999998543  3899999999999999998


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcc---------------------hhhcccccceeeCcccCCCCCCCcccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIP---------------------LFLEALSLEYLNLSFNDFEGKVPTKGIFANT  139 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~---------------------~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l  139 (452)
                       .++ .+..+++|+.+++++|...+..+                     .......|+.|++++|.++..++ ++.+++|
T Consensus        99 -~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L  175 (227)
T d1h6ua2          99 -NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKL  175 (227)
T ss_dssp             -CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTC
T ss_pred             -ccc-cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccchh-hcccccc
Confidence             555 57889999999999887765432                     12223348999999999986544 6779999


Q ss_pred             cccccccccc
Q 041632          140 SAISVAGCHR  149 (452)
Q Consensus       140 ~~l~~~~n~~  149 (452)
                      +.|++++|..
T Consensus       176 ~~L~Ls~n~l  185 (227)
T d1h6ua2         176 TTLKADDNKI  185 (227)
T ss_dssp             CEEECCSSCC
T ss_pred             eecccCCCcc
Confidence            9999999854

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.31  E-value=1.7e-12  Score=115.76  Aligned_cols=95  Identities=15%  Similarity=0.152  Sum_probs=42.5

Q ss_pred             CcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCC-ccccCCCCCCEEEcc-Cccccc
Q 041632            4 NDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIP-IELGLCSSLEDIYLG-GNFFHG   81 (452)
Q Consensus         4 N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~-~N~l~~   81 (452)
                      ++++ .+|+.+.  .++ ++|+|++|+|+...+.+|.++++|++|++++|.+...+| ..|..+++++++++. .|++..
T Consensus        18 ~~l~-~iP~~l~--~~l-~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~   93 (242)
T d1xwdc1          18 SKVT-EIPSDLP--RNA-IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY   93 (242)
T ss_dssp             CSCS-SCCSCSC--SCC-SEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE
T ss_pred             CCCC-CcCCCCC--CCC-CEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccc
Confidence            3444 5555443  244 556666666652223345556666666666655543222 233344444444432 233332


Q ss_pred             cCchhhhcccCCCeeeccccc
Q 041632           82 SIPSFFRTSRGIRKLDLSRNN  102 (452)
Q Consensus        82 ~~p~~~~~l~~L~~l~l~~N~  102 (452)
                      ..+..|..+++|+.|++++|.
T Consensus        94 ~~~~~~~~l~~L~~l~l~~~~  114 (242)
T d1xwdc1          94 INPEAFQNLPNLQYLLISNTG  114 (242)
T ss_dssp             ECTTSEECCTTCCEEEEESCC
T ss_pred             cccccccccccccccccchhh
Confidence            333333344444444444333

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.11  E-value=1.2e-10  Score=103.42  Aligned_cols=148  Identities=15%  Similarity=0.095  Sum_probs=103.6

Q ss_pred             CCCCcccccCCc-ccccccCcccEEEcc-CCccccCCCcCCcCCCCCCEEEccCccccccCCc--cccCCCCCCEEEccC
Q 041632            1 MFENDLSGTIPE-AIFSISYLSNSLNLA-ENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPI--ELGLCSSLEDIYLGG   76 (452)
Q Consensus         1 l~~N~l~~~~p~-~~~~l~~l~~~L~l~-~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~   76 (452)
                      |++|.+...+|. .|..++.+ ++|++. .|++....+..|.++++|+.|++++|++.. .+.  .+..+..|..+..++
T Consensus        60 ls~n~~~~~i~~~~f~~l~~l-~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~-~~~~~~~~~l~~l~~~~~~n  137 (242)
T d1xwdc1          60 ISQNDVLEVIEADVFSNLPKL-HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDN  137 (242)
T ss_dssp             EESCTTCCEECSSSEESCTTC-CEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCS-CCCCTTTCBSSCEEEEEESC
T ss_pred             hccccccceeecccccccccc-ccccccccccccccccccccccccccccccchhhhcc-cccccccccccccccccccc
Confidence            357777755544 56678888 777765 577876777788999999999999998873 332  233456666666677


Q ss_pred             ccccccCchhhhccc-CCCeeecccccccCCcchhhccccc-ceeeCcccCCCCCCCcc-ccccccccccccccccc
Q 041632           77 NFFHGSIPSFFRTSR-GIRKLDLSRNNLSGQIPLFLEALSL-EYLNLSFNDFEGKVPTK-GIFANTSAISVAGCHRL  150 (452)
Q Consensus        77 N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~~~~~~~~~L-~~l~l~~N~l~~~~~~~-~~~~~l~~l~~~~n~~~  150 (452)
                      +.+....+..|..++ .++.|++++|+++.+++..+....+ +.+++++|+++.+++.. ..+++|+.|++++|+..
T Consensus       138 ~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~  214 (242)
T d1xwdc1         138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  214 (242)
T ss_dssp             TTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred             cccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC
Confidence            777755556666654 6777888888888777777776664 44456777787776653 55778888888877653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.96  E-value=2.5e-09  Score=99.83  Aligned_cols=101  Identities=20%  Similarity=0.232  Sum_probs=75.7

Q ss_pred             CcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCccccccCchhhhcccCCCeeec
Q 041632           19 YLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGSIPSFFRTSRGIRKLDL   98 (452)
Q Consensus        19 ~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l   98 (452)
                      ++ ++|+|++|.|+ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|+.|++++|+++ .+++.   .+.|+.|++
T Consensus        39 ~l-~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          39 QA-HELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             TC-SEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             CC-CEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            56 78899999988 78853   467888999999998 778654   57888888888888 55531   145888999


Q ss_pred             ccccccCCcchhhcccccceeeCcccCCCCCCCcc
Q 041632           99 SRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTK  133 (452)
Q Consensus        99 ~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~  133 (452)
                      ++|.+..++. ...+..|+.|++++|.++..+...
T Consensus       106 ~~n~l~~lp~-~~~l~~L~~L~l~~~~~~~~~~~~  139 (353)
T d1jl5a_         106 SNNQLEKLPE-LQNSSFLKIIDVDNNSLKKLPDLP  139 (353)
T ss_dssp             CSSCCSSCCC-CTTCTTCCEEECCSSCCSCCCCCC
T ss_pred             cccccccccc-hhhhccceeecccccccccccccc
Confidence            9998887654 334445889999888888766544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.91  E-value=2.5e-09  Score=99.79  Aligned_cols=131  Identities=25%  Similarity=0.292  Sum_probs=100.3

Q ss_pred             CCCCcccccCCcccccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccc
Q 041632            1 MFENDLSGTIPEAIFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFH   80 (452)
Q Consensus         1 l~~N~l~~~~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~   80 (452)
                      |++|+|+ .+|+.   +++| ++|+|++|+|+ .+|..+   .+|+.|++++|+++ .+++ +  .+.|++|++++|.++
T Consensus        45 Ls~~~L~-~lp~~---~~~L-~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~  111 (353)
T d1jl5a_          45 LNNLGLS-SLPEL---PPHL-ESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE  111 (353)
T ss_dssp             CTTSCCS-CCCSC---CTTC-SEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS
T ss_pred             eCCCCCC-CCCCC---CCCC-CEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccccccc
Confidence            6789998 78864   4577 89999999999 888654   57999999999998 5653 2  256999999999999


Q ss_pred             ccCchhhhcccCCCeeecccccccCCcchhhcccccceeeCcccCCCCCCCccccccccccccccccccc
Q 041632           81 GSIPSFFRTSRGIRKLDLSRNNLSGQIPLFLEALSLEYLNLSFNDFEGKVPTKGIFANTSAISVAGCHRL  150 (452)
Q Consensus        81 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~l~~l~~~~n~~~  150 (452)
                       .+|. +..+++|+.|++++|.+...+...   ..+..+.+.++.... ......++.++.+.+.+|...
T Consensus       112 -~lp~-~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~~-~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         112 -KLPE-LQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             -SCCC-CTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCS
T ss_pred             -cccc-hhhhccceeecccccccccccccc---ccccchhhccccccc-cccccccccceeccccccccc
Confidence             6774 678999999999999998765432   236777777776653 234455777788888777543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.79  E-value=1.5e-10  Score=96.04  Aligned_cols=117  Identities=18%  Similarity=0.173  Sum_probs=86.2

Q ss_pred             cEEEccCCccccCCCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCcccccc--CchhhhcccCCCeeecc
Q 041632           22 NSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGNFFHGS--IPSFFRTSRGIRKLDLS   99 (452)
Q Consensus        22 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~l~l~   99 (452)
                      +.|+++++...   + .+..+..+..++..+|... .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+|+
T Consensus        25 ~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls   99 (162)
T d1koha1          25 QALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS   99 (162)
T ss_dssp             CCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCT
T ss_pred             CeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccc
Confidence            56777665532   3 4566666777777777665 5666667899999999999999943  24567889999999999


Q ss_pred             cccccCCcch-hhcccccceeeCcccCCCCCCCc--------ccccccccccc
Q 041632          100 RNNLSGQIPL-FLEALSLEYLNLSFNDFEGKVPT--------KGIFANTSAIS  143 (452)
Q Consensus       100 ~N~l~~~~~~-~~~~~~L~~l~l~~N~l~~~~~~--------~~~~~~l~~l~  143 (452)
                      +|+|+.+.+. .....+|+.|++++|.++.....        ...|++|+.|+
T Consensus       100 ~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             TSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            9999987663 34445699999999999876542        13467777654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.66  E-value=3.1e-09  Score=96.47  Aligned_cols=133  Identities=21%  Similarity=0.234  Sum_probs=61.6

Q ss_pred             cccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCc-ccccc-CCccccCCCCCCEEEccCc-cccc-cCchhhhc-c
Q 041632           16 SISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNN-GLSGE-IPIELGLCSSLEDIYLGGN-FFHG-SIPSFFRT-S   90 (452)
Q Consensus        16 ~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~-~~p~~~~~-l   90 (452)
                      .+++| ++|+|+++.+++..+..++.+++|++|+++++ .++.. +..-...+++|++|+++++ .++. .+...+.. +
T Consensus        69 ~c~~L-~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~  147 (284)
T d2astb2          69 QCSKL-QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVS  147 (284)
T ss_dssp             TBCCC-SEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSC
T ss_pred             hCCCc-ccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccc
Confidence            34444 44444444444444444444444555555442 33211 1111233444555555442 2221 11111222 2


Q ss_pred             cCCCeeecccc--cccCC-cchhhc-ccccceeeCcccC-CCC-CCCcccccccccccccccccc
Q 041632           91 RGIRKLDLSRN--NLSGQ-IPLFLE-ALSLEYLNLSFND-FEG-KVPTKGIFANTSAISVAGCHR  149 (452)
Q Consensus        91 ~~L~~l~l~~N--~l~~~-~~~~~~-~~~L~~l~l~~N~-l~~-~~~~~~~~~~l~~l~~~~n~~  149 (452)
                      ++|+.|++++.  .++.. ...... +..|++|++++|. ++. .+..+..+++|+.|++++|+.
T Consensus       148 ~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~  212 (284)
T d2astb2         148 ETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD  212 (284)
T ss_dssp             TTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred             cccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCC
Confidence            44555555432  22211 112222 3459999998864 553 334557788899999987654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.57  E-value=5.8e-09  Score=94.63  Aligned_cols=134  Identities=16%  Similarity=0.187  Sum_probs=85.3

Q ss_pred             ccccCcccEEEccCCccccC-CCcCCcCCCCCCEEEccCccccccCCccccCCCCCCEEEccCc-ccccc-Cchhhhccc
Q 041632           15 FSISYLSNSLNLAENHFVGS-IPPRIGNLKALRSFDVSNNGLSGEIPIELGLCSSLEDIYLGGN-FFHGS-IPSFFRTSR   91 (452)
Q Consensus        15 ~~l~~l~~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~   91 (452)
                      ....+| ++|+|+++.+++. ++..+..+++|++|+|+++.+++..+..++.+++|+.|+|+++ .++.. +..-+..++
T Consensus        43 ~~~~~L-~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~  121 (284)
T d2astb2          43 FSPFRV-QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  121 (284)
T ss_dssp             CCCBCC-CEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             ccCCCC-CEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence            345567 8888888887633 3445677888888888888887777777888888888888874 56522 233345678


Q ss_pred             CCCeeecccc-cccCC-c-chhhccc-ccceeeCcccC--CCCC-CC-cccccccccccccccccc
Q 041632           92 GIRKLDLSRN-NLSGQ-I-PLFLEAL-SLEYLNLSFND--FEGK-VP-TKGIFANTSAISVAGCHR  149 (452)
Q Consensus        92 ~L~~l~l~~N-~l~~~-~-~~~~~~~-~L~~l~l~~N~--l~~~-~~-~~~~~~~l~~l~~~~n~~  149 (452)
                      +|+.|+++++ .++.. . ....... .|+.|+++++.  ++.. .. -...+++|+.|++++|+.
T Consensus       122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~  187 (284)
T d2astb2         122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM  187 (284)
T ss_dssp             TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTT
T ss_pred             hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccC
Confidence            8888888874 44431 1 1222222 48888887642  3211 11 113457788888877654

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=1.7e-09  Score=89.46  Aligned_cols=108  Identities=20%  Similarity=0.128  Sum_probs=75.2

Q ss_pred             cccccCcccEEEccCCccccCCCcCCcCCCCCCEEEccCcccccc--CCccccCCCCCCEEEccCccccccCch-hhhcc
Q 041632           14 IFSISYLSNSLNLAENHFVGSIPPRIGNLKALRSFDVSNNGLSGE--IPIELGLCSSLEDIYLGGNFFHGSIPS-FFRTS   90 (452)
Q Consensus        14 ~~~l~~l~~~L~l~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l   90 (452)
                      +..+..+ ..|++.+|... .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+|+ .+++ .+...
T Consensus        38 l~~~~~~-~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~  114 (162)
T d1koha1          38 LVAQNID-VVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKG  114 (162)
T ss_dssp             TTTTTCC-CCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTT
T ss_pred             hhhccch-hhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhc
Confidence            3333333 44555555554 5565567899999999999999843  2345778999999999999999 4444 44455


Q ss_pred             cCCCeeecccccccCCcch-------hhccc-ccceeeCcccCC
Q 041632           91 RGIRKLDLSRNNLSGQIPL-------FLEAL-SLEYLNLSFNDF  126 (452)
Q Consensus        91 ~~L~~l~l~~N~l~~~~~~-------~~~~~-~L~~l~l~~N~l  126 (452)
                      ..|+.|++++|.+......       ++... +|+.||  ++.+
T Consensus       115 ~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             CCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred             cccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence            6799999999999875432       23344 488775  4444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.52  E-value=9.7e-09  Score=95.83  Aligned_cols=133  Identities=19%  Similarity=0.251  Sum_probs=90.8

Q ss_pred             cccCcccEEEccCCccccC----CCcCCcCCCCCCEEEccCcccccc-----CCccccCCCCCCEEEccCcccccc----
Q 041632           16 SISYLSNSLNLAENHFVGS----IPPRIGNLKALRSFDVSNNGLSGE-----IPIELGLCSSLEDIYLGGNFFHGS----   82 (452)
Q Consensus        16 ~l~~l~~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----   82 (452)
                      ....+ +.|++++|+++..    +...+...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    
T Consensus       156 ~~~~L-~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~  234 (344)
T d2ca6a1         156 NAPPL-RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA  234 (344)
T ss_dssp             TCCCC-CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHH
T ss_pred             cCccc-ceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccc
Confidence            34566 7888888888632    233456678899999999887632     445577788899999999987632    


Q ss_pred             CchhhhcccCCCeeecccccccCCcch----hh---cccccceeeCcccCCCCC-----CCcc-cccccccccccccccc
Q 041632           83 IPSFFRTSRGIRKLDLSRNNLSGQIPL----FL---EALSLEYLNLSFNDFEGK-----VPTK-GIFANTSAISVAGCHR  149 (452)
Q Consensus        83 ~p~~~~~l~~L~~l~l~~N~l~~~~~~----~~---~~~~L~~l~l~~N~l~~~-----~~~~-~~~~~l~~l~~~~n~~  149 (452)
                      +...+..+++|+.|+|++|.|++.-..    .+   ....|++|++++|+|+..     ...+ ..+++|+.|++++|..
T Consensus       235 L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~  314 (344)
T d2ca6a1         235 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF  314 (344)
T ss_dssp             HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred             ccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcC
Confidence            445667788899999999988764221    11   123488999999987531     1111 2356788888888865

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=3.3e-07  Score=81.55  Aligned_cols=146  Identities=15%  Similarity=0.102  Sum_probs=90.3

Q ss_pred             HhhcCCCCCCceeccCceeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCC-CCCceeEeeeeccccCCCCc
Q 041632          228 KATDGFSSTNLIGVGSFGSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIR-HKNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       228 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~-h~niv~l~~~~~~~~~~~~~  306 (452)
                      .....|...+..+.++.+.||+...  +++.+++|+...........+.+|...+..+. +--+.+++.++     ..++
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~   83 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDG   83 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETT
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCC
Confidence            3344555544444444578998764  56677889886554444456778888776652 22234455442     2335


Q ss_pred             eeEEEEeccCCCChhhhhcCCCCCCcccccccccCCHHHHHHHHHHHHHHHHHHhcCC----------------------
Q 041632          307 FKAIVYKYMPNGSLEKWLHPDAIPQRDREIEIQKLTLLQRISIAIDVASALDYLHQHC----------------------  364 (452)
Q Consensus       307 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------  364 (452)
                      ..++||+++++.++.+......                ....++.+++..++.||+..                      
T Consensus        84 ~~~lv~~~l~G~~~~~~~~~~~----------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T d1j7la_          84 WSNLLMSEADGVLCSEEYEDEQ----------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEEEECCSSEEHHHHTTTCS----------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             ceEEEEEecccccccccccccc----------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHH
Confidence            6789999999888765432111                11223344444444444311                      


Q ss_pred             ----------------------------------CCCeEecccCCCCeeecCCCceEECccccccc
Q 041632          365 ----------------------------------QEPILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       365 ----------------------------------~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                                                        ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                              12479999999999999877777999998864

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.48  E-value=7.8e-09  Score=96.52  Aligned_cols=147  Identities=16%  Similarity=0.111  Sum_probs=88.4

Q ss_pred             CCCCccccc----CCcccccccCcccEEEccCCccc----cCCCc---------CCcCCCCCCEEEccCccccc----cC
Q 041632            1 MFENDLSGT----IPEAIFSISYLSNSLNLAENHFV----GSIPP---------RIGNLKALRSFDVSNNGLSG----EI   59 (452)
Q Consensus         1 l~~N~l~~~----~p~~~~~l~~l~~~L~l~~n~l~----~~~p~---------~~~~l~~L~~L~l~~N~l~~----~~   59 (452)
                      |++|.++..    +.+.+...++| +.|++++|.++    ..+..         .....+.|+.|++++|.++.    .+
T Consensus       100 L~~n~i~~~~~~~l~~~l~~~~~L-~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l  178 (344)
T d2ca6a1         100 LSDNAFGPTAQEPLIDFLSKHTPL-EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW  178 (344)
T ss_dssp             CCSCCCCTTTHHHHHHHHHHCTTC-CEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHH
T ss_pred             ccccccccccccchhhhhcccccc-hheecccccccccccccccccccccccccccccCcccceeecccccccccccccc
Confidence            455666532    33445567777 88888888751    01111         12356678888888887752    23


Q ss_pred             CccccCCCCCCEEEccCcccccc-----CchhhhcccCCCeeecccccccCC----cch-hhcccccceeeCcccCCCCC
Q 041632           60 PIELGLCSSLEDIYLGGNFFHGS-----IPSFFRTSRGIRKLDLSRNNLSGQ----IPL-FLEALSLEYLNLSFNDFEGK  129 (452)
Q Consensus        60 p~~~~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~l~l~~N~l~~~----~~~-~~~~~~L~~l~l~~N~l~~~  129 (452)
                      ...+..+++|+.|+|++|+|+..     +...+..+++|+.|+|++|.++..    +.. ...+..|++|+|++|.|+..
T Consensus       179 ~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~  258 (344)
T d2ca6a1         179 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR  258 (344)
T ss_dssp             HHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred             cchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCch
Confidence            33455677888888888887631     233456677888888888887542    112 22333488888888887542


Q ss_pred             CC-cc------ccccccccccccccc
Q 041632          130 VP-TK------GIFANTSAISVAGCH  148 (452)
Q Consensus       130 ~~-~~------~~~~~l~~l~~~~n~  148 (452)
                      -. .+      .....++.|++++|.
T Consensus       259 g~~~l~~~l~~~~~~~L~~L~ls~N~  284 (344)
T d2ca6a1         259 GAAAVVDAFSKLENIGLQTLRLQYNE  284 (344)
T ss_dssp             HHHHHHHHHHTCSSCCCCEEECCSSC
T ss_pred             hhHHHHHHhhhccCCCCCEEECCCCc
Confidence            11 01      123567778888775

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.42  E-value=1.3e-08  Score=98.30  Aligned_cols=108  Identities=21%  Similarity=0.205  Sum_probs=71.4

Q ss_pred             CcccEEEccCCccccC-CCcCCcCCCCCCEEEccCccccc----cCCccccCCCCCCEEEccCccccccCchhhh-----
Q 041632           19 YLSNSLNLAENHFVGS-IPPRIGNLKALRSFDVSNNGLSG----EIPIELGLCSSLEDIYLGGNFFHGSIPSFFR-----   88 (452)
Q Consensus        19 ~l~~~L~l~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-----   88 (452)
                      +| +.|||++|++++. +.+-+..+++|+.|+|++|+++.    .++..+..+++|++|||++|+|+..--..+.     
T Consensus         3 ~l-~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           3 DI-QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EE-EEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CC-CEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            45 7888888888742 13345667888888888888763    3455567788888888888887622111222     


Q ss_pred             cccCCCeeecccccccCCc----chhhc-ccccceeeCcccCCC
Q 041632           89 TSRGIRKLDLSRNNLSGQI----PLFLE-ALSLEYLNLSFNDFE  127 (452)
Q Consensus        89 ~l~~L~~l~l~~N~l~~~~----~~~~~-~~~L~~l~l~~N~l~  127 (452)
                      ...+|+.|+|++|++++..    +..+. +..|++|++++|.+.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            1246888888888886532    22233 334888888888875

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.19  E-value=1.4e-07  Score=90.79  Aligned_cols=148  Identities=16%  Similarity=0.057  Sum_probs=94.5

Q ss_pred             CCCccccc----CCcccccccCcccEEEccCCccccCCCcCC-----cCCCCCCEEEccCccccccCC----ccccCCCC
Q 041632            2 FENDLSGT----IPEAIFSISYLSNSLNLAENHFVGSIPPRI-----GNLKALRSFDVSNNGLSGEIP----IELGLCSS   68 (452)
Q Consensus         2 ~~N~l~~~----~p~~~~~l~~l~~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~   68 (452)
                      ++|.+...    ....+...+.+ +.+++++|.++......+     .....|+.+++++|.++....    ..+..+++
T Consensus       263 ~~n~i~~~~~~~~~~~l~~~~~l-~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~  341 (460)
T d1z7xw1         263 WECGITAKGCGDLCRVLRAKESL-KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF  341 (460)
T ss_dssp             TTSCCCHHHHHHHHHHHHHCTTC-CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSS
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccc
Confidence            45555432    22334566777 889999999863222211     234689999999998875432    23455678


Q ss_pred             CCEEEccCcccccc----Cchhhh-cccCCCeeecccccccCCc----ch-hhcccccceeeCcccCCCCCCC-----cc
Q 041632           69 LEDIYLGGNFFHGS----IPSFFR-TSRGIRKLDLSRNNLSGQI----PL-FLEALSLEYLNLSFNDFEGKVP-----TK  133 (452)
Q Consensus        69 L~~L~l~~N~l~~~----~p~~~~-~l~~L~~l~l~~N~l~~~~----~~-~~~~~~L~~l~l~~N~l~~~~~-----~~  133 (452)
                      |++|+|++|+|++.    ++..+. ..+.|+.|+|++|+|+..-    .. ...+.+|++|+|++|+|+..-.     .+
T Consensus       342 L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l  421 (460)
T d1z7xw1         342 LLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV  421 (460)
T ss_dssp             CCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHH
T ss_pred             hhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHH
Confidence            99999999998743    333443 3567999999999997531    22 2234559999999999863111     01


Q ss_pred             -ccccccccccccccccc
Q 041632          134 -GIFANTSAISVAGCHRL  150 (452)
Q Consensus       134 -~~~~~l~~l~~~~n~~~  150 (452)
                       ...+.|+.+++.+|.+.
T Consensus       422 ~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         422 RQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             TSTTCCCCEEECTTCCCC
T ss_pred             HhCCCccCEEECCCCCCC
Confidence             12236788888877663

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.90  E-value=2.1e-06  Score=70.56  Aligned_cols=88  Identities=15%  Similarity=0.166  Sum_probs=53.0

Q ss_pred             ccCcccEEEccCC-ccccC----CCcCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEEccCcccccc----C
Q 041632           17 ISYLSNSLNLAEN-HFVGS----IPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSSLEDIYLGGNFFHGS----I   83 (452)
Q Consensus        17 l~~l~~~L~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~   83 (452)
                      .+.| ++|+|+++ .++..    +-.++...+.|+.|+|++|.+...    +.+.+...++|+.|+|++|.|+..    +
T Consensus        14 ~~~L-~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          14 DTDL-KEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             CSSC-CEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCC-cEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            3566 77888763 45421    223455667777888877777632    223344567777777777777632    1


Q ss_pred             chhhhcccCCCeeecccccccC
Q 041632           84 PSFFRTSRGIRKLDLSRNNLSG  105 (452)
Q Consensus        84 p~~~~~l~~L~~l~l~~N~l~~  105 (452)
                      -.++...++|+.|+|++|.+..
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCC
T ss_pred             HHHHHhCCcCCEEECCCCcCCC
Confidence            2244455667777777776554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.77  E-value=3.7e-05  Score=67.32  Aligned_cols=76  Identities=13%  Similarity=0.105  Sum_probs=46.8

Q ss_pred             ceeccCc-eeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC--ceeEeeeeccccCCCCceeEEEEec
Q 041632          238 LIGVGSF-GSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN--LVRVITSCSSVDFQGNDFKAIVYKY  314 (452)
Q Consensus       238 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n--iv~l~~~~~~~~~~~~~~~~lv~e~  314 (452)
                      .+..|.. +.||+.... ++..+++|.-...   ....+..|++.++.+....  +.+++.++.     +++..++||++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~   87 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGE   87 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEEC
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEe
Confidence            3444543 678988764 5666888876433   2234667777776663222  455555432     33567899999


Q ss_pred             cCCCChhh
Q 041632          315 MPNGSLEK  322 (452)
Q Consensus       315 ~~~gsL~~  322 (452)
                      ++|.++..
T Consensus        88 i~G~~~~~   95 (255)
T d1nd4a_          88 VPGQDLLS   95 (255)
T ss_dssp             CSSEETTT
T ss_pred             eecccccc
Confidence            98776643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.63  E-value=8.4e-05  Score=69.62  Aligned_cols=76  Identities=20%  Similarity=0.126  Sum_probs=46.1

Q ss_pred             CceeccCceeEEEEEEcCCCcEEEEEEeecc----C---CccHHHHHHHHHHHhcC-CC--CCceeEeeeeccccCCCCc
Q 041632          237 NLIGVGSFGSVYKGVFDEDGTVVAIKVINLQ----R---QGASKSFMAECKALKNI-RH--KNLVRVITSCSSVDFQGND  306 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~ei~~l~~l-~h--~niv~l~~~~~~~~~~~~~  306 (452)
                      +.||.|....||+.....+++.++||.-...    .   +....+...|.+.++.+ .+  ..+.+++.+.       .+
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------TE  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------TT
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------CC
Confidence            4689999999999987766788999965321    1   11223455677777665 22  3355565542       22


Q ss_pred             eeEEEEeccCCCC
Q 041632          307 FKAIVYKYMPNGS  319 (452)
Q Consensus       307 ~~~lv~e~~~~gs  319 (452)
                      ..++|||++++..
T Consensus       105 ~~~lvmE~L~~~~  117 (392)
T d2pula1         105 MAVTVMEDLSHLK  117 (392)
T ss_dssp             TTEEEECCCTTSE
T ss_pred             CCEEEEeccCCcc
Confidence            3478999997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.53  E-value=3.4e-05  Score=63.06  Aligned_cols=90  Identities=17%  Similarity=0.144  Sum_probs=65.2

Q ss_pred             cCCCCCCEEEccCc-ccccc----CCccccCCCCCCEEEccCcccccc----CchhhhcccCCCeeecccccccCCcc--
Q 041632           40 GNLKALRSFDVSNN-GLSGE----IPIELGLCSSLEDIYLGGNFFHGS----IPSFFRTSRGIRKLDLSRNNLSGQIP--  108 (452)
Q Consensus        40 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~--  108 (452)
                      .+.+.|+.|+|+++ .++..    +-..+...++|+.|+|++|.+...    +...+...+.|+.|+|++|.|+..-.  
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999974 46532    444577889999999999998732    33456667899999999999976321  


Q ss_pred             ---hhhcccccceeeCcccCCCCC
Q 041632          109 ---LFLEALSLEYLNLSFNDFEGK  129 (452)
Q Consensus       109 ---~~~~~~~L~~l~l~~N~l~~~  129 (452)
                         ......+|++|++++|++..+
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~~  115 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSVL  115 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCCc
Confidence               122233499999999987643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.32  E-value=1.4e-05  Score=65.47  Aligned_cols=110  Identities=14%  Similarity=0.221  Sum_probs=65.4

Q ss_pred             ccccCcccEEEccC-CccccC----CCcCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEEccCcccccc---
Q 041632           15 FSISYLSNSLNLAE-NHFVGS----IPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSSLEDIYLGGNFFHGS---   82 (452)
Q Consensus        15 ~~l~~l~~~L~l~~-n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~---   82 (452)
                      .+.+.| ++|+|++ +.|+..    +-.++...++|+.|+|++|.++..    +.+.+...++|+.+++++|.++..   
T Consensus        14 ~~~~~L-~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          14 NNDPDL-EEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             TTCTTC-CEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             hcCCCC-cEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            345677 7888886 456421    233455777888888888877643    333455677888888888877632   


Q ss_pred             -CchhhhcccCCCeeec--ccccccCC----cch-hhcccccceeeCcccC
Q 041632           83 -IPSFFRTSRGIRKLDL--SRNNLSGQ----IPL-FLEALSLEYLNLSFND  125 (452)
Q Consensus        83 -~p~~~~~l~~L~~l~l--~~N~l~~~----~~~-~~~~~~L~~l~l~~N~  125 (452)
                       +-..+...++|+.++|  ++|.+...    +.. .-.+.+|+.|+++.+.
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence             2245556677776444  45666431    111 2233347777776554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.90  E-value=0.002  Score=58.25  Aligned_cols=148  Identities=13%  Similarity=0.089  Sum_probs=77.1

Q ss_pred             eeEEEEEEcCCCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCCc--eeEeeeeccccCCCCceeEEEEeccCCCChhh
Q 041632          245 GSVYKGVFDEDGTVVAIKVINLQRQGASKSFMAECKALKNIRHKNL--VRVITSCSSVDFQGNDFKAIVYKYMPNGSLEK  322 (452)
Q Consensus       245 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~ni--v~l~~~~~~~~~~~~~~~~lv~e~~~~gsL~~  322 (452)
                      -.||+.+.. +|+.+++|+.+... ...+++..|.+.+..+....+  +..+.......+...+..+.++++++|..+..
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            479998874 78889999976432 234677888888777642222  22222211122233456788999987644321


Q ss_pred             ------------------hhcCCCCCCcccc-------------cccccCCHHH---HHHHHHHHHHHHHHH-hcCCCCC
Q 041632          323 ------------------WLHPDAIPQRDRE-------------IEIQKLTLLQ---RISIAIDVASALDYL-HQHCQEP  367 (452)
Q Consensus       323 ------------------~l~~~~~~~~~~~-------------~~~~~l~~~~---~~~i~~~i~~~l~~L-H~~~~~~  367 (452)
                                        .........+...             .....++...   ....+.++...+.-. .+....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                              0011111111000             0001111111   122222333322222 1223457


Q ss_pred             eEecccCCCCeeecCCCceEECccccccc
Q 041632          368 ILHCDLKPSNILLDNDLSAHIGDFGLSRF  396 (452)
Q Consensus       368 ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  396 (452)
                      ++|+|+.+.|||++++  ..++||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            8999999999999754  45899998763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.51  E-value=0.0048  Score=57.22  Aligned_cols=73  Identities=15%  Similarity=0.195  Sum_probs=46.8

Q ss_pred             CceeccCceeEEEEEEcC-------CCcEEEEEEeeccCCccHHHHHHHHHHHhcCCCCC-ceeEeeeeccccCCCCcee
Q 041632          237 NLIGVGSFGSVYKGVFDE-------DGTVVAIKVINLQRQGASKSFMAECKALKNIRHKN-LVRVITSCSSVDFQGNDFK  308 (452)
Q Consensus       237 ~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~ei~~l~~l~h~n-iv~l~~~~~~~~~~~~~~~  308 (452)
                      +.|+.|-.=.+|+.....       ..+.|.+++.. .. ....+..+|.++++.+.-.+ ..++++++.         -
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------~  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS---------G  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET---------T
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------C
Confidence            567778888999988752       23567777664 22 23345668888888774233 346666532         1


Q ss_pred             EEEEeccCCCCh
Q 041632          309 AIVYKYMPNGSL  320 (452)
Q Consensus       309 ~lv~e~~~~gsL  320 (452)
                      .+|+||+++..+
T Consensus       117 g~I~efi~g~~l  128 (395)
T d1nw1a_         117 GRLEEYIPSRPL  128 (395)
T ss_dssp             EEEECCCCEEEC
T ss_pred             ceEEEEeccccC
Confidence            678999987554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.05  E-value=0.00051  Score=55.62  Aligned_cols=91  Identities=14%  Similarity=0.217  Sum_probs=68.0

Q ss_pred             ccccccCcccEEEccCCccccC----CCcCCcCCCCCCEEEccCcccccc----CCccccCCCCCCEEEc--cCccccc-
Q 041632           13 AIFSISYLSNSLNLAENHFVGS----IPPRIGNLKALRSFDVSNNGLSGE----IPIELGLCSSLEDIYL--GGNFFHG-   81 (452)
Q Consensus        13 ~~~~l~~l~~~L~l~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l--~~N~l~~-   81 (452)
                      .+...+.| ++|+|++|.++..    +-..+...+.|+.|++++|.++..    +...+...++|+.++|  ++|.+.. 
T Consensus        41 al~~n~~L-~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~  119 (166)
T d1io0a_          41 ALKTNTYV-KKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN  119 (166)
T ss_dssp             HHTTCCSC-CEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred             HHhcCCcc-CeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHH
Confidence            34467788 9999999999643    233456789999999999998642    4456788899997666  5677753 


Q ss_pred             ---cCchhhhcccCCCeeeccccccc
Q 041632           82 ---SIPSFFRTSRGIRKLDLSRNNLS  104 (452)
Q Consensus        82 ---~~p~~~~~l~~L~~l~l~~N~l~  104 (452)
                         .+...+...++|+.|+++.|...
T Consensus       120 ~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_         120 VEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence               34556778899999999877654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.63  E-value=0.037  Score=49.09  Aligned_cols=31  Identities=23%  Similarity=0.324  Sum_probs=28.0

Q ss_pred             CCCeEecccCCCCeeecCCCceEECcccccc
Q 041632          365 QEPILHCDLKPSNILLDNDLSAHIGDFGLSR  395 (452)
Q Consensus       365 ~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  395 (452)
                      ..++||+|+.++||+++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4589999999999999998777899999876